id	type	name	description	target	belongs_to	pc	ts_pc	PC3	VCAP	A375	A549	HA1E	HCC515	HT29	MCF7	HEPG2	summary
BRD-A09094913	CP	strychnine	acetylcholine receptor antagonist	GLRA1, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, CHRNA10, CHRNA9, GLRA2, GLRA3, GLRB		0.00, 0.00	0.85, 0.19	8.00	-33.61	-14.63	-52.40	-24.90	35.95	57.93	-26.76	-52.20	-13.48
BRD-A55393291	CP	testosterone	androgen receptor (AR) agonist, androgen receptor agonist, testosterone receptor agonist	AR, CYP19A1, CYP2C19, CYP2C8, CYP3A5	Androgen receptor modulator	10.00, 10.00	0.84, 0.31	-17.02	-98.06	65.14	99.56	38.83	94.18	32.69	-34.68	18.15	29.75
BRD-A93255169	CP	thalidomide	angiogenesis inhibitor, cereblon inhibitor, tumor necrosis factor production inhibitor, tumor necrosis factor receptor antagonist, tumor necrosis factor receptor inhibitor	TNF, CRBN, CYP1A2, CYP2B6, CYP2C19, CYP3A5, FGFR2, NFKB1, ORM1, ORM2, PTGS2		20.00, 0.00	1.03, 0.41	57.13	29.11	56.31	20.61	95.90	-65.81	95.39	70.98	39.67	59.14
BRD-K41731458	CP	triclosan	DNA methyltransferase inhibitor, enoyl-(acyl-carrier protein) reductase Fabl inhibitor, enoyl-[acyl-carrier-protein] reductase [NADH] inhibitor	DNMT1		0.00, 0.00	1.36, 0.30	-39.88	-90.78	-90.49	-41.03	40.79	-98.99	-32.17	-74.16	-98.52	-86.66
BRD-K63675182	CP	triflupromazine	acetylcholine receptor ligand, dopamine receptor	HTR2B, CHRM1, CHRM2, CHRNA7, DRD1, DRD2	Dopamine receptor antagonist	0.00, 0.00	1.53, 0.61	-98.63	-24.87	40.32	-94.28	-82.05	-42.06	-45.38	-96.16	20.52	-87.76
BRD-A19195498	CP	trimipramine	adrenergic transmitter uptake inhibitor, dopamine receptor, norepinephrine transporter inhibitor, serotonin transporter (SERT) inhibitor, serotonin uptake inhibitor, tricyclic antidepressant, tricyclic antidepressant (TCA)	SLC6A2, SLC6A4, SLC6A3, ADRA1A, ADRA1B, ADRA2A, ADRA2B, ADRB1, ADRB2, ADRB3, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD5, HRH1, HTR1A, HTR1D, HTR2A, HTR2C, HTR3A	Norepinephrine reuptake inhibitor, Tricyclic antidepressant	10.00, 0.00	1.33, 0.50	96.72	-96.64	-14.57	-9.94	61.40	-67.26	16.08	-31.74	-93.44	-27.61
BRD-K99621550	CP	tubocurarine	acetylcholine receptor antagonist	CHRNA2, HTR3A, ACHE, HTR3B, KCNN1, KCNN2, KCNN3, ZACN		10.00, 0.00	0.68, 0.24	89.77	86.46	49.90	-92.61	97.35	18.52	-24.58	-45.32	10.39	71.39
BRD-A51714012	CP	venlafaxine	serotonin reuptake inhibitor, adrenergic transmitter uptake inhibitor, norepinephrine reuptake inhibitor, norepinephrine reputake inhibitor, serotonin uptake inhibitor	SLC6A2, SLC6A4, CYP2C19, SLC6A3		10.00, 10.00	0.63, 0.15	32.10	98.31	52.55	-37.42	-85.21	17.75	-82.85	26.45	-37.39	16.69
BRD-K45117373	CP	Y-26763	potassium channel activator, potassium channel agonist	ABCC9, KCNJ8	Potassium channel activator	0.00, 0.00	0.83, 0.22	-28.73	-30.61	-13.58	84.96	-66.13	60.28	12.84	-39.94	-31.71	-10.25
BRD-K42095107	CP	daidzein	estrogen receptor agonist	ESRRA, ESRRB, ESRRG, TRPC5	Estrogen receptor agonist	0.00, 0.00	1.38, 0.39	80.10	-16.02	-32.45	-41.93	92.67	-42.40	-32.95	30.07	NaN	-6.24
BRD-K61269089	CP	daphnetin	protein kinase inhibitor			0.00, 0.00	1.07, 0.32	-78.60	93.79	-30.13	82.23	50.96	-77.77	-47.09	-99.93	NaN	-78.06
BRD-A47494775	CP	dipivefrine	adrenergic receptor agonist	ADRA1A, ACHE, ADRA2A, ADRB2, BCHE		0.00, 0.00	0.67, 0.17	65.93	-95.08	8.70	-68.07	-49.61	-35.77	-88.00	11.18	NaN	-20.62
BRD-A18620900	CP	estriol	estrogen receptor agonist, estrogen receptor antagonist	ESR1, ESR2	Estrogen receptor agonist	11.11, 0.00	1.24, 0.34	44.41	-14.22	97.25	48.20	-52.65	-73.58	-17.61	14.11	NaN	13.44
BRD-A02367930	CP	ethinyl-estradiol	DNA directed DNA polymerase stimunlant, estrogen receptor agonist, estrogenic component in oral contraceptives	CYP2C8, ESR1, ESR2, NR1I2	Estrogen receptor agonist	11.11, 0.00	1.19, 0.38	23.05	-45.80	72.81	-33.05	96.09	36.12	-78.35	52.35	NaN	21.33
BRD-A61392169	CP	eliprodil	glutamate receptor antagonist	GRIN1, GRIN2B		0.00, 0.00	0.95, 0.35	-42.85	26.58	26.48	-39.90	-81.89	-68.06	-50.56	72.53	NaN	-32.52
BRD-A30205217	CP	ethotoin	anticonvulsant	SCN5A		11.11, 0.00	1.16, 0.38	61.01	44.87	96.99	-32.39	93.30	34.02	33.43	-90.82	NaN	62.78
BRD-A09925278	CP	etilefrine	adrenergic receptor agonist	ADRA1A, ADRB1		44.44, 44.44	0.82, 0.22	-55.53	98.29	99.63	98.08	46.22	-32.24	12.73	75.42	NaN	97.85
BRD-A18419789	CP	etoposide	topoisomerase inhibitor, cell cycle inhibitor, DNA inhibitor, DNA intercalating drug, DNA repair enzyme inhibitor	TOP2A, CYP2E1, CYP3A5, TOP2B		0.00, 0.00	2.66, 0.72	-99.98	-99.43	-99.08	-99.66	-99.82	-99.76	-99.87	-99.96	NaN	-99.61
BRD-K61951118	CP	FG-7142	GABA benzodiazepine site receptor inverse agonist			11.11, 11.11	0.82, 0.26	26.70	10.63	88.54	-37.11	99.26	-71.62	-17.94	15.50	NaN	10.36
BRD-A13133631	CP	fluorometholone	corticosteroid agonist, glucocorticoid receptor agonist	NR3C1	Glucocorticoid receptor agonist	0.00, 0.00	1.45, 0.72	21.18	-94.85	-69.92	-97.52	-63.53	-96.48	93.10	83.03	NaN	-94.79
BRD-K11129031	CP	gemfibrozil	lipase clearing factor inhibitor, lipoprotein lipase activator, PPAR receptor agonist	PPARA, CYP2C8, LPL, SLCO1B1, SLCO1B3, SLCO2B1		11.11, 11.11	0.83, 0.24	42.71	-71.53	-26.05	77.14	99.88	9.56	-71.01	70.55	NaN	56.52
BRD-K26117720	CP	gingerol	nitric oxide synthase inhibitor			11.11, 11.11	0.75, 0.14	87.98	17.56	97.86	46.60	-63.23	50.73	-12.99	-75.06	NaN	7.03
BRD-A73859745	CP	glycodeoxycholic-acid	apoptosis activator			0.00, 0.00	0.91, 0.24	90.92	75.96	37.74	42.48	13.43	94.75	-8.21	-50.10	NaN	71.57
BRD-A09539288	CP	homatropine	acetylcholine receptor antagonist	CES1, CHRM1		0.00, 0.00	1.42, 0.52	-62.85	-53.37	-86.74	-42.56	-7.69	-38.22	17.85	15.59	NaN	-37.26
BRD-A78303415	CP	hyoscyamine	acetylcholine receptor inhibitor	CHRM1, CHRM2, CHRM3, CHRM4		0.00, 0.00	1.51, 0.40	14.15	-31.82	62.38	22.18	-92.90	46.04	49.95	45.47	NaN	9.68
BRD-A63998256	CP	helveticoside	ATPase inhibitor	ATP1A1	ATPase inhibitor	0.00, 0.00	2.44, 0.81	25.46	-45.79	34.48	-79.86	91.14	-57.13	-79.66	90.42	NaN	-59.60
BRD-A47065382	CP	huperzine-a	acetylcholinesterase inhibitor, glutamate receptor antagonist	ACHE		11.11, 11.11	1.06, 0.24	35.94	99.66	9.43	30.44	-50.63	81.98	-60.41	-34.15	NaN	7.27
BRD-A98299281	CP	velnacrine	calcium channel activator	ACHE		0.00, 0.00	0.89, 0.18	17.82	-41.93	-33.20	78.16	-89.81	-72.96	-83.37	18.27	NaN	-40.67
BRD-A37776212	CP	ICI-204448	opioid receptor agonist	OPRK1		11.11, 11.11	0.93, 0.23	83.09	20.96	39.69	14.75	99.98	76.82	-36.02	-3.64	NaN	37.89
BRD-K38436528	CP	imipramine	norepinephrine reputake inhibitor, serotonin reuptake inhibitor, Sodium Channel  Blockers	SLC6A2, SLC6A4, CHRM2, ADRA1A, ADRA1B, ADRA1D, CHRM1, CHRM3, CHRM4, CHRM5, CYP2C19, DRD1, DRD2, DRD5, HRH1, HTR1A, HTR2A, HTR2C, HTR6, HTR7, KCND2, KCND3, KCNH1, KCNH2, SLC6A3	Norepinephrine reuptake inhibitor	0.00, 0.00	0.58, 0.05	14.25	47.25	-23.87	58.65	-92.95	-66.27	-33.68	-47.14	NaN	-14.53
BRD-A95869247	CP	indapamide	carbonic anhydrase inhibitor, thiazide diuretic	KCNQ1, CA7, KCNE1, SLC12A3	Na-K-Cl transporter inhibitor	22.22, 11.11	1.00, 0.23	73.02	-19.55	-31.26	99.59	76.94	96.96	-28.79	82.48	NaN	65.15
BRD-K86509404	CP	iso-olomoucine	cyclin-related kinase inhibitor			0.00, 0.00	1.30, 0.28	33.40	-9.92	11.06	15.61	-66.41	94.59	-98.06	47.39	NaN	10.51
BRD-A52326238	CP	isogedunin	HSP inhibitor			0.00, 0.00	1.13, 0.20	27.92	-49.97	31.10	-39.66	65.64	-32.87	-10.01	-59.59	NaN	-12.28
BRD-A16700644	CP	isoxsuprine	adrenergic receptor agonist	ADRB2	Beta-adrenergic receptor agonist	11.11, 11.11	0.77, 0.20	75.37	61.73	-15.45	23.80	45.99	99.20	-99.76	-5.11	NaN	46.57
BRD-K13211965	CP	L-741742	dopamine receptor antagonist	DRD4, DRD3, SCN1A, SCN3A		0.00, 0.00	1.61, 0.43	39.87	-94.41	81.59	-36.59	-67.50	32.39	-89.40	-25.37	NaN	-35.40
BRD-A68039575	CP	liquiritigenin	aromatase inhibitor	CYP19A1		11.11, 11.11	1.30, 0.45	75.23	-75.50	64.66	97.91	-64.27	43.01	-67.25	-27.76	NaN	-45.52
BRD-K88789588	CP	letrozole	aromatase inhibitor, estrogen receptor antagonist	CYP19A1		0.00, 0.00	0.50, 0.11	78.66	-28.96	-26.17	60.59	-53.72	-29.08	-31.79	-30.68	NaN	-12.15
BRD-A50764878	CP	MDL-73005EF	serotonin receptor antagonist, serotonin receptor partial agonist	HTR1A		11.11, 11.11	0.63, 0.07	20.79	10.34	74.69	99.32	49.17	-74.65	-62.19	-16.39	NaN	12.64
BRD-K02867583	CP	minaprine	serotonin uptake inhibitor	HTR2B, SLC6A4, ACHE, CHRM1, DRD1, DRD2, HTR2A, HTR2C, MAOA		0.00, 0.00	1.11, 0.28	50.72	35.34	-20.80	94.59	-37.29	-69.27	-11.71	-31.28	NaN	-16.71
BRD-A30435184	CP	metergoline	dopamine receptor agonist, serotonin receptor antagonist, prolactin inhibitor	DRD2, HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR5A, HTR6, HTR7	Serotonin receptor antagonist	0.00, 0.00	1.90, 0.58	-12.93	-97.26	-44.82	-80.34	-38.77	78.17	-85.90	-96.12	NaN	-93.11
BRD-A45543382	CP	metrizamide	iodine contrast agent			11.11, 11.11	0.84, 0.24	81.63	71.63	17.28	99.98	-71.32	-67.50	17.26	58.58	NaN	60.02
BRD-A65280694	CP	molindone	dopamine receptor antagonist	DRD2, HTR2A, CHRM1, DRD5, HRH1, HTR1A		11.11, 0.00	1.01, 0.30	28.15	90.99	-47.50	95.15	48.03	-17.21	54.49	56.74	NaN	63.03
BRD-K21548250	CP	moracizine	sodium channel blocker	SCN5A		0.00, 0.00	1.08, 0.42	75.13	-7.13	12.40	76.96	-41.50	-37.03	-88.74	-39.15	NaN	-16.51
BRD-K62056274	CP	quipazine	serotonin receptor agonist	HTR2A, HTR3A, HTR3B, HTR1A, HTR1D, HTR2B, HTR2C, HTR6, SLC6A4		11.11, 11.11	1.32, 0.41	99.94	78.90	37.36	-18.80	-21.64	43.55	-20.50	79.62	NaN	49.39
BRD-K41143549	CP	BRD-K41143549	glutamate receptor antagonist			0.00, 0.00	1.34, 0.43	80.07	39.73	90.91	33.14	80.07	38.31	60.43	15.24	NaN	76.09
BRD-K26979635	CP	NS-3694	glutamate receptor antagonist	GRIK1		0.00, 0.00	1.36, 0.32	81.37	11.62	-31.78	-12.32	86.99	70.35	78.52	-65.29	NaN	74.47
BRD-A80213327	CP	NSC-23766	RAC1 GTPase inhibitor			0.00, 0.00	0.67, 0.17	23.32	-94.74	-16.07	-40.75	-36.62	90.88	47.32	-15.66	57.29	16.04
BRD-K88172511	CP	naltrexone	opioid receptor antagonist, opioid receptor ligand	OPRK1, OPRM1, OPRD1, SIGMAR1		20.00, 10.00	0.51, 0.15	96.90	-25.94	55.11	97.74	-43.83	-12.87	-23.45	91.55	80.24	86.34
BRD-A19736161	CP	ondansetron	serotonin receptor antagonist	HTR3A, CYP2D6, CYP3A5, HTR1A, HTR1B, HTR3B, HTR4, OPRM1		0.00, 0.00	0.45, 0.02	75.83	-31.34	-32.78	85.58	67.53	-41.06	-54.29	-31.25	-47.53	-13.40
BRD-K50841342	CP	PAC-1	caspase activator	CASP3		0.00, 0.00	2.34, 0.56	-38.44	-40.71	-99.25	-99.67	-95.58	-58.24	-87.82	-98.83	NaN	-96.58
BRD-A70407468	CP	PSB-36	adenosine receptor antagonist	ADORA1, ADORA2A, ADORA2B, ADORA3		0.00, 0.00	1.01, 0.23	52.95	-44.99	20.42	28.59	-91.56	-44.49	-78.00	-21.08	NaN	-26.42
BRD-A59303141	CP	quinethazone	diuretic	CA1, CA2, SLC12A1, SLC12A2, SLC12A3	Na-K-Cl transporter inhibitor	11.11, 0.00	1.09, 0.31	96.63	-45.87	83.94	-50.76	-20.14	-45.71	-13.34	-16.55	NaN	-12.08
BRD-K86600316	CP	RS-79948	adrenoreceptor antagonist			0.00, 0.00	0.88, 0.23	61.51	33.39	32.54	42.89	-43.13	-29.68	-70.89	-17.81	NaN	6.25
BRD-A92585442	CP	RU-28318	cytochrome P450 antagonist	NR3C2		11.11, 11.11	0.86, 0.19	-45.30	94.42	5.26	-19.39	45.74	98.10	-80.55	26.14	NaN	15.28
BRD-A65739223	CP	ramipril	angiotensin converting enzyme inhibitor	ACE		0.00, 0.00	1.52, 0.49	83.97	53.16	-22.62	-23.42	22.21	-50.68	39.46	79.67	NaN	52.05
BRD-K27141178	CP	SB-203186	serotonin receptor antagonist	HTR4		0.00, 0.00	1.80, 0.59	-49.02	-81.05	-78.41	25.21	-87.14	90.18	-34.93	-31.91	NaN	-53.69
BRD-K55748775	CP	SCH-28080	ATPase inhibitor, potassium-competitive acid antagonist	ATP4A		0.00, 0.00	0.70, 0.25	-27.17	-28.41	20.59	27.16	-50.82	-39.86	80.49	-41.17	NaN	-15.85
BRD-A91992993	CP	siguazodan	histamine receptor antagonist, phosphodiesterase inhibitor	PDE3A		44.44, 44.44	1.13, 0.35	87.32	98.91	99.93	99.83	-31.31	-98.70	41.76	-24.59	NaN	98.98
BRD-K46211610	CP	tolazoline	adrenergic receptor antagonist	ADRA2A, ADRA2B, ADRA2C, ADRA1A, HRH1, HRH2		11.11, 0.00	0.48, 0.09	78.78	73.04	96.78	-55.91	90.43	49.46	52.41	36.21	NaN	75.16
BRD-A30717181	CP	triamcinolone	antiinflammatory agent, corticosteroid agonist, corticosteroid binding globulin binder, corticosteroid hormone receptor agonist, cytochrome P450 inhibitor, glucocorticoid receptor agonist, immunosuppressant, immunosuppressive agent	NR3C1, CYP3A5, CYP3A7, SERPINA6		0.00, 0.00	1.36, 0.57	-31.95	-20.63	-61.23	-98.54	-70.59	-92.97	-87.76	11.90	NaN	-90.33
BRD-K11742128	CP	triprolidine	histamine receptor antagonist	HRH1		11.11, 11.11	1.49, 0.60	93.97	-37.17	-90.18	35.68	16.38	-97.74	-84.75	99.00	NaN	-56.90
BRD-A79672927	CP	tropicamide	acetylcholine receptor antagonist, anticholinergic	CHRM3, CHRM4, CHRM1, CHRM2		0.00, 0.00	1.06, 0.39	-73.63	29.52	84.71	-36.47	-89.79	-78.15	23.64	26.41	NaN	-31.88
BRD-K48427617	CP	U-0124	MEK inhibitor			22.22, 11.11	1.41, 0.60	96.97	-54.68	19.22	93.76	42.61	66.68	-80.28	99.84	NaN	88.43
BRD-K47207162	CP	zimelidine	serotonin uptake inhibitor	SLC6A4, MAOA, MAOB		11.11, 11.11	0.98, 0.25	41.47	-38.52	20.72	-73.14	-99.05	98.23	87.34	14.53	NaN	17.06
BRD-A47513740	CP	calyculin	protein phosphatase inhibitor	PPP1CA, PPP1CC, PPP2CA		0.00, 0.00	2.60, 0.66	-92.16	-98.91	-21.31	-52.29	32.75	-98.95	-49.73	-35.66	NaN	-96.19
BRD-K56231354	CP	triprolidine	histamine receptor antagonist	HRH1		44.44, 44.44	1.32, 0.41	27.07	-42.46	-48.43	99.96	98.80	97.85	-65.72	88.42	NaN	99.54
BRD-K89732114	CP	trifluoperazine	breast cancer resistance protein inhibitor, calcium/calmodulin dependent protein kinase inhibitor, dopamine receptor, dopamine receptor antagonist, sodium channel blocker	DRD2, ABCG2, ADRA1A, CALM1, CALY, CAMK2A, DRD4, HRH1, HTR2A, HTR2C, S100A4, SCN4A, SCN9A, TNNC1	Dopamine receptor antagonist	0.00, 0.00	1.24, 0.32	-34.79	-97.96	-78.35	-52.72	-28.37	31.30	-99.01	-17.23	-42.58	-53.64
BRD-A18763547	CP	BAX-channel-blocker	cytochrome C release inhibitor	BAX		0.00, 0.00	2.48, 0.57	35.77	-61.78	-91.95	-88.77	-85.26	84.29	-91.71	-22.06	-99.33	-94.94
BRD-A83255679	CP	BRD-A83255679	estrogen receptor antagonist	GPER1		10.00, 10.00	0.50, 0.09	-39.72	57.98	86.02	78.81	98.47	90.14	87.23	-67.38	47.39	82.62
BRD-K00317371	CP	RITA	MDM inhibitor, thioredoxin reductase inhibitor	MDM2, TXNRD1, TXNRD2	MDM inhibitor	10.00, 10.00	0.65, 0.14	18.61	60.52	15.21	-92.51	48.13	99.60	-56.58	-97.82	36.15	28.53
BRD-K06593056	CP	LE-135	retinoid receptor agonist	RARB		0.00, 0.00	0.53, 0.05	84.21	-79.88	-97.57	-99.66	-96.93	-39.50	-61.81	-98.67	-41.61	-96.02
BRD-K12184916	CP	NVP-BEZ235	mTOR inhibitor, PI3K inhibitor, protein kinase inhibitor	MTOR, PIK3CA, PIK3CG, PIK3CD, ATR, PIK3CB	MTOR inhibitor, PI3K inhibitor	0.00, 0.00	2.02, 0.53	-96.16	-99.72	-99.72	-99.96	-99.81	-79.25	-99.06	-87.92	-79.30	-99.15
BRD-K15563106	CP	phloretin	VCAM expression inhibitor, ICAM1 expression inhibitor	AQP9, CLCN3, SLC23A1		0.00, 0.00	0.17, 0.02	-98.64	-99.85	-99.03	-11.85	-97.89	-97.93	-97.83	85.15	-99.51	-98.98
BRD-K19295594	CP	gossypol	BCL inhibitor, MCL1 inhibitor, 11-beta hydroxysteroid dehydrogenase inhibitor, growth factor receptor modulator, lipid peroxidase inhibitor	BCL2, BCL2L1, MCL1, BCL2L2, CTGF, EGF	BCL inhibitor	10.00, 10.00	1.26, 0.22	-70.68	14.88	-99.53	-96.62	-97.01	44.58	99.77	76.03	-75.64	-91.26
BRD-K20755323	CP	SA-792728	sphingosine kinase inhibitor, ATPase inhibitor	SPHK1, VCP		0.00, 0.00	1.88, 0.68	-99.40	-100.00	-98.26	-80.66	-99.80	-84.29	-68.04	-87.18	-99.55	-99.86
BRD-K26664453	CP	cytochalasin-b	microtubule inhibitor, phagocytosis inhibitor	ACTB		0.00, 0.00	2.51, 0.58	-99.82	-70.07	-99.28	-99.56	-91.50	-85.45	-77.14	-98.52	-39.61	-99.26
BRD-K32536677	CP	AGK-2	SIRT inhibitor, SIRT pathway	SIRT2		40.00, 40.00	0.83, 0.23	98.50	-48.15	67.86	68.44	79.90	-83.28	-48.06	98.60	99.13	98.27
BRD-K36927236	CP	glibenclamide	sulfonylurea, ATP channel blocker, ATP-sensitive potassium channel antagonist, biguanide, gluconeogenesis inhibitor, insulin secretagogue, insulin sensitizer, TRPA1 agonist	KCNJ11, ABCC8, CFTR, KCNJ5, KCNJ8, ABCA1, ABCB11, ABCC9, CPT1A, KCNJ1, SLCO2B1, TRPA1		0.00, 0.00	0.88, 0.11	-85.32	41.99	92.24	94.82	11.15	23.66	-46.40	57.62	30.48	39.80
BRD-K53414658	CP	tivozanib	VEGFR inhibitor, KIT inhibitor, tyrosine kinase inhibitor	FLT1, FLT4, KDR, KIT, PDGFRA, PDGFRB	PDGFR/KIT inhibitor, VEGFR inhibitor	10.00, 10.00	1.91, 0.52	15.55	99.93	-96.07	-86.55	-27.00	-19.10	-53.68	42.52	28.81	-20.44
BRD-K54256913	CP	MK-1775	wee1 kinase inhibitor	WEE1		50.00, 40.00	1.75, 0.60	99.63	94.44	-73.00	-81.87	87.66	99.97	97.29	99.53	83.89	99.01
BRD-K68143200	CP	SA-792541	caspase activator, CDC inhibitor	CASP3, CDC25A, CDC25B		0.00, 0.00	0.84, 0.23	-98.42	-86.70	-99.68	-57.45	-97.03	-97.39	-85.39	-55.13	-99.97	-99.40
BRD-K93176058	CP	AC-55649	RAR agonist, retinoid receptor agonist	RARB, RARA	Retinoid receptor agonist	20.00, 10.00	1.35, 0.26	41.53	70.99	59.10	97.33	33.99	98.91	94.08	52.45	57.31	94.50
BRD-K94325918	CP	kinetin-riboside	apoptosis inducer			0.00, 0.00	2.90, 0.75	92.91	-99.66	-34.21	-92.13	92.35	-42.66	66.88	-85.15	-27.24	-74.73
BRD-K95609758	CP	BMS-191011	large conductance calcium activated potassium channel opener, large conductance potassium channel activator	KCNMA1	Potassium channel activator	30.00, 30.00	1.52, 0.33	-28.24	48.03	99.66	99.44	-21.04	39.23	36.96	100.00	53.86	89.75
BRD-K96354014	CP	nifedipine	calcium channel blocker, L-type calcium channel blocker	CACNA1C, CACNA1D, CACNA1S, CACNA2D1, CACNA1F, CACNA1H, CACNB2, CALM1, CYP3A5, GLRA1, GLRA3, GLRB, KCNA1, KCNA5, NR1I2, TRPM3		10.00, 10.00	0.86, 0.28	-36.77	99.67	-93.46	25.56	-51.15	-25.69	43.87	-70.13	-92.02	-56.55
BRD-K30064966	CP	BRD-K30064966	caspase activator	CASP3		10.00, 10.00	0.91, 0.28	99.84	86.40	-42.03	65.89	27.32	46.55	75.93	56.61	32.55	69.33
BRD-K56301217	CP	ABT-737	BCL inhibitor	BCL2, BCL2L1, BCL2L2	BCL inhibitor	0.00, 0.00	1.83, 0.67	-95.46	-96.32	-69.56	-93.62	90.32	-49.70	-39.98	74.63	75.36	-90.23
BRD-K82746043	CP	navitoclax	BCL inhibitor, apoptosis stimulant	BCL2, BCL2L1, BCL2L2		60.00, 60.00	1.28, 0.36	90.82	93.58	99.95	99.98	-15.00	99.97	83.42	97.70	98.56	99.86
BRD-A67373739	CP	AICA-ribonucleotide	adenosine release stimulant, AMPK stimulant	ATIC, PRKAA1		50.00, 40.00	2.41, 0.59	99.62	99.96	22.90	99.58	94.47	65.68	86.68	95.56	28.75	99.37
BRD-K47983010	CP	BX-795	IKK inhibitor, PDK1 inhibitor, phosphoinositide dependent kinase inhibitor, serine/threonine kinase inhibitor, TBK1 inhibitor	PDPK1, CDK2, CHEK1, GSK3B, IKBKE, KDR, PDK1, TBK1	IKK inhibitor	0.00, 0.00	2.16, 0.44	-99.50	-99.80	-99.52	-45.55	-12.94	-99.34	-99.30	-99.37	-48.71	-99.65
BRD-K05653692	CP	DL-PDMP	ceramide glucosyltransferase inhibitor, glucosyltransferase inhibitor	ASAH1, UGCG		10.00, 0.00	0.67, 0.05	-99.90	-99.87	-99.68	96.95	-94.11	-99.10	-99.37	84.51	-100.00	-99.75
BRD-K01976263	CP	emetine	protein synthesis inhibitor	RPS2		20.00, 10.00	1.86, 0.60	34.37	-97.65	-53.51	91.78	99.49	90.87	-64.98	94.04	95.72	93.81
BRD-A68631409	CP	evodiamine	ATPase inhibitor, TRPV agonist	TRPV1		30.00, 10.00	0.84, 0.34	96.59	94.28	-72.24	-69.91	79.51	99.97	-31.75	82.13	58.86	95.30
BRD-K09778810	CP	FGIN-1-27	benzodiazepine receptor agonist, inositol monophosphatase inhibitor	TSPO		0.00, 0.00	0.65, 0.13	89.46	41.98	-38.27	-98.24	-39.10	60.32	-99.71	-71.05	93.21	-65.56
BRD-K85606544	CP	neratinib	EGFR inhibitor, receptor tyrosine protein kinase inhibitor, tyrosine kinase inhibitor	EGFR, ERBB2, ERBB4, KDR	EGFR inhibitor	0.00, 0.00	1.48, 0.31	-7.44	-24.37	-97.64	-73.51	-94.71	-99.71	-48.43	70.62	-68.78	-86.06
BRD-K33583600	CP	isoliquiritigenin	guanylate cyclase activator, aldose reductase inhibitor, glutamate receptor antagonist, histamine receptor antagonist, SIRT activator	AKR1B1, HRH2, SIRT1		0.00, 0.00	1.63, 0.59	-98.73	79.63	-99.49	85.79	84.52	82.75	-29.17	-96.93	-97.08	-96.51
BRD-K67566344	CP	KU-0063794	mTOR inhibitor	MTOR	MTOR inhibitor	0.00, 0.00	2.21, 0.76	-92.45	-99.37	-99.82	-57.11	-82.50	-98.88	-99.08	-99.41	-40.99	-98.66
BRD-K37865504	CP	LY-2183240	FAAH inhibitor, FAAH reuptake inhibitor	FAAH		20.00, 20.00	1.76, 0.63	-69.85	99.76	-89.77	69.11	-90.33	99.78	-91.29	13.82	-99.13	-94.36
BRD-K35960502	CP	niclosamide	DNA replication inhibitor, STAT inhibitor	STAT3		0.00, 0.00	2.25, 0.74	-94.35	-98.01	-96.43	-73.19	-99.24	-99.72	-69.24	-64.94	-96.48	-95.84
BRD-K48692744	CP	NU-1025	PARP inhibitor, DNA dependent protein kinase inhibitor	PARP1		20.00, 0.00	0.85, 0.18	95.64	41.18	31.26	97.18	-25.76	88.07	-70.89	35.66	68.20	81.49
BRD-K08589866	CP	linsitinib	insulin growth factor receptor inhibitor, insulin receptor antagonist	IGF1R, INSR, INSRR	IGF-1 inhibitor	10.00, 10.00	1.02, 0.38	76.14	-99.67	10.49	-81.08	98.81	-14.53	-39.24	-99.38	33.44	-58.15
BRD-K92991072	CP	PAC-1	caspase activator	CASP3		0.00, 0.00	1.80, 0.50	-86.32	-66.31	-96.52	-60.81	-98.40	58.21	-86.35	-89.98	-74.15	-91.65
BRD-K11853856	CP	PJ-34	PARP inhibitor	EEF2, PARP1, PARP15, PARP3	PARP inhibitor	10.00, 0.00	0.83, 0.23	95.02	-35.94	22.90	80.01	-21.57	-60.60	-15.80	84.41	37.40	49.15
BRD-K16554956	CP	PTB1	AMPK activator, tyrosine phosphatase inhibitor	PTPN1		50.00, 30.00	0.93, 0.32	22.90	-12.89	99.86	99.96	65.64	79.23	36.14	97.30	96.01	98.94
BRD-K02407574	CP	parbendazole	tubulin inhibitor	TUBB	Tubulin inhibitor	40.00, 40.00	0.89, 0.42	99.40	100.00	-44.20	-68.93	-96.75	99.73	-33.56	-35.03	91.68	99.30
BRD-K98548675	CP	parthenolide	NFkB pathway inhibitor, adiponectin receptor agonist	ADIPOR2, IKBKB, RELA	NFkB pathway inhibitor	0.00, 0.00	2.27, 0.65	-84.23	-84.10	-97.45	84.38	-92.37	69.26	-29.97	-87.07	-99.29	-92.58
BRD-K01292756	CP	pimozide	dopamine receptor antagonist, dopamine receptor, opioid receptor antagonist, serotonin receptor antagonist	DRD2, DRD3, CACNA1I, CALM1, HRH1, HTR1A, HTR2A, KCNA10, KCNH2	Dopamine receptor antagonist	0.00, 0.00	1.60, 0.57	-90.96	-98.06	20.08	-63.66	64.54	-60.44	-93.23	-75.39	-99.71	-92.10
BRD-A45889380	CP	mepacrine	NFkB pathway inhibitor, cytokine production inhibitor, TP53 expression enhancer, acetylcholinesterase inhibitor, AKT inhibitor, apoptosis stimulant, DNA inhibitor, mTOR inhibitor, phospholipase inhibitor, PI3K inhibitor, secretory phospholipase inhibitor, TP53 activator	TP53, AKT1, MTOR, NFKB1, PLA2G1B, PLA2G2A, PLA2G2D, PLA2G4A, PLA2G6, PLCL1	NFkB pathway inhibitor	0.00, 0.00	1.22, 0.24	-97.02	-94.26	-84.47	-39.98	-35.10	-67.74	-68.23	76.25	-94.88	-95.43
BRD-K21672174	CP	RO-28-1675	glucokinase activator	GCK		0.00, 0.00	0.66, 0.01	-99.95	-99.91	-98.94	10.91	-99.51	-96.81	-99.48	-19.37	-22.07	-99.15
BRD-A97437073	CP	rosiglitazone	PPAR receptor agonist, insulin sensitizer, thiazolidinedione	PPARG, ACSL4, CYP2C8, FFAR1, INS, TRPC5, TRPM3	PPAR receptor agonist	0.00, 0.00	0.39, 0.11	-70.79	59.27	-79.51	-92.94	-72.85	56.52	-99.30	47.38	-61.42	-71.94
BRD-K03816923	CP	rottlerin	large conductance potassium channel activator, MAP kinase inhibitor, PKC inhibitor, protein kinase inhibitor, tissue transglutaminase inhibitor	KCNH2, PRKCD, TGM2		0.00, 0.00	2.56, 0.93	-94.81	-36.13	-95.16	-97.27	-99.27	-99.51	-99.54	-76.41	-98.55	-97.39
BRD-K53855319	CP	SRT-1720	SIRT activator	SIRT1		30.00, 30.00	1.06, 0.16	99.37	98.91	-9.41	98.15	-65.43	50.11	44.60	41.74	23.68	87.86
BRD-A35588707	CP	teniposide	topoisomerase inhibitor, DNA inhibitor, DNA repair enzyme inhibitor, mitotic inhibitor	TOP2A, CYP3A5	Topoisomerase inhibitor	0.00, 0.00	2.61, 0.64	-99.62	-99.56	-99.41	-99.86	-99.85	42.10	-99.76	-99.89	-99.66	-99.51
BRD-K51575138	CP	TPCA-1	IKK inhibitor	IKBKB	IKK inhibitor	0.00, 0.00	1.81, 0.59	-98.63	-99.86	-98.38	-93.76	94.92	-86.51	-90.39	86.67	-36.27	-96.57
BRD-K80527266	CP	triacsin-c	adrenergic receptor antagonist	ACSL1		0.00, 0.00	1.22, 0.30	-35.28	-93.81	86.90	37.51	17.18	77.32	90.82	82.79	72.27	88.22
BRD-K74236984	CP	UNC-0321	histone lyinse methyltransferase inhibitor, histone lysine methyltransferase inhibitor	EHMT2		30.00, 20.00	0.76, 0.18	82.42	50.74	84.02	-38.47	92.33	97.98	-86.68	99.77	31.65	95.41
BRD-K87947369	CP	tozasertib	Aurora kinase inhibitor, Bcr-Abl kinase inhibitor, FLT3 inhibitor, JAK inhibitor, Abl kinase inhibitor, mitotic inhibitor	AURKA, AURKB, ABL1, AURKC, BCR, FLT3, JAK2, DDR2, LCK		70.00, 60.00	1.70, 0.50	99.98	99.96	-80.04	90.96	99.57	99.94	97.40	-70.44	99.31	99.75
BRD-K12994359	CP	valdecoxib	cyclooxygenase inhibitor	PTGS2, CA12, CYP2C19		0.00, 0.00	0.34, 0.05	35.94	-99.28	-61.74	-59.04	-20.82	-100.00	-99.56	-98.82	-99.32	-99.47
BRD-K71799949	CP	carbamazepine	potassium channel modulator, Sodium Channel  Blockers, sodium channel blocker, voltage-gated sodium channel blocker	ABCB1, CYP1A2, CYP3A4, SCN1A, SCN3A, SCN5A		10.00, 10.00	0.68, 0.16	34.85	-98.42	99.76	33.24	25.80	-27.19	11.99	45.67	92.33	29.76
BRD-A85860691	CP	chaetocin	histone lyinse methyltransferase inhibitor, histone lysine N methyltransferase inhibitor	EHMT2, SUV39H1		10.00, 10.00	0.70, 0.05	11.82	52.61	-40.44	90.28	-88.06	62.20	100.00	-27.24	87.97	77.89
BRD-A38030642	CP	cyclosporin-a	calcineurin inhibitor, cyclophilin inhibitor, immunosuppressant, insulin expression inhibitor, T cell inhibitor	PPIA, ABCB11, CAMLG, CYP3A5, CYP3A7, FPR1, PPID, PPIF, PPP3CA, PPP3R2, SLC10A1, SLCO1B1, SLCO1B3		0.00, 0.00	2.28, 0.90	-95.26	-44.68	-97.47	-99.55	-98.96	-68.92	-98.50	-99.41	-99.44	-98.31
BRD-K35723520	CP	darinaparsin	apoptosis stimulant, NADPH oxidase stimulant			50.00, 30.00	1.13, 0.31	33.77	39.50	99.69	-92.46	69.93	97.70	96.68	97.21	61.99	98.50
BRD-K82135108	CP	elesclomol	apoptosis stimulant, HSP agonist, HSP inducer, oxidative stress inducer, topoisomerase inhibitor	TOP2A		10.00, 0.00	1.14, 0.13	35.55	-92.89	-96.08	-94.75	-49.83	16.72	95.07	-95.40	7.65	-92.44
BRD-K14888893	CP	minoxidil	antialopecia agent, ATP channel activator, ATP-sensitive potassium channel agonist, KATP activator, Kir6 channel (KATP) activator, polarization activator, renin secretion stimulant	KCNJ8, ABCC9, KCNJ1, KCNJ10, KCNJ11, PTGS1, REN		0.00, 0.00	1.34, 0.35	-23.84	-66.93	29.92	41.10	58.93	-52.38	-35.63	77.44	49.98	32.65
BRD-A75517195	CP	thiazolopyrimidine	CDC inhibitor			10.00, 0.00	0.32, 0.08	-81.45	96.30	-95.93	82.85	-97.50	-84.20	57.03	-47.74	44.90	-93.80
BRD-A75409952	CP	wortmannin	PI3K inhibitor, ATM kinase inhibitor, ATR kinase inhibitor, DNA dependent protein kinase inhibitor, mTOR inhibitor, Phosphatidylinositol 3-kinase (PI3K) inhibitor, PLK inhibitor	PIK3CA, PIK3CG, PLK1, ATM, ATR, MTOR, PI4KA, PI4KB, PIK3CD, PIK3R1, PLK3, PRKDC		0.00, 0.00	1.31, 0.38	-99.71	-99.98	-98.98	-99.85	-98.29	-98.27	-95.84	-98.79	-99.73	-98.98
BRD-A81541225	CP	oligomycin-a	ATP synthase inhibitor, ATPase inhibitor	ATP5A1		30.00, 20.00	1.65, 0.45	20.92	69.54	96.78	37.80	-98.03	99.40	86.97	84.63	-98.83	97.53
BRD-K81418486	CP	vorinostat	HDAC inhibitor, cell cycle inhibitor	HDAC1, HDAC2, HDAC3, HDAC6, HDAC8, HDAC10, HDAC11, HDAC5, HDAC9	HDAC inhibitor	0.00, 0.00	1.66, 0.57	-98.77	-97.52	-99.49	-99.59	-99.65	-99.48	-99.65	-99.32	-99.47	-98.77
BRD-K61033289	CP	15-delta-prostaglandin-j2	PPAR receptor agonist, FXR antagonist	PPARG, NR1H4		0.00, 0.00	3.07, 0.89	-98.18	-38.30	-99.58	-96.03	-99.61	-29.40	-94.09	-81.80	-98.61	-96.90
BRD-K88560311	CP	rucaparib	PARP inhibitor	PARP1, PARP2	PARP inhibitor	10.00, 10.00	1.41, 0.26	-70.54	-65.29	-88.40	82.47	99.98	-8.17	-38.22	-51.05	-100.00	-56.61
BRD-K08703257	CP	3-amino-benzamide	PARP inhibitor	PARP1		30.00, 20.00	0.92, 0.16	57.61	96.30	99.88	87.05	63.19	94.03	93.77	82.26	-50.13	98.56
BRD-K09907482	CP	PRL-3-inhibitor-I	PRL phosphatase inhibitor, tyrosine phosphatase inhibitor	PTP4A3		10.00, 10.00	0.49, 0.07	-43.81	86.24	52.52	-7.34	99.47	-75.49	-27.46	83.99	-30.70	53.37
BRD-K59184148	CP	SB-216763	glycogen synthase kinase inhibitor	GSK3B, CCNA2, CDK2, GSK3A	Glycogen synthase kinase inhibitor	0.00, 0.00	0.36, 0.17	-99.63	-54.19	-86.78	-63.34	91.05	-94.88	-92.83	47.09	-35.54	-94.60
BRD-K12762134	CP	XAV-939	PARP inhibitor, TNKS inhibitor	TNKS, TNKS2		10.00, 10.00	0.88, 0.30	99.13	-24.32	-57.42	-24.88	-18.08	-95.15	-41.01	58.19	80.24	-19.99
BRD-K26657438	CP	imiquimod	interferon inducer, toll-like receptor agonist, immunostimulant	TLR7, TLR8		30.00, 20.00	1.31, 0.49	99.98	70.08	98.25	50.33	96.18	49.79	63.24	56.14	-28.60	92.37
BRD-K93754473	CP	tamoxifen	estrogen receptor antagonist, selective estrogen receptor modulator (SERM), estrogen receptor agonist, estrogen receptor modulator, PKC inhibitor	ESR1, ESR2, CYP3A5, EBP, GPER1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PRKCI, PRKCQ, PRKCZ		40.00, 30.00	0.38, 0.17	99.66	25.93	99.58	60.28	88.12	22.79	-56.94	-50.01	98.49	97.06
BRD-K27316855	CP	calcitriol	vitamin D receptor agonist, hypercalcaemic agent	VDR, CYP3A5		0.00, 0.00	0.93, 0.18	94.12	-98.69	46.55	-40.86	-33.84	-8.74	-63.64	-36.40	83.97	-10.91
BRD-A13122391	CP	triptolide	RNA polymerase inhibitor	CYP2C19, RELA		0.00, 0.00	1.92, 0.68	-99.25	-99.87	-72.71	-92.30	-99.09	-85.07	-33.46	-83.20	-91.36	-97.89
BRD-A71390734	CP	idarubicin	topoisomerase inhibitor, radical formation stimulant, RNA synthesis inhibitor	TOP2A		0.00, 0.00	1.25, 0.26	-95.39	-98.75	-98.20	-99.91	-99.94	61.18	-99.76	-99.88	-97.63	-99.58
BRD-K91623615	CP	ABT-751	tubulin inhibitor, dihydropteroate synthase inhibitor, microtubule inhibitor, PABA antagonist, tubulin polymerisation inhibitor	TUBB	Tubulin inhibitor	20.00, 20.00	1.51, 0.73	82.62	99.96	-27.29	-24.95	-56.75	99.82	-82.15	16.54	29.23	53.51
BRD-K07303502	CP	arachidonyl-trifluoro-methane	cytosolic phospholipase inhibitor	PLA2G4A		0.00, 0.00	1.40, 0.15	-99.49	-87.50	-87.04	-36.15	-70.95	-99.54	-98.85	26.44	-28.93	-97.53
BRD-K78959463	CP	FPL-64176	calcium channel agonist, L-type calcium channel activator	CACNA1C, CACNA1S		0.00, 0.00	0.98, 0.39	16.55	34.31	86.41	67.44	34.09	-92.98	68.34	17.25	23.37	32.23
BRD-K09499853	CP	KU-0060648	DNA dependent protein kinase, DNA dependent protein kinase inhibitor, PI3K inhibitor	PIK3CA, PIK3CB, PIK3CD, PIK3CG, PRKDC	DNA dependent protein kinase inhibitor, PI3K inhibitor	0.00, 0.00	1.84, 0.56	-94.89	-15.83	-98.63	76.16	-95.60	-98.79	-90.53	-95.35	-62.28	-95.24
BRD-K28470988	CP	L-690330	inositol monophophatase inhibitor	IMPA1		0.00, 0.00	1.70, 0.78	47.33	80.46	-75.08	-42.98	-69.38	-92.87	-36.23	92.05	71.85	-48.25
BRD-K69328504	CP	L-690488	nositol monophosphatase inhibitor	IMPA1		0.00, 0.00	1.00, 0.20	-99.35	-95.01	-60.82	-96.14	-95.48	-95.47	-99.73	-70.24	-72.06	-96.51
BRD-K76205745	CP	losartan	angiotensin receptor antagonist	AGTR1		20.00, 20.00	0.31, 0.02	98.24	60.35	-24.06	92.20	69.09	99.11	57.50	23.33	78.28	91.31
BRD-K78126613	CP	menadione	CDC inhibitor, mitochondrial DNA polymerase inhibitor, phosphatase inhibitor, pyruvate kinase isozyme inhibitor	AOX1, BGLAP, F10, F2, F7, F9, GGCX, NQO1, NQO2, PKM, PROC, PROS1, PROZ, VKORC1, VKORC1L1		0.00, 0.00	2.21, 0.41	-95.16	-70.90	-80.57	-75.87	-98.46	-98.82	-90.72	40.15	-92.71	-96.51
BRD-K67844266	CP	MLN-4924	nedd activating enzyme inhibitor	NAE1, UBA3		0.00, 0.00	2.53, 0.74	-93.62	-45.04	-73.63	90.83	-99.92	-95.46	68.69	-97.50	52.82	-94.68
BRD-K62810658	CP	PD-98059	MEK inhibitor, MAP kinase inhibitor	MAP2K1, AKT1, CHEK1, GSK3B, LCK, MAP2K2, MAPK1, MAPK11, MAPK12, MAPK14, MAPK3, MAPK8, PRKCA, RAF1, ROCK1, RPS6KB1, SGK1	MEK inhibitor	10.00, 0.00	0.90, 0.23	65.63	43.37	-44.71	42.13	-24.36	96.10	89.06	61.57	8.40	53.44
BRD-K80738081	CP	resveratrol	apolipoprotein expression enhancer, beta-secretase inhibitor, cyclooxygenase inhibitor, cytochrome P450 inhibitor, lipid peroxidase inhibitor, MAP kinase inhibitor, monoamine oxidase inhibitor, NFkB pathway modulator, SIRT activator, SIRT pathway, SIRT stimulant, sodium channel blocker, thioredoxin reductase inhibitor, topoisomerase inhibitor, xanthine oxidase inhibitor	PTGS1, PTGS2, SIRT1, APOA1, BACE1, CSNK2A1, MAOA, NQO2, SCN5A, TXNRD1, TXNRD2, XDH		20.00, 10.00	0.95, 0.20	49.30	95.76	-35.19	58.89	-97.86	71.76	82.94	99.52	-89.05	91.84
BRD-K23875128	CP	RHO-kinase-inhibitor-III[rockout]	ROCK inhibitor	IMPDH2, ROCK1		10.00, 10.00	1.26, 0.76	65.65	98.28	8.06	-16.69	53.70	-52.84	80.18	75.72	-41.78	56.25
BRD-K50128260	CP	sildenafil	phosphodiesterase inhibitor	PDE5A, PDE6G, PDE6H, SLCO1B1, SLCO1B3		0.00, 0.00	0.40, 0.06	67.87	-19.74	75.39	-35.79	71.31	-65.34	-56.73	-64.75	-39.69	-26.05
BRD-K28360340	CP	TW-37	BCL inhibitor, MCL1 inhibitor	BCL2, BCL2L1, MCL1	BCL inhibitor	0.00, 0.00	2.60, 0.72	-79.19	-67.06	-93.96	-99.20	-84.27	-62.28	-61.22	-97.46	-99.38	-94.99
BRD-A09533288	CP	verapamil	calcium channel blocker, L-type calcium channel blocker, dopamine receptor antagonist	CACNA1C, CACNA1D, CACNA1G, CACNA1S, CACNA1A, CACNA1B, CACNA1F, CACNA1I, CACNB1, CACNB2, CACNB3, CACNB4, CYP2C8, CYP2E1, CYP3A4, CYP3A5, CYP3A7, DRD2, KCNA10, KCNA7, KCNH2, KCNJ11, NALCN, SCN5A, SLC29A4, SLC6A4		30.00, 30.00	0.84, 0.11	32.41	71.74	66.74	99.98	99.76	81.01	91.25	16.37	88.99	99.61
BRD-U88459701	CP	atorvastatin	HMGCR inhibitor, dipeptidyl peptidase inhibitor, tumor necrosis factor expression inhibitor	HMGCR, DPP4, AHR, CYP3A5, FASLG	HMGCR inhibitor	0.00, 0.00	1.50, 0.41	80.64	84.19	-98.80	79.72	90.64	71.00	77.38	71.73	47.89	90.46
BRD-A69951442	CP	dexamethasone	glucocorticoid receptor agonist, corticosteroid agonist, immunosuppressant	ANXA1, CYP3A4, CYP3A5, NOS2, NR0B1, NR3C1, NR3C2		40.00, 30.00	1.47, 0.68	99.60	44.58	78.35	-26.98	-53.14	-95.73	26.81	99.96	99.78	96.00
BRD-A25004090	CP	erastin	anion channel modulator, ion channel antagonist	VDAC2		60.00, 40.00	0.59, 0.35	49.94	27.67	52.85	98.51	96.31	40.27	99.96	99.94	95.58	99.15
BRD-K15108141	CP	gemcitabine	cell cycle inhibitor, DNA repair enzyme inhibitor, DNA synthesis inhibitor, pyrimidine antagonist, ribonucleoside reductase inhibitor, ribonucleotide reductase inhibitor	RRM1, CMPK1, RRM2, TYMS	Ribonucleotide reductase inhibitor	0.00, 0.00	1.97, 0.58	-99.94	-99.93	-99.37	-99.80	53.47	-81.80	-99.25	-99.34	-75.07	-99.51
BRD-K59222562	CP	BRD-K59222562	CLK inhibitor, dual specificity tyrosine-(Y)-phosphorylation regulated kinase inhibitor, dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1B inhibitor	CLK1, CLK4, DYRK1A, DYRK1B		11.11, 11.11	1.36, 0.33	62.84	98.56	83.24	-69.33	NaN	-56.64	46.19	-95.39	90.45	65.92
BRD-A18279961	CP	BRD-A18279961	pyruvate kinase isozyme activator	PKM		11.11, 11.11	0.95, 0.18	34.37	32.30	-52.23	-58.52	NaN	71.38	99.49	57.90	-29.16	45.40
BRD-A38793261	CP	BRD-A38793261	ROR antagonist	RORC		11.11, 11.11	0.74, 0.19	65.79	-79.08	13.07	82.78	NaN	32.39	-42.51	-88.33	99.86	46.79
BRD-K37456065	CP	VU-0365114-2	acetylcholine receptor allosteric modulator, M5 modulator	CHRM5		0.00, 0.00	1.65, 0.58	-26.10	85.02	-96.77	80.51	NaN	32.49	-49.79	-68.47	-62.64	-52.56
BRD-K44432556	CP	VU-0418946-1	hypoxia inducible factor activator	HIF1A	HIF activator	0.00, 0.00	1.80, 0.63	-98.05	-97.19	-96.98	-98.83	-98.71	-90.73	-92.37	-98.34	-98.43	-97.11
BRD-A19500257	CP	geldanamycin	HSP inhibitor	HSP90AA1, HSP90AB1	HSP inhibitor	10.00, 10.00	0.99, 0.30	-97.71	-97.60	-99.80	63.03	99.02	-83.07	60.47	-30.41	-41.26	-92.09
BRD-K24127443	CP	BRD-K24127443	lipoxygenase inhibitor			10.00, 0.00	1.28, 0.31	-46.25	28.29	-92.34	66.53	97.17	-43.17	83.88	31.15	-52.41	32.06
BRD-K35133769	CP	BRD-K35133769	lipoxygenase inhibitor			10.00, 10.00	1.25, 0.43	-28.14	48.71	-19.42	97.65	37.49	70.40	28.76	-20.78	27.22	26.65
BRD-K68756823	CP	FR-180204	MAP kinase inhibitor	MAPK1, MAPK3		10.00, 10.00	0.89, 0.24	-7.53	-73.74	-57.25	49.04	31.84	-41.93	-56.71	94.33	97.52	-21.43
BRD-K30649484	CP	mafenide	carbonic anhydrase inhibitor, unidentified pharmacological activity	CA6, CA12, CA14, CA2, CA4, CA9		0.00, 0.00	1.82, 0.47	-85.74	-57.36	11.56	88.79	-96.85	-37.52	-46.45	-26.49	-28.44	-28.04
BRD-K39823328	CP	VU-0366037-2	glutamate receptor modulator	GRM4		0.00, 0.00	0.86, 0.16	12.48	-94.80	52.71	80.91	-54.57	-44.71	26.69	-25.69	86.17	-16.65
BRD-A34208323	CP	VU-0404997-2	glutamate receptor modulator	GRM4		10.00, 10.00	0.95, 0.26	-33.13	-67.48	-66.69	-84.99	39.66	-98.69	99.23	-28.69	-99.88	-65.24
BRD-K83010055	CP	VU-0415374-1	glutamate receptor modulator	GRM4		0.00, 0.00	1.07, 0.32	11.02	9.34	35.99	22.80	-63.77	-74.73	-44.56	45.84	85.98	8.74
BRD-K74501079	CP	azithromycin	50S ribosomal subunit inhibitor, protein synthesis inhibitor	MLNR		0.00, 0.00	1.00, 0.33	46.94	27.69	-74.02	-44.56	-63.61	39.60	-43.52	87.88	-31.14	-20.16
BRD-A35108200	CP	dexamethasone	glucocorticoid receptor agonist, corticosteroid agonist, immunosuppressant	ANXA1, CYP3A4, CYP3A5, NOS2, NR0B1, NR3C1, NR3C2	Glucocorticoid receptor agonist	40.00, 30.00	1.30, 0.85	-94.73	99.89	99.56	-34.19	-43.32	-98.07	93.79	99.95	87.78	97.29
BRD-A69512159	CP	carbidopa	aromatic L-amino acid decarboxylase inhibitor, dopa decarboxylase (aromatic L-amino acid decarboxylase) inhibitor	DDC		10.00, 0.00	2.07, 0.67	22.63	-52.77	-30.82	61.25	50.88	-15.80	-61.60	15.17	96.55	-24.38
BRD-K02637541	CP	celecoxib	cyclooxygenase inhibitor, caspase activator	PTGS2, CA12, CASP3, CYP2C19, PDPK1		0.00, 0.00	0.74, 0.09	-64.45	-12.21	-33.49	38.36	-33.18	-41.62	-25.08	-43.77	-42.42	-15.66
BRD-A42571354	CP	cetirizine	histamine receptor antagonist	HRH1		0.00, 0.00	0.81, 0.11	49.84	32.90	35.78	22.06	-56.48	-29.44	75.28	-67.38	91.36	28.31
BRD-A47598013	CP	citalopram	serotonin reuptake inhibitor, serotonin uptake inhibitor	SLC6A4, SLC6A2		0.00, 0.00	1.09, 0.23	58.24	-40.79	-34.75	-61.14	-40.32	-83.75	-95.82	59.98	39.12	-39.93
BRD-K27721098	CP	clopidogrel	purinergic receptor antagonist, platelet aggregation inhibitor, purinergic receptor inhibitor	P2RY12, CYP2B6, CYP2C19, CYP3A5		0.00, 0.00	2.81, 0.70	-59.07	-87.16	-68.52	-41.35	48.40	32.65	-90.02	68.45	36.98	-67.03
BRD-K05673000	CP	dicloxacillin	bacterial cell wall synthesis inhibitor		Bacterial cell wall synthesis inhibitor	10.00, 10.00	0.85, 0.26	46.05	-51.40	42.41	-43.82	98.02	59.25	72.82	76.86	67.58	71.89
BRD-A16998493	CP	etodolac	cyclooxygenase inhibitor, TRPV agonist	PTGS2, PTGS1, RXRA, TRPV1		11.11, 11.11	2.77, 0.81	-33.84	-32.29	-55.77	-56.02	48.15	NaN	-96.99	-11.36	100.00	-50.30
BRD-A81233518	CP	glycopyrrolate	acetylcholine receptor antagonist	CHRM1, CHRM3, CHRM2, CHRM4, CHRM5		0.00, 0.00	0.88, 0.26	71.53	-24.65	7.42	78.46	21.79	36.82	-14.61	-55.94	-44.68	-5.92
BRD-A01320529	CP	salmeterol	adrenergic receptor agonist	ADRB2	Beta-adrenergic receptor agonist	10.00, 0.00	0.56, 0.09	-98.43	-89.17	10.23	-31.59	49.92	96.00	20.19	-81.84	9.04	-17.74
BRD-K55070890	CP	thiothixene	dopamine receptor, dopamine receptor antagonist	HTR2A, DRD1, DRD2, HRH1		0.00, 0.00	1.80, 0.45	-93.78	-66.98	-24.29	-35.29	-34.56	46.58	-98.53	-22.40	-25.87	-40.70
BRD-K92000912	CP	AM-251	ACAT inhibitor, cannabinoid receptor antagonist, cannabinoid receptor inverse agonist	CNR1, GPR18, GPR55		0.00, 0.00	0.55, 0.14	-39.27	-96.25	5.29	47.62	-93.62	-33.16	9.60	-70.33	-14.26	-23.15
BRD-K41410256	CP	balsalazide	cyclooxygenase inhibitor, prostanoid receptor inhibitor, thromboxane receptor antagonist	PTGS1, PTGS2, ALOX5, PPARG		10.00, 10.00	2.14, 0.53	64.85	-85.55	-68.14	36.61	22.47	30.81	-45.05	99.73	-71.63	-74.89
BRD-A46179541	CP	doxapram	potassium channel blocker	KCNK3, KCNK9	Potassium channel blocker	0.00, 0.00	1.13, 0.48	-36.78	-92.79	-61.41	33.04	-32.25	-35.95	56.81	59.33	-43.91	-29.26
BRD-K67783091	CP	haloperidol	dopamine receptor antagonist	DRD2, DRD1, DRD3, HTR2A, CYP3A7, DRD4, DRD5, GRIN2B, HRH1, HTR1A, HTR1D, HTR2B, HTR7, KCNH1		0.00, 0.00	1.23, 0.23	27.15	-98.73	15.00	50.87	68.65	-85.43	-36.84	-26.45	-35.25	8.94
BRD-A66435872	CP	HTMT	histamine receptor agonist	HRH4		0.00, 0.00	1.00, 0.24	55.85	-44.80	34.68	34.77	-89.19	18.89	-48.35	-58.59	92.50	-26.57
BRD-K12102668	CP	nialamide	monoamine oxidase inhibitor	COMT, MAOA, MAOB		10.00, 10.00	1.83, 0.55	-68.89	-92.21	-23.23	-81.56	63.89	21.74	43.34	99.54	-26.00	-23.44
BRD-K67637637	CP	olopatadine	histamine receptor antagonist, histamine blocker, mediator release inhibitor	HRH1, S100A1, S100A12, S100A13, S100A2, S100B		0.00, 0.00	1.86, 0.53	-81.69	-35.52	-23.23	8.01	35.12	-44.24	-94.55	76.84	-99.35	-43.33
BRD-K00234327	CP	RU-24969	serotonin receptor agonist	HTR1A, HTR1B, HTR6, HTR1D, HTR2A, HTR2B, HTR2C, HTR5A		0.00, 0.00	0.51, 0.15	68.73	-99.43	-59.18	-25.64	84.51	-35.65	-65.22	-50.56	80.22	-39.88
BRD-A75769826	CP	SDM25N	opioid receptor antagonist	OPRD1		10.00, 0.00	0.41, 0.07	81.44	95.22	31.82	-46.01	55.37	-32.12	-58.04	-73.89	-36.74	-22.31
BRD-A01826957	CP	xanthinol	vasodilator			10.00, 10.00	1.31, 0.44	-26.31	20.49	8.69	99.85	65.78	-35.10	-23.51	-73.54	-39.01	6.53
BRD-A70083328	CP	secnidazole	acetylcholinesterase inhibitor, microtubule inhibitor			12.50, 0.00	1.44, 0.48	11.26	96.05	71.94	55.34	43.54	NaN	-23.66	-66.19	NaN	27.23
BRD-K98530306	CP	clonidine	adrenergic receptor agonist	ADRA2A, ADRA2B, ADRA2C, ADRA1A, ADRA1B, ADRA1D		20.00, 10.00	0.95, 0.27	76.03	95.64	-34.00	89.32	98.06	44.33	31.87	80.18	-62.03	91.66
BRD-A36074203	CP	remacemide	glutamate receptor antagonist, glutamate receptor agonist	GRIN1		0.00, 0.00	0.93, 0.22	35.53	-73.85	-41.94	53.99	-53.60	-95.17	-19.65	-48.07	92.86	-24.30
BRD-K02130563	CP	panobinostat	HDAC inhibitor, apoptosis stimulant, cell cycle inhibitor	HDAC1, HDAC2, HDAC3, HDAC4, HDAC6, HDAC7, HDAC8, HDAC9	HDAC inhibitor	0.00, 0.00	1.89, 0.52	-99.56	-78.18	-99.39	-98.31	-99.65	-99.73	-99.64	-92.38	-99.85	-98.94
BRD-K26818574	CP	BIX-01294	DNA methyltransferase inhibitor, histone lyinse methyltransferase inhibitor, histone lysine methyltransferase inhibitor	EHMT1, EHMT2		11.11, 0.00	0.95, 0.15	55.74	-87.76	-41.03	88.23	96.65	34.70	-98.46	-94.12	NaN	-88.43
BRD-K07403598	CP	CAY-10470	NFKB pathway inhibitor	NFKB1, TNF		0.00, 0.00	0.98, 0.16	-96.31	-13.29	-75.87	-94.42	-62.28	-54.77	-94.14	-97.44	NaN	-98.10
BRD-K05396879	CP	15-delta-prostaglandin-j2	PPAR receptor agonist, FXR antagonist	PPARG, NR1H4	PPAR receptor agonist	0.00, 0.00	1.39, 0.63	-98.63	71.89	-99.60	51.30	-99.75	-87.00	-87.92	-39.05	-46.60	-97.22
BRD-K00656370	CP	6-aminochrysene	inhibitor of transferase activity			0.00, 0.00	0.65, 0.15	-98.38	-12.08	-48.10	-18.23	61.86	-26.50	-20.52	-99.30	NaN	-19.10
BRD-K56001384	CP	antimycin-a	antibiotic, electron transfer inhibitor	CYCS	ATP synthase inhibitor	0.00, 0.00	1.50, 0.24	-99.98	29.56	-99.54	-57.35	-87.24	44.45	-80.81	-53.23	NaN	-71.15
BRD-K10573841	CP	tunicamycin	GLCNAC phosphotransferase inhibitor	GNPTAB		0.00, 0.00	2.39, 0.75	-98.47	-78.04	-98.19	-98.54	-98.85	-99.60	-59.75	-99.49	NaN	-97.46
BRD-A19037878	CP	trichostatin-a	HDAC inhibitor, CDK expression enhancer, ID1 expression inhibitor	HDAC7, HDAC8, HDAC1, HDAC10, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC9		0.00, 0.00	2.10, 0.64	-99.58	-95.56	-99.49	-99.63	-99.65	-99.51	-99.64	-98.73	-99.56	-98.87
BRD-K87426499	CP	BRD-K87426499	caspase inhibitor	CASP3		0.00, 0.00	2.01, 0.34	-34.52	-4.38	62.85	-23.35	31.72	27.09	59.41	37.51	-40.63	14.38
BRD-A66395008	CP	parthenolide	NFkB pathway inhibitor, adiponectin receptor agonist	ADIPOR2, IKBKB, RELA		10.00, 10.00	1.10, 0.26	-64.25	-26.17	-61.60	99.98	-55.23	-69.38	-12.08	-42.52	-41.35	-25.12
BRD-K79254416	CP	decitabine	DNA methyltransferase inhibitor, antimetabolite, DNA methylase inhibitor	DNMT1		0.00, 0.00	0.89, 0.24	-63.69	30.99	-37.68	34.90	33.83	25.55	78.01	94.99	54.49	22.43
BRD-K25504083	CP	cytochalasin-d	actin polymerization inhibitor, actin stabilizer	ACTB		0.00, 0.00	1.82, 0.44	-95.67	-94.49	-68.05	-98.99	77.77	-57.72	-81.15	-98.42	-99.48	-98.87
BRD-K97056771	CP	HY-11007	Abl kinase inhibitor, Bcr-Abl kinase inhibitor	ABL1, BCR		0.00, 0.00	1.40, 0.35	58.81	88.08	-13.56	41.54	-34.72	-45.05	-52.29	-61.47	-92.49	-32.91
BRD-K29733039	CP	deforolimus	mTOR inhibitor, angiogenesis inhibitor, cell cycle inhibitor, immunosuppressant, protein kinase inhibitor, serine/threonine kinase inhibitor, VEGFR antagonist	MTOR	MTOR inhibitor	10.00, 0.00	1.78, 0.55	-77.24	-70.66	-63.75	-8.98	33.29	33.49	95.07	-92.33	-50.48	-75.81
BRD-K07881437	CP	danusertib	Aurora kinase inhibitor, growth factor receptor inhibitor, Abl kinase inhibitor, Bcr-Abl kinase inhibitor, FGFR inhibitor, mitotic inhibitor, protein kinase inhibitor, RET tyrosine kinase inhibitor	AURKA, AURKB, AURKC, FGFR1, NTRK1, RET, BCR, SLK	Aurora kinase inhibitor	0.00, 0.00	2.02, 0.48	-88.58	-99.80	-79.82	-97.87	37.24	-75.27	-99.71	-99.37	-98.97	-99.47
BRD-K16478699	CP	PLX-4720	RAF inhibitor	BRAF, KDR	RAF inhibitor	0.00, 0.00	0.86, 0.30	92.17	81.71	-99.72	32.46	-29.30	-95.24	80.44	79.08	33.18	86.60
BRD-K71823332	CP	epothilone-a	microtubule stabilizing agent			20.00, 20.00	1.02, 0.40	91.86	99.89	49.59	-97.60	-42.85	71.07	99.67	61.55	-37.13	91.60
BRD-K47832606	CP	floxuridine	DNA synthesis inhibitor, MDCK inhibitor, PEPT1 inhibitor, pyrimidine antagonist	TYMS		0.00, 0.00	1.30, 0.31	-97.68	-52.63	-84.31	-86.32	28.26	-40.37	-99.61	-99.84	-88.11	-98.96
BRD-K35687265	CP	ON-01910	PLK inhibitor, cell cycle inhibitor, MCL1 inhibitor, protein kinase inhibitor	CDK1, FLT1, FYN, MCL1, PDGFRA, PLK1, PLK2, SRC		10.00, 10.00	1.68, 0.69	78.21	99.93	-55.63	-55.88	51.54	-31.07	-80.61	32.67	-94.81	-57.33
BRD-K64881305	CP	ispinesib	kinesin family member inhibitor, kinesin inhibitor, Kinesin-Like Spindle Protein  KIF11 (KSP, Eg5) Inhibitors	KIF11		10.00, 10.00	1.68, 0.51	-33.69	99.58	-93.87	-92.56	33.17	39.74	-20.95	-20.51	-46.16	-16.90
BRD-K31553034	CP	zibotentan	endothelin receptor antagonist	EDNRA		10.00, 10.00	1.49, 0.32	85.00	93.33	-35.01	-50.51	89.76	-25.80	21.33	97.58	-27.56	92.49
BRD-K19416115	CP	sitagliptin	dipeptidyl peptidase inhibitor, HMGCR inhibitor, insulin secretagogue, tumor necrosis factor expression inhibitor	DPP4, CYP2C8, FASLG, HMGCR, SLC22A8		0.00, 0.00	2.65, 0.89	40.15	71.81	-73.69	17.11	64.17	37.56	59.46	57.54	93.09	69.41
BRD-K31283835	CP	tofacitinib	JAK inhibitor, disease modifying antirheumatic drug, immunosuppressant, MAP kinase inhibitor, tyrosine kinase inhibitor	JAK3, JAK1, JAK2, CYP2C19, TYK2		0.00, 0.00	0.80, 0.15	77.62	57.17	-27.31	70.17	34.94	93.38	73.80	57.68	-32.95	62.23
BRD-K22096725	CP	ALW-II-49-7	ephrin inhibitor	DDR1, EPHA2, EPHA4, EPHA7, EPHB2, EPHB4, EPHB6		20.00, 20.00	2.11, 0.55	21.51	98.12	-97.88	-67.45	25.68	27.77	-36.16	-46.19	99.64	-23.04
BRD-A45664787	CP	iloprost	platelet aggregation inhibitor, prostanoid receptor agonist, prostacyclin analog	PTGIR, PTGER1, PTGER2, PDE4A, PDE4B, PDE4C, PDE4D, PLAT, PTGDR, PTGER3, PTGER4, PTGFR, TBXA2R		0.00, 0.00	0.84, 0.25	-14.49	61.31	-37.09	-73.39	-35.12	50.50	26.19	-10.42	-11.14	-3.24
BRD-K74133369	CP	oligomycin-a	ATP synthase inhibitor, ATPase inhibitor	ATP5A1	ATP synthase inhibitor, ATPase inhibitor	0.00, 0.00	1.85, 0.44	-98.06	-87.67	-96.88	-99.29	-99.81	-65.60	-89.69	-94.01	-97.81	-97.12
BRD-K55991774	CP	BAS-09104376	HIV integrase inhibitor			10.00, 10.00	1.69, 0.53	-10.11	27.05	-96.85	67.69	60.47	30.03	99.98	-58.91	-54.20	50.89
BRD-A02333338	CP	cyclopamine	smoothened receptor antagonist, hedgehog pathway inhibitor	SMO, DHH, IHH, PTCH1		0.00, 0.00	1.39, 0.55	6.02	-16.56	-99.30	-53.84	-63.53	-89.79	-74.26	-87.37	-97.47	-96.96
BRD-K07888107	CP	depudecin	HDAC inhibitor	HDAC1, HDAC2	HDAC inhibitor	0.00, 0.00	2.21, 0.53	-44.87	44.32	-64.17	-76.93	-19.68	-39.04	80.96	-96.56	20.57	-29.89
BRD-A32161980	CP	carbetocin	analogue of oxytocin	OXTR		10.00, 0.00	1.08, 0.42	-15.51	35.38	-32.58	11.00	26.19	25.41	96.67	61.87	94.43	62.47
BRD-K50140147	CP	NVP-TAE684	ALK tyrosine kinase receptor inhibitor, ALK tyrosine kinase receptor mutant inhibitor, leucine rich repeat kinase inhibitor	ALK, INSR		0.00, 0.00	1.82, 0.51	-99.86	-99.28	-99.54	-99.19	-52.51	-89.71	-99.68	-94.95	-97.63	-98.56
BRD-K92723993	CP	imatinib	PDGFR tyrosine kinase receptor inhibitor, Bcr-Abl kinase inhibitor, KIT inhibitor, Abl kinase inhibitor, apoptosis stimulant, breast cancer resistance protein inhibitor, colony stimulating factor receptor inhibitor	ABL1, KIT, PDGFRA, BCR, CSF1R, PDGFRB, ABCG2, CYP2C19, CYP2C8, CYP3A5, DDR1, NTRK1, RET		0.00, 0.00	1.03, 0.19	-74.68	45.20	-83.95	-92.51	-50.35	-43.14	-48.87	-98.60	-63.01	-78.72
BRD-K49865102	CP	PD-0325901	MEK inhibitor, MAP kinase inhibitor, protein kinase inhibitor	MAP2K1, MAP2K2	MEK inhibitor	10.00, 0.00	1.34, 0.64	-52.81	53.11	-42.04	-98.40	15.53	75.19	95.05	-53.78	81.27	39.21
BRD-K63068307	CP	ZSTK-474	PI3K inhibitor	PIK3CG, PIK3CA, PIK3CB, PIK3CD	PI3K inhibitor	0.00, 0.00	1.91, 0.60	-32.38	-100.00	-66.73	-93.93	-65.57	-31.73	22.05	-96.43	-55.73	-95.12
BRD-K17743125	CP	belinostat	HDAC inhibitor, cell cycle inhibitor	HDAC1, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9	HDAC inhibitor	0.00, 0.00	1.84, 0.53	-95.09	-70.75	-85.07	-81.61	-99.54	-29.94	-99.73	-78.23	-99.43	-98.45
BRD-K71512533	CP	SNS-314	Aurora kinase inhibitor	AURKA, AURKB, AURKC	Aurora kinase inhibitor	20.00, 10.00	0.99, 0.30	-14.63	99.96	-45.93	-93.48	54.18	-42.83	97.37	89.69	-67.24	83.18
BRD-K89839824	CP	raltitrexed	thymidylate synthase inhibitor, pyrimidine antagonist	TYMS, FPGS	Thymidylate synthase inhibitor	0.00, 0.00	0.86, 0.26	-67.88	-57.32	-99.35	-81.24	20.40	-25.45	-99.84	-98.62	36.45	-98.56
BRD-K77175907	CP	calcifediol	vitamin D receptor agonist	VDR	Vitamin D receptor agonist	0.00, 0.00	0.88, 0.28	48.68	-96.03	-30.48	-95.13	-57.71	-58.05	-24.35	-59.88	-56.00	-38.16
BRD-K50387473	CP	XMD-892	MAP kinase inhibitor, BMK inhibitor, leucine rich repeat kinase inhibitor	MAPK7, DCLK2, LRRK2, PLK4, TNK1	Bromodomain Inhibitor, Leucine rich repeat kinase inhibitor	0.00, 0.00	1.06, 0.53	-89.23	79.88	-58.51	14.73	-45.01	-66.98	49.91	-24.20	36.13	-19.65
BRD-K32836707	CP	CAY-10577	casein kinase inhibitor			10.00, 10.00	1.09, 0.41	42.40	-82.13	92.89	-87.37	-53.63	73.85	47.25	99.88	81.02	88.71
BRD-K24994810	CP	androstenol	GABA receptor modulator	NR1I3		0.00, 0.00	1.14, 0.36	89.25	78.59	38.24	94.72	-22.78	-45.04	60.96	18.48	35.37	85.38
BRD-K40255344	CP	tyrphostin-A9	protein tyrosine kinase inhibitor, tyrosine kinase inhibitor			0.00, 0.00	2.16, 0.70	-96.77	-98.40	-79.18	-96.18	-57.84	-34.83	-41.53	-94.02	-69.94	-93.27
BRD-K06080977	CP	eicosatetraynoic-acid	cyclooxygenase inhibitor, lipoxygenase inhibitor	ALOX12, PPARA, PPARG, PTGS1		0.00, 0.00	0.90, 0.25	55.42	39.89	-23.74	88.46	48.83	85.91	61.97	83.58	68.82	70.48
BRD-K72703948	CP	ZM-447439	Aurora kinase inhibitor	AURKA, AURKB	Aurora kinase inhibitor	10.00, 0.00	0.55, 0.18	32.39	-23.64	-88.05	-38.59	91.40	91.18	97.37	-99.72	-98.73	-76.87
BRD-K97764662	CP	PD-173074	FGFR inhibitor, VEGFR inhibitor	FGFR1, FGFR3, FGFR2, FGFR4, FLT1, FLT4, KDR, PDGFRA, PDGFRB	FGFR inhibitor, VEGFR inhibitor	10.00, 0.00	1.28, 0.40	-22.84	-45.20	-82.43	66.00	-43.48	-66.74	-49.25	14.71	96.90	-44.05
BRD-K99369265	CP	sirolimus	mTOR inhibitor, CCR expression inhibitor, cell cycle inhibitor, proteasome inhibitor, protein kinase inhibitor, T cell inhibitor	MTOR, FKBP1A, CCR5, FGF2		0.00, 0.00	0.99, 0.43	46.06	-93.58	-90.48	-14.27	-34.56	-68.09	-30.20	3.58	-34.06	-26.11
BRD-M64432851	CP	sunitinib	FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor, angiogenesis inhibitor, colony stimulating factor receptor antagonist, colony stimulating factor receptor inhibitor, platelet-derived growth factor receptor (PDGFR) inhibitor, vascular endothelial growth factor receptor (VEGFR) inhibitor, vascular endothelial growth factor receptor 1 (VEGFR1) inhibitor, vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor, VEGFR antagonist	FLT3, KDR, KIT, FLT4, FLT1, PDGFRA, PDGFRB, RET, CSF1R, FGFR1	FLT3 inhibitor, PDGFR/KIT inhibitor, RAF inhibitor, VEGFR inhibitor	10.00, 0.00	1.50, 0.52	-93.68	-99.90	97.36	-86.54	-86.64	-24.25	54.23	-99.36	52.82	-88.68
BRD-K83988098	CP	alvespimycin	HSP inhibitor, HSP antagonist	HSP90AA1	HSP inhibitor	0.00, 0.00	1.89, 0.56	-43.86	-53.93	-81.30	-20.56	25.19	-55.36	-61.41	-22.55	-82.03	-51.60
BRD-K17823458	CP	danoprevir	HCV inhibitor, serine protease inhibitor			0.00, 0.00	0.92, 0.30	62.84	-61.65	-27.18	84.32	-48.91	41.27	65.84	93.89	91.28	82.15
BRD-K08206212	CP	entecavir	DNA directed DNA polymerase inhibitor, DNA polymerase inhibitor, DNA replication inhibitor, reverse transcription inhibitor, transcription inhibitor		Reverse transcriptase inhibitor	10.00, 10.00	0.91, 0.33	77.64	22.96	-86.89	-40.56	41.19	-26.68	-90.28	98.48	-38.00	-20.55
BRD-K77008974	CP	WYE-354	mTOR inhibitor	MTOR	MTOR inhibitor	0.00, 0.00	1.44, 0.57	-95.25	-99.65	15.71	-99.03	-97.78	-44.61	59.25	-98.60	37.39	-98.31
BRD-K09186807	CP	KIN001-244	phosphoinositide dependent kinase inhibitor	PDPK1		0.00, 0.00	1.56, 0.55	-6.57	-99.89	-25.23	-27.03	36.52	32.95	-46.86	-33.14	78.35	-7.80
BRD-A26199074	CP	calmidazolium	calcium channel blocker, calmodulin antagonist	ATP2B1, PDE1A		0.00, 0.00	2.27, 0.38	-71.18	55.39	-77.48	-47.34	NaN	-35.38	45.64	-76.36	-84.71	-88.32
BRD-A37837077	CP	cyclazosin	adrenergic receptor antagonist	ADRA1B, ADRA1A, ADRA1D		10.00, 0.00	0.94, 0.30	38.73	-12.01	-97.55	17.72	93.98	95.27	42.50	-19.25	85.12	48.35
BRD-K98426715	CP	tubacin	HDAC inhibitor	HDAC6		0.00, 0.00	0.88, 0.25	62.17	30.31	53.88	-93.92	-28.73	-61.18	38.60	88.60	-51.34	29.79
BRD-A25576662	CP	streptozotocin	DNA alkylating drug	SLC2A2		11.11, 11.11	1.32, 0.58	30.32	60.18	-96.53	-43.99	-43.82	-65.60	46.52	99.94	NaN	27.53
BRD-A29644307	CP	nomifensine	norepinephrine-dopamine reuptake inhibitor	SLC6A2, SLC6A3, DRD2, MAOA, MAOB, MPO		11.11, 11.11	1.27, 0.43	30.00	99.42	51.37	-99.93	85.66	87.86	91.03	19.75	NaN	90.95
BRD-A64479082	CP	quinidine	cytochrome P450 inhibitor, P glycoprotein inhibitor, sodium current blocker	SCN5A, ABCB1, CYP2D6, KCNA5, KCNA7, KCNH1, KCNH2, KCNH5, KCNK1, KCNK6, SLC29A4	Sodium channel blocker	0.00, 0.00	1.06, 0.36	-58.77	-33.25	-29.00	81.46	-61.10	-65.67	38.71	9.89	NaN	-18.03
BRD-A80793822	CP	pemoline	non-narcotic dopaminergic compound			11.11, 11.11	0.68, 0.18	-50.23	-31.96	-67.66	46.68	-48.87	99.40	87.03	-33.69	NaN	-26.94
BRD-A82307304	CP	atorvastatin	HMGCR inhibitor, dipeptidyl peptidase inhibitor, tumor necrosis factor expression inhibitor	HMGCR, DPP4, AHR, CYP3A5, FASLG		0.00, 0.00	0.97, 0.35	-85.26	-73.35	70.58	42.72	-31.08	-75.35	56.76	-16.61	NaN	-55.68
BRD-K04389336	CP	labetalol	adrenergic receptor antagonist	ADRB1, ADRB2, ADRA1A, ADRA1D, ADRA1B		0.00, 0.00	1.38, 0.41	-16.05	88.15	-17.19	-21.51	46.36	34.51	-26.03	-28.83	NaN	-3.20
BRD-K10852020	CP	tolcapone	catechol O methyltransferase inhibitor, transthyretin amyloid inhibitor	COMT, TTR		22.22, 11.11	1.28, 0.36	-96.19	98.16	-29.39	-43.39	66.96	37.26	28.48	97.37	NaN	36.26
BRD-K15502390	CP	nevirapine	non-nucleoside reverse transcriptase inhibitor, reverse transcriptase inhibitor	CYP2B6, CYP2C19, CYP3A4	Reverse transcriptase inhibitor	0.00, 0.00	0.91, 0.23	83.41	91.99	5.19	-40.74	32.63	-32.18	41.23	57.68	NaN	33.29
BRD-K34098590	CP	tienilic-acid	sodium/potassium/chloride transporter inhibitor, uric acid diuretic	CYP2C9, SLC12A1, SLC22A12		0.00, 0.00	1.44, 0.52	-80.45	29.70	73.12	-41.86	86.14	45.93	55.43	-50.86	NaN	36.06
BRD-K35573744	CP	erbstatin-analog	EGFR inhibitor, tyrosine kinase inhibitor	EGFR		11.11, 0.00	1.30, 0.33	21.83	95.40	-54.68	-24.99	-77.37	81.71	37.74	-71.37	NaN	-40.57
BRD-K37194137	CP	III606050	cytochrome P450 inhibitor			0.00, 0.00	1.08, 0.27	-70.40	-99.91	-46.06	-30.64	39.99	-68.99	-45.49	-97.99	NaN	-73.35
BRD-K44276885	CP	acarbose	glucosidase inhibitor	GAA, MGAM, AMY2A, SI		0.00, 0.00	0.75, 0.22	86.34	-29.83	-77.82	-45.56	43.49	-65.76	-26.46	88.99	89.21	22.60
BRD-K47679368	CP	bromfenac	cyclooxygenase inhibitor	PTGS1, PTGS2		0.00, 0.00	1.44, 0.48	22.30	74.07	-19.00	-29.39	-47.06	38.33	-40.15	51.40	NaN	24.40
BRD-K55301415	CP	abiraterone	17,20 lyase inhibitor, androgen biosynthesis inhibitor, cytochrome P450 inhibitor, steroid sulfatase inhibitor	CYP17A1, CYP11B1		0.00, 0.00	1.34, 0.45	71.32	-15.58	-30.74	31.27	-42.59	92.87	82.27	-70.60	NaN	54.06
BRD-K64517075	CP	heliomycin	antibiotic, bacterial RNA synthesis inhibitor			0.00, 0.00	2.15, 0.80	-96.98	-98.62	-85.31	-89.62	-56.15	-70.31	-97.76	-92.96	NaN	-94.03
BRD-K66043364	CP	noscapine	bradykinin receptor antagonist, tubulin polymerization inhibitor, apoptosis stimulant, microtubule inhibitor, tubulin inhibitor	BDKRB2, SIGMAR1		11.11, 11.11	1.14, 0.39	20.83	99.93	-16.16	-58.84	-99.04	60.02	-51.62	-95.17	NaN	-34.09
BRD-K66788707	CP	fludarabine	DNA synthesis inhibitor, DNA repair enzyme inhibitor, purine antagonist, ribonucleotide reductase inhibitor	ADA, DCK, POLA1, RRM1, RRM2	DNA synthesis inhibitor, Ribonucleotide reductase inhibitor	0.00, 0.00	0.98, 0.33	-99.69	-99.26	-83.65	-98.48	-48.21	-99.97	-35.71	-50.12	NaN	-99.82
BRD-K71926323	CP	marbofloxacin	DNA gyrase inhibitor		Bacterial DNA gyrase inhibitor	0.00, 0.00	1.03, 0.36	10.59	18.12	65.88	-26.97	-45.95	41.80	56.63	11.76	NaN	20.33
BRD-K79602928	CP	metformin	insulin sensitizer, AMPK activator, biguanide, gluconeogenesis inhibitor	ACACB, INS, PRKAB1		0.00, 0.00	1.72, 0.47	56.16	18.31	-75.25	-64.94	-31.31	73.66	-63.54	-14.64	NaN	-20.86
BRD-K81473089	CP	tacrine	acetylcholinesterase inhibitor, acetylcholine release stimulant, butyrylcholinesterase inhibitors, potassium channel antagonist	ACHE, BCHE		11.11, 11.11	0.77, 0.17	-22.51	-32.94	40.49	37.16	34.11	-33.18	99.73	20.63	NaN	11.07
BRD-K93034159	CP	cladribine	adenosine deaminase inhibitor, antimetabolite, DNA synthesis inhibitor, immunosuppressant, ribonucleotide reductase inhibitor	ADA, PNP, POLA1, POLE, POLE2, POLE3, POLE4, RRM1, RRM2, RRM2B	Ribonucleotide reductase inhibitor	0.00, 0.00	1.42, 0.52	-99.13	-99.74	-99.07	-99.98	-91.44	-97.95	-99.72	-99.54	-98.14	-99.47
BRD-K98763141	CP	niflumic-acid	cyclooxgenase inhibitor	CLCNKA, PTGS2, ANO1, CLCN1, CLCNKB, KCNQ1, PLA2G1B, PLA2G4A, PTGS1, UGT1A9		0.00, 0.00	1.09, 0.39	-20.39	-47.08	61.85	42.26	94.23	49.22	76.30	49.80	NaN	50.98
BRD-K03406345	CP	azacitidine	DNA methyltransferase inhibitor, antimetabolite, DNA methylase inhibitor, DNA synthesis inhibitor, RNA synthesis inhibitor	DNMT1		0.00, 0.00	2.08, 0.81	-98.70	-99.06	-96.22	-82.17	90.99	-36.48	-35.95	-50.16	NaN	-96.41
BRD-A29260609	CP	acebutolol	adrenergic receptor antagonist	ADRB1, ADRB2		11.11, 11.11	1.13, 0.31	54.76	-9.36	85.64	54.78	99.89	49.39	-98.98	-25.89	NaN	48.55
BRD-A16754160	CP	ampicillin	cell wall synthesis inhibitor	SLC15A1		11.11, 11.11	1.13, 0.38	81.51	-32.96	-21.66	31.06	43.40	99.85	40.05	56.13	NaN	35.41
BRD-K68264559	CP	brimonidine	adrenergic receptor agonist	ADRA2A, ADRA2B, ADRA2C, AOX1		0.00, 0.00	0.86, 0.16	84.90	12.93	26.47	-44.16	-62.72	-7.64	36.93	42.68	36.90	5.87
BRD-A34299591	CP	budesonide	glucocorticoid receptor agonist, glucocordicoid receptor antagonist, immunosuppressant	NR3C1, CYP3A5, CYP3A7		0.00, 0.00	1.40, 0.80	73.29	-58.18	12.63	-44.60	-66.76	-23.25	-57.98	23.25	NaN	-18.42
BRD-K93461745	CP	buspirone	serotonin receptor agonist, serotonin receptor partial agonist	HTR1A, DRD2		0.00, 0.00	0.68, 0.15	-43.39	36.09	32.99	61.29	75.51	-66.95	56.74	28.69	-43.77	24.87
BRD-K63641886	CP	cefuroxime	cell wall synthesis inhibitor		Bacterial cell wall synthesis inhibitor	0.00, 0.00	1.75, 0.41	17.76	46.08	-21.72	-53.32	94.87	-42.72	-69.55	22.02	NaN	-11.14
BRD-K37289225	CP	clozapine	serotonin receptor antagonist, dopamine receptor antagonist, adrenergic receptor antagonist	DRD2, DRD4, ADRA1A, ADRA1B, CHRM1, DRD1, DRD3, HRH1, HRH4, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR6, HTR7, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CALY, CHRM2, CHRM3, CHRM4, CHRM5, CYP2C19, DRD5, HTR1F, HTR2B, HTR3A, HTR5A	Dopamine receptor antagonist, Serotonin receptor antagonist	0.00, 0.00	0.73, 0.14	-35.26	-80.96	28.40	48.52	89.44	-96.79	-81.99	-22.73	-46.84	-30.75
BRD-K20920669	CP	cromoglicic-acid	immunosuppressant	KCNMA1, S100P		11.11, 0.00	1.11, 0.34	46.16	-34.41	38.33	95.75	56.85	-51.86	94.56	40.50	NaN	30.96
BRD-A09722536	CP	cyclophosphamide	alkylating agrent, BCL inhibitor, galectin inhibitor	BCL2, CYP2B6, CYP2C19, CYP3A5, LGALS1		0.00, 0.00	1.06, 0.41	63.82	16.95	-54.02	-74.03	88.64	26.07	-27.84	91.77	NaN	35.56
BRD-K87226815	CP	cycloserine	glutamate receptor agonist, glutamate receptor modulator	GRIN1		11.11, 11.11	0.73, 0.23	97.86	-13.00	64.39	-40.27	-74.00	66.37	-13.25	94.63	NaN	43.16
BRD-K62363391	CP	dapsone	dihydrofolate reductase inhibitor, dihydropteroate synthase inhibitor, FOLP inhibitor	DHFR	Dihydrofolate reductase inhibitor	0.00, 0.00	1.40, 0.41	54.67	12.76	69.25	85.15	38.89	41.04	-97.13	-28.71	NaN	36.26
BRD-K81128206	CP	edrophonium	acetylcholinesterase inhibitor	ACHE, BCHE		0.00, 0.00	0.90, 0.33	50.04	-27.13	32.63	-50.03	42.07	-30.48	-28.63	23.95	NaN	7.86
BRD-K63828191	CP	raloxifene	estrogen receptor antagonist, selective estrogen receptor modulator (SERM), ALK expression enhancer, cholesterol inhibitor, endoglin expression enhancer, estrogen receptor agonist	ESR1, ESR2, ACVRL1, ENG	Estrogen receptor antagonist	40.00, 40.00	0.43, 0.34	99.69	-39.47	85.02	98.80	90.38	84.88	67.79	-99.81	99.73	97.76
BRD-A09472452	CP	flecainide	sodium channel blocker, sodium channel inhibitor, voltage-gated sodium channel blocker	SCN5A, KCNA5, KCNA7, SCN4A		0.00, 0.00	0.55, 0.09	48.94	62.60	-47.55	-49.63	47.81	42.76	64.03	32.35	39.04	30.66
BRD-K22662435	CP	ganciclovir	DNA directed DNA polymerase inhibitor, DNA polymerase inhibitor, DNA synthesis inhibitor		DNA polymerase inhibitor	0.00, 0.00	1.63, 0.35	12.84	14.40	-77.50	35.56	-47.08	-59.54	12.66	69.14	NaN	4.05
BRD-A17655518	CP	ibuprofen	cyclooxygenase inhibitor, NFkB pathway inhibitor	PTGS2, PTGS1, ASIC1, BCL2, CFTR, CYP2C8, FABP2, PLAT, PPARG, SLC5A8, THBD		0.00, 0.00	0.92, 0.19	-88.13	39.81	-41.12	43.36	47.37	50.13	-27.94	24.13	NaN	11.48
BRD-K76723084	CP	isotretinoin	retinoid receptor agonist, microbial collagenase inhibitor, protein synthesis inhibitor, RAR agonist	CYP2B6, CYP2C19, CYP2C8, CYP3A5, CYP3A7, NR2C2, PPARD, RARA, RARB, RARG, RORB, RORC	Retinoid receptor agonist	0.00, 0.00	0.82, 0.27	-93.41	-52.38	7.64	-99.96	-55.74	13.09	15.85	-48.55	-37.40	-58.39
BRD-A07440155	CP	labetalol	adrenergic receptor antagonist	ADRB1, ADRB2, ADRA1A, ADRA1D, ADRA1B		20.00, 10.00	0.61, 0.19	90.28	98.85	-9.99	96.27	19.11	-47.23	58.01	56.06	72.98	66.05
BRD-K91601245	CP	mercaptopurine	immunosuppressant, protein synthesis inhibitor, purine antagonist	HPRT1, IMPDH1, IMPDH2, PPAT		11.11, 11.11	1.15, 0.31	-75.07	63.59	-75.28	99.95	-30.75	-82.36	-31.52	-86.94	NaN	-61.79
BRD-M40783228	CP	mesna	sulfhydryl compound that inactivates toxic metabolites of some chemotherapeutics			0.00, 0.00	0.85, 0.32	67.21	-43.00	-66.28	-84.02	-47.09	88.68	44.73	-55.04	NaN	-51.77
BRD-A07780951	CP	orciprenaline	adrenergic receptor agonist	ADRB2	Beta-adrenergic receptor agonist	44.44, 33.33	1.14, 0.48	97.51	99.50	99.85	89.45	-59.03	-28.95	40.65	23.61	NaN	97.29
BRD-K63430059	CP	methoxsalen	acetylcholinesterase inhibitor, cytochrome P450 inhibitor, DNA damaging, DNA synthesis inhibitor, immunosuppressant	ACHE, CYP1A2		11.11, 0.00	1.16, 0.31	-79.35	-66.13	-85.81	42.90	96.29	35.71	-58.27	22.36	NaN	-64.51
BRD-K21680192	CP	mitoxantrone	topoisomerase inhibitor, DNA intercalating drug, HCV inhibitor, immunosuppressant, Pim kinase inhibitor	TOP2A, PIM1	Topoisomerase inhibitor	0.00, 0.00	2.56, 0.70	-92.04	-88.56	-83.85	-99.91	-88.08	-66.07	-71.44	-99.28	NaN	-97.92
BRD-A29734509	CP	disopyramide	voltage-gated sodium channel blocker	SCN5A, CHRM1, CHRM2, CHRM3, KCND2, KCND3, KCNH2		0.00, 0.00	0.70, 0.20	79.49	46.89	53.25	-31.27	94.91	-49.90	18.74	-25.63	41.40	44.24
BRD-A65013509	CP	oxybutynin	acetylcholine receptor antagonist	CHRM3, CHRM1, CHRM2, CHRM4		0.00, 0.00	1.14, 0.34	12.59	38.71	45.15	-63.68	41.40	-76.20	36.30	-22.13	NaN	18.10
BRD-A62326914	CP	paroxetine	cyclophilin inhibitor, norepinephrine reputake inhibitor, selective serotonin reuptake inhibitor (SSRI), serotonin reuptake inhibitor, serotonin uptake inhibitor	SLC6A4, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, HTR2A, SLC6A2		0.00, 0.00	1.34, 0.36	-76.92	-99.76	-53.09	-64.56	-60.06	61.11	-75.77	-64.97	NaN	-76.52
BRD-K01507359	CP	rifampicin	DNA directed RNA polymerase inhibitor, enzyme inducer	NR1I2, ABCB1, CYP2B6, CYP2C19, CYP2C8, CYP3A4, CYP3A5, SLCO1A2, SLCO1B1, SLCO1B3		10.00, 10.00	0.55, 0.14	-50.50	91.20	-92.26	98.12	16.76	89.64	22.99	-26.91	67.22	80.58
BRD-A50157456	CP	terbutaline	adrenergic receptor agonist	ADRB2	Beta-adrenergic receptor agonist	22.22, 22.22	1.10, 0.42	62.66	-61.01	99.89	67.40	-54.85	38.06	99.85	-26.83	NaN	70.53
BRD-A79479878	CP	testosterone	androgen receptor (AR) agonist, androgen receptor agonist, testosterone receptor agonist	AR, CYP19A1, CYP2C19, CYP2C8, CYP3A5		0.00, 0.00	1.01, 0.38	68.80	-98.01	-29.00	83.68	-52.10	33.73	59.48	-21.93	NaN	30.46
BRD-A24514565	CP	warfarin	cytochrome P450 inhibitor, vitamin inhibitor, vitamin K epoxide reductase inhibitor	VKORC1, CYP2C19, CYP2C8, CYP4F2		0.00, 0.00	0.85, 0.22	30.61	-69.73	-59.56	-34.23	86.95	87.47	-55.39	82.20	NaN	63.61
BRD-A23290232	CP	westcort	corticosteroid		Glucocorticoid receptor agonist	11.11, 11.11	1.26, 0.47	-71.14	31.33	-50.72	84.26	99.75	90.36	-71.00	11.00	NaN	71.47
BRD-K24023109	CP	diltiazem	L-type calcium channel blocker, calcium channel antagonist, calcium channel blocker	CACNA1C, CACNA1S, CACNA2D1, CACNG1, CYP3A5, CYP3A7, HTR3A, KCNA5		10.00, 0.00	0.70, 0.19	96.64	-34.54	-29.86	35.18	65.11	-41.57	8.70	-21.50	-90.58	-3.98
BRD-K38197229	CP	bumetanide	diuretic, solute carrier family member inhibitor	SLC12A1, SLC12A2, CFTR, GPR35, SLC12A4, SLC12A5		10.00, 10.00	1.00, 0.23	37.39	-16.45	-56.08	28.00	-36.07	-38.69	42.07	99.61	25.40	7.69
BRD-K55930204	CP	phenytoin	sodium channel blocker	ABCB1, CYP2B6, CYP2C19, CYP3A4, SCN1A, SCN2A, SCN5A		0.00, 0.00	1.84, 0.61	46.78	78.97	46.41	-32.69	37.96	91.75	89.53	55.13	NaN	68.48
BRD-A44827100	CP	erythromycin	NFkB pathway inhibitor, 50S ribosomal subunit inhibitor, motilin receptor agonist, RPLV inhibitor	CYP3A4, MLNR		0.00, 0.00	1.73, 0.48	47.37	40.98	-27.75	-76.57	74.96	73.57	-74.27	-22.17	NaN	22.24
BRD-K94353609	CP	fluocinolone	corticosteroid agonist, glucocorticoid receptor agonist	NR3C1, SERPINA6	Glucocorticoid receptor agonist	11.11, 0.00	1.72, 0.78	-50.03	97.14	94.72	57.88	-95.70	-97.25	70.47	-9.49	NaN	64.54
BRD-K48168960	CP	propylthiouracil	thyroperoxidase inhibitor	TPO, DIO1		0.00, 0.00	1.72, 0.64	58.20	44.94	76.82	-85.70	59.44	-37.43	-49.18	26.26	NaN	42.28
BRD-K89997465	CP	chlorpromazine	dopamine receptor, dopamine receptor antagonist, Kinesin-Like Spindle Protein  KIF11 (KSP, Eg5) Inhibitors	DRD2, ADRA2A, ADRA2B, ADRA2C, DRD1, DRD3, DRD4, DRD5, HRH1, HTR1A, HTR2A, HTR2C, HTR6, HTR7, ADRA1A, ADRA1B, ADRA1D, CALM1, CHRM1, CHRM3, HRH4, HTR2B, KCNH2, KIF11, ORM1, ORM2, SMPD1, TRPC5	Dopamine receptor antagonist	0.00, 0.00	1.59, 0.63	-97.48	78.52	-40.57	-93.30	-96.15	-80.26	39.87	-24.38	93.44	-86.43
BRD-K21520694	CP	sulfacetamide	antibiotic			11.11, 0.00	1.20, 0.33	95.99	43.55	89.25	-50.87	56.27	38.04	93.93	-30.13	NaN	79.87
BRD-A48631911	CP	mibefradil	T-type calcium channel blocker, angiogenesis inhibitor, calcium channel blocker, calcium channel inhibitor, L-type calcium channel blocker, sodium channel blocker	CACNA1G, CACNA1H, CACNA1C, CACNA1I, ANO1, CACNA1D, CACNA1F, CACNA1S, CACNB1, CACNB2, CACNB3, CACNB4, CATSPER1, CATSPER2, CATSPER3, CATSPER4, CYP3A5, CYP3A7, SCN2A, SCN4A, SCN5A, SCN9A		11.11, 11.11	1.25, 0.33	-95.86	-96.63	-77.91	38.05	-34.99	-39.85	99.96	-92.66	NaN	-95.10
BRD-K11801786	CP	trimidox	antimetabolite, ribonucleoside reductase inhibitor, ribonucleotide reductase inhibitor	RRM1		0.00, 0.00	1.60, 0.43	-16.42	-31.68	-36.52	-22.66	-53.14	50.87	-28.06	-23.75	NaN	-10.50
BRD-K68132782	CP	terbinafine	fungal squalene monooxygenase inhibitor, squalene epoxidase inhibitor, steroid sulfatase inhibitor	CYP2C19, CYP2C8, SQLE		0.00, 0.00	0.82, 0.14	49.16	87.47	-32.32	-89.50	92.29	-87.73	24.09	-55.26	NaN	-73.78
BRD-K57886322	CP	fluocinonide	corticosteroid agonist, corticosteroid hormone receptor agonist	NR3C1, SERPINA6, SMO	Glucocorticoid receptor agonist	11.11, 11.11	1.57, 0.53	-54.97	99.96	-48.55	-37.59	28.70	-45.15	40.04	74.22	NaN	16.88
BRD-K40645748	CP	mefloquine	acidifying agent non gastric, adenosine receptor antagonist, calmodulin antagonist, hemoglobin antagonist, pannexin inhibitor	ADORA2A, HBA1, PANX1		11.11, 11.11	1.34, 0.28	-75.44	59.06	58.06	-44.04	-69.72	-42.01	99.67	-54.71	NaN	-41.54
BRD-K10016611	CP	pyridine-2-aldoxime	acetylcholinesterase inhibitor	ACHE, BCHE		0.00, 0.00	1.45, 0.59	-88.53	-19.17	77.38	-23.70	-40.87	-43.07	77.71	43.56	NaN	-15.33
BRD-K53790871	CP	triamcinolone	antiinflammatory agent, corticosteroid agonist, corticosteroid binding globulin binder, corticosteroid hormone receptor agonist, cytochrome P450 inhibitor, glucocorticoid receptor agonist, immunosuppressant, immunosuppressive agent	NR3C1, CYP3A5, CYP3A7, SERPINA6	Glucocorticoid receptor agonist	0.00, 0.00	1.48, 0.52	-57.71	79.89	-54.54	69.16	-43.15	46.07	-62.03	11.18	NaN	26.60
BRD-K92073408	CP	norethisterone	ovulation inhibitor	PGR		10.00, 10.00	0.67, 0.20	29.63	-96.52	41.88	38.58	-33.14	55.75	55.85	99.62	58.65	24.07
BRD-K02265150	CP	amoxapine	adrenergic transmitter uptake inhibitor, dopamine receptor, norepinephrine reputake inhibitor, serotonin receptor antagonist, serotonin reuptake inhibitor, serotonin uptake inhibitor, tricyclic antidepressant	SLC6A2, SLC6A4, HTR2A, HTR6, ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, HRH1, HRH4, HTR1A, HTR1B, HTR2B, HTR2C, HTR3A, HTR7, SLC6A3	Norepinephrine reuptake inhibitor	0.00, 0.00	1.20, 0.32	-25.94	-82.74	-47.20	-45.91	-96.74	-80.67	-41.61	-31.60	-81.11	-72.79
BRD-K86434416	CP	selegiline	monoamine oxidase inhibitor, superoxide dismutase stimulant	MAOB, MAOA, CYP2B6, CYP2C19		0.00, 0.00	0.80, 0.26	42.96	-49.60	52.10	54.06	35.06	-99.32	45.08	-26.52	NaN	19.09
BRD-A67799922	CP	phenoxybenzamine	adrenergic receptor antagonist	ADRA2B, ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2C, ADRB2, CALM1		0.00, 0.00	0.77, 0.15	-75.47	-42.06	-96.08	-36.36	-91.20	72.22	-99.64	-82.24	-92.85	-93.94
BRD-K36862742	CP	hydroflumethiazide	sodium/potassium/chloride transporter inhibitor	SLC12A1, ATP1A1, CA1, CA12, CA2, CA4, CA9, KCNMA1		11.11, 0.00	1.64, 0.39	-61.64	-49.08	47.06	-68.95	67.65	89.44	96.80	39.03	NaN	51.92
BRD-K95237249	CP	probenecid	MRP inhibitor, TRPV agonist, uricosuric blocker	SLC22A6, ABCC1, PANX1, SLC22A11, SLC22A8, SLCO1C1, TRPV2		0.00, 0.00	1.38, 0.33	91.98	-13.31	-26.50	-29.99	84.20	91.50	52.85	80.36	54.51	79.94
BRD-K79116891	CP	proxymetacaine	membrane integrity inhibitor, potassium channel antagonist, sodium channel blocker	SCN10A, SCN5A, SCN9A		20.00, 10.00	0.83, 0.20	99.13	-31.28	71.19	49.46	37.33	69.01	95.42	-18.13	92.77	89.25
BRD-K50859149	CP	sulfafurazole	endothelin receptor antagonist, FOLP inhibitor		Dihydrofolate reductase inhibitor	0.00, 0.00	1.09, 0.25	13.72	15.18	32.88	-64.88	-67.34	52.10	29.71	-20.61	-27.95	-7.19
BRD-K92049597	CP	triamterene	sodium channel blocker	SCNN1A, SCNN1B, SCNN1G, SCNN1D	Sodium channel blocker	10.00, 10.00	0.78, 0.23	50.72	98.60	77.05	-86.90	-35.18	65.18	-30.97	-30.46	-52.87	49.97
BRD-A91555231	CP	norepinephrine	adrenergic receptor agonist, DNA inhibitor, free radical scavenger	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB3, ADRB2, DRD1, DRD5, PAH, SLC18A1, SLC18A2		11.11, 0.00	1.61, 0.43	43.52	-84.48	96.46	-35.75	82.11	80.06	90.58	54.48	NaN	87.73
BRD-A31312900	CP	montelukast	leukotriene receptor antagonist	CYSLTR1, ALOX5, CYP2C8		0.00, 0.00	1.17, 0.31	-49.87	53.70	59.74	-60.37	33.39	44.43	47.99	61.24	NaN	39.89
BRD-A67605442	CP	tetrahydrobiopterin	nitric oxide stimulant, nitric oxide synthase stimulant, phenylalanine 4-hydroxylase stimulant, nitric oxide synthase activator	PAH, TH, DBH, NOS3, TPH1		0.00, 0.00	1.30, 0.36	-8.88	36.26	72.15	63.72	-45.66	35.92	34.41	66.84	NaN	30.71
BRD-A79237180	CP	ascorbic-acid	vitamin C, antioxidant	AKR1B1		11.11, 11.11	1.89, 0.52	-48.61	-87.61	-32.73	-72.13	-35.81	-34.58	51.34	99.85	NaN	-34.73
BRD-K47323024	CP	methapyrilene	histamine receptor antagonist		HRH1 antagonist	0.00, 0.00	1.35, 0.44	-41.44	-27.33	50.56	75.74	33.94	-35.95	-61.91	23.73	NaN	27.33
BRD-K88568253	CP	iproniazid	monoamine oxidase inhibitor	MAOA, MAOB		11.11, 11.11	0.60, 0.25	-61.61	-32.79	-44.12	-73.04	50.71	33.89	-84.34	99.82	NaN	-54.50
BRD-K90543092	CP	levonorgestrel	estrogen receptor agonist, glucocorticoid receptor antagonist, progesterone receptor agonist, progesterone receptor antagonist	PGR, AR, CYP2E1, ESR1, SRD5A1	Progesterone receptor agonist	11.11, 11.11	1.13, 0.44	-18.67	-98.23	-69.98	-37.44	-47.71	-44.44	99.10	33.02	NaN	-24.70
BRD-K96037667	CP	norethindrone	ovulation inhibitor, progesterone receptor agonist	PGR	Progesterone receptor agonist	11.11, 11.11	1.01, 0.34	-46.32	-97.65	44.77	-83.08	97.83	-60.80	-85.36	61.66	NaN	-83.25
BRD-K97810537	CP	beclometasone	glucocorticoid receptor agonist, corticosteroid hormone receptor agonist, immunosuppressant	NR3C1, CYP3A5, GPR97, SERPINA6	Glucocorticoid receptor agonist	0.00, 0.00	1.28, 0.67	21.92	21.15	69.45	32.97	-59.73	-98.64	80.33	-37.30	-54.71	10.50
BRD-A65282128	CP	cefazolin	cell wall synthesis inhibitor	PON1, SLC22A8		0.00, 0.00	1.34, 0.35	57.27	-18.86	-99.86	-41.97	-92.57	36.57	-73.61	73.37	NaN	-66.16
BRD-K29950728	CP	clomifene	estrogen receptor antagonist, estrogen receptor modulator, selective estrogen receptor modulator (SERM), testosterone receptor agonist	ESR1, AR	Estrogen receptor antagonist	0.00, 0.00	0.81, 0.19	-46.93	-19.36	-50.98	43.75	-88.58	-48.13	51.83	-99.43	-34.19	-39.87
BRD-K86161929	CP	cortisone	glucocorticoid receptor agonist	NR3C1		0.00, 0.00	1.23, 0.40	-46.52	-22.89	-36.65	-36.92	47.69	27.46	-79.07	58.17	NaN	-10.28
BRD-A86044036	CP	flurbiprofen	cyclooxygenase inhibitor	PTGS1, PTGS2		0.00, 0.00	1.57, 0.39	-28.54	28.66	29.20	-59.11	6.86	-19.35	-46.79	-32.91	NaN	-8.06
BRD-K73978287	CP	hydrocortisone	corticosteroid agonist, glucocorticoid receptor agonist, immunosuppressant, interleukin receptor antagonist	ANXA1, NOS2, NR3C1, NR3C2	Glucocorticoid receptor agonist	11.11, 11.11	1.49, 0.48	32.73	99.93	76.34	51.90	-31.04	-43.26	26.78	-43.65	NaN	25.51
BRD-K93568044	CP	hydrocortisone	corticosteroid agonist, glucocorticoid receptor agonist, immunosuppressant, interleukin receptor antagonist	ANXA1, NOS2, NR3C1, NR3C2		0.00, 0.00	1.36, 0.50	89.41	48.95	58.33	41.98	-98.10	-89.57	88.02	20.76	NaN	56.61
BRD-K67511046	CP	naloxone	opioid receptor antagonist	OPRM1, OPRK1, OPRD1, CREB1, ESR1, TLR4		0.00, 0.00	0.55, 0.13	85.16	35.50	19.36	-28.11	64.42	-13.49	67.69	77.31	NaN	43.80
BRD-K32247306	CP	primidone	GABA receptor antagonist, unidentified pharmacological activity	GABRA1, CHRNA4, CHRNA7, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA2, GRIK2		20.00, 10.00	0.44, 0.11	99.60	74.08	-33.82	42.60	97.09	-62.11	63.06	9.98	-13.07	61.46
BRD-K90885812	CP	propantheline	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4		0.00, 0.00	1.42, 0.36	68.54	43.71	-39.23	30.70	47.25	-41.24	-45.20	76.56	NaN	63.12
BRD-K75089421	CP	procainamide	sodium channel blocker, voltage-gated sodium channel blocker	SCN5A, DNMT1		0.00, 0.00	0.63, 0.13	35.83	25.28	-66.31	60.58	93.46	-60.34	7.91	-50.37	52.51	18.78
BRD-K11905747	CP	spectinomycin	30S ribosomal subunit inhibitor		Bacterial 30S ribosomal subunit inhibitor	0.00, 0.00	0.88, 0.34	83.17	61.67	-35.37	-52.79	51.52	-64.41	-46.06	78.30	NaN	64.92
BRD-K90027355	CP	spironolactone	mineralocorticoid receptor antagonist, androgen receptor antagonist, potassium channel blocker	NR3C2, AR, CACNA1A, CACNA1B, CACNA1C, CACNA1D, CACNA1F, CACNA1G, CACNA1H, CACNA1I, CACNA1S, CACNA2D1, CACNA2D2, CACNA2D3, CACNB1, CACNB2, CACNB3, CACNB4, CACNG1, CYP11B2, KCNA5, KCND3, NR3C1, PGR, SCNN1A, SHBG		10.00, 10.00	0.53, 0.15	-30.87	-98.49	-99.02	67.53	-62.98	99.57	-29.73	69.96	24.57	34.29
BRD-K93880783	CP	stavudine	DNA directed DNA polymerase inhibitor, nucleoside reverse transcriptase inhibitor, reverse transcriptase inhibitor		Nucleoside reverse transcriptase inhibitor, Reverse transcriptase inhibitor	0.00, 0.00	0.86, 0.26	32.79	41.78	67.24	90.89	34.99	42.07	26.22	-24.51	NaN	34.79
BRD-A36217750	CP	sulfinpyrazone	platelet aggregation inhibitor	ABCC1, ABCC2, FPR1, SLC22A12		0.00, 0.00	0.36, 0.06	-64.75	55.78	-97.32	-30.13	-68.79	39.71	-51.57	41.45	NaN	-40.38
BRD-A87848830	CP	bimatoprost	prostanoid receptor agonist	PTGFR, AKR1C3, PTGER1, PTGER3		11.11, 11.11	1.51, 0.40	71.48	-83.91	-92.07	-29.09	82.63	99.93	-29.83	-35.35	NaN	-27.28
BRD-K11558771	CP	droxinostat	HDAC inhibitor	HDAC6, HDAC8	HDAC inhibitor	0.00, 0.00	0.93, 0.40	-98.76	-55.34	-64.25	-98.47	-99.80	-49.84	-78.52	-99.26	NaN	-99.19
BRD-K12002134	CP	megestrol	progesterone receptor agonist, DNA inhibitor, HegG2 inhibitor	PGR	Progesterone receptor agonist	11.11, 0.00	1.36, 0.45	-59.22	-69.27	22.38	36.11	-36.62	-70.47	41.22	96.95	NaN	-45.31
BRD-K35458079	CP	edaravone	free radical scavenger	BCL2		0.00, 0.00	1.28, 0.38	15.23	-25.05	76.69	-41.86	93.21	91.23	-76.92	-43.33	NaN	43.78
BRD-K49519144	CP	LY-2140023	glutamate receptor agonist	GRM3, GRM2		0.00, 0.00	0.95, 0.25	-24.83	-5.70	42.72	-42.13	-47.44	61.73	-27.66	79.47	NaN	-7.84
BRD-K71289571	CP	zafirlukast	leukotriene receptor antagonist	CYSLTR1, CYSLTR2		11.11, 11.11	0.97, 0.27	-85.99	48.09	-60.84	-70.60	99.28	41.33	63.81	54.26	NaN	18.61
BRD-K75430629	CP	BRD-K75430629	PI3K inhibitor	PIK3CD		0.00, 0.00	1.33, 0.44	73.93	-31.04	59.69	57.76	-82.20	41.41	58.10	-47.19	NaN	40.98
BRD-K88868628	CP	iodoacetic-acid	cysteine peptidase inhibitor			0.00, 0.00	1.67, 0.34	-99.63	-63.35	-52.32	-50.99	-39.84	-97.32	-99.96	-67.12	NaN	-95.42
BRD-K81272440	CP	dantrolene	calcium channel antagonist	RYR1, RYR3		0.00, 0.00	0.70, 0.14	-13.40	35.82	4.13	37.71	24.80	-67.59	9.43	42.77	-48.45	8.41
BRD-K22031190	CP	diflunisal	cyclooxygenase inhibitor, prostanoid receptor inhibitor	PTGS2, PTGS1		0.00, 0.00	1.05, 0.19	-38.40	46.03	61.39	-39.97	-34.98	57.58	-95.88	23.18	-30.81	-15.97
BRD-A13188892	CP	doxazosin	adrenergic receptor antagonist	ADRA1D, ADRA1A, ADRA1B, CYP2C19, KCNH2, KCNH6, KCNH7		11.11, 11.11	1.22, 0.38	-57.71	24.96	51.22	53.59	99.52	-30.55	-24.28	71.11	NaN	48.15
BRD-K44497846	CP	enalapril	angiotensin converting enzyme inhibitor, angiotensin receptor blocker	ACE		0.00, 0.00	1.09, 0.33	-26.90	-20.31	40.77	52.17	-81.44	-39.56	70.76	-7.62	NaN	12.05
BRD-K08273968	CP	griseofulvin	microtubule inhibitor, microtubule stabilizing agent, mitosis inhibitor	KRT12		0.00, 0.00	1.07, 0.24	-92.45	89.04	49.11	37.80	-39.90	32.32	88.31	-81.90	NaN	24.25
BRD-A05352148	CP	ipratropium	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5		0.00, 0.00	0.75, 0.27	76.58	21.44	-53.41	-27.67	-64.40	-40.46	-77.58	38.52	-8.31	-10.11
BRD-A79803969	CP	memantine	glutamate receptor antagonist, glutamate release inhibitor	GRIN1, CHRFAM7A, CYP2E1, DRD2, GRIN2A, GRIN2B, GRIN3A, HTR3A		11.11, 11.11	1.36, 0.72	24.02	-79.07	-97.94	97.71	70.15	-39.00	91.61	-21.29	NaN	42.57
BRD-K83153774	CP	mirtazapine	adrenergic receptor antagonist, serotonin receptor antagonist	ADRA2A, HTR2A, HTR2C, ADRA2C, HTR3A, ADRA1A, ADRA1B, ADRA1D, ADRA2B, ADRB1, ADRB2, DRD1, DRD2, DRD3, DRD5, HRH1, HRH3, HTR2B, HTR7, OPRK1, SLC6A2, SLC6A3, SLC6A4		0.00, 0.00	1.10, 0.35	37.70	-99.39	-22.93	-72.92	-82.68	-95.41	36.45	-7.23	NaN	-85.79
BRD-K89348303	CP	ramipril	angiotensin converting enzyme inhibitor	ACE		0.00, 0.00	0.77, 0.11	60.16	-91.91	-17.21	-33.78	-59.85	-31.41	-16.69	17.25	NaN	-12.36
BRD-K08806317	CP	timolol	adrenergic receptor antagonist	ADRB2, ADRB1		0.00, 0.00	0.59, 0.10	51.29	-44.59	57.35	-45.70	-98.89	-65.06	-63.66	70.11	62.82	-33.40
BRD-K85119730	CP	tolbutamide	ATP channel blocker	ABCC8, CYP2B6, CYP2C19, CYP2C8, KCNJ1, KCNJ11, KCNJ8		10.00, 10.00	1.03, 0.28	-9.71	99.61	-56.67	90.31	-42.70	32.72	68.63	20.98	77.63	65.31
BRD-K11433652	CP	aspirin	cyclooxygenase inhibitor, nitric oxide donor, platelet aggregation inhibitor, thromboxane synthase inhibitor, TP53 expression enhancer	PTGS1, PTGS2, TP53, AKR1C1, ASIC3, EDNRA, HSPA5, IKBKB, NFKB1, NFKB2, NFKBIA, PRKAA1, PRKAA2, PRKAB1, PRKAB2, PRKAG1, PRKAG2, PRKAG3, RPS6KA3		11.11, 11.11	1.47, 0.43	-51.93	47.26	-46.39	-41.99	67.91	97.91	-31.88	67.57	NaN	60.02
BRD-K51418664	CP	mitomycin-c	DNA alkylating drug, DNA inhibitor, DNA synthesis inhibitor			0.00, 0.00	1.31, 0.40	-50.48	29.95	-99.73	-33.02	71.12	52.97	-49.58	-16.14	NaN	-41.26
BRD-K67102207	CP	phenylbutyrate	HDAC inhibitor, cell cycle inhibitor, pharmacological chaperone, pyruvate dehydrogenase kinase inhibitor	CYP3A5, HDAC1		0.00, 0.00	0.95, 0.33	-30.84	-9.78	-93.59	-31.45	74.19	37.71	-75.12	-27.33	NaN	-31.22
BRD-K56515112	CP	medrysone	corticosteroid hormone receptor agonist, glucocorticoid receptor agonist	NR3C1		0.00, 0.00	0.80, 0.24	52.51	-97.90	-66.90	-78.87	-76.65	-52.25	-77.43	-18.26	50.97	-53.13
BRD-K67043667	CP	altretamine	DNA synthesis inhibitor			0.00, 0.00	0.41, 0.07	78.76	51.55	-51.31	-33.85	-44.61	74.59	68.58	-22.45	-27.81	24.06
BRD-K57631554	CP	aminolevulinic-acid	oxidizing agent	ALAD		0.00, 0.00	1.47, 0.42	-94.87	-97.35	37.05	-29.19	-70.38	-23.34	43.77	-38.65	NaN	-35.26
BRD-A50311610	CP	meclozine	constitutive androstane receptor (CAR) agonist	NR1I3, HRH1		0.00, 0.00	0.80, 0.23	-38.50	-79.13	-55.74	-83.86	-23.00	-19.93	70.02	-38.61	-93.79	-57.06
BRD-K50398167	CP	meclofenamic-acid	cyclooxygenase inhibitor, prostanoid receptor antagonist	PTGS1, PTGS2, ALOX5, CNR1, KCNQ2, KCNQ3		0.00, 0.00	0.53, 0.06	-63.90	-63.49	15.73	73.94	-32.70	-33.19	73.81	40.53	54.93	19.06
BRD-K05395900	CP	nicotine	acetylcholine receptor agonist	CHRNA10, CHRNA9, AOX1, CHAT, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNB2, CHRNB3, CHRNB4, CYP19A1, CYP2B6, TBXAS1, TRPA1		0.00, 0.00	0.69, 0.14	40.93	7.39	59.62	92.04	-33.91	35.83	68.80	-25.60	NaN	24.97
BRD-K60762818	CP	desipramine	norepinephrine transporter inhibitor, Sodium Channel  Blockers, tricyclic antidepressant (TCA)	SLC6A2, SLC6A4, ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD2, HRH1, HTR1A, HTR2A, HTR2C, SMPD1	Tricyclic antidepressant	10.00, 0.00	1.41, 0.42	44.63	-42.01	-30.77	-36.98	-95.69	-68.45	96.98	-43.14	73.37	-17.10
BRD-A99833829	CP	bethanechol	acetylcholine receptor agonist	CHRM2, CHRM1, CHRM3, CHRM4		11.11, 11.11	1.18, 0.32	29.51	40.11	-63.18	-27.78	98.81	31.00	-41.19	45.91	NaN	16.87
BRD-K72903603	CP	zidovudine	nucleoside reverse transcriptase inhibitor, reverse transcriptase inhibitor	TERT	Reverse transcriptase inhibitor	0.00, 0.00	0.92, 0.39	-32.39	59.06	-52.25	-36.39	94.12	-91.77	-60.26	-83.11	NaN	-31.34
BRD-A04308630	CP	genipin	aglycone, nitric oxide production inhibitor			0.00, 0.00	2.50, 0.86	-71.57	15.91	-62.24	-51.07	-59.23	79.33	-18.95	-11.77	NaN	-29.62
BRD-A51382177	CP	fosinopril	angiotensin converting enzyme inhibitor, breast cancer resistance protein inhibitor	ACE, ABCG2		11.11, 0.00	1.51, 0.53	-22.50	92.44	-42.54	-35.71	32.61	95.91	56.36	76.34	NaN	58.21
BRD-K01612348	CP	meropenem	cell wall synthesis inhibitor			0.00, 0.00	0.94, 0.31	20.43	42.27	-56.66	45.83	-66.85	68.95	50.72	45.16	NaN	33.99
BRD-K09900591	CP	caffeic-acid	lipoxygenase inhibitor, HIV integrase inhibitor, NFkB pathway inhibitor, nitric oxide production inhibitor, PPAR receptor modulator, tumor necrosis factor production inhibitor	ALOX5, MIF, RELA, TNF		0.00, 0.00	1.11, 0.36	25.51	22.46	-40.82	-42.03	92.69	-45.80	60.14	-43.54	NaN	-25.64
BRD-K52522949	CP	NCH-51	HDAC inhibitor	HDAC1, HDAC10, HDAC11, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9	HDAC inhibitor	0.00, 0.00	2.09, 0.66	-98.06	-38.72	-99.19	-76.23	-99.65	-95.05	-99.39	-99.62	NaN	-98.84
BRD-K74763371	CP	bosentan	endothelin receptor antagonist	EDNRB, EDNRA, ABCB1, CYP2C19, CYP3A4		0.00, 0.00	1.00, 0.30	-48.86	78.90	-38.65	27.88	-39.54	-28.08	71.14	24.49	NaN	22.45
BRD-K78373679	CP	RO-3306	CDK inhibitor	CDK1	CDK inhibitor	11.11, 11.11	1.35, 0.31	-90.79	99.93	24.33	33.20	-57.18	35.83	58.36	-75.21	NaN	-8.95
BRD-K94830329	CP	ataluren	CFTR channel agonist, coagulation stimulant, dystrophin stimulant	CFTR, DMD, F8, F9		0.00, 0.00	1.92, 0.58	-57.41	-30.50	-19.29	-44.20	76.17	-36.22	-87.29	-17.97	NaN	-32.52
BRD-A20239487	CP	atenolol	adrenergic receptor antagonist	ADRB1, ADRB2		0.00, 0.00	1.47, 0.41	80.04	83.10	40.88	37.87	45.97	-73.66	-92.82	43.20	NaN	28.56
BRD-K70976396	CP	cefoxitin	cell wall synthesis inhibitor			0.00, 0.00	1.06, 0.36	89.85	43.64	-94.87	-37.97	-30.80	46.77	-31.40	29.17	NaN	16.20
BRD-K10799896	CP	clobetasol	glucocorticoid receptor agonist	NR3C1, PLA2G1B		0.00, 0.00	1.66, 0.70	-67.21	11.69	-19.68	-27.05	-44.77	-58.63	29.34	-62.94	NaN	-23.31
BRD-A25067867	CP	benzatropine	anticholinergic	CHRM1, HRH1, SLC6A3		0.00, 0.00	1.56, 0.44	83.23	-39.24	-18.75	-55.99	75.39	70.16	-53.42	-23.77	NaN	-23.75
BRD-K38775274	CP	dexamethasone	glucocorticoid receptor agonist, corticosteroid agonist, immunosuppressant	ANXA1, CYP3A4, CYP3A5, NOS2, NR0B1, NR3C1, NR3C2		0.00, 0.00	1.60, 0.86	44.64	39.36	-12.81	75.82	43.04	-98.42	8.31	-12.19	93.81	13.56
BRD-K54462405	CP	doxepin	histamine receptor antagonist, adrenergic transmitter uptake inhibitor, histamine receptor inhibitor, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, tricyclic antidepressant	HRH1, HRH2, SLC6A2, SLC6A4, ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, CYP2C19, DRD2, HRH4, HTR1A, HTR2A, HTR2B, HTR2C, HTR6, KCNH2, SLC6A3		10.00, 0.00	0.86, 0.24	40.71	-17.94	19.59	-97.59	95.33	61.98	86.89	28.70	40.69	28.01
BRD-A88774919	CP	doxycycline	metalloproteinase inhibitor, 30S ribosomal protein inhibitor, matrix metalloprotease inhibitor, protein arginine deiminase inhibitor	MMP8, MMP1	Bacterial 30S ribosomal subunit inhibitor	0.00, 0.00	0.78, 0.23	-74.88	-7.04	-81.35	-88.99	-66.87	-50.40	-58.16	-18.29	NaN	-73.05
BRD-A75479906	CP	rimantadine	acetylcholine channel inhibitor, unidentified pharmacological activity			0.00, 0.00	1.86, 0.53	-79.70	65.56	-41.07	-37.49	17.29	-34.96	-58.65	-6.12	NaN	-11.07
BRD-K47869605	CP	podophyllotoxin	caspase activator, insulin growth factor receptor inhibitor, microtubule inhibitor, tubulin inhibitor	IGF1R, CASP3, TOP2A, TUBA4A, TUBB	Tubulin inhibitor	10.00, 10.00	1.50, 0.43	-52.31	99.85	-84.95	-26.84	-45.66	-28.67	-57.95	-66.04	-92.54	-61.68
BRD-A13946108	CP	sulindac	ABC transporter expression enhancer, cyclooxygenase inhibitor, NFkB pathway inhibitor	AKR1B1, PTGS1, PTGS2, MAPK3, PPARD, PTGDR2		11.11, 0.00	1.27, 0.35	33.24	8.95	-33.02	95.91	51.17	41.26	-67.35	81.88	NaN	40.39
BRD-K06335600	CP	tizanidine	adrenergic receptor agonist	ADRA2A, ADRA2B, ADRA2C, CYP1A2, NISCH		11.11, 11.11	1.50, 0.47	98.83	-39.24	-18.64	-38.79	-98.69	-30.01	-21.81	-16.51	NaN	-10.39
BRD-A76019558	CP	ketoconazole	14-alpha demethylase inhibitor, androgen receptor ligand, aromatase inhibitor, cell wall synthesis inhibitor, cortisol synthesis inhibitor, P glycoprotein inhibitor, sterol demethylase inhibitor	AR, CYP19A1, CYP21A2, CYP2C19, CYP3A5, CYP3A7, KCNA10		0.00, 0.00	1.42, 0.35	-39.23	-98.84	-36.34	-99.53	-35.17	-38.51	-40.96	-28.75	NaN	-28.43
BRD-K02123250	CP	JNJ-38877605	hepatocyte growth factor receptor inhibitor, tyrosine kinase inhibitor	MET		11.11, 0.00	1.05, 0.27	-18.06	-52.62	-41.04	-78.46	-49.38	39.85	-34.23	95.78	NaN	-17.85
BRD-K79131256	CP	albendazole	tubulin inhibitor, acetylcholinesterase inhibitor, microtubule inhibitor	CYP1A2, CYP2J2, TUBA1A, TUBB, TUBB4B	Tubulin inhibitor	30.00, 20.00	0.83, 0.44	-76.02	100.00	65.46	80.80	93.78	99.97	92.83	33.48	39.26	96.74
BRD-A16478930	CP	amcinonide	corticosteroid agonist, cytochrome P450 inhibitor, glucocorticoid receptor agonist, immunosuppressant	NR3C1, ANXA1	Glucocorticoid receptor agonist	11.11, 11.11	1.53, 0.59	92.50	11.42	39.45	47.36	-40.55	35.45	99.96	-24.87	NaN	22.60
BRD-K32821942	CP	azathioprine	dehydrogenase inhibitor, immunosuppressant, purine antagonist	HPRT1, IMPDH1, PPAT	IMPDH inhibitor	22.22, 11.11	0.22, 0.05	-21.93	-25.50	-93.52	-24.25	99.43	97.47	-67.32	-94.31	NaN	-32.54
BRD-K23204545	CP	busulfan	DNA damaging, DNA inhibitor			11.11, 0.00	1.14, 0.38	-26.63	23.86	-51.95	-32.82	-65.05	97.06	75.43	19.92	NaN	-13.96
BRD-A80638690	CP	floxuridine	DNA synthesis inhibitor, MDCK inhibitor, PEPT1 inhibitor, pyrimidine antagonist	TYMS	DNA synthesis inhibitor	0.00, 0.00	1.23, 0.32	-97.57	-87.24	-99.52	-96.66	-79.29	-71.37	-99.94	-99.62	NaN	-99.61
BRD-K05977355	CP	fluconazole	cell wall synthesis inhibitor, sterol demethylase inhibitor	CYP3A5, CYP3A7		0.00, 0.00	0.53, 0.09	-50.49	33.02	-48.13	40.35	74.97	-76.54	79.54	32.61	94.19	34.67
BRD-K61250553	CP	loperamide	opioid receptor agonist, atrial natriuretic peptide receptor antagonist	OPRM1, OPRD1, CACNA1A, CALM1, CYP2B6, CYP2C8, NPR2, OPRK1, POMC		0.00, 0.00	1.26, 0.56	-39.92	-50.36	84.81	55.21	21.98	-70.88	-72.17	-46.46	-32.82	-35.89
BRD-A64092382	CP	mexiletine	sodium channel blocker, potassium channel blocker	SCN5A, AHR, CYP2B6, CYP2E1, KCNK2, KCNK3, SCN4A	Sodium channel blocker	0.00, 0.00	0.61, 0.13	-19.01	-17.50	42.41	66.89	40.33	91.32	-78.44	91.83	43.70	23.98
BRD-K82381502	CP	acetylcholine	neurotransmitter of the peripheral and central nervous systems	ACHE, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, CHRNA2		22.22, 11.11	2.52, 0.67	35.85	-37.93	-43.07	-48.12	48.91	-82.25	98.79	96.27	NaN	61.71
BRD-A87606379	CP	nadolol	adrenergic receptor antagonist	ADRB1, ADRB2, ADRB3		0.00, 0.00	0.72, 0.11	68.22	35.04	-41.32	-62.72	90.46	89.08	-40.84	20.57	83.76	59.49
BRD-A24228527	CP	ofloxacin	antibiotic that inhibits DNA gyrase, topoisomerase inhibitor	TOP2A		0.00, 0.00	1.72, 0.47	79.36	16.46	56.81	-33.49	65.98	-52.84	-58.36	84.01	NaN	52.43
BRD-K77695569	CP	tiabendazole	quinol-fumarate reductase inhibitor			0.00, 0.00	0.77, 0.14	-55.81	50.09	-91.20	44.83	-50.75	-79.75	-67.78	-33.32	31.91	-26.39
BRD-A94793051	CP	gestrinone	progesterone receptor antagonist, Estradiol 17 beta dehydrogenase stimulant, estrone sulfotransferase stimulant	PGR, AR, ESR1	Androgen receptor modulator, Progesterone receptor antagonist	0.00, 0.00	1.31, 0.41	-39.94	-98.18	87.83	-50.53	-32.58	-36.04	-91.54	-57.99	NaN	-56.00
BRD-K87555556	CP	amiodarone	acetylcholine receptor ligand, adrenergic receptor antagonist, ATP-sensitive potassium channel inhibitor, HCN (hyperpolarization activated cyclic nucleotide gated) channel modulator, polarization inhibitor, potassium channel antagonist, Sodium Channel  Blockers, voltage-gated sodium channel blocker	KCNH2, ADRB1, CACNA1H, CACNA2D2, CHRM3, CYP2C8, KCNA7, SCN5A		11.11, 0.00	1.08, 0.25	-42.44	-11.63	-46.97	-84.04	96.63	-78.59	-57.08	-23.58	NaN	-47.17
BRD-K93433262	CP	alfacalcidol	hypercalcaemic agent, vitamin D receptor agonist	VDR, CYP27B1, CYP3A5	Vitamin D receptor agonist	0.00, 0.00	1.53, 0.51	42.52	-43.72	-29.81	-29.97	77.50	88.39	-38.15	-29.90	NaN	-10.58
BRD-K29458283	CP	chlorambucil	DNA damaging, DNA inhibitor			0.00, 0.00	0.51, 0.16	-99.80	-51.66	-99.29	-72.91	-99.92	35.28	65.75	-34.55	-99.56	-99.75
BRD-A75368507	CP	demeclocycline	30S ribosomal subunit inhibitor		Bacterial 30S ribosomal subunit inhibitor	0.00, 0.00	1.13, 0.25	-5.42	60.39	-29.72	-79.04	-45.94	89.39	88.52	-70.22	NaN	12.15
BRD-K63630713	CP	etacrynic-acid	not applicable, sodium/potassium/chloride transporter inhibitor	SLC12A1, ATP1A1, SLC12A2		0.00, 0.00	0.82, 0.19	-92.07	-99.28	-43.80	-58.67	-93.89	-14.53	26.34	-99.88	NaN	-96.12
BRD-K12219985	CP	glipizide	sulfonylurea, ATP channel blocker, ATP-sensitive potassium channel antagonist, insulin secretagogue	ABCC8, KCNJ10, KCNJ11, PPARG	KCNJ11 modulator	10.00, 10.00	0.94, 0.19	-83.77	98.73	45.79	91.39	-30.93	-34.66	-83.08	-51.49	-35.27	-26.72
BRD-K15262564	CP	mupirocin	isoleucyl-tRNA synthetase inhibitor			0.00, 0.00	2.06, 0.55	21.51	71.38	45.73	-52.13	81.00	34.73	63.77	-36.27	NaN	36.27
BRD-K10995081	CP	perphenazine	dopamine receptor, dopamine receptor antagonist	DRD2, CALM1, DRD1, HRH1, HTR2A, HTR2C, HTR6, HTR7	Dopamine receptor antagonist	0.00, 0.00	1.30, 0.53	-15.46	-98.45	-39.10	-88.05	-97.09	-99.99	85.15	-95.47	-45.43	-95.41
BRD-K43887077	CP	dopamine	dopamine receptor agonist	DRD2, DRD1, DRD3, DRD4, DRD5, DBH, HTR1A, HTR7, SLC6A2, SLC6A3, SLC6A4		20.00, 20.00	0.88, 0.34	82.11	-80.85	-26.10	99.19	-94.96	55.44	99.98	52.45	-35.36	65.10
BRD-A31800922	CP	procyclidine	anticholinergic	CHRM1, CHRM2, CHRM3, CHRM4		0.00, 0.00	1.05, 0.30	-36.44	-9.08	-45.74	35.56	44.90	-46.07	85.16	87.24	NaN	21.32
BRD-K77987382	CP	mebendazole	acetylcholinesterase inhibitor, microtubule inhibitor, tubulin inhibitor	TUBA1A, TUBB, TUBB4B	Tubulin inhibitor	20.00, 10.00	1.63, 0.59	-60.42	99.96	-20.09	-39.27	96.57	-46.88	-50.59	-83.27	-43.75	-51.28
BRD-K21317336	CP	phentolamine	adrenergic receptor antagonist	ADRA1A, ADRA2A, ADRA1B, ADRA1D, ADRA2B, ADRA2C		0.00, 0.00	1.24, 0.47	63.97	47.36	-53.51	-40.84	44.15	-33.19	66.00	13.20	NaN	33.37
BRD-A55815733	CP	phylloquinone	antifibrinolytic agent, gamma carboxylase enzyme	BGLAP, GGCX		0.00, 0.00	1.17, 0.43	-7.04	44.44	83.98	-48.59	87.24	-60.93	51.97	-24.02	NaN	49.84
BRD-A53952395	CP	prilocaine	anesthetic	SCN5A		0.00, 0.00	1.05, 0.44	78.53	21.26	-46.16	76.09	44.87	-36.06	-79.84	-20.86	NaN	13.07
BRD-A84481105	CP	thioridazine	acetylcholine receptor ligand, dopamine receptor, dopamine receptor antagonist, mucosa associated lymphoid tissue lymphoma translocation protein 1 (MALT1) inhibitor	DRD1, DRD2, HTR2A, ADRA1A, ADRA1B, CHRNA7, DRD5, HRH1, HTR1A, HTR2C, HTR6, HTR7, KCNH2, MALT1	Dopamine receptor antagonist	0.00, 0.00	1.84, 0.60	50.79	-62.15	-98.67	46.09	-92.14	-71.94	-99.36	20.07	-72.09	-90.32
BRD-K91699951	CP	benzonatate	non-narcotic cough suppressant thought to act as a local anesthetic	SCN5A		0.00, 0.00	0.69, 0.10	-9.72	-29.16	39.77	40.30	-91.16	-15.19	-42.63	-29.37	-41.49	-7.41
BRD-A78322124	CP	dobutamine	adrenergic receptor agonist	ADRB1, ADRB2, ADRA1A	Beta-adrenergic receptor agonist	10.00, 10.00	0.75, 0.14	-52.66	94.84	28.11	32.90	16.77	99.60	-61.31	-47.17	34.22	9.19
BRD-K55127134	CP	fluphenazine	dopamine receptor antagonist, acetylcholine receptor ligand, dopamine receptor, histamine receptor antagonist, serotonin receptor antagonist	DRD2, DRD1, CALM1, CHRNA7, DRD5, HRH1, HTR2A, HTR6, HTR7	Dopamine receptor antagonist	0.00, 0.00	1.40, 0.49	-29.87	-53.39	-39.86	-71.39	-77.67	35.66	-99.77	-92.01	-96.99	-81.45
BRD-K06926592	CP	tretinoin	RAR agonist, RAR receptor binder, retinoid receptor agonist, ROR ligand	RARG, RORB, ALDH1A1, ALDH1A2, GPRC5A, NR0B1, NR2C2, PPARD, RARA, RARB, RARRES1, RORC, RXRB, RXRG	Retinoid receptor agonist	10.00, 0.00	0.84, 0.17	31.07	-75.20	-66.01	-30.43	96.14	94.13	-82.15	-65.50	47.53	-52.77
BRD-K20655524	CP	mefexamide	psychostimulant			0.00, 0.00	0.80, 0.31	35.56	-93.36	-41.70	-19.69	68.65	-22.31	-28.00	90.21	29.49	-7.87
BRD-K77641333	CP	naphazoline	adrenergic receptor agonist, peptide agonist	ADRA1A, ADRA2A		0.00, 0.00	1.15, 0.33	63.56	-91.05	-30.69	67.39	-64.85	-89.55	-71.42	43.74	71.97	-65.81
BRD-A97701745	CP	pindolol	adrenergic receptor antagonist	ADRB1, ADRB2, HTR1A, HTR1B, HTR2A, HTR2B		30.00, 30.00	1.35, 0.31	88.87	39.68	9.96	99.09	98.09	97.52	76.81	25.60	58.23	92.12
BRD-A48430263	CP	pioglitazone	PPAR receptor agonist, insulin sensitizer, adiponectin expression enhancer, thiazolidinedione	PPARG, INS, TRPM3	PPAR receptor agonist	20.00, 10.00	0.41, 0.10	-84.64	96.61	-79.83	-66.82	-50.74	14.64	-85.95	98.70	-41.36	-70.12
BRD-K32318651	CP	acyclovir	DNA polymerase inhibitor, DNA directed DNA polymerase inhibitor	PNP		0.00, 0.00	1.99, 0.50	-44.50	-92.97	-79.00	-42.07	-24.45	55.51	-76.84	-84.59	40.63	-93.22
BRD-A09056319	CP	alfuzosin	adrenergic receptor antagonist	ADRA1A, ADRA1D, ADRA1B, KCNH2		10.00, 10.00	0.57, 0.11	93.20	89.97	-17.47	72.88	35.81	98.88	56.82	21.90	35.86	88.94
BRD-K53737926	CP	amitriptyline	norepinephrine inhibitor, serotonin receptor inhibitor, sigma receptor inhibitor	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, HRH1, HTR6, SLC6A2, SLC6A4, ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRB1, ADRB2, ADRB3, HRH2, HRH4, HTR1A, HTR1B, HTR1D, HTR2A, HTR2C, HTR7, KCNA1, KCND2, KCND3, KCNQ2, KCNQ3, NTRK1, NTRK2, OPRD1, OPRK1, OPRM1, SIGMAR1	Serotonin receptor antagonist	0.00, 0.00	1.08, 0.27	-32.64	-89.31	12.66	45.52	-82.71	-7.14	-36.13	-28.43	-34.71	-8.33
BRD-K55044200	CP	amoxicillin	cell wall synthesis inhibitor, PBPA inhibitor	SLC15A1		0.00, 0.00	1.64, 0.45	50.16	31.19	-71.42	-37.42	33.82	-75.84	-33.54	-38.40	NaN	-21.67
BRD-K97061094	CP	azacyclonol	ataractive drug used to diminish hallucinations	HRH1		0.00, 0.00	0.89, 0.14	41.81	35.26	-99.92	-13.47	78.41	-45.45	-99.96	-23.06	24.47	-10.34
BRD-A91008255	CP	bepridil	calcium channel blocker, L-type calcium channel blocker	ATP1A1, CACNA1A, CACNA1C, CACNA1H, CACNA2D2, CALM1, KCNQ1, KCNQ4, PDE1A, PDE1B, SCN5A, TNNC1		10.00, 10.00	0.27, 0.05	98.17	46.25	-26.02	-15.86	-70.47	-54.36	-5.79	50.48	43.72	14.28
BRD-A39230911	CP	chlorphensin	muscle relaxant			0.00, 0.00	0.85, 0.26	68.86	22.49	51.12	4.75	-68.25	33.71	-53.12	38.51	NaN	6.01
BRD-A26384407	CP	chlortalidone	carbonic anhydrase inhibitor, diuretic, sodium ion tranport inhibitor	CA7, CA1, CA12, CA14, CA4, SLC12A1		10.00, 10.00	0.86, 0.15	-15.59	18.09	30.15	66.12	67.52	99.72	34.06	-24.81	-42.87	40.39
BRD-K73109821	CP	diazoxide	ATP channel activator, potassium channel activator	ATP1A1, CA1, CA2, KCNJ11, KCNMA1, SLC12A3		10.00, 10.00	1.05, 0.27	-27.93	42.77	-60.12	99.93	-23.84	35.18	73.20	32.75	85.41	21.79
BRD-K68507560	CP	dicycloverine	acetylcholine receptor antagonist, anticholinergic	CHRM1, CHRM2, CHRM3		0.00, 0.00	0.75, 0.18	-42.58	43.26	-85.27	-97.93	-62.66	41.85	81.90	-28.61	87.80	34.26
BRD-K01663662	CP	diphenidol	acetylcholine receptor ligand	CHRM1, CHRM3, CHRM4, CHRM2		10.00, 10.00	1.07, 0.27	41.73	82.21	-39.88	49.19	99.98	-12.49	53.18	26.28	-37.82	29.89
BRD-A44008656	CP	doxylamine	histamine receptor antagonist	HRH1, CHRM1		0.00, 0.00	0.36, 0.09	32.77	45.42	-90.06	-62.85	52.45	17.50	91.07	-36.01	53.59	24.55
BRD-K63550407	CP	erythromycin	NFkB pathway inhibitor, 50S ribosomal subunit inhibitor, motilin receptor agonist, RPLV inhibitor	CYP3A4, MLNR		0.00, 0.00	1.20, 0.44	63.48	9.04	51.59	11.18	-16.06	16.12	-25.49	-47.92	-98.16	-2.75
BRD-K12513978	CP	fenbufen	cyclooxygenase inhibitor	PTGS1, PTGS2	Cyclooxygenase inhibitor	0.00, 0.00	0.89, 0.24	21.21	56.03	-29.29	42.43	-47.90	-26.63	-44.26	-27.11	-29.64	-13.69
BRD-K50388907	CP	fenofibrate	PPAR receptor agonist, apolipoprotein expression enhancer, lipase clearing factor inhibitor	PPARA, APOA1, CYP2C19, CYP2C8, MMP25		0.00, 0.00	1.01, 0.25	36.80	-95.60	90.03	12.76	-46.79	36.33	64.76	36.05	-74.08	22.25
BRD-K47639036	CP	flavoxate	acetylcholine receptor antagonist	CHRM1, CHRM2		0.00, 0.00	1.10, 0.34	23.04	5.97	-11.45	8.91	77.34	-19.84	-37.50	-46.04	-43.63	-4.51
BRD-A25234499	CP	aminoglutethimide	antiglucocorticoid, aromatase inhibitor, corticosteroid antagonist, steroid sulfatase inhibitor	CYP19A1, CYP11A1, NR3C1		0.00, 0.00	0.45, 0.10	-14.70	20.82	-34.63	50.34	-14.00	84.60	41.89	43.75	-64.71	20.52
BRD-A75552914	CP	isoxicam	cyclooxygenase inhibitor	PTGS1, PTGS2		10.00, 10.00	1.00, 0.19	-34.35	57.77	-18.56	12.63	99.71	51.55	-32.24	-57.03	-91.95	-12.94
BRD-A97739905	CP	ketoprofen	cyclooxygenase inhibitor	PTGS2, PTGS1, CXCR1, SLC5A8		10.00, 10.00	1.07, 0.39	99.90	-29.62	-36.77	62.75	-19.35	-93.61	53.40	46.59	41.61	38.59
BRD-K92778217	CP	mefenamic-acid	cyclooxygenase inhibitor	PTGS2, PTGS1, KCNQ1, TRPM3		10.00, 10.00	1.11, 0.33	52.80	52.50	92.62	85.48	63.71	24.24	-59.60	57.31	99.88	78.55
BRD-K07237224	CP	moclobemide	monoamine oxidase inhibitor	MAOA, CYP2C19, MAOB		0.00, 0.00	0.95, 0.32	-40.42	-98.21	-14.57	-17.76	-99.72	NaN	-32.67	19.76	NaN	-81.28
BRD-A26711594	CP	nicardipine	calcium channel blocker, L-type calcium channel blocker	CACNA1C, ADORA3, ADRA1A, ADRA1B, ADRA1D, CACNA1D, CACNA2D1, CACNB2, CALM1, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, PDE1A, PDE1B		0.00, 0.00	0.55, 0.06	-49.72	-77.32	-96.87	62.15	-35.20	-86.14	-15.27	-19.96	49.74	-35.63
BRD-K97752965	CP	nicorandil	ATP channel activator, nitric oxide donor, potassium channel agonist	ABCC9, KCNJ11, KCNJ8		0.00, 0.00	2.11, 0.73	48.51	-58.45	-9.46	90.00	-45.36	NaN	-25.22	-41.65	NaN	-13.95
BRD-K12539581	CP	nocodazole	tubulin inhibitor, Tubulin Polymerization Inhibitors	HPGDS	Tubulin inhibitor	20.00, 20.00	1.52, 0.57	-83.16	99.82	-28.49	-52.12	-29.34	99.90	-32.66	-54.22	-27.39	-20.23
BRD-A42759514	CP	ornidazole	antiprotozoal agent			10.00, 10.00	0.88, 0.17	45.86	86.46	62.15	99.81	-85.43	72.06	79.82	-52.77	20.69	63.18
BRD-A23072235	CP	pheniramine	acetylcholine receptor antagonist	HRH1		10.00, 10.00	0.61, 0.11	-45.56	-45.78	99.93	25.80	-79.26	-95.62	-65.55	54.51	77.07	-63.91
BRD-A21858158	CP	praziquantel	membrane permeability enhancer, schistosomicide			0.00, 0.00	0.72, 0.16	62.52	-25.19	27.52	9.88	48.56	10.80	-93.40	-14.50	50.51	20.19
BRD-K30816563	CP	ranitidine	histamine receptor antagonist	HRH2, SLC22A2		0.00, 0.00	1.02, 0.31	68.92	71.46	-13.63	91.23	62.54	52.25	-56.03	92.10	-88.22	75.44
BRD-K36616567	CP	doxepin	histamine receptor antagonist, adrenergic transmitter uptake inhibitor, histamine receptor inhibitor, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, tricyclic antidepressant	HRH1, HRH2, SLC6A2, SLC6A4, ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, CYP2C19, DRD2, HRH4, HTR1A, HTR2A, HTR2B, HTR2C, HTR6, KCNH2, SLC6A3		10.00, 0.00	0.76, 0.17	41.49	40.00	-29.77	-42.17	-43.39	78.94	-92.27	-40.03	95.62	23.96
BRD-A31521121	CP	methocarbamol	muscle relaxant	CA1		10.00, 10.00	1.09, 0.24	52.23	-39.67	99.10	-30.20	-8.23	18.19	-54.53	-33.17	84.97	11.45
BRD-K91263825	CP	nortriptyline	PI3K inhibitor, potassium channel blocker, tricyclic antidepressant (TCA)	KCNJ10, SLC6A2, SLC6A4, ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, CYP2C19, DRD2, HRH1, HTR1A, HTR2A, HTR2C, HTR6, PGRMC1, PIK3CD, SIGMAR1	Tricyclic antidepressant	0.00, 0.00	1.60, 0.50	-53.26	-98.18	-80.03	-7.16	26.09	-99.03	-72.58	-93.94	-93.44	-91.04
BRD-K79425933	CP	benperidol	dopamine receptor antagonist	DRD2		10.00, 10.00	1.01, 0.39	-25.43	40.72	25.28	99.59	-28.41	-66.98	-43.83	31.45	-56.14	-9.39
BRD-K66876909	CP	linezolid	50S ribosomal subunit inhibitor, protein synthesis inhibitor, monoamine oxidase inhibitor	MAOA		10.00, 10.00	1.05, 0.20	38.44	19.88	34.11	-50.78	17.32	52.35	4.03	79.95	99.97	30.36
BRD-K35559145	CP	levomepromazine	dopamine receptor	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HTR2A, HTR2C	Dopamine receptor antagonist	10.00, 10.00	0.80, 0.26	94.74	-54.34	-31.49	23.31	44.87	-49.60	-62.81	99.75	57.56	18.92
BRD-K28912512	CP	nicotinamide	oxidoreductase stimulant, protein synthesis stimulant	PARP1, AOX1, BST1, CYP2E1, LDHA, SIRT5		0.00, 0.00	2.00, 0.57	23.54	-9.69	-58.26	53.99	-37.21	-78.81	-45.15	26.48	94.73	19.75
BRD-K13571841	CP	pepstatin	aspartic protease inhibitor	CTSB, CTSD, CTSL, REN		0.00, 0.00	2.32, 0.85	25.07	57.87	-86.85	-67.42	-38.84	79.91	59.15	-91.69	NaN	-62.23
BRD-K85090592	CP	pilocarpine	acetylcholine receptor agonist	CHRM3, CHRM1, CHRM2, CHRM4, CHRM5		12.50, 0.00	1.15, 0.33	-83.91	-28.15	-65.24	-33.95	-93.62	NaN	97.23	82.33	NaN	-60.79
BRD-A08187463	CP	racecadotril	enkephalinase inhibitor, membrane metalloendopeptidase inhibitor, neprilysin inhibitor	MME		0.00, 0.00	0.98, 0.31	69.63	66.34	-47.24	-54.62	-52.66	36.46	-68.12	37.54	-41.33	23.17
BRD-K50938287	CP	sumatriptan	serotonin receptor agonist	HTR1D, HTR1B, HTR1A, HTR1F, HTR1E, HTR5A, HTR6, HTR7		0.00, 0.00	0.84, 0.25	79.23	20.77	-71.76	39.82	-52.99	NaN	29.86	51.86	NaN	26.05
BRD-K32164935	CP	tolazamide	ATP channel blocker	KCNJ1, KCNJ10		10.00, 0.00	0.97, 0.33	43.66	26.55	96.85	80.08	91.12	33.96	49.43	19.23	10.95	40.32
BRD-A60197193	CP	amisulpride	dopamine receptor antagonist	DRD2, DRD3, HTR2A, HTR7		11.11, 11.11	0.55, 0.09	99.44	76.78	93.63	92.81	55.05	-58.36	58.34	-44.21	NaN	90.47
BRD-A68723818	CP	brompheniramine	histamine receptor antagonist	HRH1, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5		0.00, 0.00	0.94, 0.28	8.24	-72.22	-30.54	-72.70	-11.48	-99.12	67.26	-15.63	-25.26	-16.86
BRD-K79145749	CP	dibenzepin	norepinephrine reuptake inhibitor			10.00, 10.00	0.90, 0.27	83.33	-80.13	-21.23	99.98	29.99	67.04	22.12	-33.84	93.47	61.73
BRD-K93280214	CP	gabazine	GABA receptor antagonist	GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRG2		10.00, 10.00	0.88, 0.17	51.74	92.38	-34.21	-61.62	97.87	88.83	77.69	69.20	-78.37	86.55
BRD-K76304753	CP	phenazopyridine	unidentified pharmacological activity	SCN1A		10.00, 0.00	0.52, 0.19	52.03	-26.06	60.28	-60.57	96.45	-86.90	-29.85	-98.12	88.00	23.42
BRD-K15933101	CP	ropinirole	dopamine receptor agonist, dopamine receptor modulator	DRD2, DRD3, ADRA2A, ADRA2B, ADRA2C, DRD1, DRD4, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C		0.00, 0.00	0.89, 0.31	14.35	12.46	-40.89	36.96	-50.24	-73.45	68.63	-32.18	17.20	-8.77
BRD-K86204871	CP	terconazole	cell wall synthesis inhibitor, sterol demethylase inhibitor		Sterol demethylase inhibitor	0.00, 0.00	0.58, 0.15	-20.74	-62.16	34.26	-92.92	-64.99	-97.74	-32.08	-72.83	-82.01	-64.09
BRD-A46393198	CP	tetramisole	alkaline phosphatase inhibitor			10.00, 10.00	1.20, 0.38	98.02	12.82	27.32	71.98	-25.24	74.22	5.84	-14.86	-67.38	21.81
BRD-K72093121	CP	vidarabine	adenylyl cyclase inhibitor, DNA directed DNA polymerase inhibitor, viral DNA synthesis inhibitor	ADCY5	Ribonucleotide reductase inhibitor	11.11, 11.11	0.84, 0.34	61.00	99.74	-99.91	-98.66	-90.60	-94.84	-99.90	-99.60	NaN	-99.61
BRD-A31159102	CP	fluoxetine	selective serotonin reuptake inhibitor (SSRI), serotonin transporter (SERT) inhibitor, serotonin uptake inhibitor, Sodium Channel  Blockers	SLC6A4, ANO1, CYP2C19, HTR2B		10.00, 0.00	1.32, 0.30	-22.16	-86.93	-31.78	-74.28	-71.60	96.52	-21.02	-96.10	-62.40	-63.12
BRD-K77925998	CP	quipazine	serotonin receptor agonist	HTR2A, HTR3A, HTR3B, HTR1A, HTR1D, HTR2B, HTR2C, HTR6, SLC6A4		10.00, 10.00	0.84, 0.26	-31.52	50.71	-37.11	-15.41	74.26	-69.08	85.15	98.42	64.79	55.48
BRD-K19111024	CP	clofibric-acid	PPAR receptor agonist	PPARA		0.00, 0.00	1.40, 0.38	-44.60	-96.63	66.27	61.45	92.08	-64.29	76.75	-30.33	-90.30	61.57
BRD-K38055836	CP	etamivan	respiratory stimulant			10.00, 10.00	1.30, 0.49	84.57	-17.33	-96.49	84.51	99.91	15.61	33.83	-16.57	66.40	56.24
BRD-K63979671	CP	etifenin	compound used in hepatobiliary scans of the liver			10.00, 10.00	0.73, 0.20	37.11	87.29	72.19	-32.45	89.34	54.12	97.89	67.41	76.23	80.90
BRD-K35531059	CP	molsidomine	activator of soluble guanylyl cyclase, nitric oxide donor, nitric oxide stimulant	GUCY1A3		0.00, 0.00	0.84, 0.31	13.04	47.91	-94.47	-96.73	61.48	49.88	84.03	-61.33	-98.82	-82.37
BRD-K14993104	CP	bemegride	chemoreceptor agonist	GABRA1		10.00, 10.00	0.85, 0.27	100.00	-16.59	-25.68	29.45	-10.22	39.60	-61.74	25.06	-31.59	13.25
BRD-K21450440	CP	benzthiazide	carbonic anhydrase inhibitor	CA2, CA1, CA12, CA4, CA9, SLC12A3		0.00, 0.00	1.08, 0.26	-65.49	28.48	37.65	-36.70	53.55	90.92	53.81	82.30	75.33	53.53
BRD-A29485665	CP	bicalutamide	androgen receptor antagonist	AR, CYP2C19		0.00, 0.00	0.67, 0.17	34.15	-49.23	-9.03	14.58	-58.25	8.11	-65.82	83.63	51.25	3.88
BRD-A77291778	CP	cyclopentolate	acetylcholine receptor antagonist	CHRM1		30.00, 10.00	0.55, 0.11	95.86	31.85	-45.90	-36.78	98.88	81.63	13.64	95.48	52.87	82.35
BRD-K22193694	CP	dioxybenzone	topical sunscreen agent			0.00, 0.00	0.84, 0.14	41.82	22.76	14.25	-27.35	-79.71	86.39	-74.01	78.88	50.70	52.54
BRD-A16311756	CP	profenamine	butyrylcholinesterase inhibitors, cholinergic receptor antagonist, glutamate receptor antagonist	CHRM1, BCHE, CHRM2, GRIN3A		0.00, 0.00	1.26, 0.40	-58.05	-47.05	-67.01	16.69	-15.23	67.52	-98.01	-73.29	NaN	-54.92
BRD-A73368467	CP	fexofenadine	histamine receptor antagonist	HRH1		10.00, 10.00	0.72, 0.16	97.77	49.50	-23.28	-26.86	-46.10	36.91	94.31	-30.51	-29.04	22.31
BRD-A74980173	CP	gatifloxacin	topoisomerase inhibitor, DNA gyrase inhibitor		Bacterial DNA gyrase inhibitor	0.00, 0.00	1.95, 0.56	-92.62	-65.41	-70.94	-14.14	88.96	73.56	-60.89	-19.76	78.21	-65.80
BRD-K80396088	CP	gliquidone	sulfonylurea, ATP channel blocker, ATP-sensitive potassium channel antagonist, insulin secretagogue	ABCC8, KCNJ10, KCNJ11, KCNJ8	KCNJ11 modulator	10.00, 10.00	0.72, 0.24	77.58	-47.73	-36.74	-25.52	98.24	-36.77	-50.74	-56.97	-51.75	-35.15
BRD-K46424862	CP	hymecromone	monoamine oxidase inhibitor	MAOA		0.00, 0.00	0.81, 0.25	94.09	-95.95	68.73	-17.70	74.23	-81.70	17.49	60.14	NaN	52.21
BRD-A44090213	CP	indoprofen	cyclooxygenase inhibitor, platelet aggregation inhibitor, prostanoid receptor inhibitor	PTGS1, PTGS2, CXCR1, CXCR2	Cyclooxygenase inhibitor	11.11, 11.11	0.86, 0.19	99.05	-35.13	-72.60	22.54	27.33	52.64	-62.51	53.82	NaN	8.78
BRD-A37492983	CP	iocetamic-acid	molecule used as a contrast medium			0.00, 0.00	0.77, 0.35	33.02	-80.94	-31.98	-88.82	-98.19	87.23	-20.53	38.60	NaN	-51.85
BRD-K67261995	CP	adipiodone	serum albumin binder	ALB		0.00, 0.00	0.93, 0.32	83.35	94.07	46.65	47.58	-15.17	85.88	-53.50	47.61	31.41	56.18
BRD-A42628519	CP	iopanoic-acid	radiopaque medium			0.00, 0.00	1.26, 0.73	52.77	90.63	-45.66	-97.93	47.73	-97.23	82.48	85.23	12.38	57.00
BRD-K33453211	CP	levocabastine	histamine receptor antagonist	HRH1, NTSR2		10.00, 10.00	0.60, 0.17	28.39	42.99	99.16	38.86	18.15	-9.78	77.74	91.14	52.82	54.32
BRD-K89152108	CP	liothyronine	thyroid hormone function stimulant	THRA, THRB		0.00, 0.00	0.84, 0.28	-22.43	32.69	69.01	-99.42	-70.60	-44.18	46.65	42.43	NaN	-19.45
BRD-A83937277	CP	mephenytoin	cytochrome P450 substrate	SCN5A, CYP2C19		11.11, 0.00	1.45, 0.38	96.20	35.58	10.99	77.48	22.47	-59.84	64.16	54.89	NaN	61.35
BRD-K65417056	CP	meprylcaine	anesthetic			10.00, 10.00	0.45, 0.11	-80.35	-16.82	-27.10	-38.45	99.56	-23.12	-82.84	26.05	35.50	-6.77
BRD-K67080878	CP	milrinone	phosphodiesterase inhibitor	PDE3A, PDE2A, PDE3B, PDE5A		20.00, 10.00	0.42, 0.07	72.33	22.01	42.93	-31.72	98.42	93.26	22.84	-22.93	95.98	77.17
BRD-K66615216	CP	moxifloxacin	DNA gyrase inhibitor, topoisomerase inhibitor	TOP2A	Bacterial DNA gyrase inhibitor	10.00, 10.00	0.51, 0.09	-20.82	50.57	12.80	97.62	-89.77	-42.91	33.03	39.43	-52.62	20.18
BRD-A58048407	CP	nimodipine	calcium channel blocker, L-type calcium channel blocker	CACNA1C, NR3C2, AHR, CACNA1D, CACNA1F, CACNA1S, CACNB1, CACNB2, CACNB3, CACNB4, CFTR		20.00, 10.00	0.64, 0.13	20.61	-24.09	96.84	46.53	-90.31	99.50	12.94	-60.22	-33.75	14.08
BRD-A02006392	CP	nitrendipine	calcium channel blocker, L-type calcium channel blocker	CACNA1C, CACNA1D, CACNA2D1, CACNA1H, CACNA1S, CACNA2D2, CACNB2, CACNG1, KCNN4		0.00, 0.00	0.77, 0.17	75.87	51.23	89.39	93.70	-30.72	24.10	51.40	12.90	-41.90	59.11
BRD-A36267905	CP	buphenine	adrenergic receptor agonist	ADRB2	Beta-adrenergic receptor agonist	40.00, 30.00	0.68, 0.27	44.25	74.93	98.71	92.26	7.65	19.52	99.95	59.49	96.45	98.80
BRD-A33447119	CP	oxfendazole	anthelmintic agent			30.00, 10.00	0.48, 0.13	-14.73	99.98	95.31	-68.19	71.78	96.35	68.07	-99.72	-41.95	85.03
BRD-K37991163	CP	paroxetine	cyclophilin inhibitor, norepinephrine reputake inhibitor, selective serotonin reuptake inhibitor (SSRI), serotonin reuptake inhibitor, serotonin uptake inhibitor	SLC6A4, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, HTR2A, SLC6A2		0.00, 0.00	1.65, 0.47	-38.53	-98.97	-31.60	-77.21	-99.60	-99.97	-62.64	-64.03	-92.21	-95.86
BRD-A18043272	CP	phensuximide	anticonvulsant			0.00, 0.00	0.60, 0.25	40.45	-23.54	21.88	21.60	62.27	60.87	-52.46	-50.19	NaN	17.79
BRD-K06388322	CP	pramipexole	dopamine receptor agonist	DRD3, DRD2, ADRA2A, ADRA2B, ADRA2C, DRD1, DRD4, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C		0.00, 0.00	1.11, 0.22	-77.95	-40.56	-22.16	-50.77	17.46	NaN	-66.78	-31.68	NaN	-42.47
BRD-K49111258	CP	prazosin	adrenergic receptor antagonist, adrenergic receptor blocker, CDK inhibitor	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CDK1, KCNH2, KCNH6, KCNH7		0.00, 0.00	0.56, 0.13	63.98	17.00	-6.88	21.16	-62.46	15.14	78.45	15.06	-37.86	2.54
BRD-K13032584	CP	procarbazine	DNA alkylating drug, transmethylation inhibitor			10.00, 10.00	0.78, 0.17	-15.19	47.06	-25.35	63.62	-57.21	32.20	99.84	-31.14	33.76	20.64
BRD-K28183345	CP	proguanil	dihydrofolate reductase inhibitor	CYP2C19, DHFR		0.00, 0.00	0.90, 0.27	-38.59	-85.74	-36.77	-11.19	-99.52	-96.69	28.82	10.40	-86.61	-72.60
BRD-A39390670	CP	rabeprazole	ATPase inhibitor, gastrin inhibitor	ATP4A, CYP2C19		12.50, 12.50	0.77, 0.14	-44.37	-37.19	-99.37	98.06	-44.93	NaN	-44.99	-45.55	NaN	-37.45
BRD-A07765530	CP	epinephrine	carbonic anhydrase activator, hormone, neurotransmitter	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, PAH, TNF		0.00, 0.00	1.24, 0.66	87.19	31.36	-43.67	-95.85	-40.64	49.39	-92.11	24.75	NaN	-15.33
BRD-K53857191	CP	risperidone	dopamine receptor antagonist, serotonin receptor antagonist, adrenergic receptor antagonist	DRD2, HTR2A, ADRA1A, ADRA1B, DRD3, HRH1, HTR1A, HTR1D, HTR2C, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CYP3A5, DRD1, DRD4, HTR1B, HTR1E, HTR1F, HTR6, HTR7		10.00, 10.00	0.63, 0.11	90.59	32.53	-40.58	15.94	97.61	-62.87	31.27	-27.98	61.19	36.08
BRD-K89923877	CP	scopolamine	acetylcholine receptor antagonist	CHRM2, CHRM1, CHRM3, CHRM4, CHRM5, SI		0.00, 0.00	0.90, 0.19	-14.96	38.39	36.26	-69.59	-42.20	76.81	-27.96	82.27	-46.58	15.23
BRD-A95939040	CP	sertaconazole	sterol demethylase inhibitor, cell wall synthesis inhibitor			0.00, 0.00	0.74, 0.25	-93.82	47.35	32.46	40.02	33.88	-22.05	-34.73	-89.30	-98.77	-25.63
BRD-A92670106	CP	tocainide	sodium channel blocker, voltage-gated sodium channel blocker	SCN5A		0.00, 0.00	0.43, 0.11	59.89	87.13	-49.82	-65.24	-78.53	67.71	91.86	-47.19	NaN	39.21
BRD-K73196317	CP	urapidil	adrenergic receptor antagonist, serotonin receptor agonist	HTR1A		12.50, 12.50	1.93, 0.51	57.90	-7.79	-33.34	99.41	-72.90	NaN	-27.96	51.94	NaN	31.09
BRD-K50417881	CP	eticlopride	dopamine receptor antagonist	DRD2, DRD3, DRD4		11.11, 0.00	1.05, 0.25	93.90	-26.48	-77.62	-92.14	95.49	-35.63	-93.73	-47.21	NaN	-70.18
BRD-K52313696	CP	tacedinaline	HDAC inhibitor, cell cycle inhibitor	HDAC1		11.11, 11.11	0.49, 0.28	-67.68	NaN	84.60	-92.23	-34.64	-41.10	93.81	40.70	97.58	77.69
BRD-K88742110	CP	BRD-K88742110	HDAC inhibitor, interleukin synthesis inhibitor	HDAC8, IL1B		20.00, 20.00	0.26, 0.17	99.39	-77.63	31.30	98.71	22.55	29.37	87.57	23.33	-66.50	57.26
BRD-K77908580	CP	entinostat	HDAC inhibitor, cell cycle inhibitor	HDAC1, HDAC2, HDAC3, HDAC9	HDAC inhibitor	0.00, 0.00	1.00, 0.38	-98.05	18.99	-98.91	-98.78	-66.05	-99.88	-98.66	-98.78	-99.35	-98.59
BRD-K85133207	CP	HDAC1-selective	HDAC inhibitor			55.56, 44.44	0.35, 0.22	96.93	NaN	99.86	99.80	14.13	99.79	-80.98	84.51	-60.91	99.75
BRD-K29313308	CP	HDAC3-selective	HDAC inhibitor	HDAC3		22.22, 11.11	0.56, 0.36	96.33	NaN	99.44	-65.48	10.10	-80.93	65.08	47.69	33.70	44.46
BRD-K00627859	CP	tubastatin-a	HDAC inhibitor	HDAC6	HDAC inhibitor	0.00, 0.00	0.35, 0.25	66.27	-91.21	80.01	38.56	33.22	-83.14	-89.57	-95.17	-98.89	-96.93
BRD-K09991945	CP	GSK-3-inhibitor-II	glycogen synthase kinase inhibitor, PKC inhibitor, superoxide dismutase expression inhibitor	GSK3B	Glycogen synthase kinase inhibitor, PKC inhibitor	0.00, 0.00	1.24, 0.44	-93.31	31.82	-69.70	-95.97	-66.85	-84.03	-86.40	58.82	NaN	-88.75
BRD-K07691486	CP	roscovitine	CDK inhibitor, apoptosis stimulant	CDK2, CDK9, CDK7, CDK1, CDK5	CDK inhibitor	0.00, 0.00	0.91, 0.40	-99.29	56.31	-98.26	-94.74	-72.17	-99.97	-96.68	-98.30	-98.45	-99.01
BRD-K57080016	CP	selumetinib	MEK inhibitor, MAP kinase inhibitor	MAP2K1, MAP2K2	MEK inhibitor	0.00, 0.00	0.89, 0.32	28.56	91.79	-99.45	-99.46	-77.66	-96.38	-53.11	-99.55	93.94	-98.38
BRD-K87909389	CP	alvocidib	CDK inhibitor, apoptosis stimulant, BCL inhibitor, cell cycle inhibitor, MCL1 inhibitor, survivin inhibitor, XIAP inhibitor	CDK2, CDK4, CDK1, CDK6, CDK7, CDK9, CDK5, CDK8, EGFR, PYGM, BCL2, BIRC5, CCNT1, MCL1, XIAP		0.00, 0.00	2.16, 0.70	-97.55	-50.42	-98.40	-88.98	-93.67	-55.72	-99.45	-98.76	-99.47	-98.31
BRD-K56343971	CP	vemurafenib	RAF inhibitor, protein kinase inhibitor	BRAF, CYP2C19, CYP3A4, CYP3A5, RAF1	RAF inhibitor	0.00, 0.00	1.58, 0.60	-99.01	-84.06	-98.84	-49.14	-50.91	-95.69	44.63	-87.80	-21.12	-93.48
BRD-K59369769	CP	tozasertib	Aurora kinase inhibitor, Bcr-Abl kinase inhibitor, FLT3 inhibitor, JAK inhibitor, Abl kinase inhibitor, mitotic inhibitor	AURKA, AURKB, ABL1, AURKC, BCR, FLT3, JAK2, DDR2, LCK	Aurora kinase inhibitor	50.00, 50.00	0.77, 0.23	99.99	100.00	-98.68	-72.96	93.75	99.94	99.33	-97.66	-97.84	99.86
BRD-K93918653	CP	quizartinib	FLT3 inhibitor, colony stimulating factor receptor inhibitor, KIT inhibitor, RET tyrosine kinase inhibitor	FLT3, CSF1R, KIT, RET, PDGFRA, PDGFRB		10.00, 10.00	0.72, 0.17	86.91	77.10	-99.81	99.45	-86.22	-99.55	46.33	-36.64	56.56	-85.01
BRD-K68191783	CP	ALW-II-38-3	ephrin inhibitor	DDR1, EPHA2, EPHA4, EPHB2, EPHB4, EPHB6		0.00, 0.00	1.26, 0.52	35.39	-14.05	32.89	51.26	-71.09	27.20	29.05	-18.36	60.31	14.32
BRD-K41895714	CP	AS-605240	Phosphatidylinositol 3-kinase (PI3K) inhibitor, PI3K inhibitor	MAOB, PIK3CA, PIK3CB, PIK3CD, PIK3CG	PI3K inhibitor	0.00, 0.00	1.70, 0.61	72.50	62.58	-99.06	-99.85	44.25	-89.15	-87.07	29.41	77.74	-93.62
BRD-K19540840	CP	saracatinib	src inhibitor, Abl kinase inhibitor	SRC, ABL1, LCK, YES1	SRC inhibitor	20.00, 20.00	1.24, 0.47	99.67	99.91	59.22	25.47	18.26	-40.72	90.96	79.44	-98.43	84.65
BRD-K46056750	CP	AZD-7762	CHK inhibitor	CHEK1, CHEK2		40.00, 20.00	1.49, 0.57	74.46	44.70	95.49	-89.06	68.56	91.90	99.96	99.99	91.66	96.55
BRD-K69932463	CP	AZD-8055	mTOR inhibitor	MTOR	MTOR inhibitor	0.00, 0.00	2.34, 0.75	-98.99	-99.50	-99.75	-99.57	-97.95	-99.63	-99.32	-93.24	46.99	-98.91
BRD-K64890080	CP	BI-2536	PLK inhibitor, apoptosis stimulant, cell cycle inhibitor, protein kinase inhibitor	PLK1, BRD4, PLK2, PLK3	Bromodomain Inhibitor	10.00, 10.00	1.49, 0.56	-23.01	98.95	-95.01	27.53	-91.02	-20.71	-18.73	88.61	-32.11	-10.92
BRD-K49669041	CP	BX-912	AKT inhibitor, phosphoinositide dependent kinase inhibitor, pyruvate dehydrogenase kinase inhibitor	PDPK1, AKT2, CDK2, CHEK1, GSK3B, KDR, PDK1		0.00, 0.00	0.92, 0.26	-98.41	-95.95	-60.20	-26.35	60.09	-92.63	-36.97	-53.86	-90.23	-92.71
BRD-K15592317	CP	CP466722	ATM kinase inhibitor	ATM		0.00, 0.00	2.06, 0.59	-99.64	9.96	-48.86	-31.91	-92.86	-37.86	-22.31	-80.99	40.24	-41.10
BRD-K52911425	CP	GDC-0941	PI3K inhibitor	PIK3CG, PIK3CA, PIK3CB, PIK3CD	PI3K inhibitor	0.00, 0.00	1.49, 0.70	-99.21	-89.41	-70.59	-97.84	-95.88	-95.66	31.10	-97.70	-22.11	-95.91
BRD-K36740062	CP	GSK-1070916	Aurora kinase inhibitor	AURKB, AURKC, AURKA, CYP2D6, CYP3A4	Aurora kinase inhibitor	20.00, 10.00	1.24, 0.53	-83.78	99.76	17.22	40.61	91.44	-98.00	95.39	91.17	54.21	80.51
BRD-A10523515	CP	GSK-429286A	ROCK inhibitor	ROCK1		0.00, 0.00	0.80, 0.28	-17.82	-29.34	-24.74	48.11	88.37	23.59	-50.14	62.95	92.53	33.16
BRD-K92428232	CP	GSK-461364	PLK inhibitor	PLK1		10.00, 10.00	1.40, 0.31	-36.11	-29.17	-99.30	-84.24	-53.16	-74.46	-93.91	99.42	-26.15	-86.10
BRD-K68407802	CP	KIN001-055	EGFR inhibitor, JAK inhibitor, leukotriene synthesis inhibitor, mediator release inhibitor	EGFR, JAK3		0.00, 0.00	1.02, 0.31	57.16	-68.31	-39.92	90.25	-64.30	-39.61	-25.85	-26.74	-41.61	-12.44
BRD-K04887706	CP	AKT-inhibitor-1-2	AKT inhibitor, PI3K inhibitor	AKT1, AKT2, AKT3		0.00, 0.00	1.42, 0.28	-99.81	-99.96	-92.11	-99.67	-52.59	-99.08	-99.22	-99.64	-56.31	-99.54
BRD-A29901043	CP	KIN001-127	ITK inhibitor	ITK		0.00, 0.00	1.63, 0.50	-57.65	-90.96	79.00	-89.70	90.48	-90.10	-30.70	-72.17	91.30	-85.43
BRD-K53561341	CP	KIN001-220	Aurora kinase inhibitor	AURKA	Aurora kinase inhibitor	30.00, 30.00	0.97, 0.33	99.86	99.96	-57.57	-67.17	39.61	-54.00	92.78	98.46	39.84	94.15
BRD-K25311561	CP	KU-55933	ATM kinase inhibitor	ATM, PRKDC		10.00, 10.00	0.84, 0.26	-14.73	37.92	-37.43	-55.89	99.18	56.31	-53.00	31.92	-71.10	17.08
BRD-K79404599	CP	enzastaurin	PKC inhibitor, AKT inhibitor, angiogenesis inhibitor, apoptosis stimulant, PI3K inhibitor	PRKCB, AKT1, GSK3B, PRKCA, PRKCD, PRKCG	PKC inhibitor	0.00, 0.00	0.86, 0.27	-19.02	54.48	-48.07	-43.61	21.41	-94.57	-58.69	-26.80	48.15	-34.79
BRD-K83963101	CP	MLN-8054	Aurora kinase inhibitor, mitotic inhibitor, protein kinase inhibitor	AURKA		50.00, 50.00	1.11, 0.33	99.96	99.96	42.15	-68.06	58.21	93.07	99.98	-28.83	99.97	99.93
BRD-K94294671	CP	OSI-027	mTOR inhibitor	MTOR	MTOR inhibitor	0.00, 0.00	1.35, 0.56	-98.95	67.85	-89.29	-99.79	-90.68	-40.12	94.34	-96.48	66.34	-95.98
BRD-K51313569	CP	palbociclib	CDK inhibitor	CDK4, CDK6, CCND3	CDK inhibitor	0.00, 0.00	2.00, 0.52	-95.43	-99.96	-56.65	-62.04	29.74	-93.95	-98.94	-100.00	-88.14	-99.30
BRD-A79768653	CP	sirolimus	mTOR inhibitor, CCR expression inhibitor, cell cycle inhibitor, proteasome inhibitor, protein kinase inhibitor, T cell inhibitor	MTOR, FKBP1A, CCR5, FGF2		0.00, 0.00	0.92, 0.30	-66.50	-98.98	-99.88	-89.52	-99.02	-99.12	-81.13	-89.87	-55.09	-98.13
BRD-A45498368	CP	WYE-125132	mTOR inhibitor, PI3K inhibitor	MTOR, PIK3CA	MTOR inhibitor	0.00, 0.00	1.59, 0.50	-99.64	-95.25	-92.75	-99.68	-99.81	-34.16	-70.91	-66.34	-42.15	-98.63
BRD-K64052750	CP	gefitinib	EGFR inhibitor	EGFR, CYP2C19	EGFR inhibitor	0.00, 0.00	1.10, 0.50	86.36	35.51	33.05	-90.17	-72.39	-35.38	73.60	17.46	40.83	10.46
ccsbBroad304_07923	OE	LSM5	LSM5 homolog, U6 small nuclear RNA associated (S. cerevisiae)			0.00, 0.00	0.76, 0.25	-74.13	62.77	-42.70	-89.71	57.60	-29.19	-99.94	71.30	42.57	29.57
ccsbBroad304_09358	OE	MAPK1IP1L	mitogen-activated protein kinase 1 interacting protein 1-like			20.00, 20.00	1.05, 0.26	-17.33	-79.15	53.41	28.59	-45.91	-71.09	99.98	-63.37	99.84	-9.96
ccsbBroad304_02332	OE	MBNL2	Zinc fingers, CCCH-type domain containing, muscleblind-like 2 (Drosophila)			0.00, 0.00	1.24, 0.36	-74.16	35.48	24.72	-98.59	82.83	-52.15	-20.86	83.66	-90.25	-10.11
ccsbBroad304_04271	OE	MXD3	Basic helix-loop-helix proteins, MAX dimerization protein 3			20.00, 20.00	1.27, 0.35	79.15	97.95	-73.24	-78.68	40.76	-99.97	99.86	-92.01	-99.26	-97.02
ccsbBroad304_01067	OE	NDUFA7	Mitochondrial respiratory chain complex / Complex I, NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 7, 14.5kDa			0.00, 0.00	1.38, 0.49	43.31	63.19	-74.78	-79.42	-30.82	-33.67	-96.91	-75.58	21.99	-76.99
ccsbBroad304_12008	OE	NLK	nmo subfamily, nemo-like kinase			0.00, 0.00	0.92, 0.27	-21.01	91.36	-75.23	-72.49	28.90	27.67	80.50	-63.90	47.75	13.65
ccsbBroad304_01927	OE	NR0B2	DAX-like receptors, nuclear receptor subfamily 0, group B, member 2			10.00, 10.00	1.06, 0.28	-99.21	-91.09	51.86	33.18	39.85	99.60	39.04	-98.99	-98.82	-99.30
ccsbBroad304_02026	OE	NRP1	CD molecules, neuropilin 1			40.00, 40.00	1.73, 0.45	99.59	89.97	99.71	29.85	92.97	99.97	36.21	86.06	64.79	99.81
ccsbBroad304_08183	OE	NSDHL	Short chain dehydrogenase/reductase superfamily / Extended SDR fold, NAD(P) dependent steroid dehydrogenase-like			10.00, 10.00	0.91, 0.17	-31.87	50.36	-72.92	30.94	28.46	98.19	56.67	-30.46	-99.89	3.66
ccsbBroad304_06681	OE	P2RY2	GPCR / Class A : Purinergic receptors, P2Y, purinergic receptor P2Y, G-protein coupled, 2		Purinergic receptors P2Y GOF	0.00, 0.00	2.13, 0.52	88.13	-50.81	-35.13	50.50	-53.12	-99.49	-99.51	-86.19	-99.15	-98.09
ccsbBroad304_02484	OE	PAICS	phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole succinocarboxamide synthetase			50.00, 10.00	1.09, 0.36	-42.30	78.70	99.02	96.04	37.33	46.43	10.23	97.15	95.28	97.41
ccsbBroad304_01832	OE	PAX8	Paired boxes, paired box 8			0.00, 0.00	1.02, 0.15	-70.15	44.24	74.39	36.14	-89.49	-45.31	-88.72	-99.67	-99.97	-97.87
ccsbBroad304_04399	OE	PGBD1	piggyBac transposable element derived 1			0.00, 0.00	0.93, 0.23	-60.92	90.04	36.74	-25.56	31.45	94.61	-42.51	-96.97	-46.66	-12.10
ccsbBroad304_01183	OE	PGD	phosphogluconate dehydrogenase			10.00, 10.00	1.01, 0.25	-35.38	-25.97	-73.62	-83.24	-46.67	-89.79	-84.10	-30.24	99.10	-62.78
ccsbBroad304_08170	OE	PIK3R4	Phosphatidylinositol kinases, phosphoinositide-3-kinase, regulatory subunit 4			0.00, 0.00	1.19, 0.39	59.86	-30.79	20.06	15.07	-97.82	42.30	-24.36	-36.73	-99.84	3.70
ccsbBroad304_04243	OE	PLA2G12A	Phospholipase A2, phospholipase A2, group XIIA			10.00, 10.00	0.94, 0.27	41.27	99.52	56.03	-53.66	-42.65	39.15	-54.11	21.02	20.60	11.80
ccsbBroad304_02825	OE	POLA2	DNA polymerases, polymerase (DNA directed), alpha 2 (70kD subunit)			40.00, 30.00	1.53, 0.36	91.04	98.53	42.96	-29.75	99.91	43.01	99.98	-77.39	-43.38	96.62
ccsbBroad304_01242	OE	POLR2I	RNA polymerase subunits, polymerase (RNA) II (DNA directed) polypeptide I, 14.5kDa			10.00, 0.00	0.64, 0.26	97.39	90.28	-24.36	88.86	-33.73	45.96	-28.88	-97.46	-47.31	35.26
ccsbBroad304_01261	OE	PPP1R8	Serine/threonine phosphatases / Protein phosphatase 1, regulatory subunits, protein phosphatase 1, regulatory subunit 8			10.00, 10.00	1.26, 0.34	98.59	54.35	94.68	-5.69	35.71	78.53	29.73	-98.83	90.91	93.51
ccsbBroad304_01277	OE	PRKAB2	AMPK subfamily, protein kinase, AMP-activated, beta 2 non-catalytic subunit			10.00, 10.00	1.03, 0.33	-82.56	-41.67	15.63	-29.42	-39.09	47.31	-28.17	99.94	82.89	7.04
ccsbBroad304_07632	OE	PROCR	CD molecules, protein C receptor, endothelial			0.00, 0.00	1.68, 0.56	69.94	-66.10	69.71	-39.53	94.10	30.04	-64.45	-98.31	58.62	-47.25
ccsbBroad304_02548	OE	PROKR1	GPCR / Class A : Prokineticin receptors, prokineticin receptor 1			10.00, 10.00	1.20, 0.33	98.04	94.76	-52.79	-82.08	-75.28	-39.85	88.41	40.24	72.88	80.28
ccsbBroad304_01320	OE	PSMD4	Proteasome (prosome, macropain) subunits, proteasome (prosome, macropain) 26S subunit, non-ATPase, 4			10.00, 10.00	0.68, 0.13	37.85	-40.07	90.71	-37.08	-38.58	99.91	-24.28	-70.66	-58.06	-19.29
ccsbBroad304_12106	OE	PXK	Slob family, PX domain containing serine/threonine kinase			0.00, 0.00	1.19, 0.39	-44.80	70.13	-90.79	-39.50	31.63	46.50	-36.36	-32.91	-63.65	-23.63
ccsbBroad304_01356	OE	QDPR	Short chain dehydrogenase/reductase superfamily / Atypical members, quinoid dihydropteridine reductase			10.00, 10.00	1.10, 0.34	-47.72	-99.91	26.80	-41.97	43.86	98.42	-28.02	-37.65	29.45	-11.54
ccsbBroad304_02009	OE	RAB11A	RAB, member RAS oncogene, RAB11A, member RAS oncogene family			10.00, 0.00	0.98, 0.31	24.38	61.74	76.06	-7.09	79.37	95.61	-42.76	-48.54	-11.52	50.51
ccsbBroad304_02601	OE	RAB31	RAB, member RAS oncogene, RAB31, member RAS oncogene family			10.00, 10.00	0.88, 0.32	-89.80	-32.99	-56.00	-32.58	-59.71	-33.45	36.43	99.93	-60.05	-33.34
ccsbBroad304_04465	OE	RERG	RAS-like, estrogen-regulated, growth inhibitor			10.00, 10.00	0.89, 0.28	50.28	69.53	40.15	58.12	85.38	65.93	99.58	-93.66	47.08	57.96
ccsbBroad304_01401	OE	RIT1	Ras-like without CAAX 1			0.00, 0.00	0.91, 0.31	44.44	-77.47	-85.30	-44.84	73.54	-24.91	85.07	-76.02	30.06	-35.56
ccsbBroad304_11324	OE	RPS6KA4	MSK subfamily, ribosomal protein S6 kinase, 90kDa, polypeptide 4			10.00, 10.00	0.98, 0.27	99.69	73.83	-99.72	57.08	93.57	-58.57	69.88	71.25	-48.00	56.61
ccsbBroad304_02738	OE	RRS1	RRS1 ribosome biogenesis regulator homolog (S. cerevisiae)			10.00, 10.00	0.76, 0.15	79.86	94.95	98.06	-96.69	-62.95	-27.37	74.65	58.58	-42.00	77.98
ccsbBroad304_07277	OE	RTCD1	RNA terminal phosphate cyclase domain 1			0.00, 0.00	1.30, 0.41	30.58	-83.24	-28.90	-99.69	-16.72	-40.52	21.55	-70.31	53.98	-21.41
ccsbBroad304_02709	OE	SCMH1	Sterile alpha motif (SAM) domain containing, sex comb on midleg homolog 1 (Drosophila)			20.00, 20.00	1.34, 0.41	73.79	-55.88	-37.15	-33.05	98.38	99.40	54.58	-56.04	66.14	69.87
ccsbBroad304_08532	OE	SIRPG	Immunoglobulin superfamily / C1-set domain containing, signal-regulatory protein gamma			0.00, 0.00	0.73, 0.22	88.87	91.14	-65.25	64.28	-99.98	62.66	-32.79	60.47	-38.16	34.71
ccsbBroad304_02761	OE	SIRT3	Histone deacetylases (HDACs), sirtuin 3		Sirtuins GOF	20.00, 10.00	0.81, 0.23	28.08	99.18	38.39	26.69	79.89	-27.51	73.01	-9.70	95.95	63.02
ccsbBroad304_06975	OE	SMARCC2	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 2			10.00, 0.00	1.43, 0.35	97.03	-42.74	-95.39	52.06	58.67	43.70	89.47	51.25	-99.15	49.97
ccsbBroad304_05425	OE	SNAI3	Snail homologs, snail homolog 3 (Drosophila)			10.00, 0.00	1.08, 0.31	19.68	-50.61	78.63	78.71	43.26	-35.36	-70.46	95.58	39.76	33.79
ccsbBroad304_01560	OE	SNAPC1	small nuclear RNA activating complex, polypeptide 1, 43kDa			10.00, 10.00	1.31, 0.44	22.71	42.71	99.58	-45.70	-34.58	-52.25	-51.93	61.29	69.64	10.18
ccsbBroad304_01563	OE	SNCA	Parkinson disease, synuclein, alpha (non A4 component of amyloid precursor)			0.00, 0.00	1.11, 0.28	59.86	-94.36	-90.41	-56.90	63.31	54.53	-39.31	55.65	-66.42	-56.69
ccsbBroad304_01579	OE	SOX2	SRY (sex determining region Y)-boxes, SRY (sex determining region Y)-box 2			0.00, 0.00	3.73, 1.18	-99.90	-96.86	-47.72	-34.10	-99.56	-88.45	-83.54	-99.93	-52.34	-99.58
ccsbBroad304_10437	OE	STMN1	stathmin 1			0.00, 0.00	0.94, 0.23	31.68	60.34	-16.84	-97.30	85.72	43.88	35.96	-58.19	24.93	9.10
ccsbBroad304_00313	OE	TBCB	tubulin folding cofactor B			10.00, 10.00	0.66, 0.28	99.75	70.15	-96.78	47.55	-53.46	-27.07	-53.94	-82.14	-27.92	-33.63
ccsbBroad304_01673	OE	TIMP3	TIMP metallopeptidase inhibitor 3			10.00, 10.00	0.92, 0.26	-91.08	-48.45	-42.95	-93.27	55.53	99.60	-26.64	-77.76	-36.47	-44.41
ccsbBroad304_01684	OE	TNF	Tumor necrosis factor (ligand) superfamily, tumor necrosis factor			0.00, 0.00	1.17, 0.32	31.18	-61.50	-8.87	-97.14	-99.87	-93.70	-93.62	-94.97	-61.12	-96.62
ccsbBroad304_01701	OE	TPI1	triosephosphate isomerase 1			10.00, 10.00	1.13, 0.24	-65.84	38.68	-70.21	99.59	28.86	-62.57	-70.16	-30.64	-51.09	-45.47
ccsbBroad304_02415	OE	TUBB3	Tubulins, tubulin, beta 3			0.00, 0.00	1.22, 0.40	-28.34	85.64	-98.82	-96.97	-58.59	-99.40	83.70	-94.22	-37.96	-95.79
ccsbBroad304_02205	OE	WTAP	Wilms tumor 1 associated protein			10.00, 10.00	1.63, 0.56	-55.73	-24.48	-36.57	-99.82	40.96	98.13	-99.49	44.75	54.21	-20.32
ccsbBroad304_13985	OE	ZNF200	Zinc fingers, C2H2-type, zinc finger protein 200			10.00, 10.00	0.86, 0.22	-83.12	72.31	-81.55	-83.74	-48.62	-70.55	98.90	-32.79	-39.33	-52.68
ccsbBroad304_09413	OE	ZNF554	Zinc fingers, C2H2-type, zinc finger protein 554			10.00, 10.00	0.92, 0.26	93.17	-47.70	-62.87	11.01	99.33	-99.94	75.09	-60.13	77.43	70.81
ccsbBroad304_09344	OE	ZNF764	Zinc fingers, C2H2-type, zinc finger protein 764			0.00, 0.00	1.17, 0.30	23.02	-57.46	-37.72	-78.91	-45.88	-87.21	-95.46	-72.02	58.74	-46.60
ccsbBroad304_03506	OE	AURKAIP1	aurora kinase A interacting protein 1			0.00, 0.00	1.43, 0.47	90.82	-38.74	39.10	-37.20	56.69	-49.89	59.05	-99.99	81.79	45.49
ccsbBroad304_01992	OE	B4GALT3	Beta 4-glycosyltransferases, UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3			0.00, 0.00	1.14, 0.24	27.73	-38.27	-35.70	53.09	-38.35	-40.06	-42.68	63.11	78.18	3.70
ccsbBroad304_03433	OE	DDIT4	DNA-damage-inducible transcript 4			10.00, 10.00	0.83, 0.15	99.95	-64.64	94.83	-92.23	-99.24	54.31	-41.28	-78.61	-90.98	-79.14
ccsbBroad304_02618	OE	DIDO1	Zinc fingers, PHD-type, death inducer-obliterator 1			0.00, 0.00	1.03, 0.26	39.84	39.53	-24.23	45.50	29.96	92.76	93.58	-47.39	-69.67	19.21
ccsbBroad304_08167	OE	DNTTIP2	deoxynucleotidyltransferase, terminal, interacting protein 2			10.00, 10.00	0.88, 0.22	91.63	-65.32	-19.08	-81.07	99.98	50.51	44.10	92.55	27.29	52.59
ccsbBroad304_00459	OE	DPYD	dihydropyrimidine dehydrogenase			10.00, 10.00	1.05, 0.33	-24.62	35.55	-74.18	-59.02	27.62	99.87	28.14	-55.04	55.21	7.44
ccsbBroad304_03510	OE	FKBP14	EF-hand domain containing, FK506 binding protein 14, 22 kDa			20.00, 0.00	0.98, 0.32	-55.26	-91.30	97.06	-98.18	-55.09	-60.37	95.80	79.51	-40.32	-26.94
ccsbBroad304_00573	OE	FKBP4	Tetratricopeptide (TTC) repeat domain containing, FK506 binding protein 4, 59kDa			20.00, 10.00	0.82, 0.25	37.55	96.50	-67.14	-28.47	-48.28	65.18	97.63	-38.66	-39.01	30.24
ccsbBroad304_07887	OE	GCAT	glycine C-acetyltransferase			0.00, 0.00	2.08, 0.57	31.80	41.35	-99.88	-24.66	-68.21	-88.64	34.29	-64.17	-91.56	-91.28
ccsbBroad304_06301	OE	GOT2	glutamic-oxaloacetic transaminase 2, mitochondrial (aspartate aminotransferase 2)			0.00, 0.00	1.03, 0.32	77.92	85.15	87.67	-40.02	-94.58	-99.09	82.48	88.67	-50.58	84.20
ccsbBroad304_06335	OE	GSTP1	Glutathione S-transferases, glutathione S-transferase pi 1			0.00, 0.00	1.13, 0.34	90.80	-94.60	-27.17	-73.25	40.99	-65.55	-21.63	-37.01	85.47	-16.50
ccsbBroad304_06336	OE	GSTT1	Glutathione S-transferases / Soluble, glutathione S-transferase theta 1			0.00, 0.00	0.76, 0.30	-43.74	60.52	57.78	-98.38	-33.80	56.50	93.41	-37.58	-99.61	17.72
ccsbBroad304_06339	OE	GTF2F2	General transcription factors, general transcription factor IIF, polypeptide 2, 30kDa			20.00, 10.00	1.73, 0.66	29.73	52.54	36.55	49.34	95.22	61.18	-46.43	-98.96	99.86	35.40
ccsbBroad304_06340	OE	GTF2H3	General transcription factors, general transcription factor IIH, polypeptide 3, 34kDa			10.00, 10.00	0.83, 0.32	99.98	44.39	-78.33	-49.77	-69.38	-86.34	41.17	-99.95	29.21	-72.20
ccsbBroad304_00782	OE	HPGD	Prostaglandin synthases, hydroxyprostaglandin dehydrogenase 15-(NAD)			10.00, 0.00	0.89, 0.28	95.44	-92.06	-72.91	92.69	69.33	46.38	71.02	64.30	44.40	60.45
ccsbBroad304_00783	OE	HPRT1	hypoxanthine phosphoribosyltransferase 1			0.00, 0.00	1.30, 0.32	-23.67	67.32	-90.07	-47.57	91.14	-52.66	-71.68	-65.68	94.03	-34.14
ccsbBroad304_00818	OE	IDH3A	isocitrate dehydrogenase 3 (NAD+) alpha			0.00, 0.00	0.95, 0.31	-31.23	-36.33	-28.76	89.52	76.61	50.86	31.81	-82.21	-35.39	13.13
ccsbBroad304_00860	OE	IL13	Interleukins and interleukin receptors, interleukin 13		Interleukins GOF	0.00, 0.00	0.80, 0.27	28.03	-58.80	-35.51	-99.48	-34.05	49.70	-83.13	-38.88	-35.15	-37.49
ccsbBroad304_00845	OE	IL1RAP	Immunoglobulin superfamily / Immunoglobulin-like domain containing, interleukin 1 receptor accessory protein			10.00, 0.00	1.08, 0.26	-99.63	83.82	-72.07	-29.21	-31.76	-60.59	68.59	35.75	96.48	-14.08
ccsbBroad304_08230	OE	IRAK4	Interleukin-1 receptor-associated kinase (IRAK) family, interleukin-1 receptor-associated kinase 4			20.00, 20.00	0.76, 0.26	90.73	50.26	98.36	66.24	-71.39	99.91	55.17	39.24	52.42	57.81
ccsbBroad304_02249	OE	KIAA0494	KIAA0494			0.00, 0.00	1.23, 0.30	-96.30	-94.40	-98.67	-46.27	-50.41	48.04	-88.29	-88.38	62.37	-98.37
ccsbBroad304_07511	OE	KIF14	Kinesins, kinesin family member 14			20.00, 20.00	0.98, 0.30	58.64	-89.76	84.76	94.65	99.94	-39.03	11.12	-35.70	97.66	86.34
ccsbBroad304_01302	OE	KLK6	Chymotrypsin, kallikrein-related peptidase 6		Serine proteases GOF	10.00, 10.00	1.26, 0.33	-68.46	-95.10	73.45	-98.03	-89.03	57.94	-99.11	64.47	98.78	-96.32
ccsbBroad304_06494	OE	KLRC1	CD molecules, killer cell lectin-like receptor subfamily C, member 1			10.00, 0.00	0.86, 0.26	46.09	-45.19	-85.56	-23.74	-56.59	95.44	-53.38	50.16	37.30	-13.73
ccsbBroad304_07605	OE	LYPLA1	lysophospholipase I			0.00, 0.00	1.27, 0.25	76.63	79.06	-84.03	11.71	46.16	-43.93	-95.39	94.84	-97.10	32.24
ccsbBroad304_00348	OE	MAP3K8	MAPKKK:STE-unique family, mitogen-activated protein kinase kinase kinase 8			0.00, 0.00	1.95, 0.65	-71.57	-98.00	-75.17	-47.94	30.72	-67.25	-24.72	-98.29	-77.37	-71.86
ccsbBroad304_01952	OE	MAPKAPK5	MAPKAPK subfamily, mitogen-activated protein kinase-activated protein kinase 5			0.00, 0.00	1.08, 0.32	18.60	-97.92	-65.65	-22.89	-52.41	-73.41	37.38	42.81	-24.87	-30.49
ccsbBroad304_01443	OE	MRPL12	Mitochondrial ribosomal proteins / large subunits, mitochondrial ribosomal protein L12			0.00, 0.00	0.98, 0.26	61.76	47.76	23.20	-26.32	-29.94	-82.73	-91.72	-91.01	18.73	-7.51
ccsbBroad304_06619	OE	NCF2	Tetratricopeptide (TTC) repeat domain containing, neutrophil cytosolic factor 2			10.00, 10.00	1.11, 0.33	9.44	32.35	-94.57	65.49	-32.13	98.06	-56.65	32.59	42.44	9.12
ccsbBroad304_05590	OE	NOTCH2NL	notch 2 N-terminal like			10.00, 10.00	0.86, 0.20	25.16	-52.24	-49.51	-98.38	-62.25	98.43	26.46	94.35	74.92	9.79
ccsbBroad304_07920	OE	NUP62	nucleoporin 62kDa			0.00, 0.00	0.95, 0.31	-47.20	34.64	-71.80	35.69	-29.85	-65.07	-87.99	45.29	-33.34	-29.58
ccsbBroad304_14439	OE	OPN5	GPCR / Class A : Opsin receptors, opsin 5			10.00, 10.00	1.24, 0.27	99.03	94.25	-99.75	-86.69	-19.62	-38.70	-72.73	-99.43	73.04	-78.37
ccsbBroad304_01247	OE	POU2AF1	POU class 2 associating factor 1			0.00, 0.00	0.91, 0.31	36.87	54.08	-94.69	-99.53	-81.32	-72.62	41.36	48.36	30.91	-71.25
ccsbBroad304_06402	OE	PRMT2	Protein arginine N-methyltransferases, protein arginine methyltransferase 2			10.00, 10.00	0.95, 0.34	49.71	75.07	-99.59	-98.35	-55.89	-76.45	-24.55	99.31	70.99	-50.92
ccsbBroad304_02632	OE	PTP4A3	Protein tyrosine phosphatases, protein tyrosine phosphatase type IVA, member 3			30.00, 20.00	1.03, 0.27	-85.67	96.74	7.04	-74.40	36.13	99.68	-78.19	98.54	33.04	71.55
ccsbBroad304_01970	OE	RFXANK	Ankyrin repeat domain containing, regulatory factor X-associated ankyrin-containing protein			10.00, 0.00	1.19, 0.34	-87.49	96.38	-40.72	-56.93	32.46	-88.26	-46.01	-99.93	-25.98	-59.98
ccsbBroad304_01411	OE	RORC	Retinoic acid-related orphans, RAR-related orphan receptor C			20.00, 20.00	1.25, 0.31	-99.89	76.55	-99.87	26.41	-68.17	99.97	-39.68	-72.30	99.21	-80.49
ccsbBroad304_01471	OE	S100A1	EF-hand domain containing, S100 calcium binding protein A1			10.00, 10.00	1.74, 0.44	27.75	-68.97	-48.59	43.58	-88.83	97.88	-46.33	-39.55	-45.82	-30.93
ccsbBroad304_01514	OE	SDHC	Mitochondrial respiratory chain complex / Complex II, succinate dehydrogenase complex, subunit C, integral membrane protein, 15kDa			10.00, 0.00	1.22, 0.32	78.62	-79.22	-83.80	-94.24	-95.03	52.37	-99.32	95.05	72.04	-96.53
ccsbBroad304_06722	OE	SERPINB6	Serine (or cysteine) peptidase inhibitors, serpin peptidase inhibitor, clade B (ovalbumin), member 6			0.00, 0.00	0.88, 0.19	25.39	38.00	-24.98	-25.75	-88.49	-44.47	-18.01	-40.80	-98.61	-7.37
ccsbBroad304_02063	OE	SLC25A14	Mitochondrial uncoupling proteins, solute carrier family 25 (mitochondrial carrier, brain), member 14			0.00, 0.00	0.74, 0.19	-49.61	-35.66	66.61	-86.84	-43.32	-64.58	-40.75	74.38	-80.81	-25.38
ccsbBroad304_05818	OE	SLC25A5	Mitochondrial nucleotide transporter subfamily, solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 5			10.00, 10.00	0.99, 0.25	-27.36	-36.65	-17.75	43.29	45.01	82.16	-70.72	99.98	-34.61	4.77
ccsbBroad304_01580	OE	SOX10	SRY (sex determining region Y)-boxes, SRY (sex determining region Y)-box 10			0.00, 0.00	1.52, 0.50	-61.80	44.85	90.62	55.56	-99.95	-97.09	44.37	-99.78	-57.81	-94.09
ccsbBroad304_05152	OE	SSBP4	single stranded DNA binding protein 4			0.00, 0.00	1.17, 0.34	-7.02	-33.72	-99.81	-97.45	-37.66	-99.94	-98.24	-58.11	30.30	-98.15
ccsbBroad304_01615	OE	SULT1A2	Sulfotransferases, cytosolic, sulfotransferase family, cytosolic, 1A, phenol-preferring, member 2			20.00, 0.00	0.73, 0.23	97.32	-37.22	29.56	40.32	-32.45	54.14	69.88	-81.00	97.33	35.25
ccsbBroad304_02213	OE	TRAF4	RING-type (C3HC4) zinc fingers, TNF receptor-associated factor 4			10.00, 10.00	1.08, 0.35	99.13	-52.45	-83.53	28.89	-59.40	-37.35	-38.41	-97.23	-24.77	-42.73
ccsbBroad304_03418	OE	ZFAND6	Zinc fingers, AN1-type domain containing, zinc finger, AN1-type domain 6			0.00, 0.00	1.06, 0.31	-99.98	88.21	-36.19	-97.74	-99.71	-85.65	-91.43	73.17	28.74	-97.62
ccsbBroad304_09590	OE	ZFP28	Zinc fingers, C2H2-type, zinc finger protein 28 homolog (mouse)			10.00, 10.00	1.11, 0.36	-19.67	73.52	-27.06	99.94	-33.66	-61.29	-42.82	38.05	-99.80	-15.14
ccsbBroad304_04903	OE	ZNF786	Zinc fingers, C2H2-type, zinc finger protein 786			10.00, 0.00	1.02, 0.36	95.45	-99.78	-53.92	73.96	46.67	49.10	81.04	37.66	-99.86	50.75
ccsbBroad304_05936	OE	CASP2	Caspases, caspase 2, apoptosis-related cysteine peptidase			10.00, 10.00	1.51, 0.39	34.04	99.03	-63.94	90.75	-67.46	-97.91	-11.44	-97.63	82.79	-83.93
ccsbBroad304_06253	OE	GALT	galactose-1-phosphate uridylyltransferase			10.00, 0.00	1.22, 0.36	96.83	38.64	-87.99	93.53	71.95	-37.43	-72.33	-89.56	70.97	63.31
ccsbBroad304_00722	OE	HSD17B10	Short chain dehydrogenase/reductase superfamily / Classical SDR fold cluster 1, hydroxysteroid (17-beta) dehydrogenase 10			0.00, 0.00	0.58, 0.13	85.61	-65.53	-31.21	30.24	-99.84	-64.22	-67.27	-99.50	87.72	-38.33
ccsbBroad304_06413	OE	HSP90AA1	Heat shock proteins / HSPC, heat shock protein 90kDa alpha (cytosolic), class A member 1			0.00, 0.00	1.00, 0.33	39.31	79.45	-77.65	-73.92	68.98	36.40	-41.01	-64.95	34.40	-15.29
ccsbBroad304_07260	OE	LGR5	GPCR / Class A : Orphans, leucine-rich repeat containing G protein-coupled receptor 5			0.00, 0.00	0.78, 0.24	62.49	-72.18	91.66	-45.82	-34.38	57.39	94.88	-99.81	-29.77	52.98
ccsbBroad304_08217	OE	SCCPDH	saccharopine dehydrogenase (putative)			0.00, 0.00	0.90, 0.24	-27.20	-55.76	-10.22	-44.19	-25.72	62.64	-77.44	-36.30	37.26	-9.00
ccsbBroad304_02394	OE	ZNF267	Zinc fingers, C2H2-type, zinc finger protein 267			0.00, 0.00	0.99, 0.26	-27.89	-31.48	85.48	86.67	-29.72	57.75	39.32	59.23	81.26	49.33
ccsbBroad304_03164	OE	MTERFD1	MTERF domain containing 1			0.00, 0.00	0.89, 0.26	93.84	29.51	94.42	NaN	-74.61	45.93	84.74	-91.04	32.35	83.70
ccsbBroad304_09258	OE	MYLK2	Myosin Light Chain Kinase (MLCK) family, myosin light chain kinase 2			0.00, 0.00	1.23, 0.36	39.14	66.03	-18.03	NaN	69.23	28.27	-30.84	-36.13	48.96	8.06
ccsbBroad304_02040	OE	NAE1	Ubiquitin-like modifier activating enzymes, NEDD8 activating enzyme E1 subunit 1			11.11, 11.11	0.99, 0.30	-42.07	-26.51	90.02	NaN	-99.65	-43.69	99.98	-88.94	-97.74	-74.20
ccsbBroad304_01091	OE	NFIB	nuclear factor I/B			11.11, 11.11	0.99, 0.18	-60.86	99.96	-48.73	NaN	82.61	-18.93	-99.43	-43.58	-99.77	-90.50
ccsbBroad304_06658	OE	NT5E	Adenosine turnover, 5'-nucleotidase, ecto (CD73)			11.11, 11.11	1.58, 0.57	31.97	-98.48	-99.89	NaN	-36.84	99.97	27.87	-34.00	-77.77	-70.44
ccsbBroad304_05142	OE	OLIG3	Basic helix-loop-helix proteins, oligodendrocyte transcription factor 3			11.11, 0.00	0.90, 0.23	-62.86	49.25	-99.89	NaN	96.70	-76.41	-48.28	28.71	-74.17	-63.79
ccsbBroad304_01146	OE	PARN	poly(A)-specific ribonuclease			11.11, 11.11	2.01, 0.59	-41.12	-87.22	-87.15	NaN	31.40	98.45	54.20	-66.41	-26.30	-57.29
ccsbBroad304_06695	OE	PCK2	phosphoenolpyruvate carboxykinase 2 (mitochondrial)			0.00, 0.00	1.19, 0.31	-18.11	38.64	34.24	NaN	-32.86	39.25	-33.91	-34.94	-63.13	-5.60
ccsbBroad304_06708	OE	PDGFRB	Type III RTKs: PDGFR, CSFR, Kit, FLT3 receptor family, platelet-derived growth factor receptor, beta polypeptide		Targets of VEGFR inhibitors GOF	0.00, 0.00	1.17, 0.30	-58.53	-65.17	59.53	NaN	-49.62	40.05	71.92	-32.60	-99.47	-39.41
ccsbBroad304_07249	OE	PIK3R3	Phosphatidylinositol kinases, phosphoinositide-3-kinase, regulatory subunit 3 (gamma)			11.11, 0.00	0.99, 0.22	-65.36	95.15	-89.31	NaN	93.82	47.57	-25.64	77.95	-92.82	50.11
ccsbBroad304_03524	OE	PLEKHJ1	Pleckstrin homology (PH) domain containing, pleckstrin homology domain containing, family J member 1			0.00, 0.00	0.86, 0.25	-86.92	39.10	-99.27	NaN	88.00	34.94	-5.99	-73.19	85.44	-27.44
ccsbBroad304_01240	OE	POLR2F	RNA polymerase subunits, polymerase (RNA) II (DNA directed) polypeptide F			11.11, 11.11	0.93, 0.31	-60.61	-98.19	26.78	NaN	53.71	-83.68	32.86	-46.55	97.60	-36.97
ccsbBroad304_04064	OE	PRR15L	proline rich 15-like			11.11, 11.11	1.05, 0.30	-81.03	99.96	22.33	NaN	-71.26	84.33	82.78	40.63	-51.81	53.33
ccsbBroad304_01307	OE	PSMA1	Proteasome subunits, proteasome (prosome, macropain) subunit, alpha type, 1			0.00, 0.00	0.73, 0.15	80.82	34.93	37.48	NaN	-37.54	73.71	-31.80	40.20	-59.30	10.88
ccsbBroad304_13931	OE	PSMA3	Proteasome subunits, proteasome (prosome, macropain) subunit, alpha type, 3			11.11, 11.11	1.40, 0.43	99.24	40.95	92.23	NaN	-43.17	50.48	39.87	94.64	-91.96	94.67
ccsbBroad304_07428	OE	PSMF1	Proteasome (prosome, macropain) subunits, proteasome (prosome, macropain) inhibitor subunit 1 (PI31)			0.00, 0.00	0.95, 0.27	-28.30	25.07	54.32	NaN	-30.25	-49.31	-27.94	-49.42	77.25	-7.36
ccsbBroad304_01340	OE	PTPN2	Protein tyrosine phosphatases, protein tyrosine phosphatase, non-receptor type 2			0.00, 0.00	0.88, 0.17	31.65	86.43	-59.95	NaN	-75.55	-88.96	-37.54	-22.64	-96.42	-83.22
ccsbBroad304_06820	OE	PTS	6-pyruvoyltetrahydropterin synthase			11.11, 11.11	1.20, 0.42	-37.70	58.03	99.95	NaN	-75.28	62.76	57.23	-78.68	-88.01	-54.38
ccsbBroad304_01375	OE	RARA	Retinoic acid receptors, retinoic acid receptor, alpha			0.00, 0.00	1.24, 0.17	-55.00	23.19	-88.25	NaN	-79.01	-99.13	-39.73	-99.98	-99.93	-99.87
ccsbBroad304_01383	OE	RBMS1	RNA binding motif (RRM) containing, RNA binding motif, single stranded interacting protein 1			0.00, 0.00	0.89, 0.25	14.02	78.07	-19.15	NaN	-36.17	26.84	30.63	-31.74	30.89	2.04
ccsbBroad304_06852	OE	RBP4	Lipocalins, retinol binding protein 4, plasma		Lipocalins GOF	0.00, 0.00	1.03, 0.31	-40.73	-76.74	5.61	NaN	-87.57	34.45	-96.70	79.21	-19.66	-36.61
ccsbBroad304_08853	OE	RGS18	Regulators of G-protein signaling, regulator of G-protein signaling 18			0.00, 0.00	1.33, 0.40	-52.02	-96.96	-98.39	NaN	-93.41	-23.69	-40.42	-32.09	-41.83	-96.46
ccsbBroad304_03122	OE	RHOD	ras homolog gene family, member D			11.11, 11.11	1.16, 0.35	77.41	47.02	97.67	NaN	82.26	24.15	30.13	69.37	44.39	64.56
ccsbBroad304_01406	OE	RNASE4	Ribonucleases, RNase A, ribonuclease, RNase A family, 4			11.11, 11.11	1.10, 0.33	-66.80	-95.62	46.62	NaN	83.43	-27.17	42.49	-62.86	99.05	-27.88
ccsbBroad304_09703	OE	RNF145	RING-type (C3HC4) zinc fingers, ring finger protein 145			0.00, 0.00	1.65, 0.50	49.56	-27.96	-98.16	NaN	60.99	93.64	-64.45	-99.98	-42.52	-41.52
ccsbBroad304_01457	OE	RPS19	S ribosomal proteins, ribosomal protein S19			0.00, 0.00	0.88, 0.26	-75.63	-80.47	86.90	NaN	-63.39	-46.11	51.36	37.08	-80.40	-54.99
ccsbBroad304_01446	OE	RPS3A	S ribosomal proteins, ribosomal protein S3A			44.44, 11.11	1.15, 0.28	93.62	34.02	96.61	NaN	-99.84	-59.15	95.58	-61.53	98.84	96.13
ccsbBroad304_07880	OE	SIRT5	Histone deacetylases, sirtuin 5		Sirtuins GOF	22.22, 22.22	1.07, 0.30	28.52	30.19	55.43	NaN	98.47	99.58	-22.06	-74.12	31.03	9.25
ccsbBroad304_05148	OE	SLC30A8	SLC30 zinc transporter family, solute carrier family 30 (zinc transporter), member 8			0.00, 0.00	1.27, 0.38	-16.84	93.07	45.25	NaN	-49.26	-67.57	56.47	-64.43	-43.28	-15.93
ccsbBroad304_00602	OE	SLC37A4	SLC37 family of phosphosugar/phosphate exchangers, solute carrier family 37 (glucose-6-phosphate transporter), member 4			0.00, 0.00	4.88, 1.31	-55.90	-96.49	-87.74	NaN	-34.75	-99.51	-98.80	-99.41	-85.62	-99.68
ccsbBroad304_03926	OE	SLC39A8	SLC39 family of metal ion transporters, solute carrier family 39 (zinc transporter), member 8			0.00, 0.00	1.24, 0.33	28.24	29.49	-86.29	NaN	-82.06	-78.30	20.58	81.95	-99.16	-66.87
ccsbBroad304_02674	OE	STK38	NDR family, serine/threonine kinase 38			0.00, 0.00	1.25, 0.32	-94.48	-44.24	-94.08	NaN	-74.03	-57.76	-91.00	47.56	63.65	-96.30
ccsbBroad304_07827	OE	STK38L	NDR family, serine/threonine kinase 38 like			0.00, 0.00	1.17, 0.42	49.21	93.84	-51.20	NaN	-54.53	-36.57	-26.24	-44.91	-50.06	-9.65
ccsbBroad304_02018	OE	SUCLA2	succinate-CoA ligase, ADP-forming, beta subunit			0.00, 0.00	1.52, 0.41	-29.01	22.26	-96.79	NaN	-96.31	-77.09	-90.81	-37.57	91.87	-96.28
ccsbBroad304_07015	OE	SULT1A1	Sulfotransferases, cytosolic, sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1			11.11, 11.11	0.85, 0.22	68.72	28.68	-52.70	NaN	38.24	99.59	58.35	-64.01	78.37	39.70
ccsbBroad304_02719	OE	SWAP70	EF-hand domain containing, SWAP switching B-cell complex 70kDa subunit			0.00, 0.00	1.01, 0.27	44.40	-88.29	-51.97	NaN	-78.16	-37.86	93.44	-81.61	78.48	-58.69
ccsbBroad304_07026	OE	SYT1	Synaptotagmins, synaptotagmin I			11.11, 11.11	1.06, 0.33	97.79	49.55	-66.77	NaN	-93.08	-96.25	29.74	-50.92	34.07	-62.66
ccsbBroad304_01672	OE	TIMP2	TIMP metallopeptidase inhibitor 2			11.11, 11.11	0.97, 0.16	99.76	54.02	59.05	NaN	80.99	-93.95	-99.77	-42.51	60.18	70.19
ccsbBroad304_03420	OE	TOLLIP	toll interacting protein			0.00, 0.00	0.89, 0.24	50.21	-83.69	-44.11	NaN	-34.56	-99.96	-99.61	38.21	41.88	-89.49
ccsbBroad304_02324	OE	TRAP1	Heat shock proteins / HSPC, TNF receptor-associated protein 1			11.11, 11.11	1.57, 0.34	-88.93	99.74	-97.82	NaN	-77.97	-66.54	46.13	-71.38	-85.70	-90.01
ccsbBroad304_01741	OE	UBE2V1	Ubiquitin-conjugating enzymes E2, ubiquitin-conjugating enzyme E2 variant 1			0.00, 0.00	1.15, 0.34	-95.90	-40.04	32.65	NaN	44.75	91.80	71.27	-45.28	36.38	11.55
ccsbBroad304_03445	OE	UGT1A1	UDP glucuronosyltransferases, UDP glucuronosyltransferase 1 family, polypeptide A1			11.11, 0.00	1.22, 0.35	-89.61	95.50	25.45	NaN	81.78	-86.82	55.14	29.38	49.82	14.80
ccsbBroad304_07126	OE	VARS	Aminoacyl tRNA synthetases / Class I, valyl-tRNA synthetase			0.00, 0.00	0.76, 0.24	-34.44	-67.40	22.85	NaN	-96.56	61.16	77.02	92.76	65.67	26.57
ccsbBroad304_04018	OE	VKORC1	Oxidoreductases, vitamin K epoxide reductase complex, subunit 1			22.22, 11.11	1.22, 0.33	97.48	81.85	99.49	NaN	-89.48	43.79	72.74	-35.33	-69.09	78.91
ccsbBroad304_04794	OE	ZFP3	Zinc fingers, C2H2-type, zinc finger protein 3 homolog (mouse)			0.00, 0.00	1.03, 0.39	51.65	66.30	-99.98	NaN	72.58	-64.92	-47.71	-30.97	94.89	52.11
ccsbBroad304_07164	OE	ZNF133	Zinc fingers, C2H2-type, zinc finger protein 133			0.00, 0.00	1.70, 0.64	-86.71	-83.95	-96.88	NaN	91.57	41.01	-40.49	-69.12	-55.54	-86.78
ccsbBroad304_01820	OE	ZNF217	Zinc fingers, C2H2-type, zinc finger protein 217			11.11, 0.00	0.99, 0.20	-89.72	83.08	95.47	NaN	55.97	85.86	-92.16	-86.96	-32.63	73.69
ccsbBroad304_05000	OE	ZNF524	Zinc fingers, C2H2-type, zinc finger protein 524			11.11, 11.11	0.82, 0.16	-15.10	31.01	-65.36	NaN	-54.64	-26.81	99.12	-90.00	-54.79	-30.81
ccsbBroad304_05485	OE	ZNF677	Zinc fingers, C2H2-type, zinc finger protein 677			0.00, 0.00	0.90, 0.31	-99.76	85.92	-94.07	NaN	-45.08	-51.03	36.48	-74.30	-81.65	-76.98
ccsbBroad304_10227	OE	ZNF85	Zinc fingers, C2H2-type, zinc finger protein 85			0.00, 0.00	1.65, 0.44	29.94	36.12	94.45	NaN	59.89	53.43	-42.15	-35.79	45.38	26.75
ccsbBroad304_04649	OE	ADC	arginine decarboxylase			0.00, 0.00	1.01, 0.26	-99.60	-27.70	-47.43	NaN	-72.90	21.31	-32.95	-60.81	-99.96	-40.54
ccsbBroad304_05779	OE	ADK	Adenosine turnover, adenosine kinase			0.00, 0.00	1.05, 0.22	60.78	36.87	41.63	NaN	-67.56	38.12	-50.02	-78.70	61.30	29.50
ccsbBroad304_13810	OE	AHCY	Adenosine turnover, adenosylhomocysteinase			11.11, 11.11	0.69, 0.16	45.30	85.50	10.38	NaN	43.96	-86.19	91.66	99.96	58.25	78.07
ccsbBroad304_03469	OE	ANKRD49	Ankyrin repeat domain containing, ankyrin repeat domain 49			22.22, 22.22	1.81, 0.52	-99.98	-43.88	-87.61	NaN	99.10	54.90	-93.62	-73.79	98.46	-87.01
ccsbBroad304_03683	OE	APOM	Apolipoproteins, apolipoprotein M		Lipocalins GOF	11.11, 11.11	1.22, 0.33	98.18	83.11	-14.08	NaN	-69.09	27.67	39.14	-58.85	-95.38	-22.04
ccsbBroad304_00098	OE	ARG1	Arginase, arginase, liver			22.22, 11.11	0.84, 0.18	70.96	96.72	-52.53	NaN	-27.25	-66.08	-41.29	99.92	-99.97	-20.72
ccsbBroad304_00106	OE	ARRB1	arrestin, beta 1			11.11, 11.11	1.00, 0.25	51.22	99.56	-94.53	NaN	64.33	-73.49	-80.28	88.43	50.82	46.10
ccsbBroad304_00126	OE	ATP5A1	ATPases / F-type, ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle			11.11, 11.11	1.16, 0.32	-13.92	-74.18	49.74	NaN	74.07	55.49	89.66	98.72	-93.41	68.02
ccsbBroad304_02292	OE	BCL2L11	BCL2-like 11 (apoptosis facilitator)			0.00, 0.00	1.35, 0.34	90.36	77.38	80.56	NaN	-25.50	-21.99	82.36	72.44	36.70	64.30
ccsbBroad304_03573	OE	BRF2	BRF2, subunit of RNA polymerase III transcription initiation factor, BRF1-like			11.11, 11.11	0.77, 0.22	90.60	90.40	99.98	NaN	-99.95	38.27	70.37	-96.30	-67.54	88.37
ccsbBroad304_00210	OE	CALR	calreticulin			11.11, 11.11	1.42, 0.51	-33.97	-94.67	-59.72	NaN	57.24	50.63	-69.81	-39.98	99.86	-27.54
ccsbBroad304_02862	OE	CCRN4L	CCR4 carbon catabolite repression 4-like (S. cerevisiae)			0.00, 0.00	1.57, 0.48	87.37	-60.97	14.25	NaN	-32.91	-20.69	54.71	52.81	-65.46	16.28
ccsbBroad304_00270	OE	CDK1	Cyclin-dependent kinases, CDK1 subfamily, cyclin-dependent kinase 1			0.00, 0.00	1.05, 0.27	22.95	24.28	-10.83	NaN	35.64	46.82	36.32	-43.08	87.14	5.83
ccsbBroad304_01955	OE	CDK10	Cyclin-dependent kinases, CDK10 subfamily, cyclin-dependent kinase 10			11.11, 0.00	1.27, 0.28	-24.12	-36.55	42.71	NaN	-89.61	95.56	94.47	42.81	-59.03	-11.25
ccsbBroad304_14174	OE	CDKAL1	CDK5 regulatory subunit associated protein 1-like 1			0.00, 0.00	1.72, 0.34	-20.61	-87.68	-30.72	NaN	31.41	92.69	-83.61	-92.29	-64.66	-77.03
ccsbBroad304_08481	OE	CEP55	centrosomal protein 55kDa			0.00, 0.00	1.00, 0.33	-88.33	-77.30	-43.85	NaN	-60.64	42.95	-17.85	-43.02	-30.05	-45.68
ccsbBroad304_07592	OE	CEPT1	choline/ethanolamine phosphotransferase 1			11.11, 11.11	1.02, 0.27	-32.99	-80.29	-79.80	NaN	-95.78	45.02	37.61	-43.08	98.51	-40.62
ccsbBroad304_00294	OE	CETN3	EF-hand domain containing, centrin, EF-hand protein, 3			11.11, 0.00	0.76, 0.15	9.16	49.24	-70.30	NaN	74.48	88.29	-47.63	97.32	76.60	78.27
ccsbBroad304_07761	OE	CORO1A	Coronins, coronin, actin binding protein, 1A			0.00, 0.00	1.06, 0.32	30.07	-79.90	-38.80	NaN	-46.99	-30.57	-65.12	-38.66	72.89	-17.12
ccsbBroad304_00379	OE	CSNK1E	Casein kinase 1 (CK1) family, casein kinase 1, epsilon			0.00, 0.00	1.17, 0.33	-20.45	-21.25	-93.96	NaN	-78.67	-33.93	-98.07	36.66	55.70	-40.71
ccsbBroad304_00380	OE	CSNK1G2	Casein kinase 1 (CK1) family, casein kinase 1, gamma 2			22.22, 22.22	1.09, 0.24	-20.98	38.23	-31.98	NaN	58.90	36.89	-58.48	99.59	97.89	68.91
ccsbBroad304_02351	OE	DHRS2	Short chain dehydrogenase/reductase superfamily / Classical SDR fold cluster 1, dehydrogenase/reductase (SDR family) member 2			11.11, 11.11	1.08, 0.36	-44.34	85.19	33.77	NaN	-45.42	86.06	93.81	-41.86	99.93	87.49
ccsbBroad304_08113	OE	DNAJC15	Heat shock proteins / DNAJ (HSP40), DnaJ (Hsp40) homolog, subfamily C, member 15			22.22, 22.22	1.27, 0.34	23.41	97.83	76.87	NaN	36.66	99.97	-27.53	-38.07	-40.94	36.13
ccsbBroad304_08952	OE	E2F8	E2F transcription factor 8			0.00, 0.00	1.43, 0.30	-24.36	-32.28	-99.89	NaN	-99.98	26.19	-82.00	-99.41	-96.57	-99.91
ccsbBroad304_03271	OE	ECSIT	Mitochondrial respiratory chain complex assembly factors, ECSIT homolog (Drosophila)			0.00, 0.00	1.50, 0.50	43.46	91.78	36.61	NaN	-97.72	-28.70	33.09	73.40	29.75	29.50
ccsbBroad304_00509	OE	EPHX1	epoxide hydrolase 1, microsomal (xenobiotic)			0.00, 0.00	1.05, 0.27	35.97	79.52	-93.20	NaN	-96.83	-38.47	-60.54	-98.92	41.53	-97.92
ccsbBroad304_06174	OE	ERCC1	excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)			0.00, 0.00	1.03, 0.33	-39.55	78.07	35.78	NaN	94.10	-79.09	33.99	39.24	65.59	55.77
ccsbBroad304_03808	OE	ERGIC1	endoplasmic reticulum-golgi intermediate compartment (ERGIC) 1			0.00, 0.00	0.76, 0.19	-98.77	-96.80	8.98	NaN	46.03	84.29	-60.03	-95.93	70.96	-84.99
ccsbBroad304_07800	OE	EXOSC8	exosome component 8			0.00, 0.00	1.16, 0.32	-91.96	76.57	-12.07	NaN	-35.32	43.42	-51.58	73.83	-61.22	-8.19
ccsbBroad304_00678	OE	GPR37	GPCR / Class A : Orphans, G protein-coupled receptor 37 (endothelin receptor type B-like)			0.00, 0.00	1.07, 0.28	37.61	31.04	-94.80	NaN	-34.67	-92.62	-99.96	-43.00	-48.32	-87.15
ccsbBroad304_14158	OE	GPR87	GPCR / Class A : Orphans, G protein-coupled receptor 87			0.00, 0.00	0.95, 0.28	-30.40	62.59	58.06	NaN	58.04	-72.23	-84.47	-25.08	73.94	27.69
ccsbBroad304_06338	OE	GTF2A2	General transcription factors, general transcription factor IIA, 2, 12kDa			11.11, 11.11	1.58, 0.33	-82.81	36.03	-57.73	NaN	51.81	99.97	70.71	-32.54	-32.32	37.63
ccsbBroad304_00744	OE	HLA-DRB3	Immunoglobulin superfamily / C1-set domain containing, major histocompatibility complex, class II, DR beta 3			0.00, 0.00	1.74, 0.55	-53.23	54.47	-15.07	NaN	38.27	-86.78	-31.38	-54.87	76.83	-28.53
ccsbBroad304_00774	OE	HOXA10	Homeoboxes / ANTP class : HOXL subclass, homeobox A10			0.00, 0.00	1.14, 0.26	34.77	76.96	36.05	NaN	-75.01	-43.96	92.96	34.62	44.11	16.72
ccsbBroad304_00770	OE	HOXA2	Homeoboxes / ANTP class : HOXL subclass, homeobox A2			0.00, 0.00	1.23, 0.31	42.45	33.19	-67.53	NaN	-65.37	-40.22	88.38	-95.24	55.04	-31.53
ccsbBroad304_06392	OE	HOXB7	Homeoboxes / ANTP class : HOXL subclass, homeobox B7			11.11, 11.11	1.22, 0.47	-56.93	51.90	94.02	NaN	-99.56	35.42	99.04	-99.38	66.16	27.38
ccsbBroad304_00861	OE	IL13RA1	IL-2 receptor family, interleukin 13 receptor, alpha 1			0.00, 0.00	0.95, 0.36	-70.82	67.65	-11.60	NaN	66.70	41.19	59.34	-69.48	43.32	16.35
ccsbBroad304_06449	OE	ILF3	interleukin enhancer binding factor 3, 90kDa			0.00, 0.00	1.26, 0.26	-33.38	-80.32	5.98	NaN	48.00	49.73	-73.92	-44.45	28.06	-19.35
ccsbBroad304_07280	OE	LAMTOR3	late endosomal/lysosomal adaptor, MAPK and MTOR activator 3			0.00, 0.00	0.83, 0.24	-41.34	-74.46	-25.35	NaN	18.15	50.24	-47.54	-45.69	-66.64	-31.41
ccsbBroad304_05194	OE	LIPH	lipase, member H			11.11, 0.00	1.38, 0.42	54.34	85.49	-23.00	NaN	38.08	39.03	-90.59	-91.98	96.31	33.17
ccsbBroad304_02990	OE	LYPD3	LY6/PLAUR domain containing 3			0.00, 0.00	1.15, 0.31	-86.44	76.38	-90.79	NaN	-29.35	-99.97	-41.27	69.14	72.23	-58.46
ccsbBroad304_00966	OE	MAFG	v-maf musculoaponeurotic fibrosarcoma oncogene homolog G (avian)			11.11, 11.11	1.01, 0.19	-57.20	99.96	-28.07	NaN	-26.87	19.19	-97.85	52.42	56.40	6.94
ccsbBroad304_04713	OE	MAS1L	GPCR / Class A : Orphans, MAS1 oncogene-like			0.00, 0.00	1.60, 0.50	-34.67	91.81	81.93	NaN	-68.56	73.02	-73.75	-83.86	-63.58	-57.22
ccsbBroad304_00993	OE	MDM4	Mdm4 p53 binding protein homolog (mouse)			0.00, 0.00	1.14, 0.47	-69.15	-62.42	74.39	NaN	-94.89	-30.39	-99.70	-32.05	25.37	-50.56
ccsbBroad304_06588	OE	MMP2	Matrix metallopeptidase, matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase)			0.00, 0.00	0.94, 0.26	79.43	55.87	23.05	NaN	61.40	-47.81	30.57	-76.92	75.77	23.84
ccsbBroad304_02349	OE	MPHOSPH9	M-phase phosphoprotein 9			22.22, 11.11	1.28, 0.28	96.94	99.12	82.36	NaN	-95.63	36.27	41.06	77.26	-42.38	72.07
ccsbBroad304_03215	OE	MRPS2	Mitochondrial ribosomal proteins / small subunits, mitochondrial ribosomal protein S2			11.11, 0.00	1.23, 0.34	-35.08	95.38	42.57	NaN	-89.29	-98.75	-56.69	-85.49	-58.55	-86.74
ccsbBroad304_06609	OE	MYL6	EF-hand domain containing, myosin, light chain 6, alkali, smooth muscle and non-muscle			11.11, 0.00	1.78, 0.55	-64.40	-38.20	87.31	NaN	39.60	35.45	-48.60	-86.46	96.04	-18.53
ccsbBroad304_01092	OE	NFIL3	basic leucine zipper proteins, nuclear factor, interleukin 3 regulated			11.11, 11.11	0.99, 0.22	-45.09	-65.07	34.03	NaN	67.58	38.48	98.35	-34.91	73.20	49.77
ccsbBroad304_01101	OE	NME1	non-metastatic cells 1, protein (NM23A) expressed in			0.00, 0.00	1.47, 0.53	-76.10	-46.98	-29.17	NaN	54.06	58.17	33.28	-60.51	-48.92	-44.50
ccsbBroad304_05564	OE	NPSR1	GPCR / Class A : Neuropeptide receptors : S, neuropeptide S receptor 1			0.00, 0.00	0.84, 0.31	80.20	-89.70	-20.54	NaN	69.84	-98.32	-19.54	-35.29	81.25	10.34
ccsbBroad304_07208	OE	NRIP1	nuclear receptor interacting protein 1			11.11, 0.00	1.10, 0.27	15.03	-88.42	-17.49	NaN	-36.81	-33.03	-79.42	51.54	96.61	-9.12
ccsbBroad304_03089	OE	PACSIN3	protein kinase C and casein kinase substrate in neurons 3			0.00, 0.00	1.08, 0.34	-44.50	-36.78	-97.56	NaN	24.40	69.83	-34.62	-45.26	-60.78	-23.55
ccsbBroad304_02208	OE	PDIA4	Protein disulfide isomerases, protein disulfide isomerase family A, member 4			11.11, 11.11	1.27, 0.41	-27.75	-98.59	44.78	NaN	-33.23	-63.93	99.94	61.55	-67.35	-28.01
ccsbBroad304_02923	OE	PHF19	Zinc fingers, PHD-type, PHD finger protein 19			11.11, 11.11	1.08, 0.25	82.44	93.36	-48.03	NaN	32.15	60.25	99.04	39.20	42.27	77.61
ccsbBroad304_08289	OE	PRKAG2	AMPK subfamily, protein kinase, AMP-activated, gamma 2 non-catalytic subunit			44.44, 44.44	0.86, 0.18	99.98	68.01	99.98	NaN	-8.20	-33.83	99.50	92.62	-95.95	99.91
ccsbBroad304_01294	OE	PRKRIR	THAP (C2CH-type zinc finger) domain containing, protein-kinase, interferon-inducible double stranded RNA dependent inhibitor, repressor of (P58 repressor)			0.00, 0.00	1.36, 0.42	68.69	51.26	-42.38	NaN	-71.11	48.94	-85.61	78.75	-97.57	-62.97
ccsbBroad304_01361	OE	RAB27A	RAB, member RAS oncogene, RAB27A, member RAS oncogene family			11.11, 11.11	1.78, 0.49	-14.37	-52.49	-69.81	NaN	46.85	33.31	-78.14	-41.00	99.70	-31.54
ccsbBroad304_06836	OE	RAD23B	RAD23 homolog B (S. cerevisiae)			0.00, 0.00	1.00, 0.19	86.29	29.91	45.67	NaN	39.63	-36.13	70.46	-34.40	-99.16	11.82
ccsbBroad304_06435	OE	RBPJ	recombination signal binding protein for immunoglobulin kappa J region			22.22, 22.22	0.78, 0.22	99.63	99.82	72.79	NaN	36.40	-50.22	-72.25	59.89	54.85	26.89
ccsbBroad304_06855	OE	RDX	radixin			0.00, 0.00	0.85, 0.25	32.60	-26.78	-95.23	NaN	-67.27	-29.20	-85.21	69.01	-48.13	-26.43
ccsbBroad304_01452	OE	RPS13	S ribosomal proteins, ribosomal protein S13			0.00, 0.00	1.26, 0.34	-99.81	-83.71	-74.68	NaN	91.83	-85.35	-94.46	-80.96	-86.91	-85.01
ccsbBroad304_00067	OE	SLC25A4	Mitochondrial nucleotide transporter subfamily, solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4			0.00, 0.00	1.27, 0.40	37.79	-90.00	-48.25	NaN	-91.01	27.68	-72.62	-98.34	45.89	-84.94
ccsbBroad304_00504	OE	SLC29A1	SLC29 family, solute carrier family 29 (nucleoside transporters), member 1			22.22, 11.11	0.97, 0.39	33.46	-73.49	-75.45	NaN	52.55	99.16	45.24	95.37	-90.85	29.73
ccsbBroad304_02469	OE	SLC35A1	SLC35 family of nucleotide sugar transporters, solute carrier family 35 (CMP-sialic acid transporter), member A1			11.11, 0.00	0.68, 0.15	-60.38	29.89	95.51	NaN	-95.19	-31.47	-41.92	93.83	-50.03	-13.98
ccsbBroad304_00960	OE	SMAD1	SMADs, SMAD family member 1			0.00, 0.00	1.16, 0.35	-53.86	-67.04	-65.41	NaN	47.56	63.18	-87.01	-99.95	70.27	-73.96
ccsbBroad304_00962	OE	SMAD4	SMADs, SMAD family member 4			11.11, 11.11	0.83, 0.30	37.63	84.83	-99.96	NaN	-87.32	-73.18	99.66	-20.11	37.77	-51.80
ccsbBroad304_06976	OE	SMARCE1	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1			0.00, 0.00	1.98, 0.60	44.32	-99.85	60.70	NaN	-83.56	69.05	-75.67	-81.35	-86.46	-78.05
ccsbBroad304_01577	OE	SOD1	superoxide dismutase 1, soluble			11.11, 11.11	1.40, 0.25	79.05	91.16	74.29	NaN	-36.12	-24.45	99.31	-59.53	33.09	77.71
ccsbBroad304_01608	OE	STAT2	SH2 domain containing, signal transducer and activator of transcription 2, 113kDa			0.00, 0.00	1.19, 0.50	-57.09	-51.45	-30.19	NaN	-54.24	75.81	-16.69	-99.98	-61.96	-25.13
ccsbBroad304_01611	OE	STAT6	SH2 domain containing, signal transducer and activator of transcription 6, interleukin-4 induced			11.11, 11.11	0.80, 0.13	-30.64	70.45	-27.32	NaN	54.31	-82.05	49.21	99.09	-55.19	40.81
ccsbBroad304_01617	OE	STX4	syntaxin 4			11.11, 11.11	1.01, 0.18	98.04	88.25	-46.23	NaN	68.88	-99.72	78.46	72.98	89.27	87.56
ccsbBroad304_07018	OE	SUPT5H	suppressor of Ty 5 homolog (S. cerevisiae)			11.11, 0.00	1.09, 0.40	-78.23	36.40	-74.12	NaN	-42.27	-39.36	-99.92	-29.91	96.97	-32.45
ccsbBroad304_01640	OE	TAF12	TAF12 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 20kDa			0.00, 0.00	1.02, 0.18	56.73	-34.19	-19.79	NaN	-53.91	-47.31	-65.63	55.47	80.55	-15.81
ccsbBroad304_01654	OE	TCTA	T-cell leukemia translocation altered gene			0.00, 0.00	1.36, 0.36	20.39	65.26	-99.89	NaN	-67.79	-33.96	-19.95	-94.49	-99.97	-94.38
ccsbBroad304_02922	OE	TES	testis derived transcript (3 LIM domains)			22.22, 22.22	0.68, 0.18	-81.43	99.64	50.21	NaN	66.40	99.97	38.21	-32.09	49.25	52.33
ccsbBroad304_09284	OE	UBE3B	ubiquitin protein ligase E3B			11.11, 11.11	1.65, 0.41	-52.36	-91.03	-29.05	NaN	56.09	98.44	-75.29	-53.13	-98.97	-90.11
ccsbBroad304_01822	OE	ZNF227	Zinc fingers, C2H2-type, zinc finger protein 227			0.00, 0.00	1.31, 0.35	35.13	41.99	35.11	NaN	76.70	-58.62	-85.41	32.29	-25.23	9.24
ccsbBroad304_08978	OE	ZNF672	Zinc fingers, C2H2-type, zinc finger protein 672			0.00, 0.00	1.16, 0.27	82.37	25.05	-59.95	NaN	-28.90	-31.92	45.81	65.92	43.27	18.71
ccsbBroad304_11714	OE	ATMIN	Zinc fingers, C2H2-type, ATM interactor			22.22, 22.22	0.90, 0.31	38.73	-54.49	99.75	NaN	-43.96	29.02	-93.38	99.67	31.58	8.61
ccsbBroad304_03404	OE	POLE3	DNA polymerases, polymerase (DNA directed), epsilon 3 (p17 subunit)			11.11, 11.11	0.98, 0.30	-11.85	55.04	-36.08	NaN	97.97	-83.09	61.69	60.10	88.89	21.27
ccsbBroad304_01237	OE	POLR2C	RNA polymerase subunits, polymerase (RNA) II (DNA directed) polypeptide C, 33kDa			0.00, 0.00	0.92, 0.20	85.62	23.67	20.51	NaN	23.06	-77.36	-80.61	90.39	45.87	4.27
ccsbBroad304_05758	OE	ACADSB	acyl-CoA dehydrogenase, short/branched chain			10.00, 10.00	1.22, 0.26	-93.93	-68.79	-46.85	31.92	76.65	97.58	-28.09	-25.64	-99.52	-12.80
ccsbBroad304_08888	OE	ACD	adrenocortical dysplasia homolog (mouse)			0.00, 0.00	1.20, 0.35	33.37	43.84	-38.74	27.91	44.43	81.36	-82.89	79.93	38.97	21.96
ccsbBroad304_08681	OE	ADCK3	ABC1-B subfamily, aarF domain containing kinase 3			0.00, 0.00	1.98, 0.45	-41.51	-98.33	-90.38	-58.49	-99.06	-56.19	-81.83	-93.73	39.97	-95.45
ccsbBroad304_05787	OE	ADRBK1	BARK/GRK2 subfamily, adrenergic, beta, receptor kinase 1			10.00, 10.00	1.16, 0.30	-53.63	-41.18	38.14	-87.00	43.24	-50.55	-42.14	63.55	99.97	-20.73
ccsbBroad304_02401	OE	AKR1A1	Aldo-keto reductases, aldo-keto reductase family 1, member A1 (aldehyde reductase)			10.00, 0.00	1.48, 0.49	35.11	91.91	20.08	-83.49	-40.65	-49.57	-28.27	-96.59	96.15	-21.83
ccsbBroad304_06088	OE	AKR1C1	Aldo-keto reductases, aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)			0.00, 0.00	0.97, 0.27	25.87	90.97	-92.36	67.29	93.05	33.39	-69.79	-69.30	-87.20	-46.25
ccsbBroad304_01979	OE	AKR1C3	Prostaglandin synthases, aldo-keto reductase family 1, member C3 (3-alpha hydroxysteroid dehydrogenase, type II)			10.00, 0.00	1.06, 0.41	22.29	-94.43	36.59	-74.72	-26.22	57.49	95.37	-15.26	54.33	15.82
ccsbBroad304_00047	OE	AKT2	Akt (Protein kinase B), v-akt murine thymoma viral oncogene homolog 2		Akt Signaling GOF	10.00, 10.00	1.70, 0.52	22.47	32.32	-29.46	99.98	91.40	40.75	89.55	-18.25	33.26	43.60
ccsbBroad304_00053	OE	ALDOA	aldolase A, fructose-bisphosphate			10.00, 0.00	1.26, 0.30	-27.59	-68.13	-22.70	-69.32	-28.74	-35.11	95.85	-95.07	-62.62	-46.49
ccsbBroad304_04478	OE	ALG2	Glycosyltransferase group 1 domain containing, asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)			0.00, 0.00	1.10, 0.26	-99.98	-75.10	-96.74	-61.82	-79.43	-75.91	-99.96	-54.99	-48.73	-95.16
ccsbBroad304_05821	OE	ANXA1	Annexins, annexin A1			0.00, 0.00	1.08, 0.25	46.68	-28.76	7.53	-40.02	-32.40	32.79	-55.85	-94.42	-24.62	-1.48
ccsbBroad304_05823	OE	ANXA2	Annexins, annexin A2			0.00, 0.00	1.41, 0.42	-99.82	33.91	-68.31	74.91	-31.75	-38.73	-28.36	92.21	61.29	4.46
ccsbBroad304_02581	OE	ASCC3	activating signal cointegrator 1 complex subunit 3			0.00, 0.00	1.30, 0.51	65.09	-92.76	34.13	-98.99	-94.70	-57.10	38.94	-48.70	-27.40	-82.34
ccsbBroad304_07288	OE	B4GALT4	Beta 4-glycosyltransferases, UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 4			10.00, 0.00	0.98, 0.20	-23.96	-58.64	85.13	-65.57	38.91	-95.99	95.82	-50.72	68.84	29.70
ccsbBroad304_00145	OE	BACH1	BTB/POZ domain containing, BTB and CNC homology 1, basic leucine zipper transcription factor 1			0.00, 0.00	1.20, 0.47	-20.20	-67.56	38.96	45.43	39.48	32.59	-99.47	90.00	39.78	11.06
ccsbBroad304_09225	OE	BUD13	BUD13 homolog (S. cerevisiae)			0.00, 0.00	1.05, 0.32	92.69	-99.39	-29.75	28.83	-59.26	69.18	-36.68	-48.66	-98.74	-21.75
ccsbBroad304_00225	OE	CAT	catalase			10.00, 0.00	1.27, 0.34	18.77	52.79	88.19	-99.98	-39.92	96.32	68.53	-94.98	-99.96	-90.37
ccsbBroad304_00155	OE	CCND1	cyclin D1			100.00, 100.00	1.36, 0.34	100.00	99.96	99.99	99.99	99.86	99.97	99.98	98.41	99.97	99.91
ccsbBroad304_05948	OE	CCND2	cyclin D2			50.00, 50.00	0.86, 0.19	99.98	-22.66	99.91	-35.08	-97.44	99.97	60.96	39.25	99.93	99.91
ccsbBroad304_00239	OE	CCNG1	cyclin G1			0.00, 0.00	0.94, 0.30	23.59	37.92	82.25	-29.99	-99.27	-98.76	-37.03	65.93	62.06	21.39
ccsbBroad304_05745	OE	CD24	CD molecules, CD24 molecule			0.00, 0.00	1.26, 0.44	-16.00	29.01	41.56	-37.14	-72.98	-32.87	64.13	-54.14	-95.96	-19.45
ccsbBroad304_02423	OE	CD2BP2	Serine/threonine phosphatases / Protein phosphatase 1, regulatory subunits, CD2 (cytoplasmic tail) binding protein 2			10.00, 10.00	0.91, 0.27	-97.82	-56.78	-12.31	-55.61	99.06	91.83	27.51	-50.90	-24.91	-15.63
ccsbBroad304_07220	OE	CDC45	cell division cycle 45 homolog (S. cerevisiae)			0.00, 0.00	1.00, 0.40	-75.52	-89.51	72.32	-42.55	-95.09	-37.97	80.18	76.18	72.48	61.14
ccsbBroad304_07219	OE	CDC7	CDC7 family, cell division cycle 7 homolog (S. cerevisiae)			0.00, 0.00	1.35, 0.32	-57.70	-72.38	92.02	39.15	-36.09	-96.90	-50.97	13.07	91.79	-28.56
ccsbBroad304_01155	OE	CDK16	Cyclin-dependent kinases, TAIRE subfamily, cyclin-dependent kinase 16			10.00, 10.00	1.28, 0.32	-34.01	-29.34	-16.05	-19.82	-58.42	-98.99	37.30	77.49	99.97	-0.93
ccsbBroad304_00280	OE	CDK7	Cyclin-dependent kinases, CDK7 subfamily, cyclin-dependent kinase 7			0.00, 0.00	0.76, 0.30	41.13	-94.93	89.78	60.38	64.57	62.84	-91.46	19.72	-44.95	43.61
ccsbBroad304_05981	OE	CDO1	cysteine dioxygenase, type I			0.00, 0.00	1.13, 0.36	60.36	-74.94	38.31	-88.38	-64.22	-31.40	-87.13	-12.58	-98.93	-87.67
ccsbBroad304_00305	OE	CHRM3	Cholinergic receptors, cholinergic receptor, muscarinic 3			10.00, 10.00	1.23, 0.43	-31.30	-74.33	99.98	-86.35	-43.22	-67.74	-34.01	14.59	23.46	-23.09
ccsbBroad304_09471	OE	CSNK1A1L	Casein kinase 1 (CK1) family, casein kinase 1, alpha 1-like			0.00, 0.00	1.13, 0.35	-69.26	30.15	-93.63	-31.01	-33.40	51.53	-37.02	-57.55	-92.37	-75.69
ccsbBroad304_06070	OE	CYC1	Mitochondrial respiratory chain complex / Complex III, cytochrome c-1			0.00, 0.00	1.93, 0.55	-97.39	-86.06	-95.12	38.20	-36.87	-99.97	-34.54	-93.38	-87.10	-98.52
ccsbBroad304_03658	OE	DCP1A	DCP1 decapping enzyme homolog A (S. cerevisiae)			10.00, 0.00	1.27, 0.35	95.61	-42.38	-6.74	-41.72	23.45	44.46	-47.66	81.19	-97.03	-3.84
ccsbBroad304_06089	OE	DDIT3	DNA-damage-inducible transcript 3			0.00, 0.00	0.95, 0.31	-28.63	78.79	-77.09	88.36	40.49	-97.16	-74.62	40.84	-99.97	-85.69
ccsbBroad304_05054	OE	DTX3L	RING-type (C3HC4) zinc fingers, deltex 3-like (Drosophila)			0.00, 0.00	1.30, 0.35	31.12	52.66	67.03	64.96	72.57	-37.82	66.98	-73.92	-69.82	55.37
ccsbBroad304_01981	OE	DYNLL1	Cytoplasmic dyneins, dynein, light chain, LC8-type 1			0.00, 0.00	1.19, 0.26	81.88	-80.85	-91.61	-99.48	-25.92	-33.52	-80.09	39.76	-95.46	-91.11
ccsbBroad304_02506	OE	EBP	emopamil binding protein (sterol isomerase)			10.00, 10.00	1.36, 0.41	22.16	99.58	-86.09	-78.07	-68.82	-98.63	-99.33	53.59	39.81	-73.94
ccsbBroad304_00501	OE	EMD	emerin			0.00, 0.00	1.34, 0.45	-99.84	-78.71	-83.36	-30.23	85.44	-85.69	-88.63	33.00	30.13	-86.84
ccsbBroad304_00518	OE	ETFA	electron-transfer-flavoprotein, alpha polypeptide			10.00, 10.00	1.83, 0.56	-73.51	-96.44	-98.25	45.04	98.20	-69.63	-98.03	-71.10	-28.49	-94.03
ccsbBroad304_03591	OE	ETNK1	ethanolamine kinase 1			0.00, 0.00	1.31, 0.38	-91.50	84.81	-52.43	63.53	-61.01	40.40	-75.20	-13.18	-99.97	-45.91
ccsbBroad304_06185	OE	EYA1	Protein tyrosine phosphatases / Asp-based PTPs, eyes absent homolog 1 (Drosophila)			30.00, 10.00	1.00, 0.34	93.56	46.92	-33.54	67.97	57.79	86.91	95.24	99.98	-71.49	95.34
ccsbBroad304_00542	OE	FBP1	fructose-1,6-bisphosphatase 1			10.00, 10.00	1.06, 0.26	-43.99	-70.67	-80.72	30.35	30.24	99.91	-43.08	-92.56	50.29	-38.99
ccsbBroad304_04189	OE	FBXO11	Protein arginine N-methyltransferases, F-box protein 11			10.00, 0.00	1.58, 0.41	-35.63	-58.81	-37.67	68.25	92.28	38.20	97.21	-88.80	-35.17	33.90
ccsbBroad304_06209	OE	FGF9	Endogenous ligands, fibroblast growth factor 9 (glia-activating factor)			10.00, 0.00	1.03, 0.26	51.03	63.61	-40.02	-83.59	96.05	84.10	-40.33	63.38	-94.97	64.28
ccsbBroad304_06264	OE	GBP2	guanylate binding protein 2, interferon-inducible			10.00, 10.00	1.42, 0.48	18.82	-94.08	-32.68	80.80	-36.52	-40.93	-45.11	-35.35	99.93	-10.29
ccsbBroad304_02029	OE	GGH	Gamma-glutamyl hydrolase, gamma-glutamyl hydrolase (conjugase, folylpolygammaglutamyl hydrolase)			0.00, 0.00	1.17, 0.26	82.19	-63.45	-28.54	36.12	-86.59	-34.92	-27.28	44.49	-94.48	-14.66
ccsbBroad304_05049	OE	GPBAR1	Bile acid receptor, G protein-coupled bile acid receptor 1		GPCR Subset GOF	50.00, 50.00	1.36, 0.36	99.46	-77.52	-59.75	-33.69	99.85	-41.30	98.40	64.55	99.58	99.77
ccsbBroad304_00677	OE	GPR34	GPCR / Class A : Orphans, G protein-coupled receptor 34			20.00, 10.00	1.40, 0.40	-20.23	98.58	96.03	26.59	-70.42	82.47	-20.94	-30.05	-26.65	20.46
ccsbBroad304_00679	OE	GPR39	GPCR / Class A : Orphans, G protein-coupled receptor 39			10.00, 0.00	0.85, 0.31	96.96	-56.64	91.75	79.60	-40.21	-86.74	-43.24	-66.35	46.03	49.80
ccsbBroad304_03394	OE	GPR84	GPCR / Class A : Fatty acid receptors, G protein-coupled receptor 84			20.00, 20.00	0.91, 0.28	79.04	99.72	79.86	-56.16	47.53	62.08	99.16	40.61	-34.36	77.08
ccsbBroad304_00702	OE	GSTM1	Glutathione S-transferases / Soluble, glutathione S-transferase mu 1			0.00, 0.00	1.40, 0.30	-38.24	35.44	-17.01	59.30	-42.53	-85.76	33.08	-53.84	-99.96	-20.28
ccsbBroad304_06350	OE	HAL	histidine ammonia-lyase			20.00, 0.00	1.16, 0.25	47.17	66.44	96.89	-27.03	33.55	-35.00	71.59	-92.37	95.62	65.33
ccsbBroad304_02408	OE	HMG20B	High mobility group / Non-canonical, high mobility group 20B			0.00, 0.00	1.39, 0.40	67.53	66.50	65.76	-38.67	-74.41	-35.15	-42.97	-66.85	-16.26	-6.41
ccsbBroad304_06382	OE	HMGCL	3-hydroxymethyl-3-methylglutaryl-CoA lyase			10.00, 10.00	1.17, 0.26	99.94	-42.51	-55.46	-99.95	-63.56	32.89	72.90	-47.53	47.15	-26.99
ccsbBroad304_06383	OE	HMMR	CD molecules, hyaluronan-mediated motility receptor (RHAMM)			20.00, 10.00	1.32, 0.47	59.60	-70.75	-19.39	-26.94	-49.92	58.39	96.51	-50.15	99.97	19.38
ccsbBroad304_06393	OE	HOXC4	Homeoboxes / ANTP class : HOXL subclass, homeobox C4		Homeobox Gene GOF	10.00, 10.00	1.23, 0.44	-52.29	-99.56	35.63	-55.86	-99.93	-26.99	84.27	-99.81	99.97	-98.10
ccsbBroad304_03314	OE	HSD17B7	Short chain dehydrogenase/reductase superfamily / Classical SDR fold cluster 2, hydroxysteroid (17-beta) dehydrogenase 7			0.00, 0.00	1.13, 0.40	-18.39	-44.38	-36.40	-92.70	-46.81	38.63	-36.59	-91.11	-35.24	-40.45
ccsbBroad304_00795	OE	HSF2	heat shock transcription factor 2			0.00, 0.00	1.17, 0.26	44.19	-91.02	66.55	-27.47	77.94	-98.85	51.04	-26.32	-98.69	-67.32
ccsbBroad304_03240	OE	HSPA14	Heat shock proteins / HSP70, heat shock 70kDa protein 14			0.00, 0.00	1.31, 0.35	-32.88	46.51	-96.63	-26.21	31.40	43.84	-85.25	-15.32	22.45	-8.38
ccsbBroad304_02958	OE	HSPB8	Heat shock proteins / HSPB, heat shock 22kDa protein 8			0.00, 0.00	1.23, 0.36	-43.59	-66.06	-44.15	-29.74	31.80	-81.03	-53.56	-47.96	-74.89	-57.81
ccsbBroad304_00810	OE	HYAL1	hyaluronoglucosaminidase 1			0.00, 0.00	1.85, 0.44	-95.70	-78.18	59.34	-66.16	73.31	87.69	-49.08	-35.65	66.77	-66.36
ccsbBroad304_08292	OE	IP6K2	inositol hexakisphosphate kinase 2			0.00, 0.00	2.13, 0.55	-24.50	69.42	24.22	-84.67	-87.88	-76.96	34.19	88.36	28.00	-32.59
ccsbBroad304_00882	OE	IRS1	Pleckstrin homology (PH) domain containing, insulin receptor substrate 1			10.00, 10.00	1.30, 0.28	28.24	-54.26	85.69	77.69	-72.01	99.87	32.53	-48.16	-52.45	58.76
ccsbBroad304_07876	OE	LARS2	Aminoacyl tRNA synthetases / Class I, leucyl-tRNA synthetase 2, mitochondrial			0.00, 0.00	1.05, 0.33	-85.19	86.89	49.44	82.11	-85.95	63.18	79.39	-53.85	-29.35	57.78
ccsbBroad304_03923	OE	LRRC4	Immunoglobulin superfamily / I-set domain containing, leucine rich repeat containing 4			10.00, 10.00	1.28, 0.31	35.69	98.98	-95.57	-70.15	-59.93	58.68	35.32	-66.97	78.21	-53.27
ccsbBroad304_01288	OE	MAPK9	MAPK:JNK subfamily, mitogen-activated protein kinase 9			0.00, 0.00	0.66, 0.15	-45.69	-99.72	-74.67	60.13	-31.15	47.26	80.43	43.50	-52.43	-24.98
ccsbBroad304_14242	OE	MCCC2	methylcrotonoyl-CoA carboxylase 2 (beta)			20.00, 20.00	0.88, 0.27	28.56	25.59	29.45	-67.41	-57.27	99.97	99.60	-75.40	56.16	10.10
ccsbBroad304_03951	OE	NARFL	nuclear prelamin A recognition factor-like			10.00, 0.00	0.82, 0.19	-28.10	95.68	12.54	76.28	93.18	43.64	35.05	-86.12	-79.85	26.30
ccsbBroad304_03554	OE	NAT10	N-acetyltransferase 10 (GCN5-related)			10.00, 10.00	1.32, 0.36	-30.08	24.57	60.10	74.26	82.49	-97.77	-93.79	99.98	-26.86	56.37
ccsbBroad304_01103	OE	NONO	RNA binding motif (RRM) containing, non-POU domain containing, octamer-binding			10.00, 10.00	1.34, 0.36	-97.14	-73.66	-77.53	-97.38	99.91	50.83	-68.84	54.49	36.29	-77.67
ccsbBroad304_03618	OE	OSGEP	O-sialoglycoprotein endopeptidase			0.00, 0.00	0.89, 0.16	-47.37	-51.23	78.20	-15.71	27.23	22.82	-50.92	47.30	21.80	-5.14
ccsbBroad304_02086	OE	PDLIM1	PDZ and LIM domain 1			10.00, 10.00	0.91, 0.25	-12.18	-63.25	-32.55	-99.63	53.42	99.87	-49.70	-73.59	-37.34	-26.83
ccsbBroad304_07267	OE	PDLIM4	PDZ and LIM domain 4			0.00, 0.00	2.22, 0.53	55.64	87.76	-90.68	-25.13	-44.12	-27.17	-36.33	-59.83	-42.65	-34.47
ccsbBroad304_01265	OE	PPP2R4	Serine/threonine phosphatases / Protein phosphatase 2, regulatory subunits, protein phosphatase 2A activator, regulatory subunit 4			0.00, 0.00	1.03, 0.25	-17.58	-60.63	-99.98	34.75	93.87	41.29	-80.33	-92.64	-44.29	-65.85
ccsbBroad304_06785	OE	PRSS2	Serine peptidases, protease, serine, 2 (trypsin 2)			10.00, 0.00	2.19, 0.58	-99.98	68.71	62.06	68.06	35.91	95.73	68.00	-54.00	-50.13	64.74
ccsbBroad304_01342	OE	PTPN6	Protein tyrosine phosphatases, protein tyrosine phosphatase, non-receptor type 6			0.00, 0.00	1.06, 0.43	40.77	-90.14	-21.92	-99.96	-84.80	-29.70	-34.69	-74.48	-36.10	-65.32
ccsbBroad304_09095	OE	PUS7L	pseudouridylate synthase 7 homolog (S. cerevisiae)-like			0.00, 0.00	1.28, 0.32	-62.02	-88.47	-51.64	-19.92	40.33	-99.79	-77.82	-38.25	-61.35	-68.85
ccsbBroad304_02565	OE	RALBP1	ralA binding protein 1			0.00, 0.00	1.73, 0.43	-80.53	-86.49	-63.42	-35.78	-53.16	57.40	32.79	-54.68	78.20	-54.18
ccsbBroad304_06840	OE	RAP1GDS1	Armadillo repeat containing, RAP1, GTP-GDP dissociation stimulator 1			10.00, 10.00	0.93, 0.20	34.49	33.52	99.92	30.86	64.35	-38.41	77.81	-71.45	-59.40	13.38
ccsbBroad304_01391	OE	RFC5	ATPases / AAA-type, replication factor C (activator 1) 5, 36.5kDa			0.00, 0.00	0.98, 0.32	42.26	42.79	-99.11	-77.79	-23.07	43.20	47.97	34.87	-36.82	5.82
ccsbBroad304_01394	OE	RFX4	regulatory factor X, 4 (influences HLA class II expression)			10.00, 10.00	1.51, 0.42	17.13	-48.43	-98.46	-54.46	-29.03	-36.97	98.73	28.82	-49.48	-18.30
ccsbBroad304_01447	OE	RPS6KA3	RSK subfamily, ribosomal protein S6 kinase, 90kDa, polypeptide 3			10.00, 10.00	1.23, 0.36	-88.76	44.82	-99.87	99.57	74.17	61.98	-65.20	-62.52	41.53	-40.37
ccsbBroad304_02500	OE	RRAGA	Ras-related GTP binding A			0.00, 0.00	1.09, 0.34	-21.24	-99.93	-52.26	24.00	-56.25	45.48	-42.49	32.28	-82.92	-15.78
ccsbBroad304_00478	OE	S1PR3	GPCR / Class A : Lysophospholipid receptors : Sphingosine 1-phosphate, sphingosine-1-phosphate receptor 3			10.00, 10.00	2.77, 0.88	-35.57	31.22	18.13	-49.95	-31.44	99.93	92.48	-99.39	-98.92	-16.26
ccsbBroad304_07814	OE	SACM1L	SAC1 suppressor of actin mutations 1-like (yeast)			0.00, 0.00	1.41, 0.36	-20.79	-85.78	83.92	-45.59	87.50	-96.74	44.09	-81.83	26.95	-55.04
ccsbBroad304_01825	OE	SLC30A2	SLC30 zinc transporter family, solute carrier family 30 (zinc transporter), member 2			0.00, 0.00	1.18, 0.27	76.83	27.68	-98.81	94.83	62.42	-83.79	-37.65	-72.98	-79.65	-86.16
ccsbBroad304_10507	OE	SNX7	Sorting nexins, sorting nexin 7			0.00, 0.00	0.82, 0.19	-24.21	-33.71	-79.72	37.20	-87.53	-23.14	52.16	67.93	-75.33	-21.27
ccsbBroad304_07238	OE	STK24	YSK subfamily, serine/threonine kinase 24			0.00, 0.00	1.36, 0.31	80.61	-75.60	46.93	48.59	-34.85	-84.01	84.35	-99.98	-82.37	-60.53
ccsbBroad304_02458	OE	STK25	YSK subfamily, serine/threonine kinase 25			10.00, 10.00	0.92, 0.27	99.28	-44.67	-84.74	-83.64	-69.68	-90.93	-51.84	-65.02	29.23	-67.06
ccsbBroad304_01632	OE	SYPL1	synaptophysin-like 1			0.00, 0.00	1.75, 0.49	-99.96	-94.33	-65.51	-19.73	43.81	34.82	-45.34	-80.15	26.01	-57.05
ccsbBroad304_01685	OE	TNFAIP1	BTB/POZ domain containing, tumor necrosis factor, alpha-induced protein 1 (endothelial)			20.00, 20.00	0.90, 0.28	98.10	-63.55	38.78	51.76	42.72	99.94	-90.00	-34.05	-59.65	-14.04
ccsbBroad304_01686	OE	TNFAIP3	OTU domain containing, tumor necrosis factor, alpha-induced protein 3			0.00, 0.00	1.45, 0.28	41.17	42.13	-40.94	-40.50	72.14	78.29	84.38	90.64	32.96	49.68
ccsbBroad304_04655	OE	TRIM9	tripartite motif containing 9			10.00, 10.00	1.13, 0.36	-36.54	69.27	-92.21	59.38	27.12	42.59	98.91	-63.40	-99.52	-48.20
ccsbBroad304_01774	OE	WARS	Aminoacyl tRNA synthetases / Class I, tryptophanyl-tRNA synthetase			0.00, 0.00	0.72, 0.16	-32.19	-85.04	40.00	49.21	-32.94	37.53	45.63	93.27	-99.96	-8.13
ccsbBroad304_01779	OE	WNT5A	Endogenous ligands, wingless-type MMTV integration site family, member 5A		Wnt family GOF	0.00, 0.00	1.35, 0.52	-32.39	-86.24	-77.91	65.14	-43.61	-60.53	-94.18	-70.60	-44.42	-62.58
ccsbBroad304_07832	OE	XPO7	Exportins, exportin 7			10.00, 10.00	1.09, 0.20	99.21	-76.01	-99.76	-56.46	92.09	-77.31	-58.93	-99.14	25.30	-87.25
ccsbBroad304_02109	OE	XPR1	xenotropic and polytropic retrovirus receptor 1			10.00, 10.00	1.08, 0.32	-56.12	94.45	-60.63	99.98	-73.20	-29.58	-55.10	-48.46	-88.41	-45.88
ccsbBroad304_05213	OE	ZNF449	Zinc fingers, C2H2-type, zinc finger protein 449			10.00, 0.00	0.60, 0.19	-44.48	-32.57	-74.79	95.96	-43.38	-36.90	-57.34	70.66	-54.22	-20.74
ccsbBroad304_02879	OE	ZNF473	Zinc fingers, C2H2-type, zinc finger protein 473			0.00, 0.00	1.58, 0.48	-35.44	-91.49	57.25	-38.38	24.91	-86.03	-64.49	-25.92	-77.33	-75.98
ccsbBroad304_09676	OE	ZSWIM2	Zinc fingers, SWIM-type, zinc finger, SWIM-type containing 2			0.00, 0.00	0.94, 0.32	-50.57	39.07	-52.82	-99.96	-50.79	-60.79	-76.07	-11.95	27.85	-25.61
ccsbBroad304_00055	OE	AKR1B1	Aldo-keto reductases, aldo-keto reductase family 1, member B1 (aldose reductase)			0.00, 0.00	1.03, 0.28	-99.25	-31.22	-86.39	-36.01	-49.90	35.46	36.01	-34.94	-88.46	-50.58
ccsbBroad304_07529	OE	AKT3	Akt (Protein kinase B), v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma)		Akt Signaling GOF	10.00, 10.00	0.98, 0.19	-99.22	-60.80	33.23	99.80	56.67	39.18	62.54	-62.72	-95.11	-49.47
ccsbBroad304_03945	OE	AKTIP	Ubiquitin-conjugating enzymes E2, AKT interacting protein			10.00, 10.00	1.01, 0.30	99.98	-49.57	39.17	-35.62	66.37	-40.15	-78.60	88.59	27.97	25.48
ccsbBroad304_00070	OE	ANXA5	Annexins, annexin A5			0.00, 0.00	1.27, 0.33	19.70	-81.25	80.09	-48.37	-22.07	-28.53	-37.12	56.69	-21.66	-6.69
ccsbBroad304_13813	OE	ARAF	RAF family, v-raf murine sarcoma 3611 viral oncogene homolog			10.00, 10.00	1.09, 0.26	99.58	-59.56	32.62	-42.74	-41.57	-45.13	46.99	41.04	83.51	-13.97
ccsbBroad304_00112	OE	ASNA1	arsA arsenite transporter, ATP-binding, homolog 1 (bacterial)			10.00, 10.00	1.33, 0.44	-85.26	-41.76	98.68	-49.28	49.52	-85.72	-77.81	-26.61	33.09	-50.49
ccsbBroad304_00078	OE	BIRC2	Inhibitors of apoptosis (IAP) protein family, baculoviral IAP repeat containing 2			10.00, 10.00	1.24, 0.35	98.56	55.79	-27.26	57.82	76.23	71.07	-24.10	-71.69	28.41	40.65
ccsbBroad304_10423	OE	BMPR1A	Type I receptor serine/threonine kinases, bone morphogenetic protein receptor, type IA			0.00, 0.00	1.40, 0.36	-92.08	-40.17	-21.28	-32.88	-77.98	-92.73	-38.25	79.81	54.75	-47.10
ccsbBroad304_00173	OE	BRCA1	Fanconi anemia, complementation groups, breast cancer 1, early onset			0.00, 0.00	0.93, 0.20	86.51	-66.29	-23.97	-50.91	-60.93	31.91	46.40	-99.04	31.74	-24.72
ccsbBroad304_00211	OE	CALU	EF-hand domain containing, calumenin			10.00, 10.00	0.78, 0.36	-25.51	79.05	37.92	-99.50	99.50	49.52	-67.62	71.58	-29.42	41.81
ccsbBroad304_01960	OE	CASK	CASK family, calcium/calmodulin-dependent serine protein kinase (MAGUK family)			10.00, 10.00	1.60, 0.47	-49.46	32.38	-30.53	-33.25	42.21	-81.63	99.48	14.46	-60.49	-20.77
ccsbBroad304_05972	OE	CDC25C	Serine/threonine phosphatases / Protein phosphatase 1, regulatory subunits, cell division cycle 25 homolog C (S. pombe)			0.00, 0.00	0.91, 0.13	-60.93	-42.70	-85.39	37.02	-95.86	-56.46	56.21	36.92	-30.31	-35.64
ccsbBroad304_00326	OE	CLK1	CDC-like kinases, CDC-like kinase 1			20.00, 20.00	1.10, 0.34	-44.42	-34.83	90.60	99.85	-80.44	-35.79	-47.42	67.42	99.14	77.15
ccsbBroad304_02686	OE	COPZ1	coatomer protein complex, subunit zeta 1			10.00, 10.00	1.23, 0.27	33.73	99.54	-74.87	-54.73	85.98	33.71	66.72	73.22	-23.42	43.46
ccsbBroad304_06028	OE	CPE	Carboxypeptidase A, carboxypeptidase E			0.00, 0.00	0.94, 0.23	26.12	36.27	92.75	77.73	-88.07	63.83	-88.79	33.50	-97.26	18.08
ccsbBroad304_02501	OE	DCTN6	dynactin 6			0.00, 0.00	0.86, 0.26	-48.59	75.33	-12.34	-32.07	-34.43	64.79	54.03	50.63	-82.46	10.42
ccsbBroad304_02298	OE	DNM1L	dynamin 1-like			0.00, 0.00	1.66, 0.49	63.70	-64.78	55.26	78.62	-43.37	-39.56	-18.68	35.90	68.87	31.27
ccsbBroad304_00472	OE	EBF1	early B-cell factor 1			10.00, 10.00	2.63, 0.56	-97.09	-99.91	-97.27	-41.01	-94.65	-96.26	99.48	-87.04	21.34	-99.54
ccsbBroad304_01984	OE	EIF3G	RNA binding motif (RRM) containing, eukaryotic translation initiation factor 3, subunit G			0.00, 0.00	1.31, 0.25	37.17	90.28	-19.60	72.52	-32.32	94.29	-49.05	-44.37	-65.18	19.27
ccsbBroad304_00517	OE	ESR1	Estrogen receptors, estrogen receptor 1			0.00, 0.00	1.17, 0.30	34.99	-94.09	-39.43	62.90	-99.73	-98.98	-99.33	-99.98	-95.43	-99.91
ccsbBroad304_06229	OE	FUS	RNA binding motif (RRM) containing, fused in sarcoma			20.00, 10.00	0.85, 0.28	-99.81	99.30	95.95	-38.27	75.32	66.90	81.93	-16.49	-96.69	70.51
ccsbBroad304_00600	OE	FYN	Src family, FYN oncogene related to SRC, FGR, YES			0.00, 0.00	1.40, 0.36	-77.18	-61.53	-67.67	-58.50	34.45	-21.77	59.76	-93.94	87.96	-51.19
ccsbBroad304_01890	OE	FZD7	GPCR / Class F : Frizzled receptors, frizzled family receptor 7			10.00, 10.00	1.35, 0.35	99.96	76.70	-99.98	36.82	42.43	-50.23	37.55	-86.48	28.41	10.79
ccsbBroad304_07945	OE	GCA	EF-hand domain containing, grancalcin, EF-hand calcium binding protein			10.00, 10.00	1.15, 0.34	99.98	-35.99	59.50	-32.96	-73.27	-79.49	82.78	72.03	-88.24	62.31
ccsbBroad304_03415	OE	GFOD1	glucose-fructose oxidoreductase domain containing 1			20.00, 20.00	1.38, 0.42	-80.39	73.33	83.55	99.56	50.87	57.47	99.98	-42.30	36.17	80.41
ccsbBroad304_00654	OE	GNB1	WD repeat domain containing, guanine nucleotide binding protein (G protein), beta polypeptide 1			0.00, 0.00	1.25, 0.36	-33.39	-99.23	-51.44	-22.75	79.70	-40.99	-28.25	42.94	93.38	-5.98
ccsbBroad304_06411	OE	HSPA9	Heat shock proteins / HSP70, heat shock 70kDa protein 9 (mortalin)			0.00, 0.00	0.89, 0.25	63.18	31.88	46.39	72.70	49.09	64.23	-94.13	-92.08	-99.73	37.70
ccsbBroad304_06431	OE	IFNAR2	Interferon receptor family, interferon (alpha, beta and omega) receptor 2			10.00, 10.00	1.18, 0.38	76.68	-98.53	-40.34	81.62	85.18	-57.02	-28.94	-21.41	99.65	70.94
ccsbBroad304_00857	OE	IL10	Interleukins and interleukin receptors, interleukin 10			0.00, 0.00	1.20, 0.39	55.99	82.82	-43.31	-34.11	-99.85	40.94	62.40	-51.63	-37.34	18.64
ccsbBroad304_06448	OE	IL18	Interleukins and interleukin receptors, interleukin 18 (interferon-gamma-inducing factor)		Interleukins GOF	0.00, 0.00	1.18, 0.35	-79.30	-60.64	29.11	42.95	-61.56	-75.02	-84.60	33.62	-44.93	-54.47
ccsbBroad304_00879	OE	IRAK2	Interleukin-1 receptor-associated kinase (IRAK) family, interleukin-1 receptor-associated kinase 2			0.00, 0.00	1.31, 0.38	-27.70	-80.45	49.86	-60.50	-62.11	-31.09	-70.89	-88.57	-22.61	-54.07
ccsbBroad304_00883	OE	ISG20	interferon stimulated exonuclease gene 20kDa			10.00, 0.00	1.28, 0.25	-99.59	95.14	32.82	66.33	-56.27	-71.01	84.07	-99.60	-95.19	-85.10
ccsbBroad304_00933	OE	LDHB	lactate dehydrogenase B			0.00, 0.00	1.52, 0.30	-26.00	68.14	77.08	46.43	-27.18	93.96	-56.52	-29.84	-36.08	6.71
ccsbBroad304_08825	OE	LHPP	phospholysine phosphohistidine inorganic pyrophosphate phosphatase			20.00, 20.00	0.74, 0.32	-22.28	-63.75	99.58	-98.27	58.57	99.69	-63.45	-84.12	-26.95	-28.90
ccsbBroad304_00944	OE	LIMK2	LIMK subfamily, LIM domain kinase 2			10.00, 10.00	1.05, 0.35	-82.17	-76.35	-74.43	-53.94	98.47	-73.95	92.22	36.93	33.18	-61.82
ccsbBroad304_00945	OE	LMNA	Intermediate filaments type V, lamins, lamin A/C			10.00, 10.00	1.60, 0.39	-30.12	-50.86	-93.86	99.11	-34.14	-82.95	84.99	-44.97	61.06	-44.58
ccsbBroad304_04715	OE	MRGPRF	GPCR / Class A : Orphans, MAS-related GPR, member F			10.00, 10.00	1.67, 0.34	-32.65	-35.25	-88.28	-33.45	-36.60	-82.02	38.57	-38.72	99.24	-32.61
ccsbBroad304_06642	OE	NIT1	nitrilase 1			40.00, 30.00	0.95, 0.25	95.40	99.69	97.50	-40.23	80.25	89.10	-34.25	-55.00	-99.54	98.42
ccsbBroad304_03040	OE	NKIRAS2	NFKB inhibitor interacting Ras-like 2			0.00, 0.00	1.73, 0.47	-91.75	-70.01	48.13	-39.78	-71.49	-72.17	27.56	71.75	37.75	-35.50
ccsbBroad304_05313	OE	NUDT14	Nudix motif containing, nudix (nucleoside diphosphate linked moiety X)-type motif 14			0.00, 0.00	1.33, 0.38	-20.87	44.54	-79.95	94.07	56.59	67.47	43.03	-45.23	49.65	17.62
ccsbBroad304_08605	OE	PBK	TOPK family, PDZ binding kinase			30.00, 30.00	1.35, 0.40	36.46	97.77	98.16	-76.33	-43.41	99.94	30.21	-44.54	-99.90	57.10
ccsbBroad304_01953	OE	PIAS1	Zinc fingers, MIZ-type, protein inhibitor of activated STAT, 1			0.00, 0.00	1.00, 0.25	75.19	88.47	-38.60	-37.93	31.75	84.00	-89.94	54.38	51.24	60.77
ccsbBroad304_02295	OE	PIGK	Phosphatidylinositol glycan anchor biosynthesis, phosphatidylinositol glycan anchor biosynthesis, class K			0.00, 0.00	0.92, 0.26	85.50	38.91	-30.83	-52.80	-81.64	38.57	48.93	50.05	-37.51	16.32
ccsbBroad304_01249	OE	PPARG	Peroxisome proliferator-activated receptors, peroxisome proliferator-activated receptor gamma			0.00, 0.00	0.93, 0.23	-82.42	-33.30	76.21	-28.35	-79.17	-31.70	78.76	-39.04	-99.41	-45.59
ccsbBroad304_01258	OE	PPP1CA	Serine/threonine phosphatases / Protein phosphatase, catalytic subunits, protein phosphatase 1, catalytic subunit, alpha isozyme			0.00, 0.00	1.02, 0.22	33.40	-28.97	-66.49	19.46	-58.14	90.17	81.33	-49.77	-92.82	-20.34
ccsbBroad304_06797	OE	PSMA5	Proteasome subunits, proteasome (prosome, macropain) subunit, alpha type, 5			10.00, 0.00	0.82, 0.15	53.19	39.22	-99.87	-95.92	-72.74	32.29	96.59	-91.09	-55.69	-94.83
ccsbBroad304_06837	OE	RAF1	RAF family, v-raf-1 murine leukemia viral oncogene homolog 1			0.00, 0.00	1.97, 0.50	27.90	62.31	-87.56	-34.00	69.39	-99.71	-90.83	-97.02	-99.90	-99.26
ccsbBroad304_01372	OE	RALB	v-ral simian leukemia viral oncogene homolog B (ras related; GTP binding protein)			10.00, 10.00	0.86, 0.20	21.16	68.42	78.87	-30.01	99.35	-38.04	89.65	76.77	-26.06	71.69
ccsbBroad304_01376	OE	RARB	Retinoic acid receptors, retinoic acid receptor, beta			0.00, 0.00	1.13, 0.23	-54.34	-31.49	30.45	47.49	-21.99	-93.58	-19.27	-90.92	72.26	-10.09
ccsbBroad304_06856	OE	RET	Type XIV RTKs: RET, ret proto-oncogene			0.00, 0.00	1.19, 0.41	-86.48	26.53	-33.08	-68.01	-90.25	-48.37	-92.74	-77.21	41.04	-93.70
ccsbBroad304_08715	OE	SALL4	Zinc fingers, C2H2-type, sal-like 4 (Drosophila)			20.00, 20.00	1.88, 0.38	99.76	-75.54	54.82	-52.41	99.98	-95.24	-35.80	-19.24	50.39	-25.91
ccsbBroad304_00961	OE	SMAD2	SMADs, SMAD family member 2			10.00, 10.00	1.08, 0.36	-41.18	-26.40	-74.12	-45.16	-24.73	99.97	-76.46	86.74	78.48	-10.51
ccsbBroad304_08694	OE	TBX20	T-boxes, T-box 20			10.00, 10.00	1.13, 0.43	-86.27	-92.71	53.01	25.89	99.70	58.84	-96.00	77.53	23.88	33.12
ccsbBroad304_01660	OE	TFAP4	Basic helix-loop-helix proteins, transcription factor AP-4 (activating enhancer binding protein 4)			10.00, 10.00	1.57, 0.36	99.54	-65.40	-59.26	83.15	-76.45	27.68	-55.12	-36.12	34.74	-49.94
ccsbBroad304_07061	OE	TGM2	Transglutaminases, transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase)			0.00, 0.00	0.99, 0.31	-32.61	18.68	-9.41	-80.12	-82.70	43.18	-35.48	-37.26	-27.12	-2.92
ccsbBroad304_02708	OE	TRIM32	tripartite motif containing 32			0.00, 0.00	1.16, 0.36	26.60	37.30	28.68	59.90	-36.94	33.84	-99.82	-99.84	-99.97	-76.87
ccsbBroad304_01720	OE	TSTA3	Short chain dehydrogenase/reductase superfamily / Extended SDR fold, tissue specific transplantation antigen P35B			10.00, 10.00	0.99, 0.31	-58.86	29.58	-97.10	33.35	59.78	99.45	-30.01	-36.64	-34.45	-9.88
ccsbBroad304_08296	OE	UBE2J1	Ubiquitin-conjugating enzymes E2, ubiquitin-conjugating enzyme E2, J1, U			10.00, 10.00	0.80, 0.17	97.71	-97.69	57.17	-96.97	-24.30	34.93	22.16	-90.48	87.96	-20.79
ccsbBroad304_02582	OE	UQCR11	Mitochondrial respiratory chain complex / Complex III, ubiquinol-cytochrome c reductase, complex III subunit XI			10.00, 10.00	1.31, 0.35	14.27	-95.48	-96.21	-36.20	99.39	90.92	28.12	-98.08	-24.14	-59.72
ccsbBroad304_02197	OE	VPS26A	vacuolar protein sorting 26 homolog A (S. pombe)			0.00, 0.00	1.11, 0.27	37.88	-10.26	72.82	-99.89	-66.84	-48.29	33.49	-55.05	-35.46	-23.49
ccsbBroad304_02421	OE	WFDC2	WAP four-disulfide core domain containing, WAP four-disulfide core domain 2			10.00, 10.00	1.44, 0.59	-98.88	-75.79	99.01	-92.86	-29.69	-31.23	30.84	-53.06	28.00	-49.10
ccsbBroad304_02497	OE	YKT6	YKT6 v-SNARE homolog (S. cerevisiae)			10.00, 10.00	1.08, 0.30	86.23	-28.18	-9.54	26.02	-44.50	97.90	-70.03	-67.31	-37.33	-2.45
ccsbBroad304_07993	OE	ZBTB20	BTB/POZ domain containing, zinc finger and BTB domain containing 20			0.00, 0.00	0.76, 0.19	31.85	-33.52	58.74	-99.83	-71.87	-99.23	-24.42	-46.75	-76.09	-64.15
ccsbBroad304_01803	OE	ZBTB25	BTB/POZ domain containing, zinc finger and BTB domain containing 25			0.00, 0.00	0.91, 0.30	37.35	-16.81	-20.55	-34.48	-70.06	53.07	-71.68	36.77	39.14	-3.90
ccsbBroad304_00175	OE	ZFP36L1	RING-type (C3HC4) zinc fingers, zinc finger protein 36, C3H type-like 1			0.00, 0.00	2.30, 0.52	-93.59	-78.78	-87.16	33.62	-53.76	-99.97	38.02	-99.79	40.03	-94.30
ccsbBroad304_05124	OE	ZNF114	Zinc fingers, C2H2-type, zinc finger protein 114			0.00, 0.00	0.95, 0.30	-80.59	49.77	-24.33	-55.97	-44.54	62.42	-82.58	85.06	76.25	50.11
ccsbBroad304_07172	OE	ZNF195	Zinc fingers, C2H2-type, zinc finger protein 195			0.00, 0.00	1.63, 0.40	-26.54	-27.01	33.29	53.83	75.74	50.93	70.20	42.47	-48.42	24.13
ccsbBroad304_05121	OE	ZNF296	Zinc fingers, C2H2-type, zinc finger protein 296			0.00, 0.00	2.40, 0.64	-38.89	24.98	-80.25	-46.76	-38.80	-99.71	-39.45	-53.86	17.49	-34.09
ccsbBroad304_04046	OE	ZNF426	Zinc fingers, C2H2-type, zinc finger protein 426			10.00, 0.00	1.08, 0.40	96.23	76.91	35.37	65.98	30.39	29.45	-90.40	55.42	-63.92	33.87
ccsbBroad304_05002	OE	ZNF563	Zinc fingers, C2H2-type, zinc finger protein 563			10.00, 10.00	1.52, 0.45	-94.45	-38.25	-58.41	-51.13	98.81	-80.00	39.40	-12.77	-43.02	-45.32
ccsbBroad304_13811	OE	ALDH3B1	Aldehyde dehydrogenases, aldehyde dehydrogenase 3 family, member B1			20.00, 10.00	1.06, 0.32	-16.82	18.79	98.78	33.52	23.75	96.38	65.74	54.11	64.06	34.51
ccsbBroad304_01841	OE	BAG6	BCL2-associated athanogene 6			20.00, 20.00	1.58, 0.49	13.17	99.74	-15.55	99.88	77.74	45.65	-54.58	-46.53	52.07	46.95
ccsbBroad304_02837	OE	BHMT2	betaine--homocysteine S-methyltransferase 2			0.00, 0.00	0.78, 0.20	41.88	45.17	-22.34	-80.94	-93.49	52.77	-44.20	-63.91	-99.56	-54.69
ccsbBroad304_08993	OE	DHDDS	dehydrodolichyl diphosphate synthase			0.00, 0.00	1.27, 0.42	-94.18	-96.69	-94.61	81.80	56.93	-56.14	-46.17	70.46	27.20	-74.60
ccsbBroad304_03637	OE	DOK4	Pleckstrin homology (PH) domain containing, docking protein 4			0.00, 0.00	0.61, 0.16	-90.36	58.05	4.80	-84.85	-68.42	-28.80	60.77	-29.69	-70.97	-40.49
ccsbBroad304_10806	OE	ERBB3	Type I RTKs: ErbB (epidermal growth factor) receptor family, v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian)			10.00, 0.00	1.13, 0.32	-98.65	45.40	-46.82	-79.25	-95.11	96.84	-45.50	-99.93	-40.18	-96.29
ccsbBroad304_10207	OE	ERLIN1	ER lipid raft associated 1			10.00, 0.00	1.08, 0.24	-35.22	-52.62	-73.63	-78.17	-43.06	96.18	52.96	40.82	-50.16	-33.37
ccsbBroad304_06535	OE	LPL	lipoprotein lipase			0.00, 0.00	1.51, 0.55	60.93	-34.65	-20.92	-95.32	-99.98	-52.91	-69.45	-88.33	45.89	-77.10
ccsbBroad304_00001	OE	NAT1	N-acetyltransferase 1 (arylamine N-acetyltransferase)			10.00, 10.00	1.64, 0.42	-18.49	84.36	37.49	99.89	-90.39	38.84	-90.42	-14.41	38.49	-9.47
ccsbBroad304_02452	OE	NXF1	nuclear RNA export factor 1			0.00, 0.00	1.20, 0.39	-40.93	-47.26	-95.41	-52.78	60.78	66.59	53.53	-33.15	-56.08	-12.84
ccsbBroad304_14044	OE	PCGF3	Polycomb group ring fingers, polycomb group ring finger 3			10.00, 10.00	1.11, 0.26	57.90	-99.30	99.01	-77.35	-43.85	62.37	-74.45	-98.90	-99.97	-98.89
ccsbBroad304_06974	OE	SLC22A5	Organic zwitterions/cation transporters (OCTN), solute carrier family 22 (organic cation/carnitine transporter), member 5			20.00, 20.00	1.03, 0.34	-37.98	33.21	99.53	44.39	-36.24	-99.97	37.47	99.11	-33.24	20.84
ccsbBroad304_08862	OE	SMYD3	Chromatin-modifying enzymes / K-methyltransferases, SET and MYND domain containing 3			0.00, 0.00	0.86, 0.22	-89.33	63.20	92.93	35.09	-55.89	59.74	-29.04	-33.39	-97.77	-23.43
ccsbBroad304_04235	OE	TDRD3	Tudor domain containing, tudor domain containing 3			0.00, 0.00	1.47, 0.44	-56.65	78.38	51.98	34.26	-35.19	69.62	-29.33	52.91	-46.23	20.84
ccsbBroad304_02554	OE	TRAFD1	TRAF-type zinc finger domain containing 1			10.00, 0.00	0.92, 0.27	-97.99	71.05	89.27	-99.77	-48.28	97.40	53.84	-91.59	-99.97	-98.93
ccsbBroad304_09765	OE	ZBTB49	BTB/POZ domain containing, zinc finger and BTB domain containing 49			10.00, 10.00	1.08, 0.39	-43.13	58.08	98.95	-47.38	-44.60	-66.14	-49.08	-90.13	63.97	-18.36
ccsbBroad304_07178	OE	ZFP112	zinc finger protein 112 homolog (mouse)			0.00, 0.00	1.26, 0.45	80.66	-35.32	16.20	-30.22	-30.28	21.15	51.06	-70.58	43.23	4.72
ccsbBroad304_01819	OE	ZNF213	Zinc fingers, C2H2-type, zinc finger protein 213			10.00, 10.00	0.78, 0.30	75.37	99.93	-39.05	-43.96	91.70	-35.90	49.41	-84.24	-99.76	48.96
ccsbBroad304_05865	OE	ATP1A3	ATPases / P-type, ATPase, Na+/K+ transporting, alpha 3 polypeptide			0.00, 0.00	1.59, 0.40	-66.22	-48.80	18.02	69.82	91.09	-24.51	69.67	-38.43	-99.26	18.34
ccsbBroad304_02934	OE	B3GAT3	Beta-1,3-glucuronyltransferases, beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)			0.00, 0.00	1.11, 0.31	52.27	-63.23	-81.43	-47.65	-91.18	36.74	47.58	-51.80	41.31	-34.82
ccsbBroad304_02553	OE	BLCAP	bladder cancer associated protein			0.00, 0.00	0.86, 0.28	42.20	-36.63	-42.38	-31.00	-54.96	67.43	27.20	-84.25	-73.53	-25.76
ccsbBroad304_03080	OE	C16ORF80	chromosome 16 open reading frame 80			20.00, 20.00	0.99, 0.31	-23.79	-21.60	99.58	-99.35	39.86	99.03	-46.01	55.99	-50.41	-11.98
ccsbBroad304_07641	OE	CCT7	Heat Shock Proteins / Chaperonins, chaperonin containing TCP1, subunit 7 (eta)			0.00, 0.00	1.45, 0.41	-24.74	21.61	60.88	77.98	-95.71	43.29	67.14	-24.61	-60.36	-5.03
ccsbBroad304_06022	OE	COX7B	Mitochondrial respiratory chain complex, cytochrome c oxidase subunit VIIb			0.00, 0.00	1.27, 0.39	45.14	-27.14	17.81	-65.87	-37.92	-60.06	77.12	-35.50	93.42	-7.13
ccsbBroad304_02243	OE	DLGAP5	discs, large (Drosophila) homolog-associated protein 5			0.00, 0.00	1.58, 0.40	-23.88	-71.88	91.88	30.76	-54.35	-22.72	44.37	41.24	-84.39	-12.73
ccsbBroad304_04454	OE	FBXL20	F-boxes / Leucine-rich repeats, F-box and leucine-rich repeat protein 20			20.00, 20.00	1.80, 0.49	82.42	-51.05	-97.46	99.94	41.94	-48.16	18.66	-40.82	97.91	39.82
ccsbBroad304_01889	OE	FZD4	GPCR / Class F : Frizzled receptors, frizzled family receptor 4			0.00, 0.00	0.99, 0.23	-29.78	27.11	74.81	-46.35	26.73	-31.13	-33.41	52.68	31.64	-4.07
ccsbBroad304_00839	OE	IGFBP6	insulin-like growth factor (IGF) binding proteins, insulin-like growth factor binding protein 6			10.00, 10.00	0.93, 0.24	78.10	98.51	83.78	-40.80	25.25	57.19	-30.90	-92.36	-79.52	62.11
ccsbBroad304_06255	OE	LRRC32	leucine rich repeat containing 32			0.00, 0.00	1.24, 0.34	46.11	57.99	-41.96	-65.29	-58.83	-87.21	42.09	-99.59	21.56	-59.75
ccsbBroad304_03732	OE	NPDC1	neural proliferation, differentiation and control, 1			0.00, 0.00	1.45, 0.36	-24.34	66.24	-96.50	46.86	-66.23	-99.94	33.77	-43.91	70.52	-55.70
ccsbBroad304_09368	OE	OPN4	GPCR / Class A : Opsin receptors, opsin 4			0.00, 0.00	0.97, 0.40	80.64	-97.79	32.36	79.26	35.15	63.22	-98.42	-74.14	-90.42	-86.58
ccsbBroad304_14011	OE	PAPSS1	3'-phosphoadenosine 5'-phosphosulfate synthase 1			10.00, 10.00	0.98, 0.23	-76.96	-97.34	33.09	-65.78	-24.77	-68.05	99.73	-41.02	87.06	-60.22
ccsbBroad304_04383	OE	PCGF5	Polycomb group ring fingers, polycomb group ring finger 5			0.00, 0.00	1.10, 0.35	36.40	-40.81	9.82	47.94	-30.13	34.50	-34.17	-74.26	-99.92	-3.01
ccsbBroad304_06727	OE	PIK3CG	Phosphatidylinositol kinases, phosphoinositide-3-kinase, catalytic, gamma polypeptide			0.00, 0.00	1.27, 0.35	-72.02	36.89	-87.62	32.42	-98.35	-38.20	49.95	11.57	-92.44	-68.14
ccsbBroad304_06750	OE	POLR2H	RNA polymerase subunits, polymerase (RNA) II (DNA directed) polypeptide H			0.00, 0.00	1.02, 0.33	51.78	-62.11	90.45	-80.09	79.20	-64.11	52.06	68.56	44.82	31.65
ccsbBroad304_06765	OE	PRCC	papillary renal cell carcinoma (translocation-associated)			0.00, 0.00	1.31, 0.42	88.17	-47.84	17.19	83.49	-89.34	-50.97	65.12	-13.55	-34.33	11.78
ccsbBroad304_01323	OE	PSMD9	Proteasome (prosome, macropain) subunits, proteasome (prosome, macropain) 26S subunit, non-ATPase, 9			0.00, 0.00	0.75, 0.16	71.82	61.85	-92.49	-98.97	-86.66	47.09	-45.56	-65.39	-71.89	-77.22
ccsbBroad304_13934	OE	PTK2	Serine/threonine phosphatases / Protein phosphatase 1, regulatory subunits, PTK2 protein tyrosine kinase 2			20.00, 10.00	1.36, 0.42	99.84	96.14	83.45	-99.17	-32.17	35.77	31.82	-37.67	85.65	85.60
ccsbBroad304_01974	OE	RNASET2	ribonuclease T2			0.00, 0.00	1.02, 0.34	-73.20	93.74	-95.59	-63.45	-56.51	39.48	36.43	-82.42	20.41	-61.61
ccsbBroad304_07291	OE	RNGTT	Protein tyrosine phosphatases / Class I Cys-based PTPs : Atypical dual specificity phosphatases, RNA guanylyltransferase and 5'-phosphatase			20.00, 20.00	0.88, 0.34	99.94	99.93	58.71	-58.85	-86.97	86.70	58.48	-98.94	27.15	64.58
ccsbBroad304_02041	OE	SLC5A6	Sodium iodide symporter, sodium-dependent multivitamin transporter and sodium-coupled monocarboxylate transporters, solute carrier family 5 (sodium-dependent vitamin transporter), member 6			40.00, 20.00	1.18, 0.39	-37.25	43.38	81.61	99.61	99.63	-52.67	-51.22	95.33	35.95	95.37
ccsbBroad304_02625	OE	SLC7A9	SLC7 family, solute carrier family 7 (glycoprotein-associated amino acid transporter light chain, bo,+ system), member 9			0.00, 0.00	1.75, 0.56	27.50	-40.19	-28.79	-40.25	25.37	-92.50	-62.28	-42.13	68.60	-10.51
ccsbBroad304_02571	OE	TOMM34	Tetratricopeptide (TTC) repeat domain containing, translocase of outer mitochondrial membrane 34			20.00, 10.00	1.82, 0.42	96.00	99.08	-91.16	-42.40	-72.02	-44.37	-71.25	-16.39	-19.23	-40.41
ccsbBroad304_02715	OE	WDTC1	DDB1 and CUL4 associated factors, WD and tetratricopeptide repeats 1			10.00, 10.00	0.82, 0.25	81.48	27.48	78.58	31.81	41.89	-29.09	84.26	99.98	-86.85	71.06
ccsbBroad304_11549	OE	ZNF273	Zinc fingers, C2H2-type, zinc finger protein 273			10.00, 10.00	1.00, 0.27	-40.31	87.61	78.40	-73.79	90.31	99.97	79.58	56.32	-22.37	74.95
ccsbBroad304_09768	OE	ZNF366	Zinc fingers, C2H2-type, zinc finger protein 366			0.00, 0.00	0.99, 0.23	28.64	61.95	-99.67	51.96	-65.74	-86.89	-26.38	-36.14	50.71	-22.96
ccsbBroad304_09983	OE	ZNF454	Zinc fingers, C2H2-type, zinc finger protein 454			10.00, 0.00	0.88, 0.23	55.97	-32.92	-27.16	96.73	18.36	44.85	91.74	-97.58	-99.97	16.25
ccsbBroad304_09745	OE	ZNF519	Zinc fingers, C2H2-type, zinc finger protein 519			0.00, 0.00	1.15, 0.35	60.74	44.76	64.79	-55.14	54.86	-76.59	-87.96	-56.27	52.84	37.93
ccsbBroad304_07738	OE	ABHD2	Abhydrolase domain containing, abhydrolase domain containing 2			0.00, 0.00	0.91, 0.26	52.68	-43.32	-47.74	82.18	56.73	56.64	-43.34	-36.17	70.49	61.78
ccsbBroad304_13830	OE	FOXN3	Forkhead boxes, forkhead box N3			0.00, 0.00	1.27, 0.31	30.42	78.14	58.91	80.20	-29.87	45.44	-90.84	-50.41	-34.79	25.38
ccsbBroad304_07314	OE	ASAP2	Ankyrin repeat domain containing, ArfGAP with SH3 domain, ankyrin repeat and PH domain 2			10.00, 0.00	0.97, 0.24	18.22	-76.71	30.03	97.04	-86.94	-25.08	45.93	-43.37	55.32	10.11
ccsbBroad304_00361	OE	ATF2	basic leucine zipper proteins, activating transcription factor 2			10.00, 10.00	0.97, 0.24	45.94	69.37	71.49	-88.03	-44.12	99.32	-95.33	-34.23	52.04	26.00
ccsbBroad304_05907	OE	BUB1B	Bub family, budding uninhibited by benzimidazoles 1 homolog beta (yeast)			10.00, 10.00	1.06, 0.19	12.75	-72.25	-73.04	-52.58	-50.50	85.74	-47.03	-66.87	99.97	-24.69
ccsbBroad304_00360	OE	CREB1	basic leucine zipper proteins, cAMP responsive element binding protein 1			0.00, 0.00	0.82, 0.18	23.84	-28.56	-26.44	-79.83	-42.61	-65.69	-77.84	-49.84	-98.84	-47.10
ccsbBroad304_07358	OE	DNAJA3	Heat shock proteins / DNAJ (HSP40), DnaJ (Hsp40) homolog, subfamily A, member 3			10.00, 10.00	2.01, 0.64	99.00	-84.41	-99.94	52.55	-49.10	-98.04	39.33	-88.76	-75.96	-86.76
ccsbBroad304_00462	OE	DR1	down-regulator of transcription 1, TBP-binding (negative cofactor 2)			0.00, 0.00	0.84, 0.22	72.09	33.45	-16.94	32.38	-42.93	-63.26	-94.89	-14.94	-28.99	-2.45
ccsbBroad304_10212	OE	GRHL3	grainyhead-like 3 (Drosophila)			10.00, 10.00	0.90, 0.31	-87.29	-39.97	-83.29	99.96	79.97	-84.59	-53.10	-40.99	-41.56	-45.62
ccsbBroad304_00778	OE	HOXC10	Homeoboxes / ANTP class : HOXL subclass, homeobox C10		Homeobox Gene GOF	10.00, 0.00	1.20, 0.34	93.19	29.34	-52.13	95.58	-90.89	77.00	46.01	-98.67	-74.76	-50.41
ccsbBroad304_02019	OE	IL18RAP	CD molecules, interleukin 18 receptor accessory protein			10.00, 0.00	0.93, 0.30	-20.06	-82.55	88.49	-56.24	93.96	-33.23	-45.60	96.59	-34.54	-18.60
ccsbBroad304_03310	OE	LCMT1	leucine carboxyl methyltransferase 1			0.00, 0.00	1.14, 0.24	-34.21	-37.48	-80.42	-99.03	-21.74	-45.06	-96.74	74.89	-76.19	-80.73
ccsbBroad304_00954	OE	LYN	Src family, v-yes-1 Yamaguchi sarcoma viral related oncogene homolog			0.00, 0.00	2.61, 0.74	-68.21	73.43	-98.68	-77.31	-42.64	-99.13	72.54	-69.90	-98.58	-98.15
ccsbBroad304_02276	OE	MVP	major vault protein			0.00, 0.00	0.67, 0.10	87.72	57.56	25.23	94.38	-28.57	-65.08	-88.80	-49.78	-61.90	24.12
ccsbBroad304_01165	OE	PDK1	pyruvate dehydrogenase kinase, isozyme 1			0.00, 0.00	1.38, 0.39	67.86	-71.12	-69.26	-78.87	-72.64	-98.79	-64.48	33.94	-60.01	-80.40
ccsbBroad304_01218	OE	PLK1	Polo-like kinase (PLK) family, polo-like kinase 1			50.00, 40.00	1.27, 0.33	99.98	-39.50	69.10	77.11	72.65	98.41	99.89	97.48	88.15	99.58
ccsbBroad304_02884	OE	POT1	protection of telomeres 1 homolog (S. pombe)			10.00, 0.00	0.89, 0.28	95.39	57.01	87.13	-60.04	-26.86	45.28	-75.17	73.02	41.47	53.94
ccsbBroad304_01450	OE	RPS10	S ribosomal proteins, ribosomal protein S10			10.00, 10.00	0.93, 0.28	-49.27	-91.83	52.40	-55.93	99.47	-32.94	49.94	-82.95	-55.29	-51.23
ccsbBroad304_01659	OE	TERF1	telomeric repeat binding factor (NIMA-interacting) 1			0.00, 0.00	1.55, 0.33	-75.03	-44.63	82.66	-13.76	-25.28	-45.68	34.36	62.69	24.02	-12.40
ccsbBroad304_07683	OE	ZNF268	Zinc fingers, C2H2-type, zinc finger protein 268			10.00, 10.00	1.20, 0.36	71.86	76.72	93.08	53.44	-71.04	82.50	-31.72	-41.29	98.90	81.15
ccsbBroad304_09910	OE	BCL6B	BTB/POZ domain containing, B-cell CLL/lymphoma 6, member B			20.00, 20.00	1.02, 0.25	61.45	99.96	80.57	-47.10	-52.92	99.16	42.92	-43.94	-35.51	57.83
ccsbBroad304_00471	OE	E2F6	E2F transcription factor 6			0.00, 0.00	1.26, 0.31	-89.69	-31.46	-88.73	22.13	-99.98	-99.62	-63.83	-75.38	-31.42	-98.55
ccsbBroad304_05612	OE	GPR152	GPCR / Class A : Orphans, G protein-coupled receptor 152			20.00, 20.00	1.24, 0.31	-46.51	77.00	98.57	98.20	52.70	-99.82	63.40	40.57	-83.12	78.33
ccsbBroad304_10431	OE	HADHB	hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein), beta subunit			0.00, 0.00	1.30, 0.31	-33.51	-34.94	-33.27	-37.38	-41.99	52.03	-50.64	-99.98	-97.48	-36.68
ccsbBroad304_00863	OE	IL15	Interleukins and interleukin receptors, interleukin 15		Interleukins GOF	20.00, 10.00	0.91, 0.27	90.28	-28.86	-31.72	-68.45	95.39	-56.02	99.98	89.30	-65.52	92.34
ccsbBroad304_00929	OE	LBR	Tudor domain containing, lamin B receptor			10.00, 10.00	1.41, 0.39	35.09	99.74	58.67	61.53	-96.71	89.84	67.03	-21.23	54.60	38.21
ccsbBroad304_06542	OE	LTBR	Tumor necrosis factor receptor superfamily, lymphotoxin beta receptor (TNFR superfamily, member 3)		NFKB Activation GOF	0.00, 0.00	5.06, 1.33	-43.02	-99.96	-73.64	41.85	-92.54	-98.23	-99.71	-93.40	49.60	-98.98
ccsbBroad304_07275	OE	PSMG1	proteasome (prosome, macropain) assembly chaperone 1			0.00, 0.00	1.35, 0.41	12.61	-96.52	45.06	88.66	56.82	-81.48	-61.79	-38.16	90.01	29.63
ccsbBroad304_02838	OE	SDF2L1	stromal cell-derived factor 2-like 1			0.00, 0.00	1.34, 0.43	-25.87	-89.75	46.64	-32.20	33.24	77.12	-65.69	-80.99	94.23	-32.05
ccsbBroad304_01648	OE	SERPINA7	Serine (or cysteine) peptidase inhibitors, serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 7			0.00, 0.00	1.36, 0.38	-17.34	32.60	92.88	-99.96	-50.05	51.09	32.34	-19.68	39.09	-8.31
ccsbBroad304_00094	OE	ARF1	ADP-ribosylation factors, ADP-ribosylation factor 1			10.00, 0.00	0.80, 0.17	31.78	96.78	-55.67	-15.40	-97.88	43.89	94.70	60.00	-32.44	26.38
ccsbBroad304_02822	OE	ARFIP2	ADP-ribosylation factor interacting protein 2			30.00, 30.00	0.86, 0.22	-52.12	-58.21	-29.86	-61.97	98.21	-98.72	-40.88	98.80	99.92	-28.03
ccsbBroad304_03119	OE	C16ORF5	chromosome 16 open reading frame 5			10.00, 10.00	0.78, 0.26	-57.79	99.91	8.45	-75.33	-59.20	24.56	-33.22	-87.35	-24.53	-12.42
ccsbBroad304_04471	OE	C5ORF62	chromosome 5 open reading frame 62			20.00, 20.00	0.94, 0.35	61.25	-26.88	99.52	-97.65	58.58	65.76	74.22	36.68	98.49	60.22
ccsbBroad304_05930	OE	CAMK2D	CAMK2 family, calcium/calmodulin-dependent protein kinase II delta			0.00, 0.00	1.36, 0.41	-13.37	-98.98	-43.05	84.16	41.97	-81.88	-80.07	14.49	-25.78	-28.61
ccsbBroad304_06159	OE	CTTN	cortactin			0.00, 0.00	0.88, 0.28	-97.03	42.60	-87.58	-67.53	39.18	43.11	-94.95	74.37	41.28	-81.00
ccsbBroad304_02012	OE	FADD	Fas (TNFRSF6)-associated via death domain		NFKB Activation GOF	0.00, 0.00	4.21, 1.23	-56.85	82.57	-59.21	-61.47	NaN	-99.84	42.41	-95.37	NaN	-86.38
ccsbBroad304_02217	OE	FEZ1	fasciculation and elongation protein zeta 1 (zygin I)			20.00, 20.00	0.99, 0.33	83.33	81.02	57.45	-32.74	60.25	99.44	56.13	-36.36	99.97	88.64
ccsbBroad304_06206	OE	FGA	Endogenous ligands, fibrinogen alpha chain			0.00, 0.00	0.93, 0.31	-25.23	20.26	18.44	-85.09	52.01	-19.88	-95.52	-99.94	-92.41	-93.18
ccsbBroad304_06483	OE	KCNK1	Two-P potassium channels, potassium channel, subfamily K, member 1			10.00, 10.00	1.77, 0.44	78.17	-99.96	-31.26	70.94	85.93	82.17	99.27	61.73	41.20	85.97
ccsbBroad304_09615	OE	LACC1	laccase (multicopper oxidoreductase) domain containing 1			20.00, 10.00	1.01, 0.38	95.48	-93.69	30.62	-40.04	24.59	99.97	-16.17	-37.07	-38.35	-7.82
ccsbBroad304_01291	OE	MAP2K6	MAPKK:STE7 family, mitogen-activated protein kinase kinase 6			0.00, 0.00	4.98, 1.41	-63.54	-99.93	-90.46	-99.95	-25.37	66.74	-79.88	-99.73	-99.97	-99.86
ccsbBroad304_02566	OE	MORF4L1	mortality factor 4 like 1			10.00, 10.00	1.32, 0.49	25.45	29.97	-63.73	-50.10	-27.59	39.07	99.96	-99.90	74.87	6.40
ccsbBroad304_07557	OE	NAMPT	nicotinamide phosphoribosyltransferase			10.00, 10.00	0.77, 0.24	16.48	99.93	88.53	52.22	48.87	-30.45	38.65	76.02	-95.42	29.34
ccsbBroad304_01811	OE	PCGF2	Polycomb group ring fingers, polycomb group ring finger 2			0.00, 0.00	1.02, 0.41	-79.97	71.52	-31.16	39.37	-79.68	39.16	-83.99	-87.72	31.33	-74.29
ccsbBroad304_08594	OE	PECR	Short chain dehydrogenase/reductase superfamily / Classical SDR fold cluster 1, peroxisomal trans-2-enoyl-CoA reductase			0.00, 0.00	1.33, 0.38	21.30	-31.54	-56.48	52.29	81.52	57.09	-46.82	-15.43	25.05	6.25
ccsbBroad304_06728	OE	PIK3R1	Phosphatidylinositol kinases, phosphoinositide-3-kinase, regulatory subunit 1 (alpha)			10.00, 10.00	2.38, 0.64	-42.89	36.84	69.05	39.81	44.15	99.20	-51.59	-36.22	-94.80	-24.35
ccsbBroad304_01239	OE	POLR2E	RNA polymerase subunits, polymerase (RNA) II (DNA directed) polypeptide E, 25kDa			0.00, 0.00	1.20, 0.39	-99.37	94.09	87.31	71.03	-33.81	-40.31	23.39	-12.30	-36.84	6.70
ccsbBroad304_01269	OE	PPP3R2	EF-hand domain containing, protein phosphatase 3, regulatory subunit B, beta			10.00, 0.00	1.19, 0.32	94.66	-23.29	-47.79	58.40	95.51	-68.16	-30.51	33.96	-61.06	9.67
ccsbBroad304_01341	OE	PTPN4	Protein tyrosine phosphatases, protein tyrosine phosphatase, non-receptor type 4 (megakaryocyte)			10.00, 0.00	1.70, 0.55	-36.85	-98.26	36.24	-78.12	-34.19	-34.44	96.65	-67.46	43.26	-36.30
ccsbBroad304_01448	OE	RPS7	S ribosomal proteins, ribosomal protein S7			10.00, 10.00	0.82, 0.22	41.54	99.82	-79.45	-42.01	27.82	80.12	59.77	-99.98	-37.69	-18.09
ccsbBroad304_02572	OE	SERINC3	serine incorporator 3			0.00, 0.00	1.28, 0.38	-70.26	28.18	-88.80	-92.23	-32.00	83.88	-29.68	90.60	-38.01	-27.02
ccsbBroad304_01546	OE	SLC7A1	SLC7 family, solute carrier family 7 (cationic amino acid transporter, y+ system), member 1			20.00, 20.00	0.89, 0.28	-22.36	99.52	-43.51	76.13	99.96	28.01	52.92	-84.58	-36.00	55.44
ccsbBroad304_02786	OE	ZNF281	Zinc fingers, C2H2-type, zinc finger protein 281			10.00, 0.00	1.68, 0.36	-99.09	-28.28	-88.37	-47.95	22.70	-98.28	-99.98	-83.93	97.39	-98.43
ccsbBroad304_09656	OE	ZNF555	Zinc fingers, C2H2-type, zinc finger protein 555			0.00, 0.00	1.14, 0.32	-22.53	-56.44	23.46	81.16	71.98	90.24	37.93	29.14	-56.22	14.75
ccsbBroad304_00085	OE	APRT	adenine phosphoribosyltransferase			10.00, 10.00	1.40, 0.50	-30.31	-88.01	99.45	-84.96	-97.06	-75.47	43.57	85.82	22.11	-88.86
ccsbBroad304_02036	OE	ARHGEF7	Rho guanine nucleotide exchange factors, Rho guanine nucleotide exchange factor (GEF) 7			20.00, 0.00	0.70, 0.17	-90.39	26.38	-60.54	58.48	-32.01	97.03	-65.34	-89.71	95.62	-27.65
ccsbBroad304_00233	OE	CBR1	Prostaglandin synthases, carbonyl reductase 1			0.00, 0.00	2.23, 0.68	-96.85	-99.54	66.10	-45.03	37.08	-97.64	-99.31	35.99	89.80	-98.10
ccsbBroad304_00281	OE	CDK8	Cyclin-dependent kinases, CDK8 subfamily, cyclin-dependent kinase 8			0.00, 0.00	1.84, 0.59	83.29	-39.91	-77.07	22.01	39.22	51.07	81.25	91.16	67.30	67.19
ccsbBroad304_00283	OE	CDKN2C	Ankyrin repeat domain containing, cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4)		Cell Cycle Inhibition GOF	0.00, 0.00	4.81, 1.57	-98.08	-93.79	-99.60	-99.42	90.37	-99.85	-97.92	-99.95	-48.71	-99.81
ccsbBroad304_01872	OE	DGCR14	DiGeorge syndrome critical region gene 14			0.00, 0.00	1.11, 0.25	-42.36	-95.02	51.72	40.59	42.52	-47.75	31.83	-52.08	-71.54	-12.30
ccsbBroad304_07240	OE	DYRK3	Dyrk2 subfamily, dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 3			0.00, 0.00	1.38, 0.44	-72.98	72.39	-80.07	-84.99	-52.47	52.96	-92.56	-51.21	-28.08	-73.10
ccsbBroad304_00658	OE	GNG5	guanine nucleotide binding protein (G protein), gamma 5			10.00, 10.00	1.10, 0.30	-95.47	14.57	-7.71	99.98	-50.14	78.72	33.69	-35.40	-54.81	-13.22
ccsbBroad304_04309	OE	HDAC10	Histone deacetylases, histone deacetylase 10			20.00, 10.00	1.13, 0.28	99.12	97.15	22.34	-74.86	-99.46	-91.83	-36.37	38.83	-51.10	-58.81
ccsbBroad304_06574	OE	MDH2	malate dehydrogenase 2, NAD (mitochondrial)			0.00, 0.00	1.03, 0.24	25.82	-71.61	86.74	-31.44	-70.96	40.21	-35.86	-92.60	49.85	-35.08
ccsbBroad304_01198	OE	PIGA	Glycosyltransferase group 1 domain containing, phosphatidylinositol glycan anchor biosynthesis, class A			10.00, 0.00	0.76, 0.17	88.15	95.35	7.76	-30.15	-99.08	-30.72	-56.19	-96.20	-44.73	-13.33
ccsbBroad304_01380	OE	RBBP7	WD repeat domain containing, retinoblastoma binding protein 7			10.00, 10.00	1.14, 0.24	99.62	-33.61	59.19	-74.44	33.73	-78.93	52.26	-94.75	-50.78	-51.18
ccsbBroad304_07436	OE	SPTLC2	Serine palmitoyltransferase, serine palmitoyltransferase, long chain base subunit 2			0.00, 0.00	1.03, 0.28	64.43	-36.22	83.87	-47.28	28.83	-90.11	-65.97	-74.09	-22.03	-40.19
ccsbBroad304_01613	OE	STK11	LKB subfamily, serine/threonine kinase 11			20.00, 10.00	0.90, 0.14	97.42	-98.12	-36.22	-55.96	-99.26	99.90	39.27	77.29	41.76	46.94
ccsbBroad304_02345	OE	TXNDC9	thioredoxin domain containing 9			0.00, 0.00	1.67, 0.56	-34.42	-87.25	-68.25	-91.93	-91.64	-22.28	39.57	-98.57	-34.73	-96.01
ccsbBroad304_11405	OE	UBE3C	ubiquitin protein ligase E3C			10.00, 0.00	1.03, 0.22	78.27	29.77	44.41	-26.44	35.40	-36.75	-34.57	-25.68	95.29	5.79
ccsbBroad304_03441	OE	UGT1A9	UDP glucuronosyltransferases, UDP glucuronosyltransferase 1 family, polypeptide A9			0.00, 0.00	1.34, 0.43	-99.98	50.56	24.43	91.31	93.80	-23.85	-83.29	41.33	-70.64	22.71
ccsbBroad304_07123	OE	UQCRFS1	Mitochondrial respiratory chain complex / Complex III, ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1			0.00, 0.00	1.11, 0.27	-32.87	68.53	93.84	-46.05	-33.13	-58.25	-64.86	67.59	56.37	37.37
ccsbBroad304_03842	OE	ZNF317	Zinc fingers, C2H2-type, zinc finger protein 317			0.00, 0.00	1.38, 0.41	65.23	47.61	20.12	-41.16	-59.96	-27.22	-44.63	77.59	27.55	-3.99
ccsbBroad304_04909	OE	ZNF572	Zinc fingers, C2H2-type, zinc finger protein 572			10.00, 10.00	1.35, 0.35	-32.57	-29.81	-41.66	98.33	-41.01	36.97	58.22	86.66	-17.08	20.13
ccsbBroad304_00049	OE	ALDH2	Aldehyde dehydrogenases, aldehyde dehydrogenase 2 family (mitochondrial)			0.00, 0.00	1.14, 0.39	55.94	NaN	-79.58	-97.32	-66.65	55.86	-99.54	-89.77	-53.72	-96.61
ccsbBroad304_04128	OE	ALG9	Dolichyl D-mannosyl phosphate dependent mannosyltransferases, asparagine-linked glycosylation 9, alpha-1,2-mannosyltransferase homolog (S. cerevisiae)			11.11, 11.11	1.00, 0.42	36.96	NaN	88.12	53.38	99.91	94.68	62.56	-72.45	-59.22	69.52
ccsbBroad304_00063	OE	AMPD2	adenosine monophosphate deaminase 2			0.00, 0.00	0.65, 0.11	-56.44	NaN	36.11	89.51	-32.20	31.96	61.32	47.66	-81.00	18.49
ccsbBroad304_01977	OE	AOC3	Oxidoreductases, amine oxidase, copper containing 3 (vascular adhesion protein 1)			11.11, 11.11	1.13, 0.28	32.26	NaN	99.76	-28.41	-83.32	-89.67	93.01	-58.56	-23.87	-9.98
ccsbBroad304_02047	OE	AP1S2	adaptor-related protein complex 1, sigma 2 subunit			11.11, 11.11	0.90, 0.24	99.71	NaN	-99.16	-98.18	31.31	76.25	-82.70	83.76	-77.47	-84.42
ccsbBroad304_08282	OE	ATP6V1D	ATPases / V-type, ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D			11.11, 0.00	1.18, 0.40	-44.98	NaN	-99.78	-33.78	91.69	97.10	41.46	-97.58	33.76	-13.50
ccsbBroad304_02857	OE	BAMBI	BMP and activin membrane-bound inhibitor homolog (Xenopus laevis)			0.00, 0.00	1.63, 0.40	44.15	NaN	-59.84	-99.98	-99.21	-41.82	-83.67	85.09	-40.52	-93.75
ccsbBroad304_02053	OE	BTRC	F-boxes / WD-40 domains, beta-transducin repeat containing			0.00, 0.00	1.11, 0.23	43.50	NaN	94.85	-40.20	81.51	26.66	-48.87	-20.39	78.30	68.82
ccsbBroad304_05927	OE	CALM1	EF-hand domain containing, calmodulin 1 (phosphorylase kinase, delta)			0.00, 0.00	1.03, 0.30	-94.85	NaN	40.84	-35.12	-58.67	-98.53	-77.09	-73.31	26.19	-67.02
ccsbBroad304_00219	OE	CARS	Aminoacyl tRNA synthetases / Class I, cysteinyl-tRNA synthetase			0.00, 0.00	1.33, 0.31	-40.20	NaN	-99.55	35.83	-94.94	-42.94	-98.38	-48.82	-36.58	-93.77
ccsbBroad304_08935	OE	CERS4	Homeoboxes / CERS class, ceramide synthase 4			11.11, 11.11	1.19, 0.31	15.91	NaN	99.68	54.25	68.26	-85.12	27.24	-36.50	40.41	23.57
ccsbBroad304_00327	OE	CLK2	CDC-like kinases, CDC-like kinase 2			0.00, 0.00	0.95, 0.28	-34.65	NaN	-55.69	-45.92	-42.79	-96.89	81.00	-44.68	32.47	-15.78
ccsbBroad304_02510	OE	CNPY3	Trinucleotide (CAG) repeat containing, canopy 3 homolog (zebrafish)			0.00, 0.00	1.34, 0.32	-99.03	NaN	-69.48	86.26	83.61	-28.89	60.68	-15.49	-83.39	-59.40
ccsbBroad304_02683	OE	COG2	Components of oligomeric golgi complex, component of oligomeric golgi complex 2			22.22, 22.22	1.52, 0.39	86.79	NaN	37.10	-93.70	99.89	99.97	-75.27	22.42	13.68	67.51
ccsbBroad304_06040	OE	CRY1	cryptochrome 1 (photolyase-like)			0.00, 0.00	1.38, 0.39	-40.65	NaN	-21.62	-95.29	48.20	36.29	-34.19	-93.77	20.93	-8.81
ccsbBroad304_01930	OE	CUL2	cullin 2			22.22, 22.22	0.97, 0.27	99.31	NaN	37.41	37.38	-97.61	31.99	-7.06	99.98	-39.28	8.10
ccsbBroad304_00401	OE	CYB5A	Cytochrome b genes, cytochrome b5 type A (microsomal)			0.00, 0.00	1.22, 0.36	55.53	NaN	-92.10	-99.98	-55.61	-55.76	-19.35	-23.80	60.76	-48.92
ccsbBroad304_04154	OE	DENND2D	DENN/MADD domain containing, DENN/MADD domain containing 2D			0.00, 0.00	0.80, 0.18	-23.03	NaN	27.99	57.03	-62.71	-30.77	16.80	-36.98	65.34	5.67
ccsbBroad304_03728	OE	DIABLO	diablo, IAP-binding mitochondrial protein			0.00, 0.00	1.53, 0.51	68.88	NaN	-31.87	-26.14	-63.20	31.86	-59.97	-29.11	15.31	-11.41
ccsbBroad304_02297	OE	DNAJB6	Heat shock proteins / DNAJ (HSP40), DnaJ (Hsp40) homolog, subfamily B, member 6			0.00, 0.00	1.57, 0.43	28.63	NaN	42.02	-43.40	-67.08	48.83	65.17	-89.00	-62.05	-32.42
ccsbBroad304_06150	OE	EIF4E	Translation Initiation Factor 4E, eukaryotic translation initiation factor 4E			11.11, 11.11	1.08, 0.38	-83.20	NaN	-44.22	-41.86	99.37	40.45	81.43	-83.94	25.97	-18.33
ccsbBroad304_06180	OE	ESD	esterase D			0.00, 0.00	1.02, 0.31	56.50	NaN	-22.76	-89.07	-23.96	-55.64	-15.49	29.69	-70.97	-24.49
ccsbBroad304_08392	OE	EXOC6	exocyst complex component 6			22.22, 11.11	1.24, 0.32	98.31	NaN	-98.04	-44.84	34.22	96.59	9.41	-33.07	-33.37	4.86
ccsbBroad304_03428	OE	EXOSC4	exosome component 4			44.44, 22.22	0.90, 0.28	-28.22	NaN	-44.76	25.13	-33.74	99.22	98.25	95.81	-40.97	95.53
ccsbBroad304_00523	OE	EXT1	Exostosin glycosyltransferase family, exostosin 1			11.11, 11.11	1.32, 0.39	-25.60	NaN	27.60	34.75	99.85	-97.24	-51.69	-42.09	68.38	4.92
ccsbBroad304_07688	OE	FAM114A2	family with sequence similarity 114, member A2			11.11, 0.00	1.56, 0.35	-33.45	NaN	-23.31	47.21	95.97	-61.26	38.39	44.03	-98.31	13.74
ccsbBroad304_08797	OE	FASTKD5	FAST kinase domains 5			11.11, 11.11	1.08, 0.27	98.99	NaN	42.14	-53.56	79.72	-50.74	32.73	-94.16	-87.57	-24.41
ccsbBroad304_02746	OE	FBXW11	F-boxes / WD-40 domains, F-box and WD repeat domain containing 11			22.22, 22.22	1.26, 0.33	-45.35	NaN	-46.42	99.91	25.78	-99.87	-9.42	-61.90	98.04	-16.44
ccsbBroad304_07754	OE	FGFR1OP	FGFR1 oncogene partner			11.11, 11.11	1.06, 0.36	-93.99	NaN	-97.72	47.35	-62.81	-26.46	51.39	72.98	99.86	-55.89
ccsbBroad304_06225	OE	FTH1	ferritin, heavy polypeptide 1			0.00, 0.00	1.47, 0.44	-90.45	NaN	-81.62	-45.05	-72.94	36.56	92.26	-45.09	47.64	-52.25
ccsbBroad304_02505	OE	GNB5	WD repeat domain containing, guanine nucleotide binding protein (G protein), beta 5			0.00, 0.00	0.99, 0.32	66.52	NaN	-91.72	-99.83	-78.50	29.71	-83.37	-48.62	-30.58	-73.66
ccsbBroad304_00690	OE	GRN	granulin			0.00, 0.00	1.41, 0.36	37.30	NaN	-22.29	74.94	-73.23	28.78	-75.23	14.15	-89.67	-28.35
ccsbBroad304_02771	OE	HEY1	Basic helix-loop-helix proteins, hairy/enhancer-of-split related with YRPW motif 1			0.00, 0.00	1.59, 0.50	-87.65	NaN	-85.35	89.39	-41.91	-99.51	-27.25	-99.85	-99.74	-99.68
ccsbBroad304_03625	OE	HIF1AN	hypoxia inducible factor 1, alpha subunit inhibitor			22.22, 11.11	1.09, 0.35	48.67	NaN	-55.13	99.93	47.35	97.10	5.52	-80.44	92.51	92.49
ccsbBroad304_06370	OE	HLA-DMB	Immunoglobulin superfamily / C1-set domain containing, major histocompatibility complex, class II, DM beta			11.11, 11.11	1.16, 0.31	-62.26	NaN	-67.16	-99.95	-99.27	-27.87	57.83	99.77	93.29	-58.70
ccsbBroad304_06372	OE	HLA-DPB1	Immunoglobulin superfamily / C1-set domain containing, major histocompatibility complex, class II, DP beta 1			0.00, 0.00	0.92, 0.17	-76.49	NaN	85.89	58.87	-49.40	-44.79	-72.04	-85.13	22.59	-54.98
ccsbBroad304_00794	OE	HSF1	heat shock transcription factor 1			0.00, 0.00	1.58, 0.51	-99.93	NaN	-20.10	83.19	-63.65	-99.93	-48.23	34.22	69.20	-57.48
ccsbBroad304_00809	OE	HUS1	HUS1 checkpoint homolog (S. pombe)			11.11, 0.00	1.05, 0.31	96.32	NaN	29.10	-99.98	-63.73	-66.00	15.73	-38.52	41.39	-16.03
ccsbBroad304_00815	OE	ID2	Basic helix-loop-helix proteins, inhibitor of DNA binding 2, dominant negative helix-loop-helix protein			0.00, 0.00	1.13, 0.35	76.36	NaN	-34.09	-99.75	-81.90	-92.94	63.45	-96.30	-96.72	-98.40
ccsbBroad304_13880	OE	IDH3G	isocitrate dehydrogenase 3 (NAD+) gamma			11.11, 0.00	1.00, 0.28	89.63	NaN	-46.52	28.46	-96.82	37.24	95.31	47.81	46.76	12.96
ccsbBroad304_06424	OE	IFI16	interferon, gamma-inducible protein 16			11.11, 11.11	1.17, 0.36	-97.89	NaN	74.89	-69.43	54.78	99.10	-35.81	87.61	33.53	47.90
ccsbBroad304_06464	OE	ITGB2	Integrins, integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)			0.00, 0.00	1.49, 0.48	-70.70	NaN	-99.98	-81.76	-30.97	-36.85	58.27	-47.90	62.58	-64.77
ccsbBroad304_02919	OE	KIAA1279	KIAA1279			22.22, 11.11	1.16, 0.34	96.61	NaN	-69.70	99.46	-42.22	26.64	31.33	33.29	-47.37	31.21
ccsbBroad304_06021	OE	KLF6	Kruppel-like transcription factors, Kruppel-like factor 6			11.11, 11.11	3.55, 1.36	-98.11	NaN	-98.77	-60.42	-99.85	-99.97	99.96	-99.94	-91.36	-99.91
ccsbBroad304_03237	OE	LEF1	lymphoid enhancer-binding factor 1			11.11, 11.11	1.17, 0.31	98.02	NaN	31.08	-49.68	-60.06	73.82	17.03	63.36	-81.58	53.09
ccsbBroad304_02097	OE	LPAR2	GPCR / Class A : Lysophospholipid receptors : Lysophosphatidic acid, lysophosphatidic acid receptor 2			11.11, 11.11	1.57, 0.43	97.60	NaN	-94.47	-52.13	73.25	59.66	-85.07	-23.09	36.71	-49.13
ccsbBroad304_09303	OE	LRSAM1	Sterile alpha motif (SAM) domain containing, leucine rich repeat and sterile alpha motif containing 1			0.00, 0.00	1.20, 0.40	86.24	NaN	-37.72	-74.39	-91.69	-77.54	-97.00	71.85	55.14	-65.36
ccsbBroad304_00371	OE	MAPK14	MAPK:p38 subfamily, mitogen-activated protein kinase 14			0.00, 0.00	1.45, 0.34	-72.33	NaN	-35.18	-98.97	69.34	-48.66	-95.29	-19.51	89.60	-85.78
ccsbBroad304_08662	OE	MCCC1	methylcrotonoyl-CoA carboxylase 1 (alpha)			11.11, 0.00	1.39, 0.40	51.67	NaN	-78.06	95.03	47.56	91.38	-38.15	-56.94	88.32	91.36
ccsbBroad304_00987	OE	MCM3	minichromosome maintenance complex component 3			11.11, 11.11	1.23, 0.20	-87.86	NaN	-32.07	26.93	85.66	49.08	99.31	75.55	-28.36	69.49
ccsbBroad304_06569	OE	MCM5	minichromosome maintenance complex component 5			22.22, 22.22	1.11, 0.24	-30.85	NaN	-25.47	69.34	70.89	99.73	19.77	99.98	50.53	79.33
ccsbBroad304_02157	OE	MED21	mediator complex subunit 21			0.00, 0.00	1.01, 0.24	-45.42	NaN	53.76	-43.29	90.04	35.82	43.62	47.39	-28.76	12.39
ccsbBroad304_06575	OE	MEF2A	Myocyte enhancer factors, myocyte enhancer factor 2A			0.00, 0.00	0.77, 0.24	-47.57	NaN	-92.46	-63.22	-90.24	66.36	90.33	-78.32	-86.40	-93.66
ccsbBroad304_01013	OE	MIF	macrophage migration inhibitory factor (glycosylation-inhibiting factor)			11.11, 11.11	1.69, 0.61	38.07	NaN	-29.68	44.25	53.97	99.78	48.99	-59.82	-54.10	15.42
ccsbBroad304_06583	OE	MITF	Basic helix-loop-helix proteins, microphthalmia-associated transcription factor			0.00, 0.00	1.13, 0.27	-28.43	NaN	-53.06	-98.82	-66.88	-32.27	-64.16	-49.64	30.90	-54.17
ccsbBroad304_04387	OE	MKI67IP	MKI67 (FHA domain) interacting nucleolar phosphoprotein			0.00, 0.00	1.41, 0.31	-99.46	NaN	-99.88	-99.55	80.51	91.49	46.59	-64.35	-84.99	-99.49
ccsbBroad304_01019	OE	MLH1	mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli)			11.11, 11.11	1.57, 0.50	44.74	NaN	-28.88	-37.46	99.98	-35.97	49.29	-47.88	30.80	-13.29
ccsbBroad304_08102	OE	MRPL18	Mitochondrial ribosomal proteins / large subunits, mitochondrial ribosomal protein L18			0.00, 0.00	1.22, 0.26	-98.75	NaN	-82.76	-54.12	-25.97	36.40	-24.89	-89.98	36.53	-90.32
ccsbBroad304_01073	OE	NDUFB8	Mitochondrial respiratory chain complex / Complex I, NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 8, 19kDa			0.00, 0.00	1.34, 0.36	58.09	NaN	-99.04	42.13	-53.13	27.34	-42.41	-99.44	44.60	-21.05
ccsbBroad304_06654	OE	NPM1	nucleophosmin (nucleolar phosphoprotein B23, numatrin)			11.11, 0.00	1.23, 0.36	63.36	NaN	88.57	-99.93	-70.74	-31.94	96.12	-36.10	-56.93	-18.51
ccsbBroad304_05417	OE	P2RY8	GPCR / Class A : Purinergic receptors, P2Y, purinergic receptor P2Y, G-protein coupled, 8		Purinergic receptors P2Y GOF	22.22, 22.22	1.01, 0.17	-79.46	NaN	98.63	99.88	-83.28	-95.01	14.63	-67.68	82.56	65.12
ccsbBroad304_09254	OE	PAQR8	progestin and adipoQ receptor family member VIII			11.11, 11.11	1.63, 0.53	-85.47	NaN	-31.27	-45.87	99.94	-38.94	62.97	-32.47	-39.22	-19.27
ccsbBroad304_03812	OE	PBXIP1	pre-B-cell leukemia homeobox interacting protein 1			0.00, 0.00	1.06, 0.31	-97.23	NaN	-99.48	45.37	-59.75	-66.71	-98.80	-93.81	-48.25	-98.33
ccsbBroad304_01150	OE	PCCB	Carboxylases, propionyl CoA carboxylase, beta polypeptide			0.00, 0.00	1.11, 0.24	65.12	NaN	-39.81	-51.18	-53.69	91.09	-93.80	-88.62	59.61	-48.85
ccsbBroad304_01163	OE	PDHA1	pyruvate dehydrogenase (lipoamide) alpha 1			11.11, 11.11	1.07, 0.32	64.09	NaN	99.79	-99.59	-99.50	-38.21	-9.14	-60.03	54.74	-45.64
ccsbBroad304_01189	OE	PHF1	Zinc fingers, PHD-type, PHD finger protein 1			0.00, 0.00	0.95, 0.25	39.92	NaN	23.04	-67.92	-28.13	-46.16	-92.07	-96.61	70.28	-40.42
ccsbBroad304_06734	OE	PLAT	Chymotrypsin, plasminogen activator, tissue			11.11, 11.11	1.38, 0.27	-97.91	NaN	-9.31	30.59	-22.95	-30.71	-69.40	93.07	98.93	-7.50
ccsbBroad304_08340	OE	POLR3K	RNA polymerase subunits, polymerase (RNA) III (DNA directed) polypeptide K, 12.3 kDa			0.00, 0.00	1.15, 0.30	-36.65	NaN	89.18	-23.75	41.95	-43.53	47.05	40.48	-24.72	4.21
ccsbBroad304_01271	OE	PPT1	palmitoyl-protein thioesterase 1			0.00, 0.00	1.58, 0.32	89.56	NaN	-32.15	84.54	42.21	87.74	-89.06	57.09	-36.72	86.71
ccsbBroad304_02622	OE	PRDM4	Zinc fingers, C2H2-type, PR domain containing 4			0.00, 0.00	1.02, 0.35	-60.10	NaN	69.02	-40.04	-98.59	-41.66	26.25	69.91	78.14	58.99
ccsbBroad304_14389	OE	PSMA8	Proteasome (prosome, macropain) subunits, proteasome (prosome, macropain) subunit, alpha type, 8			11.11, 11.11	1.02, 0.36	63.52	NaN	-33.83	74.21	48.71	49.82	-49.35	56.52	99.64	37.40
ccsbBroad304_06801	OE	PSMB10	Proteasome (prosome, macropain) subunits, proteasome (prosome, macropain) subunit, beta type, 10			0.00, 0.00	1.13, 0.26	43.27	NaN	-46.91	-51.43	-30.23	-28.42	92.25	-51.57	-78.22	-21.09
ccsbBroad304_01337	OE	PTHLH	Endogenous ligands, parathyroid hormone-like hormone			0.00, 0.00	1.32, 0.24	72.77	NaN	40.05	45.72	-98.54	-55.73	-77.12	-50.84	19.55	-35.46
ccsbBroad304_03371	OE	RAB23	RAB, member RAS oncogene, RAB23, member RAS oncogene family			0.00, 0.00	1.09, 0.28	61.96	NaN	-51.67	-57.82	-50.69	-20.77	57.89	-36.14	-38.01	-1.71
ccsbBroad304_01845	OE	RDBP	RD RNA binding protein			0.00, 0.00	1.22, 0.31	-30.55	NaN	29.15	-90.77	-75.57	-39.26	-65.98	36.83	87.56	-61.79
ccsbBroad304_01395	OE	RFX5	regulatory factor X, 5 (influences HLA class II expression)			0.00, 0.00	0.93, 0.25	-56.53	NaN	57.55	-64.35	-95.80	-32.53	-30.05	36.44	64.07	-11.12
ccsbBroad304_02010	OE	RIPK2	Receptor interacting protein kinase (RIPK) family, receptor-interacting serine-threonine kinase 2			0.00, 0.00	1.92, 0.52	-85.81	NaN	42.47	61.11	-99.56	-22.87	-74.36	-74.71	-97.64	-92.73
ccsbBroad304_00102	OE	RND3	Rho family GTPase 3			0.00, 0.00	1.34, 0.27	-13.13	NaN	-70.33	-98.29	51.61	28.85	85.03	-31.25	69.79	6.06
ccsbBroad304_01413	OE	RPA2	replication protein A2, 32kDa			11.11, 11.11	2.17, 0.65	-85.58	NaN	42.87	-99.41	83.17	98.19	-95.40	-31.28	85.91	-90.42
ccsbBroad304_06894	OE	RPS6	S ribosomal proteins, ribosomal protein S6			11.11, 0.00	1.57, 0.43	65.44	NaN	-45.02	67.66	97.36	33.76	-24.92	-29.42	-43.97	29.69
ccsbBroad304_04288	OE	RPS6KL1	RSKL family, ribosomal protein S6 kinase-like 1			44.44, 33.33	1.11, 0.40	96.96	NaN	-26.65	-15.09	56.56	99.97	99.84	-83.57	80.47	99.58
ccsbBroad304_06902	OE	RRM1	Ribonucleoside-diphosphate reductases, ribonucleotide reductase M1			0.00, 0.00	1.42, 0.44	33.12	NaN	-18.37	-32.82	-65.98	40.58	19.96	-55.41	-90.91	-19.40
ccsbBroad304_01485	OE	SC5DL	sterol-C5-desaturase (ERG3 delta-5-desaturase homolog, S. cerevisiae)-like			22.22, 22.22	0.98, 0.34	-87.25	NaN	99.64	99.68	-92.80	69.00	-53.54	-39.37	-64.91	-71.14
ccsbBroad304_06916	OE	SCP2	sterol carrier protein 2			11.11, 11.11	1.01, 0.28	52.26	NaN	-28.97	-99.53	-45.97	-78.10	99.98	-65.39	-99.93	-80.06
ccsbBroad304_09833	OE	SENP5	SUMO1/sentrin specific peptidase 5			0.00, 0.00	1.45, 0.38	-41.35	NaN	-70.03	77.97	36.44	-34.19	-31.57	-82.62	-17.43	-9.99
ccsbBroad304_10231	OE	SETDB1	Histone methyltransferases (HMTs), SET domain, bifurcated 1			22.22, 22.22	1.43, 0.33	-64.55	NaN	-35.13	46.53	97.81	98.25	45.46	-84.04	-59.64	-28.97
ccsbBroad304_02831	OE	SGK3	SGK family, serum/glucocorticoid regulated kinase family, member 3			11.11, 11.11	0.85, 0.18	-83.92	NaN	58.58	-78.50	98.45	-87.47	-70.10	59.26	34.82	-67.08
ccsbBroad304_13952	OE	SHMT2	serine hydroxymethyltransferase 2 (mitochondrial)			11.11, 11.11	2.07, 0.60	88.08	NaN	-27.43	88.56	99.93	-66.40	84.70	-28.65	69.22	94.77
ccsbBroad304_06954	OE	SLC1A1	Glutamate transporter subfamily, solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1			0.00, 0.00	1.24, 0.24	45.94	NaN	27.66	40.43	-51.26	-84.20	-76.25	-83.39	47.90	-66.83
ccsbBroad304_02337	OE	SLC25A13	Mitochondrial amino acid transporter subfamily, solute carrier family 25, member 13 (citrin)			0.00, 0.00	1.47, 0.28	-44.90	NaN	-16.58	-37.89	-77.28	39.31	-61.48	-17.42	45.10	-5.21
ccsbBroad304_08660	OE	SMARCAD1	SWI/SNF-related, matrix-associated actin-dependent regulator of chromatin, subfamily a, containing DEAD/H box 1			22.22, 22.22	0.78, 0.16	82.90	NaN	58.36	98.15	-56.94	-64.69	-60.99	-74.16	98.01	65.44
ccsbBroad304_06996	OE	SRM	spermidine synthase			11.11, 0.00	1.24, 0.34	97.07	NaN	-90.44	-98.35	-96.44	-28.58	7.56	-70.25	72.49	-86.65
ccsbBroad304_06998	OE	SRPK1	SRPK family, SRSF protein kinase 1			11.11, 11.11	1.67, 0.45	80.17	NaN	58.35	90.70	38.72	99.68	40.42	-26.60	46.44	72.47
ccsbBroad304_01605	OE	SSX2	synovial sarcoma, X breakpoint 2			0.00, 0.00	0.99, 0.25	-99.31	NaN	-96.21	-92.18	65.48	-34.20	-42.21	-99.17	-24.23	-99.77
ccsbBroad304_07012	OE	STK3	MST subfamily, serine/threonine kinase 3			0.00, 0.00	1.01, 0.28	65.93	NaN	-46.68	62.82	-39.50	-43.11	4.88	66.35	-43.11	-11.54
ccsbBroad304_07045	OE	TEAD4	TEA domain family member 4			0.00, 0.00	1.23, 0.27	85.61	NaN	-85.15	47.83	-34.55	-98.19	93.06	-32.62	-31.38	-7.36
ccsbBroad304_02778	OE	TGDS	Short chain dehydrogenase/reductase superfamily / Extended SDR fold, TDP-glucose 4,6-dehydratase			11.11, 0.00	0.86, 0.22	-73.03	NaN	45.17	-99.29	-58.63	95.29	-48.69	73.98	-31.91	-34.71
ccsbBroad304_02368	OE	TIMM17B	translocase of inner mitochondrial membrane 17 homolog B (yeast)			22.22, 22.22	1.47, 0.44	-79.15	NaN	-87.02	97.62	46.88	99.10	-84.27	-78.98	-42.24	-82.56
ccsbBroad304_09396	OE	TIRAP	toll-interleukin 1 receptor (TIR) domain containing adaptor protein			0.00, 0.00	5.51, 1.74	83.89	NaN	-95.11	-54.47	-87.82	-98.06	-99.81	-99.21	-40.94	-98.70
ccsbBroad304_05547	OE	TMEM110	transmembrane protein 110			11.11, 0.00	2.73, 0.94	-98.59	NaN	96.51	83.94	85.68	83.90	-49.37	-50.64	-33.41	94.73
ccsbBroad304_07292	OE	TNFSF13	CD molecules, tumor necrosis factor (ligand) superfamily, member 13			22.22, 22.22	1.74, 0.39	-45.62	NaN	-38.09	70.41	99.98	98.35	-99.20	-35.03	64.28	77.93
ccsbBroad304_06133	OE	TOR1A	torsin family 1, member A (torsin A)			11.11, 11.11	1.33, 0.40	91.97	NaN	-99.27	-91.30	-95.72	-47.96	40.50	56.10	99.97	-84.33
ccsbBroad304_08898	OE	TRAK2	trafficking protein, kinesin binding 2			11.11, 11.11	1.15, 0.27	-28.72	NaN	-71.23	80.04	-68.33	99.97	-99.98	-41.56	31.83	-54.73
ccsbBroad304_13975	OE	TYRO3	Type XI RTKs: TAM (TYRO3-, AXL- and MER-TK) receptor family, TYRO3 protein tyrosine kinase			0.00, 0.00	0.89, 0.23	-56.95	NaN	22.73	79.93	-42.62	-40.31	82.41	-39.72	-85.01	-13.00
ccsbBroad304_01744	OE	UCHL1	Ubiquitin C-terminal hydrolase, ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase)			11.11, 0.00	1.17, 0.31	95.04	NaN	-50.99	19.62	-78.58	24.04	-62.30	-35.66	-28.85	-15.35
ccsbBroad304_07137	OE	WT1	Zinc fingers, C2H2-type, Wilms tumor 1			11.11, 11.11	1.35, 0.41	99.92	NaN	-93.54	93.07	-99.98	-99.94	-6.13	48.88	-99.97	-99.91
ccsbBroad304_07372	OE	ZBED1	Pseudoautosomal regions / PAR1, zinc finger, BED-type containing 1			11.11, 11.11	1.33, 0.44	65.90	NaN	-92.49	-95.45	65.06	99.94	-32.51	-84.19	-41.68	-85.17
ccsbBroad304_00739	OE	ZBTB48	BTB/POZ domain containing, zinc finger and BTB domain containing 48			0.00, 0.00	1.27, 0.31	-45.40	NaN	-61.27	58.65	71.57	-99.12	55.42	-46.34	41.34	-32.63
ccsbBroad304_07173	OE	ZNF202	Zinc fingers, C2H2-type, zinc finger protein 202			11.11, 0.00	1.40, 0.38	-94.10	NaN	69.19	94.97	96.87	-33.73	69.02	-99.00	30.15	50.84
ccsbBroad304_02322	OE	ZNF263	Zinc fingers, C2H2-type, zinc finger protein 263			11.11, 11.11	0.95, 0.34	-56.09	NaN	-71.63	73.80	99.64	33.06	-96.62	-96.31	-75.24	-76.66
ccsbBroad304_04396	OE	ZNF559	Zinc fingers, C2H2-type, zinc finger protein 559			0.00, 0.00	1.10, 0.38	49.61	NaN	-82.30	93.63	-85.35	-25.87	45.13	45.22	-24.32	14.48
ccsbBroad304_04683	OE	ZNF689	Zinc fingers, C2H2-type, zinc finger protein 689			0.00, 0.00	1.97, 0.64	-97.71	NaN	21.14	27.36	73.65	30.13	-86.69	59.72	-63.11	-11.62
ccsbBroad304_09774	OE	ZNF92	Zinc fingers, C2H2-type, zinc finger protein 92			11.11, 11.11	1.42, 0.36	35.80	NaN	-27.57	-52.31	99.00	-46.76	45.98	-72.95	40.85	-38.64
ccsbBroad304_05763	OE	ACTB	actin, beta			11.11, 11.11	0.89, 0.30	-38.96	NaN	-58.68	-33.49	27.05	99.93	15.16	-99.95	-94.28	-18.65
ccsbBroad304_05791	OE	AGT	Endogenous ligands, angiotensinogen (serpin peptidase inhibitor, clade A, member 8)			11.11, 11.11	1.52, 0.43	98.55	NaN	-14.66	63.17	38.21	-20.64	-42.79	-79.64	21.85	6.12
ccsbBroad304_01025	OE	ALDH6A1	Aldehyde dehydrogenases, aldehyde dehydrogenase 6 family, member A1			0.00, 0.00	1.13, 0.27	62.62	NaN	-96.68	-47.50	-99.85	-39.81	-16.42	55.22	32.20	-18.28
ccsbBroad304_03305	OE	ANAPC5	Anaphase promoting complex subunits, anaphase promoting complex subunit 5			0.00, 0.00	1.05, 0.39	-98.51	NaN	-91.74	85.33	-92.56	81.58	-47.24	-76.62	35.34	-95.55
ccsbBroad304_05833	OE	APEH	Prolyl oligopeptidase, N-acylaminoacyl-peptide hydrolase			0.00, 0.00	1.52, 0.49	82.13	NaN	-60.19	41.22	70.30	-35.42	-41.48	-79.60	79.68	56.36
ccsbBroad304_00097	OE	ARF6	ADP-ribosylation factors, ADP-ribosylation factor 6			0.00, 0.00	1.17, 0.35	89.78	NaN	-60.10	-27.26	-69.27	-44.75	50.41	-46.28	-99.97	-40.59
ccsbBroad304_02460	OE	ATG7	Ubiquitin-like modifier activating enzymes, ATG7 autophagy related 7 homolog (S. cerevisiae)			0.00, 0.00	1.15, 0.28	-29.37	NaN	-54.49	-41.29	-24.95	18.06	65.95	-47.82	-27.11	-6.04
ccsbBroad304_05890	OE	BHMT	betaine--homocysteine S-methyltransferase			0.00, 0.00	2.15, 0.67	-37.90	NaN	-14.92	-22.05	72.41	28.99	-76.47	-22.17	87.70	-4.31
ccsbBroad304_05894	OE	BLVRA	biliverdin reductase A			11.11, 11.11	1.27, 0.33	16.08	NaN	98.54	-64.18	42.85	-27.00	-30.08	-94.04	34.17	-5.78
ccsbBroad304_02100	OE	BUB3	WD repeat domain containing, budding uninhibited by benzimidazoles 3 homolog (yeast)			0.00, 0.00	1.49, 0.35	-99.98	NaN	-61.49	-99.84	-88.03	-32.78	84.12	-37.12	93.03	-86.34
ccsbBroad304_00276	OE	CDK2	Cyclin-dependent kinases, CDK1 subfamily, cyclin-dependent kinase 2			11.11, 11.11	0.77, 0.27	-71.30	NaN	-99.79	51.22	-85.07	-32.02	55.63	-73.80	99.97	-68.74
ccsbBroad304_05887	OE	CFB	Complement system, complement factor B			0.00, 0.00	1.31, 0.38	25.41	NaN	-31.31	-50.75	-32.89	50.15	21.02	39.12	-82.06	-3.33
ccsbBroad304_03647	OE	CNDP2	Carnosine dipeptidase, CNDP dipeptidase 2 (metallopeptidase M20 family)			22.22, 22.22	0.97, 0.31	-70.52	NaN	-63.89	62.60	99.87	99.53	65.07	-48.11	-44.89	28.81
ccsbBroad304_06648	OE	CNOT3	CCR4-NOT transcription complex, subunit 3			0.00, 0.00	1.33, 0.27	-99.78	NaN	-67.27	-66.88	-99.72	-99.71	30.32	-91.95	-91.73	-99.91
ccsbBroad304_06018	OE	COMT	Catecholamine turnover, catechol-O-methyltransferase			11.11, 11.11	1.20, 0.32	-85.05	NaN	-98.80	-66.35	-70.76	-94.67	-80.83	-86.90	99.97	-94.49
ccsbBroad304_02551	OE	CPSF4	cleavage and polyadenylation specific factor 4, 30kDa			11.11, 0.00	1.63, 0.39	97.35	NaN	20.75	-68.24	85.90	85.70	52.90	-38.69	-40.14	81.38
ccsbBroad304_00856	OE	CXCR2	Chemokine receptors, chemokine (C-X-C motif) receptor 2			11.11, 11.11	1.18, 0.33	75.58	NaN	99.88	-36.94	-98.50	68.62	-99.98	45.70	-44.08	43.11
ccsbBroad304_00424	OE	DBI	diazepam binding inhibitor (GABA receptor modulator, acyl-CoA binding protein)			11.11, 11.11	1.60, 0.43	48.02	NaN	27.30	55.42	84.32	42.07	97.52	-68.98	-42.39	35.97
ccsbBroad304_07906	OE	DDAH2	Dimethylarginine dimethylaminohydrolases, dimethylarginine dimethylaminohydrolase 2			11.11, 11.11	1.07, 0.23	84.77	NaN	65.91	-65.03	-71.24	-42.75	99.56	78.27	61.63	51.94
ccsbBroad304_13850	OE	EIF4A2	DEAD-boxes, eukaryotic translation initiation factor 4A2			11.11, 11.11	1.38, 0.33	41.60	NaN	98.42	-43.32	-98.98	53.11	44.08	-38.29	-32.41	32.97
ccsbBroad304_00499	OE	ELK3	ETS Transcription Factors, ELK3, ETS-domain protein (SRF accessory protein 2)			11.11, 11.11	2.35, 0.60	-42.17	NaN	-31.75	25.89	-35.81	-43.06	-35.79	-61.12	99.65	-41.44
ccsbBroad304_00524	OE	EXT2	Exostosin glycosyltransferase family, exostosin 2			0.00, 0.00	1.25, 0.38	-95.41	NaN	-91.28	-96.68	-49.65	-65.27	-81.34	-78.98	80.11	-91.90
ccsbBroad304_00533	OE	FABP4	Fatty acid binding protein family, fatty acid binding protein 4, adipocyte			0.00, 0.00	1.16, 0.32	62.03	NaN	16.15	-99.96	-36.63	-44.58	-28.42	67.54	-41.50	-6.79
ccsbBroad304_00606	OE	GABPB1	Ankyrin repeat domain containing, GA binding protein transcription factor, beta subunit 1			11.11, 11.11	1.18, 0.22	76.95	NaN	-97.83	-44.70	-86.22	-91.96	99.98	-35.53	-92.50	-95.99
ccsbBroad304_08602	OE	HDAC8	Histone deacetylases, histone deacetylase 8			0.00, 0.00	1.45, 0.36	41.90	NaN	-14.11	-40.75	42.56	-59.30	14.55	43.11	92.65	3.52
ccsbBroad304_06365	OE	HIF1A	Basic helix-loop-helix proteins, hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)			11.11, 11.11	1.00, 0.35	22.20	NaN	-78.37	31.56	80.26	65.92	18.73	98.67	39.50	40.04
ccsbBroad304_00746	OE	HLA-DRB5	Immunoglobulin superfamily / C1-set domain containing, major histocompatibility complex, class II, DR beta 5			0.00, 0.00	1.44, 0.34	-62.60	NaN	-61.36	36.30	29.58	65.60	41.95	89.42	-45.27	29.09
ccsbBroad304_04072	OE	HMGN5	High-mobility group / Canonical, high mobility group nucleosome binding domain 5			0.00, 0.00	2.18, 0.56	23.62	NaN	-83.17	-49.23	-25.88	-83.46	-99.93	-26.00	-18.41	-78.88
ccsbBroad304_00799	OE	HSP90AB1	Heat shock proteins / HSPC, heat shock protein 90kDa alpha (cytosolic), class B member 1			0.00, 0.00	1.78, 0.53	-80.60	NaN	-27.86	-30.04	-28.69	19.24	-27.48	-50.05	-30.13	-12.71
ccsbBroad304_00837	OE	IGFBP4	insulin-like growth factor (IGF) binding proteins, insulin-like growth factor binding protein 4			11.11, 0.00	1.80, 0.39	-88.87	NaN	-54.51	43.95	-43.00	96.64	-99.98	-79.03	-78.24	-85.06
ccsbBroad304_03148	OE	IL21R	IL-2 receptor family, interleukin 21 receptor			22.22, 22.22	1.26, 0.35	97.55	NaN	89.80	99.91	-86.17	-48.33	45.10	-75.05	35.37	87.36
ccsbBroad304_00865	OE	ILF2	interleukin enhancer binding factor 2, 45kDa			0.00, 0.00	1.20, 0.31	-99.75	NaN	-76.36	-83.08	-99.87	31.27	53.53	52.59	-99.93	-99.63
ccsbBroad304_00866	OE	IMPA1	Inositol monophosphatase, inositol(myo)-1(or 4)-monophosphatase 1			0.00, 0.00	0.97, 0.38	-99.42	NaN	-95.05	-66.37	61.53	-91.71	-53.59	-77.80	-97.96	-98.26
ccsbBroad304_00876	OE	INSIG1	insulin induced gene 1			0.00, 0.00	1.05, 0.27	76.76	NaN	22.45	-66.66	-27.08	37.45	20.83	79.27	24.31	7.35
ccsbBroad304_00881	OE	IRF5	interferon regulatory factor 5			11.11, 0.00	1.45, 0.32	-33.12	NaN	76.22	18.08	96.86	27.12	93.17	-99.62	-23.57	56.39
ccsbBroad304_13891	OE	LCK	Src family, lymphocyte-specific protein tyrosine kinase			0.00, 0.00	1.17, 0.26	80.92	NaN	53.87	-95.16	-49.11	-35.83	38.20	36.02	91.03	28.60
ccsbBroad304_00969	OE	MAGEA10	melanoma antigen family A, 10			0.00, 0.00	1.60, 0.40	62.87	NaN	-80.45	-50.67	37.19	-24.62	19.82	40.37	43.36	7.55
ccsbBroad304_00980	OE	MBNL1	Zinc fingers, CCCH-type domain containing, muscleblind-like (Drosophila)			0.00, 0.00	1.89, 0.51	-49.21	NaN	-21.24	-58.73	-56.54	-76.36	26.24	43.09	-30.12	-58.36
ccsbBroad304_01035	OE	MSH5	mutS homolog 5 (E. coli)			0.00, 0.00	0.94, 0.36	-33.86	NaN	61.70	-85.51	-29.63	-52.69	94.65	-76.28	-57.60	-32.00
ccsbBroad304_01074	OE	NDUFS3	Mitochondrial respiratory chain complex / Complex I, NADH dehydrogenase (ubiquinone) Fe-S protein 3, 30kDa (NADH-coenzyme Q reductase)		NADH ubiquinone oxidoreductase core subunits GOF	0.00, 0.00	1.13, 0.34	31.62	NaN	-80.21	-92.24	-99.29	-54.44	22.00	83.13	26.96	-78.79
ccsbBroad304_02716	OE	NMNAT2	nicotinamide nucleotide adenylyltransferase 2			11.11, 11.11	1.17, 0.38	28.83	NaN	-78.61	-99.72	99.71	43.31	35.02	-97.81	5.24	-18.97
ccsbBroad304_03739	OE	NRIP3	nuclear receptor interacting protein 3			22.22, 11.11	1.43, 0.33	95.74	NaN	71.41	-64.14	-44.71	62.57	99.96	22.03	84.30	75.07
ccsbBroad304_04788	OE	OVCA2	ovarian tumor suppressor candidate 2			11.11, 11.11	1.38, 0.41	-86.45	NaN	-9.49	-54.69	64.99	99.79	32.62	-99.13	26.18	-31.67
ccsbBroad304_06680	OE	P2RX4	Ligand-gated ion channels / Purinergic receptors, ionotropic, purinergic receptor P2X, ligand-gated ion channel, 4			11.11, 11.11	1.98, 0.40	65.44	NaN	99.87	-55.31	-71.53	56.92	90.25	-17.26	44.30	49.76
ccsbBroad304_01152	OE	PCNA	proliferating cell nuclear antigen			11.11, 11.11	0.99, 0.27	99.98	NaN	84.69	45.68	40.97	-99.66	35.11	-66.98	81.12	81.14
ccsbBroad304_01263	OE	PPP2R1A	Serine/threonine phosphatases / Protein phosphatase 2, regulatory subunits, protein phosphatase 2, regulatory subunit A, alpha			0.00, 0.00	1.40, 0.41	80.32	NaN	-50.18	-43.02	41.84	88.70	-87.75	-61.39	-43.75	-26.87
ccsbBroad304_01280	OE	PRKAR1A	Protein kinase A, protein kinase, cAMP-dependent, regulatory, type I, alpha (tissue specific extinguisher 1)			0.00, 0.00	1.35, 0.27	93.11	NaN	-54.63	-45.00	-94.66	31.44	-13.39	-28.41	-99.96	-31.61
ccsbBroad304_09020	OE	RUFY1	Zinc fingers, FYVE domain containing, RUN and FYVE domain containing 1			11.11, 11.11	1.17, 0.25	-30.42	NaN	-80.76	-67.70	62.65	35.94	99.98	-60.67	32.70	-39.06
ccsbBroad304_06549	OE	SMAD3	SMADs, SMAD family member 3			11.11, 11.11	1.67, 0.47	-53.95	NaN	22.68	-51.25	58.69	77.07	-92.65	-63.27	99.97	-35.30
ccsbBroad304_03103	OE	SNX11	Sorting nexins, sorting nexin 11			0.00, 0.00	1.36, 0.38	81.56	NaN	-75.96	-43.13	-84.79	-68.73	-59.04	-12.54	-81.82	-63.68
ccsbBroad304_02357	OE	SSX3	synovial sarcoma, X breakpoint 3			0.00, 0.00	1.25, 0.41	-72.26	NaN	54.02	-46.05	72.88	-25.15	4.52	48.41	-57.80	6.67
ccsbBroad304_07008	OE	STAT5A	SH2 domain containing, signal transducer and activator of transcription 5A			11.11, 0.00	0.99, 0.31	-38.25	NaN	-49.19	47.64	-45.30	-30.95	-71.49	96.17	66.95	-8.71
ccsbBroad304_02378	OE	STUB1	Tetratricopeptide (TTC) repeat domain containing, STIP1 homology and U-box containing protein 1, E3 ubiquitin protein ligase			11.11, 11.11	0.92, 0.26	81.90	NaN	-69.68	-63.86	99.98	-31.55	63.66	-72.68	39.83	46.87
ccsbBroad304_07024	OE	SYK	Syk family, spleen tyrosine kinase			33.33, 11.11	1.43, 0.44	96.59	NaN	32.16	-33.72	55.07	96.84	-45.60	-99.18	99.54	94.72
ccsbBroad304_01641	OE	TAF13	TAF13 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 18kDa			0.00, 0.00	0.76, 0.17	37.71	NaN	-29.50	-90.41	-31.42	-47.08	-99.33	-99.96	-99.97	-99.86
ccsbBroad304_01661	OE	TFCP2	transcription factor CP2			0.00, 0.00	1.35, 0.33	-99.76	NaN	39.68	-80.18	-64.41	78.16	-45.11	81.41	-49.68	-49.08
ccsbBroad304_02405	OE	TFG	TRK-fused gene			0.00, 0.00	1.14, 0.28	-89.21	NaN	50.95	41.86	-99.45	-51.88	-21.21	-37.26	73.54	-36.08
ccsbBroad304_02399	OE	TNIP1	TNFAIP3 interacting protein 1			22.22, 11.11	1.81, 0.42	47.27	NaN	95.40	99.57	75.93	-18.56	84.51	-52.61	46.73	71.84
ccsbBroad304_03767	OE	TOMM22	translocase of outer mitochondrial membrane 22 homolog (yeast)			0.00, 0.00	0.83, 0.26	-58.59	NaN	-23.20	93.08	-55.59	70.21	-84.51	93.36	-99.85	-38.69
ccsbBroad304_07094	OE	TPMT	thiopurine S-methyltransferase			44.44, 11.11	1.20, 0.28	68.08	NaN	42.64	-34.29	-27.04	96.57	99.94	92.84	96.40	96.67
ccsbBroad304_02229	OE	TRAM2	translocation associated membrane protein 2			0.00, 0.00	1.51, 0.44	69.32	NaN	-89.35	-52.44	-96.64	-94.65	-6.18	-34.49	49.91	-84.25
ccsbBroad304_01923	OE	UXT	ubiquitously-expressed transcript			11.11, 11.11	0.97, 0.33	-99.88	NaN	-98.79	-39.87	-49.45	99.88	35.79	-77.78	35.50	-82.83
ccsbBroad304_02110	OE	VAPB	VAMP (vesicle-associated membrane protein)-associated protein B and C			0.00, 0.00	1.18, 0.40	-45.79	NaN	93.63	73.12	41.51	-35.46	-31.99	37.05	-51.05	21.66
ccsbBroad304_01764	OE	VDAC1	Voltage-dependent anion channels, voltage-dependent anion channel 1			0.00, 0.00	2.49, 0.61	-40.50	NaN	-91.36	-96.96	-26.32	-84.16	29.66	-97.86	-99.55	-98.98
ccsbBroad304_03232	OE	VPS28	vacuolar protein sorting 28 homolog (S. cerevisiae)			0.00, 0.00	3.31, 1.00	-38.89	NaN	-87.05	-68.00	-99.92	-90.03	-17.05	-59.57	43.76	-78.40
ccsbBroad304_04541	OE	ZNF502	Zinc fingers, C2H2-type, zinc finger protein 502			11.11, 0.00	1.38, 0.38	-19.42	NaN	79.42	-95.43	-46.95	36.05	-93.58	95.33	-97.02	-85.41
ccsbBroad304_08925	OE	ZNF576	Zinc fingers, C2H2-type, zinc finger protein 576			0.00, 0.00	1.39, 0.36	86.74	NaN	-85.24	-63.04	24.29	-93.24	-62.56	54.97	29.19	-44.65
ccsbBroad304_10024	OE	ZNF680	Zinc fingers, C2H2-type, zinc finger protein 680			11.11, 11.11	0.99, 0.31	77.14	NaN	-49.34	-49.69	-37.20	41.53	-64.16	-89.35	99.78	-26.92
ccsbBroad304_02030	OE	CFLAR	Endogenous ligands, CASP8 and FADD-like apoptosis regulator			0.00, 0.00	1.23, 0.32	50.02	NaN	42.27	50.32	84.36	86.19	-99.95	65.55	-30.85	75.76
ccsbBroad304_04565	OE	COG7	Components of oligomeric golgi complex, component of oligomeric golgi complex 7			11.11, 11.11	0.98, 0.27	98.24	NaN	-94.88	-63.06	32.39	34.65	-51.39	-33.44	-41.57	-31.54
ccsbBroad304_06191	OE	FABP6	Fatty acid binding protein family, fatty acid binding protein 6, ileal			0.00, 0.00	1.39, 0.40	-82.37	NaN	69.30	44.95	-30.64	71.07	-38.23	-91.94	89.65	46.23
ccsbBroad304_01855	OE	NCOA4	nuclear receptor coactivator 4			0.00, 0.00	1.42, 0.49	-99.98	NaN	-50.72	-23.75	-71.54	-33.80	-99.68	-28.08	-42.70	-67.63
ccsbBroad304_07780	OE	POLG2	DNA polymerases, polymerase (DNA directed), gamma 2, accessory subunit			11.11, 0.00	1.24, 0.39	48.63	NaN	44.65	41.97	54.03	95.28	-56.32	-20.47	45.77	13.00
ccsbBroad304_06754	OE	PPARD	Nuclear hormone receptors, peroxisome proliferator-activated receptor delta			11.11, 0.00	1.26, 0.40	-64.75	NaN	-99.96	-95.92	95.03	40.94	-57.46	-54.25	72.44	-66.23
ccsbBroad304_11910	OE	RBM15B	RNA binding motif (RRM) containing, RNA binding motif protein 15B			11.11, 0.00	0.99, 0.24	95.23	NaN	27.92	-35.99	-37.10	-30.53	13.69	48.52	-56.60	4.74
ccsbBroad304_01421	OE	RPL11	L ribosomal proteins, ribosomal protein L11			11.11, 11.11	1.00, 0.28	59.42	NaN	-32.41	-92.60	-87.96	-58.17	-60.65	-97.67	99.41	-86.08
ccsbBroad304_03235	OE	TUBD1	Tubulins, tubulin, delta 1			0.00, 0.00	1.27, 0.27	52.74	NaN	-99.85	-69.06	-65.20	-99.88	72.70	-93.78	-27.25	-99.03
ccsbBroad304_07117	OE	UGCG	Glycosyltransferase family 2 domain containing, UDP-glucose ceramide glucosyltransferase			0.00, 0.00	6.62, 2.05	-85.54	NaN	-99.98	-99.59	-91.50	-99.87	-98.52	-80.06	-99.80	-99.81
ccsbBroad304_02080	OE	USP14	Ubiquitin-specific peptidases, ubiquitin specific peptidase 14 (tRNA-guanine transglycosylase)			0.00, 0.00	1.02, 0.27	-30.05	NaN	-21.89	-64.55	-99.77	-62.36	-14.12	61.41	-31.07	-25.96
ccsbBroad304_01768	OE	VEGFA	Cytokines and growth factors, vascular endothelial growth factor A			0.00, 0.00	1.38, 0.45	-79.21	NaN	-45.00	29.22	-68.36	-58.16	-99.88	-87.77	-36.00	-63.03
ccsbBroad304_09689	OE	ZNF595	Zinc fingers, C2H2-type, zinc finger protein 595			0.00, 0.00	1.39, 0.34	73.34	NaN	86.79	30.07	93.66	-56.91	-83.20	57.50	77.56	63.94
ccsbBroad304_03580	OE	ABCF3	ATP binding cassette transporters / subfamily F, ATP-binding cassette, sub-family F (GCN20), member 3			44.44, 33.33	1.65, 0.35	97.43	NaN	62.56	37.67	-99.81	99.93	65.31	-62.04	99.97	97.96
ccsbBroad304_05802	OE	ALDH1B1	Aldehyde dehydrogenases, aldehyde dehydrogenase 1 family, member B1			22.22, 22.22	0.95, 0.27	-35.55	NaN	-91.76	-91.71	-58.80	-32.27	99.39	-34.45	97.88	-49.43
ccsbBroad304_00162	OE	BIK	BCL2-interacting killer (apoptosis-inducing)			0.00, 0.00	1.38, 0.35	-16.98	NaN	22.13	-43.35	-37.04	-18.47	-35.77	86.52	22.53	-2.82
ccsbBroad304_05963	OE	CD44	CD molecules, CD44 molecule (Indian blood group)			11.11, 11.11	1.11, 0.26	91.70	NaN	-99.98	-99.91	37.39	-31.48	-45.54	-93.48	99.78	-94.94
ccsbBroad304_04240	OE	CLPB	Ankyrin repeat domain containing, ClpB caseinolytic peptidase B homolog (E. coli)			11.11, 11.11	1.32, 0.45	-81.22	NaN	-99.56	-41.74	-28.72	-24.22	99.68	-72.44	-65.17	-78.97
ccsbBroad304_02499	OE	CTCF	Zinc fingers, C2H2-type, CCCTC-binding factor (zinc finger protein)			0.00, 0.00	1.03, 0.25	36.66	NaN	-94.68	84.78	78.17	-41.35	24.25	82.56	-99.78	51.12
ccsbBroad304_06140	OE	EEF1D	eukaryotic translation elongation factor 1 delta (guanine nucleotide exchange protein)			22.22, 11.11	1.40, 0.30	-48.20	NaN	-42.22	-76.54	-38.97	-22.44	99.48	-33.93	97.44	-4.40
ccsbBroad304_06172	OE	EPS8	epidermal growth factor receptor pathway substrate 8			11.11, 11.11	1.60, 0.53	41.27	NaN	74.92	66.29	36.72	91.64	35.35	-37.45	99.20	70.84
ccsbBroad304_00745	OE	HLA-DRB4	Immunoglobulin superfamily / C1-set domain containing, major histocompatibility complex, class II, DR beta 4			0.00, 0.00	1.27, 0.34	-95.49	NaN	-99.85	-89.56	-54.14	61.61	-92.21	-14.13	66.52	-95.00
ccsbBroad304_00811	OE	ICAM1	CD molecules, intercellular adhesion molecule 1			0.00, 0.00	1.09, 0.31	75.01	NaN	81.78	35.57	50.39	59.91	87.18	94.54	-99.82	85.39
ccsbBroad304_13903	OE	MTAP	methylthioadenosine phosphorylase			44.44, 33.33	1.11, 0.34	30.41	NaN	-44.10	-62.68	-94.50	97.85	-48.97	99.98	99.97	96.85
ccsbBroad304_01087	OE	NF2	A-kinase anchor proteins, neurofibromin 2 (merlin)			11.11, 11.11	0.93, 0.23	-81.51	NaN	-58.52	-88.76	56.28	99.38	62.92	-75.96	32.85	-59.67
ccsbBroad304_01090	OE	NFE2L2	basic leucine zipper proteins, nuclear factor (erythroid-derived 2)-like 2			0.00, 0.00	2.05, 0.77	48.19	NaN	-39.36	-32.58	-39.83	-91.45	58.37	-38.30	-99.89	-19.12
ccsbBroad304_10491	OE	PFKL	phosphofructokinase, liver			0.00, 0.00	1.56, 0.50	-45.50	NaN	-20.13	-51.87	-43.36	49.52	-99.72	-93.18	62.10	-21.42
ccsbBroad304_01326	OE	PSME1	Proteasome (prosome, macropain) subunits, proteasome (prosome, macropain) activator subunit 1 (PA28 alpha)			0.00, 0.00	1.25, 0.28	-97.28	NaN	-46.55	45.91	28.53	-98.07	-45.87	-21.14	44.71	-38.84
ccsbBroad304_02853	OE	QPCT	Aminopeptidase Y, glutaminyl-peptide cyclotransferase			0.00, 0.00	1.03, 0.27	-39.08	NaN	34.58	-77.21	-99.17	78.25	86.49	-53.18	24.77	-31.27
ccsbBroad304_01408	OE	RNF5	RING-type (C3HC4) zinc fingers, ring finger protein 5			11.11, 11.11	1.20, 0.34	-57.76	NaN	-93.95	92.45	-68.19	94.81	99.84	20.37	41.77	85.09
ccsbBroad304_10116	OE	SHC4	SH2 domain containing, SHC (Src homology 2 domain containing) family, member 4			0.00, 0.00	1.10, 0.38	-56.40	NaN	35.98	-28.75	-88.52	-82.54	-28.96	-92.37	67.64	-65.67
ccsbBroad304_01538	OE	SKP2	F-boxes / Leucine-rich repeats, S-phase kinase-associated protein 2 (p45)			0.00, 0.00	1.31, 0.26	48.17	NaN	81.46	-99.53	-60.77	79.84	81.62	-28.40	-39.14	47.81
ccsbBroad304_07564	OE	SLC25A15	Mitochondrial amino acid transporter subfamily, solute carrier family 25 (mitochondrial carrier; ornithine transporter) member 15			11.11, 11.11	1.00, 0.31	46.16	NaN	37.41	19.22	99.98	-14.80	47.83	-30.77	32.19	5.96
ccsbBroad304_04726	OE	TAGAP	Rho GTPase activating proteins, T-cell activation RhoGTPase activating protein			0.00, 0.00	0.92, 0.27	-41.12	NaN	-39.19	54.75	-98.75	47.33	-99.98	-41.49	-89.65	-71.61
ccsbBroad304_01735	OE	UBE2D1	Ubiquitin-conjugating enzymes E2, ubiquitin-conjugating enzyme E2D 1			11.11, 11.11	0.85, 0.35	-63.94	NaN	-52.32	-62.61	-92.14	48.61	99.72	-64.32	73.47	-48.44
ccsbBroad304_01812	OE	ZNF175	Zinc fingers, C2H2-type, zinc finger protein 175			11.11, 11.11	1.78, 0.39	17.48	NaN	-24.14	98.95	59.54	91.99	-40.87	-26.19	32.48	21.68
ccsbBroad304_00130	OE	ATP5F1	ATPases / F-type, ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1			0.00, 0.00	0.94, 0.30	-44.19	NaN	-31.71	82.96	-64.36	-45.05	87.60	32.85	-94.62	-8.41
ccsbBroad304_03179	OE	BOLA1	bolA homolog 1 (E. coli)			33.33, 11.11	1.17, 0.42	96.99	NaN	96.18	41.54	-80.44	30.91	29.98	99.98	42.73	94.63
ccsbBroad304_14066	OE	CHEK2	CHK1 subfamily, CHK2 checkpoint homolog (S. pombe)			22.22, 11.11	1.14, 0.24	34.61	NaN	90.37	-43.51	-19.64	-96.03	96.92	98.24	-50.23	89.20
ccsbBroad304_01835	OE	CXCR4	Chemokine receptors, chemokine (C-X-C motif) receptor 4			0.00, 0.00	1.40, 0.34	32.04	NaN	-65.11	22.11	31.44	-28.38	-99.33	-70.89	28.28	-33.89
ccsbBroad304_03239	OE	DCXR	Short chain dehydrogenase/reductase superfamily / Classical SDR fold cluster 1, dicarbonyl/L-xylulose reductase			0.00, 0.00	1.08, 0.40	-99.18	NaN	-65.23	53.16	46.84	-99.90	53.01	-39.38	39.08	-23.80
ccsbBroad304_04053	OE	DERL1	Der1-like domain family, member 1			11.11, 0.00	1.43, 0.25	46.78	NaN	20.85	96.19	-55.19	-27.62	-79.22	-51.95	-50.47	-20.57
ccsbBroad304_01976	OE	EIF4EBP3	eukaryotic translation initiation factor 4E binding protein 3			11.11, 0.00	2.02, 0.43	96.85	NaN	-99.96	-91.23	28.30	-83.92	-85.72	-61.85	-66.44	-85.89
ccsbBroad304_00525	OE	EZH1	Chromatin-modifying enzymes / K-methyltransferases, enhancer of zeste homolog 1 (Drosophila)			0.00, 0.00	1.49, 0.40	-64.90	NaN	27.47	70.73	27.57	-26.00	75.21	-11.25	-65.29	-7.90
ccsbBroad304_00710	OE	GUSB	glucuronidase, beta			22.22, 22.22	1.14, 0.27	97.94	NaN	99.90	62.97	-38.67	78.75	-36.97	38.95	51.95	86.36
ccsbBroad304_07651	OE	HEXIM1	hexamethylene bis-acetamide inducible 1			0.00, 0.00	1.58, 0.59	-31.26	NaN	-44.74	-42.83	-93.96	-23.64	-89.90	47.71	-98.87	-77.11
ccsbBroad304_04534	OE	HN1L	hematological and neurological expressed 1-like			0.00, 0.00	1.34, 0.30	-99.49	NaN	-67.24	-42.75	-98.43	-56.93	-99.67	40.44	84.24	-98.84
ccsbBroad304_02370	OE	HRSP12	heat-responsive protein 12			0.00, 0.00	3.48, 0.68	-96.32	NaN	-99.67	-99.66	-60.96	-46.57	-38.70	-99.09	-59.50	-99.63
ccsbBroad304_02221	OE	HS2ST1	Sulfotransferases, membrane-bound, heparan sulfate 2-O-sulfotransferase 1			0.00, 0.00	1.05, 0.32	-40.01	NaN	-55.62	-89.04	63.97	-98.57	-75.77	-37.45	40.00	-62.61
ccsbBroad304_03032	OE	HTATSF1	RNA binding motif (RRM) containing, HIV-1 Tat specific factor 1			0.00, 0.00	0.82, 0.19	63.09	NaN	85.15	-93.41	55.04	12.76	-6.11	-34.13	93.46	12.94
ccsbBroad304_07760	OE	KAT7	Histone acetyltransferases (HATs), K(lysine) acetyltransferase 7			11.11, 11.11	1.19, 0.27	99.95	NaN	-88.03	-95.22	48.32	-75.10	-23.64	31.43	87.62	-70.99
ccsbBroad304_02592	OE	KIF2C	Kinesins, kinesin family member 2C			11.11, 11.11	1.02, 0.36	-27.93	NaN	99.75	45.53	-42.28	-74.20	13.77	34.79	-99.93	-7.00
ccsbBroad304_06525	OE	LIPA	lipase A, lysosomal acid, cholesterol esterase			0.00, 0.00	1.34, 0.45	65.23	NaN	-29.88	-96.16	-44.15	25.93	-66.09	91.32	-48.73	-29.76
ccsbBroad304_04398	OE	MRPL43	Mitochondrial ribosomal proteins / large subunits, mitochondrial ribosomal protein L43			11.11, 11.11	0.94, 0.38	-99.96	NaN	57.68	84.92	-62.88	-52.33	30.72	98.89	53.64	54.08
ccsbBroad304_03197	OE	NDUFA13	Mitochondrial respiratory chain complex / Complex I, NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 13			0.00, 0.00	3.25, 0.72	-98.62	NaN	-94.31	-24.10	-97.77	-99.97	-93.77	-93.10	-76.54	-98.89
ccsbBroad304_01142	OE	PAFAH1B2	platelet-activating factor acetylhydrolase 1b, catalytic subunit 2 (30kDa)			0.00, 0.00	1.19, 0.39	79.87	NaN	-62.84	-73.41	-27.94	-91.89	-17.97	-42.62	24.04	-50.82
ccsbBroad304_11024	OE	PDGFRA	Type III RTKs: PDGFR, CSFR, Kit, FLT3 receptor family, platelet-derived growth factor receptor, alpha polypeptide			11.11, 0.00	0.98, 0.31	-47.62	NaN	-94.88	-64.92	68.84	95.82	-98.20	54.76	-26.05	-63.45
ccsbBroad304_10232	OE	PDIA5	Protein disulfide isomerases, protein disulfide isomerase family A, member 5			0.00, 0.00	1.34, 0.41	46.48	NaN	-78.03	-76.54	-99.93	-55.95	-32.38	-40.63	-45.08	-61.33
ccsbBroad304_07598	OE	PEMT	phosphatidylethanolamine N-methyltransferase			11.11, 11.11	1.49, 0.39	35.62	NaN	-69.39	99.95	67.27	-52.86	28.93	69.37	-98.28	54.53
ccsbBroad304_01351	OE	PEX19	peroxisomal biogenesis factor 19			0.00, 0.00	1.39, 0.35	33.24	NaN	-99.24	-29.06	-74.83	-99.97	10.03	50.98	24.15	-43.40
ccsbBroad304_01211	OE	PKM2	pyruvate kinase, muscle			0.00, 0.00	1.32, 0.33	47.08	NaN	19.45	-23.65	-27.31	26.90	-56.79	-94.48	74.15	-5.40
ccsbBroad304_06755	OE	PPAT	Phosphoribosyl pyrophosphate amidotransferase, phosphoribosyl pyrophosphate amidotransferase			11.11, 11.11	1.42, 0.35	48.44	NaN	97.88	54.81	64.32	43.77	-61.84	73.87	-32.77	52.21
ccsbBroad304_02440	OE	PPIE	RNA binding motif (RRM) containing, peptidylprolyl isomerase E (cyclophilin E)			11.11, 11.11	2.07, 0.34	-83.68	NaN	98.28	-39.43	50.22	-15.67	-74.96	43.90	-44.46	-28.64
ccsbBroad304_01282	OE	PRKCB	Alpha subfamily, protein kinase C, beta			11.11, 0.00	1.22, 0.34	85.53	NaN	96.38	-59.60	-85.66	-59.92	35.88	87.62	-84.12	82.24
ccsbBroad304_02087	OE	PRPF4	WD repeat domain containing, PRP4 pre-mRNA processing factor 4 homolog (yeast)			11.11, 0.00	1.24, 0.43	-75.04	NaN	36.64	-38.90	-76.99	95.68	-98.76	59.46	90.11	77.78
ccsbBroad304_13933	OE	PSME2	Proteasome (prosome, macropain) subunits, proteasome (prosome, macropain) activator subunit 2 (PA28 beta)			0.00, 0.00	0.70, 0.13	-55.11	NaN	14.44	91.44	-22.34	-40.36	92.03	-70.63	-99.92	-16.75
ccsbBroad304_01333	OE	PTGFR	GPCR / Class A : Prostanoid receptors, prostaglandin F receptor (FP)			22.22, 22.22	1.57, 0.56	33.18	NaN	88.45	76.45	98.81	69.65	99.49	-99.94	59.49	91.67
ccsbBroad304_01360	OE	RAB4A	RAB, member RAS oncogene, RAB4A, member RAS oncogene family			11.11, 11.11	0.78, 0.26	-90.57	NaN	-24.99	98.82	68.86	-84.09	42.49	38.31	35.87	4.61
ccsbBroad304_03309	OE	RNF138	RING-type (C3HC4) zinc fingers, ring finger protein 138			0.00, 0.00	1.25, 0.40	-33.47	NaN	-18.87	51.42	-26.41	49.43	27.62	-40.19	-31.17	-2.31
ccsbBroad304_01445	OE	RPS3	S ribosomal proteins, ribosomal protein S3			11.11, 11.11	1.47, 0.47	-41.02	NaN	98.06	-61.46	86.40	35.70	-45.41	51.30	-44.14	40.92
ccsbBroad304_01469	OE	RSU1	Ras suppressor protein 1			0.00, 0.00	1.19, 0.27	26.70	NaN	50.97	-50.78	-96.96	-64.98	-48.74	53.68	89.96	-33.81
ccsbBroad304_00068	OE	SLC25A6	Mitochondrial nucleotide transporter subfamily, solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 6			44.44, 11.11	1.19, 0.35	98.13	NaN	96.08	-69.65	-64.61	-17.47	-11.71	96.51	55.36	95.68
ccsbBroad304_01523	OE	SRSF4	RNA binding motif (RRM) containing, serine/arginine-rich splicing factor 4			22.22, 22.22	1.16, 0.43	-72.42	NaN	98.12	99.74	-90.90	-88.70	44.75	-61.15	-27.66	-61.73
ccsbBroad304_01618	OE	STXBP1	syntaxin binding protein 1			11.11, 11.11	1.45, 0.53	-85.56	NaN	-33.11	-46.68	56.57	99.62	31.20	46.12	51.13	29.56
ccsbBroad304_02396	OE	TCIRG1	ATPases / V-type, T-cell, immune regulator 1, ATPase, H+ transporting, lysosomal V0 subunit A3			0.00, 0.00	0.99, 0.38	-43.83	NaN	-96.83	91.18	-61.44	-97.09	25.40	-79.66	92.72	-53.50
ccsbBroad304_07050	OE	TFAP2A	transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha)			11.11, 11.11	0.85, 0.26	-41.77	NaN	51.32	54.69	-55.38	-99.97	82.26	99.80	-42.56	20.95
ccsbBroad304_01675	OE	TK1	thymidine kinase 1, soluble			22.22, 0.00	0.89, 0.25	87.99	NaN	33.20	-99.85	95.87	95.66	-29.36	58.10	42.80	87.32
ccsbBroad304_02138	OE	TRIP10	thyroid hormone receptor interactor 10			0.00, 0.00	1.65, 0.43	-98.09	NaN	-98.97	-94.25	-98.50	-72.67	-88.31	-97.06	-97.98	-99.07
ccsbBroad304_07102	OE	TSG101	tumor susceptibility gene 101			0.00, 0.00	1.02, 0.26	-80.93	NaN	65.66	-94.50	33.20	85.17	-85.73	40.84	85.48	56.63
ccsbBroad304_07078	OE	TSPAN6	Tetraspanins, tetraspanin 6			11.11, 11.11	1.02, 0.28	46.44	NaN	-71.01	-34.80	-34.03	-72.75	-63.64	69.21	99.00	-25.56
ccsbBroad304_01724	OE	TTR	transthyretin			22.22, 22.22	0.95, 0.24	99.52	NaN	98.29	-35.36	-61.67	-58.13	-36.53	34.28	32.64	-32.27
ccsbBroad304_07118	OE	UGDH	UDP-glucose 6-dehydrogenase			0.00, 0.00	1.36, 0.30	41.25	NaN	36.21	59.21	58.82	29.63	30.27	28.87	-99.97	18.69
ccsbBroad304_07119	OE	UGP2	UDP-glucose pyrophosphorylase 2			22.22, 11.11	1.26, 0.30	98.31	NaN	95.25	-41.59	-36.93	-62.27	8.07	83.94	37.29	86.76
ccsbBroad304_01852	OE	ZNF212	Zinc fingers, C2H2-type, zinc finger protein 212			0.00, 0.00	0.97, 0.35	-46.77	NaN	57.71	-23.19	-94.47	48.01	-67.59	56.93	21.80	7.33
ccsbBroad304_04522	OE	ZNF625	Zinc fingers, C2H2-type, zinc finger protein 625			0.00, 0.00	1.27, 0.38	64.03	NaN	78.93	-77.30	31.25	-24.48	-73.55	36.83	-43.41	-18.02
ccsbBroad304_07412	OE	ZRANB2	Zinc fingers, RAN-binding domain containing, zinc finger, RAN-binding domain containing 2			11.11, 11.11	1.55, 0.31	11.03	NaN	22.30	23.69	99.98	-99.69	-26.24	-86.78	-99.81	-75.33
ccsbBroad304_05899	OE	BMP4	Bone morphogenetic proteins, bone morphogenetic protein 4			0.00, 0.00	0.86, 0.23	-85.63	NaN	-99.58	67.19	-38.26	75.70	39.48	-84.12	-93.53	-97.22
ccsbBroad304_00278	OE	CDK5	Cyclin-dependent kinases, CDK5 subfamily, cyclin-dependent kinase 5			0.00, 0.00	1.44, 0.53	66.15	NaN	-57.47	33.52	72.44	88.10	-53.40	-73.55	42.54	36.89
ccsbBroad304_00359	OE	CPT1A	carnitine palmitoyltransferase 1A (liver)			11.11, 11.11	1.32, 0.36	-38.89	NaN	-61.31	86.41	91.84	83.56	90.52	97.64	41.44	86.91
ccsbBroad304_00689	OE	GRB7	Pleckstrin homology (PH) domain containing, growth factor receptor-bound protein 7			11.11, 11.11	1.01, 0.23	92.55	NaN	-36.62	39.44	-32.53	97.95	46.32	-32.12	27.90	30.85
ccsbBroad304_06539	OE	LSS	Lanosterol biosynthesis pathway, lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase)			0.00, 0.00	1.11, 0.39	69.64	NaN	-67.04	-88.75	-25.55	37.38	39.91	36.60	52.88	27.14
ccsbBroad304_02220	OE	MTFR1	mitochondrial fission regulator 1			33.33, 11.11	1.58, 0.42	94.86	NaN	53.22	79.50	96.34	-53.75	75.89	86.30	95.86	98.14
ccsbBroad304_03817	OE	NMRAL1	Short chain dehydrogenase/reductase superfamily / Atypical members, NmrA-like family domain containing 1			0.00, 0.00	0.84, 0.18	-47.08	NaN	-23.06	36.98	39.57	47.18	32.03	-85.54	41.94	10.61
ccsbBroad304_00693	OE	NR3C1	3-Ketosteroid receptors, nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)			0.00, 0.00	1.95, 0.43	-83.74	NaN	50.15	-61.34	-81.30	-60.37	-71.81	-29.85	24.29	-78.19
ccsbBroad304_01143	OE	PAFAH1B3	platelet-activating factor acetylhydrolase 1b, catalytic subunit 3 (29kDa)			0.00, 0.00	1.26, 0.39	73.82	NaN	17.16	-35.46	69.32	-64.22	39.33	50.51	66.66	38.25
ccsbBroad304_02560	OE	RNPS1	RNA binding motif (RRM) containing, RNA binding protein S1, serine-rich domain			22.22, 22.22	1.39, 0.41	90.56	NaN	-99.98	99.98	34.00	-99.97	37.94	97.79	-58.66	86.57
ccsbBroad304_01483	OE	SAT1	spermidine/spermine N1-acetyltransferase 1			0.00, 0.00	1.06, 0.35	49.03	NaN	-29.50	41.19	51.54	-19.72	-97.50	-37.56	-51.21	-7.45
ccsbBroad304_02384	OE	SMNDC1	Tudor domain containing, survival motor neuron domain containing 1			0.00, 0.00	1.26, 0.30	-87.49	NaN	-99.07	38.77	-52.80	62.53	-89.27	-52.97	-70.14	-87.47
ccsbBroad304_01584	OE	SPARC	secreted protein, acidic, cysteine-rich (osteonectin)			11.11, 11.11	1.49, 0.43	24.78	NaN	99.98	-35.76	88.50	-82.35	-98.23	-40.19	-48.35	-15.11
ccsbBroad304_04891	OE	TMEM174	transmembrane protein 174			0.00, 0.00	1.55, 0.39	-40.91	NaN	39.51	44.84	-92.53	33.08	87.07	-98.88	53.88	17.74
ccsbBroad304_07616	OE	ZNF238	zinc finger protein 238			0.00, 0.00	1.56, 0.34	67.77	NaN	-74.93	-95.70	-97.81	-99.96	-75.50	-44.03	-99.39	-99.58
ccsbBroad304_08786	OE	ZNF350	Zinc fingers, C2H2-type, zinc finger protein 350			11.11, 11.11	1.56, 0.38	99.92	NaN	42.83	-72.23	-69.50	93.82	57.33	61.52	-56.42	38.95
ccsbBroad304_00214	OE	CAPN1	EF-hand domain containing, calpain 1, (mu/I) large subunit			22.22, 22.22	1.03, 0.39	-80.57	NaN	-92.23	-28.48	-92.04	99.66	79.37	-92.48	99.95	-92.50
ccsbBroad304_05937	OE	CASP7	Caspases, caspase 7, apoptosis-related cysteine peptidase			0.00, 0.00	1.84, 0.44	76.33	NaN	43.28	34.98	-84.61	92.71	-16.79	50.18	-99.85	37.96
ccsbBroad304_00514	OE	ERF	ETS Transcription Factors, Ets2 repressor factor			0.00, 0.00	1.36, 0.42	-65.68	NaN	-90.13	-33.77	53.34	60.27	-50.58	-44.29	35.60	-31.47
ccsbBroad304_05817	OE	ANPEP	Aminopeptidase N, alanyl (membrane) aminopeptidase			40.00, 30.00	1.06, 0.28	22.17	91.01	99.94	-42.30	99.82	-49.86	36.52	-99.17	97.26	98.52
ccsbBroad304_06055	OE	CSNK1A1	Casein kinase 1 (CK1) family, casein kinase 1, alpha 1			10.00, 10.00	1.36, 0.28	-20.37	94.99	70.34	-18.36	-66.77	98.93	-86.00	-45.97	-63.77	-30.10
ccsbBroad304_00381	OE	CSNK2A1	Casein kinase 2 (CK2) family, casein kinase 2, alpha 1 polypeptide			10.00, 10.00	0.95, 0.32	-99.96	42.51	84.77	-99.98	99.16	66.49	-99.27	-88.13	-95.55	-99.26
ccsbBroad304_03859	OE	ENOPH1	enolase-phosphatase 1			10.00, 10.00	1.28, 0.44	24.29	-21.99	75.38	-45.21	53.96	99.45	37.40	67.24	-85.48	30.13
ccsbBroad304_00088	OE	FASLG	Tumour necrosis factor (TNF) receptor family, Fas ligand (TNF superfamily, member 6)			0.00, 0.00	0.84, 0.19	22.97	-74.25	-78.86	-99.58	91.59	-42.15	-63.40	-38.04	83.60	-46.51
ccsbBroad304_06238	OE	GABBR1	GABA receptors, gamma-aminobutyric acid (GABA) B receptor, 1			10.00, 10.00	1.27, 0.45	-16.37	-24.68	-77.19	-99.98	-37.96	36.16	-33.82	99.81	34.12	-8.64
ccsbBroad304_05527	OE	GPR141	GPCR / Class A : Orphans, G protein-coupled receptor 141			0.00, 0.00	1.61, 0.39	51.95	-99.47	38.23	-99.90	-31.10	-52.21	26.21	24.27	56.00	13.04
ccsbBroad304_00899	OE	KCNK2	Two-P potassium channels, potassium channel, subfamily K, member 2			10.00, 10.00	0.98, 0.34	-59.89	-31.26	-33.55	-60.55	-37.46	42.02	-59.45	-29.65	99.97	-20.80
ccsbBroad304_01008	OE	KITLG	KIT ligand			10.00, 10.00	0.89, 0.20	-30.65	-24.74	-22.31	-36.98	94.57	-29.56	99.98	80.58	-37.84	-3.98
ccsbBroad304_04406	OE	PLA2G12B	phospholipase A2, group XIIB		Phospholipases GOF	0.00, 0.00	0.84, 0.27	56.27	-41.60	88.52	-83.70	-49.42	24.31	-77.67	-99.98	-83.33	-65.14
ccsbBroad304_06774	OE	PRKCQ	Delta subfamily, protein kinase C, theta			0.00, 0.00	1.20, 0.40	70.67	-40.28	16.55	70.15	-56.25	35.07	58.64	-92.09	-99.85	-10.92
ccsbBroad304_07097	OE	TRAF1	TNF receptor-associated factor 1			10.00, 10.00	1.66, 0.45	93.16	-30.38	37.97	61.86	-96.23	99.81	-46.39	-30.39	-50.06	23.76
ccsbBroad304_07129	OE	VIPR1	GPCR / Class B : VIP and PACAP (ADCYAP1) receptors, vasoactive intestinal peptide receptor 1			20.00, 20.00	0.75, 0.18	-92.09	54.12	-14.40	99.96	-25.64	-45.70	37.29	99.98	27.77	13.85
ccsbBroad304_02579	OE	YWHAQ	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta polypeptide			0.00, 0.00	1.03, 0.26	-95.38	-36.27	-76.98	47.05	69.86	93.76	32.96	-33.49	-63.78	-15.15
ccsbBroad304_04567	OE	ZNF300	Zinc fingers, C2H2-type, zinc finger protein 300			0.00, 0.00	1.60, 0.59	-97.37	-31.83	-89.32	-39.89	33.20	-98.42	63.93	-68.78	37.81	-70.99
ccsbBroad304_01797	OE	ZNF32	Zinc fingers, C2H2-type, zinc finger protein 32			10.00, 10.00	1.02, 0.26	39.60	-99.93	-77.35	60.24	-57.04	32.10	98.12	-65.65	-70.87	-42.64
ccsbBroad304_08531	OE	ZNF331	Zinc fingers, C2H2-type, zinc finger protein 331			20.00, 10.00	1.09, 0.34	99.62	85.17	-54.59	-91.36	-23.31	57.23	-96.99	-90.21	95.05	-63.11
ccsbBroad304_05757	OE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain			0.00, 0.00	1.10, 0.30	47.27	-62.99	-63.54	-98.03	-99.92	-57.72	39.92	89.56	92.41	-76.46
ccsbBroad304_00017	OE	ACTN2	EF-hand domain containing, actinin, alpha 2			10.00, 10.00	0.98, 0.27	-53.31	-33.07	-35.05	16.36	-97.75	-89.02	99.94	39.36	-96.35	-57.32
ccsbBroad304_05773	OE	ADCY9	Adenylyl cyclases, adenylate cyclase 9			20.00, 20.00	1.34, 0.26	-38.29	-71.52	79.56	54.44	-53.32	97.75	-70.05	-33.76	99.69	63.05
ccsbBroad304_00038	OE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase			0.00, 0.00	1.03, 0.39	25.96	61.46	86.85	59.01	-85.16	20.80	86.87	-37.14	44.17	23.85
ccsbBroad304_07363	OE	AIFM1	apoptosis-inducing factor, mitochondrion-associated, 1			0.00, 0.00	0.95, 0.26	-99.41	-28.41	72.24	-100.00	21.12	-25.78	38.33	-92.69	-95.06	-98.24
ccsbBroad304_05560	OE	AMIGO3	Immunoglobulin superfamily / Immunoglobulin-like domain containing, adhesion molecule with Ig-like domain 3			0.00, 0.00	0.81, 0.16	13.72	-39.97	-68.09	-40.71	-62.71	-38.56	-57.02	-98.77	14.52	-7.49
ccsbBroad304_07217	OE	AXIN2	axin 2			10.00, 10.00	0.90, 0.28	-48.48	-36.41	-68.56	-85.55	-96.70	-99.73	-59.56	99.98	61.55	-93.12
ccsbBroad304_05882	OE	BCL6	BTB/POZ domain containing, B-cell CLL/lymphoma 6			10.00, 10.00	1.67, 0.39	60.40	48.88	-36.26	-84.08	54.85	34.83	-99.00	-33.24	99.50	23.33
ccsbBroad304_10487	OE	BPHL	biphenyl hydrolase-like (serine hydrolase)			0.00, 0.00	1.82, 0.43	-26.64	-70.20	88.34	58.46	57.26	-27.14	56.34	-70.51	36.86	54.17
ccsbBroad304_00174	OE	BRAF	RAF family, v-raf murine sarcoma viral oncogene homolog B1			0.00, 0.00	1.52, 0.45	77.96	-18.81	-99.96	90.52	80.05	-99.68	-40.68	-30.66	-99.40	-98.98
ccsbBroad304_07183	OE	BRPF1	Non-enzymatic BRD containing proteins, bromodomain and PHD finger containing, 1			10.00, 10.00	1.28, 0.33	-36.28	32.33	29.32	37.58	66.21	99.56	-35.57	-68.24	-86.64	16.75
ccsbBroad304_00180	OE	BTK	Pleckstrin homology (PH) domain containing, Bruton agammaglobulinemia tyrosine kinase			10.00, 0.00	1.18, 0.33	-78.26	-90.24	-98.88	97.49	-43.91	-30.57	20.02	-98.45	-81.34	-94.68
ccsbBroad304_09592	OE	CTCFL	Zinc fingers, C2H2-type, CCCTC-binding factor (zinc finger protein)-like			10.00, 10.00	0.78, 0.23	-21.24	36.40	-62.65	92.49	-97.36	-99.47	99.68	-62.69	53.05	-35.16
ccsbBroad304_00390	OE	CTGF	connective tissue growth factor			0.00, 0.00	1.15, 0.24	42.95	-53.42	55.67	30.99	84.31	29.14	59.84	94.92	35.41	41.23
ccsbBroad304_06095	OE	DFFB	DNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase)			0.00, 0.00	1.01, 0.25	49.69	-99.65	-74.84	-77.94	-32.98	-35.27	37.45	-36.32	-99.96	-60.25
ccsbBroad304_03155	OE	DHH	desert hedgehog			0.00, 0.00	1.30, 0.34	78.43	47.31	-99.80	-8.87	-53.99	92.78	-83.87	-32.07	78.93	62.03
ccsbBroad304_00454	OE	DNMT3A	Methyltransferases, DNA (cytosine-5-)-methyltransferase 3 alpha			10.00, 10.00	1.34, 0.40	-84.80	-76.30	-69.31	-43.26	67.67	78.59	70.85	43.39	98.99	66.17
ccsbBroad304_13848	OE	EGFR	Type I RTKs: ErbB (epidermal growth factor) receptor family, epidermal growth factor receptor			10.00, 10.00	0.59, 0.16	12.44	64.42	-65.11	-41.59	99.60	43.69	-37.84	-92.23	65.08	15.10
ccsbBroad304_03604	OE	ENOSF1	enolase superfamily member 1			0.00, 0.00	1.24, 0.34	37.71	-40.41	82.79	20.48	-67.95	44.31	-25.78	-99.94	27.04	3.53
ccsbBroad304_06168	OE	EPHA3	Type XIII RTKs: Ephrin receptor family, EPH receptor A3			0.00, 0.00	0.74, 0.24	89.05	30.39	55.64	-39.86	-47.49	-32.83	-38.49	-33.83	88.93	12.86
ccsbBroad304_07798	OE	EXOC3	exocyst complex component 3			10.00, 10.00	1.03, 0.30	99.56	28.77	-20.21	-94.31	-62.16	-39.14	-97.63	-74.23	-84.91	-85.45
ccsbBroad304_00554	OE	FGB	Endogenous ligands, fibrinogen beta chain			0.00, 0.00	0.75, 0.27	94.92	52.43	82.11	92.91	-64.45	-43.99	-63.90	-55.00	-46.09	61.11
ccsbBroad304_06211	OE	FGFR2	Type V RTKs: FGF (fibroblast growth factor) receptor family, fibroblast growth factor receptor 2			20.00, 10.00	1.00, 0.25	76.35	99.19	46.85	95.18	-85.88	-87.56	80.08	-67.67	70.40	85.83
ccsbBroad304_00597	OE	FUT1	Fucosyltransferases, fucosyltransferase 1 (galactoside 2-alpha-L-fucosyltransferase, H blood group)			0.00, 0.00	1.18, 0.36	-44.30	-28.73	-36.52	89.82	34.83	-29.76	-26.00	47.18	-24.11	-1.25
ccsbBroad304_01054	OE	GADD45B	growth arrest and DNA-damage-inducible, beta			10.00, 0.00	4.74, 1.25	-68.68	-89.24	-99.98	89.85	-59.73	95.81	-91.23	-27.42	-99.93	-99.13
ccsbBroad304_00617	OE	GBA	glucosidase, beta, acid			0.00, 0.00	1.33, 0.43	-56.39	-82.00	82.92	52.46	84.16	-99.79	-37.86	-88.50	39.11	-76.26
ccsbBroad304_08014	OE	GBGT1	Glycosyltransferase family 6 domain containing, globoside alpha-1,3-N-acetylgalactosaminyltransferase 1			0.00, 0.00	1.01, 0.31	-93.55	-56.46	91.68	51.42	-81.14	90.40	52.74	80.37	38.00	71.88
ccsbBroad304_06304	OE	GPC1	Proteoglycans / Cell Surface : Glypicans, glypican 1			0.00, 0.00	1.22, 0.33	94.41	-58.44	-33.90	45.47	-54.87	-42.88	-29.12	37.30	80.18	-25.41
ccsbBroad304_03847	OE	GPR107	GPCR / Unclassified : 7TM orphan receptors, G protein-coupled receptor 107			10.00, 10.00	1.81, 0.58	-89.57	-74.59	-52.53	-60.46	-38.52	-48.33	-58.92	45.66	97.73	-46.32
ccsbBroad304_06317	OE	GPR26	GPCR / Class A : Orphans, G protein-coupled receptor 26			0.00, 0.00	1.17, 0.40	63.54	-66.69	58.02	-29.07	-33.54	-78.27	32.45	91.03	94.45	50.72
ccsbBroad304_00670	OE	GPR4	GPCR / Class A : Orphans, G protein-coupled receptor 4			0.00, 0.00	0.80, 0.28	-87.31	-21.29	-50.60	61.94	-41.91	-84.73	-26.04	-39.38	47.73	-14.56
ccsbBroad304_03072	OE	GTPBP8	GTP-binding protein 8 (putative)			10.00, 10.00	0.47, 0.10	98.77	76.65	45.60	-99.16	-55.23	54.04	-24.49	-98.50	58.82	30.24
ccsbBroad304_06394	OE	HOXC9	Homeoboxes / ANTP class : HOXL subclass, homeobox C9		Homeobox Gene GOF	0.00, 0.00	2.98, 0.63	-99.82	-97.78	-85.67	-36.96	-93.47	-68.42	79.98	-99.62	90.07	-99.03
ccsbBroad304_00840	OE	IGFBP7	insulin-like growth factor (IGF) binding proteins, insulin-like growth factor binding protein 7			10.00, 10.00	1.08, 0.43	22.41	-46.34	-32.56	99.26	-62.88	22.04	-84.64	-37.02	-31.45	-7.02
ccsbBroad304_06433	OE	IGHMBP2	Zinc fingers, AN1-type domain containing, immunoglobulin mu binding protein 2			0.00, 0.00	1.53, 0.44	-90.52	35.52	-96.16	34.52	27.13	53.25	-96.72	31.69	36.91	10.15
ccsbBroad304_00841	OE	IKBKB	IKK family, inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta			0.00, 0.00	1.00, 0.33	-41.22	-63.90	-34.24	-73.63	33.28	47.15	-42.11	-99.82	72.25	-35.38
ccsbBroad304_00846	OE	IL2	Interleukins and interleukin receptors, interleukin 2			0.00, 0.00	1.17, 0.33	-17.70	-37.18	-25.85	-39.07	76.34	-69.99	46.64	-58.66	41.25	-12.19
ccsbBroad304_00849	OE	IL4	Interleukins and interleukin receptors, interleukin 4			0.00, 0.00	1.25, 0.30	-95.65	-99.96	67.17	-52.25	37.19	-91.01	76.07	-27.91	45.07	-87.78
ccsbBroad304_06451	OE	IMPDH1	Oxidoreductases, IMP (inosine 5'-monophosphate) dehydrogenase 1			0.00, 0.00	1.26, 0.36	15.24	81.07	-73.99	-92.12	-95.61	32.89	79.67	-97.29	-26.48	-73.30
ccsbBroad304_06481	OE	KCNJ11	Inwardly rectifying potassium channels, potassium inwardly-rectifying channel, subfamily J, member 11			0.00, 0.00	1.56, 0.44	43.15	40.32	65.54	29.83	-89.75	-52.07	36.44	39.20	26.48	18.03
ccsbBroad304_03788	OE	LPAR5	GPCR / Class A : Lysophospholipid receptors : Lysophosphatidic acid, lysophosphatidic acid receptor 5			0.00, 0.00	1.09, 0.42	50.62	25.34	-31.81	-37.72	94.44	-42.21	-56.98	32.14	-99.88	-10.24
ccsbBroad304_04379	OE	LZIC	leucine zipper and CTNNBIP1 domain containing			0.00, 0.00	1.17, 0.39	-44.43	-43.48	-54.52	74.76	72.72	-22.31	-81.62	-78.70	-99.31	-51.01
ccsbBroad304_01038	OE	MSRA	methionine sulfoxide reductase A			0.00, 0.00	1.14, 0.38	-16.95	-51.56	-74.14	-43.77	-58.25	-98.34	-80.90	-37.27	-62.80	-63.59
ccsbBroad304_02496	OE	MTX2	metaxin 2			20.00, 10.00	1.01, 0.23	-23.92	-43.09	71.60	-99.78	-38.40	98.16	96.27	-82.49	-94.70	-24.97
ccsbBroad304_01052	OE	MYB	v-myb myeloblastosis viral oncogene homolog (avian)			0.00, 0.00	1.52, 0.49	-99.01	-99.87	-98.30	-79.73	41.41	33.69	53.28	-69.61	-61.31	-93.77
ccsbBroad304_10994	OE	NEK2	NIMA (never in mitosis gene a)- related kinase (NEK) family, NIMA (never in mitosis gene a)-related kinase 2			0.00, 0.00	1.14, 0.36	77.51	-58.32	-34.45	-31.49	92.20	92.33	78.13	-32.30	49.00	76.87
ccsbBroad304_06637	OE	NFKB1	NFkappaB transcription factor family, nuclear factor of kappa light polypeptide gene enhancer in B-cells 1			20.00, 20.00	0.86, 0.25	99.84	31.54	-34.65	-61.64	73.92	-73.69	99.98	-72.80	-75.63	-49.55
ccsbBroad304_01102	OE	NMT1	N-myristoyltransferase 1			10.00, 0.00	1.26, 0.39	-24.46	-95.25	55.40	53.03	34.33	-37.92	95.70	-99.12	-75.17	-60.02
ccsbBroad304_08045	OE	NOX1	NADPH oxidase 1			0.00, 0.00	1.35, 0.45	65.10	-43.26	61.31	54.79	81.39	-40.58	88.48	-29.01	26.78	57.75
ccsbBroad304_05133	OE	OXER1	GPCR / Class A : Leukotriene receptors, oxoeicosanoid (OXE) receptor 1			0.00, 0.00	1.56, 0.35	-95.85	-34.71	-98.55	-82.51	-46.62	-99.47	-69.87	-26.96	65.10	-99.68
ccsbBroad304_01141	OE	PAFAH1B1	WD repeat domain containing, platelet-activating factor acetylhydrolase 1b, regulatory subunit 1 (45kDa)			20.00, 10.00	1.07, 0.33	-14.95	98.12	33.07	-48.08	-63.29	24.26	-76.79	96.75	-76.99	-27.46
ccsbBroad304_02605	OE	PAPD7	PAP associated domain containing 7			0.00, 0.00	0.84, 0.31	-91.14	39.64	-14.90	-56.06	-50.36	-32.72	75.70	48.51	-32.30	-3.06
ccsbBroad304_01184	OE	PGK1	phosphoglycerate kinase 1			0.00, 0.00	0.84, 0.15	39.42	-99.89	24.48	-41.38	-91.04	-57.55	25.41	-39.31	33.21	-6.63
ccsbBroad304_01204	OE	PIK3CD	Phosphatidylinositol kinases, phosphoinositide-3-kinase, catalytic, delta polypeptide			0.00, 0.00	1.22, 0.38	-40.06	36.99	-74.31	94.97	-43.47	46.51	37.92	30.10	36.69	15.06
ccsbBroad304_07859	OE	PLCB1	Phosphoinositide-specific phospholipase C, phospholipase C, beta 1 (phosphoinositide-specific)		Phospholipases GOF	10.00, 10.00	0.93, 0.27	99.81	50.85	-65.35	-99.72	31.54	30.47	27.40	51.54	36.40	10.50
ccsbBroad304_01222	OE	PLP2	proteolipid protein 2 (colonic epithelium-enriched)			0.00, 0.00	1.20, 0.36	93.81	-86.20	-44.43	-46.63	-30.72	-52.93	-61.08	41.19	-25.78	-20.86
ccsbBroad304_08480	OE	PNPO	pyridoxamine 5'-phosphate oxidase			0.00, 0.00	0.99, 0.38	-77.16	-39.43	-27.07	-33.43	-22.42	25.59	45.02	36.82	-41.36	-8.76
ccsbBroad304_01234	OE	POLB	DNA polymerases, polymerase (DNA directed), beta			0.00, 0.00	0.85, 0.15	-54.53	33.47	-77.86	-99.98	-51.07	55.21	92.39	-22.20	77.04	-33.54
ccsbBroad304_06760	OE	PPP2R3A	EF-hand domain containing, protein phosphatase 2, regulatory subunit B'', alpha			10.00, 10.00	0.91, 0.24	99.77	-42.02	34.11	42.20	-44.75	44.61	-99.94	-74.81	47.80	-18.64
ccsbBroad304_13929	OE	PRKACA	Protein kinase A, protein kinase, cAMP-dependent, catalytic, alpha			10.00, 10.00	0.99, 0.22	88.98	-46.11	-99.89	63.79	-28.87	-97.89	-85.86	33.88	99.95	-28.23
ccsbBroad304_07328	OE	PRPF4B	PRP4 subfamily, PRP4 pre-mRNA processing factor 4 homolog B (yeast)			10.00, 10.00	1.06, 0.38	99.84	-86.31	-56.89	55.99	-26.81	-33.91	28.23	-48.13	27.03	-17.02
ccsbBroad304_02845	OE	PRPF6	PRP6 pre-mRNA processing factor 6 homolog (S. cerevisiae)			0.00, 0.00	2.01, 0.55	42.74	57.81	85.56	-99.96	45.15	78.20	79.19	59.62	47.33	71.62
ccsbBroad304_01327	OE	PSPH	phosphoserine phosphatase			0.00, 0.00	0.94, 0.30	-89.89	-47.83	33.72	-40.89	34.94	56.64	93.74	38.88	51.76	22.99
ccsbBroad304_06814	OE	PTPN12	Protein tyrosine phosphatases / Class I Cys-based PTPs : Non-receptor, protein tyrosine phosphatase, non-receptor type 12			0.00, 0.00	1.22, 0.34	67.75	-73.84	-23.84	-62.75	41.25	56.57	-65.14	41.00	59.70	24.89
ccsbBroad304_09954	OE	PTRF	polymerase I and transcript release factor			30.00, 20.00	1.05, 0.26	-31.65	-63.21	42.70	97.30	99.98	85.87	99.03	55.00	-89.51	94.78
ccsbBroad304_01936	OE	RAE1	WD repeat domain containing, RAE1 RNA export 1 homolog (S. pombe)			0.00, 0.00	1.47, 0.47	-85.91	88.45	25.29	94.06	70.48	32.66	34.28	-27.83	50.26	70.71
ccsbBroad304_09420	OE	RASGRP4	EF-hand domain containing, RAS guanyl releasing protein 4			30.00, 20.00	1.68, 0.66	95.55	-35.38	-27.22	78.20	97.62	99.97	25.61	-22.94	-54.56	85.04
ccsbBroad304_09425	OE	RNF166	RING-type (C3HC4) zinc fingers, ring finger protein 166			0.00, 0.00	1.17, 0.34	-40.32	-80.63	-34.44	-46.52	-47.24	53.47	-76.64	-47.08	-43.55	-30.66
ccsbBroad304_08709	OE	SCYL3	SCY1-like 3 (S. cerevisiae)			0.00, 0.00	1.06, 0.36	-24.01	-53.51	35.53	-91.54	-82.08	56.29	-97.15	-43.65	-64.75	-82.35
ccsbBroad304_06928	OE	SDHB	Mitochondrial respiratory chain complex / Complex II, succinate dehydrogenase complex, subunit B, iron sulfur (Ip)			0.00, 0.00	0.64, 0.15	78.57	47.21	-99.49	48.57	-29.71	72.81	-92.74	51.39	-85.96	36.89
ccsbBroad304_01536	OE	SIM2	Basic helix-loop-helix proteins, single-minded homolog 2 (Drosophila)			10.00, 0.00	1.01, 0.25	-58.79	-35.43	96.78	-92.30	-40.78	35.08	39.55	-36.34	-99.89	-22.09
ccsbBroad304_02659	OE	SLC6A14	Glycine transporter subfamily, solute carrier family 6 (amino acid transporter), member 14			10.00, 10.00	1.42, 0.30	-27.73	44.64	-19.62	-61.55	71.32	-89.94	-99.25	-19.96	98.99	-30.05
ccsbBroad304_03961	OE	SMURF2	SMAD specific E3 ubiquitin protein ligase 2			10.00, 0.00	0.99, 0.36	-50.46	-95.08	77.36	42.70	52.98	-24.61	85.52	31.63	97.26	35.53
ccsbBroad304_07820	OE	SNW1	SNW domain containing 1			10.00, 10.00	1.42, 0.31	-10.23	-39.60	-43.24	-35.65	97.80	-25.79	22.63	-38.12	73.49	-2.44
ccsbBroad304_05192	OE	SPRED2	sprouty-related, EVH1 domain containing 2			10.00, 0.00	0.84, 0.23	-32.17	35.64	47.39	-92.87	25.88	-60.10	-67.79	-72.48	95.47	-36.07
ccsbBroad304_01593	OE	SRP14	signal recognition particle 14kDa (homologous Alu RNA binding protein)			0.00, 0.00	1.81, 0.55	-58.80	-91.29	42.59	35.56	-81.86	72.48	-27.74	-74.34	-99.25	-78.62
ccsbBroad304_02784	OE	SUZ12	Zinc fingers, C2H2-type, suppressor of zeste 12 homolog (Drosophila)			0.00, 0.00	1.02, 0.28	42.91	-95.65	-38.14	-98.10	33.59	-87.56	43.28	93.28	-27.37	-66.20
ccsbBroad304_07064	OE	TH	Amino acid hydroxylases, tyrosine hydroxylase			10.00, 10.00	0.80, 0.22	-70.02	-73.02	-39.78	-45.13	-49.06	22.35	-30.12	88.10	98.64	-9.35
ccsbBroad304_00256	OE	TNFSF8	CD molecules, tumor necrosis factor (ligand) superfamily, member 8			0.00, 0.00	1.13, 0.31	84.26	65.61	-39.80	-44.19	-54.67	-98.52	61.74	70.37	30.91	56.66
ccsbBroad304_01732	OE	UBA52	L ribosomal proteins, ubiquitin A-52 residue ribosomal protein fusion product 1			10.00, 0.00	1.15, 0.35	-20.64	-99.93	-25.88	95.55	-62.25	-36.65	-80.54	-85.12	-91.56	-89.79
ccsbBroad304_06309	OE	UTS2R	Urotensin receptor, urotensin 2 receptor			10.00, 10.00	0.80, 0.17	-99.98	-80.52	97.76	48.00	-43.08	-96.73	-88.36	-35.62	38.15	-90.06
ccsbBroad304_07131	OE	VRK1	Vaccina related kinase (VRK) family, vaccinia related kinase 1			0.00, 0.00	1.73, 0.44	-91.19	-55.71	25.01	-27.58	-55.04	-43.22	35.31	-51.50	65.40	-37.90
ccsbBroad304_03479	OE	YTHDF1	YTH domain family, member 1			10.00, 0.00	1.24, 0.39	-99.94	-55.93	-37.76	52.12	94.00	43.25	35.08	96.91	-36.48	42.26
ccsbBroad304_12885	OE	ZFYVE19	Zinc fingers, FYVE domain containing, zinc finger, FYVE domain containing 19			0.00, 0.00	1.49, 0.52	-27.88	54.11	-86.00	52.08	40.19	-98.54	-65.43	-32.90	-73.27	-63.98
ccsbBroad304_07678	OE	ZNF266	Zinc fingers, C2H2-type, zinc finger protein 266			40.00, 40.00	1.59, 0.41	-24.45	98.90	56.56	86.24	78.79	99.97	98.63	-31.53	69.57	99.07
ccsbBroad304_08971	OE	ZNF669	Zinc fingers, C2H2-type, zinc finger protein 669			10.00, 10.00	1.51, 0.44	-41.38	28.11	33.24	-99.82	-30.27	50.86	-76.91	98.26	-46.15	-13.84
ccsbBroad304_03950	OE	ATG3	ATG3 autophagy related 3 homolog (S. cerevisiae)			0.00, 0.00	0.80, 0.30	59.64	-36.25	-8.85	-94.00	-39.43	67.38	-88.78	-32.53	56.28	-8.23
ccsbBroad304_00183	OE	C1S	Complement system, complement component 1, s subcomponent			0.00, 0.00	1.48, 0.48	75.17	82.41	81.86	-95.66	37.81	-52.31	28.59	64.88	-94.23	47.79
ccsbBroad304_08879	OE	CASD1	CAS1 domain containing 1			0.00, 0.00	2.53, 0.85	-90.75	-99.28	-72.26	34.20	-47.18	56.05	-50.72	-24.73	-40.27	-58.81
ccsbBroad304_00238	OE	CCNE1	cyclin E1			10.00, 10.00	0.93, 0.28	98.73	61.02	-28.21	-26.38	-99.55	-59.37	-37.88	41.45	-31.87	-11.87
ccsbBroad304_10489	OE	CSF3	Endogenous ligands, colony stimulating factor 3 (granulocyte)			20.00, 0.00	1.72, 0.56	-86.78	32.83	97.17	32.07	56.24	-43.52	-61.74	-99.81	96.76	59.79
ccsbBroad304_06058	OE	CSNK2B	Casein kinase 2 (CK2) family, casein kinase 2, beta polypeptide			10.00, 0.00	1.48, 0.49	-97.37	-17.96	-28.39	-98.86	-33.43	38.90	44.87	-64.66	96.41	-27.27
ccsbBroad304_09177	OE	EFCAB2	EF-hand domain containing, EF-hand calcium binding domain 2			0.00, 0.00	1.08, 0.35	-86.40	-92.96	-44.97	43.78	-52.06	22.01	57.00	-36.27	-50.32	-33.15
ccsbBroad304_00551	OE	FECH	ferrochelatase			10.00, 10.00	1.05, 0.18	-57.75	98.95	27.83	-99.74	-94.42	33.86	-47.42	-89.90	37.21	-69.61
ccsbBroad304_00564	OE	FGR	Src family, Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog			10.00, 10.00	1.53, 0.38	-32.03	-78.96	-76.88	48.81	-71.90	-24.47	36.29	-94.92	99.66	-80.09
ccsbBroad304_06683	OE	FURIN	Subtilisin, furin (paired basic amino acid cleaving enzyme)			20.00, 10.00	1.27, 0.39	-98.75	-79.34	81.97	97.10	57.46	-54.71	-47.08	-45.70	99.85	72.06
ccsbBroad304_10846	OE	GGT1	CD molecules, gamma-glutamyltransferase 1			0.00, 0.00	0.81, 0.34	-88.66	61.53	-23.41	73.48	38.67	-40.46	-64.25	65.30	-92.40	-23.80
ccsbBroad304_02981	OE	GPR160	GPCR / Class A : Orphans, G protein-coupled receptor 160			10.00, 10.00	0.97, 0.20	-45.68	27.87	-63.61	49.05	-26.53	42.07	98.10	52.82	90.42	24.16
ccsbBroad304_00707	OE	GTF2E2	General transcription factors, general transcription factor IIE, polypeptide 2, beta 34kDa			0.00, 0.00	0.78, 0.20	-21.77	35.98	18.64	50.44	-25.38	-83.38	56.49	52.08	-78.00	4.91
ccsbBroad304_03005	OE	HCAR1	GPCR / Class A : Hydroxy-carboxylic acid receptors, hydroxycarboxylic acid receptor 1			0.00, 0.00	1.31, 0.39	31.81	-99.89	-37.94	-42.50	-96.76	-98.38	-81.50	-91.17	-98.62	-99.10
ccsbBroad304_06401	OE	HRH1	Histamine receptors, histamine receptor H1			10.00, 10.00	0.80, 0.22	-54.90	-64.93	91.92	-97.04	-69.88	-57.12	99.05	48.04	29.22	-61.36
ccsbBroad304_06420	OE	ICAM3	CD molecules, intercellular adhesion molecule 3			10.00, 10.00	0.93, 0.20	67.94	99.85	-95.23	92.40	-33.82	-25.88	-65.23	-51.05	67.38	65.08
ccsbBroad304_00851	OE	IL6R	IL-6 receptor family, interleukin 6 receptor			0.00, 0.00	1.15, 0.35	-73.41	-64.42	72.13	47.24	-99.88	28.20	-71.90	-37.83	-23.10	-58.34
ccsbBroad304_06453	OE	ING2	Zinc fingers, PHD-type, inhibitor of growth family, member 2			0.00, 0.00	0.97, 0.33	-78.94	-68.47	-86.31	-34.01	37.59	64.18	-69.55	-70.31	-58.83	-67.18
ccsbBroad304_10929	OE	JAK2	Janus kinase (JakA) family, Janus kinase 2			0.00, 0.00	1.07, 0.31	77.45	-45.20	59.63	64.49	60.97	-62.15	-35.59	78.75	-29.28	57.32
ccsbBroad304_07727	OE	LIAS	lipoic acid synthetase			10.00, 10.00	1.02, 0.32	75.53	70.45	-40.93	-95.39	39.27	25.28	99.90	-36.82	-78.97	22.17
ccsbBroad304_07381	OE	MAPKAPK2	MAPKAPK subfamily, mitogen-activated protein kinase-activated protein kinase 2			0.00, 0.00	0.70, 0.16	-70.40	-74.89	-79.52	-69.48	84.25	57.66	70.73	42.63	54.00	-36.06
ccsbBroad304_01065	OE	NDUFA3	Mitochondrial respiratory chain complex / Complex I, NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 3, 9kDa			10.00, 0.00	1.11, 0.34	96.69	-35.05	-27.19	41.25	44.58	63.21	-91.73	-82.69	-36.04	-11.27
ccsbBroad304_05309	OE	OR52B2	GPCR / Class A : Olfactory receptors, olfactory receptor, family 52, subfamily B, member 2			0.00, 0.00	1.56, 0.44	-34.81	-84.59	-21.80	-84.84	-75.54	-29.90	-83.50	-72.35	-89.86	-82.12
ccsbBroad304_01216	OE	PLD1	Phosphatidylcholine-specific phospholipase D, phospholipase D1, phosphatidylcholine-specific		Phospholipases GOF	10.00, 0.00	0.89, 0.35	96.08	-42.77	-56.73	77.67	-54.06	-59.52	39.47	-45.26	-91.43	-14.13
ccsbBroad304_06739	OE	PLOD1	procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1			20.00, 20.00	1.68, 0.39	-12.89	41.69	63.62	-87.36	56.05	60.53	97.82	-27.37	99.40	57.48
ccsbBroad304_01332	OE	PTGER4	GPCR / Class A : Prostanoid receptors, prostaglandin E receptor 4 (subtype EP4)			10.00, 10.00	1.44, 0.51	78.37	23.50	45.32	25.70	75.21	-78.55	-99.84	34.06	99.78	29.22
ccsbBroad304_04261	OE	RAB1B	RAB, member RAS oncogene, RAB1B, member RAS oncogene family			0.00, 0.00	0.97, 0.25	88.36	-11.44	19.73	-54.62	-46.71	-31.36	-46.65	-27.85	-92.34	-11.55
ccsbBroad304_01425	OE	RPL22	L ribosomal proteins, ribosomal protein L22			10.00, 10.00	0.86, 0.27	62.40	32.25	99.47	82.75	39.78	90.15	69.83	-53.72	-51.67	78.76
ccsbBroad304_07322	OE	SGPL1	Sphingosine 1-phosphate lyase, sphingosine-1-phosphate lyase 1			20.00, 20.00	0.89, 0.23	99.84	-28.29	-19.71	-52.49	73.51	66.26	-49.53	99.71	42.08	56.17
ccsbBroad304_08805	OE	SLC22A23	Orphan or poorly characterized SLC22 family members, solute carrier family 22, member 23			11.11, 0.00	1.36, 0.43	-78.64	-28.63	95.40	NaN	85.14	-35.99	44.03	-50.56	-62.48	-33.74
ccsbBroad304_00964	OE	SMAD7	SMADs, SMAD family member 7			40.00, 40.00	1.58, 0.39	92.63	99.39	-61.99	55.96	94.09	99.85	50.25	97.67	90.73	99.91
ccsbBroad304_08424	OE	SNRK	SNRK subfamily, SNF related kinase			40.00, 40.00	0.82, 0.23	-14.07	99.85	99.69	-88.27	74.38	99.78	-37.27	40.51	-72.12	98.33
ccsbBroad304_07017	OE	SUOX	sulfite oxidase			10.00, 10.00	1.98, 0.63	45.44	-32.61	-30.93	92.55	-48.92	82.47	99.98	-50.20	-98.95	65.17
ccsbBroad304_07531	OE	TANK	TRAF family member-associated NFKB activator			10.00, 10.00	1.76, 0.49	-20.74	-99.30	11.14	69.64	-78.48	-98.17	99.02	-40.15	-99.97	-97.18
ccsbBroad304_03264	OE	UBAP1	ubiquitin associated protein 1			10.00, 0.00	1.31, 0.42	55.27	-34.49	41.08	96.93	-59.18	53.65	-93.45	54.53	50.01	34.25
ccsbBroad304_08394	OE	UGT1A6	UDP glucuronosyltransferases, UDP glucuronosyltransferase 1 family, polypeptide A6			0.00, 0.00	1.00, 0.31	-50.37	-30.16	-94.87	-99.80	-61.48	-34.06	40.56	-44.39	39.29	-41.43
ccsbBroad304_07135	OE	WNT10B	Wingless-type MMTV integration sites, wingless-type MMTV integration site family, member 10B		Wnt family GOF	10.00, 10.00	1.19, 0.32	42.88	99.47	66.47	41.04	27.35	-62.06	-37.68	75.87	46.77	40.32
ccsbBroad304_03623	OE	ZNF692	Zinc fingers, C2H2-type, zinc finger protein 692			0.00, 0.00	1.13, 0.28	52.86	-99.32	-44.00	-97.38	-42.62	-35.96	-48.18	-65.10	-41.46	-42.48
ccsbBroad304_05390	OE	DUSP28	Protein tyrosine phosphatases / Class I Cys-based PTPs : Atypical dual specificity phosphatases, dual specificity phosphatase 28			0.00, 0.00	1.05, 0.25	-99.15	-65.41	-64.38	42.98	-97.99	32.90	69.07	-99.38	-78.63	-98.94
ccsbBroad304_00784	OE	HRAS	RAS subfamily, v-Ha-ras Harvey rat sarcoma viral oncogene homolog			10.00, 10.00	2.17, 0.70	-96.44	35.30	-25.77	60.25	-31.91	78.70	-71.85	86.88	99.25	53.10
ccsbBroad304_14047	OE	TACC3	transforming, acidic coiled-coil containing protein 3			10.00, 10.00	1.00, 0.40	-84.05	93.11	99.95	-55.60	-38.14	-49.95	-49.71	72.89	-95.36	-31.74
ccsbBroad304_02140	OE	ZNHIT3	Zinc fingers, HIT-type, zinc finger, HIT-type containing 3			0.00, 0.00	1.11, 0.31	36.74	28.74	-96.33	-33.84	-26.74	-46.23	42.94	-67.16	-35.36	-14.25
ccsbBroad304_00269	OE	CD97	Adhesion Class GPCRs, CD97 molecule			10.00, 10.00	1.24, 0.38	21.51	99.26	-69.79	-74.72	-37.61	-32.43	-53.24	50.63	76.28	14.37
ccsbBroad304_00772	OE	HOXA6	Homeoboxes / ANTP class : HOXL subclass, homeobox A6		Homeobox Gene GOF	0.00, 0.00	1.35, 0.38	-90.91	-59.59	-56.12	70.73	-94.07	-43.76	-21.94	-99.84	-99.77	-97.25
ccsbBroad304_02432	OE	IFI30	interferon, gamma-inducible protein 30			0.00, 0.00	1.09, 0.33	-19.83	-77.95	-51.82	37.42	30.13	-29.67	-46.83	-26.36	85.04	-7.59
ccsbBroad304_06663	OE	OAS1	2'-5'-oligoadenylate synthetase 1, 40/46kDa			0.00, 0.00	1.43, 0.36	-21.13	-59.30	-9.37	-23.99	-47.24	33.07	-29.79	-36.14	-34.43	-4.58
ccsbBroad304_06671	OE	OPA1	optic atrophy 1 (autosomal dominant)			10.00, 0.00	0.94, 0.30	-68.37	-83.10	53.90	97.20	-57.73	-26.76	68.34	61.29	27.83	17.99
ccsbBroad304_06679	OE	OXTR	GPCR / Class A : Vasopressin and oxytocin receptors, oxytocin receptor			0.00, 0.00	1.16, 0.41	72.79	27.43	-64.14	-20.20	-78.47	-47.93	-99.29	-85.83	65.45	-66.48
ccsbBroad304_01658	OE	PRDX2	peroxiredoxin 2			20.00, 10.00	1.25, 0.36	-34.96	97.85	68.52	45.15	-55.25	34.18	35.97	96.52	-91.46	27.61
ccsbBroad304_01388	OE	RELB	NFkappaB transcription factor family, v-rel reticuloendotheliosis viral oncogene homolog B			10.00, 0.00	3.91, 1.07	-97.02	97.20	-88.50	23.66	-31.57	-90.08	-49.45	-97.32	-98.24	-97.50
ccsbBroad304_02002	OE	RNMT	RNA (guanine-7-) methyltransferase			0.00, 0.00	1.36, 0.45	16.42	35.68	49.40	52.56	45.16	64.36	-95.97	-97.60	-87.98	13.58
ccsbBroad304_02487	OE	TXNIP	thioredoxin interacting protein			10.00, 10.00	1.16, 0.34	37.73	97.55	-91.98	-79.20	-37.08	-99.88	85.02	73.54	-51.36	45.05
ccsbBroad304_05749	OE	A2M	alpha-2-macroglobulin			10.00, 10.00	1.25, 0.33	-93.88	-39.72	-51.54	-58.29	98.07	-46.26	84.75	75.15	-57.51	-13.19
ccsbBroad304_01998	OE	ABCC3	ATP binding cassette transporters / subfamily C, ATP-binding cassette, sub-family C (CFTR/MRP), member 3			10.00, 10.00	1.08, 0.34	99.75	-53.91	-18.83	-33.75	29.85	-36.53	-37.83	-81.89	-41.96	-11.50
ccsbBroad304_09758	OE	APOBEC3H	Apolipoprotein B mRNA editing enzymes, apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3H			0.00, 0.00	0.83, 0.22	-68.52	-54.13	-23.72	61.81	-27.78	27.61	-31.17	-49.88	-80.82	-23.18
ccsbBroad304_02311	OE	ARPC3	Actin related protein 2/3 complex subunits, actin related protein 2/3 complex, subunit 3, 21kDa			0.00, 0.00	0.83, 0.24	34.29	-63.17	-65.34	35.19	30.86	-32.07	-67.98	-31.98	-39.85	-15.86
ccsbBroad304_02045	OE	BUD31	BUD31 homolog (S. cerevisiae)			0.00, 0.00	1.26, 0.35	-89.76	-99.87	-56.31	-36.46	-68.32	43.75	39.85	43.71	-99.86	-97.99
ccsbBroad304_08461	OE	CDCA4	cell division cycle associated 4			0.00, 0.00	1.11, 0.27	-94.26	-99.47	-73.19	-44.83	-99.73	-99.97	-85.55	-99.95	88.74	-99.91
ccsbBroad304_06048	OE	CRYZ	crystallin, zeta (quinone reductase)			0.00, 0.00	1.06, 0.25	-36.83	-48.31	-63.40	-99.31	41.79	88.75	49.29	29.95	-47.95	-25.87
ccsbBroad304_06057	OE	CSNK1G3	Casein kinase 1 (CK1) family, casein kinase 1, gamma 3			0.00, 0.00	0.99, 0.27	-99.96	-29.80	-32.02	-90.11	-94.15	47.23	39.78	66.21	-70.78	-83.84
ccsbBroad304_02759	OE	DICER1	dicer 1, ribonuclease type III			30.00, 20.00	1.07, 0.20	86.82	-92.12	98.07	97.27	91.34	34.63	48.03	67.58	-36.48	98.49
ccsbBroad304_00464	OE	DTNA	dystrobrevin, alpha			10.00, 10.00	1.41, 0.40	89.99	-81.02	34.05	-38.57	97.75	40.67	60.39	-63.35	-64.37	19.71
ccsbBroad304_00488	OE	EGR3	Zinc fingers, C2H2-type, early growth response 3			0.00, 0.00	1.42, 0.34	20.68	-39.25	43.73	-35.88	90.47	-29.63	32.72	-80.35	40.52	-5.93
ccsbBroad304_01292	OE	EIF2AK2	Other PEK family kinases, eukaryotic translation initiation factor 2-alpha kinase 2			0.00, 0.00	1.33, 0.51	-62.87	-84.98	-27.55	-93.29	-92.23	-50.78	44.50	-44.81	43.99	-76.55
ccsbBroad304_05420	OE	EIF4E3	Translation Initiation Factor 4E, eukaryotic translation initiation factor 4E family member 3			0.00, 0.00	1.24, 0.42	57.83	37.74	-52.84	85.66	67.64	91.43	55.76	-64.25	-83.78	81.39
ccsbBroad304_04194	OE	ELL3	elongation factor RNA polymerase II-like 3			0.00, 0.00	0.90, 0.25	33.18	32.37	93.95	-90.63	-22.47	88.10	40.94	-34.87	45.52	8.77
ccsbBroad304_04038	OE	ELOVL6	ELOVL fatty acid elongase 6			0.00, 0.00	0.90, 0.23	-70.53	32.68	-51.02	-53.83	-49.64	-92.16	-67.35	37.96	41.02	-55.97
ccsbBroad304_00512	OE	EPO	Endogenous ligands, erythropoietin			0.00, 0.00	1.44, 0.49	20.62	29.49	25.46	-31.06	53.41	-21.37	-41.62	-76.74	66.10	3.41
ccsbBroad304_00519	OE	ETFB	electron-transfer-flavoprotein, beta polypeptide			0.00, 0.00	0.86, 0.27	27.57	30.70	-83.55	39.17	-40.59	-47.49	71.24	-82.82	59.02	13.78
ccsbBroad304_00549	OE	FDX1	ferredoxin 1			0.00, 0.00	1.07, 0.35	-58.96	-43.53	-69.03	45.27	45.14	-41.60	-40.09	-99.66	-99.96	-53.30
ccsbBroad304_03659	OE	FOXJ2	Forkhead boxes, forkhead box J2			0.00, 0.00	1.22, 0.18	26.30	-62.16	-26.50	-59.14	40.64	-40.60	-44.32	-69.69	-52.73	-25.93
ccsbBroad304_02843	OE	FTSJ1	FtsJ homolog 1 (E. coli)			10.00, 10.00	0.75, 0.15	-27.77	-99.19	-5.91	-91.12	50.09	98.17	69.87	36.55	-72.32	-13.50
ccsbBroad304_00614	OE	GAMT	guanidinoacetate N-methyltransferase			0.00, 0.00	1.26, 0.30	19.08	-40.43	-10.33	-43.12	-53.43	80.28	24.45	60.04	-46.01	5.54
ccsbBroad304_06282	OE	GLDC	glycine dehydrogenase (decarboxylating)			0.00, 0.00	1.66, 0.32	-30.27	-88.95	42.44	-37.89	-21.63	38.09	94.95	84.38	-27.89	9.32
ccsbBroad304_00651	OE	GNAI3	guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 3			0.00, 0.00	1.56, 0.47	-88.11	-28.09	67.30	-99.91	85.91	51.82	-42.12	-97.76	75.77	-78.15
ccsbBroad304_10047	OE	GPR148	GPCR / Class A : Orphans, G protein-coupled receptor 148			0.00, 0.00	0.94, 0.26	15.45	-36.46	20.59	39.91	-35.91	-92.78	-36.23	-36.42	-65.62	-14.85
ccsbBroad304_06329	OE	GRPR	GPCR / Class A : Bombesin receptors, gastrin-releasing peptide receptor			0.00, 0.00	1.47, 0.41	-54.06	36.91	-45.17	55.90	56.08	31.40	94.84	-41.64	77.71	39.30
ccsbBroad304_02218	OE	IKBKE	IKK family, inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon			0.00, 0.00	1.63, 0.44	-56.30	-91.28	36.73	-41.16	-50.44	-29.87	-62.12	-31.18	-95.80	-69.70
ccsbBroad304_00859	OE	IL12A	Interleukins and interleukin receptors, interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35)		Interleukins GOF	50.00, 40.00	0.99, 0.25	39.47	-90.97	99.78	96.85	-28.03	99.93	74.67	98.95	33.41	99.91
ccsbBroad304_03147	OE	IL20	Interleukins and interleukin receptors, interleukin 20			0.00, 0.00	1.09, 0.34	-37.34	69.68	87.56	-93.74	-39.24	27.24	62.76	59.71	-73.40	23.95
ccsbBroad304_06521	OE	LGALS3	Endogenous ligands, lectin, galactoside-binding, soluble, 3			20.00, 20.00	0.94, 0.32	26.00	99.82	33.73	-88.37	-30.18	77.35	99.98	-94.44	-93.58	53.07
ccsbBroad304_03761	OE	LHX9	Homeoboxes / LIM class, LIM homeobox 9		LIM class homeoboxes GOF	0.00, 0.00	0.92, 0.31	39.51	37.86	37.74	-38.86	35.59	-76.38	40.13	-99.61	-51.37	-6.35
ccsbBroad304_06523	OE	LIG1	ligase I, DNA, ATP-dependent			0.00, 0.00	1.88, 0.57	28.84	94.27	-66.35	58.56	-99.93	-36.92	-59.37	-99.95	-97.78	-97.56
ccsbBroad304_00949	OE	LRPAP1	low density lipoprotein receptor-related protein associated protein 1			20.00, 20.00	1.06, 0.23	98.31	-30.22	-99.50	-20.92	57.11	50.07	-98.47	98.76	-33.19	22.54
ccsbBroad304_05098	OE	MAGEB6	melanoma antigen family B, 6			0.00, 0.00	5.60, 1.82	-93.99	-82.45	-99.24	-99.90	-77.43	-35.95	-50.27	-99.62	-99.97	-99.91
ccsbBroad304_08878	OE	METTL4	methyltransferase like 4			0.00, 0.00	1.03, 0.28	-91.90	-96.62	-62.31	-96.87	-43.51	-27.42	-60.64	59.54	63.12	-90.70
ccsbBroad304_01010	OE	MGST2	Glutathione S-transferases / Microsomal, microsomal glutathione S-transferase 2			0.00, 0.00	1.43, 0.32	-53.90	-63.42	-44.57	-93.61	-87.44	-32.30	54.67	-25.22	-77.05	-71.47
ccsbBroad304_13939	OE	MOK	RCK family, MOK protein kinase			30.00, 20.00	1.10, 0.38	91.31	-34.30	97.88	71.40	27.91	-45.79	98.66	-42.44	-91.07	95.87
ccsbBroad304_06621	OE	NDUFA8	Mitochondrial respiratory chain complex / Complex I, NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 8, 19kDa			0.00, 0.00	1.15, 0.34	-31.94	-30.09	-48.29	-92.88	-70.89	28.96	-58.16	-37.81	-56.47	-37.65
ccsbBroad304_06623	OE	NDUFAB1	Mitochondrial respiratory chain complex / Complex I, NADH dehydrogenase (ubiquinone) 1, alpha/beta subcomplex, 1, 8kDa			0.00, 0.00	0.82, 0.18	-18.12	-79.16	81.47	-79.90	94.79	-58.65	34.36	-57.57	-68.07	-45.64
ccsbBroad304_01114	OE	NUP88	nucleoporin 88kDa			0.00, 0.00	0.95, 0.25	-48.72	57.37	91.50	41.89	36.27	64.13	60.55	59.95	63.67	47.24
ccsbBroad304_05439	OE	O3FAR1	omega-3 fatty acid receptor 1			0.00, 0.00	1.48, 0.39	-89.94	67.68	50.66	-34.97	-88.22	-92.60	55.13	-97.64	-95.53	-98.29
ccsbBroad304_01203	OE	PIM1	PIM family, pim-1 oncogene			0.00, 0.00	1.45, 0.33	-79.81	65.40	-51.05	71.10	-99.82	-95.76	-67.81	72.85	-99.24	-96.48
ccsbBroad304_06748	OE	POLE2	DNA polymerases, polymerase (DNA directed), epsilon 2 (p59 subunit)			0.00, 0.00	1.35, 0.28	31.14	66.79	-64.36	-16.70	-35.07	39.25	-95.72	-34.92	59.45	-6.36
ccsbBroad304_02306	OE	PQBP1	polyglutamine binding protein 1			0.00, 0.00	1.11, 0.33	38.43	-99.93	-17.96	55.02	-49.99	51.39	44.64	-42.98	50.68	9.76
ccsbBroad304_02653	OE	PRAF2	PRA1 domain family, member 2			0.00, 0.00	0.99, 0.28	-74.03	-33.21	26.59	39.38	79.36	-77.06	41.67	92.28	94.16	22.66
ccsbBroad304_00163	OE	PRDM1	Zinc fingers, C2H2-type, PR domain containing 1, with ZNF domain			10.00, 10.00	1.88, 0.48	-99.86	-98.99	-51.16	-68.31	80.50	-81.44	69.21	-20.39	99.97	-86.17
ccsbBroad304_04490	OE	RSPH1	radial spoke head 1 homolog (Chlamydomonas)			0.00, 0.00	1.36, 0.35	-89.73	-88.57	80.26	-52.45	-54.75	67.92	51.40	66.05	-99.69	-94.59
ccsbBroad304_07671	OE	SIX2	Homeoboxes / SINE class, SIX homeobox 2			10.00, 10.00	0.91, 0.25	-30.65	-84.96	-36.96	-28.52	98.35	58.00	45.75	-45.48	90.99	-10.61
ccsbBroad304_01556	OE	SMARCB1	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1			10.00, 10.00	1.19, 0.28	17.34	99.39	-49.27	52.03	-29.82	-75.29	-82.61	58.17	-38.56	13.52
ccsbBroad304_07875	OE	SPECC1L	sperm antigen with calponin homology and coiled-coil domains 1-like			10.00, 0.00	0.93, 0.24	37.78	33.04	57.84	96.40	-52.37	-64.81	74.26	34.26	-51.22	21.69
ccsbBroad304_02372	OE	SPRY1	sprouty homolog 1, antagonist of FGF signaling (Drosophila)			20.00, 20.00	1.03, 0.41	-56.88	-99.85	-96.49	100.00	-80.48	35.43	35.76	99.98	-76.04	-76.42
ccsbBroad304_08553	OE	STAP2	signal transducing adaptor family member 2			0.00, 0.00	0.86, 0.31	-92.21	-99.58	-40.22	-47.40	-41.27	53.94	53.33	59.32	-80.61	-39.76
ccsbBroad304_07383	OE	STK17A	Death-associated kinase (DAPK) family, serine/threonine kinase 17a			0.00, 0.00	1.14, 0.38	22.84	-79.17	-42.57	-50.99	-82.85	39.36	91.38	78.30	-80.63	-39.98
ccsbBroad304_01651	OE	TCF7L2	transcription factor 7-like 2 (T-cell specific, HMG-box)			10.00, 10.00	1.45, 0.31	-32.52	-63.78	-37.78	39.99	-48.63	99.72	45.86	-43.17	-38.53	-18.43
ccsbBroad304_01666	OE	TGFBR1	Type I receptor serine/threonine kinases, transforming growth factor, beta receptor 1			0.00, 0.00	0.95, 0.35	-20.59	86.79	59.60	-37.56	46.66	45.72	-49.65	63.72	33.82	27.57
ccsbBroad304_07075	OE	TLR5	Toll-like receptor family, toll-like receptor 5			0.00, 0.00	0.99, 0.32	-14.41	-36.83	59.00	-88.34	45.48	77.45	30.28	79.95	-61.28	29.67
ccsbBroad304_07569	OE	TRIB1	Trbl family, tribbles homolog 1 (Drosophila)			10.00, 10.00	1.35, 0.44	77.05	23.17	-98.93	-99.98	-29.52	31.16	99.98	31.14	59.50	7.21
ccsbBroad304_01716	OE	TSN	translin			20.00, 10.00	0.88, 0.30	99.03	29.73	96.72	-99.24	24.60	55.74	-47.06	45.97	-29.30	38.51
ccsbBroad304_01754	OE	UCK2	uridine-cytidine kinase 2			0.00, 0.00	1.19, 0.42	-81.12	-98.27	-83.02	-99.44	-57.61	-95.18	-74.47	-97.34	-97.68	-99.26
ccsbBroad304_07140	OE	XPC	xeroderma pigmentosum, complementation group C			10.00, 10.00	1.39, 0.32	-44.57	44.28	45.49	-48.24	49.52	99.93	74.24	-97.82	-65.98	32.68
ccsbBroad304_04998	OE	ZNF418	Zinc fingers, C2H2-type, zinc finger protein 418			0.00, 0.00	1.45, 0.45	64.76	-53.48	-78.09	-39.73	-74.72	-29.30	92.69	-59.96	94.15	-52.06
ccsbBroad304_04801	OE	ZNF543	Zinc fingers, C2H2-type, zinc finger protein 543			20.00, 10.00	0.97, 0.28	62.18	42.18	-36.15	-56.95	-99.04	99.90	-26.32	97.04	76.29	45.13
ccsbBroad304_05006	OE	ZNF583	Zinc fingers, C2H2-type, zinc finger protein 583			0.00, 0.00	1.22, 0.31	-19.33	27.64	-27.80	-47.79	-53.74	-25.24	77.33	-72.00	-98.68	-22.14
ccsbBroad304_05123	OE	ZNF791	Zinc fingers, C2H2-type, zinc finger protein 791			0.00, 0.00	1.05, 0.26	-28.39	23.04	-20.09	46.04	-59.76	40.43	58.56	93.44	59.53	17.45
ccsbBroad304_08849	OE	ABCG8	ATP binding cassette transporters / subfamily G, ATP-binding cassette, sub-family G (WHITE), member 8			0.00, 0.00	0.99, 0.23	24.53	-82.08	-19.27	-98.16	51.25	49.51	-92.28	-35.33	-48.37	-20.82
ccsbBroad304_03903	OE	ABHD4	Abhydrolase domain containing, abhydrolase domain containing 4			0.00, 0.00	1.09, 0.23	42.44	44.19	-25.79	-79.49	93.18	-61.05	-36.39	-96.96	91.49	27.48
ccsbBroad304_07345	OE	CCRL2	Chemokine receptors, chemokine (C-C motif) receptor-like 2			10.00, 0.00	1.13, 0.23	-29.16	68.35	20.44	-46.58	95.92	51.25	-88.23	49.47	-93.10	17.70
ccsbBroad304_00273	OE	CDC25B	Protein tyrosine phosphatases / Class III Cys-based PTPs, cell division cycle 25 homolog B (S. pombe)			10.00, 10.00	1.30, 0.28	-94.72	65.37	99.84	67.43	-36.62	-49.79	87.93	51.03	-35.04	82.96
ccsbBroad304_04802	OE	COX6B2	Mitochondrial respiratory chain complex / Complex IV, cytochrome c oxidase subunit VIb polypeptide 2 (testis)			0.00, 0.00	0.67, 0.18	-41.34	-93.87	-41.18	-70.48	-87.72	-15.96	-54.70	-38.99	44.45	-32.95
ccsbBroad304_00392	OE	CTLA4	CD molecules, cytotoxic T-lymphocyte-associated protein 4			10.00, 0.00	1.03, 0.30	16.03	-74.38	92.22	95.58	-47.25	-36.42	77.71	50.40	-93.48	26.59
ccsbBroad304_00433	OE	DECR1	Short chain dehydrogenase/reductase superfamily / Classical SDR fold cluster 1, 2,4-dienoyl CoA reductase 1, mitochondrial			0.00, 0.00	0.92, 0.27	39.23	46.75	-70.94	-46.17	-72.65	92.52	40.75	28.50	-83.74	-20.17
ccsbBroad304_07851	OE	FAM120A	family with sequence similarity 120A			0.00, 0.00	0.73, 0.18	-70.53	43.93	-95.10	-85.61	-58.19	74.13	-39.42	-41.83	-46.79	-72.07
ccsbBroad304_00650	OE	GNA11	guanine nucleotide binding protein (G protein), alpha 11 (Gq class)			0.00, 0.00	1.22, 0.27	81.24	-76.08	-48.72	-87.43	37.82	-36.26	93.02	-59.17	-76.93	-50.51
ccsbBroad304_07699	OE	GPR83	GPCR / Class A : Orphans, G protein-coupled receptor 83			0.00, 0.00	1.31, 0.40	21.24	51.73	-23.47	-88.23	75.67	-39.93	-37.61	40.80	-74.20	-14.10
ccsbBroad304_04405	OE	KISS1R	GPCR / Class A : RF amide peptide receptors, KISS1 receptor			10.00, 10.00	1.35, 0.43	58.24	72.71	-79.03	-94.96	-54.75	24.96	-32.42	-60.64	99.56	-37.87
ccsbBroad304_08613	OE	KLHL9	BTB/POZ domain containing, kelch-like 9 (Drosophila)			10.00, 10.00	1.06, 0.25	-30.00	98.58	73.30	52.28	-98.24	30.35	-59.74	54.75	-42.36	46.27
ccsbBroad304_01880	OE	LAGE3	L antigen family, member 3			0.00, 0.00	0.67, 0.24	-42.26	43.43	-14.57	-46.07	91.06	52.12	-40.26	-37.00	-60.27	-7.69
ccsbBroad304_00931	OE	LCN2	Lipocalins, lipocalin 2		Lipocalins GOF	10.00, 0.00	1.03, 0.34	86.38	96.52	63.84	-99.98	-99.95	40.07	47.65	46.10	23.88	42.34
ccsbBroad304_02336	OE	LPAR6	GPCR / Class A : Lysophospholipid receptors : Lysophosphatidic acid, lysophosphatidic acid receptor 6			0.00, 0.00	0.83, 0.20	78.36	59.32	-92.32	-50.58	-58.35	84.65	-22.78	81.44	36.15	59.29
ccsbBroad304_07768	OE	NISCH	nischarin			0.00, 0.00	1.19, 0.34	-46.92	21.49	-67.28	-81.32	11.43	66.36	-46.47	-40.36	57.17	-9.52
ccsbBroad304_04216	OE	PBX4	Homeoboxes / TALE class, pre-B-cell leukemia homeobox 4			0.00, 0.00	0.82, 0.25	28.99	27.17	25.31	-68.59	-18.68	-35.96	-58.22	-83.01	92.91	-18.21
ccsbBroad304_07427	OE	PIGB	Dolichyl D-mannosyl phosphate dependent mannosyltransferases, phosphatidylinositol glycan anchor biosynthesis, class B			40.00, 40.00	0.88, 0.18	-26.84	99.06	-82.01	99.98	-37.90	26.64	-30.88	79.74	98.36	97.81
ccsbBroad304_06753	OE	POU5F1	Homeoboxes / POU class, POU class 5 homeobox 1		Homeobox Gene GOF	10.00, 10.00	1.81, 0.45	-99.58	-40.50	-99.87	-74.19	-87.13	-95.15	-98.66	-99.94	99.82	-99.58
ccsbBroad304_01268	OE	PPP3CB	Serine/threonine phosphatases / Protein phosphatase, catalytic subunits, protein phosphatase 3, catalytic subunit, beta isozyme			20.00, 20.00	1.34, 0.38	98.23	73.24	7.65	46.07	55.07	-29.98	72.75	28.49	98.04	49.30
ccsbBroad304_02115	OE	PTTG1	pituitary tumor-transforming 1			0.00, 0.00	1.15, 0.33	-69.21	-29.27	-51.20	-97.57	-84.51	-39.47	-91.51	57.44	-99.97	-95.03
ccsbBroad304_07766	OE	RASSF1	Ras association (RalGDS/AF-6) domain family member 1			0.00, 0.00	1.13, 0.19	56.85	26.50	-55.91	93.02	76.83	-35.52	42.12	-38.82	-75.73	21.67
ccsbBroad304_03917	OE	RBKS	ribokinase			0.00, 0.00	1.15, 0.34	11.67	-65.73	30.41	-55.60	71.95	61.48	31.72	-62.21	-69.05	-21.46
ccsbBroad304_03940	OE	RFWD2	RING-type (C3HC4) zinc fingers, ring finger and WD repeat domain 2			0.00, 0.00	1.34, 0.49	-67.55	47.01	-88.61	-75.59	51.76	-27.11	-94.53	-91.78	78.93	-79.45
ccsbBroad304_10014	OE	RXFP4	GPCR / Class A : Relaxin family peptide receptors, relaxin/insulin-like family peptide receptor 4			0.00, 0.00	1.77, 0.48	-90.53	-70.48	-88.57	-99.84	35.75	86.51	-60.64	-26.88	46.08	-80.45
ccsbBroad304_07805	OE	SCAF8	RNA binding motif (RRM) containing, SR-related CTD-associated factor 8			0.00, 0.00	1.70, 0.33	-99.98	85.59	61.63	-51.73	40.29	81.88	44.56	-67.84	-42.13	30.36
ccsbBroad304_06982	OE	SNRNP70	RNA binding motif (RRM) containing, small nuclear ribonucleoprotein 70kDa (U1)			0.00, 0.00	1.25, 0.20	28.43	-89.40	-91.49	-53.71	-68.06	-66.60	55.75	-51.66	74.97	-75.76
ccsbBroad304_03858	OE	SRPRB	signal recognition particle receptor, B subunit			10.00, 10.00	1.00, 0.33	-46.97	21.68	-15.44	-73.14	36.44	99.93	39.05	58.80	94.89	7.18
ccsbBroad304_03037	OE	TMEM97	transmembrane protein 97			0.00, 0.00	1.31, 0.35	-95.77	-71.92	6.58	-84.42	94.85	-40.31	-94.29	35.43	47.38	-53.51
ccsbBroad304_10026	OE	ZNF517	Zinc fingers, C2H2-type, zinc finger protein 517			10.00, 10.00	1.17, 0.42	91.99	-89.79	35.84	91.21	-19.60	53.41	98.62	27.34	-95.54	62.01
ccsbBroad304_05005	OE	ZNF582	Zinc fingers, C2H2-type, zinc finger protein 582			10.00, 0.00	0.84, 0.19	-60.72	91.12	96.96	39.74	-36.99	-48.74	24.97	-89.97	-32.71	-5.95
ccsbBroad304_00487	OE	EGR1	Zinc fingers, C2H2-type, early growth response 1			0.00, 0.00	1.35, 0.41	-37.69	-54.20	-99.92	48.48	-99.82	51.54	-83.94	-79.79	-35.14	-87.82
ccsbBroad304_03340	OE	LSR	Immunoglobulin superfamily / Immunoglobulin-like domain containing, lipolysis stimulated lipoprotein receptor			0.00, 0.00	0.85, 0.20	-44.14	-33.83	-88.90	-99.23	-82.56	54.87	50.19	-87.98	-44.39	-85.82
CGS001-2	KD	A2M	alpha-2-macroglobulin			0.00, 0.00	1.39, 0.35	91.93	-20.32	31.52	-18.96	-77.65	NaN	61.12	65.47	-34.73	53.34
CGS001-16	KD	AARS	Aminoacyl tRNA synthetases / Class II, alanyl-tRNA synthetase			40.00, 30.00	1.43, 0.45	99.52	-25.97	98.78	99.94	-99.56	35.66	18.71	90.62	-37.31	97.40
CGS001-26574	KD	AATF	apoptosis antagonizing transcription factor			22.22, 22.22	1.38, 0.39	98.97	22.71	99.40	-99.71	-99.98	NaN	-99.87	-36.41	-26.57	-99.53
CGS001-18	KD	ABAT	GABA turnover, 4-aminobutyrate aminotransferase			0.00, 0.00	1.30, 0.41	-48.71	-21.69	-87.30	-99.61	-50.97	-71.10	-66.50	-99.89	-18.50	-85.09
CGS001-19	KD	ABCA1	ATP binding cassette transporters / subfamily A, ATP-binding cassette, sub-family A (ABC1), member 1			0.00, 0.00	1.24, 0.39	32.64	-24.63	-97.26	-99.86	-98.40	NaN	-54.14	-99.71	-99.50	-99.82
CGS001-21	KD	ABCA3	ATP binding cassette transporters / subfamily A, ATP-binding cassette, sub-family A (ABC1), member 3			0.00, 0.00	0.98, 0.30	41.32	NaN	37.23	-99.93	91.99	NaN	31.78	-99.94	-99.75	-99.95
CGS001-23461	KD	ABCA5	ATP binding cassette transporters / subfamily A, ATP-binding cassette, sub-family A (ABC1), member 5			12.50, 12.50	1.22, 0.38	58.46	NaN	93.00	38.54	38.36	NaN	97.83	63.79	46.97	78.22
CGS001-5243	KD	ABCB1	ATP binding cassette transporters / subfamily B, ATP-binding cassette, sub-family B (MDR/TAP), member 1			0.00, 0.00	1.48, 0.39	-78.99	42.19	-13.31	27.46	38.44	-66.06	34.07	-45.73	-28.55	-8.26
CGS001-5244	KD	ABCB4	ATP binding cassette transporters / subfamily B, ATP-binding cassette, sub-family B (MDR/TAP), member 4			22.22, 22.22	1.19, 0.33	17.13	25.00	24.41	99.44	-98.68	32.68	99.90	17.00	NaN	11.54
CGS001-10058	KD	ABCB6	ATP binding cassette transporters / subfamily B, ATP-binding cassette, sub-family B (MDR/TAP), member 6			55.56, 44.44	1.56, 0.55	33.12	28.99	96.68	85.05	-69.92	NaN	99.98	99.89	99.97	99.92
CGS001-4363	KD	ABCC1	ATP binding cassette transporters / subfamily C, ATP-binding cassette, sub-family C (CFTR/MRP), member 1			0.00, 0.00	1.52, 0.41	-68.94	NaN	29.03	52.64	-66.24	NaN	NaN	79.09	-92.27	-65.29
CGS001-89845	KD	ABCC10	ATP binding cassette transporters / subfamily C, ATP-binding cassette, sub-family C (CFTR/MRP), member 10			28.57, 14.29	0.78, 0.25	-84.73	NaN	-77.27	95.33	-99.98	NaN	NaN	99.89	-92.46	-98.43
CGS001-1244	KD	ABCC2	ATP binding cassette transporters / subfamily C, ATP-binding cassette, sub-family C (CFTR/MRP), member 2			10.00, 10.00	1.10, 0.39	58.50	-77.43	27.75	33.59	99.54	23.06	80.41	-53.04	90.68	67.13
CGS001-8714	KD	ABCC3	ATP binding cassette transporters / subfamily C, ATP-binding cassette, sub-family C (CFTR/MRP), member 3			0.00, 0.00	1.14, 0.53	-73.48	NaN	70.48	57.17	52.68	NaN	48.73	63.48	27.67	50.83
CGS001-10257	KD	ABCC4	ATP binding cassette transporters / subfamily C, ATP-binding cassette, sub-family C (CFTR/MRP), member 4			57.14, 42.86	2.06, 0.80	-97.06	NaN	-25.97	96.99	99.92	NaN	NaN	98.93	-29.38	98.44
CGS001-10057	KD	ABCC5	ATP binding cassette transporters / subfamily C, ATP-binding cassette, sub-family C (CFTR/MRP), member 5			0.00, 0.00	1.24, 0.24	-99.47	NaN	-99.15	-93.59	-59.26	-99.93	-94.13	-99.98	-82.83	-99.84
CGS001-5825	KD	ABCD3	ATP binding cassette transporters / subfamily D, ATP-binding cassette, sub-family D (ALD), member 3			42.86, 42.86	1.17, 0.39	99.90	NaN	99.95	65.49	-98.99	NaN	NaN	91.96	51.99	99.68
CGS001-23	KD	ABCF1	ATP binding cassette transporters / subfamily F, ATP-binding cassette, sub-family F (GCN20), member 1			0.00, 0.00	1.85, 0.69	NaN	-99.19	68.64	-45.44	25.76	NaN	-38.49	-99.21	-96.99	-97.35
CGS001-10061	KD	ABCF2	ATP binding cassette transporters / subfamily F, ATP-binding cassette, sub-family F (GCN20), member 2			11.11, 11.11	1.11, 0.42	90.56	63.59	82.64	79.64	-71.21	61.49	NaN	51.01	99.20	85.17
CGS001-55324	KD	ABCF3	ATP binding cassette transporters / subfamily F, ATP-binding cassette, sub-family F (GCN20), member 3			12.50, 12.50	1.84, 0.56	94.96	NaN	97.76	38.84	22.74	NaN	-63.79	-57.28	43.99	59.95
CGS001-9429	KD	ABCG2	ATP binding cassette transporters / subfamily G, ATP-binding cassette, sub-family G (WHITE), member 2			14.29, 14.29	1.15, 0.36	-55.70	NaN	-68.90	33.75	-55.86	NaN	NaN	99.54	32.91	-51.86
CGS001-64240	KD	ABCG5	ATP binding cassette transporters / subfamily G, ATP-binding cassette, sub-family G (WHITE), member 5			22.22, 0.00	1.52, 0.66	-38.89	NaN	40.28	-93.07	97.14	-65.96	96.38	-53.66	22.25	-36.05
CGS001-64241	KD	ABCG8	ATP binding cassette transporters / subfamily G, ATP-binding cassette, sub-family G (WHITE), member 8			0.00, 0.00	1.27, 0.35	-56.78	32.34	-98.57	48.97	-94.13	NaN	26.35	21.47	-75.67	-53.18
CGS001-11057	KD	ABHD2	Abhydrolase domain containing, abhydrolase domain containing 2			10.00, 10.00	1.89, 0.64	38.21	26.37	99.19	-25.73	-70.56	-76.61	-38.45	-78.57	-94.51	-67.16
CGS001-63874	KD	ABHD4	Abhydrolase domain containing, abhydrolase domain containing 4			0.00, 0.00	1.74, 0.52	-58.03	-63.41	67.69	58.30	54.47	NaN	NaN	73.87	-76.01	63.86
CGS001-57406	KD	ABHD6	Abhydrolase domain containing, abhydrolase domain containing 6			12.50, 12.50	1.70, 0.59	-46.14	NaN	-99.98	-62.31	-90.58	NaN	32.89	99.51	40.11	-52.43
CGS001-25	KD	ABL1	Abl family, c-abl oncogene 1, non-receptor tyrosine kinase			10.00, 0.00	0.39, 0.10	-26.76	-82.35	-23.46	48.36	-22.21	75.31	-40.99	67.26	96.26	9.32
CGS001-27	KD	ABL2	Abl family, v-abl Abelson murine leukemia viral oncogene homolog 2			0.00, 0.00	1.45, 0.41	-98.61	-99.96	-92.55	-99.94	-25.69	NaN	-82.79	-67.30	-86.05	-99.18
CGS001-30	KD	ACAA1	acetyl-CoA acyltransferase 1			0.00, 0.00	1.08, 0.40	62.40	-53.50	-18.16	30.72	76.62	-24.16	63.78	-21.17	-80.68	13.75
CGS001-31	KD	ACACA	Carboxylases, acetyl-CoA carboxylase alpha			10.00, 10.00	0.93, 0.20	-93.88	24.12	-95.06	31.12	55.93	-22.71	-22.24	99.10	21.57	5.05
CGS001-32	KD	ACACB	Carboxylases, acetyl-CoA carboxylase beta			0.00, 0.00	0.84, 0.15	-18.33	-37.06	-15.74	-25.74	78.91	45.00	47.13	-93.04	NaN	4.15
CGS001-27034	KD	ACAD8	acyl-CoA dehydrogenase family, member 8			11.11, 11.11	1.41, 0.39	-49.14	-91.21	23.59	-33.50	98.33	-44.76	-58.98	-25.38	NaN	-30.05
CGS001-34	KD	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain			11.11, 11.11	1.26, 0.38	-22.39	-35.46	-97.50	-57.92	97.66	NaN	-41.25	-88.09	28.68	-42.72
CGS001-35	KD	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain			0.00, 0.00	0.89, 0.24	-31.15	-94.72	-47.69	NaN	-90.85	-45.29	-67.40	-83.89	-30.89	-80.85
CGS001-36	KD	ACADSB	acyl-CoA dehydrogenase, short/branched chain			0.00, 0.00	1.42, 0.42	NaN	26.53	-57.86	-46.09	-95.92	63.30	59.30	37.49	41.58	27.86
CGS001-38	KD	ACAT1	Lanosterol biosynthesis pathway, acetyl-CoA acetyltransferase 1			0.00, 0.00	1.02, 0.38	-87.97	NaN	-86.33	51.90	-95.33	-32.48	-61.65	-94.33	-33.35	-89.46
CGS001-39	KD	ACAT2	Lanosterol biosynthesis pathway, acetyl-CoA acetyltransferase 2			0.00, 0.00	1.28, 0.35	-99.50	-98.34	-99.58	-67.12	-99.98	NaN	-99.98	-99.94	-61.41	-99.95
CGS001-64746	KD	ACBD3	A-kinase anchor proteins, acyl-CoA binding domain containing 3			0.00, 0.00	1.61, 0.47	-87.78	-36.72	-99.88	-99.98	42.84	-98.54	-22.97	-96.50	NaN	-99.74
CGS001-65057	KD	ACD	adrenocortical dysplasia homolog (mouse)			0.00, 0.00	3.40, 1.27	NaN	NaN	-53.63	-29.84	28.32	NaN	NaN	57.26	47.09	29.96
CGS001-47	KD	ACLY	ATP citrate lyase			0.00, 0.00	1.02, 0.26	-51.44	94.71	-24.31	-99.96	-36.09	34.40	-41.93	-14.70	90.12	-19.13
CGS001-50	KD	ACO2	aconitase 2, mitochondrial			0.00, 0.00	1.14, 0.28	-57.75	-99.87	-98.15	-22.22	-99.81	NaN	-99.21	-97.58	-41.59	-99.87
CGS001-23597	KD	ACOT9	Acyl CoA thioesterases, acyl-CoA thioesterase 9			0.00, 0.00	1.26, 0.39	72.26	54.77	-34.04	86.66	-39.60	NaN	NaN	76.57	66.02	87.47
CGS001-2180	KD	ACSL1	Acyl-CoA synthetase family, acyl-CoA synthetase long-chain family member 1			20.00, 0.00	0.84, 0.28	-32.14	-37.42	-89.46	96.04	-77.25	-99.18	53.34	95.12	69.70	-59.60
CGS001-2181	KD	ACSL3	Acyl-CoA synthetase family, acyl-CoA synthetase long-chain family member 3			0.00, 0.00	1.23, 0.42	-40.56	22.67	-52.57	25.42	35.15	NaN	-29.80	-40.61	-99.85	-16.95
CGS001-2182	KD	ACSL4	Acyl-CoA synthetase family, acyl-CoA synthetase long-chain family member 4			0.00, 0.00	1.69, 0.66	-88.53	-96.52	-91.85	29.69	49.94	NaN	-30.27	-33.31	94.20	-86.64
CGS001-60	KD	ACTB	actin, beta			0.00, 0.00	1.90, 0.45	-90.53	-79.01	-46.74	-39.42	58.01	NaN	60.13	-62.37	-49.74	-48.84
CGS001-87	KD	ACTN1	EF-hand domain containing, actinin, alpha 1			0.00, 0.00	0.76, 0.23	-57.55	-88.35	32.62	29.72	-99.98	-34.50	-34.76	-99.70	-72.77	-90.35
CGS001-10097	KD	ACTR2	ARP2 actin-related protein 2 homolog (yeast)			11.11, 11.11	1.17, 0.27	-35.98	99.78	-99.96	32.10	-60.66	NaN	-25.16	-89.92	36.23	-29.54
CGS001-10096	KD	ACTR3	ARP3 actin-related protein 3 homolog (yeast)			11.11, 11.11	1.43, 0.47	-50.01	NaN	25.22	71.00	-30.28	99.94	18.53	-21.65	-24.24	3.89
CGS001-90	KD	ACVR1	Type I receptor serine/threonine kinases, activin A receptor, type I			11.11, 11.11	1.69, 0.45	26.45	29.16	81.88	97.76	34.76	-28.86	NaN	59.04	-80.69	53.92
CGS001-95	KD	ACY1	aminoacylase 1			11.11, 0.00	1.55, 0.39	-64.68	28.81	-21.86	62.11	96.70	NaN	-85.61	28.12	-14.08	5.10
CGS001-100	KD	ADA	Adenosine turnover, adenosine deaminase			0.00, 0.00	1.01, 0.30	-98.24	-96.63	-28.99	-35.64	87.52	-27.64	-99.59	-90.02	-47.33	-91.96
CGS001-102	KD	ADAM10	ADAM metallopeptidase domain containing, ADAM metallopeptidase domain 10			14.29, 0.00	0.98, 0.22	40.70	NaN	-98.83	-39.02	-22.65	NaN	NaN	95.19	-42.41	-22.20
CGS001-8751	KD	ADAM15	ADAM metallopeptidase domain containing, ADAM metallopeptidase domain 15			0.00, 0.00	1.06, 0.27	-73.13	19.24	-99.96	-97.60	-31.23	-90.43	-99.16	-98.81	26.34	-99.71
CGS001-6868	KD	ADAM17	ADAM metallopeptidase domain containing, ADAM metallopeptidase domain 17			11.11, 11.11	1.40, 0.35	-23.92	-22.09	-47.09	-48.92	-23.97	-20.55	-39.22	99.60	NaN	-8.67
CGS001-103	KD	ADAR	adenosine deaminase, RNA-specific			10.00, 10.00	1.44, 0.40	94.15	-97.01	-42.68	-46.31	99.79	-93.71	-99.09	-20.71	89.56	-72.66
CGS001-23536	KD	ADAT1	adenosine deaminase, tRNA-specific 1			0.00, 0.00	1.20, 0.45	-6.88	-93.45	-99.87	-24.99	NaN	34.85	-98.75	-97.29	-99.82	-99.27
CGS001-56997	KD	ADCK3	ABC1-B subfamily, aarF domain containing kinase 3			0.00, 0.00	1.02, 0.19	-92.13	-100.00	-87.36	27.79	21.82	-99.79	-58.21	-97.05	17.65	-96.17
CGS001-109	KD	ADCY3	Adenylyl cyclases, adenylate cyclase 3			0.00, 0.00	1.58, 0.47	-98.38	-27.33	-99.98	-99.84	-78.51	NaN	-76.32	-33.48	-64.24	-98.16
CGS001-111	KD	ADCY5	Adenylate cyclases, adenylate cyclase 5			10.00, 10.00	1.13, 0.40	38.83	-92.45	-27.50	-66.19	99.59	28.04	-28.55	-25.53	17.64	-4.61
CGS001-115	KD	ADCY9	Adenylyl cyclases, adenylate cyclase 9			10.00, 10.00	0.90, 0.25	99.85	-88.20	-36.35	-86.66	-64.57	32.96	-99.21	-69.83	45.42	-65.99
CGS001-128	KD	ADH5	Alcohol dehydrogenases, alcohol dehydrogenase 5 (class III), chi polypeptide			40.00, 30.00	0.86, 0.18	99.68	94.50	-60.29	-68.86	90.58	84.30	98.81	-38.55	97.29	98.50
CGS001-130	KD	ADH6	Alcohol dehydrogenases, alcohol dehydrogenase 6 (class V)			12.50, 0.00	1.47, 0.45	-92.15	-27.93	-55.24	-32.06	49.07	97.03	-36.17	NaN	NaN	-27.89
CGS001-55256	KD	ADI1	acireductone dioxygenase 1			0.00, 0.00	1.25, 0.19	-9.99	41.20	-37.39	25.42	-99.70	NaN	-69.26	91.80	-24.23	-9.00
CGS001-132	KD	ADK	Adenosine turnover, adenosine kinase			22.22, 11.11	1.63, 0.47	64.11	-96.54	97.36	71.77	98.12	NaN	24.19	45.33	32.99	72.85
CGS001-22850	KD	ADNP2	Zinc fingers, C2H2-type, ADNP homeobox 2			0.00, 0.00	0.77, 0.24	27.34	35.94	40.56	36.80	22.61	NaN	NaN	44.43	-60.91	18.82
CGS001-84890	KD	ADO	2-aminoethanethiol (cysteamine) dioxygenase			0.00, 0.00	1.66, 0.55	NaN	-76.50	-58.52	-99.74	-99.91	-82.48	-76.24	-98.74	-18.79	-98.34
CGS001-135	KD	ADORA2A	GPCR / Class A : Adenosine receptors, adenosine A2a receptor			0.00, 0.00	1.64, 0.44	41.09	-96.00	-36.21	-26.44	-41.56	NaN	90.72	-27.36	9.34	-7.48
CGS001-136	KD	ADORA2B	GPCR / Class A : Adenosine receptors, adenosine A2b receptor			44.44, 33.33	1.45, 0.34	-31.95	80.04	34.10	99.61	-35.62	NaN	-18.75	99.85	97.21	99.42
CGS001-83440	KD	ADPGK	ADP-dependent glucokinase			0.00, 0.00	1.13, 0.36	-14.67	-99.85	-51.07	57.93	90.37	-33.83	-98.25	-98.99	NaN	-94.72
CGS001-150	KD	ADRA2A	GPCR / Class A : Adrenoceptors : alpha, adrenergic, alpha-2A-, receptor			0.00, 0.00	1.73, 0.47	50.77	38.87	20.62	-31.50	-25.29	91.62	85.70	-48.49	NaN	21.59
CGS001-152	KD	ADRA2C	GPCR / Class A : Adrenoceptors : alpha, adrenergic, alpha-2C-, receptor			0.00, 0.00	1.16, 0.30	91.99	42.80	-13.83	-98.50	52.24	NaN	-99.85	-88.93	29.67	-47.06
CGS001-154	KD	ADRB2	GPCR / Class A : Adrenoceptors : beta, adrenergic, beta-2-, receptor, surface			12.50, 12.50	1.23, 0.49	-31.96	NaN	-24.41	-36.92	-40.49	NaN	99.64	39.18	-80.91	-18.09
CGS001-158	KD	ADSL	adenylosuccinate lyase			22.22, 11.11	1.20, 0.36	-25.39	99.87	82.65	NaN	-91.43	50.62	96.68	20.05	27.34	51.93
CGS001-159	KD	ADSS	adenylosuccinate synthase			12.50, 0.00	0.88, 0.25	-58.39	NaN	-41.08	-47.66	95.22	NaN	-27.48	-26.96	-46.45	-41.70
CGS001-166	KD	AES	amino-terminal enhancer of split			12.50, 12.50	1.01, 0.44	-99.74	NaN	-63.12	-36.03	99.41	NaN	-76.68	-31.49	25.37	-78.95
CGS001-4299	KD	AFF1	AF4/FMR2 family, member 1			0.00, 0.00	1.06, 0.19	-76.66	-99.85	-84.53	-15.40	-57.09	-99.65	-98.08	-99.20	-44.51	-98.87
CGS001-27125	KD	AFF4	AF4/FMR2 family, member 4			0.00, 0.00	0.82, 0.26	-27.23	-45.42	-76.59	-99.96	-96.42	-99.96	NaN	-91.11	-26.71	-97.82
CGS001-10939	KD	AFG3L2	ATPases / AAA-type, AFG3 ATPase family gene 3-like 2 (S. cerevisiae)			0.00, 0.00	2.03, 0.70	-99.27	79.31	-52.96	-95.08	94.32	NaN	-88.70	-95.32	-29.72	-98.87
CGS001-174	KD	AFP	alpha-fetoprotein			0.00, 0.00	1.60, 0.52	56.81	-23.45	-24.11	-68.16	-50.87	-24.96	NaN	-57.41	-99.25	-52.49
CGS001-178	KD	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase			0.00, 0.00	1.36, 0.26	-13.57	-99.93	-41.77	-58.94	-20.78	-99.22	-97.90	39.83	34.54	-82.94
CGS001-10554	KD	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferases, 1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)			22.22, 22.22	1.82, 0.53	55.79	85.22	98.96	83.45	58.26	NaN	99.19	-27.88	-52.14	86.70
CGS001-10555	KD	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferases, 1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)			0.00, 0.00	1.23, 0.19	-20.22	-28.02	-46.30	22.55	-98.59	-65.27	-57.05	-99.84	-98.00	-93.83
CGS001-183	KD	AGT	Endogenous ligands, angiotensinogen (serpin peptidase inhibitor, clade A, member 8)			0.00, 0.00	1.39, 0.45	-27.29	-87.25	-22.35	36.01	70.51	-25.28	66.29	-39.31	19.65	-7.16
CGS001-185	KD	AGTR1	Angiotensin receptors, angiotensin II receptor, type 1			11.11, 11.11	1.49, 0.42	22.01	-45.18	-38.68	20.87	-99.13	-27.19	28.69	99.98	NaN	7.74
CGS001-191	KD	AHCY	Adenosine turnover, adenosylhomocysteinase			0.00, 0.00	1.31, 0.36	15.71	-35.48	-30.10	-44.46	-50.36	NaN	-38.63	-40.93	81.73	-13.32
CGS001-57491	KD	AHRR	Basic helix-loop-helix proteins, aryl-hydrocarbon receptor repressor			22.22, 11.11	1.32, 0.42	-18.59	97.34	44.23	40.82	90.85	99.96	-30.44	81.80	NaN	86.52
CGS001-9131	KD	AIFM1	apoptosis-inducing factor, mitochondrion-associated, 1			10.00, 10.00	1.38, 0.41	80.30	99.98	-96.44	65.37	67.29	21.49	26.84	75.32	78.98	81.79
CGS001-9447	KD	AIM2	absent in melanoma 2			0.00, 0.00	1.20, 0.27	-27.01	48.25	81.90	86.95	41.39	25.99	65.40	22.86	-26.26	28.89
CGS001-7965	KD	AIMP2	aminoacyl tRNA synthetase complex-interacting multifunctional protein 2			10.00, 10.00	1.17, 0.48	99.27	-87.57	-84.58	-99.40	-69.87	68.01	53.09	-77.08	-64.74	-83.80
CGS001-326	KD	AIRE	Zinc fingers, PHD-type, autoimmune regulator			12.50, 12.50	1.51, 0.39	-63.76	NaN	-21.93	-39.92	98.45	NaN	25.98	-91.39	72.18	-17.29
CGS001-203	KD	AK1	Adenylate kinases, adenylate kinase 1			22.22, 11.11	1.97, 0.63	-31.44	-27.96	97.76	34.13	53.41	NaN	83.81	96.80	-7.91	77.05
CGS001-204	KD	AK2	Adenylate kinases, adenylate kinase 2			11.11, 0.00	1.52, 0.53	14.09	97.16	-45.13	-72.77	-99.98	NaN	-46.35	-13.73	-23.97	-49.07
CGS001-50808	KD	AK3	adenylate kinase 3			0.00, 0.00	1.17, 0.43	-98.38	-99.96	-61.20	-29.42	-40.02	-49.89	-8.50	-94.81	NaN	-97.29
CGS001-8165	KD	AKAP1	A-kinase anchor proteins, A kinase (PRKA) anchor protein 1			10.00, 10.00	1.24, 0.32	11.61	100.00	-26.95	33.63	-31.17	-86.01	-34.62	71.11	-99.96	-17.47
CGS001-11215	KD	AKAP11	A-kinase anchor proteins, A kinase (PRKA) anchor protein 11		Kinase anchoring proteins LOF	0.00, 0.00	1.88, 0.52	37.11	NaN	-63.01	-83.14	-48.26	NaN	-98.81	6.89	28.95	-73.19
CGS001-11214	KD	AKAP13	A-kinase anchor proteins, A kinase (PRKA) anchor protein 13		Kinase anchoring proteins LOF	25.00, 25.00	1.44, 0.51	-84.70	98.98	-40.09	-33.21	-62.05	NaN	NaN	48.93	99.93	51.07
CGS001-8227	KD	AKAP17A	A-kinase anchor proteins, A kinase (PRKA) anchor protein 17A			0.00, 0.00	1.81, 0.43	-59.85	-30.91	31.98	-80.30	-65.05	46.18	-21.59	NaN	NaN	-50.39
CGS001-10270	KD	AKAP8	A-kinase anchor proteins, A kinase (PRKA) anchor protein 8			0.00, 0.00	1.26, 0.38	88.62	37.69	-97.12	-99.96	-25.75	-45.61	93.96	-43.11	-99.18	-80.33
CGS001-26993	KD	AKAP8L	A kinase (PRKA) anchor protein 8-like			0.00, 0.00	1.76, 0.47	88.17	-95.86	25.32	-78.74	-22.94	-38.10	-90.64	-24.78	83.02	-29.99
CGS001-10142	KD	AKAP9	A-kinase anchor proteins, A kinase (PRKA) anchor protein (yotiao) 9		Kinase anchoring proteins LOF	0.00, 0.00	1.35, 0.45	32.82	-99.69	-99.22	-53.92	35.97	NaN	-21.81	22.68	-54.19	-58.66
CGS001-10327	KD	AKR1A1	Aldo-keto reductases, aldo-keto reductase family 1, member A1 (aldehyde reductase)			0.00, 0.00	1.55, 0.50	-82.18	-92.25	-35.22	-93.21	-60.44	-99.97	-52.75	-43.61	-21.10	-72.79
CGS001-231	KD	AKR1B1	Aldo-keto reductases, aldo-keto reductase family 1, member B1 (aldose reductase)			0.00, 0.00	1.63, 0.42	-53.20	-76.29	73.82	-30.14	-66.37	-75.16	-54.22	-24.34	27.61	-30.67
CGS001-1645	KD	AKR1C1	Aldo-keto reductases, aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)			0.00, 0.00	0.90, 0.25	-70.20	NaN	-98.34	-68.80	73.23	NaN	47.34	-40.86	-91.18	-83.19
CGS001-1646	KD	AKR1C2	Aldo-keto reductases, aldo-keto reductase family 1, member C2 (dihydrodiol dehydrogenase 2; bile acid binding protein; 3-alpha hydroxysteroid dehydrogenase, type III)			10.00, 0.00	2.05, 0.51	42.74	-19.34	93.79	95.83	54.15	60.50	80.08	78.00	-42.50	80.75
CGS001-8574	KD	AKR7A2	Aldo-keto reductases, aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)			0.00, 0.00	1.17, 0.28	28.11	-96.30	-93.65	-23.88	74.85	73.80	-74.71	-27.56	94.33	25.89
CGS001-207	KD	AKT1	Akt (Protein kinase B), v-akt murine thymoma viral oncogene homolog 1		Akt Signaling LOF, IL4 Pathway LOF	0.00, 0.00	0.88, 0.26	-33.51	-21.78	79.60	-30.02	-27.96	54.39	-99.87	-87.77	-99.97	-38.33
CGS001-208	KD	AKT2	Akt (Protein kinase B), v-akt murine thymoma viral oncogene homolog 2		Akt Signaling LOF	0.00, 0.00	1.17, 0.26	-33.30	-20.05	-63.58	30.64	40.32	-61.03	-26.76	12.89	-64.37	-19.90
CGS001-64400	KD	AKTIP	Ubiquitin-conjugating enzymes E2, AKT interacting protein			0.00, 0.00	1.52, 0.49	43.18	-99.07	-14.59	44.73	-69.93	-29.37	57.58	-37.93	NaN	-24.07
CGS001-210	KD	ALAD	aminolevulinate dehydratase		AHSP Pathway LOF	0.00, 0.00	1.23, 0.30	-23.71	-26.37	-85.58	22.68	-78.60	NaN	-56.63	-99.13	19.43	-41.87
CGS001-211	KD	ALAS1	aminolevulinate, delta-, synthase 1			0.00, 0.00	1.35, 0.45	-90.97	68.88	38.42	-74.78	-48.12	NaN	87.47	-74.59	-31.23	-53.47
CGS001-213	KD	ALB	albumin			10.00, 0.00	1.20, 0.41	-34.24	-88.07	-96.75	-23.75	96.21	-84.76	-28.10	-22.91	69.63	-34.50
CGS001-5832	KD	ALDH18A1	Aldehyde dehydrogenases, aldehyde dehydrogenase 18 family, member A1		Aldehyde dehydrogenases LOF	0.00, 0.00	1.34, 0.34	-78.61	-92.87	-98.70	-99.96	-99.95	-54.22	35.75	-84.19	-22.68	-99.11
CGS001-216	KD	ALDH1A1	Aldehyde dehydrogenases, aldehyde dehydrogenase 1 family, member A1			0.00, 0.00	1.95, 0.67	-39.12	NaN	-18.55	-64.71	-95.62	-56.36	NaN	-20.34	NaN	-34.32
CGS001-220	KD	ALDH1A3	Aldehyde dehydrogenases, aldehyde dehydrogenase 1 family, member A3		Aldehyde dehydrogenases LOF	0.00, 0.00	1.08, 0.38	-90.92	NaN	93.50	-95.34	53.08	NaN	-33.49	-11.53	-18.61	-15.82
CGS001-217	KD	ALDH2	Aldehyde dehydrogenases, aldehyde dehydrogenase 2 family (mitochondrial)			30.00, 10.00	0.76, 0.23	91.32	99.98	22.95	34.39	-38.36	57.48	90.07	-95.73	95.05	96.71
CGS001-218	KD	ALDH3A1	Aldehyde dehydrogenases, aldehyde dehydrogenase 3 family, member A1			11.11, 11.11	2.36, 0.69	76.01	98.91	93.26	45.43	25.26	NaN	40.99	34.44	-65.22	63.55
CGS001-221	KD	ALDH3B1	Aldehyde dehydrogenases, aldehyde dehydrogenase 3 family, member B1			0.00, 0.00	1.44, 0.47	-98.90	45.09	-62.67	-36.02	55.98	30.62	-82.15	54.64	21.16	-29.10
CGS001-8659	KD	ALDH4A1	Aldehyde dehydrogenases, aldehyde dehydrogenase 4 family, member A1			11.11, 11.11	1.64, 0.41	77.47	45.10	99.70	46.70	33.40	NaN	-93.82	35.09	27.39	43.43
CGS001-7915	KD	ALDH5A1	Aldehyde dehydrogenases, aldehyde dehydrogenase 5 family, member A1		Aldehyde dehydrogenases LOF	11.11, 0.00	1.36, 0.36	96.72	-96.24	29.76	-21.78	-65.52	NaN	67.51	-98.20	-97.36	-94.64
CGS001-4329	KD	ALDH6A1	Aldehyde dehydrogenases, aldehyde dehydrogenase 6 family, member A1		Aldehyde dehydrogenases LOF	0.00, 0.00	1.22, 0.28	18.11	-58.26	-27.73	-65.47	-42.92	NaN	-36.95	-99.54	34.01	-64.25
CGS001-501	KD	ALDH7A1	Aldehyde dehydrogenases, aldehyde dehydrogenase 7 family, member A1			0.00, 0.00	1.35, 0.39	-81.95	-68.15	55.50	-99.85	25.46	NaN	-76.29	-99.15	-16.30	-81.30
CGS001-223	KD	ALDH9A1	Aldehyde dehydrogenases, aldehyde dehydrogenase 9 family, member A1			10.00, 10.00	1.42, 0.36	-42.13	15.18	18.16	65.57	33.40	32.00	92.91	99.24	32.88	43.35
CGS001-230	KD	ALDOC	aldolase C, fructose-bisphosphate			10.00, 10.00	1.09, 0.34	-99.90	39.93	-53.32	-99.73	99.37	-96.02	-93.32	-27.39	-29.39	-96.57
CGS001-29880	KD	ALG5	Glycosyltransferase family 2 domain containing, asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)			0.00, 0.00	1.66, 0.41	-74.44	-65.47	-42.39	-63.28	-60.61	NaN	NaN	-82.62	29.80	-71.13
CGS001-79796	KD	ALG9	Dolichyl D-mannosyl phosphate dependent mannosyltransferases, asparagine-linked glycosylation 9, alpha-1,2-mannosyltransferase homolog (S. cerevisiae)			0.00, 0.00	1.01, 0.47	-99.64	NaN	56.26	52.19	26.13	NaN	86.94	-99.49	84.09	54.51
CGS001-238	KD	ALK	Leukocyte tyrosine kinase (LTK) receptor family, anaplastic lymphoma receptor tyrosine kinase			22.22, 22.22	0.83, 0.32	99.48	-40.13	-77.21	-87.08	30.34	NaN	65.38	56.08	99.95	59.47
CGS001-7840	KD	ALMS1	Alstrom syndrome 1			0.00, 0.00	0.82, 0.27	76.75	NaN	-98.41	79.37	-70.85	77.39	38.10	-87.17	-70.96	-77.86
CGS001-8092	KD	ALX1	Homeoboxes / PRD class, ALX homeobox 1			0.00, 0.00	1.24, 0.36	16.96	39.83	83.89	68.00	-48.54	-53.77	85.96	-90.86	-99.75	42.47
CGS001-259	KD	AMBP	Lipocalins, alpha-1-microglobulin/bikunin precursor			0.00, 0.00	1.55, 0.38	25.66	51.28	-36.33	-46.08	29.15	NaN	-73.96	NaN	24.70	-10.91
CGS001-262	KD	AMD1	Decarboxylases, adenosylmethionine decarboxylase 1			0.00, 0.00	1.49, 0.41	-64.54	-41.34	-33.69	24.76	54.19	NaN	-78.11	-10.94	25.15	-11.75
CGS001-51005	KD	AMDHD2	amidohydrolase domain containing 2			0.00, 0.00	1.48, 0.38	-59.37	28.68	-97.35	-96.56	87.81	NaN	-35.38	-99.81	-17.40	-94.23
CGS001-386724	KD	AMIGO3	Immunoglobulin superfamily / Immunoglobulin-like domain containing, adhesion molecule with Ig-like domain 3			0.00, 0.00	1.57, 0.35	-65.96	-27.41	-94.25	-18.78	-25.23	36.41	-92.59	-64.92	37.39	-33.15
CGS001-271	KD	AMPD2	adenosine monophosphate deaminase 2			0.00, 0.00	1.23, 0.39	92.73	17.78	-31.73	24.88	92.07	72.27	70.04	68.87	-52.46	69.37
CGS001-275	KD	AMT	aminomethyltransferase			0.00, 0.00	1.27, 0.43	87.17	-42.34	-35.81	-24.98	-98.72	73.80	-30.77	-82.84	-85.39	-39.48
CGS001-51433	KD	ANAPC5	Anaphase promoting complex subunits, anaphase promoting complex subunit 5			22.22, 22.22	1.58, 0.55	48.04	20.70	-29.51	42.64	52.84	98.81	-22.32	99.95	NaN	42.56
CGS001-284	KD	ANGPT1	Fibrinogen C domain containing, angiopoietin 1			0.00, 0.00	1.03, 0.23	39.75	33.13	-80.39	22.28	-64.21	NaN	68.31	31.16	-99.27	-35.34
CGS001-55608	KD	ANKRD10	Ankyrin repeat domain containing, ankyrin repeat domain 10			12.50, 12.50	1.25, 0.28	75.97	NaN	-99.80	-99.85	23.71	NaN	92.62	36.66	98.48	68.46
CGS001-353322	KD	ANKRD37	Ankyrin repeat domain containing, ankyrin repeat domain 37			10.00, 10.00	1.34, 0.36	88.21	99.96	42.44	26.82	-89.36	-51.46	73.91	38.87	-66.45	62.68
CGS001-54851	KD	ANKRD49	Ankyrin repeat domain containing, ankyrin repeat domain 49			0.00, 0.00	1.41, 0.44	-91.04	21.95	-93.51	-69.64	NaN	NaN	-33.37	-52.71	29.16	-78.24
CGS001-79722	KD	ANKRD55	Ankyrin repeat domain containing, ankyrin repeat domain 55			0.00, 0.00	1.20, 0.43	-18.99	90.24	52.94	29.17	22.47	NaN	-63.38	-29.97	-32.96	4.94
CGS001-55139	KD	ANKZF1	Ankyrin repeat domain containing, ankyrin repeat and zinc finger domain containing 1			0.00, 0.00	1.33, 0.32	-92.58	NaN	-99.56	54.10	58.92	NaN	-96.31	22.87	44.19	-91.92
CGS001-55107	KD	ANO1	Calcium activated chloride channel, anoctamin 1, calcium activated chloride channel			11.11, 11.11	1.50, 0.39	-45.64	52.61	-33.06	20.78	72.10	NaN	-64.96	31.80	99.95	30.06
CGS001-55129	KD	ANO10	Calcium activated chloride channel, anoctamin 10			0.00, 0.00	2.15, 0.68	-69.56	NaN	-99.24	-92.44	NaN	NaN	NaN	-49.75	51.58	-93.06
CGS001-81611	KD	ANP32E	ANP32 acidic nuclear phosphoproteins, acidic (leucine-rich) nuclear phosphoprotein 32 family, member E			0.00, 0.00	2.05, 0.56	72.82	42.84	25.85	67.91	28.15	NaN	49.70	-32.54	57.23	60.58
CGS001-290	KD	ANPEP	Aminopeptidase N, alanyl (membrane) aminopeptidase			0.00, 0.00	1.01, 0.30	28.96	56.73	-74.49	-71.84	-50.75	NaN	-20.65	-98.20	37.09	-47.78
CGS001-302	KD	ANXA2	Annexins, annexin A2			0.00, 0.00	1.15, 0.36	-24.09	54.27	-50.99	-91.45	-48.25	68.21	NaN	-89.16	31.77	-44.66
CGS001-306	KD	ANXA3	Annexins, annexin A3			12.50, 12.50	2.15, 0.81	35.24	92.84	43.31	99.98	NaN	43.07	24.37	51.03	NaN	47.78
CGS001-308	KD	ANXA5	Annexins, annexin A5			10.00, 0.00	1.48, 0.43	54.65	96.75	-20.76	-62.11	-97.69	-29.38	70.52	-97.59	-96.87	-87.86
CGS001-310	KD	ANXA7	Annexins, annexin A7			0.00, 0.00	1.23, 0.22	54.18	-66.59	-65.90	-19.80	21.67	-99.69	29.51	-15.88	-32.04	-27.80
CGS001-8639	KD	AOC3	Oxidoreductases, amine oxidase, copper containing 3 (vascular adhesion protein 1)			0.00, 0.00	1.70, 0.43	-85.60	-100.00	-23.78	31.82	-88.27	-98.54	30.64	-42.18	48.49	-71.23
CGS001-162	KD	AP1B1	adaptor-related protein complex 1, beta 1 subunit			12.50, 12.50	1.47, 0.41	-29.47	-34.29	77.96	99.36	-61.65	NaN	NaN	64.21	-53.94	51.10
CGS001-160	KD	AP2A1	adaptor-related protein complex 2, alpha 1 subunit			0.00, 0.00	1.43, 0.36	54.95	-28.32	60.90	-26.09	93.50	NaN	-45.05	48.59	-28.43	35.71
CGS001-161	KD	AP2A2	adaptor-related protein complex 2, alpha 2 subunit			0.00, 0.00	1.84, 0.64	-99.98	NaN	-99.98	-26.14	-67.89	-99.97	-66.72	32.56	-83.37	-99.95
CGS001-1173	KD	AP2M1	adaptor-related protein complex 2, mu 1 subunit			0.00, 0.00	1.51, 0.38	35.57	66.55	-99.74	-99.95	-99.90	NaN	-96.45	-45.93	-96.02	-99.95
CGS001-323	KD	APBB2	amyloid beta (A4) precursor protein-binding, family B, member 2			12.50, 0.00	2.48, 0.69	-99.31	NaN	96.19	53.08	-61.17	NaN	-29.92	-48.29	-30.86	-45.90
CGS001-324	KD	APC	Armadillo repeat containing, adenomatous polyposis coli			0.00, 0.00	1.57, 0.45	-80.93	-22.29	-19.13	-99.26	-95.40	NaN	-84.84	-98.45	-92.09	-97.61
CGS001-328	KD	APEX1	APEX nuclease (multifunctional DNA repair enzyme) 1			10.00, 10.00	1.33, 0.34	-66.60	42.18	-34.12	-88.36	-89.84	99.94	25.57	-42.86	32.56	-48.44
CGS001-335	KD	APOA1	Apolipoproteins, apolipoprotein A-I			0.00, 0.00	1.43, 0.47	-24.78	-99.65	-17.84	67.49	NaN	-59.99	-60.73	55.60	-72.57	-41.55
CGS001-336	KD	APOA2	Apolipoproteins, apolipoprotein A-II			11.11, 0.00	1.31, 0.40	-23.48	96.13	-46.64	36.76	-90.02	NaN	-18.53	-27.77	-97.70	-17.59
CGS001-116519	KD	APOA5	Apolipoproteins, apolipoprotein A-V			10.00, 0.00	1.09, 0.38	-69.57	58.21	-99.37	24.78	50.85	96.64	-57.48	85.77	-24.45	34.87
CGS001-338	KD	APOB	Apolipoproteins, apolipoprotein B (including Ag(x) antigen)		Apolipoproteins LOF	22.22, 22.22	1.27, 0.40	-27.69	-22.95	-55.46	-99.98	-48.75	97.51	98.50	-99.83	NaN	-28.59
CGS001-164668	KD	APOBEC3H	Apolipoprotein B mRNA editing enzymes, apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3H			33.33, 22.22	1.30, 0.35	-9.48	99.78	-17.59	95.19	98.86	-88.37	NaN	20.82	-29.35	64.07
CGS001-344	KD	APOC2	Apolipoproteins, apolipoprotein C-II		Apolipoproteins LOF	0.00, 0.00	1.42, 0.42	70.14	-97.37	-84.91	-98.42	-33.73	NaN	-25.13	-99.67	79.35	-97.76
CGS001-345	KD	APOC3	Apolipoproteins, apolipoprotein C-III			11.11, 11.11	1.48, 0.36	98.39	28.01	79.23	NaN	52.57	32.52	88.15	25.12	27.24	62.07
CGS001-348	KD	APOE	Apolipoproteins, apolipoprotein E		Apolipoproteins LOF	0.00, 0.00	1.26, 0.35	-29.61	-30.15	29.66	-96.05	49.83	55.29	-89.02	-99.37	NaN	-79.99
CGS001-350	KD	APOH	Apolipoproteins, apolipoprotein H (beta-2-glycoprotein I)			0.00, 0.00	1.38, 0.31	-85.52	-100.00	-91.88	-99.90	-99.98	-77.31	-29.46	-98.66	45.77	-99.87
CGS001-55937	KD	APOM	Apolipoproteins, apolipoprotein M			11.11, 11.11	1.41, 0.40	-38.81	99.89	-77.83	31.62	23.67	NaN	41.80	-22.34	-31.69	15.35
CGS001-79135	KD	APOO	Apolipoproteins, apolipoprotein O			50.00, 37.50	2.55, 0.74	-31.10	33.16	91.63	99.90	61.28	NaN	NaN	95.57	99.40	99.63
CGS001-351	KD	APP	Endogenous ligands, amyloid beta (A4) precursor protein			0.00, 0.00	1.97, 0.70	-97.22	-81.10	-99.21	-98.72	-74.68	-75.62	-44.98	NaN	-99.36	-99.24
CGS001-10513	KD	APPBP2	amyloid beta precursor protein (cytoplasmic tail) binding protein 2			10.00, 10.00	1.58, 0.44	-89.84	-22.73	93.01	85.93	31.54	-34.08	32.28	49.23	99.97	76.35
CGS001-353	KD	APRT	adenine phosphoribosyltransferase			0.00, 0.00	1.34, 0.44	20.55	62.16	22.23	-23.79	19.92	55.29	-16.80	32.12	21.01	4.66
CGS001-375318	KD	AQP12A	Ion channels / Aquaporins, aquaporin 12A			44.44, 44.44	1.72, 0.57	22.12	-91.16	99.98	99.37	99.73	NaN	59.63	-32.45	-90.22	98.53
CGS001-367	KD	AR	Nuclear hormone receptors, androgen receptor			10.00, 10.00	1.07, 0.35	89.33	-99.91	-10.93	24.55	26.37	-28.24	-53.89	67.22	99.81	25.31
CGS001-369	KD	ARAF	RAF family, v-raf murine sarcoma 3611 viral oncogene homolog			33.33, 22.22	0.81, 0.24	99.96	-100.00	-59.57	-71.74	-74.92	NaN	99.35	96.27	29.63	93.13
CGS001-116985	KD	ARAP1	Ankyrin repeat domain containing, ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1			22.22, 22.22	1.34, 0.45	99.33	-96.08	67.75	NaN	99.38	-38.97	-20.67	-77.88	-85.15	-62.59
CGS001-375	KD	ARF1	ADP-ribosylation factors, ADP-ribosylation factor 1			10.00, 10.00	1.15, 0.32	-49.16	33.78	29.82	37.44	-46.64	-31.84	99.59	-26.77	43.79	9.88
CGS001-378	KD	ARF4	ADP-ribosylation factors, ADP-ribosylation factor 4			0.00, 0.00	1.42, 0.42	-99.98	-98.14	-23.42	-24.88	-94.41	-38.41	-68.98	-97.41	-28.83	-96.57
CGS001-382	KD	ARF6	ADP-ribosylation factors, ADP-ribosylation factor 6			30.00, 20.00	1.31, 0.28	-43.95	71.84	95.86	99.73	-58.65	26.05	89.91	93.47	61.21	97.80
CGS001-23647	KD	ARFIP2	ADP-ribosylation factor interacting protein 2			0.00, 0.00	1.08, 0.23	-87.69	-57.71	-84.94	-29.52	-99.51	46.28	-92.90	48.54	23.58	-76.86
CGS001-10139	KD	ARFRP1	ADP-ribosylation factors, ADP-ribosylation factor related protein 1			10.00, 10.00	1.19, 0.25	48.35	62.30	58.62	36.00	-37.25	86.79	29.08	30.31	99.67	56.17
CGS001-383	KD	ARG1	Arginase, arginase, liver			0.00, 0.00	1.38, 0.34	-26.72	-23.32	-74.11	-99.41	20.16	-69.19	-43.13	12.73	-21.03	-42.30
CGS001-384	KD	ARG2	Arginase, arginase, type II			0.00, 0.00	1.27, 0.27	-73.59	-91.11	39.43	NaN	22.22	-95.60	-33.59	-81.53	62.03	-83.84
CGS001-55082	KD	ARGLU1	arginine and glutamate rich 1			12.50, 12.50	1.25, 0.42	-89.27	59.74	-16.85	25.09	-37.52	99.34	NaN	NaN	9.27	5.34
CGS001-392	KD	ARHGAP1	Rho GTPase activating proteins, Rho GTPase activating protein 1		Rho GTPase activating proteins LOF	0.00, 0.00	1.32, 0.41	-82.51	56.69	-98.08	-46.30	-90.06	NaN	-93.81	-98.53	34.89	-96.76
CGS001-2909	KD	ARHGAP35	Rho GTPase activating proteins, Rho GTPase activating protein 35			0.00, 0.00	1.83, 0.49	-28.40	-21.62	-92.63	-34.33	-43.12	NaN	-16.74	-65.40	-53.55	-27.07
CGS001-64333	KD	ARHGAP9	Rho GTPase activating proteins, Rho GTPase activating protein 9			0.00, 0.00	1.73, 0.76	-96.38	NaN	-98.28	-26.58	NaN	48.02	NaN	-50.31	NaN	-93.00
CGS001-397	KD	ARHGDIB	Endogenous ligands, Rho GDP dissociation inhibitor (GDI) beta			11.11, 0.00	1.55, 0.49	-53.04	49.99	-17.84	-99.91	96.41	77.42	57.67	-29.80	NaN	44.11
CGS001-23365	KD	ARHGEF12	Rho guanine nucleotide exchange factors, Rho guanine nucleotide exchange factor (GEF) 12			44.44, 33.33	0.98, 0.31	-84.31	75.53	-31.68	96.22	99.92	NaN	35.58	66.42	99.93	98.62
CGS001-9181	KD	ARHGEF2	Rho guanine nucleotide exchange factors, Rho/Rac guanine nucleotide exchange factor (GEF) 2			55.56, 55.56	1.39, 0.47	99.76	100.00	43.43	99.77	44.14	NaN	81.29	99.77	20.44	99.82
CGS001-7984	KD	ARHGEF5	Rho guanine nucleotide exchange factors, Rho guanine nucleotide exchange factor (GEF) 5			0.00, 0.00	1.17, 0.24	-98.82	-88.47	-15.80	-25.76	-22.88	-88.86	-96.99	14.35	30.37	-94.84
CGS001-9459	KD	ARHGEF6	Rho guanine nucleotide exchange factors, Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6		X linked mental retardation group 2 LOF	11.11, 11.11	1.80, 0.52	40.93	-23.63	94.29	-25.35	37.70	NaN	26.01	-34.66	99.85	26.56
CGS001-8874	KD	ARHGEF7	Rho guanine nucleotide exchange factors, Rho guanine nucleotide exchange factor (GEF) 7			0.00, 0.00	1.33, 0.41	30.55	42.53	-99.98	-99.68	88.66	NaN	-18.82	-68.85	-48.78	-41.96
CGS001-1820	KD	ARID3A	AT rich interactive domain 3A (BRIGHT-like)			0.00, 0.00	1.22, 0.33	-97.58	NaN	-97.53	32.74	-36.01	NaN	-99.70	-97.31	-99.68	-99.92
CGS001-51742	KD	ARID4B	AT rich interactive domain 4B (RBP1-like)			28.57, 0.00	1.47, 0.35	-69.16	NaN	-99.96	95.34	96.42	NaN	NaN	-38.86	-86.29	-74.55
CGS001-84159	KD	ARID5B	AT rich interactive domain 5B (MRF1-like)			0.00, 0.00	1.85, 0.67	33.48	NaN	-99.03	-50.65	43.80	NaN	-55.62	63.14	-26.08	-18.60
CGS001-400	KD	ARL1	ADP-ribosylation factors, ADP-ribosylation factor-like 1			0.00, 0.00	1.74, 0.56	-80.68	-33.14	19.03	26.19	20.52	-99.90	-91.88	-69.35	47.09	-61.20
CGS001-403	KD	ARL3	ADP-ribosylation factors, ADP-ribosylation factor-like 3			0.00, 0.00	1.51, 0.47	-56.52	-22.01	85.82	58.89	73.13	-34.61	-85.91	-72.03	NaN	-25.69
CGS001-10123	KD	ARL4C	ADP-ribosylation factors, ADP-ribosylation factor-like 4C			62.50, 62.50	1.45, 0.49	-18.19	90.91	97.60	99.98	-46.08	NaN	NaN	99.44	99.63	99.89
CGS001-405	KD	ARNT	Basic helix-loop-helix proteins, aryl hydrocarbon receptor nuclear translocator			0.00, 0.00	1.06, 0.35	-86.35	54.68	-73.03	-28.86	88.17	NaN	46.73	36.61	22.83	11.56
CGS001-9915	KD	ARNT2	Basic helix-loop-helix proteins, aryl-hydrocarbon receptor nuclear translocator 2			0.00, 0.00	1.06, 0.26	41.64	-99.78	-99.95	-25.91	84.29	-35.23	-88.16	13.57	48.36	-51.48
CGS001-406	KD	ARNTL	Basic helix-loop-helix proteins, aryl hydrocarbon receptor nuclear translocator-like			0.00, 0.00	2.06, 0.53	-46.07	-19.40	21.78	-25.03	-34.40	NaN	21.92	23.24	20.82	-5.64
CGS001-56938	KD	ARNTL2	Basic helix-loop-helix proteins, aryl hydrocarbon receptor nuclear translocator-like 2			50.00, 30.00	1.27, 0.50	95.79	-29.52	-42.04	99.41	-92.77	30.44	47.55	96.95	98.80	98.97
CGS001-10552	KD	ARPC1A	Actin related protein 2/3 complex subunits, actin related protein 2/3 complex, subunit 1A, 41kDa			0.00, 0.00	1.38, 0.39	-98.24	-83.61	-28.30	-44.95	-30.67	-99.97	-17.82	-62.84	NaN	-91.75
CGS001-10095	KD	ARPC1B	Actin related protein 2/3 complex subunits, actin related protein 2/3 complex, subunit 1B, 41kDa			10.00, 0.00	1.51, 0.44	20.13	-99.43	24.49	-26.03	95.82	-88.81	31.46	-34.56	-99.90	-37.44
CGS001-10109	KD	ARPC2	Actin related protein 2/3 complex subunits, actin related protein 2/3 complex, subunit 2, 34kDa			0.00, 0.00	1.48, 0.42	-57.60	-44.19	21.46	33.91	-22.53	32.87	33.04	-96.88	NaN	-13.36
CGS001-10094	KD	ARPC3	Actin related protein 2/3 complex subunits, actin related protein 2/3 complex, subunit 3, 21kDa			11.11, 0.00	1.20, 0.24	95.78	-98.36	24.03	-26.00	23.30	NaN	61.69	-74.78	28.94	5.77
CGS001-10093	KD	ARPC4	Actin related protein 2/3 complex subunits, actin related protein 2/3 complex, subunit 4, 20kDa			0.00, 0.00	1.16, 0.35	78.11	85.86	61.82	29.04	-98.97	47.97	-30.71	-33.73	62.85	41.66
CGS001-10092	KD	ARPC5	Actin related protein 2/3 complex subunits, actin related protein 2/3 complex, subunit 5, 16kDa			0.00, 0.00	1.38, 0.44	-31.96	59.88	86.96	-76.76	23.02	-80.49	65.52	NaN	-41.33	28.31
CGS001-10776	KD	ARPP19	cAMP-regulated phosphoprotein, 19kDa			14.29, 14.29	3.32, 1.09	-40.73	NaN	-56.34	-26.70	99.48	NaN	NaN	-35.82	-98.22	-41.39
CGS001-408	KD	ARRB1	arrestin, beta 1			0.00, 0.00	1.02, 0.32	-35.34	48.04	56.93	-44.14	-26.21	NaN	42.26	-30.75	-11.96	-8.53
CGS001-170302	KD	ARX	Homeoboxes / PRD class, aristaless related homeobox		PRD class homeoboxes and psudogenes LOF, X linked mental retardation group 2 LOF	12.50, 12.50	1.85, 0.60	85.73	NaN	74.32	-59.82	29.17	98.15	30.22	28.69	NaN	87.60
CGS001-427	KD	ASAH1	Acid ceramidase, N-acylsphingosine amidohydrolase (acid ceramidase) 1			0.00, 0.00	1.09, 0.24	-76.17	NaN	63.59	30.79	59.11	76.32	46.77	30.79	-14.91	27.07
CGS001-8853	KD	ASAP2	Ankyrin repeat domain containing, ArfGAP with SH3 domain, ankyrin repeat and PH domain 2			0.00, 0.00	2.07, 0.77	-98.69	-85.64	-32.55	-90.72	NaN	NaN	-30.82	-37.42	-94.78	-95.38
CGS001-10973	KD	ASCC3	activating signal cointegrator 1 complex subunit 3			22.22, 22.22	1.52, 0.42	-96.18	NaN	-34.88	99.60	28.64	-76.26	65.43	99.89	57.63	58.93
CGS001-25842	KD	ASF1A	ASF1 anti-silencing function 1 homolog A (S. cerevisiae)			0.00, 0.00	1.49, 0.43	-16.65	34.71	-42.21	-23.40	-38.73	-37.09	NaN	-80.82	-40.00	-17.16
CGS001-55723	KD	ASF1B	ASF1 anti-silencing function 1 homolog B (S. cerevisiae)			0.00, 0.00	1.60, 0.44	29.96	21.99	-58.64	-59.70	-98.37	NaN	38.84	37.51	-38.41	-29.93
CGS001-433	KD	ASGR2	C-type lectin domain containing, asialoglycoprotein receptor 2			0.00, 0.00	1.55, 0.56	24.18	71.24	69.31	29.93	22.62	-94.90	80.32	18.52	NaN	27.90
CGS001-9070	KD	ASH2L	Zinc fingers, PHD-type, ash2 (absent, small, or homeotic)-like (Drosophila)			10.00, 0.00	0.98, 0.35	-47.98	-72.17	-99.78	82.56	-30.16	78.88	78.92	79.40	95.98	83.70
CGS001-435	KD	ASL	argininosuccinate lyase			0.00, 0.00	1.11, 0.35	93.60	-89.28	-22.31	-70.40	92.84	35.37	-99.84	44.92	-24.68	-27.31
CGS001-8623	KD	ASMTL	Pseudoautosomal regions / PAR1, acetylserotonin O-methyltransferase-like			33.33, 22.22	2.89, 0.97	40.92	NaN	76.41	99.50	-95.99	97.80	-53.60	30.93	78.75	95.94
CGS001-439	KD	ASNA1	arsA arsenite transporter, ATP-binding, homolog 1 (bacterial)			10.00, 10.00	1.07, 0.48	-23.49	-31.99	-37.24	-23.89	74.04	-82.66	78.88	98.66	-28.56	-8.15
CGS001-440	KD	ASNS	asparagine synthetase (glutamine-hydrolyzing)			11.11, 11.11	0.78, 0.28	-63.46	-97.97	-81.18	-22.92	99.40	NaN	-97.14	-99.27	-72.84	-99.79
CGS001-444	KD	ASPH	aspartate beta-hydroxylase			55.56, 44.44	1.38, 0.34	41.20	100.00	18.09	99.91	32.30	NaN	-37.11	95.45	99.97	99.95
CGS001-80150	KD	ASRGL1	asparaginase like 1			0.00, 0.00	2.06, 0.53	38.75	NaN	-22.14	34.94	40.92	NaN	-80.53	60.15	19.36	11.73
CGS001-445	KD	ASS1	argininosuccinate synthase 1			83.33, 66.67	2.07, 0.61	99.94	NaN	94.06	99.83	NaN	NaN	97.48	99.83	NaN	99.95
CGS001-466	KD	ATF1	basic leucine zipper proteins, activating transcription factor 1			12.50, 0.00	1.03, 0.36	NaN	52.03	38.22	93.68	-93.92	NaN	71.09	97.31	32.68	84.31
CGS001-1386	KD	ATF2	basic leucine zipper proteins, activating transcription factor 2			22.22, 22.22	1.13, 0.53	-39.82	-37.48	43.67	98.14	99.98	NaN	-86.74	44.19	-91.02	-43.21
CGS001-467	KD	ATF3	basic leucine zipper proteins, activating transcription factor 3			11.11, 0.00	1.20, 0.43	62.79	88.00	75.68	79.45	-82.54	NaN	97.30	61.37	-66.75	89.81
CGS001-468	KD	ATF4	basic leucine zipper proteins, activating transcription factor 4 (tax-responsive enhancer element B67)			37.50, 37.50	1.53, 0.43	-98.45	NaN	99.43	60.19	91.19	NaN	99.98	-89.09	-97.54	98.64
CGS001-22809	KD	ATF5	basic leucine zipper proteins, activating transcription factor 5			30.00, 20.00	1.49, 0.31	-67.87	59.28	98.18	42.23	-34.52	-23.87	-81.69	98.28	95.06	90.55
CGS001-22926	KD	ATF6	basic leucine zipper proteins, activating transcription factor 6			0.00, 0.00	1.27, 0.34	-59.42	-70.95	15.90	NaN	-38.81	-86.11	-99.98	-99.11	32.76	-74.73
CGS001-9140	KD	ATG12	ATG12 autophagy related 12 homolog (S. cerevisiae)			10.00, 10.00	1.42, 0.43	56.35	97.75	43.44	36.50	63.02	-34.39	94.64	42.35	-40.69	69.89
CGS001-55054	KD	ATG16L1	WD repeat domain containing, ATG16 autophagy related 16-like 1 (S. cerevisiae)			28.57, 28.57	1.16, 0.35	98.83	NaN	82.73	88.21	86.29	NaN	NaN	99.48	64.73	88.71
CGS001-89849	KD	ATG16L2	WD repeat domain containing, ATG16 autophagy related 16-like 2 (S. cerevisiae)			0.00, 0.00	1.01, 0.17	-35.40	31.33	-98.22	-96.04	-22.10	94.19	29.24	-97.55	-99.95	-99.31
CGS001-64422	KD	ATG3	ATG3 autophagy related 3 homolog (S. cerevisiae)			10.00, 10.00	1.70, 0.55	-70.78	24.03	-81.57	-99.12	26.01	99.97	33.05	-37.58	92.84	-39.35
CGS001-115201	KD	ATG4A	ATG4 autophagy related 4 homolog A (S. cerevisiae)			0.00, 0.00	1.32, 0.44	-96.44	-23.12	-99.50	-46.12	-58.90	NaN	-99.96	-28.78	-98.72	-99.76
CGS001-23192	KD	ATG4B	Aut2 peptidase, ATG4 autophagy related 4 homolog B (S. cerevisiae)			11.11, 0.00	1.77, 0.58	45.66	68.21	-24.63	-96.90	-70.55	-99.56	38.07	96.94	NaN	48.03
CGS001-84971	KD	ATG4D	ATG4 autophagy related 4 homolog D (S. cerevisiae)			11.11, 11.11	0.88, 0.19	56.90	98.29	78.49	NaN	32.06	-90.18	-79.23	50.24	64.08	48.09
CGS001-9474	KD	ATG5	ATG5 autophagy related 5 homolog (S. cerevisiae)			0.00, 0.00	1.07, 0.31	-42.57	72.19	-22.93	-26.39	31.28	-40.93	-97.80	-61.79	33.05	-18.24
CGS001-10533	KD	ATG7	Ubiquitin-like modifier activating enzymes, ATG7 autophagy related 7 homolog (S. cerevisiae)			0.00, 0.00	1.15, 0.44	-92.27	-95.93	17.99	36.81	35.65	-39.39	-33.52	62.32	-23.83	-20.61
CGS001-471	KD	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase			12.50, 12.50	1.41, 0.52	49.83	NaN	79.87	-99.01	-63.26	NaN	99.72	71.52	19.38	62.97
CGS001-23300	KD	ATMIN	Zinc fingers, C2H2-type, ATM interactor			10.00, 0.00	1.40, 0.50	-25.75	-29.73	89.00	-58.73	51.02	-30.93	-69.15	95.99	-83.35	-27.95
CGS001-475	KD	ATOX1	ATX1 antioxidant protein 1 homolog (yeast)			10.00, 10.00	1.36, 0.40	54.75	33.76	99.23	31.15	84.74	78.89	57.70	65.28	63.96	78.97
CGS001-23200	KD	ATP11B	Phospholipid-transporting ATPases, ATPase, class VI, type 11B			20.00, 20.00	1.07, 0.36	99.06	74.52	20.20	-61.89	44.75	-34.50	-32.57	32.62	99.86	48.78
CGS001-478	KD	ATP1A3	ATPases / P-type, ATPase, Na+/K+ transporting, alpha 3 polypeptide			0.00, 0.00	1.50, 0.43	-98.35	-100.00	-97.97	-77.78	-98.37	NaN	-34.50	-99.98	27.72	-99.82
CGS001-481	KD	ATP1B1	ATPases / P-type, ATPase, Na+/K+ transporting, beta 1 polypeptide			10.00, 10.00	1.00, 0.25	19.32	-32.31	-77.59	-95.57	22.01	99.97	-27.63	-84.01	21.15	-30.12
CGS001-488	KD	ATP2A2	Calcium-ATPases, ATPase, Ca++ transporting, cardiac muscle, slow twitch 2			0.00, 0.00	1.67, 0.43	-66.91	-74.96	-51.43	25.04	-44.35	NaN	-88.82	-81.70	-20.08	-67.59
CGS001-27032	KD	ATP2C1	Calcium-ATPases, ATPase, Ca++ transporting, type 2C, member 1			0.00, 0.00	1.51, 0.47	-57.70	57.52	-89.96	-99.98	86.46	78.16	-82.20	-56.28	87.67	75.27
CGS001-498	KD	ATP5A1	ATPases / F-type, ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle			0.00, 0.00	0.94, 0.25	36.20	48.26	82.99	87.72	58.48	37.82	-45.18	92.95	-51.90	75.08
CGS001-506	KD	ATP5B	ATPases / F-type, ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide			0.00, 0.00	1.16, 0.31	46.81	-82.10	-77.46	26.41	39.23	-98.85	64.78	26.57	-89.52	-53.28
CGS001-509	KD	ATP5C1	ATPases / F-type, ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1			22.22, 22.22	1.85, 0.42	38.36	24.50	99.84	38.83	59.68	NaN	99.96	-35.43	93.85	87.18
CGS001-513	KD	ATP5D	ATPases / F-type, ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit			0.00, 0.00	1.53, 0.49	-99.56	NaN	-91.67	-99.98	-99.98	-20.77	-99.16	-99.83	-53.26	-99.89
CGS001-515	KD	ATP5F1	ATPases / F-type, ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1			0.00, 0.00	1.67, 0.44	-22.37	49.72	-17.34	13.78	69.67	NaN	94.64	18.90	29.46	17.62
CGS001-10476	KD	ATP5H	ATPases / F-type, ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d			50.00, 40.00	2.47, 0.81	93.61	41.83	99.96	96.03	92.02	99.97	99.96	90.75	22.30	99.89
CGS001-10632	KD	ATP5L	ATPases / F-type, ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G			0.00, 0.00	1.47, 0.36	-66.10	-58.47	-99.87	-95.93	-99.78	NaN	-44.76	-86.95	11.31	-95.48
CGS001-539	KD	ATP5O	ATPases / F-type, ATP synthase, H+ transporting, mitochondrial F1 complex, O subunit			0.00, 0.00	1.63, 0.41	-73.58	21.31	-41.30	50.70	48.84	NaN	83.68	-67.85	-73.89	-51.12
CGS001-27109	KD	ATP5S	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit s (factor B)			0.00, 0.00	1.11, 0.34	-26.60	-24.76	-73.31	-82.41	-72.97	NaN	94.63	10.83	65.60	-66.31
CGS001-537	KD	ATP6AP1	ATPase, H+ transporting, lysosomal accessory protein 1			0.00, 0.00	1.48, 0.36	-73.82	-76.34	-99.75	-27.64	-27.10	NaN	-95.99	80.21	-21.51	-70.73
CGS001-535	KD	ATP6V0A1	ATPases / V-type, ATPase, H+ transporting, lysosomal V0 subunit a1			0.00, 0.00	2.09, 0.60	34.68	NaN	-29.38	82.87	NaN	83.52	-40.15	-23.39	NaN	47.01
CGS001-533	KD	ATP6V0B	ATPases / V-type, ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b		V type ATPases LOF	20.00, 20.00	1.31, 0.25	14.25	99.98	-44.89	99.80	-21.27	-98.37	-86.69	-74.85	78.61	-44.79
CGS001-523	KD	ATP6V1A	ATPases / V-type, ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A		V type ATPases LOF	10.00, 0.00	1.33, 0.38	-61.84	-21.56	-35.51	-99.96	95.18	-33.52	-93.00	-98.83	-97.43	-98.41
CGS001-51382	KD	ATP6V1D	ATPases / V-type, ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D			0.00, 0.00	1.57, 0.36	12.09	-99.74	-95.87	-28.38	-96.72	-96.14	-91.22	-68.96	-29.05	-99.13
CGS001-9296	KD	ATP6V1F	ATPases / V-type, ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F		V type ATPases LOF	0.00, 0.00	1.48, 0.33	-87.00	NaN	-77.32	-62.18	-62.68	-99.76	-66.45	-27.32	-99.92	-95.21
CGS001-538	KD	ATP7A	ATPases / P-type, ATPase, Cu++ transporting, alpha polypeptide			0.00, 0.00	1.03, 0.27	-29.71	54.59	-18.77	-63.24	-56.30	-99.94	94.76	-23.85	NaN	-20.21
CGS001-545	KD	ATR	ATR subfamily, ataxia telangiectasia and Rad3 related			0.00, 0.00	1.32, 0.32	-41.77	-99.72	-78.78	-64.89	-25.82	-98.85	-99.56	-81.38	-98.45	-99.87
CGS001-546	KD	ATRX	alpha thalassemia/mental retardation syndrome X-linked			0.00, 0.00	1.60, 0.47	-98.44	-99.38	-99.66	-44.85	-32.15	NaN	-78.27	-76.02	38.51	-99.37
CGS001-4287	KD	ATXN3	Ataxins, ataxin 3			10.00, 10.00	1.22, 0.33	-51.34	66.60	-53.43	32.45	-75.79	99.20	59.20	-65.72	86.37	27.32
CGS001-6790	KD	AURKA	Aurora kinase, aurora kinase A			0.00, 0.00	0.66, 0.15	93.04	-100.00	-81.66	-97.14	-31.80	NaN	-99.09	-93.73	-24.49	-99.87
CGS001-54998	KD	AURKAIP1	aurora kinase A interacting protein 1			0.00, 0.00	1.17, 0.28	-76.27	NaN	-56.96	-85.60	24.19	NaN	-25.19	-94.35	-91.61	-87.25
CGS001-9212	KD	AURKB	Aurora kinase, aurora kinase B			0.00, 0.00	2.18, 0.84	-32.38	30.85	-97.06	-86.21	-51.54	NaN	-92.67	-87.60	-99.80	-96.06
CGS001-8312	KD	AXIN1	Serine/threonine phosphatases / Protein phosphatase 1, regulatory subunits, axin 1			0.00, 0.00	1.20, 0.41	-60.13	NaN	-29.18	-31.96	-78.56	NaN	NaN	78.73	34.63	-37.03
CGS001-8313	KD	AXIN2	axin 2			0.00, 0.00	1.50, 0.28	40.64	-100.00	-15.83	NaN	86.57	-22.70	-26.34	-32.00	-53.79	-14.26
CGS001-558	KD	AXL	Fibronectin type III domain containing, AXL receptor tyrosine kinase			11.11, 11.11	1.67, 0.47	-44.99	100.00	16.75	-99.05	-99.26	NaN	-92.10	-98.57	-43.55	-99.21
CGS001-563	KD	AZGP1	Immunoglobulin superfamily / C1-set domain containing, alpha-2-glycoprotein 1, zinc-binding			0.00, 0.00	1.56, 0.48	-52.31	84.99	28.88	-41.63	-97.69	NaN	-22.44	70.03	-83.13	-24.29
CGS001-567	KD	B2M	Immunoglobulin superfamily / C1-set domain containing, beta-2-microglobulin			0.00, 0.00	1.59, 0.50	38.80	67.81	40.30	34.82	-17.21	-37.36	-41.90	24.79	25.60	11.61
CGS001-26229	KD	B3GAT3	Beta-1,3-glucuronyltransferases, beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)			0.00, 0.00	0.89, 0.28	29.16	22.03	-75.30	-54.25	34.63	29.43	NaN	-67.10	-95.05	-46.23
CGS001-11041	KD	B3GNT1	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 1			0.00, 0.00	1.19, 0.27	-59.54	85.71	-99.98	-99.94	35.49	-67.39	-62.62	-95.15	70.08	-84.22
CGS001-2583	KD	B4GALNT1	Beta 4-glycosyltransferases, beta-1,4-N-acetyl-galactosaminyl transferase 1			0.00, 0.00	1.35, 0.35	-45.86	-75.90	-19.21	-26.51	32.24	-94.00	85.35	-21.62	18.94	-7.13
CGS001-2683	KD	B4GALT1	Beta 4-glycosyltransferases, UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1			12.50, 12.50	1.20, 0.43	-38.18	NaN	-76.81	-81.94	-25.14	NaN	99.96	-66.69	-26.55	-53.50
CGS001-8703	KD	B4GALT3	Beta 4-glycosyltransferases, UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3			0.00, 0.00	1.49, 0.44	-28.34	24.00	88.65	-23.37	40.44	-60.62	NaN	23.76	-21.97	4.04
CGS001-8702	KD	B4GALT4	Beta 4-glycosyltransferases, UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 4			11.11, 11.11	1.67, 0.43	74.78	99.82	-67.96	-99.23	-24.72	NaN	-48.23	-66.45	-23.39	-60.17
CGS001-23621	KD	BACE1	Pepsin, beta-site APP-cleaving enzyme 1			0.00, 0.00	1.33, 0.35	-38.08	54.28	41.82	-48.68	23.83	78.87	29.92	44.06	70.17	38.04
CGS001-25825	KD	BACE2	Pepsin, beta-site APP-cleaving enzyme 2			0.00, 0.00	0.97, 0.26	-82.78	NaN	-91.01	-90.88	-82.18	NaN	NaN	21.32	-83.89	-90.46
CGS001-571	KD	BACH1	BTB/POZ domain containing, BTB and CNC homology 1, basic leucine zipper transcription factor 1			90.00, 80.00	1.55, 0.51	99.51	87.42	99.85	99.96	99.94	99.93	97.94	95.03	99.85	99.95
CGS001-60468	KD	BACH2	BTB/POZ domain containing, BTB and CNC homology 1, basic leucine zipper transcription factor 2			10.00, 10.00	1.11, 0.42	-98.07	34.59	98.95	-75.29	-37.56	26.15	-93.36	26.79	-33.42	-52.75
CGS001-573	KD	BAG1	BCL2-associated athanogene			0.00, 0.00	1.24, 0.52	45.84	21.58	87.34	84.06	-27.69	NaN	27.28	62.27	25.89	61.73
CGS001-9531	KD	BAG3	BCL2-associated athanogene 3			0.00, 0.00	1.42, 0.42	-73.27	93.08	-99.94	-32.59	-20.00	-79.15	-96.79	-43.60	-99.62	-92.00
CGS001-7917	KD	BAG6	BCL2-associated athanogene 6			0.00, 0.00	1.52, 0.26	-96.67	-99.96	-97.25	-99.47	35.36	-30.91	-94.57	-93.80	-99.67	-99.92
CGS001-578	KD	BAK1	BCL2-antagonist/killer 1			10.00, 10.00	1.57, 0.51	-24.13	100.00	28.59	50.47	-69.10	-29.72	21.95	42.14	82.66	31.23
CGS001-25805	KD	BAMBI	BMP and activin membrane-bound inhibitor homolog (Xenopus laevis)			0.00, 0.00	1.50, 0.48	89.75	NaN	89.60	70.21	58.30	NaN	NaN	-41.22	82.90	90.80
CGS001-56033	KD	BARX1	Homeoboxes / ANTP class : NKL subclass, BARX homeobox 1			0.00, 0.00	1.35, 0.39	-30.81	-90.74	34.29	-49.63	30.74	26.16	72.64	-74.92	NaN	-18.69
CGS001-581	KD	BAX	BCL2-associated X protein			0.00, 0.00	2.24, 0.65	-30.81	-28.37	-96.86	57.50	-35.95	NaN	-21.54	-27.53	16.43	-6.55
CGS001-9031	KD	BAZ1B	Zinc fingers, PHD-type, bromodomain adjacent to zinc finger domain, 1B			0.00, 0.00	1.28, 0.34	-50.31	27.57	-84.12	-99.93	25.26	90.88	-96.68	-80.70	-99.92	-91.08
CGS001-29994	KD	BAZ2B	Zinc fingers, PHD-type, bromodomain adjacent to zinc finger domain, 2B			0.00, 0.00	1.48, 0.43	-85.12	-34.04	-96.65	28.41	25.17	-66.45	NaN	43.44	-99.62	-69.01
CGS001-27113	KD	BBC3	BCL2 binding component 3			0.00, 0.00	1.22, 0.36	-59.74	-15.18	-99.93	-28.28	-99.98	-64.76	-89.34	40.83	-57.10	-69.35
CGS001-27241	KD	BBS9	Bardet-Biedl syndrome 9			0.00, 0.00	1.28, 0.28	79.89	NaN	-63.50	-84.65	-40.03	-87.44	-57.21	-28.33	22.52	-52.06
CGS001-9564	KD	BCAR1	Cas scaffolding proteins, breast cancer anti-estrogen resistance 1			0.00, 0.00	1.43, 0.43	-22.65	69.15	-80.42	NaN	36.87	-99.14	NaN	26.84	-41.79	-37.06
CGS001-586	KD	BCAT1	branched chain amino-acid transaminase 1, cytosolic			0.00, 0.00	2.11, 0.61	-61.97	80.85	-27.08	80.19	-47.13	NaN	-98.84	-30.81	-47.35	-23.13
CGS001-587	KD	BCAT2	branched chain amino-acid transaminase 2, mitochondrial			0.00, 0.00	1.36, 0.38	61.02	NaN	-58.11	55.54	83.09	43.94	NaN	-96.23	-25.16	29.45
CGS001-56647	KD	BCCIP	BRCA2 and CDKN1A interacting protein			0.00, 0.00	2.02, 0.44	-24.77	-91.31	-17.48	-85.17	56.25	-81.87	-19.89	-35.75	-24.87	-41.42
CGS001-593	KD	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide			0.00, 0.00	1.23, 0.35	41.49	85.35	-91.38	-75.92	-82.80	-36.83	-70.78	-15.33	-24.35	-59.17
CGS001-10295	KD	BCKDK	Pyruvate dehydrogenase kinase (PDHK) family, branched chain ketoacid dehydrogenase kinase			0.00, 0.00	1.63, 0.47	81.31	-99.93	93.79	56.66	-67.48	NaN	-18.82	-91.37	94.98	76.28
CGS001-8915	KD	BCL10	B-cell CLL/lymphoma 10			0.00, 0.00	1.01, 0.28	-70.90	NaN	45.95	40.10	-43.80	NaN	-91.48	89.69	17.98	-28.59
CGS001-596	KD	BCL2	Serine/threonine phosphatases / Protein phosphatase 1, regulatory subunits, B-cell CLL/lymphoma 2			0.00, 0.00	1.05, 0.14	45.23	-46.37	-53.07	-97.83	-68.41	-48.07	-19.11	54.28	-64.61	-37.94
CGS001-597	KD	BCL2A1	BCL2-related protein A1			10.00, 10.00	1.15, 0.35	-99.95	-50.60	22.98	-50.29	-34.55	59.21	-70.61	-65.81	99.97	-47.34
CGS001-598	KD	BCL2L1	Serine/threonine phosphatases / Protein phosphatase 1, regulatory subunits, BCL2-like 1			11.11, 11.11	1.40, 0.48	99.87	94.56	49.53	87.09	57.40	NaN	27.59	-99.09	-99.97	93.79
CGS001-10018	KD	BCL2L11	BCL2-like 11 (apoptosis facilitator)			12.50, 12.50	2.18, 0.60	35.50	99.98	31.84	72.23	-95.80	65.16	29.57	NaN	NaN	58.96
CGS001-23786	KD	BCL2L13	BCL2-like 13 (apoptosis facilitator)			0.00, 0.00	1.55, 0.47	23.97	-61.04	-27.29	-13.60	-99.58	NaN	-80.58	-98.02	-22.92	-87.86
CGS001-599	KD	BCL2L2	Serine/threonine phosphatases / Protein phosphatase 1, regulatory subunits, BCL2-like 2			12.50, 12.50	1.02, 0.26	-17.34	NaN	-98.74	61.39	32.23	NaN	37.56	99.96	46.31	46.95
CGS001-602	KD	BCL3	Ankyrin repeat domain containing, B-cell CLL/lymphoma 3			25.00, 12.50	1.18, 0.49	99.27	NaN	95.78	81.27	42.58	NaN	-48.41	-89.56	-50.91	86.00
CGS001-604	KD	BCL6	BTB/POZ domain containing, B-cell CLL/lymphoma 6			22.22, 22.22	1.32, 0.40	-70.50	-96.02	26.12	-25.35	94.53	NaN	31.25	99.73	99.31	94.08
CGS001-255877	KD	BCL6B	BTB/POZ domain containing, B-cell CLL/lymphoma 6, member B			0.00, 0.00	1.83, 0.72	78.07	NaN	21.51	32.38	35.86	27.77	NaN	35.13	NaN	25.12
CGS001-9275	KD	BCL7B	B-cell CLL/lymphoma 7B			30.00, 30.00	0.91, 0.20	98.26	-39.97	99.20	-19.45	75.73	23.17	-37.12	99.77	90.80	94.50
CGS001-607	KD	BCL9	B-cell CLL/lymphoma 9			0.00, 0.00	1.07, 0.28	51.83	-56.39	-44.63	-99.98	-36.94	NaN	37.65	-95.71	-99.97	-97.22
CGS001-9774	KD	BCLAF1	BCL2-associated transcription factor 1			0.00, 0.00	1.25, 0.32	54.72	-38.15	-67.68	22.56	-29.93	NaN	-34.83	40.45	-22.71	-11.99
CGS001-613	KD	BCR	Rho guanine nucleotide exchange factors, breakpoint cluster region			0.00, 0.00	0.82, 0.22	-83.38	-91.89	-99.92	-24.73	-65.13	54.43	-33.68	-95.30	-31.27	-95.29
CGS001-622	KD	BDH1	Short chain dehydrogenase/reductase superfamily / Classical SDR fold cluster 2, 3-hydroxybutyrate dehydrogenase, type 1			0.00, 0.00	0.86, 0.24	-97.12	-91.34	-54.45	-97.13	30.01	40.36	-85.75	-41.77	-99.97	-90.62
CGS001-624	KD	BDKRB2	Bradykinin receptors, bradykinin receptor B2			10.00, 10.00	1.40, 0.45	-29.87	-66.89	78.14	99.98	-24.78	-33.51	92.68	-35.75	-88.73	-7.68
CGS001-8678	KD	BECN1	beclin 1, autophagy related			10.00, 0.00	1.13, 0.38	34.69	-87.85	86.96	-96.78	-41.98	95.71	-28.59	39.18	-16.05	-13.66
CGS001-8553	KD	BHLHE40	Basic helix-loop-helix proteins, basic helix-loop-helix family, member e40			0.00, 0.00	1.38, 0.31	-43.31	49.51	-98.01	-48.77	-99.93	NaN	NaN	89.97	39.06	-71.91
CGS001-635	KD	BHMT	betaine--homocysteine S-methyltransferase			12.50, 12.50	1.86, 0.60	-89.12	NaN	99.31	-51.05	39.99	NaN	78.16	-32.58	18.64	36.27
CGS001-23743	KD	BHMT2	betaine--homocysteine S-methyltransferase 2			0.00, 0.00	1.84, 0.55	-21.47	-54.00	-21.01	-58.10	-21.37	-33.06	-61.05	NaN	NaN	-30.77
CGS001-637	KD	BID	Endogenous ligands, BH3 interacting domain death agonist			0.00, 0.00	1.08, 0.24	-35.91	-98.89	-96.29	-87.95	-25.09	-96.70	31.68	-19.35	56.73	-85.78
CGS001-638	KD	BIK	BCL2-interacting killer (apoptosis-inducing)			0.00, 0.00	1.19, 0.19	21.94	-51.76	-41.63	30.79	-99.46	26.66	53.17	-29.03	-22.45	-11.89
CGS001-329	KD	BIRC2	Inhibitors of apoptosis (IAP) protein family, baculoviral IAP repeat containing 2		Baculoviral IAP repeat domain containing LOF	11.11, 11.11	0.81, 0.25	-35.36	NaN	-15.58	98.67	24.99	59.38	-24.67	88.30	-99.50	38.27
CGS001-330	KD	BIRC3	Inhibitors of apoptosis (IAP) protein family, baculoviral IAP repeat containing 3		Baculoviral IAP repeat domain containing LOF	11.11, 11.11	1.52, 0.56	-86.01	22.81	-18.02	-97.50	-94.45	NaN	-23.13	-66.03	99.18	-79.95
CGS001-332	KD	BIRC5	Inhibitors of apoptosis (IAP) protein family, baculoviral IAP repeat containing 5			0.00, 0.00	1.65, 0.24	-61.51	84.39	-98.89	-99.96	87.43	-93.84	-99.34	-53.79	-32.35	-99.61
CGS001-57448	KD	BIRC6	Inhibitors of apoptosis (IAP) protein family, baculoviral IAP repeat containing 6			0.00, 0.00	1.89, 0.55	-95.14	-87.71	-95.80	-30.63	25.22	-69.37	-99.98	-44.26	32.55	-81.13
CGS001-10904	KD	BLCAP	bladder cancer associated protein			0.00, 0.00	2.91, 0.91	NaN	NaN	-31.91	-95.27	-52.20	-46.68	NaN	-37.37	-83.02	-85.07
CGS001-641	KD	BLM	Bloom syndrome, RecQ helicase-like			0.00, 0.00	1.47, 0.57	-69.32	-97.67	-86.22	-99.57	-21.63	NaN	-60.46	-97.72	19.18	-96.21
CGS001-642	KD	BLMH	bleomycin hydrolase			11.11, 11.11	1.22, 0.35	-28.16	NaN	45.27	-88.05	25.78	32.24	99.48	11.76	-43.43	14.03
CGS001-2647	KD	BLOC1S1	Biogenesis of lysosomal organelles complex-1 subunits, biogenesis of lysosomal organelles complex-1, subunit 1			11.11, 11.11	1.38, 0.38	98.65	34.86	94.69	80.09	-63.26	-32.57	-85.55	21.90	NaN	59.95
CGS001-644	KD	BLVRA	biliverdin reductase A			0.00, 0.00	0.85, 0.24	-95.56	-99.21	-40.98	-88.54	-23.15	-99.66	-95.87	-92.73	30.13	-95.27
CGS001-8548	KD	BLZF1	basic leucine zipper nuclear factor 1			12.50, 12.50	1.61, 0.64	90.07	99.69	-26.04	27.30	-31.78	NaN	27.70	-26.00	NaN	15.49
CGS001-648	KD	BMI1	Polycomb group ring fingers, BMI1 polycomb ring finger oncogene			0.00, 0.00	1.28, 0.42	92.79	NaN	23.16	92.22	94.63	NaN	33.28	50.05	-99.74	91.74
CGS001-650	KD	BMP2	Bone morphogenetic proteins, bone morphogenetic protein 2			11.11, 11.11	1.34, 0.47	54.97	99.23	71.49	55.60	21.19	NaN	91.68	73.41	26.87	70.19
CGS001-652	KD	BMP4	Bone morphogenetic proteins, bone morphogenetic protein 4			0.00, 0.00	1.18, 0.38	-58.72	76.80	-88.74	-34.71	53.11	NaN	17.28	35.92	-85.71	-44.98
CGS001-657	KD	BMPR1A	Type I receptor serine/threonine kinases, bone morphogenetic protein receptor, type IA		BMP Signaling LOF	0.00, 0.00	1.42, 0.48	-29.21	-95.34	22.52	54.89	-34.13	NaN	-99.45	-94.13	-41.73	-64.18
CGS001-662	KD	BNIP1	BCL2/adenovirus E1B 19kDa interacting protein 1			20.00, 10.00	1.31, 0.33	30.03	-22.38	96.03	75.77	-33.92	72.65	98.65	-40.13	-47.55	78.45
CGS001-663	KD	BNIP2	BCL2/adenovirus E1B 19kDa interacting protein 2			0.00, 0.00	1.70, 0.55	-33.25	22.58	68.20	-77.53	-55.21	-44.65	20.83	NaN	-95.18	-26.37
CGS001-664	KD	BNIP3	BCL2/adenovirus E1B 19kDa interacting protein 3			0.00, 0.00	1.18, 0.39	-99.82	-27.02	-87.59	-42.27	-33.22	-54.17	-78.99	-59.91	-66.81	-63.86
CGS001-665	KD	BNIP3L	BCL2/adenovirus E1B 19kDa interacting protein 3-like			0.00, 0.00	1.06, 0.23	-83.15	-42.88	-28.60	-37.08	-97.71	-32.81	-36.05	-99.93	23.68	-44.51
CGS001-149428	KD	BNIPL	BCL2/adenovirus E1B 19kD interacting protein like			14.29, 14.29	1.73, 0.67	25.30	99.54	88.63	37.70	23.46	76.08	NaN	NaN	NaN	72.45
CGS001-51027	KD	BOLA1	bolA homolog 1 (E. coli)			25.00, 25.00	1.45, 0.40	-49.84	-78.34	97.90	99.89	NaN	NaN	75.77	-26.91	-48.29	77.02
CGS001-670	KD	BPHL	biphenyl hydrolase-like (serine hydrolase)			0.00, 0.00	1.59, 0.35	-99.98	-99.69	-79.67	-99.57	-27.48	-97.53	94.45	-98.59	-84.70	-99.92
CGS001-673	KD	BRAF	RAF family, v-raf murine sarcoma viral oncogene homolog B1			10.00, 0.00	0.98, 0.20	90.04	95.50	-99.65	-41.47	36.97	-27.64	-92.91	-39.23	37.12	22.34
CGS001-672	KD	BRCA1	Fanconi anemia, complementation groups, breast cancer 1, early onset			10.00, 0.00	1.19, 0.26	-59.29	39.16	-13.48	-20.58	-76.40	35.57	-91.95	56.32	96.49	-18.49
CGS001-675	KD	BRCA2	Fanconi anemia, complementation groups, breast cancer 2, early onset			0.00, 0.00	1.26, 0.35	-87.60	-46.48	-53.30	-32.37	-81.50	-51.99	-37.51	34.80	32.09	-37.90
CGS001-6046	KD	BRD2	Bromodomain kinase (BRDK) family, bromodomain containing 2			62.50, 50.00	1.30, 0.48	97.07	98.89	68.46	NaN	-33.93	NaN	52.64	99.83	99.97	99.89
CGS001-8019	KD	BRD3	Bromodomain kinase (BRDK) family, bromodomain containing 3			0.00, 0.00	1.20, 0.33	-92.48	-100.00	-64.39	NaN	93.87	-49.28	-26.45	-98.96	39.83	-89.00
CGS001-23476	KD	BRD4	Bromodomain kinase (BRDK) family, bromodomain containing 4			11.11, 11.11	1.36, 0.39	-84.31	97.75	-93.14	NaN	-63.37	-90.38	-99.98	-97.86	36.24	-99.03
CGS001-55290	KD	BRF2	BRF2, subunit of RNA polymerase III transcription initiation factor, BRF1-like			0.00, 0.00	2.49, 0.88	-45.95	NaN	64.48	51.39	57.32	NaN	NaN	NaN	NaN	52.48
CGS001-25874	KD	BRP44	brain protein 44			11.11, 0.00	1.40, 0.51	-64.66	NaN	-28.88	-72.77	-31.78	69.61	31.58	37.34	97.48	16.77
CGS001-7862	KD	BRPF1	Non-enzymatic BRD containing proteins, bromodomain and PHD finger containing, 1			0.00, 0.00	1.17, 0.24	-95.52	-99.37	-99.15	20.81	NaN	NaN	-99.98	-29.51	-25.41	-99.90
CGS001-27154	KD	BRPF3	Non-enzymatic BRD containing proteins, bromodomain and PHD finger containing, 3			0.00, 0.00	1.82, 0.69	-97.46	-19.19	-74.66	22.10	-48.93	-98.91	-64.90	-22.22	24.69	-51.76
CGS001-22903	KD	BTBD3	BTB/POZ domain containing, BTB (POZ) domain containing 3			12.50, 12.50	2.42, 0.69	NaN	NaN	-78.95	97.88	-84.75	-49.79	24.31	-36.66	34.03	-25.25
CGS001-694	KD	BTG1	B-cell translocation gene 1, anti-proliferative			0.00, 0.00	1.69, 0.51	-97.67	NaN	-72.62	NaN	-84.23	-97.43	-29.12	-99.83	-88.93	-97.87
CGS001-7832	KD	BTG2	BTG family, member 2			0.00, 0.00	1.09, 0.32	-9.17	-28.41	-22.29	-99.83	-99.94	48.68	-99.62	-58.98	51.60	-82.01
CGS001-10950	KD	BTG3	BTG family, member 3			14.29, 14.29	1.30, 0.38	NaN	NaN	99.74	-49.60	36.93	NaN	-46.67	-32.84	75.32	65.44
CGS001-695	KD	BTK	Pleckstrin homology (PH) domain containing, Bruton agammaglobulinemia tyrosine kinase			0.00, 0.00	1.10, 0.27	-30.77	63.23	15.18	27.72	-21.01	32.25	27.73	-21.62	24.61	3.32
CGS001-8945	KD	BTRC	F-boxes / WD-40 domains, beta-transducin repeat containing			0.00, 0.00	1.44, 0.43	-22.58	-29.57	-89.07	-37.31	-21.00	NaN	-39.15	84.78	62.17	-7.18
CGS001-699	KD	BUB1	Bub family, budding uninhibited by benzimidazoles 1 homolog (yeast)			62.50, 62.50	1.57, 0.61	97.73	-25.33	98.84	NaN	58.98	NaN	98.95	99.98	91.26	98.29
CGS001-701	KD	BUB1B	Bub family, budding uninhibited by benzimidazoles 1 homolog beta (yeast)			20.00, 10.00	1.49, 0.35	88.08	-99.89	-44.38	-99.36	-60.11	98.39	-90.28	36.55	96.75	-86.47
CGS001-9184	KD	BUB3	WD repeat domain containing, budding uninhibited by benzimidazoles 3 homolog (yeast)			0.00, 0.00	2.07, 0.38	-87.36	-99.58	-83.76	-86.21	-68.10	NaN	-99.10	-42.09	28.47	-95.08
CGS001-84811	KD	BUD13	BUD13 homolog (S. cerevisiae)			44.44, 22.22	1.19, 0.41	22.48	95.66	49.88	99.98	57.46	NaN	54.21	99.11	26.25	95.64
CGS001-8896	KD	BUD31	BUD31 homolog (S. cerevisiae)			12.50, 12.50	1.34, 0.41	-27.26	99.28	-36.05	-28.22	NaN	-54.52	-64.84	86.42	NaN	-29.11
CGS001-28969	KD	BZW2	basic leucine zipper and W2 domains 2			14.29, 14.29	1.60, 0.50	NaN	NaN	-97.62	40.84	-64.38	NaN	-97.58	57.85	97.69	-95.36
CGS001-283450	KD	C12ORF51	chromosome 12 open reading frame 51			0.00, 0.00	1.49, 0.58	-67.51	-21.26	-90.52	-22.23	-32.00	30.81	18.81	-24.08	NaN	-6.99
CGS001-29965	KD	C16ORF5	chromosome 16 open reading frame 5			0.00, 0.00	1.67, 0.57	77.48	29.17	71.26	-51.05	NaN	NaN	27.49	31.90	-86.07	15.18
CGS001-29105	KD	C16ORF80	chromosome 16 open reading frame 80			30.00, 30.00	1.36, 0.40	97.86	98.40	-74.87	-78.78	47.96	99.90	-23.57	23.56	-65.51	78.09
CGS001-56005	KD	C19ORF10	chromosome 19 open reading frame 10			0.00, 0.00	1.19, 0.48	-39.11	NaN	-43.47	-99.78	-98.34	-99.88	-61.97	-62.77	86.94	-96.26
CGS001-55765	KD	C1ORF106	chromosome 1 open reading frame 106			22.22, 11.11	1.70, 0.56	95.98	-95.50	94.44	91.07	38.46	NaN	-57.42	-19.03	99.97	87.12
CGS001-708	KD	C1QBP	complement component 1, q subcomponent binding protein			30.00, 30.00	1.16, 0.38	20.79	26.56	42.02	27.53	-99.91	99.97	99.98	35.74	98.50	82.71
CGS001-114904	KD	C1QTNF6	C1q and tumor necrosis factor related protein 6			0.00, 0.00	1.15, 0.36	-94.97	NaN	-67.33	-70.98	-26.32	NaN	53.32	-56.63	-28.59	-71.18
CGS001-716	KD	C1S	Complement system, complement component 1, s subcomponent			33.33, 22.22	1.27, 0.48	84.69	29.47	30.86	-27.72	99.96	NaN	76.57	98.92	50.39	96.35
CGS001-717	KD	C2	Complement system, complement component 2			30.00, 20.00	1.66, 0.58	88.68	-37.07	95.28	66.56	31.89	98.53	98.24	82.93	33.43	94.73
CGS001-25966	KD	C2CD2	C2 calcium-dependent domain containing 2		C2 domain containing LOF	0.00, 0.00	1.78, 0.53	NaN	31.79	-66.93	-99.98	-64.95	-87.66	53.13	-98.91	-97.72	-97.57
CGS001-9854	KD	C2CD2L	C2CD2-like			0.00, 0.00	2.13, 0.86	-93.27	-91.04	31.45	-33.67	47.53	NaN	42.32	-85.56	22.92	-64.55
CGS001-6936	KD	C2ORF3	chromosome 2 open reading frame 3			0.00, 0.00	1.61, 0.53	-77.49	NaN	-92.17	NaN	-95.94	NaN	20.65	-18.06	63.31	-90.49
CGS001-718	KD	C3	Endogenous ligands, complement component 3			0.00, 0.00	1.11, 0.32	-25.42	91.66	19.11	-97.40	-99.67	-88.06	-13.67	90.02	-99.89	-96.23
CGS001-727	KD	C5	Endogenous ligands, complement component 5			0.00, 0.00	1.58, 0.51	-33.34	70.80	-36.96	-96.78	53.67	-98.86	23.31	NaN	NaN	-37.32
CGS001-85027	KD	C5ORF62	chromosome 5 open reading frame 62			0.00, 0.00	1.40, 0.56	82.19	83.27	38.06	-25.79	32.12	NaN	69.74	34.16	-99.05	47.52
CGS001-771	KD	CA12	Carbonic anhydrases, carbonic anhydrase XII			30.00, 30.00	0.77, 0.14	80.18	98.07	-48.75	-32.30	46.13	-97.87	-77.40	99.92	99.97	87.05
CGS001-760	KD	CA2	Carbonic anhydrases, carbonic anhydrase II			0.00, 0.00	1.65, 0.34	-90.27	63.03	50.50	-98.39	23.21	NaN	-36.92	-86.98	-21.69	-56.52
CGS001-51719	KD	CAB39	calcium binding protein 39			0.00, 0.00	1.27, 0.35	-99.86	NaN	-38.14	-39.71	-31.88	NaN	-96.46	88.98	43.75	-56.04
CGS001-23523	KD	CABIN1	calcineurin binding protein 1			22.22, 22.22	1.55, 0.50	-16.16	80.99	99.79	99.78	79.52	NaN	57.72	-28.67	-43.25	88.45
CGS001-775	KD	CACNA1C	Calcium channel subunits, calcium channel, voltage-dependent, L type, alpha 1C subunit			22.22, 22.22	1.31, 0.40	-83.14	46.72	47.87	-15.02	-67.54	NaN	98.01	-76.56	99.10	-47.87
CGS001-776	KD	CACNA1D	Calcium channel subunits, calcium channel, voltage-dependent, L type, alpha 1D subunit			0.00, 0.00	1.10, 0.28	NaN	70.10	-41.93	49.05	-88.38	22.63	-47.08	-24.00	45.44	-6.25
CGS001-790	KD	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase			10.00, 0.00	1.27, 0.47	-52.65	36.92	-34.59	39.29	43.99	96.17	-67.90	-43.43	85.32	20.51
CGS001-10241	KD	CALCOCO2	calcium binding and coiled-coil domain 2			0.00, 0.00	0.83, 0.22	-92.16	NaN	-71.89	-32.49	-97.25	NaN	NaN	33.09	53.48	-76.49
CGS001-801	KD	CALM1	EF-hand domain containing, calmodulin 1 (phosphorylase kinase, delta)			0.00, 0.00	1.44, 0.48	-91.93	-100.00	29.20	-99.15	-99.52	90.65	65.83	-99.47	21.28	-99.84
CGS001-808	KD	CALM3	EF-hand domain containing, calmodulin 3 (phosphorylase kinase, delta)			22.22, 22.22	1.02, 0.38	28.22	-100.00	42.38	14.66	-53.21	NaN	99.98	99.98	91.96	92.25
CGS001-163688	KD	CALML6	EF-hand domain containing, calmodulin-like 6			25.00, 25.00	2.02, 0.52	46.96	64.61	99.82	NaN	97.77	NaN	92.58	81.32	29.41	92.33
CGS001-811	KD	CALR	calreticulin			11.11, 0.00	1.17, 0.28	-64.67	66.43	-90.52	-61.52	-93.95	NaN	96.61	-99.25	-77.34	-79.61
CGS001-813	KD	CALU	EF-hand domain containing, calumenin			40.00, 40.00	1.33, 0.39	-37.47	-89.78	98.17	53.25	74.95	76.78	72.02	98.53	99.78	98.56
CGS001-8536	KD	CAMK1	CAMK1 family, calcium/calmodulin-dependent protein kinase I			0.00, 0.00	0.73, 0.32	-53.95	-96.74	27.39	-37.34	-27.42	-78.34	15.68	-49.78	-11.44	-26.27
CGS001-817	KD	CAMK2D	CAMK2 family, calcium/calmodulin-dependent protein kinase II delta			0.00, 0.00	1.25, 0.38	-41.96	85.46	-70.53	NaN	-34.86	NaN	-69.96	26.42	-22.33	-17.95
CGS001-818	KD	CAMK2G	CAMK2 family, calcium/calmodulin-dependent protein kinase II gamma			0.00, 0.00	1.66, 0.42	-28.81	-39.86	-53.44	72.37	36.54	-28.73	-50.84	22.37	-31.66	-9.52
CGS001-10645	KD	CAMKK2	Meta subfamily, calcium/calmodulin-dependent protein kinase kinase 2, beta			0.00, 0.00	1.28, 0.33	-40.45	-95.48	-23.71	-25.97	-48.51	83.35	-99.98	-44.51	NaN	-42.26
CGS001-819	KD	CAMLG	calcium modulating ligand			0.00, 0.00	1.09, 0.26	-31.21	NaN	-79.32	76.01	-29.02	-99.97	-33.24	NaN	NaN	-39.13
CGS001-23271	KD	CAMSAP2	calmodulin regulated spectrin-associated protein family, member 2			0.00, 0.00	2.19, 0.77	NaN	NaN	47.74	-92.31	-99.98	NaN	NaN	-58.40	-90.24	-87.20
CGS001-55832	KD	CAND1	cullin-associated and neddylation-dissociated 1			12.50, 12.50	1.66, 0.38	-86.36	43.22	77.12	57.70	NaN	NaN	39.26	-49.83	99.40	38.73
CGS001-23066	KD	CAND2	cullin-associated and neddylation-dissociated 2 (putative)			11.11, 11.11	1.35, 0.26	-56.87	-96.17	-36.40	24.01	79.92	NaN	99.98	-94.71	-94.26	-83.36
CGS001-124583	KD	CANT1	calcium activated nucleotidase 1			10.00, 10.00	1.40, 0.42	76.16	65.95	92.65	88.18	39.91	-61.52	99.20	-49.29	38.18	78.54
CGS001-821	KD	CANX	calnexin			11.11, 0.00	0.97, 0.22	97.05	33.80	-71.44	31.98	-80.37	NaN	68.66	40.48	-99.35	40.32
CGS001-822	KD	CAPG	capping protein (actin filament), gelsolin-like			0.00, 0.00	1.34, 0.40	25.04	66.55	-18.29	31.59	-22.44	-44.93	-36.97	-91.16	NaN	-6.69
CGS001-823	KD	CAPN1	EF-hand domain containing, calpain 1, (mu/I) large subunit			20.00, 10.00	1.84, 0.52	51.15	16.43	88.03	97.88	38.15	34.95	96.79	63.69	26.58	75.01
CGS001-826	KD	CAPNS1	EF-hand domain containing, calpain, small subunit 1			0.00, 0.00	1.24, 0.40	-99.95	-44.65	27.89	-62.79	-77.80	-83.28	-21.30	-76.61	NaN	-59.71
CGS001-133690	KD	CAPSL	EF-hand domain containing, calcyphosine-like			12.50, 12.50	2.25, 0.81	85.40	35.39	65.97	42.91	NaN	97.98	22.71	80.15	NaN	90.14
CGS001-29775	KD	CARD10	caspase recruitment domain family, member 10			20.00, 10.00	1.16, 0.39	32.48	-90.99	99.96	48.67	-99.56	38.52	76.73	95.66	78.94	85.29
CGS001-84433	KD	CARD11	caspase recruitment domain family, member 11			10.00, 10.00	1.48, 0.38	31.22	-32.32	19.46	74.82	-51.28	63.35	99.95	-30.30	76.47	66.00
CGS001-64170	KD	CARD9	caspase recruitment domain family, member 9			0.00, 0.00	2.05, 0.68	-99.81	NaN	-82.20	-92.45	65.66	-54.10	-99.49	-99.70	-44.99	-99.71
CGS001-22794	KD	CASC3	cancer susceptibility candidate 3			0.00, 0.00	1.30, 0.33	-33.48	-59.84	-91.78	-73.01	66.54	-84.45	-94.40	-35.32	31.50	-71.22
CGS001-64921	KD	CASD1	CAS1 domain containing 1			12.50, 12.50	1.99, 0.66	20.49	56.53	99.61	NaN	-87.98	NaN	-25.79	46.96	-41.07	45.89
CGS001-8573	KD	CASK	CASK family, calcium/calmodulin-dependent serine protein kinase (MAGUK family)			44.44, 22.22	1.59, 0.51	-93.26	58.75	97.19	99.36	45.62	NaN	37.87	98.93	-26.32	96.80
CGS001-843	KD	CASP10	Caspases, caspase 10, apoptosis-related cysteine peptidase			0.00, 0.00	1.66, 0.50	70.94	33.93	-33.58	68.75	83.59	-35.54	-28.98	-52.37	NaN	59.93
CGS001-23581	KD	CASP14	Caspases, caspase 14, apoptosis-related cysteine peptidase			0.00, 0.00	1.47, 0.41	-69.95	92.91	76.79	63.03	-63.77	-68.06	-16.13	45.26	44.04	44.18
CGS001-835	KD	CASP2	Caspases, caspase 2, apoptosis-related cysteine peptidase			20.00, 10.00	1.27, 0.39	47.50	70.40	-47.25	96.10	-64.62	79.98	-28.67	-91.41	98.91	85.60
CGS001-836	KD	CASP3	Caspases, caspase 3, apoptosis-related cysteine peptidase			10.00, 10.00	0.94, 0.23	-94.24	98.25	-99.96	-99.21	25.75	32.89	-31.27	-65.47	-99.97	-98.89
CGS001-837	KD	CASP4	Caspases, caspase 4, apoptosis-related cysteine peptidase			0.00, 0.00	1.10, 0.40	-36.20	37.05	-97.93	-35.50	-87.78	NaN	-31.31	61.14	39.24	-14.30
CGS001-839	KD	CASP6	Caspases, caspase 6, apoptosis-related cysteine peptidase			0.00, 0.00	1.18, 0.30	14.30	91.08	-52.38	-99.82	-66.67	-25.85	-98.91	-90.16	NaN	-93.66
CGS001-840	KD	CASP7	Caspases, caspase 7, apoptosis-related cysteine peptidase			0.00, 0.00	1.65, 0.60	-41.75	-83.62	-13.23	-66.81	63.59	-65.76	-42.31	-88.41	-89.12	-75.37
CGS001-841	KD	CASP8	Caspases, caspase 8, apoptosis-related cysteine peptidase			0.00, 0.00	1.41, 0.39	82.54	NaN	16.96	NaN	91.99	NaN	25.22	-33.90	-34.85	36.96
CGS001-842	KD	CASP9	Caspases, caspase 9, apoptosis-related cysteine peptidase			57.14, 57.14	2.07, 0.69	NaN	NaN	29.96	99.79	-58.21	53.14	NaN	99.05	99.39	99.82
CGS001-831	KD	CAST	calpastatin			0.00, 0.00	1.39, 0.47	-99.44	20.13	-47.47	29.99	-36.99	NaN	-25.49	-61.24	40.91	-40.12
CGS001-847	KD	CAT	catalase			0.00, 0.00	1.78, 0.51	94.55	-24.64	-22.92	25.38	-97.34	-99.88	-79.50	-96.68	54.59	-89.28
CGS001-857	KD	CAV1	caveolin 1, caveolae protein, 22kDa			11.11, 0.00	1.58, 0.65	67.46	-88.18	96.16	-72.33	-23.66	71.39	NaN	26.27	-89.70	-45.48
CGS001-863	KD	CBFA2T3	A-kinase anchor proteins, core-binding factor, runt domain, alpha subunit 2; translocated to, 3			0.00, 0.00	1.45, 0.40	-98.81	-23.15	23.91	-34.85	-98.02	-42.97	-52.79	-29.25	NaN	-28.87
CGS001-865	KD	CBFB	core-binding factor, beta subunit			12.50, 12.50	1.40, 0.39	-70.74	NaN	41.30	-99.59	97.84	NaN	-24.14	19.91	-43.79	-22.76
CGS001-868	KD	CBLB	RING-type (C3HC4) zinc fingers, Cas-Br-M (murine) ecotropic retroviral transforming sequence b			0.00, 0.00	1.41, 0.35	28.53	44.00	-22.92	39.19	NaN	82.87	-47.81	35.20	NaN	19.85
CGS001-23624	KD	CBLC	RING-type (C3HC4) zinc fingers, Cas-Br-M (murine) ecotropic retroviral transforming sequence c			11.11, 0.00	1.84, 0.44	94.27	-25.06	88.05	54.11	61.55	37.94	NaN	25.52	96.53	82.45
CGS001-873	KD	CBR1	Prostaglandin synthases, carbonyl reductase 1			10.00, 10.00	0.67, 0.16	57.32	79.40	-93.58	45.65	-47.18	94.88	-99.70	-30.07	99.48	45.26
CGS001-874	KD	CBR3	Short chain dehydrogenase/reductase superfamily / Classical SDR fold cluster 1, carbonyl reductase 3			10.00, 10.00	1.23, 0.35	39.94	-23.93	-21.60	-31.99	99.94	-27.39	-90.78	-26.61	-15.21	-10.68
CGS001-875	KD	CBS	Hydrogen sulphide synthesis, cystathionine-beta-synthase			0.00, 0.00	0.98, 0.24	-52.31	73.11	20.45	-20.27	19.46	-29.43	-29.52	-97.90	-34.76	-13.12
CGS001-8535	KD	CBX4	chromobox homolog 4			0.00, 0.00	1.55, 0.68	-86.90	17.61	64.98	-45.72	-85.31	55.91	-41.14	-98.89	NaN	-72.69
CGS001-23466	KD	CBX6	chromobox homolog 6			0.00, 0.00	1.93, 0.53	-90.80	-87.77	-50.50	-51.25	-99.93	NaN	-99.98	-40.73	-25.01	-93.20
CGS001-23492	KD	CBX7	chromobox homolog 7			33.33, 22.22	1.31, 0.41	50.35	64.40	99.73	33.04	NaN	72.40	99.84	93.63	-37.01	96.24
CGS001-883	KD	CCBL1	Hydrogen sulphide synthesis, cysteine conjugate-beta lyase, cytoplasmic			22.22, 22.22	1.32, 0.44	60.78	23.45	99.72	84.38	37.62	NaN	45.26	99.69	-85.79	74.87
CGS001-11007	KD	CCDC85B	coiled-coil domain containing 85B			20.00, 20.00	1.97, 0.59	99.96	99.98	-97.21	74.60	-87.81	69.58	-31.85	41.21	74.05	91.65
CGS001-79080	KD	CCDC86	coiled-coil domain containing 86			0.00, 0.00	1.59, 0.39	13.57	NaN	-93.03	89.72	-39.21	NaN	-61.42	-96.00	69.33	-79.60
CGS001-63933	KD	CCDC90A	coiled-coil domain containing 90A			0.00, 0.00	2.14, 0.82	NaN	NaN	-43.00	24.30	60.67	-40.90	-99.98	NaN	-24.10	-26.95
CGS001-80212	KD	CCDC92	coiled-coil domain containing 92			11.11, 0.00	1.53, 0.44	-38.71	-79.57	-77.55	96.06	73.91	-99.93	NaN	-37.97	93.16	-75.59
CGS001-6347	KD	CCL2	Chemokine ligands, chemokine (C-C motif) ligand 2			0.00, 0.00	0.75, 0.20	37.11	-36.41	-45.55	41.87	-53.36	19.90	52.98	35.87	-93.93	-20.09
CGS001-6364	KD	CCL20	Chemokine ligands, chemokine (C-C motif) ligand 20			0.00, 0.00	1.17, 0.33	-20.28	-98.31	-43.34	-21.31	-76.38	-31.23	-75.39	-94.95	-49.24	-73.00
CGS001-8900	KD	CCNA1	cyclin A1		Cyclins LOF	0.00, 0.00	1.39, 0.39	-26.70	-85.23	-19.80	-41.01	30.98	21.44	-92.02	-65.32	59.20	-44.59
CGS001-890	KD	CCNA2	cyclin A2			0.00, 0.00	0.77, 0.20	-98.86	-72.22	-35.19	-70.41	-99.98	-99.38	-95.37	-48.42	-24.59	-99.91
CGS001-891	KD	CCNB1	cyclin B1		G2 M Checkpoint LOF	12.50, 12.50	1.19, 0.32	23.27	26.54	93.89	93.38	99.98	NaN	NaN	-22.28	34.27	70.89
CGS001-9133	KD	CCNB2	cyclin B2			0.00, 0.00	1.39, 0.33	-91.75	-99.74	-99.95	-99.04	-22.99	-45.65	-99.68	-93.15	-24.84	-99.92
CGS001-892	KD	CCNC	cyclin C			0.00, 0.00	1.89, 0.45	-36.36	-61.00	-20.99	-26.42	-23.65	NaN	-51.81	-99.67	61.39	-15.86
CGS001-894	KD	CCND2	cyclin D2			44.44, 33.33	0.92, 0.31	98.33	62.05	93.82	98.41	95.28	NaN	90.09	35.43	90.24	98.89
CGS001-896	KD	CCND3	cyclin D3			11.11, 0.00	0.86, 0.24	30.34	NaN	68.75	-28.94	20.55	-99.87	-99.98	-98.35	95.60	-94.55
CGS001-898	KD	CCNE1	cyclin E1			0.00, 0.00	1.18, 0.38	-84.78	33.31	-28.41	66.16	45.16	NaN	NaN	-99.71	-97.76	-97.93
CGS001-899	KD	CCNF	F-boxes / other, cyclin F			44.44, 44.44	1.03, 0.30	-58.76	38.81	28.19	99.96	24.16	NaN	99.88	-83.69	99.90	99.92
CGS001-900	KD	CCNG1	cyclin G1			0.00, 0.00	1.32, 0.35	-99.96	21.11	-75.75	-98.24	-99.75	31.25	28.33	-97.16	-55.50	-99.79
CGS001-901	KD	CCNG2	cyclin G2			10.00, 10.00	1.09, 0.27	69.72	-29.13	16.91	-24.52	-30.92	-27.71	-21.45	99.98	14.98	3.68
CGS001-902	KD	CCNH	General transcription factor IIH complex subunits, cyclin H		Cyclins LOF	0.00, 0.00	1.65, 0.55	-70.28	-21.15	20.60	-27.84	44.47	-33.53	-53.69	90.96	NaN	-4.39
CGS001-57018	KD	CCNL1	cyclin L1		Cyclins LOF	11.11, 0.00	1.56, 0.43	24.08	43.48	23.23	89.40	92.90	97.18	-18.68	-22.54	NaN	70.18
CGS001-9738	KD	CCP110	centriolar coiled coil protein 110kDa			0.00, 0.00	1.10, 0.30	NaN	36.74	-90.85	45.24	-38.15	34.52	-37.35	-78.80	-82.20	-48.70
CGS001-9034	KD	CCRL2	Chemokine receptors, chemokine (C-C motif) receptor-like 2			0.00, 0.00	2.07, 0.59	-51.86	74.43	-55.21	-24.67	26.22	NaN	NaN	NaN	40.29	-18.71
CGS001-25819	KD	CCRN4L	CCR4 carbon catabolite repression 4-like (S. cerevisiae)			0.00, 0.00	1.23, 0.43	-52.44	30.35	-36.33	-99.63	-52.26	-99.79	-97.95	-77.58	NaN	-97.12
CGS001-10574	KD	CCT7	Heat Shock Proteins / Chaperonins, chaperonin containing TCP1, subunit 7 (eta)			0.00, 0.00	1.93, 0.75	NaN	23.97	-98.49	-98.86	24.58	-50.45	32.19	-85.84	33.65	-85.90
CGS001-10694	KD	CCT8	Heat Shock Proteins / Chaperonins, chaperonin containing TCP1, subunit 8 (theta)			0.00, 0.00	1.58, 0.45	NaN	25.00	-98.00	-99.98	-28.62	33.11	-35.96	-77.54	34.38	-58.32
CGS001-929	KD	CD14	CD molecules, CD14 molecule			0.00, 0.00	2.21, 0.78	-93.37	-19.58	65.04	-27.61	-61.46	NaN	-50.13	39.86	32.78	-42.09
CGS001-930	KD	CD19	CD molecules, CD19 molecule			0.00, 0.00	0.91, 0.30	-54.58	81.11	51.54	-91.95	-45.16	83.21	38.36	-23.95	39.19	50.25
CGS001-100133941	KD	CD24	CD molecules, CD24 molecule			14.29, 14.29	1.20, 0.40	99.15	NaN	-99.96	NaN	-87.55	NaN	93.69	37.67	-22.49	60.26
CGS001-10421	KD	CD2BP2	Serine/threonine phosphatases / Protein phosphatase 1, regulatory subunits, CD2 (cytoplasmic tail) binding protein 2			0.00, 0.00	1.68, 0.45	-69.40	93.57	25.90	23.93	41.93	NaN	-16.93	-17.38	20.43	5.79
CGS001-51293	KD	CD320	CD molecules, CD320 molecule			11.11, 11.11	1.08, 0.43	20.75	NaN	73.50	72.56	44.56	61.10	-30.60	59.10	99.41	78.76
CGS001-958	KD	CD40	Tumour necrosis factor (TNF) receptor family, CD40 molecule, TNF receptor superfamily member 5			0.00, 0.00	1.28, 0.39	-70.85	-95.43	-99.96	23.70	NaN	-22.09	NaN	91.13	42.38	-76.39
CGS001-960	KD	CD44	CD molecules, CD44 molecule (Indian blood group)			44.44, 44.44	1.13, 0.32	93.04	99.25	61.52	66.06	99.72	NaN	67.15	99.84	-63.48	99.61
CGS001-4179	KD	CD46	CD molecules, CD46 molecule, complement regulatory protein			0.00, 0.00	1.72, 0.44	-23.85	41.08	-31.38	28.45	NaN	71.13	30.22	25.45	NaN	17.07
CGS001-1604	KD	CD55	CD molecules, CD55 molecule, decay accelerating factor for complement (Cromer blood group)			0.00, 0.00	1.57, 0.44	62.60	68.32	-33.75	-45.87	-99.54	-37.26	NaN	-26.54	NaN	-23.58
CGS001-965	KD	CD58	CD molecules, CD58 molecule			0.00, 0.00	1.38, 0.32	-99.83	-93.67	-90.02	-95.18	-95.58	-26.26	-62.77	-98.86	25.72	-97.96
CGS001-966	KD	CD59	CD molecules, CD59 molecule, complement regulatory protein			0.00, 0.00	2.10, 0.51	-99.77	33.55	-31.32	44.95	36.42	-34.65	-89.25	-27.59	-94.08	-72.78
CGS001-975	KD	CD81	CD molecules, CD81 molecule			0.00, 0.00	1.85, 0.59	94.64	25.16	92.73	76.14	-57.81	NaN	31.09	-22.85	34.55	77.73
CGS001-9308	KD	CD83	CD molecules, CD83 molecule			0.00, 0.00	1.66, 0.53	-53.18	-54.47	-87.10	36.25	-99.98	NaN	-92.23	10.71	18.96	-78.14
CGS001-976	KD	CD97	Adhesion Class GPCRs, CD97 molecule			11.11, 11.11	1.26, 0.39	-60.31	98.29	-33.84	-99.71	-87.37	NaN	-34.13	73.64	-24.12	-39.79
CGS001-4267	KD	CD99	CD molecules, CD99 molecule			50.00, 37.50	1.23, 0.32	38.85	NaN	86.27	NaN	99.96	56.27	99.90	97.12	-25.45	99.47
CGS001-978	KD	CDA	cytidine deaminase			11.11, 0.00	1.34, 0.42	-78.83	96.74	-74.89	-96.67	-70.24	NaN	-91.91	-93.48	-99.97	-90.86
CGS001-8872	KD	CDC123	cell division cycle 123 homolog (S. cerevisiae)			0.00, 0.00	1.34, 0.33	-49.03	24.76	45.82	-21.42	-84.12	47.44	NaN	NaN	-25.84	3.76
CGS001-991	KD	CDC20	WD repeat domain containing, cell division cycle 20 homolog (S. cerevisiae)			22.22, 11.11	2.00, 0.66	96.15	22.69	98.45	33.59	77.10	NaN	42.70	66.19	79.95	81.20
CGS001-993	KD	CDC25A	Protein tyrosine phosphatases / Class III Cys-based PTPs, cell division cycle 25 homolog A (S. pombe)			0.00, 0.00	1.40, 0.38	59.22	-39.83	-92.16	-95.51	-21.55	-23.27	-99.60	29.75	-25.12	-53.05
CGS001-994	KD	CDC25B	Protein tyrosine phosphatases / Class III Cys-based PTPs, cell division cycle 25 homolog B (S. pombe)			0.00, 0.00	1.30, 0.42	59.34	-100.00	26.41	55.67	93.83	-36.33	74.55	28.25	-29.18	58.82
CGS001-995	KD	CDC25C	Serine/threonine phosphatases / Protein phosphatase 1, regulatory subunits, cell division cycle 25 homolog C (S. pombe)			0.00, 0.00	1.13, 0.32	-83.68	-25.81	-87.98	-25.45	-30.71	NaN	-55.48	-57.07	-74.91	-46.38
CGS001-11140	KD	CDC37	cell division cycle 37 homolog (S. cerevisiae)			10.00, 0.00	1.09, 0.27	96.62	61.72	-25.24	82.57	-64.90	-27.86	-40.43	28.89	94.85	72.92
CGS001-998	KD	CDC42	cell division cycle 42 (GTP binding protein, 25kDa)			0.00, 0.00	1.42, 0.36	-91.87	-20.24	-65.98	-99.93	-38.40	NaN	-94.15	-33.81	-39.77	-93.58
CGS001-56882	KD	CDC42SE1	CDC42 small effector 1			0.00, 0.00	1.48, 0.49	-21.69	59.29	46.18	82.64	29.09	-100.00	36.02	NaN	NaN	34.59
CGS001-8318	KD	CDC45	cell division cycle 45 homolog (S. cerevisiae)			14.29, 14.29	2.44, 0.73	99.98	NaN	62.74	64.72	61.91	NaN	NaN	48.06	-96.73	67.71
CGS001-8317	KD	CDC7	CDC7 family, cell division cycle 7 homolog (S. cerevisiae)			28.57, 14.29	1.56, 0.61	-14.74	81.00	49.60	NaN	NaN	NaN	94.60	99.02	-27.36	97.11
CGS001-55038	KD	CDCA4	cell division cycle associated 4			0.00, 0.00	1.18, 0.39	75.21	23.35	-80.82	-81.86	-95.30	19.64	36.45	-89.22	-17.89	-71.54
CGS001-55536	KD	CDCA7L	cell division cycle associated 7-like			0.00, 0.00	1.14, 0.39	-25.88	25.72	14.82	92.88	85.67	22.95	85.20	22.52	NaN	59.82
CGS001-55143	KD	CDCA8	cell division cycle associated 8			25.00, 12.50	0.97, 0.40	-88.05	NaN	82.13	95.63	-97.71	NaN	23.85	-95.00	99.88	-91.58
CGS001-999	KD	CDH1	CD molecules, cadherin 1, type 1, E-cadherin (epithelial)			12.50, 0.00	1.31, 0.34	-53.77	NaN	95.28	56.43	-71.99	NaN	92.71	86.20	46.04	94.54
CGS001-1009	KD	CDH11	Cadherins / Major cadherins, cadherin 11, type 2, OB-cadherin (osteoblast)			0.00, 0.00	1.26, 0.35	-80.49	-49.83	-91.46	35.67	-98.14	-99.06	-8.42	-46.06	NaN	-77.13
CGS001-1001	KD	CDH3	Cadherins / Major cadherins, cadherin 3, type 1, P-cadherin (placental)			12.50, 12.50	1.07, 0.42	-33.21	99.89	-38.60	31.60	-40.29	NaN	NaN	-79.83	17.90	-15.41
CGS001-10423	KD	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase			33.33, 33.33	1.97, 0.52	99.51	NaN	74.31	-39.09	49.65	46.35	-57.03	93.48	99.97	97.55
CGS001-983	KD	CDK1	Cyclin-dependent kinases, CDK1 subfamily, cyclin-dependent kinase 1			0.00, 0.00	0.77, 0.23	-80.69	-98.91	83.50	-92.75	22.61	-90.02	-99.96	59.86	82.34	-95.41
CGS001-8558	KD	CDK10	Cyclin-dependent kinases, CDK10 subfamily, cyclin-dependent kinase 10		Cyclin dependent kinases LOF	0.00, 0.00	1.19, 0.28	-21.03	81.45	89.91	-23.40	37.85	-99.23	-93.04	-34.10	-46.55	-20.45
CGS001-984	KD	CDK11B	Cyclin-dependent kinases, PITSLRE subfamily, cyclin-dependent kinase 11B			0.00, 0.00	1.68, 0.47	-82.64	37.95	-58.42	24.16	-35.20	-53.17	-83.53	-31.23	-42.76	-30.74
CGS001-5127	KD	CDK16	Cyclin-dependent kinases, TAIRE subfamily, cyclin-dependent kinase 16			11.11, 11.11	0.93, 0.25	-24.82	-47.34	-37.29	-91.67	99.03	-32.50	-67.72	NaN	-96.86	-71.73
CGS001-23097	KD	CDK19	Cyclin-dependent kinases, CDK8 subfamily, cyclin-dependent kinase 19			0.00, 0.00	1.41, 0.36	94.20	-96.49	20.85	66.39	NaN	-36.05	-75.85	-53.30	17.74	-30.79
CGS001-1017	KD	CDK2	Cyclin-dependent kinases, CDK1 subfamily, cyclin-dependent kinase 2		Cyclin dependent kinases LOF	0.00, 0.00	1.65, 0.35	-8.30	34.79	74.15	35.33	26.27	56.58	74.22	47.07	-39.33	30.24
CGS001-1020	KD	CDK5	Cyclin-dependent kinases, CDK5 subfamily, cyclin-dependent kinase 5			22.22, 22.22	1.41, 0.33	75.81	-25.92	86.04	-29.71	26.09	NaN	-37.44	98.78	99.97	83.90
CGS001-1021	KD	CDK6	Cyclin-dependent kinases, CDK4 subfamily, cyclin-dependent kinase 6		Cyclin dependent kinases LOF	0.00, 0.00	0.25, 0.11	-91.83	-66.83	-22.83	37.62	41.37	-99.72	-55.17	-86.24	-14.14	-37.37
CGS001-1024	KD	CDK8	Cyclin-dependent kinases, CDK8 subfamily, cyclin-dependent kinase 8			10.00, 10.00	1.26, 0.25	-97.75	99.93	-99.39	-38.36	-66.18	-97.17	-53.65	-79.32	-66.45	-88.40
CGS001-1025	KD	CDK9	Cyclin-dependent kinases, CDK9 subfamily, cyclin-dependent kinase 9		Cyclin dependent kinases LOF	0.00, 0.00	1.43, 0.48	-79.78	53.21	-78.18	36.12	44.84	-99.72	-92.29	-30.27	-71.34	-83.60
CGS001-54901	KD	CDKAL1	CDK5 regulatory subunit associated protein 1-like 1			11.11, 11.11	2.18, 0.70	-91.98	99.87	68.44	-27.23	-38.57	NaN	90.39	-93.09	-98.19	-70.91
CGS001-344387	KD	CDKL4	Cyclin-dependent kinases, cyclin-dependent kinase-like 4		Cyclin dependent kinases LOF	0.00, 0.00	1.70, 0.55	28.85	-20.69	91.49	-59.44	65.09	-37.21	NaN	89.94	88.89	87.63
CGS001-1026	KD	CDKN1A	cyclin-dependent kinase inhibitor 1A (p21, Cip1)			40.00, 40.00	0.70, 0.20	91.85	-24.22	99.87	77.94	65.86	-27.51	-62.42	99.68	99.28	99.35
CGS001-1027	KD	CDKN1B	cyclin-dependent kinase inhibitor 1B (p27, Kip1)			0.00, 0.00	1.20, 0.39	-99.34	NaN	64.12	NaN	-40.28	NaN	23.63	-88.53	29.06	-47.10
CGS001-1028	KD	CDKN1C	cyclin-dependent kinase inhibitor 1C (p57, Kip2)			0.00, 0.00	1.35, 0.35	23.75	91.06	57.89	-25.78	-54.05	88.41	73.36	-28.94	NaN	59.18
CGS001-1029	KD	CDKN2A	cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4)			10.00, 10.00	1.00, 0.25	77.72	-66.44	99.15	-43.42	30.28	25.92	49.32	-39.13	-26.02	30.02
CGS001-1030	KD	CDKN2B	cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)			55.56, 33.33	1.33, 0.34	97.43	45.11	97.92	75.36	80.60	NaN	99.98	97.25	35.18	98.13
CGS001-1031	KD	CDKN2C	Ankyrin repeat domain containing, cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4)			28.57, 28.57	1.39, 0.33	97.61	NaN	69.50	-88.29	38.81	NaN	NaN	99.96	54.37	92.62
CGS001-1036	KD	CDO1	cysteine dioxygenase, type I			0.00, 0.00	1.31, 0.35	31.79	32.41	40.92	26.39	67.43	-99.96	15.08	-97.20	-23.05	5.26
CGS001-1044	KD	CDX1	Homeoboxes / ANTP class : HOXL subclass, caudal type homeobox 1			40.00, 30.00	1.34, 0.34	86.98	60.43	52.01	97.29	94.77	-30.35	99.70	-18.46	99.92	97.66
CGS001-1045	KD	CDX2	Homeoboxes / ANTP class : HOXL subclass, caudal type homeobox 2			11.11, 11.11	0.92, 0.25	-23.14	-21.00	76.17	-43.62	-94.68	NaN	99.78	-42.64	83.48	41.79
CGS001-634	KD	CEACAM1	CD molecules, carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein)			20.00, 20.00	1.56, 0.40	99.37	-86.66	44.56	99.83	-25.61	82.01	94.23	-55.46	-96.08	86.47
CGS001-1050	KD	CEBPA	basic leucine zipper proteins, CCAAT/enhancer binding protein (C/EBP), alpha			0.00, 0.00	1.13, 0.36	-99.28	NaN	-91.61	-22.71	38.34	NaN	93.39	-71.02	-96.00	-99.16
CGS001-1051	KD	CEBPB	basic leucine zipper proteins, CCAAT/enhancer binding protein (C/EBP), beta			28.57, 28.57	1.07, 0.48	-93.05	NaN	99.12	NaN	25.39	NaN	-80.47	99.29	40.46	82.28
CGS001-1052	KD	CEBPD	basic leucine zipper proteins, CCAAT/enhancer binding protein (C/EBP), delta			10.00, 10.00	0.80, 0.27	-94.87	80.42	-60.46	-66.73	46.08	-28.60	98.43	-19.53	-47.25	-32.27
CGS001-1054	KD	CEBPG	basic leucine zipper proteins, CCAAT/enhancer binding protein (C/EBP), gamma			0.00, 0.00	1.76, 0.57	-99.71	NaN	-34.44	NaN	-78.38	-61.28	-97.48	-99.95	-99.20	-99.82
CGS001-10153	KD	CEBPZ	CCAAT/enhancer binding protein (C/EBP), zeta			0.00, 0.00	1.01, 0.32	-99.95	-100.00	-90.57	-22.99	-42.79	NaN	-97.93	-98.91	-99.97	-99.95
CGS001-1952	KD	CELSR2	Cadherins / Major cadherins, cadherin, EGF LAG seven-pass G-type receptor 2 (flamingo homolog, Drosophila)			0.00, 0.00	1.58, 0.44	-99.56	-28.72	-63.45	-71.53	-99.88	61.91	63.26	-83.76	-30.24	-84.90
CGS001-1951	KD	CELSR3	Cadherins / Major cadherins, cadherin, EGF LAG seven-pass G-type receptor 3 (flamingo homolog, Drosophila)			14.29, 14.29	1.99, 0.70	47.39	NaN	-24.25	24.25	-47.99	43.35	NaN	98.62	NaN	33.52
CGS001-1062	KD	CENPE	Kinesins, centromere protein E, 312kDa			11.11, 11.11	1.30, 0.33	97.91	30.25	-41.89	58.47	NaN	37.02	58.08	-29.86	23.68	29.84
CGS001-55165	KD	CEP55	centrosomal protein 55kDa			0.00, 0.00	1.90, 0.73	-96.72	-98.64	-99.40	-98.23	38.50	-99.72	-97.25	-98.40	-94.64	-99.29
CGS001-9702	KD	CEP57	centrosomal protein 57kDa			0.00, 0.00	2.51, 0.75	NaN	NaN	61.39	-33.78	88.02	NaN	NaN	56.16	-39.91	56.43
CGS001-55722	KD	CEP72	centrosomal protein 72kDa			0.00, 0.00	1.59, 0.47	-99.98	NaN	-69.56	-99.34	-63.37	NaN	33.48	-99.98	59.07	-99.87
CGS001-10390	KD	CEPT1	choline/ethanolamine phosphotransferase 1			20.00, 10.00	1.15, 0.19	50.82	-20.74	22.12	-87.89	25.22	99.79	37.39	-64.11	96.69	42.43
CGS001-64781	KD	CERK	Ceramide kinase, ceramide kinase			22.22, 22.22	1.58, 0.44	93.98	99.06	31.95	99.37	25.65	-92.99	NaN	45.85	-78.98	74.52
CGS001-29956	KD	CERS2	Homeoboxes / CERS class, ceramide synthase 2			10.00, 10.00	1.45, 0.49	-29.47	84.12	98.52	-79.08	27.45	-78.84	-33.15	-22.19	-22.57	-11.72
CGS001-204219	KD	CERS3	Homeoboxes / CERS class, ceramide synthase 3			0.00, 0.00	1.20, 0.40	-23.32	62.51	30.57	-24.77	92.52	51.17	38.58	-32.82	NaN	13.50
CGS001-79603	KD	CERS4	Homeoboxes / CERS class, ceramide synthase 4			10.00, 0.00	2.08, 0.65	57.25	96.56	53.93	94.93	32.88	82.03	93.16	84.82	-64.02	92.58
CGS001-1066	KD	CES1	Carboxylesterases, carboxylesterase 1			10.00, 0.00	1.34, 0.44	-21.69	23.59	18.76	-34.98	97.28	56.38	59.65	91.64	50.14	53.18
CGS001-8824	KD	CES2	Carboxylesterases, carboxylesterase 2			0.00, 0.00	1.19, 0.38	-96.35	NaN	-38.30	-88.02	55.86	NaN	-50.92	64.10	27.53	-54.21
CGS001-1069	KD	CETN2	EF-hand domain containing, centrin, EF-hand protein, 2			0.00, 0.00	1.88, 0.57	47.45	NaN	25.18	26.07	39.69	-68.53	70.16	-72.63	NaN	14.43
CGS001-1070	KD	CETN3	EF-hand domain containing, centrin, EF-hand protein, 3			10.00, 10.00	1.80, 0.49	94.63	99.05	-21.75	61.66	-30.38	33.19	-79.35	-54.53	-78.78	29.49
CGS001-629	KD	CFB	Complement system, complement factor B			10.00, 10.00	1.43, 0.43	97.83	-29.67	92.87	37.41	-63.20	-29.70	40.63	-81.09	-24.68	25.39
CGS001-1675	KD	CFD	Complement system, complement factor D (adipsin)			0.00, 0.00	1.90, 0.61	-34.34	-55.66	62.23	-32.77	-35.02	NaN	-23.50	-74.28	-64.41	-47.54
CGS001-8837	KD	CFLAR	Endogenous ligands, CASP8 and FADD-like apoptosis regulator			40.00, 30.00	0.80, 0.23	69.18	-56.38	98.11	96.01	99.96	-40.37	-99.98	-56.30	91.45	98.32
CGS001-1080	KD	CFTR	ATP binding cassette transporters / subfamily C, cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)			0.00, 0.00	1.67, 0.43	-99.92	-100.00	30.63	-99.51	-26.52	-99.97	-99.76	-30.77	-80.22	-99.95
CGS001-10668	KD	CGRRF1	RING-type (C3HC4) zinc fingers, cell growth regulator with ring finger domain 1			0.00, 0.00	1.35, 0.49	65.90	-75.90	-94.28	38.05	-45.62	64.81	30.26	-99.50	-54.39	-79.76
CGS001-79094	KD	CHAC1	ChaC, cation transport regulator homolog 1 (E. coli)			0.00, 0.00	1.43, 0.45	NaN	-33.50	-63.30	61.53	-99.86	-27.89	-98.07	-88.71	-58.19	-88.04
CGS001-8208	KD	CHAF1B	WD repeat domain containing, chromatin assembly factor 1, subunit B (p60)			10.00, 10.00	1.08, 0.28	32.90	24.83	-89.75	46.35	31.56	-35.44	-91.10	99.85	48.94	12.39
CGS001-79145	KD	CHCHD7	Coiled-coil-helix-coiled-coil-helix domain containing, coiled-coil-helix-coiled-coil-helix domain containing 7			12.50, 12.50	2.02, 0.49	-29.80	-26.71	-99.34	-63.92	30.04	NaN	NaN	-32.39	99.90	-10.85
CGS001-1105	KD	CHD1	chromodomain helicase DNA binding protein 1			0.00, 0.00	1.35, 0.45	32.81	79.53	-69.07	33.48	-72.91	-92.93	-24.84	46.73	-28.78	-36.82
CGS001-57680	KD	CHD8	chromodomain helicase DNA binding protein 8			14.29, 14.29	2.23, 0.68	-14.49	NaN	99.08	NaN	NaN	-93.12	-75.98	-74.60	-32.17	-60.76
CGS001-1111	KD	CHEK1	CHK1 subfamily, CHK1 checkpoint homolog (S. pombe)		G2 M Checkpoint LOF	0.00, 0.00	0.93, 0.36	-33.50	44.62	-14.63	-16.42	80.57	24.14	15.58	32.52	9.34	0.95
CGS001-11200	KD	CHEK2	CHK1 subfamily, CHK2 checkpoint homolog (S. pombe)		G2 M Checkpoint LOF	30.00, 30.00	0.25, 0.08	30.39	99.89	-13.01	68.13	76.07	-25.25	36.40	99.98	98.89	91.15
CGS001-10523	KD	CHERP	G patch domain containing, calcium homeostasis endoplasmic reticulum protein			0.00, 0.00	1.27, 0.35	-43.65	86.01	-70.45	-99.86	24.06	-81.13	-90.74	-51.58	-87.27	-83.70
CGS001-26511	KD	CHIC2	cysteine-rich hydrophobic domain 2			0.00, 0.00	1.17, 0.36	NaN	NaN	-40.67	-27.04	69.08	-37.81	NaN	58.69	80.71	53.95
CGS001-1120	KD	CHKB	choline kinase beta			0.00, 0.00	1.60, 0.60	31.21	-63.36	45.93	57.37	39.34	-40.07	45.39	38.26	NaN	22.57
CGS001-27243	KD	CHMP2A	Charged multivesicular body proteins, charged multivesicular body protein 2A			0.00, 0.00	1.47, 0.43	-51.04	-20.49	-29.23	-32.28	-60.85	-64.11	-94.17	-51.34	NaN	-45.47
CGS001-29082	KD	CHMP4A	Charged multivesicular body proteins, charged multivesicular body protein 4A			10.00, 10.00	0.93, 0.20	57.95	-41.72	-27.07	50.35	-46.95	87.38	-51.85	58.70	99.62	42.06
CGS001-79643	KD	CHMP6	Charged multivesicular body proteins, charged multivesicular body protein 6			33.33, 33.33	3.34, 1.05	NaN	NaN	97.96	99.98	-97.61	NaN	NaN	-42.96	-37.74	82.63
CGS001-1123	KD	CHN1	Rho GTPase activating proteins, chimerin (chimaerin) 1			10.00, 10.00	1.20, 0.32	-50.08	-99.96	-99.80	-78.37	-62.10	-78.78	-59.03	99.25	-63.37	-75.85
CGS001-54108	KD	CHRAC1	chromatin accessibility complex 1			10.00, 0.00	1.10, 0.30	-99.19	95.23	29.34	-35.68	-37.64	-98.51	93.18	-23.90	-39.22	-17.10
CGS001-1128	KD	CHRM1	Cholinergic receptors, cholinergic receptor, muscarinic 1			0.00, 0.00	1.33, 0.35	27.41	-37.76	32.17	-25.81	-29.68	60.15	-94.02	NaN	NaN	-17.80
CGS001-1131	KD	CHRM3	Cholinergic receptors, cholinergic receptor, muscarinic 3			62.50, 62.50	1.93, 0.68	91.20	NaN	98.50	99.79	89.18	-23.26	NaN	99.76	99.97	99.92
CGS001-1147	KD	CHUK	IKK family, conserved helix-loop-helix ubiquitous kinase			25.00, 25.00	2.16, 0.88	NaN	67.12	98.75	99.34	91.49	NaN	25.36	-85.09	-28.11	94.92
CGS001-57019	KD	CIAPIN1	cytokine induced apoptosis inhibitor 1			14.29, 0.00	1.84, 0.68	NaN	NaN	96.00	43.11	82.79	48.46	NaN	92.54	-24.99	88.18
CGS001-1153	KD	CIRBP	RNA binding motif (RRM) containing, cold inducible RNA binding protein			10.00, 10.00	0.98, 0.28	91.64	-33.33	-40.69	-89.26	63.85	-34.33	-35.15	-40.23	99.96	-37.54
CGS001-55847	KD	CISD1	CDGSH iron sulfur domain containing, CDGSH iron sulfur domain 1			0.00, 0.00	1.55, 0.55	NaN	-95.66	31.99	49.24	-28.01	29.01	61.72	-16.30	-97.23	-26.48
CGS001-1154	KD	CISH	SH2 domain containing, cytokine inducible SH2-containing protein			20.00, 20.00	1.44, 0.53	46.04	-32.48	99.12	79.14	-37.23	99.97	30.48	87.50	84.04	94.73
CGS001-1152	KD	CKB	creatine kinase, brain			22.22, 11.11	1.60, 0.43	49.84	99.52	-16.79	62.31	34.96	-86.70	-82.14	96.63	NaN	52.11
CGS001-1163	KD	CKS1B	CDC28 protein kinase regulatory subunit 1B			0.00, 0.00	1.20, 0.30	-92.23	-100.00	-34.51	36.63	-99.78	27.53	-59.50	31.47	23.91	-90.39
CGS001-11129	KD	CLASRP	CLK4-associating serine/arginine rich protein			10.00, 10.00	1.20, 0.25	23.25	100.00	-84.59	-99.36	42.80	26.44	93.31	30.46	-53.05	8.55
CGS001-1182	KD	CLCN3	Ion channels / Chloride channels : Voltage-sensitive, chloride channel 3			0.00, 0.00	1.52, 0.53	-97.79	-25.01	-97.67	-73.55	-76.97	-82.24	-80.03	-98.65	68.70	-93.62
CGS001-1184	KD	CLCN5	Ion channels / Chloride channels : Voltage-sensitive, chloride channel 5			0.00, 0.00	1.99, 0.66	-50.27	-100.00	-16.75	-26.79	66.95	NaN	-56.33	NaN	32.26	-30.44
CGS001-23274	KD	CLEC16A	C-type lectin domain containing, C-type lectin domain family 16, member A			0.00, 0.00	0.88, 0.24	-96.96	-99.98	-89.23	-22.88	-26.87	NaN	-99.98	-60.92	-36.17	-92.51
CGS001-25932	KD	CLIC4	Ion channels / Chloride channels : Intracellular, chloride intracellular channel 4			10.00, 10.00	1.17, 0.43	-52.31	32.57	-58.01	-50.35	-62.83	99.36	24.20	-21.03	-93.45	-33.40
CGS001-1195	KD	CLK1	CDC-like kinases, CDC-like kinase 1			0.00, 0.00	1.20, 0.39	-81.41	-89.01	87.88	-70.96	-62.50	-38.73	-18.34	-53.09	-99.17	-75.99
CGS001-1196	KD	CLK2	CDC-like kinases, CDC-like kinase 2			0.00, 0.00	1.11, 0.25	78.94	-48.96	9.48	NaN	56.69	77.18	-95.70	45.63	-65.77	30.67
CGS001-1198	KD	CLK3	CDC-like kinases, CDC-like kinase 3			11.11, 11.11	1.51, 0.50	-16.98	99.98	-93.04	NaN	-97.92	-66.84	83.25	-46.92	-21.30	-48.58
CGS001-57396	KD	CLK4	CDC-like kinases, CDC-like kinase 4			0.00, 0.00	0.99, 0.35	-68.50	89.03	-8.91	NaN	37.78	NaN	-52.43	-99.96	92.81	-30.77
CGS001-1201	KD	CLN3	ceroid-lipofuscinosis, neuronal 3			20.00, 20.00	1.93, 0.58	77.46	92.83	99.98	81.91	28.92	-61.37	99.30	93.21	-84.83	94.50
CGS001-9575	KD	CLOCK	Histone acetyltransferases, clock homolog (mouse)			11.11, 11.11	1.61, 0.48	35.86	41.85	49.83	99.24	81.52	62.70	40.94	-22.54	NaN	42.65
CGS001-81570	KD	CLPB	Ankyrin repeat domain containing, ClpB caseinolytic peptidase B homolog (E. coli)			0.00, 0.00	1.51, 0.44	-23.99	-19.98	14.78	20.89	NaN	36.28	49.03	28.93	90.15	6.32
CGS001-8192	KD	CLPP	ATPases / AAA-type, ClpP caseinolytic peptidase, ATP-dependent, proteolytic subunit homolog (E. coli)			0.00, 0.00	1.52, 0.43	-94.88	-98.03	-65.71	-30.30	-96.89	30.71	-99.32	30.54	NaN	-97.36
CGS001-1209	KD	CLPTM1	cleft lip and palate associated transmembrane protein 1			12.50, 12.50	1.34, 0.36	-60.52	65.42	-68.11	88.15	43.40	NaN	NaN	98.82	53.38	67.79
CGS001-10845	KD	CLPX	ATPases / AAA-type, ClpX caseinolytic peptidase X homolog (E. coli)			14.29, 0.00	1.49, 0.51	NaN	97.32	-99.67	-80.48	NaN	NaN	-34.10	23.85	-99.84	-97.98
CGS001-1211	KD	CLTA	clathrin, light chain A			11.11, 0.00	1.45, 0.55	49.83	28.22	89.69	31.21	-26.26	97.22	87.47	-88.43	NaN	74.53
CGS001-1212	KD	CLTB	clathrin, light chain B			0.00, 0.00	1.50, 0.33	54.81	-98.25	-87.08	-95.96	-98.91	-27.23	27.81	11.92	81.69	-84.46
CGS001-1213	KD	CLTC	clathrin, heavy chain (Hc)			0.00, 0.00	1.49, 0.40	-29.56	92.22	66.45	40.95	-81.41	NaN	-42.31	80.25	40.76	65.77
CGS001-55907	KD	CMAS	cytidine monophosphate N-acetylneuraminic acid synthetase			0.00, 0.00	1.83, 0.67	-18.73	-21.73	93.52	-29.89	35.01	NaN	48.81	NaN	NaN	23.83
CGS001-51727	KD	CMPK1	cytidine monophosphate (UMP-CMP) kinase 1, cytosolic			0.00, 0.00	1.31, 0.36	-54.73	-90.39	-53.75	-99.98	-34.08	-99.63	39.79	-99.87	-99.89	-99.92
CGS001-55748	KD	CNDP2	Carnosine dipeptidase, CNDP dipeptidase 2 (metallopeptidase M20 family)			0.00, 0.00	1.48, 0.35	52.22	NaN	-19.68	-90.39	-38.49	-89.41	39.41	-73.56	-74.89	-57.17
CGS001-4849	KD	CNOT3	CCR4-NOT transcription complex, subunit 3			0.00, 0.00	1.90, 0.66	NaN	-96.26	-21.86	-38.92	-99.98	21.70	-69.59	-95.15	-99.96	-98.92
CGS001-4850	KD	CNOT4	RNA binding motif (RRM) containing, CCR4-NOT transcription complex, subunit 4			10.00, 10.00	0.78, 0.20	80.97	69.33	-45.62	99.98	-32.21	58.88	35.74	87.23	30.51	81.34
CGS001-29883	KD	CNOT7	CCR4-NOT transcription complex, subunit 7			0.00, 0.00	1.88, 0.58	-50.55	34.44	15.89	27.47	-99.74	-28.13	NaN	-47.62	-25.46	-21.88
CGS001-9337	KD	CNOT8	CCR4-NOT transcription complex, subunit 8			0.00, 0.00	1.67, 0.57	-22.96	20.96	-80.84	NaN	-34.16	NaN	-72.21	-23.58	-22.82	-13.64
CGS001-10695	KD	CNPY3	Trinucleotide (CAG) repeat containing, canopy 3 homolog (zebrafish)			37.50, 25.00	3.81, 1.15	54.86	25.99	98.40	-28.31	99.98	NaN	NaN	94.15	43.15	96.88
CGS001-80347	KD	COASY	CoA synthase			10.00, 10.00	1.38, 0.42	29.24	-100.00	32.10	-39.19	22.95	31.81	-96.90	-18.20	97.60	11.72
CGS001-23242	KD	COBL	cordon-bleu homolog (mouse)			0.00, 0.00	1.17, 0.43	-97.47	76.91	71.71	-62.98	26.80	-98.18	94.13	20.21	-68.84	-75.01
CGS001-22796	KD	COG2	Components of oligomeric golgi complex, component of oligomeric golgi complex 2			11.11, 11.11	1.08, 0.33	42.11	-51.05	-24.25	91.63	47.48	NaN	-84.60	37.21	99.97	50.14
CGS001-25839	KD	COG4	Components of oligomeric golgi complex, component of oligomeric golgi complex 4			0.00, 0.00	1.59, 0.42	-83.95	-59.12	-40.15	-51.54	-61.17	-43.38	-96.06	-84.02	42.59	-60.78
CGS001-91949	KD	COG7	Components of oligomeric golgi complex, component of oligomeric golgi complex 7			0.00, 0.00	1.27, 0.36	NaN	-94.73	-99.98	-99.79	-98.77	NaN	-99.98	-99.92	-32.23	-99.95
CGS001-1305	KD	COL13A1	Collagens, collagen, type XIII, alpha 1			11.11, 0.00	1.58, 0.44	-92.83	-98.80	96.96	29.67	-35.35	NaN	43.82	-21.93	23.44	9.36
CGS001-1284	KD	COL4A2	Collagens, collagen, type IV, alpha 2			10.00, 10.00	1.16, 0.33	-99.96	-94.14	25.31	-38.48	-55.14	34.57	-72.97	22.33	99.96	-35.21
CGS001-1287	KD	COL4A5	Collagens, collagen, type IV, alpha 5			20.00, 10.00	1.02, 0.32	40.32	78.46	-82.84	-69.51	99.56	43.06	-33.48	14.91	95.70	67.97
CGS001-1312	KD	COMT	Catecholamine turnover, catechol-O-methyltransferase			10.00, 10.00	0.75, 0.23	69.83	-20.83	-11.35	25.84	-97.62	-34.25	-96.42	98.98	94.85	13.83
CGS001-9276	KD	COPB2	WD repeat domain containing, coatomer protein complex, subunit beta 2 (beta prime)		Vesicular Transport LOF	0.00, 0.00	3.17, 1.01	-81.06	-44.61	-93.91	-99.96	-69.18	-99.75	-98.69	-31.30	-99.65	-99.89
CGS001-10987	KD	COPS5	COP9 constitutive photomorphogenic homolog subunit 5 (Arabidopsis)			0.00, 0.00	1.26, 0.43	74.29	90.84	-50.04	-99.85	72.93	NaN	44.88	-62.56	-99.33	-55.67
CGS001-50813	KD	COPS7A	COP9 constitutive photomorphogenic homolog subunit 7A (Arabidopsis)			0.00, 0.00	1.45, 0.48	NaN	-26.02	83.42	-99.82	-27.77	-42.01	-83.53	18.40	24.30	-14.28
CGS001-22818	KD	COPZ1	coatomer protein complex, subunit zeta 1		Vesicular Transport LOF	0.00, 0.00	2.01, 0.57	-35.57	-98.38	-69.45	-85.87	-44.49	NaN	-97.72	-63.27	31.94	-64.30
CGS001-51805	KD	COQ3	coenzyme Q3 homolog, methyltransferase (S. cerevisiae)			25.00, 25.00	2.60, 0.94	-16.48	NaN	99.81	98.63	54.27	29.34	NaN	72.56	35.58	90.12
CGS001-11151	KD	CORO1A	Coronins, coronin, actin binding protein, 1A			55.56, 44.44	1.30, 0.41	100.00	99.15	-53.55	63.65	81.35	56.12	NaN	97.17	99.97	99.45
CGS001-1327	KD	COX4I1	Mitochondrial respiratory chain complex, cytochrome c oxidase subunit IV isoform 1		Mitochondrial complex IV LOF	0.00, 0.00	1.18, 0.49	-98.95	NaN	-28.26	NaN	-95.51	NaN	69.86	44.84	-21.59	-66.47
CGS001-9377	KD	COX5A	Mitochondrial respiratory chain complex, cytochrome c oxidase subunit Va		Mitochondrial complex IV LOF	12.50, 12.50	1.27, 0.35	NaN	76.11	30.45	-42.80	99.96	NaN	-81.06	-72.26	83.15	91.35
CGS001-1329	KD	COX5B	Mitochondrial respiratory chain complex, cytochrome c oxidase subunit Vb		Mitochondrial complex IV LOF	12.50, 12.50	0.93, 0.26	-91.94	NaN	98.66	NaN	23.85	-85.45	-99.98	43.66	-83.58	-96.59
CGS001-125965	KD	COX6B2	Mitochondrial respiratory chain complex / Complex IV, cytochrome c oxidase subunit VIb polypeptide 2 (testis)			0.00, 0.00	1.73, 0.50	-27.96	NaN	88.06	-47.15	-52.54	-47.30	NaN	-42.07	NaN	-38.20
CGS001-1345	KD	COX6C	Mitochondrial respiratory chain complex, cytochrome c oxidase subunit VIc			0.00, 0.00	1.92, 0.49	89.24	55.78	-28.41	50.28	68.62	NaN	41.65	32.65	-99.97	55.74
CGS001-1349	KD	COX7B	Mitochondrial respiratory chain complex, cytochrome c oxidase subunit VIIb			0.00, 0.00	1.44, 0.42	-99.50	NaN	-88.99	-44.36	-99.91	NaN	-75.69	-99.60	75.08	-99.66
CGS001-1356	KD	CP	ceruloplasmin (ferroxidase)			10.00, 10.00	1.57, 0.42	30.05	100.00	-95.79	35.21	-52.15	94.62	88.09	31.83	49.54	66.42
CGS001-1362	KD	CPD	Carboxypeptidase A, carboxypeptidase D			0.00, 0.00	1.41, 0.41	-64.94	15.47	-34.09	-34.82	44.22	-40.94	-91.06	-24.05	NaN	-15.50
CGS001-1363	KD	CPE	Carboxypeptidase A, carboxypeptidase E			0.00, 0.00	1.73, 0.42	-89.01	NaN	22.82	-38.27	-25.06	NaN	93.31	41.43	-97.78	-46.07
CGS001-8895	KD	CPNE3	copine III			0.00, 0.00	0.97, 0.27	-25.02	65.22	-90.31	-33.02	-28.10	-55.74	-34.74	-24.69	-57.59	-37.82
CGS001-10898	KD	CPSF4	cleavage and polyadenylation specific factor 4, 30kDa			0.00, 0.00	1.14, 0.41	78.63	34.71	-22.71	-93.88	88.52	-54.02	94.83	-20.27	-87.89	50.18
CGS001-1374	KD	CPT1A	carnitine palmitoyltransferase 1A (liver)			0.00, 0.00	0.99, 0.24	-98.83	-40.09	-42.07	-36.57	44.12	33.69	-30.14	-89.36	-23.84	-18.77
CGS001-1376	KD	CPT2	carnitine palmitoyltransferase 2			0.00, 0.00	1.41, 0.45	84.91	76.52	-23.09	37.08	-31.29	68.59	-13.46	24.13	-39.67	31.60
CGS001-1381	KD	CRABP1	Fatty acid-binding proteins, cellular retinoic acid binding protein 1			0.00, 0.00	1.49, 0.40	-28.37	28.27	34.16	-94.53	27.17	-67.42	-44.61	-65.24	-71.67	-47.82
CGS001-1382	KD	CRABP2	Fatty acid-binding proteins, cellular retinoic acid binding protein 2			0.00, 0.00	1.65, 0.52	-51.34	NaN	16.13	-76.74	-36.66	-53.51	-36.68	-31.81	NaN	-23.34
CGS001-8738	KD	CRADD	CASP2 and RIPK1 domain containing adaptor with death domain			0.00, 0.00	2.18, 0.80	-36.77	-99.30	-58.72	-28.45	-32.64	NaN	47.96	-83.26	-99.03	-81.73
CGS001-1384	KD	CRAT	carnitine O-acetyltransferase			50.00, 20.00	1.35, 0.41	43.92	22.61	99.98	43.12	-26.91	96.00	96.60	99.95	38.26	96.74
CGS001-1385	KD	CREB1	basic leucine zipper proteins, cAMP responsive element binding protein 1			10.00, 10.00	0.95, 0.23	-51.98	100.00	-85.90	-46.51	57.69	92.11	9.41	94.69	-93.11	73.07
CGS001-10488	KD	CREB3	basic leucine zipper proteins, cAMP responsive element binding protein 3			12.50, 12.50	1.28, 0.39	-99.11	-32.23	-38.44	51.25	68.70	99.96	-96.38	NaN	NaN	32.70
CGS001-90993	KD	CREB3L1	basic leucine zipper proteins, cAMP responsive element binding protein 3-like 1			22.22, 11.11	1.24, 0.47	-56.96	64.82	65.70	95.12	72.63	83.45	-49.83	99.60	NaN	76.09
CGS001-64764	KD	CREB3L2	basic leucine zipper proteins, cAMP responsive element binding protein 3-like 2			0.00, 0.00	1.01, 0.32	13.42	-100.00	-30.19	-48.98	26.33	44.18	-98.97	-98.40	-98.99	-98.76
CGS001-148327	KD	CREB3L4	basic leucine zipper proteins, cAMP responsive element binding protein 3-like 4			0.00, 0.00	1.52, 0.40	-26.93	-89.66	-71.98	-72.83	-94.10	NaN	22.41	-24.32	-42.10	-55.63
CGS001-1387	KD	CREBBP	Chromatin-modifying enzymes / K-acetyltransferases, CREB binding protein			25.00, 25.00	1.38, 0.44	-99.45	NaN	-23.99	84.31	68.65	NaN	98.51	94.45	91.86	97.82
CGS001-1389	KD	CREBL2	basic leucine zipper proteins, cAMP responsive element binding protein-like 2			0.00, 0.00	1.59, 0.65	-90.61	NaN	-99.93	-99.05	25.05	NaN	-69.24	-97.52	-80.74	-98.63
CGS001-8804	KD	CREG1	cellular repressor of E1A-stimulated genes 1			0.00, 0.00	1.31, 0.36	-70.39	72.83	-99.96	-89.22	25.94	-57.87	87.38	-99.49	21.10	-73.48
CGS001-79174	KD	CRELD2	cysteine-rich with EGF-like domains 2			37.50, 25.00	2.10, 0.89	-64.84	98.84	99.70	93.70	89.32	NaN	NaN	87.14	49.00	96.96
CGS001-1390	KD	CREM	basic leucine zipper proteins, cAMP responsive element modulator			12.50, 12.50	1.55, 0.49	-90.52	NaN	99.95	36.56	62.55	NaN	63.37	-95.23	92.68	90.30
CGS001-1398	KD	CRK	SH2 domain containing, v-crk sarcoma virus CT10 oncogene homolog (avian)			11.11, 0.00	1.43, 0.41	83.59	NaN	-34.93	-39.19	21.90	-98.04	78.64	90.69	96.38	68.38
CGS001-1399	KD	CRKL	SH2 domain containing, v-crk sarcoma virus CT10 oncogene homolog (avian)-like			0.00, 0.00	0.91, 0.24	-15.67	81.46	-95.42	-81.42	-33.96	-99.64	-90.31	-18.78	-21.87	-86.25
CGS001-54677	KD	CROT	carnitine O-octanoyltransferase			12.50, 12.50	1.75, 0.51	-96.05	NaN	-99.68	-66.39	99.54	NaN	-48.76	-99.58	54.76	-95.54
CGS001-10491	KD	CRTAP	cartilage associated protein			0.00, 0.00	1.75, 0.51	NaN	NaN	-69.01	-96.23	-37.09	26.59	25.67	-78.15	33.27	-55.05
CGS001-1407	KD	CRY1	cryptochrome 1 (photolyase-like)			0.00, 0.00	1.61, 0.53	-25.72	66.44	-19.35	39.51	-68.59	NaN	94.53	52.41	-81.50	26.19
CGS001-1409	KD	CRYAA	Heat shock proteins / HSPB, crystallin, alpha A			11.11, 11.11	1.30, 0.42	72.79	29.60	57.43	91.97	38.61	75.41	NaN	99.09	33.49	81.76
CGS001-1429	KD	CRYZ	crystallin, zeta (quinone reductase)			10.00, 10.00	1.16, 0.36	-99.70	31.27	-99.05	-98.55	-91.51	54.52	74.66	84.55	99.69	-99.36
CGS001-1431	KD	CS	citrate synthase			0.00, 0.00	1.08, 0.39	94.74	-83.08	70.66	NaN	80.73	NaN	NaN	-99.24	-70.07	78.88
CGS001-51380	KD	CSAD	cysteine sulfinic acid decarboxylase			0.00, 0.00	1.61, 0.47	-80.05	22.73	-33.88	-25.73	-82.15	72.06	NaN	-57.43	-32.90	-40.24
CGS001-8531	KD	CSDA	cold shock domain protein A			50.00, 40.00	1.57, 0.61	-99.56	100.00	89.54	96.84	-89.75	99.63	97.88	-95.68	-26.11	99.00
CGS001-1440	KD	CSF3	Endogenous ligands, colony stimulating factor 3 (granulocyte)			20.00, 20.00	1.57, 0.49	99.87	-76.71	99.98	-24.39	24.96	72.19	-34.67	-53.34	38.42	41.55
CGS001-1445	KD	CSK	Csk family, c-src tyrosine kinase			10.00, 10.00	0.85, 0.30	-33.94	45.90	85.67	71.96	29.18	94.73	99.71	90.44	-45.98	80.99
CGS001-1452	KD	CSNK1A1	Casein kinase 1 (CK1) family, casein kinase 1, alpha 1			0.00, 0.00	1.38, 0.53	-86.92	-50.25	-99.91	-36.23	-96.64	NaN	-90.15	-99.85	43.30	-98.25
CGS001-122011	KD	CSNK1A1L	Casein kinase 1 (CK1) family, casein kinase 1, alpha 1-like			0.00, 0.00	1.67, 0.59	56.03	-37.05	32.39	-29.65	42.32	33.17	-26.51	57.12	-26.85	18.39
CGS001-1453	KD	CSNK1D	Casein kinase 1 (CK1) family, casein kinase 1, delta			11.11, 11.11	1.50, 0.49	80.95	99.78	44.74	-71.84	-53.30	NaN	-66.55	-37.26	28.62	52.53
CGS001-1454	KD	CSNK1E	Casein kinase 1 (CK1) family, casein kinase 1, epsilon			0.00, 0.00	1.10, 0.33	-83.41	-27.09	18.06	46.59	-93.15	35.14	-78.35	-32.28	41.39	-30.86
CGS001-1457	KD	CSNK2A1	Casein kinase 2 (CK2) family, casein kinase 2, alpha 1 polypeptide			62.50, 62.50	1.52, 0.64	73.11	99.61	-20.20	99.94	-99.77	NaN	NaN	99.93	99.97	99.95
CGS001-1459	KD	CSNK2A2	Casein kinase 2 (CK2) family, casein kinase 2, alpha prime polypeptide			10.00, 10.00	0.80, 0.09	-17.77	22.91	74.00	-25.35	-76.94	39.72	-58.74	-26.28	99.90	-1.82
CGS001-1460	KD	CSNK2B	Casein kinase 2 (CK2) family, casein kinase 2, beta polypeptide			22.22, 22.22	1.36, 0.34	90.70	-100.00	-34.45	99.96	-69.17	NaN	32.39	98.71	18.20	72.30
CGS001-1465	KD	CSRP1	cysteine and glycine-rich protein 1			14.29, 14.29	1.67, 0.32	NaN	-84.52	-68.51	NaN	-35.57	99.73	NaN	-70.74	-42.99	-43.79
CGS001-1488	KD	CTBP2	C-terminal binding protein 2			20.00, 20.00	1.74, 0.55	99.98	-25.16	-76.56	-97.16	-78.30	75.24	99.95	-31.60	-93.73	-78.03
CGS001-10664	KD	CTCF	Zinc fingers, C2H2-type, CCCTC-binding factor (zinc finger protein)			0.00, 0.00	0.89, 0.14	-17.24	82.40	-74.05	-33.43	28.24	33.32	52.82	-69.57	46.76	17.50
CGS001-140690	KD	CTCFL	Zinc fingers, C2H2-type, CCCTC-binding factor (zinc finger protein)-like			22.22, 11.11	1.58, 0.50	25.37	99.91	-91.80	58.56	82.91	NaN	90.70	90.96	75.70	95.10
CGS001-58190	KD	CTDSP1	Serine/threonine phosphatases / CTD aspartate-based phosphatases, CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase 1			11.11, 11.11	1.15, 0.28	-24.17	23.84	-21.24	-28.80	-95.79	99.96	30.33	NaN	30.47	7.26
CGS001-1490	KD	CTGF	connective tissue growth factor			22.22, 0.00	1.72, 0.48	40.65	-36.31	-71.52	-72.27	95.66	-61.21	NaN	-36.50	97.31	-53.70
CGS001-1491	KD	CTH	Hydrogen sulphide synthesis, cystathionase (cystathionine gamma-lyase)			0.00, 0.00	1.07, 0.33	-80.31	-19.36	-47.95	23.09	-72.81	-99.18	-25.32	-33.44	NaN	-53.02
CGS001-1493	KD	CTLA4	CD molecules, cytotoxic T-lymphocyte-associated protein 4			0.00, 0.00	0.91, 0.19	-38.44	23.78	-98.42	-42.21	-85.07	-99.22	41.29	-92.77	55.10	-96.51
CGS001-1495	KD	CTNNA1	Catenins, catenin (cadherin-associated protein), alpha 1, 102kDa			44.44, 44.44	1.58, 0.48	16.81	100.00	56.96	47.58	-49.10	99.94	99.96	-62.07	NaN	99.84
CGS001-8727	KD	CTNNAL1	Catenins, catenin (cadherin-associated protein), alpha-like 1			0.00, 0.00	1.43, 0.38	92.25	NaN	-99.54	-99.95	-22.16	-81.68	-88.83	-30.89	21.25	-71.12
CGS001-1499	KD	CTNNB1	Catenins, catenin (cadherin-associated protein), beta 1, 88kDa			0.00, 0.00	1.32, 0.23	-65.09	-99.13	-88.21	-94.91	-50.82	29.90	-57.75	-99.34	-98.35	-99.55
CGS001-56998	KD	CTNNBIP1	Catenins, catenin, beta interacting protein 1			0.00, 0.00	1.68, 0.52	-72.48	80.77	29.31	31.29	28.75	NaN	-40.54	33.29	-29.70	8.53
CGS001-1500	KD	CTNND1	Catenins, catenin (cadherin-associated protein), delta 1			0.00, 0.00	1.98, 0.57	NaN	NaN	-98.37	-95.33	51.17	NaN	38.62	-34.81	61.56	-43.67
CGS001-1497	KD	CTNS	cystinosin, lysosomal cystine transporter			0.00, 0.00	1.20, 0.27	-68.34	-29.93	-39.64	-85.08	-86.96	-99.97	-29.66	-30.59	23.38	-60.22
CGS001-1503	KD	CTPS	CTP synthase			0.00, 0.00	1.49, 0.42	-60.91	-71.62	-99.98	-42.81	-99.86	-99.97	NaN	-21.78	-42.31	-99.68
CGS001-1504	KD	CTRB1	chymotrypsinogen B1			0.00, 0.00	1.17, 0.35	-97.28	NaN	-16.38	-92.86	-45.36	-28.08	59.28	-99.77	45.22	-89.90
CGS001-440387	KD	CTRB2	chymotrypsinogen B2			0.00, 0.00	1.15, 0.35	-98.87	-90.60	37.40	-50.81	62.20	NaN	26.51	-99.73	25.62	-92.56
CGS001-1508	KD	CTSB	Cathepsins, cathepsin B			0.00, 0.00	1.60, 0.49	-99.84	NaN	-86.13	NaN	93.01	NaN	-96.10	-87.22	28.20	-94.95
CGS001-1509	KD	CTSD	Cathepsins, cathepsin D			0.00, 0.00	1.31, 0.42	-34.13	-85.91	-46.21	-68.41	66.17	44.93	-29.42	-57.24	-22.02	-58.36
CGS001-1513	KD	CTSK	Cathepsins, cathepsin K			57.14, 14.29	1.82, 0.56	95.57	-26.19	30.17	97.09	31.92	NaN	NaN	99.68	NaN	97.15
CGS001-1514	KD	CTSL1	cathepsin L1			0.00, 0.00	0.69, 0.13	-99.69	-34.04	-63.48	-99.84	21.25	-29.76	-99.98	-9.53	23.83	-94.02
CGS001-1515	KD	CTSL2	cathepsin L2			0.00, 0.00	1.68, 0.48	-17.25	88.84	-99.82	-99.52	-67.73	NaN	-71.80	-17.90	87.94	-70.22
CGS001-2017	KD	CTTN	cortactin			20.00, 20.00	1.10, 0.28	-73.51	98.64	-99.54	30.44	92.23	31.33	62.06	97.50	-27.07	75.48
CGS001-8453	KD	CUL2	cullin 2			10.00, 0.00	1.51, 0.42	32.41	27.90	-30.02	95.27	-99.45	29.13	93.87	-47.90	56.00	19.77
CGS001-1525	KD	CXADR	Immunoglobulin superfamily / Immunoglobulin-like domain containing, coxsackie virus and adenovirus receptor			10.00, 10.00	1.95, 0.60	66.29	-27.72	99.69	62.37	49.08	-74.34	90.63	85.85	-99.55	77.67
CGS001-2919	KD	CXCL1	Endogenous ligands, chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)			0.00, 0.00	1.61, 0.53	-99.57	-100.00	-21.83	30.07	-27.07	-17.75	70.09	-96.20	-21.33	-49.36
CGS001-6387	KD	CXCL12	Endogenous ligands, chemokine (C-X-C motif) ligand 12			0.00, 0.00	1.40, 0.42	75.35	27.97	-59.20	-99.80	21.39	-99.50	17.76	-80.87	-32.99	-77.59
CGS001-2920	KD	CXCL2	Endogenous ligands, chemokine (C-X-C motif) ligand 2			25.00, 25.00	1.93, 0.73	-97.94	NaN	66.65	98.17	-81.64	NaN	89.47	99.98	51.62	92.27
CGS001-7852	KD	CXCR4	Chemokine receptors, chemokine (C-X-C motif) receptor 4			0.00, 0.00	1.49, 0.34	32.81	-31.27	60.40	-29.62	-98.05	-40.89	44.63	-94.06	-98.96	-56.75
CGS001-57007	KD	CXCR7	chemokine (C-X-C motif) receptor 7			50.00, 50.00	2.22, 0.88	99.62	82.91	99.93	98.58	35.28	NaN	NaN	80.02	88.14	98.39
CGS001-1534	KD	CYB561	Cytochrome b genes, cytochrome b-561			60.00, 60.00	1.57, 0.63	99.98	-28.52	99.86	88.48	98.74	-34.66	99.98	41.26	99.95	99.95
CGS001-1727	KD	CYB5R3	cytochrome b5 reductase 3			0.00, 0.00	1.50, 0.52	82.91	-29.23	85.63	-68.23	86.87	-29.62	-59.42	23.03	-99.54	-35.25
CGS001-1537	KD	CYC1	Mitochondrial respiratory chain complex / Complex III, cytochrome c-1			11.11, 11.11	1.52, 0.35	19.73	-27.70	-18.18	99.98	-23.80	-99.72	-32.13	NaN	-99.97	-12.82
CGS001-1545	KD	CYP1B1	Cytochrome P450s, cytochrome P450, family 1, subfamily B, polypeptide 1			37.50, 37.50	1.09, 0.27	-96.49	81.51	54.21	18.91	22.58	NaN	NaN	99.92	99.88	97.94
CGS001-57404	KD	CYP20A1	Cytochrome P450s, cytochrome P450, family 20, subfamily A, polypeptide 1			0.00, 0.00	1.56, 0.45	15.39	NaN	-40.40	69.40	68.74	22.17	-24.03	27.98	59.88	23.52
CGS001-1591	KD	CYP24A1	Cytochrome P450s, cytochrome P450, family 24, subfamily A, polypeptide 1			20.00, 10.00	1.92, 0.49	83.72	30.14	-27.09	96.40	-30.96	43.44	45.23	99.32	-25.83	64.15
CGS001-1594	KD	CYP27B1	Cytochrome P450s, cytochrome P450, family 27, subfamily B, polypeptide 1			12.50, 12.50	1.63, 0.63	-87.33	-39.05	18.34	99.67	-62.39	NaN	22.29	-26.05	NaN	-14.03
CGS001-1577	KD	CYP3A5	Cytochrome P450s, cytochrome P450, family 3, subfamily A, polypeptide 5			0.00, 0.00	1.48, 0.41	23.74	-22.34	-16.84	-42.66	-24.77	-99.97	-63.59	NaN	-64.58	-47.24
CGS001-1595	KD	CYP51A1	Cytochrome P450s, cytochrome P450, family 51, subfamily A, polypeptide 1			0.00, 0.00	1.24, 0.38	25.39	NaN	-96.45	-68.92	-43.83	NaN	-85.39	-60.22	23.03	-57.25
CGS001-9267	KD	CYTH1	Pleckstrin homology (PH) domain containing, cytohesin 1			0.00, 0.00	1.16, 0.34	NaN	NaN	40.72	-85.60	-44.37	31.00	46.90	-85.74	73.02	-69.20
CGS001-117154	KD	DACH2	dachshund homolog 2 (Drosophila)			0.00, 0.00	1.26, 0.34	-95.07	-55.55	-64.07	-47.17	-99.71	-99.97	NaN	-99.51	-31.43	-99.92
CGS001-1605	KD	DAG1	dystroglycan 1 (dystrophin-associated glycoprotein 1)			37.50, 25.00	1.41, 0.42	33.32	88.16	32.76	99.94	-49.45	99.62	-23.69	NaN	NaN	95.61
CGS001-1611	KD	DAP	death-associated protein			20.00, 20.00	1.50, 0.56	63.35	-33.44	59.09	98.91	38.05	33.84	65.55	-63.72	99.97	52.45
CGS001-1612	KD	DAPK1	Death-associated kinase (DAPK) family, death-associated protein kinase 1			12.50, 12.50	1.39, 0.31	24.36	99.58	48.02	-24.00	21.90	-99.85	-52.67	NaN	NaN	-9.32
CGS001-1615	KD	DARS	Aminoacyl tRNA synthetases / Class II, aspartyl-tRNA synthetase		Aminoacyl tRNA synthetases class II LOF	0.00, 0.00	1.59, 0.49	-41.04	-47.55	-96.79	53.51	-97.44	-25.87	NaN	-30.61	-29.22	-33.10
CGS001-1616	KD	DAXX	death-domain associated protein			0.00, 0.00	1.56, 0.58	-96.18	-100.00	-49.88	-99.90	35.32	NaN	-99.96	-99.88	40.66	-99.95
CGS001-1622	KD	DBI	diazepam binding inhibitor (GABA receptor modulator, acyl-CoA binding protein)			0.00, 0.00	1.67, 0.59	-90.93	-24.35	29.02	86.01	-63.82	NaN	-75.13	87.15	-99.08	-66.40
CGS001-1633	KD	DCK	deoxycytidine kinase			10.00, 10.00	1.44, 0.36	99.81	-99.93	-99.79	-99.95	-23.47	-14.55	31.63	-38.86	64.62	-90.30
CGS001-64858	KD	DCLRE1B	DNA cross-link repair 1B			0.00, 0.00	1.05, 0.23	-91.29	-99.87	-99.59	NaN	-25.46	-56.88	-20.80	-79.55	-98.45	-98.71
CGS001-55802	KD	DCP1A	DCP1 decapping enzyme homolog A (S. cerevisiae)			0.00, 0.00	1.36, 0.49	22.76	NaN	77.26	-72.47	-88.32	-91.20	16.13	-52.40	-99.85	-67.99
CGS001-28960	KD	DCPS	decapping enzyme, scavenger			0.00, 0.00	1.97, 0.51	-82.38	NaN	-99.96	-78.21	-87.91	-25.44	-99.36	-65.15	34.62	-80.40
CGS001-1635	KD	DCTD	dCMP deaminase			0.00, 0.00	1.30, 0.42	-65.15	-44.01	86.44	50.33	-96.51	NaN	-57.63	-77.55	27.75	-48.18
CGS001-10671	KD	DCTN6	dynactin 6			0.00, 0.00	1.47, 0.38	NaN	22.43	-94.08	73.36	-96.84	61.12	-44.84	65.54	-43.41	-41.04
CGS001-23142	KD	DCUN1D4	DCN1, defective in cullin neddylation 1, domain containing 4 (S. cerevisiae)			12.50, 12.50	2.07, 0.72	NaN	92.93	22.06	NaN	44.50	99.54	-80.09	43.37	27.35	59.83
CGS001-51181	KD	DCXR	Short chain dehydrogenase/reductase superfamily / Classical SDR fold cluster 1, dicarbonyl/L-xylulose reductase			37.50, 12.50	1.09, 0.49	25.42	66.48	91.06	97.11	58.37	NaN	NaN	98.50	-22.51	97.28
CGS001-23576	KD	DDAH1	Dimethylarginine dimethylaminohydrolases, dimethylarginine dimethylaminohydrolase 1			25.00, 12.50	1.67, 0.42	40.82	100.00	23.94	30.67	90.45	NaN	97.26	NaN	54.38	86.78
CGS001-23564	KD	DDAH2	Dimethylarginine dimethylaminohydrolases, dimethylarginine dimethylaminohydrolase 2			22.22, 22.22	1.01, 0.27	55.24	99.30	99.75	NaN	71.58	19.92	14.80	47.08	86.81	66.67
CGS001-1642	KD	DDB1	damage-specific DNA binding protein 1, 127kDa			0.00, 0.00	1.10, 0.38	-99.30	-26.36	-35.40	-27.62	68.09	NaN	27.58	-91.63	-93.09	-85.63
CGS001-1643	KD	DDB2	WD repeat domain containing, damage-specific DNA binding protein 2, 48kDa			0.00, 0.00	1.13, 0.22	-82.59	40.59	-99.70	-52.89	-24.01	-95.84	-98.81	62.97	-24.92	-85.11
CGS001-1644	KD	DDC	Catecholamine turnover, dopa decarboxylase (aromatic L-amino acid decarboxylase)			0.00, 0.00	1.33, 0.50	-36.90	82.19	-15.99	-20.15	NaN	NaN	32.56	-69.39	30.57	6.95
CGS001-1649	KD	DDIT3	DNA-damage-inducible transcript 3			22.22, 11.11	1.48, 0.53	99.98	-24.68	-47.78	30.93	-22.83	NaN	20.49	70.42	96.61	19.67
CGS001-54541	KD	DDIT4	DNA-damage-inducible transcript 4			0.00, 0.00	1.24, 0.26	-36.12	-96.95	-83.30	-77.95	-67.81	-32.49	-78.94	-99.58	-98.20	-97.78
CGS001-1650	KD	DDOST	dolichyl-diphosphooligosaccharide--protein glycosyltransferase			0.00, 0.00	1.56, 0.56	93.54	-23.26	-50.22	-39.06	-26.98	NaN	NaN	-75.40	29.96	-27.37
CGS001-780	KD	DDR1	Type XVI RTKs: DDR (collagen receptor) family, discoidin domain receptor tyrosine kinase 1			0.00, 0.00	0.95, 0.16	58.55	-71.75	15.38	-40.56	27.90	43.96	-58.21	90.60	40.39	24.05
CGS001-1662	KD	DDX10	DEAD-boxes, DEAD (Asp-Glu-Ala-Asp) box polypeptide 10			0.00, 0.00	1.45, 0.59	NaN	-38.98	-99.93	-99.64	-86.62	-99.97	-96.12	-88.14	21.95	-99.95
CGS001-7919	KD	DDX39B	DEAD-boxes, DEAD (Asp-Glu-Ala-Asp) box polypeptide 39B			11.11, 0.00	1.23, 0.45	-73.98	-48.89	95.08	34.53	NaN	-66.62	-21.70	-44.57	-16.28	-19.56
CGS001-11325	KD	DDX42	DEAD-boxes, DEAD (Asp-Glu-Ala-Asp) box polypeptide 42			20.00, 20.00	1.48, 0.39	70.73	100.00	-83.91	-23.71	99.98	51.64	-31.02	-34.11	-58.93	26.58
CGS001-54555	KD	DDX49	DEAD-boxes, DEAD (Asp-Glu-Ala-Asp) box polypeptide 49			0.00, 0.00	1.59, 0.44	-96.96	-98.49	-81.01	-95.19	-62.20	-80.05	-90.00	-64.30	-22.01	-91.51
CGS001-1655	KD	DDX5	DEAD-boxes, DEAD (Asp-Glu-Ala-Asp) box polypeptide 5			0.00, 0.00	1.19, 0.39	-99.42	NaN	-87.74	NaN	-59.90	-87.67	-99.38	-47.59	-86.05	-98.32
CGS001-1666	KD	DECR1	Short chain dehydrogenase/reductase superfamily / Classical SDR fold cluster 1, 2,4-dienoyl CoA reductase 1, mitochondrial			0.00, 0.00	1.43, 0.40	-87.25	88.80	-99.98	-99.31	-51.91	-48.03	-51.25	-77.92	-99.97	-98.86
CGS001-7913	KD	DEK	DEK oncogene			0.00, 0.00	1.33, 0.36	49.26	NaN	-90.64	-70.20	69.70	37.53	-99.98	-80.41	21.57	-55.70
CGS001-163486	KD	DENND1B	DENN/MADD domain containing, DENN/MADD domain containing 1B			0.00, 0.00	1.15, 0.27	-98.61	NaN	-77.38	-69.95	30.80	NaN	-98.70	41.59	33.11	-91.77
CGS001-79961	KD	DENND2D	DENN/MADD domain containing, DENN/MADD domain containing 2D			11.11, 11.11	1.01, 0.33	NaN	100.00	-63.41	52.84	92.84	-58.42	65.98	57.58	27.19	63.89
CGS001-51071	KD	DERA	deoxyribose-phosphate aldolase (putative)			0.00, 0.00	1.60, 0.44	-79.13	NaN	-77.34	-99.94	-66.89	61.78	40.93	-85.41	-88.37	-94.61
CGS001-79139	KD	DERL1	Der1-like domain family, member 1			40.00, 40.00	1.13, 0.34	97.90	-92.92	-29.18	92.54	-52.38	48.03	-16.47	99.61	99.93	97.64
CGS001-1676	KD	DFFA	DNA fragmentation factor, 45kDa, alpha polypeptide			55.56, 44.44	0.82, 0.17	96.39	66.90	-59.46	-40.66	99.93	98.90	NaN	92.53	99.93	99.92
CGS001-1677	KD	DFFB	DNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase)			0.00, 0.00	1.45, 0.35	27.30	-79.60	20.72	87.84	-50.99	NaN	-39.94	27.91	-30.09	-16.59
CGS001-25861	KD	DFNB31	deafness, autosomal recessive 31			0.00, 0.00	1.58, 0.41	23.83	22.77	67.81	36.41	60.38	NaN	-34.96	38.35	-44.26	30.22
CGS001-8220	KD	DGCR14	DiGeorge syndrome critical region gene 14			25.00, 0.00	2.21, 0.72	94.33	85.24	81.66	95.50	NaN	96.52	-19.38	83.73	NaN	88.30
CGS001-1606	KD	DGKA	EF-hand domain containing, diacylglycerol kinase, alpha 80kDa			0.00, 0.00	1.30, 0.35	31.96	-54.80	77.26	-46.39	28.99	-30.53	38.20	-99.93	-73.95	-29.26
CGS001-8527	KD	DGKD	Pleckstrin homology (PH) domain containing, diacylglycerol kinase, delta 130kDa			0.00, 0.00	2.17, 0.72	-73.22	36.53	-12.31	-99.91	-22.75	NaN	-20.81	-97.36	NaN	-70.41
CGS001-8525	KD	DGKZ	diacylglycerol kinase, zeta			11.11, 11.11	1.48, 0.50	-95.07	92.37	-46.44	-40.37	-69.01	98.04	-94.52	-35.95	NaN	-59.83
CGS001-1718	KD	DHCR24	24-dehydrocholesterol reductase			11.11, 11.11	1.41, 0.41	-95.90	99.23	29.10	-36.93	-44.53	NaN	90.99	-65.18	77.00	74.91
CGS001-1717	KD	DHCR7	7-dehydrocholesterol reductase			0.00, 0.00	1.15, 0.28	-30.78	NaN	-97.87	-99.86	56.50	NaN	-79.95	-81.54	23.09	-92.24
CGS001-79947	KD	DHDDS	dehydrodolichyl diphosphate synthase			0.00, 0.00	1.50, 0.55	18.73	-93.31	-98.84	-98.01	-99.60	-50.17	-29.12	-99.46	44.09	-99.63
CGS001-1719	KD	DHFR	Oxidoreductases, dihydrofolate reductase			0.00, 0.00	1.43, 0.35	-55.33	23.97	-99.43	-87.13	-85.30	NaN	-41.10	-97.72	-60.48	-96.74
CGS001-50846	KD	DHH	desert hedgehog			40.00, 30.00	1.75, 0.61	89.30	91.29	98.87	98.91	-32.41	-64.33	88.68	97.57	-31.26	97.20
CGS001-1725	KD	DHPS	deoxyhypusine synthase			0.00, 0.00	1.24, 0.41	73.98	NaN	-16.20	-98.47	-45.69	38.44	-37.59	31.51	89.60	-14.32
CGS001-10202	KD	DHRS2	Short chain dehydrogenase/reductase superfamily / Classical SDR fold cluster 1, dehydrogenase/reductase (SDR family) member 2			12.50, 0.00	1.22, 0.39	-68.27	NaN	-97.66	-91.90	-95.31	NaN	73.64	51.92	95.10	-91.64
CGS001-9249	KD	DHRS3	Short chain dehydrogenase/reductase superfamily / Classical SDR fold cluster 3, dehydrogenase/reductase (SDR family) member 3			0.00, 0.00	1.40, 0.51	-79.98	NaN	-90.03	31.04	-73.94	36.38	-34.19	-50.48	NaN	-79.55
CGS001-51635	KD	DHRS7	Short chain dehydrogenase/reductase superfamily / Classical SDR fold cluster 3, dehydrogenase/reductase (SDR family) member 7			10.00, 10.00	0.99, 0.30	-36.92	-99.98	-93.62	-21.37	27.04	-96.53	99.85	-90.45	-30.47	-84.85
CGS001-55526	KD	DHTKD1	dehydrogenase E1 and transketolase domain containing 1			0.00, 0.00	0.85, 0.23	19.48	23.17	34.21	27.98	32.75	-80.77	NaN	NaN	26.22	10.95
CGS001-8449	KD	DHX16	DEAH-boxes, DEAH (Asp-Glu-Ala-His) box polypeptide 16			62.50, 50.00	1.59, 0.66	26.06	46.86	99.98	99.59	46.07	NaN	NaN	97.74	96.91	99.18
CGS001-54505	KD	DHX29	DEAH-boxes, DEAH (Asp-Glu-Ala-His) box polypeptide 29			0.00, 0.00	1.28, 0.33	-34.47	-59.65	-44.77	-56.67	-22.44	-63.98	80.55	-49.74	50.71	-33.76
CGS001-1659	KD	DHX8	DEAH-boxes, DEAH (Asp-Glu-Ala-His) box polypeptide 8			40.00, 40.00	0.83, 0.28	99.81	98.56	99.67	70.65	85.75	-42.79	94.51	81.19	40.41	99.89
CGS001-56616	KD	DIABLO	diablo, IAP-binding mitochondrial protein			0.00, 0.00	1.49, 0.51	-59.24	-95.16	28.87	25.65	-36.77	63.20	NaN	26.28	NaN	-32.04
CGS001-23405	KD	DICER1	dicer 1, ribonuclease type III			0.00, 0.00	1.14, 0.22	58.18	NaN	-98.79	-84.43	-56.23	NaN	33.37	-39.31	-38.32	-61.97
CGS001-11083	KD	DIDO1	Zinc fingers, PHD-type, death inducer-obliterator 1			10.00, 10.00	1.00, 0.28	-29.22	54.27	34.84	27.57	-20.06	-24.40	-52.86	-17.61	99.78	8.20
CGS001-1736	KD	DKC1	dyskeratosis congenita 1, dyskerin			55.56, 55.56	1.88, 0.61	84.19	81.13	47.29	99.70	99.95	-22.10	99.88	99.62	NaN	99.68
CGS001-1737	KD	DLAT	dihydrolipoamide S-acetyltransferase			0.00, 0.00	1.09, 0.32	66.56	54.07	-13.83	42.63	78.43	-21.90	NaN	79.21	61.26	47.60
CGS001-10395	KD	DLC1	Rho GTPase activating proteins, deleted in liver cancer 1		Rho GTPase activating proteins LOF	0.00, 0.00	1.61, 0.57	-99.06	NaN	17.51	69.82	23.95	NaN	NaN	-63.49	-95.54	-75.51
CGS001-1738	KD	DLD	dihydrolipoamide dehydrogenase			0.00, 0.00	0.99, 0.25	48.30	29.18	-16.05	-96.57	-99.95	-59.54	-24.52	-88.09	23.32	-80.26
CGS001-9231	KD	DLG5	discs, large homolog 5 (Drosophila)			10.00, 0.00	1.18, 0.36	-31.93	27.09	-24.24	32.18	-88.80	30.66	36.84	-40.41	95.19	10.06
CGS001-9787	KD	DLGAP5	discs, large (Drosophila) homolog-associated protein 5			20.00, 20.00	0.99, 0.22	99.46	-98.99	-99.96	-32.72	-48.61	99.97	-92.35	-29.53	-98.97	-98.76
CGS001-1746	KD	DLX2	Homeoboxes / ANTP class : NKL subclass, distal-less homeobox 2		NKL subclass homeoboxes and pseudogenes LOF	0.00, 0.00	1.63, 0.58	-58.52	NaN	23.23	-33.01	-96.58	75.84	-23.13	-82.57	NaN	-46.68
CGS001-1747	KD	DLX3	Homeoboxes / ANTP class : NKL subclass, distal-less homeobox 3		NKL subclass homeoboxes and pseudogenes LOF	0.00, 0.00	1.50, 0.55	-13.90	-99.82	-16.66	34.94	-99.86	57.96	NaN	-31.50	32.25	-4.00
CGS001-1756	KD	DMD	dystrophin			0.00, 0.00	1.44, 0.47	-39.79	56.95	77.80	-22.34	NaN	34.99	19.26	-78.74	-32.25	8.16
CGS001-63948	KD	DMRTB1	DMRT-like family B with proline-rich C-terminal, 1			0.00, 0.00	1.85, 0.58	64.90	21.21	35.23	-28.74	-45.50	85.67	NaN	-22.41	-28.82	-8.37
CGS001-9988	KD	DMTF1	cyclin D binding myb-like transcription factor 1			50.00, 40.00	1.48, 0.50	-96.32	93.40	57.95	99.82	98.04	97.41	80.01	99.66	74.78	99.58
CGS001-1763	KD	DNA2	DNA replication helicase 2 homolog (yeast)			0.00, 0.00	1.89, 0.40	80.87	33.51	49.26	40.67	86.86	25.35	37.53	52.28	NaN	50.84
CGS001-9093	KD	DNAJA3	Heat shock proteins / DNAJ (HSP40), DnaJ (Hsp40) homolog, subfamily A, member 3			10.00, 10.00	0.66, 0.19	-95.42	65.94	-24.30	62.28	86.47	-68.22	57.40	99.92	43.01	47.08
CGS001-3337	KD	DNAJB1	Heat shock proteins / DNAJ (HSP40), DnaJ (Hsp40) homolog, subfamily B, member 1			0.00, 0.00	1.15, 0.34	-52.59	44.80	-99.49	-40.10	82.28	-87.79	52.00	-33.51	-86.97	-68.19
CGS001-54788	KD	DNAJB12	Heat shock proteins / DNAJ (HSP40), DnaJ (Hsp40) homolog, subfamily B, member 12			0.00, 0.00	1.20, 0.35	86.73	-21.79	65.69	34.92	23.92	NaN	47.80	-38.43	-37.11	29.37
CGS001-3300	KD	DNAJB2	Heat shock proteins / DNAJ (HSP40), DnaJ (Hsp40) homolog, subfamily B, member 2			0.00, 0.00	1.17, 0.26	-44.99	-78.69	-99.04	-54.20	-72.47	-96.35	-71.03	-99.90	-99.97	-99.76
CGS001-10049	KD	DNAJB6	Heat shock proteins / DNAJ (HSP40), DnaJ (Hsp40) homolog, subfamily B, member 6			20.00, 20.00	1.47, 0.47	94.13	26.51	99.81	97.77	59.04	35.47	-30.45	41.47	26.79	75.36
CGS001-4189	KD	DNAJB9	Heat shock proteins / DNAJ (HSP40), DnaJ (Hsp40) homolog, subfamily B, member 9			0.00, 0.00	1.57, 0.47	-20.84	70.93	-22.46	24.31	-37.56	21.82	25.38	-49.58	29.89	-4.71
CGS001-64215	KD	DNAJC1	Heat shock proteins / DNAJ (HSP40), DnaJ (Hsp40) homolog, subfamily C, member 1			0.00, 0.00	1.65, 0.30	-65.73	-25.88	-99.92	-59.37	-21.03	-95.97	-85.84	-53.76	-21.69	-77.83
CGS001-56521	KD	DNAJC12	Heat shock proteins / DNAJ (HSP40), DnaJ (Hsp40) homolog, subfamily C, member 12			11.11, 0.00	0.93, 0.17	80.37	NaN	-80.13	-77.50	45.74	57.95	96.32	-97.43	20.84	44.47
CGS001-29103	KD	DNAJC15	Heat shock proteins / DNAJ (HSP40), DnaJ (Hsp40) homolog, subfamily C, member 15			0.00, 0.00	1.52, 0.58	85.10	NaN	-53.01	-97.71	-77.74	48.62	-32.55	-69.33	-47.58	-72.38
CGS001-1759	KD	DNM1	Pleckstrin homology (PH) domain containing, dynamin 1			10.00, 10.00	1.07, 0.28	98.41	44.71	-18.68	-45.07	-85.57	-56.98	94.45	-57.08	-64.28	-30.35
CGS001-10059	KD	DNM1L	dynamin 1-like			11.11, 11.11	1.19, 0.36	77.78	86.61	-99.94	-99.95	97.69	NaN	-33.28	-38.73	-91.42	-87.81
CGS001-1786	KD	DNMT1	Methyltransferases, DNA (cytosine-5-)-methyltransferase 1			0.00, 0.00	1.07, 0.23	-99.93	NaN	-92.91	-99.61	71.95	83.51	-34.94	-96.59	61.72	-99.13
CGS001-1788	KD	DNMT3A	Methyltransferases, DNA (cytosine-5-)-methyltransferase 3 alpha			0.00, 0.00	1.39, 0.34	22.83	22.75	-18.88	22.81	21.92	37.02	NaN	56.29	22.19	7.13
CGS001-29947	KD	DNMT3L	DNA (cytosine-5-)-methyltransferase 3-like			0.00, 0.00	1.49, 0.39	-30.24	NaN	89.62	55.38	-41.44	NaN	47.48	30.41	-43.61	48.16
CGS001-23549	KD	DNPEP	Aminopeptidase I, aspartyl aminopeptidase			11.11, 11.11	1.43, 0.52	-60.19	98.49	-25.37	41.28	-38.16	NaN	-19.84	-47.00	-75.10	-28.64
CGS001-30836	KD	DNTTIP2	deoxynucleotidyltransferase, terminal, interacting protein 2			20.00, 10.00	1.58, 0.65	-73.31	-99.91	-99.94	-99.14	-65.24	98.12	95.34	-99.98	-95.86	-99.95
CGS001-55715	KD	DOK4	Pleckstrin homology (PH) domain containing, docking protein 4			37.50, 25.00	1.90, 0.59	-83.09	NaN	98.11	99.70	70.97	88.09	NaN	-42.78	34.30	97.34
CGS001-8193	KD	DPF1	Zinc fingers, PHD-type, D4, zinc and double PHD fingers family 1			0.00, 0.00	1.52, 0.42	-28.81	34.29	-40.54	-32.71	NaN	NaN	-84.39	34.62	-31.02	-28.83
CGS001-1802	KD	DPH2	DPH2 homolog (S. cerevisiae)			20.00, 20.00	3.24, 0.92	NaN	NaN	20.73	99.98	-58.68	NaN	NaN	NaN	80.47	91.42
CGS001-1803	KD	DPP4	Prolyl oligopeptidase, dipeptidyl-peptidase 4			0.00, 0.00	1.60, 0.52	-26.51	-23.87	32.04	78.54	23.39	-22.61	31.41	38.60	-46.24	5.18
CGS001-1806	KD	DPYD	dihydropyrimidine dehydrogenase			25.00, 25.00	1.35, 0.42	36.79	NaN	81.80	-99.77	99.98	NaN	-57.11	99.37	-68.01	86.32
CGS001-1810	KD	DR1	down-regulator of transcription 1, TBP-binding (negative cofactor 2)			33.33, 22.22	1.44, 0.45	72.43	89.45	87.43	84.89	-28.24	NaN	99.94	39.42	99.97	95.24
CGS001-10589	KD	DRAP1	DR1-associated protein 1 (negative cofactor 2 alpha)			12.50, 12.50	1.70, 0.66	-98.86	-16.10	-28.73	59.16	51.87	NaN	NaN	87.85	99.95	75.01
CGS001-29102	KD	DROSHA	drosha, ribonuclease type III			0.00, 0.00	1.51, 0.42	-60.20	-86.43	19.01	-30.37	-21.73	-98.99	NaN	-37.59	26.75	-50.07
CGS001-29940	KD	DSE	dermatan sulfate epimerase			0.00, 0.00	1.07, 0.39	92.52	-33.68	22.81	-96.70	-90.56	-99.94	28.52	-40.08	-99.95	-99.11
CGS001-1829	KD	DSG2	Cadherins / Major cadherins, desmoglein 2			0.00, 0.00	0.84, 0.23	60.14	25.00	-27.73	-61.98	-89.20	-64.76	-99.73	43.84	55.79	-62.35
CGS001-1837	KD	DTNA	dystrobrevin, alpha			0.00, 0.00	1.50, 0.36	-12.85	-81.14	-90.35	-86.36	-52.46	86.13	51.72	-99.94	-22.89	-84.07
CGS001-1840	KD	DTX1	deltex homolog 1 (Drosophila)			11.11, 0.00	1.50, 0.41	81.13	-47.99	71.05	49.35	96.89	-56.54	NaN	24.65	66.42	66.23
CGS001-113878	KD	DTX2	RING-type (C3HC4) zinc fingers, deltex homolog 2 (Drosophila)			0.00, 0.00	2.03, 0.72	-52.17	73.49	75.04	NaN	86.45	NaN	65.21	NaN	40.91	81.51
CGS001-151636	KD	DTX3L	RING-type (C3HC4) zinc fingers, deltex 3-like (Drosophila)			0.00, 0.00	1.31, 0.39	67.22	64.29	-97.37	-91.36	36.87	23.99	83.03	-31.45	75.87	51.42
CGS001-1841	KD	DTYMK	deoxythymidylate kinase (thymidylate kinase)			25.00, 12.50	1.27, 0.38	99.52	-32.62	-38.53	96.93	35.61	78.44	-13.42	NaN	NaN	61.29
CGS001-1843	KD	DUSP1	Protein tyrosine phosphatases / Class I Cys-based PTPs : MAP kinase phosphatases, dual specificity phosphatase 1			33.33, 11.11	1.70, 0.48	32.67	-100.00	99.19	71.76	-79.78	NaN	96.24	90.40	75.09	96.49
CGS001-8446	KD	DUSP11	Protein tyrosine phosphatases / Class I Cys-based PTPs : Atypical dual specificity phosphatases, dual specificity phosphatase 11 (RNA/RNP complex 1-interacting)			11.11, 0.00	1.86, 0.53	23.85	86.63	-89.69	-70.34	26.75	NaN	-22.86	91.49	95.98	76.43
CGS001-11072	KD	DUSP14	Protein tyrosine phosphatases / Class I Cys-based PTPs : Atypical dual specificity phosphatases, dual specificity phosphatase 14			20.00, 20.00	1.25, 0.34	-17.39	97.85	85.34	39.58	53.83	24.60	38.91	48.72	98.90	79.88
CGS001-1844	KD	DUSP2	Protein tyrosine phosphatases / Class I Cys-based PTPs : MAP kinase phosphatases, dual specificity phosphatase 2			11.11, 11.11	1.26, 0.27	56.44	99.43	19.39	37.16	66.39	NaN	42.18	-33.37	-99.01	37.19
CGS001-56940	KD	DUSP22	Protein tyrosine phosphatases / Class I Cys-based PTPs : Atypical dual specificity phosphatases, dual specificity phosphatase 22			11.11, 11.11	1.74, 0.47	-87.20	NaN	19.69	99.67	85.03	53.17	90.31	-91.84	-83.82	92.24
CGS001-1845	KD	DUSP3	Protein tyrosine phosphatases / Class I Cys-based PTPs : Atypical dual specificity phosphatases, dual specificity phosphatase 3			33.33, 22.22	1.47, 0.44	17.86	94.96	24.02	75.80	96.62	98.45	98.69	-14.76	NaN	92.77
CGS001-1848	KD	DUSP6	Protein tyrosine phosphatases / Class I Cys-based PTPs : MAP kinase phosphatases, dual specificity phosphatase 6			0.00, 0.00	1.24, 0.39	-55.95	-44.66	20.58	-32.12	-35.01	-53.32	-95.02	79.54	-68.35	-32.38
CGS001-1849	KD	DUSP7	Protein tyrosine phosphatases / Class I Cys-based PTPs : MAP kinase phosphatases, dual specificity phosphatase 7			11.11, 11.11	1.77, 0.52	67.82	44.68	42.01	94.73	82.66	98.31	44.39	-29.02	NaN	78.16
CGS001-1852	KD	DUSP9	Protein tyrosine phosphatases / Class I Cys-based PTPs : MAP kinase phosphatases, dual specificity phosphatase 9			0.00, 0.00	1.47, 0.51	-26.18	-26.56	-21.45	-38.88	-37.48	34.36	-32.94	-33.49	NaN	-16.22
CGS001-1854	KD	DUT	deoxyuridine triphosphatase			0.00, 0.00	1.52, 0.48	37.65	NaN	-65.87	NaN	20.54	26.11	-17.91	13.60	-21.12	-3.66
CGS001-1855	KD	DVL1	Dishevelled homologs, dishevelled, dsh homolog 1 (Drosophila)			0.00, 0.00	1.72, 0.60	NaN	NaN	83.82	91.98	-48.93	NaN	51.96	81.92	-48.34	84.30
CGS001-1856	KD	DVL2	Dishevelled homologs, dishevelled, dsh homolog 2 (Drosophila)			25.00, 25.00	0.91, 0.26	98.37	100.00	-91.31	28.63	24.50	NaN	86.52	-62.64	NaN	87.33
CGS001-8655	KD	DYNLL1	Cytoplasmic dyneins, dynein, light chain, LC8-type 1			0.00, 0.00	1.35, 0.40	-75.59	-98.23	-69.58	-99.98	-48.56	NaN	-99.76	-92.26	-19.73	-98.78
CGS001-140735	KD	DYNLL2	Cytoplasmic dyneins, dynein, light chain, LC8-type 2			0.00, 0.00	1.63, 0.55	-90.44	-25.07	17.77	-32.75	NaN	-58.81	-51.09	-82.82	-82.65	-53.77
CGS001-6990	KD	DYNLT3	Cytoplasmic dyneins, dynein, light chain, Tctex-type 3			0.00, 0.00	1.90, 0.56	71.95	-98.77	-99.67	-95.06	54.70	NaN	NaN	-97.88	45.17	-99.47
CGS001-1859	KD	DYRK1A	Dyrk1 subfamily, dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A			77.78, 77.78	1.08, 0.28	99.98	98.75	54.88	98.67	88.32	NaN	99.94	98.45	99.96	99.95
CGS001-8444	KD	DYRK3	Dyrk2 subfamily, dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 3			20.00, 20.00	1.08, 0.26	97.79	30.46	-95.84	27.64	60.36	-31.02	52.45	-54.70	99.65	36.35
CGS001-1869	KD	E2F1	E2F transcription factor 1			10.00, 0.00	0.94, 0.25	39.71	-19.18	27.20	38.92	47.01	28.84	-61.51	97.09	28.60	14.07
CGS001-1874	KD	E2F4	E2F transcription factor 4, p107/p130-binding			0.00, 0.00	1.26, 0.32	-95.26	NaN	-35.82	-36.93	35.38	NaN	NaN	48.88	18.06	12.42
CGS001-1875	KD	E2F5	E2F transcription factor 5, p130-binding			0.00, 0.00	1.13, 0.27	70.49	NaN	-99.56	-86.34	-40.76	NaN	-47.43	-99.30	-41.92	-96.54
CGS001-1876	KD	E2F6	E2F transcription factor 6			57.14, 42.86	1.92, 0.59	-40.18	NaN	95.85	43.38	-27.09	NaN	NaN	99.49	99.93	99.66
CGS001-55837	KD	EAPP	E2F-associated phosphoprotein			0.00, 0.00	2.00, 0.61	NaN	-71.61	-99.23	-75.76	-26.88	-41.27	-35.35	-96.16	-99.59	-99.42
CGS001-1879	KD	EBF1	early B-cell factor 1			0.00, 0.00	1.32, 0.22	68.01	38.26	-97.19	-26.62	72.06	-98.54	-31.49	NaN	NaN	-39.52
CGS001-10969	KD	EBNA1BP2	EBNA1 binding protein 2			10.00, 10.00	1.16, 0.35	89.30	72.74	46.62	78.95	93.57	97.50	-22.82	-83.74	59.87	86.69
CGS001-10682	KD	EBP	emopamil binding protein (sterol isomerase)			0.00, 0.00	1.32, 0.34	-95.66	-48.15	-97.75	-99.95	19.67	-99.96	-84.56	-34.94	-29.97	-96.80
CGS001-11319	KD	ECD	ecdysoneless homolog (Drosophila)			10.00, 10.00	1.31, 0.44	93.66	87.99	-21.04	99.58	21.37	81.15	62.04	-16.86	42.63	94.91
CGS001-1891	KD	ECH1	enoyl CoA hydratase 1, peroxisomal			25.00, 12.50	2.46, 0.86	-91.09	NaN	49.64	97.19	27.49	NaN	56.04	99.51	34.95	69.06
CGS001-1892	KD	ECHS1	enoyl CoA hydratase, short chain, 1, mitochondrial			0.00, 0.00	1.47, 0.49	94.44	-23.10	-85.89	80.44	57.25	67.45	NaN	82.91	33.49	56.80
CGS001-1632	KD	ECI1	enoyl-CoA delta isomerase 1			0.00, 0.00	1.30, 0.41	-24.71	41.46	-90.01	-21.20	38.29	-23.44	-85.85	20.27	NaN	-21.86
CGS001-51295	KD	ECSIT	Mitochondrial respiratory chain complex assembly factors, ECSIT homolog (Drosophila)			0.00, 0.00	1.49, 0.36	-76.47	-28.75	-86.43	-27.17	-99.71	-99.97	-99.95	-95.99	NaN	-99.24
CGS001-9695	KD	EDEM1	ER degradation enhancer, mannosidase alpha-like 1			0.00, 0.00	1.41, 0.56	NaN	-17.92	91.11	53.61	39.57	30.32	-88.00	66.57	53.71	32.04
CGS001-1906	KD	EDN1	Endogenous ligands, endothelin 1			0.00, 0.00	0.98, 0.33	-58.11	-100.00	-89.31	-27.30	38.75	NaN	69.74	-99.05	-86.94	-88.32
CGS001-1910	KD	EDNRB	Endothelin receptors, endothelin receptor type B			0.00, 0.00	1.19, 0.30	-91.53	-85.10	-36.01	-99.24	-99.96	NaN	-49.21	-49.89	-73.63	-92.98
CGS001-8726	KD	EED	Neutral sphingomyelinase coupling factors, embryonic ectoderm development			0.00, 0.00	2.07, 0.59	89.18	NaN	93.47	NaN	NaN	NaN	70.13	87.09	83.04	92.60
CGS001-1936	KD	EEF1D	eukaryotic translation elongation factor 1 delta (guanine nucleotide exchange protein)			57.14, 42.86	0.88, 0.44	79.85	NaN	99.98	NaN	91.59	NaN	44.96	99.17	97.08	99.74
CGS001-84288	KD	EFCAB2	EF-hand domain containing, EF-hand calcium binding domain 2			0.00, 0.00	1.66, 0.55	28.00	35.26	45.84	-70.45	60.05	NaN	NaN	-96.83	-46.92	-40.70
CGS001-1948	KD	EFNB2	Ephrins, ephrin-B2			22.22, 11.11	1.63, 0.41	19.92	75.18	97.35	98.58	49.60	21.17	NaN	-25.19	37.48	61.26
CGS001-1949	KD	EFNB3	Ephrins, ephrin-B3			0.00, 0.00	0.95, 0.27	-39.36	-30.44	-41.25	-56.86	-53.62	-74.57	26.98	-25.04	-26.84	-38.56
CGS001-1950	KD	EGF	epidermal growth factor			0.00, 0.00	1.08, 0.25	73.82	48.26	58.06	-34.15	47.61	27.47	33.35	50.49	-25.65	42.40
CGS001-54583	KD	EGLN1	2-oxoglutarate oxygenases, egl nine homolog 1 (C. elegans)			20.00, 10.00	1.85, 0.68	49.78	-38.52	98.76	96.49	85.61	-44.04	-23.61	23.17	32.54	63.25
CGS001-112398	KD	EGLN2	2-oxoglutarate oxygenases, egl nine homolog 2 (C. elegans)			25.00, 25.00	1.67, 0.50	61.33	87.72	21.10	-27.45	NaN	99.47	73.46	98.68	NaN	93.45
CGS001-1958	KD	EGR1	Zinc fingers, C2H2-type, early growth response 1			0.00, 0.00	1.19, 0.26	-28.23	-44.23	-67.55	36.35	93.27	-40.89	-91.33	-95.97	NaN	-69.77
CGS001-1959	KD	EGR2	Zinc fingers, C2H2-type, early growth response 2			50.00, 40.00	1.09, 0.39	90.11	58.45	94.69	43.37	-26.68	99.38	96.58	99.95	99.97	99.79
CGS001-1960	KD	EGR3	Zinc fingers, C2H2-type, early growth response 3			22.22, 22.22	1.65, 0.35	-25.58	44.74	-70.79	98.29	42.92	-75.39	NaN	17.58	99.43	22.79
CGS001-26298	KD	EHF	ets homologous factor			0.00, 0.00	1.91, 0.65	-19.44	-23.28	-31.88	-29.48	43.16	-62.76	-83.32	-41.47	NaN	-24.47
CGS001-1962	KD	EHHADH	enoyl-CoA, hydratase/3-hydroxyacyl CoA dehydrogenase			0.00, 0.00	1.10, 0.32	22.55	-88.27	25.27	38.65	-61.86	-35.41	-40.37	-56.89	-31.84	-35.67
CGS001-10919	KD	EHMT2	Histone methyltransferases, euchromatic histone-lysine N-methyltransferase 2			57.14, 57.14	2.43, 0.94	-95.07	NaN	98.07	99.98	41.06	NaN	NaN	94.29	97.58	99.05
CGS001-10289	KD	EIF1B	eukaryotic translation initiation factor 1B			11.11, 11.11	1.27, 0.31	-93.96	NaN	-45.48	-54.06	34.14	53.13	41.85	-35.14	98.14	43.34
CGS001-27102	KD	EIF2AK1	Other PEK family kinases, eukaryotic translation initiation factor 2-alpha kinase 1			50.00, 50.00	1.53, 0.55	-72.75	99.85	99.95	NaN	89.22	NaN	21.67	98.79	89.61	99.89
CGS001-5610	KD	EIF2AK2	Other PEK family kinases, eukaryotic translation initiation factor 2-alpha kinase 2			0.00, 0.00	2.02, 0.65	-78.32	NaN	-99.38	NaN	-99.80	NaN	-26.04	-12.03	-32.30	-94.90
CGS001-9451	KD	EIF2AK3	PEK subfamily, eukaryotic translation initiation factor 2-alpha kinase 3			10.00, 10.00	1.00, 0.42	-14.77	86.73	-88.05	-70.94	-98.96	-25.40	21.84	-23.33	99.97	-21.98
CGS001-8892	KD	EIF2B2	eukaryotic translation initiation factor 2B, subunit 2 beta, 39kDa		EIF Proteins LOF	11.11, 0.00	2.18, 0.57	95.25	61.78	40.59	-41.07	57.53	NaN	90.55	-96.76	-99.48	62.48
CGS001-8891	KD	EIF2B3	eukaryotic translation initiation factor 2B, subunit 3 gamma, 58kDa		EIF Proteins LOF	25.00, 25.00	2.77, 1.41	99.89	NaN	-23.24	23.18	99.44	NaN	-96.65	-94.26	-41.63	-46.84
CGS001-8893	KD	EIF2B5	eukaryotic translation initiation factor 2B, subunit 5 epsilon, 82kDa		EIF Proteins LOF	12.50, 12.50	2.34, 0.76	-53.37	NaN	-82.21	63.16	98.61	NaN	-71.15	81.35	41.93	49.21
CGS001-26523	KD	EIF2C1	eukaryotic translation initiation factor 2C, 1			0.00, 0.00	1.05, 0.28	-71.89	-97.11	-88.64	-96.79	-43.25	NaN	41.13	-94.29	-31.30	-95.81
CGS001-27161	KD	EIF2C2	eukaryotic translation initiation factor 2C, 2			11.11, 11.11	1.41, 0.44	98.72	-25.94	87.17	41.50	-19.56	-48.12	-17.20	NaN	-99.62	-9.16
CGS001-192669	KD	EIF2C3	eukaryotic translation initiation factor 2C, 3			0.00, 0.00	1.68, 0.43	-52.78	NaN	80.27	25.79	-38.96	NaN	-82.99	-33.19	-39.95	-30.28
CGS001-8894	KD	EIF2S2	Serine/threonine phosphatases / Protein phosphatase 1, regulatory subunits, eukaryotic translation initiation factor 2, subunit 2 beta, 38kDa		EIF Proteins LOF	0.00, 0.00	3.34, 1.70	80.39	NaN	27.61	-98.73	52.17	NaN	-96.47	-81.39	-32.27	-92.23
CGS001-8667	KD	EIF3H	eukaryotic translation initiation factor 3, subunit H			0.00, 0.00	1.35, 0.32	40.95	62.77	-75.48	-98.59	-98.34	-34.63	-99.96	-31.25	-56.80	-94.19
CGS001-8669	KD	EIF3J	eukaryotic translation initiation factor 3, subunit J			0.00, 0.00	1.38, 0.43	-69.15	42.78	-30.90	-57.34	-88.71	-26.50	80.82	29.12	81.37	-29.66
CGS001-1974	KD	EIF4A2	DEAD-boxes, eukaryotic translation initiation factor 4A2		EIF Proteins LOF	0.00, 0.00	1.35, 0.42	-99.10	NaN	-66.38	NaN	-79.12	NaN	-65.97	-99.19	-94.45	-98.42
CGS001-1975	KD	EIF4B	RNA binding motif (RRM) containing, eukaryotic translation initiation factor 4B		EIF Proteins LOF	0.00, 0.00	1.06, 0.31	-66.64	-86.91	25.24	-52.39	42.03	NaN	-33.56	13.18	-40.73	-20.06
CGS001-1977	KD	EIF4E	Translation Initiation Factor 4E, eukaryotic translation initiation factor 4E		EIF Proteins LOF	0.00, 0.00	1.35, 0.39	26.51	-20.81	-65.87	-82.79	-68.24	NaN	28.06	56.66	-44.86	-70.05
CGS001-1978	KD	EIF4EBP1	eukaryotic translation initiation factor 4E binding protein 1			11.11, 11.11	1.15, 0.33	-33.31	40.63	-50.40	-63.42	-99.98	NaN	-63.27	-98.46	99.58	-47.22
CGS001-1981	KD	EIF4G1	Parkinson disease, eukaryotic translation initiation factor 4 gamma, 1			0.00, 0.00	0.88, 0.25	59.26	NaN	-52.26	-99.98	39.16	-22.56	-62.34	-81.74	-32.74	-47.20
CGS001-1983	KD	EIF5	eukaryotic translation initiation factor 5			0.00, 0.00	2.75, 0.77	NaN	NaN	-61.57	-38.54	32.31	NaN	NaN	-38.87	31.36	-19.00
CGS001-1984	KD	EIF5A	eukaryotic translation initiation factor 5A			12.50, 0.00	1.92, 0.49	NaN	96.41	-53.53	-63.79	88.11	NaN	-92.80	56.43	-99.36	-62.81
CGS001-3692	KD	EIF6	eukaryotic translation initiation factor 6			44.44, 44.44	1.51, 0.48	75.23	99.63	99.98	40.04	-29.15	NaN	-24.25	84.24	99.40	99.26
CGS001-60528	KD	ELAC2	elaC homolog 2 (E. coli)			0.00, 0.00	1.08, 0.22	-53.62	-29.34	-24.97	-44.71	39.67	-99.63	-79.55	-77.23	31.41	-45.18
CGS001-1994	KD	ELAVL1	RNA binding motif (RRM) containing, ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1 (Hu antigen R)			0.00, 0.00	1.09, 0.26	-99.95	-93.03	-58.13	-99.98	48.18	-99.97	-89.43	-85.65	-99.85	-99.95
CGS001-1997	KD	ELF1	ETS Transcription Factors, E74-like factor 1 (ets domain transcription factor)			0.00, 0.00	1.07, 0.32	-49.44	-37.63	33.16	29.42	54.42	-26.95	NaN	-55.72	50.50	-11.17
CGS001-1999	KD	ELF3	ETS Transcription Factors, E74-like factor 3 (ets domain transcription factor, epithelial-specific )			10.00, 10.00	1.09, 0.31	29.72	85.29	60.97	-27.34	63.68	-48.90	54.09	-54.98	98.34	46.01
CGS001-2000	KD	ELF4	ETS Transcription Factors, E74-like factor 4 (ets domain transcription factor)			20.00, 10.00	1.36, 0.40	19.13	16.30	35.88	33.67	-24.57	70.82	32.29	96.64	99.33	64.26
CGS001-2002	KD	ELK1	ETS Transcription Factors, ELK1, member of ETS oncogene family			10.00, 0.00	1.10, 0.28	95.53	-55.89	37.55	-63.17	-21.48	36.61	48.23	-63.41	-19.53	-12.34
CGS001-80237	KD	ELL3	elongation factor RNA polymerase II-like 3			11.11, 11.11	1.13, 0.30	-98.99	-97.69	45.28	-95.82	64.67	NaN	-35.00	42.78	97.82	-83.82
CGS001-79071	KD	ELOVL6	ELOVL fatty acid elongase 6			0.00, 0.00	1.48, 0.56	NaN	-65.30	-90.86	-98.56	92.32	-99.87	-97.73	-38.40	23.98	-98.36
CGS001-2010	KD	EMD	emerin			11.11, 11.11	1.45, 0.38	31.02	-21.63	51.53	99.67	-98.80	78.76	48.24	NaN	31.97	34.88
CGS001-256364	KD	EML3	WD repeat domain containing, echinoderm microtubule associated protein like 3			0.00, 0.00	1.59, 0.56	-91.04	-23.80	68.57	33.24	57.84	NaN	89.39	-70.06	91.58	79.26
CGS001-2015	KD	EMR1	Adhesion Class GPCRs, egf-like module containing, mucin-like, hormone receptor-like 1			11.11, 11.11	1.67, 0.41	-87.48	-28.77	-77.05	-97.73	97.69	NaN	-33.37	-91.67	-90.24	-93.16
CGS001-2021	KD	ENDOG	endonuclease G			0.00, 0.00	0.91, 0.25	43.99	-28.57	-39.83	35.79	27.15	NaN	-53.26	23.29	78.62	7.17
CGS001-2023	KD	ENO1	enolase 1, (alpha)			20.00, 20.00	1.24, 0.39	-47.49	62.23	-29.50	-36.85	49.93	89.26	42.03	99.06	99.97	75.46
CGS001-58478	KD	ENOPH1	enolase-phosphatase 1			0.00, 0.00	1.25, 0.35	-34.03	36.40	-96.59	-33.92	-76.81	68.08	NaN	-20.30	-76.16	-47.88
CGS001-55556	KD	ENOSF1	enolase superfamily member 1			0.00, 0.00	1.40, 0.41	72.74	-40.06	-90.53	-99.96	73.53	-45.17	-45.36	-100.00	25.58	-86.30
CGS001-5167	KD	ENPP1	ectonucleotide pyrophosphatase/phosphodiesterase 1			0.00, 0.00	1.74, 0.51	-51.35	-97.06	-18.13	26.95	-74.15	-67.16	-71.54	-92.27	53.51	-56.45
CGS001-955	KD	ENTPD6	ectonucleoside triphosphate diphosphohydrolase 6 (putative)			0.00, 0.00	1.42, 0.41	-26.54	-100.00	-99.79	-99.45	-25.45	88.10	-89.88	-33.47	-25.20	-97.25
CGS001-2033	KD	EP300	Chromatin-modifying enzymes / K-acetyltransferases, E1A binding protein p300			10.00, 0.00	1.13, 0.34	52.05	52.21	37.20	48.14	-97.86	96.06	-56.97	35.71	40.41	17.06
CGS001-2034	KD	EPAS1	Basic helix-loop-helix proteins, endothelial PAS domain protein 1			0.00, 0.00	1.88, 0.65	-93.48	NaN	17.80	NaN	36.58	21.98	-94.25	-22.51	-84.70	-84.63
CGS001-2037	KD	EPB41L2	erythrocyte membrane protein band 4.1-like 2			0.00, 0.00	1.73, 0.56	NaN	22.12	-96.25	-48.62	-95.92	-94.18	-25.54	-44.57	60.96	-91.01
CGS001-54566	KD	EPB41L4B	erythrocyte membrane protein band 4.1 like 4B			12.50, 0.00	1.34, 0.40	-84.12	-43.26	-92.46	-63.01	97.30	NaN	NaN	-17.53	-39.42	-43.21
CGS001-80314	KD	EPC1	enhancer of polycomb homolog 1 (Drosophila)			0.00, 0.00	1.49, 0.52	-86.56	-28.33	50.71	-26.23	20.97	32.03	-99.23	NaN	NaN	-7.61
CGS001-4072	KD	EPCAM	CD molecules, epithelial cell adhesion molecule			0.00, 0.00	1.32, 0.31	-98.79	-24.55	-99.98	-95.08	-56.06	NaN	23.16	-88.19	-82.55	-98.85
CGS001-1969	KD	EPHA2	Type XIII RTKs: Ephrin receptor family, EPH receptor A2			40.00, 20.00	1.39, 0.39	-16.23	-74.80	95.96	99.79	84.34	-61.98	99.87	67.37	-40.95	95.68
CGS001-2042	KD	EPHA3	Type XIII RTKs: Ephrin receptor family, EPH receptor A3			44.44, 33.33	1.95, 0.59	60.76	-51.46	95.57	98.88	-51.49	39.31	57.46	99.90	NaN	97.90
CGS001-285220	KD	EPHA6	Type XIII RTKs: Ephrin receptor family, EPH receptor A6			0.00, 0.00	0.55, 0.26	-45.88	-64.51	25.71	68.24	-31.93	58.11	20.04	68.44	-9.02	9.13
CGS001-2048	KD	EPHB2	Type XIII RTKs: Ephrin receptor family, EPH receptor B2			11.11, 11.11	1.45, 0.39	16.92	-97.79	-26.10	-36.57	-42.47	NaN	58.33	66.01	99.93	34.96
CGS001-2050	KD	EPHB4	Type XIII RTKs: Ephrin receptor family, EPH receptor B4			0.00, 0.00	1.10, 0.28	-91.93	-28.11	-36.57	-90.58	63.17	43.50	-95.89	-82.93	26.64	-72.73
CGS001-2052	KD	EPHX1	epoxide hydrolase 1, microsomal (xenobiotic)			0.00, 0.00	0.92, 0.22	16.36	NaN	-12.86	NaN	-69.30	NaN	84.67	-44.23	39.34	14.43
CGS001-2053	KD	EPHX2	epoxide hydrolase 2, cytoplasmic			12.50, 12.50	1.63, 0.63	88.66	45.37	59.09	99.13	-27.83	40.97	NaN	-77.05	NaN	66.30
CGS001-22905	KD	EPN2	epsin 2			14.29, 14.29	1.98, 0.78	-46.42	NaN	99.87	55.69	27.53	NaN	NaN	88.32	38.43	72.08
CGS001-2056	KD	EPO	Endogenous ligands, erythropoietin			11.11, 11.11	1.40, 0.34	-87.62	99.23	-32.36	50.73	-23.15	NaN	-22.34	41.79	43.62	26.01
CGS001-2057	KD	EPOR	Prolactin receptor family, erythropoietin receptor			11.11, 11.11	1.17, 0.42	-85.09	19.19	-35.11	-32.52	32.57	-60.73	99.71	-28.03	NaN	-12.39
CGS001-2058	KD	EPRS	Aminoacyl tRNA synthetases / Class I, glutamyl-prolyl-tRNA synthetase			10.00, 10.00	1.25, 0.36	15.64	30.24	12.56	94.12	98.33	33.28	61.37	25.28	-28.42	19.21
CGS001-2059	KD	EPS8	epidermal growth factor receptor pathway substrate 8			42.86, 14.29	1.40, 0.34	59.10	NaN	-86.52	NaN	88.39	NaN	96.85	-55.46	99.05	95.49
CGS001-51752	KD	ERAP1	Aminopeptidase N, endoplasmic reticulum aminopeptidase 1			0.00, 0.00	1.26, 0.28	16.84	25.41	-99.65	-26.80	20.58	NaN	-95.85	-99.81	92.99	-97.57
CGS001-64167	KD	ERAP2	Aminopeptidase N, endoplasmic reticulum aminopeptidase 2			0.00, 0.00	1.20, 0.35	-45.72	NaN	-99.88	-59.91	-41.68	NaN	-98.55	-95.26	31.73	-97.14
CGS001-2065	KD	ERBB3	Type I RTKs: ErbB (epidermal growth factor) receptor family, v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian)			0.00, 0.00	0.13, 0.05	-48.09	-30.85	-94.34	-96.12	93.65	-97.57	-99.89	-94.68	57.95	-96.77
CGS001-2066	KD	ERBB4	Type I RTKs: ErbB (epidermal growth factor) receptor family, v-erb-a erythroblastic leukemia viral oncogene homolog 4 (avian)			10.00, 0.00	1.47, 0.41	-74.06	-62.53	49.85	-43.03	32.36	96.03	89.46	58.37	74.86	60.73
CGS001-2067	KD	ERCC1	excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)			0.00, 0.00	1.02, 0.19	-29.90	NaN	-28.62	-87.49	29.15	-77.40	-93.90	-89.05	-69.59	-83.74
CGS001-2068	KD	ERCC2	General transcription factor IIH complex subunits, excision repair cross-complementing rodent repair deficiency, complementation group 2		General transcription factors group 1 LOF	20.00, 10.00	1.24, 0.36	-32.93	-97.09	-60.92	28.74	37.32	97.24	-35.98	99.81	24.99	-21.48
CGS001-2071	KD	ERCC3	General transcription factors, excision repair cross-complementing rodent repair deficiency, complementation group 3 (xeroderma pigmentosum group B complementing)			0.00, 0.00	1.22, 0.41	65.96	NaN	-17.67	-38.08	86.13	NaN	42.86	-37.88	26.25	31.05
CGS001-2072	KD	ERCC4	excision repair cross-complementing rodent repair deficiency, complementation group 4			22.22, 0.00	1.67, 0.49	95.87	NaN	-91.72	27.73	36.67	-24.81	26.34	63.79	95.40	51.74
CGS001-2073	KD	ERCC5	excision repair cross-complementing rodent repair deficiency, complementation group 5			0.00, 0.00	1.15, 0.44	-72.17	89.99	-94.67	-99.89	-25.81	-77.62	27.44	54.55	-61.00	-75.95
CGS001-54821	KD	ERCC6L	excision repair cross-complementing rodent repair deficiency, complementation group 6-like			0.00, 0.00	1.30, 0.30	-40.89	27.07	-91.01	-95.82	25.49	-82.88	-94.10	-12.39	40.39	-74.46
CGS001-2077	KD	ERF	ETS Transcription Factors, Ets2 repressor factor			0.00, 0.00	1.78, 0.49	90.91	85.81	-81.78	NaN	-94.45	86.48	NaN	-87.73	-74.54	87.13
CGS001-2078	KD	ERG	ETS Transcription Factors, v-ets erythroblastosis virus E26 oncogene homolog (avian)			30.00, 30.00	0.77, 0.20	99.94	-92.22	99.98	46.22	-23.67	43.81	-29.55	10.26	99.29	93.17
CGS001-57222	KD	ERGIC1	endoplasmic reticulum-golgi intermediate compartment (ERGIC) 1			0.00, 0.00	1.14, 0.42	NaN	-96.63	-99.96	60.16	34.35	26.92	17.72	33.86	-53.64	-6.88
CGS001-51290	KD	ERGIC2	ERGIC and golgi 2			0.00, 0.00	2.01, 0.68	-90.30	-100.00	-81.32	-79.66	-47.41	-99.97	NaN	-96.28	NaN	-99.39
CGS001-2079	KD	ERH	enhancer of rudimentary homolog (Drosophila)			0.00, 0.00	1.65, 0.39	-41.08	-29.63	26.82	-34.46	30.13	-65.47	-65.26	-29.22	NaN	-17.08
CGS001-10613	KD	ERLIN1	ER lipid raft associated 1			0.00, 0.00	2.06, 0.55	42.85	34.56	-20.73	-43.20	24.82	87.30	NaN	-66.32	-99.97	11.11
CGS001-30001	KD	ERO1L	ERO1-like (S. cerevisiae)			10.00, 10.00	2.58, 0.67	82.49	58.16	98.60	-44.75	28.00	-64.03	74.65	30.07	46.07	80.84
CGS001-2098	KD	ESD	esterase D			0.00, 0.00	1.36, 0.57	-33.71	32.43	-32.92	-89.76	43.41	-47.76	-93.68	-93.09	NaN	-78.05
CGS001-9700	KD	ESPL1	extra spindle pole bodies homolog 1 (S. cerevisiae)			0.00, 0.00	1.53, 0.58	-94.86	-60.70	-32.26	-24.19	-51.35	NaN	-21.00	-77.91	59.33	-44.84
CGS001-2100	KD	ESR2	Estrogen receptors, estrogen receptor 2 (ER beta)			0.00, 0.00	1.35, 0.33	-99.34	-68.00	-20.77	21.15	-55.70	26.54	-97.14	7.78	25.94	-42.00
CGS001-2101	KD	ESRRA	Estrogen-related receptors, estrogen-related receptor alpha			0.00, 0.00	1.05, 0.39	-96.83	-31.25	-54.03	-68.79	-79.90	NaN	28.61	74.25	-30.25	-68.01
CGS001-23344	KD	ESYT1	Synaptotagmins, extended synaptotagmin-like protein 1			22.22, 11.11	0.97, 0.32	95.72	NaN	87.37	53.92	99.98	60.65	82.72	29.71	-25.89	90.59
CGS001-2108	KD	ETFA	electron-transfer-flavoprotein, alpha polypeptide			0.00, 0.00	1.30, 0.30	26.11	-30.21	-68.83	-29.15	63.75	65.11	NaN	-48.63	-44.59	-19.45
CGS001-2109	KD	ETFB	electron-transfer-flavoprotein, beta polypeptide			11.11, 11.11	1.27, 0.28	-57.47	-60.00	-26.22	-46.33	-35.22	43.86	NaN	38.27	99.97	-32.98
CGS001-55500	KD	ETNK1	ethanolamine kinase 1			0.00, 0.00	1.18, 0.33	50.07	-85.95	-26.02	-21.43	39.20	NaN	-52.51	-26.10	81.83	-7.94
CGS001-2113	KD	ETS1	ETS Transcription Factors, v-ets erythroblastosis virus E26 oncogene homolog 1 (avian)			0.00, 0.00	1.01, 0.30	90.60	NaN	-31.69	55.59	-25.37	-29.83	-27.71	-77.79	23.07	-11.08
CGS001-2114	KD	ETS2	ETS Transcription Factors, v-ets erythroblastosis virus E26 oncogene homolog 2 (avian)			0.00, 0.00	1.26, 0.39	-80.58	65.38	-72.59	-99.77	-65.39	-30.62	-99.47	-70.15	-99.50	-99.24
CGS001-2115	KD	ETV1	ETS Transcription Factors, ets variant 1			0.00, 0.00	1.47, 0.32	88.27	-100.00	-45.65	-87.08	-99.24	-99.01	-99.94	-99.17	-99.01	-99.89
CGS001-2118	KD	ETV4	ETS Transcription Factors, ets variant 4			33.33, 33.33	1.50, 0.44	99.94	99.58	-17.86	24.49	-51.25	NaN	98.41	33.26	66.96	94.87
CGS001-2119	KD	ETV5	ETS Transcription Factors, ets variant 5			0.00, 0.00	1.35, 0.39	-96.90	-48.51	-85.26	-34.16	-76.41	NaN	64.41	36.93	-89.80	-89.81
CGS001-51466	KD	EVL	Enah/Vasp-like			10.00, 10.00	1.14, 0.31	-66.50	-97.23	-38.18	-76.74	-62.72	-60.38	-68.35	99.38	13.53	-68.61
CGS001-2130	KD	EWSR1	RNA binding motif (RRM) containing, Ewing sarcoma breakpoint region 1			37.50, 12.50	1.53, 0.64	-89.35	NaN	55.88	97.32	35.62	NaN	98.87	94.01	26.00	95.26
CGS001-9156	KD	EXO1	exonuclease 1			0.00, 0.00	1.53, 0.41	40.91	54.07	19.13	-88.57	77.45	47.68	-8.65	-34.29	NaN	11.88
CGS001-55770	KD	EXOC2	exocyst complex component 2			0.00, 0.00	1.52, 0.33	-58.56	20.33	88.20	27.62	-21.51	NaN	NaN	-39.28	-92.15	-25.80
CGS001-11336	KD	EXOC3	exocyst complex component 3			11.11, 0.00	1.24, 0.44	-64.33	97.41	-53.80	NaN	-99.98	48.44	-27.45	-73.12	-80.25	-63.57
CGS001-54512	KD	EXOSC4	exosome component 4			0.00, 0.00	1.41, 0.32	15.52	-41.81	-81.03	-40.91	-21.37	69.26	-91.97	-92.34	61.56	-64.89
CGS001-11340	KD	EXOSC8	exosome component 8			0.00, 0.00	1.43, 0.38	-89.72	-23.27	-70.63	-31.55	-24.97	45.58	-70.61	-62.64	22.26	-43.21
CGS001-2131	KD	EXT1	Exostosin glycosyltransferase family, exostosin 1			10.00, 0.00	0.93, 0.15	-99.81	74.66	97.03	35.39	36.51	93.56	-88.56	30.14	34.80	43.68
CGS001-2132	KD	EXT2	Exostosin glycosyltransferase family, exostosin 2			0.00, 0.00	1.40, 0.50	-25.73	53.01	74.96	52.61	-91.76	25.78	NaN	-90.44	73.17	50.76
CGS001-2138	KD	EYA1	Protein tyrosine phosphatases / Asp-based PTPs, eyes absent homolog 1 (Drosophila)			37.50, 25.00	2.09, 0.64	93.96	84.16	-26.95	46.12	NaN	NaN	96.44	-25.43	99.35	98.88
CGS001-2145	KD	EZH1	Chromatin-modifying enzymes / K-methyltransferases, enhancer of zeste homolog 1 (Drosophila)			0.00, 0.00	1.00, 0.30	-34.58	70.52	-22.90	-23.81	-83.58	NaN	-72.29	-85.00	26.78	-44.19
CGS001-2146	KD	EZH2	Chromatin-modifying enzymes / K-methyltransferases, enhancer of zeste homolog 2 (Drosophila)			0.00, 0.00	1.45, 0.38	-83.57	-44.66	-71.06	-74.36	-27.12	-99.97	-95.19	-54.05	24.36	-64.44
CGS001-2159	KD	F10	Chymotrypsin, coagulation factor X			30.00, 10.00	2.08, 0.70	92.97	79.16	97.32	69.58	-83.10	99.88	91.11	84.68	-30.36	95.64
CGS001-2161	KD	F12	Chymotrypsin, coagulation factor XII (Hageman factor)			10.00, 10.00	0.92, 0.32	36.81	-93.85	-22.71	97.75	27.41	45.58	-16.71	25.05	-58.38	9.26
CGS001-2147	KD	F2	Endogenous ligands, coagulation factor II (thrombin)			0.00, 0.00	1.40, 0.42	22.66	56.75	-94.83	26.45	-21.81	25.19	30.26	29.51	42.29	7.99
CGS001-2149	KD	F2R	Protease activated receptors, coagulation factor II (thrombin) receptor			0.00, 0.00	1.13, 0.39	-99.94	-72.00	-98.84	-31.40	-96.43	NaN	-91.49	47.13	17.16	-94.23
CGS001-2150	KD	F2RL1	GPCR / Class A : Protease activated receptors, coagulation factor II (thrombin) receptor-like 1			0.00, 0.00	1.47, 0.44	-31.18	-18.44	38.61	37.98	91.64	-19.86	-29.35	29.07	-30.70	-6.18
CGS001-2152	KD	F3	CD molecules, coagulation factor III (thromboplastin, tissue factor)			40.00, 30.00	1.00, 0.24	81.40	28.74	14.64	99.94	93.15	55.86	-76.50	99.98	95.47	99.26
CGS001-2153	KD	F5	Blood coagulation components, coagulation factor V (proaccelerin, labile factor)			55.56, 55.56	1.55, 0.44	44.22	99.37	99.88	99.72	35.08	NaN	29.03	58.97	99.86	99.92
CGS001-2155	KD	F7	Chymotrypsin, coagulation factor VII (serum prothrombin conversion accelerator)			20.00, 20.00	1.40, 0.36	27.41	100.00	-16.58	76.97	25.32	71.88	84.19	-26.91	99.92	82.12
CGS001-2166	KD	FAAH	Endocannabinoid turnover, fatty acid amide hydrolase			44.44, 44.44	1.42, 0.43	53.05	-97.92	63.69	99.50	-75.66	59.97	99.94	99.13	NaN	99.58
CGS001-2168	KD	FABP1	Fatty acid-binding proteins, fatty acid binding protein 1, liver			0.00, 0.00	1.50, 0.39	35.35	29.46	-66.52	-49.51	-25.18	NaN	36.33	90.99	-52.76	-19.58
CGS001-2167	KD	FABP4	Fatty acid binding protein family, fatty acid binding protein 4, adipocyte			11.11, 11.11	1.23, 0.48	75.10	-25.02	-79.42	-42.42	-99.58	NaN	-99.79	-46.10	98.26	-73.83
CGS001-2171	KD	FABP5	Fatty acid-binding proteins, fatty acid binding protein 5 (psoriasis-associated)			11.11, 0.00	1.43, 0.48	-99.19	-23.39	96.71	-88.73	NaN	-32.96	-66.35	-99.81	-93.88	-96.13
CGS001-2172	KD	FABP6	Fatty acid binding protein family, fatty acid binding protein 6, ileal			11.11, 11.11	1.34, 0.25	-38.32	28.26	-71.29	-23.15	41.86	NaN	-86.96	84.88	99.86	-21.36
CGS001-8772	KD	FADD	Fas (TNFRSF6)-associated via death domain			10.00, 10.00	1.50, 0.38	-70.96	-35.40	76.73	33.08	77.93	55.85	99.02	-33.12	-94.30	73.53
CGS001-3992	KD	FADS1	Fatty acid desaturases, fatty acid desaturase 1			0.00, 0.00	1.88, 0.59	-45.51	54.92	-18.42	23.23	-74.98	22.41	-76.26	-35.33	35.73	-19.29
CGS001-9415	KD	FADS2	Fatty acid desaturases, fatty acid desaturase 2			0.00, 0.00	1.42, 0.50	-90.39	-88.52	-18.43	NaN	64.72	-92.19	29.59	32.46	NaN	-80.47
CGS001-3995	KD	FADS3	Fatty acid desaturases, fatty acid desaturase 3			11.11, 11.11	1.34, 0.45	28.74	62.61	37.99	NaN	45.08	93.21	72.52	37.04	99.80	87.74
CGS001-11124	KD	FAF1	UBX domain containing, Fas (TNFRSF6) associated factor 1			12.50, 12.50	1.44, 0.39	-70.00	NaN	-18.35	NaN	-86.18	-59.19	-99.70	99.47	91.96	-55.63
CGS001-2184	KD	FAH	fumarylacetoacetate hydrolase (fumarylacetoacetase)			0.00, 0.00	2.21, 0.61	86.54	55.87	-94.07	-93.94	-99.75	-42.09	-58.11	-98.24	-23.56	-96.52
CGS001-55179	KD	FAIM	Fas apoptotic inhibitory molecule			25.00, 0.00	1.66, 0.61	-38.11	NaN	-19.09	-85.53	97.08	96.60	NaN	-33.91	-49.35	-17.66
CGS001-84923	KD	FAM104A	family with sequence similarity 104, member A			0.00, 0.00	1.16, 0.41	-18.32	-40.31	-30.35	-67.66	-65.40	73.57	-34.40	85.29	NaN	-30.50
CGS001-10827	KD	FAM114A2	family with sequence similarity 114, member A2			0.00, 0.00	1.52, 0.50	-78.54	NaN	-99.82	-99.11	-97.30	-28.01	-38.03	41.75	40.35	-98.42
CGS001-23196	KD	FAM120A	family with sequence similarity 120A			33.33, 11.11	1.33, 0.50	33.39	96.79	93.39	88.23	99.17	31.50	-30.81	72.05	NaN	95.98
CGS001-9917	KD	FAM20B	family with sequence similarity 20, member B			25.00, 12.50	1.49, 0.41	99.10	65.90	-39.58	67.54	97.45	NaN	NaN	-31.27	62.51	90.90
CGS001-10447	KD	FAM3C	family with sequence similarity 3, member C			30.00, 10.00	1.30, 0.35	43.24	96.92	84.72	99.73	90.89	77.14	-87.63	89.25	73.29	97.35
CGS001-79850	KD	FAM57A	family with sequence similarity 57, member A			14.29, 14.29	2.25, 0.57	-82.21	NaN	62.67	-76.89	98.26	NaN	NaN	-55.15	17.55	-52.48
CGS001-55793	KD	FAM63A	family with sequence similarity 63, member A			25.00, 12.50	2.02, 0.58	84.91	NaN	97.49	99.93	60.03	26.24	NaN	-88.87	38.42	83.18
CGS001-388650	KD	FAM69A	family with sequence similarity 69, member A			0.00, 0.00	1.44, 0.40	-93.44	NaN	-90.96	-90.72	44.87	36.73	NaN	51.83	-52.39	-87.58
CGS001-2175	KD	FANCA	Fanconi anemia, complementation groups, Fanconi anemia, complementation group A			22.22, 0.00	2.24, 0.75	96.66	NaN	-31.17	29.55	33.00	-93.44	91.94	44.83	96.11	94.76
CGS001-2188	KD	FANCF	Fanconi anemia, complementation groups, Fanconi anemia, complementation group F			0.00, 0.00	1.39, 0.39	-38.18	30.31	-50.39	-82.06	31.04	35.72	-77.45	-15.24	21.14	-13.76
CGS001-2189	KD	FANCG	Fanconi anemia, complementation groups, Fanconi anemia, complementation group G			0.00, 0.00	1.35, 0.41	87.35	-88.58	27.89	-31.55	59.41	25.48	-45.65	54.58	-74.76	-27.55
CGS001-55120	KD	FANCL	Fanconi anemia, complementation groups, Fanconi anemia, complementation group L			0.00, 0.00	0.93, 0.27	-61.48	70.19	-26.25	-99.94	-77.99	NaN	-99.94	37.63	35.30	-86.13
CGS001-355	KD	FAS	Tumour necrosis factor (TNF) receptor family, Fas (TNF receptor superfamily, member 6)			10.00, 10.00	0.76, 0.24	-96.98	100.00	15.26	-92.34	-19.88	-34.31	-65.82	-35.23	-26.56	-18.11
CGS001-356	KD	FASLG	Tumour necrosis factor (TNF) receptor family, Fas ligand (TNF superfamily, member 6)			10.00, 0.00	1.43, 0.44	-76.93	-96.32	-18.68	21.33	-28.57	96.65	-25.96	-23.38	53.79	-7.88
CGS001-2194	KD	FASN	Short chain dehydrogenase/reductase superfamily / Atypical members, fatty acid synthase			11.11, 11.11	1.45, 0.47	-9.00	-78.62	99.60	-95.36	23.95	NaN	-93.18	-81.77	-98.28	-96.16
CGS001-60493	KD	FASTKD5	FAST kinase domains 5			11.11, 11.11	1.77, 0.63	92.77	97.80	25.25	-35.33	-21.34	-98.42	NaN	-34.43	91.73	68.31
CGS001-2195	KD	FAT1	Cadherins / Cadherin-related, FAT tumor suppressor homolog 1 (Drosophila)			10.00, 10.00	1.06, 0.23	37.48	-16.30	-22.22	-49.03	-43.10	82.23	25.04	-21.84	99.93	9.15
CGS001-2197	KD	FAU	S ribosomal proteins, Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV) ubiquitously expressed		Ribosomal 40s Subunit LOF	0.00, 0.00	0.98, 0.36	-50.10	45.05	-31.61	-51.68	-32.04	-26.34	-98.53	-93.73	NaN	-52.05
CGS001-2203	KD	FBP1	fructose-1,6-bisphosphatase 1			0.00, 0.00	1.67, 0.57	47.29	-40.84	-99.98	-99.86	83.33	-95.73	-91.08	-87.98	-24.52	-95.89
CGS001-64319	KD	FBRS	fibrosin			0.00, 0.00	1.89, 0.60	NaN	NaN	55.55	-59.85	94.74	NaN	43.29	35.95	28.67	34.64
CGS001-54850	KD	FBXL12	F-boxes / Leucine-rich repeats, F-box and leucine-rich repeat protein 12			0.00, 0.00	1.65, 0.61	68.13	-99.96	82.87	-96.83	85.71	-28.79	-42.58	-93.88	-98.99	-97.65
CGS001-54620	KD	FBXL19	F-boxes / Leucine-rich repeats, F-box and leucine-rich repeat protein 19			10.00, 10.00	1.36, 0.42	27.52	26.14	-39.48	34.98	99.87	-94.58	48.38	85.01	61.99	40.86
CGS001-84961	KD	FBXL20	F-boxes / Leucine-rich repeats, F-box and leucine-rich repeat protein 20			10.00, 10.00	0.80, 0.22	-84.21	-88.83	-64.84	-20.27	85.14	-99.57	97.80	-64.96	-19.93	-60.35
CGS001-80204	KD	FBXO11	Protein arginine N-methyltransferases, F-box protein 11			0.00, 0.00	1.08, 0.34	38.67	NaN	-42.13	-37.62	90.55	70.96	44.59	-96.54	32.94	18.79
CGS001-23014	KD	FBXO21	F-boxes / other, F-box protein 21			0.00, 0.00	0.97, 0.28	51.10	NaN	-59.20	93.64	-39.06	68.72	-15.28	94.87	82.72	89.76
CGS001-26271	KD	FBXO5	F-boxes / other, F-box protein 5			11.11, 11.11	1.32, 0.34	99.95	-30.26	-32.47	54.54	-68.31	NaN	30.25	41.50	-62.85	-17.29
CGS001-25793	KD	FBXO7	F-boxes / other, F-box protein 7			0.00, 0.00	0.98, 0.38	-59.67	-98.61	-67.77	-94.82	-41.60	51.01	-89.40	-96.25	32.92	-95.07
CGS001-23291	KD	FBXW11	F-boxes / WD-40 domains, F-box and WD repeat domain containing 11			10.00, 0.00	1.55, 0.56	-22.13	82.46	96.69	-62.53	80.67	33.73	-45.30	59.19	37.35	71.68
CGS001-2212	KD	FCGR2A	CD molecules, Fc fragment of IgG, low affinity IIa, receptor (CD32)			0.00, 0.00	1.20, 0.27	-29.35	-37.51	-18.77	-28.53	-87.80	-92.25	23.77	-28.68	27.17	-6.95
CGS001-23149	KD	FCHO1	FCH domain only 1			0.00, 0.00	1.35, 0.44	-44.64	NaN	-23.15	-72.13	-97.26	-25.17	NaN	-87.04	23.10	-38.90
CGS001-2222	KD	FDFT1	Lanosterol biosynthesis pathway, farnesyl-diphosphate farnesyltransferase 1			0.00, 0.00	1.10, 0.31	-99.73	-57.59	-91.81	-99.75	-99.21	-99.96	-95.23	-90.10	-24.67	-99.82
CGS001-2224	KD	FDPS	Lanosterol biosynthesis pathway, farnesyl diphosphate synthase			11.11, 11.11	1.16, 0.33	99.96	52.60	70.43	25.87	-26.77	NaN	-98.27	-99.75	51.46	48.83
CGS001-2230	KD	FDX1	ferredoxin 1			0.00, 0.00	1.75, 0.48	-72.14	-100.00	-99.94	-99.89	24.83	32.15	-20.02	-98.78	-95.88	-99.84
CGS001-112812	KD	FDX1L	ferredoxin 1-like			11.11, 0.00	1.80, 0.42	-19.46	-99.96	96.65	31.12	-29.31	NaN	-43.40	-93.02	-27.46	-30.67
CGS001-2232	KD	FDXR	ferredoxin reductase			0.00, 0.00	1.14, 0.30	-92.83	-42.44	14.02	56.06	-53.31	36.39	-94.00	-52.99	-31.17	-25.51
CGS001-2235	KD	FECH	ferrochelatase		AHSP Pathway LOF	0.00, 0.00	1.47, 0.50	-99.24	-16.79	-87.17	-81.60	NaN	52.01	-53.09	-21.16	23.44	-63.10
CGS001-2237	KD	FEN1	flap structure-specific endonuclease 1		Non Homologous End Joining LOF	50.00, 25.00	1.49, 0.34	56.44	26.56	99.80	NaN	95.78	NaN	78.07	99.47	28.59	96.41
CGS001-2241	KD	FER	Serine/threonine phosphatases / Protein phosphatase 1, regulatory subunits, fer (fps/fes related) tyrosine kinase			11.11, 0.00	1.92, 0.66	87.05	-44.37	72.44	96.99	NaN	-46.60	-25.83	-23.06	-32.84	30.43
CGS001-222894	KD	FERD3L	Basic helix-loop-helix proteins, Fer3-like (Drosophila)			0.00, 0.00	1.98, 0.65	35.52	81.56	29.46	-39.22	-56.65	NaN	27.32	-29.04	NaN	25.40
CGS001-55612	KD	FERMT1	Fermitins, fermitin family member 1			0.00, 0.00	1.01, 0.22	-93.62	27.04	-63.90	25.66	-97.51	-37.52	-70.76	NaN	-32.94	-63.66
CGS001-2242	KD	FES	Fer family, feline sarcoma oncogene			0.00, 0.00	0.98, 0.19	-99.95	-91.60	-95.96	-99.96	94.23	-99.60	-87.02	-99.00	16.97	-99.92
CGS001-9638	KD	FEZ1	fasciculation and elongation protein zeta 1 (zygin I)			44.44, 33.33	1.00, 0.24	92.38	35.96	28.21	96.59	99.98	99.97	NaN	34.12	-51.80	99.10
CGS001-9637	KD	FEZ2	fasciculation and elongation protein zeta 2 (zygin II)			20.00, 20.00	1.07, 0.34	43.97	99.85	-50.84	99.57	-26.72	22.32	-26.05	-50.43	56.91	43.19
CGS001-2864	KD	FFAR1	Fatty acid receptors, free fatty acid receptor 1			0.00, 0.00	1.67, 0.55	-21.66	-42.32	-22.90	NaN	31.33	-23.85	-97.07	-49.84	-38.49	-28.50
CGS001-2243	KD	FGA	Endogenous ligands, fibrinogen alpha chain			22.22, 11.11	1.88, 0.47	80.50	-27.01	96.88	75.70	86.70	NaN	99.98	-29.57	28.33	88.15
CGS001-2244	KD	FGB	Endogenous ligands, fibrinogen beta chain			22.22, 11.11	1.53, 0.50	26.91	99.89	-59.28	-61.41	NaN	96.15	22.16	-76.21	57.67	42.69
CGS001-2247	KD	FGF2	Endogenous ligands, fibroblast growth factor 2 (basic)			10.00, 10.00	0.82, 0.13	99.37	23.99	-15.89	-35.38	42.89	37.01	-49.58	-21.80	32.83	14.89
CGS001-2254	KD	FGF9	Endogenous ligands, fibroblast growth factor 9 (glia-activating factor)			0.00, 0.00	1.40, 0.40	-79.53	-99.93	-30.47	24.98	-64.06	NaN	-99.01	-96.69	-84.81	-99.21
CGS001-2260	KD	FGFR1	Type V RTKs: FGF (fibroblast growth factor) receptor family, fibroblast growth factor receptor 1			11.11, 0.00	1.07, 0.28	95.90	-41.25	-8.26	-30.80	-22.19	NaN	-84.10	-99.92	-99.26	-42.51
CGS001-11116	KD	FGFR1OP	FGFR1 oncogene partner			0.00, 0.00	1.70, 0.57	-99.87	NaN	-37.97	-99.86	-23.17	-32.25	88.12	-99.85	-99.84	-99.95
CGS001-2263	KD	FGFR2	Type V RTKs: FGF (fibroblast growth factor) receptor family, fibroblast growth factor receptor 2			0.00, 0.00	1.44, 0.38	-99.57	-52.81	-84.07	-35.68	-83.11	NaN	-99.98	24.88	29.23	-80.71
CGS001-2261	KD	FGFR3	Type V RTKs: FGF (fibroblast growth factor) receptor family, fibroblast growth factor receptor 3			0.00, 0.00	0.92, 0.33	-65.06	-86.78	-35.87	-51.05	-95.28	NaN	-33.87	93.97	-99.90	-89.87
CGS001-2264	KD	FGFR4	Type V RTKs: FGF (fibroblast growth factor) receptor family, fibroblast growth factor receptor 4			50.00, 37.50	0.98, 0.38	93.24	-58.31	99.68	98.12	NaN	NaN	96.81	90.31	25.24	99.16
CGS001-53834	KD	FGFRL1	Immunoglobulin superfamily / I-set domain containing, fibroblast growth factor receptor-like 1			22.22, 11.11	1.59, 0.49	82.39	-100.00	-62.44	96.91	-63.29	NaN	99.98	35.07	90.85	89.79
CGS001-2266	KD	FGG	Endogenous ligands, fibrinogen gamma chain			0.00, 0.00	1.86, 0.45	-98.47	82.90	-23.17	-23.99	-46.48	-22.98	-73.07	-19.94	82.10	-13.47
CGS001-2274	KD	FHL2	four and a half LIM domains 2			20.00, 20.00	1.10, 0.31	16.07	99.96	-17.57	-33.97	99.53	26.98	-38.44	88.96	34.54	59.61
CGS001-9158	KD	FIBP	fibroblast growth factor (acidic) intracellular binding protein			11.11, 11.11	1.80, 0.58	61.20	NaN	-80.77	99.57	-75.78	92.37	-24.99	-92.72	28.12	-77.50
CGS001-2277	KD	FIGF	c-fos induced growth factor (vascular endothelial growth factor D)			0.00, 0.00	1.26, 0.34	-24.09	79.33	16.61	23.95	-32.48	-18.48	-58.95	24.79	22.68	-4.87
CGS001-51024	KD	FIS1	fission 1 (mitochondrial outer membrane) homolog (S. cerevisiae)			0.00, 0.00	2.97, 0.97	NaN	NaN	80.65	40.88	91.55	NaN	-59.46	NaN	36.47	74.78
CGS001-55033	KD	FKBP14	EF-hand domain containing, FK506 binding protein 14, 22 kDa			50.00, 37.50	1.78, 0.69	-84.06	96.00	27.84	99.91	99.85	NaN	NaN	48.41	89.63	98.76
CGS001-2280	KD	FKBP1A	Cis-trans-isomerases, FK506 binding protein 1A, 12kDa			0.00, 0.00	0.97, 0.20	81.47	-51.34	45.67	-93.37	-99.87	NaN	-99.42	-90.77	-50.96	-94.47
CGS001-2287	KD	FKBP3	FK506 binding protein 3, 25kDa			10.00, 10.00	1.36, 0.30	-98.80	43.24	-87.91	-22.83	-92.91	49.40	-20.09	26.32	99.95	-49.48
CGS001-2288	KD	FKBP4	Tetratricopeptide (TTC) repeat domain containing, FK506 binding protein 4, 59kDa			37.50, 25.00	1.80, 0.57	65.00	NaN	90.82	97.81	-68.68	10.14	NaN	68.75	99.88	95.87
CGS001-2289	KD	FKBP5	Tetratricopeptide (TTC) repeat domain containing, FK506 binding protein 5			0.00, 0.00	2.11, 0.69	-94.91	-22.77	-65.10	-84.80	-48.89	NaN	-16.89	-50.23	-99.93	-89.53
CGS001-23770	KD	FKBP8	Tetratricopeptide (TTC) repeat domain containing, FK506 binding protein 8, 38kDa			0.00, 0.00	1.76, 0.55	-99.60	-88.98	-31.57	-30.66	-55.51	40.15	-33.65	-40.90	-98.67	-85.64
CGS001-2313	KD	FLI1	ETS Transcription Factors, Friend leukemia virus integration 1			0.00, 0.00	0.84, 0.26	-57.58	NaN	-89.28	-97.11	-68.12	49.43	34.52	-96.89	-75.42	-92.67
CGS001-2321	KD	FLT1	Type IV RTKs: VEGF (vascular endothelial growth factor) receptor family, fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor)			10.00, 0.00	1.35, 0.38	34.35	-56.61	-98.81	64.45	-28.64	-57.49	96.45	86.47	-28.46	52.29
CGS001-2324	KD	FLT4	Type IV RTKs: VEGF (vascular endothelial growth factor) receptor family, fms-related tyrosine kinase 4			0.00, 0.00	1.65, 0.42	-22.35	-70.69	-39.25	-29.43	24.17	-36.51	-49.63	-42.29	NaN	-20.46
CGS001-2335	KD	FN1	Endogenous ligands, fibronectin 1			10.00, 10.00	1.18, 0.35	-34.12	-85.01	-53.90	-76.75	-80.44	99.90	-23.13	27.52	68.48	-32.25
CGS001-2348	KD	FOLR1	folate receptor 1 (adult)			0.00, 0.00	1.56, 0.48	-23.93	-37.22	57.64	32.79	-29.11	NaN	82.21	-24.18	-97.97	-6.92
CGS001-2353	KD	FOS	basic leucine zipper proteins, FBJ murine osteosarcoma viral oncogene homolog			20.00, 10.00	0.63, 0.13	95.24	100.00	-26.09	-75.79	27.01	43.01	-23.26	-25.61	53.99	16.82
CGS001-8061	KD	FOSL1	basic leucine zipper proteins, FOS-like antigen 1			0.00, 0.00	1.32, 0.39	94.13	NaN	-75.97	-93.28	-27.26	NaN	-99.50	-92.95	-58.58	-96.32
CGS001-2355	KD	FOSL2	basic leucine zipper proteins, FOS-like antigen 2			0.00, 0.00	1.80, 0.61	-67.72	-100.00	93.81	-86.24	-75.79	NaN	-63.74	-99.84	-52.16	-93.82
CGS001-3169	KD	FOXA1	Forkhead boxes, forkhead box A1			0.00, 0.00	1.31, 0.28	16.92	24.57	73.06	-28.19	-47.09	65.23	25.76	-89.47	NaN	14.01
CGS001-3170	KD	FOXA2	Forkhead boxes, forkhead box A2			0.00, 0.00	1.08, 0.25	-99.93	-99.98	23.46	-91.28	35.63	NaN	41.89	-25.62	-41.30	-84.61
CGS001-3171	KD	FOXA3	Forkhead boxes, forkhead box A3			10.00, 0.00	1.22, 0.40	84.56	22.25	-61.44	54.71	96.09	64.50	48.47	-30.07	74.39	54.37
CGS001-2295	KD	FOXF2	Forkhead boxes, forkhead box F2			10.00, 0.00	0.97, 0.39	62.74	-51.67	-99.86	-26.15	39.26	28.49	-26.15	95.71	-63.38	16.61
CGS001-55810	KD	FOXJ2	Forkhead boxes, forkhead box J2			0.00, 0.00	1.28, 0.31	-50.75	93.69	-35.55	-96.67	-42.70	-67.80	-36.76	36.32	-88.54	-41.11
CGS001-22887	KD	FOXJ3	Forkhead boxes, forkhead box J3			0.00, 0.00	1.24, 0.42	11.25	NaN	-99.98	-99.98	-50.99	-70.43	-97.86	-40.78	23.92	-95.72
CGS001-1112	KD	FOXN3	Forkhead boxes, forkhead box N3			22.22, 22.22	2.02, 0.74	71.37	100.00	99.53	70.79	-72.85	NaN	49.09	80.82	-68.73	88.87
CGS001-2308	KD	FOXO1	Forkhead boxes, forkhead box O1			0.00, 0.00	1.58, 0.24	-59.63	NaN	69.57	83.28	38.94	NaN	84.94	51.29	71.40	87.13
CGS001-2309	KD	FOXO3	Forkhead boxes, forkhead box O3			11.11, 0.00	1.02, 0.22	-99.30	95.06	20.74	-26.66	-29.03	-39.54	NaN	-57.77	-22.43	-12.90
CGS001-4303	KD	FOXO4	Forkhead boxes, forkhead box O4			33.33, 11.11	0.83, 0.26	51.35	NaN	-44.94	96.53	99.98	47.84	93.81	-88.10	82.50	96.51
CGS001-50943	KD	FOXP3	Forkhead boxes, forkhead box P3			10.00, 10.00	1.05, 0.17	32.89	-60.90	-82.64	-99.98	-89.00	99.03	-40.12	70.51	-44.04	-79.66
CGS001-94234	KD	FOXQ1	Forkhead boxes, forkhead box Q1			10.00, 10.00	0.99, 0.28	85.86	-49.31	29.90	-90.88	60.92	99.20	76.79	-24.48	-81.87	67.17
CGS001-283150	KD	FOXR1	Forkhead boxes, forkhead box R1			0.00, 0.00	1.50, 0.55	28.71	-18.14	27.88	30.55	NaN	-21.54	-62.14	-31.01	-99.95	-7.18
CGS001-2356	KD	FPGS	folylpolyglutamate synthase			10.00, 10.00	0.92, 0.27	-97.43	-23.28	-66.73	25.29	98.67	82.96	88.88	-25.23	-29.87	18.71
CGS001-10023	KD	FRAT1	frequently rearranged in advanced T-cell lymphomas			0.00, 0.00	2.16, 0.55	27.15	-37.14	21.19	31.38	-21.27	NaN	39.78	-23.48	22.15	5.26
CGS001-23401	KD	FRAT2	frequently rearranged in advanced T-cell lymphomas 2			12.50, 12.50	1.76, 0.59	90.58	NaN	91.83	62.73	99.94	NaN	46.49	69.76	85.94	92.47
CGS001-79187	KD	FSD1	Fibronectin type III domain containing, fibronectin type III and SPRY domain containing 1			0.00, 0.00	1.19, 0.36	NaN	73.71	-98.96	-59.18	34.55	NaN	-96.29	-92.31	-99.56	-97.35
CGS001-10468	KD	FST	follistatin			0.00, 0.00	1.65, 0.55	83.92	-100.00	-40.04	NaN	83.63	-29.09	NaN	-22.85	29.86	-12.28
CGS001-2495	KD	FTH1	ferritin, heavy polypeptide 1			11.11, 0.00	2.05, 0.66	36.52	53.46	97.43	33.13	38.05	NaN	31.57	-28.43	-88.78	33.21
CGS001-2512	KD	FTL	ferritin, light polypeptide			0.00, 0.00	1.19, 0.49	-15.66	-45.36	-96.36	-71.53	-35.94	NaN	NaN	-26.38	-84.76	-39.74
CGS001-24140	KD	FTSJ1	FtsJ homolog 1 (E. coli)		X linked mental retardation group 1 LOF	10.00, 10.00	1.18, 0.28	99.76	30.98	-99.64	-91.05	-27.68	42.33	59.49	-58.91	-99.18	-79.54
CGS001-5045	KD	FURIN	Subtilisin, furin (paired basic amino acid cleaving enzyme)			0.00, 0.00	1.10, 0.22	-19.19	-99.85	-94.44	-45.92	-23.05	29.75	-99.95	-98.86	22.23	-98.19
CGS001-2521	KD	FUS	RNA binding motif (RRM) containing, fused in sarcoma			44.44, 33.33	1.41, 0.27	74.38	99.69	15.46	99.79	23.31	55.03	35.03	99.98	NaN	95.42
CGS001-2523	KD	FUT1	Fucosyltransferases, fucosyltransferase 1 (galactoside 2-alpha-L-fucosyltransferase, H blood group)			0.00, 0.00	1.28, 0.32	-97.35	57.70	-32.08	-85.10	-31.60	-54.60	65.54	-81.20	-99.95	-81.11
CGS001-2524	KD	FUT2	Fucosyltransferases, fucosyltransferase 2 (secretor status included)			0.00, 0.00	2.14, 0.89	-16.75	NaN	-97.35	-82.35	85.18	-32.69	NaN	-75.20	NaN	-79.03
CGS001-486	KD	FXYD2	Ion transport regulator, FXYD domain containing ion transport regulator 2			0.00, 0.00	1.33, 0.41	18.78	-17.80	-29.72	NaN	-99.80	NaN	-55.61	-96.14	65.43	-77.63
CGS001-2534	KD	FYN	Src family, FYN oncogene related to SRC, FGR, YES			0.00, 0.00	0.74, 0.25	64.29	-99.63	-58.95	36.48	33.62	-34.25	92.18	87.37	34.53	22.18
CGS001-8321	KD	FZD1	GPCR / Class F : Frizzled receptors, frizzled family receptor 1			0.00, 0.00	1.27, 0.34	27.68	-99.91	-98.13	-22.06	-93.32	56.49	31.63	-26.50	-85.09	-76.04
CGS001-2535	KD	FZD2	GPCR / Class F : Frizzled receptors, frizzled family receptor 2			20.00, 20.00	1.70, 0.50	56.80	75.90	82.36	-37.80	99.54	99.97	-33.08	-21.63	-60.15	71.67
CGS001-7976	KD	FZD3	GPCR / Class F : Frizzled receptors, frizzled family receptor 3			11.11, 0.00	1.26, 0.42	-32.97	23.31	-55.44	-30.26	28.42	95.38	36.03	-96.56	NaN	-16.05
CGS001-8322	KD	FZD4	GPCR / Class F : Frizzled receptors, frizzled family receptor 4			0.00, 0.00	1.72, 0.51	-79.10	28.92	-16.13	23.24	-26.12	-53.47	22.12	-25.06	46.73	3.35
CGS001-7855	KD	FZD5	GPCR / Class F : Frizzled receptors, frizzled family receptor 5			0.00, 0.00	1.61, 0.40	-99.51	-99.67	-98.91	-94.10	18.52	-99.97	-94.61	32.92	93.91	-99.32
CGS001-8323	KD	FZD6	GPCR / Class F : Frizzled receptors, frizzled family receptor 6			0.00, 0.00	2.07, 0.64	47.45	NaN	43.15	59.91	71.68	37.89	36.90	NaN	NaN	57.48
CGS001-8324	KD	FZD7	GPCR / Class F : Frizzled receptors, frizzled family receptor 7			0.00, 0.00	1.41, 0.32	-99.53	-97.22	-99.93	-22.82	-85.39	49.50	-99.98	-72.09	-68.46	-99.76
CGS001-8325	KD	FZD8	GPCR / Class F : Frizzled receptors, frizzled family receptor 8			0.00, 0.00	1.41, 0.44	-72.70	-99.50	-61.94	-29.00	-99.81	-51.91	-28.87	-71.52	-68.11	-86.80
CGS001-55632	KD	G2E3	Zinc fingers, PHD-type, G2/M-phase specific E3 ubiquitin protein ligase			12.50, 12.50	1.64, 0.50	-30.04	-55.55	-96.61	45.42	-57.28	NaN	NaN	-66.32	99.74	-38.79
CGS001-10146	KD	G3BP1	RNA binding motif (RRM) containing, GTPase activating protein (SH3 domain) binding protein 1			25.00, 25.00	1.35, 0.41	-67.40	NaN	-29.93	NaN	23.11	97.80	97.80	69.60	36.07	55.34
CGS001-9908	KD	G3BP2	RNA binding motif (RRM) containing, GTPase activating protein (SH3 domain) binding protein 2			10.00, 10.00	1.72, 0.56	-19.93	33.55	98.81	47.14	-42.76	50.14	37.07	-34.47	35.10	28.60
CGS001-2538	KD	G6PC	glucose-6-phosphatase, catalytic subunit			0.00, 0.00	1.66, 0.53	-24.39	-25.28	-41.67	-51.14	-88.74	-25.80	-47.54	22.36	40.71	-10.90
CGS001-2548	KD	GAA	Glycosidases, glucosidase, alpha; acid			0.00, 0.00	0.91, 0.18	91.56	NaN	-21.04	-29.57	23.25	-99.96	NaN	-23.79	-84.58	-20.96
CGS001-23710	KD	GABARAPL1	GABA(A) receptor-associated protein like 1			0.00, 0.00	1.02, 0.36	59.76	49.06	-72.93	-97.13	-99.44	71.79	31.10	-86.44	-22.37	-85.65
CGS001-2550	KD	GABBR1	GABA receptors, gamma-aminobutyric acid (GABA) B receptor, 1			10.00, 0.00	1.49, 0.39	72.42	27.41	-55.80	96.33	-25.33	-28.73	-61.74	-46.23	39.89	16.20
CGS001-9568	KD	GABBR2	GABA receptors, gamma-aminobutyric acid (GABA) B receptor, 2			0.00, 0.00	1.58, 0.51	50.70	27.28	43.48	29.99	68.85	NaN	-98.66	-28.85	NaN	16.28
CGS001-2553	KD	GABPB1	Ankyrin repeat domain containing, GA binding protein transcription factor, beta subunit 1			0.00, 0.00	0.88, 0.39	92.02	-31.28	60.54	-99.56	-98.28	-81.46	-48.56	-99.36	33.66	-97.82
CGS001-126626	KD	GABPB2	Ankyrin repeat domain containing, GA binding protein transcription factor, beta subunit 2			0.00, 0.00	1.14, 0.25	-60.95	73.88	23.49	30.20	-84.86	-99.67	-48.77	NaN	29.54	-33.45
CGS001-2562	KD	GABRB3	GABA receptors, gamma-aminobutyric acid (GABA) A receptor, beta 3			42.86, 42.86	2.21, 0.90	89.71	NaN	99.17	83.83	-85.01	NaN	99.15	86.90	NaN	98.03
CGS001-2565	KD	GABRG1	GABA receptors, gamma-aminobutyric acid (GABA) A receptor, gamma 1			44.44, 44.44	1.44, 0.44	-28.71	99.89	32.17	57.10	-66.47	NaN	92.59	99.71	99.56	99.95
CGS001-2568	KD	GABRP	GABA receptors, gamma-aminobutyric acid (GABA) A receptor, pi			11.11, 11.11	1.95, 0.53	-33.84	60.96	44.52	62.60	99.93	NaN	25.25	-71.42	28.25	40.17
CGS001-1647	KD	GADD45A	growth arrest and DNA-damage-inducible, alpha			10.00, 0.00	1.22, 0.31	-90.79	82.28	-29.97	94.94	-23.32	31.51	80.14	95.80	-24.97	87.75
CGS001-4616	KD	GADD45B	growth arrest and DNA-damage-inducible, beta			0.00, 0.00	0.85, 0.17	65.99	38.26	40.10	-96.28	46.38	-62.17	-30.92	-13.52	22.02	9.94
CGS001-2580	KD	GAK	Heat shock proteins / DNAJ (HSP40), cyclin G associated kinase			11.11, 11.11	1.03, 0.25	-39.41	25.52	23.76	57.86	-89.23	NaN	81.38	99.74	-95.74	65.11
CGS001-2581	KD	GALC	galactosylceramidase			0.00, 0.00	1.41, 0.43	-96.31	NaN	-78.49	-33.06	NaN	93.83	-34.38	-28.43	-83.43	-61.27
CGS001-2582	KD	GALE	Short chain dehydrogenase/reductase superfamily / Extended SDR fold, UDP-galactose-4-epimerase			11.11, 11.11	1.74, 0.42	35.03	NaN	99.49	80.06	43.63	-20.77	-24.44	67.39	-66.79	47.85
CGS001-2588	KD	GALNS	Arylsulfatase family, galactosamine (N-acetyl)-6-sulfate sulfatase			10.00, 10.00	1.22, 0.35	99.21	-31.48	-31.11	89.95	-58.19	91.59	-23.01	-14.90	-99.52	-4.68
CGS001-2589	KD	GALNT1	Glycosyltransferase family 2 domain containing, UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 1 (GalNAc-T1)			0.00, 0.00	0.89, 0.33	34.57	-39.43	-25.22	36.43	25.95	-25.75	-33.81	29.67	50.44	4.68
CGS001-2592	KD	GALT	galactose-1-phosphate uridylyltransferase			10.00, 10.00	2.33, 0.67	-50.16	68.71	36.79	-24.05	-88.17	76.87	-40.33	99.72	67.24	65.04
CGS001-2593	KD	GAMT	guanidinoacetate N-methyltransferase			22.22, 11.11	1.17, 0.35	99.98	32.66	96.25	-22.45	64.70	NaN	21.73	73.07	-54.66	56.77
CGS001-2597	KD	GAPDH	glyceraldehyde-3-phosphate dehydrogenase			20.00, 20.00	1.23, 0.31	74.26	99.50	-99.38	31.02	40.36	32.19	69.60	83.57	99.92	73.79
CGS001-2617	KD	GARS	Aminoacyl tRNA synthetases / Class II, glycyl-tRNA synthetase		Aminoacyl tRNA synthetases class II LOF	0.00, 0.00	1.19, 0.34	22.24	NaN	-35.83	NaN	43.76	NaN	52.32	47.91	-99.86	20.09
CGS001-2618	KD	GART	Ribosyl transferases, phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase			11.11, 11.11	1.49, 0.53	97.96	-76.24	-23.23	72.13	-82.00	NaN	21.54	-75.57	70.57	-50.45
CGS001-2621	KD	GAS6	growth arrest-specific 6			60.00, 60.00	1.49, 0.42	99.98	99.98	99.98	70.73	99.94	48.61	63.24	99.75	90.40	99.95
CGS001-8522	KD	GAS7	growth arrest-specific 7			25.00, 12.50	1.61, 0.49	-31.88	68.87	39.39	NaN	96.22	NaN	-38.33	98.68	34.67	86.11
CGS001-2623	KD	GATA1	GATA zinc finger domain containing, GATA binding protein 1 (globin transcription factor 1)		AHSP Pathway LOF	0.00, 0.00	0.47, 0.08	-27.25	-98.07	-9.44	-26.57	-19.53	-87.80	-95.98	-94.03	20.21	-74.04
CGS001-2624	KD	GATA2	GATA zinc finger domain containing, GATA binding protein 2			0.00, 0.00	0.82, 0.26	73.91	-33.44	-97.98	-99.71	35.77	-31.46	-50.33	28.42	-22.32	-23.18
CGS001-2625	KD	GATA3	GATA zinc finger domain containing, GATA binding protein 3			0.00, 0.00	0.52, 0.11	37.59	31.74	-22.15	69.06	29.48	-41.32	-30.47	-93.26	-98.45	-14.30
CGS001-2627	KD	GATA6	GATA zinc finger domain containing, GATA binding protein 6			0.00, 0.00	1.32, 0.32	-99.96	88.06	-92.97	-99.73	-94.94	-34.27	-70.08	-74.94	-63.65	-94.63
CGS001-54815	KD	GATAD2A	GATA zinc finger domain containing, GATA zinc finger domain containing 2A			0.00, 0.00	1.13, 0.22	64.76	81.32	-99.38	-32.97	-48.61	NaN	31.11	-44.29	-38.11	-28.45
CGS001-57459	KD	GATAD2B	GATA zinc finger domain containing, GATA zinc finger domain containing 2B			22.22, 22.22	1.44, 0.35	30.26	-28.52	70.33	89.29	-99.80	NaN	99.95	41.59	99.81	87.42
CGS001-2629	KD	GBA	glucosidase, beta, acid			0.00, 0.00	2.42, 0.74	-39.42	28.51	34.55	-25.47	-30.20	NaN	-26.31	32.75	-52.34	-10.82
CGS001-26301	KD	GBGT1	Glycosyltransferase family 6 domain containing, globoside alpha-1,3-N-acetylgalactosaminyltransferase 1			0.00, 0.00	1.36, 0.40	-10.45	22.55	-99.13	-98.97	-45.22	26.64	NaN	39.29	-37.80	-25.38
CGS001-2634	KD	GBP2	guanylate binding protein 2, interferon-inducible			0.00, 0.00	1.50, 0.41	-95.10	36.57	-21.98	-26.92	-37.61	NaN	34.70	-86.86	45.29	-11.00
CGS001-25801	KD	GCA	EF-hand domain containing, grancalcin, EF-hand calcium binding protein			0.00, 0.00	1.02, 0.22	-63.38	45.53	-16.96	73.53	-84.53	NaN	-37.50	-34.25	45.25	-13.17
CGS001-23464	KD	GCAT	glycine C-acetyltransferase			0.00, 0.00	1.49, 0.42	-32.20	-99.93	-52.91	22.29	87.11	-38.90	78.48	-90.07	21.03	-17.26
CGS001-2639	KD	GCDH	glutaryl-CoA dehydrogenase			11.11, 11.11	1.52, 0.35	-42.59	-30.48	60.46	63.46	26.77	98.57	-94.22	NaN	64.10	55.46
CGS001-2643	KD	GCH1	GTP cyclohydrolase 1			12.50, 12.50	1.40, 0.41	-79.18	NaN	-80.95	-76.12	-32.97	NaN	-95.39	-70.59	99.92	-70.32
CGS001-2729	KD	GCLC	glutamate-cysteine ligase, catalytic subunit			0.00, 0.00	1.67, 0.55	NaN	81.78	35.29	44.79	-78.80	20.22	-72.53	-21.83	88.94	15.71
CGS001-2730	KD	GCLM	glutamate-cysteine ligase, modifier subunit			11.11, 0.00	1.56, 0.47	-97.73	30.22	82.41	95.25	49.36	NaN	66.20	32.75	-36.13	55.37
CGS001-2664	KD	GDI1	GDP dissociation inhibitor 1			0.00, 0.00	1.43, 0.30	18.77	-97.78	-49.45	-76.40	-42.54	-19.19	NaN	-41.60	34.67	-24.52
CGS001-81544	KD	GDPD5	glycerophosphodiester phosphodiesterase domain containing 5			0.00, 0.00	1.15, 0.33	-21.96	31.23	-99.33	-99.95	-49.67	NaN	-32.32	-96.18	-97.26	-99.47
CGS001-54438	KD	GFOD1	glucose-fructose oxidoreductase domain containing 1			10.00, 10.00	1.30, 0.40	78.44	-20.98	-80.13	27.92	-95.64	-27.92	-34.90	-53.08	98.27	-27.81
CGS001-81577	KD	GFOD2	glucose-fructose oxidoreductase domain containing 2			11.11, 11.11	1.24, 0.36	98.26	-91.81	-92.84	-96.28	-99.44	NaN	-73.23	20.44	21.26	-94.04
CGS001-2673	KD	GFPT1	glutamine--fructose-6-phosphate transaminase 1			10.00, 0.00	1.07, 0.36	35.25	-87.48	86.49	81.41	95.14	-28.97	24.29	70.59	-51.90	58.39
CGS001-9945	KD	GFPT2	glutamine-fructose-6-phosphate transaminase 2			22.22, 22.22	1.30, 0.33	53.03	64.78	98.48	-48.01	-32.39	NaN	43.25	99.04	-48.51	60.80
CGS001-2674	KD	GFRA1	GDNF receptor family, GDNF family receptor alpha 1			0.00, 0.00	1.09, 0.33	24.27	-80.72	-44.67	28.40	32.32	NaN	-36.95	-92.01	48.21	-44.01
CGS001-23062	KD	GGA2	golgi-associated, gamma adaptin ear containing, ARF binding protein 2			14.29, 14.29	1.69, 0.50	NaN	-38.94	-94.91	-49.72	74.02	NaN	NaN	-76.16	99.97	-29.85
CGS001-79017	KD	GGCT	Leukotriene and lipoxin metabolism, gamma-glutamylcyclotransferase			0.00, 0.00	1.20, 0.34	17.41	-19.14	-27.70	-26.89	-36.95	38.43	NaN	-58.58	33.26	-8.27
CGS001-2677	KD	GGCX	Carboxylases, gamma-glutamyl carboxylase			0.00, 0.00	1.35, 0.47	-65.06	NaN	-28.88	-33.81	-71.03	NaN	-59.26	28.09	59.13	-46.77
CGS001-8836	KD	GGH	Gamma-glutamyl hydrolase, gamma-glutamyl hydrolase (conjugase, folylpolygammaglutamyl hydrolase)			11.11, 11.11	1.91, 0.72	-59.29	99.80	62.19	40.29	33.17	NaN	-44.29	62.26	-99.70	48.15
CGS001-9453	KD	GGPS1	Lanosterol biosynthesis pathway, geranylgeranyl diphosphate synthase 1			0.00, 0.00	1.17, 0.36	-46.04	30.78	-80.24	-30.66	-99.70	NaN	-79.81	-21.83	-99.75	-81.83
CGS001-2678	KD	GGT1	CD molecules, gamma-glutamyltransferase 1			10.00, 0.00	1.39, 0.40	-37.48	-81.27	-58.87	28.00	-27.51	96.55	23.32	21.62	81.15	-12.89
CGS001-2690	KD	GHR	Prolactin receptor family, growth hormone receptor			12.50, 12.50	0.68, 0.20	-14.05	-30.71	-59.08	-62.24	-87.57	NaN	NaN	99.72	-74.46	-59.96
CGS001-10755	KD	GIPC1	GIPC PDZ domain containing family, member 1			0.00, 0.00	1.55, 0.49	-99.71	-55.37	42.98	-97.49	-29.67	-40.41	NaN	-75.71	21.31	-75.64
CGS001-28964	KD	GIT1	Ankyrin repeat domain containing, G protein-coupled receptor kinase interacting ArfGAP 1			0.00, 0.00	1.78, 0.61	-97.09	-24.15	-66.93	-30.55	-35.21	NaN	NaN	-20.28	-99.93	-51.12
CGS001-9815	KD	GIT2	Ankyrin repeat domain containing, G protein-coupled receptor kinase interacting ArfGAP 2			11.11, 11.11	1.06, 0.33	33.43	44.34	-44.20	29.60	-99.70	NaN	-56.17	97.93	-44.59	-26.52
CGS001-2710	KD	GK	Glycerol kinases, glycerol kinase			11.11, 0.00	1.25, 0.32	36.69	27.34	72.18	-30.89	97.17	NaN	49.54	-29.36	42.40	38.44
CGS001-2717	KD	GLA	galactosidase, alpha			10.00, 10.00	1.45, 0.33	26.70	-25.55	16.82	99.45	-74.44	86.15	-20.66	-31.05	33.81	6.03
CGS001-2731	KD	GLDC	glycine dehydrogenase (decarboxylating)			12.50, 12.50	1.99, 0.56	-21.97	25.98	-47.71	-28.03	-68.75	87.39	99.20	NaN	NaN	20.46
CGS001-2735	KD	GLI1	Zinc fingers, C2H2-type, GLI family zinc finger 1			0.00, 0.00	1.56, 0.50	-28.48	-23.22	-19.09	-92.53	-26.41	NaN	-58.95	-64.04	-99.89	-57.11
CGS001-2737	KD	GLI3	Zinc fingers, C2H2-type, GLI family zinc finger 3			0.00, 0.00	1.67, 0.44	-99.66	NaN	-22.10	-94.68	-60.32	NaN	-73.84	-31.48	25.28	-65.60
CGS001-169792	KD	GLIS3	Zinc fingers, C2H2-type, GLIS family zinc finger 3			25.00, 25.00	1.59, 0.43	-96.35	NaN	-74.54	98.40	-45.81	NaN	-25.62	98.38	-43.93	-39.48
CGS001-51031	KD	GLOD4	glyoxalase domain containing 4			12.50, 12.50	1.75, 0.43	-42.30	NaN	37.04	-42.66	47.16	NaN	99.93	52.41	49.16	51.73
CGS001-2745	KD	GLRX	glutaredoxin (thioltransferase)			20.00, 10.00	1.02, 0.31	99.86	19.04	28.91	45.35	36.31	96.86	-73.67	17.80	25.52	35.44
CGS001-51022	KD	GLRX2	glutaredoxin 2			0.00, 0.00	1.24, 0.35	30.78	-40.94	-99.69	34.59	-99.73	-29.56	-31.13	-74.28	33.37	-39.17
CGS001-2744	KD	GLS	Ankyrin repeat domain containing, glutaminase			50.00, 25.00	1.44, 0.41	97.37	NaN	-17.71	-20.77	99.94	NaN	99.62	-81.33	-85.02	96.82
CGS001-29998	KD	GLTSCR1	glioma tumor suppressor candidate region gene 1			12.50, 12.50	2.07, 0.68	-74.35	83.32	98.93	49.07	-27.26	NaN	NaN	-20.77	-28.22	52.38
CGS001-2746	KD	GLUD1	glutamate dehydrogenase 1			0.00, 0.00	1.17, 0.32	38.72	NaN	50.64	24.66	24.19	NaN	58.59	-99.60	27.55	19.21
CGS001-2747	KD	GLUD2	glutamate dehydrogenase 2			12.50, 12.50	1.72, 0.50	-19.68	93.24	52.81	99.59	-99.64	-28.39	NaN	-21.52	NaN	48.14
CGS001-2752	KD	GLUL	glutamate-ammonia ligase			0.00, 0.00	1.88, 0.48	27.51	31.42	-36.06	-31.91	88.25	90.45	21.01	-22.68	-56.33	12.45
CGS001-2760	KD	GM2A	GM2 ganglioside activator			30.00, 10.00	0.91, 0.32	-61.59	95.06	-65.28	95.75	66.60	99.57	-28.24	19.83	51.81	86.14
CGS001-2762	KD	GMDS	Short chain dehydrogenase/reductase superfamily / Extended SDR fold, GDP-mannose 4,6-dehydratase			10.00, 10.00	1.00, 0.26	-86.78	99.80	-99.85	-42.45	-88.22	-99.97	-84.24	-99.89	-99.95	-99.92
CGS001-10691	KD	GMEB1	glucocorticoid modulatory element binding protein 1			0.00, 0.00	1.28, 0.38	-67.16	NaN	-46.95	-99.80	31.30	-42.53	-98.47	-99.74	-38.73	-99.18
CGS001-26205	KD	GMEB2	glucocorticoid modulatory element binding protein 2			83.33, 83.33	1.50, 0.39	NaN	NaN	49.28	97.81	99.16	NaN	NaN	99.87	99.96	99.95
CGS001-51053	KD	GMNN	geminin, DNA replication inhibitor			0.00, 0.00	1.94, 0.68	-57.69	-99.57	-96.24	-99.94	-99.98	-93.20	-81.68	-95.92	-99.21	-99.79
CGS001-51292	KD	GMPR2	guanosine monophosphate reductase 2			11.11, 11.11	1.36, 0.41	17.75	47.90	85.94	46.15	68.73	-55.80	NaN	67.12	99.66	61.34
CGS001-8833	KD	GMPS	guanine monphosphate synthetase			10.00, 10.00	1.73, 0.59	-89.20	-95.86	-33.99	-28.66	28.33	-99.96	-97.06	-69.90	99.36	-94.59
CGS001-2767	KD	GNA11	guanine nucleotide binding protein (G protein), alpha 11 (Gq class)			0.00, 0.00	0.61, 0.27	-20.88	-33.27	-61.06	-21.40	-35.78	-29.73	-37.47	-51.87	26.78	-14.61
CGS001-2768	KD	GNA12	guanine nucleotide binding protein (G protein) alpha 12			0.00, 0.00	1.41, 0.35	-24.58	25.10	21.65	-98.08	-95.41	23.67	-49.67	-99.05	22.55	-67.14
CGS001-10672	KD	GNA13	guanine nucleotide binding protein (G protein), alpha 13			25.00, 25.00	1.65, 0.49	22.78	99.72	27.96	90.29	NaN	99.79	21.31	24.42	NaN	85.69
CGS001-2769	KD	GNA15	guanine nucleotide binding protein (G protein), alpha 15 (Gq class)			0.00, 0.00	1.52, 0.52	-31.35	-96.14	87.13	31.47	-63.03	NaN	-35.27	26.24	-30.65	-21.80
CGS001-2770	KD	GNAI1	guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1			0.00, 0.00	1.27, 0.34	-97.53	-83.71	-26.02	-26.44	40.23	76.28	-66.36	NaN	NaN	-38.75
CGS001-2771	KD	GNAI2	guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2			50.00, 40.00	1.07, 0.27	96.99	100.00	52.73	39.06	91.59	99.97	24.60	-57.91	99.80	99.79
CGS001-2773	KD	GNAI3	guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 3			22.22, 22.22	1.58, 0.39	67.22	-34.72	-42.37	23.82	99.93	98.17	-99.12	-31.81	NaN	54.72
CGS001-2776	KD	GNAQ	guanine nucleotide binding protein (G protein), q polypeptide			0.00, 0.00	2.58, 0.83	90.55	92.04	-45.15	-30.91	90.50	NaN	NaN	93.25	70.24	91.00
CGS001-2778	KD	GNAS	GNAS complex locus			0.00, 0.00	1.83, 0.48	-37.58	-89.26	85.67	-29.30	66.77	NaN	35.36	-91.90	33.11	-18.33
CGS001-2782	KD	GNB1	WD repeat domain containing, guanine nucleotide binding protein (G protein), beta polypeptide 1			0.00, 0.00	1.36, 0.49	35.29	-82.70	-99.73	NaN	-99.95	89.22	-86.20	-84.85	-96.49	-97.44
CGS001-54584	KD	GNB1L	WD repeat domain containing, guanine nucleotide binding protein (G protein), beta polypeptide 1-like			25.00, 12.50	1.76, 0.50	95.26	99.91	-72.83	NaN	39.51	26.46	-37.30	NaN	-22.62	28.33
CGS001-2783	KD	GNB2	WD repeat domain containing, guanine nucleotide binding protein (G protein), beta polypeptide 2			33.33, 22.22	1.15, 0.33	80.20	87.00	-23.75	50.34	99.05	60.23	NaN	99.44	69.46	96.89
CGS001-10681	KD	GNB5	WD repeat domain containing, guanine nucleotide binding protein (G protein), beta 5			10.00, 0.00	0.91, 0.20	42.19	-67.11	22.94	97.36	-42.20	-55.76	92.36	46.49	-98.29	-43.08
CGS001-2786	KD	GNG4	guanine nucleotide binding protein (G protein), gamma 4			0.00, 0.00	1.31, 0.35	-75.86	-98.47	-99.89	-41.00	NaN	NaN	-20.49	-84.40	50.41	-87.89
CGS001-2787	KD	GNG5	guanine nucleotide binding protein (G protein), gamma 5			0.00, 0.00	1.69, 0.45	-70.45	-54.26	-99.66	-65.57	-31.19	NaN	-99.93	29.56	78.51	-53.79
CGS001-94235	KD	GNG8	guanine nucleotide binding protein (G protein), gamma 8			11.11, 11.11	1.56, 0.61	48.87	-66.55	39.06	92.74	63.02	NaN	15.30	32.28	99.90	53.86
CGS001-2793	KD	GNGT2	guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 2			44.44, 44.44	2.16, 0.70	71.69	99.72	91.21	44.42	-32.00	NaN	77.11	99.88	99.96	99.21
CGS001-10007	KD	GNPDA1	glucosamine-6-phosphate deaminase 1			0.00, 0.00	0.92, 0.17	92.83	67.12	-83.74	-27.69	29.85	58.29	35.57	-23.86	23.19	21.99
CGS001-27333	KD	GOLIM4	golgi integral membrane protein 4			0.00, 0.00	1.84, 0.74	NaN	30.55	-35.14	38.50	55.70	NaN	NaN	46.67	20.98	11.42
CGS001-51026	KD	GOLT1B	golgi transport 1B			0.00, 0.00	1.83, 0.64	NaN	32.66	-61.40	NaN	76.78	NaN	NaN	41.46	-92.70	17.50
CGS001-2805	KD	GOT1	glutamic-oxaloacetic transaminase 1, soluble (aspartate aminotransferase 1)			0.00, 0.00	1.15, 0.38	-83.43	33.69	29.23	-73.36	-99.94	NaN	24.14	-91.21	-90.60	-87.18
CGS001-2806	KD	GOT2	glutamic-oxaloacetic transaminase 2, mitochondrial (aspartate aminotransferase 2)			11.11, 11.11	1.59, 0.56	32.82	-64.01	97.73	69.25	92.92	NaN	-94.71	-32.58	-28.87	72.05
CGS001-23131	KD	GPATCH8	G patch domain containing, G patch domain containing 8			25.00, 25.00	1.22, 0.39	NaN	NaN	67.96	-32.52	69.60	-39.92	59.32	99.15	98.98	84.70
CGS001-151306	KD	GPBAR1	Bile acid receptor, G protein-coupled bile acid receptor 1			0.00, 0.00	1.84, 0.66	-35.88	-31.25	17.70	27.09	-99.29	-42.69	-69.59	NaN	NaN	-28.05
CGS001-2817	KD	GPC1	Proteoglycans / Cell Surface : Glypicans, glypican 1			0.00, 0.00	1.92, 0.64	-30.89	NaN	-93.44	-99.41	-97.92	NaN	-37.13	-97.42	-75.25	-99.44
CGS001-2852	KD	GPER	G protein-coupled estrogen receptor 1			0.00, 0.00	1.88, 0.63	-97.53	-99.00	-84.55	-96.92	54.44	-99.53	-98.04	-85.86	-37.63	-99.26
CGS001-83550	KD	GPR101	GPCR / Class A : Orphans, G protein-coupled receptor 101			0.00, 0.00	1.15, 0.30	86.94	27.45	21.59	35.22	93.46	77.36	20.21	37.91	26.52	26.07
CGS001-57720	KD	GPR107	GPCR / Unclassified : 7TM orphan receptors, G protein-coupled receptor 107			0.00, 0.00	2.01, 0.59	-26.38	-33.38	69.17	-49.19	NaN	NaN	-64.85	27.64	NaN	-21.74
CGS001-222611	KD	GPR111	Adhesion Class GPCRs, G protein-coupled receptor 111			0.00, 0.00	1.58, 0.50	-99.94	-82.34	-51.47	-25.20	78.53	-99.90	-99.77	-99.50	24.89	-99.95
CGS001-139378	KD	GPR112	Adhesion Class GPCRs, G protein-coupled receptor 112			0.00, 0.00	1.57, 0.52	-88.85	-44.09	20.96	-61.58	43.55	63.75	-23.83	25.09	NaN	-20.56
CGS001-165082	KD	GPR113	Adhesion Class GPCRs, G protein-coupled receptor 113			0.00, 0.00	1.76, 0.64	26.34	-25.97	22.84	-53.07	43.79	NaN	-53.53	-71.66	NaN	-32.75
CGS001-221393	KD	GPR115	Adhesion Class GPCRs, G protein-coupled receptor 115			0.00, 0.00	1.66, 0.50	20.63	-76.57	17.79	78.71	-96.00	NaN	-25.34	-56.50	-99.81	-42.97
CGS001-139760	KD	GPR119	GPCR / Class A : Orphans, G protein-coupled receptor 119			0.00, 0.00	1.39, 0.26	-86.21	-99.71	-99.98	-99.85	-99.96	NaN	-97.32	-96.98	-99.86	-99.95
CGS001-84435	KD	GPR123	Adhesion Class GPCRs, G protein-coupled receptor 123			0.00, 0.00	1.68, 0.58	-36.59	-30.39	-66.02	-52.17	-22.86	-58.58	-29.69	-84.66	-99.18	-59.67
CGS001-166647	KD	GPR125	Adhesion Class GPCRs, G protein-coupled receptor 125			33.33, 11.11	1.11, 0.31	-57.07	NaN	-99.96	-47.99	99.65	97.10	-65.32	70.53	74.51	95.44
CGS001-57211	KD	GPR126	Adhesion Class GPCRs, G protein-coupled receptor 126			0.00, 0.00	1.30, 0.35	-55.75	-86.58	-26.66	-87.61	-26.70	23.64	32.55	-80.51	NaN	-63.18
CGS001-84873	KD	GPR128	Adhesion Class GPCRs, G protein-coupled receptor 128			50.00, 40.00	1.36, 0.39	28.42	99.89	-52.91	97.47	99.44	42.51	63.24	-26.12	99.96	98.71
CGS001-283383	KD	GPR133	Adhesion Class GPCRs, G protein-coupled receptor 133			0.00, 0.00	1.30, 0.48	35.97	-28.83	29.05	79.86	-97.94	-33.85	65.96	31.37	-99.71	21.60
CGS001-56834	KD	GPR137	GPCR / Unclassified : 7TM orphan receptors, G protein-coupled receptor 137			57.14, 42.86	1.34, 0.51	-74.76	NaN	49.05	99.98	96.19	NaN	NaN	99.55	74.49	99.84
CGS001-124274	KD	GPR139	GPCR / Class A : Orphans, G protein-coupled receptor 139			0.00, 0.00	1.38, 0.41	-94.98	-41.16	-40.45	24.41	-47.43	-98.10	-18.53	-27.35	NaN	-33.13
CGS001-353345	KD	GPR141	GPCR / Class A : Orphans, G protein-coupled receptor 141			0.00, 0.00	1.32, 0.35	-92.71	NaN	-99.83	48.38	-70.19	NaN	-46.23	-25.60	-25.98	-63.14
CGS001-350383	KD	GPR142	GPCR / Class A : Orphans, G protein-coupled receptor 142			11.11, 11.11	1.19, 0.33	33.24	30.20	-34.27	-70.12	26.67	99.15	-34.71	37.09	NaN	17.72
CGS001-115330	KD	GPR146	GPCR / Class A : Orphans, G protein-coupled receptor 146			20.00, 20.00	1.15, 0.33	87.44	76.71	-20.50	32.90	-59.44	99.93	21.07	52.10	97.92	59.22
CGS001-285601	KD	GPR150	GPCR / Class A : Orphans, G protein-coupled receptor 150			22.22, 11.11	1.81, 0.64	90.00	19.73	99.98	94.96	-39.91	94.42	NaN	33.07	-44.28	96.34
CGS001-134391	KD	GPR151	GPCR / Class A : Orphans, G protein-coupled receptor 151			0.00, 0.00	1.66, 0.44	25.20	-51.84	-39.18	NaN	-37.00	34.69	23.71	-40.42	NaN	-22.45
CGS001-390212	KD	GPR152	GPCR / Class A : Orphans, G protein-coupled receptor 152			0.00, 0.00	1.32, 0.28	23.63	60.66	-23.71	27.53	69.58	NaN	82.60	31.35	54.01	32.22
CGS001-387509	KD	GPR153	GPCR / Class A : Orphans, G protein-coupled receptor 153			0.00, 0.00	1.45, 0.35	-99.71	-100.00	28.03	-27.56	74.91	-51.82	-19.01	-99.98	35.11	-95.68
CGS001-165829	KD	GPR156	GPCR / Class C : Orphans, G protein-coupled receptor 156			0.00, 0.00	1.40, 0.42	56.65	-66.79	-68.82	-31.23	34.49	-35.25	-69.38	-31.96	25.77	-27.11
CGS001-57512	KD	GPR158	GPCR / Class C : Orphans, G protein-coupled receptor 158			22.22, 22.22	1.16, 0.41	36.81	45.29	-35.49	NaN	99.95	98.84	19.01	44.60	76.18	81.01
CGS001-26996	KD	GPR160	GPCR / Class A : Orphans, G protein-coupled receptor 160			20.00, 20.00	1.43, 0.42	-99.71	62.95	40.89	-27.30	-35.79	93.73	-57.76	99.34	99.84	70.76
CGS001-79581	KD	GPR172A	G protein-coupled receptor 172A			10.00, 10.00	1.41, 0.28	-43.46	22.59	-18.98	-92.08	64.73	-68.71	-52.27	18.91	99.97	-24.13
CGS001-84636	KD	GPR174	GPCR / Class A : Orphans, G protein-coupled receptor 174			0.00, 0.00	1.64, 0.58	23.54	-30.38	-24.47	-35.38	32.63	-56.70	32.95	NaN	NaN	-12.19
CGS001-11245	KD	GPR176	GPCR / Class A : Orphans, G protein-coupled receptor 176			0.00, 0.00	1.74, 0.53	-65.80	20.21	-15.81	-96.21	-30.62	-98.95	37.61	-22.34	NaN	-53.90
CGS001-440435	KD	GPR179	GPCR / Class C : Orphans, G protein-coupled receptor 179			22.22, 11.11	1.69, 0.50	82.73	94.06	44.98	30.81	97.44	-37.26	NaN	99.98	91.25	92.06
CGS001-2842	KD	GPR19	GPCR / Class A : Orphans, G protein-coupled receptor 19			30.00, 30.00	2.03, 0.59	76.47	97.83	91.13	62.08	99.96	99.93	81.43	76.30	-40.03	94.79
CGS001-2849	KD	GPR26	GPCR / Class A : Orphans, G protein-coupled receptor 26			0.00, 0.00	1.65, 0.52	-99.98	-98.25	-36.20	-45.87	-55.66	NaN	-97.16	-85.16	-68.96	-96.31
CGS001-2853	KD	GPR31	GPCR / Class A : Orphans, G protein-coupled receptor 31			0.00, 0.00	1.09, 0.36	-40.03	30.55	-63.57	-96.66	25.78	NaN	82.49	46.34	-99.67	-35.88
CGS001-2857	KD	GPR34	GPCR / Class A : Orphans, G protein-coupled receptor 34			12.50, 0.00	1.78, 0.53	91.18	NaN	96.72	44.15	-61.67	NaN	-36.38	83.72	63.80	82.68
CGS001-2859	KD	GPR35	GPCR / Class A : Orphans, G protein-coupled receptor 35			0.00, 0.00	1.11, 0.30	35.17	-21.51	62.32	79.57	-61.80	NaN	-24.96	-48.98	26.01	18.04
CGS001-2861	KD	GPR37	GPCR / Class A : Orphans, G protein-coupled receptor 37 (endothelin receptor type B-like)			0.00, 0.00	1.47, 0.35	-80.78	-63.70	-82.02	-33.43	-99.25	-49.21	-24.26	-22.28	NaN	-46.59
CGS001-2863	KD	GPR39	GPCR / Class A : Orphans, G protein-coupled receptor 39			0.00, 0.00	1.70, 0.39	-42.13	NaN	-15.24	22.48	32.47	NaN	94.50	-58.21	22.06	-7.05
CGS001-2828	KD	GPR4	GPCR / Class A : Orphans, G protein-coupled receptor 4			0.00, 0.00	1.65, 0.63	52.35	22.69	48.59	47.93	-83.45	NaN	NaN	26.86	28.36	19.77
CGS001-9290	KD	GPR55	GPCR / Class A : Orphans, G protein-coupled receptor 55			11.11, 0.00	1.32, 0.25	48.61	-28.06	-88.07	-98.38	95.31	NaN	86.61	-44.61	27.15	51.07
CGS001-9289	KD	GPR56	Adhesion Class GPCRs, G protein-coupled receptor 56			0.00, 0.00	1.44, 0.40	-88.66	-56.48	-31.79	-21.23	-21.28	-95.30	-99.98	20.95	-24.10	-56.01
CGS001-83873	KD	GPR61	GPCR / Class A : Orphans, G protein-coupled receptor 61			12.50, 12.50	1.86, 0.41	49.81	72.09	70.38	NaN	NaN	99.97	-22.51	-42.99	91.08	67.54
CGS001-118442	KD	GPR62	GPCR / Class A : Orphans, G protein-coupled receptor 62			11.11, 11.11	1.56, 0.49	21.16	-93.02	99.95	-35.66	36.02	NaN	23.46	-71.78	58.83	-7.99
CGS001-10149	KD	GPR64	Adhesion Class GPCRs, G protein-coupled receptor 64			0.00, 0.00	1.43, 0.57	-25.81	32.99	-27.38	-28.85	NaN	62.68	-98.83	-21.85	66.23	-5.05
CGS001-8477	KD	GPR65	GPCR / Class A : Orphans, G protein-coupled receptor 65			0.00, 0.00	1.26, 0.33	-86.38	-24.15	22.22	-43.30	66.54	NaN	40.96	21.28	23.46	16.36
CGS001-27201	KD	GPR78	GPCR / Class A : Orphans, G protein-coupled receptor 78			0.00, 0.00	1.13, 0.35	-28.10	-18.49	-82.98	-32.33	28.18	-61.89	-32.29	23.19	-30.72	-12.30
CGS001-10888	KD	GPR83	GPCR / Class A : Orphans, G protein-coupled receptor 83			50.00, 37.50	1.90, 0.56	94.30	NaN	99.98	70.12	99.31	NaN	95.54	81.52	81.31	99.34
CGS001-53831	KD	GPR84	GPCR / Class A : Fatty acid receptors, G protein-coupled receptor 84			30.00, 0.00	1.61, 0.57	-78.22	-96.74	97.11	30.04	-40.77	95.85	-96.48	-28.96	95.65	45.50
CGS001-53836	KD	GPR87	GPCR / Class A : Orphans, G protein-coupled receptor 87			11.11, 11.11	2.14, 0.55	34.00	-34.38	28.45	-37.66	97.91	NaN	31.66	-21.21	-16.69	-3.78
CGS001-9052	KD	GPRC5A	GPCR / Class C : Orphans, G protein-coupled receptor, family C, group 5, member A			16.67, 16.67	2.11, 0.56	NaN	NaN	88.07	-29.89	98.22	NaN	NaN	-63.00	36.81	92.93
CGS001-55890	KD	GPRC5C	GPCR / Class C : Orphans, G protein-coupled receptor, family C, group 5, member C			10.00, 10.00	0.86, 0.16	47.23	31.00	-51.79	31.17	37.98	-24.65	-99.76	99.95	24.75	15.92
CGS001-222545	KD	GPRC6A	GPCR / Class C : Calcium-sensing receptors, G protein-coupled receptor, family C, group 6, member A			11.11, 0.00	1.61, 0.36	68.29	97.44	93.40	58.24	NaN	-37.13	69.62	66.32	67.75	68.35
CGS001-26086	KD	GPSM1	Tetratricopeptide (TTC) repeat domain containing, G-protein signaling modulator 1			0.00, 0.00	1.47, 0.49	-29.26	21.52	-19.07	30.84	79.98	NaN	48.04	-25.38	85.23	17.19
CGS001-29899	KD	GPSM2	Tetratricopeptide (TTC) repeat domain containing, G-protein signaling modulator 2			37.50, 25.00	2.44, 0.73	-71.30	27.01	99.52	98.84	45.35	NaN	NaN	90.92	76.35	96.35
CGS001-2876	KD	GPX1	glutathione peroxidase 1			0.00, 0.00	2.28, 0.57	-29.26	-30.59	91.85	35.52	90.31	NaN	85.10	85.34	-98.71	90.99
CGS001-2877	KD	GPX2	glutathione peroxidase 2 (gastrointestinal)			0.00, 0.00	1.48, 0.44	70.87	-21.48	-25.46	72.19	33.94	66.60	NaN	-82.77	20.80	37.83
CGS001-2878	KD	GPX3	glutathione peroxidase 3 (plasma)			10.00, 10.00	1.63, 0.57	-47.89	76.12	-13.50	-30.79	72.60	99.73	-28.03	-30.86	82.02	60.91
CGS001-2882	KD	GPX7	glutathione peroxidase 7			20.00, 20.00	1.70, 0.52	92.63	56.29	-34.09	43.98	77.58	99.96	84.75	29.13	98.33	87.30
CGS001-2887	KD	GRB10	Pleckstrin homology (PH) domain containing, growth factor receptor-bound protein 10			42.86, 14.29	2.13, 0.83	51.63	NaN	97.41	96.34	-37.86	NaN	NaN	91.49	-51.53	98.29
CGS001-2885	KD	GRB2	SH2 domain containing, growth factor receptor-bound protein 2			11.11, 11.11	1.20, 0.19	35.23	NaN	-41.85	-44.60	-39.29	-56.90	19.83	-74.49	99.05	-18.80
CGS001-2886	KD	GRB7	Pleckstrin homology (PH) domain containing, growth factor receptor-bound protein 7			22.22, 22.22	1.01, 0.32	NaN	85.87	-20.54	33.92	25.16	-54.55	99.98	99.98	61.53	82.15
CGS001-9687	KD	GREB1	growth regulation by estrogen in breast cancer 1			0.00, 0.00	1.68, 0.52	-46.95	-88.97	17.52	25.35	-21.29	85.67	-26.82	30.09	NaN	-6.44
CGS001-9380	KD	GRHPR	glyoxylate reductase/hydroxypyruvate reductase			0.00, 0.00	1.44, 0.40	-36.54	44.53	-98.36	-99.91	-41.81	32.91	-38.79	-98.00	-19.92	-76.42
CGS001-2869	KD	GRK5	GRK1/3 subfamily, G protein-coupled receptor kinase 5			0.00, 0.00	1.42, 0.35	-26.35	-28.97	-19.31	-75.39	29.64	NaN	60.62	NaN	36.27	11.93
CGS001-2870	KD	GRK6	GRK1/3 subfamily, G protein-coupled receptor kinase 6			0.00, 0.00	1.27, 0.33	43.31	-98.95	-25.59	56.29	40.00	-30.74	-25.15	-38.85	41.83	20.36
CGS001-2896	KD	GRN	granulin			0.00, 0.00	1.22, 0.34	-74.15	-99.23	-98.16	-99.98	50.25	-99.96	-92.34	-84.52	-63.42	-99.53
CGS001-2925	KD	GRPR	GPCR / Class A : Bombesin receptors, gastrin-releasing peptide receptor			0.00, 0.00	1.43, 0.43	32.15	-26.87	17.41	50.93	-56.16	41.62	-38.27	NaN	NaN	-13.36
CGS001-83743	KD	GRWD1	WD repeat domain containing, glutamate-rich WD repeat containing 1			0.00, 0.00	2.58, 0.65	NaN	-99.32	-82.66	-46.08	31.44	NaN	NaN	-93.02	-99.89	-95.53
CGS001-55876	KD	GSDMB	gasdermin B			0.00, 0.00	1.63, 0.43	-41.43	-40.02	-97.25	-65.47	-44.75	NaN	NaN	-49.35	17.82	-44.98
CGS001-2931	KD	GSK3A	GSK subfamily, glycogen synthase kinase 3 alpha			20.00, 20.00	0.13, 0.02	-33.50	9.16	-63.30	77.77	24.44	99.69	-8.27	-87.81	97.99	5.02
CGS001-2932	KD	GSK3B	GSK subfamily, glycogen synthase kinase 3 beta			20.00, 10.00	2.15, 0.74	98.45	-13.44	27.98	35.02	-47.13	40.34	-47.41	95.58	23.50	11.66
CGS001-2936	KD	GSR	Oxidoreductases, glutathione reductase			0.00, 0.00	0.82, 0.31	-98.98	-28.42	-76.85	-99.35	43.77	NaN	NaN	-78.66	-99.13	-99.51
CGS001-2937	KD	GSS	glutathione synthetase			11.11, 11.11	1.25, 0.26	99.86	-28.17	-38.77	75.60	-23.04	NaN	-88.87	-22.74	-99.36	-40.17
CGS001-2944	KD	GSTM1	Glutathione S-transferases / Soluble, glutathione S-transferase mu 1			0.00, 0.00	1.26, 0.40	79.40	NaN	-96.82	37.75	-99.98	NaN	-96.38	51.38	21.12	-98.72
CGS001-2950	KD	GSTP1	Glutathione S-transferases, glutathione S-transferase pi 1			0.00, 0.00	1.30, 0.43	-85.86	-55.93	-84.02	-99.90	-93.13	NaN	83.35	-91.25	-99.93	-95.94
CGS001-2952	KD	GSTT1	Glutathione S-transferases / Soluble, glutathione S-transferase theta 1			0.00, 0.00	1.11, 0.43	20.70	NaN	45.09	56.02	68.91	NaN	58.51	-65.93	-99.97	61.86
CGS001-2954	KD	GSTZ1	Glutathione S-transferases / Soluble, glutathione transferase zeta 1			0.00, 0.00	1.27, 0.40	-69.04	-30.50	-15.25	72.90	88.31	-76.97	-35.21	-18.69	-29.03	-6.16
CGS001-79712	KD	GTDC1	Glycosyltransferase group 1 domain containing, glycosyltransferase-like domain containing 1			0.00, 0.00	1.60, 0.53	-99.98	-50.75	-55.09	-30.90	-24.21	NaN	NaN	-10.65	-67.45	-46.09
CGS001-2957	KD	GTF2A1	General transcription factors, general transcription factor IIA, 1, 19/37kDa		General transcription factors group 2 LOF	0.00, 0.00	1.42, 0.56	-33.08	39.93	-15.32	-44.00	37.16	-17.96	-95.38	71.51	-99.92	-5.34
CGS001-2958	KD	GTF2A2	General transcription factors, general transcription factor IIA, 2, 12kDa			0.00, 0.00	0.92, 0.32	-99.95	-30.14	-95.44	-99.77	-99.95	NaN	-43.02	-26.96	-44.83	-99.92
CGS001-2961	KD	GTF2E2	General transcription factors, general transcription factor IIE, polypeptide 2, beta 34kDa			10.00, 0.00	1.33, 0.38	73.64	97.15	-98.46	-69.33	-35.47	-77.53	-83.67	18.09	23.32	-66.23
CGS001-2963	KD	GTF2F2	General transcription factors, general transcription factor IIF, polypeptide 2, 30kDa		General transcription factors group 2 LOF	0.00, 0.00	1.11, 0.25	-39.25	-49.12	-19.38	93.47	-24.39	-99.66	-21.86	NaN	-95.78	-48.76
CGS001-2966	KD	GTF2H2	General transcription factors, general transcription factor IIH, polypeptide 2, 44kDa			10.00, 0.00	1.32, 0.36	-22.87	22.31	-38.97	25.90	-82.28	-59.12	-93.81	-50.88	96.44	-29.58
CGS001-2967	KD	GTF2H3	General transcription factors, general transcription factor IIH, polypeptide 3, 34kDa		General transcription factors group 2 LOF	0.00, 0.00	1.34, 0.36	-74.51	48.67	-60.49	-57.14	-84.08	-96.26	-99.98	33.49	NaN	-77.36
CGS001-2969	KD	GTF2I	General transcription factors, general transcription factor IIi		General transcription factors group 1 LOF	0.00, 0.00	1.39, 0.48	-86.91	NaN	56.67	50.58	-90.84	NaN	-87.33	-75.33	87.08	-79.05
CGS001-2976	KD	GTF3C2	General transcription factors, general transcription factor IIIC, polypeptide 2, beta 110kDa		General transcription factors group 1 LOF	44.44, 22.22	0.92, 0.25	67.70	96.19	99.55	91.98	31.93	NaN	-19.84	98.01	-63.34	95.07
CGS001-29083	KD	GTPBP8	GTP-binding protein 8 (putative)			0.00, 0.00	1.20, 0.38	NaN	NaN	-99.98	-39.49	35.78	41.11	-86.94	-76.43	-99.64	-96.41
CGS001-2987	KD	GUK1	guanylate kinase 1			10.00, 10.00	1.32, 0.39	-49.02	100.00	91.61	-25.56	49.29	45.69	33.67	-41.73	-86.84	25.89
CGS001-2990	KD	GUSB	glucuronidase, beta			12.50, 0.00	1.36, 0.48	49.27	44.71	96.89	22.43	41.47	NaN	35.54	NaN	-19.61	16.27
CGS001-2992	KD	GYG1	Glycosyltransferase family 8 domain containing, glycogenin 1			0.00, 0.00	1.55, 0.40	-65.37	-24.00	-17.82	-26.06	24.05	-30.77	-48.58	NaN	59.78	-5.97
CGS001-2997	KD	GYS1	Glycosyltransferase group 1 domain containing, glycogen synthase 1 (muscle)			0.00, 0.00	1.08, 0.22	90.44	91.29	20.33	-40.95	-40.45	-28.50	47.96	-33.70	-57.66	23.93
CGS001-94239	KD	H2AFV	Histones / Replication-independent, H2A histone family, member V			11.11, 11.11	1.06, 0.36	-99.36	-94.45	-31.80	-95.80	99.45	NaN	-99.87	-99.12	32.25	-99.53
CGS001-3033	KD	HADH	hydroxyacyl-CoA dehydrogenase			0.00, 0.00	0.98, 0.27	34.35	-99.63	-93.97	-20.21	-97.79	24.75	-28.48	-15.83	-99.40	-99.04
CGS001-3030	KD	HADHA	hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein), alpha subunit			0.00, 0.00	1.17, 0.35	46.28	-20.87	62.36	-29.39	46.86	-20.49	82.80	-30.69	25.94	30.91
CGS001-3032	KD	HADHB	hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein), beta subunit			20.00, 10.00	1.41, 0.39	-38.06	95.22	-7.67	-83.72	-26.41	99.97	-39.53	-91.73	59.03	-16.78
CGS001-3029	KD	HAGH	hydroxyacylglutathione hydrolase			37.50, 25.00	2.34, 0.83	30.45	-19.27	92.31	97.99	70.26	-66.31	99.79	NaN	NaN	96.25
CGS001-3034	KD	HAL	histidine ammonia-lyase			0.00, 0.00	1.38, 0.36	-53.94	-49.71	-89.12	-24.44	-71.18	60.36	-37.98	NaN	NaN	-55.92
CGS001-3035	KD	HARS	Aminoacyl tRNA synthetases / Class II, histidyl-tRNA synthetase			12.50, 12.50	1.34, 0.45	84.05	NaN	63.74	-38.38	98.58	92.28	NaN	41.22	29.98	93.55
CGS001-8520	KD	HAT1	Histone acetyltransferases (HATs), histone acetyltransferase 1			11.11, 11.11	1.18, 0.18	98.51	-81.98	-45.66	86.32	24.06	-77.51	NaN	-20.09	-48.24	-54.66
CGS001-26762	KD	HAVCR1	Immunoglobulin superfamily / V-set domain containing, hepatitis A virus cellular receptor 1			0.00, 0.00	1.49, 0.48	-22.66	82.28	13.11	-56.53	34.32	37.61	42.13	66.42	NaN	16.35
CGS001-10456	KD	HAX1	HCLS1 associated protein X-1			37.50, 25.00	0.98, 0.30	90.22	98.83	-23.54	39.30	42.17	NaN	NaN	98.98	45.87	97.24
CGS001-3046	KD	HBE1	hemoglobin, epsilon 1			40.00, 40.00	1.19, 0.41	93.62	88.16	99.98	99.50	74.06	60.76	79.24	99.18	85.39	99.55
CGS001-26959	KD	HBP1	HMG-box transcription factor 1			25.00, 25.00	2.09, 0.58	99.45	29.48	89.27	-33.15	-38.52	NaN	98.40	20.94	NaN	83.95
CGS001-27198	KD	HCAR1	GPCR / Class A : Hydroxy-carboxylic acid receptors, hydroxycarboxylic acid receptor 1			0.00, 0.00	1.80, 0.60	66.50	26.25	49.25	-44.80	30.55	78.95	31.24	32.17	-41.13	30.11
CGS001-3054	KD	HCFC1	host cell factor C1 (VP16-accessory protein)			11.11, 11.11	1.51, 0.44	48.67	-19.95	99.96	-28.32	44.65	NaN	64.68	33.88	-91.64	44.85
CGS001-57657	KD	HCN3	Cyclic nucleotide-regulated channels, hyperpolarization activated cyclic nucleotide-gated potassium channel 3			0.00, 0.00	1.14, 0.31	39.34	24.31	46.14	28.19	-27.96	NaN	87.42	-48.89	-94.81	9.50
CGS001-83933	KD	HDAC10	Histone deacetylases, histone deacetylase 10		Histone deacetylases LOF	10.00, 10.00	1.69, 0.47	-60.58	-27.22	99.69	-85.19	-94.72	22.20	28.44	-42.19	48.70	-50.56
CGS001-3066	KD	HDAC2	Histone deacetylases, histone deacetylase 2			0.00, 0.00	1.06, 0.23	-24.05	55.32	-99.65	20.21	-97.27	-27.11	-78.95	50.73	84.85	-37.30
CGS001-8841	KD	HDAC3	Histone deacetylases, histone deacetylase 3			0.00, 0.00	1.91, 0.60	-99.56	33.56	-56.92	-99.62	-98.02	-90.51	-98.51	-98.52	57.83	-99.63
CGS001-9759	KD	HDAC4	Histone deacetylases, histone deacetylase 4		Histone deacetylases LOF	40.00, 40.00	0.94, 0.17	47.90	99.89	87.19	41.00	21.98	38.63	99.98	99.93	16.66	99.87
CGS001-10014	KD	HDAC5	Histone deacetylases, histone deacetylase 5			0.00, 0.00	1.52, 0.56	-72.82	-80.04	-64.87	-87.01	87.73	NaN	-68.67	-89.64	-43.80	-80.11
CGS001-10013	KD	HDAC6	Histone deacetylases, histone deacetylase 6			0.00, 0.00	1.51, 0.45	46.97	-15.72	-54.53	-42.26	21.34	-99.84	-20.29	-98.15	-58.61	-46.13
CGS001-51564	KD	HDAC7	Histone deacetylases, histone deacetylase 7			40.00, 40.00	1.23, 0.38	88.94	63.18	33.63	88.33	93.01	99.97	99.90	99.51	63.20	99.54
CGS001-55869	KD	HDAC8	Histone deacetylases, histone deacetylase 8			11.11, 11.11	1.67, 0.51	50.86	93.71	65.78	70.75	-33.05	NaN	99.11	57.91	-52.66	80.51
CGS001-50810	KD	HDGFRP3	hepatoma-derived growth factor, related protein 3			0.00, 0.00	1.94, 0.55	75.75	NaN	-18.07	NaN	-99.65	NaN	-41.27	-20.86	-91.65	-42.28
CGS001-8226	KD	HDHD1	haloacid dehalogenase-like hydrolase domain containing 1			0.00, 0.00	1.25, 0.40	-25.34	-37.56	-28.89	-49.70	-35.14	24.04	25.73	-41.70	NaN	-13.45
CGS001-55127	KD	HEATR1	HEAT repeat containing 1		Minor histocompatibility antigens LOF	0.00, 0.00	2.33, 0.78	35.52	NaN	-99.19	-90.19	67.88	NaN	NaN	-55.27	-99.97	-98.86
CGS001-50865	KD	HEBP1	Endogenous ligands, heme binding protein 1			11.11, 0.00	1.10, 0.59	97.19	-17.80	-43.39	57.76	91.42	NaN	-42.54	-56.61	-48.10	-29.84
CGS001-55008	KD	HERC6	hect domain and RLD 6			16.67, 16.67	4.44, 1.72	NaN	NaN	50.13	98.10	57.11	NaN	NaN	63.56	-42.74	71.69
CGS001-9709	KD	HERPUD1	homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1			0.00, 0.00	1.16, 0.31	-18.96	-22.14	-99.98	-99.94	23.17	82.33	72.19	-95.18	-94.73	-97.75
CGS001-3280	KD	HES1	Basic helix-loop-helix proteins, hairy and enhancer of split 1, (Drosophila)			10.00, 10.00	1.48, 0.35	-71.28	-67.30	-18.99	-47.95	-98.98	41.93	97.75	-98.56	-29.34	-58.04
CGS001-388585	KD	HES5	Basic helix-loop-helix proteins, hairy and enhancer of split 5 (Drosophila)			22.22, 22.22	1.99, 0.70	99.94	35.13	73.48	-33.75	36.40	-37.01	63.90	99.96	NaN	59.21
CGS001-3074	KD	HEXB	hexosaminidase B (beta polypeptide)			0.00, 0.00	1.74, 0.43	-86.76	-92.66	-61.62	-88.66	-93.18	NaN	-55.34	-30.63	-96.54	-95.69
CGS001-10614	KD	HEXIM1	hexamethylene bis-acetamide inducible 1			11.11, 11.11	1.24, 0.40	-32.60	21.00	-30.28	-24.05	-24.62	99.73	NaN	-45.75	-46.44	-9.35
CGS001-23462	KD	HEY1	Basic helix-loop-helix proteins, hairy/enhancer-of-split related with YRPW motif 1			11.11, 11.11	1.30, 0.42	-71.26	NaN	-46.64	-49.17	98.85	60.78	55.48	26.56	-36.29	34.55
CGS001-3077	KD	HFE	Immunoglobulin superfamily / C1-set domain containing, hemochromatosis			11.11, 0.00	1.35, 0.43	57.42	NaN	-89.01	-99.91	97.26	32.40	26.99	-84.84	-96.02	-93.30
CGS001-9146	KD	HGS	Zinc fingers, FYVE domain containing, hepatocyte growth factor-regulated tyrosine kinase substrate			0.00, 0.00	2.67, 0.93	-59.07	-89.51	-57.99	-98.44	24.37	NaN	-99.34	-92.12	-25.00	-97.18
CGS001-3087	KD	HHEX	Homeoboxes / ANTP class : NKL subclass, hematopoietically expressed homeobox		NKL subclass homeoboxes and pseudogenes LOF	0.00, 0.00	1.52, 0.36	-67.15	93.81	49.24	-45.08	-33.85	-52.73	-21.23	NaN	NaN	-19.34
CGS001-11112	KD	HIBADH	3-hydroxyisobutyrate dehydrogenase			0.00, 0.00	1.53, 0.40	-30.35	47.87	37.10	24.58	-76.06	NaN	61.42	31.16	75.17	28.14
CGS001-23119	KD	HIC2	BTB/POZ domain containing, hypermethylated in cancer 2			0.00, 0.00	1.00, 0.28	-95.35	63.99	82.72	63.34	27.64	-48.91	-96.18	31.52	24.81	24.80
CGS001-3091	KD	HIF1A	Basic helix-loop-helix proteins, hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)			20.00, 20.00	1.06, 0.33	-82.86	35.13	97.80	-99.98	-43.90	99.79	53.18	-48.77	20.88	-19.09
CGS001-55662	KD	HIF1AN	hypoxia inducible factor 1, alpha subunit inhibitor			0.00, 0.00	1.57, 0.47	40.68	-34.99	27.73	76.81	71.19	30.23	31.42	-52.63	61.92	34.39
CGS001-192286	KD	HIGD2A	HIG1 hypoxia inducible domain family, member 2A			0.00, 0.00	3.06, 0.90	NaN	NaN	-39.78	-28.14	-52.01	NaN	NaN	-94.45	30.24	-41.98
CGS001-204851	KD	HIPK1	HIPK subfamily, homeodomain interacting protein kinase 1			0.00, 0.00	1.30, 0.32	-75.70	-63.27	49.42	-94.77	-83.73	35.93	NaN	26.71	90.39	-75.51
CGS001-8334	KD	HIST1H2AC	Histones / Replication-dependent, histone cluster 1, H2ac			44.44, 33.33	1.55, 0.52	-45.99	-45.99	99.53	61.93	-97.22	NaN	21.06	97.56	96.33	97.82
CGS001-3017	KD	HIST1H2BD	Histones / Replication-dependent, histone cluster 1, H2bd			0.00, 0.00	1.14, 0.31	80.46	-62.51	15.95	-99.83	-96.08	NaN	68.83	-35.16	28.27	-70.42
CGS001-85236	KD	HIST1H2BK	Histones / Replication-dependent, histone cluster 1, H2bk			0.00, 0.00	1.69, 0.52	NaN	-100.00	-97.00	-97.46	-28.36	55.39	-29.05	12.20	27.00	-76.16
CGS001-8349	KD	HIST2H2BE	Histones / Replication-dependent, histone cluster 2, H2be			0.00, 0.00	2.57, 0.84	74.10	NaN	-79.30	-99.74	-99.85	55.13	88.24	-98.10	-96.95	-98.44
CGS001-3098	KD	HK1	hexokinase 1			0.00, 0.00	1.36, 0.36	16.99	-83.91	-93.13	-51.63	-89.26	44.18	-29.77	-19.82	-98.04	-96.13
CGS001-3105	KD	HLA-A	Immunoglobulin superfamily / C1-set domain containing, major histocompatibility complex, class I, A			20.00, 10.00	1.08, 0.32	84.67	88.88	-16.13	96.43	80.72	-17.44	-70.82	99.65	17.24	83.27
CGS001-3108	KD	HLA-DMA	Immunoglobulin superfamily / C1-set domain containing, major histocompatibility complex, class II, DM alpha			10.00, 10.00	1.19, 0.38	-41.12	50.01	-65.68	-98.08	79.95	-24.91	26.48	25.35	98.23	8.18
CGS001-3109	KD	HLA-DMB	Immunoglobulin superfamily / C1-set domain containing, major histocompatibility complex, class II, DM beta			0.00, 0.00	1.74, 0.55	-99.98	-88.15	-67.37	-85.45	-59.24	NaN	20.16	-69.21	22.71	-81.42
CGS001-3113	KD	HLA-DPA1	Immunoglobulin superfamily / C1-set domain containing, major histocompatibility complex, class II, DP alpha 1			10.00, 10.00	1.65, 0.49	-79.70	99.49	-37.58	52.94	-35.25	-26.51	-35.26	-74.09	21.08	-12.16
CGS001-3115	KD	HLA-DPB1	Immunoglobulin superfamily / C1-set domain containing, major histocompatibility complex, class II, DP beta 1			22.22, 11.11	1.77, 0.43	-24.50	95.16	39.51	22.26	20.86	28.08	99.73	-28.40	NaN	20.74
CGS001-3117	KD	HLA-DQA1	Immunoglobulin superfamily / C1-set domain containing, major histocompatibility complex, class II, DQ alpha 1			0.00, 0.00	1.17, 0.38	-18.56	-96.51	-66.36	-24.24	27.24	-25.68	-67.26	44.14	-23.15	-20.11
CGS001-3119	KD	HLA-DQB1	Immunoglobulin superfamily / C1-set domain containing, major histocompatibility complex, class II, DQ beta 1			11.11, 11.11	1.36, 0.34	-99.94	-41.77	-24.63	-27.33	26.67	NaN	-79.27	-64.55	99.22	-61.11
CGS001-3122	KD	HLA-DRA	Immunoglobulin superfamily / C1-set domain containing, major histocompatibility complex, class II, DR alpha			11.11, 11.11	1.28, 0.34	29.25	47.20	79.04	41.59	40.27	67.99	99.62	-34.76	NaN	44.07
CGS001-3123	KD	HLA-DRB1	Immunoglobulin superfamily / C1-set domain containing, major histocompatibility complex, class II, DR beta 1			0.00, 0.00	1.08, 0.32	-23.79	-98.42	92.21	93.35	35.05	NaN	58.21	75.07	83.45	74.52
CGS001-3126	KD	HLA-DRB4	Immunoglobulin superfamily / C1-set domain containing, major histocompatibility complex, class II, DR beta 4			0.00, 0.00	1.18, 0.39	-96.20	-99.67	-62.24	46.21	-99.77	-99.71	-88.90	-98.34	59.96	-99.74
CGS001-3127	KD	HLA-DRB5	Immunoglobulin superfamily / C1-set domain containing, major histocompatibility complex, class II, DR beta 5			0.00, 0.00	1.65, 0.48	53.66	93.15	68.96	27.33	-49.83	NaN	21.02	67.39	72.25	54.93
CGS001-3131	KD	HLF	hepatic leukemia factor			22.22, 22.22	1.74, 0.43	-68.94	NaN	99.55	99.13	39.06	-29.31	78.56	-46.77	33.96	67.58
CGS001-79618	KD	HMBOX1	Homeoboxes / HNF class, homeobox containing 1			0.00, 0.00	1.64, 0.55	39.94	62.45	-35.26	92.97	93.16	NaN	16.64	-96.18	55.19	45.22
CGS001-10362	KD	HMG20B	High mobility group / Non-canonical, high mobility group 20B			14.29, 14.29	1.55, 0.49	9.88	NaN	-28.15	-84.32	99.85	NaN	NaN	34.09	68.03	13.68
CGS001-3159	KD	HMGA1	High-mobility group / Canonical, high mobility group AT-hook 1			22.22, 11.11	1.52, 0.63	-45.46	NaN	99.15	95.46	53.33	-63.49	50.61	-85.16	-28.48	58.80
CGS001-8091	KD	HMGA2	High-mobility group / Canonical, high mobility group AT-hook 2			0.00, 0.00	0.89, 0.22	-14.65	35.85	-99.91	37.98	-25.75	-21.81	-18.36	54.03	65.33	19.10
CGS001-3148	KD	HMGB2	High-mobility group / Canonical, high mobility group box 2			0.00, 0.00	2.17, 0.80	40.22	-42.10	39.06	61.76	27.99	-97.89	25.70	36.42	NaN	25.21
CGS001-3149	KD	HMGB3	High-mobility group / Canonical, high mobility group box 3			11.11, 11.11	1.57, 0.55	20.99	-32.16	83.29	26.66	-33.69	NaN	-23.55	-47.80	99.50	-5.58
CGS001-127540	KD	HMGB4	High-mobility group / Canonical, high mobility group box 4		Canonical high mobility group proteins LOF	0.00, 0.00	1.81, 0.55	-30.28	21.83	47.62	34.96	-84.11	-82.83	-70.83	-47.02	NaN	-58.14
CGS001-3155	KD	HMGCL	3-hydroxymethyl-3-methylglutaryl-CoA lyase			0.00, 0.00	0.94, 0.27	54.12	31.66	25.13	-96.86	25.06	64.24	-58.27	-13.63	-23.29	6.71
CGS001-3156	KD	HMGCR	Lanosterol biosynthesis pathway, 3-hydroxy-3-methylglutaryl-CoA reductase			20.00, 10.00	1.11, 0.30	-86.00	95.74	-19.14	-54.08	98.55	78.89	-46.45	11.22	85.43	65.74
CGS001-3157	KD	HMGCS1	Lanosterol biosynthesis pathway, 3-hydroxy-3-methylglutaryl-CoA synthase 1 (soluble)			0.00, 0.00	1.22, 0.26	-54.90	NaN	-97.92	22.73	-65.33	-69.87	-57.92	78.44	-81.61	-66.00
CGS001-3158	KD	HMGCS2	Lanosterol biosynthesis pathway, 3-hydroxy-3-methylglutaryl-CoA synthase 2 (mitochondrial)			11.11, 11.11	1.88, 0.52	85.45	-18.97	51.53	99.98	36.89	-30.63	NaN	91.21	49.98	82.40
CGS001-9324	KD	HMGN3	High-mobility group / Canonical, high mobility group nucleosomal binding domain 3			0.00, 0.00	0.95, 0.19	-27.80	21.83	-19.79	-56.74	-99.78	-90.26	-84.92	NaN	70.66	-66.10
CGS001-10473	KD	HMGN4	High-mobility group / Canonical, high mobility group nucleosomal binding domain 4		Canonical high mobility group proteins LOF	0.00, 0.00	1.33, 0.52	-29.11	30.33	24.01	56.77	-51.23	-21.82	-28.05	-45.37	NaN	-11.06
CGS001-79366	KD	HMGN5	High-mobility group / Canonical, high mobility group nucleosome binding domain 5			0.00, 0.00	1.30, 0.31	-25.89	90.09	19.85	66.33	-99.98	-74.77	94.58	NaN	26.09	70.26
CGS001-3161	KD	HMMR	CD molecules, hyaluronan-mediated motility receptor (RHAMM)			0.00, 0.00	1.94, 0.63	-91.10	-28.49	-46.29	-23.38	-21.53	62.11	-59.61	-86.06	NaN	-34.13
CGS001-3162	KD	HMOX1	Haem oxygenase, heme oxygenase (decycling) 1			37.50, 25.00	0.93, 0.23	99.52	NaN	86.54	-33.35	73.24	NaN	81.43	97.44	57.67	99.10
CGS001-3163	KD	HMOX2	Haem oxygenase, heme oxygenase (decycling) 2			20.00, 20.00	1.03, 0.24	18.83	74.83	-22.69	-23.75	99.95	32.12	14.04	-46.92	98.56	41.06
CGS001-90861	KD	HN1L	hematological and neurological expressed 1-like			0.00, 0.00	2.59, 0.69	72.70	28.21	-19.49	-99.76	-51.69	-26.87	39.22	-66.51	-97.86	-54.42
CGS001-6927	KD	HNF1A	Homeoboxes / HNF class, HNF1 homeobox A			28.57, 28.57	1.65, 0.55	-36.46	22.26	97.74	NaN	NaN	NaN	99.98	27.28	-38.84	66.69
CGS001-6928	KD	HNF1B	Homeoboxes / HNF class, HNF1 homeobox B			0.00, 0.00	0.95, 0.32	-99.95	-82.40	-37.13	-54.86	-97.90	39.60	37.63	40.95	-22.17	-52.43
CGS001-3172	KD	HNF4A	Hepatocyte nuclear factor-4 receptors, hepatocyte nuclear factor 4, alpha			10.00, 10.00	1.27, 0.32	-56.97	-44.68	-36.65	22.59	71.51	-89.81	23.57	99.84	-80.14	-35.75
CGS001-3174	KD	HNF4G	Hepatocyte nuclear factor-4 receptors, hepatocyte nuclear factor 4, gamma			20.00, 10.00	1.49, 0.42	41.54	95.62	58.53	-93.99	55.24	99.93	15.39	-93.16	-27.22	44.62
CGS001-3176	KD	HNMT	histamine N-methyltransferase			0.00, 0.00	2.02, 0.49	36.92	18.17	55.73	27.14	-46.36	93.91	50.27	-26.95	-28.13	41.12
CGS001-9455	KD	HOMER2	homer homolog 2 (Drosophila)			10.00, 0.00	1.20, 0.42	-95.96	88.11	-72.26	-93.35	-78.93	-90.57	95.26	30.83	-19.35	-93.61
CGS001-57594	KD	HOMEZ	Homeoboxes / ZF class, homeobox and leucine zipper encoding			20.00, 20.00	1.59, 0.58	31.29	28.39	93.95	-22.62	99.93	99.49	-23.06	28.11	-46.84	56.21
CGS001-29911	KD	HOOK2	hook homolog 2 (Drosophila)			44.44, 44.44	1.33, 0.47	99.11	NaN	-98.18	98.36	43.36	94.83	98.87	51.08	-79.68	97.59
CGS001-84525	KD	HOPX	Homeoboxes / PRD class, HOP homeobox			11.11, 0.00	1.57, 0.38	-26.17	35.42	56.96	45.77	48.84	-24.34	NaN	73.54	95.02	48.38
CGS001-150280	KD	HORMAD2	HORMA domain containing 2			20.00, 20.00	0.97, 0.30	99.87	100.00	84.91	-97.47	24.09	38.97	22.28	13.09	-98.77	31.62
CGS001-3198	KD	HOXA1	Homeoboxes / ANTP class : HOXL subclass, homeobox A1		HOXL subclass homeoboxes LOF	10.00, 0.00	1.31, 0.42	-99.98	-59.57	-33.03	-25.00	96.18	-37.44	-90.99	-71.78	-98.57	-85.38
CGS001-3206	KD	HOXA10	Homeoboxes / ANTP class : HOXL subclass, homeobox A10			10.00, 10.00	0.95, 0.25	99.04	88.51	73.12	-34.05	73.05	-29.73	73.81	-84.43	-54.80	89.60
CGS001-3199	KD	HOXA2	Homeoboxes / ANTP class : HOXL subclass, homeobox A2			37.50, 25.00	1.26, 0.38	98.37	-95.95	93.80	95.78	-31.49	NaN	NaN	55.89	91.98	98.16
CGS001-3202	KD	HOXA5	Homeoboxes / ANTP class : HOXL subclass, homeobox A5			0.00, 0.00	0.82, 0.11	71.49	51.79	52.36	32.29	21.57	-20.76	89.55	48.35	23.09	39.18
CGS001-3203	KD	HOXA6	Homeoboxes / ANTP class : HOXL subclass, homeobox A6			33.33, 22.22	1.48, 0.35	93.60	-99.76	99.98	98.49	-34.93	NaN	30.16	87.54	27.37	96.67
CGS001-3205	KD	HOXA9	Homeoboxes / ANTP class : HOXL subclass, homeobox A9			37.50, 25.00	1.07, 0.35	99.76	NaN	99.42	-32.92	89.22	NaN	47.16	32.32	-32.29	97.34
CGS001-10481	KD	HOXB13	Homeoboxes / ANTP class : HOXL subclass, homeobox B13			25.00, 12.50	1.70, 0.45	99.75	-22.78	89.32	47.93	56.98	NaN	64.16	97.05	NaN	80.83
CGS001-3212	KD	HOXB2	Homeoboxes / ANTP class : HOXL subclass, homeobox B2			0.00, 0.00	1.76, 0.40	-60.28	25.69	45.93	-49.70	26.93	-50.43	-85.56	-49.33	-93.80	-41.00
CGS001-3214	KD	HOXB4	Homeoboxes / ANTP class : HOXL subclass, homeobox B4			0.00, 0.00	1.20, 0.39	-68.13	-97.76	-31.61	32.25	-32.78	-63.57	-33.59	36.30	23.55	-31.07
CGS001-3215	KD	HOXB5	Homeoboxes / ANTP class : HOXL subclass, homeobox B5		HOXL subclass homeoboxes LOF	0.00, 0.00	1.66, 0.56	-75.63	-100.00	-15.39	26.38	88.51	-29.67	-57.13	-51.78	-20.04	-34.77
CGS001-3217	KD	HOXB7	Homeoboxes / ANTP class : HOXL subclass, homeobox B7			10.00, 10.00	1.55, 0.47	-39.49	22.73	-61.06	-93.77	-59.10	-30.06	-82.34	-18.46	97.65	-32.80
CGS001-3226	KD	HOXC10	Homeoboxes / ANTP class : HOXL subclass, homeobox C10			0.00, 0.00	1.22, 0.34	-83.84	-74.75	-70.04	-99.86	-96.72	NaN	-46.78	-91.12	71.88	-96.86
CGS001-3221	KD	HOXC4	Homeoboxes / ANTP class : HOXL subclass, homeobox C4			10.00, 10.00	1.60, 0.44	19.36	36.84	-52.08	41.99	78.86	34.62	-77.21	99.89	79.13	38.53
CGS001-3225	KD	HOXC9	Homeoboxes / ANTP class : HOXL subclass, homeobox C9			33.33, 22.22	0.82, 0.25	96.89	-27.67	-90.30	64.83	91.40	NaN	99.95	-21.47	-36.15	97.56
CGS001-3242	KD	HPD	Oxidoreductases, 4-hydroxyphenylpyruvate dioxygenase			0.00, 0.00	1.14, 0.36	-20.82	-79.76	18.60	32.64	-41.08	21.85	16.46	-92.48	20.74	-6.99
CGS001-3248	KD	HPGD	Prostaglandin synthases, hydroxyprostaglandin dehydrogenase 15-(NAD)			22.22, 11.11	1.58, 0.40	21.52	98.83	-99.94	NaN	-50.98	96.02	-44.62	-70.23	62.85	36.81
CGS001-3249	KD	HPN	Serine peptidases / Transmembrane, hepsin			11.11, 0.00	1.59, 0.58	96.05	26.05	31.80	38.83	-42.50	54.25	17.90	-49.77	NaN	11.76
CGS001-3251	KD	HPRT1	hypoxanthine phosphoribosyltransferase 1			20.00, 10.00	0.92, 0.33	93.97	98.47	16.51	71.25	88.86	96.21	21.09	-45.88	-83.40	93.54
CGS001-3265	KD	HRAS	RAS subfamily, v-Ha-ras Harvey rat sarcoma viral oncogene homolog			0.00, 0.00	0.56, 0.16	-30.41	-20.68	-23.61	-22.41	-20.93	39.57	-69.29	-38.80	83.30	-8.87
CGS001-3269	KD	HRH1	Histamine receptors, histamine receptor H1			0.00, 0.00	1.45, 0.59	-22.15	-65.66	-26.06	-86.45	55.29	-46.13	35.29	-51.01	-22.04	-30.52
CGS001-10247	KD	HRSP12	heat-responsive protein 12			0.00, 0.00	1.34, 0.41	91.65	NaN	-30.60	NaN	-71.00	-37.50	-90.37	-90.03	33.45	-70.22
CGS001-9653	KD	HS2ST1	Sulfotransferases, membrane-bound, heparan sulfate 2-O-sulfotransferase 1			0.00, 0.00	1.27, 0.31	13.52	-99.96	-34.91	-55.70	21.87	-99.31	-34.48	52.58	-48.64	-24.76
CGS001-9955	KD	HS3ST3A1	Sulfotransferases, membrane-bound, heparan sulfate (glucosamine) 3-O-sulfotransferase 3A1			12.50, 0.00	1.57, 0.40	-94.19	NaN	47.48	92.65	86.14	NaN	-37.84	96.98	28.52	93.36
CGS001-3281	KD	HSBP1	heat shock factor binding protein 1			0.00, 0.00	1.84, 0.53	-37.78	-20.39	35.45	36.86	48.41	-86.63	-29.31	-69.54	NaN	-23.63
CGS001-3028	KD	HSD17B10	Short chain dehydrogenase/reductase superfamily / Classical SDR fold cluster 1, hydroxysteroid (17-beta) dehydrogenase 10			10.00, 0.00	1.76, 0.58	-46.92	57.73	82.12	77.87	62.01	48.83	-54.70	93.03	96.94	88.72
CGS001-51170	KD	HSD17B11	Short chain dehydrogenase/reductase superfamily / Classical SDR fold cluster 3, hydroxysteroid (17-beta) dehydrogenase 11			10.00, 10.00	1.59, 0.41	18.64	-30.09	-99.72	-97.46	99.10	-42.57	-98.89	-99.79	29.28	-99.82
CGS001-3294	KD	HSD17B2	Short chain dehydrogenase/reductase superfamily / Classical SDR fold cluster 2, hydroxysteroid (17-beta) dehydrogenase 2			44.44, 44.44	1.18, 0.28	91.51	26.41	47.22	99.16	98.48	99.47	-30.51	NaN	81.71	98.32
CGS001-3295	KD	HSD17B4	Short chain dehydrogenase/reductase superfamily / Classical SDR fold cluster 3, hydroxysteroid (17-beta) dehydrogenase 4			11.11, 11.11	1.32, 0.42	32.64	28.81	-49.19	-60.78	99.75	82.93	66.59	-21.11	NaN	53.58
CGS001-51478	KD	HSD17B7	Short chain dehydrogenase/reductase superfamily / Classical SDR fold cluster 2, hydroxysteroid (17-beta) dehydrogenase 7			22.22, 22.22	1.78, 0.60	-82.26	79.43	31.09	99.94	54.24	82.13	NaN	99.67	63.90	91.34
CGS001-7923	KD	HSD17B8	Short chain dehydrogenase/reductase superfamily / Classical SDR fold cluster 1, hydroxysteroid (17-beta) dehydrogenase 8			50.00, 50.00	1.81, 0.57	99.06	100.00	88.78	99.85	99.03	91.85	32.77	80.69	74.35	99.76
CGS001-3297	KD	HSF1	heat shock transcription factor 1			55.56, 33.33	1.98, 0.59	97.25	45.85	99.60	97.01	99.43	NaN	83.99	-34.54	-25.03	99.37
CGS001-3298	KD	HSF2	heat shock transcription factor 2			0.00, 0.00	1.23, 0.36	94.29	46.12	-57.74	32.99	-89.24	NaN	-18.65	33.57	-55.95	33.44
CGS001-124535	KD	HSF5	heat shock transcription factor family member 5			0.00, 0.00	1.69, 0.42	-90.22	48.12	62.08	-33.35	-88.89	-92.17	-99.46	NaN	NaN	-95.78
CGS001-3320	KD	HSP90AA1	Heat shock proteins / HSPC, heat shock protein 90kDa alpha (cytosolic), class A member 1			20.00, 10.00	0.97, 0.26	26.76	99.80	-21.49	95.98	-47.71	86.51	47.76	-90.69	-36.52	61.71
CGS001-3326	KD	HSP90AB1	Heat shock proteins / HSPC, heat shock protein 90kDa alpha (cytosolic), class B member 1			0.00, 0.00	1.07, 0.41	-75.46	NaN	-98.03	51.74	45.57	29.32	-24.52	43.91	-99.83	-44.68
CGS001-7184	KD	HSP90B1	Heat shock proteins / HSPC, heat shock protein 90kDa beta (Grp94), member 1			0.00, 0.00	0.95, 0.19	50.72	NaN	-95.44	-68.30	-98.05	NaN	-98.28	-24.73	42.13	-99.06
CGS001-51182	KD	HSPA14	Heat shock proteins / HSP70, heat shock 70kDa protein 14		Heat shock 70kDa proteins LOF	0.00, 0.00	1.82, 0.59	-96.18	NaN	-25.37	NaN	NaN	NaN	-97.92	14.52	85.45	-83.47
CGS001-3303	KD	HSPA1A	Heat shock proteins / HSP70, heat shock 70kDa protein 1A			0.00, 0.00	1.27, 0.40	-55.46	-45.16	-99.39	-99.95	-79.90	-29.87	47.12	-43.35	-99.16	-89.64
CGS001-3304	KD	HSPA1B	Heat shock proteins / HSP70, heat shock 70kDa protein 1B			55.56, 33.33	1.72, 0.47	98.95	42.67	99.35	96.81	69.70	-50.40	96.89	71.71	NaN	97.69
CGS001-3306	KD	HSPA2	Heat shock proteins / HSP70, heat shock 70kDa protein 2			44.44, 33.33	1.32, 0.43	97.62	38.22	90.10	81.73	67.37	95.77	27.31	98.50	NaN	97.66
CGS001-3308	KD	HSPA4	Heat shock proteins / HSP70, heat shock 70kDa protein 4			0.00, 0.00	0.68, 0.16	-22.64	23.30	71.37	-58.28	50.77	42.09	72.93	47.22	87.75	29.59
CGS001-3309	KD	HSPA5	Heat shock proteins / HSP70, heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)		Heat shock 70kDa proteins LOF	0.00, 0.00	3.57, 1.59	-67.61	NaN	-36.97	NaN	-94.64	NaN	-96.71	-90.38	67.41	-95.32
CGS001-3312	KD	HSPA8	Heat shock proteins / HSP70, heat shock 70kDa protein 8			0.00, 0.00	1.15, 0.32	-79.01	NaN	-19.90	NaN	-99.24	NaN	-94.82	-71.39	-39.99	-87.01
CGS001-3313	KD	HSPA9	Heat shock proteins / HSP70, heat shock 70kDa protein 9 (mortalin)		Heat shock 70kDa proteins LOF	0.00, 0.00	1.77, 0.50	-94.78	NaN	-58.51	NaN	23.81	NaN	-56.56	14.40	-96.38	-67.64
CGS001-3315	KD	HSPB1	Heat shock proteins / HSPB, heat shock 27kDa protein 1			12.50, 0.00	1.35, 0.45	80.34	NaN	97.37	-26.80	93.33	NaN	-77.04	77.86	34.48	75.21
CGS001-26353	KD	HSPB8	Heat shock proteins / HSPB, heat shock 22kDa protein 8			11.11, 11.11	0.86, 0.28	-85.23	-99.06	-99.92	NaN	-95.32	-74.90	-99.84	99.88	-30.81	-99.84
CGS001-3329	KD	HSPD1	Heat Shock Proteins / Chaperonins, heat shock 60kDa protein 1 (chaperonin)			0.00, 0.00	1.28, 0.40	-98.70	NaN	-28.45	NaN	46.26	NaN	-99.60	-98.47	-29.51	-99.24
CGS001-3336	KD	HSPE1	Heat Shock Proteins / Chaperonins, heat shock 10kDa protein 1 (chaperonin 10)			0.00, 0.00	1.60, 0.38	-91.45	50.78	-95.91	-59.44	-77.26	21.42	14.67	-83.55	-44.63	-89.92
CGS001-3339	KD	HSPG2	Immunoglobulin superfamily / Immunoglobulin-like domain containing, heparan sulfate proteoglycan 2			0.00, 0.00	1.47, 0.63	27.27	-34.22	-90.55	33.92	-42.31	NaN	24.48	-98.40	-99.85	-76.55
CGS001-10553	KD	HTATIP2	Short chain dehydrogenase/reductase superfamily / Atypical members, HIV-1 Tat interactive protein 2, 30kDa			44.44, 22.22	1.39, 0.35	99.63	97.53	-24.81	41.94	-55.00	NaN	71.15	97.12	-66.34	96.25
CGS001-27336	KD	HTATSF1	RNA binding motif (RRM) containing, HIV-1 Tat specific factor 1			11.11, 0.00	2.01, 0.69	-55.68	55.48	60.72	95.66	-21.46	NaN	36.55	77.08	45.06	60.52
CGS001-5654	KD	HTRA1	Serine peptidases / Serine peptidases, HtrA serine peptidase 1			0.00, 0.00	1.63, 0.50	-69.68	-86.23	-91.15	-99.36	-53.31	NaN	-44.77	20.04	-62.59	-91.02
CGS001-3364	KD	HUS1	HUS1 checkpoint homolog (S. pombe)			0.00, 0.00	1.33, 0.38	-93.89	NaN	-18.32	-29.33	-24.38	NaN	-38.01	-44.24	-24.92	-9.87
CGS001-3373	KD	HYAL1	hyaluronoglucosaminidase 1			0.00, 0.00	1.30, 0.33	-29.15	71.85	-83.50	34.20	-93.58	NaN	40.92	-30.41	79.97	-11.57
CGS001-8692	KD	HYAL2	hyaluronoglucosaminidase 2			0.00, 0.00	1.08, 0.34	-33.15	-96.29	-28.58	27.12	-35.03	-98.56	38.24	-88.49	-24.25	-51.93
CGS001-3376	KD	IARS	Aminoacyl tRNA synthetases / Class I, isoleucyl-tRNA synthetase			11.11, 11.11	1.15, 0.19	34.83	99.96	29.69	45.19	-38.13	NaN	33.80	38.97	8.43	19.14
CGS001-55699	KD	IARS2	Aminoacyl tRNA synthetases / Class I, isoleucyl-tRNA synthetase 2, mitochondrial			0.00, 0.00	1.22, 0.28	-64.17	-99.47	-44.38	-41.72	-33.92	NaN	-99.05	77.76	-23.47	-37.61
CGS001-3383	KD	ICAM1	CD molecules, intercellular adhesion molecule 1			10.00, 10.00	1.49, 0.41	-25.28	-19.97	-18.53	23.93	29.83	-44.88	-13.41	-65.71	99.21	-4.84
CGS001-3385	KD	ICAM3	CD molecules, intercellular adhesion molecule 3			28.57, 0.00	1.49, 0.40	NaN	NaN	21.00	95.40	84.44	NaN	93.99	56.06	87.48	96.43
CGS001-23463	KD	ICMT	isoprenylcysteine carboxyl methyltransferase			11.11, 11.11	1.30, 0.51	51.73	28.20	35.13	-36.66	-52.45	98.17	NaN	53.62	-91.39	33.44
CGS001-3398	KD	ID2	Basic helix-loop-helix proteins, inhibitor of DNA binding 2, dominant negative helix-loop-helix protein			0.00, 0.00	1.38, 0.38	-38.12	-40.32	-64.14	-99.98	29.42	-99.97	-91.79	-18.83	52.63	-84.72
CGS001-3399	KD	ID3	Basic helix-loop-helix proteins, inhibitor of DNA binding 3, dominant negative helix-loop-helix protein			10.00, 10.00	1.40, 0.42	99.06	23.62	63.86	52.35	92.59	19.13	32.64	90.22	-21.89	68.61
CGS001-3400	KD	ID4	Basic helix-loop-helix proteins, inhibitor of DNA binding 4, dominant negative helix-loop-helix protein			0.00, 0.00	1.03, 0.18	56.73	72.42	-14.83	-18.79	18.72	38.76	-32.93	-16.31	-68.41	-1.74
CGS001-3416	KD	IDE	Pitrilysin, insulin-degrading enzyme			0.00, 0.00	0.70, 0.11	-64.69	-25.40	-21.77	-28.99	21.46	49.16	-24.25	32.01	-89.83	-7.81
CGS001-3417	KD	IDH1	isocitrate dehydrogenase 1 (NADP+), soluble			0.00, 0.00	1.32, 0.35	-97.66	NaN	-32.03	NaN	33.09	NaN	-29.96	-97.95	-20.47	-71.19
CGS001-3418	KD	IDH2	isocitrate dehydrogenase 2 (NADP+), mitochondrial			0.00, 0.00	1.05, 0.36	-35.42	NaN	33.97	NaN	-86.69	39.06	48.95	-96.17	81.00	20.65
CGS001-3419	KD	IDH3A	isocitrate dehydrogenase 3 (NAD+) alpha			0.00, 0.00	1.88, 0.53	61.52	-22.51	-86.46	-33.01	-99.52	NaN	-25.44	31.43	45.85	-8.71
CGS001-3420	KD	IDH3B	isocitrate dehydrogenase 3 (NAD+) beta			0.00, 0.00	1.36, 0.45	-87.45	-72.14	39.47	-38.56	-95.74	48.45	-73.85	-84.14	-96.00	-91.83
CGS001-3421	KD	IDH3G	isocitrate dehydrogenase 3 (NAD+) gamma			40.00, 30.00	1.40, 0.42	99.96	-24.97	99.74	-26.63	95.17	44.81	92.76	-65.45	-46.00	98.19
CGS001-8870	KD	IER3	immediate early response 3			22.22, 11.11	1.32, 0.44	NaN	33.15	99.53	96.89	77.87	25.21	-32.85	84.26	-53.42	88.72
CGS001-3428	KD	IFI16	interferon, gamma-inducible protein 16			0.00, 0.00	0.97, 0.36	-32.54	27.51	24.02	61.87	-29.78	NaN	34.86	-35.98	37.08	16.93
CGS001-10437	KD	IFI30	interferon, gamma-inducible protein 30			11.11, 11.11	1.47, 0.45	59.71	22.60	99.23	34.43	51.90	NaN	-16.32	-25.47	33.77	29.81
CGS001-64135	KD	IFIH1	interferon induced with helicase C domain 1			0.00, 0.00	1.03, 0.28	78.82	NaN	-20.82	46.58	-50.16	-29.01	-68.96	91.77	-73.80	-28.27
CGS001-24138	KD	IFIT5	Tetratricopeptide (TTC) repeat domain containing, interferon-induced protein with tetratricopeptide repeats 5			14.29, 14.29	2.18, 0.70	-38.14	NaN	99.63	-68.67	-57.46	NaN	NaN	-59.33	-24.84	-57.89
CGS001-3455	KD	IFNAR2	Interferon receptor family, interferon (alpha, beta and omega) receptor 2			0.00, 0.00	1.42, 0.40	74.09	22.78	-30.80	53.76	-54.21	NaN	53.09	57.67	NaN	42.99
CGS001-3456	KD	IFNB1	Interferons, interferon, beta 1, fibroblast			40.00, 40.00	1.82, 0.74	99.15	-69.74	-29.50	84.67	99.82	-32.27	99.21	87.35	-54.57	97.56
CGS001-3458	KD	IFNG	Interferons, interferon, gamma			11.11, 0.00	1.50, 0.43	-71.46	-20.13	97.09	-87.06	-32.38	NaN	-28.58	17.46	42.80	-12.89
CGS001-3459	KD	IFNGR1	Interferon receptor family, interferon gamma receptor 1			0.00, 0.00	1.16, 0.27	-22.07	46.94	-65.08	33.55	-30.48	NaN	-35.58	70.84	35.95	13.50
CGS001-3460	KD	IFNGR2	Interferon receptor family, interferon gamma receptor 2 (interferon gamma transducer 1)			40.00, 40.00	1.88, 0.57	-24.58	-93.84	31.22	98.16	99.98	-22.04	98.83	90.62	55.62	97.66
CGS001-7866	KD	IFRD2	interferon-related developmental regulator 2			37.50, 37.50	1.07, 0.33	-11.32	NaN	93.23	99.96	-88.01	NaN	-71.69	85.57	99.44	99.45
CGS001-3476	KD	IGBP1	immunoglobulin (CD79A) binding protein 1			0.00, 0.00	0.91, 0.28	-22.20	-92.27	-61.28	-89.43	-94.04	-94.39	-73.21	-82.87	NaN	-88.94
CGS001-3481	KD	IGF2	insulin-like growth factor 2 (somatomedin A)			0.00, 0.00	1.41, 0.53	-23.58	-62.62	19.36	-66.54	-89.67	-93.25	-15.70	NaN	NaN	-39.86
CGS001-10642	KD	IGF2BP1	RNA binding motif (RRM) containing, insulin-like growth factor 2 mRNA binding protein 1			0.00, 0.00	1.36, 0.38	-65.76	25.75	-31.02	-24.92	35.40	-99.97	NaN	-26.01	-47.94	-9.05
CGS001-10644	KD	IGF2BP2	RNA binding motif (RRM) containing, insulin-like growth factor 2 mRNA binding protein 2			0.00, 0.00	1.24, 0.39	-30.03	21.31	16.02	-77.79	-60.35	46.53	NaN	NaN	85.90	-31.42
CGS001-10643	KD	IGF2BP3	RNA binding motif (RRM) containing, insulin-like growth factor 2 mRNA binding protein 3			11.11, 0.00	1.59, 0.59	-92.02	95.41	-97.70	-78.50	47.12	-60.26	NaN	63.34	55.27	-69.11
CGS001-3482	KD	IGF2R	CD molecules, insulin-like growth factor 2 receptor			0.00, 0.00	1.33, 0.45	-76.16	-95.61	-98.85	-99.98	-28.99	88.20	-42.36	-99.93	-80.52	-99.53
CGS001-3485	KD	IGFBP2	insulin-like growth factor (IGF) binding proteins, insulin-like growth factor binding protein 2, 36kDa			0.00, 0.00	1.72, 0.42	82.18	-81.77	-99.09	-61.83	-21.91	NaN	-99.72	-94.52	-24.48	-91.42
CGS001-3486	KD	IGFBP3	insulin-like growth factor (IGF) binding proteins, insulin-like growth factor binding protein 3			14.29, 14.29	2.44, 0.83	24.81	56.04	-34.06	99.50	-34.21	NaN	-27.50	NaN	NaN	23.67
CGS001-3487	KD	IGFBP4	insulin-like growth factor (IGF) binding proteins, insulin-like growth factor binding protein 4			28.57, 14.29	1.80, 0.65	-97.20	NaN	96.68	NaN	99.98	NaN	60.73	69.87	-95.06	94.03
CGS001-3488	KD	IGFBP5	insulin-like growth factor (IGF) binding proteins, insulin-like growth factor binding protein 5			0.00, 0.00	1.28, 0.33	-96.65	-54.94	75.51	-80.66	92.61	NaN	NaN	-26.22	75.61	40.54
CGS001-3489	KD	IGFBP6	insulin-like growth factor (IGF) binding proteins, insulin-like growth factor binding protein 6			40.00, 30.00	1.89, 0.50	97.48	-22.42	99.94	97.85	-24.77	63.26	85.96	85.57	77.28	99.50
CGS001-3490	KD	IGFBP7	insulin-like growth factor (IGF) binding proteins, insulin-like growth factor binding protein 7			20.00, 10.00	1.83, 0.65	62.73	78.08	99.58	94.74	58.14	56.50	-17.71	90.36	97.16	92.71
CGS001-3508	KD	IGHMBP2	Zinc fingers, AN1-type domain containing, immunoglobulin mu binding protein 2			33.33, 22.22	1.47, 0.47	-62.91	NaN	87.77	94.41	-99.45	23.69	-84.02	99.21	97.67	95.79
CGS001-93185	KD	IGSF8	CD molecules, immunoglobulin superfamily, member 8			60.00, 20.00	1.24, 0.40	96.39	20.26	98.35	29.42	97.43	97.55	72.17	30.92	97.26	97.49
CGS001-8518	KD	IKBKAP	Elongator acetyltransferase complex subunits, inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase complex-associated protein			10.00, 10.00	1.24, 0.36	-69.13	26.31	-99.92	-99.80	99.98	-37.56	-99.56	-67.67	-31.22	-97.50
CGS001-9641	KD	IKBKE	IKK family, inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon			10.00, 0.00	1.01, 0.19	95.11	-99.91	-21.85	-90.26	85.15	-99.72	-25.08	-40.35	-58.07	-76.83
CGS001-8517	KD	IKBKG	Zinc fingers, C2HC-type containing, inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma			0.00, 0.00	1.01, 0.31	-30.32	90.75	-98.28	84.81	-96.83	-36.31	-40.76	-36.30	-65.36	-38.90
CGS001-10320	KD	IKZF1	IKAROS zinc fingers, IKAROS family zinc finger 1 (Ikaros)			0.00, 0.00	0.90, 0.22	91.89	57.26	85.25	-75.01	53.64	-31.74	-67.75	-54.42	-46.35	46.20
CGS001-64376	KD	IKZF5	IKAROS zinc fingers, IKAROS family zinc finger 5 (Pegasus)			0.00, 0.00	1.64, 0.61	-39.22	-99.96	-82.54	NaN	-43.21	NaN	-28.02	-77.35	-99.65	-86.85
CGS001-3586	KD	IL10	Interleukins and interleukin receptors, interleukin 10			11.11, 11.11	1.66, 0.50	29.67	34.90	-67.69	46.62	65.36	NaN	99.98	77.30	29.11	58.51
CGS001-3588	KD	IL10RB	IL-10 receptor family, interleukin 10 receptor, beta			0.00, 0.00	1.49, 0.42	43.16	NaN	-24.60	NaN	91.14	NaN	-68.52	93.03	28.99	50.81
CGS001-3589	KD	IL11	Endogenous ligands, interleukin 11			44.44, 22.22	0.94, 0.19	97.42	64.98	29.88	32.51	97.56	NaN	98.45	-64.03	-23.34	97.48
CGS001-3590	KD	IL11RA	IL-6 receptor family, interleukin 11 receptor, alpha		Interleukin receptors LOF	0.00, 0.00	1.25, 0.38	-92.19	-19.10	-93.55	-44.61	-26.03	29.26	-99.79	94.13	92.43	-60.99
CGS001-3592	KD	IL12A	Interleukins and interleukin receptors, interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35)			11.11, 11.11	0.99, 0.35	66.82	99.50	-91.96	NaN	65.27	31.89	-22.44	-37.30	54.81	26.10
CGS001-3593	KD	IL12B	Interleukins and interleukin receptors, interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40)			66.67, 55.56	1.09, 0.31	99.96	100.00	-68.30	34.27	96.55	NaN	99.59	28.14	99.22	99.79
CGS001-3596	KD	IL13	Interleukins and interleukin receptors, interleukin 13			11.11, 0.00	1.20, 0.42	30.99	47.66	-53.97	43.73	31.50	NaN	95.59	43.77	30.63	14.56
CGS001-3597	KD	IL13RA1	IL-2 receptor family, interleukin 13 receptor, alpha 1			50.00, 40.00	2.14, 0.53	22.97	89.92	95.80	99.90	93.90	99.75	26.75	99.93	52.37	99.87
CGS001-3598	KD	IL13RA2	IL-2 receptor family, interleukin 13 receptor, alpha 2			0.00, 0.00	1.15, 0.27	-29.98	-27.47	-59.33	-48.12	-37.89	47.56	60.52	-69.11	-91.88	-36.01
CGS001-3600	KD	IL15	Interleukins and interleukin receptors, interleukin 15			0.00, 0.00	1.17, 0.31	-15.74	76.21	34.96	62.34	-33.24	25.98	29.37	-54.86	NaN	9.08
CGS001-3601	KD	IL15RA	IL-2 receptor family, interleukin 15 receptor, alpha			11.11, 11.11	1.53, 0.57	-26.39	-23.08	66.27	52.22	99.34	NaN	41.71	33.03	19.84	36.21
CGS001-8807	KD	IL18RAP	CD molecules, interleukin 18 receptor accessory protein			10.00, 10.00	0.94, 0.22	-99.75	-91.11	-61.12	-98.71	98.38	-95.48	-83.91	-15.29	70.10	-89.49
CGS001-3553	KD	IL1B	Interleukins and interleukin receptors, interleukin 1, beta			0.00, 0.00	1.67, 0.57	-98.79	NaN	-99.81	-99.47	-62.30	NaN	-96.93	-22.53	80.91	-99.61
CGS001-3554	KD	IL1R1	Interleukins and interleukin receptors, interleukin 1 receptor, type I			20.00, 10.00	1.24, 0.31	-81.85	94.71	95.77	-34.99	-25.85	-36.72	99.92	-20.85	64.06	87.88
CGS001-7850	KD	IL1R2	Immunoglobulin-like family of IL-1 receptors, interleukin 1 receptor, type II			20.00, 20.00	1.42, 0.36	53.39	27.49	99.83	-29.87	-20.86	-21.17	74.40	79.31	98.41	78.74
CGS001-3556	KD	IL1RAP	Immunoglobulin superfamily / Immunoglobulin-like domain containing, interleukin 1 receptor accessory protein			60.00, 60.00	1.30, 0.30	99.03	100.00	-96.81	99.91	62.98	97.74	74.55	99.68	86.07	99.84
CGS001-3558	KD	IL2	Interleukins and interleukin receptors, interleukin 2			0.00, 0.00	0.70, 0.25	47.76	-32.04	-25.60	26.94	-23.88	-99.97	30.57	-86.05	-45.83	-19.23
CGS001-149233	KD	IL23R	IL-12 receptor family, interleukin 23 receptor			0.00, 0.00	1.48, 0.34	-99.93	37.40	-61.75	-64.36	-97.27	-51.54	-99.66	-99.98	-26.96	-99.63
CGS001-246778	KD	IL27	Interleukins and interleukin receptors, interleukin 27			0.00, 0.00	1.16, 0.38	-93.98	43.13	14.30	-41.07	-86.61	44.27	-94.98	-74.41	22.90	-61.62
CGS001-3559	KD	IL2RA	IL-2 receptor family, interleukin 2 receptor, alpha			0.00, 0.00	0.95, 0.36	-32.19	78.25	-96.26	28.08	87.54	NaN	22.18	-32.11	24.57	9.15
CGS001-3560	KD	IL2RB	IL-2 receptor family, interleukin 2 receptor, beta			0.00, 0.00	2.27, 0.82	-90.80	-73.20	33.57	26.52	-26.85	-99.88	-39.54	-45.66	NaN	-38.36
CGS001-3565	KD	IL4	Interleukins and interleukin receptors, interleukin 4		IL4 Pathway LOF	11.11, 0.00	1.11, 0.16	94.95	-53.34	-17.47	-33.65	96.45	NaN	-29.95	-50.67	-24.98	-6.19
CGS001-3566	KD	IL4R	IL-2 receptor family, interleukin 4 receptor		IL4 Pathway LOF, Interleukin receptors LOF	0.00, 0.00	0.88, 0.17	-75.85	-21.47	-15.27	-32.82	-28.87	-75.86	11.76	-15.26	19.22	-9.03
CGS001-3567	KD	IL5	Interleukins and interleukin receptors, interleukin 5 (colony-stimulating factor, eosinophil)			0.00, 0.00	1.44, 0.45	-97.60	-23.63	-58.44	-52.06	80.29	-99.45	NaN	-41.27	NaN	-59.71
CGS001-3569	KD	IL6	Interferons, interleukin 6 (interferon, beta 2)			0.00, 0.00	1.40, 0.36	94.54	22.75	21.13	89.24	25.07	-26.74	-29.28	-31.72	34.01	13.75
CGS001-3570	KD	IL6R	IL-6 receptor family, interleukin 6 receptor			0.00, 0.00	1.77, 0.57	19.82	NaN	-83.60	45.21	43.76	NaN	NaN	28.88	-51.13	22.35
CGS001-3572	KD	IL6ST	IL-6 receptor family, interleukin 6 signal transducer (gp130, oncostatin M receptor)		Interleukin receptors LOF	0.00, 0.00	1.09, 0.38	-44.45	-70.58	-62.69	-51.03	-99.98	-99.96	70.47	-28.72	46.90	-82.89
CGS001-3575	KD	IL7R	IL-2 receptor family, interleukin 7 receptor			10.00, 10.00	1.52, 0.55	23.59	40.77	65.94	99.67	21.52	-25.97	93.07	91.94	80.61	83.20
CGS001-3608	KD	ILF2	interleukin enhancer binding factor 2, 45kDa			0.00, 0.00	1.44, 0.43	-98.21	88.27	-94.30	-96.95	77.63	-61.58	-99.90	17.55	26.19	-97.30
CGS001-3609	KD	ILF3	interleukin enhancer binding factor 3, 90kDa			14.29, 0.00	1.19, 0.30	78.33	NaN	-23.19	NaN	32.62	NaN	95.75	-87.56	40.96	37.34
CGS001-3611	KD	ILK	Ankyrin repeat domain containing, integrin-linked kinase			10.00, 10.00	0.63, 0.15	-9.09	98.53	-74.43	27.91	-99.78	-27.96	-33.19	-67.53	20.15	-19.86
CGS001-3612	KD	IMPA1	Inositol monophosphatase, inositol(myo)-1(or 4)-monophosphatase 1			0.00, 0.00	1.24, 0.39	-99.94	NaN	9.53	NaN	-88.80	NaN	70.72	-99.94	-51.29	-99.07
CGS001-3613	KD	IMPA2	Inositol monophosphatase, inositol(myo)-1(or 4)-monophosphatase 2			0.00, 0.00	0.94, 0.24	-92.55	-37.00	-30.46	-46.88	27.93	-99.82	-60.85	-68.03	-99.74	-72.83
CGS001-3614	KD	IMPDH1	Oxidoreductases, IMP (inosine 5'-monophosphate) dehydrogenase 1			12.50, 12.50	1.32, 0.43	-12.27	-27.06	52.17	65.85	79.36	NaN	NaN	97.56	82.93	80.41
CGS001-3615	KD	IMPDH2	Oxidoreductases, IMP (inosine 5'-monophosphate) dehydrogenase 2			12.50, 0.00	1.65, 0.53	-18.11	NaN	-32.09	81.52	-98.63	NaN	-26.43	95.95	82.33	88.90
CGS001-3622	KD	ING2	Zinc fingers, PHD-type, inhibitor of growth family, member 2			0.00, 0.00	1.35, 0.48	-24.49	26.02	63.29	-37.32	-94.94	38.92	-80.35	-66.85	NaN	-63.26
CGS001-83729	KD	INHBE	inhibin, beta E			40.00, 30.00	1.80, 0.57	26.37	32.79	86.29	98.69	-62.63	-22.93	-84.23	99.87	99.06	96.05
CGS001-3628	KD	INPP1	Inositol polyphosphate phosphatases, inositol polyphosphate-1-phosphatase			10.00, 10.00	1.38, 0.35	-12.39	67.22	-27.39	98.77	-33.64	-99.97	-23.18	-38.11	47.89	-7.68
CGS001-8821	KD	INPP4B	Inositol polyphosphate phosphatases, inositol polyphosphate-4-phosphatase, type II, 105kDa			10.00, 10.00	0.95, 0.24	43.69	27.30	19.35	25.81	-91.73	27.79	86.27	85.08	99.68	33.37
CGS001-3635	KD	INPP5D	Inositol polyphosphate phosphatases, inositol polyphosphate-5-phosphatase, 145kDa			0.00, 0.00	1.43, 0.40	-91.36	-59.62	-29.13	33.10	-40.58	-45.37	-99.93	-20.70	-99.13	-81.62
CGS001-3636	KD	INPPL1	Inositol polyphosphate phosphatases, inositol polyphosphate phosphatase-like 1			0.00, 0.00	1.52, 0.58	-35.94	NaN	12.83	NaN	93.64	-69.61	94.89	-27.74	-61.84	12.61
CGS001-3630	KD	INS	insulin			0.00, 0.00	2.24, 0.67	NaN	NaN	37.20	-67.75	NaN	-28.56	NaN	89.53	-39.87	-24.89
CGS001-3638	KD	INSIG1	insulin induced gene 1			20.00, 10.00	1.47, 0.65	77.89	98.38	-99.20	-93.64	58.77	-72.49	-46.59	-23.50	97.37	57.19
CGS001-65123	KD	INTS3	integrator complex subunit 3			50.00, 50.00	1.01, 0.26	-26.44	69.75	99.98	99.88	99.91	-22.99	94.54	94.28	99.97	99.95
CGS001-9807	KD	IP6K1	inositol hexakisphosphate kinase 1			10.00, 10.00	1.13, 0.31	31.65	-99.96	78.73	53.35	-21.28	82.21	-18.23	24.37	99.93	45.18
CGS001-51447	KD	IP6K2	inositol hexakisphosphate kinase 2			10.00, 0.00	1.41, 0.40	96.76	-63.50	-28.19	66.97	-35.29	-23.60	60.69	-55.95	26.75	24.69
CGS001-253430	KD	IPMK	inositol polyphosphate multikinase			0.00, 0.00	1.53, 0.48	-88.18	94.81	82.96	-46.45	76.08	-97.75	-30.15	-26.90	21.88	29.91
CGS001-9670	KD	IPO13	Importins, importin 13			0.00, 0.00	1.26, 0.47	NaN	78.23	-98.19	-95.85	-98.16	-35.68	NaN	-96.13	-21.78	-97.51
CGS001-79711	KD	IPO4	Importins, importin 4			0.00, 0.00	1.63, 0.53	-98.94	-26.51	-98.44	-75.59	-33.76	NaN	-21.20	-97.72	-97.37	-99.47
CGS001-8826	KD	IQGAP1	IQ motif containing GTPase activating protein 1			0.00, 0.00	1.01, 0.23	-71.44	-100.00	-75.33	-95.62	-42.12	-97.28	-99.98	-28.21	17.63	-96.01
CGS001-3654	KD	IRAK1	Interleukin-1 receptor-associated kinase (IRAK) family, interleukin-1 receptor-associated kinase 1			0.00, 0.00	1.45, 0.41	-45.00	85.25	-32.78	NaN	-71.31	NaN	50.88	-22.95	83.41	49.82
CGS001-3656	KD	IRAK2	Interleukin-1 receptor-associated kinase (IRAK) family, interleukin-1 receptor-associated kinase 2			10.00, 10.00	1.10, 0.42	-97.42	-70.96	-98.79	-98.51	99.52	-74.90	-75.80	-99.21	-97.11	-99.21
CGS001-51135	KD	IRAK4	Interleukin-1 receptor-associated kinase (IRAK) family, interleukin-1 receptor-associated kinase 4			0.00, 0.00	1.35, 0.35	29.79	-27.05	-95.45	-44.97	-97.82	NaN	-99.88	-25.65	50.70	-94.89
CGS001-3659	KD	IRF1	interferon regulatory factor 1			22.22, 22.22	1.85, 0.60	16.84	40.66	99.94	-28.96	76.42	97.52	NaN	-25.77	25.72	53.53
CGS001-3660	KD	IRF2	interferon regulatory factor 2			0.00, 0.00	0.99, 0.28	-27.39	32.18	-28.19	-35.04	-30.85	-48.37	23.75	-91.69	-48.77	-10.69
CGS001-3661	KD	IRF3	interferon regulatory factor 3			28.57, 14.29	1.02, 0.48	95.57	NaN	97.87	NaN	90.03	NaN	-67.75	74.10	39.29	89.30
CGS001-3663	KD	IRF5	interferon regulatory factor 5			40.00, 40.00	1.35, 0.31	99.97	-22.05	-33.20	-69.80	99.98	94.10	44.08	92.26	98.96	99.61
CGS001-3664	KD	IRF6	interferon regulatory factor 6			10.00, 10.00	1.40, 0.44	85.60	64.64	-38.13	81.98	98.88	-32.42	60.28	-21.16	38.87	84.78
CGS001-3665	KD	IRF7	interferon regulatory factor 7			44.44, 44.44	1.57, 0.48	94.70	79.96	99.85	83.32	94.68	NaN	99.87	99.38	80.14	99.89
CGS001-10379	KD	IRF9	interferon regulatory factor 9			0.00, 0.00	1.72, 0.48	-99.65	NaN	-47.60	-94.85	-84.97	NaN	26.56	-97.71	-15.68	-95.01
CGS001-345611	KD	IRGM	immunity-related GTPase family, M			10.00, 10.00	1.14, 0.39	-41.27	53.03	-28.77	-48.75	37.10	-92.72	-24.97	-33.57	99.86	-18.73
CGS001-3667	KD	IRS1	Pleckstrin homology (PH) domain containing, insulin receptor substrate 1			0.00, 0.00	1.25, 0.33	-79.27	-26.02	15.07	-28.06	-24.25	-22.31	27.31	-82.00	-30.07	-1.50
CGS001-8660	KD	IRS2	Pleckstrin homology (PH) domain containing, insulin receptor substrate 2			42.86, 42.86	1.69, 0.61	36.46	NaN	88.70	99.86	99.92	NaN	NaN	-83.27	32.43	99.47
CGS001-3669	KD	ISG20	interferon stimulated exonuclease gene 20kDa			0.00, 0.00	1.68, 0.45	-98.09	25.29	-19.80	NaN	-66.89	-37.89	-95.26	-38.63	73.43	-57.80
CGS001-3670	KD	ISL1	Homeoboxes / LIM class, ISL LIM homeobox 1			11.11, 0.00	2.21, 0.65	-99.93	95.31	-29.18	-34.29	-45.46	NaN	-96.50	-90.89	-57.21	-75.02
CGS001-51015	KD	ISOC1	isochorismatase domain containing 1			0.00, 0.00	1.55, 0.49	NaN	NaN	-98.37	-60.01	-96.61	-99.62	NaN	66.06	-41.47	-98.93
CGS001-91464	KD	ISX	Homeoboxes / PRD class, intestine-specific homeobox			0.00, 0.00	1.58, 0.47	-41.07	-92.18	80.20	-91.78	92.00	26.08	-98.80	18.87	NaN	-63.69
CGS001-83737	KD	ITCH	itchy E3 ubiquitin protein ligase homolog (mouse)			11.11, 11.11	1.16, 0.35	16.65	41.82	-95.63	-32.29	-92.82	NaN	-57.68	-44.58	99.96	-42.67
CGS001-81533	KD	ITFG1	integrin alpha FG-GAP repeat containing 1			0.00, 0.00	1.53, 0.36	NaN	-93.58	22.92	NaN	35.71	26.26	93.63	92.93	31.68	34.10
CGS001-3672	KD	ITGA1	Integrins, integrin, alpha 1			22.22, 11.11	1.68, 0.51	-40.30	94.93	96.96	76.41	NaN	33.18	-21.23	98.52	-23.17	92.75
CGS001-3673	KD	ITGA2	Integrins, integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)		Integrin subunits alpha LOF	0.00, 0.00	2.09, 0.68	-35.47	-24.00	-88.61	-27.66	-53.08	NaN	-28.73	19.08	-23.24	-17.56
CGS001-3675	KD	ITGA3	Integrins, integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor)		Integrin subunits alpha LOF	0.00, 0.00	1.61, 0.68	-81.21	52.06	-25.88	-91.84	-57.59	NaN	20.96	53.09	NaN	-54.32
CGS001-3676	KD	ITGA4	Integrins, integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor)			0.00, 0.00	1.40, 0.31	64.74	-40.68	-27.52	34.07	24.11	-29.77	-21.39	-25.86	80.95	6.53
CGS001-3682	KD	ITGAE	Integrins, integrin, alpha E (antigen CD103, human mucosal lymphocyte antigen 1; alpha polypeptide)			20.00, 20.00	1.78, 0.50	-13.66	100.00	-85.95	86.05	-37.47	29.82	49.86	99.44	-99.16	77.89
CGS001-3685	KD	ITGAV	Integrins, integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51)		Integrin subunits alpha LOF	10.00, 10.00	2.01, 0.67	-24.55	40.13	-37.04	25.87	31.34	-97.35	-61.03	29.09	99.89	-9.13
CGS001-3688	KD	ITGB1	Integrins, integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)		Integrin subunits beta LOF	0.00, 0.00	2.27, 0.51	-90.75	NaN	48.31	NaN	24.89	NaN	-55.22	48.94	-32.18	-30.79
CGS001-9270	KD	ITGB1BP1	integrin beta 1 binding protein 1			22.22, 22.22	1.53, 0.43	97.99	NaN	-25.46	99.95	-48.86	62.12	-27.68	-28.15	-46.22	10.79
CGS001-3689	KD	ITGB2	Integrins, integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)			25.00, 12.50	1.67, 0.50	-75.83	22.08	99.75	89.83	NaN	91.95	-79.96	95.59	NaN	94.50
CGS001-3690	KD	ITGB3	Integrins, integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)			11.11, 11.11	1.34, 0.40	94.02	-32.51	18.91	-38.06	NaN	97.98	46.31	-34.55	-24.85	13.93
CGS001-3691	KD	ITGB4	Integrins, integrin, beta 4		Integrin subunits beta LOF	71.43, 28.57	1.70, 0.70	95.00	NaN	97.14	NaN	48.22	NaN	97.52	99.08	34.88	96.44
CGS001-3693	KD	ITGB5	Integrins, integrin, beta 5		Integrin subunits beta LOF	44.44, 44.44	1.56, 0.52	-32.75	-40.99	99.89	98.55	51.76	NaN	91.93	98.61	85.57	99.30
CGS001-3705	KD	ITPK1	inositol-tetrakisphosphate 1-kinase			22.22, 11.11	2.25, 0.63	98.49	-27.71	89.77	88.12	95.40	NaN	24.71	46.53	36.80	89.85
CGS001-3706	KD	ITPKA	Inositol 1,4,5-trisphosphate 3-kinases, inositol-trisphosphate 3-kinase A		PI3K Signaling LOF	0.00, 0.00	2.31, 0.63	-64.91	-50.05	43.66	76.95	-47.13	47.40	-48.26	49.26	-79.25	-42.02
CGS001-3708	KD	ITPR1	Ion channels / Inositol triphosphate receptors, inositol 1,4,5-trisphosphate receptor, type 1			11.11, 0.00	1.26, 0.31	97.03	-43.51	-25.15	-32.15	27.05	NaN	-31.62	-20.02	28.20	-7.62
CGS001-3709	KD	ITPR2	Ion channels / Inositol triphosphate receptors, inositol 1,4,5-trisphosphate receptor, type 2			0.00, 0.00	1.43, 0.40	-94.11	85.49	-35.49	-20.95	-36.91	-19.66	21.25	23.16	31.65	-6.42
CGS001-3710	KD	ITPR3	Ion channels / Inositol triphosphate receptors, inositol 1,4,5-trisphosphate receptor, type 3			0.00, 0.00	1.88, 0.64	-27.07	-31.51	-41.50	66.74	NaN	-58.36	28.99	-43.08	NaN	-13.14
CGS001-6453	KD	ITSN1	Rho guanine nucleotide exchange factors, intersectin 1 (SH3 domain protein)			66.67, 50.00	1.18, 0.47	96.57	NaN	99.08	NaN	NaN	NaN	98.94	88.84	90.00	98.63
CGS001-182	KD	JAG1	CD molecules, jagged 1			0.00, 0.00	1.36, 0.43	-81.01	-99.52	-24.17	-22.34	-96.71	20.17	-94.11	-28.41	-81.20	-87.46
CGS001-3716	KD	JAK1	Janus kinase (JakA) family, Janus kinase 1		IL4 Pathway LOF	0.00, 0.00	0.66, 0.27	-42.49	-93.52	-33.06	-53.55	44.72	-26.04	-98.70	-92.72	-21.24	-31.07
CGS001-3717	KD	JAK2	Janus kinase (JakA) family, Janus kinase 2			11.11, 0.00	1.52, 0.42	-42.17	84.81	-86.53	73.71	50.55	NaN	-40.57	95.33	-99.36	87.07
CGS001-3718	KD	JAK3	Janus kinase (JakA) family, Janus kinase 3			0.00, 0.00	1.22, 0.36	-99.60	-100.00	-97.96	8.02	-98.56	NaN	88.19	86.58	-65.58	-99.71
CGS001-221895	KD	JAZF1	Zinc fingers, C2H2-type, JAZF zinc finger 1			0.00, 0.00	1.68, 0.44	-93.11	-100.00	-99.65	-69.41	35.86	NaN	-95.92	-94.42	78.67	-99.20
CGS001-23210	KD	JMJD6	jumonji domain containing 6			10.00, 10.00	1.42, 0.36	-31.38	94.23	22.60	-99.90	75.52	-30.46	-69.22	-95.80	99.24	-41.45
CGS001-8681	KD	JMJD7-PLA2G4B	JMJD7-PLA2G4B readthrough			0.00, 0.00	1.16, 0.25	-45.56	-92.45	-61.81	-62.48	-28.50	29.75	-16.88	NaN	-99.97	-66.06
CGS001-9929	KD	JOSD1	Josephin domain containing 1			0.00, 0.00	1.36, 0.40	82.20	19.86	-90.85	35.32	44.99	NaN	25.18	-28.85	31.15	17.71
CGS001-3725	KD	JUN	basic leucine zipper proteins, jun proto-oncogene			0.00, 0.00	0.85, 0.33	-25.04	-32.06	-99.98	-99.91	-23.48	-98.84	-16.53	-99.49	-85.79	-99.53
CGS001-3726	KD	JUNB	basic leucine zipper proteins, jun B proto-oncogene			20.00, 20.00	1.85, 0.56	30.58	100.00	98.88	40.30	-99.63	93.11	35.05	43.18	35.68	81.16
CGS001-3735	KD	KARS	Aminoacyl tRNA synthetases / Class II, lysyl-tRNA synthetase		Aminoacyl tRNA synthetases class II LOF	20.00, 0.00	1.56, 0.34	-21.01	96.23	-99.16	-56.89	22.78	46.83	96.82	44.73	67.99	46.86
CGS001-8850	KD	KAT2B	Histone acetyltransferases (HATs), K(lysine) acetyltransferase 2B			0.00, 0.00	1.40, 0.35	-96.55	-99.65	32.18	-35.82	-99.98	NaN	-31.91	-50.79	-79.11	-98.61
CGS001-10524	KD	KAT5	Histone acetyltransferases (HATs), K(lysine) acetyltransferase 5			0.00, 0.00	1.41, 0.26	-80.95	50.06	16.93	25.41	-26.62	-23.82	-30.73	77.98	24.24	-4.71
CGS001-7994	KD	KAT6A	Histone acetyltransferases (HATs), K(lysine) acetyltransferase 6A		Lysine acetyltransferases LOF	0.00, 0.00	1.16, 0.28	-31.18	-99.91	-75.58	-75.93	23.51	-95.67	-28.81	-99.96	-99.97	-99.87
CGS001-23522	KD	KAT6B	Histone acetyltransferases (HATs), K(lysine) acetyltransferase 6B		Lysine acetyltransferases LOF	0.00, 0.00	1.03, 0.22	-97.82	-22.83	-92.22	-96.25	-23.47	-91.53	-20.80	-82.75	-85.18	-94.26
CGS001-11143	KD	KAT7	Histone acetyltransferases (HATs), K(lysine) acetyltransferase 7			0.00, 0.00	1.20, 0.33	-99.83	53.92	-97.29	-99.18	-88.99	-30.84	-36.23	-17.15	23.85	-95.92
CGS001-81621	KD	KAZALD1	Immunoglobulin superfamily / I-set domain containing, Kazal-type serine peptidase inhibitor domain 1			14.29, 14.29	1.97, 0.41	99.25	NaN	-98.20	-91.30	31.30	NaN	NaN	-60.44	-57.94	-87.49
CGS001-25948	KD	KBTBD2	BTB/POZ domain containing, kelch repeat and BTB (POZ) domain containing 2			57.14, 57.14	1.40, 0.57	NaN	68.90	99.66	99.02	99.94	NaN	NaN	78.82	93.73	99.87
CGS001-3755	KD	KCNG1	Voltage-gated potassium channels, potassium voltage-gated channel, subfamily G, member 1			44.44, 22.22	1.14, 0.32	-12.55	64.43	90.63	98.02	-22.10	NaN	96.62	-45.31	99.96	96.79
CGS001-3767	KD	KCNJ11	Inwardly rectifying potassium channels, potassium inwardly-rectifying channel, subfamily J, member 11			10.00, 0.00	1.67, 0.59	-26.93	57.80	27.95	-32.49	-26.78	97.40	-21.89	-50.19	-21.92	-5.82
CGS001-3775	KD	KCNK1	Two-P potassium channels, potassium channel, subfamily K, member 1			11.11, 0.00	1.68, 0.41	74.07	-98.84	18.27	-31.75	-27.22	NaN	-55.84	-48.28	97.08	-45.81
CGS001-3776	KD	KCNK2	Two-P potassium channels, potassium channel, subfamily K, member 2			11.11, 0.00	1.57, 0.39	-51.20	96.92	-13.89	24.79	-99.94	NaN	-19.76	-99.56	-44.40	-34.53
CGS001-3778	KD	KCNMA1	Calcium-activated potassium channels, potassium large conductance calcium-activated channel, subfamily M, alpha member 1			12.50, 12.50	1.60, 0.49	39.04	NaN	99.87	-70.44	-98.91	NaN	33.81	51.37	33.26	32.23
CGS001-3783	KD	KCNN4	Calcium-activated potassium channels, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4			55.56, 55.56	1.91, 0.63	99.95	28.44	99.98	94.88	-35.82	NaN	99.98	99.84	-34.92	99.95
CGS001-3784	KD	KCNQ1	Voltage-gated potassium channels, potassium voltage-gated channel, KQT-like subfamily, member 1			0.00, 0.00	1.15, 0.42	25.05	-99.87	-22.70	-25.17	-97.73	-50.68	18.47	-85.49	-76.31	-53.66
CGS001-23510	KD	KCTD2	potassium channel tetramerisation domain containing 2			0.00, 0.00	2.67, 0.85	-37.93	NaN	56.58	77.74	36.53	20.70	NaN	-93.35	-90.38	-34.78
CGS001-54442	KD	KCTD5	potassium channel tetramerisation domain containing 5			0.00, 0.00	1.23, 0.39	-87.95	41.26	64.02	-25.27	90.56	-53.69	NaN	58.84	21.48	39.85
CGS001-11014	KD	KDELR2	KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 2			20.00, 10.00	0.84, 0.27	-34.78	20.89	-98.92	97.02	-52.33	-99.97	-95.61	55.17	99.97	-83.87
CGS001-11015	KD	KDELR3	KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 3			0.00, 0.00	1.41, 0.35	93.94	-54.25	-91.02	-83.39	87.45	NaN	74.87	-45.11	31.02	32.40
CGS001-23028	KD	KDM1A	Histone demethylase, lysine (K)-specific demethylase 1A			50.00, 25.00	1.36, 0.59	12.28	95.90	45.84	NaN	99.46	36.18	96.96	-95.59	NaN	97.66
CGS001-55818	KD	KDM3A	Histone demethylases, lysine (K)-specific demethylase 3A			0.00, 0.00	1.27, 0.28	61.37	69.68	-73.07	-36.16	-53.92	NaN	32.81	-78.15	24.12	-42.02
CGS001-23030	KD	KDM4B	Histone demethylases, lysine (K)-specific demethylase 4B			20.00, 20.00	1.28, 0.52	99.94	45.73	99.82	58.03	-34.40	40.90	36.75	-29.15	-56.52	51.46
CGS001-23081	KD	KDM4C	Histone demethylases, lysine (K)-specific demethylase 4C			0.00, 0.00	1.25, 0.49	-86.99	NaN	33.19	-83.57	-85.42	-16.36	-28.92	-48.45	9.08	-60.51
CGS001-5927	KD	KDM5A	Histone demethylases, lysine (K)-specific demethylase 5A			0.00, 0.00	1.26, 0.41	-97.04	41.27	-99.86	-99.98	31.50	-99.78	-99.90	-90.56	24.82	-99.95
CGS001-10765	KD	KDM5B	Histone demethylases, lysine (K)-specific demethylase 5B			0.00, 0.00	1.13, 0.28	-77.13	35.36	76.91	59.40	-27.72	68.74	59.61	-62.95	94.80	72.01
CGS001-3791	KD	KDR	Type IV RTKs: VEGF (vascular endothelial growth factor) receptor family, kinase insert domain receptor (a type III receptor tyrosine kinase)			20.00, 10.00	0.82, 0.16	97.87	-96.76	-20.27	-21.68	96.12	-32.97	-99.04	-61.89	27.07	-20.97
CGS001-9817	KD	KEAP1	Kelch-like proteins, kelch-like ECH-associated protein 1			0.00, 0.00	2.01, 0.75	-48.61	-64.66	-25.88	84.18	35.45	53.43	-45.91	55.96	44.88	34.88
CGS001-10657	KD	KHDRBS1	KH domain containing, RNA binding, signal transduction associated 1			20.00, 10.00	1.34, 0.30	99.96	-28.42	97.01	-39.93	33.57	58.83	27.36	79.47	83.84	86.40
CGS001-9703	KD	KIAA0100	KIAA0100			0.00, 0.00	2.43, 0.82	NaN	-39.62	-28.31	-36.93	81.73	NaN	NaN	NaN	52.11	23.46
CGS001-9897	KD	KIAA0196	KIAA0196			0.00, 0.00	1.55, 0.36	-37.26	-95.69	-45.02	-62.36	36.70	NaN	NaN	-95.77	-99.03	-99.37
CGS001-9870	KD	KIAA0317	KIAA0317			40.00, 30.00	1.28, 0.42	85.44	91.60	96.91	83.98	99.98	89.66	99.55	9.82	21.85	99.13
CGS001-9710	KD	KIAA0355	KIAA0355			0.00, 0.00	1.33, 0.39	NaN	-33.78	-95.77	-83.80	28.72	-60.48	60.15	84.32	90.84	-43.00
CGS001-9813	KD	KIAA0494	KIAA0494			0.00, 0.00	1.90, 0.70	46.17	39.54	-26.18	-99.16	-49.74	-42.20	-35.66	-38.82	82.13	-19.03
CGS001-9847	KD	KIAA0528	KIAA0528			0.00, 0.00	1.73, 0.52	40.55	NaN	-42.46	-99.96	-35.74	37.46	80.09	-45.79	59.45	22.04
CGS001-9851	KD	KIAA0753	KIAA0753			0.00, 0.00	1.52, 0.47	-80.95	NaN	-89.02	-99.64	-53.66	NaN	-99.98	-91.88	-28.94	-97.70
CGS001-22889	KD	KIAA0907	KIAA0907			0.00, 0.00	1.76, 0.61	NaN	40.73	-23.84	NaN	33.62	-77.56	-86.77	-70.39	57.40	-37.77
CGS001-23240	KD	KIAA0922	KIAA0922			16.67, 16.67	3.64, 1.30	NaN	NaN	72.32	97.75	38.60	NaN	NaN	-32.27	63.07	74.06
CGS001-22832	KD	KIAA1009	KIAA1009			0.00, 0.00	2.21, 0.74	67.93	NaN	-96.77	-97.82	-93.86	NaN	-8.19	26.67	-85.61	-95.89
CGS001-23325	KD	KIAA1033	KIAA1033			0.00, 0.00	1.41, 0.41	NaN	18.63	-73.72	-70.48	-98.11	NaN	-37.29	-57.11	34.69	-60.53
CGS001-26128	KD	KIAA1279	KIAA1279			10.00, 10.00	1.23, 0.32	-55.07	-35.80	-84.13	-40.61	-81.04	-51.40	-40.06	-64.43	99.00	-42.31
CGS001-9928	KD	KIF14	Kinesins, kinesin family member 14			0.00, 0.00	1.43, 0.51	-67.21	23.18	33.62	61.60	-99.08	NaN	NaN	-99.90	-99.89	-99.95
CGS001-10112	KD	KIF20A	Kinesins, kinesin family member 20A			0.00, 0.00	1.09, 0.27	87.19	-30.36	-99.41	-99.98	81.83	NaN	-42.03	-44.79	-99.58	-99.87
CGS001-23046	KD	KIF21B	Kinesins, kinesin family member 21B			0.00, 0.00	0.84, 0.19	18.85	-40.88	56.49	-79.77	-71.98	NaN	-50.08	58.37	-87.42	-56.83
CGS001-11004	KD	KIF2C	Kinesins, kinesin family member 2C			0.00, 0.00	0.94, 0.31	-91.56	28.65	-99.67	-76.47	-99.62	82.88	-94.74	-99.93	-95.11	-99.79
CGS001-3799	KD	KIF5B	Kinesins, kinesin family member 5B			0.00, 0.00	1.36, 0.36	23.49	-19.34	-31.37	-67.14	-21.33	NaN	-78.04	22.29	-96.52	-42.94
CGS001-3800	KD	KIF5C	Kinesins, kinesin family member 5C			12.50, 0.00	2.00, 0.53	33.85	NaN	-89.02	95.77	-22.33	58.26	NaN	-90.29	-83.63	-95.95
CGS001-64147	KD	KIF9	Kinesins, kinesin family member 9			44.44, 44.44	1.25, 0.32	33.82	-19.64	99.18	98.40	89.64	NaN	42.16	28.10	99.82	98.49
CGS001-84634	KD	KISS1R	GPCR / Class A : RF amide peptide receptors, KISS1 receptor			0.00, 0.00	1.55, 0.48	-24.47	54.86	-68.04	23.19	91.98	NaN	-19.71	-25.22	-54.86	-6.67
CGS001-3815	KD	KIT	Type III RTKs: PDGFR, CSFR, Kit, FLT3 receptor family, v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog			10.00, 10.00	0.88, 0.23	-44.60	-98.63	98.04	-24.21	23.97	-77.52	-72.45	-61.36	-37.02	-40.21
CGS001-4254	KD	KITLG	KIT ligand			37.50, 12.50	1.82, 0.53	94.19	72.08	96.41	98.50	27.54	NaN	NaN	86.36	-64.11	96.34
CGS001-7071	KD	KLF10	Kruppel-like transcription factors, Kruppel-like factor 10			11.11, 11.11	1.15, 0.40	-53.42	-33.16	-34.76	-72.66	-94.03	99.50	80.79	NaN	39.17	-30.31
CGS001-8462	KD	KLF11	Kruppel-like transcription factors, Kruppel-like factor 11			0.00, 0.00	1.32, 0.27	-68.08	-70.37	-90.74	-33.86	-64.66	-84.56	-47.94	-53.21	33.71	-62.86
CGS001-136259	KD	KLF14	Kruppel-like transcription factors, Kruppel-like factor 14		Kruppel like transcription factors LOF	20.00, 10.00	1.42, 0.34	-76.45	-26.65	25.61	-49.78	96.56	99.97	-96.38	18.91	-49.67	-24.40
CGS001-10365	KD	KLF2	Kruppel-like transcription factors, Kruppel-like factor 2 (lung)		Kruppel like transcription factors LOF	11.11, 11.11	1.03, 0.42	10.00	-67.16	97.53	45.60	40.52	-38.45	NaN	-22.43	85.50	21.52
CGS001-51274	KD	KLF3	Kruppel-like transcription factors, Kruppel-like factor 3 (basic)		Kruppel like transcription factors LOF	0.00, 0.00	1.05, 0.25	-99.71	-71.44	-52.76	30.48	-99.16	-27.71	-99.87	30.46	-61.90	-99.84
CGS001-9314	KD	KLF4	Kruppel-like transcription factors, Kruppel-like factor 4 (gut)			0.00, 0.00	1.85, 0.59	64.55	-40.56	32.33	30.15	38.77	26.15	30.08	NaN	87.58	23.38
CGS001-688	KD	KLF5	Kruppel-like transcription factors, Kruppel-like factor 5 (intestinal)			0.00, 0.00	1.24, 0.49	-79.59	NaN	90.85	NaN	41.03	NaN	-97.93	54.71	55.29	49.19
CGS001-1316	KD	KLF6	Kruppel-like transcription factors, Kruppel-like factor 6			11.11, 11.11	1.17, 0.30	NaN	24.46	79.94	58.55	-47.89	90.42	-36.69	-22.81	99.97	73.14
CGS001-8609	KD	KLF7	Kruppel-like transcription factors, Kruppel-like factor 7 (ubiquitous)			77.78, 44.44	1.61, 0.45	63.60	95.08	96.62	-43.72	95.07	99.97	97.50	99.94	NaN	98.84
CGS001-23588	KD	KLHDC2	kelch domain containing 2			0.00, 0.00	1.34, 0.32	NaN	90.95	41.53	-94.96	-27.06	94.34	31.26	-50.44	36.04	28.95
CGS001-126823	KD	KLHDC9	kelch domain containing 9			0.00, 0.00	1.15, 0.40	-58.89	-22.45	39.58	-42.67	56.81	-38.67	-40.47	43.62	-82.75	-34.11
CGS001-9903	KD	KLHL21	BTB/POZ domain containing, kelch-like 21 (Drosophila)			57.14, 42.86	1.92, 0.78	75.93	24.33	99.98	NaN	80.84	NaN	NaN	97.37	99.55	98.92
CGS001-55958	KD	KLHL9	BTB/POZ domain containing, kelch-like 9 (Drosophila)			11.11, 11.11	1.17, 0.42	99.96	71.09	94.41	-79.47	-99.75	NaN	34.40	70.63	29.59	91.32
CGS001-5653	KD	KLK6	Chymotrypsin, kallikrein-related peptidase 6			25.00, 25.00	1.73, 0.47	-65.25	NaN	28.99	28.81	59.21	99.97	99.98	-43.87	NaN	81.76
CGS001-3821	KD	KLRC1	CD molecules, killer cell lectin-like receptor subfamily C, member 1			0.00, 0.00	1.39, 0.42	-25.90	-23.07	81.83	87.45	25.16	-62.86	66.08	58.36	NaN	62.28
CGS001-85442	KD	KNDC1	kinase non-catalytic C-lobe domain (KIND) containing 1			0.00, 0.00	0.55, 0.07	-97.88	-99.11	-20.92	-42.49	-22.61	-96.07	-57.85	-24.84	NaN	-72.39
CGS001-3827	KD	KNG1	Endogenous ligands, kininogen 1			0.00, 0.00	1.65, 0.52	-26.18	-80.79	15.07	26.84	-20.33	-99.94	-24.60	NaN	21.31	-12.93
CGS001-83999	KD	KREMEN1	kringle containing transmembrane protein 1			0.00, 0.00	1.16, 0.33	-99.80	-47.23	-78.51	-99.36	NaN	-22.74	-52.56	-64.40	-22.22	-59.42
CGS001-3880	KD	KRT19	Intermediate filaments type I, keratins (acidic), keratin 19			11.11, 11.11	1.53, 0.43	78.83	21.02	87.93	51.52	41.56	NaN	-18.27	-23.93	99.93	50.19
CGS001-147183	KD	KRT25	Intermediate filaments type I, keratins (acidic), keratin 25			10.00, 10.00	1.41, 0.41	46.18	-42.62	-14.29	-40.47	-22.43	99.97	59.97	71.86	92.43	46.76
CGS001-353288	KD	KRT26	Intermediate filaments type I, keratins (acidic), keratin 26			11.11, 11.11	1.41, 0.35	89.45	-25.68	50.94	56.70	-55.74	55.40	99.61	28.68	NaN	36.36
CGS001-3856	KD	KRT8	Intermediate filaments type II, keratins (basic), keratin 8			0.00, 0.00	1.70, 0.55	21.34	50.58	-96.61	-29.47	-48.87	NaN	27.35	37.60	-79.12	-12.18
CGS001-283455	KD	KSR2	RAF family, kinase suppressor of ras 2			0.00, 0.00	1.65, 0.50	-72.06	-99.93	22.71	-25.84	-97.21	NaN	27.40	-77.61	-94.47	-93.65
CGS001-3895	KD	KTN1	kinectin 1 (kinesin receptor)			10.00, 10.00	1.16, 0.42	-21.95	-99.52	-97.87	-99.83	-31.35	99.65	-97.71	-54.72	-39.15	-99.39
CGS001-8942	KD	KYNU	kynureninase			0.00, 0.00	1.75, 0.42	50.92	91.62	-23.86	-49.06	NaN	NaN	-24.62	55.19	-29.67	47.15
CGS001-3897	KD	L1CAM	CD molecules, L1 cell adhesion molecule			12.50, 12.50	1.75, 0.41	51.10	-21.06	-79.52	56.09	77.57	NaN	NaN	98.92	47.64	45.20
CGS001-91133	KD	L3MBTL4	Sterile alpha motif (SAM) domain containing, l(3)mbt-like 4 (Drosophila)			0.00, 0.00	1.60, 0.59	-78.15	-33.09	60.98	-29.57	-45.37	-45.53	-91.79	-27.53	NaN	-18.33
CGS001-144811	KD	LACC1	laccase (multicopper oxidoreductase) domain containing 1			11.11, 0.00	0.91, 0.33	-91.27	NaN	-65.78	-94.18	27.25	-84.18	-99.55	97.35	35.76	-91.95
CGS001-8270	KD	LAGE3	L antigen family, member 3			14.29, 14.29	3.82, 1.59	-90.82	NaN	52.96	99.86	23.64	NaN	NaN	-49.67	-26.98	34.10
CGS001-3909	KD	LAMA3	Laminins, laminin, alpha 3			50.00, 50.00	0.76, 0.16	98.53	98.20	58.51	99.89	-42.81	32.26	62.36	98.68	-73.98	99.34
CGS001-3912	KD	LAMB1	Laminins, laminin, beta 1			0.00, 0.00	1.57, 0.48	-97.45	28.83	-64.38	86.66	89.84	NaN	-37.64	-98.40	26.15	-73.13
CGS001-3920	KD	LAMP2	CD molecules, lysosomal-associated membrane protein 2			0.00, 0.00	1.47, 0.28	-79.73	34.79	-99.62	38.48	-42.79	-76.47	NaN	-25.25	-84.23	-84.30
CGS001-8649	KD	LAMTOR3	late endosomal/lysosomal adaptor, MAPK and MTOR activator 3			10.00, 0.00	0.89, 0.33	83.65	-32.63	-46.50	-96.20	-63.84	97.10	-36.45	-80.93	89.14	-65.71
CGS001-10314	KD	LANCL1	LanC lantibiotic synthetase component C-like 1 (bacterial)			20.00, 20.00	1.53, 0.42	-42.59	98.60	80.23	37.04	-53.57	-17.39	99.19	29.23	35.99	48.52
CGS001-51056	KD	LAP3	Leucyl aminopeptidase, leucine aminopeptidase 3			0.00, 0.00	1.05, 0.31	-99.95	-86.82	-99.94	-99.98	-67.30	-67.58	-96.28	-16.12	-99.97	-99.95
CGS001-51520	KD	LARS	Aminoacyl tRNA synthetases / Class I, leucyl-tRNA synthetase			0.00, 0.00	1.34, 0.48	-39.91	-19.91	-77.26	40.49	-66.27	NaN	-98.73	-83.73	15.36	-67.62
CGS001-23395	KD	LARS2	Aminoacyl tRNA synthetases / Class I, leucyl-tRNA synthetase 2, mitochondrial			0.00, 0.00	1.22, 0.19	-98.53	-44.73	-21.61	-33.04	-94.21	-58.85	-21.47	NaN	-94.90	-66.56
CGS001-3927	KD	LASP1	LIM and SH3 protein 1			10.00, 10.00	1.20, 0.50	-93.75	-35.54	47.14	-94.08	-48.15	29.48	42.40	-48.53	97.69	-42.36
CGS001-3930	KD	LBR	Tudor domain containing, lamin B receptor			25.00, 25.00	1.75, 0.59	-30.56	NaN	99.96	NaN	53.02	27.48	47.11	98.97	-49.24	79.90
CGS001-3932	KD	LCK	Src family, lymphocyte-specific protein tyrosine kinase			10.00, 10.00	1.05, 0.22	55.51	-99.12	-60.07	-30.73	20.17	39.86	98.39	-44.28	-28.73	-9.90
CGS001-51451	KD	LCMT1	leucine carboxyl methyltransferase 1			44.44, 44.44	1.33, 0.35	77.13	58.42	54.33	99.94	36.02	NaN	23.31	99.81	99.97	99.89
CGS001-3934	KD	LCN2	Lipocalins, lipocalin 2			11.11, 11.11	0.97, 0.28	53.26	99.78	-24.28	-48.31	67.76	NaN	-96.81	57.47	-58.55	35.54
CGS001-3939	KD	LDHA	lactate dehydrogenase A			0.00, 0.00	1.41, 0.45	5.34	89.09	82.63	-69.02	-53.96	-91.91	-92.11	-99.70	41.12	-64.58
CGS001-3945	KD	LDHB	lactate dehydrogenase B			0.00, 0.00	0.98, 0.38	40.61	NaN	-40.60	37.71	24.91	NaN	-48.58	-98.70	94.98	-16.40
CGS001-3949	KD	LDLR	Low density lipoprotein receptors, low density lipoprotein receptor			42.86, 28.57	1.66, 0.49	29.34	NaN	99.01	40.72	87.07	62.44	99.00	NaN	NaN	97.29
CGS001-51176	KD	LEF1	lymphoid enhancer-binding factor 1			12.50, 0.00	2.23, 0.84	97.40	-23.04	86.48	36.13	37.06	NaN	NaN	61.64	-55.98	53.14
CGS001-55214	KD	LEPREL1	leprecan-like 1			11.11, 11.11	2.41, 0.67	-40.80	79.55	-32.47	45.86	-37.38	-95.61	-46.12	97.71	NaN	-30.45
CGS001-3956	KD	LGALS1	Endogenous ligands, lectin, galactoside-binding, soluble, 1			0.00, 0.00	1.39, 0.44	-91.62	-66.15	25.26	23.02	-27.55	29.30	37.87	-78.26	-91.84	-64.26
CGS001-3957	KD	LGALS2	Lectins, galactoside-binding, lectin, galactoside-binding, soluble, 2			0.00, 0.00	1.14, 0.30	-27.32	21.63	66.07	-49.16	49.75	NaN	-47.23	24.00	30.88	8.03
CGS001-3958	KD	LGALS3	Endogenous ligands, lectin, galactoside-binding, soluble, 3			11.11, 11.11	1.80, 0.73	65.52	90.31	81.73	99.72	24.18	NaN	77.29	91.17	35.62	75.61
CGS001-3964	KD	LGALS8	Lectins, galactoside-binding, lectin, galactoside-binding, soluble, 8			20.00, 0.00	1.53, 0.51	50.04	-61.53	13.35	95.21	25.07	96.79	31.71	67.28	38.43	39.24
CGS001-5641	KD	LGMN	Legumain, legumain			25.00, 25.00	1.11, 0.36	100.00	98.88	-41.54	80.11	-85.47	NaN	NaN	-20.78	-98.64	94.12
CGS001-55366	KD	LGR4	GPCR / Class A : Orphans, leucine-rich repeat containing G protein-coupled receptor 4			10.00, 10.00	1.06, 0.18	-49.50	26.45	-40.95	33.29	-50.95	-22.04	18.43	99.48	-37.93	-12.12
CGS001-8549	KD	LGR5	GPCR / Class A : Orphans, leucine-rich repeat containing G protein-coupled receptor 5			0.00, 0.00	1.57, 0.25	-44.24	-32.88	31.52	25.06	-98.56	41.38	40.81	NaN	25.66	9.06
CGS001-59352	KD	LGR6	GPCR / Class A : Orphans, leucine-rich repeat containing G protein-coupled receptor 6			0.00, 0.00	1.03, 0.30	-53.12	-77.80	50.60	NaN	-41.81	33.25	-46.76	-68.20	-76.45	-42.71
CGS001-64077	KD	LHPP	phospholysine phosphohistidine inorganic pyrophosphate phosphatase			0.00, 0.00	0.84, 0.25	-99.42	-21.26	-43.45	-85.61	-96.43	-39.19	-99.90	42.71	-99.88	-99.74
CGS001-9355	KD	LHX2	Homeoboxes / LIM class, LIM homeobox 2			10.00, 10.00	1.26, 0.35	22.53	99.80	-80.68	92.71	-81.08	-22.19	92.44	-34.81	28.72	33.05
CGS001-8022	KD	LHX3	Homeoboxes / LIM class, LIM homeobox 3			11.11, 11.11	1.44, 0.40	99.59	-27.75	73.94	36.64	91.22	NaN	-54.05	-87.42	92.14	90.93
CGS001-89884	KD	LHX4	Homeoboxes / LIM class, LIM homeobox 4			10.00, 10.00	0.98, 0.16	-19.27	-99.34	26.27	-62.14	38.47	24.46	80.58	99.96	-51.20	-8.93
CGS001-56956	KD	LHX9	Homeoboxes / LIM class, LIM homeobox 9			0.00, 0.00	1.97, 0.50	50.22	37.63	43.96	90.10	28.17	-40.61	-23.66	92.69	37.07	38.42
CGS001-11019	KD	LIAS	lipoic acid synthetase			0.00, 0.00	1.13, 0.33	-18.81	20.17	-99.91	NaN	-74.74	-28.17	NaN	-41.92	-52.77	-27.17
CGS001-3976	KD	LIF	leukemia inhibitory factor (cholinergic differentiation factor)			25.00, 12.50	1.50, 0.53	96.13	NaN	84.49	-32.88	-72.60	NaN	45.49	-26.99	99.88	94.78
CGS001-3978	KD	LIG1	ligase I, DNA, ATP-dependent			0.00, 0.00	1.00, 0.27	-97.13	-32.74	-53.59	-35.59	NaN	-35.18	-77.62	-86.01	-93.53	-78.23
CGS001-3980	KD	LIG3	ligase III, DNA, ATP-dependent			12.50, 12.50	1.72, 0.52	-32.90	66.70	-20.24	-53.75	99.98	62.69	NaN	-42.41	NaN	23.19
CGS001-3985	KD	LIMK2	LIMK subfamily, LIM domain kinase 2			10.00, 0.00	1.31, 0.25	95.23	-82.23	-17.62	-42.25	-57.70	26.28	-92.52	84.91	-28.43	-30.25
CGS001-79727	KD	LIN28A	Zinc fingers, CCHC domain containing, lin-28 homolog A (C. elegans)			0.00, 0.00	2.46, 0.88	-20.16	21.18	-38.37	43.96	-40.62	-28.48	NaN	NaN	73.02	-8.28
CGS001-389421	KD	LIN28B	lin-28 homolog B (C. elegans)			0.00, 0.00	1.28, 0.39	-31.12	74.56	78.87	-26.54	33.09	85.32	NaN	NaN	-30.79	61.78
CGS001-3988	KD	LIPA	lipase A, lysosomal acid, cholesterol esterase			50.00, 50.00	1.31, 0.41	-48.23	-25.84	99.84	99.91	-30.65	84.13	-23.91	99.50	99.97	99.89
CGS001-200879	KD	LIPH	lipase, member H			0.00, 0.00	1.03, 0.15	51.04	-45.69	-98.47	25.25	-25.08	NaN	30.06	-96.55	32.25	-10.20
CGS001-51601	KD	LIPT1	lipoyltransferase 1			0.00, 0.00	1.95, 0.61	25.20	-80.20	37.66	72.53	-27.03	NaN	83.11	82.35	-33.82	62.18
CGS001-3998	KD	LMAN1	lectin, mannose-binding, 1			22.22, 11.11	1.58, 0.43	35.25	96.65	-46.21	34.67	74.51	53.82	22.00	NaN	99.97	64.30
CGS001-4000	KD	LMNA	Intermediate filaments type V, lamins, lamin A/C			20.00, 20.00	1.55, 0.27	85.16	-96.18	46.83	26.60	99.81	-22.04	97.69	31.61	-80.12	47.85
CGS001-84823	KD	LMNB2	Intermediate filaments type V, lamins, lamin B2			20.00, 20.00	0.85, 0.39	-13.07	-77.31	64.71	99.47	-95.42	-70.39	-16.91	99.67	-44.74	-14.89
CGS001-8543	KD	LMO4	LIM domain only 4			0.00, 0.00	1.33, 0.32	-59.66	-42.57	94.39	61.42	-90.33	NaN	-30.08	-24.89	25.68	-14.49
CGS001-4012	KD	LNPEP	Aminopeptidase N, leucyl/cystinyl aminopeptidase			0.00, 0.00	1.16, 0.34	12.32	57.84	-20.14	NaN	-60.17	NaN	-27.18	33.28	-98.62	-9.21
CGS001-164832	KD	LONRF2	RING-type (C3HC4) zinc fingers, LON peptidase N-terminal domain and ring finger 2			0.00, 0.00	1.42, 0.47	-85.73	51.47	-13.34	NaN	-56.49	-86.38	28.19	-98.68	NaN	-80.34
CGS001-4016	KD	LOXL1	lysyl oxidase-like 1			0.00, 0.00	1.20, 0.40	16.69	-29.53	64.15	-80.75	-99.34	36.97	38.54	-42.86	-94.99	-59.59
CGS001-1902	KD	LPAR1	GPCR / Class A : Lysophospholipid receptors : Lysophosphatidic acid, lysophosphatidic acid receptor 1			0.00, 0.00	1.17, 0.33	52.20	NaN	83.16	-46.59	-23.86	-19.72	64.92	34.83	25.71	19.89
CGS001-9170	KD	LPAR2	GPCR / Class A : Lysophospholipid receptors : Lysophosphatidic acid, lysophosphatidic acid receptor 2			37.50, 37.50	1.02, 0.31	-24.68	NaN	65.63	92.50	99.74	74.64	NaN	98.93	94.37	98.95
CGS001-23566	KD	LPAR3	GPCR / Class A : Lysophospholipid receptors : Lysophosphatidic acid, lysophosphatidic acid receptor 3			0.00, 0.00	1.45, 0.47	-11.36	-81.33	72.73	85.24	24.47	NaN	-25.24	-28.74	-31.05	-6.24
CGS001-57121	KD	LPAR5	GPCR / Class A : Lysophospholipid receptors : Lysophosphatidic acid, lysophosphatidic acid receptor 5			0.00, 0.00	1.50, 0.33	-27.84	-27.91	23.92	-64.96	-22.70	NaN	88.72	-66.74	83.15	-7.65
CGS001-10161	KD	LPAR6	GPCR / Class A : Lysophospholipid receptors : Lysophosphatidic acid, lysophosphatidic acid receptor 6			0.00, 0.00	1.40, 0.39	-37.82	89.10	31.94	34.29	-75.66	NaN	-43.49	-25.94	-99.81	-26.94
CGS001-9926	KD	LPGAT1	lysophosphatidylglycerol acyltransferase 1			37.50, 25.00	2.58, 0.77	87.82	NaN	92.03	99.84	-51.60	74.12	NaN	99.07	38.45	96.10
CGS001-22859	KD	LPHN1	Adhesion Class GPCRs, latrophilin 1			12.50, 12.50	1.32, 0.45	-66.26	99.91	-36.71	46.19	74.45	-35.64	NaN	54.13	NaN	51.50
CGS001-23266	KD	LPHN2	Adhesion Class GPCRs, latrophilin 2			0.00, 0.00	1.43, 0.45	-31.18	-59.39	-25.63	-31.39	-99.92	NaN	-37.19	-99.93	-87.14	-62.35
CGS001-4023	KD	LPL	lipoprotein lipase			12.50, 0.00	1.61, 0.42	-21.99	96.67	-68.79	39.54	-39.58	NaN	44.68	NaN	-99.88	-18.18
CGS001-9404	KD	LPXN	leupaxin			0.00, 0.00	0.97, 0.28	-30.66	24.34	-17.09	-60.59	-50.37	-95.53	52.96	20.70	28.70	-5.07
CGS001-26020	KD	LRP10	Low density lipoprotein receptors, low density lipoprotein receptor-related protein 10			0.00, 0.00	0.91, 0.24	-34.59	59.86	-20.40	-89.30	40.09	73.95	82.02	-18.46	-21.47	39.58
CGS001-4038	KD	LRP4	Low density lipoprotein receptors, low density lipoprotein receptor-related protein 4			20.00, 10.00	1.32, 0.39	-69.58	-94.87	-83.77	-47.64	99.92	97.37	-37.87	-95.56	-80.87	-89.61
CGS001-4043	KD	LRPAP1	low density lipoprotein receptor-related protein associated protein 1			0.00, 0.00	1.15, 0.38	43.45	NaN	-56.81	-83.72	31.23	NaN	-33.59	39.81	-99.89	-69.08
CGS001-10128	KD	LRPPRC	leucine-rich PPR-motif containing			0.00, 0.00	1.35, 0.38	-85.02	78.56	-16.69	41.63	35.22	33.58	39.24	-99.98	NaN	13.98
CGS001-55604	KD	LRRC16A	leucine rich repeat containing 16A			0.00, 0.00	2.36, 0.60	47.85	NaN	-20.02	93.57	94.50	-29.14	NaN	-94.19	-67.09	44.88
CGS001-474354	KD	LRRC18	leucine rich repeat containing 18			12.50, 12.50	1.31, 0.36	88.12	NaN	99.94	19.76	40.01	NaN	-39.45	-39.17	-48.33	50.14
CGS001-2615	KD	LRRC32	leucine rich repeat containing 32			0.00, 0.00	1.05, 0.40	-84.37	NaN	-90.71	-86.87	24.72	-22.34	73.26	-97.90	-20.93	-78.92
CGS001-55631	KD	LRRC40	leucine rich repeat containing 40			11.11, 11.11	1.19, 0.34	83.99	99.96	46.26	92.29	32.51	NaN	25.97	-28.88	40.07	63.50
CGS001-10489	KD	LRRC41	leucine rich repeat containing 41			0.00, 0.00	1.39, 0.41	NaN	-23.09	-34.20	48.78	-27.78	NaN	41.69	-19.87	24.84	9.65
CGS001-55379	KD	LRRC59	leucine rich repeat containing 59			20.00, 20.00	1.18, 0.33	81.11	-21.31	-17.01	30.10	99.98	-80.18	-19.58	80.80	97.73	85.99
CGS001-120892	KD	LRRK2	Leucine-rich repeat kinase (LRRK) family, leucine-rich repeat kinase 2			0.00, 0.00	1.09, 0.33	-25.41	-79.45	63.10	41.26	-96.25	68.09	-72.45	-14.95	35.55	-26.18
CGS001-90678	KD	LRSAM1	Sterile alpha motif (SAM) domain containing, leucine rich repeat and sterile alpha motif containing 1			0.00, 0.00	1.67, 0.61	-84.52	-46.21	-28.10	-25.13	-20.66	-99.36	-61.94	-87.10	-36.02	-61.72
CGS001-57819	KD	LSM2	LSM2 homolog, U6 small nuclear RNA associated (S. cerevisiae)			37.50, 37.50	1.57, 0.49	-62.74	97.88	91.45	72.11	99.36	-45.52	NaN	26.82	NaN	97.75
CGS001-23658	KD	LSM5	LSM5 homolog, U6 small nuclear RNA associated (S. cerevisiae)			10.00, 0.00	1.27, 0.45	97.22	27.85	-71.13	27.93	60.39	44.64	-51.83	-21.57	19.80	14.19
CGS001-11157	KD	LSM6	LSM6 homolog, U6 small nuclear RNA associated (S. cerevisiae)			0.00, 0.00	1.01, 0.31	38.94	81.38	-38.31	-55.98	-65.66	-36.40	-50.50	-96.75	32.09	-28.61
CGS001-4046	KD	LSP1	lymphocyte-specific protein 1			11.11, 11.11	1.25, 0.53	70.62	NaN	27.34	-61.17	45.88	18.63	-34.64	-64.90	99.97	19.98
CGS001-51599	KD	LSR	Immunoglobulin superfamily / Immunoglobulin-like domain containing, lipolysis stimulated lipoprotein receptor			11.11, 11.11	1.03, 0.40	-41.85	NaN	35.55	63.59	84.65	44.61	35.37	99.31	31.61	52.98
CGS001-4047	KD	LSS	Lanosterol biosynthesis pathway, lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase)			0.00, 0.00	1.23, 0.38	89.05	-99.19	-99.96	29.12	-60.29	NaN	-65.89	-77.27	32.24	-62.50
CGS001-4048	KD	LTA4H	Hydrolases, leukotriene A4 hydrolase			11.11, 0.00	1.19, 0.48	-29.25	92.97	20.84	-33.89	-58.13	97.36	-92.61	24.65	NaN	8.65
CGS001-4055	KD	LTBR	Tumor necrosis factor receptor superfamily, lymphotoxin beta receptor (TNFR superfamily, member 3)			11.11, 0.00	1.58, 0.59	37.81	-21.31	92.80	39.39	95.18	-34.53	75.53	-21.89	NaN	53.58
CGS001-4067	KD	LYN	Src family, v-yes-1 Yamaguchi sarcoma viral related oncogene homolog			10.00, 10.00	0.78, 0.19	33.00	100.00	-70.89	-83.68	19.54	-87.75	-75.85	-97.39	-28.90	-74.18
CGS001-27076	KD	LYPD3	LY6/PLAUR domain containing 3			25.00, 25.00	2.26, 0.73	99.94	NaN	-91.45	-99.57	-24.74	NaN	-82.51	34.05	99.69	-89.60
CGS001-10434	KD	LYPLA1	lysophospholipase I			10.00, 10.00	1.14, 0.35	-77.42	36.88	75.51	24.20	56.93	77.67	26.32	99.39	-32.54	64.59
CGS001-57149	KD	LYRM1	LYR motif containing, LYR motif containing 1			0.00, 0.00	1.22, 0.25	-27.86	NaN	-61.07	74.91	-25.30	-97.84	-70.15	-26.27	69.85	-30.45
CGS001-84328	KD	LZIC	leucine zipper and CTNNBIP1 domain containing			11.11, 0.00	1.36, 0.44	-37.48	-23.66	-96.04	-95.51	56.26	NaN	96.44	-99.60	-99.28	-99.32
CGS001-4074	KD	M6PR	mannose-6-phosphate receptor (cation dependent)			25.00, 25.00	1.57, 0.48	78.14	NaN	55.57	99.98	97.76	-55.34	-14.90	NaN	-35.19	76.05
CGS001-23499	KD	MACF1	EF-hand domain containing, microtubule-actin crosslinking factor 1			0.00, 0.00	1.66, 0.41	-51.09	-59.61	-86.82	-23.53	33.76	-33.01	-98.07	-98.04	18.67	-88.22
CGS001-9587	KD	MAD2L1BP	MAD2L1 binding protein			0.00, 0.00	1.75, 0.49	NaN	NaN	-97.92	33.79	-98.16	NaN	67.16	-99.75	-99.40	-99.56
CGS001-4094	KD	MAF	v-maf musculoaponeurotic fibrosarcoma oncogene homolog (avian)			0.00, 0.00	1.61, 0.51	-11.42	75.72	55.04	94.87	60.62	NaN	-79.85	94.77	93.51	88.96
CGS001-4097	KD	MAFG	v-maf musculoaponeurotic fibrosarcoma oncogene homolog G (avian)			11.11, 11.11	1.69, 0.55	31.99	-81.38	99.39	42.73	70.04	NaN	-43.62	45.72	92.02	55.11
CGS001-9500	KD	MAGED1	melanoma antigen family D, 1			12.50, 12.50	1.98, 0.78	82.68	NaN	65.50	92.96	38.23	-34.55	-24.89	99.98	NaN	89.40
CGS001-10892	KD	MALT1	Immunoglobulin superfamily / Immunoglobulin-like domain containing, mucosa associated lymphoid tissue lymphoma translocation gene 1			30.00, 10.00	1.39, 0.44	-39.90	-45.27	-65.40	98.47	51.09	47.66	-58.99	95.09	95.44	74.30
CGS001-10046	KD	MAMLD1	mastermind-like domain containing 1			11.11, 11.11	1.99, 0.77	NaN	60.05	76.12	-93.48	99.80	90.74	25.46	-44.33	-46.59	78.98
CGS001-4121	KD	MAN1A1	mannosidase, alpha, class 1A, member 1			0.00, 0.00	1.17, 0.33	-87.58	47.96	75.84	84.24	-38.74	-98.92	-24.85	-78.48	36.66	-47.80
CGS001-4122	KD	MAN2A2	mannosidase, alpha, class 2A, member 2			0.00, 0.00	1.52, 0.51	-90.66	-25.85	-75.38	-61.51	-50.43	-98.12	50.49	-11.45	-38.71	-75.19
CGS001-4125	KD	MAN2B1	mannosidase, alpha, class 2B, member 1			55.56, 55.56	1.93, 0.73	93.11	NaN	99.78	98.67	97.61	80.59	76.31	99.15	94.44	99.51
CGS001-5604	KD	MAP2K1	MAPKK:STE7 family, mitogen-activated protein kinase kinase 1			0.00, 0.00	1.17, 0.27	-99.21	-52.01	-75.03	-84.44	-98.15	38.73	-92.83	-59.78	-30.81	-98.10
CGS001-5605	KD	MAP2K2	MAPKK:STE7 family, mitogen-activated protein kinase kinase 2			20.00, 10.00	1.33, 0.48	80.23	99.98	-91.17	74.54	18.46	76.72	95.89	-98.94	-59.19	75.71
CGS001-5606	KD	MAP2K3	MAPKK:STE7 family, mitogen-activated protein kinase kinase 3			10.00, 0.00	0.73, 0.24	-27.41	54.98	-28.37	95.83	-25.45	73.58	-98.49	-39.41	19.74	6.42
CGS001-6416	KD	MAP2K4	MAPKK:STE7 family, mitogen-activated protein kinase kinase 4			10.00, 10.00	1.34, 0.43	52.74	4.74	-30.96	-54.90	48.86	98.61	-42.80	-18.40	59.61	35.63
CGS001-5607	KD	MAP2K5	MAPKK:STE7 family, mitogen-activated protein kinase kinase 5			0.00, 0.00	1.00, 0.27	62.21	-99.52	-98.64	-70.80	-19.67	-34.93	-67.18	26.47	23.97	-56.23
CGS001-5608	KD	MAP2K6	MAPKK:STE7 family, mitogen-activated protein kinase kinase 6			0.00, 0.00	1.45, 0.44	-99.84	-97.21	19.55	-25.38	-21.99	NaN	-99.93	-45.23	-18.87	-92.13
CGS001-4214	KD	MAP3K1	MAPKKK:STE11 family, mitogen-activated protein kinase kinase kinase 1			10.00, 0.00	1.38, 0.47	56.17	54.07	-17.15	96.78	92.07	42.95	80.18	73.14	91.74	87.36
CGS001-9020	KD	MAP3K14	MAPKKK:STE-unique family, mitogen-activated protein kinase kinase kinase 14			0.00, 0.00	1.93, 0.52	-85.14	-72.95	-49.27	-94.57	-29.34	NaN	-83.40	-18.87	28.04	-72.68
CGS001-4216	KD	MAP3K4	MAPKKK:STE11 family, mitogen-activated protein kinase kinase kinase 4			0.00, 0.00	1.09, 0.38	-40.27	32.46	-99.60	-99.86	-38.49	-97.59	-97.15	-58.41	20.94	-99.55
CGS001-4217	KD	MAP3K5	MAPKKK:STE11 family, mitogen-activated protein kinase kinase kinase 5			10.00, 10.00	1.60, 0.57	97.98	-37.43	82.85	59.50	88.80	71.26	19.55	88.72	-21.88	85.86
CGS001-6885	KD	MAP3K7	MAPKKK:TAK1 subfamily, mitogen-activated protein kinase kinase kinase 7			0.00, 0.00	1.03, 0.16	-72.93	-62.44	-80.24	-41.74	91.74	NaN	-46.66	-97.15	-94.81	-96.60
CGS001-1326	KD	MAP3K8	MAPKKK:STE-unique family, mitogen-activated protein kinase kinase kinase 8			0.00, 0.00	1.41, 0.33	-96.42	-93.94	-61.39	-97.59	-33.82	-65.97	-37.02	-78.10	NaN	-90.56
CGS001-8491	KD	MAP4K3	MAPKKKK:KHS subfamily, mitogen-activated protein kinase kinase kinase kinase 3			10.00, 0.00	0.95, 0.27	96.35	-25.33	-61.91	-29.28	22.56	94.70	-55.67	-98.72	-97.55	-59.74
CGS001-9448	KD	MAP4K4	MAPKKKK:MSN subfamily, mitogen-activated protein kinase kinase kinase kinase 4			0.00, 0.00	0.97, 0.17	-18.50	82.68	-73.36	-99.03	-55.43	-31.84	-16.59	-99.98	-28.07	-73.33
CGS001-9053	KD	MAP7	microtubule-associated protein 7			0.00, 0.00	2.07, 0.53	NaN	NaN	-20.28	56.57	-98.53	NaN	NaN	-59.89	68.28	-29.73
CGS001-5594	KD	MAPK1	MAPK:ERK subfamily, mitogen-activated protein kinase 1		Mitogen activated protein kinases LOF	0.00, 0.00	1.50, 0.50	-86.56	-96.22	-98.65	-69.53	36.92	NaN	29.19	67.82	-30.77	-76.36
CGS001-6300	KD	MAPK12	MAPK:p38 subfamily, mitogen-activated protein kinase 12			0.00, 0.00	1.28, 0.35	-40.95	-98.99	-87.39	31.02	-45.95	23.38	-41.79	-33.78	-92.34	-56.84
CGS001-5603	KD	MAPK13	MAPK:p38 subfamily, mitogen-activated protein kinase 13			10.00, 10.00	0.76, 0.10	98.01	-46.92	-13.13	33.87	33.50	-93.48	55.10	54.78	-99.97	14.75
CGS001-1432	KD	MAPK14	MAPK:p38 subfamily, mitogen-activated protein kinase 14		Mitogen activated protein kinases LOF	10.00, 10.00	1.64, 0.63	-51.52	99.80	17.60	-25.49	-13.67	-64.63	23.33	56.65	26.79	0.71
CGS001-93487	KD	MAPK1IP1L	mitogen-activated protein kinase 1 interacting protein 1-like			0.00, 0.00	1.63, 0.68	NaN	-61.98	-21.32	-56.02	-48.46	NaN	-24.77	-62.34	65.54	-52.68
CGS001-5595	KD	MAPK3	MAPK:ERK subfamily, mitogen-activated protein kinase 3		Mitogen activated protein kinases LOF	0.00, 0.00	1.47, 0.45	-45.61	29.68	35.18	NaN	87.57	NaN	88.91	35.21	35.95	41.67
CGS001-5599	KD	MAPK8	MAPK:JNK subfamily, mitogen-activated protein kinase 8			10.00, 10.00	0.88, 0.18	-30.61	-96.61	-99.49	-25.49	99.13	26.41	-50.68	-25.04	-19.74	-22.70
CGS001-79109	KD	MAPKAP1	mitogen-activated protein kinase associated protein 1			0.00, 0.00	1.09, 0.31	-55.80	37.25	-68.54	-25.88	-99.98	68.68	-25.09	-92.52	NaN	-62.15
CGS001-9261	KD	MAPKAPK2	MAPKAPK subfamily, mitogen-activated protein kinase-activated protein kinase 2			22.22, 11.11	1.34, 0.42	-22.94	-70.71	97.26	89.13	44.27	NaN	72.05	99.94	-68.99	89.23
CGS001-7867	KD	MAPKAPK3	MAPKAPK subfamily, mitogen-activated protein kinase-activated protein kinase 3			10.00, 10.00	0.99, 0.24	75.19	99.89	-17.26	71.63	-55.61	87.09	-96.31	40.07	92.49	77.69
CGS001-8550	KD	MAPKAPK5	MAPKAPK subfamily, mitogen-activated protein kinase-activated protein kinase 5			10.00, 10.00	1.16, 0.33	-53.85	99.84	-69.17	-99.98	-31.56	-97.22	-95.12	22.03	-17.46	-86.89
CGS001-57787	KD	MARK4	MARK subfamily, MAP/microtubule affinity-regulating kinase 4			0.00, 0.00	1.92, 0.61	-79.23	86.50	77.29	90.44	30.42	-34.48	28.01	-80.42	-47.23	66.66
CGS001-4141	KD	MARS	Aminoacyl tRNA synthetases / Class I, methionyl-tRNA synthetase			30.00, 20.00	0.98, 0.27	59.51	-49.71	63.33	38.24	99.98	97.30	-99.96	-53.01	99.58	83.55
CGS001-116511	KD	MAS1L	GPCR / Class A : Orphans, MAS1 oncogene-like			12.50, 0.00	1.64, 0.30	-56.48	NaN	30.15	-44.57	NaN	60.57	21.28	90.01	95.62	34.26
CGS001-23139	KD	MAST2	MAST family, microtubule associated serine/threonine kinase 2			40.00, 30.00	1.01, 0.33	-16.63	-98.23	74.16	98.29	29.42	28.54	-36.82	99.90	99.01	97.46
CGS001-375449	KD	MAST4	MAST family, microtubule associated serine/threonine kinase family member 4			0.00, 0.00	0.35, 0.10	31.86	51.99	78.62	83.58	44.32	-33.34	NaN	94.51	61.38	68.00
CGS001-84930	KD	MASTL	MAST family, microtubule associated serine/threonine kinase-like			0.00, 0.00	1.25, 0.34	49.48	46.61	-98.64	57.20	35.47	NaN	-18.10	37.56	87.70	25.88
CGS001-4144	KD	MAT2A	methionine adenosyltransferase II, alpha			10.00, 10.00	1.27, 0.45	-46.66	23.81	-79.31	76.26	-46.65	-99.32	-73.96	-26.11	99.97	-40.91
CGS001-4149	KD	MAX	Basic helix-loop-helix proteins, MYC associated factor X			10.00, 10.00	1.08, 0.22	-27.02	99.76	89.69	68.52	-30.68	-98.59	-13.00	7.99	-94.98	21.02
CGS001-4151	KD	MB	myoglobin			11.11, 11.11	1.74, 0.50	99.75	NaN	-87.64	-66.50	-86.11	75.26	-94.26	-89.31	27.00	-88.42
CGS001-114785	KD	MBD6	methyl-CpG binding domain protein 6			20.00, 20.00	1.18, 0.45	-43.23	97.81	-42.95	25.34	70.67	76.84	39.21	97.59	-47.73	61.91
CGS001-4154	KD	MBNL1	Zinc fingers, CCCH-type domain containing, muscleblind-like (Drosophila)			0.00, 0.00	1.14, 0.33	-15.81	90.18	-91.73	-33.76	-83.70	-99.07	-98.36	-83.15	53.42	-94.19
CGS001-10150	KD	MBNL2	Zinc fingers, CCCH-type domain containing, muscleblind-like 2 (Drosophila)			11.11, 0.00	1.50, 0.48	NaN	-36.30	-35.61	96.46	-57.11	38.50	63.73	75.49	-85.09	-59.65
CGS001-79143	KD	MBOAT7	membrane bound O-acyltransferase domain containing 7			0.00, 0.00	1.38, 0.52	70.88	-25.96	32.88	-76.71	35.83	NaN	-59.97	18.48	34.09	10.37
CGS001-8720	KD	MBTPS1	Subtilisin, membrane-bound transcription factor peptidase, site 1			10.00, 10.00	1.63, 0.39	62.15	25.92	18.37	-47.78	-36.49	99.79	-53.28	-39.20	24.03	21.36
CGS001-56922	KD	MCCC1	methylcrotonoyl-CoA carboxylase 1 (alpha)			75.00, 75.00	1.63, 0.55	-27.19	NaN	97.76	99.85	97.76	99.37	92.55	99.33	NaN	99.61
CGS001-64087	KD	MCCC2	methylcrotonoyl-CoA carboxylase 2 (beta)			11.11, 11.11	1.41, 0.35	-24.29	49.47	-33.04	99.46	-32.52	NaN	72.14	-41.64	24.47	17.51
CGS001-84539	KD	MCHR2	GPCR / Class A : MCH receptors, melanin-concentrating hormone receptor 2			0.00, 0.00	2.73, 0.84	72.54	65.68	65.33	NaN	NaN	NaN	53.62	50.76	-37.41	56.37
CGS001-4170	KD	MCL1	myeloid cell leukemia sequence 1 (BCL2-related)			11.11, 0.00	1.85, 0.45	26.99	97.23	71.50	26.46	NaN	38.64	-25.74	60.74	21.94	38.09
CGS001-4171	KD	MCM2	minichromosome maintenance complex component 2			10.00, 0.00	1.43, 0.32	-33.02	-36.87	-49.07	64.84	-24.28	96.56	-20.46	-40.12	-73.12	-25.94
CGS001-4172	KD	MCM3	minichromosome maintenance complex component 3			0.00, 0.00	1.44, 0.38	-79.81	-99.89	-95.42	-97.92	69.93	-87.32	-90.48	-99.12	-18.82	-97.97
CGS001-4173	KD	MCM4	minichromosome maintenance complex component 4			10.00, 0.00	1.13, 0.32	33.58	24.11	-43.03	45.99	-38.89	92.17	95.44	-26.54	-42.89	14.42
CGS001-4174	KD	MCM5	minichromosome maintenance complex component 5		MCM family LOF	0.00, 0.00	0.83, 0.20	-21.08	-80.73	37.41	39.18	21.61	33.70	73.70	-19.51	29.35	5.13
CGS001-4175	KD	MCM6	minichromosome maintenance complex component 6		MCM family LOF	0.00, 0.00	1.26, 0.34	-22.92	62.56	-50.25	87.44	83.83	-70.64	-30.20	25.46	NaN	45.69
CGS001-4176	KD	MCM7	minichromosome maintenance complex component 7			10.00, 10.00	0.89, 0.23	-68.45	100.00	-28.21	-25.34	-99.22	53.01	73.20	-29.30	72.50	34.92
CGS001-57192	KD	MCOLN1	Voltage-gated ion channels / Transient receptor potential cation channels, mucolipin 1			0.00, 0.00	2.21, 0.68	-64.83	NaN	68.95	93.32	31.22	NaN	NaN	70.10	-61.93	67.00
CGS001-4190	KD	MDH1	malate dehydrogenase 1, NAD (soluble)			0.00, 0.00	1.83, 0.36	-16.74	55.64	30.93	-22.46	NaN	36.42	12.98	38.65	-38.32	12.26
CGS001-4191	KD	MDH2	malate dehydrogenase 2, NAD (mitochondrial)			0.00, 0.00	1.73, 0.48	-65.13	-52.76	-98.38	-80.08	-27.46	NaN	-97.15	-83.42	26.34	-80.21
CGS001-4193	KD	MDM2	Mdm2 p53 binding protein homolog (mouse)		Zinc fingers RanBP2 type LOF	0.00, 0.00	0.78, 0.15	-99.31	-19.49	78.81	-99.05	25.67	91.53	-13.95	-99.98	-98.47	-99.84
CGS001-4194	KD	MDM4	Mdm4 p53 binding protein homolog (mouse)			0.00, 0.00	1.60, 0.58	-99.66	94.79	-42.94	-23.48	-77.37	38.79	31.85	-98.20	NaN	-57.94
CGS001-4199	KD	ME1	malic enzyme 1, NADP(+)-dependent, cytosolic			0.00, 0.00	1.23, 0.30	-71.09	-97.09	-87.52	-66.71	86.16	-23.44	NaN	-61.98	-94.53	-79.53
CGS001-4200	KD	ME2	malic enzyme 2, NAD(+)-dependent, mitochondrial			0.00, 0.00	1.44, 0.36	-99.02	-78.12	-86.40	-99.48	22.54	-74.01	-29.13	-85.06	21.16	-87.06
CGS001-10873	KD	ME3	malic enzyme 3, NADP(+)-dependent, mitochondrial			11.11, 11.11	1.30, 0.42	-17.25	65.66	-89.38	27.13	98.44	41.04	-39.92	-73.29	NaN	-13.45
CGS001-4204	KD	MECP2	methyl CpG binding protein 2 (Rett syndrome)		X linked mental retardation group 1 LOF	22.22, 22.22	0.98, 0.32	99.93	99.78	-98.41	-99.86	-30.09	NaN	-23.58	-47.90	-67.49	-59.48
CGS001-5469	KD	MED1	mediator complex subunit 1		Mediator complex LOF	12.50, 0.00	1.43, 0.45	-20.55	NaN	-25.50	-76.11	-94.62	NaN	95.64	-97.37	-93.60	-97.71
CGS001-116931	KD	MED12L	mediator complex subunit 12-like			0.00, 0.00	1.69, 0.58	-30.38	90.70	-97.96	34.75	44.11	84.78	-73.79	-26.62	-41.65	-15.54
CGS001-51586	KD	MED15	mediator complex subunit 15			0.00, 0.00	1.22, 0.42	-36.40	-98.56	-81.60	-91.68	77.82	22.11	-46.87	-99.02	27.21	-92.34
CGS001-9441	KD	MED26	mediator complex subunit 26			0.00, 0.00	1.27, 0.28	-80.40	-39.66	18.92	-29.67	74.87	-21.61	79.53	-22.12	33.70	4.76
CGS001-80306	KD	MED28	mediator complex subunit 28		Mediator complex LOF	25.00, 25.00	1.66, 0.51	-97.67	NaN	-32.53	26.50	98.45	NaN	97.96	-91.20	29.21	-31.72
CGS001-10001	KD	MED6	mediator complex subunit 6		Mediator complex LOF	0.00, 0.00	1.43, 0.45	-35.62	74.14	40.25	50.90	26.49	-99.09	22.47	32.08	NaN	17.66
CGS001-9443	KD	MED7	mediator complex subunit 7		Mediator complex LOF	30.00, 20.00	0.89, 0.28	99.93	27.61	-39.95	97.27	26.69	36.57	60.68	25.46	99.22	87.05
CGS001-4205	KD	MEF2A	Myocyte enhancer factors, myocyte enhancer factor 2A			25.00, 12.50	1.17, 0.33	59.59	NaN	-40.48	-83.31	-99.89	NaN	99.89	21.56	96.45	72.63
CGS001-4208	KD	MEF2C	Myocyte enhancer factors, myocyte enhancer factor 2C			0.00, 0.00	1.22, 0.28	-47.38	30.28	-26.72	45.25	80.36	NaN	92.79	-92.27	-81.19	-39.86
CGS001-1955	KD	MEGF9	multiple EGF-like-domains 9			0.00, 0.00	1.24, 0.40	81.24	-51.01	-27.61	-40.72	25.87	-80.27	-45.62	34.98	-19.99	-19.68
CGS001-9833	KD	MELK	MELK subfamily, maternal embryonic leucine zipper kinase			10.00, 10.00	1.80, 0.44	49.26	-99.58	90.73	82.45	-97.23	83.42	-33.64	77.05	99.95	89.83
CGS001-4223	KD	MEOX2	Homeoboxes / ANTP class : HOXL subclass, mesenchyme homeobox 2		HOXL subclass homeoboxes LOF	0.00, 0.00	1.36, 0.32	-45.74	47.77	-15.53	-30.96	-24.51	-13.41	-84.19	16.59	NaN	-5.28
CGS001-55897	KD	MESP1	Basic helix-loop-helix proteins, mesoderm posterior 1 homolog (mouse)			0.00, 0.00	1.27, 0.41	-28.07	53.83	-19.50	34.83	-32.23	90.31	-27.71	-26.80	NaN	-5.77
CGS001-4232	KD	MEST	mesoderm specific transcript homolog (mouse)			11.11, 11.11	1.28, 0.43	62.35	NaN	-99.96	-77.81	98.61	-32.68	-98.45	-76.19	-96.10	-98.54
CGS001-4233	KD	MET	Type X RTKs: HGF (hepatocyte growth factor) receptor family, met proto-oncogene (hepatocyte growth factor receptor)			50.00, 30.00	0.42, 0.18	95.23	26.54	35.35	97.38	52.10	-41.06	-72.42	99.87	99.90	99.63
CGS001-10988	KD	METAP2	Methionyl aminopeptidase, methionyl aminopeptidase 2			0.00, 0.00	1.28, 0.45	55.79	NaN	-95.08	-53.21	-52.52	-96.67	-97.89	-34.05	-98.17	-99.09
CGS001-79006	KD	METRN	meteorin, glial cell differentiation regulator			20.00, 20.00	0.73, 0.28	-54.80	-67.73	99.00	-31.09	24.46	31.72	-34.58	-98.79	99.97	-18.44
CGS001-4234	KD	METTL1	methyltransferase like 1			22.22, 11.11	1.59, 0.61	57.77	48.35	33.37	-45.71	-97.44	NaN	-39.76	96.87	99.97	46.93
CGS001-57721	KD	METTL14	methyltransferase like 14			0.00, 0.00	1.44, 0.40	90.26	-46.84	-92.77	53.47	NaN	-34.02	25.11	-29.82	-47.32	-15.18
CGS001-64863	KD	METTL4	methyltransferase like 4			10.00, 0.00	1.10, 0.27	88.48	-15.61	15.23	33.09	-31.30	-29.27	96.62	63.18	54.27	34.75
CGS001-399664	KD	MEX3D	Mex-3 homologs, mex-3 homolog D (C. elegans)			0.00, 0.00	1.20, 0.41	-24.31	-20.87	36.80	37.72	22.71	47.02	NaN	NaN	42.39	9.57
CGS001-9258	KD	MFHAS1	malignant fibrous histiocytoma amplified sequence 1			11.11, 11.11	0.73, 0.16	-18.54	13.67	8.57	-86.08	-22.54	NaN	77.12	98.33	39.79	22.89
CGS001-10227	KD	MFSD10	major facilitator superfamily domain containing 10			50.00, 37.50	1.69, 0.53	-37.25	NaN	-60.14	97.07	99.65	NaN	-39.49	63.29	99.67	99.11
CGS001-4245	KD	MGAT1	mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase			0.00, 0.00	1.23, 0.19	-81.58	83.06	-18.83	-70.53	24.54	-96.56	-99.95	-64.60	-68.57	-70.07
CGS001-11320	KD	MGAT4A	mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme A			0.00, 0.00	1.95, 0.58	42.74	46.84	-48.88	-87.71	-22.47	NaN	NaN	-59.80	-19.44	-30.74
CGS001-11343	KD	MGLL	Endocannabinoid turnover, monoglyceride lipase			0.00, 0.00	1.05, 0.25	-23.71	-20.63	-99.93	-99.98	76.78	NaN	85.93	73.61	-99.74	-99.87
CGS001-4255	KD	MGMT	O-6-methylguanine-DNA methyltransferase			0.00, 0.00	1.90, 0.53	-41.54	37.22	-50.40	49.10	-99.98	56.08	23.86	NaN	NaN	-18.25
CGS001-4258	KD	MGST2	Glutathione S-transferases / Microsomal, microsomal glutathione S-transferase 2			0.00, 0.00	1.57, 0.52	-55.49	-99.61	-95.53	-99.89	-71.59	-99.37	-84.43	-50.53	-28.75	-99.50
CGS001-85377	KD	MICALL1	MICAL-like 1			50.00, 33.33	3.24, 1.15	NaN	NaN	97.62	97.76	41.22	NaN	NaN	59.96	-58.78	96.87
CGS001-4282	KD	MIF	macrophage migration inhibitory factor (glycosylation-inhibiting factor)			0.00, 0.00	1.18, 0.39	31.58	45.15	-43.45	-94.09	45.35	32.65	74.68	-52.89	NaN	28.22
CGS001-4286	KD	MITF	Basic helix-loop-helix proteins, microphthalmia-associated transcription factor			0.00, 0.00	1.25, 0.38	-76.43	81.53	-13.68	-99.64	25.54	-52.62	59.13	-40.95	24.45	-28.71
CGS001-83881	KD	MIXL1	Homeoboxes / PRD class, Mix paired-like homeobox		PRD class homeoboxes and psudogenes LOF	0.00, 0.00	1.74, 0.55	-92.10	-84.39	55.37	38.14	31.52	40.97	NaN	-28.89	-23.11	32.21
CGS001-84365	KD	MKI67IP	MKI67 (FHA domain) interacting nucleolar phosphoprotein			0.00, 0.00	1.26, 0.44	38.35	19.17	-96.14	57.08	68.04	-30.68	40.58	-40.00	88.64	35.23
CGS001-8569	KD	MKNK1	MKN subfamily, MAP kinase interacting serine/threonine kinase 1			0.00, 0.00	1.06, 0.38	38.31	26.43	69.00	77.93	-99.03	62.23	-78.63	33.09	-46.72	18.90
CGS001-2872	KD	MKNK2	MKN subfamily, MAP kinase interacting serine/threonine kinase 2			28.57, 28.57	1.51, 0.44	-96.20	100.00	-70.84	NaN	NaN	NaN	55.39	98.86	-84.12	91.48
CGS001-283078	KD	MKX	Homeoboxes / TALE class, mohawk homeobox			0.00, 0.00	1.33, 0.38	-28.10	54.25	-44.36	-35.83	-36.50	-46.05	NaN	27.96	23.80	-14.18
CGS001-9761	KD	MLEC	malectin			0.00, 0.00	1.23, 0.43	-18.67	36.52	-60.46	-80.10	-23.94	NaN	-49.56	-58.90	26.09	-50.98
CGS001-4292	KD	MLH1	mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli)			0.00, 0.00	1.70, 0.31	31.97	26.14	69.01	92.22	20.44	32.44	84.90	-9.95	-48.74	38.31
CGS001-4297	KD	MLL	myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila)			0.00, 0.00	1.38, 0.28	-28.69	NaN	-18.85	-67.46	27.15	NaN	-27.07	-81.52	21.68	-11.96
CGS001-58508	KD	MLL3	myeloid/lymphoid or mixed-lineage leukemia 3			0.00, 0.00	2.08, 0.52	91.27	-23.90	53.79	92.53	19.93	NaN	-30.76	58.87	67.04	65.36
CGS001-8028	KD	MLLT10	Zinc fingers, PHD-type, myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 10			10.00, 10.00	1.42, 0.36	80.08	-27.17	57.58	-14.17	33.67	30.93	99.96	-94.69	-95.95	15.61
CGS001-10962	KD	MLLT11	myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 11			0.00, 0.00	1.32, 0.43	-76.61	-77.66	-42.61	-73.96	92.88	NaN	NaN	NaN	18.19	-58.18
CGS001-4300	KD	MLLT3	myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 3			33.33, 22.22	1.66, 0.57	49.78	40.16	70.90	37.05	-56.92	98.36	99.96	91.25	NaN	96.45
CGS001-4302	KD	MLLT6	Zinc fingers, PHD-type, myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 6			0.00, 0.00	1.69, 0.43	19.27	-25.49	-24.42	24.59	48.17	22.18	-32.58	-87.06	22.38	-6.42
CGS001-64223	KD	MLST8	WD repeat domain containing, MTOR associated protein, LST8 homolog (S. cerevisiae)			0.00, 0.00	0.76, 0.15	20.61	-46.23	19.68	-85.27	73.01	-30.38	-54.69	-99.01	19.72	-18.28
CGS001-22877	KD	MLXIP	Basic helix-loop-helix proteins, MLX interacting protein			0.00, 0.00	1.08, 0.45	-61.98	-26.18	94.99	25.67	-41.15	82.07	56.53	-72.57	NaN	-21.91
CGS001-79258	KD	MMEL1	membrane metallo-endopeptidase-like 1			0.00, 0.00	1.16, 0.43	-66.04	-67.46	-99.98	56.10	87.55	NaN	-81.09	50.66	-21.43	-62.91
CGS001-4312	KD	MMP1	Matrix metallopeptidase, matrix metallopeptidase 1 (interstitial collagenase)			0.00, 0.00	1.60, 0.58	84.56	NaN	55.33	93.68	-24.89	52.16	NaN	51.31	NaN	65.27
CGS001-4323	KD	MMP14	Matrix metallopeptidase, matrix metallopeptidase 14 (membrane-inserted)			0.00, 0.00	1.82, 0.50	35.80	-81.54	28.22	NaN	-51.34	NaN	46.13	-96.68	86.07	-38.21
CGS001-4313	KD	MMP2	Matrix metallopeptidase, matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase)			0.00, 0.00	1.25, 0.33	-43.67	-45.04	-33.35	-36.74	-89.35	-24.57	-55.63	-79.34	-99.93	-81.84
CGS001-4316	KD	MMP7	Matrix metallopeptidase, matrix metallopeptidase 7 (matrilysin, uterine)			0.00, 0.00	1.59, 0.43	-58.90	53.66	-21.10	45.54	41.14	NaN	32.86	37.40	87.96	33.93
CGS001-4331	KD	MNAT1	RING-type (C3HC4) zinc fingers, menage a trois homolog 1, cyclin H assembly factor (Xenopus laevis)			22.22, 11.11	1.75, 0.52	96.91	97.72	67.17	91.75	41.93	NaN	62.91	-96.66	-95.73	89.59
CGS001-5891	KD	MOK	RCK family, MOK protein kinase			0.00, 0.00	1.19, 0.31	-99.36	-97.96	48.66	-34.88	-99.47	-42.80	-99.70	-75.74	-74.04	-99.76
CGS001-10933	KD	MORF4L1	mortality factor 4 like 1		EMSY complex LOF	11.11, 11.11	1.23, 0.35	32.59	98.20	-40.57	28.11	-24.58	NaN	59.19	-50.69	24.86	9.64
CGS001-9643	KD	MORF4L2	mortality factor 4 like 2			0.00, 0.00	0.93, 0.16	54.92	-17.15	-21.12	71.57	-23.43	NaN	-42.40	67.92	-80.58	-5.21
CGS001-8777	KD	MPDZ	multiple PDZ domain protein			14.29, 0.00	1.36, 0.52	NaN	72.42	-99.61	NaN	56.26	NaN	-50.50	-97.62	97.40	-91.12
CGS001-10198	KD	MPHOSPH9	M-phase phosphoprotein 9			40.00, 40.00	1.83, 0.57	88.87	25.96	97.82	83.72	98.14	-90.47	99.98	84.11	-60.06	97.87
CGS001-4351	KD	MPI	mannose phosphate isomerase			0.00, 0.00	2.23, 0.88	89.57	26.95	90.78	22.66	17.69	-22.13	30.13	25.32	NaN	12.80
CGS001-4352	KD	MPL	Prolactin receptor family, myeloproliferative leukemia virus oncogene			0.00, 0.00	1.30, 0.43	-95.74	NaN	-93.80	-77.82	-25.60	NaN	-47.47	45.52	51.23	-82.79
CGS001-9019	KD	MPZL1	Immunoglobulin superfamily / V-set domain containing, myelin protein zero-like 1			0.00, 0.00	1.38, 0.35	NaN	-29.06	-40.19	-66.35	-25.69	-30.50	-44.63	48.96	46.42	-52.33
CGS001-116512	KD	MRGPRD	GPCR / Class A : Orphans, MAS-related GPR, member D			10.00, 10.00	1.69, 0.44	-33.20	-54.40	-21.44	22.81	94.83	-61.24	-21.27	87.41	98.72	43.20
CGS001-116535	KD	MRGPRF	GPCR / Class A : Orphans, MAS-related GPR, member F			0.00, 0.00	1.07, 0.35	-90.28	-95.60	-78.07	-38.24	28.42	NaN	-28.16	-41.66	25.24	-63.92
CGS001-259249	KD	MRGPRX1	GPCR / Class A : Orphans, MAS-related GPR, member X1			0.00, 0.00	1.94, 0.59	60.80	32.93	44.58	-32.08	44.80	-43.60	NaN	65.83	33.10	35.66
CGS001-117194	KD	MRGPRX2	GPCR / Class A : Orphans, MAS-related GPR, member X2			0.00, 0.00	1.32, 0.47	22.78	93.34	-66.50	30.34	26.76	39.24	-26.05	90.39	-20.23	13.19
CGS001-117195	KD	MRGPRX3	GPCR / Class A : Orphans, MAS-related GPR, member X3			0.00, 0.00	1.61, 0.39	-57.28	21.33	93.38	34.29	56.30	25.81	NaN	90.36	-35.57	38.25
CGS001-117196	KD	MRGPRX4	GPCR / Class A : Orphans, MAS-related GPR, member X4			0.00, 0.00	2.23, 0.66	58.70	22.11	-36.89	29.25	-36.25	68.17	49.13	-42.29	-35.01	33.85
CGS001-6182	KD	MRPL12	Mitochondrial ribosomal proteins / large subunits, mitochondrial ribosomal protein L12			22.22, 22.22	1.60, 0.49	-43.36	54.33	99.82	99.33	64.31	64.16	NaN	-29.96	-44.10	73.59
CGS001-29074	KD	MRPL18	Mitochondrial ribosomal proteins / large subunits, mitochondrial ribosomal protein L18			0.00, 0.00	1.56, 0.48	NaN	NaN	-99.44	-99.48	-73.35	51.21	-13.09	-77.01	-93.32	-96.79
CGS001-9801	KD	MRPL19	Mitochondrial ribosomal proteins / large subunits, mitochondrial ribosomal protein L19			33.33, 22.22	0.73, 0.20	69.61	NaN	67.91	98.48	41.08	49.16	68.31	98.79	82.03	96.50
CGS001-51021	KD	MRPS16	Mitochondrial ribosomal proteins / small subunits, mitochondrial ribosomal protein S16			0.00, 0.00	1.18, 0.35	36.40	26.83	20.39	38.53	60.62	-98.83	-27.28	-81.73	30.81	4.26
CGS001-51116	KD	MRPS2	Mitochondrial ribosomal proteins / small subunits, mitochondrial ribosomal protein S2			22.22, 11.11	1.17, 0.33	NaN	99.06	-23.88	-98.17	95.18	47.75	-32.34	-91.81	-97.07	-91.19
CGS001-4436	KD	MSH2	mutS homolog 2, colon cancer, nonpolyposis type 1 (E. coli)			10.00, 0.00	0.58, 0.10	-23.77	21.42	-48.95	24.22	-21.82	-65.90	-15.33	96.20	-19.32	-2.84
CGS001-4439	KD	MSH5	mutS homolog 5 (E. coli)			0.00, 0.00	0.86, 0.23	-37.76	19.36	41.85	-44.40	53.03	-70.19	-84.49	-91.73	NaN	-44.08
CGS001-2956	KD	MSH6	mutS homolog 6 (E. coli)			0.00, 0.00	1.06, 0.19	-35.49	-42.96	23.69	-38.75	52.19	-38.58	-69.35	-31.17	22.91	-10.55
CGS001-10943	KD	MSL3	male-specific lethal 3 homolog (Drosophila)			0.00, 0.00	0.97, 0.25	56.88	62.61	-99.42	19.34	56.44	-96.08	-56.46	-27.08	49.95	16.65
CGS001-6307	KD	MSMO1	Fatty acid hydroxylase domain containing, methylsterol monooxygenase 1			11.11, 0.00	1.88, 0.63	95.84	-76.86	45.94	91.01	-19.86	NaN	-83.86	-48.48	-24.40	-27.76
CGS001-4482	KD	MSRA	methionine sulfoxide reductase A			10.00, 10.00	1.22, 0.47	-70.89	-89.22	-37.91	23.81	-69.10	41.42	41.17	-33.55	99.97	-41.09
CGS001-4485	KD	MST1	macrophage stimulating 1 (hepatocyte growth factor-like)			0.00, 0.00	1.40, 0.47	-99.90	NaN	-24.77	-37.48	-41.79	NaN	-66.37	85.56	52.65	-24.05
CGS001-4486	KD	MST1R	Type X RTKs: HGF (hepatocyte growth factor) receptor family, macrophage stimulating 1 receptor (c-met-related tyrosine kinase)			0.00, 0.00	0.91, 0.38	-23.03	6.48	-62.25	-72.70	48.15	-95.64	-99.77	-83.31	-99.97	-91.28
CGS001-4487	KD	MSX1	Homeoboxes / ANTP class : NKL subclass, msh homeobox 1			0.00, 0.00	0.97, 0.30	-96.92	49.87	-37.17	70.06	-90.50	75.42	82.02	-73.71	-79.35	-88.17
CGS001-9112	KD	MTA1	GATA zinc finger domain containing, metastasis associated 1		GATA Zinc finger domain containing LOF	0.00, 0.00	0.88, 0.14	-37.48	-89.60	-99.88	-26.64	41.31	51.43	32.03	-60.41	76.30	-18.43
CGS001-57504	KD	MTA3	GATA zinc finger domain containing, metastasis associated 1 family, member 3		GATA Zinc finger domain containing LOF	0.00, 0.00	1.36, 0.40	-89.08	-31.44	-74.44	-23.95	-45.66	NaN	-83.34	-97.47	65.34	-84.08
CGS001-4507	KD	MTAP	methylthioadenosine phosphorylase			10.00, 10.00	1.28, 0.42	34.26	-66.38	99.86	34.79	-65.86	36.41	40.90	86.53	-17.64	22.51
CGS001-51001	KD	MTERFD1	MTERF domain containing 1			11.11, 11.11	1.02, 0.35	NaN	47.87	-50.08	84.42	43.77	40.51	-28.54	-36.91	99.97	40.80
CGS001-22823	KD	MTF2	Zinc fingers, PHD-type, metal response element binding transcription factor 2			0.00, 0.00	1.52, 0.27	-69.13	NaN	-98.62	-93.26	NaN	-84.24	-35.42	-35.27	-74.73	-77.40
CGS001-9650	KD	MTFR1	mitochondrial fission regulator 1			14.29, 0.00	2.14, 0.50	-56.70	NaN	30.98	96.69	-95.06	NaN	NaN	-81.65	25.53	-80.89
CGS001-4522	KD	MTHFD1	methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1, methenyltetrahydrofolate cyclohydrolase, formyltetrahydrofolate synthetase			10.00, 0.00	1.09, 0.30	-96.52	31.70	-54.80	-47.49	73.85	95.66	-99.86	-89.75	25.27	-85.43
CGS001-10797	KD	MTHFD2	methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase			0.00, 0.00	1.15, 0.32	-98.24	-99.26	-74.84	-96.95	-46.53	-99.95	-99.39	-76.80	21.68	-99.05
CGS001-4548	KD	MTR	5-methyltetrahydrofolate-homocysteine methyltransferase			44.44, 11.11	2.07, 0.64	-72.78	69.72	96.35	-35.71	76.55	NaN	99.73	95.66	81.54	95.66
CGS001-4552	KD	MTRR	5-methyltetrahydrofolate-homocysteine methyltransferase reductase			0.00, 0.00	1.52, 0.30	26.36	60.36	-29.19	22.71	36.65	NaN	72.50	15.88	-23.10	19.91
CGS001-9788	KD	MTSS1	metastasis suppressor 1			10.00, 10.00	1.84, 0.60	98.07	-23.10	-31.21	27.16	-59.72	29.51	34.55	-36.21	-99.86	-14.87
CGS001-4547	KD	MTTP	microsomal triglyceride transfer protein			0.00, 0.00	1.14, 0.38	-30.74	24.81	-32.42	-82.30	57.32	-21.71	42.41	-32.70	35.88	8.37
CGS001-10651	KD	MTX2	metaxin 2			0.00, 0.00	1.33, 0.32	-67.39	26.93	-98.45	-22.71	NaN	NaN	-96.56	-99.51	-99.92	-99.82
CGS001-4594	KD	MUT	methylmalonyl CoA mutase			0.00, 0.00	1.15, 0.36	19.58	49.85	-88.68	-30.21	-42.49	-74.13	21.05	-91.99	NaN	-44.40
CGS001-9961	KD	MVP	major vault protein			11.11, 0.00	1.59, 0.47	92.48	24.11	96.69	84.80	51.27	NaN	62.15	-38.48	29.29	89.56
CGS001-83463	KD	MXD3	Basic helix-loop-helix proteins, MAX dimerization protein 3			0.00, 0.00	1.30, 0.40	-29.90	67.73	18.07	-22.25	-54.14	28.88	15.21	-98.76	NaN	-11.46
CGS001-10608	KD	MXD4	Basic helix-loop-helix proteins, MAX dimerization protein 4			44.44, 22.22	1.11, 0.24	38.88	56.21	76.35	99.72	97.45	NaN	22.58	96.12	-64.38	97.81
CGS001-4601	KD	MXI1	Basic helix-loop-helix proteins, MAX interactor 1			0.00, 0.00	1.09, 0.42	86.05	-49.07	-44.26	-97.11	-96.37	-33.23	86.53	-90.00	58.32	-63.04
CGS001-4602	KD	MYB	v-myb myeloblastosis viral oncogene homolog (avian)			0.00, 0.00	1.15, 0.30	-43.13	-60.97	-15.41	-98.29	-63.07	-29.43	-13.42	-98.31	-89.19	-54.01
CGS001-4605	KD	MYBL2	v-myb myeloblastosis viral oncogene homolog (avian)-like 2			0.00, 0.00	1.25, 0.25	-96.54	-66.54	-25.51	36.58	-36.75	-73.26	-99.95	-96.41	23.01	-79.37
CGS001-4609	KD	MYC	Basic helix-loop-helix proteins, v-myc myelocytomatosis viral oncogene homolog (avian)			0.00, 0.00	0.81, 0.18	-8.91	-99.82	-99.14	-54.74	-65.49	-99.91	-73.77	-96.10	-21.39	-99.03
CGS001-26292	KD	MYCBP	c-myc binding protein			0.00, 0.00	1.15, 0.28	18.00	23.86	-80.34	34.02	25.25	-26.86	-98.14	-17.41	60.21	5.73
CGS001-23077	KD	MYCBP2	MYC binding protein 2			88.89, 77.78	1.19, 0.33	99.94	99.43	-19.06	99.98	99.93	99.44	NaN	97.05	99.96	99.95
CGS001-4610	KD	MYCL1	v-myc myelocytomatosis viral oncogene homolog 1, lung carcinoma derived (avian)			11.11, 11.11	0.94, 0.27	40.86	NaN	66.12	-90.06	-72.11	-36.01	-99.07	-15.29	99.73	-46.72
CGS001-4613	KD	MYCN	Basic helix-loop-helix proteins, v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian)			0.00, 0.00	0.95, 0.25	-99.12	60.85	-96.66	-42.58	-25.01	48.26	-99.15	-95.92	17.77	-98.84
CGS001-4615	KD	MYD88	myeloid differentiation primary response gene (88)			12.50, 12.50	1.64, 0.36	-88.88	99.34	-83.56	-92.84	-87.83	NaN	NaN	-95.82	-61.24	-94.83
CGS001-4637	KD	MYL6	EF-hand domain containing, myosin, light chain 6, alkali, smooth muscle and non-muscle			0.00, 0.00	1.55, 0.48	-77.79	41.03	63.02	-41.39	59.19	-71.23	-27.15	-24.79	-64.18	-36.62
CGS001-140465	KD	MYL6B	EF-hand domain containing, myosin, light chain 6B, alkali, smooth muscle and non-muscle			12.50, 0.00	2.01, 0.63	96.56	72.22	29.09	94.05	-31.68	NaN	NaN	-33.60	-62.22	74.54
CGS001-10398	KD	MYL9	EF-hand domain containing, myosin, light chain 9, regulatory			0.00, 0.00	1.97, 0.64	-37.12	62.73	44.47	-99.86	NaN	-83.58	19.18	-28.10	NaN	-58.08
CGS001-29116	KD	MYLIP	myosin regulatory light chain interacting protein			20.00, 20.00	1.85, 0.59	91.32	38.61	99.50	65.13	-59.70	24.10	99.49	-35.62	-60.07	88.29
CGS001-4638	KD	MYLK	Myosin Light Chain Kinase (MLCK) family, myosin light chain kinase			0.00, 0.00	1.28, 0.33	-36.64	-98.83	-91.74	-99.95	-80.48	NaN	-35.46	-98.88	-88.38	-99.80
CGS001-85366	KD	MYLK2	Myosin Light Chain Kinase (MLCK) family, myosin light chain kinase 2			62.50, 62.50	2.02, 0.63	99.96	99.69	79.54	NaN	47.81	99.97	92.47	NaN	99.60	99.92
CGS001-4651	KD	MYO10	Pleckstrin homology (PH) domain containing, myosin X			11.11, 11.11	1.44, 0.44	97.60	NaN	-82.49	-36.71	-21.10	-89.98	-76.62	41.26	38.73	-63.02
CGS001-80018	KD	NAA25	N(alpha)-acetyltransferase subunits, N(alpha)-acetyltransferase 25, NatB auxiliary subunit			0.00, 0.00	1.80, 0.53	58.17	NaN	79.37	68.70	-24.63	81.13	-24.49	-83.85	34.85	68.87
CGS001-80218	KD	NAA50	N(alpha)-acetyltransferase subunits, N(alpha)-acetyltransferase 50, NatE catalytic subunit			40.00, 40.00	1.53, 0.51	63.32	99.02	76.09	97.81	-25.73	76.24	99.50	-28.48	-87.46	98.13
CGS001-4664	KD	NAB1	NGFI-A binding protein 1 (EGR1 binding protein 1)			0.00, 0.00	1.31, 0.49	-68.34	-46.14	-17.89	45.84	-29.22	-20.72	-92.15	-46.14	52.14	-19.69
CGS001-4665	KD	NAB2	NGFI-A binding protein 2 (EGR1 binding protein 2)			0.00, 0.00	1.01, 0.34	-58.47	-31.55	-20.03	-25.63	57.26	29.96	NaN	-73.20	20.39	-4.27
CGS001-55191	KD	NADSYN1	NAD synthetase 1			0.00, 0.00	1.25, 0.38	-17.66	22.70	53.59	64.20	81.30	-59.30	74.87	NaN	91.61	57.07
CGS001-8883	KD	NAE1	Ubiquitin-like modifier activating enzymes, NEDD8 activating enzyme E1 subunit 1			0.00, 0.00	1.15, 0.44	-66.91	55.83	-95.31	-72.44	39.31	-29.11	76.73	-99.79	-22.79	-45.16
CGS001-4668	KD	NAGA	N-acetylgalactosaminidase, alpha-			0.00, 0.00	0.75, 0.17	NaN	43.40	-72.15	-32.17	-39.80	-88.67	-36.41	-26.61	-68.06	-41.25
CGS001-55577	KD	NAGK	N-acetylglucosamine kinase			0.00, 0.00	1.48, 0.45	54.25	-76.93	78.38	38.45	29.20	33.41	-66.59	-35.62	NaN	20.17
CGS001-51172	KD	NAGPA	N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase			0.00, 0.00	1.36, 0.36	-46.74	-38.73	64.42	56.46	69.51	24.96	91.63	-88.03	NaN	42.23
CGS001-4671	KD	NAIP	Inhibitors of apoptosis (IAP) protein family, NLR family, apoptosis inhibitory protein		Baculoviral IAP repeat domain containing LOF	0.00, 0.00	1.74, 0.48	-94.04	-98.59	28.95	NaN	-55.68	NaN	-41.33	52.16	-48.94	-60.88
CGS001-10135	KD	NAMPT	nicotinamide phosphoribosyltransferase			0.00, 0.00	1.48, 0.47	-30.09	54.60	-98.93	-97.52	-99.63	NaN	-33.03	-32.57	-75.67	-99.36
CGS001-64428	KD	NARFL	nuclear prelamin A recognition factor-like			0.00, 0.00	2.57, 0.76	NaN	NaN	-26.35	-30.06	-29.54	-29.57	NaN	-41.25	55.21	-8.26
CGS001-4677	KD	NARS	Aminoacyl tRNA synthetases / Class II, asparaginyl-tRNA synthetase			0.00, 0.00	1.70, 0.56	-99.19	31.41	-19.16	42.92	-30.19	-99.73	36.22	-62.35	NaN	-45.68
CGS001-4678	KD	NASP	Tetratricopeptide (TTC) repeat domain containing, nuclear autoantigenic sperm protein (histone-binding)			55.56, 44.44	1.45, 0.33	29.39	99.96	18.51	99.30	-30.94	97.78	64.26	97.07	NaN	99.61
CGS001-9	KD	NAT1	N-acetyltransferase 1 (arylamine N-acetyltransferase)			20.00, 20.00	1.31, 0.41	80.22	-33.10	99.66	-33.93	98.63	75.27	71.07	-99.28	44.71	85.51
CGS001-55226	KD	NAT10	N-acetyltransferase 10 (GCN5-related)			55.56, 44.44	2.34, 0.65	43.88	88.96	67.21	97.10	98.23	NaN	97.93	66.80	99.89	98.00
CGS001-4077	KD	NBR1	neighbor of BRCA1 gene 1			10.00, 10.00	1.09, 0.30	-99.92	-99.91	-99.05	-49.44	98.74	34.88	-68.34	-99.95	-99.93	-99.95
CGS001-9918	KD	NCAPD2	non-SMC condensin I complex, subunit D2			42.86, 28.57	2.96, 1.14	-41.35	NaN	99.46	99.83	39.57	NaN	NaN	40.19	-73.69	96.55
CGS001-4688	KD	NCF2	Tetratricopeptide (TTC) repeat domain containing, neutrophil cytosolic factor 2			0.00, 0.00	1.03, 0.34	-96.22	NaN	93.97	-88.11	-69.34	NaN	36.54	31.09	-97.49	-97.63
CGS001-4691	KD	NCL	RNA binding motif (RRM) containing, nucleolin			0.00, 0.00	1.99, 0.74	-94.58	NaN	23.22	-41.62	NaN	54.60	19.80	-90.09	NaN	-64.04
CGS001-8202	KD	NCOA3	Histone acetyltransferases, nuclear receptor coactivator 3		Lysine acetyltransferases LOF	0.00, 0.00	1.24, 0.31	-97.15	-96.03	-75.52	-90.63	34.41	-95.58	-92.91	-24.18	-43.58	-90.13
CGS001-8031	KD	NCOA4	nuclear receptor coactivator 4			0.00, 0.00	1.66, 0.49	-97.94	NaN	-18.03	NaN	-21.25	NaN	-37.83	-90.57	-31.68	-50.86
CGS001-9612	KD	NCOR2	nuclear receptor corepressor 2			0.00, 0.00	1.45, 0.38	-96.39	NaN	-20.92	-24.24	-57.22	-97.24	-62.15	-99.05	-58.42	-74.39
CGS001-80762	KD	NDFIP1	Nedd4 family interacting protein 1			11.11, 11.11	1.55, 0.45	-93.58	28.48	-14.42	89.72	58.40	NaN	-41.95	97.83	-95.16	43.06
CGS001-10397	KD	NDRG1	N-myc downstream regulated 1			11.11, 0.00	1.27, 0.44	70.49	-23.96	-99.42	84.40	-29.21	NaN	95.44	-97.24	-96.52	-90.96
CGS001-4694	KD	NDUFA1	Mitochondrial respiratory chain complex / Complex I, NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 1, 7.5kDa			0.00, 0.00	2.03, 0.65	-26.39	-100.00	-23.21	25.07	50.43	-33.84	-25.00	-20.80	22.26	-8.31
CGS001-51079	KD	NDUFA13	Mitochondrial respiratory chain complex / Complex I, NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 13			50.00, 37.50	1.43, 0.41	73.80	30.83	77.76	99.80	-24.76	NaN	95.88	99.08	NaN	99.66
CGS001-4695	KD	NDUFA2	Mitochondrial respiratory chain complex / Complex I, NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 2, 8kDa			0.00, 0.00	1.09, 0.25	-79.03	NaN	-97.60	-99.96	-84.00	-49.24	-95.79	-75.07	23.27	-95.95
CGS001-4696	KD	NDUFA3	Mitochondrial respiratory chain complex / Complex I, NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 3, 9kDa			11.11, 11.11	1.65, 0.42	-34.98	NaN	99.82	88.65	90.02	-84.60	40.75	-38.07	32.27	88.03
CGS001-4697	KD	NDUFA4	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4, 9kDa			0.00, 0.00	1.34, 0.35	-38.32	-38.36	-24.52	33.43	-94.72	-35.47	-31.51	-78.25	NaN	-24.73
CGS001-4698	KD	NDUFA5	Mitochondrial respiratory chain complex / Complex I, NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 5, 13kDa			0.00, 0.00	1.14, 0.26	-92.27	-41.68	-31.84	-98.58	-98.23	-38.12	-66.51	-97.08	21.58	-88.30
CGS001-4701	KD	NDUFA7	Mitochondrial respiratory chain complex / Complex I, NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 7, 14.5kDa			0.00, 0.00	1.45, 0.50	60.63	NaN	-17.59	-56.35	-46.21	-99.93	39.69	41.36	NaN	-18.67
CGS001-4702	KD	NDUFA8	Mitochondrial respiratory chain complex / Complex I, NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 8, 19kDa			40.00, 30.00	1.66, 0.47	90.93	99.12	85.53	99.61	76.91	79.64	96.24	28.30	65.48	98.15
CGS001-4704	KD	NDUFA9	Short chain dehydrogenase/reductase superfamily / Extended SDR fold, NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 9, 39kDa		NADH ubiquinone oxidoreductase supernumerary subunits LOF	44.44, 44.44	1.31, 0.26	85.21	99.06	59.19	83.88	-34.76	NaN	18.63	99.77	99.64	99.55
CGS001-4706	KD	NDUFAB1	Mitochondrial respiratory chain complex / Complex I, NADH dehydrogenase (ubiquinone) 1, alpha/beta subcomplex, 1, 8kDa		NADH ubiquinone oxidoreductase supernumerary subunits LOF	25.00, 25.00	2.56, 0.92	26.13	100.00	-26.10	84.23	-89.19	NaN	NaN	99.95	82.61	91.67
CGS001-29078	KD	NDUFAF4	Mitochondrial respiratory chain complex assembly factors, NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, assembly factor 4			11.11, 0.00	1.15, 0.47	-43.55	-23.88	15.07	97.11	21.28	-23.47	10.68	-29.01	NaN	-1.61
CGS001-4707	KD	NDUFB1	Mitochondrial respiratory chain complex / Complex I, NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 1, 7kDa			50.00, 37.50	1.78, 0.57	57.75	100.00	79.50	26.42	NaN	NaN	99.98	89.52	95.36	98.55
CGS001-4708	KD	NDUFB2	Mitochondrial respiratory chain complex / Complex I, NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 2, 8kDa			0.00, 0.00	1.13, 0.26	-99.65	34.16	18.42	27.93	93.68	NaN	-44.68	48.86	-28.35	6.35
CGS001-4709	KD	NDUFB3	Mitochondrial respiratory chain complex / Complex I, NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 3, 12kDa			0.00, 0.00	1.60, 0.39	-91.57	-26.87	-21.93	NaN	-47.26	NaN	28.66	-67.68	86.76	-14.30
CGS001-4710	KD	NDUFB4	Mitochondrial respiratory chain complex / Complex I, NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 4, 15kDa			0.00, 0.00	2.02, 0.55	-40.09	NaN	-33.58	39.38	NaN	-49.97	24.24	-72.50	NaN	-33.95
CGS001-4712	KD	NDUFB6	Mitochondrial respiratory chain complex / Complex I, NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 6, 17kDa			50.00, 50.00	1.80, 0.60	-33.27	NaN	98.30	99.26	-30.22	NaN	-32.01	9.23	99.92	99.74
CGS001-4713	KD	NDUFB7	Mitochondrial respiratory chain complex / Complex I, NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 7, 18kDa			0.00, 0.00	1.60, 0.64	-33.18	-74.38	-30.19	-38.45	NaN	35.07	27.19	-79.55	-49.48	-27.08
CGS001-4714	KD	NDUFB8	Mitochondrial respiratory chain complex / Complex I, NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 8, 19kDa		NADH ubiquinone oxidoreductase supernumerary subunits LOF	0.00, 0.00	2.05, 0.65	NaN	38.50	77.89	76.58	55.01	94.60	NaN	92.43	51.42	81.80
CGS001-4717	KD	NDUFC1	Mitochondrial respiratory chain complex / Complex I, NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 1, 6kDa			0.00, 0.00	1.34, 0.48	-38.77	46.63	-32.22	-81.13	62.83	NaN	-99.98	-21.61	-69.27	-59.12
CGS001-4718	KD	NDUFC2	Mitochondrial respiratory chain complex / Complex I, NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2, 14.5kDa			0.00, 0.00	1.82, 0.63	-42.80	-31.31	85.30	-18.50	24.18	NaN	-20.37	47.42	37.09	9.43
CGS001-4719	KD	NDUFS1	Mitochondrial respiratory chain complex / Complex I, NADH dehydrogenase (ubiquinone) Fe-S protein 1, 75kDa (NADH-coenzyme Q reductase)			0.00, 0.00	1.22, 0.40	-97.60	-35.59	83.71	-41.29	-42.76	-56.92	-72.77	-68.14	-92.01	-84.12
CGS001-4720	KD	NDUFS2	Mitochondrial respiratory chain complex / Complex I, NADH dehydrogenase (ubiquinone) Fe-S protein 2, 49kDa (NADH-coenzyme Q reductase)			10.00, 10.00	1.17, 0.41	-25.74	-36.41	36.27	-29.22	93.80	54.15	97.99	-18.72	-31.90	12.65
CGS001-4722	KD	NDUFS3	Mitochondrial respiratory chain complex / Complex I, NADH dehydrogenase (ubiquinone) Fe-S protein 3, 30kDa (NADH-coenzyme Q reductase)			10.00, 10.00	1.30, 0.34	-27.58	27.38	31.93	57.73	33.40	-26.80	99.98	22.60	-40.26	6.35
CGS001-4724	KD	NDUFS4	Mitochondrial respiratory chain complex / Complex I, NADH dehydrogenase (ubiquinone) Fe-S protein 4, 18kDa (NADH-coenzyme Q reductase)		NADH ubiquinone oxidoreductase supernumerary subunits LOF	0.00, 0.00	1.90, 0.74	-72.45	53.83	25.11	59.15	-45.17	NaN	24.99	70.52	87.59	54.36
CGS001-4726	KD	NDUFS6	Mitochondrial respiratory chain complex / Complex I, NADH dehydrogenase (ubiquinone) Fe-S protein 6, 13kDa (NADH-coenzyme Q reductase)			30.00, 20.00	1.23, 0.36	83.11	71.67	99.87	-47.67	22.74	96.49	99.39	-93.91	-21.93	94.02
CGS001-374291	KD	NDUFS7	Mitochondrial respiratory chain complex / Complex I, NADH dehydrogenase (ubiquinone) Fe-S protein 7, 20kDa (NADH-coenzyme Q reductase)			12.50, 12.50	1.99, 0.76	50.03	-86.52	92.40	99.31	41.98	NaN	-98.41	NaN	-28.81	48.89
CGS001-4723	KD	NDUFV1	Mitochondrial respiratory chain complex / Complex I, NADH dehydrogenase (ubiquinone) flavoprotein 1, 51kDa			12.50, 12.50	1.69, 0.44	21.16	NaN	-18.82	-90.54	39.72	-94.93	99.98	-92.36	NaN	-77.12
CGS001-4729	KD	NDUFV2	Mitochondrial respiratory chain complex / Complex I, NADH dehydrogenase (ubiquinone) flavoprotein 2, 24kDa			0.00, 0.00	1.30, 0.38	-52.77	-44.79	-31.91	23.14	-46.00	26.55	-37.42	23.60	87.69	-16.51
CGS001-4734	KD	NEDD4	neural precursor cell expressed, developmentally down-regulated 4			0.00, 0.00	1.20, 0.49	15.57	33.88	22.87	84.74	79.55	67.18	NaN	-94.14	25.70	40.36
CGS001-4751	KD	NEK2	NIMA (never in mitosis gene a)- related kinase (NEK) family, NIMA (never in mitosis gene a)-related kinase 2			22.22, 11.11	1.15, 0.30	-56.33	99.67	-32.15	61.44	64.42	NaN	-96.87	97.20	-26.27	58.48
CGS001-6787	KD	NEK4	NIMA (never in mitosis gene a)- related kinase (NEK) family, NIMA (never in mitosis gene a)-related kinase 4			0.00, 0.00	1.22, 0.40	-99.84	NaN	82.50	NaN	23.08	NaN	73.85	-99.53	67.63	72.54
CGS001-140609	KD	NEK7	NIMA (never in mitosis gene a)- related kinase (NEK) family, NIMA (never in mitosis gene a)-related kinase 7			0.00, 0.00	1.16, 0.32	-87.37	-15.25	9.03	NaN	-39.32	-99.59	-99.65	-51.48	41.51	-61.61
CGS001-91754	KD	NEK9	NIMA (never in mitosis gene a)- related kinase (NEK) family, NIMA (never in mitosis gene a)- related kinase 9			11.11, 11.11	0.85, 0.20	-61.89	-35.45	-27.14	36.19	21.52	45.11	NaN	-41.38	99.95	19.78
CGS001-29937	KD	NENF	neudesin neurotrophic factor			11.11, 0.00	1.98, 0.49	NaN	88.62	-65.05	67.59	-99.56	33.83	96.29	-97.55	44.96	45.09
CGS001-10276	KD	NET1	Rho guanine nucleotide exchange factors, neuroepithelial cell transforming 1			0.00, 0.00	1.25, 0.34	85.99	-67.71	-37.54	-97.07	72.92	-43.98	NaN	-33.35	-24.37	-23.08
CGS001-4758	KD	NEU1	sialidase 1 (lysosomal sialidase)			0.00, 0.00	1.92, 0.59	-67.00	-43.46	-71.36	-89.86	57.73	-55.58	NaN	-76.57	-32.82	-73.71
CGS001-4763	KD	NF1	neurofibromin 1			22.22, 11.11	1.61, 0.34	23.51	-32.22	29.25	-30.04	95.73	NaN	98.84	-87.98	41.60	42.18
CGS001-4771	KD	NF2	A-kinase anchor proteins, neurofibromin 2 (merlin)			0.00, 0.00	0.78, 0.26	-37.45	NaN	-53.35	NaN	-90.81	NaN	94.52	75.40	91.66	87.82
CGS001-10725	KD	NFAT5	Nuclear factor of activated T-cells, nuclear factor of activated T-cells 5, tonicity-responsive			11.11, 11.11	1.06, 0.28	-63.20	99.06	-24.52	-30.44	33.79	NaN	-68.06	89.43	-22.91	-6.24
CGS001-4773	KD	NFATC2	Nuclear factor of activated T-cells, nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2			11.11, 11.11	1.75, 0.67	91.73	-68.23	99.91	35.89	86.02	NaN	-27.86	35.46	-29.23	89.59
CGS001-4775	KD	NFATC3	Nuclear factor of activated T-cells, nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 3			11.11, 0.00	1.02, 0.39	-99.69	39.38	45.01	33.80	72.16	97.32	-37.90	-94.76	NaN	22.66
CGS001-4779	KD	NFE2L1	basic leucine zipper proteins, nuclear factor (erythroid-derived 2)-like 1			11.11, 11.11	1.70, 0.50	83.78	32.41	99.48	56.57	28.15	NaN	45.07	-32.07	-86.05	45.67
CGS001-4780	KD	NFE2L2	basic leucine zipper proteins, nuclear factor (erythroid-derived 2)-like 2			10.00, 10.00	0.95, 0.20	33.52	-31.36	-17.90	-26.80	24.40	37.39	-35.32	77.38	99.67	16.15
CGS001-4781	KD	NFIB	nuclear factor I/B			0.00, 0.00	1.25, 0.44	-96.07	-100.00	-75.16	-87.74	-41.83	34.67	-73.07	-26.78	24.39	-91.31
CGS001-4782	KD	NFIC	nuclear factor I/C (CCAAT-binding transcription factor)			0.00, 0.00	1.64, 0.45	-28.27	NaN	-34.09	-61.45	-99.98	59.47	62.57	-93.36	-95.35	-95.56
CGS001-4783	KD	NFIL3	basic leucine zipper proteins, nuclear factor, interleukin 3 regulated			0.00, 0.00	1.16, 0.41	66.57	92.39	-39.08	-95.17	-91.72	-41.29	NaN	16.97	-21.12	-30.93
CGS001-4790	KD	NFKB1	NFkappaB transcription factor family, nuclear factor of kappa light polypeptide gene enhancer in B-cells 1			11.11, 0.00	1.19, 0.26	96.51	-26.03	-35.44	-99.98	41.02	NaN	-32.13	-94.17	-17.70	-17.78
CGS001-4791	KD	NFKB2	NFkappaB transcription factor family, nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100)			0.00, 0.00	1.23, 0.34	-21.15	-27.22	-68.65	-99.14	-20.63	NaN	-23.25	-97.83	-81.42	-78.77
CGS001-4792	KD	NFKBIA	Ankyrin repeat domain containing, nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha			0.00, 0.00	1.83, 0.51	84.79	-73.73	28.94	59.62	62.03	-23.01	94.56	-93.92	-48.22	47.89
CGS001-4793	KD	NFKBIB	Ankyrin repeat domain containing, nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta			0.00, 0.00	1.92, 0.58	-99.93	-99.91	-76.95	-23.68	-91.30	-99.97	-95.53	-91.29	-99.88	-99.84
CGS001-4794	KD	NFKBIE	Ankyrin repeat domain containing, nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon			40.00, 40.00	1.40, 0.41	-36.74	36.14	77.53	77.42	99.96	84.85	-30.66	99.94	99.34	99.61
CGS001-4795	KD	NFKBIL1	nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 1			10.00, 10.00	1.44, 0.39	-62.22	-46.13	-27.66	-92.16	73.34	99.23	38.51	-41.73	-99.14	-44.10
CGS001-4798	KD	NFRKB	INO80 complex subunits, nuclear factor related to kappaB binding protein			22.22, 22.22	1.73, 0.34	59.65	-45.76	-47.56	24.63	62.88	NaN	99.96	99.88	62.82	66.60
CGS001-4801	KD	NFYB	nuclear transcription factor Y, beta			20.00, 10.00	1.53, 0.51	97.42	-59.61	-94.77	-89.23	99.93	-92.74	27.84	-95.94	-61.31	-92.28
CGS001-4804	KD	NGFR	Tumour necrosis factor (TNF) receptor family, nerve growth factor receptor			22.22, 11.11	1.25, 0.40	46.56	NaN	29.41	23.26	95.83	-36.92	93.67	99.68	33.18	91.99
CGS001-51335	KD	NGRN	neugrin, neurite outgrowth associated			12.50, 12.50	1.57, 0.68	NaN	99.76	-47.82	51.26	-38.08	NaN	53.83	29.63	-26.06	35.35
CGS001-4811	KD	NID1	nidogen 1			11.11, 11.11	1.59, 0.44	91.09	71.57	-34.16	NaN	83.02	58.25	-24.05	99.17	86.13	90.06
CGS001-25836	KD	NIPBL	Nipped-B homolog (Drosophila)			0.00, 0.00	1.89, 0.52	-90.05	NaN	-42.59	-31.07	-78.97	-64.80	NaN	-91.40	32.96	-84.62
CGS001-8508	KD	NIPSNAP1	nipsnap homolog 1 (C. elegans)			22.22, 11.11	1.85, 0.66	NaN	-62.19	81.96	99.64	95.98	28.52	25.43	-17.13	73.69	91.17
CGS001-11188	KD	NISCH	nischarin			0.00, 0.00	1.74, 0.50	37.65	-36.21	77.59	55.88	-24.80	NaN	NaN	-35.12	28.17	13.64
CGS001-4817	KD	NIT1	nitrilase 1			0.00, 0.00	1.99, 0.38	58.68	-98.67	-88.43	-99.91	-68.60	-99.80	NaN	-72.54	-35.88	-98.64
CGS001-28512	KD	NKIRAS1	NFKB inhibitor interacting Ras-like 1			0.00, 0.00	1.72, 0.47	NaN	NaN	48.82	39.95	58.01	NaN	61.54	74.94	86.78	70.49
CGS001-28511	KD	NKIRAS2	NFKB inhibitor interacting Ras-like 2			20.00, 10.00	1.35, 0.40	-73.88	-41.33	-58.74	-83.56	95.23	-37.41	-45.48	-89.39	97.97	-43.36
CGS001-7080	KD	NKX2-1	Homeoboxes / ANTP class : NKL subclass, NK2 homeobox 1			40.00, 40.00	1.36, 0.45	92.74	21.30	24.32	65.57	99.15	-28.67	-18.56	99.89	99.97	99.13
CGS001-159296	KD	NKX2-3	Homeoboxes / ANTP class : NKL subclass, NK2 homeobox 3			0.00, 0.00	1.86, 0.52	-99.98	-99.98	-16.99	-37.14	-65.91	-70.65	-99.53	-85.99	26.56	-99.61
CGS001-1482	KD	NKX2-5	Homeoboxes / ANTP class : NKL subclass, NK2 homeobox 5			11.11, 11.11	1.63, 0.50	-61.62	-87.56	-24.98	99.00	NaN	24.07	-32.25	45.46	67.84	15.50
CGS001-51701	KD	NLK	nmo subfamily, nemo-like kinase			50.00, 37.50	0.76, 0.30	97.02	100.00	-56.94	81.26	-27.09	NaN	NaN	98.26	94.45	99.42
CGS001-4830	KD	NME1	non-metastatic cells 1, protein (NM23A) expressed in			0.00, 0.00	0.80, 0.23	-68.28	65.55	-95.44	-67.73	-46.02	-57.04	31.78	-99.59	23.36	-58.25
CGS001-4833	KD	NME4	non-metastatic cells 4, protein expressed in			0.00, 0.00	1.31, 0.45	-98.76	-94.07	65.14	-99.90	-70.64	-99.91	-99.98	-33.46	19.51	-99.89
CGS001-347736	KD	NME9	NME gene family member 9			0.00, 0.00	1.34, 0.35	-39.60	85.63	18.72	23.75	22.23	-99.43	-62.77	-24.24	NaN	-21.66
CGS001-9111	KD	NMI	N-myc (and STAT) interactor			0.00, 0.00	1.45, 0.45	-24.07	NaN	31.13	-47.58	31.76	53.89	-35.81	-98.88	NaN	-23.77
CGS001-23057	KD	NMNAT2	nicotinamide nucleotide adenylyltransferase 2			0.00, 0.00	1.56, 0.57	-24.49	-65.50	-26.24	-93.35	38.96	NaN	-14.66	-57.61	NaN	-38.20
CGS001-4836	KD	NMT1	N-myristoyltransferase 1			10.00, 0.00	1.08, 0.36	-19.05	44.11	-91.97	-28.28	30.78	95.93	-30.21	-13.62	-56.48	-6.87
CGS001-56923	KD	NMUR2	GPCR / Class A : Neuromedin U receptors, neuromedin U receptor 2			0.00, 0.00	1.90, 0.61	-98.51	-30.27	-88.02	34.43	-95.96	49.12	-95.18	-98.95	-67.15	-95.41
CGS001-23530	KD	NNT	nicotinamide nucleotide transhydrogenase			20.00, 10.00	1.24, 0.45	-39.38	99.34	83.33	96.59	-98.88	42.21	74.58	-84.34	-93.85	85.42
CGS001-10392	KD	NOD1	Nucleotide-binding domain and leucine rich repeat containing, nucleotide-binding oligomerization domain containing 1			0.00, 0.00	1.82, 0.39	-73.31	-96.66	-99.24	-95.70	-48.95	NaN	38.88	-99.68	-99.05	-99.57
CGS001-64127	KD	NOD2	Nucleotide-binding domain and leucine rich repeat containing, nucleotide-binding oligomerization domain containing 2			10.00, 10.00	1.03, 0.32	-80.58	19.73	-99.94	98.21	-50.47	25.10	-99.96	51.35	22.70	-47.86
CGS001-8996	KD	NOL3	nucleolar protein 3 (apoptosis repressor with CARD domain)			22.22, 22.22	1.68, 0.49	NaN	17.98	31.14	98.28	26.04	45.70	98.33	80.28	28.50	58.94
CGS001-9221	KD	NOLC1	nucleolar and coiled-body phosphoprotein 1			0.00, 0.00	0.98, 0.20	93.29	48.94	-47.27	-39.68	21.78	-28.89	35.96	28.34	-79.83	7.74
CGS001-4841	KD	NONO	RNA binding motif (RRM) containing, non-POU domain containing, octamer-binding			14.29, 14.29	1.85, 0.60	99.89	NaN	67.32	NaN	87.96	NaN	-35.89	59.35	-58.67	81.58
CGS001-4846	KD	NOS3	Nitric oxide synthases, nitric oxide synthase 3 (endothelial cell)			0.00, 0.00	1.57, 0.47	-89.32	-36.81	-53.61	61.45	NaN	85.74	-24.41	-89.49	-22.69	-25.06
CGS001-51070	KD	NOSIP	nitric oxide synthase interacting protein			0.00, 0.00	1.56, 0.47	-32.98	-36.99	-95.80	-80.03	-65.42	-24.37	-59.59	-20.67	26.30	-65.01
CGS001-4851	KD	NOTCH1	Ankyrin repeat domain containing, notch 1			0.00, 0.00	0.89, 0.24	-30.43	-21.53	-91.15	28.01	-99.98	64.11	-89.18	-99.89	-99.96	-99.74
CGS001-4853	KD	NOTCH2	Ankyrin repeat domain containing, notch 2			50.00, 37.50	1.15, 0.32	98.83	NaN	-14.59	NaN	97.55	-26.76	99.95	-80.24	35.33	95.67
CGS001-388677	KD	NOTCH2NL	notch 2 N-terminal like			0.00, 0.00	1.28, 0.35	-41.25	-54.52	27.91	-87.25	61.89	21.98	-56.77	67.69	44.54	-20.97
CGS001-4856	KD	NOV	nephroblastoma overexpressed gene			0.00, 0.00	1.75, 0.51	NaN	19.62	72.96	NaN	43.19	NaN	-31.63	-84.93	33.55	17.44
CGS001-27035	KD	NOX1	NADPH oxidase 1			0.00, 0.00	1.19, 0.38	-55.83	-100.00	19.20	26.39	31.46	-58.52	-49.92	-40.70	47.31	-19.88
CGS001-2831	KD	NPBWR1	GPCR / Class A : Neuropeptide receptors : W/B, neuropeptides B/W receptor 1			0.00, 0.00	1.48, 0.40	-87.16	90.14	21.75	-39.39	47.04	71.67	-24.42	69.90	21.56	30.95
CGS001-4864	KD	NPC1	Niemann-Pick disease, type C1			0.00, 0.00	1.26, 0.33	56.71	60.67	-99.64	-25.23	-26.51	-65.16	NaN	-87.53	26.63	-42.81
CGS001-56654	KD	NPDC1	neural proliferation, differentiation and control, 1			22.22, 11.11	1.45, 0.50	NaN	-35.21	33.27	-39.03	99.74	95.43	-20.83	42.19	89.74	89.07
CGS001-79716	KD	NPEPL1	Leucyl aminopeptidase, aminopeptidase-like 1			0.00, 0.00	1.40, 0.33	-87.68	NaN	-98.94	-25.33	30.71	-92.61	-27.25	-52.67	-99.77	-93.35
CGS001-9520	KD	NPEPPS	Aminopeptidase N, aminopeptidase puromycin sensitive			0.00, 0.00	1.15, 0.35	45.87	69.41	74.35	29.41	-73.64	-29.82	-16.15	-23.21	-60.24	10.44
CGS001-10886	KD	NPFFR2	GPCR / Class A : Neuropeptide receptors : FF/AF, neuropeptide FF receptor 2			55.56, 55.56	1.36, 0.50	-28.42	-24.78	72.71	99.75	99.98	99.97	99.89	81.82	NaN	99.95
CGS001-4869	KD	NPM1	nucleophosmin (nucleolar phosphoprotein B23, numatrin)			0.00, 0.00	1.83, 0.56	76.06	-99.98	-14.13	-96.42	-78.72	NaN	-61.64	-99.24	-99.97	-99.87
CGS001-10641	KD	NPRL2	nitrogen permease regulator-like 2 (S. cerevisiae)			0.00, 0.00	0.99, 0.22	34.09	-96.05	-41.42	-20.88	-54.89	-33.93	-33.48	-46.20	26.32	-24.90
CGS001-387129	KD	NPSR1	GPCR / Class A : Neuropeptide receptors : S, neuropeptide S receptor 1			22.22, 11.11	1.36, 0.39	24.99	-31.73	-25.46	99.35	97.06	-96.02	-53.43	-47.64	NaN	-26.58
CGS001-27020	KD	NPTN	Immunoglobulin superfamily / Immunoglobulin-like domain containing, neuroplastin			0.00, 0.00	1.22, 0.38	-95.50	-90.85	-90.23	-58.48	-99.82	-99.94	-99.95	-98.19	NaN	-99.76
CGS001-4886	KD	NPY1R	GPCR / Class A : Neuropeptide receptors : Y, neuropeptide Y receptor Y1			0.00, 0.00	1.50, 0.40	-90.36	-98.29	-98.02	-99.94	91.12	-71.66	-20.44	-95.82	-93.82	-98.81
CGS001-1728	KD	NQO1	NAD(P)H dehydrogenase, quinone 1			0.00, 0.00	1.35, 0.45	-50.93	-35.28	89.69	25.63	30.36	NaN	-69.04	-26.57	63.26	16.09
CGS001-190	KD	NR0B1	DAX-like receptors, nuclear receptor subfamily 0, group B, member 1			0.00, 0.00	1.31, 0.42	-73.89	20.78	34.73	-47.59	-25.93	-75.70	30.29	-84.32	-85.21	-73.86
CGS001-8431	KD	NR0B2	DAX-like receptors, nuclear receptor subfamily 0, group B, member 2			30.00, 30.00	1.42, 0.49	-69.83	97.53	18.94	99.29	98.27	-77.05	-56.49	-22.00	88.87	83.39
CGS001-9975	KD	NR1D2	Rev-Erb receptors, nuclear receptor subfamily 1, group D, member 2			42.86, 42.86	1.24, 0.38	-85.35	NaN	-44.46	25.54	99.67	NaN	NaN	92.57	98.08	99.37
CGS001-7376	KD	NR1H2	Liver X receptor-like receptors, nuclear receptor subfamily 1, group H, member 2			10.00, 0.00	1.25, 0.33	-17.04	-60.83	79.46	96.00	-43.73	36.04	-21.53	-65.32	23.37	22.37
CGS001-10062	KD	NR1H3	Liver X receptor-like receptors, nuclear receptor subfamily 1, group H, member 3			0.00, 0.00	2.03, 0.67	-21.78	-34.64	40.63	67.41	90.86	-95.09	-32.10	57.16	NaN	52.16
CGS001-7181	KD	NR2C1	Testicular receptors, nuclear receptor subfamily 2, group C, member 1			0.00, 0.00	1.42, 0.36	20.80	38.78	-84.83	67.24	-44.82	NaN	69.74	58.73	77.09	60.04
CGS001-7182	KD	NR2C2	Testicular receptors, nuclear receptor subfamily 2, group C, member 2			0.00, 0.00	1.47, 0.44	8.62	NaN	-12.15	-97.00	84.60	NaN	NaN	-32.45	-96.65	-67.55
CGS001-7025	KD	NR2F1	COUP-TF-like receptors, nuclear receptor subfamily 2, group F, member 1			44.44, 22.22	1.01, 0.38	98.88	-32.12	81.02	40.36	99.93	NaN	84.46	96.32	52.06	96.53
CGS001-7026	KD	NR2F2	COUP-TF-like receptors, nuclear receptor subfamily 2, group F, member 2			0.00, 0.00	1.47, 0.35	-78.80	30.54	-64.11	-98.67	24.54	-66.41	-30.98	-98.98	-35.60	-71.94
CGS001-2063	KD	NR2F6	COUP-TF-like receptors, nuclear receptor subfamily 2, group F, member 6			0.00, 0.00	1.49, 0.49	-45.28	77.05	-99.58	-78.84	-74.11	38.26	-31.94	-99.52	-79.18	-81.57
CGS001-2908	KD	NR3C1	3-Ketosteroid receptors, nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)			0.00, 0.00	1.08, 0.22	-37.41	-80.59	-89.69	-32.43	-73.27	-70.20	-32.65	-21.60	22.14	-43.31
CGS001-4929	KD	NR4A2	Nerve growth factor IB-like receptors, nuclear receptor subfamily 4, group A, member 2			25.00, 12.50	1.57, 0.61	-22.64	99.61	47.31	-28.59	34.00	NaN	15.36	95.89	NaN	34.80
CGS001-2494	KD	NR5A2	Fushi tarazu F1-like receptors, nuclear receptor subfamily 5, group A, member 2			0.00, 0.00	0.99, 0.33	29.67	-53.56	29.08	-23.95	-29.03	-94.44	-29.41	94.70	NaN	-12.97
CGS001-29982	KD	NRBF2	nuclear receptor binding factor 2			20.00, 20.00	1.70, 0.58	-50.31	71.19	26.43	99.80	-27.00	99.97	49.09	-50.28	91.80	81.43
CGS001-29959	KD	NRBP1	NRBP family, nuclear receptor binding protein 1			0.00, 0.00	1.26, 0.31	-99.96	-100.00	-63.23	NaN	31.14	NaN	-63.98	-99.07	23.12	-99.95
CGS001-340371	KD	NRBP2	NRBP family, nuclear receptor binding protein 2			20.00, 20.00	1.23, 0.36	86.31	-44.84	80.72	63.29	65.47	99.73	19.91	-21.12	99.17	80.45
CGS001-3084	KD	NRG1	Immunoglobulin superfamily / I-set domain containing, neuregulin 1			0.00, 0.00	1.84, 0.58	-52.69	-54.67	17.78	87.73	-87.95	-20.90	NaN	28.44	51.01	-35.73
CGS001-8204	KD	NRIP1	nuclear receptor interacting protein 1			0.00, 0.00	1.08, 0.31	-71.37	93.41	-74.95	-76.12	-28.87	NaN	-38.26	-77.05	-99.97	-74.45
CGS001-56675	KD	NRIP3	nuclear receptor interacting protein 3			0.00, 0.00	1.34, 0.40	29.74	-99.74	-97.32	91.74	91.28	35.01	-23.40	-46.57	21.05	11.34
CGS001-8829	KD	NRP1	CD molecules, neuropilin 1			12.50, 12.50	1.27, 0.41	34.15	-25.09	66.76	-77.25	-25.64	99.22	26.71	NaN	NaN	39.88
CGS001-10412	KD	NSA2	NSA2 ribosome biogenesis homolog (S. cerevisiae)			11.11, 0.00	1.39, 0.50	97.04	NaN	-33.36	-97.96	-53.83	-72.15	46.64	-39.70	-38.63	-77.28
CGS001-64324	KD	NSD1	Histone methyltransferases (HMTs), nuclear receptor binding SET domain protein 1			44.44, 22.22	1.07, 0.42	99.98	NaN	88.94	-68.85	-23.29	-41.85	96.66	99.51	36.37	95.71
CGS001-50814	KD	NSDHL	Short chain dehydrogenase/reductase superfamily / Extended SDR fold, NAD(P) dependent steroid dehydrogenase-like			11.11, 11.11	1.94, 0.63	25.84	30.20	94.92	99.09	42.04	NaN	-26.32	-13.92	-15.23	32.56
CGS001-55968	KD	NSFL1C	UBX domain containing, NSFL1 (p97) cofactor (p47)			37.50, 25.00	1.64, 0.43	77.32	NaN	71.97	98.77	-40.51	78.31	NaN	93.08	99.21	95.17
CGS001-22978	KD	NT5C2	Adenosine turnover, 5'-nucleotidase, cytosolic II			0.00, 0.00	1.39, 0.48	-54.99	23.63	25.22	32.20	-27.59	91.75	-27.47	-64.93	NaN	-8.65
CGS001-64943	KD	NT5DC2	5'-nucleotidase domain containing 2			11.11, 11.11	1.09, 0.35	-54.44	NaN	-30.01	-49.75	75.02	52.42	46.63	-26.61	99.96	45.93
CGS001-4907	KD	NT5E	Adenosine turnover, 5'-nucleotidase, ecto (CD73)			0.00, 0.00	1.64, 0.57	-87.24	35.37	-32.66	29.61	23.13	-87.50	-31.45	-23.55	24.27	-13.53
CGS001-123803	KD	NTAN1	N-terminal asparagine amidase			0.00, 0.00	0.86, 0.27	90.40	-37.48	-42.46	19.38	-90.26	NaN	32.89	-99.64	22.44	-34.93
CGS001-4914	KD	NTRK1	Type VII RTKs: Neurotrophin receptor/Trk family, neurotrophic tyrosine kinase, receptor, type 1			0.00, 0.00	1.15, 0.27	-25.35	-100.00	-99.34	-99.73	-71.18	-32.10	36.91	82.76	-98.86	-99.87
CGS001-4916	KD	NTRK3	Type VII RTKs: Neurotrophin receptor/Trk family, neurotrophic tyrosine kinase, receptor, type 3			0.00, 0.00	1.09, 0.42	93.43	-32.23	26.21	-87.22	60.31	NaN	92.73	-93.95	-31.83	44.52
CGS001-4923	KD	NTSR1	GPCR / Class A : Neurotensin receptors, neurotensin receptor 1 (high affinity)			10.00, 0.00	1.20, 0.38	-20.56	50.65	-31.49	95.93	53.14	-94.85	-99.66	31.77	-75.62	-30.31
CGS001-9891	KD	NUAK1	NuaK subfamily, NUAK family, SNF1-like kinase, 1			0.00, 0.00	1.23, 0.39	58.66	30.06	-72.15	NaN	-99.94	NaN	41.25	-46.62	43.69	-33.08
CGS001-4925	KD	NUCB2	EF-hand domain containing, nucleobindin 2			0.00, 0.00	1.22, 0.25	-88.57	NaN	-98.29	-93.16	-26.66	-30.44	NaN	-56.58	-76.27	-79.77
CGS001-64710	KD	NUCKS1	nuclear casein kinase and cyclin-dependent kinase substrate 1			0.00, 0.00	1.69, 0.53	30.25	-87.54	-77.98	83.64	26.70	NaN	60.26	-97.83	-70.97	-68.44
CGS001-23386	KD	NUDCD3	NudC domain containing 3			11.11, 11.11	1.33, 0.34	NaN	50.65	98.88	83.26	79.87	-24.97	56.12	17.18	44.63	84.46
CGS001-256281	KD	NUDT14	Nudix motif containing, nudix (nucleoside diphosphate linked moiety X)-type motif 14			11.11, 11.11	1.48, 0.55	-29.26	99.65	-27.11	-89.89	-70.30	-25.73	-31.38	38.90	NaN	-15.66
CGS001-11164	KD	NUDT5	Nudix motif containing, nudix (nucleoside diphosphate linked moiety X)-type motif 5			0.00, 0.00	0.97, 0.39	-99.03	-42.12	-35.91	-99.90	-86.25	24.34	-99.10	-52.78	NaN	-99.42
CGS001-11162	KD	NUDT6	Nudix motif containing, nudix (nucleoside diphosphate linked moiety X)-type motif 6			0.00, 0.00	1.76, 0.52	-91.86	NaN	-48.58	NaN	41.64	NaN	-98.38	-59.62	-19.57	-58.80
CGS001-53343	KD	NUDT9	Nudix motif containing, nudix (nucleoside diphosphate linked moiety X)-type motif 9			0.00, 0.00	1.23, 0.28	55.45	-43.12	-96.39	-51.38	-46.55	-99.38	-69.61	-48.92	31.28	-45.06
CGS001-4926	KD	NUMA1	nuclear mitotic apparatus protein 1			0.00, 0.00	1.55, 0.39	-54.66	-51.13	-99.70	-33.93	-28.82	NaN	-79.24	-91.04	-43.58	-48.49
CGS001-55746	KD	NUP133	nucleoporin 133kDa		Minor histocompatibility antigens LOF, Nucleoporin LOF	33.33, 22.22	1.23, 0.40	NaN	-47.07	-25.52	95.13	99.81	-27.48	-25.87	13.19	97.99	82.69
CGS001-23636	KD	NUP62	nucleoporin 62kDa			33.33, 22.22	1.88, 0.55	-10.72	-100.00	76.70	99.48	-98.42	93.31	NaN	88.95	99.95	97.03
CGS001-79902	KD	NUP85	nucleoporin 85kDa		Nucleoporin LOF	10.00, 10.00	1.26, 0.50	89.77	-93.62	69.80	-81.50	23.60	-91.02	-35.29	62.05	99.65	52.97
CGS001-4927	KD	NUP88	nucleoporin 88kDa		Nucleoporin LOF	0.00, 0.00	1.52, 0.65	NaN	54.03	-99.86	-90.82	-99.98	NaN	-52.78	14.61	77.47	-95.37
CGS001-9688	KD	NUP93	nucleoporin 93kDa		Nucleoporin LOF	0.00, 0.00	1.38, 0.39	89.06	NaN	-41.55	36.44	-99.96	-86.64	-96.37	-42.61	-64.42	-96.40
CGS001-51203	KD	NUSAP1	nucleolar and spindle associated protein 1			12.50, 0.00	1.88, 0.61	NaN	95.56	-61.31	-99.66	-39.67	NaN	-99.88	-80.78	54.60	-76.06
CGS001-4931	KD	NVL	ATPases / AAA-type, nuclear VCP-like			11.11, 0.00	1.88, 0.51	95.13	NaN	-97.78	-99.95	-99.94	-99.81	-60.74	-97.77	-53.51	-99.92
CGS001-10482	KD	NXF1	nuclear RNA export factor 1			0.00, 0.00	1.60, 0.44	-31.03	-23.63	30.16	33.24	-99.96	-22.88	32.39	29.97	31.86	8.37
CGS001-338557	KD	O3FAR1	omega-3 fatty acid receptor 1			33.33, 0.00	1.63, 0.28	96.78	-23.56	97.45	44.19	50.69	NaN	-20.63	96.82	-53.33	89.16
CGS001-4938	KD	OAS1	2'-5'-oligoadenylate synthetase 1, 40/46kDa			11.11, 11.11	2.13, 0.61	26.69	100.00	42.98	-40.49	-29.65	NaN	-20.90	-26.58	-41.74	-15.78
CGS001-4942	KD	OAT	ornithine aminotransferase			0.00, 0.00	1.52, 0.50	NaN	53.24	31.06	30.04	-40.96	NaN	52.29	82.07	-99.65	51.34
CGS001-4946	KD	OAZ1	ornithine decarboxylase antizyme 1			10.00, 0.00	1.80, 0.51	48.72	60.76	95.98	79.29	30.76	94.84	87.90	-28.59	66.95	88.84
CGS001-4953	KD	ODC1	Decarboxylases, ornithine decarboxylase 1			0.00, 0.00	1.41, 0.41	-56.46	-70.54	-26.38	-34.61	-17.94	NaN	66.54	-37.59	71.54	-10.67
CGS001-4967	KD	OGDH	oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide)			0.00, 0.00	0.98, 0.23	-48.12	-43.01	-37.00	42.71	31.85	NaN	-23.68	85.56	88.69	28.49
CGS001-55239	KD	OGFOD1	2-oxoglutarate and iron-dependent oxygenase domain containing 1			0.00, 0.00	1.13, 0.30	93.96	45.85	-31.46	-98.85	51.57	NaN	81.39	-69.02	-47.63	46.83
CGS001-4968	KD	OGG1	8-oxoguanine DNA glycosylase			0.00, 0.00	1.30, 0.43	-94.99	65.31	-93.35	-35.43	-62.59	NaN	32.03	-43.40	69.37	-42.98
CGS001-167826	KD	OLIG3	Basic helix-loop-helix proteins, oligodendrocyte transcription factor 3			0.00, 0.00	2.05, 0.95	-45.66	-34.35	-95.91	43.44	74.41	NaN	22.81	-33.55	-99.01	-18.95
CGS001-23596	KD	OPN3	GPCR / Class A : Opsin receptors, opsin 3			0.00, 0.00	1.48, 0.43	67.40	38.63	89.66	NaN	-84.42	84.81	NaN	94.47	-31.63	94.45
CGS001-94233	KD	OPN4	GPCR / Class A : Opsin receptors, opsin 4			0.00, 0.00	1.18, 0.32	-40.69	-100.00	72.71	-31.34	-65.68	-71.01	-18.96	-61.71	NaN	-59.92
CGS001-221391	KD	OPN5	GPCR / Class A : Opsin receptors, opsin 5			22.22, 22.22	1.55, 0.36	40.37	57.51	-39.64	99.82	-29.98	NaN	99.91	70.89	75.38	69.80
CGS001-128368	KD	OR10Z1	GPCR / Class A : Olfactory receptors, olfactory receptor, family 10, subfamily Z, member 1			0.00, 0.00	1.52, 0.45	57.76	36.28	76.58	-37.45	58.36	-69.76	31.66	NaN	30.45	41.71
CGS001-255725	KD	OR52B2	GPCR / Class A : Olfactory receptors, olfactory receptor, family 52, subfamily B, member 2			0.00, 0.00	2.03, 0.61	-30.15	29.95	22.53	28.62	29.93	87.44	80.38	36.66	NaN	19.63
CGS001-390148	KD	OR5W2	GPCR / Class A : Olfactory receptors, olfactory receptor, family 5, subfamily W, member 2			10.00, 0.00	0.85, 0.32	20.29	-22.62	-15.97	43.95	29.63	92.91	-29.14	24.37	96.35	7.19
CGS001-4998	KD	ORC1	ATPases / AAA-type, origin recognition complex, subunit 1			0.00, 0.00	1.99, 0.47	NaN	NaN	-86.18	-97.50	-31.63	-99.97	NaN	-77.58	22.02	-97.62
CGS001-5004	KD	ORM1	Lipocalins, orosomucoid 1			10.00, 0.00	1.51, 0.42	39.95	51.92	-41.57	31.43	97.30	30.75	67.10	48.71	74.19	73.79
CGS001-94103	KD	ORMDL3	ORM1-like 3 (S. cerevisiae)			0.00, 0.00	0.99, 0.22	93.22	-98.77	14.42	-89.82	-32.55	NaN	-31.55	-99.96	-28.59	-88.75
CGS001-55644	KD	OSGEP	O-sialoglycoprotein endopeptidase			11.11, 11.11	1.77, 0.63	48.57	73.04	69.74	26.64	-18.61	-23.97	NaN	98.51	-28.45	61.61
CGS001-9180	KD	OSMR	IL-6 receptor family, oncostatin M receptor			0.00, 0.00	1.35, 0.35	-33.34	88.01	15.28	25.76	74.17	93.88	15.64	21.21	NaN	22.25
CGS001-130497	KD	OSR1	Zinc fingers, C2H2-type, odd-skipped related 1 (Drosophila)			0.00, 0.00	1.32, 0.32	58.39	-42.83	-33.11	-32.41	32.85	NaN	-31.30	84.81	-30.88	-13.78
CGS001-23252	KD	OTUD3	OTU domain containing, OTU domain containing 3			28.57, 28.57	1.94, 0.80	-95.73	NaN	98.07	73.31	32.72	NaN	NaN	99.26	83.43	91.54
CGS001-161725	KD	OTUD7A	OTU domain containing, OTU domain containing 7A			0.00, 0.00	1.82, 0.72	-61.81	-67.39	-20.49	31.37	-23.14	-99.97	-92.11	-49.36	16.69	-27.47
CGS001-5013	KD	OTX1	Homeoboxes / PRD class, orthodenticle homeobox 1		PRD class homeoboxes and psudogenes LOF	55.56, 55.56	1.95, 0.51	98.04	21.52	94.45	98.74	99.56	99.17	NaN	53.70	27.86	99.58
CGS001-5015	KD	OTX2	Homeoboxes / PRD class, orthodenticle homeobox 2		PRD class homeoboxes and psudogenes LOF	0.00, 0.00	1.83, 0.57	30.33	NaN	-38.12	33.60	92.31	-28.57	-41.80	36.63	NaN	13.80
CGS001-124641	KD	OVCA2	ovarian tumor suppressor candidate 2			0.00, 0.00	1.45, 0.53	-79.68	-25.27	-71.08	24.43	27.17	NaN	24.42	-67.13	-25.75	-28.55
CGS001-5018	KD	OXA1L	oxidase (cytochrome c) assembly 1-like			10.00, 10.00	1.16, 0.40	-98.91	-28.76	-21.39	52.79	98.77	41.98	61.87	-74.10	-33.04	20.92
CGS001-5019	KD	OXCT1	3-oxoacid CoA transferase 1			40.00, 10.00	0.94, 0.19	90.73	41.54	-51.58	98.91	95.99	95.66	68.57	51.04	27.96	95.83
CGS001-27199	KD	OXGR1	GPCR / Class A : Orphans, Oxoglutarate receptor, oxoglutarate (alpha-ketoglutarate) receptor 1			10.00, 10.00	1.14, 0.47	74.13	-98.67	-60.67	35.17	99.12	-35.87	18.56	-34.49	26.12	-14.49
CGS001-9943	KD	OXSR1	FRAY subfamily, oxidative-stress responsive 1			10.00, 0.00	1.34, 0.28	-73.45	-66.32	-37.71	91.32	95.24	74.62	79.34	-61.68	34.25	77.10
CGS001-5021	KD	OXTR	GPCR / Class A : Vasopressin and oxytocin receptors, oxytocin receptor			0.00, 0.00	1.07, 0.22	-84.85	45.19	-99.80	-99.73	-98.01	-76.50	-52.10	-98.54	-25.62	-99.37
CGS001-5025	KD	P2RX4	Ligand-gated ion channels / Purinergic receptors, ionotropic, purinergic receptor P2X, ligand-gated ion channel, 4			0.00, 0.00	1.17, 0.32	-24.52	33.34	28.45	-58.59	-34.93	NaN	-87.31	NaN	NaN	-27.11
CGS001-5031	KD	P2RY6	GPCR / Class A : Purinergic receptors, P2Y, pyrimidinergic receptor P2Y, G-protein coupled, 6			10.00, 0.00	1.13, 0.49	33.88	-38.24	95.49	52.79	86.26	33.73	39.19	-55.99	39.52	34.27
CGS001-286530	KD	P2RY8	GPCR / Class A : Purinergic receptors, P2Y, purinergic receptor P2Y, G-protein coupled, 8			44.44, 22.22	1.92, 0.55	59.67	58.15	90.59	32.12	99.81	NaN	97.35	-27.07	99.96	97.26
CGS001-5033	KD	P4HA1	prolyl 4-hydroxylase, alpha polypeptide I			0.00, 0.00	2.02, 0.60	-99.94	-75.21	17.88	-24.80	-28.21	-99.76	-78.74	-89.21	NaN	-93.38
CGS001-8974	KD	P4HA2	prolyl 4-hydroxylase, alpha polypeptide II			0.00, 0.00	1.08, 0.31	-65.71	-98.78	40.97	-23.44	32.67	-56.29	-99.90	-98.52	-94.03	-98.68
CGS001-5034	KD	P4HB	Protein disulfide isomerases, prolyl 4-hydroxylase, beta polypeptide			0.00, 0.00	1.44, 0.40	-99.98	-77.45	35.54	43.51	-61.09	33.49	-99.08	-98.24	-76.23	-97.51
CGS001-54681	KD	P4HTM	prolyl 4-hydroxylase, transmembrane (endoplasmic reticulum)			0.00, 0.00	1.25, 0.34	-99.94	-40.56	-98.32	-23.25	32.96	-51.21	-65.00	-85.16	-21.03	-66.51
CGS001-5036	KD	PA2G4	proliferation-associated 2G4, 38kDa			0.00, 0.00	2.16, 0.68	-32.85	68.72	32.29	37.36	-25.31	NaN	NaN	NaN	NaN	22.23
CGS001-26986	KD	PABPC1	RNA binding motif (RRM) containing, poly(A) binding protein, cytoplasmic 1			0.00, 0.00	0.89, 0.18	-91.70	-34.99	-94.34	-97.87	-33.10	33.91	-26.46	-45.93	50.06	-64.81
CGS001-29763	KD	PACSIN3	protein kinase C and casein kinase substrate in neurons 3			0.00, 0.00	0.91, 0.25	-76.32	-99.30	-40.85	26.13	-72.93	-30.54	-31.14	13.83	73.93	-44.13
CGS001-54623	KD	PAF1	Paf1, RNA polymerase II associated factor, homolog (S. cerevisiae)			10.00, 0.00	1.64, 0.53	-54.23	-21.37	-99.13	-99.56	19.65	91.58	53.34	-97.68	96.56	-87.98
CGS001-5048	KD	PAFAH1B1	WD repeat domain containing, platelet-activating factor acetylhydrolase 1b, regulatory subunit 1 (45kDa)			11.11, 11.11	1.38, 0.42	99.16	64.12	-97.11	-32.71	-73.85	NaN	84.53	-99.30	-99.68	-99.55
CGS001-5049	KD	PAFAH1B2	platelet-activating factor acetylhydrolase 1b, catalytic subunit 2 (30kDa)			25.00, 25.00	1.16, 0.31	99.69	NaN	99.41	-47.05	-91.61	NaN	-61.06	14.55	-95.97	-81.52
CGS001-5050	KD	PAFAH1B3	platelet-activating factor acetylhydrolase 1b, catalytic subunit 3 (29kDa)			0.00, 0.00	1.06, 0.34	20.33	-98.80	-22.56	-50.55	52.78	-99.76	-99.45	-94.63	30.17	-98.32
CGS001-5053	KD	PAH	Amino acid hydroxylases, phenylalanine hydroxylase			0.00, 0.00	1.40, 0.45	-26.05	-21.26	-30.58	-74.40	69.36	-40.97	-22.93	-86.78	-51.52	-26.13
CGS001-10606	KD	PAICS	phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole succinocarboxamide synthetase			33.33, 22.22	1.24, 0.25	99.59	49.34	29.67	92.92	97.58	72.88	NaN	74.28	-80.90	97.08
CGS001-5058	KD	PAK1	PAKA subfamily, p21 protein (Cdc42/Rac)-activated kinase 1			0.00, 0.00	2.18, 0.82	-25.09	-38.98	-35.35	69.94	-31.63	NaN	-22.43	-19.39	90.14	-7.49
CGS001-5062	KD	PAK2	PAKA subfamily, p21 protein (Cdc42/Rac)-activated kinase 2			0.00, 0.00	1.24, 0.30	-77.24	31.65	-79.29	-36.32	-22.24	33.13	-92.99	-21.83	NaN	-28.67
CGS001-5063	KD	PAK3	PAKA subfamily, p21 protein (Cdc42/Rac)-activated kinase 3		X linked mental retardation group 1 LOF	14.29, 14.29	1.59, 0.52	99.57	67.58	80.41	26.21	-74.24	NaN	-19.16	NaN	NaN	63.43
CGS001-10298	KD	PAK4	PAKB subfamily, p21 protein (Cdc42/Rac)-activated kinase 4			0.00, 0.00	1.41, 0.42	49.35	-99.39	50.91	93.26	58.28	35.59	-87.72	22.05	71.67	38.19
CGS001-5066	KD	PAM	peptidylglycine alpha-amidating monooxygenase			12.50, 12.50	2.13, 0.58	62.25	NaN	82.55	52.81	69.82	NaN	98.84	-28.89	50.55	72.88
CGS001-9924	KD	PAN2	Ubiquitin-specific peptidases, PAN2 poly(A) specific ribonuclease subunit homolog (S. cerevisiae)			0.00, 0.00	1.63, 0.40	-55.61	-26.84	-90.04	-94.39	26.58	-40.78	-27.06	-97.03	-85.25	-87.13
CGS001-80025	KD	PANK2	pantothenate kinase 2			44.44, 33.33	2.01, 0.59	-56.99	39.64	92.40	99.84	70.45	NaN	26.98	97.86	99.88	96.50
CGS001-55229	KD	PANK4	pantothenate kinase 4			12.50, 12.50	1.22, 0.48	-99.49	97.72	-95.13	-96.03	22.95	NaN	NaN	-93.33	19.03	-80.74
CGS001-11044	KD	PAPD7	PAP associated domain containing 7			0.00, 0.00	1.09, 0.33	-25.65	-100.00	-36.61	-95.44	51.24	-99.97	-23.90	-81.30	-39.71	-84.01
CGS001-10914	KD	PAPOLA	poly(A) polymerase alpha			0.00, 0.00	1.72, 0.49	-91.84	-70.60	-53.63	-20.83	47.57	-89.55	-56.75	-39.08	-95.87	-63.65
CGS001-9061	KD	PAPSS1	3'-phosphoadenosine 5'-phosphosulfate synthase 1			44.44, 44.44	1.47, 0.40	-30.56	100.00	99.83	48.64	61.38	NaN	34.66	99.86	-42.30	99.95
CGS001-164091	KD	PAQR7	progestin and adipoQ receptor family member VII			0.00, 0.00	1.67, 0.47	36.17	-22.79	-88.71	-66.95	32.43	NaN	-77.07	-91.95	-53.43	-69.84
CGS001-85315	KD	PAQR8	progestin and adipoQ receptor family member VIII			22.22, 22.22	1.26, 0.38	-33.90	-20.98	-39.04	-61.12	-30.96	NaN	52.10	97.60	99.12	24.84
CGS001-8505	KD	PARG	poly (ADP-ribose) glycohydrolase			0.00, 0.00	0.43, 0.08	-51.90	-82.72	-98.84	-18.67	54.41	NaN	-70.57	-21.05	-95.57	-78.90
CGS001-11315	KD	PARK7	Parkinson disease, parkinson protein 7			0.00, 0.00	1.23, 0.36	25.32	-99.93	91.19	25.47	73.40	-27.77	-94.61	-28.89	28.09	10.01
CGS001-55486	KD	PARL	presenilin associated, rhomboid-like			0.00, 0.00	1.64, 0.40	24.69	NaN	26.88	-99.95	91.98	-99.68	-27.05	-99.51	-98.31	-99.79
CGS001-5073	KD	PARN	poly(A)-specific ribonuclease			0.00, 0.00	1.66, 0.51	38.00	-67.55	-33.11	-22.71	-99.11	-96.40	-66.78	-95.37	25.56	-76.76
CGS001-84875	KD	PARP10	Poly (ADP-ribose) polymerases, poly (ADP-ribose) polymerase family, member 10			11.11, 11.11	1.28, 0.43	11.18	-21.55	-99.30	-64.72	-95.42	NaN	51.88	31.13	99.97	-12.00
CGS001-143	KD	PARP4	Poly (ADP-ribose) polymerases, poly (ADP-ribose) polymerase family, member 4		Poly ADP ribose polymerases LOF	0.00, 0.00	1.49, 0.36	66.98	NaN	-98.05	-84.10	-99.98	NaN	-32.51	-96.69	-26.83	-97.62
CGS001-139135	KD	PASD1	PAS domain containing 1			10.00, 10.00	1.49, 0.28	-31.56	84.92	14.04	-62.69	99.85	55.39	62.82	-38.05	-62.49	34.47
CGS001-5080	KD	PAX6	Paired boxes, paired box 6			50.00, 50.00	0.99, 0.31	94.89	NaN	81.81	98.32	62.66	NaN	-39.78	98.70	98.14	99.84
CGS001-7849	KD	PAX8	Paired boxes, paired box 8			0.00, 0.00	0.80, 0.17	-58.31	-68.26	-49.26	-92.56	-22.60	27.33	-40.11	-81.32	-99.97	-66.21
CGS001-55872	KD	PBK	TOPK family, PDZ binding kinase			0.00, 0.00	1.36, 0.55	-25.75	26.49	56.64	NaN	-26.63	NaN	-40.84	-31.28	30.16	-14.38
CGS001-55193	KD	PBRM1	Non-enzymatic BRD containing proteins, polybromo 1			11.11, 11.11	1.43, 0.63	-72.46	-26.04	-92.65	98.45	-46.24	NaN	-66.81	-79.53	25.36	-79.65
CGS001-80714	KD	PBX4	Homeoboxes / TALE class, pre-B-cell leukemia homeobox 4			11.11, 11.11	1.22, 0.40	-48.54	37.72	27.16	97.58	91.66	NaN	-90.47	30.95	-82.55	20.50
CGS001-57326	KD	PBXIP1	pre-B-cell leukemia homeobox interacting protein 1			0.00, 0.00	2.32, 0.73	-31.61	62.73	-17.72	-27.97	52.18	NaN	NaN	70.46	-63.21	48.11
CGS001-5091	KD	PC	Carboxylases, pyruvate carboxylase			10.00, 10.00	1.32, 0.43	47.79	20.61	-34.77	-99.31	99.98	-38.49	-93.87	-24.38	-68.97	-43.39
CGS001-5092	KD	PCBD1	pterin-4 alpha-carbinolamine dehydratase/dimerization cofactor of hepatocyte nuclear factor 1 alpha			0.00, 0.00	1.58, 0.48	78.48	-56.97	-24.62	63.20	-36.87	-69.04	-42.19	-47.66	27.00	-32.05
CGS001-5096	KD	PCCB	Carboxylases, propionyl CoA carboxylase, beta polypeptide			0.00, 0.00	1.35, 0.41	-92.91	NaN	51.62	-29.67	41.50	NaN	32.67	-28.44	-82.72	-22.03
CGS001-65217	KD	PCDH15	Cadherins / Cadherin-related, protocadherin-related 15			12.50, 0.00	1.57, 0.49	-99.68	96.94	-20.49	-39.44	-82.90	86.95	33.47	NaN	NaN	35.32
CGS001-84759	KD	PCGF1	Polycomb group ring fingers, polycomb group ring finger 1			55.56, 55.56	1.26, 0.47	77.22	99.83	-87.35	31.18	99.93	NaN	99.93	99.51	36.63	99.95
CGS001-10336	KD	PCGF3	Polycomb group ring fingers, polycomb group ring finger 3			20.00, 20.00	1.15, 0.38	99.23	22.53	28.56	39.65	-42.08	29.74	98.87	-34.17	88.92	73.88
CGS001-84333	KD	PCGF5	Polycomb group ring fingers, polycomb group ring finger 5			0.00, 0.00	1.72, 0.52	-82.10	-26.81	-81.27	28.88	-93.28	NaN	-99.86	-21.63	79.69	-79.19
CGS001-5105	KD	PCK1	phosphoenolpyruvate carboxykinase 1 (soluble)			10.00, 10.00	1.65, 0.57	-19.13	-96.22	-89.75	-21.78	70.39	-35.88	-75.57	57.37	99.16	-50.71
CGS001-5106	KD	PCK2	phosphoenolpyruvate carboxykinase 2 (mitochondrial)			20.00, 10.00	1.39, 0.56	13.89	-31.47	23.85	-25.92	96.37	32.45	97.64	93.81	-82.41	61.07
CGS001-5108	KD	PCM1	pericentriolar material 1			0.00, 0.00	1.77, 0.43	NaN	-49.45	-24.38	38.79	-91.26	-25.11	59.48	-83.41	-99.97	-91.00
CGS001-5110	KD	PCMT1	protein-L-isoaspartate (D-aspartate) O-methyltransferase			0.00, 0.00	1.09, 0.40	-43.91	-92.74	-91.46	-83.35	-51.36	-98.11	-39.25	-95.47	27.35	-96.45
CGS001-5111	KD	PCNA	proliferating cell nuclear antigen		DNA Replication LOF	0.00, 0.00	1.40, 0.28	-47.63	NaN	-66.52	NaN	-99.80	NaN	80.49	-92.01	-25.72	-65.06
CGS001-9159	KD	PCSK7	Subtilisin, proprotein convertase subtilisin/kexin type 7			25.00, 12.50	1.20, 0.33	95.07	NaN	57.63	NaN	97.71	-60.61	-72.81	-53.61	65.90	82.80
CGS001-255738	KD	PCSK9	Subtilisin, proprotein convertase subtilisin/kexin type 9			11.11, 0.00	1.58, 0.56	-33.87	-75.65	-89.14	NaN	97.15	-73.80	-32.36	-23.63	-35.53	-63.27
CGS001-11333	KD	PDAP1	PDGFA associated protein 1			33.33, 33.33	1.07, 0.32	26.80	-31.71	99.09	98.20	31.72	NaN	99.63	-78.68	24.05	94.88
CGS001-5134	KD	PDCD2	Zinc fingers, MYND-type, programmed cell death 2			0.00, 0.00	1.03, 0.27	-70.42	92.96	-86.72	35.50	42.43	NaN	-72.73	63.42	26.15	15.81
CGS001-5144	KD	PDE4D	Phosphodiesterases, phosphodiesterase 4D, cAMP-specific			0.00, 0.00	1.41, 0.40	-58.66	-23.42	19.92	NaN	-71.96	69.59	-31.71	-44.66	54.01	-10.34
CGS001-5156	KD	PDGFRA	Type III RTKs: PDGFR, CSFR, Kit, FLT3 receptor family, platelet-derived growth factor receptor, alpha polypeptide			0.00, 0.00	1.02, 0.17	-56.23	-28.94	75.00	73.92	29.28	-32.79	-21.76	76.40	50.08	62.35
CGS001-5159	KD	PDGFRB	Type III RTKs: PDGFR, CSFR, Kit, FLT3 receptor family, platelet-derived growth factor receptor, beta polypeptide			0.00, 0.00	0.77, 0.14	-47.15	-22.33	52.33	94.28	87.08	NaN	-22.10	-33.18	-30.96	-3.23
CGS001-5160	KD	PDHA1	pyruvate dehydrogenase (lipoamide) alpha 1			0.00, 0.00	1.00, 0.28	-20.60	42.94	36.32	-98.89	86.74	-31.41	-82.95	NaN	-21.39	-4.76
CGS001-5162	KD	PDHB	pyruvate dehydrogenase (lipoamide) beta			0.00, 0.00	1.64, 0.26	61.67	40.95	-45.94	-41.13	72.42	23.68	43.77	47.22	-95.68	39.44
CGS001-8050	KD	PDHX	pyruvate dehydrogenase complex, component X			0.00, 0.00	0.89, 0.16	-90.88	-100.00	-64.83	-79.35	-88.59	-44.32	-49.97	-83.23	-49.75	-83.28
CGS001-9601	KD	PDIA4	Protein disulfide isomerases, protein disulfide isomerase family A, member 4			0.00, 0.00	1.02, 0.24	-15.77	46.67	-27.81	-97.05	29.27	73.72	20.35	24.63	NaN	7.68
CGS001-10954	KD	PDIA5	Protein disulfide isomerases, protein disulfide isomerase family A, member 5			0.00, 0.00	1.05, 0.28	-72.90	-29.86	-99.18	-73.78	-58.13	-43.81	-95.83	-98.15	78.39	-93.48
CGS001-5163	KD	PDK1	pyruvate dehydrogenase kinase, isozyme 1			10.00, 10.00	1.35, 0.48	-82.15	99.98	-22.97	32.56	31.16	66.14	-17.86	20.04	-61.97	7.52
CGS001-5164	KD	PDK2	PDHK family, pyruvate dehydrogenase kinase, isozyme 2			10.00, 10.00	0.95, 0.30	99.29	-91.93	-38.98	-31.69	44.76	77.64	80.63	70.74	78.81	66.89
CGS001-9124	KD	PDLIM1	PDZ and LIM domain 1			14.29, 0.00	3.26, 1.19	NaN	NaN	78.33	41.52	68.60	-30.00	-79.24	NaN	97.43	68.98
CGS001-8572	KD	PDLIM4	PDZ and LIM domain 4			12.50, 12.50	1.88, 0.57	-55.00	NaN	27.78	27.97	-36.60	NaN	-37.64	-70.41	98.97	-23.53
CGS001-5170	KD	PDPK1	PDK1 family, 3-phosphoinositide dependent protein kinase-1		Akt Signaling LOF	0.00, 0.00	1.19, 0.41	-79.80	-50.15	17.31	-25.98	-22.68	-89.46	-60.82	-81.14	22.92	-31.78
CGS001-23244	KD	PDS5A	PDS5, regulator of cohesion maintenance, homolog A (S. cerevisiae)			11.11, 11.11	1.93, 0.53	NaN	99.26	-40.14	-65.13	-20.48	-90.54	22.41	-45.85	19.53	-17.80
CGS001-23047	KD	PDS5B	PDS5, regulator of cohesion maintenance, homolog B (S. cerevisiae)			10.00, 10.00	1.40, 0.34	-89.65	99.96	-99.46	-33.17	-33.25	38.53	88.05	-37.13	44.02	-22.03
CGS001-3651	KD	PDX1	Homeoboxes / ANTP class : HOXL subclass, pancreatic and duodenal homeobox 1			0.00, 0.00	1.28, 0.33	37.25	84.10	76.60	70.29	-89.05	NaN	88.51	31.74	26.35	75.96
CGS001-57026	KD	PDXP	pyridoxal (pyridoxine, vitamin B6) phosphatase			20.00, 20.00	0.80, 0.25	-11.94	-27.47	18.44	-93.11	-97.86	-50.04	98.21	-34.78	98.04	-8.61
CGS001-5037	KD	PEBP1	phosphatidylethanolamine binding protein 1			0.00, 0.00	1.70, 0.65	-49.18	27.23	29.44	23.71	-34.34	-27.80	40.48	49.08	NaN	15.45
CGS001-55825	KD	PECR	Short chain dehydrogenase/reductase superfamily / Classical SDR fold cluster 1, peroxisomal trans-2-enoyl-CoA reductase			20.00, 20.00	1.65, 0.51	-84.52	-19.42	99.97	82.79	32.14	-32.00	54.84	19.85	99.97	68.95
CGS001-10400	KD	PEMT	phosphatidylethanolamine N-methyltransferase			0.00, 0.00	1.11, 0.32	-31.63	-31.79	87.60	93.28	88.53	26.08	-23.94	-37.18	27.98	62.75
CGS001-5184	KD	PEPD	Methionyl aminopeptidase, peptidase D			0.00, 0.00	1.99, 0.61	69.32	72.41	-52.91	-30.02	88.21	NaN	-25.54	-60.59	-77.96	-15.07
CGS001-8864	KD	PER2	period homolog 2 (Drosophila)			40.00, 10.00	1.36, 0.45	-78.96	-76.64	95.65	95.26	-39.61	58.07	84.76	97.50	38.17	95.86
CGS001-5188	KD	PET112	PET112 homolog (yeast)			0.00, 0.00	1.85, 0.69	58.48	NaN	-99.98	-99.44	42.03	-86.80	-29.02	-31.78	-85.58	-98.71
CGS001-8800	KD	PEX11A	peroxisomal biogenesis factor 11 alpha			10.00, 10.00	1.56, 0.47	-33.05	83.66	98.75	-99.01	-23.11	-99.65	44.37	-99.94	-92.32	-99.37
CGS001-5193	KD	PEX12	peroxisomal biogenesis factor 12			0.00, 0.00	1.77, 0.60	85.75	-56.14	-37.08	-60.15	31.72	NaN	NaN	-35.02	-48.53	-45.91
CGS001-5824	KD	PEX19	peroxisomal biogenesis factor 19			12.50, 12.50	2.46, 0.72	-29.92	NaN	20.25	83.15	34.63	63.69	NaN	99.79	32.45	69.33
CGS001-5198	KD	PFAS	phosphoribosylformylglycinamidine synthase			0.00, 0.00	1.60, 0.44	-99.75	-100.00	-55.93	-37.62	45.22	-38.17	-83.87	-90.04	-40.23	-90.46
CGS001-5209	KD	PFKFB3	6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3			0.00, 0.00	1.60, 0.50	-76.25	-77.25	77.16	-46.99	-22.36	-32.27	-57.87	-40.96	-83.80	-47.66
CGS001-5211	KD	PFKL	phosphofructokinase, liver			0.00, 0.00	1.17, 0.27	-52.59	-32.67	-26.83	-21.53	-21.27	NaN	21.59	-54.71	-97.53	-16.08
CGS001-5217	KD	PFN2	profilin 2			11.11, 11.11	1.28, 0.39	-73.98	-36.61	-34.52	-38.09	99.86	NaN	-25.88	-90.76	-91.93	-54.92
CGS001-5223	KD	PGAM1	phosphoglycerate mutase 1 (brain)			0.00, 0.00	1.33, 0.42	-29.99	-36.66	31.69	24.91	-91.14	-35.63	-66.64	-99.26	-69.56	-51.51
CGS001-84547	KD	PGBD1	piggyBac transposable element derived 1			0.00, 0.00	1.28, 0.35	52.50	-46.58	-83.10	51.58	-29.30	78.61	53.26	93.27	-29.57	43.79
CGS001-5226	KD	PGD	phosphogluconate dehydrogenase			12.50, 12.50	1.03, 0.24	-31.58	NaN	99.95	-41.08	51.66	NaN	-99.16	-32.63	25.21	-11.42
CGS001-5230	KD	PGK1	phosphoglycerate kinase 1			11.11, 11.11	1.07, 0.38	-32.97	14.36	-59.42	32.55	98.56	-24.21	-45.97	-43.95	NaN	-20.77
CGS001-5236	KD	PGM1	phosphoglucomutase 1			33.33, 22.22	1.51, 0.34	99.98	NaN	88.01	92.47	-92.87	79.19	29.37	22.31	99.55	96.92
CGS001-10857	KD	PGRMC1	progesterone receptor membrane component 1			22.22, 22.22	1.30, 0.33	-58.37	46.84	99.98	99.88	51.68	NaN	-23.32	49.86	-87.66	71.82
CGS001-221692	KD	PHACTR1	Phosphatase and actin regulators, phosphatase and actin regulator 1			0.00, 0.00	1.41, 0.45	-93.37	-99.78	-15.12	-41.46	-34.77	26.05	-94.37	-22.58	NaN	-92.72
CGS001-5245	KD	PHB	prohibitin			0.00, 0.00	1.83, 0.51	-98.28	-98.29	-99.78	-27.33	-67.21	-98.72	-88.21	-92.10	-72.98	-98.61
CGS001-11331	KD	PHB2	prohibitin 2			0.00, 0.00	2.92, 0.99	-72.98	NaN	44.40	NaN	39.98	NaN	-97.92	-97.53	22.40	-85.12
CGS001-5252	KD	PHF1	Zinc fingers, PHD-type, PHD finger protein 1			0.00, 0.00	1.19, 0.35	34.79	-82.99	-99.59	-94.90	54.89	-65.67	-79.75	-27.97	-26.99	-86.86
CGS001-55274	KD	PHF10	Zinc fingers, PHD-type, PHD finger protein 10			11.11, 11.11	1.28, 0.35	-37.06	17.27	-54.65	35.56	64.07	54.13	NaN	77.28	99.97	67.25
CGS001-51131	KD	PHF11	Zinc fingers, PHD-type, PHD finger protein 11			22.22, 11.11	0.94, 0.35	-91.83	99.91	-36.88	67.37	NaN	-43.94	-26.35	97.17	62.73	82.72
CGS001-148479	KD	PHF13	Zinc fingers, PHD-type, PHD finger protein 13			0.00, 0.00	1.35, 0.36	-96.81	27.70	-20.05	-30.89	-77.87	-77.49	82.78	-90.13	-88.01	-92.35
CGS001-23338	KD	PHF15	PHD finger protein 15			62.50, 37.50	1.18, 0.45	99.58	NaN	95.58	69.96	96.01	NaN	69.86	55.76	99.81	99.34
CGS001-9767	KD	PHF16	PHD finger protein 16			33.33, 22.22	1.42, 0.38	-25.45	80.60	-38.23	-43.80	-70.90	98.47	99.83	NaN	93.11	95.58
CGS001-79960	KD	PHF17	PHD finger protein 17			0.00, 0.00	1.50, 0.32	-29.58	52.69	-98.85	-83.64	-59.55	NaN	84.89	-46.07	-78.64	-71.33
CGS001-5253	KD	PHF2	Histone demethylases, PHD finger protein 2			0.00, 0.00	0.66, 0.17	72.95	-51.14	-76.03	-65.08	-35.09	75.31	-16.99	-88.41	30.88	-35.33
CGS001-112885	KD	PHF21B	Zinc fingers, PHD-type, PHD finger protein 21B			20.00, 10.00	2.07, 0.89	29.54	95.56	-28.08	35.66	-20.15	-23.12	99.40	36.07	38.92	23.26
CGS001-79142	KD	PHF23	Zinc fingers, PHD-type, PHD finger protein 23			10.00, 0.00	1.69, 0.47	37.18	-24.46	96.80	-29.48	-39.70	30.34	-73.69	-66.68	-38.15	-16.03
CGS001-84844	KD	PHF5A	Zinc fingers, PHD-type, PHD finger protein 5A			0.00, 0.00	1.01, 0.25	-50.32	-25.67	-25.29	79.11	-50.37	-89.96	-19.75	-33.50	93.38	-9.76
CGS001-26227	KD	PHGDH	phosphoglycerate dehydrogenase			10.00, 0.00	1.36, 0.38	-35.87	95.25	-90.27	-85.89	-25.96	-97.23	71.44	-28.69	-99.51	-96.79
CGS001-5255	KD	PHKA1	phosphorylase kinase, alpha 1 (muscle)			0.00, 0.00	1.27, 0.24	48.78	34.57	-19.45	-23.81	37.45	-25.40	-76.79	60.03	43.65	24.73
CGS001-5257	KD	PHKB	phosphorylase kinase, beta			10.00, 10.00	0.99, 0.27	50.43	52.80	-21.09	-77.98	27.19	-87.48	99.77	-63.89	-99.58	-58.30
CGS001-5261	KD	PHKG2	Phosphorylase kinase (PHK) family, phosphorylase kinase, gamma 2 (testis)			10.00, 0.00	0.99, 0.27	-4.61	-23.15	59.61	-94.92	-36.77	-25.92	95.49	-97.32	-79.11	-37.86
CGS001-23239	KD	PHLPP1	Pleckstrin homology (PH) domain containing, PH domain and leucine rich repeat protein phosphatase 1			0.00, 0.00	1.30, 0.31	-99.96	-99.98	-99.93	-42.15	NaN	NaN	-59.42	-96.96	72.03	-99.95
CGS001-57661	KD	PHRF1	Zinc fingers, PHD-type, PHD and ring finger domains 1			0.00, 0.00	1.77, 0.73	25.77	29.01	-42.69	-86.45	-99.98	NaN	-33.70	-37.68	-71.08	-60.66
CGS001-10745	KD	PHTF1	putative homeodomain transcription factor 1			11.11, 11.11	2.23, 0.65	79.79	21.40	59.98	29.33	54.84	NaN	87.14	99.31	-49.76	79.70
CGS001-57157	KD	PHTF2	putative homeodomain transcription factor 2			0.00, 0.00	1.55, 0.56	-57.88	85.56	36.19	51.46	NaN	-99.84	-80.05	-90.57	NaN	-79.03
CGS001-55300	KD	PI4K2B	Phosphatidylinositol kinases, phosphatidylinositol 4-kinase type 2 beta			0.00, 0.00	0.59, 0.17	60.75	34.59	-24.66	56.81	58.37	92.05	NaN	NaN	-28.26	70.43
CGS001-5297	KD	PI4KA	1-phosphatidylinositol 4-kinase family, phosphatidylinositol 4-kinase, catalytic, alpha			0.00, 0.00	1.49, 0.49	-82.17	94.99	-90.19	27.97	-48.84	71.19	-29.44	NaN	-94.27	-82.29
CGS001-375133	KD	PI4KAP2	phosphatidylinositol 4-kinase, catalytic, alpha pseudogene 2			0.00, 0.00	0.78, 0.23	-58.39	-15.60	-13.25	20.84	-50.88	37.03	-99.70	-59.11	-31.57	-22.33
CGS001-8554	KD	PIAS1	Zinc fingers, MIZ-type, protein inhibitor of activated STAT, 1			0.00, 0.00	1.22, 0.38	-16.18	-37.11	-97.78	-35.14	-91.43	-24.54	NaN	-24.84	70.29	-17.46
CGS001-9063	KD	PIAS2	Zinc fingers, MIZ-type, protein inhibitor of activated STAT, 2			0.00, 0.00	1.17, 0.39	-95.41	34.66	-44.38	-91.93	-29.62	-26.29	-99.79	-99.05	-27.38	-90.57
CGS001-10401	KD	PIAS3	Zinc fingers, MIZ-type, protein inhibitor of activated STAT, 3			0.00, 0.00	1.90, 0.50	-29.71	24.32	-41.99	-30.76	-32.71	NaN	19.76	38.82	45.48	-20.12
CGS001-51588	KD	PIAS4	Zinc fingers, MIZ-type, protein inhibitor of activated STAT, 4			0.00, 0.00	1.44, 0.41	-44.43	-44.37	30.21	31.74	-37.13	NaN	23.60	-81.41	52.67	-17.35
CGS001-10026	KD	PIGK	Phosphatidylinositol glycan anchor biosynthesis, phosphatidylinositol glycan anchor biosynthesis, class K			0.00, 0.00	1.15, 0.26	-93.70	-29.68	-43.85	-99.98	25.61	49.95	-98.88	29.82	-94.75	-90.66
CGS001-55011	KD	PIH1D1	PIH1 domain containing 1			0.00, 0.00	1.80, 0.44	-68.58	-83.02	-80.79	-52.05	-60.74	NaN	17.82	-37.14	18.86	-60.61
CGS001-5286	KD	PIK3C2A	Phosphatidylinositol-4-phosphate 3-kinase family, phosphoinositide-3-kinase, class 2, alpha polypeptide		PI3K Signaling LOF	20.00, 20.00	1.40, 0.42	-94.07	99.85	-82.55	-19.55	-95.25	31.89	-63.23	-25.61	99.84	-69.74
CGS001-5287	KD	PIK3C2B	Phosphatidylinositol-4-phosphate 3-kinase family, phosphoinositide-3-kinase, class 2, beta polypeptide			10.00, 10.00	1.14, 0.26	99.77	-69.40	39.97	43.54	-32.03	94.80	-16.43	20.24	-98.20	14.06
CGS001-5289	KD	PIK3C3	Phosphatidylinositol 3-kinase family, phosphoinositide-3-kinase, class 3		PI3K Signaling LOF	11.11, 11.11	2.26, 0.73	87.31	-97.07	48.60	99.98	20.00	65.44	-27.25	70.96	NaN	67.43
CGS001-5291	KD	PIK3CB	Phosphatidylinositol kinases, phosphoinositide-3-kinase, catalytic, beta polypeptide			10.00, 10.00	0.40, 0.17	-7.10	-25.57	98.84	20.07	20.49	-93.10	-99.95	62.80	5.30	0.82
CGS001-5293	KD	PIK3CD	Phosphatidylinositol kinases, phosphoinositide-3-kinase, catalytic, delta polypeptide			11.11, 11.11	1.32, 0.33	-28.72	97.54	-97.04	39.52	-48.97	NaN	-82.81	-17.30	-98.41	-81.64
CGS001-5295	KD	PIK3R1	Phosphatidylinositol kinases, phosphoinositide-3-kinase, regulatory subunit 1 (alpha)			0.00, 0.00	0.76, 0.23	-94.81	26.36	-98.68	51.70	-27.54	-46.89	-20.10	6.51	-25.64	-8.46
CGS001-30849	KD	PIK3R4	Phosphatidylinositol kinases, phosphoinositide-3-kinase, regulatory subunit 4			10.00, 0.00	1.36, 0.32	96.94	-93.37	-51.43	-79.91	-34.06	-37.90	-96.10	-99.11	-20.26	-82.22
CGS001-5292	KD	PIM1	PIM family, pim-1 oncogene			0.00, 0.00	1.23, 0.27	91.88	-83.56	33.21	-50.90	61.93	-75.74	-14.06	49.37	-19.44	16.28
CGS001-415116	KD	PIM3	PIM family, pim-3 oncogene			55.56, 55.56	1.55, 0.34	99.96	99.93	99.78	99.14	92.46	NaN	-25.57	51.71	69.60	99.89
CGS001-5300	KD	PIN1	peptidylprolyl cis/trans isomerase, NIMA-interacting 1			0.00, 0.00	1.85, 0.73	-99.58	-68.53	81.73	-60.14	-44.10	-90.70	-60.99	-99.19	-84.59	-92.91
CGS001-8396	KD	PIP4K2B	1-phosphatidylinositol-5-phosphate 4-kinase family, phosphatidylinositol-5-phosphate 4-kinase, type II, beta			22.22, 11.11	1.16, 0.24	98.01	NaN	96.69	89.31	87.02	73.13	27.56	91.87	23.19	93.00
CGS001-79837	KD	PIP4K2C	1-phosphatidylinositol-5-phosphate 4-kinase family, phosphatidylinositol-5-phosphate 4-kinase, type II, gamma			11.11, 11.11	1.25, 0.49	-41.11	-63.05	82.28	-34.40	-20.61	66.97	NaN	35.27	99.58	53.62
CGS001-51268	KD	PIPOX	pipecolic acid oxidase			11.11, 11.11	1.40, 0.38	24.51	13.93	-30.71	51.26	41.07	98.67	86.96	-54.11	NaN	15.03
CGS001-23761	KD	PISD	Decarboxylases, phosphatidylserine decarboxylase			0.00, 0.00	1.86, 0.64	-82.20	37.06	-20.39	-96.46	NaN	NaN	-19.43	-31.46	-27.12	-33.34
CGS001-5306	KD	PITPNA	phosphatidylinositol transfer protein, alpha			55.56, 55.56	1.82, 0.53	94.95	37.15	91.71	99.98	75.10	98.44	99.42	99.94	NaN	98.99
CGS001-64219	KD	PJA1	RING-type (C3HC4) zinc fingers, praja ring finger 1			12.50, 0.00	1.42, 0.35	-71.33	31.18	96.55	-44.88	75.85	NaN	NaN	-50.53	32.00	-29.42
CGS001-9867	KD	PJA2	RING-type (C3HC4) zinc fingers, praja ring finger 2			0.00, 0.00	1.39, 0.48	-95.27	-100.00	-21.88	63.12	-39.21	NaN	-84.20	22.07	36.75	-37.73
CGS001-5310	KD	PKD1	Voltage-gated ion channels / Transient receptor potential cation channels, polycystic kidney disease 1 (autosomal dominant)			10.00, 10.00	0.73, 0.25	-13.78	52.82	-23.25	32.41	68.23	-85.32	91.83	-69.80	99.65	46.29
CGS001-11142	KD	PKIG	protein kinase (cAMP-dependent, catalytic) inhibitor gamma			10.00, 10.00	0.94, 0.27	54.04	42.02	-28.20	-58.93	33.60	98.92	-76.99	-73.48	-49.15	-37.20
CGS001-5315	KD	PKM2	pyruvate kinase, muscle			33.33, 33.33	1.07, 0.32	99.12	98.80	-77.40	-99.88	-61.05	NaN	-46.62	-17.44	99.96	84.27
CGS001-5585	KD	PKN1	Protein kinase N (PKN) family, protein kinase N1		C2 domain containing protein kinases LOF	20.00, 20.00	1.86, 0.67	65.19	-88.68	28.45	22.36	99.66	99.97	26.10	-30.89	49.79	49.11
CGS001-5586	KD	PKN2	Protein kinase N (PKN) family, protein kinase N2			0.00, 0.00	1.48, 0.41	-98.93	-99.14	-99.98	-42.17	-99.96	NaN	-99.98	18.05	23.85	-99.95
CGS001-84647	KD	PLA2G12B	phospholipase A2, group XIIB			22.22, 22.22	1.28, 0.36	-24.89	-91.65	-22.35	-37.37	97.80	99.72	25.30	-33.98	NaN	-18.41
CGS001-23659	KD	PLA2G15	phospholipase A2, group XV			28.57, 28.57	1.56, 0.45	-52.90	NaN	-83.81	99.74	30.36	NaN	NaN	98.17	29.86	70.23
CGS001-5320	KD	PLA2G2A	Hydrolases, phospholipase A2, group IIA (platelets, synovial fluid)		Phospholipases LOF	11.11, 11.11	1.53, 0.44	40.04	99.96	71.07	24.62	53.23	NaN	-41.71	59.74	-88.88	59.54
CGS001-391013	KD	PLA2G2C	phospholipase A2, group IIC			55.56, 44.44	1.53, 0.52	-97.66	26.87	-31.40	99.91	99.11	99.60	93.95	96.32	NaN	99.39
CGS001-5321	KD	PLA2G4A	Phospholipase A2, phospholipase A2, group IVA (cytosolic, calcium-dependent)			11.11, 11.11	1.59, 0.38	-17.41	82.23	28.96	60.23	82.83	47.71	NaN	-25.86	98.50	53.40
CGS001-5327	KD	PLAT	Chymotrypsin, plasminogen activator, tissue			0.00, 0.00	1.98, 0.91	-74.56	27.51	-98.28	-97.09	27.74	NaN	54.14	-96.38	21.53	-92.40
CGS001-5328	KD	PLAU	Chymotrypsin, plasminogen activator, urokinase			0.00, 0.00	1.18, 0.50	-67.84	30.89	-58.24	31.14	28.64	NaN	78.58	17.86	-23.18	12.29
CGS001-5329	KD	PLAUR	CD molecules, plasminogen activator, urokinase receptor			14.29, 14.29	1.64, 0.61	-95.69	NaN	-69.50	NaN	97.65	NaN	73.27	-98.31	47.53	-72.48
CGS001-23236	KD	PLCB1	Phosphoinositide-specific phospholipase C, phospholipase C, beta 1 (phosphoinositide-specific)		Phospholipases LOF	50.00, 37.50	1.64, 0.53	98.02	30.68	83.88	86.28	99.96	75.62	NaN	99.43	NaN	97.28
CGS001-5331	KD	PLCB3	Phosphoinositide-specific phospholipase C, phospholipase C, beta 3 (phosphatidylinositol-specific)			20.00, 10.00	1.43, 0.42	69.57	95.39	86.20	69.36	30.92	86.83	-32.23	99.81	39.10	88.12
CGS001-5335	KD	PLCG1	Phosphoinositide-specific phospholipase C, phospholipase C, gamma 1		Phospholipases LOF	44.44, 44.44	1.35, 0.43	79.56	30.89	99.36	99.96	99.64	NaN	-74.31	-54.17	29.85	99.55
CGS001-5336	KD	PLCG2	Phosphoinositide-specific phospholipase C, phospholipase C, gamma 2 (phosphatidylinositol-specific)			0.00, 0.00	1.35, 0.56	-80.77	24.06	-39.38	-52.16	93.36	NaN	-89.87	-21.71	NaN	-47.22
CGS001-5337	KD	PLD1	Phosphatidylcholine-specific phospholipase D, phospholipase D1, phosphatidylcholine-specific			0.00, 0.00	1.55, 0.52	37.53	-79.98	-99.94	25.66	-37.61	-65.34	-80.50	-25.29	-36.68	-64.56
CGS001-5338	KD	PLD2	Hydrolases, phospholipase D2		Phospholipases LOF	11.11, 11.11	1.83, 0.39	-39.13	100.00	91.87	NaN	54.43	75.68	47.32	-22.44	-76.15	69.29
CGS001-55111	KD	PLEKHJ1	Pleckstrin homology (PH) domain containing, pleckstrin homology domain containing, family J member 1			12.50, 12.50	1.23, 0.32	28.33	NaN	-96.67	80.94	-95.28	99.16	NaN	-43.82	48.03	-46.52
CGS001-9842	KD	PLEKHM1	Pleckstrin homology (PH) domain containing, pleckstrin homology domain containing, family M (with RUN domain) member 1			28.57, 14.29	2.23, 0.84	-63.78	NaN	98.67	50.40	87.04	NaN	NaN	86.41	29.25	96.00
CGS001-5347	KD	PLK1	Polo-like kinase (PLK) family, polo-like kinase 1			10.00, 10.00	1.85, 0.75	-57.65	-62.20	16.88	37.77	99.31	28.46	-41.47	94.00	79.27	36.38
CGS001-10769	KD	PLK2	Polo-like kinase (PLK) family, polo-like kinase 2			0.00, 0.00	1.31, 0.44	64.59	-99.96	-32.96	-43.05	-18.93	NaN	-85.64	72.61	31.14	-33.32
CGS001-10733	KD	PLK4	Polo-like kinase (PLK) family, polo-like kinase 4			0.00, 0.00	1.42, 0.57	-85.43	-41.53	-99.13	-95.12	-32.02	-99.78	-99.96	-99.53	-67.65	-99.53
CGS001-5351	KD	PLOD1	procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1			12.50, 0.00	1.44, 0.48	-93.06	-84.62	-90.01	96.34	NaN	NaN	-24.87	-83.78	-41.47	-85.85
CGS001-5352	KD	PLOD2	procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2			44.44, 33.33	1.49, 0.36	92.15	36.27	77.75	99.90	61.26	NaN	96.97	99.75	39.62	99.30
CGS001-8985	KD	PLOD3	procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3			10.00, 0.00	0.97, 0.26	8.64	75.72	96.27	-83.07	-19.97	50.67	91.73	-62.45	-24.68	67.67
CGS001-5355	KD	PLP2	proteolipid protein 2 (colonic epithelium-enriched)			60.00, 40.00	1.58, 0.56	97.10	78.72	95.36	-26.40	98.44	98.26	-50.51	-92.27	99.92	99.23
CGS001-5357	KD	PLS1	EF-hand domain containing, plastin 1			0.00, 0.00	1.27, 0.36	-99.84	NaN	-99.93	-86.40	47.41	-99.06	-91.53	-58.23	-77.66	-99.89
CGS001-5359	KD	PLSCR1	phospholipid scramblase 1			10.00, 10.00	1.35, 0.39	99.71	25.88	-91.40	-56.08	-89.31	29.75	-99.54	-30.13	42.29	-86.35
CGS001-57048	KD	PLSCR3	phospholipid scramblase 3			10.00, 0.00	1.51, 0.39	41.77	78.07	-76.99	-64.89	80.40	71.68	-92.10	52.68	96.69	84.69
CGS001-5362	KD	PLXNA2	Plexins, plexin A2			44.44, 33.33	2.14, 0.69	-99.72	-26.11	97.41	98.50	-65.14	84.18	NaN	90.80	99.92	98.48
CGS001-5366	KD	PMAIP1	phorbol-12-myristate-13-acetate-induced protein 1			0.00, 0.00	2.23, 0.75	-61.41	NaN	-64.85	78.31	44.53	94.17	63.68	90.42	-87.14	85.71
CGS001-11243	KD	PMF1	polyamine-modulated factor 1			0.00, 0.00	1.55, 0.41	-99.86	-49.90	-92.02	-94.00	-78.70	-24.32	-39.55	-98.97	43.10	-94.15
CGS001-5371	KD	PML	RING-type (C3HC4) zinc fingers, promyelocytic leukemia			0.00, 0.00	1.55, 0.56	-59.62	57.24	-63.40	-58.67	72.70	NaN	-58.59	-45.30	-25.20	-44.20
CGS001-5373	KD	PMM2	phosphomannomutase 2			10.00, 10.00	2.13, 0.60	89.89	-80.36	71.29	-37.39	73.96	98.79	32.06	-69.35	-25.35	63.80
CGS001-9512	KD	PMPCB	peptidase (mitochondrial processing) beta			0.00, 0.00	1.31, 0.48	75.22	-70.08	-31.57	-22.40	30.45	-43.81	-97.94	-86.42	29.06	-50.93
CGS001-5378	KD	PMS1	PMS1 postmeiotic segregation increased 1 (S. cerevisiae)			0.00, 0.00	1.06, 0.39	-96.27	20.11	-99.68	-27.87	-99.98	-17.65	-86.08	-99.58	52.73	-98.75
CGS001-5387	KD	PMS2P3	postmeiotic segregation increased 2 pseudogene 3			0.00, 0.00	1.00, 0.25	-56.95	73.06	-98.49	-26.48	-35.39	-36.68	-93.95	-51.03	-99.93	-58.17
CGS001-11284	KD	PNKP	polynucleotide kinase 3'-phosphatase			0.00, 0.00	2.19, 0.55	-44.84	29.53	-97.74	-92.26	-99.31	42.67	63.52	-98.77	-85.84	-98.36
CGS001-154197	KD	PNLDC1	poly(A)-specific ribonuclease (PARN)-like domain containing 1			10.00, 10.00	1.31, 0.34	-29.28	-51.78	-89.19	47.54	38.96	-21.31	-42.85	63.87	99.97	36.06
CGS001-4860	KD	PNP	purine nucleoside phosphorylase			0.00, 0.00	1.17, 0.20	-70.77	32.64	25.46	-80.77	-82.77	-99.57	-99.25	-46.95	27.27	-70.48
CGS001-55163	KD	PNPO	pyridoxamine 5'-phosphate oxidase			0.00, 0.00	1.06, 0.24	-93.75	-99.93	-41.90	33.01	-21.49	-45.46	61.43	-98.52	-78.53	-73.07
CGS001-10957	KD	PNRC1	proline-rich nuclear receptor coactivator 1			0.00, 0.00	1.49, 0.51	31.57	-27.25	66.34	-94.10	91.29	NaN	65.45	80.98	72.61	65.68
CGS001-5422	KD	POLA1	DNA polymerases, polymerase (DNA directed), alpha 1, catalytic subunit			11.11, 11.11	1.11, 0.36	-61.30	-82.94	-51.63	86.17	-49.31	NaN	98.68	-71.63	-83.75	-73.70
CGS001-5423	KD	POLB	DNA polymerases, polymerase (DNA directed), beta			10.00, 10.00	1.14, 0.27	54.61	79.74	-89.73	-99.96	99.98	-44.87	-56.02	16.75	27.35	-38.49
CGS001-57804	KD	POLD4	DNA polymerases, polymerase (DNA-directed), delta 4			10.00, 10.00	1.27, 0.31	-45.16	100.00	-47.61	82.47	-34.56	71.61	23.55	-80.92	-95.05	-37.10
CGS001-5427	KD	POLE2	DNA polymerases, polymerase (DNA directed), epsilon 2 (p59 subunit)		DNA Replication LOF	0.00, 0.00	0.98, 0.26	33.51	32.01	-53.58	-37.14	21.85	68.20	22.27	-97.36	-36.74	-10.43
CGS001-54107	KD	POLE3	DNA polymerases, polymerase (DNA directed), epsilon 3 (p17 subunit)			0.00, 0.00	1.63, 0.48	-36.82	NaN	-36.62	-56.04	56.77	NaN	30.38	-38.01	32.49	-24.25
CGS001-5428	KD	POLG	DNA polymerases, polymerase (DNA directed), gamma			10.00, 10.00	1.77, 0.53	77.99	62.47	91.69	26.14	34.67	87.15	99.89	-29.29	35.88	78.86
CGS001-11232	KD	POLG2	DNA polymerases, polymerase (DNA directed), gamma 2, accessory subunit			0.00, 0.00	0.94, 0.28	93.28	NaN	-71.61	26.58	60.38	59.94	54.08	-93.36	76.41	58.52
CGS001-10721	KD	POLQ	DNA polymerases, polymerase (DNA directed), theta			0.00, 0.00	1.36, 0.43	75.17	NaN	56.22	47.38	-68.16	NaN	67.30	75.39	24.62	72.57
CGS001-25885	KD	POLR1A	RNA polymerase subunits, polymerase (RNA) I polypeptide A, 194kDa			0.00, 0.00	1.31, 0.43	-65.61	NaN	-99.48	-74.04	-48.38	-45.75	NaN	-35.28	-23.90	-56.85
CGS001-9533	KD	POLR1C	RNA polymerase subunits, polymerase (RNA) I polypeptide C, 30kDa			10.00, 10.00	0.78, 0.15	76.97	-23.80	-98.50	35.58	-43.81	-53.37	99.98	-30.28	67.22	31.69
CGS001-64425	KD	POLR1E	RNA polymerase subunits, polymerase (RNA) I polypeptide E, 53kDa			50.00, 50.00	1.72, 0.47	97.89	99.32	-49.08	NaN	92.68	NaN	99.54	59.05	-21.04	99.61
CGS001-5430	KD	POLR2A	RNA polymerase subunits, polymerase (RNA) II (DNA directed) polypeptide A, 220kDa		RNA Polymerase Enzymes LOF	0.00, 0.00	1.55, 0.51	49.90	58.59	-21.04	-29.64	46.55	-31.49	-84.01	-52.41	-22.35	-13.24
CGS001-5432	KD	POLR2C	RNA polymerase subunits, polymerase (RNA) II (DNA directed) polypeptide C, 33kDa		RNA Polymerase Enzymes LOF	0.00, 0.00	1.30, 0.33	-31.41	43.95	-26.90	56.11	-94.54	NaN	-29.48	-45.44	-41.04	-19.35
CGS001-5433	KD	POLR2D	RNA polymerase subunits, polymerase (RNA) II (DNA directed) polypeptide D		RNA Polymerase Enzymes LOF	22.22, 11.11	1.36, 0.45	96.00	99.21	-42.75	-99.23	-97.33	NaN	-38.20	-49.16	-99.67	-99.45
CGS001-5435	KD	POLR2F	RNA polymerase subunits, polymerase (RNA) II (DNA directed) polypeptide F		RNA Polymerase Enzymes LOF	0.00, 0.00	1.49, 0.61	57.65	-23.13	34.30	-27.02	23.51	48.52	27.11	-36.12	-32.61	11.16
CGS001-5437	KD	POLR2H	RNA polymerase subunits, polymerase (RNA) II (DNA directed) polypeptide H			0.00, 0.00	1.77, 0.44	-79.12	64.05	-28.58	-58.28	-70.33	-85.59	NaN	-37.38	21.46	-54.77
CGS001-5438	KD	POLR2I	RNA polymerase subunits, polymerase (RNA) II (DNA directed) polypeptide I, 14.5kDa		RNA Polymerase Enzymes LOF	0.00, 0.00	1.56, 0.45	77.79	-44.74	-45.17	-26.58	45.41	40.58	-56.63	-60.89	-61.94	-33.97
CGS001-5440	KD	POLR2K	RNA polymerase subunits, polymerase (RNA) II (DNA directed) polypeptide K, 7.0kDa		RNA Polymerase Enzymes LOF	30.00, 30.00	1.67, 0.48	91.47	99.93	41.54	98.27	99.49	-28.45	-59.91	14.37	45.92	92.32
CGS001-55703	KD	POLR3B	RNA polymerase subunits, polymerase (RNA) III (DNA directed) polypeptide B			44.44, 33.33	1.42, 0.41	53.67	NaN	99.98	91.77	99.49	58.33	96.79	63.26	55.22	97.77
CGS001-661	KD	POLR3D	RNA polymerase subunits, polymerase (RNA) III (DNA directed) polypeptide D, 44kDa			10.00, 10.00	0.93, 0.26	16.71	98.47	-27.24	-50.02	-68.27	43.75	-61.69	27.83	85.87	11.40
CGS001-55718	KD	POLR3E	RNA polymerase subunits, polymerase (RNA) III (DNA directed) polypeptide E (80kD)			12.50, 12.50	1.70, 0.39	-61.13	-66.80	58.56	99.90	92.86	NaN	-97.52	NaN	19.34	51.48
CGS001-10621	KD	POLR3F	RNA polymerase subunits, polymerase (RNA) III (DNA directed) polypeptide F, 39 kDa			20.00, 20.00	1.48, 0.41	70.47	76.82	-17.69	49.93	-66.52	97.52	46.09	34.04	99.97	50.49
CGS001-51728	KD	POLR3K	RNA polymerase subunits, polymerase (RNA) III (DNA directed) polypeptide K, 12.3 kDa			0.00, 0.00	1.78, 0.58	-95.02	24.21	-95.64	-39.29	81.91	68.98	NaN	47.69	34.03	23.44
CGS001-5442	KD	POLRMT	polymerase (RNA) mitochondrial (DNA directed)			12.50, 12.50	2.38, 0.63	51.40	33.52	99.75	23.72	42.02	NaN	NaN	43.16	-39.07	42.31
CGS001-5446	KD	PON3	Paraoxonases, paraoxonase 3			0.00, 0.00	1.80, 0.56	-76.15	-97.25	51.55	-58.96	25.84	-99.94	79.48	-73.03	NaN	-65.43
CGS001-10775	KD	POP4	processing of precursor 4, ribonuclease P/MRP subunit (S. cerevisiae)			10.00, 10.00	1.34, 0.31	-42.65	88.16	-32.77	-20.82	99.98	-33.92	-32.09	9.63	-21.61	-9.16
CGS001-5447	KD	POR	P450 (cytochrome) oxidoreductase			0.00, 0.00	1.55, 0.57	70.30	NaN	38.65	52.20	-99.98	NaN	29.56	90.53	92.17	52.35
CGS001-25913	KD	POT1	protection of telomeres 1 homolog (S. pombe)			11.11, 11.11	1.07, 0.23	48.75	72.98	-51.33	-23.93	38.56	99.94	12.58	-99.19	NaN	19.63
CGS001-5450	KD	POU2AF1	POU class 2 associating factor 1			11.11, 11.11	1.91, 0.51	-62.21	99.45	42.56	50.78	-39.24	NaN	-38.01	51.96	32.87	35.55
CGS001-5451	KD	POU2F1	Homeoboxes / POU class, POU class 2 homeobox 1			12.50, 12.50	0.93, 0.27	-98.06	-99.89	41.80	66.02	-61.42	NaN	NaN	99.62	67.22	-81.33
CGS001-5460	KD	POU5F1	Homeoboxes / POU class, POU class 5 homeobox 1			22.22, 11.11	1.84, 0.55	33.13	42.76	99.39	95.28	-25.74	NaN	40.67	34.58	60.70	53.26
CGS001-134187	KD	POU5F2	Homeoboxes / POU class, POU domain class 5, transcription factor 2			12.50, 12.50	1.70, 0.59	80.57	NaN	-99.92	70.33	36.00	NaN	98.99	46.32	25.41	79.18
CGS001-8611	KD	PPAP2A	Lipid phosphate phosphatases, phosphatidic acid phosphatase type 2A			0.00, 0.00	1.22, 0.30	-97.66	-30.68	53.52	-98.95	-99.99	-99.47	-20.63	-96.65	-72.40	-97.79
CGS001-8613	KD	PPAP2B	Lipid phosphate phosphatases, phosphatidic acid phosphatase type 2B			0.00, 0.00	1.02, 0.26	-99.11	-90.19	-39.96	-24.85	-76.31	-90.18	-99.98	-58.90	23.02	-63.18
CGS001-5465	KD	PPARA	Peroxisome proliferator-activated receptors, peroxisome proliferator-activated receptor alpha			11.11, 11.11	1.60, 0.45	56.37	34.43	23.04	-66.62	-99.59	-30.99	-58.02	97.68	NaN	-40.45
CGS001-5467	KD	PPARD	Nuclear hormone receptors, peroxisome proliferator-activated receptor delta			14.29, 14.29	1.42, 0.40	46.67	NaN	-42.00	NaN	51.39	NaN	56.78	99.95	-48.32	50.22
CGS001-5468	KD	PPARG	Peroxisome proliferator-activated receptors, peroxisome proliferator-activated receptor gamma			0.00, 0.00	0.49, 0.11	-99.21	47.57	-39.14	-67.99	-97.15	92.74	-35.45	-99.45	-51.19	-90.14
CGS001-10891	KD	PPARGC1A	RNA binding motif (RRM) containing, peroxisome proliferator-activated receptor gamma, coactivator 1 alpha			0.00, 0.00	1.27, 0.30	-26.20	31.63	-49.16	-24.83	75.38	NaN	-18.24	-27.86	80.81	-4.60
CGS001-133522	KD	PPARGC1B	RNA binding motif (RRM) containing, peroxisome proliferator-activated receptor gamma, coactivator 1 beta			0.00, 0.00	1.15, 0.31	-42.30	29.52	-67.23	35.14	-83.75	NaN	38.41	17.86	-37.36	-19.80
CGS001-5471	KD	PPAT	Phosphoribosyl pyrophosphate amidotransferase, phosphoribosyl pyrophosphate amidotransferase			11.11, 11.11	1.51, 0.40	66.07	-20.33	12.41	41.71	-50.43	NaN	26.68	-45.95	99.61	18.09
CGS001-8495	KD	PPFIBP2	Sterile alpha motif (SAM) domain containing, PTPRF interacting protein, binding protein 2 (liprin beta 2)			0.00, 0.00	2.07, 0.78	-82.27	-99.98	-11.58	84.33	-94.06	NaN	-17.43	-82.54	NaN	-80.56
CGS001-5478	KD	PPIA	Cis-trans-isomerases, peptidylprolyl isomerase A (cyclophilin A)			0.00, 0.00	1.18, 0.27	-31.57	-98.39	-61.38	-25.19	-26.69	25.90	-92.34	-97.21	-98.93	-87.23
CGS001-5479	KD	PPIB	peptidylprolyl isomerase B (cyclophilin B)			22.22, 11.11	1.57, 0.60	36.67	97.39	58.18	74.15	91.05	-38.11	39.27	99.98	NaN	87.73
CGS001-5480	KD	PPIC	peptidylprolyl isomerase C (cyclophilin C)			25.00, 25.00	1.63, 0.47	99.65	NaN	-22.93	NaN	99.12	36.75	-37.57	-88.81	79.79	92.10
CGS001-10450	KD	PPIE	RNA binding motif (RRM) containing, peptidylprolyl isomerase E (cyclophilin E)			0.00, 0.00	1.67, 0.44	-92.71	-99.96	-98.31	-99.01	-48.49	-99.93	-21.44	-97.66	-83.64	-99.82
CGS001-10105	KD	PPIF	peptidylprolyl isomerase F			22.22, 22.22	1.25, 0.36	-99.04	-19.30	-30.30	-86.03	53.65	99.66	NaN	-26.90	99.80	-9.00
CGS001-5495	KD	PPM1B	Serine/threonine phosphatases / Protein phosphatases, Mg2+/Mn2+ dependent, protein phosphatase, Mg2+/Mn2+ dependent, 1B			11.11, 0.00	1.39, 0.42	34.26	70.18	11.96	24.83	-36.52	89.04	NaN	33.63	95.06	49.77
CGS001-8493	KD	PPM1D	Serine/threonine phosphatases / Protein phosphatases, Mg2+/Mn2+ dependent, protein phosphatase, Mg2+/Mn2+ dependent, 1D			0.00, 0.00	1.05, 0.27	-97.47	-81.91	-93.39	-99.98	-99.98	-63.33	-36.03	-99.39	44.34	-99.95
CGS001-5498	KD	PPOX	protoporphyrinogen oxidase			0.00, 0.00	1.18, 0.27	-87.66	67.06	18.40	27.85	58.66	75.09	-64.28	-25.14	40.15	24.86
CGS001-5499	KD	PPP1CA	Serine/threonine phosphatases / Protein phosphatase, catalytic subunits, protein phosphatase 1, catalytic subunit, alpha isozyme		Protein phosphatase catalytic subunits LOF	0.00, 0.00	1.09, 0.27	-22.92	-26.47	-46.29	-67.53	27.88	87.20	32.59	-99.72	-99.93	-25.20
CGS001-5501	KD	PPP1CC	Serine/threonine phosphatases / Protein phosphatase, catalytic subunits, protein phosphatase 1, catalytic subunit, gamma isozyme			0.00, 0.00	1.11, 0.30	-95.27	NaN	-24.11	NaN	-99.98	NaN	-73.59	-92.59	-85.27	-88.82
CGS001-23368	KD	PPP1R13B	Ankyrin repeat domain containing, protein phosphatase 1, regulatory subunit 13B			0.00, 0.00	1.44, 0.47	-53.08	-99.19	-29.16	-85.48	-99.04	-34.26	NaN	-45.70	-97.39	-95.84
CGS001-26472	KD	PPP1R14B	Serine/threonine phosphatases / Protein phosphatase 1, regulatory subunits, protein phosphatase 1, regulatory (inhibitor) subunit 14B			0.00, 0.00	1.70, 0.41	75.06	-100.00	-92.86	-37.01	21.58	-36.29	-49.47	-99.88	-97.85	-99.26
CGS001-5511	KD	PPP1R8	Serine/threonine phosphatases / Protein phosphatase 1, regulatory subunits, protein phosphatase 1, regulatory subunit 8			0.00, 0.00	1.03, 0.27	76.49	-18.60	-42.98	-51.97	-42.37	NaN	-62.46	-61.63	-99.92	-54.15
CGS001-5515	KD	PPP2CA	Serine/threonine phosphatases / Protein phosphatase, catalytic subunits, protein phosphatase 2, catalytic subunit, alpha isozyme			11.11, 0.00	1.20, 0.33	89.57	59.94	-26.67	-29.53	-55.65	NaN	96.98	-44.85	23.80	39.60
CGS001-5518	KD	PPP2R1A	Serine/threonine phosphatases / Protein phosphatase 2, regulatory subunits, protein phosphatase 2, regulatory subunit A, alpha			0.00, 0.00	1.07, 0.38	-31.07	NaN	-99.98	-81.16	22.24	-24.50	79.27	-89.59	-97.54	-92.32
CGS001-5522	KD	PPP2R2C	Serine/threonine phosphatases / Protein phosphatase 2, regulatory subunits, protein phosphatase 2, regulatory subunit B, gamma			0.00, 0.00	1.45, 0.43	21.89	20.46	22.72	33.83	-77.46	84.20	-35.77	30.28	35.01	7.55
CGS001-5523	KD	PPP2R3A	EF-hand domain containing, protein phosphatase 2, regulatory subunit B'', alpha			0.00, 0.00	1.16, 0.38	-81.91	-95.77	-99.95	-99.96	36.95	-98.68	-99.98	-14.22	33.66	-99.92
CGS001-55012	KD	PPP2R3C	Serine/threonine phosphatases / Protein phosphatase 2, regulatory subunits, protein phosphatase 2, regulatory subunit B'', gamma			0.00, 0.00	1.17, 0.33	36.34	-30.51	-26.73	83.44	74.78	NaN	NaN	-99.54	29.98	28.18
CGS001-5524	KD	PPP2R4	Serine/threonine phosphatases / Protein phosphatase 2, regulatory subunits, protein phosphatase 2A activator, regulatory subunit 4			0.00, 0.00	1.08, 0.23	-78.95	-41.28	15.61	22.23	-24.77	-94.81	-67.67	NaN	NaN	-65.97
CGS001-5525	KD	PPP2R5A	Serine/threonine phosphatases / Protein phosphatase 2, regulatory subunits, protein phosphatase 2, regulatory subunit B', alpha			10.00, 10.00	1.05, 0.34	25.45	23.88	92.08	-43.05	-73.56	99.56	-31.89	-88.83	38.09	11.94
CGS001-5526	KD	PPP2R5B	Serine/threonine phosphatases / Protein phosphatase 2, regulatory subunits, protein phosphatase 2, regulatory subunit B', beta			0.00, 0.00	1.31, 0.45	72.90	91.90	-99.93	-32.30	62.52	-33.02	NaN	54.73	53.46	54.35
CGS001-5529	KD	PPP2R5E	Serine/threonine phosphatases / Protein phosphatase 2, regulatory subunits, protein phosphatase 2, regulatory subunit B', epsilon isoform			11.11, 11.11	1.55, 0.60	50.12	NaN	99.61	72.32	-24.44	35.31	32.40	27.01	39.19	35.57
CGS001-5530	KD	PPP3CA	Serine/threonine phosphatases / Protein phosphatase, catalytic subunits, protein phosphatase 3, catalytic subunit, alpha isozyme			50.00, 50.00	0.98, 0.31	-88.95	89.23	99.89	98.57	89.57	36.76	-49.43	97.79	99.97	98.66
CGS001-5532	KD	PPP3CB	Serine/threonine phosphatases / Protein phosphatase, catalytic subunits, protein phosphatase 3, catalytic subunit, beta isozyme			0.00, 0.00	1.26, 0.27	22.21	75.35	76.70	NaN	-25.41	-98.70	45.77	23.82	NaN	29.94
CGS001-5533	KD	PPP3CC	Serine/threonine phosphatases / Protein phosphatase, catalytic subunits, protein phosphatase 3, catalytic subunit, gamma isozyme			0.00, 0.00	1.45, 0.44	35.20	-23.85	-40.70	73.07	94.85	-29.37	24.24	70.93	-52.19	41.23
CGS001-5534	KD	PPP3R1	EF-hand domain containing, protein phosphatase 3, regulatory subunit B, alpha			0.00, 0.00	1.52, 0.48	13.96	-29.91	-59.51	-63.45	-32.14	-48.03	NaN	55.71	21.91	-17.03
CGS001-5535	KD	PPP3R2	EF-hand domain containing, protein phosphatase 3, regulatory subunit B, beta			11.11, 0.00	1.40, 0.32	-34.94	88.04	-34.31	-39.90	49.24	NaN	71.34	26.25	97.04	41.66
CGS001-5531	KD	PPP4C	Serine/threonine phosphatases / Protein phosphatase, catalytic subunits, protein phosphatase 4, catalytic subunit		Protein phosphatase catalytic subunits LOF	0.00, 0.00	1.11, 0.42	16.91	-98.21	-21.36	-32.66	-71.97	-50.08	-74.62	-75.56	-51.52	-63.32
CGS001-9989	KD	PPP4R1	Serine/threonine phosphatases / Protein phosphatase 4, regulatory subunits, protein phosphatase 4, regulatory subunit 1			0.00, 0.00	1.28, 0.50	-33.75	-97.29	-99.81	-99.98	-99.98	-92.93	-97.70	-99.99	-99.82	-99.95
CGS001-5538	KD	PPT1	palmitoyl-protein thioesterase 1			0.00, 0.00	1.42, 0.47	30.03	-26.80	62.89	-29.54	-74.92	-32.69	35.37	NaN	-35.06	6.49
CGS001-9374	KD	PPT2	palmitoyl-protein thioesterase 2			20.00, 20.00	0.98, 0.25	20.12	88.25	99.38	-28.87	-53.72	99.69	-33.23	17.97	28.70	38.26
CGS001-10084	KD	PQBP1	polyglutamine binding protein 1			0.00, 0.00	1.22, 0.42	37.31	-99.91	-23.31	-99.98	NaN	55.02	-65.92	-93.57	8.84	-94.48
CGS001-11230	KD	PRAF2	PRA1 domain family, member 2			11.11, 0.00	1.67, 0.48	-99.05	NaN	-53.00	-80.67	-35.13	96.15	-71.36	-42.88	29.56	-63.81
CGS001-5546	KD	PRCC	papillary renal cell carcinoma (translocation-associated)			11.11, 11.11	1.07, 0.38	-15.57	64.67	30.01	-48.34	87.85	NaN	99.83	-60.39	24.74	62.72
CGS001-5547	KD	PRCP	Lysosomal Pro-Xaa carboxypeptidase, prolylcarboxypeptidase (angiotensinase C)			0.00, 0.00	1.32, 0.30	-81.70	22.23	-69.85	-94.46	-25.90	-80.75	-94.38	-81.18	-83.11	-81.04
CGS001-639	KD	PRDM1	Zinc fingers, C2H2-type, PR domain containing 1, with ZNF domain			0.00, 0.00	1.31, 0.44	-65.34	41.59	80.70	35.26	21.80	30.88	NaN	84.29	49.16	55.12
CGS001-11108	KD	PRDM4	Zinc fingers, C2H2-type, PR domain containing 4			0.00, 0.00	1.38, 0.39	26.15	NaN	47.87	71.50	24.64	-22.26	23.76	-99.27	NaN	8.78
CGS001-11105	KD	PRDM7	Zinc fingers, C2H2-type, PR domain containing 7			0.00, 0.00	1.69, 0.50	-22.63	94.68	38.76	28.36	32.72	32.62	81.90	NaN	27.28	13.76
CGS001-5052	KD	PRDX1	peroxiredoxin 1			0.00, 0.00	1.55, 0.43	-99.93	-71.69	-99.23	-82.56	NaN	NaN	-22.60	-99.73	-99.69	-99.95
CGS001-10113	KD	PREB	WD repeat domain containing, prolactin regulatory element binding			0.00, 0.00	1.35, 0.30	-34.92	NaN	-59.85	-44.04	-99.98	NaN	75.54	-99.21	-34.80	-56.50
CGS001-5550	KD	PREP	Prolyl oligopeptidase, prolyl endopeptidase			25.00, 12.50	1.09, 0.38	-92.83	-29.26	-91.20	67.93	99.04	NaN	NaN	95.83	-20.87	78.86
CGS001-5562	KD	PRKAA1	AMPK subfamily, protein kinase, AMP-activated, alpha 1 catalytic subunit			0.00, 0.00	1.18, 0.27	-99.24	-100.00	-15.92	-97.48	-99.84	-72.24	-82.53	NaN	-26.60	-99.95
CGS001-5563	KD	PRKAA2	AMPK subfamily, protein kinase, AMP-activated, alpha 2 catalytic subunit			0.00, 0.00	1.39, 0.34	-33.76	39.10	36.67	27.32	-43.49	NaN	-55.26	69.39	-99.89	-46.48
CGS001-5564	KD	PRKAB1	AMPK subfamily, protein kinase, AMP-activated, beta 1 non-catalytic subunit			12.50, 12.50	1.30, 0.42	-97.15	-80.35	53.26	54.12	50.16	NaN	NaN	98.81	-44.11	55.94
CGS001-5565	KD	PRKAB2	AMPK subfamily, protein kinase, AMP-activated, beta 2 non-catalytic subunit			11.11, 11.11	2.10, 0.68	98.41	79.22	56.10	65.91	-48.29	21.94	47.55	91.70	NaN	70.46
CGS001-5566	KD	PRKACA	Protein kinase A, protein kinase, cAMP-dependent, catalytic, alpha			10.00, 0.00	0.72, 0.23	70.82	66.80	94.06	25.22	-29.40	88.50	-43.11	87.52	96.89	71.22
CGS001-5567	KD	PRKACB	Protein kinase A, protein kinase, cAMP-dependent, catalytic, beta			0.00, 0.00	1.31, 0.20	-55.15	84.28	-99.35	84.81	94.97	NaN	NaN	16.68	94.23	85.82
CGS001-5571	KD	PRKAG1	AMPK subfamily, protein kinase, AMP-activated, gamma 1 non-catalytic subunit			11.11, 0.00	1.81, 0.45	80.97	-99.37	28.04	-65.96	96.89	NaN	-30.65	-47.12	-99.96	-61.81
CGS001-51422	KD	PRKAG2	AMPK subfamily, protein kinase, AMP-activated, gamma 2 non-catalytic subunit			12.50, 12.50	2.13, 0.57	17.16	-97.09	-86.79	81.02	-50.74	NaN	NaN	-22.88	99.03	-31.16
CGS001-53632	KD	PRKAG3	AMPK subfamily, protein kinase, AMP-activated, gamma 3 non-catalytic subunit			11.11, 11.11	2.03, 0.56	85.92	-99.96	99.96	47.16	-96.33	-59.88	NaN	-96.93	-98.22	-99.26
CGS001-5573	KD	PRKAR1A	Protein kinase A, protein kinase, cAMP-dependent, regulatory, type I, alpha (tissue specific extinguisher 1)			0.00, 0.00	1.06, 0.32	54.90	48.38	-51.90	-32.62	-58.90	-96.74	-18.19	-61.37	37.18	-15.21
CGS001-5575	KD	PRKAR1B	Protein kinase A, protein kinase, cAMP-dependent, regulatory, type I, beta			11.11, 11.11	1.05, 0.20	-71.71	-100.00	38.89	-96.39	-94.79	99.88	-34.12	-43.39	NaN	-91.63
CGS001-5576	KD	PRKAR2A	Protein kinase A, protein kinase, cAMP-dependent, regulatory, type II, alpha			22.22, 22.22	1.57, 0.48	63.27	27.17	-28.86	99.72	99.29	NaN	39.05	88.77	-98.02	87.36
CGS001-5577	KD	PRKAR2B	Protein kinase A, protein kinase, cAMP-dependent, regulatory, type II, beta			0.00, 0.00	1.52, 0.48	-38.25	-24.57	22.31	-96.94	57.79	NaN	93.06	-99.81	-49.36	-30.75
CGS001-5578	KD	PRKCA	Delta subfamily, protein kinase C, alpha			22.22, 11.11	0.90, 0.35	84.44	55.20	-20.47	99.53	96.97	NaN	-26.28	-48.11	20.61	64.31
CGS001-5579	KD	PRKCB	Alpha subfamily, protein kinase C, beta		C2 domain containing protein kinases LOF	0.00, 0.00	1.93, 0.55	-44.96	-56.74	-30.72	94.26	49.87	38.17	NaN	62.65	48.21	35.35
CGS001-5580	KD	PRKCD	Delta subfamily, protein kinase C, delta			10.00, 10.00	0.76, 0.20	-27.32	-67.68	-94.66	36.01	99.98	30.59	-99.50	20.64	43.52	-18.31
CGS001-5581	KD	PRKCE	Eta subfamily, protein kinase C, epsilon			10.00, 0.00	1.52, 0.47	96.25	-54.33	90.95	85.76	-61.17	-85.94	-41.48	91.84	-43.16	90.54
CGS001-5584	KD	PRKCI	Iota subfamily, protein kinase C, iota			50.00, 37.50	1.27, 0.40	NaN	95.34	99.89	-51.99	-53.91	NaN	98.81	-97.60	-99.51	97.72
CGS001-5588	KD	PRKCQ	Delta subfamily, protein kinase C, theta		C2 domain containing protein kinases LOF	11.11, 11.11	2.09, 0.68	-52.04	-83.03	-74.52	97.97	-28.36	-29.68	NaN	-31.20	-21.59	-24.35
CGS001-5590	KD	PRKCZ	Iota subfamily, protein kinase C, zeta			0.00, 0.00	1.34, 0.45	44.63	64.10	-45.86	24.78	24.69	48.44	-37.44	-98.16	-24.49	9.52
CGS001-5591	KD	PRKDC	Other PIKK family kinases, protein kinase, DNA-activated, catalytic polypeptide			0.00, 0.00	1.32, 0.34	-99.96	-90.28	-61.33	-30.92	-49.38	NaN	-51.76	-98.83	25.64	-91.02
CGS001-8575	KD	PRKRA	protein kinase, interferon-inducible double stranded RNA dependent activator			11.11, 11.11	1.58, 0.47	28.79	-91.23	55.29	82.24	10.52	76.89	99.98	-24.54	NaN	62.42
CGS001-5612	KD	PRKRIR	THAP (C2CH-type zinc finger) domain containing, protein-kinase, interferon-inducible double stranded RNA dependent inhibitor, repressor of (P58 repressor)			11.11, 11.11	1.28, 0.41	-25.44	77.97	88.92	99.98	81.42	NaN	-43.50	-29.62	88.37	89.73
CGS001-5613	KD	PRKX	Protein kinase A, protein kinase, X-linked			11.11, 11.11	1.35, 0.44	97.97	37.04	50.07	94.60	-43.61	-24.36	23.65	36.65	NaN	43.85
CGS001-2834	KD	PRLHR	GPCR / Class A : RF amide peptide receptors, prolactin releasing hormone receptor			0.00, 0.00	2.28, 0.78	34.14	90.74	92.84	33.05	43.93	NaN	-61.02	NaN	-65.69	39.77
CGS001-5618	KD	PRLR	Prolactin receptor family, prolactin receptor			0.00, 0.00	1.52, 0.40	27.90	81.03	-86.51	31.05	-80.53	94.41	41.79	81.46	22.82	50.07
CGS001-3275	KD	PRMT2	Protein arginine N-methyltransferases, protein arginine methyltransferase 2			0.00, 0.00	0.85, 0.24	-29.08	-24.91	-98.66	-51.64	-74.91	27.17	-26.29	-38.41	-23.91	-27.75
CGS001-10196	KD	PRMT3	Protein arginine N-methyltransferases, protein arginine methyltransferase 3			0.00, 0.00	0.84, 0.33	-63.93	NaN	-63.16	-91.21	-99.94	NaN	-20.66	-99.71	-27.54	-97.24
CGS001-5621	KD	PRNP	CD molecules, prion protein			0.00, 0.00	1.40, 0.27	-27.38	-36.09	-95.85	-42.34	45.92	22.64	-99.96	-86.75	-67.69	-70.31
CGS001-5624	KD	PROC	Endogenous ligands, protein C (inactivator of coagulation factors Va and VIIIa)			10.00, 10.00	1.33, 0.40	-99.80	-25.42	77.78	-99.13	-25.69	-41.24	-43.23	-85.43	99.18	-63.36
CGS001-10544	KD	PROCR	CD molecules, protein C receptor, endothelial			0.00, 0.00	1.73, 0.43	-71.25	-19.45	-52.08	29.50	-40.25	-98.16	-82.47	-20.89	20.55	-43.58
CGS001-10887	KD	PROKR1	GPCR / Class A : Prokineticin receptors, prokineticin receptor 1			11.11, 11.11	2.03, 0.56	84.12	94.07	78.52	34.68	-32.43	NaN	98.77	92.83	-28.16	86.76
CGS001-128674	KD	PROKR2	GPCR / Class A : Prokineticin receptors, prokineticin receptor 2			0.00, 0.00	1.78, 0.67	34.24	-26.60	34.48	22.62	33.09	-28.77	NaN	22.76	NaN	16.41
CGS001-11212	KD	PROSC	proline synthetase co-transcribed homolog (bacterial)			0.00, 0.00	1.16, 0.26	-97.52	56.62	75.79	-24.18	32.72	-89.82	-98.91	92.52	NaN	-59.99
CGS001-5629	KD	PROX1	Homeoboxes / PROS class, prospero homeobox 1			11.11, 11.11	1.38, 0.39	-19.05	28.53	99.82	26.10	28.79	92.98	84.04	NaN	-65.62	62.09
CGS001-9128	KD	PRPF4	WD repeat domain containing, PRP4 pre-mRNA processing factor 4 homolog (yeast)			33.33, 11.11	1.49, 0.43	70.38	NaN	92.91	62.74	35.98	58.73	99.96	95.80	83.19	96.61
CGS001-8899	KD	PRPF4B	PRP4 subfamily, PRP4 pre-mRNA processing factor 4 homolog B (yeast)			0.00, 0.00	1.43, 0.40	45.02	18.31	-75.06	-99.86	92.21	32.90	84.91	-99.96	-94.08	-97.73
CGS001-24148	KD	PRPF6	PRP6 pre-mRNA processing factor 6 homolog (S. cerevisiae)			10.00, 10.00	1.02, 0.31	97.60	-98.90	-22.54	-79.12	-34.19	-49.94	64.99	-99.83	72.92	-50.83
CGS001-5636	KD	PRPSAP2	phosphoribosyl pyrophosphate synthetase-associated protein 2			0.00, 0.00	2.01, 0.63	-40.66	NaN	58.77	NaN	NaN	NaN	-35.73	-23.08	22.97	-16.35
CGS001-79170	KD	PRR15L	proline rich 15-like			0.00, 0.00	2.40, 0.72	84.03	NaN	-61.74	-98.65	-39.08	NaN	33.28	63.72	67.85	50.79
CGS001-80758	KD	PRR7	proline rich 7 (synaptic)			0.00, 0.00	2.25, 0.68	-47.58	NaN	23.74	67.65	80.42	NaN	38.00	37.14	24.63	21.42
CGS001-11098	KD	PRSS23	Serine peptidases / Serine peptidases, protease, serine, 23			30.00, 30.00	1.16, 0.32	-32.54	97.59	-33.69	-64.14	37.42	99.76	57.95	97.77	32.45	93.59
CGS001-5646	KD	PRSS3	Serine peptidases / Serine peptidases, protease, serine, 3			20.00, 20.00	1.75, 0.50	99.96	-92.74	75.25	39.05	98.19	28.39	52.25	86.66	-96.36	81.80
CGS001-58497	KD	PRUNE	prune homolog (Drosophila)			0.00, 0.00	0.81, 0.17	NaN	-26.56	39.19	NaN	78.47	NaN	82.28	78.78	69.20	79.79
CGS001-5660	KD	PSAP	Endogenous ligands, prosaposin			0.00, 0.00	1.07, 0.32	-99.96	24.43	-99.39	57.61	-27.44	-60.26	50.00	63.60	-26.01	-16.87
CGS001-5663	KD	PSEN1	Presenilin, presenilin 1			11.11, 0.00	1.24, 0.26	-99.95	-29.13	-15.39	-93.94	-22.09	-23.47	-98.82	NaN	97.09	-74.48
CGS001-11168	KD	PSIP1	PC4 and SFRS1 interacting protein 1			0.00, 0.00	1.34, 0.44	-98.51	-86.13	-99.60	59.67	68.57	-51.74	94.09	-97.59	-97.62	-99.39
CGS001-5684	KD	PSMA3	Proteasome subunits, proteasome (prosome, macropain) subunit, alpha type, 3		Proteasome Pathway LOF	0.00, 0.00	2.09, 0.88	-89.23	-99.52	-89.04	92.04	-25.76	-31.28	-97.75	-94.43	22.81	-97.32
CGS001-5686	KD	PSMA5	Proteasome subunits, proteasome (prosome, macropain) subunit, alpha type, 5		Proteasome Pathway LOF	0.00, 0.00	1.41, 0.49	-34.37	-21.74	50.94	-28.81	-49.64	81.36	-30.33	-35.94	NaN	-11.43
CGS001-5688	KD	PSMA7	Proteasome subunits, proteasome (prosome, macropain) subunit, alpha type, 7		Proteasome Pathway LOF	22.22, 22.22	1.53, 0.49	-92.25	-58.22	-73.02	99.94	-69.78	23.17	NaN	-27.55	99.71	-51.25
CGS001-143471	KD	PSMA8	Proteasome (prosome, macropain) subunits, proteasome (prosome, macropain) subunit, alpha type, 8			11.11, 11.11	1.58, 0.44	78.90	64.91	26.16	99.44	-49.55	56.66	-15.85	30.92	NaN	68.47
CGS001-5689	KD	PSMB1	Proteasome subunits, proteasome (prosome, macropain) subunit, beta type, 1		Proteasome Pathway LOF	0.00, 0.00	2.42, 0.85	-83.39	-97.18	-99.95	-99.98	-65.20	NaN	-74.40	-99.90	-55.46	-99.76
CGS001-5699	KD	PSMB10	Proteasome (prosome, macropain) subunits, proteasome (prosome, macropain) subunit, beta type, 10			33.33, 33.33	1.84, 0.50	89.71	25.03	91.61	93.19	84.08	NaN	99.98	99.17	92.48	97.76
CGS001-5690	KD	PSMB2	Proteasome subunits, proteasome (prosome, macropain) subunit, beta type, 2		Proteasome Pathway LOF	0.00, 0.00	1.81, 0.67	-95.75	NaN	-99.74	-93.58	-76.98	-86.30	-96.28	-99.00	-61.43	-98.49
CGS001-5693	KD	PSMB5	Proteasome subunits, proteasome (prosome, macropain) subunit, beta type, 5		Proteasome Pathway LOF	0.00, 0.00	2.14, 0.76	-98.41	-99.91	53.38	31.80	-99.71	NaN	-95.97	-99.19	NaN	-99.53
CGS001-5695	KD	PSMB7	Proteasome subunits, proteasome (prosome, macropain) subunit, beta type, 7		Proteasome Pathway LOF	0.00, 0.00	1.78, 0.51	-99.77	-99.96	-47.58	23.83	39.53	NaN	-83.52	-71.97	46.13	-75.65
CGS001-5696	KD	PSMB8	Proteasome (prosome, macropain) subunits, proteasome (prosome, macropain) subunit, beta type, 8 (large multifunctional peptidase 7)			22.22, 11.11	1.94, 0.44	96.11	25.07	93.08	99.93	64.00	NaN	59.48	89.05	-14.87	94.15
CGS001-5698	KD	PSMB9	Proteasome (prosome, macropain) subunits, proteasome (prosome, macropain) subunit, beta type, 9 (large multifunctional peptidase 2)			66.67, 55.56	2.05, 0.63	83.33	-20.70	99.98	96.02	69.44	99.26	NaN	97.99	99.97	98.70
CGS001-5716	KD	PSMD10	Ankyrin repeat domain containing, proteasome (prosome, macropain) 26S subunit, non-ATPase, 10			10.00, 0.00	1.47, 0.56	57.52	29.70	25.61	-54.02	40.21	69.01	89.62	-42.35	97.09	52.13
CGS001-5708	KD	PSMD2	Proteasome subunits, proteasome (prosome, macropain) 26S subunit, non-ATPase, 2			10.00, 10.00	1.64, 0.64	-99.77	-99.26	-31.95	-98.26	99.96	27.31	-98.06	-95.65	-99.85	-99.50
CGS001-5709	KD	PSMD3	Proteasome (prosome, macropain) subunits, proteasome (prosome, macropain) 26S subunit, non-ATPase, 3			0.00, 0.00	2.08, 0.66	-39.38	46.71	24.16	-82.63	-24.37	26.02	-80.75	-66.15	-87.04	-61.05
CGS001-5710	KD	PSMD4	Proteasome (prosome, macropain) subunits, proteasome (prosome, macropain) 26S subunit, non-ATPase, 4			0.00, 0.00	1.60, 0.45	22.19	-99.93	-99.00	-88.51	-99.96	NaN	-97.30	-99.95	-25.51	-99.92
CGS001-5711	KD	PSMD5	Proteasome (prosome, macropain) subunits, proteasome (prosome, macropain) 26S subunit, non-ATPase, 5			0.00, 0.00	1.39, 0.25	46.74	45.87	-65.02	-27.62	-99.94	-21.36	32.96	-99.50	31.00	-30.90
CGS001-5714	KD	PSMD8	Proteasome (prosome, macropain) subunits, proteasome (prosome, macropain) 26S subunit, non-ATPase, 8		Proteasome Pathway LOF	0.00, 0.00	1.66, 0.55	30.96	-28.38	-57.51	44.17	33.18	-77.82	91.21	-33.95	NaN	22.74
CGS001-5715	KD	PSMD9	Proteasome (prosome, macropain) subunits, proteasome (prosome, macropain) 26S subunit, non-ATPase, 9			0.00, 0.00	0.95, 0.20	27.12	-81.94	87.44	32.85	38.23	-20.22	87.69	28.41	55.93	22.21
CGS001-5720	KD	PSME1	Proteasome (prosome, macropain) subunits, proteasome (prosome, macropain) activator subunit 1 (PA28 alpha)			20.00, 20.00	1.19, 0.38	24.27	-21.19	-53.24	50.15	97.78	34.22	21.01	51.68	99.33	28.59
CGS001-9491	KD	PSMF1	Proteasome (prosome, macropain) subunits, proteasome (prosome, macropain) inhibitor subunit 1 (PI31)			0.00, 0.00	1.30, 0.38	36.77	-65.08	-68.87	33.63	-26.58	-96.06	-52.82	43.52	-78.80	-41.00
CGS001-8624	KD	PSMG1	proteasome (prosome, macropain) assembly chaperone 1			0.00, 0.00	1.84, 0.70	-97.28	NaN	-89.94	-83.59	-99.86	69.16	-39.56	-66.85	-53.77	-98.56
CGS001-5723	KD	PSPH	phosphoserine phosphatase			11.11, 0.00	1.39, 0.43	-97.99	-55.61	-31.02	96.55	-94.48	NaN	-61.25	-33.02	85.78	-37.72
CGS001-84722	KD	PSRC1	proline/serine-rich coiled-coil 1			0.00, 0.00	1.43, 0.39	NaN	-18.60	77.62	-99.78	74.72	-26.77	45.45	17.25	24.85	11.51
CGS001-5727	KD	PTCH1	patched 1			20.00, 20.00	1.17, 0.26	33.70	-33.24	47.36	-63.01	99.68	27.44	-23.18	-94.54	99.16	7.62
CGS001-9791	KD	PTDSS1	phosphatidylserine synthase 1			0.00, 0.00	1.82, 0.64	65.72	-52.33	28.70	-28.04	NaN	54.67	74.80	-39.70	NaN	46.34
CGS001-5728	KD	PTEN	Protein tyrosine phosphatases / Class I Cys-based PTPs : PTENs, phosphatase and tensin homolog			10.00, 10.00	1.17, 0.35	25.28	-35.41	37.63	-95.68	-87.89	54.02	99.96	-97.41	-35.27	-51.95
CGS001-5734	KD	PTGER4	GPCR / Class A : Prostanoid receptors, prostaglandin E receptor 4 (subtype EP4)			50.00, 25.00	0.86, 0.39	33.58	63.65	-30.00	96.34	92.04	NaN	NaN	96.26	99.17	97.79
CGS001-5737	KD	PTGFR	GPCR / Class A : Prostanoid receptors, prostaglandin F receptor (FP)			0.00, 0.00	1.31, 0.35	-97.18	66.71	-26.31	NaN	-60.07	-53.99	-55.76	-20.33	-78.57	-50.90
CGS001-22949	KD	PTGR1	prostaglandin reductase 1			11.11, 11.11	1.49, 0.33	-88.84	-85.58	-96.71	-81.78	-99.95	NaN	99.87	-98.63	-98.37	-99.74
CGS001-5743	KD	PTGS2	Cyclooxygenase, prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)			0.00, 0.00	1.76, 0.57	-38.72	72.80	88.23	30.38	-64.51	-56.60	-56.95	NaN	-28.24	-27.17
CGS001-5744	KD	PTHLH	Endogenous ligands, parathyroid hormone-like hormone			0.00, 0.00	1.59, 0.44	-87.28	-73.06	-60.58	85.98	80.08	NaN	-99.14	-81.17	23.27	-80.39
CGS001-2185	KD	PTK2B	Serine/threonine phosphatases / Protein phosphatase 1, regulatory subunits, PTK2B protein tyrosine kinase 2 beta			12.50, 12.50	2.21, 0.91	35.59	100.00	72.41	NaN	NaN	26.78	30.73	36.44	-91.41	39.35
CGS001-5754	KD	PTK7	Type VI RTKs: PTK7/CCK4, PTK7 protein tyrosine kinase 7			11.11, 11.11	1.27, 0.41	-85.75	-27.35	-36.41	-99.72	-62.08	99.97	42.78	-95.84	NaN	-85.36
CGS001-5763	KD	PTMS	parathymosin			0.00, 0.00	2.35, 0.58	-80.87	-88.85	-17.72	-98.34	-95.94	-60.33	34.34	-81.74	NaN	-93.91
CGS001-7803	KD	PTP4A1	Protein tyrosine phosphatases / Class I Cys-based PTPs : PRLs, protein tyrosine phosphatase type IVA, member 1			0.00, 0.00	1.49, 0.50	-90.92	-35.87	-77.75	-35.72	-30.80	-91.21	-96.15	21.17	NaN	-91.56
CGS001-9200	KD	PTPLA	protein tyrosine phosphatase-like (proline instead of catalytic arginine), member A			0.00, 0.00	1.05, 0.40	-64.49	30.80	-42.38	-33.28	-43.67	-35.60	23.08	-17.90	-47.32	-27.54
CGS001-51495	KD	PTPLAD1	protein tyrosine phosphatase-like A domain containing 1			0.00, 0.00	1.31, 0.36	-94.72	-51.20	-94.15	-88.98	-57.55	NaN	-39.14	28.60	-99.88	-94.09
CGS001-5770	KD	PTPN1	Protein tyrosine phosphatases, protein tyrosine phosphatase, non-receptor type 1			10.00, 10.00	1.28, 0.36	-98.87	-86.84	-73.59	-37.20	-84.80	-97.95	-63.49	53.34	99.88	-89.08
CGS001-5781	KD	PTPN11	Protein tyrosine phosphatases, protein tyrosine phosphatase, non-receptor type 11			0.00, 0.00	2.15, 0.80	NaN	NaN	-63.62	-32.99	-99.98	NaN	-28.45	-97.13	-22.69	-89.89
CGS001-5782	KD	PTPN12	Protein tyrosine phosphatases / Class I Cys-based PTPs : Non-receptor, protein tyrosine phosphatase, non-receptor type 12			20.00, 20.00	1.10, 0.27	29.76	87.58	98.03	98.54	73.76	93.70	64.13	75.33	-31.44	94.95
CGS001-5771	KD	PTPN2	Protein tyrosine phosphatases, protein tyrosine phosphatase, non-receptor type 2			0.00, 0.00	1.31, 0.32	-61.37	NaN	-29.76	-96.14	94.98	NaN	-41.00	-66.30	-36.97	-44.38
CGS001-26191	KD	PTPN22	Protein tyrosine phosphatases / Class I Cys-based PTPs : Non-receptor, protein tyrosine phosphatase, non-receptor type 22 (lymphoid)			0.00, 0.00	1.03, 0.23	-85.33	45.41	-46.71	-28.58	44.15	NaN	-98.08	-70.06	-56.63	-48.69
CGS001-5775	KD	PTPN4	Protein tyrosine phosphatases, protein tyrosine phosphatase, non-receptor type 4 (megakaryocyte)			0.00, 0.00	1.64, 0.47	27.41	26.13	-62.16	-32.76	NaN	-63.21	-34.19	37.82	-54.44	-37.85
CGS001-5777	KD	PTPN6	Protein tyrosine phosphatases, protein tyrosine phosphatase, non-receptor type 6			44.44, 44.44	1.19, 0.30	-38.73	52.61	65.16	99.31	94.44	NaN	-74.07	99.98	99.97	99.79
CGS001-5792	KD	PTPRF	Receptor tyrosine phosphatases (RTP), protein tyrosine phosphatase, receptor type, F			0.00, 0.00	1.48, 0.34	45.00	90.98	53.25	-14.65	-34.95	28.93	58.35	-32.48	56.66	48.98
CGS001-5796	KD	PTPRK	Receptor tyrosine phosphatases (RTP), protein tyrosine phosphatase, receptor type, K			25.00, 25.00	1.43, 0.48	-98.81	NaN	74.15	26.10	99.74	NaN	-31.30	50.26	99.77	83.89
CGS001-284119	KD	PTRF	polymerase I and transcript release factor			0.00, 0.00	1.67, 0.48	-23.94	42.13	-42.03	-26.02	-20.57	-78.56	NaN	-98.54	18.79	-21.26
CGS001-5805	KD	PTS	6-pyruvoyltetrahydropterin synthase			12.50, 12.50	1.10, 0.30	67.93	NaN	-94.87	99.41	-79.65	NaN	-50.21	75.04	28.36	-57.72
CGS001-9232	KD	PTTG1	pituitary tumor-transforming 1			11.11, 11.11	1.01, 0.22	50.98	22.28	57.57	-98.27	-21.13	-29.50	NaN	99.94	-35.10	-17.98
CGS001-22827	KD	PUF60	RNA binding motif (RRM) containing, poly-U binding splicing factor 60KDa			0.00, 0.00	1.09, 0.25	94.17	-26.97	-21.76	-34.87	31.21	-77.39	92.46	-79.02	-45.06	-9.75
CGS001-23369	KD	PUM2	pumilio homolog 2 (Drosophila)			0.00, 0.00	2.35, 0.80	33.58	24.83	-67.72	-90.22	23.49	-23.88	NaN	-78.76	39.06	-48.74
CGS001-5813	KD	PURA	purine-rich element binding protein A			50.00, 25.00	1.64, 0.56	46.24	NaN	99.68	90.41	30.79	NaN	-31.63	98.25	95.49	96.74
CGS001-150962	KD	PUS10	pseudouridylate synthase 10			0.00, 0.00	1.27, 0.44	-83.40	NaN	-99.91	-93.83	-25.25	NaN	-86.75	-19.65	-18.47	-94.72
CGS001-83448	KD	PUS7L	pseudouridylate synthase 7 homolog (S. cerevisiae)-like			0.00, 0.00	1.99, 0.55	NaN	-33.98	-99.76	-99.98	-99.98	-26.89	-78.16	-45.89	-78.53	-99.95
CGS001-5817	KD	PVR	Immunoglobulin superfamily / C2-set domain containing, poliovirus receptor			37.50, 25.00	1.56, 0.49	-30.51	-20.51	-29.13	90.06	NaN	NaN	67.12	99.76	99.92	96.51
CGS001-5819	KD	PVRL2	Immunoglobulin superfamily / C2-set domain containing, poliovirus receptor-related 2 (herpesvirus entry mediator B)			11.11, 11.11	1.83, 0.63	70.31	58.47	56.68	-26.70	71.75	98.52	27.25	77.30	NaN	74.03
CGS001-11137	KD	PWP1	WD repeat domain containing, PWP1 homolog (S. cerevisiae)			50.00, 50.00	3.33, 1.00	NaN	NaN	99.33	99.98	31.60	NaN	NaN	88.43	35.51	99.66
CGS001-54899	KD	PXK	Slob family, PX domain containing serine/threonine kinase			10.00, 10.00	1.03, 0.36	-84.99	-100.00	-54.15	25.78	31.43	-54.67	-78.31	98.11	52.67	-57.15
CGS001-5827	KD	PXMP2	peroxisomal membrane protein 2, 22kDa			25.00, 12.50	1.55, 0.39	-66.62	NaN	70.28	-96.81	99.80	-21.16	NaN	52.96	97.35	83.74
CGS001-5829	KD	PXN	paxillin			0.00, 0.00	1.65, 0.43	-84.10	-85.49	-96.38	-98.51	-99.75	-98.41	-39.30	-82.40	-99.62	-99.71
CGS001-5831	KD	PYCR1	pyrroline-5-carboxylate reductase 1			11.11, 11.11	1.31, 0.43	25.50	NaN	56.16	30.77	-32.14	35.23	-35.55	98.80	51.78	36.65
CGS001-65263	KD	PYCRL	pyrroline-5-carboxylate reductase-like			0.00, 0.00	1.17, 0.25	-96.90	-94.49	-39.00	-30.07	-99.92	-38.68	-43.92	-77.24	NaN	-91.03
CGS001-5836	KD	PYGL	Glycogen phosphorylases, phosphorylase, glycogen, liver			0.00, 0.00	1.74, 0.53	-97.62	NaN	28.63	-37.62	-32.14	90.48	33.18	86.24	34.60	18.33
CGS001-5859	KD	QARS	Aminoacyl tRNA synthetases / Class I, glutaminyl-tRNA synthetase			0.00, 0.00	1.43, 0.57	-29.59	59.67	-27.34	-31.73	-76.07	-33.91	NaN	-67.33	56.43	-37.58
CGS001-25797	KD	QPCT	Aminopeptidase Y, glutaminyl-peptide cyclotransferase			0.00, 0.00	0.85, 0.19	12.41	87.87	-39.61	91.40	26.04	26.72	NaN	51.67	NaN	49.79
CGS001-23475	KD	QPRT	quinolinate phosphoribosyltransferase			0.00, 0.00	1.24, 0.28	-99.29	-55.18	-15.56	33.23	-33.22	-99.97	-16.79	-34.51	-23.53	-19.89
CGS001-84109	KD	QRFPR	GPCR / Class A : RF amide peptide receptors, pyroglutamylated RFamide peptide receptor			0.00, 0.00	2.11, 0.73	26.18	49.19	-97.95	-45.37	-99.79	NaN	32.56	-80.60	-99.05	-95.83
CGS001-55278	KD	QRSL1	glutaminyl-tRNA synthase (glutamine-hydrolyzing)-like 1			0.00, 0.00	1.30, 0.38	-88.80	-40.36	-21.21	-27.18	55.91	-99.97	-28.69	-19.84	34.33	-11.20
CGS001-8766	KD	RAB11A	RAB, member RAS oncogene, RAB11A, member RAS oncogene family			0.00, 0.00	1.84, 0.73	-31.47	-83.93	23.92	-29.48	-42.43	-99.93	-49.87	-80.85	-91.48	-44.25
CGS001-22841	KD	RAB11FIP2	RAB11 family interacting protein 2 (class I)		C2 domain containing LOF	0.00, 0.00	3.03, 0.97	NaN	NaN	-83.41	94.03	58.78	NaN	-87.80	NaN	-35.44	-80.86
CGS001-81876	KD	RAB1B	RAB, member RAS oncogene, RAB1B, member RAS oncogene family			22.22, 22.22	1.53, 0.32	-36.33	99.85	-60.25	-93.45	-56.85	-29.09	NaN	-77.50	99.63	-61.94
CGS001-23011	KD	RAB21	RAB, member RAS oncogene, RAB21, member RAS oncogene family			10.00, 10.00	1.28, 0.43	-29.41	40.71	-18.93	99.90	32.99	62.93	66.72	36.62	-49.10	36.77
CGS001-51715	KD	RAB23	RAB, member RAS oncogene, RAB23, member RAS oncogene family			0.00, 0.00	1.17, 0.26	-40.77	90.15	-49.41	41.13	-26.67	36.38	-32.66	93.95	-99.97	-14.94
CGS001-5873	KD	RAB27A	RAB, member RAS oncogene, RAB27A, member RAS oncogene family			10.00, 10.00	1.03, 0.31	-99.24	-98.18	-97.03	-18.46	-22.08	98.26	87.35	-61.62	19.20	-80.03
CGS001-11031	KD	RAB31	RAB, member RAS oncogene, RAB31, member RAS oncogene family			0.00, 0.00	1.14, 0.27	72.18	NaN	-60.56	-30.16	-37.75	NaN	NaN	-96.16	-48.73	-56.77
CGS001-22930	KD	RAB3GAP1	RAB3 GTPase activating protein subunit 1 (catalytic)			0.00, 0.00	1.49, 0.43	NaN	35.77	-99.82	-96.27	45.90	-27.37	-41.35	-98.92	-62.46	-97.28
CGS001-5867	KD	RAB4A	RAB, member RAS oncogene, RAB4A, member RAS oncogene family			33.33, 33.33	1.66, 0.59	89.53	50.11	99.98	77.72	-23.32	-42.70	NaN	93.87	99.95	98.00
CGS001-5868	KD	RAB5A	RAB, member RAS oncogene, RAB5A, member RAS oncogene family			0.00, 0.00	1.11, 0.32	-34.79	58.60	-33.72	-82.73	-36.27	-95.00	NaN	-53.59	-97.53	-53.58
CGS001-5869	KD	RAB5B	RAB, member RAS oncogene, RAB5B, member RAS oncogene family			71.43, 57.14	1.70, 0.56	99.00	NaN	89.44	99.30	99.56	NaN	NaN	97.41	-78.66	99.84
CGS001-7879	KD	RAB7A	RAB, member RAS oncogene, RAB7A, member RAS oncogene family			22.22, 22.22	1.40, 0.36	-23.74	99.96	98.58	83.52	33.81	NaN	-96.03	-18.57	24.77	49.88
CGS001-5875	KD	RABGGTA	Prenyltransferase alpha subunit repeat containing, Rab geranylgeranyltransferase, alpha subunit			14.29, 14.29	2.35, 0.78	-98.47	NaN	99.61	48.97	44.62	NaN	NaN	87.41	-96.28	76.90
CGS001-5879	KD	RAC1	Endogenous ligands, ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)			0.00, 0.00	1.45, 0.38	-99.12	-22.04	-93.57	-40.58	-38.37	NaN	-99.02	-61.34	15.52	-89.41
CGS001-5881	KD	RAC3	Endogenous ligands, ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)			11.11, 11.11	1.41, 0.35	99.94	82.16	76.46	45.19	-54.84	-99.91	-26.40	-55.73	NaN	44.44
CGS001-5810	KD	RAD1	RAD1 homolog (S. pombe)			11.11, 11.11	0.95, 0.32	75.14	30.09	-67.57	-99.90	-30.57	NaN	-32.59	98.46	57.94	35.02
CGS001-5887	KD	RAD23B	RAD23 homolog B (S. cerevisiae)		DNA Replication LOF	0.00, 0.00	2.07, 0.88	73.22	26.60	64.36	-69.34	-27.33	-67.67	72.23	-31.33	-99.07	-31.09
CGS001-10111	KD	RAD50	RAD50 homolog (S. cerevisiae)		Non Homologous End Joining LOF	0.00, 0.00	0.73, 0.18	-52.58	79.41	30.88	23.37	23.83	93.19	20.60	45.25	NaN	12.69
CGS001-5888	KD	RAD51	RAD51 homolog (S. cerevisiae)			0.00, 0.00	1.39, 0.27	-98.83	NaN	-99.96	-98.61	-99.96	NaN	-84.28	-99.81	-54.00	-99.95
CGS001-5889	KD	RAD51C	Fanconi anemia, complementation groups, RAD51 homolog C (S. cerevisiae)			33.33, 22.22	1.47, 0.38	NaN	68.69	-66.30	-47.12	-89.63	99.97	92.78	-96.91	99.97	96.02
CGS001-8438	KD	RAD54L	RAD54-like (S. cerevisiae)			0.00, 0.00	1.25, 0.41	73.74	-84.00	-85.29	-98.79	23.04	NaN	51.91	-98.68	-98.01	-98.26
CGS001-5883	KD	RAD9A	RAD9 homolog A (S. pombe)			0.00, 0.00	1.38, 0.28	69.63	-22.83	-99.91	43.34	-49.85	-27.00	-90.08	-33.48	-99.86	-66.66
CGS001-8480	KD	RAE1	WD repeat domain containing, RAE1 RNA export 1 homolog (S. pombe)			0.00, 0.00	1.24, 0.32	NaN	-40.02	-82.85	-84.33	-27.57	56.10	-58.60	-92.18	28.02	-78.26
CGS001-5894	KD	RAF1	RAF family, v-raf-1 murine leukemia viral oncogene homolog 1			0.00, 0.00	1.49, 0.38	-74.10	-99.87	-80.55	28.43	-60.81	28.07	-65.91	-34.49	-61.73	-42.81
CGS001-26064	KD	RAI14	Ankyrin repeat domain containing, retinoic acid induced 14			0.00, 0.00	2.94, 0.94	-52.39	NaN	-31.20	38.81	-87.92	NaN	NaN	-61.94	-91.30	-87.04
CGS001-5898	KD	RALA	v-ral simian leukemia viral oncogene homolog A (ras related)			20.00, 10.00	1.26, 0.40	-93.01	66.30	-87.06	98.50	96.54	35.70	71.19	-90.68	-24.14	54.84
CGS001-5899	KD	RALB	v-ral simian leukemia viral oncogene homolog B (ras related; GTP binding protein)			12.50, 12.50	0.95, 0.36	98.12	NaN	44.96	-84.80	-99.37	NaN	93.91	-20.75	81.99	93.34
CGS001-10928	KD	RALBP1	ralA binding protein 1			0.00, 0.00	1.57, 0.63	-75.16	-46.50	-77.90	-99.55	-37.84	-93.85	-54.01	-99.84	-96.29	-99.05
CGS001-5900	KD	RALGDS	ral guanine nucleotide dissociation stimulator			0.00, 0.00	1.36, 0.48	16.70	28.11	-30.62	59.28	56.73	-98.19	-18.85	-75.52	NaN	14.96
CGS001-10267	KD	RAMP1	Receptor (G protein-coupled) activity modifying proteins, receptor (G protein-coupled) activity modifying protein 1			20.00, 20.00	0.86, 0.22	-24.22	-33.18	-68.24	-57.54	99.37	-53.37	71.74	-27.99	99.95	-19.61
CGS001-10048	KD	RANBP9	RAN binding protein 9			0.00, 0.00	1.26, 0.34	-99.13	25.43	-21.99	-40.78	-99.95	NaN	36.48	-71.42	-86.35	-96.94
CGS001-5906	KD	RAP1A	RAP1A, member of RAS oncogene family			10.00, 0.00	1.08, 0.31	95.02	51.22	-92.83	-99.94	-23.26	39.53	41.76	-98.24	-78.68	-92.55
CGS001-5909	KD	RAP1GAP	RAP1 GTPase activating protein			12.50, 12.50	1.31, 0.43	-99.52	NaN	19.59	99.47	46.66	-31.79	NaN	-62.61	27.24	-32.08
CGS001-5910	KD	RAP1GDS1	Armadillo repeat containing, RAP1, GTP-GDP dissociation stimulator 1			0.00, 0.00	1.08, 0.39	-99.93	-96.72	-55.95	20.95	-99.98	NaN	-29.87	-99.17	-96.63	-99.79
CGS001-5914	KD	RARA	Retinoic acid receptors, retinoic acid receptor, alpha			10.00, 0.00	0.98, 0.16	-93.16	48.49	96.00	37.10	-92.79	35.39	-60.35	-16.50	-17.88	-15.48
CGS001-5915	KD	RARB	Retinoic acid receptors, retinoic acid receptor, beta			22.22, 0.00	1.26, 0.28	-37.80	28.13	97.36	45.16	32.87	NaN	95.33	84.52	87.57	85.24
CGS001-5916	KD	RARG	Retinoic acid receptors, retinoic acid receptor, gamma			11.11, 11.11	1.33, 0.30	19.15	79.02	-39.36	99.75	-75.35	NaN	16.40	76.04	-86.86	68.10
CGS001-5918	KD	RARRES1	retinoic acid receptor responder (tazarotene induced) 1			12.50, 12.50	2.34, 0.84	48.66	NaN	-21.58	98.99	80.42	NaN	-35.12	71.20	77.70	72.10
CGS001-5920	KD	RARRES3	retinoic acid receptor responder (tazarotene induced) 3			0.00, 0.00	1.44, 0.35	-49.59	28.20	57.59	88.13	40.54	-51.80	-47.24	NaN	49.12	23.69
CGS001-5921	KD	RASA1	Pleckstrin homology (PH) domain containing, RAS p21 protein activator (GTPase activating protein) 1			0.00, 0.00	1.39, 0.50	40.32	NaN	-92.56	-97.05	-56.58	NaN	NaN	-99.60	-26.64	-98.05
CGS001-51655	KD	RASD1	RAS, dexamethasone-induced 1			66.67, 66.67	1.40, 0.32	49.16	27.58	99.92	54.79	99.98	98.57	98.39	NaN	99.14	99.95
CGS001-10125	KD	RASGRP1	EF-hand domain containing, RAS guanyl releasing protein 1 (calcium and DAG-regulated)			22.22, 11.11	1.40, 0.56	-21.89	-79.60	96.11	-87.73	-41.60	-35.37	99.30	-47.18	NaN	-28.80
CGS001-115727	KD	RASGRP4	EF-hand domain containing, RAS guanyl releasing protein 4			11.11, 0.00	1.40, 0.47	-59.74	68.99	97.27	-23.14	-66.73	NaN	-94.31	81.20	-63.74	-53.60
CGS001-9770	KD	RASSF2	Ras association (RalGDS/AF-6) domain family member 2			0.00, 0.00	1.86, 0.49	-95.36	NaN	42.09	84.25	-21.45	NaN	-96.98	35.81	64.11	28.32
CGS001-5925	KD	RB1	Endogenous ligands, retinoblastoma 1			60.00, 60.00	1.41, 0.33	91.90	20.54	99.98	74.80	50.89	99.97	99.98	99.98	99.58	99.95
CGS001-5928	KD	RBBP4	WD repeat domain containing, retinoblastoma binding protein 4		EMSY complex LOF	11.11, 0.00	1.59, 0.47	95.19	-50.39	40.62	-32.68	-27.50	NaN	78.22	30.08	-71.24	16.07
CGS001-5930	KD	RBBP6	retinoblastoma binding protein 6			0.00, 0.00	0.97, 0.31	68.67	93.42	-25.34	34.64	-34.51	NaN	42.20	47.85	-49.46	38.30
CGS001-5931	KD	RBBP7	WD repeat domain containing, retinoblastoma binding protein 7		EMSY complex LOF	12.50, 12.50	1.42, 0.35	-23.50	NaN	52.87	70.05	47.65	NaN	-36.85	74.97	99.97	67.69
CGS001-5932	KD	RBBP8	retinoblastoma binding protein 8			10.00, 10.00	0.80, 0.28	-80.66	65.67	36.88	-26.90	-43.84	92.39	-68.30	99.89	94.10	72.30
CGS001-10616	KD	RBCK1	RING-type (C3HC4) zinc fingers, RanBP-type and C3HC4-type zinc finger containing 1			0.00, 0.00	1.49, 0.32	-20.76	41.43	-32.91	37.95	41.54	NaN	-19.38	-61.20	51.02	9.66
CGS001-64080	KD	RBKS	ribokinase			0.00, 0.00	0.77, 0.17	-99.60	25.31	-84.12	-99.71	19.16	-67.65	-95.72	-96.02	-82.32	-97.61
CGS001-5933	KD	RBL1	retinoblastoma-like 1 (p107)			11.11, 11.11	1.02, 0.25	99.68	35.13	77.85	-67.89	41.84	-75.15	73.71	15.81	NaN	38.46
CGS001-5934	KD	RBL2	retinoblastoma-like 2 (p130)			20.00, 20.00	1.39, 0.35	-43.25	27.60	88.39	-37.03	-99.79	41.08	99.68	99.98	-29.53	46.67
CGS001-64783	KD	RBM15	RNA binding motif (RRM) containing, RNA binding motif protein 15			0.00, 0.00	1.38, 0.43	-67.14	NaN	-50.40	NaN	85.30	NaN	-89.78	-21.95	-19.61	-34.19
CGS001-29890	KD	RBM15B	RNA binding motif (RRM) containing, RNA binding motif protein 15B			0.00, 0.00	2.60, 0.88	NaN	NaN	-49.11	-97.98	-40.03	NaN	NaN	NaN	-83.67	-83.14
CGS001-23029	KD	RBM34	RNA binding motif (RRM) containing, RNA binding motif protein 34			0.00, 0.00	1.47, 0.28	NaN	-33.33	-89.43	-78.41	-35.87	-23.89	-32.19	83.84	26.80	-25.34
CGS001-10180	KD	RBM6	G patch domain containing, RNA binding motif protein 6			11.11, 11.11	1.42, 0.40	NaN	39.12	22.93	98.81	-54.44	72.93	40.73	-39.41	-43.61	26.78
CGS001-5937	KD	RBMS1	RNA binding motif (RRM) containing, RNA binding motif, single stranded interacting protein 1			11.11, 11.11	1.64, 0.49	75.97	-25.55	28.12	87.93	21.90	99.73	-30.00	-27.64	NaN	52.98
CGS001-27316	KD	RBMX	RNA binding motif (RRM) containing, RNA binding motif protein, X-linked			30.00, 20.00	1.16, 0.36	32.10	96.16	13.20	-23.19	98.69	-22.92	32.78	-92.34	98.42	34.92
CGS001-5950	KD	RBP4	Lipocalins, retinol binding protein 4, plasma			0.00, 0.00	0.98, 0.32	-92.31	-62.83	-78.58	-62.47	45.63	NaN	-83.67	-29.20	39.65	-76.51
CGS001-3516	KD	RBPJ	recombination signal binding protein for immunoglobulin kappa J region			0.00, 0.00	1.33, 0.23	-98.44	-66.50	-60.98	-27.15	-81.97	-99.97	-91.83	NaN	NaN	-86.78
CGS001-9978	KD	RBX1	RING-type (C3HC4) zinc fingers, ring-box 1, E3 ubiquitin protein ligase			0.00, 0.00	1.38, 0.30	-29.99	-24.13	-99.98	-99.64	-98.86	NaN	35.69	25.18	-95.30	-99.34
CGS001-1827	KD	RCAN1	regulator of calcineurin 1			0.00, 0.00	1.11, 0.34	-45.73	32.17	-30.28	NaN	44.62	-23.82	52.52	-43.64	22.59	-9.07
CGS001-91433	KD	RCCD1	RCC1 domain containing 1			20.00, 10.00	1.61, 0.50	96.48	28.97	35.49	45.82	44.12	99.87	36.56	75.17	33.62	59.71
CGS001-25898	KD	RCHY1	RING-type (C3HC4) zinc fingers, ring finger and CHY zinc finger domain containing 1			11.11, 11.11	1.11, 0.35	-33.60	24.64	-19.05	90.03	31.05	NaN	-66.07	97.85	-83.40	16.31
CGS001-7936	KD	RDBP	RD RNA binding protein			0.00, 0.00	1.06, 0.33	-99.98	NaN	-87.51	30.82	37.79	NaN	-38.04	-94.39	78.37	-89.73
CGS001-51109	KD	RDH11	Short chain dehydrogenase/reductase superfamily / Classical SDR fold cluster 2, retinol dehydrogenase 11 (all-trans/9-cis/11-cis)			10.00, 10.00	2.05, 0.57	92.74	74.11	99.98	-27.64	-34.64	-53.62	58.02	-87.53	35.57	44.24
CGS001-57665	KD	RDH14	Short chain dehydrogenase/reductase superfamily / Classical SDR fold cluster 2, retinol dehydrogenase 14 (all-trans/9-cis/11-cis)			11.11, 11.11	1.26, 0.38	-21.64	98.04	-70.88	23.01	94.83	NaN	-18.14	73.50	35.78	68.29
CGS001-5962	KD	RDX	radixin			0.00, 0.00	1.17, 0.39	-28.43	88.96	19.72	-33.77	35.22	51.02	-29.04	-95.44	NaN	6.08
CGS001-7905	KD	REEP5	Receptor accessory proteins, receptor accessory protein 5			0.00, 0.00	2.55, 0.77	NaN	NaN	78.03	44.53	27.95	NaN	-42.13	-27.05	54.43	51.08
CGS001-5966	KD	REL	NFkappaB transcription factor family, v-rel reticuloendotheliosis viral oncogene homolog (avian)			0.00, 0.00	0.99, 0.23	65.83	27.48	-97.52	-67.77	19.92	55.42	-33.35	-84.52	-64.56	-60.87
CGS001-5970	KD	RELA	NFkappaB transcription factor family, v-rel reticuloendotheliosis viral oncogene homolog A (avian)			28.57, 14.29	1.67, 0.40	-76.86	NaN	52.92	-87.29	96.78	NaN	NaN	99.98	-64.08	94.03
CGS001-5971	KD	RELB	NFkappaB transcription factor family, v-rel reticuloendotheliosis viral oncogene homolog B			0.00, 0.00	1.33, 0.40	-40.72	-27.82	75.62	-44.26	54.70	-29.16	NaN	-38.22	33.99	-18.31
CGS001-85004	KD	RERG	RAS-like, estrogen-regulated, growth inhibitor			0.00, 0.00	1.11, 0.35	-83.59	-23.06	-35.51	-28.14	-26.21	-83.25	-52.25	-91.28	NaN	-66.89
CGS001-5979	KD	RET	Type XIV RTKs: RET, ret proto-oncogene			20.00, 10.00	0.85, 0.28	19.34	17.24	-14.06	74.79	98.89	95.97	51.61	65.47	41.43	41.30
CGS001-5981	KD	RFC1	ATPases / AAA-type, replication factor C (activator 1) 1, 145kDa			11.11, 11.11	1.11, 0.36	88.03	88.25	-80.85	-93.65	-99.53	NaN	98.36	12.75	74.67	91.93
CGS001-5982	KD	RFC2	ATPases / AAA-type, replication factor C (activator 1) 2, 40kDa			11.11, 11.11	1.56, 0.36	99.62	20.81	28.94	22.38	NaN	-37.86	-35.37	54.39	44.29	24.59
CGS001-5985	KD	RFC5	ATPases / AAA-type, replication factor C (activator 1) 5, 36.5kDa			0.00, 0.00	0.92, 0.28	NaN	77.78	-99.96	-30.28	53.32	NaN	-31.07	64.96	-53.82	40.13
CGS001-55312	KD	RFK	riboflavin kinase			0.00, 0.00	1.82, 0.55	-99.33	-97.38	-19.84	25.39	-61.20	NaN	21.70	-66.01	-22.66	-51.78
CGS001-5986	KD	RFNG	Beta 3-glycosyltransferases, RFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase			0.00, 0.00	1.64, 0.52	NaN	39.81	79.34	-53.46	-98.00	NaN	-36.30	-70.92	58.41	-22.62
CGS001-5992	KD	RFX4	regulatory factor X, 4 (influences HLA class II expression)			10.00, 10.00	1.44, 0.45	16.70	97.98	63.25	-41.56	-38.82	89.77	-31.41	-85.41	41.91	19.19
CGS001-5993	KD	RFX5	regulatory factor X, 5 (influences HLA class II expression)			0.00, 0.00	1.13, 0.36	-90.95	26.90	-64.76	-69.03	-20.44	NaN	-34.09	86.80	27.60	-50.36
CGS001-8625	KD	RFXANK	Ankyrin repeat domain containing, regulatory factor X-associated ankyrin-containing protein			10.00, 10.00	1.55, 0.34	-26.27	-33.97	24.86	30.38	60.71	68.54	-38.98	99.87	81.89	54.85
CGS001-6004	KD	RGS16	Regulators of G-protein signaling, regulator of G-protein signaling 16			0.00, 0.00	1.28, 0.39	-98.15	-27.07	-18.55	-97.42	-39.61	-85.40	45.51	-93.66	-72.13	-93.57
CGS001-64407	KD	RGS18	Regulators of G-protein signaling, regulator of G-protein signaling 18			0.00, 0.00	0.88, 0.25	-22.98	-27.65	-56.86	14.04	24.03	74.06	84.93	-77.15	-24.29	3.00
CGS001-10287	KD	RGS19	Regulators of G-protein signaling, regulator of G-protein signaling 19			11.11, 0.00	1.19, 0.32	94.05	-76.98	96.53	-71.18	22.84	NaN	35.44	-20.83	89.96	71.69
CGS001-5997	KD	RGS2	Endogenous ligands, regulator of G-protein signaling 2, 24kDa			10.00, 10.00	0.93, 0.15	99.42	-100.00	-18.42	-99.98	38.11	24.24	-32.37	-99.23	-97.86	-99.18
CGS001-5999	KD	RGS4	Regulators of G-protein signaling, regulator of G-protein signaling 4			0.00, 0.00	1.56, 0.49	-22.78	86.58	-79.89	-37.51	79.86	66.50	-24.79	23.23	NaN	37.62
CGS001-6009	KD	RHEB	Ras homolog enriched in brain			10.00, 10.00	1.22, 0.24	-15.64	-28.99	18.31	-41.13	-66.77	99.94	-14.52	54.12	-98.95	-5.19
CGS001-387	KD	RHOA	ras homolog gene family, member A			11.11, 0.00	1.14, 0.33	-98.95	NaN	-97.92	-45.58	-28.04	-28.90	-97.61	95.38	27.99	-98.39
CGS001-388	KD	RHOB	ras homolog gene family, member B			0.00, 0.00	1.05, 0.27	-99.95	-90.83	-15.31	-45.08	NaN	74.20	-17.01	-87.41	NaN	-68.25
CGS001-9886	KD	RHOBTB1	BTB/POZ domain containing, Rho-related BTB domain containing 1			0.00, 0.00	1.63, 0.38	-17.92	-88.73	-99.31	-94.87	94.13	-99.07	45.42	-99.61	-45.85	-99.29
CGS001-29984	KD	RHOD	ras homolog gene family, member D			40.00, 20.00	1.49, 0.38	-92.62	99.89	99.92	-28.62	-93.78	71.63	-40.86	95.47	35.33	95.15
CGS001-253260	KD	RICTOR	RPTOR independent companion of MTOR, complex 2			0.00, 0.00	1.45, 0.42	-98.99	-98.45	-24.08	-28.21	37.49	-98.85	-34.38	-90.11	-90.85	-99.58
CGS001-8780	KD	RIOK3	RIO3 subfamily, RIO kinase 3 (yeast)			0.00, 0.00	1.31, 0.44	-99.59	89.57	-39.65	-53.09	-15.64	-84.90	-49.56	66.65	NaN	-41.36
CGS001-8737	KD	RIPK1	Receptor interacting protein kinase (RIPK) family, receptor (TNFRSF)-interacting serine-threonine kinase 1			0.00, 0.00	1.94, 0.55	-19.90	31.11	-15.30	-92.48	31.89	-94.31	-34.75	24.25	76.24	-5.47
CGS001-8767	KD	RIPK2	Receptor interacting protein kinase (RIPK) family, receptor-interacting serine-threonine kinase 2			22.22, 22.22	0.91, 0.27	99.96	87.54	-78.13	29.30	-44.50	NaN	55.62	90.08	-69.78	97.90
CGS001-11035	KD	RIPK3	Receptor interacting protein kinase (RIPK) family, receptor-interacting serine-threonine kinase 3			0.00, 0.00	1.53, 0.44	-62.66	84.53	-55.40	27.16	-28.05	91.83	-84.05	-24.92	-80.15	-37.08
CGS001-54101	KD	RIPK4	Receptor interacting protein kinase (RIPK) family, receptor-interacting serine-threonine kinase 4			11.11, 11.11	1.67, 0.65	52.66	98.20	68.93	62.35	-38.90	47.77	33.00	83.51	NaN	69.49
CGS001-6016	KD	RIT1	Ras-like without CAAX 1			0.00, 0.00	1.52, 0.38	27.53	16.51	-90.26	-20.34	-86.36	-82.34	NaN	26.68	59.08	-38.45
CGS001-6038	KD	RNASE4	Ribonucleases, RNase A, ribonuclease, RNase A family, 4			0.00, 0.00	1.30, 0.34	31.50	34.83	-31.58	-33.58	-27.59	-24.64	53.35	-33.54	-99.97	-13.78
CGS001-8635	KD	RNASET2	ribonuclease T2			33.33, 33.33	1.16, 0.44	-97.62	87.85	-22.93	63.24	99.54	NaN	98.66	75.28	-41.39	97.59
CGS001-26994	KD	RNF11	RING-type (C3HC4) zinc fingers, ring finger protein 11			10.00, 0.00	2.55, 0.83	-93.75	20.13	37.63	96.62	-83.75	19.33	-17.50	-68.88	-94.01	-87.36
CGS001-63891	KD	RNF123	RING-type (C3HC4) zinc fingers, ring finger protein 123			11.11, 11.11	1.22, 0.33	-55.34	NaN	-63.94	-47.35	76.07	-86.30	99.88	-99.90	-96.21	-97.87
CGS001-54941	KD	RNF125	RING-type (C3HC4) zinc fingers, ring finger protein 125			0.00, 0.00	1.47, 0.31	-98.34	51.27	-19.44	-54.90	-27.36	65.92	-83.65	NaN	-42.38	-39.76
CGS001-51444	KD	RNF138	RING-type (C3HC4) zinc fingers, ring finger protein 138			0.00, 0.00	1.51, 0.49	-37.94	-25.55	53.13	-96.65	-20.47	29.75	-24.55	-86.07	-88.63	-39.80
CGS001-9604	KD	RNF14	RING-type (C3HC4) zinc fingers, ring finger protein 14			0.00, 0.00	1.45, 0.45	-97.26	-24.13	39.68	37.80	-99.89	48.12	-82.38	-86.21	NaN	-91.77
CGS001-153830	KD	RNF145	RING-type (C3HC4) zinc fingers, ring finger protein 145			20.00, 10.00	1.13, 0.32	15.74	84.09	96.73	26.26	-40.30	-52.64	99.54	79.90	20.64	89.02
CGS001-115992	KD	RNF166	RING-type (C3HC4) zinc fingers, ring finger protein 166			0.00, 0.00	1.18, 0.33	-42.18	-99.98	31.18	30.56	-22.58	-92.83	-15.80	-98.19	-39.61	-40.46
CGS001-26001	KD	RNF167	RING-type (C3HC4) zinc fingers, ring finger protein 167			10.00, 10.00	0.83, 0.26	56.40	64.33	99.98	29.56	-35.81	48.96	-21.99	-85.22	87.47	51.30
CGS001-54546	KD	RNF186	RING-type (C3HC4) zinc fingers, ring finger protein 186			0.00, 0.00	1.35, 0.30	-99.78	-96.13	-71.52	-28.07	-55.71	-99.97	-99.83	-24.05	-92.03	-99.13
CGS001-6048	KD	RNF5	RING-type (C3HC4) zinc fingers, ring finger protein 5			10.00, 10.00	1.38, 0.34	27.64	99.96	55.21	43.17	-23.62	66.96	30.94	37.93	71.27	48.38
CGS001-8732	KD	RNGTT	Protein tyrosine phosphatases / Class I Cys-based PTPs : Atypical dual specificity phosphatases, RNA guanylyltransferase and 5'-phosphatase			0.00, 0.00	1.20, 0.45	28.24	-20.89	86.81	54.03	-62.40	90.86	-18.84	45.04	79.09	51.45
CGS001-6050	KD	RNH1	ribonuclease/angiogenin inhibitor 1			20.00, 10.00	1.14, 0.33	93.44	96.26	44.82	-38.70	-47.89	99.91	25.64	-76.80	-87.16	76.15
CGS001-55328	KD	RNLS	renalase, FAD-dependent amine oxidase			14.29, 14.29	0.88, 0.30	94.84	NaN	21.97	75.04	45.52	NaN	NaN	99.79	32.50	74.30
CGS001-8731	KD	RNMT	RNA (guanine-7-) methyltransferase			11.11, 11.11	1.40, 0.51	-97.96	NaN	99.61	92.23	-25.59	56.62	-43.83	39.90	52.87	64.45
CGS001-10921	KD	RNPS1	RNA binding motif (RRM) containing, RNA binding protein S1, serine-rich domain			11.11, 11.11	1.31, 0.35	31.89	98.14	-73.81	-84.84	-44.92	NaN	-36.99	-32.87	-99.95	-62.87
CGS001-9475	KD	ROCK2	Pleckstrin homology (PH) domain containing, Rho-associated, coiled-coil containing protein kinase 2			0.00, 0.00	1.41, 0.42	73.73	-28.04	-45.37	-96.72	92.39	NaN	26.46	-80.78	-74.63	-72.18
CGS001-6097	KD	RORC	Retinoic acid-related orphans, RAR-related orphan receptor C			0.00, 0.00	0.85, 0.22	-53.65	-32.02	-28.81	58.79	-99.48	-35.10	-52.93	-11.16	-95.46	-23.54
CGS001-6098	KD	ROS1	Type XVII RTKs: ROS receptors, c-ros oncogene 1 , receptor tyrosine kinase			11.11, 11.11	1.10, 0.27	59.34	-35.44	-27.92	22.78	-21.46	NaN	78.60	-84.53	97.54	31.31
CGS001-6117	KD	RPA1	replication protein A1, 70kDa		DNA Replication LOF	20.00, 20.00	1.31, 0.34	98.30	88.94	-99.27	44.31	21.74	-73.41	98.86	-99.67	-49.74	66.63
CGS001-6118	KD	RPA2	replication protein A2, 32kDa		DNA Replication LOF	20.00, 10.00	1.56, 0.63	89.79	98.86	-94.21	-99.93	-87.80	96.69	71.93	-98.24	-34.02	-98.22
CGS001-6119	KD	RPA3	replication protein A3, 14kDa		DNA Replication LOF	0.00, 0.00	0.85, 0.18	-37.62	-74.19	-54.76	-21.53	48.30	-24.90	31.67	-99.84	90.20	-21.77
CGS001-80135	KD	RPF1	ribosome production factor 1 homolog (S. cerevisiae)			22.22, 22.22	1.84, 0.59	NaN	81.95	99.02	73.47	99.41	38.47	55.87	-68.00	-77.67	76.66
CGS001-22934	KD	RPIA	ribose 5-phosphate isomerase A			11.11, 11.11	1.53, 0.51	-99.80	-100.00	-99.08	-48.52	-45.98	NaN	-80.06	-14.75	98.38	-98.97
CGS001-6146	KD	RPL22	L ribosomal proteins, ribosomal protein L22			28.57, 28.57	1.61, 0.59	-96.38	NaN	70.95	58.57	NaN	NaN	22.15	97.75	99.97	92.63
CGS001-116832	KD	RPL39L	L ribosomal proteins, ribosomal protein L39-like			0.00, 0.00	1.75, 0.55	63.60	NaN	-24.64	90.74	41.18	-99.01	-98.35	-99.15	70.30	-98.67
CGS001-6129	KD	RPL7	L ribosomal proteins, ribosomal protein L7			14.29, 14.29	1.90, 0.80	-74.59	NaN	-88.89	NaN	98.95	NaN	-99.64	-98.92	-93.98	-99.10
CGS001-6184	KD	RPN1	ribophorin I			0.00, 0.00	1.32, 0.31	-83.95	21.52	-99.46	71.50	-86.96	42.32	-78.56	-44.40	21.66	-72.41
CGS001-6185	KD	RPN2	ribophorin II			0.00, 0.00	1.85, 0.43	-99.86	NaN	-99.66	-99.71	-98.88	-50.27	NaN	-99.94	-43.85	-99.95
CGS001-10557	KD	RPP38	ribonuclease P/MRP 38kDa subunit			0.00, 0.00	0.94, 0.25	49.79	94.47	-99.31	85.98	-32.42	NaN	-98.25	-91.46	-66.85	-93.16
CGS001-6204	KD	RPS10	S ribosomal proteins, ribosomal protein S10		Ribosomal 40s Subunit LOF	11.11, 11.11	1.49, 0.55	33.34	NaN	-15.19	-48.32	-22.85	99.91	-33.84	-92.10	-58.80	-22.70
CGS001-6207	KD	RPS13	S ribosomal proteins, ribosomal protein S13		Ribosomal 40s Subunit LOF	0.00, 0.00	1.75, 0.60	-65.40	-39.02	-95.84	50.99	-27.40	NaN	-89.42	-60.57	-91.51	-89.05
CGS001-6208	KD	RPS14	S ribosomal proteins, ribosomal protein S14		Ribosomal 40s Subunit LOF	0.00, 0.00	1.77, 0.65	-43.14	66.29	-17.27	26.34	-33.27	86.46	-99.10	NaN	-94.66	-26.51
CGS001-6210	KD	RPS15A	S ribosomal proteins, ribosomal protein S15a		Ribosomal 40s Subunit LOF	11.11, 11.11	1.63, 0.45	41.93	25.48	-60.83	31.62	98.06	-32.50	NaN	-33.08	-27.82	-11.63
CGS001-6217	KD	RPS16	S ribosomal proteins, ribosomal protein S16		Ribosomal 40s Subunit LOF	0.00, 0.00	2.50, 0.93	-64.23	-99.98	-28.61	-47.98	-23.34	-32.08	NaN	-41.44	NaN	-34.66
CGS001-6223	KD	RPS19	S ribosomal proteins, ribosomal protein S19		Ribosomal 40s Subunit LOF	0.00, 0.00	1.53, 0.42	-95.54	24.29	-99.78	-98.69	-77.01	-68.85	-99.85	-80.27	25.83	-98.34
CGS001-6233	KD	RPS27A	S ribosomal proteins, ribosomal protein S27a		Ribosomal 40s Subunit LOF	0.00, 0.00	1.83, 0.60	-89.46	-80.70	-99.82	-29.79	-99.80	-46.57	-99.31	-70.06	-26.42	-98.79
CGS001-6188	KD	RPS3	S ribosomal proteins, ribosomal protein S3		Ribosomal 40s Subunit LOF	0.00, 0.00	1.20, 0.39	-96.64	26.98	-44.56	-84.79	-98.55	-49.56	-94.97	-40.76	21.02	-93.46
CGS001-6189	KD	RPS3A	S ribosomal proteins, ribosomal protein S3A		Ribosomal 40s Subunit LOF	0.00, 0.00	1.81, 0.45	-97.91	72.76	-68.45	-25.57	-27.90	-82.63	NaN	-68.17	22.23	-56.98
CGS001-6193	KD	RPS5	S ribosomal proteins, ribosomal protein S5		Ribosomal 40s Subunit LOF	0.00, 0.00	1.72, 0.52	-23.75	51.24	78.70	55.04	-71.36	-37.12	-99.77	-99.51	NaN	-57.99
CGS001-6194	KD	RPS6	S ribosomal proteins, ribosomal protein S6		Ribosomal 40s Subunit LOF	0.00, 0.00	1.39, 0.59	-99.10	31.32	-90.71	-91.12	-35.63	-74.70	-99.55	-99.98	-75.51	-98.81
CGS001-6195	KD	RPS6KA1	RSK subfamily, ribosomal protein S6 kinase, 90kDa, polypeptide 1			10.00, 10.00	0.98, 0.30	33.95	44.81	39.01	77.23	38.68	-86.47	-73.71	98.67	30.50	22.10
CGS001-6196	KD	RPS6KA2	RSK subfamily, ribosomal protein S6 kinase, 90kDa, polypeptide 2			0.00, 0.00	1.22, 0.31	75.35	69.01	-24.50	-31.64	-35.61	57.36	-76.18	30.13	51.76	28.30
CGS001-6197	KD	RPS6KA3	RSK subfamily, ribosomal protein S6 kinase, 90kDa, polypeptide 3			22.22, 22.22	1.09, 0.31	-16.82	99.50	29.37	87.56	73.22	39.29	NaN	97.69	91.38	94.31
CGS001-8986	KD	RPS6KA4	MSK subfamily, ribosomal protein S6 kinase, 90kDa, polypeptide 4			12.50, 12.50	0.98, 0.24	32.08	-98.12	99.96	40.96	76.86	NaN	NaN	29.27	24.86	55.99
CGS001-6198	KD	RPS6KB1	p70 subfamily, ribosomal protein S6 kinase, 70kDa, polypeptide 1			11.11, 11.11	1.80, 0.52	-19.52	94.37	29.59	87.75	98.50	NaN	-81.20	-19.03	-37.32	71.33
CGS001-6199	KD	RPS6KB2	p70 subfamily, ribosomal protein S6 kinase, 70kDa, polypeptide 2			0.00, 0.00	0.99, 0.25	-68.19	-22.99	-32.72	NaN	-99.69	NaN	-99.98	-55.71	-30.32	-85.70
CGS001-83694	KD	RPS6KL1	RSKL family, ribosomal protein S6 kinase-like 1			11.11, 11.11	1.32, 0.45	99.47	-100.00	-99.96	-58.83	-84.32	NaN	-99.24	-9.45	48.19	-99.87
CGS001-6201	KD	RPS7	S ribosomal proteins, ribosomal protein S7		Ribosomal 40s Subunit LOF	0.00, 0.00	1.35, 0.53	-44.52	NaN	-98.88	NaN	20.96	70.59	-99.72	-99.12	88.86	-99.32
CGS001-6203	KD	RPS9	S ribosomal proteins, ribosomal protein S9		Ribosomal 40s Subunit LOF	0.00, 0.00	1.76, 0.59	-77.75	-37.47	-94.97	-32.84	29.53	NaN	-99.61	-97.56	-99.81	-99.53
CGS001-57521	KD	RPTOR	WD repeat domain containing, regulatory associated protein of MTOR, complex 1			0.00, 0.00	1.18, 0.36	-33.69	-20.24	23.96	-99.98	-38.53	-97.80	29.97	-52.89	-99.42	-85.82
CGS001-10670	KD	RRAGA	Ras-related GTP binding A			0.00, 0.00	1.34, 0.42	-31.06	-99.87	-23.29	-99.24	29.55	-36.31	-98.67	-99.28	-36.83	-99.13
CGS001-10325	KD	RRAGB	Ras-related GTP binding B			0.00, 0.00	1.41, 0.35	-22.23	-33.41	-91.15	-82.24	77.48	-29.81	NaN	54.74	24.83	-8.29
CGS001-64121	KD	RRAGC	Ras-related GTP binding C			0.00, 0.00	1.23, 0.33	-86.64	57.94	-94.63	-20.04	-99.52	-59.65	-93.79	-78.25	-28.63	-88.83
CGS001-58528	KD	RRAGD	Ras-related GTP binding D			30.00, 20.00	1.70, 0.34	51.10	-35.82	99.88	79.86	95.22	81.73	26.33	44.59	98.33	93.89
CGS001-6240	KD	RRM1	Ribonucleoside-diphosphate reductases, ribonucleotide reductase M1			0.00, 0.00	1.89, 0.56	85.42	-25.13	-20.76	23.85	-90.53	89.11	46.67	-27.11	92.75	38.56
CGS001-6241	KD	RRM2	Ribonucleoside-diphosphate reductases, ribonucleotide reductase M2			28.57, 14.29	1.19, 0.45	98.94	NaN	69.39	NaN	-98.24	NaN	96.72	-37.22	-28.43	86.53
CGS001-23223	KD	RRP12	ribosomal RNA processing 12 homolog (S. cerevisiae)			10.00, 10.00	1.03, 0.38	99.59	-31.43	-99.73	-99.96	42.71	69.01	-56.41	-85.24	-44.49	-85.38
CGS001-23076	KD	RRP1B	ribosomal RNA processing 1 homolog B (S. cerevisiae)			0.00, 0.00	1.16, 0.23	-66.94	NaN	-28.08	-99.90	-25.08	-29.56	-47.11	80.41	-27.76	-25.33
CGS001-23378	KD	RRP8	ribosomal RNA processing 8, methyltransferase, homolog (yeast)			0.00, 0.00	1.74, 0.39	NaN	-51.57	-72.32	-99.82	-31.26	-28.64	-33.26	-99.41	-25.57	-61.26
CGS001-23212	KD	RRS1	RRS1 ribosome biogenesis regulator homolog (S. cerevisiae)			0.00, 0.00	1.84, 0.56	NaN	-20.32	-94.05	-90.91	84.81	62.88	83.04	-73.81	24.60	71.59
CGS001-89765	KD	RSPH1	radial spoke head 1 homolog (Chlamydomonas)			14.29, 14.29	2.09, 0.81	73.66	-23.91	99.60	46.36	81.86	NaN	57.98	NaN	NaN	82.98
CGS001-6251	KD	RSU1	Ras suppressor protein 1			44.44, 44.44	1.93, 0.88	45.08	86.21	99.98	99.98	53.78	NaN	30.22	97.72	46.07	98.89
CGS001-8634	KD	RTCD1	RNA terminal phosphate cyclase domain 1			80.00, 70.00	1.19, 0.47	49.35	99.61	97.48	99.91	99.08	99.97	-43.79	97.78	99.70	99.87
CGS001-51750	KD	RTEL1	regulator of telomere elongation helicase 1			0.00, 0.00	1.47, 0.27	-77.18	-66.61	-99.98	-27.60	-99.92	21.29	NaN	-93.06	-99.75	-99.95
CGS001-6253	KD	RTN2	reticulon 2			16.67, 16.67	1.95, 0.88	NaN	-27.37	99.82	NaN	24.64	NaN	NaN	76.87	-41.80	61.30
CGS001-80230	KD	RUFY1	Zinc fingers, FYVE domain containing, RUN and FYVE domain containing 1			30.00, 30.00	1.16, 0.32	-92.48	99.93	-36.77	27.21	-88.92	97.81	28.03	-31.44	99.96	45.74
CGS001-861	KD	RUNX1	runt-related transcription factor 1			50.00, 50.00	1.41, 0.27	-24.06	99.84	94.26	99.98	70.91	-38.05	99.98	99.89	-48.33	99.95
CGS001-8607	KD	RUVBL1	ATPases / AAA-type, RuvB-like 1 (E. coli)			0.00, 0.00	1.64, 0.34	-97.39	-100.00	-91.44	-99.98	-41.28	-98.52	-98.27	-99.64	-55.49	-99.82
CGS001-10856	KD	RUVBL2	ATPases / AAA-type, RuvB-like 2 (E. coli)			0.00, 0.00	1.81, 0.42	-81.48	-96.90	-60.43	24.25	-42.38	-97.24	-98.80	-68.30	38.66	-80.88
CGS001-59350	KD	RXFP1	GPCR / Class A : Relaxin family peptide receptors, relaxin/insulin-like family peptide receptor 1			0.00, 0.00	1.07, 0.31	-43.31	-25.94	90.52	34.56	50.51	-58.99	35.42	-38.06	NaN	20.53
CGS001-6256	KD	RXRA	Retinoid X receptors, retinoid X receptor, alpha			0.00, 0.00	1.48, 0.40	-94.57	NaN	-99.49	-65.94	28.20	-66.99	-88.15	-64.41	-27.86	-73.22
CGS001-6257	KD	RXRB	Retinoid X receptors, retinoid X receptor, beta			22.22, 22.22	1.73, 0.45	48.90	98.38	87.31	97.85	53.35	NaN	74.22	55.88	65.77	80.48
CGS001-23429	KD	RYBP	RING1 and YY1 binding protein			0.00, 0.00	1.19, 0.34	22.26	-27.70	25.07	-24.85	31.54	NaN	-74.77	87.38	76.53	32.65
CGS001-6259	KD	RYK	Type XV RTKs: RYK, RYK receptor-like tyrosine kinase			0.00, 0.00	2.31, 0.51	-99.43	-99.98	-67.77	-94.50	-99.98	NaN	-92.64	-99.17	-98.62	-99.92
CGS001-6271	KD	S100A1	EF-hand domain containing, S100 calcium binding protein A1		S100 calcium binding proteins LOF	66.67, 66.67	1.58, 0.36	99.95	21.11	99.76	99.98	89.98	NaN	-16.53	99.78	99.90	99.95
CGS001-6282	KD	S100A11	EF-hand domain containing, S100 calcium binding protein A11			11.11, 0.00	1.33, 0.43	35.48	60.33	-83.66	30.70	95.47	-84.57	NaN	-40.01	14.84	10.25
CGS001-6284	KD	S100A13	S100 calcium binding proteins, S100 calcium binding protein A13			0.00, 0.00	1.80, 0.51	51.03	NaN	43.49	-68.73	59.72	94.13	-95.90	-69.10	-58.31	-63.41
CGS001-6275	KD	S100A4	EF-hand domain containing, S100 calcium binding protein A4			0.00, 0.00	1.15, 0.26	73.67	25.88	74.13	-65.85	-37.02	-33.29	-68.78	60.87	94.27	51.36
CGS001-6277	KD	S100A6	EF-hand domain containing, S100 calcium binding protein A6		S100 calcium binding proteins LOF	11.11, 11.11	1.48, 0.57	24.39	-34.62	34.46	-46.26	NaN	26.47	26.34	99.49	58.76	20.13
CGS001-6285	KD	S100B	EF-hand domain containing, S100 calcium binding protein B		S100 calcium binding proteins LOF	22.22, 22.22	1.49, 0.47	93.38	99.56	44.64	90.68	34.89	-94.36	NaN	85.26	58.94	98.21
CGS001-6286	KD	S100P	EF-hand domain containing, S100 calcium binding protein P			0.00, 0.00	1.90, 0.50	19.25	86.35	24.71	80.61	-98.17	NaN	29.02	-37.59	83.89	69.66
CGS001-170591	KD	S100Z	EF-hand domain containing, S100 calcium binding protein Z			11.11, 11.11	1.22, 0.31	28.22	100.00	-87.13	37.57	40.99	NaN	28.42	-21.86	90.23	19.04
CGS001-1903	KD	S1PR3	GPCR / Class A : Lysophospholipid receptors : Sphingosine 1-phosphate, sphingosine-1-phosphate receptor 3			50.00, 37.50	2.09, 0.59	99.98	99.91	35.09	-37.42	96.68	NaN	NaN	-25.04	42.65	99.61
CGS001-22908	KD	SACM1L	SAC1 suppressor of actin mutations 1-like (yeast)			12.50, 0.00	1.33, 0.50	96.88	NaN	-75.58	41.18	44.97	40.97	NaN	45.45	-63.71	36.22
CGS001-57167	KD	SALL4	Zinc fingers, C2H2-type, sal-like 4 (Drosophila)			11.11, 11.11	1.41, 0.28	-49.57	-93.28	99.98	-27.63	32.81	NaN	44.54	-37.87	-96.25	-34.17
CGS001-10284	KD	SAP18	Sin3A-associated protein, 18kDa			10.00, 10.00	1.72, 0.48	26.39	-32.90	-49.30	-97.30	21.41	99.48	-69.10	-80.25	79.18	-46.79
CGS001-51128	KD	SAR1B	SAR1 homolog B (S. cerevisiae)			10.00, 10.00	1.20, 0.42	25.52	20.04	-22.02	98.66	32.45	47.30	32.16	31.89	-19.92	11.95
CGS001-6301	KD	SARS	Aminoacyl tRNA synthetases / Class II, seryl-tRNA synthetase			11.11, 11.11	1.51, 0.50	-30.28	NaN	97.50	33.02	-98.46	27.15	-57.14	-50.84	61.63	-22.41
CGS001-6303	KD	SAT1	spermidine/spermine N1-acetyltransferase 1			0.00, 0.00	1.73, 0.63	-95.12	-98.90	23.54	-43.47	44.57	NaN	-95.45	-98.20	NaN	-98.87
CGS001-6304	KD	SATB1	Homeoboxes / CUT class, SATB homeobox 1			0.00, 0.00	1.53, 0.52	-92.17	-100.00	-86.85	25.63	48.62	NaN	-20.75	90.86	33.96	-79.24
CGS001-23314	KD	SATB2	Homeoboxes / CUT class, SATB homeobox 2			0.00, 0.00	1.68, 0.44	-35.10	-23.52	58.51	24.25	-74.82	NaN	-97.59	-27.58	NaN	-46.72
CGS001-55206	KD	SBNO1	strawberry notch homolog 1 (Drosophila)			10.00, 0.00	0.94, 0.26	62.81	27.02	-11.43	72.04	-96.54	96.23	-34.77	82.60	24.05	52.61
CGS001-6309	KD	SC5DL	sterol-C5-desaturase (ERG3 delta-5-desaturase homolog, S. cerevisiae)-like			11.11, 0.00	1.23, 0.59	47.76	42.57	-97.41	-29.97	50.67	NaN	-74.02	96.01	89.15	42.11
CGS001-22828	KD	SCAF8	RNA binding motif (RRM) containing, SR-related CTD-associated factor 8			0.00, 0.00	1.93, 0.56	NaN	NaN	52.77	-48.37	38.90	-41.53	-18.25	-81.78	35.38	20.64
CGS001-51282	KD	SCAND1	SCAN domain containing 1			12.50, 12.50	2.49, 1.05	40.31	NaN	99.92	73.37	-32.56	NaN	-23.16	55.98	30.87	31.09
CGS001-22937	KD	SCAP	WD repeat domain containing, SREBF chaperone			0.00, 0.00	1.93, 0.60	NaN	NaN	-75.25	89.76	39.23	NaN	40.69	38.38	-92.12	27.11
CGS001-949	KD	SCARB1	scavenger receptor class B, member 1			10.00, 10.00	1.07, 0.33	55.99	26.88	-66.65	-95.67	62.43	-74.97	-60.06	99.22	41.46	-57.53
CGS001-51097	KD	SCCPDH	saccharopine dehydrogenase (putative)			0.00, 0.00	1.63, 0.44	NaN	-29.78	-35.28	-99.20	-99.98	32.15	-98.10	-25.54	49.72	-97.29
CGS001-22955	KD	SCMH1	Sterile alpha motif (SAM) domain containing, sex comb on midleg homolog 1 (Drosophila)			0.00, 0.00	1.05, 0.28	-98.81	-57.89	-95.51	-77.78	-47.60	81.07	-85.32	-98.82	-99.89	-99.84
CGS001-6335	KD	SCN9A	Voltage-gated sodium channels, sodium channel, voltage-gated, type IX, alpha subunit			0.00, 0.00	1.27, 0.31	25.73	-32.49	-99.68	-95.68	23.10	-35.80	-46.30	-54.73	-79.31	-64.69
CGS001-6337	KD	SCNN1A	Epithelial sodium channels (ENaC), sodium channel, nonvoltage-gated 1 alpha			0.00, 0.00	1.27, 0.23	-99.31	-99.80	-99.03	-22.49	-60.37	NaN	-88.77	-98.91	91.29	-99.24
CGS001-6342	KD	SCP2	sterol carrier protein 2			0.00, 0.00	1.91, 0.64	40.02	NaN	-69.65	68.19	82.87	66.49	NaN	47.42	-70.22	75.64
CGS001-9805	KD	SCRN1	secernin 1			0.00, 0.00	1.27, 0.36	NaN	-42.26	-40.95	67.08	-36.50	-78.77	48.63	-62.04	54.09	-54.12
CGS001-80274	KD	SCUBE1	signal peptide, CUB domain, EGF-like 1			22.22, 11.11	1.82, 0.56	72.48	85.95	-40.19	55.64	-94.01	96.23	74.46	98.14	NaN	84.94
CGS001-57147	KD	SCYL3	SCY1-like 3 (S. cerevisiae)			20.00, 10.00	0.40, 0.06	96.11	-100.00	14.13	-23.94	70.30	-35.97	94.90	99.28	67.64	79.99
CGS001-23753	KD	SDF2L1	stromal cell-derived factor 2-like 1			0.00, 0.00	1.56, 0.51	30.06	35.86	47.78	35.43	63.92	-23.07	-71.52	-42.19	18.23	11.74
CGS001-6389	KD	SDHA	Mitochondrial respiratory chain complex, succinate dehydrogenase complex, subunit A, flavoprotein (Fp)			10.00, 10.00	1.26, 0.31	-43.16	-97.27	58.37	43.64	42.42	-99.29	-17.49	-99.78	99.24	-65.46
CGS001-6390	KD	SDHB	Mitochondrial respiratory chain complex / Complex II, succinate dehydrogenase complex, subunit B, iron sulfur (Ip)			60.00, 60.00	0.86, 0.19	99.34	100.00	-50.32	99.89	99.94	87.88	99.66	-11.85	-88.05	99.95
CGS001-6391	KD	SDHC	Mitochondrial respiratory chain complex / Complex II, succinate dehydrogenase complex, subunit C, integral membrane protein, 15kDa			22.22, 0.00	1.32, 0.49	14.69	31.18	96.47	-38.16	96.98	NaN	43.67	-92.26	-42.68	51.01
CGS001-6392	KD	SDHD	Mitochondrial respiratory chain complex / Complex II, succinate dehydrogenase complex, subunit D, integral membrane protein			20.00, 20.00	0.63, 0.19	75.17	98.58	37.89	-98.61	-28.46	99.97	-15.97	-58.58	29.45	9.25
CGS001-6397	KD	SEC14L1	SEC14-like 1 (S. cerevisiae)			12.50, 12.50	1.74, 0.51	-47.35	NaN	87.80	99.86	-29.86	60.32	NaN	-38.15	-48.64	83.18
CGS001-9919	KD	SEC16A	SEC16 homolog A (S. cerevisiae)			14.29, 14.29	0.78, 0.30	34.76	NaN	-38.10	-54.85	-96.70	NaN	NaN	99.25	-64.85	-63.77
CGS001-10427	KD	SEC24B	SEC24 family, member B (S. cerevisiae)			11.11, 11.11	1.80, 0.55	-53.36	99.72	-43.96	45.56	-72.75	37.60	NaN	78.55	-52.30	-35.37
CGS001-9632	KD	SEC24C	SEC24 family, member C (S. cerevisiae)			0.00, 0.00	1.38, 0.31	46.06	26.21	-89.57	-30.42	-77.57	NaN	-34.99	-93.58	-97.86	-98.98
CGS001-9871	KD	SEC24D	SEC24 family, member D (S. cerevisiae)			0.00, 0.00	1.53, 0.58	-99.61	-96.83	-97.33	-99.73	NaN	58.69	-69.55	-93.52	-22.23	-99.37
CGS001-55176	KD	SEC61A2	Sec61 alpha 2 subunit (S. cerevisiae)			0.00, 0.00	1.09, 0.36	42.63	74.62	-98.91	-98.72	-48.32	-36.39	-98.10	-67.33	-89.50	-95.93
CGS001-59343	KD	SENP2	SUMO1/sentrin/SMT3 specific peptidase 2			0.00, 0.00	1.24, 0.32	-96.52	81.87	37.75	-52.78	21.45	-99.88	-27.75	-40.97	-89.81	-67.02
CGS001-205564	KD	SENP5	SUMO1/sentrin specific peptidase 5			0.00, 0.00	1.17, 0.30	-90.17	-99.87	-57.23	-39.04	76.07	NaN	-54.00	-97.91	24.21	-89.75
CGS001-26054	KD	SENP6	Ulp1 endopeptidase, SUMO1/sentrin specific peptidase 6			0.00, 0.00	1.50, 0.35	-98.46	-34.21	-99.63	-99.98	-97.21	-49.83	-97.05	-88.58	-70.01	-98.53
CGS001-51734	KD	SEPX1	selenoprotein X, 1			40.00, 40.00	1.05, 0.32	-30.36	74.16	94.76	74.98	65.55	99.44	51.38	98.39	99.96	99.53
CGS001-10955	KD	SERINC3	serine incorporator 3			11.11, 11.11	1.08, 0.28	-99.32	97.78	-46.96	-49.36	93.14	NaN	35.37	33.99	-87.36	-38.68
CGS001-5265	KD	SERPINA1	Serine (or cysteine) peptidase inhibitors, serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1			11.11, 0.00	1.25, 0.38	96.29	54.76	80.10	79.91	53.47	-56.93	85.95	-45.03	NaN	79.20
CGS001-5104	KD	SERPINA5	Serine (or cysteine) peptidase inhibitors, serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5			0.00, 0.00	1.22, 0.27	-44.75	63.99	-21.73	-27.85	84.50	-29.19	-23.23	-93.72	-64.69	-15.04
CGS001-866	KD	SERPINA6	Serine (or cysteine) peptidase inhibitors, serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 6			12.50, 0.00	1.69, 0.56	87.12	96.15	94.29	-24.65	51.67	42.19	NaN	38.45	NaN	83.10
CGS001-6906	KD	SERPINA7	Serine (or cysteine) peptidase inhibitors, serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 7		Serpin peptidase inhibitors LOF	0.00, 0.00	1.81, 0.74	29.89	32.51	-89.88	-27.32	29.07	22.25	45.29	94.33	82.60	39.82
CGS001-5055	KD	SERPINB2	Serine (or cysteine) peptidase inhibitors, serpin peptidase inhibitor, clade B (ovalbumin), member 2		Serpin peptidase inhibitors LOF	0.00, 0.00	1.78, 0.44	-48.14	-23.13	50.37	56.78	75.78	-35.69	-28.15	59.67	-66.72	50.13
CGS001-5268	KD	SERPINB5	Serine (or cysteine) peptidase inhibitors, serpin peptidase inhibitor, clade B (ovalbumin), member 5		Serpin peptidase inhibitors LOF	10.00, 10.00	1.43, 0.45	-37.71	94.71	40.55	-44.32	-32.34	98.26	28.00	-30.35	21.53	16.21
CGS001-462	KD	SERPINC1	Serine (or cysteine) peptidase inhibitors, serpin peptidase inhibitor, clade C (antithrombin), member 1			0.00, 0.00	0.90, 0.24	-99.98	68.62	-98.41	-84.22	-99.75	NaN	-28.33	-84.88	20.61	-99.76
CGS001-3053	KD	SERPIND1	Serine (or cysteine) peptidase inhibitors, serpin peptidase inhibitor, clade D (heparin cofactor), member 1			0.00, 0.00	1.47, 0.30	-92.79	-98.42	49.65	91.93	-98.76	NaN	-14.10	93.72	-26.78	-91.41
CGS001-5054	KD	SERPINE1	Serine (or cysteine) peptidase inhibitors, serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1			0.00, 0.00	1.60, 0.52	-22.08	NaN	-33.36	33.84	82.31	NaN	-60.75	-44.02	94.45	35.10
CGS001-5345	KD	SERPINF2	Serine (or cysteine) peptidase inhibitors, serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 2			0.00, 0.00	1.33, 0.43	-35.20	-99.78	-72.05	-30.51	-23.70	NaN	-19.18	39.72	50.70	-19.29
CGS001-29946	KD	SERTAD3	SERTA domain containing 3			40.00, 20.00	1.09, 0.36	98.73	97.05	63.14	28.85	99.98	-52.43	-27.83	88.40	-62.98	97.26
CGS001-27244	KD	SESN1	sestrin 1			11.11, 0.00	1.40, 0.39	-97.07	NaN	-24.36	29.50	-77.12	96.36	-36.96	-36.70	59.98	-6.57
CGS001-6418	KD	SET	SET nuclear oncogene			0.00, 0.00	1.26, 0.34	-98.61	NaN	-99.98	-30.35	88.22	NaN	-99.95	-98.94	-70.07	-99.87
CGS001-23067	KD	SETD1B	Histone methyltransferases (HMTs), SET domain containing 1B			0.00, 0.00	3.35, 0.90	NaN	NaN	-82.48	74.33	-63.01	NaN	NaN	88.03	41.18	78.17
CGS001-80854	KD	SETD7	Histone methyltransferases (HMTs), SET domain containing (lysine methyltransferase) 7			10.00, 10.00	1.63, 0.47	39.35	27.39	57.62	84.44	-37.25	65.48	98.05	-20.76	64.90	63.65
CGS001-9869	KD	SETDB1	Histone methyltransferases (HMTs), SET domain, bifurcated 1			0.00, 0.00	1.23, 0.38	-45.39	-97.93	-23.75	-97.42	-23.17	NaN	-96.67	28.13	30.21	-90.70
CGS001-7536	KD	SF1	Zinc fingers, CCHC domain containing, splicing factor 1			10.00, 10.00	1.10, 0.31	-29.84	64.22	37.43	64.20	-70.71	-27.24	37.72	99.95	76.13	74.88
CGS001-51460	KD	SFMBT1	Sterile alpha motif (SAM) domain containing, Scm-like with four mbt domains 1			0.00, 0.00	2.61, 0.89	70.35	NaN	-97.10	30.61	NaN	NaN	-99.90	38.74	21.61	15.52
CGS001-2810	KD	SFN	stratifin			0.00, 0.00	0.73, 0.14	32.14	24.36	25.51	-29.30	-50.52	-48.54	-99.87	-63.61	29.00	-30.50
CGS001-6421	KD	SFPQ	RNA binding motif (RRM) containing, splicing factor proline/glutamine-rich			0.00, 0.00	2.01, 0.50	-80.56	-67.77	-70.06	-72.20	-94.31	NaN	-98.47	-39.82	37.24	-70.05
CGS001-6443	KD	SGCB	sarcoglycan, beta (43kDa dystrophin-associated glycoprotein)			0.00, 0.00	1.57, 0.50	-42.04	-39.01	-30.95	NaN	88.89	-78.63	-93.87	-66.73	26.18	-60.73
CGS001-6446	KD	SGK1	SGK family, serum/glucocorticoid regulated kinase 1			0.00, 0.00	0.86, 0.17	-95.67	-35.21	-58.58	-92.14	-48.88	-22.09	-99.70	-93.99	-26.98	-79.05
CGS001-8879	KD	SGPL1	Sphingosine 1-phosphate lyase, sphingosine-1-phosphate lyase 1			10.00, 0.00	1.01, 0.24	-93.49	21.65	-60.68	-66.54	-97.12	95.30	33.24	89.63	53.80	-47.64
CGS001-10019	KD	SH2B3	Pleckstrin homology (PH) domain containing, SH2B adaptor protein 3			0.00, 0.00	1.02, 0.43	-54.13	NaN	-47.98	-64.06	-28.53	NaN	NaN	77.24	26.01	-30.80
CGS001-9467	KD	SH3BP5	SH3-domain binding protein 5 (BTK-associated)			0.00, 0.00	1.16, 0.41	NaN	-57.13	-43.63	-35.85	-99.63	-67.14	-90.53	79.09	83.83	-81.06
CGS001-6455	KD	SH3GL1	SH3-domain GRB2-like 1			12.50, 0.00	1.17, 0.35	26.74	NaN	85.60	73.49	90.39	NaN	96.90	-62.69	-18.69	89.62
CGS001-6461	KD	SHB	SH2 domain containing, Src homology 2 domain containing adaptor protein B			11.11, 11.11	1.30, 0.44	NaN	-31.99	-52.76	-60.31	-79.84	-68.51	-74.04	-94.17	97.75	-74.91
CGS001-6469	KD	SHH	sonic hedgehog			0.00, 0.00	1.16, 0.33	-22.76	22.08	-51.11	38.99	-28.17	30.33	32.66	9.61	-41.25	-5.53
CGS001-6472	KD	SHMT2	serine hydroxymethyltransferase 2 (mitochondrial)			0.00, 0.00	1.34, 0.40	-55.46	NaN	-26.19	77.80	-90.48	NaN	30.68	-25.75	-93.23	-27.02
CGS001-6477	KD	SIAH1	seven in absentia homolog 1 (Drosophila)			11.11, 0.00	0.92, 0.26	95.73	NaN	-19.34	-82.95	-60.26	-40.04	-63.22	-99.98	37.53	-65.13
CGS001-6478	KD	SIAH2	seven in absentia homolog 2 (Drosophila)			50.00, 37.50	0.98, 0.32	73.61	NaN	99.07	95.49	94.43	NaN	31.05	92.93	99.97	99.82
CGS001-150094	KD	SIK1	QIK subfamily, salt-inducible kinase 1			50.00, 20.00	1.14, 0.42	99.43	40.87	95.29	59.40	14.56	32.62	-87.54	96.60	99.04	95.37
CGS001-23387	KD	SIK3	QIK subfamily, SIK family kinase 3			0.00, 0.00	1.41, 0.44	-10.82	23.82	-50.77	-89.74	49.71	NaN	NaN	-27.82	-99.97	-47.18
CGS001-6493	KD	SIM2	Basic helix-loop-helix proteins, single-minded homolog 2 (Drosophila)			0.00, 0.00	2.28, 0.78	-99.60	-20.62	60.17	-25.69	NaN	NaN	-78.42	-24.27	24.44	-9.94
CGS001-25942	KD	SIN3A	SIN3 homolog A, transcription regulator (yeast)			0.00, 0.00	1.64, 0.60	25.59	23.95	-37.10	79.03	26.85	-32.22	NaN	47.93	-95.21	25.26
CGS001-55423	KD	SIRPG	Immunoglobulin superfamily / C1-set domain containing, signal-regulatory protein gamma			0.00, 0.00	1.32, 0.30	45.85	NaN	73.30	48.78	47.12	NaN	54.96	54.56	-99.39	56.53
CGS001-23411	KD	SIRT1	Histone deacetylases, sirtuin 1			57.14, 42.86	1.65, 0.43	-99.89	NaN	75.45	99.90	96.89	NaN	NaN	99.98	-56.39	99.92
CGS001-22933	KD	SIRT2	Histone deacetylases, sirtuin 2			20.00, 10.00	1.25, 0.30	-52.64	96.73	-41.83	28.32	67.39	-60.76	99.98	92.52	-14.81	72.11
CGS001-23410	KD	SIRT3	Histone deacetylases (HDACs), sirtuin 3			0.00, 0.00	1.25, 0.33	24.61	84.78	-99.78	-40.96	-99.07	43.96	26.11	-60.41	55.75	-31.21
CGS001-23408	KD	SIRT5	Histone deacetylases, sirtuin 5			0.00, 0.00	1.41, 0.40	-22.10	-22.49	63.47	25.57	91.41	NaN	28.96	-97.50	-99.19	20.36
CGS001-51548	KD	SIRT6	Histone deacetylases (HDACs), sirtuin 6			0.00, 0.00	1.20, 0.20	-32.75	36.36	-97.21	-80.94	-22.76	NaN	-24.55	-90.31	29.63	-65.41
CGS001-10736	KD	SIX2	Homeoboxes / SINE class, SIX homeobox 2			11.11, 0.00	0.91, 0.20	-50.13	NaN	36.90	61.10	96.89	58.37	-44.77	17.69	-60.19	35.72
CGS001-51804	KD	SIX4	Homeoboxes / SINE class, SIX homeobox 4			11.11, 11.11	1.53, 0.45	52.63	72.09	38.29	93.29	-99.01	99.96	55.04	55.18	NaN	75.06
CGS001-8935	KD	SKAP2	Pleckstrin homology (PH) domain containing, src kinase associated phosphoprotein 2		Akt Signaling LOF	0.00, 0.00	1.91, 0.69	23.21	70.88	-25.27	-76.38	-57.74	NaN	-52.62	-99.42	NaN	-35.18
CGS001-6499	KD	SKIV2L	superkiller viralicidic activity 2-like (S. cerevisiae)			20.00, 20.00	1.06, 0.31	99.58	37.70	-95.25	94.82	32.28	99.00	90.73	-95.68	-89.81	93.48
CGS001-6500	KD	SKP1	S-phase kinase-associated protein 1			50.00, 40.00	1.08, 0.31	-33.23	51.78	99.98	99.98	51.29	99.15	95.20	-25.21	16.15	98.53
CGS001-6502	KD	SKP2	F-boxes / Leucine-rich repeats, S-phase kinase-associated protein 2 (p45)			0.00, 0.00	1.10, 0.30	86.27	-26.15	-94.67	-88.43	50.71	NaN	-96.73	-96.35	-78.70	-98.40
CGS001-4891	KD	SLC11A2	SLC11 family of proton-coupled metal ion transporters, solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2			11.11, 11.11	1.33, 0.42	45.30	100.00	-29.56	-84.02	-68.27	46.19	NaN	-69.84	-35.45	-56.41
CGS001-10723	KD	SLC12A7	SLC12 family of cation-coupled chloride transporters, solute carrier family 12 (potassium/chloride transporters), member 7			0.00, 0.00	0.93, 0.28	-22.65	72.84	-27.09	26.99	-75.16	73.71	-71.83	52.07	NaN	13.37
CGS001-6567	KD	SLC16A2	SLC16 family of monocarboxylate transporters, solute carrier family 16, member 2 (monocarboxylic acid transporter 8)			0.00, 0.00	1.42, 0.32	14.96	NaN	58.92	50.35	-31.99	90.70	-95.14	82.91	NaN	54.68
CGS001-9123	KD	SLC16A3	SLC16 family of monocarboxylate transporters, solute carrier family 16, member 3 (monocarboxylic acid transporter 4)			0.00, 0.00	1.34, 0.53	58.84	-96.27	-96.41	27.45	-37.05	-28.54	NaN	48.44	-86.51	-64.82
CGS001-9122	KD	SLC16A4	SLC16 family of monocarboxylate transporters, solute carrier family 16, member 4 (monocarboxylic acid transporter 5)			22.22, 22.22	1.52, 0.47	-24.03	98.15	98.80	-40.38	80.29	NaN	-94.58	47.71	-45.83	74.45
CGS001-9121	KD	SLC16A5	SLC16 family of monocarboxylate transporters, solute carrier family 16, member 5 (monocarboxylic acid transporter 6)			0.00, 0.00	1.14, 0.34	-94.64	21.29	69.33	47.48	-35.81	-30.82	NaN	-74.35	-77.42	-50.11
CGS001-9120	KD	SLC16A6	SLC16 family of monocarboxylate transporters, solute carrier family 16, member 6 (monocarboxylic acid transporter 7)			11.11, 11.11	1.42, 0.32	58.93	NaN	98.55	93.78	52.09	25.46	-30.25	56.34	43.70	62.83
CGS001-6509	KD	SLC1A4	Alanine/serine/cysteine transporter subfamily, solute carrier family 1 (glutamate/neutral amino acid transporter), member 4			11.11, 11.11	1.05, 0.23	47.30	NaN	38.51	-97.54	23.79	99.78	28.52	23.64	-31.26	13.80
CGS001-6510	KD	SLC1A5	Alanine/serine/cysteine transporter subfamily, solute carrier family 1 (neutral amino acid transporter), member 5			20.00, 20.00	1.02, 0.27	63.64	40.73	97.60	-72.96	99.98	33.20	68.87	-32.54	-82.40	77.10
CGS001-6511	KD	SLC1A6	Glutamate transporter subfamily, solute carrier family 1 (high affinity aspartate/glutamate transporter), member 6			14.29, 14.29	2.33, 0.82	62.44	NaN	35.46	80.94	99.98	-59.65	22.74	NaN	NaN	72.89
CGS001-5002	KD	SLC22A18	Orphan or poorly characterized SLC22 family members, solute carrier family 22, member 18			0.00, 0.00	2.13, 0.64	51.55	NaN	29.14	-86.38	-94.49	-32.32	29.62	47.65	NaN	-29.48
CGS001-63027	KD	SLC22A23	Orphan or poorly characterized SLC22 family members, solute carrier family 22, member 23			11.11, 0.00	1.36, 0.28	52.29	-23.20	32.00	-94.93	-46.81	-33.81	17.83	NaN	96.30	12.27
CGS001-6583	KD	SLC22A4	Organic zwitterions/cation transporters (OCTN), solute carrier family 22 (organic cation/ergothioneine transporter), member 4			10.00, 10.00	1.93, 0.67	76.54	100.00	35.06	-88.68	88.75	34.45	72.72	32.02	-75.93	74.90
CGS001-6584	KD	SLC22A5	Organic zwitterions/cation transporters (OCTN), solute carrier family 22 (organic cation/carnitine transporter), member 5			0.00, 0.00	1.36, 0.59	23.65	55.06	-18.91	-55.37	-72.25	82.45	53.77	-30.19	-99.95	-21.85
CGS001-6576	KD	SLC25A1	Mitochondrial di- and tri-carboxylic acid transporter subfamily, solute carrier family 25 (mitochondrial carrier; citrate transporter), member 1			0.00, 0.00	1.17, 0.42	-22.91	22.56	65.21	-96.65	-83.10	39.94	NaN	21.62	NaN	-25.51
CGS001-1468	KD	SLC25A10	Mitochondrial di- and tri-carboxylic acid transporter subfamily, solute carrier family 25 (mitochondrial carrier; dicarboxylate transporter), member 10			25.00, 12.50	1.39, 0.34	32.31	81.02	99.86	NaN	89.42	NaN	42.57	82.09	68.26	96.72
CGS001-8604	KD	SLC25A12	Mitochondrial amino acid transporter subfamily, solute carrier family 25 (mitochondrial carrier, Aralar), member 12			33.33, 22.22	1.00, 0.27	-12.66	-22.26	-52.47	99.55	96.19	79.58	NaN	44.45	99.92	87.63
CGS001-10165	KD	SLC25A13	Mitochondrial amino acid transporter subfamily, solute carrier family 25, member 13 (citrin)			33.33, 22.22	1.34, 0.43	39.16	56.24	-26.58	90.98	98.93	NaN	71.90	34.11	99.97	96.20
CGS001-9016	KD	SLC25A14	Mitochondrial uncoupling proteins, solute carrier family 25 (mitochondrial carrier, brain), member 14			10.00, 10.00	1.07, 0.27	-99.70	-73.51	-76.33	-97.52	99.17	-99.97	34.21	-31.91	-34.29	-98.68
CGS001-10166	KD	SLC25A15	Mitochondrial amino acid transporter subfamily, solute carrier family 25 (mitochondrial carrier; ornithine transporter) member 15			0.00, 0.00	1.70, 0.50	91.34	26.84	20.33	31.57	NaN	90.32	-19.60	91.95	22.38	72.33
CGS001-788	KD	SLC25A20	Mitochondrial amino acid transporter subfamily, solute carrier family 25 (carnitine/acylcarnitine translocase), member 20			20.00, 20.00	1.58, 0.45	-21.15	79.32	-99.66	98.73	52.17	36.14	-53.75	94.43	99.75	94.29
CGS001-79751	KD	SLC25A22	Mitochondrial amino acid transporter subfamily, solute carrier family 25 (mitochondrial carrier: glutamate), member 22			14.29, 14.29	2.48, 0.98	-36.98	71.94	93.78	76.39	NaN	99.31	NaN	NaN	-34.84	89.80
CGS001-29957	KD	SLC25A24	Mitochondrial nucleotide transporter subfamily, solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 24			0.00, 0.00	1.53, 0.56	-28.03	-28.69	22.17	-60.85	52.19	38.93	59.82	-37.95	NaN	-6.50
CGS001-81894	KD	SLC25A28	Miscellaneous SLC25 mitochondrial transporters, solute carrier family 25, member 28			0.00, 0.00	1.16, 0.33	-98.48	NaN	-30.70	-58.74	-59.31	NaN	-99.01	-99.24	69.36	-97.25
CGS001-81034	KD	SLC25A32	Mitochondrial nucleotide transporter subfamily, solute carrier family 25, member 32			0.00, 0.00	1.58, 0.53	-56.86	-32.19	-15.48	-33.31	29.48	84.07	-45.59	NaN	NaN	-15.10
CGS001-291	KD	SLC25A4	Mitochondrial nucleotide transporter subfamily, solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4			0.00, 0.00	1.23, 0.35	-51.52	-57.90	-98.69	-99.85	-58.61	-22.00	-99.34	-99.53	-99.92	-99.87
CGS001-91137	KD	SLC25A46	Miscellaneous SLC25 mitochondrial transporters, solute carrier family 25, member 46			50.00, 50.00	2.25, 0.66	NaN	NaN	98.84	94.98	99.04	NaN	NaN	-37.13	-27.01	98.87
CGS001-292	KD	SLC25A5	Mitochondrial nucleotide transporter subfamily, solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 5			0.00, 0.00	1.60, 0.57	-99.23	87.70	18.15	-99.78	-54.05	30.69	83.70	-95.57	NaN	-95.27
CGS001-293	KD	SLC25A6	Mitochondrial nucleotide transporter subfamily, solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 6			0.00, 0.00	2.09, 0.59	-28.34	NaN	-46.92	26.11	-24.73	NaN	70.20	23.29	20.98	-5.68
CGS001-11000	KD	SLC27A3	SLC27 family of fatty acid transporters, solute carrier family 27 (fatty acid transporter), member 3			0.00, 0.00	1.13, 0.30	13.94	76.30	32.25	34.47	-69.61	-97.45	86.31	83.44	-43.37	46.74
CGS001-2030	KD	SLC29A1	SLC29 family, solute carrier family 29 (nucleoside transporters), member 1			0.00, 0.00	1.38, 0.48	74.08	86.07	42.04	NaN	27.58	-36.41	-31.18	-24.53	NaN	15.30
CGS001-3177	KD	SLC29A2	SLC29 family, solute carrier family 29 (nucleoside transporters), member 2			0.00, 0.00	1.55, 0.52	-29.45	19.22	38.74	-30.31	90.62	NaN	82.32	29.76	41.19	37.65
CGS001-6513	KD	SLC2A1	Solute carriers, solute carrier family 2 (facilitated glucose transporter), member 1			20.00, 20.00	1.01, 0.20	99.46	67.72	-18.51	59.87	25.71	91.09	98.55	40.49	66.58	88.26
CGS001-6514	KD	SLC2A2	Solute carriers, solute carrier family 2 (facilitated glucose transporter), member 2			11.11, 11.11	1.25, 0.32	-99.92	98.92	-26.08	-24.17	-44.05	-92.75	-50.11	NaN	-36.53	-49.19
CGS001-11182	KD	SLC2A6	Solute carriers, solute carrier family 2 (facilitated glucose transporter), member 6			30.00, 30.00	0.93, 0.32	-40.37	99.56	21.59	-34.33	99.98	99.56	-26.38	-48.63	-31.22	71.26
CGS001-7780	KD	SLC30A2	SLC30 zinc transporter family, solute carrier family 30 (zinc transporter), member 2			0.00, 0.00	1.64, 0.44	-52.78	37.24	-20.13	-31.03	-40.85	-99.90	-35.44	NaN	-99.24	-40.79
CGS001-169026	KD	SLC30A8	SLC30 zinc transporter family, solute carrier family 30 (zinc transporter), member 8			0.00, 0.00	1.73, 0.52	57.06	NaN	-32.63	29.60	51.10	-38.31	17.63	33.89	19.92	9.95
CGS001-10559	KD	SLC35A1	SLC35 family of nucleotide sugar transporters, solute carrier family 35 (CMP-sialic acid transporter), member A1			10.00, 0.00	1.03, 0.32	95.79	-97.14	-98.84	-99.94	-56.99	-87.91	-99.88	-20.93	88.65	-98.77
CGS001-23443	KD	SLC35A3	SLC35 family of nucleotide sugar transporters, solute carrier family 35 (UDP-N-acetylglucosamine (UDP-GlcNAc) transporter), member A3			0.00, 0.00	1.07, 0.27	-57.90	-100.00	-86.96	-34.35	-26.56	29.55	26.62	-91.05	-99.67	-85.27
CGS001-10237	KD	SLC35B1	SLC35 family of nucleotide sugar transporters, solute carrier family 35, member B1			11.11, 0.00	1.42, 0.36	95.49	60.43	-24.63	32.25	93.08	NaN	38.87	48.84	-93.77	71.69
CGS001-54733	KD	SLC35F2	SLC35 family of nucleotide sugar transporters, solute carrier family 35, member F2			10.00, 10.00	1.15, 0.39	84.67	100.00	-23.14	-27.61	58.08	-23.68	93.89	-22.03	-25.92	71.43
CGS001-206358	KD	SLC36A1	SLC36 family of proton-coupled amino acid transporters, solute carrier family 36 (proton/amino acid symporter), member 1			0.00, 0.00	2.00, 0.50	10.84	53.87	-25.32	-99.55	-57.47	NaN	24.68	-90.00	73.83	-21.11
CGS001-120103	KD	SLC36A4	SLC36 family of proton-coupled amino acid transporters, solute carrier family 36 (proton/amino acid symporter), member 4			10.00, 10.00	1.33, 0.40	-47.69	99.63	-28.63	-27.05	55.98	29.46	24.40	29.77	-59.46	-6.04
CGS001-2542	KD	SLC37A4	SLC37 family of phosphosugar/phosphate exchangers, solute carrier family 37 (glucose-6-phosphate transporter), member 4			25.00, 12.50	1.94, 0.58	-43.91	-50.29	99.96	41.88	-33.70	NaN	NaN	55.91	97.35	72.47
CGS001-81539	KD	SLC38A1	System A-like transporters, solute carrier family 38, member 1			20.00, 20.00	1.19, 0.33	30.93	88.77	-29.59	-31.13	-43.57	-19.06	99.98	-32.25	99.97	35.57
CGS001-54407	KD	SLC38A2	System A-like transporters, solute carrier family 38, member 2			0.00, 0.00	1.78, 0.51	-28.91	NaN	-25.24	-39.61	-98.62	24.51	-31.55	33.63	NaN	-21.35
CGS001-10991	KD	SLC38A3	System N-like transporters, solute carrier family 38, member 3			22.22, 22.22	1.83, 0.48	-92.38	52.45	98.60	68.82	50.21	NaN	-78.09	61.81	99.04	73.98
CGS001-25800	KD	SLC39A6	SLC39 family of metal ion transporters, solute carrier family 39 (zinc transporter), member 6			25.00, 25.00	0.97, 0.16	-99.89	97.70	-17.75	-50.94	-40.28	99.97	NaN	NaN	-15.25	-18.29
CGS001-64116	KD	SLC39A8	SLC39 family of metal ion transporters, solute carrier family 39 (zinc transporter), member 8			11.11, 11.11	0.99, 0.23	55.88	NaN	26.71	-99.03	-80.91	-61.85	93.53	-98.89	97.78	-79.48
CGS001-6519	KD	SLC3A1	SLC3 family, solute carrier family 3 (cystine, dibasic and neutral amino acid transporters, activator of cystine, dibasic and neutral amino acid transport), member 1			0.00, 0.00	1.30, 0.33	68.19	-30.64	-99.98	-72.80	32.67	-35.56	47.14	-66.67	-25.60	-48.59
CGS001-6520	KD	SLC3A2	SLC3 family, solute carrier family 3 (activators of dibasic and neutral amino acid transport), member 2			0.00, 0.00	2.36, 0.80	92.94	-51.20	-38.13	-63.71	NaN	90.88	-69.00	-33.96	-22.52	-41.72
CGS001-8884	KD	SLC5A6	Sodium iodide symporter, sodium-dependent multivitamin transporter and sodium-coupled monocarboxylate transporters, solute carrier family 5 (sodium-dependent vitamin transporter), member 6			22.22, 11.11	1.15, 0.41	99.86	NaN	-21.83	96.78	65.13	-36.87	-47.74	-36.92	-57.32	25.93
CGS001-11254	KD	SLC6A14	Glycine transporter subfamily, solute carrier family 6 (amino acid transporter), member 14			0.00, 0.00	1.33, 0.36	-57.49	22.27	-97.29	-42.37	-50.04	NaN	-96.97	-95.92	-98.54	-98.63
CGS001-6535	KD	SLC6A8	GABA transporter subfamily, solute carrier family 6 (neurotransmitter transporter, creatine), member 8			0.00, 0.00	1.24, 0.47	-49.73	-99.87	-98.41	-87.57	-51.61	-78.97	-22.35	-96.98	-30.96	-95.84
CGS001-6541	KD	SLC7A1	SLC7 family, solute carrier family 7 (cationic amino acid transporter, y+ system), member 1			0.00, 0.00	1.47, 0.43	-90.49	-28.21	-96.31	-30.74	-51.10	NaN	50.62	-79.42	-30.16	-71.24
CGS001-23657	KD	SLC7A11	Solute carriers, solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11			0.00, 0.00	2.49, 0.90	-31.38	-77.91	39.97	-55.04	39.56	NaN	NaN	NaN	NaN	-41.43
CGS001-8140	KD	SLC7A5	SLC7 family, solute carrier family 7 (amino acid transporter light chain, L system), member 5			0.00, 0.00	1.20, 0.32	-99.16	NaN	-98.68	-99.83	-42.38	NaN	NaN	-97.58	-99.97	-99.92
CGS001-11136	KD	SLC7A9	SLC7 family, solute carrier family 7 (glycoprotein-associated amino acid transporter light chain, bo,+ system), member 9			0.00, 0.00	1.56, 0.45	26.34	64.44	40.73	22.56	60.45	29.32	-50.15	-30.70	-28.42	8.95
CGS001-6548	KD	SLC9A1	SLC9 family of sodium/hydrogen exchangers, solute carrier family 9 (sodium/hydrogen exchanger), member 1			0.00, 0.00	1.59, 0.51	-33.94	60.36	20.16	35.42	31.86	-98.48	21.72	-81.62	86.05	12.31
CGS001-9748	KD	SLK	SLK subfamily, STE20-like kinase			0.00, 0.00	0.91, 0.22	33.18	-87.61	-99.96	-99.98	-19.46	NaN	62.36	-91.85	21.51	-97.14
CGS001-4086	KD	SMAD1	SMADs, SMAD family member 1		BMP Signaling LOF	11.11, 0.00	1.61, 0.41	97.26	NaN	-93.04	34.06	-48.26	-42.04	-95.02	-95.32	11.33	-87.98
CGS001-4089	KD	SMAD4	SMADs, SMAD family member 4		SMAD family LOF	0.00, 0.00	1.25, 0.28	-28.40	23.50	-17.64	-60.71	-20.35	-66.00	-17.93	-14.43	-96.70	-18.33
CGS001-4090	KD	SMAD5	SMADs, SMAD family member 5		SMAD family LOF	12.50, 12.50	1.75, 0.55	55.83	94.06	54.29	NaN	99.98	-29.27	76.03	27.65	NaN	73.76
CGS001-4091	KD	SMAD6	SMADs, SMAD family member 6			12.50, 12.50	1.19, 0.35	35.91	NaN	-13.86	54.53	-92.30	NaN	99.91	-97.00	15.85	-15.15
CGS001-4092	KD	SMAD7	SMADs, SMAD family member 7		BMP Signaling LOF	0.00, 0.00	1.63, 0.44	86.55	-33.52	-72.97	-71.26	-35.59	NaN	34.77	-99.86	-23.16	-62.97
CGS001-6597	KD	SMARCA4	Non-enzymatic BRD containing proteins, SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4			10.00, 10.00	1.63, 0.30	-15.95	100.00	61.68	86.78	84.63	-22.52	90.42	55.48	-93.56	94.42
CGS001-8467	KD	SMARCA5	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5			10.00, 10.00	1.40, 0.49	50.55	-29.30	97.65	-29.02	36.32	32.88	60.31	28.97	-35.67	30.51
CGS001-56916	KD	SMARCAD1	SWI/SNF-related, matrix-associated actin-dependent regulator of chromatin, subfamily a, containing DEAD/H box 1			10.00, 10.00	1.36, 0.50	-28.72	-76.44	99.98	-28.10	40.89	-77.96	38.25	26.49	94.07	16.03
CGS001-6599	KD	SMARCC1	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 1			0.00, 0.00	1.19, 0.39	45.62	-34.89	36.37	-74.57	28.07	41.34	-28.24	34.33	29.47	26.95
CGS001-6601	KD	SMARCC2	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 2			10.00, 10.00	1.20, 0.35	-31.12	27.40	-68.85	88.64	-39.02	99.35	-28.65	-26.04	43.88	17.18
CGS001-6603	KD	SMARCD2	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 2			0.00, 0.00	1.31, 0.33	66.56	68.92	-55.37	-43.93	-78.77	33.70	-32.53	-52.27	-98.87	-44.72
CGS001-8243	KD	SMC1A	Structural maintenance of chromosomes proteins, structural maintenance of chromosomes 1A		Structural maintenance of chromosomes proteins LOF	44.44, 22.22	0.94, 0.20	-99.75	100.00	-98.93	NaN	24.53	96.84	-80.56	-43.58	99.50	95.60
CGS001-9126	KD	SMC3	Structural maintenance of chromosomes proteins, structural maintenance of chromosomes 3		Structural maintenance of chromosomes proteins LOF	0.00, 0.00	1.26, 0.40	NaN	-37.77	-49.33	-83.97	-32.40	-99.82	-99.05	-94.39	-22.79	-89.39
CGS001-10051	KD	SMC4	Structural maintenance of chromosomes proteins, structural maintenance of chromosomes 4		Structural maintenance of chromosomes proteins LOF	11.11, 11.11	1.76, 0.51	98.24	-32.96	-74.99	-41.19	-98.42	NaN	38.80	-93.39	41.16	-72.18
CGS001-9887	KD	SMG7	smg-7 homolog, nonsense mediated mRNA decay factor (C. elegans)			0.00, 0.00	1.38, 0.38	-60.39	-99.76	-72.28	-88.45	24.12	NaN	NaN	-99.09	-50.64	-99.00
CGS001-10285	KD	SMNDC1	Tudor domain containing, survival motor neuron domain containing 1			0.00, 0.00	2.10, 0.66	92.86	18.18	-17.37	-90.23	31.82	-62.36	-36.98	-34.72	-41.24	-19.11
CGS001-6608	KD	SMO	GPCR / Class F : Frizzled receptors, smoothened, frizzled family receptor			0.00, 0.00	2.86, 0.80	48.43	78.47	92.89	31.92	NaN	NaN	54.54	90.93	-59.30	89.31
CGS001-64094	KD	SMOC2	EF-hand domain containing, SPARC related modular calcium binding 2			0.00, 0.00	1.32, 0.41	-35.86	92.58	-64.85	-99.69	48.89	-31.33	NaN	-62.28	-49.82	-53.21
CGS001-54498	KD	SMOX	spermine oxidase			0.00, 0.00	1.35, 0.47	-37.29	44.02	-82.57	NaN	-36.23	-35.89	53.63	30.31	NaN	-16.34
CGS001-6611	KD	SMS	spermine synthase			22.22, 22.22	1.01, 0.34	-23.55	100.00	-47.43	-36.67	-95.44	97.87	NaN	-81.91	-56.32	-37.67
CGS001-55234	KD	SMU1	WD repeat domain containing, smu-1 suppressor of mec-8 and unc-52 homolog (C. elegans)			44.44, 44.44	1.34, 0.41	-61.04	100.00	-25.09	99.83	26.88	NaN	79.88	-20.38	99.78	99.79
CGS001-57154	KD	SMURF1	SMAD specific E3 ubiquitin protein ligase 1		BMP Signaling LOF	0.00, 0.00	1.57, 0.34	-98.54	-73.92	-96.89	-99.90	34.84	NaN	-21.36	-96.29	-99.97	-98.63
CGS001-64750	KD	SMURF2	SMAD specific E3 ubiquitin protein ligase 2		BMP Signaling LOF	10.00, 10.00	1.20, 0.26	-70.76	-20.59	-99.81	-58.46	28.16	-83.98	-99.98	36.88	99.77	-67.70
CGS001-64754	KD	SMYD3	Chromatin-modifying enzymes / K-methyltransferases, SET and MYND domain containing 3			14.29, 0.00	1.57, 0.49	-44.23	NaN	-41.83	79.38	32.57	NaN	NaN	95.13	-22.40	56.92
CGS001-6591	KD	SNAI2	Snail homologs, snail homolog 2 (Drosophila)			0.00, 0.00	1.26, 0.34	-48.78	69.38	-94.78	59.63	-92.33	NaN	72.57	-35.93	-29.42	-24.54
CGS001-333929	KD	SNAI3	Snail homologs, snail homolog 3 (Drosophila)			66.67, 55.56	1.74, 0.57	99.70	91.43	51.20	96.27	46.25	NaN	99.93	99.65	97.59	99.92
CGS001-6617	KD	SNAPC1	small nuclear RNA activating complex, polypeptide 1, 43kDa			0.00, 0.00	1.90, 0.66	-35.73	-45.94	-19.71	51.86	-95.75	NaN	31.70	-70.32	26.64	-13.63
CGS001-6621	KD	SNAPC4	small nuclear RNA activating complex, polypeptide 4, 190kDa			0.00, 0.00	2.13, 0.60	54.07	-38.27	83.70	33.21	NaN	NaN	26.41	30.48	-31.06	25.56
CGS001-6622	KD	SNCA	Parkinson disease, synuclein, alpha (non A4 component of amyloid precursor)			0.00, 0.00	0.99, 0.35	-78.96	-66.64	-66.24	19.21	-91.33	12.43	-94.04	-74.38	-23.79	-65.23
CGS001-11267	KD	SNF8	SNF8, ESCRT-II complex subunit, homolog (S. cerevisiae)			0.00, 0.00	1.48, 0.31	-57.21	-26.67	-64.25	-48.52	-49.39	-25.83	52.46	NaN	NaN	-28.71
CGS001-54861	KD	SNRK	SNRK subfamily, SNF related kinase			11.11, 11.11	1.26, 0.48	-24.66	97.65	-27.86	NaN	-17.36	21.84	-94.73	-20.80	39.20	-5.47
CGS001-6626	KD	SNRPA	RNA binding motif (RRM) containing, small nuclear ribonucleoprotein polypeptide A			0.00, 0.00	1.75, 0.53	-99.72	-28.48	-20.30	-31.48	-28.51	-42.91	NaN	-70.11	NaN	-23.72
CGS001-6632	KD	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide 16kDa		Nucleoporin LOF	0.00, 0.00	1.70, 0.56	23.19	-44.78	-70.36	-99.98	-22.05	88.55	-74.39	-67.53	-40.00	-54.44
CGS001-22938	KD	SNW1	SNW domain containing 1			10.00, 10.00	1.61, 0.60	-50.87	100.00	-18.79	57.18	-53.88	93.79	-70.09	-25.58	-87.62	-30.77
CGS001-29916	KD	SNX11	Sorting nexins, sorting nexin 11			12.50, 0.00	1.42, 0.45	NaN	NaN	-99.85	-40.47	95.23	-24.47	-88.72	-90.81	-40.68	-89.58
CGS001-23161	KD	SNX13	Sorting nexins, sorting nexin 13			0.00, 0.00	1.02, 0.26	-39.70	21.13	-31.65	-97.48	-99.13	92.85	39.53	-87.60	-94.17	-96.43
CGS001-9784	KD	SNX17	Sorting nexins, sorting nexin 17			0.00, 0.00	1.43, 0.42	81.23	-24.17	-96.22	-95.52	-96.18	-47.78	-22.47	-40.60	-98.63	-97.37
CGS001-6643	KD	SNX2	Sorting nexins, sorting nexin 2			11.11, 11.11	1.51, 0.35	72.67	84.45	74.08	-18.77	-17.76	99.29	NaN	-82.73	-40.90	57.35
CGS001-58533	KD	SNX6	Sorting nexins, sorting nexin 6			0.00, 0.00	1.05, 0.28	78.26	-27.53	-89.03	-99.68	24.68	-37.64	-65.21	-99.02	-42.36	-83.25
CGS001-51375	KD	SNX7	Sorting nexins, sorting nexin 7			57.14, 57.14	1.75, 0.61	NaN	23.98	-20.13	99.60	-60.91	NaN	NaN	99.73	98.98	99.47
CGS001-6646	KD	SOAT1	sterol O-acyltransferase 1			0.00, 0.00	1.90, 0.47	-56.16	NaN	-25.48	NaN	-99.98	-42.43	-99.98	-99.51	-31.77	-99.95
CGS001-8435	KD	SOAT2	sterol O-acyltransferase 2			0.00, 0.00	1.47, 0.45	-46.36	89.23	16.56	NaN	-40.43	62.13	86.99	-17.21	31.43	29.82
CGS001-8651	KD	SOCS1	SH2 domain containing, suppressor of cytokine signaling 1			0.00, 0.00	1.83, 0.49	-33.42	NaN	78.19	90.95	37.32	NaN	-39.96	-34.42	63.85	59.34
CGS001-8835	KD	SOCS2	SH2 domain containing, suppressor of cytokine signaling 2			22.22, 11.11	1.03, 0.35	34.56	NaN	23.59	31.75	67.99	64.86	-20.31	99.78	95.81	79.97
CGS001-122809	KD	SOCS4	SH2 domain containing, suppressor of cytokine signaling 4			0.00, 0.00	2.16, 0.66	-50.07	-21.05	-24.65	NaN	82.44	-72.66	-25.05	-22.51	NaN	-14.10
CGS001-9655	KD	SOCS5	SH2 domain containing, suppressor of cytokine signaling 5			22.22, 11.11	1.47, 0.42	-36.25	98.38	41.31	24.30	-47.02	83.36	78.17	95.94	NaN	80.04
CGS001-10174	KD	SORBS3	sorbin and SH3 domain containing 3			10.00, 10.00	1.14, 0.40	93.12	28.62	-99.98	-99.96	-52.73	-96.21	34.39	97.79	-65.70	-95.70
CGS001-6272	KD	SORT1	sortilin 1			25.00, 25.00	1.88, 0.67	67.30	99.93	-51.81	99.83	NaN	NaN	58.29	-31.37	-58.38	79.13
CGS001-6654	KD	SOS1	Rho guanine nucleotide exchange factors, son of sevenless homolog 1 (Drosophila)			0.00, 0.00	0.84, 0.33	89.99	NaN	86.97	-65.03	-99.98	NaN	-39.37	26.50	26.46	-52.06
CGS001-6655	KD	SOS2	Rho guanine nucleotide exchange factors, son of sevenless homolog 2 (Drosophila)			0.00, 0.00	1.27, 0.36	-44.02	49.43	-98.84	-99.98	-59.27	47.42	-29.88	-89.17	-99.42	-98.49
CGS001-6663	KD	SOX10	SRY (sex determining region Y)-boxes, SRY (sex determining region Y)-box 10		SRY LOF	0.00, 0.00	1.36, 0.24	-56.46	83.96	-99.91	-25.32	50.10	NaN	39.76	52.64	24.69	13.76
CGS001-6664	KD	SOX11	SRY (sex determining region Y)-boxes, SRY (sex determining region Y)-box 11		SRY LOF	0.00, 0.00	1.38, 0.49	-33.08	-34.54	27.21	24.51	40.44	-98.25	-41.58	52.42	NaN	-17.33
CGS001-6657	KD	SOX2	SRY (sex determining region Y)-boxes, SRY (sex determining region Y)-box 2		SRY LOF	0.00, 0.00	1.53, 0.35	-46.12	-93.06	-25.15	30.54	-44.89	49.24	-61.85	-76.40	31.44	-36.60
CGS001-6658	KD	SOX3	SRY (sex determining region Y)-boxes, SRY (sex determining region Y)-box 3		SRY LOF	11.11, 0.00	0.91, 0.23	-27.83	33.35	-18.27	-27.24	36.00	NaN	97.28	-33.03	37.38	8.12
CGS001-6659	KD	SOX4	SRY (sex determining region Y)-boxes, SRY (sex determining region Y)-box 4			40.00, 10.00	1.44, 0.41	-78.18	-66.56	79.25	95.55	83.31	50.31	99.98	95.05	82.04	95.44
CGS001-6660	KD	SOX5	SRY (sex determining region Y)-boxes, SRY (sex determining region Y)-box 5			11.11, 11.11	1.28, 0.20	25.43	22.96	54.66	NaN	-99.94	-24.62	99.76	-88.74	91.34	28.41
CGS001-6672	KD	SP100	Zinc fingers, PHD-type, SP100 nuclear antigen			0.00, 0.00	1.23, 0.44	-98.94	29.32	-35.69	-27.10	81.27	-92.83	11.90	-37.35	67.95	-8.05
CGS001-3431	KD	SP110	Non-enzymatic BRD containing proteins, SP110 nuclear body protein			44.44, 44.44	1.72, 0.59	-22.38	-30.96	64.07	99.78	99.26	NaN	-49.76	99.73	25.31	98.94
CGS001-11262	KD	SP140	Zinc fingers, PHD-type, SP140 nuclear body protein			11.11, 0.00	1.13, 0.42	-93.61	NaN	-99.74	-78.72	96.58	-57.06	41.09	-99.31	-23.22	-91.26
CGS001-93349	KD	SP140L	Zinc fingers, PHD-type, SP140 nuclear body protein-like			11.11, 11.11	1.07, 0.28	50.53	93.83	15.90	36.62	97.68	NaN	89.28	-97.82	85.18	93.79
CGS001-6670	KD	SP3	Specificity protein transcription factors, Sp3 transcription factor			33.33, 22.22	1.33, 0.42	-96.38	20.97	97.96	33.74	95.17	NaN	48.52	99.92	34.23	93.63
CGS001-53340	KD	SPA17	sperm autoantigenic protein 17			0.00, 0.00	1.51, 0.41	NaN	-75.85	-89.88	-54.40	-36.96	40.03	NaN	-73.93	-61.19	-59.78
CGS001-6676	KD	SPAG4	sperm associated antigen 4			0.00, 0.00	1.95, 0.61	NaN	NaN	81.78	-51.56	43.39	NaN	48.05	-25.08	-99.25	39.63
CGS001-9552	KD	SPAG7	sperm associated antigen 7			0.00, 0.00	1.90, 0.58	NaN	NaN	-23.21	-95.24	-80.78	-73.06	-86.07	-83.61	-33.15	-89.26
CGS001-6678	KD	SPARC	secreted protein, acidic, cysteine-rich (osteonectin)			14.29, 14.29	2.72, 0.80	83.09	77.06	-29.47	98.34	-58.71	NaN	88.09	NaN	NaN	92.04
CGS001-25803	KD	SPDEF	ETS Transcription Factors, SAM pointed domain containing ets transcription factor			10.00, 10.00	1.01, 0.31	-99.89	61.19	-98.40	-44.79	-54.62	-66.47	99.18	-64.92	50.27	-71.39
CGS001-23384	KD	SPECC1L	sperm antigen with calponin homology and coiled-coil domains 1-like			0.00, 0.00	2.52, 0.81	NaN	-17.43	30.60	NaN	56.09	NaN	-95.16	-85.65	75.47	37.68
CGS001-23013	KD	SPEN	RNA binding motif (RRM) containing, spen homolog, transcriptional regulator (Drosophila)			22.22, 22.22	1.05, 0.34	-88.25	99.52	-95.47	-23.71	83.30	NaN	99.74	-93.20	-24.59	-67.11
CGS001-56848	KD	SPHK2	Sphingosine kinase, sphingosine kinase 2			44.44, 33.33	1.33, 0.43	98.20	97.95	-72.21	95.55	-39.92	NaN	88.34	-38.13	-34.01	98.66
CGS001-121599	KD	SPIC	ETS Transcription Factors, Spi-C transcription factor (Spi-1/PU.1 related)			0.00, 0.00	1.31, 0.41	-32.20	34.13	25.39	41.05	-21.93	-29.84	28.49	23.14	90.29	5.55
CGS001-6697	KD	SPR	Short chain dehydrogenase/reductase superfamily / Classical SDR fold cluster 1, sepiapterin reductase (7,8-dihydrobiopterin:NADP+ oxidoreductase)			10.00, 10.00	1.58, 0.45	-80.39	-59.02	-96.50	-99.98	-22.90	99.47	94.98	-99.95	-99.68	-99.82
CGS001-200734	KD	SPRED2	sprouty-related, EVH1 domain containing 2			22.22, 11.11	1.93, 0.78	-71.84	NaN	99.92	86.72	-51.87	91.45	-39.67	96.81	75.51	90.21
CGS001-10252	KD	SPRY1	sprouty homolog 1, antagonist of FGF signaling (Drosophila)			10.00, 10.00	1.15, 0.40	30.97	53.97	21.48	-29.38	56.30	65.89	-34.23	-97.76	99.66	45.65
CGS001-81848	KD	SPRY4	sprouty homolog 4 (Drosophila)			10.00, 10.00	1.64, 0.55	67.33	76.13	73.87	36.24	-90.56	90.29	65.81	98.59	-53.61	89.61
CGS001-6709	KD	SPTAN1	EF-hand domain containing, spectrin, alpha, non-erythrocytic 1 (alpha-fodrin)			11.11, 11.11	0.88, 0.20	-99.53	-40.22	-22.58	-70.35	52.45	NaN	99.94	-97.98	-21.10	-39.12
CGS001-10558	KD	SPTLC1	Serine palmitoyltransferase, serine palmitoyltransferase, long chain base subunit 1			0.00, 0.00	1.56, 0.36	-99.47	-100.00	-22.43	-41.30	-95.74	-99.97	-67.17	-25.22	-82.85	-99.45
CGS001-9517	KD	SPTLC2	Serine palmitoyltransferase, serine palmitoyltransferase, long chain base subunit 2			10.00, 10.00	0.97, 0.33	94.02	48.78	-53.49	-30.47	22.71	99.00	-38.27	71.79	31.35	40.38
CGS001-58472	KD	SQRDL	sulfide quinone reductase-like (yeast)			0.00, 0.00	1.34, 0.41	-91.45	-100.00	-97.78	-92.95	-91.39	37.98	-47.22	-85.22	31.07	-97.24
CGS001-8878	KD	SQSTM1	sequestosome 1			0.00, 0.00	0.89, 0.36	59.22	-76.81	-91.58	77.53	-76.30	NaN	28.86	-88.63	-46.48	-92.61
CGS001-6714	KD	SRC	Src family, v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)			0.00, 0.00	1.39, 0.41	-97.31	85.86	-99.98	-99.95	-99.74	-80.89	-96.14	-97.80	-28.25	-99.79
CGS001-6715	KD	SRD5A1	steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1)			0.00, 0.00	1.20, 0.53	-36.33	-23.86	61.66	35.18	23.25	NaN	-59.71	-58.32	87.94	8.28
CGS001-6720	KD	SREBF1	Basic helix-loop-helix proteins, sterol regulatory element binding transcription factor 1			14.29, 14.29	1.97, 0.53	33.21	-76.44	99.10	22.93	32.96	NaN	92.35	NaN	NaN	55.92
CGS001-6721	KD	SREBF2	Basic helix-loop-helix proteins, sterol regulatory element binding transcription factor 2			0.00, 0.00	1.16, 0.31	37.15	56.00	-98.33	-98.49	67.82	NaN	-99.90	-38.76	-75.33	-99.49
CGS001-6722	KD	SRF	serum response factor (c-fos serum response element-binding transcription factor)			50.00, 40.00	1.16, 0.40	58.27	100.00	99.86	56.60	74.70	95.14	80.59	99.94	-22.31	99.82
CGS001-23380	KD	SRGAP2	Rho GTPase activating proteins, SLIT-ROBO Rho GTPase activating protein 2			55.56, 33.33	2.22, 0.84	67.15	98.67	95.80	NaN	27.22	99.49	92.94	96.90	50.62	99.08
CGS001-6723	KD	SRM	spermidine synthase			0.00, 0.00	1.69, 0.43	-86.94	-96.98	54.95	45.05	34.22	-99.79	-96.70	-18.48	NaN	-95.89
CGS001-6727	KD	SRP14	signal recognition particle 14kDa (homologous Alu RNA binding protein)			0.00, 0.00	1.27, 0.27	NaN	-54.02	-97.91	-99.19	89.06	-62.17	-52.43	93.25	-99.93	-98.66
CGS001-6732	KD	SRPK1	SRPK family, SRSF protein kinase 1			11.11, 11.11	1.26, 0.30	16.58	99.96	-57.27	-86.68	-28.07	81.08	NaN	-28.23	47.95	19.77
CGS001-58477	KD	SRPRB	signal recognition particle receptor, B subunit			10.00, 10.00	1.34, 0.26	-47.01	-98.60	-81.34	-76.84	87.46	-83.52	-99.78	-83.17	97.98	-87.51
CGS001-10250	KD	SRRM1	serine/arginine repetitive matrix 1			0.00, 0.00	0.93, 0.30	-97.88	-35.74	-99.94	-98.78	-82.52	-58.90	43.68	-89.69	-47.05	-98.18
CGS001-51593	KD	SRRT	serrate RNA effector molecule homolog (Arabidopsis)			0.00, 0.00	1.53, 0.43	-99.15	-100.00	22.11	-29.03	NaN	85.13	70.88	-70.03	-23.87	-64.43
CGS001-6427	KD	SRSF2	RNA binding motif (RRM) containing, serine/arginine-rich splicing factor 2			20.00, 20.00	0.61, 0.24	12.13	29.55	-27.33	22.02	63.69	99.97	99.64	16.00	39.70	21.43
CGS001-6428	KD	SRSF3	RNA binding motif (RRM) containing, serine/arginine-rich splicing factor 3			0.00, 0.00	1.77, 0.61	-76.87	-64.45	-51.68	-85.19	87.35	-54.53	-89.90	-36.97	37.53	-69.31
CGS001-6429	KD	SRSF4	RNA binding motif (RRM) containing, serine/arginine-rich splicing factor 4			0.00, 0.00	1.52, 0.58	-73.88	-26.49	94.73	74.04	23.04	NaN	NaN	-18.20	54.46	55.05
CGS001-10929	KD	SRSF8	Serine/arginine-rich splicing factors, serine/arginine-rich splicing factor 8			0.00, 0.00	1.24, 0.39	-90.44	-66.79	-86.47	-62.38	93.38	-98.57	-93.27	59.89	-98.19	-95.81
CGS001-26039	KD	SS18L1	synovial sarcoma translocation gene on chromosome 18-like 1			0.00, 0.00	1.35, 0.35	20.05	NaN	-83.03	-98.59	21.26	NaN	-70.53	-99.83	-97.58	-98.98
CGS001-6741	KD	SSB	La ribonucleoprotein domain containing, Sjogren syndrome antigen B (autoantigen La)			0.00, 0.00	1.90, 0.44	-99.30	62.34	-56.67	-27.46	-65.54	NaN	-59.08	-33.18	-17.41	-22.77
CGS001-23635	KD	SSBP2	single-stranded DNA binding protein 2			0.00, 0.00	0.91, 0.32	-51.76	-33.73	-95.08	69.22	38.79	NaN	-33.90	84.62	76.46	61.64
CGS001-170463	KD	SSBP4	single stranded DNA binding protein 4			44.44, 11.11	1.38, 0.40	96.09	-38.02	31.78	96.54	29.57	99.97	-64.89	87.16	NaN	95.58
CGS001-6757	KD	SSX2	synovial sarcoma, X breakpoint 2			10.00, 10.00	1.40, 0.32	99.71	92.95	-24.13	31.05	-48.00	53.96	77.34	-25.96	-91.32	58.77
CGS001-8869	KD	ST3GAL5	Sialyltransferases, ST3 beta-galactoside alpha-2,3-sialyltransferase 5			20.00, 10.00	1.02, 0.24	88.31	81.60	90.97	93.83	53.28	92.31	-20.14	99.90	64.00	97.27
CGS001-10610	KD	ST6GALNAC2	Sialyltransferases, ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2			10.00, 10.00	1.24, 0.35	-87.56	99.93	75.46	-44.81	-37.64	50.42	77.61	35.09	-26.85	68.83
CGS001-7982	KD	ST7	suppression of tumorigenicity 7			10.00, 10.00	1.03, 0.28	35.57	-30.15	58.30	-99.86	98.92	-68.13	28.34	-14.91	42.33	20.40
CGS001-8027	KD	STAM	signal transducing adaptor molecule (SH3 domain and ITAM motif) 1			12.50, 12.50	0.83, 0.22	97.64	-54.94	-14.32	NaN	49.09	NaN	92.89	84.40	23.24	62.05
CGS001-10254	KD	STAM2	signal transducing adaptor molecule (SH3 domain and ITAM motif) 2			0.00, 0.00	1.63, 0.52	-76.98	-45.54	-94.39	-99.96	72.30	NaN	-68.09	21.66	94.98	-59.81
CGS001-10617	KD	STAMBP	STAM binding protein			0.00, 0.00	1.55, 0.61	-76.45	-91.34	-92.56	-99.98	94.55	-91.25	45.26	-95.61	-73.32	-95.67
CGS001-55620	KD	STAP2	signal transducing adaptor family member 2			14.29, 14.29	3.31, 1.03	NaN	NaN	41.55	-98.54	98.34	33.46	-89.81	NaN	-29.77	-59.09
CGS001-6773	KD	STAT2	SH2 domain containing, signal transducer and activator of transcription 2, 113kDa			14.29, 14.29	1.78, 0.65	80.71	29.98	23.72	52.24	99.98	NaN	NaN	40.39	NaN	59.25
CGS001-6774	KD	STAT3	SH2 domain containing, signal transducer and activator of transcription 3 (acute-phase response factor)			0.00, 0.00	1.15, 0.49	-19.84	57.23	-25.17	-30.03	22.28	45.53	-24.24	73.52	-99.18	8.86
CGS001-6775	KD	STAT4	SH2 domain containing, signal transducer and activator of transcription 4			0.00, 0.00	1.08, 0.34	-92.81	35.77	85.84	-42.16	-99.04	NaN	22.64	-74.95	-78.70	-93.14
CGS001-6776	KD	STAT5A	SH2 domain containing, signal transducer and activator of transcription 5A			0.00, 0.00	0.93, 0.18	-88.29	41.32	-18.43	64.48	88.34	-17.74	20.86	48.42	86.11	17.86
CGS001-6777	KD	STAT5B	SH2 domain containing, signal transducer and activator of transcription 5B			0.00, 0.00	1.84, 0.58	-85.13	NaN	-40.11	-46.13	44.44	NaN	-93.79	-58.79	94.33	-65.64
CGS001-6778	KD	STAT6	SH2 domain containing, signal transducer and activator of transcription 6, interleukin-4 induced			0.00, 0.00	1.31, 0.28	-51.47	-22.94	-66.98	-64.31	-80.75	51.07	-28.99	-99.67	-64.61	-58.09
CGS001-6491	KD	STIL	SCL/TAL1 interrupting locus			10.00, 0.00	1.65, 0.51	-77.92	-75.77	-63.75	-25.80	-53.40	24.18	-24.58	-57.24	97.39	-48.08
CGS001-6793	KD	STK10	SLK subfamily, serine/threonine kinase 10			10.00, 10.00	1.43, 0.45	49.37	-99.87	92.47	62.39	50.43	35.11	97.56	-73.30	57.73	63.08
CGS001-6794	KD	STK11	LKB subfamily, serine/threonine kinase 11			11.11, 0.00	1.35, 0.41	90.28	24.01	33.86	97.16	-61.63	NaN	-81.32	92.32	43.45	75.07
CGS001-8576	KD	STK16	NAK family, serine/threonine kinase 16			0.00, 0.00	1.44, 0.41	-35.39	-98.49	38.97	-36.84	-20.43	33.73	-55.62	-37.65	NaN	-27.39
CGS001-9263	KD	STK17A	Death-associated kinase (DAPK) family, serine/threonine kinase 17a			11.11, 11.11	1.43, 0.43	72.72	50.92	41.51	44.32	99.85	NaN	60.89	86.32	52.77	71.50
CGS001-8859	KD	STK19	G11 family, serine/threonine kinase 19			25.00, 12.50	1.43, 0.50	-40.32	96.03	51.98	40.95	-44.82	NaN	NaN	15.86	99.23	70.96
CGS001-10494	KD	STK25	YSK subfamily, serine/threonine kinase 25			0.00, 0.00	1.10, 0.33	-88.00	-69.70	-62.15	-79.67	-82.01	-99.73	-45.80	-67.09	-55.27	-70.47
CGS001-6788	KD	STK3	MST subfamily, serine/threonine kinase 3			0.00, 0.00	1.13, 0.32	38.25	-99.72	-67.18	-95.55	-20.29	-69.15	71.97	22.27	33.94	-79.11
CGS001-65975	KD	STK33	CAMK-unique family, serine/threonine kinase 33			0.00, 0.00	0.53, 0.14	88.09	-55.43	-58.49	-99.94	17.27	NaN	46.37	-91.27	21.90	-55.10
CGS001-27148	KD	STK36	Unc-51-like kinase (ULK) family, serine/threonine kinase 36			77.78, 55.56	1.35, 0.42	95.26	97.33	85.17	99.89	98.14	NaN	99.10	-53.72	98.54	99.66
CGS001-11329	KD	STK38	NDR family, serine/threonine kinase 38			11.11, 11.11	1.32, 0.42	59.28	-42.02	-45.57	-57.89	22.71	-53.45	NaN	98.91	-30.56	-55.86
CGS001-27347	KD	STK39	FRAY subfamily, serine threonine kinase 39			11.11, 11.11	1.27, 0.38	59.53	99.89	-30.74	-23.09	26.28	NaN	-91.95	13.35	-22.85	-7.04
CGS001-3925	KD	STMN1	stathmin 1			10.00, 10.00	1.93, 0.48	99.99	61.74	-66.89	-99.02	-71.73	-93.15	-25.04	-98.46	-75.53	-81.75
CGS001-55437	KD	STRADB	STLK subfamily, STE20-related kinase adaptor beta			0.00, 0.00	1.20, 0.40	-99.51	-99.69	-43.02	14.17	90.57	-93.33	49.58	-31.54	-57.19	-72.04
CGS001-10273	KD	STUB1	Tetratricopeptide (TTC) repeat domain containing, STIP1 homology and U-box containing protein 1, E3 ubiquitin protein ligase			0.00, 0.00	1.47, 0.44	45.78	28.93	-22.52	87.59	37.37	-26.34	NaN	68.22	50.51	45.67
CGS001-6804	KD	STX1A	syntaxin 1A (brain)			11.11, 0.00	1.14, 0.24	95.84	27.48	27.56	19.99	-63.15	NaN	36.56	-81.20	-17.47	7.04
CGS001-6810	KD	STX4	syntaxin 4			0.00, 0.00	1.05, 0.28	-65.41	-98.69	-99.72	-61.38	32.51	24.03	16.49	-34.46	-38.21	-21.01
CGS001-6812	KD	STXBP1	syntaxin binding protein 1			37.50, 25.00	1.93, 0.50	NaN	99.93	99.94	84.62	71.92	NaN	-37.33	30.87	-33.52	96.39
CGS001-6813	KD	STXBP2	syntaxin binding protein 2			11.11, 11.11	1.44, 0.42	46.29	53.10	-34.31	99.83	-89.19	NaN	60.69	27.46	-23.59	52.37
CGS001-10923	KD	SUB1	SUB1 homolog (S. cerevisiae)			0.00, 0.00	1.36, 0.40	-40.97	-41.11	23.28	29.33	-25.87	-25.29	-22.35	56.29	-61.57	-8.22
CGS001-8803	KD	SUCLA2	succinate-CoA ligase, ADP-forming, beta subunit			0.00, 0.00	1.74, 0.44	-54.92	NaN	-39.69	-30.52	-52.33	NaN	-83.00	-59.22	40.17	-32.66
CGS001-8802	KD	SUCLG1	succinate-CoA ligase, alpha subunit			10.00, 10.00	1.03, 0.24	-69.40	99.98	-71.38	-99.45	-19.90	37.36	-24.15	-57.01	-94.93	-59.74
CGS001-8801	KD	SUCLG2	succinate-CoA ligase, GDP-forming, beta subunit			0.00, 0.00	1.18, 0.28	-52.56	NaN	-32.14	-40.06	-86.25	91.92	-86.20	-97.13	-99.93	-92.58
CGS001-56670	KD	SUCNR1	GPCR / Class A : Orphans, succinate receptor 1			0.00, 0.00	1.01, 0.26	-36.50	52.42	-70.27	85.18	76.82	69.79	-16.37	NaN	-70.07	45.33
CGS001-51684	KD	SUFU	suppressor of fused homolog (Drosophila)			0.00, 0.00	0.84, 0.24	-66.95	-27.90	-37.53	33.21	31.51	NaN	-79.40	-87.68	-88.54	-50.44
CGS001-6817	KD	SULT1A1	Sulfotransferases, cytosolic, sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1			0.00, 0.00	1.20, 0.42	34.08	NaN	-51.58	34.36	-99.96	NaN	NaN	-20.31	47.74	19.83
CGS001-6799	KD	SULT1A2	Sulfotransferases, cytosolic, sulfotransferase family, cytosolic, 1A, phenol-preferring, member 2			50.00, 50.00	1.52, 0.45	-43.70	50.77	37.38	98.96	34.17	NaN	NaN	99.98	99.95	99.76
CGS001-6818	KD	SULT1A3	Sulfotransferases, cytosolic, sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3			0.00, 0.00	1.58, 0.49	-55.41	-99.60	-22.31	-99.01	27.36	17.75	71.75	-90.74	-80.66	-93.61
CGS001-6820	KD	SULT2B1	Sulfotransferases, cytosolic, sulfotransferase family, cytosolic, 2B, member 1			10.00, 10.00	1.34, 0.47	98.75	-63.11	-57.78	-32.08	-27.14	90.27	76.03	-38.94	-40.65	-12.81
CGS001-6821	KD	SUOX	sulfite oxidase			22.22, 11.11	1.68, 0.45	-22.25	-72.79	37.69	93.19	66.69	NaN	99.90	95.76	-26.67	91.52
CGS001-11198	KD	SUPT16H	suppressor of Ty 16 homolog (S. cerevisiae)			0.00, 0.00	1.48, 0.36	-63.43	52.66	-16.92	NaN	-92.96	-99.94	-85.60	-95.91	29.66	-91.55
CGS001-6829	KD	SUPT5H	suppressor of Ty 5 homolog (S. cerevisiae)			0.00, 0.00	1.48, 0.56	-98.32	82.40	-99.83	-52.99	-99.98	71.68	-71.22	-98.40	24.37	-99.79
CGS001-6832	KD	SUPV3L1	suppressor of var1, 3-like 1 (S. cerevisiae)			0.00, 0.00	1.66, 0.47	-71.24	-30.32	-99.43	-37.36	38.21	-99.76	57.95	-97.96	-62.37	-85.50
CGS001-23512	KD	SUZ12	Zinc fingers, C2H2-type, suppressor of zeste 12 homolog (Drosophila)			0.00, 0.00	1.47, 0.43	54.60	NaN	-84.29	NaN	-34.39	NaN	54.56	-99.92	-32.67	-63.25
CGS001-9900	KD	SV2A	Major facilitator superfamily (MFS) of transporters, synaptic vesicle glycoprotein 2A			0.00, 0.00	1.33, 0.33	-59.63	20.19	-96.80	-32.60	-93.08	NaN	-30.41	-83.61	27.48	-82.30
CGS001-23075	KD	SWAP70	EF-hand domain containing, SWAP switching B-cell complex 70kDa subunit			0.00, 0.00	0.94, 0.24	25.46	36.51	-42.35	-83.43	-99.40	-99.94	-50.55	-84.11	24.84	-80.16
CGS001-25949	KD	SYF2	SYF2 homolog, RNA splicing factor (S. cerevisiae)			0.00, 0.00	1.70, 0.50	21.41	51.10	-69.07	44.69	NaN	NaN	36.73	-38.58	-89.53	-20.05
CGS001-23224	KD	SYNE2	spectrin repeat containing, nuclear envelope 2			11.11, 11.11	1.16, 0.28	38.17	64.62	20.18	-68.61	97.68	NaN	-78.37	-19.63	-76.00	-35.30
CGS001-9143	KD	SYNGR3	synaptogyrin 3			0.00, 0.00	2.18, 0.68	NaN	NaN	-51.58	-40.82	NaN	NaN	-95.19	-44.33	22.07	-19.66
CGS001-6856	KD	SYPL1	synaptophysin-like 1			10.00, 10.00	1.83, 0.53	33.44	22.38	-29.36	68.20	-89.27	97.73	-55.33	-42.15	-33.35	-28.92
CGS001-134864	KD	TAAR1	GPCR / Class A : Trace amine associated receptors, trace amine associated receptor 1			10.00, 10.00	1.66, 0.50	-36.55	56.43	99.88	44.18	44.27	-46.46	76.94	41.24	42.85	51.81
CGS001-319100	KD	TAAR6	GPCR / Class A : Trace amine associated receptors, trace amine associated receptor 6		Trace amine receptors LOF	0.00, 0.00	1.10, 0.28	-34.15	-21.57	58.95	-30.39	77.59	NaN	NaN	52.65	34.77	41.47
CGS001-83551	KD	TAAR8	GPCR / Class A : Trace amine associated receptors, trace amine associated receptor 8		Trace amine receptors LOF	0.00, 0.00	1.53, 0.48	13.33	-16.39	-31.52	33.74	26.08	-72.10	NaN	-21.22	-23.28	-4.23
CGS001-23118	KD	TAB2	TGF-beta activated kinase 1/MAP3K7 binding protein 2		Zinc fingers RanBP2 type LOF	0.00, 0.00	1.40, 0.38	-99.94	-100.00	-89.79	35.85	31.99	61.77	-98.01	-96.05	-22.00	-98.97
CGS001-257397	KD	TAB3	TGF-beta activated kinase 1/MAP3K7 binding protein 3		Zinc fingers RanBP2 type LOF	0.00, 0.00	1.57, 0.41	-32.35	63.70	-41.63	-95.71	50.74	66.12	-28.85	-41.86	48.22	27.63
CGS001-10460	KD	TACC3	transforming, acidic coiled-coil containing protein 3			0.00, 0.00	1.77, 0.48	-29.41	37.98	-98.97	33.88	-62.70	NaN	-84.39	-20.39	30.87	-26.33
CGS001-6871	KD	TADA2A	transcriptional adaptor 2A			0.00, 0.00	1.23, 0.28	-29.64	-16.70	-42.97	-26.55	-99.98	-98.41	-34.07	-97.12	-33.02	-62.25
CGS001-10474	KD	TADA3	transcriptional adaptor 3			0.00, 0.00	1.92, 0.65	-42.50	23.67	48.77	70.95	53.14	-31.09	19.35	72.54	14.04	35.19
CGS001-6883	KD	TAF12	TAF12 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 20kDa			22.22, 11.11	1.60, 0.40	-31.30	99.93	23.53	24.10	60.18	NaN	-38.49	25.94	97.41	32.15
CGS001-6884	KD	TAF13	TAF13 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 18kDa			10.00, 10.00	1.55, 0.49	-46.82	-40.21	-60.79	-37.87	31.65	93.24	99.98	-34.89	-41.23	-23.76
CGS001-8148	KD	TAF15	RNA binding motif (RRM) containing, TAF15 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 68kDa			44.44, 33.33	1.23, 0.43	83.94	39.51	10.44	96.73	-49.80	NaN	99.87	85.37	99.81	98.76
CGS001-27097	KD	TAF5L	WD repeat domain containing, TAF5-like RNA polymerase II, p300/CBP-associated factor (PCAF)-associated factor, 65kDa			0.00, 0.00	0.93, 0.24	-62.42	-55.50	-96.90	-39.89	-32.53	38.27	28.54	84.74	75.41	-36.89
CGS001-129685	KD	TAF8	TAF8 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 43kDa			0.00, 0.00	1.32, 0.43	-22.45	-89.37	17.97	61.51	-34.68	NaN	30.93	25.82	NaN	5.84
CGS001-117289	KD	TAGAP	Rho GTPase activating proteins, T-cell activation RhoGTPase activating protein		Rho GTPase activating proteins LOF	0.00, 0.00	1.44, 0.53	37.85	NaN	-20.95	-94.69	-21.18	84.43	93.00	-97.06	24.86	9.76
CGS001-6886	KD	TAL1	Basic helix-loop-helix proteins, T-cell acute lymphocytic leukemia 1			0.00, 0.00	1.41, 0.36	-16.39	NaN	71.38	80.65	53.90	NaN	-33.72	-35.89	-32.60	70.18
CGS001-6887	KD	TAL2	Basic helix-loop-helix proteins, T-cell acute lymphocytic leukemia 2			11.11, 11.11	1.31, 0.40	31.44	99.70	-59.75	50.38	80.79	NaN	64.60	-58.07	42.78	46.25
CGS001-10010	KD	TANK	TRAF family member-associated NFKB activator			0.00, 0.00	1.35, 0.42	-60.89	-99.43	-91.60	-31.93	46.32	NaN	90.19	-95.53	18.16	-84.62
CGS001-9344	KD	TAOK2	TAO subfamily, TAO kinase 2			37.50, 25.00	1.58, 0.43	NaN	27.59	-38.74	98.96	97.80	NaN	52.25	80.73	69.84	96.32
CGS001-51347	KD	TAOK3	TAO subfamily, TAO kinase 3			0.00, 0.00	1.52, 0.48	-89.19	-99.93	-88.22	-99.88	-99.88	NaN	-81.89	-90.62	-33.94	-99.92
CGS001-6890	KD	TAP1	ATP binding cassette transporters / subfamily B, transporter 1, ATP-binding cassette, sub-family B (MDR/TAP)			11.11, 11.11	1.64, 0.61	-20.04	99.43	-44.69	71.35	27.16	-96.14	37.18	-44.66	NaN	40.86
CGS001-6894	KD	TARBP1	TAR (HIV-1) RNA binding protein 1			55.56, 55.56	1.03, 0.35	27.69	98.81	99.17	99.95	56.84	NaN	-58.63	98.37	-42.00	99.89
CGS001-6895	KD	TARBP2	TAR (HIV-1) RNA binding protein 2			10.00, 10.00	0.81, 0.24	71.26	35.66	-98.37	27.28	45.92	-25.00	98.76	-37.02	37.00	23.07
CGS001-23435	KD	TARDBP	RNA binding motif (RRM) containing, TAR DNA binding protein			0.00, 0.00	1.67, 0.55	-99.84	-100.00	-99.81	31.47	74.47	-74.38	-81.46	-36.60	-39.96	-97.27
CGS001-6897	KD	TARS	Aminoacyl tRNA synthetases / Class II, threonyl-tRNA synthetase			0.00, 0.00	0.86, 0.18	-96.57	-99.26	-97.99	-37.41	-55.65	NaN	-85.44	-39.51	-93.64	-97.63
CGS001-55617	KD	TASP1	Glycosylasparaginase precursor, taspase, threonine aspartase, 1			0.00, 0.00	1.75, 0.63	-93.30	53.45	33.07	-57.98	-96.43	-62.77	93.31	80.26	NaN	-30.61
CGS001-9797	KD	TATDN2	TatD DNase domain containing 2			0.00, 0.00	0.98, 0.33	-95.22	64.53	-99.38	-36.46	58.64	34.32	52.42	65.24	49.52	40.06
CGS001-64786	KD	TBC1D15	TBC1 domain family, member 15			12.50, 12.50	1.67, 0.34	NaN	NaN	26.57	-97.46	-86.30	-31.35	97.53	33.58	-98.71	-98.95
CGS001-23102	KD	TBC1D2B	TBC1 domain family, member 2B			0.00, 0.00	1.17, 0.31	28.72	-65.94	84.84	44.62	-47.46	-34.55	23.58	-26.35	26.19	7.87
CGS001-23061	KD	TBC1D9B	EF-hand domain containing, TBC1 domain family, member 9B (with GRAM domain)			50.00, 30.00	1.65, 0.48	9.15	95.04	95.21	98.38	44.44	98.89	22.32	44.16	-22.54	98.90
CGS001-1155	KD	TBCB	tubulin folding cofactor B			11.11, 11.11	1.40, 0.52	57.91	NaN	-61.20	-40.87	41.42	75.42	-96.44	36.21	99.66	46.23
CGS001-29110	KD	TBK1	IKK family, TANK-binding kinase 1			0.00, 0.00	0.99, 0.26	71.12	21.96	15.14	26.81	-22.76	53.09	50.52	-25.02	41.51	22.90
CGS001-10607	KD	TBL3	WD repeat domain containing, transducin (beta)-like 3			11.11, 0.00	1.11, 0.32	-21.97	95.84	-78.99	27.24	-29.36	54.64	NaN	-83.53	-84.08	-48.65
CGS001-6908	KD	TBP	General transcription factors, TATA box binding protein			12.50, 12.50	2.24, 0.83	-99.96	97.90	40.77	62.72	-21.27	NaN	NaN	92.60	44.07	90.39
CGS001-9519	KD	TBPL1	TBP-like 1			0.00, 0.00	1.24, 0.33	80.37	-26.91	19.03	26.33	22.89	NaN	-76.04	-87.20	35.05	7.19
CGS001-6909	KD	TBX2	T-boxes, T-box 2			0.00, 0.00	1.31, 0.50	-97.59	-99.28	-54.39	-99.08	38.66	NaN	-50.97	-99.42	-34.62	-99.42
CGS001-57057	KD	TBX20	T-boxes, T-box 20			11.11, 11.11	1.25, 0.40	39.37	29.46	-55.48	-25.38	98.86	-97.97	NaN	-99.42	27.07	-28.15
CGS001-6926	KD	TBX3	T-boxes, T-box 3			12.50, 12.50	1.38, 0.43	72.15	NaN	-45.54	63.23	-39.68	NaN	-35.86	98.19	94.31	73.34
CGS001-6915	KD	TBXA2R	GPCR / Class A : Prostanoid receptors, thromboxane A2 receptor			20.00, 20.00	1.50, 0.59	-58.64	-96.13	99.81	44.87	99.96	56.35	53.97	90.77	-64.78	81.37
CGS001-6917	KD	TCEA1	General transcription factors, transcription elongation factor A (SII), 1			0.00, 0.00	1.16, 0.35	-95.94	NaN	-61.08	28.06	-33.15	NaN	22.20	24.17	-99.45	-55.86
CGS001-6919	KD	TCEA2	transcription elongation factor A (SII), 2			0.00, 0.00	1.52, 0.43	-61.72	19.99	-91.64	-99.41	-24.71	NaN	-29.09	-43.46	21.78	-31.29
CGS001-79921	KD	TCEAL4	transcription elongation factor A (SII)-like 4			0.00, 0.00	1.60, 0.42	NaN	NaN	19.75	67.55	79.97	NaN	82.04	34.31	-50.27	54.56
CGS001-6924	KD	TCEB3	transcription elongation factor B (SIII), polypeptide 3 (110kDa, elongin A)			0.00, 0.00	1.02, 0.26	77.32	-55.05	14.68	55.75	-39.05	NaN	NaN	-94.97	-48.28	-25.85
CGS001-162699	KD	TCEB3C	transcription elongation factor B polypeptide 3C (elongin A3)			0.00, 0.00	1.57, 0.43	-96.41	-88.34	-95.00	-31.70	-46.97	-82.39	-88.39	-32.43	-97.35	-98.16
CGS001-10915	KD	TCERG1	transcription elongation regulator 1			11.11, 11.11	1.20, 0.30	-40.36	-37.59	-94.43	-24.44	-97.46	NaN	42.14	73.40	99.80	-29.38
CGS001-6938	KD	TCF12	Basic helix-loop-helix proteins, transcription factor 12			22.22, 22.22	0.99, 0.27	94.57	NaN	99.78	99.57	51.80	26.46	-26.53	-38.66	-27.33	88.16
CGS001-6929	KD	TCF3	Basic helix-loop-helix proteins, transcription factor 3 (E2A immunoglobulin enhancer binding factors E12/E47)			0.00, 0.00	1.35, 0.51	34.26	-99.52	74.03	22.19	21.50	NaN	-51.69	11.76	-86.16	-9.87
CGS001-6925	KD	TCF4	Basic helix-loop-helix proteins, transcription factor 4			12.50, 0.00	2.50, 0.69	74.11	78.37	33.66	96.50	27.96	NaN	-20.32	86.56	NaN	78.03
CGS001-6932	KD	TCF7	transcription factor 7 (T-cell specific, HMG-box)			12.50, 12.50	1.40, 0.50	-37.70	98.60	-28.69	-23.56	27.14	NaN	49.01	-19.65	NaN	10.58
CGS001-83439	KD	TCF7L1	transcription factor 7-like 1 (T-cell specific, HMG-box)			11.11, 0.00	2.24, 0.70	31.99	-22.39	91.75	22.65	25.12	NaN	97.04	49.39	44.39	34.50
CGS001-6934	KD	TCF7L2	transcription factor 7-like 2 (T-cell specific, HMG-box)			11.11, 11.11	1.07, 0.41	-76.30	-31.13	-60.63	79.67	-32.79	NaN	-40.75	99.77	31.85	-20.65
CGS001-10732	KD	TCFL5	Basic helix-loop-helix proteins, transcription factor-like 5 (basic helix-loop-helix)			0.00, 0.00	1.55, 0.55	45.42	-53.85	28.83	-90.30	65.09	38.45	-68.51	-94.33	20.72	-61.48
CGS001-10312	KD	TCIRG1	ATPases / V-type, T-cell, immune regulator 1, ATPase, H+ transporting, lysosomal V0 subunit A3			0.00, 0.00	1.36, 0.41	-36.68	-29.91	-55.15	-99.96	-20.55	24.96	-41.69	-20.49	48.01	-11.33
CGS001-6988	KD	TCTA	T-cell leukemia translocation altered gene			0.00, 0.00	1.88, 0.56	-50.06	NaN	26.14	-52.90	-34.89	NaN	-33.78	37.21	-98.65	-32.88
CGS001-79600	KD	TCTN1	Tectonic proteins, tectonic family member 1			14.29, 0.00	1.61, 0.53	NaN	NaN	45.09	96.58	-99.96	-37.60	NaN	-99.58	32.27	-88.67
CGS001-81550	KD	TDRD3	Tudor domain containing, tudor domain containing 3			0.00, 0.00	1.66, 0.50	94.28	-27.52	29.79	-96.43	-93.58	NaN	NaN	-83.68	-99.86	-93.94
CGS001-122402	KD	TDRD9	Tudor domain containing, tudor domain containing 9			11.11, 11.11	1.75, 0.47	-27.16	89.01	22.75	-32.37	-27.96	-99.61	-31.54	99.50	NaN	-12.63
CGS001-7003	KD	TEAD1	TEA domain family member 1 (SV40 transcriptional enhancer factor)			12.50, 12.50	2.01, 0.56	-45.71	99.96	85.90	71.42	-38.00	-23.09	NaN	49.57	NaN	52.32
CGS001-8463	KD	TEAD2	TEA domain family member 2			0.00, 0.00	1.26, 0.35	-41.84	-56.32	-60.83	26.56	60.64	NaN	91.51	-59.23	-38.84	-31.88
CGS001-7004	KD	TEAD4	TEA domain family member 4			0.00, 0.00	1.25, 0.52	-20.99	-95.78	-96.93	29.13	26.47	NaN	-25.47	-46.34	-99.56	-94.22
CGS001-7010	KD	TEK	Type XII RTKs: TIE family of angiopoietin receptors, TEK tyrosine kinase, endothelial			0.00, 0.00	1.06, 0.35	-95.08	-25.58	-97.24	-96.93	-47.92	NaN	-50.79	-92.77	26.72	-94.45
CGS001-7013	KD	TERF1	telomeric repeat binding factor (NIMA-interacting) 1			0.00, 0.00	1.10, 0.17	-67.27	-97.88	14.81	-33.71	-30.36	-97.79	-97.96	-89.55	-98.57	-96.63
CGS001-54386	KD	TERF2IP	telomeric repeat binding factor 2, interacting protein			0.00, 0.00	0.95, 0.15	51.70	38.05	-75.50	-21.94	-69.99	21.38	-99.93	-99.84	77.54	-74.96
CGS001-26136	KD	TES	testis derived transcript (3 LIM domains)			57.14, 57.14	1.95, 0.78	-90.78	NaN	-38.89	99.72	99.38	NaN	NaN	84.11	99.10	99.79
CGS001-7016	KD	TESK1	TESK subfamily, testis-specific kinase 1			10.00, 10.00	1.10, 0.22	-84.73	-50.36	-25.16	98.21	42.90	-81.60	-97.00	-62.98	-99.97	-91.90
CGS001-54881	KD	TEX10	testis expressed 10			0.00, 0.00	1.30, 0.43	NaN	87.00	-75.99	74.87	32.70	-43.69	55.03	-52.71	-81.09	66.89
CGS001-7018	KD	TF	transferrin			0.00, 0.00	1.82, 0.44	12.65	58.37	58.43	-28.31	89.15	-24.12	-48.67	NaN	NaN	35.02
CGS001-7020	KD	TFAP2A	transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha)			40.00, 40.00	1.35, 0.45	-16.11	-100.00	92.54	99.45	99.95	36.61	-83.00	-92.17	99.21	99.11
CGS001-7023	KD	TFAP4	Basic helix-loop-helix proteins, transcription factor AP-4 (activating enhancer binding protein 4)			10.00, 10.00	1.74, 0.50	39.66	37.13	92.30	41.05	43.44	-67.94	68.68	39.75	99.53	56.08
CGS001-7024	KD	TFCP2	transcription factor CP2			0.00, 0.00	0.91, 0.35	89.48	-86.29	-74.81	16.62	-99.96	NaN	-29.77	-65.86	30.12	-79.93
CGS001-7027	KD	TFDP1	transcription factor Dp-1			0.00, 0.00	0.98, 0.30	-16.06	NaN	-95.33	49.55	-46.45	NaN	-94.62	45.19	-69.04	-83.29
CGS001-7030	KD	TFE3	Basic helix-loop-helix proteins, transcription factor binding to IGHM enhancer 3			0.00, 0.00	1.35, 0.51	-11.54	-100.00	-34.66	30.40	83.78	NaN	NaN	-97.05	-97.56	-99.37
CGS001-7031	KD	TFF1	trefoil factor 1			12.50, 0.00	0.93, 0.27	67.31	NaN	-29.65	-33.57	-33.69	NaN	95.95	58.78	28.74	39.74
CGS001-7032	KD	TFF2	trefoil factor 2			55.56, 44.44	1.97, 0.56	94.25	24.94	97.42	99.68	99.81	NaN	24.47	92.12	99.11	99.61
CGS001-10342	KD	TFG	TRK-fused gene			25.00, 12.50	1.36, 0.39	-71.98	NaN	-51.38	99.90	-65.57	NaN	-45.77	96.22	79.98	90.16
CGS001-7035	KD	TFPI	tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)			0.00, 0.00	1.23, 0.40	-64.37	NaN	46.14	67.95	-95.98	-30.66	92.79	-99.20	20.65	-49.73
CGS001-7037	KD	TFRC	CD molecules, transferrin receptor (p90, CD71)			0.00, 0.00	1.00, 0.31	85.79	-26.22	-36.96	85.76	88.99	NaN	-92.07	-96.42	68.79	70.28
CGS001-23483	KD	TGDS	Short chain dehydrogenase/reductase superfamily / Extended SDR fold, TDP-glucose 4,6-dehydratase			0.00, 0.00	1.28, 0.30	-99.88	-99.67	-98.84	-95.63	-99.49	-98.10	-23.17	-86.41	-42.27	-99.92
CGS001-7039	KD	TGFA	transforming growth factor, alpha			10.00, 10.00	1.39, 0.43	-99.06	-39.96	-96.86	15.08	-59.99	-74.25	-26.80	-82.27	97.77	-54.19
CGS001-7040	KD	TGFB1	Endogenous ligands, transforming growth factor, beta 1			22.22, 22.22	0.97, 0.32	99.56	NaN	-69.13	-60.89	75.07	-98.23	-58.19	49.29	98.57	75.17
CGS001-7046	KD	TGFBR1	Type I receptor serine/threonine kinases, transforming growth factor, beta receptor 1			10.00, 0.00	1.17, 0.39	-30.95	86.40	-92.48	-98.20	96.28	-48.62	-25.32	-93.71	85.15	-74.41
CGS001-7048	KD	TGFBR2	Type II receptor serine/threonine kinases, transforming growth factor, beta receptor II (70/80kDa)			0.00, 0.00	0.68, 0.18	-12.86	16.87	65.06	24.22	70.25	38.08	-64.00	-27.04	19.85	3.78
CGS001-90655	KD	TGIF2LY	Homeoboxes / TALE class, TGFB-induced factor homeobox 2-like, Y-linked			12.50, 12.50	1.73, 0.69	-75.74	-26.33	-38.83	45.71	-49.34	NaN	-35.37	99.77	NaN	-37.48
CGS001-7052	KD	TGM2	Transglutaminases, transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase)			0.00, 0.00	1.67, 0.56	-64.07	16.70	35.72	86.78	-43.78	NaN	68.16	28.04	-55.95	13.78
CGS001-7054	KD	TH	Amino acid hydroxylases, tyrosine hydroxylase			0.00, 0.00	1.24, 0.34	21.44	-77.47	23.41	-30.43	54.33	-93.98	-40.21	30.94	-42.70	-10.24
CGS001-63892	KD	THADA	thyroid adenoma associated			0.00, 0.00	0.93, 0.36	-61.63	-38.92	63.59	20.39	-25.12	-85.45	-98.80	16.31	37.27	-13.47
CGS001-57215	KD	THAP11	THAP (C2CH-type zinc finger) domain containing, THAP domain containing 11			0.00, 0.00	1.78, 0.58	-17.86	-61.46	-99.81	-59.79	-98.92	NaN	-34.99	-77.81	-40.20	-62.21
CGS001-7056	KD	THBD	CD molecules, thrombomodulin			10.00, 10.00	1.03, 0.23	-81.82	34.03	60.27	45.93	28.73	-27.27	99.22	-69.82	30.99	23.27
CGS001-7057	KD	THBS1	thrombospondin 1			20.00, 20.00	0.98, 0.26	41.63	100.00	26.96	-84.16	-24.24	22.56	-23.08	99.90	-15.18	3.58
CGS001-7074	KD	TIAM1	Rho guanine nucleotide exchange factors, T-cell lymphoma invasion and metastasis 1			0.00, 0.00	0.83, 0.30	-98.67	41.44	-46.30	-94.23	-60.84	-84.18	-99.96	-98.72	24.56	-96.93
CGS001-8914	KD	TIMELESS	timeless homolog (Drosophila)			0.00, 0.00	1.55, 0.58	NaN	NaN	-96.36	40.04	25.26	-65.62	41.96	-80.36	-99.16	-82.70
CGS001-10245	KD	TIMM17B	translocase of inner mitochondrial membrane 17 homolog B (yeast)			0.00, 0.00	2.48, 0.90	71.49	NaN	55.22	94.98	70.67	NaN	NaN	86.53	24.78	86.46
CGS001-29928	KD	TIMM22	translocase of inner mitochondrial membrane 22 homolog (yeast)			14.29, 14.29	2.18, 0.86	-97.63	NaN	-66.64	98.26	-32.78	NaN	NaN	64.60	15.60	-31.61
CGS001-92609	KD	TIMM50	Serine/threonine phosphatases / CTD aspartate-based phosphatases, translocase of inner mitochondrial membrane 50 homolog (S. cerevisiae)			0.00, 0.00	1.48, 0.53	39.04	33.22	91.47	72.38	-33.10	78.46	94.85	-69.84	NaN	85.94
CGS001-26520	KD	TIMM9	translocase of inner mitochondrial membrane 9 homolog (yeast)			0.00, 0.00	1.89, 0.61	NaN	-28.03	-26.80	60.51	-98.16	NaN	-65.52	-38.98	32.96	-22.26
CGS001-7076	KD	TIMP1	TIMP metallopeptidase inhibitor 1			44.44, 33.33	1.15, 0.36	88.34	96.83	-44.72	99.73	-75.57	NaN	-99.81	37.61	99.84	99.84
CGS001-7077	KD	TIMP2	TIMP metallopeptidase inhibitor 2			10.00, 10.00	0.99, 0.31	99.94	-78.95	-28.51	-64.02	30.95	-87.71	49.98	-98.53	-50.85	-79.93
CGS001-7078	KD	TIMP3	TIMP metallopeptidase inhibitor 3			0.00, 0.00	1.26, 0.38	-33.35	51.71	20.82	-23.16	74.94	27.90	-69.20	37.71	-99.85	11.40
CGS001-7079	KD	TIMP4	TIMP metallopeptidase inhibitor 4			11.11, 0.00	1.35, 0.44	-87.18	-51.09	25.27	95.56	-98.70	68.69	70.46	-99.92	NaN	-91.15
CGS001-26277	KD	TINF2	TERF1 (TRF1)-interacting nuclear factor 2			10.00, 10.00	1.11, 0.23	19.59	27.04	76.78	54.54	-33.91	99.94	-36.52	-72.16	31.43	33.45
CGS001-25976	KD	TIPARP	Poly (ADP-ribose) polymerases, TCDD-inducible poly(ADP-ribose) polymerase			0.00, 0.00	1.34, 0.31	-70.96	-63.16	-71.26	23.39	-22.79	-86.67	-99.66	-49.93	26.63	-57.24
CGS001-114609	KD	TIRAP	toll-interleukin 1 receptor (TIR) domain containing adaptor protein			10.00, 10.00	0.85, 0.22	-34.39	25.02	98.66	-27.20	28.89	93.18	69.70	77.01	57.08	76.05
CGS001-7082	KD	TJP1	tight junction protein 1 (zona occludens 1)			11.11, 0.00	1.16, 0.28	-69.96	NaN	-21.72	96.04	37.15	-44.95	94.15	25.34	60.54	48.24
CGS001-7086	KD	TKT	transketolase			0.00, 0.00	1.58, 0.50	-85.14	36.18	85.98	-9.24	90.22	-59.54	-56.55	45.89	NaN	20.82
CGS001-7088	KD	TLE1	WD repeat domain containing, transducin-like enhancer of split 1 (E(sp1) homolog, Drosophila)			0.00, 0.00	1.06, 0.28	77.71	-25.97	-47.76	-19.06	23.19	22.36	-87.96	-14.67	45.94	4.22
CGS001-7089	KD	TLE2	WD repeat domain containing, transducin-like enhancer of split 2 (E(sp1) homolog, Drosophila)			11.11, 11.11	1.60, 0.44	-23.99	100.00	-29.30	33.62	-34.82	-23.65	NaN	-48.46	-67.57	-18.53
CGS001-7090	KD	TLE3	WD repeat domain containing, transducin-like enhancer of split 3 (E(sp1) homolog, Drosophila)			10.00, 10.00	1.15, 0.44	-96.61	-87.84	-94.45	-99.95	98.09	70.69	-28.19	-38.93	36.54	-97.37
CGS001-11011	KD	TLK2	Tousled-like kinase (TLK) family, tousled-like kinase 2			10.00, 0.00	2.64, 0.76	82.74	25.46	92.73	-28.32	65.54	-25.68	97.21	-90.00	-57.22	65.29
CGS001-7097	KD	TLR2	Toll-like receptor family, toll-like receptor 2		Toll like receptors LOF	0.00, 0.00	1.15, 0.43	-47.51	73.15	-90.39	-99.85	35.53	62.26	NaN	-13.83	-69.03	-51.82
CGS001-7099	KD	TLR4	Toll-like receptor family, toll-like receptor 4		Toll like receptors LOF	20.00, 20.00	1.24, 0.44	22.37	-24.98	51.16	99.52	99.72	83.36	64.35	-49.64	88.85	71.60
CGS001-51284	KD	TLR7	Toll-like receptor family, toll-like receptor 7			0.00, 0.00	0.86, 0.23	86.61	53.77	-38.71	18.89	-21.21	NaN	-93.62	-82.71	70.73	33.73
CGS001-51311	KD	TLR8	Toll-like receptor family, toll-like receptor 8			14.29, 14.29	1.38, 0.48	-61.65	NaN	-22.91	-81.23	79.67	NaN	NaN	99.43	-94.77	-70.86
CGS001-7108	KD	TM7SF2	transmembrane 7 superfamily member 2			0.00, 0.00	1.28, 0.43	58.27	NaN	50.19	-30.15	-43.81	NaN	52.52	20.53	94.59	49.25
CGS001-9375	KD	TM9SF2	transmembrane 9 superfamily member 2			10.00, 10.00	1.22, 0.44	-16.77	-62.73	-96.77	43.52	86.26	-99.93	-65.98	-73.49	98.55	-72.34
CGS001-56889	KD	TM9SF3	transmembrane 9 superfamily member 3			0.00, 0.00	0.99, 0.31	-62.69	-56.85	-99.80	-98.68	-87.86	-21.65	-73.18	-91.21	-46.36	-96.17
CGS001-54499	KD	TMCO1	transmembrane and coiled-coil domains 1			0.00, 0.00	1.91, 0.59	-75.29	NaN	-96.68	-47.77	-92.55	-89.59	NaN	89.91	-27.57	-93.05
CGS001-10972	KD	TMED10	transmembrane emp24-like trafficking protein 10 (yeast)			0.00, 0.00	1.63, 0.44	-81.02	-99.10	-98.44	-49.45	67.04	-97.55	-89.59	-82.60	16.09	-92.27
CGS001-51014	KD	TMED7	transmembrane emp24 protein transport domain containing 7			10.00, 10.00	0.94, 0.28	-51.66	64.76	33.28	-34.60	99.96	58.27	-21.21	36.03	61.11	37.79
CGS001-54732	KD	TMED9	transmembrane emp24 protein transport domain containing 9			0.00, 0.00	2.31, 0.61	27.91	31.80	91.79	-96.59	54.51	NaN	-23.15	78.93	-48.81	39.54
CGS001-79073	KD	TMEM109	transmembrane protein 109			0.00, 0.00	1.57, 0.49	NaN	44.26	-99.86	41.28	19.58	-66.09	-75.48	-89.31	31.55	-81.57
CGS001-8834	KD	TMEM11	transmembrane protein 11			11.11, 11.11	1.26, 0.34	-31.64	-26.30	-21.59	85.83	-22.57	NaN	27.69	21.93	99.81	6.61
CGS001-375346	KD	TMEM110	transmembrane protein 110			0.00, 0.00	1.72, 0.53	44.68	NaN	66.99	37.60	-33.66	NaN	NaN	-85.49	25.52	10.72
CGS001-55654	KD	TMEM127	transmembrane protein 127			16.67, 16.67	3.33, 1.26	NaN	NaN	-96.14	77.07	-99.23	NaN	NaN	59.21	98.61	62.83
CGS001-201799	KD	TMEM154	transmembrane protein 154			0.00, 0.00	1.31, 0.34	-97.54	NaN	-15.11	-47.53	-23.61	NaN	-27.21	-44.07	-21.55	-16.08
CGS001-23670	KD	TMEM2	transmembrane protein 2			0.00, 0.00	1.39, 0.31	-48.63	-100.00	-94.32	-85.03	91.22	-93.62	-97.73	-87.42	-20.49	-93.57
CGS001-10329	KD	TMEM5	transmembrane protein 5			11.11, 0.00	2.14, 0.56	NaN	-49.09	-25.29	-97.80	38.31	-98.03	-24.07	-87.76	97.05	-74.97
CGS001-23585	KD	TMEM50A	transmembrane protein 50A			22.22, 22.22	1.80, 0.63	NaN	25.34	-96.20	99.19	-41.77	30.96	52.64	97.82	-40.86	42.47
CGS001-27346	KD	TMEM97	transmembrane protein 97			0.00, 0.00	2.49, 0.78	-53.89	NaN	15.19	-96.85	-29.76	NaN	NaN	-53.20	50.21	-37.09
CGS001-7124	KD	TNF	Tumor necrosis factor (ligand) superfamily, tumor necrosis factor			0.00, 0.00	1.89, 0.41	11.63	-30.17	35.39	85.21	-23.08	77.98	NaN	27.91	-51.17	14.05
CGS001-7126	KD	TNFAIP1	BTB/POZ domain containing, tumor necrosis factor, alpha-induced protein 1 (endothelial)			11.11, 0.00	1.24, 0.39	97.14	NaN	-26.07	-30.10	62.32	88.45	-79.94	-73.86	65.57	70.00
CGS001-7128	KD	TNFAIP3	OTU domain containing, tumor necrosis factor, alpha-induced protein 3			10.00, 10.00	1.26, 0.36	-38.31	-67.91	-71.66	-99.07	99.82	-37.30	43.91	-25.60	94.56	-41.61
CGS001-8797	KD	TNFRSF10A	Tumour necrosis factor (TNF) receptor family, tumor necrosis factor receptor superfamily, member 10a			11.11, 0.00	1.05, 0.33	58.48	73.17	-20.56	-89.45	48.54	NaN	26.34	95.89	-34.68	29.46
CGS001-8795	KD	TNFRSF10B	Tumour necrosis factor (TNF) receptor family, tumor necrosis factor receptor superfamily, member 10b			0.00, 0.00	1.10, 0.34	-93.20	NaN	48.84	-80.58	-22.60	NaN	NaN	21.98	40.88	-23.07
CGS001-8792	KD	TNFRSF11A	Tumour necrosis factor (TNF) receptor family, tumor necrosis factor receptor superfamily, member 11a, NFKB activator			11.11, 11.11	1.85, 0.52	-87.82	100.00	23.58	-30.43	-45.90	-99.48	-31.29	-64.48	NaN	-49.27
CGS001-115650	KD	TNFRSF13C	Tumour necrosis factor (TNF) receptor family, tumor necrosis factor receptor superfamily, member 13C			0.00, 0.00	1.58, 0.30	-23.52	-45.66	-98.30	-52.43	-97.74	NaN	-23.46	-79.46	89.24	-89.96
CGS001-8764	KD	TNFRSF14	Tumour necrosis factor (TNF) receptor family, tumor necrosis factor receptor superfamily, member 14			0.00, 0.00	1.51, 0.38	-57.16	-99.96	-83.03	79.19	61.96	NaN	NaN	-24.55	64.14	46.38
CGS001-8784	KD	TNFRSF18	Tumour necrosis factor (TNF) receptor family, tumor necrosis factor receptor superfamily, member 18			0.00, 0.00	1.74, 0.60	-37.30	88.45	33.53	-93.63	33.95	-63.58	-99.09	-94.08	72.10	-67.52
CGS001-55504	KD	TNFRSF19	Tumour necrosis factor (TNF) receptor family, tumor necrosis factor receptor superfamily, member 19			11.11, 0.00	1.41, 0.38	-25.40	82.48	97.28	42.62	79.74	40.30	39.87	NaN	23.19	53.45
CGS001-7132	KD	TNFRSF1A	Tumour necrosis factor (TNF) receptor family, tumor necrosis factor receptor superfamily, member 1A			12.50, 12.50	1.34, 0.39	43.04	NaN	-38.49	99.28	64.52	NaN	70.18	88.41	81.71	92.94
CGS001-27242	KD	TNFRSF21	Tumour necrosis factor (TNF) receptor family, tumor necrosis factor receptor superfamily, member 21			0.00, 0.00	1.14, 0.24	-98.78	-17.98	-71.95	-27.68	45.44	-72.79	-76.10	-76.59	-55.17	-56.48
CGS001-8771	KD	TNFRSF6B	Tumour necrosis factor (TNF) receptor family, tumor necrosis factor receptor superfamily, member 6b, decoy			14.29, 14.29	1.70, 0.58	-31.22	NaN	35.28	NaN	-49.73	-99.42	-17.43	99.98	NaN	-24.69
CGS001-8743	KD	TNFSF10	CD molecules, tumor necrosis factor (ligand) superfamily, member 10			20.00, 0.00	1.89, 0.68	47.15	-56.76	96.93	94.48	23.98	27.87	-22.92	95.41	-30.22	75.24
CGS001-8741	KD	TNFSF13	CD molecules, tumor necrosis factor (ligand) superfamily, member 13			44.44, 44.44	1.41, 0.33	38.30	98.99	53.89	99.86	-29.55	-29.60	91.03	99.92	NaN	99.32
CGS001-9966	KD	TNFSF15	Tumor necrosis factor (ligand) superfamily, tumor necrosis factor (ligand) superfamily, member 15		Tumor necrosis factor superfamily LOF	11.11, 11.11	1.35, 0.53	-75.40	NaN	-68.99	-23.40	-87.29	-47.53	-55.10	-24.19	99.90	-48.51
CGS001-7292	KD	TNFSF4	CD molecules, tumor necrosis factor (ligand) superfamily, member 4		Tumor necrosis factor superfamily LOF	0.00, 0.00	1.41, 0.60	-97.92	-99.63	25.49	-98.30	-58.13	-49.59	-68.18	-59.03	64.32	-95.03
CGS001-944	KD	TNFSF8	CD molecules, tumor necrosis factor (ligand) superfamily, member 8		Tumor necrosis factor superfamily LOF	0.00, 0.00	0.75, 0.20	-56.22	-99.78	-80.49	-49.46	-47.04	-87.97	-85.66	-71.28	31.11	-79.57
CGS001-23043	KD	TNIK	MSN subfamily, TRAF2 and NCK interacting kinase			22.22, 11.11	1.49, 0.42	99.41	47.56	-25.33	65.46	36.66	NaN	76.52	97.45	76.67	83.79
CGS001-10318	KD	TNIP1	TNFAIP3 interacting protein 1			0.00, 0.00	1.67, 0.60	94.57	22.08	35.14	-28.13	-22.55	-99.97	-45.28	-29.48	23.70	-12.31
CGS001-80351	KD	TNKS2	Ankyrin repeat domain containing, tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase 2		Poly ADP ribose polymerases LOF	0.00, 0.00	1.26, 0.45	-50.88	NaN	-21.64	-90.51	-98.96	NaN	84.28	-77.15	-96.93	-95.29
CGS001-23534	KD	TNPO3	Importins, transportin 3			11.11, 11.11	1.92, 0.42	21.38	98.86	-26.25	25.24	86.05	NaN	78.95	-30.75	-82.90	72.84
CGS001-54472	KD	TOLLIP	toll interacting protein			0.00, 0.00	2.30, 0.52	-43.02	-60.46	-22.79	24.79	-33.76	NaN	94.09	NaN	63.18	-19.77
CGS001-56993	KD	TOMM22	translocase of outer mitochondrial membrane 22 homolog (yeast)			10.00, 10.00	1.10, 0.27	-16.83	-26.27	-31.21	97.69	73.22	-99.94	33.35	38.38	94.20	45.91
CGS001-10953	KD	TOMM34	Tetratricopeptide (TTC) repeat domain containing, translocase of outer mitochondrial membrane 34			0.00, 0.00	1.28, 0.30	-99.18	NaN	-99.46	-99.35	-47.96	-25.78	-26.74	-44.57	51.82	-99.61
CGS001-10452	KD	TOMM40	translocase of outer mitochondrial membrane 40 homolog (yeast)			0.00, 0.00	1.28, 0.44	-24.89	-24.03	27.74	33.05	89.73	-98.31	94.15	-34.28	NaN	7.87
CGS001-9868	KD	TOMM70A	Tetratricopeptide (TTC) repeat domain containing, translocase of outer mitochondrial membrane 70 homolog A (S. cerevisiae)			0.00, 0.00	1.38, 0.38	-63.47	61.46	-78.80	-28.82	83.49	NaN	92.41	-79.83	29.32	35.80
CGS001-7150	KD	TOP1	DNA Topoisomerases, topoisomerase (DNA) I			0.00, 0.00	1.15, 0.25	76.52	-22.88	-56.88	-56.68	26.01	NaN	-44.01	-79.91	17.21	-34.05
CGS001-7153	KD	TOP2A	DNA Topoisomerases, topoisomerase (DNA) II alpha 170kDa			10.00, 0.00	0.86, 0.25	-59.38	56.38	-32.27	-78.92	93.34	-31.13	-86.99	95.16	29.97	-24.16
CGS001-11073	KD	TOPBP1	topoisomerase (DNA) II binding protein 1			0.00, 0.00	1.69, 0.40	56.02	-25.44	-99.98	-99.98	-38.36	NaN	NaN	-95.03	-84.31	-99.11
CGS001-1861	KD	TOR1A	torsin family 1, member A (torsin A)			0.00, 0.00	2.38, 0.85	-23.09	-40.33	-35.66	66.11	88.74	NaN	NaN	-20.67	-99.12	-11.56
CGS001-84969	KD	TOX2	TOX high mobility group box family member 2			0.00, 0.00	1.97, 0.77	-37.88	-77.69	-91.65	33.26	-39.68	NaN	77.73	-59.22	-55.26	-46.52
CGS001-7157	KD	TP53	tumor protein p53			10.00, 10.00	1.07, 0.22	-82.05	64.20	-45.36	81.51	-99.15	36.06	-72.24	48.75	99.50	-54.63
CGS001-7158	KD	TP53BP1	tumor protein p53 binding protein 1			55.56, 55.56	1.41, 0.50	-78.95	NaN	55.13	99.45	-36.89	98.28	32.27	99.42	99.97	99.84
CGS001-7159	KD	TP53BP2	Ankyrin repeat domain containing, tumor protein p53 binding protein, 2			0.00, 0.00	1.00, 0.32	-13.53	29.58	-81.61	-32.93	-78.91	NaN	20.49	-94.03	-37.20	-69.44
CGS001-112858	KD	TP53RK	Bud32 family, TP53 regulating kinase			0.00, 0.00	0.91, 0.33	-21.96	-35.87	-43.29	84.23	-59.50	27.08	-71.04	43.01	NaN	-7.08
CGS001-11257	KD	TP53TG1	TP53 target 1 (non-protein coding)			37.50, 37.50	1.72, 0.35	NaN	53.10	92.57	99.44	99.86	NaN	62.05	81.05	-62.92	99.18
CGS001-7165	KD	TPD52L2	tumor protein D52-like 2			0.00, 0.00	1.91, 0.57	-83.01	-99.06	-29.63	-69.99	-32.88	-31.27	-26.16	-70.73	27.20	-53.73
CGS001-7168	KD	TPM1	Tropomyosins, tropomyosin 1 (alpha)			16.67, 16.67	2.21, 0.77	NaN	NaN	27.13	76.91	28.22	NaN	NaN	98.18	23.15	68.23
CGS001-7172	KD	TPMT	thiopurine S-methyltransferase			11.11, 11.11	1.28, 0.33	-93.99	46.68	57.53	58.41	-35.65	NaN	99.79	68.06	65.89	75.64
CGS001-7175	KD	TPR	translocated promoter region (to activated MET oncogene)			12.50, 0.00	1.43, 0.53	NaN	33.11	-95.19	-23.95	62.82	NaN	-50.99	95.60	27.67	22.26
CGS001-51002	KD	TPRKB	TP53RK binding protein			10.00, 10.00	0.72, 0.18	54.21	36.19	63.87	51.73	-96.06	46.55	-55.86	99.96	-87.43	44.77
CGS001-6434	KD	TRA2B	RNA binding motif (RRM) containing, transformer 2 beta homolog (Drosophila)			0.00, 0.00	2.02, 0.58	86.70	-56.70	76.56	NaN	-24.80	NaN	23.54	33.76	-38.30	27.14
CGS001-8717	KD	TRADD	TNFRSF1A-associated via death domain			0.00, 0.00	1.19, 0.45	-98.04	NaN	83.03	-30.95	-73.45	NaN	-58.41	-27.45	-99.92	-92.44
CGS001-7185	KD	TRAF1	TNF receptor-associated factor 1			0.00, 0.00	1.63, 0.45	-96.61	NaN	-99.94	-28.64	-99.87	-29.29	-21.74	-85.02	-53.06	-99.76
CGS001-7186	KD	TRAF2	RING-type (C3HC4) zinc fingers, TNF receptor-associated factor 2			10.00, 0.00	1.53, 0.35	-57.98	-62.84	-55.81	-80.31	48.91	-48.63	95.84	32.22	-99.97	-51.97
CGS001-7187	KD	TRAF3	TNF receptor-associated factor 3			11.11, 11.11	1.23, 0.31	19.24	-68.37	53.46	NaN	82.54	19.89	-17.29	99.52	48.82	39.72
CGS001-9618	KD	TRAF4	RING-type (C3HC4) zinc fingers, TNF receptor-associated factor 4			0.00, 0.00	1.72, 0.57	-32.15	34.70	-65.15	-95.81	-94.30	-32.74	-29.81	-19.64	NaN	-57.42
CGS001-7188	KD	TRAF5	RING-type (C3HC4) zinc fingers, TNF receptor-associated factor 5			0.00, 0.00	1.58, 0.55	-97.72	20.34	-27.76	-40.61	-43.65	61.45	NaN	-69.79	-24.36	-25.90
CGS001-7189	KD	TRAF6	RING-type (C3HC4) zinc fingers, TNF receptor-associated factor 6			0.00, 0.00	1.90, 0.60	-32.93	73.64	-32.97	-87.10	-78.07	-87.41	-21.34	-29.73	-95.32	-88.09
CGS001-84231	KD	TRAF7	RING-type (C3HC4) zinc fingers, TNF receptor-associated factor 7			40.00, 30.00	1.53, 0.55	97.29	-36.11	45.51	99.98	94.02	-55.76	90.59	39.67	99.23	99.13
CGS001-10906	KD	TRAFD1	TRAF-type zinc finger domain containing 1			0.00, 0.00	1.01, 0.36	54.34	-32.68	-41.52	65.93	71.37	NaN	51.30	-88.11	27.10	24.38
CGS001-66008	KD	TRAK2	trafficking protein, kinesin binding 2			0.00, 0.00	1.88, 0.68	-51.95	-96.72	-99.46	-99.85	-99.98	NaN	NaN	-52.25	-51.80	-99.79
CGS001-9697	KD	TRAM2	translocation associated membrane protein 2			0.00, 0.00	1.91, 0.58	NaN	-39.16	-99.49	-99.84	34.09	-29.96	-37.17	-93.15	-52.12	-97.68
CGS001-10131	KD	TRAP1	Heat shock proteins / HSPC, TNF receptor-associated protein 1			11.11, 11.11	1.76, 0.55	27.09	-99.93	30.15	81.92	99.39	NaN	-26.55	-98.49	24.63	8.27
CGS001-27095	KD	TRAPPC3	Trafficking protein particle complex, trafficking protein particle complex 3			0.00, 0.00	1.28, 0.34	-23.91	-26.54	-99.56	-93.44	-99.98	-85.26	61.05	-72.72	-42.48	-87.46
CGS001-79090	KD	TRAPPC6A	Trafficking protein particle complex, trafficking protein particle complex 6A			0.00, 0.00	1.63, 0.66	NaN	NaN	-99.60	-97.28	27.46	NaN	87.32	-29.10	-91.07	-96.68
CGS001-10221	KD	TRIB1	Trbl family, tribbles homolog 1 (Drosophila)			10.00, 10.00	1.17, 0.32	-57.18	52.41	-52.16	-96.97	-21.61	62.84	-96.22	33.01	99.75	-46.40
CGS001-57761	KD	TRIB3	Trbl family, tribbles homolog 3 (Drosophila)			22.22, 22.22	1.32, 0.30	97.69	22.58	99.70	25.61	57.54	NaN	61.56	-95.05	52.79	68.97
CGS001-10206	KD	TRIM13	RING-type (C3HC4) zinc fingers, tripartite motif containing 13			0.00, 0.00	1.17, 0.45	-81.22	-51.32	-99.23	-99.66	-99.96	50.10	-88.09	-88.97	89.61	-99.07
CGS001-10626	KD	TRIM16	Tripartite motif containing, tripartite motif containing 16			0.00, 0.00	1.35, 0.31	49.18	66.11	-99.78	-31.31	-62.74	NaN	-65.61	-98.00	-58.90	-75.38
CGS001-23321	KD	TRIM2	RING-type (C3HC4) zinc fingers, tripartite motif containing 2			10.00, 10.00	0.95, 0.16	88.66	-80.98	-29.93	-99.39	27.71	-87.15	59.09	-99.66	99.22	-90.66
CGS001-8805	KD	TRIM24	TIF1 family, tripartite motif containing 24			40.00, 30.00	1.23, 0.43	99.93	43.64	98.06	89.50	90.42	27.54	62.01	90.34	95.59	97.83
CGS001-5987	KD	TRIM27	tripartite motif containing 27			11.11, 11.11	1.18, 0.33	-53.20	97.86	-81.47	-67.73	55.19	NaN	-14.03	77.74	-29.75	-23.88
CGS001-23650	KD	TRIM29	tripartite motif containing 29			0.00, 0.00	1.43, 0.39	-46.50	-31.81	-68.24	-24.51	73.31	-28.45	85.92	-64.61	79.25	-8.19
CGS001-22954	KD	TRIM32	tripartite motif containing 32			11.11, 11.11	2.00, 0.74	74.17	63.62	-31.38	-33.10	94.69	97.64	NaN	66.63	-84.86	83.78
CGS001-10475	KD	TRIM38	tripartite motif containing 38			0.00, 0.00	1.63, 0.52	-72.57	NaN	-74.59	-99.98	-21.42	43.55	-74.87	39.71	-64.66	-63.46
CGS001-7204	KD	TRIO	Rho guanine nucleotide exchange factors, triple functional domain (PTPRF interacting)			20.00, 10.00	1.13, 0.28	96.93	41.09	-37.06	-24.67	38.13	-22.40	99.96	26.27	24.05	11.63
CGS001-9322	KD	TRIP10	thyroid hormone receptor interactor 10		Minor histocompatibility antigens LOF	0.00, 0.00	1.50, 0.48	57.33	-99.63	-95.57	-92.13	-62.96	-99.97	-97.04	-86.59	-30.73	-99.14
CGS001-9319	KD	TRIP13	ATPases / AAA-type, thyroid hormone receptor interactor 13			0.00, 0.00	1.41, 0.47	84.93	42.76	-99.19	-91.77	-88.45	NaN	79.88	-99.95	-20.19	-92.26
CGS001-7226	KD	TRPM2	Transient Receptor Potential channels, transient receptor potential cation channel, subfamily M, member 2			12.50, 12.50	1.70, 0.47	27.21	-26.08	-30.25	NaN	32.13	86.26	NaN	-24.88	99.15	25.27
CGS001-29850	KD	TRPM5	Transient Receptor Potential channels, transient receptor potential cation channel, subfamily M, member 5			0.00, 0.00	1.33, 0.38	16.11	53.43	65.03	-42.03	80.73	-24.19	-19.77	-47.46	22.28	10.50
CGS001-7227	KD	TRPS1	GATA zinc finger domain containing, trichorhinophalangeal syndrome I		GATA Zinc finger domain containing LOF	0.00, 0.00	1.93, 0.59	-99.31	-22.79	-27.05	-23.20	-65.07	-25.56	-29.54	-35.47	36.01	-8.76
CGS001-8295	KD	TRRAP	TRRAP subfamily, transformation/transcription domain-associated protein			0.00, 0.00	1.30, 0.38	-27.02	-78.61	18.88	82.81	23.67	49.69	-98.36	NaN	NaN	-10.99
CGS001-7249	KD	TSC2	tuberous sclerosis 2			0.00, 0.00	1.22, 0.43	-85.09	NaN	28.58	NaN	43.36	NaN	35.53	77.18	54.90	53.97
CGS001-8848	KD	TSC22D1	TSC22 domain family, member 1			10.00, 10.00	1.33, 0.41	25.65	-25.31	-33.27	21.25	99.54	32.10	61.28	-21.52	-24.39	3.13
CGS001-1831	KD	TSC22D3	TSC22 domain family, member 3			0.00, 0.00	1.07, 0.23	-69.84	-28.14	-92.21	24.57	-23.73	-62.30	21.88	49.38	74.16	-20.22
CGS001-80746	KD	TSEN2	tRNA splicing endonuclease subunits, tRNA splicing endonuclease 2 homolog (S. cerevisiae)			0.00, 0.00	1.64, 0.30	-44.86	NaN	35.62	-99.04	-83.46	70.14	-40.25	-68.79	-93.02	-92.42
CGS001-7251	KD	TSG101	tumor susceptibility gene 101			11.11, 11.11	1.09, 0.35	-99.95	29.69	-24.71	-95.29	-67.27	99.96	-99.76	-64.68	NaN	-76.28
CGS001-57616	KD	TSHZ3	Teashirt zinc fingers, teashirt zinc finger homeobox 3			0.00, 0.00	1.32, 0.31	-79.46	23.86	94.24	-27.54	-66.09	NaN	-43.24	-31.63	57.53	-22.87
CGS001-25987	KD	TSKU	tsukushi small leucine rich proteoglycan homolog (Xenopus laevis)			0.00, 0.00	1.47, 0.43	-97.33	NaN	-27.94	-37.63	94.97	-58.32	68.94	-88.21	-89.25	-89.62
CGS001-7247	KD	TSN	translin			0.00, 0.00	2.34, 0.74	-82.92	-37.24	-54.79	-88.10	51.29	NaN	-25.13	-96.86	-99.97	-85.86
CGS001-10099	KD	TSPAN3	Tetraspanins, tetraspanin 3			12.50, 0.00	1.52, 0.49	43.50	NaN	-91.50	96.98	86.64	NaN	-81.51	-70.24	-84.41	-90.39
CGS001-7106	KD	TSPAN4	Tetraspanins, tetraspanin 4			0.00, 0.00	1.98, 0.53	-80.78	NaN	-98.91	-87.55	-26.90	NaN	NaN	-95.07	-32.19	-95.38
CGS001-7105	KD	TSPAN6	Tetraspanins, tetraspanin 6			11.11, 11.11	1.56, 0.53	NaN	72.61	-99.64	-73.47	99.18	-29.40	-99.81	-71.94	40.62	-72.41
CGS001-7103	KD	TSPAN8	Tetraspanins, tetraspanin 8			11.11, 11.11	1.44, 0.42	52.35	99.31	-99.96	-42.79	30.65	NaN	80.76	-24.55	-27.42	16.62
CGS001-10078	KD	TSSC4	tumor suppressing subtransferable candidate 4			10.00, 0.00	1.07, 0.42	-37.66	31.41	28.78	36.78	55.66	45.91	14.39	91.00	95.49	23.94
CGS001-7263	KD	TST	thiosulfate sulfurtransferase (rhodanese)			0.00, 0.00	1.36, 0.49	-98.91	-99.65	-88.20	67.48	-99.98	-53.94	-97.50	30.07	-26.53	-99.45
CGS001-7264	KD	TSTA3	Short chain dehydrogenase/reductase superfamily / Extended SDR fold, tissue specific transplantation antigen P35B			0.00, 0.00	0.99, 0.22	-47.88	24.85	-99.59	-34.77	41.54	25.57	-99.22	-14.43	51.71	-25.94
CGS001-7270	KD	TTF1	transcription termination factor, RNA polymerase I			0.00, 0.00	1.52, 0.49	48.73	NaN	-74.70	-91.86	41.85	37.99	-36.47	-55.87	61.47	-36.09
CGS001-7272	KD	TTK	TTK family, TTK protein kinase			0.00, 0.00	1.99, 0.53	-91.13	-39.60	-59.85	-99.98	88.95	NaN	-98.13	-98.92	-90.05	-99.11
CGS001-7276	KD	TTR	transthyretin			0.00, 0.00	0.93, 0.18	-96.41	-99.56	-82.26	-87.57	-98.02	-93.30	-15.86	NaN	-99.78	-98.38
CGS001-7846	KD	TUBA1A	Tubulins, tubulin, alpha 1a			0.00, 0.00	1.74, 0.59	31.19	-26.56	29.26	24.94	43.54	NaN	21.78	-62.05	NaN	12.97
CGS001-10383	KD	TUBB2C	Tubulins, tubulin, beta 2C			12.50, 12.50	1.15, 0.26	-89.99	NaN	-46.73	-24.23	-99.46	NaN	98.35	23.58	25.37	-60.78
CGS001-10381	KD	TUBB3	Tubulins, tubulin, beta 3			0.00, 0.00	1.72, 0.49	-91.53	-45.82	-99.98	-99.96	-47.79	NaN	86.56	-99.67	-27.44	-99.95
CGS001-84617	KD	TUBB6	Tubulins, tubulin, beta 6			0.00, 0.00	1.44, 0.40	NaN	NaN	41.99	-26.81	27.49	64.15	NaN	-72.43	70.41	26.49
CGS001-51174	KD	TUBD1	Tubulins, tubulin, delta 1			0.00, 0.00	1.41, 0.39	-56.67	25.42	-85.06	-31.42	-56.72	NaN	-68.35	-99.04	-25.72	-34.75
CGS001-11344	KD	TWF2	Twinfilin subfamily, twinfilin, actin-binding protein, homolog 2 (Drosophila)			0.00, 0.00	1.81, 0.45	-84.16	-28.53	-30.67	-98.38	42.93	-18.08	NaN	-78.36	-65.76	-65.86
CGS001-7291	KD	TWIST1	Basic helix-loop-helix proteins, twist homolog 1 (Drosophila)			11.11, 0.00	1.70, 0.59	-47.23	-28.67	16.18	-35.25	-38.19	96.32	-31.20	-21.15	NaN	-7.51
CGS001-117581	KD	TWIST2	Basic helix-loop-helix proteins, twist homolog 2 (Drosophila)			11.11, 0.00	1.63, 0.44	45.50	-30.61	97.07	40.90	-85.52	NaN	65.01	31.28	-36.12	40.84
CGS001-200081	KD	TXLNA	taxilin alpha			0.00, 0.00	2.52, 0.83	33.02	NaN	-22.36	-53.89	-83.45	NaN	NaN	-96.32	-76.02	-83.19
CGS001-7295	KD	TXN	thioredoxin			0.00, 0.00	1.31, 0.43	-54.97	-32.34	-99.51	NaN	-97.81	-22.46	-78.72	-81.98	67.57	-91.20
CGS001-10190	KD	TXNDC9	thioredoxin domain containing 9			22.22, 11.11	1.19, 0.28	-69.22	NaN	79.87	-57.06	97.98	44.05	29.46	96.99	60.69	79.89
CGS001-10628	KD	TXNIP	thioredoxin interacting protein			11.11, 11.11	1.10, 0.34	74.73	52.15	28.47	-47.18	76.46	NaN	99.57	23.33	51.34	71.53
CGS001-9352	KD	TXNL1	thioredoxin-like 1			11.11, 0.00	1.14, 0.36	-89.55	96.46	25.02	55.61	-24.95	NaN	40.51	-34.98	-58.57	13.79
CGS001-54957	KD	TXNL4B	thioredoxin-like 4B			0.00, 0.00	0.90, 0.22	-79.14	-98.23	-99.81	-96.89	-27.80	-35.92	-98.90	-98.24	-99.44	-99.34
CGS001-7296	KD	TXNRD1	thioredoxin reductase 1			10.00, 10.00	1.15, 0.35	92.90	-24.74	-69.54	-51.13	77.18	99.69	83.87	-74.17	-96.28	69.33
CGS001-10587	KD	TXNRD2	thioredoxin reductase 2			10.00, 10.00	1.56, 0.59	-30.49	32.60	-34.73	-36.28	48.33	99.97	-73.20	-83.86	50.72	-13.69
CGS001-114112	KD	TXNRD3	thioredoxin reductase 3			55.56, 33.33	1.63, 0.44	-36.14	100.00	99.59	95.56	-33.21	NaN	55.93	96.34	60.77	99.58
CGS001-7297	KD	TYK2	Janus kinase (JakA) family, tyrosine kinase 2			25.00, 25.00	1.01, 0.45	99.69	37.59	69.79	-60.18	-98.88	NaN	NaN	98.70	-19.20	80.12
CGS001-7298	KD	TYMS	Methyltransferases, thymidylate synthetase			20.00, 0.00	1.45, 0.48	95.41	-73.12	-47.87	-43.68	27.22	54.21	96.68	-99.71	-35.96	-51.88
CGS001-7301	KD	TYRO3	Type XI RTKs: TAM (TYRO3-, AXL- and MER-TK) receptor family, TYRO3 protein tyrosine kinase			0.00, 0.00	1.34, 0.32	93.61	-83.75	23.53	-22.11	-54.46	-19.50	-22.29	-44.06	24.44	-9.25
CGS001-6675	KD	UAP1	UDP-N-acteylglucosamine pyrophosphorylase 1			0.00, 0.00	1.26, 0.34	55.65	33.94	82.60	26.35	29.09	NaN	-29.49	-66.74	42.20	20.26
CGS001-7311	KD	UBA52	L ribosomal proteins, ubiquitin A-52 residue ribosomal protein fusion product 1			0.00, 0.00	2.02, 0.81	-99.46	66.48	-34.09	-99.98	-61.16	-40.80	-91.03	-98.81	-99.97	-99.76
CGS001-337867	KD	UBAC2	UBA domain containing 2			0.00, 0.00	1.33, 0.45	-99.53	-23.76	-40.97	-32.72	77.04	-92.89	26.28	-90.83	-34.03	-70.18
CGS001-51271	KD	UBAP1	ubiquitin associated protein 1			10.00, 10.00	1.07, 0.39	99.98	24.61	-60.51	-46.20	-75.69	-31.35	92.52	52.01	59.96	52.65
CGS001-53347	KD	UBASH3A	ubiquitin associated and SH3 domain containing A			22.22, 22.22	1.50, 0.60	97.86	-46.70	99.86	-50.40	21.67	NaN	-48.45	-94.87	31.13	-25.86
CGS001-7314	KD	UBB	ubiquitin B			0.00, 0.00	1.86, 0.52	-62.13	-56.98	78.77	22.58	-32.98	NaN	-86.40	-59.36	-19.77	-43.54
CGS001-7316	KD	UBC	ubiquitin C			0.00, 0.00	1.98, 0.50	-35.22	-98.12	-82.12	-31.35	-69.07	-99.68	-69.83	-67.51	-69.79	-77.64
CGS001-11065	KD	UBE2C	Ubiquitin-conjugating enzymes E2, ubiquitin-conjugating enzyme E2C			0.00, 0.00	1.28, 0.28	93.58	-69.92	-29.97	-38.94	-84.26	-41.94	72.69	-75.24	-21.08	-34.77
CGS001-7321	KD	UBE2D1	Ubiquitin-conjugating enzymes E2, ubiquitin-conjugating enzyme E2D 1			0.00, 0.00	1.43, 0.41	-50.30	NaN	-99.32	-99.91	-99.39	NaN	-73.18	-98.43	-85.77	-99.87
CGS001-7323	KD	UBE2D3	Ubiquitin-conjugating enzymes E2, ubiquitin-conjugating enzyme E2D 3			12.50, 0.00	0.85, 0.17	51.72	NaN	90.05	95.38	37.75	NaN	67.36	-99.83	59.38	83.62
CGS001-10477	KD	UBE2E3	Ubiquitin-conjugating enzymes E2, ubiquitin-conjugating enzyme E2E 3			55.56, 44.44	1.28, 0.35	99.96	99.87	-28.37	96.40	89.17	NaN	-95.66	46.32	98.19	99.87
CGS001-51465	KD	UBE2J1	Ubiquitin-conjugating enzymes E2, ubiquitin-conjugating enzyme E2, J1, U			11.11, 11.11	1.55, 0.51	53.81	-96.27	-83.97	64.81	46.23	NaN	25.91	-75.86	99.50	53.89
CGS001-9246	KD	UBE2L6	Ubiquitin-conjugating enzymes E2, ubiquitin-conjugating enzyme E2L 6			0.00, 0.00	1.11, 0.40	-67.38	-99.98	-72.60	-99.44	-56.37	-17.68	-98.19	-46.30	-98.64	-99.63
CGS001-7334	KD	UBE2N	Ubiquitin-conjugating enzymes E2, ubiquitin-conjugating enzyme E2N			0.00, 0.00	2.01, 0.44	36.58	40.36	44.48	22.10	24.25	63.52	49.22	80.13	-44.57	33.56
CGS001-7335	KD	UBE2V1	Ubiquitin-conjugating enzymes E2, ubiquitin-conjugating enzyme E2 variant 1			0.00, 0.00	1.22, 0.42	-85.65	-45.38	-69.45	29.41	40.69	-72.86	-77.35	-19.41	27.94	-42.40
CGS001-65264	KD	UBE2Z	Ubiquitin-conjugating enzymes E2, ubiquitin-conjugating enzyme E2Z			0.00, 0.00	1.15, 0.30	-98.93	-28.09	-21.31	-26.59	64.26	-56.31	-73.53	-76.46	78.33	-42.11
CGS001-7337	KD	UBE3A	ubiquitin protein ligase E3A			0.00, 0.00	1.20, 0.34	21.35	-94.83	-97.14	-72.16	-66.39	NaN	-24.57	-69.12	-20.16	-58.64
CGS001-89910	KD	UBE3B	ubiquitin protein ligase E3B			0.00, 0.00	1.15, 0.33	-41.48	28.21	-98.82	-47.43	64.58	89.51	-28.85	45.88	-36.17	-21.27
CGS001-9690	KD	UBE3C	ubiquitin protein ligase E3C			0.00, 0.00	1.34, 0.32	-63.98	-25.64	-51.39	-35.08	-34.08	NaN	NaN	-98.63	-37.10	-41.49
CGS001-9354	KD	UBE4A	U-box domain containing, ubiquitination factor E4A			0.00, 0.00	1.31, 0.35	-95.24	-26.36	-92.66	-63.11	79.35	-36.82	NaN	-65.70	-99.97	-88.23
CGS001-59286	KD	UBL5	ubiquitin-like 5			11.11, 0.00	0.89, 0.31	62.72	-98.14	44.54	-89.35	60.25	96.83	-41.58	NaN	-50.87	42.38
CGS001-7342	KD	UBP1	upstream binding protein 1 (LBP-1a)			11.11, 0.00	1.60, 0.35	21.73	33.39	96.90	83.01	-89.73	NaN	58.91	42.50	40.02	33.60
CGS001-29978	KD	UBQLN2	Ubiquilin family, ubiquilin 2			0.00, 0.00	1.48, 0.40	-62.13	-95.13	-99.73	-99.23	38.90	-95.36	-94.23	-92.30	-99.97	-99.67
CGS001-55148	KD	UBR7	Ubiquitin protein ligase E3 component n-recognins, ubiquitin protein ligase E3 component n-recognin 7 (putative)			40.00, 40.00	1.15, 0.45	70.58	99.39	29.54	99.98	-39.85	46.57	99.61	71.95	-63.69	98.05
CGS001-7343	KD	UBTF	upstream binding transcription factor, RNA polymerase I			55.56, 55.56	2.34, 0.69	-36.73	100.00	99.98	48.05	99.78	NaN	-30.09	99.09	35.85	99.87
CGS001-7345	KD	UCHL1	Ubiquitin C-terminal hydrolase, ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase)			0.00, 0.00	1.33, 0.32	-73.73	56.67	42.78	70.22	-32.78	NaN	43.95	42.26	-35.59	48.68
CGS001-7371	KD	UCK2	uridine-cytidine kinase 2			12.50, 12.50	1.47, 0.41	57.77	98.44	93.06	80.29	-37.56	NaN	NaN	-28.76	52.44	79.37
CGS001-7353	KD	UFD1L	ubiquitin fusion degradation 1 like (yeast)			44.44, 33.33	1.36, 0.43	99.95	28.98	-31.94	34.51	99.98	99.53	27.40	27.82	NaN	97.39
CGS001-51569	KD	UFM1	ubiquitin-fold modifier 1			0.00, 0.00	1.97, 0.66	-96.14	25.73	-78.05	30.18	-98.01	NaN	NaN	43.70	-39.89	-89.82
CGS001-7357	KD	UGCG	Glycosyltransferase family 2 domain containing, UDP-glucose ceramide glucosyltransferase			0.00, 0.00	1.86, 0.51	-48.71	-22.12	72.28	-59.83	-27.85	NaN	-99.89	16.97	-41.38	-37.87
CGS001-7358	KD	UGDH	UDP-glucose 6-dehydrogenase			10.00, 10.00	1.31, 0.30	77.10	99.91	-27.90	-92.13	20.45	-49.28	-39.40	-60.12	32.95	-23.74
CGS001-7360	KD	UGP2	UDP-glucose pyrophosphorylase 2			0.00, 0.00	1.22, 0.26	-93.63	28.74	-16.87	41.81	-89.90	-81.01	-19.92	24.89	-99.88	-85.60
CGS001-54658	KD	UGT1A1	UDP glucuronosyltransferases, UDP glucuronosyltransferase 1 family, polypeptide A1			0.00, 0.00	1.94, 0.53	72.83	20.34	71.62	91.76	-22.50	NaN	79.09	39.91	-49.61	55.55
CGS001-54659	KD	UGT1A3	UDP glucuronosyltransferases, UDP glucuronosyltransferase 1 family, polypeptide A3			0.00, 0.00	1.73, 0.50	-99.96	22.51	-96.33	-41.37	-34.44	NaN	-25.54	-55.52	27.08	-43.90
CGS001-54600	KD	UGT1A9	UDP glucuronosyltransferases, UDP glucuronosyltransferase 1 family, polypeptide A9			0.00, 0.00	1.19, 0.43	94.53	-34.88	62.37	53.77	-95.02	-20.16	35.31	-52.05	32.24	31.73
CGS001-54490	KD	UGT2B28	UDP glucuronosyltransferases, UDP glucuronosyltransferase 2 family, polypeptide B28			44.44, 44.44	1.52, 0.48	-32.75	29.09	99.98	86.71	-70.36	NaN	28.43	99.43	99.97	99.74
CGS001-8408	KD	ULK1	Unc-51-like kinase (ULK) family, unc-51-like kinase 1 (C. elegans)			0.00, 0.00	2.02, 0.48	24.84	-98.95	36.97	-24.16	-98.07	NaN	-75.79	NaN	NaN	-91.20
CGS001-9706	KD	ULK2	Unc-51-like kinase (ULK) family, unc-51-like kinase 2 (C. elegans)			0.00, 0.00	1.78, 0.57	42.62	-100.00	-29.49	39.89	38.91	-66.10	24.53	56.31	NaN	30.45
CGS001-25989	KD	ULK3	Unc-51-like kinase (ULK) family, unc-51-like kinase 3 (C. elegans)			0.00, 0.00	1.45, 0.42	-94.28	-99.96	-22.97	-95.12	32.43	NaN	-19.96	-98.44	59.44	-95.09
CGS001-89766	KD	UMODL1	uromodulin-like 1			0.00, 0.00	0.25, 0.01	-87.61	69.03	21.58	22.22	-24.58	22.96	-63.94	18.60	17.90	2.05
CGS001-10497	KD	UNC13B	unc-13 homolog B (C. elegans)			0.00, 0.00	1.33, 0.39	-79.92	NaN	14.13	NaN	-36.73	-99.02	-57.86	-90.98	19.77	-46.28
CGS001-7374	KD	UNG	uracil-DNA glycosylase			11.11, 11.11	1.45, 0.45	31.77	83.92	60.17	27.96	87.40	49.22	19.94	99.33	NaN	73.88
CGS001-10975	KD	UQCR11	Mitochondrial respiratory chain complex / Complex III, ubiquinol-cytochrome c reductase, complex III subunit XI			0.00, 0.00	1.28, 0.33	50.41	-22.76	-62.64	65.33	-61.81	NaN	84.74	-34.33	21.25	9.71
CGS001-7381	KD	UQCRB	Mitochondrial respiratory chain complex / Complex III, ubiquinol-cytochrome c reductase binding protein			0.00, 0.00	1.59, 0.36	-27.53	-22.45	-27.43	-23.52	NaN	-72.97	34.60	-90.59	-25.69	-16.39
CGS001-7384	KD	UQCRC1	Mitochondrial respiratory chain complex / Complex III, ubiquinol-cytochrome c reductase core protein I			0.00, 0.00	1.40, 0.56	-84.61	34.58	-17.08	-23.11	-42.31	-99.58	-22.65	-32.41	-94.34	-56.17
CGS001-7386	KD	UQCRFS1	Mitochondrial respiratory chain complex / Complex III, ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1			22.22, 22.22	0.95, 0.35	-95.68	NaN	54.56	-37.40	98.50	68.45	-52.71	34.47	99.05	79.87
CGS001-7391	KD	USF1	Basic helix-loop-helix proteins, upstream transcription factor 1			20.00, 20.00	1.36, 0.40	-16.10	51.03	99.93	15.92	-75.13	-85.19	32.28	-49.04	99.94	8.86
CGS001-7398	KD	USP1	Ubiquitin-specific peptidases, ubiquitin specific peptidase 1			11.11, 11.11	1.42, 0.28	78.70	98.67	93.34	-99.86	59.26	-22.47	NaN	-98.82	-30.18	66.12
CGS001-9097	KD	USP14	Ubiquitin-specific peptidases, ubiquitin specific peptidase 14 (tRNA-guanine transglycosylase)		Ubiquitin-specific peptidases LOF	0.00, 0.00	1.08, 0.41	-75.30	21.75	-50.90	-97.36	-26.13	-56.30	-37.13	-88.10	-99.92	-81.35
CGS001-9958	KD	USP15	Ubiquitin-specific peptidases, ubiquitin specific peptidase 15			44.44, 22.22	1.55, 0.26	-42.38	88.36	22.78	99.62	95.70	NaN	17.85	40.93	99.86	95.99
CGS001-10600	KD	USP16	Ubiquitin-specific peptidases, ubiquitin specific peptidase 16			0.00, 0.00	1.16, 0.38	-50.84	32.57	-95.58	-87.10	-19.85	-78.22	-75.20	-90.28	-99.97	-82.48
CGS001-10868	KD	USP20	Ubiquitin-specific peptidases, ubiquitin specific peptidase 20			0.00, 0.00	0.98, 0.19	-99.00	NaN	-47.20	-96.11	-25.38	-99.74	-36.27	-88.27	19.65	-80.36
CGS001-23326	KD	USP22	Ubiquitin-specific peptidases, ubiquitin specific peptidase 22			10.00, 0.00	1.19, 0.20	79.29	-24.87	-95.72	67.85	80.85	41.01	-99.16	-44.98	96.44	63.59
CGS001-84669	KD	USP32	EF-hand domain containing, ubiquitin specific peptidase 32			10.00, 10.00	1.33, 0.40	-46.81	-96.59	-17.55	30.70	-37.14	86.34	27.48	14.18	99.58	7.03
CGS001-55031	KD	USP47	Ubiquitin-specific peptidases, ubiquitin specific peptidase 47			0.00, 0.00	1.67, 0.50	46.93	79.66	77.04	29.97	-96.94	-45.47	31.08	NaN	-99.97	33.24
CGS001-9712	KD	USP6NL	USP6 N-terminal like			0.00, 0.00	2.69, 0.88	NaN	22.88	-59.30	-91.98	-25.63	NaN	-33.52	-62.32	-99.97	-71.49
CGS001-7874	KD	USP7	Ubiquitin-specific peptidases, ubiquitin specific peptidase 7 (herpes virus-associated)		Ubiquitin-specific peptidases LOF	0.00, 0.00	1.07, 0.26	-99.63	-53.34	-98.10	-29.03	-50.65	-30.78	-21.08	-96.57	-45.44	-80.19
CGS001-10813	KD	UTP14A	UTP14, U3 small nucleolar ribonucleoprotein, homolog A (yeast)			0.00, 0.00	3.55, 1.18	-26.30	NaN	-65.17	44.07	-75.92	NaN	-44.52	-73.93	24.89	-65.52
CGS001-51096	KD	UTP18	WD repeat domain containing, UTP18, small subunit (SSU) processome component, homolog (yeast)			0.00, 0.00	1.51, 0.45	-97.51	NaN	-99.08	-99.98	-99.70	NaN	-46.17	-99.94	-59.18	-99.95
CGS001-2837	KD	UTS2R	Urotensin receptor, urotensin 2 receptor			0.00, 0.00	1.47, 0.49	-53.76	-53.46	86.80	-75.21	76.73	NaN	-17.58	-74.39	-92.16	-58.17
CGS001-7405	KD	UVRAG	UV radiation resistance associated gene		C2 domain containing LOF	0.00, 0.00	1.65, 0.51	-99.88	NaN	-99.67	-99.98	-89.98	-32.31	-99.94	-99.95	-99.86	-99.95
CGS001-8409	KD	UXT	ubiquitously-expressed transcript			0.00, 0.00	1.33, 0.36	89.36	NaN	-93.23	-96.96	-69.20	NaN	37.39	-87.85	-30.64	-93.03
CGS001-9341	KD	VAMP3	Vesicle-associated membrane proteins, vesicle-associated membrane protein 3 (cellubrevin)			0.00, 0.00	1.48, 0.36	-97.24	-85.41	-99.95	-99.98	-99.80	NaN	-83.32	-97.50	-94.15	-99.95
CGS001-6845	KD	VAMP7	Pseudoautosomal regions / PAR2, vesicle-associated membrane protein 7			10.00, 10.00	1.07, 0.34	-84.54	-92.81	-99.91	-29.82	55.71	-26.35	99.25	-99.76	85.20	-92.71
CGS001-9217	KD	VAPB	VAMP (vesicle-associated membrane protein)-associated protein B and C			14.29, 14.29	1.70, 0.48	-74.52	NaN	-24.40	-40.39	-96.00	NaN	NaN	51.88	98.34	-35.73
CGS001-7407	KD	VARS	Aminoacyl tRNA synthetases / Class I, valyl-tRNA synthetase			0.00, 0.00	1.20, 0.39	28.79	36.24	31.71	30.92	63.73	-96.25	79.26	NaN	NaN	17.66
CGS001-10493	KD	VAT1	vesicle amine transport protein 1 homolog (T. californica)			10.00, 10.00	1.20, 0.28	-98.29	-24.79	-99.92	-98.69	-23.30	50.23	98.33	-50.24	55.50	-73.05
CGS001-10451	KD	VAV3	Rho guanine nucleotide exchange factors, vav 3 guanine nucleotide exchange factor			0.00, 0.00	1.45, 0.41	-89.95	21.21	72.96	60.17	29.38	NaN	38.92	94.86	-93.66	64.33
CGS001-1462	KD	VCAN	Immunoglobulin superfamily / V-set domain containing, versican			40.00, 40.00	0.92, 0.38	35.75	-19.16	79.41	97.95	67.53	-29.17	99.98	45.46	99.31	98.71
CGS001-7415	KD	VCP	ATPases / AAA-type, valosin containing protein			0.00, 0.00	3.15, 0.99	-96.65	NaN	-99.63	-95.91	-44.22	NaN	-91.53	-84.70	-99.77	-99.82
CGS001-7416	KD	VDAC1	Voltage-dependent anion channels, voltage-dependent anion channel 1			0.00, 0.00	1.23, 0.41	89.05	NaN	37.72	-46.90	86.62	55.62	-36.23	-15.54	27.06	44.10
CGS001-7421	KD	VDR	Vitamin D receptors, vitamin D (1,25- dihydroxyvitamin D3) receptor			11.11, 11.11	1.08, 0.35	25.48	27.74	-30.72	-53.34	68.75	NaN	99.90	75.08	-21.96	31.31
CGS001-7422	KD	VEGFA	Cytokines and growth factors, vascular endothelial growth factor A			0.00, 0.00	1.14, 0.24	-65.64	28.92	-25.54	44.28	81.08	59.29	79.50	-45.20	33.26	43.57
CGS001-7423	KD	VEGFB	vascular endothelial growth factor B			11.11, 11.11	1.14, 0.36	-99.29	30.65	-98.76	89.70	37.25	42.27	-75.43	99.67	NaN	-19.37
CGS001-7424	KD	VEGFC	vascular endothelial growth factor C			11.11, 0.00	1.88, 0.45	55.89	42.84	29.20	97.43	30.84	NaN	93.11	-36.34	-43.06	44.32
CGS001-9686	KD	VGLL4	vestigial like 4 (Drosophila)			0.00, 0.00	2.23, 0.73	NaN	NaN	-29.62	-98.85	-99.94	NaN	NaN	-35.01	43.02	-98.74
CGS001-7428	KD	VHL	von Hippel-Lindau tumor suppressor			11.11, 11.11	1.60, 0.40	90.51	99.46	-29.72	-51.64	20.61	NaN	-51.88	88.52	86.92	91.76
CGS001-7431	KD	VIM	Intermediate filaments type III, vimentin			0.00, 0.00	1.57, 0.49	-36.30	-27.33	-16.37	25.87	-25.53	-88.84	-59.69	NaN	-98.24	-38.59
CGS001-7433	KD	VIPR1	GPCR / Class B : VIP and PACAP (ADCYAP1) receptors, vasoactive intestinal peptide receptor 1			0.00, 0.00	1.80, 0.68	85.31	21.31	75.39	-28.48	NaN	-56.78	-72.81	41.37	67.15	43.63
CGS001-79001	KD	VKORC1	Oxidoreductases, vitamin K epoxide reductase complex, subunit 1			25.00, 25.00	1.34, 0.56	-97.89	NaN	99.95	99.40	-24.12	NaN	35.99	-81.58	-99.47	-85.96
CGS001-317701	KD	VN1R2	GPCR / Unclassified : Vomeronasal receptors, type 1, vomeronasal 1 receptor 2			37.50, 12.50	1.99, 0.53	95.48	86.63	19.22	NaN	NaN	64.27	87.46	80.32	99.97	96.23
CGS001-317703	KD	VN1R4	GPCR / Unclassified : Vomeronasal receptors, type 1, vomeronasal 1 receptor 4			0.00, 0.00	1.44, 0.35	40.34	33.32	20.66	-41.16	81.06	54.56	35.61	-21.14	NaN	29.95
CGS001-317705	KD	VN1R5	GPCR / Unclassified : Vomeronasal receptors, type 1, vomeronasal 1 receptor 5 (gene/pseudogene)			0.00, 0.00	1.78, 0.56	NaN	NaN	41.68	52.72	52.65	-67.95	NaN	47.16	94.94	56.92
CGS001-9559	KD	VPS26A	vacuolar protein sorting 26 homolog A (S. pombe)			0.00, 0.00	2.11, 0.76	-74.55	NaN	-47.01	19.55	-90.32	NaN	NaN	-37.46	-53.58	-40.32
CGS001-51160	KD	VPS28	vacuolar protein sorting 28 homolog (S. cerevisiae)			0.00, 0.00	2.30, 0.64	86.88	-33.89	-99.54	-52.21	-48.86	24.13	-92.51	-79.77	-43.26	-55.52
CGS001-6944	KD	VPS72	vacuolar protein sorting 72 homolog (S. cerevisiae)			44.44, 44.44	1.19, 0.34	-61.47	99.96	98.57	72.31	33.67	99.97	NaN	56.48	54.50	98.84
CGS001-23355	KD	VPS8	vacuolar protein sorting 8 homolog (S. cerevisiae)			0.00, 0.00	0.84, 0.20	-99.72	19.80	-37.68	-22.10	-92.31	NaN	-48.22	-77.60	66.64	-44.63
CGS001-7443	KD	VRK1	Vaccina related kinase (VRK) family, vaccinia related kinase 1			11.11, 11.11	1.31, 0.33	-95.20	-35.02	-48.81	NaN	-39.19	-97.29	99.23	-96.77	-56.18	-73.84
CGS001-7444	KD	VRK2	Vaccina related kinase (VRK) family, vaccinia related kinase 2			0.00, 0.00	1.56, 0.38	-99.96	-100.00	-99.93	-99.98	-69.56	NaN	-99.96	-99.96	-73.64	-99.95
CGS001-51231	KD	VRK3	Vaccina related kinase (VRK) family, vaccinia related kinase 3			0.00, 0.00	1.15, 0.36	-54.14	42.61	-20.99	-53.89	31.98	-98.84	-32.82	-98.35	72.25	-23.44
CGS001-143187	KD	VTI1A	vesicle transport through interaction with t-SNAREs homolog 1A (yeast)			11.11, 11.11	1.48, 0.41	-91.16	62.26	92.56	-70.50	99.18	NaN	-80.14	-30.28	20.00	-42.57
CGS001-7453	KD	WARS	Aminoacyl tRNA synthetases / Class I, tryptophanyl-tRNA synthetase			0.00, 0.00	1.26, 0.34	-99.95	-37.66	-98.58	-99.89	-42.32	53.33	-36.73	-94.07	-99.11	-99.76
CGS001-10352	KD	WARS2	Aminoacyl tRNA synthetases / Class I, tryptophanyl tRNA synthetase 2, mitochondrial			0.00, 0.00	1.08, 0.24	-35.08	-35.23	-16.09	33.05	-71.29	-22.45	-88.13	-66.05	75.73	-24.42
CGS001-10810	KD	WASF3	WAS protein family, member 3			33.33, 33.33	1.47, 0.48	NaN	93.15	94.35	98.09	65.67	54.05	74.50	99.92	31.17	98.32
CGS001-11180	KD	WDR6	WD repeat domain containing, WD repeat domain 6			11.11, 11.11	1.09, 0.31	73.72	NaN	57.34	-37.91	-31.55	99.75	-46.84	-91.84	37.72	44.37
CGS001-80349	KD	WDR61	WD repeat domain containing, WD repeat domain 61			11.11, 11.11	1.63, 0.43	-86.69	NaN	-99.86	-99.33	-59.37	-99.96	44.96	-99.75	97.63	-99.95
CGS001-93594	KD	WDR67	WD repeat domain 67			0.00, 0.00	1.02, 0.20	-89.63	NaN	-99.98	-99.96	-65.05	-28.72	-96.60	-99.11	25.76	-99.92
CGS001-23335	KD	WDR7	WD repeat domain containing, WD repeat domain 7			14.29, 14.29	2.71, 1.09	NaN	46.24	-46.60	-56.88	99.34	NaN	NaN	-64.92	-49.89	-56.35
CGS001-23038	KD	WDTC1	DDB1 and CUL4 associated factors, WD and tetratricopeptide repeats 1			0.00, 0.00	1.76, 0.55	NaN	NaN	-23.85	72.56	51.02	NaN	-30.84	61.41	57.08	52.97
CGS001-7465	KD	WEE1	WEE family, WEE1 homolog (S. pombe)			0.00, 0.00	1.39, 0.47	-99.41	-22.74	-98.77	-99.94	35.29	NaN	-98.64	-98.77	20.49	-98.85
CGS001-10406	KD	WFDC2	WAP four-disulfide core domain containing, WAP four-disulfide core domain 2			11.11, 0.00	1.65, 0.56	-56.41	82.74	-42.74	-31.93	96.70	-88.24	44.37	-68.62	NaN	-39.23
CGS001-7466	KD	WFS1	Wolfram syndrome 1 (wolframin)			0.00, 0.00	1.05, 0.32	-56.01	47.11	-99.94	-94.77	-99.37	63.44	-58.76	-38.84	-49.55	-93.95
CGS001-7468	KD	WHSC1	Zinc fingers, PHD-type, Wolf-Hirschhorn syndrome candidate 1			12.50, 12.50	1.05, 0.27	99.83	22.77	-38.53	-12.15	36.98	NaN	NaN	84.83	37.86	44.95
CGS001-147179	KD	WIPF2	WAS/WASL interacting protein family, member 2			10.00, 10.00	1.24, 0.28	-42.89	98.51	-99.93	43.43	-45.69	76.29	66.05	-96.95	71.92	42.95
CGS001-7471	KD	WNT1	Endogenous ligands, wingless-type MMTV integration site family, member 1			0.00, 0.00	0.70, 0.13	7.66	-23.01	-76.10	-41.65	65.46	28.36	22.81	-29.67	57.51	-7.32
CGS001-7480	KD	WNT10B	Wingless-type MMTV integration sites, wingless-type MMTV integration site family, member 10B			0.00, 0.00	1.34, 0.44	-97.34	NaN	-55.58	-63.17	-64.93	NaN	-94.73	18.86	-72.52	-82.34
CGS001-7481	KD	WNT11	Wingless-type MMTV integration sites, wingless-type MMTV integration site family, member 11		Wnt family LOF	0.00, 0.00	1.91, 0.42	32.31	33.00	-29.17	-24.33	-56.49	-23.69	-33.32	NaN	84.83	10.78
CGS001-7474	KD	WNT5A	Endogenous ligands, wingless-type MMTV integration site family, member 5A			11.11, 0.00	1.20, 0.30	-68.80	65.03	95.93	81.22	-95.79	NaN	-72.54	-95.01	94.72	-78.30
CGS001-7477	KD	WNT7B	Endogenous ligands, wingless-type MMTV integration site family, member 7B		Wnt family LOF	0.00, 0.00	1.51, 0.43	81.26	-34.15	-26.55	83.76	-95.68	71.89	90.64	57.23	65.93	78.58
CGS001-7483	KD	WNT9A	Wingless-type MMTV integration sites, wingless-type MMTV integration site family, member 9A		Wnt family LOF	60.00, 30.00	1.90, 0.60	97.87	34.58	97.08	-25.10	-51.15	96.05	96.09	99.78	-68.75	98.68
CGS001-7484	KD	WNT9B	Wingless-type MMTV integration sites, wingless-type MMTV integration site family, member 9B		Wnt family LOF	22.22, 22.22	1.70, 0.61	34.79	99.96	48.47	79.04	63.24	NaN	48.05	38.39	98.95	79.60
CGS001-7485	KD	WRB	tryptophan rich basic protein			12.50, 12.50	1.69, 0.65	NaN	99.91	-26.14	47.10	42.96	85.53	NaN	-46.64	23.34	32.95
CGS001-7486	KD	WRN	Werner syndrome, RecQ helicase-like			0.00, 0.00	1.24, 0.26	-93.98	57.38	-28.32	-99.78	-37.77	-22.73	-94.56	-97.15	-37.73	-72.51
CGS001-7490	KD	WT1	Zinc fingers, C2H2-type, Wilms tumor 1			0.00, 0.00	1.06, 0.31	77.40	-61.20	-74.89	-56.61	-78.57	-99.29	-68.64	79.33	-15.46	-54.46
CGS001-9589	KD	WTAP	Wilms tumor 1 associated protein			11.11, 11.11	0.85, 0.23	67.07	59.47	-13.09	-29.81	73.62	NaN	-34.10	49.83	97.74	27.48
CGS001-51741	KD	WWOX	Short chain dehydrogenase/reductase superfamily / Classical SDR fold cluster 2, WW domain containing oxidoreductase			12.50, 0.00	1.60, 0.33	96.65	NaN	-80.84	21.18	-24.41	-29.50	NaN	-40.76	24.23	-11.07
CGS001-25937	KD	WWTR1	Hippo Signaling, WW domain containing transcription regulator 1			0.00, 0.00	1.08, 0.31	-32.43	68.01	21.34	63.74	-85.22	NaN	-19.72	48.73	53.84	29.48
CGS001-7494	KD	XBP1	basic leucine zipper proteins, X-box binding protein 1			0.00, 0.00	2.33, 0.63	-81.38	-20.70	-92.73	-99.86	-68.81	39.56	28.31	-99.73	-92.19	-91.69
CGS001-7504	KD	XK	Blood group antigens, X-linked Kx blood group (McLeod syndrome)			0.00, 0.00	2.21, 0.45	-33.77	24.58	-76.43	52.33	44.25	37.56	-39.68	-75.71	-80.59	-51.12
CGS001-7508	KD	XPC	xeroderma pigmentosum, complementation group C			0.00, 0.00	1.92, 0.65	-66.39	NaN	93.39	NaN	-99.69	NaN	NaN	-92.53	-88.18	-93.60
CGS001-7511	KD	XPNPEP1	Methionyl aminopeptidase, X-prolyl aminopeptidase (aminopeptidase P) 1, soluble			11.11, 11.11	2.36, 0.65	53.51	-19.43	25.09	53.29	99.98	NaN	76.04	26.47	-33.72	63.72
CGS001-63929	KD	XPNPEP3	Methionyl aminopeptidase, X-prolyl aminopeptidase (aminopeptidase P) 3, putative			10.00, 0.00	1.36, 0.48	95.15	28.83	-54.54	-31.56	-45.53	32.65	-62.00	89.88	-99.95	-41.59
CGS001-23039	KD	XPO7	Exportins, exportin 7			0.00, 0.00	1.78, 0.67	NaN	NaN	-58.73	73.77	74.50	NaN	NaN	-49.18	37.55	60.45
CGS001-9213	KD	XPR1	xenotropic and polytropic retrovirus receptor 1			22.22, 22.22	1.83, 0.53	34.24	93.29	69.94	39.83	99.67	NaN	99.03	22.18	92.21	93.99
CGS001-7518	KD	XRCC4	XRCC DNA Repair, X-ray repair complementing defective repair in Chinese hamster cells 4		Non Homologous End Joining LOF	0.00, 0.00	1.90, 0.60	50.84	53.42	72.90	-61.23	94.46	53.35	19.70	89.77	NaN	77.37
CGS001-7520	KD	XRCC5	XRCC DNA Repair, X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining)		Non Homologous End Joining LOF	0.00, 0.00	1.11, 0.27	78.40	-56.65	-37.36	30.42	-18.99	-99.97	-30.46	-85.42	20.20	-14.45
CGS001-2547	KD	XRCC6	XRCC DNA Repair, X-ray repair complementing defective repair in Chinese hamster cells 6			25.00, 25.00	1.64, 0.55	-15.93	-99.61	49.34	68.00	98.36	99.96	NaN	NaN	-75.88	70.10
CGS001-10413	KD	YAP1	Hippo Signaling, Yes-associated protein 1			0.00, 0.00	1.45, 0.42	-54.38	NaN	-34.82	NaN	75.77	NaN	-99.59	-87.15	19.41	-42.04
CGS001-4904	KD	YBX1	Y box binding protein 1			11.11, 11.11	1.40, 0.48	-76.07	26.66	71.23	27.68	-39.96	NaN	34.09	94.82	99.97	74.82
CGS001-7525	KD	YES1	Src family, v-yes-1 Yamaguchi sarcoma viral oncogene homolog 1			0.00, 0.00	0.63, 0.11	-11.81	-45.90	30.10	29.17	-21.36	-49.15	-68.34	-52.14	72.37	-9.38
CGS001-10652	KD	YKT6	YKT6 v-SNARE homolog (S. cerevisiae)			0.00, 0.00	1.22, 0.39	10.76	-40.82	-84.27	28.99	-38.31	-98.54	-64.12	80.43	91.21	-32.48
CGS001-10730	KD	YME1L1	ATPases / AAA-type, YME1-like 1 (S. cerevisiae)			0.00, 0.00	1.47, 0.49	-99.50	91.85	-99.40	-94.75	-26.40	-99.97	-99.91	-74.44	27.96	-99.71
CGS001-54915	KD	YTHDF1	YTH domain family, member 1			0.00, 0.00	1.82, 0.36	-77.76	NaN	-97.52	-98.79	-64.67	28.15	-80.85	-72.33	-99.97	-99.39
CGS001-51441	KD	YTHDF2	YTH domain family, member 2			0.00, 0.00	1.44, 0.42	-81.66	NaN	34.10	-72.37	-38.29	-36.17	-24.99	-62.80	-33.76	-65.94
CGS001-7533	KD	YWHAH	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide			0.00, 0.00	2.07, 0.58	-32.17	-55.90	-69.82	-99.90	-99.98	NaN	-79.41	-94.19	-26.11	-96.70
CGS001-10971	KD	YWHAQ	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta polypeptide			0.00, 0.00	1.94, 0.85	-28.33	NaN	-54.66	-49.34	-34.89	NaN	94.55	-31.01	-45.69	-21.78
CGS001-7528	KD	YY1	INO80 complex subunits, YY1 transcription factor			22.22, 22.22	1.13, 0.33	99.72	-29.53	57.09	-64.38	-68.52	NaN	99.51	-97.55	-25.40	-56.94
CGS001-51776	KD	ZAK	MLK subfamily, sterile alpha motif and leucine zipper containing kinase AZK			44.44, 44.44	1.08, 0.30	94.17	-22.16	99.83	99.02	99.98	NaN	-60.27	34.02	25.58	99.89
CGS001-7535	KD	ZAP70	Syk family, zeta-chain (TCR) associated protein kinase 70kDa			62.50, 62.50	2.08, 0.88	-43.46	92.11	99.82	99.93	94.10	NaN	NaN	99.82	99.80	99.92
CGS001-9189	KD	ZBED1	Pseudoautosomal regions / PAR1, zinc finger, BED-type containing 1			37.50, 37.50	1.97, 0.65	65.74	NaN	29.32	28.34	99.89	NaN	99.17	81.37	53.65	98.28
CGS001-9841	KD	ZBTB24	BTB/POZ domain containing, zinc finger and BTB domain containing 24			11.11, 11.11	1.40, 0.40	32.19	NaN	-28.29	46.16	39.02	51.23	53.99	23.22	99.97	26.83
CGS001-7597	KD	ZBTB25	BTB/POZ domain containing, zinc finger and BTB domain containing 25			12.50, 12.50	1.36, 0.44	-60.51	NaN	-99.00	-91.13	99.00	NaN	-41.34	-99.04	-25.03	-86.40
CGS001-57684	KD	ZBTB26	BTB/POZ domain containing, zinc finger and BTB domain containing 26			22.22, 11.11	1.97, 0.72	98.52	89.37	96.41	-48.51	75.23	-71.93	-51.57	24.36	NaN	90.62
CGS001-360023	KD	ZBTB41	BTB/POZ domain containing, zinc finger and BTB domain containing 41			0.00, 0.00	0.98, 0.42	37.63	-32.42	-37.88	-17.75	-87.37	-99.15	-79.58	-39.13	NaN	-58.56
CGS001-84878	KD	ZBTB45	BTB/POZ domain containing, zinc finger and BTB domain containing 45			0.00, 0.00	1.47, 0.40	-22.27	-44.60	-17.98	25.17	-43.29	NaN	-87.78	-90.55	90.11	-24.36
CGS001-140685	KD	ZBTB46	BTB/POZ domain containing, zinc finger and BTB domain containing 46			14.29, 0.00	1.31, 0.48	96.37	NaN	45.02	46.85	-68.16	NaN	NaN	-76.94	-36.05	-47.83
CGS001-3104	KD	ZBTB48	BTB/POZ domain containing, zinc finger and BTB domain containing 48			0.00, 0.00	1.70, 0.67	23.90	32.79	-12.01	-18.95	-67.50	-99.19	-82.03	-54.48	NaN	-38.06
CGS001-166793	KD	ZBTB49	BTB/POZ domain containing, zinc finger and BTB domain containing 49			0.00, 0.00	1.57, 0.35	-35.28	-99.58	-68.63	34.66	57.26	NaN	-19.44	-99.20	32.02	-33.06
CGS001-9925	KD	ZBTB5	BTB/POZ domain containing, zinc finger and BTB domain containing 5			50.00, 50.00	0.91, 0.34	67.17	100.00	-22.48	99.58	84.93	NaN	NaN	99.24	-99.33	99.84
CGS001-23211	KD	ZC3H4	Zinc fingers, CCCH-type domain containing, zinc finger CCCH-type containing 4			12.50, 12.50	0.92, 0.25	NaN	-63.16	99.91	65.68	56.77	NaN	44.67	66.02	-30.96	52.20
CGS001-51530	KD	ZC3HC1	Zinc fingers, C3HC-type, zinc finger, C3HC-type containing 1			14.29, 14.29	1.66, 0.47	-32.00	NaN	48.59	37.06	99.92	NaN	NaN	93.11	-93.88	78.42
CGS001-64429	KD	ZDHHC6	Zinc fingers, DHHC-type, zinc finger, DHHC-type containing 6			0.00, 0.00	1.58, 0.42	NaN	-49.48	-99.80	-80.05	-87.38	-52.26	NaN	-21.54	23.07	-75.11
CGS001-6935	KD	ZEB1	Zinc fingers, C2H2-type, zinc finger E-box binding homeobox 1			0.00, 0.00	1.53, 0.40	-36.25	-98.16	-39.02	92.10	62.74	-23.30	22.26	-30.50	-73.52	-17.33
CGS001-10444	KD	ZER1	ZYG11 cell cycle regulator family, zer-1 homolog (C. elegans)			25.00, 25.00	1.36, 0.60	98.79	NaN	-67.85	-97.84	99.95	NaN	-76.75	40.09	54.45	78.76
CGS001-54469	KD	ZFAND6	Zinc fingers, AN1-type domain containing, zinc finger, AN1-type domain 6			0.00, 0.00	1.49, 0.42	-92.34	-40.83	-64.73	-56.66	-85.12	38.18	-73.74	-21.53	25.64	-57.51
CGS001-162239	KD	ZFP1	Zinc fingers, C2H2-type, zinc finger protein 1 homolog (mouse)			11.11, 11.11	1.75, 0.49	-41.44	93.64	-36.26	54.65	-79.51	99.00	-68.02	-28.05	NaN	-20.05
CGS001-7771	KD	ZFP112	zinc finger protein 112 homolog (mouse)			0.00, 0.00	1.52, 0.38	-59.66	-24.80	-13.91	-37.85	26.81	-53.08	-16.99	NaN	NaN	-5.05
CGS001-7541	KD	ZFP161	zinc finger protein 161 homolog (mouse)			0.00, 0.00	1.33, 0.27	-13.21	-84.45	-99.56	-83.83	-34.18	NaN	-95.59	-97.14	-93.46	-98.53
CGS001-124961	KD	ZFP3	Zinc fingers, C2H2-type, zinc finger protein 3 homolog (mouse)			0.00, 0.00	1.40, 0.45	-98.79	-100.00	-15.43	-28.80	-79.39	-98.92	24.55	-99.98	-54.79	-99.17
CGS001-7538	KD	ZFP36	RING-type (C3HC4) zinc fingers, zinc finger protein 36, C3H type, homolog (mouse)			20.00, 10.00	1.13, 0.40	-99.59	-32.53	-77.06	-77.80	-87.87	-63.27	99.78	-99.87	95.96	-88.07
CGS001-677	KD	ZFP36L1	RING-type (C3HC4) zinc fingers, zinc finger protein 36, C3H type-like 1			0.00, 0.00	1.32, 0.50	-59.48	89.28	-34.01	25.17	35.15	NaN	-26.51	-25.20	NaN	-9.87
CGS001-678	KD	ZFP36L2	RING-type (C3HC4) zinc fingers, zinc finger protein 36, C3H type-like 2			0.00, 0.00	1.58, 0.36	55.49	-58.94	-98.47	75.58	32.05	NaN	50.97	-38.66	40.40	20.40
CGS001-7543	KD	ZFX	Zinc fingers, C2H2-type, zinc finger protein, X-linked			0.00, 0.00	1.82, 0.47	60.94	-76.61	-75.43	-88.59	66.42	-60.32	-99.94	-90.79	-54.26	-87.55
CGS001-84936	KD	ZFYVE19	Zinc fingers, FYVE domain containing, zinc finger, FYVE domain containing 19			0.00, 0.00	1.72, 0.63	-22.50	38.33	-30.75	27.12	20.95	NaN	-98.52	26.61	87.12	6.00
CGS001-84619	KD	ZGPAT	G patch domain containing, zinc finger, CCCH-type with G patch domain			22.22, 22.22	1.60, 0.55	NaN	99.67	-21.76	59.63	91.66	32.78	-23.55	-16.38	99.97	89.55
CGS001-7546	KD	ZIC2	Zinc fingers, C2H2-type, Zic family member 2			0.00, 0.00	1.13, 0.24	-98.59	27.30	-97.94	-99.98	-23.54	-84.69	-98.55	-72.69	-37.92	-98.64
CGS001-114026	KD	ZIM3	Zinc fingers, C2H2-type, zinc finger, imprinted 3			0.00, 0.00	1.51, 0.50	-99.47	-59.88	-40.44	-49.26	-99.98	-99.97	-98.51	NaN	22.49	-99.95
CGS001-342357	KD	ZKSCAN2	Zinc fingers, C2H2-type, zinc finger with KRAB and SCAN domains 2			11.11, 0.00	1.30, 0.41	36.67	42.81	-70.79	NaN	-59.13	-64.60	25.30	95.17	-97.24	-59.42
CGS001-57178	KD	ZMIZ1	Zinc fingers, MIZ-type, zinc finger, MIZ-type containing 1			10.00, 10.00	1.31, 0.47	-89.50	-94.87	-73.68	-99.88	99.08	70.39	-39.64	-62.75	-99.81	-96.06
CGS001-83637	KD	ZMIZ2	Zinc fingers, MIZ-type, zinc finger, MIZ-type containing 2			0.00, 0.00	1.48, 0.51	-52.91	-32.01	-73.26	11.80	-21.56	NaN	-54.86	-99.71	-76.58	-40.38
CGS001-10269	KD	ZMPSTE24	zinc metallopeptidase (STE24 homolog, S. cerevisiae)			12.50, 0.00	1.19, 0.36	87.56	NaN	-34.08	95.35	49.77	NaN	-56.36	76.33	58.78	80.84
CGS001-7750	KD	ZMYM2	Zinc fingers, MYM type, zinc finger, MYM-type 2			0.00, 0.00	1.76, 0.64	75.69	NaN	-99.41	-93.72	-24.32	NaN	-28.70	-94.13	-90.87	-99.02
CGS001-10771	KD	ZMYND11	Zinc fingers, MYND-type, zinc finger, MYND-type containing 11			10.00, 0.00	1.33, 0.28	29.40	-82.38	-99.68	-22.08	-33.79	-20.05	95.93	-39.11	-56.90	-27.03
CGS001-163071	KD	ZNF114	Zinc fingers, C2H2-type, zinc finger protein 114			12.50, 0.00	1.82, 0.50	-57.06	95.64	-36.64	-39.40	-68.81	-38.79	NaN	NaN	-63.53	-46.92
CGS001-7690	KD	ZNF131	BTB/POZ domain containing, zinc finger protein 131			11.11, 0.00	1.58, 0.55	NaN	-40.27	-99.01	95.34	24.86	64.76	-37.61	51.90	32.38	26.17
CGS001-7692	KD	ZNF133	Zinc fingers, C2H2-type, zinc finger protein 133			22.22, 11.11	2.03, 0.72	82.55	98.50	27.93	42.62	26.40	49.33	96.36	78.84	NaN	85.49
CGS001-7693	KD	ZNF134	Zinc fingers, C2H2-type, zinc finger protein 134			0.00, 0.00	0.89, 0.27	-20.08	-38.70	-26.50	-98.64	76.52	NaN	54.09	-99.70	-82.84	-94.61
CGS001-7697	KD	ZNF138	Zinc fingers, C2H2-type, zinc finger protein 138			0.00, 0.00	1.32, 0.34	-33.21	-39.22	16.03	21.78	42.93	-69.46	-90.49	NaN	NaN	-14.34
CGS001-7702	KD	ZNF143	Zinc fingers, C2H2-type, zinc finger protein 143			0.00, 0.00	0.89, 0.26	-87.00	-93.72	-97.18	-30.96	35.51	-30.84	50.30	-99.27	-35.20	-75.93
CGS001-7727	KD	ZNF174	Zinc fingers, C2H2-type, zinc finger protein 174			14.29, 0.00	1.83, 0.64	-22.84	29.89	-52.79	-94.59	NaN	NaN	96.10	-94.51	NaN	-76.17
CGS001-7728	KD	ZNF175	Zinc fingers, C2H2-type, zinc finger protein 175			0.00, 0.00	1.73, 0.41	60.53	NaN	24.49	40.07	-43.56	87.64	NaN	NaN	71.71	70.86
CGS001-7569	KD	ZNF182	Zinc fingers, C2H2-type, zinc finger protein 182			0.00, 0.00	1.35, 0.41	-99.86	25.28	18.23	-80.51	47.18	-44.14	-45.36	-71.70	NaN	-59.03
CGS001-7748	KD	ZNF195	Zinc fingers, C2H2-type, zinc finger protein 195			14.29, 14.29	2.22, 0.56	23.94	80.38	27.51	99.43	-22.31	31.55	NaN	NaN	NaN	34.79
CGS001-7752	KD	ZNF200	Zinc fingers, C2H2-type, zinc finger protein 200			0.00, 0.00	2.39, 0.88	87.94	57.61	65.02	46.98	-53.01	-22.01	NaN	NaN	NaN	53.92
CGS001-7753	KD	ZNF202	Zinc fingers, C2H2-type, zinc finger protein 202			0.00, 0.00	1.36, 0.43	-17.20	-28.02	-93.01	-37.41	-86.52	-53.22	NaN	-91.00	-22.40	-58.35
CGS001-7756	KD	ZNF207	Zinc fingers, C2H2-type, zinc finger protein 207			0.00, 0.00	1.53, 0.58	-70.89	NaN	60.18	81.13	24.07	NaN	NaN	90.67	32.78	81.32
CGS001-7988	KD	ZNF212	Zinc fingers, C2H2-type, zinc finger protein 212			0.00, 0.00	1.48, 0.49	-20.83	90.18	38.28	-42.50	-98.88	70.62	-26.22	-48.31	NaN	-26.12
CGS001-7760	KD	ZNF213	Zinc fingers, C2H2-type, zinc finger protein 213			0.00, 0.00	1.91, 0.45	70.99	51.12	85.44	41.46	57.93	-77.72	NaN	NaN	NaN	60.18
CGS001-7764	KD	ZNF217	Zinc fingers, C2H2-type, zinc finger protein 217			0.00, 0.00	1.75, 0.61	-59.07	NaN	-17.84	48.91	NaN	NaN	-98.07	-97.71	-49.36	-84.50
CGS001-51222	KD	ZNF219	Zinc fingers, C2H2-type, zinc finger protein 219			11.11, 11.11	1.32, 0.36	-69.39	98.40	-99.34	-20.74	-97.86	NaN	-27.52	-98.85	34.28	-96.30
CGS001-7775	KD	ZNF232	Zinc fingers, C2H2-type, zinc finger protein 232			0.00, 0.00	1.41, 0.33	-22.56	-53.64	18.13	24.97	45.06	-99.94	-70.88	NaN	26.58	-13.26
CGS001-10472	KD	ZNF238	zinc finger protein 238			0.00, 0.00	1.61, 0.36	-22.43	-82.88	79.55	64.00	-35.89	-42.08	80.44	NaN	NaN	61.28
CGS001-7572	KD	ZNF24	Zinc fingers, C2H2-type, zinc finger protein 24			11.11, 11.11	1.25, 0.27	74.22	71.32	-58.18	41.41	28.75	NaN	99.98	23.05	37.72	39.53
CGS001-10127	KD	ZNF263	Zinc fingers, C2H2-type, zinc finger protein 263			0.00, 0.00	2.27, 0.69	-97.80	-99.98	-31.94	-36.78	-29.20	-65.67	-35.22	-57.17	23.33	-41.11
CGS001-10781	KD	ZNF266	Zinc fingers, C2H2-type, zinc finger protein 266			10.00, 10.00	1.13, 0.33	-50.03	99.04	-91.18	-32.44	-41.64	-88.44	-17.47	-31.26	30.02	-16.07
CGS001-10308	KD	ZNF267	Zinc fingers, C2H2-type, zinc finger protein 267			0.00, 0.00	2.15, 0.66	-24.33	73.98	82.96	41.63	48.12	NaN	82.55	85.30	-98.52	89.45
CGS001-10795	KD	ZNF268	Zinc fingers, C2H2-type, zinc finger protein 268			11.11, 11.11	1.27, 0.26	32.97	30.19	-47.80	32.80	-45.30	NaN	99.30	-30.15	32.44	16.95
CGS001-10793	KD	ZNF273	Zinc fingers, C2H2-type, zinc finger protein 273			0.00, 0.00	0.89, 0.11	15.52	94.21	52.76	-69.52	-20.81	53.99	NaN	NaN	74.64	37.96
CGS001-10782	KD	ZNF274	Zinc fingers, C2H2-type, zinc finger protein 274			22.22, 22.22	1.51, 0.36	-15.54	99.87	93.01	98.59	-99.98	-73.65	NaN	-25.25	-99.90	72.69
CGS001-11179	KD	ZNF277	zinc finger protein 277			12.50, 0.00	1.43, 0.45	95.51	-27.59	-47.78	31.93	NaN	-69.18	-97.03	-72.95	NaN	-52.40
CGS001-23528	KD	ZNF281	Zinc fingers, C2H2-type, zinc finger protein 281			0.00, 0.00	1.53, 0.45	-19.34	76.50	-27.46	-28.43	57.59	-99.07	-46.99	-69.75	-96.23	-44.02
CGS001-162979	KD	ZNF296	Zinc fingers, C2H2-type, zinc finger protein 296			0.00, 0.00	1.48, 0.40	93.37	28.15	81.84	85.73	89.06	34.02	92.40	68.10	NaN	84.32
CGS001-91975	KD	ZNF300	Zinc fingers, C2H2-type, zinc finger protein 300			12.50, 0.00	1.50, 0.44	-72.03	NaN	-25.69	-99.44	22.28	NaN	16.95	96.82	-33.67	-17.55
CGS001-57693	KD	ZNF317	Zinc fingers, C2H2-type, zinc finger protein 317			0.00, 0.00	1.89, 0.69	-25.82	66.29	20.27	39.43	-95.35	-97.84	37.74	-33.67	NaN	-11.20
CGS001-24149	KD	ZNF318	Zinc fingers, C2H2-type, zinc finger protein 318			0.00, 0.00	1.36, 0.44	NaN	-37.94	-96.73	-96.72	-28.00	-32.09	-29.73	-26.15	84.91	-36.48
CGS001-7580	KD	ZNF32	Zinc fingers, C2H2-type, zinc finger protein 32			10.00, 0.00	1.59, 0.44	45.38	-24.17	30.53	36.48	-93.29	40.30	-25.16	27.54	95.35	26.63
CGS001-25799	KD	ZNF324	Zinc fingers, C2H2-type, zinc finger protein 324			0.00, 0.00	2.16, 0.69	-63.97	-98.93	-60.32	-25.49	-96.99	-88.30	-99.49	-97.73	NaN	-96.35
CGS001-55422	KD	ZNF331	Zinc fingers, C2H2-type, zinc finger protein 331			0.00, 0.00	1.19, 0.43	-35.46	NaN	-84.53	-40.60	-99.12	NaN	NaN	41.95	-99.20	-98.23
CGS001-84449	KD	ZNF333	Zinc fingers, C2H2-type, zinc finger protein 333			0.00, 0.00	1.56, 0.42	-28.54	44.45	27.49	-86.18	-58.26	30.20	29.48	-26.95	NaN	-22.40
CGS001-59348	KD	ZNF350	Zinc fingers, C2H2-type, zinc finger protein 350			12.50, 12.50	1.69, 0.53	57.64	43.63	-94.37	-31.45	NaN	33.70	-89.39	98.95	NaN	36.24
CGS001-117608	KD	ZNF354B	Zinc fingers, C2H2-type, zinc finger protein 354B			11.11, 11.11	1.91, 0.57	99.10	47.18	33.67	36.40	79.86	59.54	48.01	92.35	NaN	74.65
CGS001-22891	KD	ZNF365	Zinc fingers, C2H2-type, zinc finger protein 365			12.50, 0.00	0.95, 0.27	-99.82	NaN	-13.22	86.04	-20.81	NaN	-95.29	-13.55	97.08	-21.23
CGS001-167465	KD	ZNF366	Zinc fingers, C2H2-type, zinc finger protein 366			0.00, 0.00	1.64, 0.38	-83.52	-35.73	23.62	NaN	42.13	-52.95	-94.84	-43.16	21.20	-39.94
CGS001-171017	KD	ZNF384	Zinc fingers, C2H2-type, zinc finger protein 384			0.00, 0.00	1.23, 0.34	-16.71	33.74	-99.28	-54.61	43.85	NaN	60.16	13.26	-80.75	-15.20
CGS001-151126	KD	ZNF385B	zinc finger protein 385B			0.00, 0.00	1.42, 0.45	-99.43	41.33	74.40	23.66	-99.98	-29.67	39.00	31.09	34.93	7.26
CGS001-55893	KD	ZNF395	Zinc fingers, C2H2-type, zinc finger protein 395			25.00, 25.00	1.69, 0.61	-50.39	NaN	87.07	91.31	99.94	45.07	NaN	68.16	94.34	98.13
CGS001-147686	KD	ZNF418	Zinc fingers, C2H2-type, zinc finger protein 418			0.00, 0.00	1.06, 0.41	-49.67	-85.98	-73.84	32.87	-60.72	NaN	NaN	-68.58	-44.62	-59.40
CGS001-79088	KD	ZNF426	Zinc fingers, C2H2-type, zinc finger protein 426			11.11, 0.00	1.60, 0.51	67.24	38.48	71.92	-27.89	96.13	77.86	-75.86	62.56	NaN	64.98
CGS001-9668	KD	ZNF432	Zinc fingers, C2H2-type, zinc finger protein 432			0.00, 0.00	1.47, 0.50	-30.92	-100.00	44.01	-52.89	-68.50	35.76	-76.34	-98.58	NaN	-72.25
CGS001-163059	KD	ZNF433	Zinc fingers, C2H2-type, zinc finger protein 433			0.00, 0.00	1.30, 0.40	-96.57	-26.50	48.67	-33.25	46.65	22.97	69.97	-99.07	-99.21	-66.84
CGS001-54925	KD	ZNF434	zinc finger protein 434			0.00, 0.00	1.27, 0.27	-22.95	53.64	-99.86	-49.87	-25.25	NaN	-99.98	-33.24	-42.55	-14.33
CGS001-80818	KD	ZNF436	Zinc fingers, C2H2-type, zinc finger protein 436			0.00, 0.00	1.45, 0.43	-73.17	31.63	66.46	-21.27	-23.20	42.69	30.06	-36.26	34.54	15.83
CGS001-55311	KD	ZNF444	Zinc fingers, C2H2-type, zinc finger protein 444			0.00, 0.00	1.15, 0.31	-34.01	23.84	-94.91	66.43	-25.23	NaN	-49.57	64.96	-92.22	-28.97
CGS001-203523	KD	ZNF449	Zinc fingers, C2H2-type, zinc finger protein 449			12.50, 12.50	2.17, 0.58	-18.44	100.00	-27.25	-27.35	NaN	NaN	-78.95	-21.39	36.98	-7.85
CGS001-26036	KD	ZNF451	Zinc fingers, C2H2-type, zinc finger protein 451			12.50, 0.00	1.40, 0.48	NaN	-23.39	-96.30	94.32	28.64	NaN	76.60	85.59	96.83	87.02
CGS001-285676	KD	ZNF454	Zinc fingers, C2H2-type, zinc finger protein 454			22.22, 22.22	2.02, 0.51	99.50	76.95	68.35	53.27	-93.55	NaN	-24.24	99.75	44.49	78.97
CGS001-58499	KD	ZNF462	Zinc fingers, C2H2-type, zinc finger protein 462			22.22, 22.22	1.55, 0.33	-27.79	-89.65	98.93	70.59	-39.64	-33.69	99.77	46.48	NaN	71.46
CGS001-25888	KD	ZNF473	Zinc fingers, C2H2-type, zinc finger protein 473			11.11, 11.11	1.26, 0.40	68.63	-49.87	89.71	86.49	99.98	NaN	-20.26	-76.26	-96.22	78.95
CGS001-90649	KD	ZNF486	Zinc fingers, C2H2-type, zinc finger protein 486			0.00, 0.00	1.25, 0.44	44.10	66.59	-24.09	35.31	54.27	-38.66	-58.75	-38.23	22.74	9.17
CGS001-118738	KD	ZNF488	Zinc fingers, C2H2-type, zinc finger protein 488			12.50, 0.00	1.73, 0.56	-25.99	-44.61	96.39	42.77	57.91	NaN	70.72	-26.88	NaN	39.61
CGS001-57474	KD	ZNF490	Zinc fingers, C2H2-type, zinc finger protein 490			10.00, 10.00	1.02, 0.22	74.58	64.85	93.01	22.51	50.15	85.94	99.55	22.26	-28.90	71.69
CGS001-115560	KD	ZNF501	Zinc fingers, C2H2-type, zinc finger protein 501			0.00, 0.00	1.30, 0.34	-38.80	48.53	-23.24	-57.29	-90.22	-41.12	-33.70	33.11	-95.40	-30.91
CGS001-91392	KD	ZNF502	Zinc fingers, C2H2-type, zinc finger protein 502			22.22, 22.22	1.48, 0.40	85.49	-24.06	99.94	99.85	88.26	NaN	-51.98	62.75	25.46	89.73
CGS001-340385	KD	ZNF517	Zinc fingers, C2H2-type, zinc finger protein 517			0.00, 0.00	1.74, 0.73	28.69	-99.78	-20.94	-90.24	24.07	-92.58	-62.21	-28.39	59.15	-57.04
CGS001-162655	KD	ZNF519	Zinc fingers, C2H2-type, zinc finger protein 519			12.50, 12.50	2.47, 0.69	84.99	99.34	56.89	58.23	94.96	NaN	NaN	-44.44	53.49	91.73
CGS001-25925	KD	ZNF521	Zinc fingers, C2H2-type, zinc finger protein 521			55.56, 11.11	1.60, 0.41	96.69	96.56	91.38	96.11	76.46	NaN	96.94	33.36	39.41	99.42
CGS001-147807	KD	ZNF524	Zinc fingers, C2H2-type, zinc finger protein 524			20.00, 20.00	1.53, 0.43	20.68	-18.56	-92.94	66.54	13.45	-54.94	-75.03	99.51	99.12	19.70
CGS001-125919	KD	ZNF543	Zinc fingers, C2H2-type, zinc finger protein 543			0.00, 0.00	1.60, 0.55	-99.76	29.91	-16.43	-69.92	-79.71	NaN	-61.40	-73.67	NaN	-62.87
CGS001-339327	KD	ZNF546	Zinc fingers, C2H2-type, zinc finger protein 546			0.00, 0.00	1.18, 0.42	-37.16	-98.24	22.64	84.27	-30.78	-37.80	-23.47	31.17	NaN	-14.45
CGS001-147694	KD	ZNF548	Zinc fingers, C2H2-type, zinc finger protein 548			10.00, 10.00	2.06, 0.65	48.94	61.68	63.26	93.04	-24.55	85.63	72.53	98.64	92.03	87.00
CGS001-90233	KD	ZNF551	Zinc fingers, C2H2-type, zinc finger protein 551			44.44, 44.44	1.36, 0.48	94.76	98.97	75.96	98.46	-89.49	97.98	NaN	27.97	-21.94	98.69
CGS001-115196	KD	ZNF554	Zinc fingers, C2H2-type, zinc finger protein 554			0.00, 0.00	1.22, 0.39	-99.98	-94.47	-63.33	-99.46	-99.80	-63.30	-99.98	-71.46	NaN	-99.95
CGS001-148156	KD	ZNF558	Zinc fingers, C2H2-type, zinc finger protein 558			0.00, 0.00	1.35, 0.41	15.68	40.50	-65.66	22.99	-96.31	46.20	NaN	-97.36	NaN	-43.89
CGS001-84527	KD	ZNF559	Zinc fingers, C2H2-type, zinc finger protein 559			0.00, 0.00	1.32, 0.42	-90.83	75.72	29.60	-57.85	43.47	NaN	38.49	-38.45	55.72	18.09
CGS001-93134	KD	ZNF561	Zinc fingers, C2H2-type, zinc finger protein 561			12.50, 12.50	1.49, 0.51	-59.69	NaN	98.17	-30.23	86.27	NaN	-29.23	-73.71	36.03	-17.20
CGS001-54811	KD	ZNF562	Zinc fingers, C2H2-type, zinc finger protein 562			0.00, 0.00	1.43, 0.34	-23.33	33.96	-25.57	-67.94	64.14	NaN	20.78	69.90	85.28	42.96
CGS001-147837	KD	ZNF563	Zinc fingers, C2H2-type, zinc finger protein 563			25.00, 25.00	1.60, 0.44	-24.15	-22.93	92.37	99.98	60.12	NaN	59.03	97.53	NaN	93.69
CGS001-163081	KD	ZNF567	Zinc fingers, C2H2-type, zinc finger protein 567			0.00, 0.00	1.42, 0.42	-68.70	-78.95	73.49	21.94	76.34	-99.97	31.03	-99.98	-23.42	-62.32
CGS001-126295	KD	ZNF57	Zinc fingers, C2H2-type, zinc finger protein 57			0.00, 0.00	1.98, 0.56	29.50	-97.95	37.01	88.55	NaN	86.34	73.91	-60.15	NaN	57.60
CGS001-79177	KD	ZNF576	Zinc fingers, C2H2-type, zinc finger protein 576			20.00, 10.00	2.18, 0.67	91.87	-26.08	83.90	78.36	-89.21	19.52	99.96	97.12	82.25	92.71
CGS001-84765	KD	ZNF577	Zinc fingers, C2H2-type, zinc finger protein 577			0.00, 0.00	1.73, 0.57	-18.61	-71.19	-94.16	-59.36	-99.77	31.79	NaN	-64.76	NaN	-61.01
CGS001-147948	KD	ZNF582	Zinc fingers, C2H2-type, zinc finger protein 582			0.00, 0.00	1.35, 0.31	-55.99	56.99	37.41	-66.71	-54.79	NaN	-59.98	37.22	22.47	-30.93
CGS001-147949	KD	ZNF583	Zinc fingers, C2H2-type, zinc finger protein 583			11.11, 0.00	1.36, 0.33	-23.19	24.87	23.82	86.15	81.32	96.70	-89.75	NaN	24.44	54.22
CGS001-199704	KD	ZNF585A	Zinc fingers, C2H2-type, zinc finger protein 585A			11.11, 11.11	2.21, 0.57	78.43	64.61	32.54	56.44	56.16	NaN	97.75	37.16	31.64	82.12
CGS001-54807	KD	ZNF586	Zinc fingers, C2H2-type, zinc finger protein 586			44.44, 33.33	2.60, 1.02	-43.60	77.78	99.76	99.89	-21.15	NaN	-47.06	94.48	96.66	98.50
CGS001-51385	KD	ZNF589	Zinc fingers, C2H2-type, zinc finger protein 589			10.00, 10.00	1.03, 0.33	-61.82	22.88	-32.48	99.15	-75.38	32.48	-27.00	13.20	-23.02	-4.94
CGS001-169270	KD	ZNF596	Zinc fingers, C2H2-type, zinc finger protein 596			10.00, 0.00	1.53, 0.42	-91.32	97.12	19.08	29.19	-35.52	51.54	-35.16	-46.02	20.57	-12.38
CGS001-146434	KD	ZNF597	Zinc fingers, C2H2-type, zinc finger protein 597			10.00, 10.00	1.14, 0.30	37.70	21.67	68.64	42.05	98.22	-78.79	-67.40	-37.78	-44.36	16.50
CGS001-84775	KD	ZNF607	Zinc fingers, C2H2-type, zinc finger protein 607			0.00, 0.00	1.17, 0.36	19.24	41.64	-64.01	81.73	93.02	NaN	-39.68	20.31	77.19	25.02
CGS001-162963	KD	ZNF610	Zinc fingers, C2H2-type, zinc finger protein 610			10.00, 10.00	1.53, 0.48	-21.58	31.41	18.96	-45.43	-61.27	99.38	-71.64	-61.45	-31.26	-12.83
CGS001-81856	KD	ZNF611	Zinc fingers, C2H2-type, zinc finger protein 611			30.00, 30.00	1.48, 0.41	33.31	-22.23	55.54	99.91	28.52	33.11	99.57	49.96	99.84	93.56
CGS001-285267	KD	ZNF619	Zinc fingers, C2H2-type, zinc finger protein 619			0.00, 0.00	1.42, 0.50	-29.41	26.76	-58.36	-74.90	-51.05	NaN	-44.96	-35.92	50.16	-41.06
CGS001-285268	KD	ZNF621	Zinc fingers, C2H2-type, zinc finger protein 621			0.00, 0.00	1.28, 0.39	-99.66	-66.31	36.71	-71.89	-97.36	71.99	57.33	45.94	-98.27	-89.78
CGS001-9831	KD	ZNF623	Zinc fingers, C2H2-type, zinc finger protein 623			10.00, 10.00	2.02, 0.53	-59.76	64.93	-62.03	37.03	99.54	-56.72	-97.90	-22.48	88.54	-37.88
CGS001-57547	KD	ZNF624	Zinc fingers, C2H2-type, zinc finger protein 624			0.00, 0.00	1.16, 0.22	-75.20	-98.33	26.33	-88.61	-58.34	-46.50	-85.08	-99.95	NaN	-85.13
CGS001-90589	KD	ZNF625	Zinc fingers, C2H2-type, zinc finger protein 625			0.00, 0.00	1.32, 0.32	93.04	-23.63	77.73	82.04	53.56	-26.00	30.00	47.36	19.06	43.01
CGS001-199777	KD	ZNF626	Zinc fingers, C2H2-type, zinc finger protein 626			0.00, 0.00	1.19, 0.53	-17.59	-29.89	-89.71	-69.20	23.13	-55.95	-93.87	-52.91	28.30	-34.41
CGS001-23361	KD	ZNF629	Zinc fingers, C2H2-type, zinc finger protein 629			16.67, 16.67	2.66, 0.94	NaN	NaN	40.29	99.74	-34.28	NaN	NaN	87.33	-46.89	65.33
CGS001-115950	KD	ZNF653	Zinc fingers, C2H2-type, zinc finger protein 653			0.00, 0.00	1.34, 0.47	-50.83	-93.05	47.52	-92.43	-38.15	35.52	NaN	-45.23	-98.27	-81.60
CGS001-26149	KD	ZNF658	Zinc fingers, C2H2-type, zinc finger protein 658			11.11, 11.11	1.17, 0.43	43.01	-67.46	-14.46	99.52	-52.78	NaN	-24.40	32.21	24.31	15.97
CGS001-389114	KD	ZNF662	Zinc fingers, C2H2-type, zinc finger protein 662			0.00, 0.00	1.53, 0.42	-67.32	-27.03	-19.56	-27.63	-36.63	91.28	-21.80	-32.83	-21.21	-8.03
CGS001-79862	KD	ZNF669	Zinc fingers, C2H2-type, zinc finger protein 669			12.50, 0.00	1.91, 0.63	NaN	-22.88	-73.32	53.09	-99.28	NaN	-37.11	95.57	71.82	-57.73
CGS001-79891	KD	ZNF671	Zinc fingers, C2H2-type, zinc finger protein 671			0.00, 0.00	0.91, 0.26	9.11	54.75	-68.17	-25.24	38.85	-90.68	NaN	-22.77	-15.61	-3.39
CGS001-79894	KD	ZNF672	Zinc fingers, C2H2-type, zinc finger protein 672			44.44, 44.44	1.72, 0.44	-67.33	20.22	-58.79	99.90	98.85	33.27	NaN	99.15	-53.27	99.58
CGS001-55634	KD	ZNF673	zinc finger family member 673			20.00, 20.00	1.16, 0.23	-81.46	-96.75	88.07	99.88	20.76	25.70	-99.16	-24.10	99.97	-40.42
CGS001-342926	KD	ZNF677	Zinc fingers, C2H2-type, zinc finger protein 677			0.00, 0.00	1.26, 0.30	-99.81	-95.67	-99.67	-73.89	-99.96	NaN	69.79	-47.53	-77.90	-99.89
CGS001-339500	KD	ZNF678	Zinc fingers, C2H2-type, zinc finger protein 678			0.00, 0.00	1.47, 0.59	30.11	74.10	40.13	-35.15	31.08	-40.85	17.06	-41.74	NaN	11.63
CGS001-127396	KD	ZNF684	Zinc fingers, C2H2-type, zinc finger protein 684			10.00, 0.00	1.14, 0.32	-56.90	-35.07	-85.70	40.79	30.96	23.57	-46.46	-22.08	95.23	-13.74
CGS001-55657	KD	ZNF692	Zinc fingers, C2H2-type, zinc finger protein 692			11.11, 0.00	1.03, 0.38	-51.99	-22.80	-72.90	41.91	38.29	-30.33	88.60	NaN	97.19	47.19
CGS001-286075	KD	ZNF707	Zinc fingers, C2H2-type, zinc finger protein 707			11.11, 11.11	1.25, 0.28	-43.07	63.31	-32.14	98.63	26.74	NaN	90.03	-47.75	52.67	55.20
CGS001-7625	KD	ZNF74	Zinc fingers, C2H2-type, zinc finger protein 74			44.44, 33.33	2.03, 0.58	41.45	99.96	90.66	90.27	99.98	NaN	33.52	97.46	94.41	99.03
CGS001-92595	KD	ZNF764	Zinc fingers, C2H2-type, zinc finger protein 764			20.00, 20.00	1.69, 0.47	90.69	23.19	91.96	62.59	-24.08	99.23	41.80	99.77	35.58	93.66
CGS001-79724	KD	ZNF768	Zinc fingers, C2H2-type, zinc finger protein 768			0.00, 0.00	2.24, 0.53	-10.41	-99.52	21.44	-99.78	28.02	-85.99	-93.47	-97.89	-84.31	-96.87
CGS001-58492	KD	ZNF77	Zinc fingers, C2H2-type, zinc finger protein 77			0.00, 0.00	2.26, 0.72	-43.60	47.47	-88.80	-53.56	78.72	NaN	79.88	30.94	-42.47	39.12
CGS001-146540	KD	ZNF785	Zinc fingers, C2H2-type, zinc finger protein 785			0.00, 0.00	1.75, 0.57	-98.50	-72.74	-20.85	-46.27	80.49	-52.64	-24.90	-99.98	-96.18	-82.54
CGS001-136051	KD	ZNF786	Zinc fingers, C2H2-type, zinc finger protein 786			20.00, 10.00	1.53, 0.55	-17.23	-40.53	38.83	73.13	43.03	30.15	99.95	54.85	95.30	52.35
CGS001-126208	KD	ZNF787	Zinc fingers, C2H2-type, zinc finger protein 787			11.11, 0.00	1.28, 0.33	28.90	78.46	-99.96	39.37	23.92	NaN	95.39	-30.30	37.56	9.01
CGS001-163049	KD	ZNF791	Zinc fingers, C2H2-type, zinc finger protein 791			30.00, 30.00	0.94, 0.32	-37.68	43.19	98.67	99.84	99.77	-39.48	-40.03	-36.19	-82.71	93.84
CGS001-126375	KD	ZNF792	Zinc fingers, C2H2-type, zinc finger protein 792			0.00, 0.00	1.58, 0.57	30.49	-28.50	-63.60	-28.77	-64.96	-8.68	35.92	-99.32	NaN	-25.72
CGS001-7554	KD	ZNF8	Zinc fingers, C2H2-type, zinc finger protein 8			0.00, 0.00	1.94, 0.55	-20.28	-33.81	-18.85	-25.31	-31.16	81.76	NaN	-97.35	66.47	-11.08
CGS001-390980	KD	ZNF805	Zinc fingers, C2H2-type, zinc finger protein 805			11.11, 11.11	1.93, 0.56	22.59	32.06	99.53	31.16	-86.11	NaN	-17.81	60.45	-95.98	21.22
CGS001-7639	KD	ZNF85	Zinc fingers, C2H2-type, zinc finger protein 85			0.00, 0.00	1.11, 0.30	-54.39	-92.44	16.74	-47.85	43.43	-99.12	73.71	-99.33	NaN	-94.36
CGS001-168374	KD	ZNF92	Zinc fingers, C2H2-type, zinc finger protein 92			0.00, 0.00	1.75, 0.68	-33.29	NaN	75.68	26.23	-51.98	NaN	21.25	-30.81	-32.21	-14.84
CGS001-9326	KD	ZNHIT3	Zinc fingers, HIT-type, zinc finger, HIT-type containing 3			0.00, 0.00	1.63, 0.33	-89.00	-22.14	-88.30	-50.06	-23.54	NaN	-92.94	-98.12	-98.29	-91.53
CGS001-124626	KD	ZPBP2	Immunoglobulin superfamily / Immunoglobulin-like domain containing, zona pellucida binding protein 2			11.11, 11.11	1.51, 0.40	98.03	-39.78	-99.41	-83.16	21.64	NaN	-88.01	-88.31	22.45	-83.76
CGS001-9406	KD	ZRANB2	Zinc fingers, RAN-binding domain containing, zinc finger, RAN-binding domain containing 2		Zinc fingers RanBP2 type LOF	22.22, 11.11	1.30, 0.24	99.78	96.49	-46.35	21.83	-22.12	NaN	-21.86	-36.23	-22.52	-6.07
CGS001-8233	KD	ZRSR2	RNA binding motif (RRM) containing, zinc finger (CCCH type), RNA-binding motif and serine/arginine rich 2			44.44, 33.33	1.11, 0.36	-28.81	79.52	99.76	97.95	-93.32	NaN	74.53	97.09	-92.09	99.32
CGS001-284312	KD	ZSCAN1	Zinc fingers, C2H2-type, zinc finger and SCAN domain containing 1			11.11, 11.11	1.24, 0.42	41.99	26.32	17.84	99.90	57.34	-99.97	-22.37	86.73	NaN	38.76
CGS001-146050	KD	ZSCAN29	Zinc fingers, C2H2-type, zinc finger and SCAN domain containing 29			44.44, 33.33	1.51, 0.55	27.92	26.67	36.61	98.42	99.72	99.86	-26.60	-87.53	NaN	95.82
CGS001-201516	KD	ZSCAN4	Zinc fingers, C2H2-type, zinc finger and SCAN domain containing 4			0.00, 0.00	1.56, 0.47	28.23	NaN	66.54	33.01	-99.06	51.44	-31.70	-39.53	-33.76	-22.12
CGS001-151112	KD	ZSWIM2	Zinc fingers, SWIM-type, zinc finger, SWIM-type containing 2			0.00, 0.00	2.02, 0.56	33.74	89.46	67.36	-42.76	28.38	92.11	48.83	28.33	26.92	45.84
CGS001-9183	KD	ZW10	ZW10, kinetochore associated, homolog (Drosophila)			37.50, 37.50	1.31, 0.43	NaN	NaN	99.98	48.33	92.01	46.03	85.86	64.49	98.14	98.50
CGS001-340273	KD	ABCB5	ATP binding cassette transporters / subfamily B, ATP-binding cassette, sub-family B (MDR/TAP), member 5			0.00, 0.00	1.32, 0.41	42.72	92.04	NaN	-31.34	-88.25	-47.47	-65.62	-30.51	26.72	-25.95
CGS001-22	KD	ABCB7	ATP binding cassette transporters / subfamily B, ATP-binding cassette, sub-family B (MDR/TAP), member 7			57.14, 57.14	1.15, 0.39	-93.96	NaN	NaN	98.77	99.98	NaN	-97.12	82.55	99.97	99.89
CGS001-113451	KD	ADC	arginine decarboxylase			12.50, 12.50	1.41, 0.41	-64.06	-66.48	NaN	-50.74	NaN	98.51	33.94	-96.35	28.24	-69.28
CGS001-156	KD	ADRBK1	BARK/GRK2 subfamily, adrenergic, beta, receptor kinase 1			0.00, 0.00	2.49, 0.69	-96.59	-25.05	NaN	-67.45	NaN	-28.87	NaN	-23.07	NaN	-42.04
CGS001-196	KD	AHR	Basic helix-loop-helix proteins, aryl hydrocarbon receptor			0.00, 0.00	1.16, 0.31	-56.42	-47.44	NaN	-24.74	-96.70	-32.58	-88.79	-67.37	-46.83	-60.39
CGS001-205	KD	AK4	Adenylate kinases, adenylate kinase 4			11.11, 0.00	0.66, 0.16	35.00	66.15	21.87	41.99	96.08	83.98	-30.34	94.81	NaN	48.42
CGS001-8644	KD	AKR1C3	Prostaglandin synthases, aldo-keto reductase family 1, member C3 (3-alpha hydroxysteroid dehydrogenase, type II)			0.00, 0.00	1.18, 0.35	-97.11	NaN	NaN	-96.73	-58.56	NaN	-32.70	-57.91	-21.90	-83.40
CGS001-10000	KD	AKT3	Akt (Protein kinase B), v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma)		Akt Signaling LOF	0.00, 0.00	0.16, 0.03	-28.35	-47.65	-11.96	-21.70	24.79	61.04	-89.13	-81.17	-94.06	-39.25
CGS001-219	KD	ALDH1B1	Aldehyde dehydrogenases, aldehyde dehydrogenase 1 family, member B1			11.11, 11.11	1.20, 0.34	41.32	87.76	NaN	47.44	-29.96	99.50	-50.95	-12.28	53.89	25.67
CGS001-224	KD	ALDH3A2	Aldehyde dehydrogenases, aldehyde dehydrogenase 3 family, member A2			20.00, 20.00	1.90, 0.95	NaN	NaN	NaN	73.48	62.77	NaN	NaN	99.51	82.65	85.46
CGS001-222	KD	ALDH3B2	Aldehyde dehydrogenases, aldehyde dehydrogenase 3 family, member B2			50.00, 50.00	1.77, 0.86	-75.11	NaN	NaN	99.98	47.98	NaN	NaN	98.61	-57.06	97.60
CGS001-226	KD	ALDOA	aldolase A, fructose-bisphosphate			12.50, 12.50	1.35, 0.42	-50.00	99.85	NaN	-25.82	-47.32	-99.91	-99.67	-66.92	NaN	-81.10
CGS001-283	KD	ANG	Ribonucleases, RNase A, angiogenin, ribonuclease, RNase A family, 5			11.11, 11.11	1.36, 0.35	24.91	45.22	NaN	-52.22	98.57	-98.21	36.89	32.39	-87.86	19.66
CGS001-301	KD	ANXA1	Annexins, annexin A1			0.00, 0.00	1.30, 0.41	-98.95	54.10	NaN	-25.73	-31.73	NaN	-26.05	-99.07	19.58	-31.81
CGS001-8905	KD	AP1S2	adaptor-related protein complex 1, sigma 2 subunit			0.00, 0.00	1.97, 0.65	-51.47	57.63	NaN	-32.51	NaN	NaN	-37.25	-41.41	-98.04	-44.65
CGS001-11154	KD	AP4S1	adaptor-related protein complex 4, sigma 1 subunit			0.00, 0.00	0.98, 0.34	-94.62	66.71	NaN	-97.41	-98.36	NaN	NaN	92.22	-43.49	-98.18
CGS001-9826	KD	ARHGEF11	Rho guanine nucleotide exchange factors, Rho guanine nucleotide exchange factor (GEF) 11			0.00, 0.00	1.35, 0.33	-80.34	-28.35	NaN	46.48	-56.68	-88.67	36.38	-54.66	-99.56	-76.01
CGS001-121549	KD	ASCL4	Basic helix-loop-helix proteins, achaete-scute complex homolog 4 (Drosophila)			0.00, 0.00	1.45, 0.49	36.78	-45.66	NaN	-31.11	-65.40	NaN	-68.91	-33.05	-41.37	-19.68
CGS001-476	KD	ATP1A1	ATPases / P-type, ATPase, Na+/K+ transporting, alpha 1 polypeptide			50.00, 50.00	1.45, 0.69	73.65	NaN	NaN	97.68	38.68	NaN	NaN	99.98	38.53	97.88
CGS001-516	KD	ATP5G1	ATPases / F-type, ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)			12.50, 12.50	1.48, 0.41	99.98	54.04	NaN	64.98	86.96	NaN	-27.34	94.93	60.93	91.69
CGS001-527	KD	ATP6V0C	ATPases / V-type, ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c		V type ATPases LOF	0.00, 0.00	1.89, 0.56	-26.47	-87.89	NaN	-54.40	-32.12	36.52	-97.83	-38.43	-92.93	-54.16
CGS001-64343	KD	AZI2	5-azacytidine induced 2			0.00, 0.00	1.57, 0.48	-99.21	-83.54	NaN	-26.52	-99.81	-87.22	NaN	-39.54	NaN	-93.87
CGS001-572	KD	BAD	BCL2-associated agonist of cell death			0.00, 0.00	1.01, 0.20	20.85	-79.44	-91.60	63.46	23.95	-78.16	-94.57	-91.61	-80.18	-79.37
CGS001-10538	KD	BATF	basic leucine zipper proteins, basic leucine zipper transcription factor, ATF-like			0.00, 0.00	1.65, 0.51	-88.36	62.61	NaN	-97.14	-82.65	-73.93	-16.35	-80.83	NaN	-89.50
CGS001-55509	KD	BATF3	basic leucine zipper proteins, basic leucine zipper transcription factor, ATF-like 3			57.14, 57.14	1.56, 0.53	91.49	98.79	NaN	92.92	NaN	NaN	97.63	56.20	98.45	98.61
CGS001-645	KD	BLVRB	Short chain dehydrogenase/reductase superfamily / Atypical members, biliverdin reductase B (flavin reductase (NADPH))			14.29, 14.29	1.27, 0.49	93.06	40.27	NaN	-99.53	-60.99	NaN	NaN	98.68	23.61	81.34
CGS001-8315	KD	BRAP	RING-type (C3HC4) zinc fingers, BRCA1 associated protein			0.00, 0.00	1.20, 0.43	41.43	26.93	NaN	-67.69	-25.45	-83.55	81.03	-28.79	-28.62	-7.58
CGS001-10902	KD	BRD8	Bromodomain kinase (BRDK) family, bromodomain containing 8			0.00, 0.00	1.69, 0.43	57.57	25.59	NaN	24.54	NaN	-42.89	-51.29	-43.15	28.53	-12.66
CGS001-91304	KD	C19ORF6	chromosome 19 open reading frame 6			0.00, 0.00	1.40, 0.45	-46.06	-75.12	NaN	-28.83	23.25	27.80	-35.44	-97.04	21.98	-31.28
CGS001-805	KD	CALM2	EF-hand domain containing, calmodulin 2 (phosphorylase kinase, delta)			25.00, 0.00	1.38, 0.50	-78.63	84.26	NaN	54.53	97.27	NaN	-89.53	88.98	89.45	96.14
CGS001-84290	KD	CAPNS2	EF-hand domain containing, calpain, small subunit 2			0.00, 0.00	1.75, 0.52	-95.78	-98.75	NaN	-69.01	-56.87	NaN	-91.23	-68.22	-60.69	-96.83
CGS001-833	KD	CARS	Aminoacyl tRNA synthetases / Class I, cysteinyl-tRNA synthetase			0.00, 0.00	1.40, 0.42	44.93	50.47	NaN	-35.11	-99.86	NaN	-26.75	-30.51	80.28	19.41
CGS001-9134	KD	CCNE2	cyclin E2			0.00, 0.00	1.66, 0.56	-33.42	-97.16	NaN	-37.07	-64.82	NaN	-86.06	-76.63	-95.73	-84.84
CGS001-1019	KD	CDK4	Cyclin-dependent kinases, CDK4 subfamily, cyclin-dependent kinase 4		Cyclin dependent kinases LOF	0.00, 0.00	1.63, 0.61	-95.75	-100.00	-91.95	-98.76	-73.60	-99.90	-99.22	-96.92	-66.56	-99.92
CGS001-81620	KD	CDT1	chromatin licensing and DNA replication factor 1			12.50, 12.50	1.23, 0.45	92.30	37.88	NaN	53.70	-42.59	NaN	98.53	86.26	34.72	73.70
CGS001-4680	KD	CEACAM6	CD molecules, carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen)			0.00, 0.00	1.11, 0.30	-99.85	-70.33	NaN	-93.67	-99.37	NaN	-51.03	18.96	-61.02	-98.22
CGS001-1072	KD	CFL1	cofilin 1 (non-muscle)			0.00, 0.00	2.05, 0.64	25.59	-38.73	NaN	21.80	NaN	-80.26	-99.57	-17.94	-99.97	-76.76
CGS001-1119	KD	CHKA	choline kinase alpha			11.11, 11.11	1.27, 0.41	-35.49	30.18	NaN	49.52	-30.94	98.92	-38.20	-87.19	85.02	-14.74
CGS001-9541	KD	CIR1	corepressor interacting with RBPJ, 1			11.11, 0.00	1.40, 0.41	97.45	90.72	NaN	-36.47	32.18	17.21	93.39	-23.36	62.87	68.21
CGS001-11113	KD	CIT	Other DMPK family kinases, citron (rho-interacting, serine/threonine kinase 21)			12.50, 0.00	1.22, 0.35	-28.39	-100.00	NaN	-94.77	95.16	NaN	-37.27	-33.66	-86.71	-88.78
CGS001-22883	KD	CLSTN1	Cadherins / Cadherin-related, calsyntenin 1			0.00, 0.00	2.19, 0.58	39.28	NaN	NaN	58.69	35.72	NaN	NaN	-41.24	-15.22	18.41
CGS001-54805	KD	CNNM2	cyclin M2			12.50, 12.50	1.91, 0.58	-73.30	87.21	NaN	91.30	44.55	-22.15	60.15	99.72	NaN	88.90
CGS001-1314	KD	COPA	Endogenous ligands, coatomer protein complex, subunit alpha		Vesicular Transport LOF	0.00, 0.00	3.22, 1.47	-99.42	-97.79	NaN	-94.13	-44.63	-72.16	-97.05	-63.10	-99.50	-99.71
CGS001-9318	KD	COPS2	COP9 constitutive photomorphogenic homolog subunit 2 (Arabidopsis)			0.00, 0.00	1.16, 0.41	-52.60	-63.68	NaN	-27.41	-99.91	-33.12	92.66	-89.56	14.32	-40.20
CGS001-27297	KD	CRCP	CGRP receptor component			37.50, 25.00	1.36, 0.45	36.37	63.67	NaN	98.91	NaN	99.97	74.06	83.51	27.79	97.24
CGS001-1455	KD	CSNK1G2	Casein kinase 1 (CK1) family, casein kinase 1, gamma 2			12.50, 0.00	1.41, 0.44	-84.84	96.94	NaN	-29.57	-98.26	36.96	-89.83	-63.27	NaN	-85.60
CGS001-1456	KD	CSNK1G3	Casein kinase 1 (CK1) family, casein kinase 1, gamma 3			0.00, 0.00	1.76, 0.51	-56.09	-98.60	NaN	-24.62	-98.75	57.26	25.03	-60.15	20.75	-47.11
CGS001-1487	KD	CTBP1	C-terminal binding protein 1			16.67, 16.67	1.28, 0.41	-98.11	NaN	NaN	59.00	-99.48	NaN	NaN	24.56	99.75	72.89
CGS001-1512	KD	CTSH	Cathepsins, cathepsin H			11.11, 11.11	1.07, 0.32	-66.13	73.09	NaN	87.81	-55.71	-29.40	99.68	-38.97	21.89	44.48
CGS001-3579	KD	CXCR2	Chemokine receptors, chemokine (C-X-C motif) receptor 2			0.00, 0.00	1.48, 0.49	-35.57	40.67	NaN	22.38	81.50	24.37	-43.30	-76.25	-67.56	-39.70
CGS001-1528	KD	CYB5A	Cytochrome b genes, cytochrome b5 type A (microsomal)			0.00, 0.00	1.18, 0.27	-90.18	-47.12	NaN	-99.33	-68.27	-96.90	-27.68	-99.84	13.76	-95.47
CGS001-80777	KD	CYB5B	cytochrome b5 type B (outer mitochondrial membrane)			0.00, 0.00	1.91, 0.58	26.64	91.15	NaN	-24.78	-22.99	NaN	-72.37	47.11	-21.22	8.68
CGS001-54205	KD	CYCS	cytochrome c, somatic			0.00, 0.00	1.00, 0.32	-78.51	18.20	NaN	-68.59	-97.14	-99.44	-99.47	-73.59	22.58	-98.22
CGS001-1543	KD	CYP1A1	Cytochrome P450s, cytochrome P450, family 1, subfamily A, polypeptide 1			0.00, 0.00	1.90, 0.58	36.76	39.55	NaN	-37.02	78.71	25.76	-68.72	NaN	NaN	14.91
CGS001-1613	KD	DAPK3	Death-associated kinase (DAPK) family, death-associated protein kinase 3			44.44, 44.44	1.13, 0.23	86.82	30.37	99.35	79.86	-76.14	99.97	71.38	99.98	NaN	99.82
CGS001-160851	KD	DGKH	Pleckstrin homology (PH) domain containing, diacylglycerol kinase, eta			0.00, 0.00	1.48, 0.42	-37.10	-92.13	NaN	27.39	-80.43	-96.82	46.35	67.31	NaN	-68.53
CGS001-10901	KD	DHRS4	Short chain dehydrogenase/reductase superfamily / Classical SDR fold cluster 1, dehydrogenase/reductase (SDR family) member 4			0.00, 0.00	1.36, 0.30	-26.63	-24.46	NaN	-23.07	-30.14	NaN	NaN	27.97	-71.92	-9.39
CGS001-22894	KD	DIS3	DIS3 mitotic control homolog (S. cerevisiae)			0.00, 0.00	1.75, 0.57	-28.43	NaN	NaN	-31.96	NaN	NaN	-75.62	30.78	-99.96	-86.94
CGS001-1871	KD	E2F3	E2F transcription factor 3			0.00, 0.00	1.80, 0.60	NaN	NaN	NaN	-97.86	-99.80	NaN	NaN	-99.28	-90.82	-99.87
CGS001-79733	KD	E2F8	E2F transcription factor 8			44.44, 33.33	1.85, 0.45	99.66	-28.20	NaN	95.58	-55.90	79.70	-26.38	98.65	-85.62	98.05
CGS001-2004	KD	ELK3	ETS Transcription Factors, ELK3, ETS-domain protein (SRF accessory protein 2)			0.00, 0.00	0.94, 0.38	-84.77	-31.09	NaN	-24.31	-58.89	-99.07	74.36	-38.90	50.77	-38.67
CGS001-64123	KD	ELTD1	Adhesion Class GPCRs, EGF, latrophilin and seven transmembrane domain containing 1			0.00, 0.00	1.36, 0.30	29.42	-23.12	NaN	89.03	-21.57	-18.55	-26.32	-29.17	-58.12	-9.00
CGS001-54749	KD	EPDR1	ependymin related protein 1 (zebrafish)			14.29, 14.29	1.91, 0.51	75.47	52.96	NaN	99.95	NaN	NaN	26.50	28.70	88.22	85.60
CGS001-2064	KD	ERBB2	Type I RTKs: ErbB (epidermal growth factor) receptor family, v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian)			10.00, 10.00	0.84, 0.22	-97.51	-51.34	30.72	-23.56	-94.53	47.68	35.06	47.34	98.92	6.49
CGS001-2099	KD	ESR1	Estrogen receptors, estrogen receptor 1			30.00, 20.00	0.86, 0.23	-46.96	95.69	-79.83	56.83	99.63	-22.96	-86.55	-60.35	99.85	76.26
CGS001-54536	KD	EXOC6	exocyst complex component 6			14.29, 14.29	1.60, 0.44	-99.36	99.91	NaN	-29.59	NaN	NaN	25.77	78.12	-44.43	39.23
CGS001-2160	KD	F11	Chymotrypsin, coagulation factor XI			25.00, 12.50	1.44, 0.38	-16.26	23.43	NaN	97.86	40.04	45.10	96.20	-25.74	NaN	36.08
CGS001-2322	KD	FLT3	Type III RTKs: PDGFR, CSFR, Kit, FLT3 receptor family, fms-related tyrosine kinase 3			10.00, 10.00	1.36, 0.35	-31.04	32.21	64.02	43.92	99.91	75.11	55.60	93.18	25.57	69.30
CGS001-286380	KD	FOXD4L3	forkhead box D4-like 3			0.00, 0.00	1.35, 0.38	55.50	88.09	-23.09	-66.06	-23.61	56.61	33.97	-30.50	NaN	31.94
CGS001-116113	KD	FOXP4	Forkhead boxes, forkhead box P4			0.00, 0.00	1.43, 0.52	-83.96	-38.80	NaN	-53.61	-97.43	NaN	-42.21	-29.32	-31.65	-58.15
CGS001-10841	KD	FTCD	formiminotransferase cyclodeaminase			33.33, 22.22	1.49, 0.45	48.07	99.91	NaN	52.28	78.02	96.30	99.91	-30.79	-60.29	88.18
CGS001-2539	KD	G6PD	glucose-6-phosphate dehydrogenase			0.00, 0.00	1.39, 0.44	-21.66	-93.08	NaN	-99.98	43.19	NaN	-30.38	61.61	-60.53	-71.79
CGS001-2558	KD	GABRA5	GABA receptors, gamma-aminobutyric acid (GABA) A receptor, alpha 5			0.00, 0.00	1.77, 0.50	40.45	NaN	NaN	-33.17	-27.55	NaN	-22.10	23.77	39.01	-16.13
CGS001-57798	KD	GATAD1	GATA zinc finger domain containing, GATA zinc finger domain containing 1			0.00, 0.00	1.39, 0.43	-99.95	31.64	NaN	-24.87	-21.76	-35.59	-63.24	-83.38	41.01	-21.24
CGS001-2645	KD	GCK	Hexokinases, glucokinase (hexokinase 4)			0.00, 0.00	1.40, 0.45	-16.84	-99.74	NaN	69.27	-82.78	-99.94	-70.16	-61.40	NaN	-90.67
CGS001-2697	KD	GJA1	Ion channels / Gap junction proteins (connexins), gap junction protein, alpha 1, 43kDa			42.86, 28.57	1.91, 0.61	-28.69	NaN	NaN	94.44	64.41	98.24	NaN	99.12	79.51	97.18
CGS001-2781	KD	GNAZ	guanine nucleotide binding protein (G protein), alpha z polypeptide			0.00, 0.00	1.99, 0.65	-25.54	NaN	NaN	-94.31	40.65	-99.06	-95.18	23.28	NaN	-95.73
CGS001-10020	KD	GNE	glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase			0.00, 0.00	1.25, 0.47	-67.91	-89.19	-24.03	-25.32	-41.34	-99.91	-68.12	-19.41	NaN	-66.42
CGS001-2821	KD	GPI	glucose-6-phosphate isomerase			0.00, 0.00	1.47, 0.49	-63.40	-40.30	NaN	49.27	40.66	-99.94	-99.98	-99.83	26.59	-99.67
CGS001-266977	KD	GPR110	Adhesion Class GPCRs, G protein-coupled receptor 110			12.50, 12.50	1.26, 0.30	-59.63	23.61	NaN	51.57	-26.16	99.97	-26.91	-31.70	NaN	-15.54
CGS001-221188	KD	GPR114	Adhesion Class GPCRs, G protein-coupled receptor 114			28.57, 14.29	2.13, 0.69	32.43	-96.22	NaN	34.25	99.98	NaN	-15.68	96.59	NaN	63.41
CGS001-344561	KD	GPR148	GPCR / Class A : Orphans, G protein-coupled receptor 148			12.50, 12.50	1.07, 0.38	78.13	45.94	NaN	32.76	99.84	-31.20	-24.13	58.56	NaN	51.02
CGS001-27197	KD	GPR82	GPCR / Class A : Orphans, G protein-coupled receptor 82			12.50, 12.50	1.58, 0.41	34.16	28.46	NaN	87.94	-50.86	99.68	81.90	84.83	NaN	85.93
CGS001-51704	KD	GPRC5B	GPCR / Class C : Orphans, G protein-coupled receptor, family C, group 5, member B			12.50, 12.50	1.47, 0.50	59.74	-38.13	NaN	99.94	-67.02	-61.47	64.95	-24.57	NaN	53.61
CGS001-2879	KD	GPX4	glutathione peroxidase 4 (phospholipid hydroperoxidase)			28.57, 28.57	1.59, 0.58	98.18	33.21	NaN	74.39	NaN	42.54	NaN	32.92	99.97	79.57
CGS001-57822	KD	GRHL3	grainyhead-like 3 (Drosophila)			0.00, 0.00	1.59, 0.43	70.49	53.01	NaN	48.65	-98.49	NaN	NaN	-74.83	NaN	43.91
CGS001-116443	KD	GRIN3A	Glutamate receptors, glutamate receptor, ionotropic, N-methyl-D-aspartate 3A			0.00, 0.00	1.39, 0.45	49.27	60.24	NaN	61.03	-62.46	-32.64	29.08	-73.26	-92.66	-44.08
CGS001-2959	KD	GTF2B	General transcription factors, general transcription factor IIB			12.50, 12.50	1.15, 0.34	14.92	-28.50	NaN	78.47	99.52	NaN	38.83	90.01	77.08	93.10
CGS001-29915	KD	HCFC2	host cell factor C2			0.00, 0.00	1.42, 0.33	-17.92	-39.57	NaN	-19.84	-74.92	-16.68	-32.84	-20.71	39.71	-12.11
CGS001-79885	KD	HDAC11	Histone deacetylases, histone deacetylase 11		Histone deacetylases LOF	0.00, 0.00	1.38, 0.50	-56.85	-64.79	NaN	29.78	-77.22	NaN	15.04	-31.26	-72.70	-33.66
CGS001-3094	KD	HINT1	histidine triad nucleotide binding protein 1			0.00, 0.00	1.68, 0.47	-12.56	NaN	NaN	-99.86	-68.28	NaN	39.77	-97.98	-17.34	-93.64
CGS001-3125	KD	HLA-DRB3	Immunoglobulin superfamily / C1-set domain containing, major histocompatibility complex, class II, DR beta 3			0.00, 0.00	1.57, 0.45	28.55	-67.31	NaN	-99.66	-99.61	52.16	-25.32	-66.66	NaN	-84.53
CGS001-3146	KD	HMGB1	High-mobility group / Canonical, high mobility group box 1		Canonical high mobility group proteins LOF	0.00, 0.00	1.69, 0.41	-98.79	-29.70	NaN	-27.74	-36.74	-23.94	-79.22	-79.68	-98.86	-86.91
CGS001-10525	KD	HYOU1	Heat shock proteins / HSP70, hypoxia up-regulated 1		Heat shock 70kDa proteins LOF	0.00, 0.00	1.92, 0.47	-95.05	-90.70	NaN	76.06	-21.45	NaN	-28.95	-73.00	61.27	-70.88
CGS001-3397	KD	ID1	Basic helix-loop-helix proteins, inhibitor of DNA binding 1, dominant negative helix-loop-helix protein			0.00, 0.00	1.61, 0.50	-99.59	28.99	NaN	-81.37	49.67	NaN	NaN	-61.26	-42.81	-83.27
CGS001-3479	KD	IGF1	Endogenous ligands, insulin-like growth factor 1 (somatomedin C)			10.00, 0.00	1.06, 0.18	46.31	95.18	93.74	-34.15	-44.62	-16.39	87.90	-81.62	-22.69	30.25
CGS001-3480	KD	IGF1R	Type II RTKs: Insulin receptor family, insulin-like growth factor 1 receptor			0.00, 0.00	0.76, 0.15	-14.24	-53.55	18.40	94.51	-60.40	-25.62	-47.92	83.89	-9.00	-16.62
CGS001-3551	KD	IKBKB	IKK family, inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta			10.00, 10.00	0.67, 0.14	38.49	-68.97	68.45	-21.02	24.91	99.94	28.64	-35.64	19.96	6.52
CGS001-3606	KD	IL18	Interleukins and interleukin receptors, interleukin 18 (interferon-gamma-inducing factor)			25.00, 25.00	1.22, 0.34	-25.79	NaN	NaN	98.71	43.53	38.01	-65.79	99.62	-32.79	69.87
CGS001-50604	KD	IL20	Interleukins and interleukin receptors, interleukin 20			0.00, 0.00	1.76, 0.44	-99.82	-29.18	NaN	-95.56	-99.89	NaN	-76.45	-38.92	23.40	-98.95
CGS001-3576	KD	IL8	interleukin 8			16.67, 16.67	1.14, 0.43	-98.62	NaN	NaN	76.46	-32.14	NaN	NaN	99.95	-51.78	-58.25
CGS001-54556	KD	ING3	Zinc fingers, PHD-type, inhibitor of growth family, member 3			12.50, 12.50	1.35, 0.24	-53.04	23.19	NaN	37.81	-22.06	NaN	-44.55	99.85	-96.04	-29.99
CGS001-3643	KD	INSR	Type II RTKs: Insulin receptor family, insulin receptor			0.00, 0.00	0.88, 0.18	27.77	-99.93	15.35	20.70	-24.20	-26.80	-60.46	-7.88	18.54	0.53
CGS001-57117	KD	INTS12	Zinc fingers, PHD-type, integrator complex subunit 12			0.00, 0.00	2.01, 0.63	-96.97	34.68	NaN	-75.83	-67.49	26.26	38.80	-50.46	-82.32	-72.49
CGS001-3832	KD	KIF11	Kinesins, kinesin family member 11			0.00, 0.00	1.13, 0.39	-41.16	71.16	-7.82	23.30	-28.99	-26.60	91.61	-21.89	66.98	10.87
CGS001-22944	KD	KIN	KIN, antigenic determinant of recA protein homolog (mouse)			57.14, 28.57	1.65, 0.35	60.16	100.00	NaN	-26.91	95.37	NaN	44.63	97.24	NaN	99.26
CGS001-3845	KD	KRAS	RAS subfamily, v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog			0.00, 0.00	0.33, 0.13	-99.44	-60.96	-95.05	-99.34	-67.28	-99.63	-99.98	-89.68	20.65	-99.89
CGS001-64175	KD	LEPRE1	leucine proline-enriched proteoglycan (leprecan) 1			0.00, 0.00	1.66, 0.50	-56.89	-21.32	NaN	61.24	48.82	NaN	-49.82	-69.86	-44.71	-37.84
CGS001-431707	KD	LHX8	Homeoboxes / LIM class, LIM homeobox 8			0.00, 0.00	0.86, 0.23	17.33	-58.11	39.47	-28.61	-34.69	-99.97	-81.65	-20.75	NaN	-30.10
CGS001-4069	KD	LYZ	lysozyme			0.00, 0.00	1.40, 0.36	33.43	-36.39	NaN	-98.91	-46.74	27.00	-32.69	-99.75	-69.16	-71.86
CGS001-4129	KD	MAOB	Catecholamine turnover, monoamine oxidase B			57.14, 42.86	1.84, 0.57	-32.37	-27.32	NaN	99.98	-67.91	NaN	NaN	95.75	99.55	99.76
CGS001-5601	KD	MAPK9	MAPK:JNK subfamily, mitogen-activated protein kinase 9		Mitogen activated protein kinases LOF	20.00, 10.00	0.85, 0.26	7.40	95.16	73.40	17.52	37.28	87.99	98.82	56.52	-21.03	56.24
CGS001-4143	KD	MAT1A	methionine adenosyltransferase I, alpha			0.00, 0.00	1.57, 0.49	-99.45	-37.74	NaN	26.06	NaN	NaN	58.01	-74.92	37.16	-34.57
CGS001-27430	KD	MAT2B	Short chain dehydrogenase/reductase superfamily / Extended SDR fold, methionine adenosyltransferase II, beta			0.00, 0.00	1.51, 0.51	-21.52	46.57	NaN	31.10	-62.86	68.41	89.89	-94.06	NaN	14.71
CGS001-84515	KD	MCM8	minichromosome maintenance complex component 8		MCM family LOF	0.00, 0.00	1.63, 0.50	-15.59	-36.46	NaN	27.34	-25.00	36.12	-25.67	20.79	NaN	-9.76
CGS001-28985	KD	MCTS1	malignant T cell amplified sequence 1			0.00, 0.00	0.67, 0.24	92.91	-27.26	NaN	-99.96	-94.90	NaN	19.34	-95.42	37.97	-96.15
CGS001-2122	KD	MECOM	Zinc fingers, C2H2-type, MDS1 and EVI1 complex locus			0.00, 0.00	0.45, 0.09	-99.98	71.88	NaN	47.03	88.23	29.60	-61.77	41.24	-24.25	19.13
CGS001-9412	KD	MED21	mediator complex subunit 21			0.00, 0.00	1.33, 0.42	-27.52	53.33	NaN	-26.50	-75.41	-24.70	-97.49	38.09	35.34	-13.55
CGS001-29079	KD	MED4	mediator complex subunit 4			0.00, 0.00	1.50, 0.49	-31.77	-98.51	NaN	-98.49	-53.76	NaN	-91.46	-98.77	-83.75	-98.89
CGS001-4212	KD	MEIS2	Homeoboxes / TALE class, Meis homeobox 2			11.11, 11.11	1.19, 0.41	60.75	-22.42	NaN	-58.00	87.38	-99.94	40.01	99.96	73.75	63.46
CGS001-4221	KD	MEN1	multiple endocrine neoplasia I			0.00, 0.00	1.02, 0.28	49.51	43.45	-34.32	-19.06	71.13	-99.74	-73.87	57.30	60.90	10.12
CGS001-10461	KD	MERTK	Type XI RTKs: TAM (TYRO3-, AXL- and MER-TK) receptor family, c-mer proto-oncogene tyrosine kinase			0.00, 0.00	1.64, 0.45	28.87	-95.14	NaN	39.73	NaN	-29.33	31.67	33.59	-21.54	17.32
CGS001-22921	KD	MSRB2	methionine sulfoxide reductase B2			22.22, 22.22	0.91, 0.20	99.98	98.99	NaN	55.04	38.50	51.67	-75.20	-71.80	-33.77	68.36
CGS001-4488	KD	MSX2	Homeoboxes / ANTP class : NKL subclass, msh homeobox 2			0.00, 0.00	1.20, 0.28	28.76	-32.58	NaN	72.96	63.92	-99.96	-30.17	47.71	23.72	31.45
CGS001-2475	KD	MTOR	FRAP subfamily, mechanistic target of rapamycin (serine/threonine kinase)		Akt Signaling LOF	0.00, 0.00	1.02, 0.41	39.46	-42.69	63.88	-94.30	62.58	77.87	-12.81	-56.17	19.26	-11.50
CGS001-55892	KD	MYNN	BTB/POZ domain containing, myoneurin			0.00, 0.00	1.61, 0.52	-42.56	36.43	NaN	-32.76	91.59	42.63	27.69	41.05	-46.70	17.81
CGS001-4683	KD	NBN	nibrin			10.00, 10.00	0.68, 0.15	-38.77	29.18	38.32	-36.17	-21.70	98.93	29.18	87.10	43.44	24.66
CGS001-4700	KD	NDUFA6	LYR motif containing, NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 6, 14kDa			12.50, 12.50	0.92, 0.39	22.40	-97.64	NaN	-28.56	-33.09	99.99	63.95	24.56	NaN	9.26
CGS001-4711	KD	NDUFB5	Mitochondrial respiratory chain complex / Complex I, NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 5, 16kDa			0.00, 0.00	1.28, 0.35	-43.55	94.20	NaN	-74.99	33.76	NaN	-52.99	-95.87	NaN	-49.48
CGS001-4728	KD	NDUFS8	Mitochondrial respiratory chain complex / Complex I, NADH dehydrogenase (ubiquinone) Fe-S protein 8, 23kDa (NADH-coenzyme Q reductase)			0.00, 0.00	1.77, 0.60	-91.86	39.34	NaN	44.76	89.55	45.95	NaN	78.87	24.04	39.01
CGS001-10783	KD	NEK6	NIMA (never in mitosis gene a)- related kinase (NEK) family, NIMA (never in mitosis gene a)-related kinase 6			0.00, 0.00	1.25, 0.28	-99.92	37.67	NaN	-31.18	-51.48	-91.70	NaN	-99.28	-28.45	-97.31
CGS001-57407	KD	NMRAL1	Short chain dehydrogenase/reductase superfamily / Atypical members, NmrA-like family domain containing 1			11.11, 0.00	1.59, 0.41	31.00	-38.76	NaN	-85.59	32.91	95.70	-33.11	-57.43	-35.38	-13.56
CGS001-4837	KD	NNMT	nicotinamide N-methyltransferase			0.00, 0.00	1.38, 0.35	-44.89	-74.41	NaN	-22.11	-51.10	-85.74	-77.30	-73.64	85.27	-43.27
CGS001-4835	KD	NQO2	NAD(P)H dehydrogenase, quinone 2			0.00, 0.00	1.31, 0.39	44.46	26.35	NaN	-97.16	-99.80	NaN	-98.72	84.50	-24.04	-98.16
CGS001-9971	KD	NR1H4	Liver X receptor-like receptors, nuclear receptor subfamily 1, group H, member 4			12.50, 12.50	1.36, 0.28	-80.63	52.24	NaN	74.40	99.04	49.82	71.84	NaN	46.97	78.88
CGS001-4893	KD	NRAS	RAS subfamily, neuroblastoma RAS viral (v-ras) oncogene homolog			0.00, 0.00	0.72, 0.18	-57.63	-32.09	-63.85	34.76	-42.55	-43.16	-42.03	-65.62	56.89	-13.47
CGS001-4905	KD	NSF	ATPases / AAA-type, N-ethylmaleimide-sensitive factor			12.50, 12.50	0.97, 0.22	-42.77	34.88	NaN	99.93	-19.17	90.45	-26.78	41.86	NaN	33.06
CGS001-8650	KD	NUMB	numb homolog (Drosophila)			0.00, 0.00	1.91, 0.55	-86.16	-83.65	NaN	33.63	-99.98	NaN	-82.72	-58.28	-28.09	-74.73
CGS001-4947	KD	OAZ2	ornithine decarboxylase antizyme 2			0.00, 0.00	1.45, 0.31	31.50	-81.17	NaN	23.44	-40.43	75.25	-42.25	-94.47	27.44	-19.35
CGS001-4976	KD	OPA1	optic atrophy 1 (autosomal dominant)			0.00, 0.00	1.33, 0.26	-77.57	-22.80	NaN	-22.00	-29.82	16.85	-50.79	28.89	38.83	-10.70
CGS001-116039	KD	OSR2	Zinc fingers, C2H2-type, odd-skipped related 2 (Drosophila)			11.11, 11.11	1.78, 0.55	41.38	48.36	NaN	99.98	46.43	-49.21	-28.79	91.09	61.92	54.67
CGS001-58495	KD	OVOL2	Zinc fingers, C2H2-type, ovo-like 2 (Drosophila)			0.00, 0.00	1.35, 0.35	60.43	-64.72	NaN	-28.33	NaN	-89.68	18.75	-22.42	27.71	-10.98
CGS001-165140	KD	OXER1	GPCR / Class A : Leukotriene receptors, oxoeicosanoid (OXE) receptor 1			12.50, 12.50	1.39, 0.40	29.25	-34.91	NaN	-38.79	99.98	-42.86	-59.84	-28.84	NaN	-15.66
CGS001-64805	KD	P2RY12	GPCR / Class A : Purinergic receptors, P2Y, purinergic receptor P2Y, G-protein coupled, 12			14.29, 14.29	2.39, 0.75	64.87	86.65	NaN	99.16	NaN	94.06	NaN	65.09	90.39	93.34
CGS001-5029	KD	P2RY2	GPCR / Class A : Purinergic receptors, P2Y, purinergic receptor P2Y, G-protein coupled, 2			0.00, 0.00	1.14, 0.35	-94.32	34.24	NaN	65.76	86.77	-19.93	NaN	-28.62	84.91	63.12
CGS001-142	KD	PARP1	Poly (ADP-ribose) polymerases, poly (ADP-ribose) polymerase 1			0.00, 0.00	1.60, 0.52	-97.46	-63.49	NaN	94.67	-99.98	-19.31	-43.14	-89.57	-32.42	-88.74
CGS001-10038	KD	PARP2	Poly (ADP-ribose) polymerases, poly (ADP-ribose) polymerase 2		Poly ADP ribose polymerases LOF	0.00, 0.00	0.98, 0.26	-14.40	-21.01	-16.19	27.91	-21.95	25.36	-45.90	30.21	31.67	4.05
CGS001-5087	KD	PBX1	Homeoboxes / TALE class, pre-B-cell leukemia homeobox 1			0.00, 0.00	0.80, 0.24	-95.36	NaN	NaN	25.84	-96.76	NaN	NaN	-98.72	-99.89	-98.99
CGS001-56139	KD	PCDHA10	Cadherins / Protocadherins : Clustered, protocadherin alpha 10			0.00, 0.00	2.16, 0.61	-32.90	-95.06	NaN	19.64	NaN	NaN	-67.93	-23.42	-66.19	-45.64
CGS001-7703	KD	PCGF2	Polycomb group ring fingers, polycomb group ring finger 2			0.00, 0.00	1.32, 0.31	-39.94	88.13	NaN	-34.63	-42.36	54.71	65.95	-49.87	-97.18	-34.13
CGS001-84108	KD	PCGF6	Polycomb group ring fingers, polycomb group ring finger 6			0.00, 0.00	2.28, 0.76	32.28	38.60	NaN	-27.15	50.01	NaN	NaN	44.06	50.20	31.11
CGS001-5194	KD	PEX13	peroxisomal biogenesis factor 13			0.00, 0.00	1.23, 0.42	-67.20	93.54	NaN	-41.58	-44.56	-48.55	-29.72	-38.33	38.55	-16.02
CGS001-5202	KD	PFDN2	prefoldin subunit 2			0.00, 0.00	1.34, 0.41	-71.02	-75.53	-20.53	-48.02	-97.04	68.61	NaN	NaN	-29.69	-45.14
CGS001-5228	KD	PGF	placental growth factor			71.43, 57.14	1.67, 0.64	99.33	89.20	NaN	76.01	97.00	NaN	NaN	99.92	99.78	99.95
CGS001-26147	KD	PHF19	Zinc fingers, PHD-type, PHD finger protein 19			12.50, 12.50	2.22, 0.69	-23.83	77.04	NaN	40.36	38.17	99.69	30.48	62.49	NaN	68.36
CGS001-5264	KD	PHYH	phytanoyl-CoA 2-hydroxylase			0.00, 0.00	1.91, 0.56	-64.63	38.76	NaN	27.51	NaN	-11.21	-25.87	66.46	NaN	10.86
CGS001-5277	KD	PIGA	Glycosyltransferase group 1 domain containing, phosphatidylinositol glycan anchor biosynthesis, class A			0.00, 0.00	2.02, 0.51	83.64	61.86	NaN	90.50	81.50	NaN	66.57	-28.50	-33.10	88.65
CGS001-9488	KD	PIGB	Dolichyl D-mannosyl phosphate dependent mannosyltransferases, phosphatidylinositol glycan anchor biosynthesis, class B			16.67, 16.67	1.50, 0.51	-59.14	NaN	NaN	-96.70	-30.87	NaN	NaN	-38.04	99.67	-64.61
CGS001-5294	KD	PIK3CG	Phosphatidylinositol kinases, phosphoinositide-3-kinase, catalytic, gamma polypeptide		PI3K Signaling LOF	12.50, 12.50	2.11, 0.53	37.11	-60.77	NaN	34.90	54.76	NaN	-65.16	51.19	99.88	53.49
CGS001-8503	KD	PIK3R3	Phosphatidylinositol kinases, phosphoinositide-3-kinase, regulatory subunit 3 (gamma)			0.00, 0.00	1.59, 0.48	-31.56	-24.52	NaN	-83.59	-84.25	NaN	88.10	-23.64	30.09	-20.58
CGS001-11040	KD	PIM2	PIM family, pim-2 oncogene			0.00, 0.00	1.33, 0.39	-36.99	43.61	NaN	36.97	-72.06	54.78	-27.08	-22.13	-28.98	-4.23
CGS001-81579	KD	PLA2G12A	Phospholipase A2, phospholipase A2, group XIIA			0.00, 0.00	1.19, 0.33	-81.27	-22.53	NaN	-86.37	32.30	-89.61	-99.81	-98.11	83.42	-92.04
CGS001-5325	KD	PLAGL1	Zinc fingers, C2H2-type, pleiomorphic adenoma gene-like 1			11.11, 11.11	1.33, 0.47	-24.09	23.58	NaN	29.62	99.58	43.19	26.92	-30.91	-27.99	10.51
CGS001-5332	KD	PLCB4	Phosphoinositide-specific phospholipase C, phospholipase C, beta 4			12.50, 12.50	1.61, 0.41	-29.59	99.51	NaN	-82.64	25.67	23.64	89.92	28.87	NaN	25.63
CGS001-122618	KD	PLD4	phospholipase D family, member 4			0.00, 0.00	2.03, 0.65	-43.27	NaN	NaN	36.53	25.81	-93.94	-53.47	-56.76	NaN	-56.95
CGS001-5361	KD	PLXNA1	Plexins, plexin A1			0.00, 0.00	0.63, 0.14	-17.26	-99.91	-36.97	68.87	29.77	23.13	-16.36	-12.92	-24.66	-5.50
CGS001-5411	KD	PNN	pinin, desmosome associated protein			0.00, 0.00	1.63, 0.40	-45.55	23.52	NaN	-97.71	-99.98	-99.97	-94.22	-75.14	25.76	-99.02
CGS001-23509	KD	POFUT1	Fucosyltransferases, protein O-fucosyltransferase 1			0.00, 0.00	2.25, 0.73	-98.17	-91.86	NaN	-51.00	NaN	-26.68	-95.11	-78.37	-21.62	-77.41
CGS001-23649	KD	POLA2	DNA polymerases, polymerase (DNA directed), alpha 2 (70kD subunit)			0.00, 0.00	1.49, 0.42	-34.05	NaN	NaN	-48.38	-25.09	NaN	-98.63	-99.93	-43.91	-94.33
CGS001-5434	KD	POLR2E	RNA polymerase subunits, polymerase (RNA) II (DNA directed) polypeptide E, 25kDa		RNA Polymerase Enzymes LOF	0.00, 0.00	1.83, 0.63	-27.10	-87.63	NaN	24.16	21.57	70.90	27.53	-95.67	NaN	-14.27
CGS001-10623	KD	POLR3C	RNA polymerase subunits, polymerase (RNA) III (DNA directed) polypeptide C (62kD)			0.00, 0.00	1.61, 0.44	35.29	-38.26	NaN	-43.76	-23.79	38.75	-20.21	-48.72	70.65	-9.87
CGS001-5445	KD	PON2	Paraoxonases, paraoxonase 2			50.00, 50.00	1.69, 0.49	93.31	76.90	NaN	99.47	99.93	NaN	99.98	-24.81	-99.85	99.95
CGS001-9360	KD	PPIG	peptidylprolyl isomerase G (cyclophilin G)			0.00, 0.00	1.61, 0.51	-38.47	-24.50	NaN	31.33	-83.34	NaN	-43.51	-43.15	NaN	-28.18
CGS001-10465	KD	PPIH	peptidylprolyl isomerase H (cyclophilin H)			0.00, 0.00	1.26, 0.32	-97.98	-46.34	NaN	26.60	-29.41	-69.34	19.99	-97.91	24.12	-25.86
CGS001-151742	KD	PPM1L	Serine/threonine phosphatases / Protein phosphatases, Mg2+/Mn2+ dependent, protein phosphatase, Mg2+/Mn2+ dependent, 1L			14.29, 0.00	1.85, 0.56	-21.84	NaN	NaN	-25.33	-99.39	NaN	95.56	-47.80	-32.29	-20.18
CGS001-5516	KD	PPP2CB	Serine/threonine phosphatases / Protein phosphatase, catalytic subunits, protein phosphatase 2, catalytic subunit, beta isozyme		Protein phosphatase catalytic subunits LOF	0.00, 0.00	1.56, 0.43	-21.97	-33.53	NaN	-43.77	-33.96	35.26	32.33	-95.11	-98.42	-23.18
CGS001-7001	KD	PRDX2	peroxiredoxin 2			11.11, 11.11	1.00, 0.27	99.08	40.33	NaN	67.82	-99.24	78.79	-48.03	67.96	35.45	56.24
CGS001-25824	KD	PRDX5	peroxiredoxin 5			0.00, 0.00	1.28, 0.30	64.43	62.55	NaN	-98.74	49.64	22.01	-87.68	24.69	34.53	24.20
CGS001-5583	KD	PRKCH	Eta subfamily, protein kinase C, eta			12.50, 12.50	1.28, 0.36	-96.72	-25.25	NaN	-75.19	63.28	NaN	27.48	98.00	-51.02	-59.69
CGS001-25865	KD	PRKD2	Pleckstrin homology (PH) domain containing, protein kinase D2		Akt Signaling LOF	11.11, 11.11	1.51, 0.36	41.56	99.26	NaN	30.92	-30.02	78.66	-24.53	22.52	-19.25	17.62
CGS001-3276	KD	PRMT1	Protein arginine N-methyltransferases, protein arginine methyltransferase 1			0.00, 0.00	1.06, 0.25	-97.72	-29.80	NaN	-50.74	-37.87	32.32	-14.19	-19.50	-75.57	-27.18
CGS001-5627	KD	PROS1	protein S (alpha)			0.00, 0.00	2.65, 0.86	-56.66	NaN	NaN	-78.87	NaN	NaN	NaN	48.21	61.79	-61.02
CGS001-5645	KD	PRSS2	Serine peptidases, protease, serine, 2 (trypsin 2)			12.50, 12.50	1.30, 0.48	-96.76	-46.94	NaN	36.23	NaN	52.84	72.87	66.58	97.90	40.84
CGS001-29968	KD	PSAT1	phosphoserine aminotransferase 1			16.67, 16.67	2.21, 0.73	63.94	14.27	NaN	41.90	NaN	NaN	-86.41	98.53	NaN	58.04
CGS001-5664	KD	PSEN2	Presenilin, presenilin 2 (Alzheimer disease 4)			0.00, 0.00	1.58, 0.38	-19.46	20.01	NaN	-81.08	-22.67	-28.52	45.98	-58.72	NaN	-7.31
CGS001-5682	KD	PSMA1	Proteasome subunits, proteasome (prosome, macropain) subunit, alpha type, 1		Proteasome Pathway LOF	0.00, 0.00	1.56, 0.64	-99.74	-99.23	NaN	32.83	-36.28	-33.92	-39.27	-99.05	NaN	-99.55
CGS001-5707	KD	PSMD1	Proteasome subunits, proteasome (prosome, macropain) 26S subunit, non-ATPase, 1			0.00, 0.00	2.63, 1.09	22.22	-99.85	NaN	-81.08	-25.96	NaN	-91.22	-97.59	-96.04	-96.02
CGS001-5721	KD	PSME2	Proteasome (prosome, macropain) subunits, proteasome (prosome, macropain) activator subunit 2 (PA28 beta)			57.14, 57.14	1.36, 0.39	-40.27	99.19	NaN	69.32	99.82	-36.75	NaN	99.79	NaN	99.77
CGS001-256297	KD	PTF1A	Basic helix-loop-helix proteins, pancreas specific transcription factor, 1a			42.86, 28.57	2.09, 0.67	99.95	-91.76	NaN	70.34	-83.88	91.92	NaN	97.61	NaN	96.50
CGS001-5747	KD	PTK2	Serine/threonine phosphatases / Protein phosphatase 1, regulatory subunits, PTK2 protein tyrosine kinase 2			0.00, 0.00	1.00, 0.35	-13.19	13.62	-99.61	34.65	-99.21	-9.23	-17.58	-39.25	-78.13	-32.67
CGS001-5793	KD	PTPRG	Receptor tyrosine phosphatases (RTP), protein tyrosine phosphatase, receptor type, G			11.11, 0.00	1.24, 0.40	-38.66	-27.17	NaN	97.23	-96.80	90.91	76.31	-24.40	-26.33	31.10
CGS001-5860	KD	QDPR	Short chain dehydrogenase/reductase superfamily / Atypical members, quinoid dihydropteridine reductase			50.00, 50.00	1.69, 0.50	78.89	43.04	NaN	26.97	99.64	NaN	74.23	99.96	98.31	98.99
CGS001-5901	KD	RAN	RAN, member RAS oncogene family			0.00, 0.00	1.23, 0.39	-82.45	-47.00	NaN	62.62	-99.98	NaN	-65.58	-61.56	37.03	-49.41
CGS001-11186	KD	RASSF1	Ras association (RalGDS/AF-6) domain family member 1			0.00, 0.00	2.00, 0.57	-23.57	25.84	NaN	-92.52	NaN	NaN	NaN	41.08	-93.85	-62.90
CGS001-83593	KD	RASSF5	Ras association (RalGDS/AF-6) domain family member 5			88.89, 66.67	1.51, 0.40	97.96	99.98	NaN	98.03	95.80	98.61	97.16	99.96	-57.56	99.82
CGS001-125950	KD	RAVER1	RNA binding motif (RRM) containing, ribonucleoprotein, PTB-binding 1			0.00, 0.00	1.94, 0.57	-48.14	NaN	NaN	-23.72	-27.83	NaN	67.94	21.87	NaN	-10.08
CGS001-5947	KD	RBP1	Fatty acid binding protein family, retinol binding protein 1, cellular			0.00, 0.00	2.06, 0.59	-99.98	-39.45	NaN	33.45	NaN	-99.94	-98.62	-68.80	NaN	-99.68
CGS001-5649	KD	RELN	reelin			0.00, 0.00	1.39, 0.42	85.63	NaN	NaN	31.22	-58.65	NaN	35.10	-81.00	-70.93	-59.19
CGS001-54884	KD	RETSAT	retinol saturase (all-trans-retinol 13,14-reductase)			12.50, 0.00	1.24, 0.38	-72.13	95.52	NaN	27.59	NaN	22.95	35.75	28.08	22.11	8.89
CGS001-64326	KD	RFWD2	RING-type (C3HC4) zinc fingers, ring finger and WD repeat domain 2			12.50, 12.50	1.69, 0.47	-29.60	98.56	NaN	37.30	NaN	-42.24	-93.11	42.38	-23.64	16.59
CGS001-222546	KD	RFX6	regulatory factor X, 6			11.11, 11.11	1.41, 0.43	-25.33	98.29	NaN	-93.48	-79.63	-44.43	22.81	24.97	-31.20	-22.55
CGS001-55781	KD	RIOK2	RIO2 subfamily, RIO kinase 2 (yeast)			0.00, 0.00	1.20, 0.38	-85.61	-61.39	NaN	-84.72	-89.58	NaN	-99.71	-99.30	-63.26	-95.62
CGS001-390	KD	RND3	Rho family GTPase 3			0.00, 0.00	2.35, 0.53	72.27	-63.31	NaN	32.55	88.68	NaN	-74.91	62.85	-57.15	65.55
CGS001-9616	KD	RNF7	RING-type (C3HC4) zinc fingers, ring finger protein 7			0.00, 0.00	1.57, 0.38	44.12	46.98	NaN	-98.26	-32.76	NaN	62.82	-53.38	-23.14	31.65
CGS001-6093	KD	ROCK1	Pleckstrin homology (PH) domain containing, Rho-associated, coiled-coil containing protein kinase 1			0.00, 0.00	1.24, 0.22	-38.31	-7.45	-46.68	-22.29	81.90	-36.15	NaN	75.57	-84.56	-21.22
CGS001-9252	KD	RPS6KA5	MSK subfamily, ribosomal protein S6 kinase, 90kDa, polypeptide 5			14.29, 14.29	2.16, 0.65	19.13	-99.93	NaN	91.88	98.00	NaN	67.40	55.51	NaN	75.43
CGS001-339403	KD	RXFP4	GPCR / Class A : Relaxin family peptide receptors, relaxin/insulin-like family peptide receptor 4			0.00, 0.00	2.07, 0.80	-63.77	-28.28	NaN	-65.95	48.20	NaN	NaN	-45.79	65.77	-44.88
CGS001-6258	KD	RXRG	Retinoid X receptors, retinoid X receptor, gamma			0.00, 0.00	1.65, 0.50	-26.55	-50.18	NaN	-98.80	70.26	-35.99	-97.40	-66.44	19.78	-56.59
CGS001-5269	KD	SERPINB6	Serine (or cysteine) peptidase inhibitors, serpin peptidase inhibitor, clade B (ovalbumin), member 6		Serpin peptidase inhibitors LOF	0.00, 0.00	2.43, 0.80	64.63	-40.48	NaN	50.77	67.68	NaN	NaN	53.43	NaN	51.59
CGS001-871	KD	SERPINH1	Serine (or cysteine) peptidase inhibitors, serpin peptidase inhibitor, clade H (heat shock protein 47), member 1, (collagen binding protein 1)			33.33, 11.11	1.38, 0.40	99.92	37.34	NaN	97.28	-29.44	95.64	31.39	25.71	33.92	82.17
CGS001-23451	KD	SF3B1	splicing factor 3b, subunit 1, 155kDa			0.00, 0.00	2.38, 0.68	-56.45	26.93	NaN	25.95	-33.05	-32.32	NaN	-79.10	31.69	-18.89
CGS001-23678	KD	SGK3	SGK family, serum/glucocorticoid regulated kinase family, member 3			0.00, 0.00	0.65, 0.19	-16.32	-21.46	22.74	-50.72	27.23	-77.89	-78.72	-22.88	NaN	-27.76
CGS001-6464	KD	SHC1	SH2 domain containing, SHC (Src homology 2 domain containing) transforming protein 1			0.00, 0.00	1.00, 0.23	-43.51	-19.67	-48.90	52.33	-53.94	-26.42	68.61	10.31	-23.31	-7.71
CGS001-399694	KD	SHC4	SH2 domain containing, SHC (Src homology 2 domain containing) family, member 4			12.50, 0.00	1.15, 0.32	28.39	95.37	NaN	28.92	60.22	-99.37	-65.54	39.27	NaN	25.77
CGS001-51547	KD	SIRT7	Histone deacetylases (HDACs), sirtuin 7			0.00, 0.00	2.59, 0.67	-26.47	67.40	NaN	79.50	NaN	NaN	74.52	-85.26	-61.68	69.08
CGS001-6558	KD	SLC12A2	SLC12 family of cation-coupled chloride transporters, solute carrier family 12 (sodium/potassium/chloride transporters), member 2			0.00, 0.00	1.90, 0.70	-83.03	26.97	NaN	92.28	NaN	49.92	NaN	-42.98	-48.21	-28.87
CGS001-6566	KD	SLC16A1	SLC16 family of monocarboxylate transporters, solute carrier family 16, member 1 (monocarboxylic acid transporter 1)			0.00, 0.00	0.97, 0.20	-91.27	40.50	NaN	-99.29	61.62	-64.27	69.82	-99.56	27.17	-68.32
CGS001-6505	KD	SLC1A1	Glutamate transporter subfamily, solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1			12.50, 12.50	1.41, 0.40	41.28	99.91	NaN	29.80	40.11	56.54	NaN	84.02	33.59	39.39
CGS001-56731	KD	SLC2A4RG	SLC2A4 regulator			0.00, 0.00	1.26, 0.33	37.34	94.91	NaN	53.72	-21.13	88.24	9.72	92.79	-46.28	46.41
CGS001-4088	KD	SMAD3	SMADs, SMAD family member 3			10.00, 10.00	0.74, 0.23	-27.14	69.50	-17.70	-37.76	31.44	-96.97	-27.65	93.93	97.93	20.46
CGS001-6595	KD	SMARCA2	Non-enzymatic BRD containing proteins, SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2			12.50, 12.50	1.34, 0.39	-91.27	25.68	NaN	40.94	26.90	NaN	-82.98	99.42	41.43	12.58
CGS001-6598	KD	SMARCB1	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1			0.00, 0.00	0.95, 0.18	83.33	16.01	-14.77	-26.87	-97.80	48.30	11.08	7.67	62.52	3.33
CGS001-6605	KD	SMARCE1	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1			0.00, 0.00	1.20, 0.36	-79.16	38.96	NaN	-23.69	-88.45	NaN	-89.88	-73.75	-28.29	-83.60
CGS001-6625	KD	SNRNP70	RNA binding motif (RRM) containing, small nuclear ribonucleoprotein 70kDa (U1)			0.00, 0.00	1.74, 0.51	26.00	30.41	NaN	65.17	-85.35	NaN	-33.19	-34.80	-50.82	-27.60
CGS001-6648	KD	SOD2	superoxide dismutase 2, mitochondrial			0.00, 0.00	1.77, 0.77	83.48	-99.98	NaN	-69.11	-36.21	NaN	NaN	-42.79	24.18	-44.81
CGS001-6652	KD	SORD	sorbitol dehydrogenase			11.11, 11.11	1.15, 0.32	35.96	71.12	NaN	-53.75	99.64	59.42	-16.66	64.79	61.60	52.47
CGS001-6696	KD	SPP1	Endogenous ligands, secreted phosphoprotein 1			0.00, 0.00	1.68, 0.44	-97.26	84.18	NaN	-22.77	-63.17	-82.74	-95.32	-56.45	60.67	-49.46
CGS001-10253	KD	SPRY2	sprouty homolog 2 (Drosophila)			0.00, 0.00	1.11, 0.36	-89.78	35.74	NaN	-25.92	-64.38	-37.93	-13.43	-96.40	28.77	-39.50
CGS001-6713	KD	SQLE	Lanosterol biosynthesis pathway, squalene epoxidase			0.00, 0.00	1.42, 0.43	82.15	-22.91	NaN	-91.38	-99.71	NaN	34.35	-38.86	-99.88	-97.92
CGS001-10214	KD	SSX3	synovial sarcoma, X breakpoint 3			28.57, 28.57	1.99, 0.59	27.17	98.38	NaN	53.82	42.03	50.13	NaN	97.91	NaN	86.36
CGS001-6767	KD	ST13	Tetratricopeptide (TTC) repeat domain containing, suppression of tumorigenicity 13 (colon carcinoma) (Hsp70 interacting protein)			0.00, 0.00	1.41, 0.44	51.27	NaN	NaN	94.01	-99.32	NaN	-27.20	75.54	-54.46	47.56
CGS001-6768	KD	ST14	Serine peptidases / Transmembrane, suppression of tumorigenicity 14 (colon carcinoma)			11.11, 0.00	1.26, 0.30	27.49	27.48	NaN	29.10	-24.86	28.05	-62.94	-26.43	97.38	6.96
CGS001-6772	KD	STAT1	SH2 domain containing, signal transducer and activator of transcription 1, 91kDa			0.00, 0.00	1.07, 0.24	-21.32	-21.28	-85.06	-49.72	-21.19	-99.97	-36.22	-58.11	-77.14	-50.65
CGS001-8428	KD	STK24	YSK subfamily, serine/threonine kinase 24			22.22, 11.11	1.52, 0.44	-19.23	94.85	NaN	-25.71	59.65	98.59	30.93	58.74	87.45	95.73
CGS001-23012	KD	STK38L	NDR family, serine/threonine kinase 38 like			0.00, 0.00	1.49, 0.60	-98.75	-29.62	NaN	-79.67	-84.28	NaN	-60.25	-21.78	-98.72	-90.94
CGS001-29888	KD	STRN4	WD repeat domain containing, striatin, calmodulin binding protein 4			22.22, 22.22	1.14, 0.26	98.27	25.87	NaN	53.04	-82.29	-93.83	-36.86	52.16	97.79	33.98
CGS001-6822	KD	SULT2A1	Sulfotransferases, cytosolic, sulfotransferase family, cytosolic, 2A, dehydroepiandrosterone (DHEA)-preferring, member 1			0.00, 0.00	1.85, 0.47	68.11	39.53	NaN	-80.52	-47.83	NaN	-45.49	-41.57	-84.00	-49.21
CGS001-8464	KD	SUPT3H	suppressor of Ty 3 homolog (S. cerevisiae)			12.50, 12.50	1.45, 0.41	-20.80	99.93	NaN	34.78	40.95	62.34	NaN	-25.75	39.86	25.57
CGS001-6827	KD	SUPT4H1	suppressor of Ty 4 homolog 1 (S. cerevisiae)			0.00, 0.00	1.19, 0.32	-52.35	94.44	NaN	-33.69	-90.87	37.10	-64.98	40.17	NaN	-53.93
CGS001-6850	KD	SYK	Syk family, spleen tyrosine kinase			10.00, 10.00	1.52, 0.33	-48.13	56.05	31.99	37.68	-48.86	36.34	-42.93	98.05	-62.40	-40.05
CGS001-6857	KD	SYT1	Synaptotagmins, synaptotagmin I			0.00, 0.00	1.40, 0.55	-99.83	49.53	NaN	-81.79	-28.38	-91.38	-99.16	-85.89	-99.39	-99.13
CGS001-134860	KD	TAAR9	GPCR / Class A : Trace amine associated receptors, trace amine associated receptor 9 (gene/pseudogene)		Trace amine receptors LOF	14.29, 14.29	1.39, 0.25	-37.45	NaN	NaN	27.93	-86.13	99.97	33.91	49.41	NaN	24.04
CGS001-9014	KD	TAF1B	TATA box binding protein (TBP)-associated factor, RNA polymerase I, B, 63kDa			0.00, 0.00	1.75, 0.59	-98.28	81.33	NaN	-99.84	-38.62	NaN	NaN	-99.73	24.51	-99.89
CGS001-7029	KD	TFDP2	transcription factor Dp-2 (E2F dimerization partner 2)			12.50, 0.00	1.14, 0.23	-55.41	-23.98	NaN	50.36	NaN	48.39	-26.12	73.37	97.15	29.87
CGS001-9967	KD	THRAP3	thyroid hormone receptor associated protein 3			0.00, 0.00	0.98, 0.23	-20.51	-39.64	NaN	-98.26	-21.98	37.79	20.98	-33.16	-22.07	-8.73
CGS001-7083	KD	TK1	thymidine kinase 1, soluble			0.00, 0.00	1.58, 0.47	-99.94	-56.93	NaN	-36.17	82.74	-54.47	-24.39	-96.29	-20.66	-32.03
CGS001-7100	KD	TLR5	Toll-like receptor family, toll-like receptor 5		Toll like receptors LOF	11.11, 11.11	1.52, 0.30	41.49	-19.73	NaN	25.41	68.74	-32.42	-31.47	-22.40	99.85	11.46
CGS001-54106	KD	TLR9	Toll-like receptor family, toll-like receptor 9			0.00, 0.00	1.07, 0.27	-99.95	-99.82	NaN	-53.41	-26.04	-27.88	-53.86	-26.47	64.87	-28.55
CGS001-134288	KD	TMEM174	transmembrane protein 174			0.00, 0.00	1.30, 0.38	13.71	NaN	NaN	-52.16	-19.09	NaN	-96.08	-72.65	-32.66	-63.57
CGS001-51330	KD	TNFRSF12A	Tumour necrosis factor (TNF) receptor family, tumor necrosis factor receptor superfamily, member 12A			12.50, 12.50	1.20, 0.27	-70.35	33.32	NaN	-28.24	99.79	-41.40	30.40	-51.13	NaN	14.12
CGS001-10673	KD	TNFSF13B	CD molecules, tumor necrosis factor (ligand) superfamily, member 13b			0.00, 0.00	1.42, 0.39	63.18	-97.66	NaN	69.44	41.14	-80.37	NaN	-28.78	25.37	21.49
CGS001-7155	KD	TOP2B	DNA Topoisomerases, topoisomerase (DNA) II beta 180kDa			28.57, 14.29	1.64, 0.47	-40.36	99.09	NaN	44.95	90.16	NaN	NaN	93.81	-99.75	96.55
CGS001-89882	KD	TPD52L3	tumor protein D52-like 3			0.00, 0.00	1.07, 0.27	-99.62	-13.39	NaN	-70.20	-81.79	30.54	-29.25	-87.70	66.47	-62.88
CGS001-7167	KD	TPI1	triosephosphate isomerase 1			12.50, 12.50	2.03, 0.59	99.70	43.70	NaN	-99.98	-99.73	NaN	87.95	-99.37	-97.66	-99.95
CGS001-7248	KD	TSC1	tuberous sclerosis 1			20.00, 20.00	1.17, 0.36	-56.49	100.00	99.95	-29.31	-32.07	-36.40	79.85	85.84	39.88	82.16
CGS001-85480	KD	TSLP	thymic stromal lymphopoietin			0.00, 0.00	1.24, 0.34	30.90	82.57	NaN	-89.63	-64.67	-99.97	-36.99	23.85	-95.10	-81.94
CGS001-7267	KD	TTC3	RING-type (C3HC4) zinc fingers, tetratricopeptide repeat domain 3			0.00, 0.00	1.81, 0.58	-72.78	NaN	NaN	72.44	-39.03	NaN	-80.76	94.43	-25.67	-33.93
CGS001-7280	KD	TUBB2A	Tubulins, tubulin, beta 2A			0.00, 0.00	1.16, 0.27	-61.31	-79.93	NaN	-40.19	-30.50	NaN	-35.83	-78.88	-97.90	-68.98
CGS001-9898	KD	UBAP2L	ubiquitin associated protein 2-like			0.00, 0.00	1.01, 0.27	68.53	-28.46	NaN	36.45	-92.45	NaN	84.51	-86.60	-59.20	-59.62
CGS001-7319	KD	UBE2A	Ubiquitin-conjugating enzymes E2, ubiquitin-conjugating enzyme E2A			10.00, 10.00	0.50, 0.11	-22.27	30.45	-99.20	-65.57	-26.14	77.12	56.72	98.35	38.07	24.49
CGS001-3093	KD	UBE2K	Ubiquitin-conjugating enzymes E2, ubiquitin-conjugating enzyme E2K			37.50, 25.00	1.35, 0.42	-28.05	89.51	NaN	61.54	NaN	-96.29	21.42	99.95	98.26	95.02
CGS001-7332	KD	UBE2L3	Ubiquitin-conjugating enzymes E2, ubiquitin-conjugating enzyme E2L 3			12.50, 12.50	1.72, 0.42	54.92	88.87	NaN	64.55	25.65	65.32	99.34	-32.23	NaN	56.56
CGS001-54578	KD	UGT1A6	UDP glucuronosyltransferases, UDP glucuronosyltransferase 1 family, polypeptide A6			22.22, 11.11	1.56, 0.38	50.13	87.30	NaN	99.98	-24.50	96.69	88.59	52.26	-26.79	92.46
CGS001-51720	KD	UIMC1	ubiquitin interaction motif containing 1			0.00, 0.00	1.44, 0.32	-26.33	-26.43	NaN	78.83	47.20	-96.75	35.04	-78.53	-45.40	-9.74
CGS001-7389	KD	UROD	uroporphyrinogen decarboxylase		AHSP Pathway LOF	0.00, 0.00	1.82, 0.53	-99.88	-86.69	NaN	-47.70	-48.82	-99.81	-69.88	-25.26	75.69	-58.99
CGS001-219333	KD	USP12	Ubiquitin-specific peptidases, ubiquitin specific peptidase 12		Ubiquitin-specific peptidases LOF	0.00, 0.00	1.44, 0.47	-40.10	NaN	NaN	-97.16	-31.43	NaN	-35.75	-81.96	-99.19	-96.84
CGS001-8239	KD	USP9X	Ubiquitin-specific peptidases, ubiquitin specific peptidase 9, X-linked		X linked mental retardation group 2 LOF	22.22, 22.22	1.23, 0.41	-23.30	-60.66	NaN	44.13	-44.53	98.14	99.96	-54.24	-83.09	-27.20
CGS001-10138	KD	YAF2	YY1 associated factor 2			12.50, 12.50	1.44, 0.38	-38.39	-33.01	NaN	-27.20	-21.38	NaN	-93.49	-40.52	99.97	-17.53
CGS001-8565	KD	YARS	Aminoacyl tRNA synthetases / Class I, tyrosyl-tRNA synthetase			0.00, 0.00	1.48, 0.42	-33.31	84.53	NaN	48.00	46.97	-82.88	-35.40	53.78	44.55	29.03
CGS001-8089	KD	YEATS4	YEATS domain containing 4			11.11, 11.11	1.40, 0.40	77.75	39.78	NaN	53.80	79.75	28.91	63.17	99.92	47.47	66.21
CGS001-7534	KD	YWHAZ	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide			0.00, 0.00	0.89, 0.28	-30.84	93.70	NaN	-98.99	-99.08	NaN	-22.26	-98.92	50.20	-99.87
CGS001-26137	KD	ZBTB20	BTB/POZ domain containing, zinc finger and BTB domain containing 20			0.00, 0.00	1.10, 0.33	25.10	-33.91	NaN	30.71	-28.52	10.86	54.53	-26.14	22.86	7.87
CGS001-140612	KD	ZFP28	Zinc fingers, C2H2-type, zinc finger protein 28 homolog (mouse)			14.29, 0.00	2.15, 0.63	38.82	96.78	NaN	-36.98	87.17	NaN	-38.14	34.22	NaN	46.23
CGS001-7695	KD	ZNF136	Zinc fingers, C2H2-type, zinc finger protein 136			0.00, 0.00	1.67, 0.39	-23.67	31.31	NaN	-25.17	-25.47	-84.45	NaN	NaN	-41.76	-14.42
CGS001-169841	KD	ZNF169	Zinc fingers, C2H2-type, zinc finger protein 169			20.00, 20.00	1.31, 0.28	84.48	NaN	NaN	99.93	80.13	-31.75	NaN	NaN	NaN	93.57
CGS001-7733	KD	ZNF180	Zinc fingers, C2H2-type, zinc finger protein 180			0.00, 0.00	1.82, 0.45	40.01	25.99	NaN	23.40	88.93	-27.02	NaN	NaN	-39.85	17.35
CGS001-7570	KD	ZNF22	Zinc fingers, C2H2-type, zinc finger protein 22 (KOX 15)			0.00, 0.00	1.90, 0.61	-72.57	-53.52	NaN	-30.30	-22.67	-99.40	-98.49	-99.96	NaN	-99.61
CGS001-57541	KD	ZNF398	Zinc fingers, C2H2-type, zinc finger protein 398			0.00, 0.00	1.82, 0.57	-31.62	-62.73	NaN	32.46	49.21	-55.20	-62.42	41.12	NaN	-50.29
CGS001-84838	KD	ZNF496	Zinc fingers, C2H2-type, zinc finger protein 496			12.50, 0.00	1.48, 0.45	83.15	97.22	NaN	-79.30	-96.96	87.95	-21.59	-65.25	NaN	85.86
CGS001-137209	KD	ZNF572	Zinc fingers, C2H2-type, zinc finger protein 572			12.50, 0.00	1.77, 0.49	-77.10	-61.16	NaN	82.83	NaN	-25.29	42.22	95.35	-41.37	32.57
CGS001-51545	KD	ZNF581	Zinc fingers, C2H2-type, zinc finger protein 581			0.00, 0.00	1.60, 0.44	15.07	-98.45	NaN	-30.90	25.72	NaN	NaN	-32.89	80.72	-10.88
CGS001-152687	KD	ZNF595	Zinc fingers, C2H2-type, zinc finger protein 595			0.00, 0.00	1.73, 0.49	24.55	33.48	NaN	-23.15	40.97	94.38	29.03	48.84	-35.38	27.17
CGS001-148103	KD	ZNF599	Zinc fingers, C2H2-type, zinc finger protein 599			12.50, 0.00	1.80, 0.55	21.65	18.17	NaN	57.37	95.16	NaN	20.49	19.25	-91.15	11.63
CGS001-65243	KD	ZNF643	zinc finger protein 643			0.00, 0.00	1.33, 0.45	-93.02	-26.92	NaN	-26.69	31.37	-29.26	-13.15	-30.57	-25.65	-12.21
CGS001-115509	KD	ZNF689	Zinc fingers, C2H2-type, zinc finger protein 689			0.00, 0.00	1.52, 0.44	-95.13	-99.37	NaN	-63.78	-99.92	-99.85	-94.73	-99.94	-99.95	-99.81
CGS001-327	KD	APEH	Prolyl oligopeptidase, N-acylaminoacyl-peptide hydrolase			0.00, 0.00	1.24, 0.33	-46.16	25.17	NaN	NaN	-35.40	40.67	-11.90	-21.38	NaN	-9.25
CGS001-169436	KD	C9ORF96	chromosome 9 open reading frame 96			0.00, 0.00	0.30, 0.10	-11.24	-79.63	-85.54	-47.37	-25.51	15.39	7.20	-99.94	NaN	-22.36
CGS001-595	KD	CCND1	cyclin D1		Cyclins LOF	20.00, 20.00	1.23, 0.36	-97.25	-100.00	-16.75	98.01	-30.78	-99.97	-93.49	-75.33	98.91	-98.90
CGS001-1022	KD	CDK7	Cyclin-dependent kinases, CDK7 subfamily, cyclin-dependent kinase 7			0.00, 0.00	1.15, 0.32	94.24	-97.53	NaN	NaN	-98.22	NaN	-41.18	-98.98	21.57	-98.42
CGS001-8566	KD	PDXK	pyridoxal (pyridoxine, vitamin B6) kinase			0.00, 0.00	1.64, 0.59	-66.92	75.30	NaN	NaN	-99.92	NaN	82.62	90.05	-30.49	89.66
CGS001-11156	KD	PTP4A3	Protein tyrosine phosphatases, protein tyrosine phosphatase type IVA, member 3			50.00, 50.00	2.11, 0.58	79.51	NaN	NaN	NaN	-32.25	99.97	99.12	90.83	NaN	99.87
CGS001-4087	KD	SMAD2	SMADs, SMAD family member 2		SMAD family LOF	10.00, 10.00	1.28, 0.35	-9.39	33.09	-22.26	43.24	-44.60	29.51	-23.21	-77.26	99.40	7.29
CGS001-6647	KD	SOD1	superoxide dismutase 1, soluble			10.00, 10.00	1.45, 0.28	-81.28	-26.24	-22.78	-23.61	-39.07	99.63	17.47	-54.36	-99.79	-33.69
CGS001-9218	KD	VAPA	VAMP (vesicle-associated membrane protein)-associated protein A, 33kDa			0.00, 0.00	1.89, 0.48	16.83	58.32	NaN	NaN	78.34	29.66	NaN	53.89	-62.80	40.62
CGS001-472	KD	ATM	Other PIKK family kinases, ataxia telangiectasia mutated		G2 M Checkpoint LOF, PI3K Signaling LOF	0.00, 0.00	0.85, 0.31	-82.19	29.70	54.08	53.08	16.57	-98.18	-51.87	-53.52	-85.60	-55.30
CGS001-1956	KD	EGFR	Type I RTKs: ErbB (epidermal growth factor) receptor family, epidermal growth factor receptor			0.00, 0.00	1.14, 0.45	-10.14	-23.78	-15.45	27.23	50.95	-46.29	-28.08	-25.66	59.99	-7.66
CGS001-3065	KD	HDAC1	Histone deacetylases, histone deacetylase 1		Histone deacetylases LOF	0.00, 0.00	1.01, 0.20	-90.65	88.71	-46.28	-79.90	74.88	21.30	42.40	-70.33	-95.68	-69.83
CGS001-5290	KD	PIK3CA	Phosphatidylinositol kinases, phosphoinositide-3-kinase, catalytic, alpha polypeptide		PI3K Signaling LOF	0.00, 0.00	1.40, 0.38	-22.78	71.32	70.97	32.29	23.10	32.64	-48.04	11.43	-41.56	6.88
BRD-A85280935	CP	quinpirole	dopamine receptor agonist	DRD2, DRD3, DRD4, DRD1, HTR1A, HTR2A, HTR2B, HTR2C		11.11, 11.11	1.22, 0.32	-70.55	99.96	-16.61	-94.48	92.68	-38.34	31.70	-25.90	NaN	-7.25
BRD-A07824748	CP	flavanone	11-beta hydroxysteroid dehydrogenase inhibitor	ADORA3, HSD11B1		11.11, 11.11	1.26, 0.28	89.09	-15.53	-41.07	-82.03	18.73	99.53	-26.48	53.96	NaN	22.86
BRD-K20482099	CP	rutin	aldose reductase inhibitor, antioxidant, capillary stabilizing agent, nitric oxide scavenger, prolyl 4-hydroxylase inhibitor	AKR1C3, AKR1B1, F10		0.00, 0.00	0.81, 0.10	17.01	29.42	-52.88	85.61	-28.68	-12.44	36.81	68.98	79.52	31.50
BRD-K62929068	CP	6-benzylaminopurine	purinergic receptor activator			0.00, 0.00	0.53, 0.08	88.82	33.22	16.28	-27.37	43.81	84.03	-31.71	29.80	NaN	16.17
BRD-K43405658	CP	tyrphostin-AG-527	protein tyrosine kinase inhibitor	EGFR		0.00, 0.00	1.23, 0.41	-8.31	50.67	-94.22	-89.23	-59.46	-45.68	9.40	-89.31	NaN	-82.51
BRD-K03670461	CP	tyrphostin-AG-82	EGFR inhibitor, epidermal growth factor receptor (EGFR) inhibitor, tyrosine kinase inhibitor	EGFR, LCK		10.00, 0.00	0.80, 0.15	30.26	12.20	-41.73	-23.72	18.37	95.34	29.51	31.32	-99.28	4.23
BRD-K36737713	CP	AG-957	Abl kinase inhibitor, protein tyrosine kinase inhibitor	ABL1, EGFR		0.00, 0.00	1.59, 0.56	-98.67	-41.22	-99.43	-68.97	-99.88	-19.13	14.37	-86.27	-97.14	-96.88
BRD-K51223576	CP	AG-99	tyrosine kinase inhibitor	EGFR		44.44, 11.11	1.05, 0.27	99.79	95.44	95.15	95.63	-25.32	-44.57	34.78	-56.19	NaN	92.96
BRD-A14966924	CP	alaproclate	serotonin receptor antagonist, serotonin reuptake inhibitor	SLC6A4		0.00, 0.00	0.58, 0.13	79.09	36.57	-56.02	93.02	-17.55	-68.35	42.25	-66.76	23.30	-12.45
BRD-A90131694	CP	alclometasone	glucocorticoid receptor agonist, immunosuppressant	NR3C1, SERPINA6	Glucocorticoid receptor agonist	0.00, 0.00	1.36, 0.61	13.41	63.55	-34.69	-72.70	71.86	-98.67	-22.74	-47.57	63.07	21.84
BRD-K30020243	CP	aliskiren	renin inhibitor, peptidase inhibitor, protease inhibitor	REN		10.00, 10.00	0.56, 0.11	-72.22	14.66	-27.15	99.51	67.13	7.99	-34.83	-67.88	56.15	-14.09
BRD-A00993607	CP	alprenolol	adrenergic receptor antagonist	ADRB1, ADRB2, HTR1A		0.00, 0.00	0.57, 0.13	42.72	-19.45	-56.15	-43.82	-92.14	43.23	45.87	45.85	66.94	18.41
BRD-K35498378	CP	alrestatin	aldose reductase inhibitor	AKR1B1		10.00, 10.00	1.06, 0.25	58.50	9.37	-44.74	92.83	26.26	49.97	-6.62	-62.15	98.62	44.84
BRD-A56675431	CP	altizide	thiazide diuretic		Na-K-Cl transporter inhibitor	11.11, 11.11	1.28, 0.43	98.76	73.46	13.44	89.06	82.17	60.82	47.58	67.57	NaN	74.96
BRD-A27554692	CP	altrenogest	progestogen steroid hormone	PGR		0.00, 0.00	0.70, 0.16	-77.54	-98.12	-5.15	94.95	79.03	-71.81	-49.35	-59.54	-90.89	-62.67
BRD-K53979406	CP	ALX-5407	glycine transporter inhibitor, GlyT-1 inhibitor	SLC6A9		0.00, 0.00	1.20, 0.44	87.32	91.30	25.74	12.07	-15.99	-57.63	-24.38	70.89	NaN	32.10
BRD-K59419204	CP	AM-281	cannabinoid receptor antagonist, cannabinoid receptor inhibitor	CNR1, CNR2, GPR55		0.00, 0.00	0.94, 0.30	-36.09	-95.10	-98.63	-97.53	-99.21	-59.72	23.34	-36.37	NaN	-98.60
BRD-A10969569	CP	ambelline	plant alkaloid			0.00, 0.00	0.69, 0.16	30.53	-39.59	33.27	-65.23	48.72	-32.77	-62.40	42.43	NaN	-20.04
BRD-A36010170	CP	amcinonide	corticosteroid agonist, cytochrome P450 inhibitor, glucocorticoid receptor agonist, immunosuppressant	NR3C1, ANXA1		0.00, 0.00	1.36, 0.45	-15.14	-10.61	-75.98	-96.28	-12.72	-87.53	-14.33	-38.00	-37.67	-38.41
BRD-K43068349	CP	AMG-9810	TRPV antagonist	TRPV1		0.00, 0.00	0.85, 0.15	3.87	-66.81	-95.85	3.61	-26.30	72.83	-24.92	-97.14	-96.84	-89.01
BRD-K94512704	CP	spiramide	dopamine receptor antagonist, serotonin receptor antagonist	DRD2, HTR1A, HTR2A, HTR2B, HTR2C	Serotonin receptor antagonist	0.00, 0.00	0.69, 0.23	19.81	-59.49	-42.45	-72.70	28.44	15.82	12.50	-67.48	-91.38	-57.01
BRD-A69917777	CP	aminopentamide	anticholinergic agent			0.00, 0.00	0.72, 0.16	75.67	-15.29	-62.32	18.65	85.54	18.39	54.82	83.28	65.25	73.34
BRD-K17561142	CP	amiodarone	acetylcholine receptor ligand, adrenergic receptor antagonist, ATP-sensitive potassium channel inhibitor, HCN (hyperpolarization activated cyclic nucleotide gated) channel modulator, polarization inhibitor, potassium channel antagonist, Sodium Channel  Blockers, voltage-gated sodium channel blocker	KCNH2, ADRB1, CACNA1H, CACNA2D2, CHRM3, CYP2C8, KCNA7, SCN5A		0.00, 0.00	1.55, 0.49	-71.08	-25.67	-51.43	-82.37	-92.12	-27.69	-33.62	-89.88	-95.99	-85.57
BRD-A22032524	CP	amlodipine	breast cancer resistance protein inhibitor, calcium channel blocker, calcium channel inhibitor, L-type calcium channel blocker	CACNA1C, CACNA1D, CACNA2D1, ABCG2, CA1, CACNA1B, CACNA1S, CACNA2D3, CACNB1, CACNB2, SMPD1		0.00, 0.00	1.70, 0.73	-85.34	-99.69	-35.61	-87.10	16.29	-99.26	-73.21	-70.54	-97.45	-90.31
BRD-K98490050	CP	amsacrine	topoisomerase inhibitor, DNA intercalating drug	TOP2A, KCNH2	Topoisomerase inhibitor	0.00, 0.00	2.77, 0.68	-99.88	-93.02	-99.24	-99.88	-99.15	-91.36	-99.44	-99.87	-98.37	-99.51
BRD-K62200014	CP	anagrelide	phosphodiesterase inhibitor	PDE3A		0.00, 0.00	0.98, 0.31	35.69	59.46	-93.51	-42.81	-68.15	-7.89	-69.16	-61.68	9.65	-43.07
BRD-K46937689	CP	phenazone	cyclooxygenase inhibitor	PTGS1, PTGS2		30.00, 10.00	0.56, 0.14	-65.72	96.03	99.67	8.30	70.10	62.88	59.53	95.25	48.51	90.36
BRD-K12057390	CP	apigenin	casein kinase inhibitor, cell proliferation inhibitor, cytochrome P450 inhibitor, GABA receptor antagonist, glutamate receptor antagonist, monoamine oxidase inhibitor, nitric oxide production inhibitor, ornithine decarboxylase inhibitor, quorum sensing signaling modulator, VEGF expression inhibitor, xanthine oxidase inhibitor	AKR1B1, AR, CDK6, CFTR, CYP19A1, CYP1A2, CYP1B1, HSD17B1, MAOA, ODC1, XDH		10.00, 10.00	0.89, 0.16	-11.01	99.80	-62.38	31.11	41.02	27.12	-88.81	74.92	-14.76	10.04
BRD-K93188295	CP	ARC-239	adrenergic receptor antagonist	ADRA2B, ADRA2A, ADRA2C		11.11, 11.11	1.82, 0.45	-55.11	57.85	-14.62	18.05	99.19	70.09	5.91	-65.28	NaN	26.91
BRD-A72758037	CP	asiatic-acid	antioxidant and antiinflammatory agent	PYGM		0.00, 0.00	0.67, 0.16	21.21	7.61	-48.65	10.82	-44.47	87.01	94.07	81.44	54.63	56.46
BRD-A65145453	CP	ATPA	glutamate receptor agonist	GRIK1, GRIA2		0.00, 0.00	1.16, 0.27	-53.26	85.73	-72.89	-28.51	-67.57	-86.58	-56.89	19.58	NaN	-58.02
BRD-K45861246	CP	azaperone	dopamine receptor antagonist	DRD2, DRD3		0.00, 0.00	0.59, 0.11	74.52	-30.92	-40.07	21.19	-60.56	-39.47	75.29	-32.63	-73.15	-18.81
BRD-K93080877	CP	Ala-Ala-Phe-CMK	tripeptidyl peptidase inhibitor	TPP2		0.00, 0.00	1.13, 0.43	-84.66	-86.43	-99.52	-62.65	-97.88	-76.71	15.54	-99.68	NaN	-98.27
BRD-K41445866	CP	alfaxalone	11-beta hydroxysteroid dehydrogenase inhibitor, chloride channel agonist, general pump inhibitor	HSD11B1		11.11, 11.11	1.35, 0.51	94.55	31.37	26.56	70.00	-30.11	99.87	-26.53	-88.53	NaN	52.97
BRD-K56558538	CP	ambroxol	glucosylceramidase inhibitor, mucolytic agent, sodium channel blocker	GBA		20.00, 10.00	0.84, 0.24	54.30	57.99	84.52	95.33	-87.62	47.79	42.76	87.49	99.15	83.92
BRD-K50214219	CP	CS-1657	PARP inhibitor	PARP1		11.11, 11.11	0.98, 0.32	99.96	-75.46	34.22	24.13	50.50	30.50	26.74	-82.23	NaN	12.97
BRD-K91290917	CP	amodiaquine	histamine N-methyltransferase inhibitor	HNMT, CYP2C8		0.00, 0.00	1.06, 0.34	-86.38	-36.45	-57.09	33.01	-65.13	-26.61	-48.42	-27.55	1.89	-18.95
BRD-K52397688	CP	amperozide	dopamine receptor antagonist, FAAH inhibitor, serotonin receptor antagonist	HTR2A, DRD2, FAAH		0.00, 0.00	0.45, 0.09	8.74	-39.15	18.98	-95.92	25.35	-72.22	-26.80	-54.35	-93.42	-51.59
BRD-A09062839	CP	amylocaine	local anesthetic			0.00, 0.00	1.07, 0.43	59.12	-41.94	-54.43	-56.86	-17.07	-82.17	-91.24	81.73	NaN	-28.19
BRD-K55424922	CP	anpirtoline	serotonin receptor agonist, serotonin receptor antagonist	HTR1B, HTR3A		11.11, 11.11	1.08, 0.35	63.10	11.42	84.66	14.25	99.74	60.89	-81.29	21.82	NaN	39.16
BRD-K72726508	CP	arcyriaflavin-a	CDK inhibitor	CCND1, CCNE1, CDK2, CDK4		0.00, 0.00	0.88, 0.23	10.27	-83.50	-66.96	33.55	92.44	-97.94	-39.73	-90.96	69.88	-81.37
BRD-A70514680	CP	articaine	local anesthetic			22.22, 0.00	1.18, 0.34	97.18	48.89	97.39	-39.68	-17.49	-91.98	24.01	33.21	NaN	38.56
BRD-A66199457	CP	asiaticoside	possible antitumor agent			0.00, 0.00	1.50, 0.44	87.64	-54.54	55.87	-8.23	-40.33	90.68	-35.01	-14.94	NaN	-19.50
BRD-A84493640	CP	atovaquone	cytochrome b-c1 complex inhibitor, dihydroorotate dehydrogenase inhibitor, mitochondrial electron transport inhibitor	DHODH		0.00, 0.00	1.27, 0.34	93.24	34.83	85.03	59.03	58.84	-46.53	62.37	92.15	NaN	78.98
BRD-K04877770	CP	FTase-inhibitor-B581	farnesyltransferase inhibitor, protein farnesyltransferase inhibitor			10.00, 10.00	0.83, 0.30	-27.53	18.00	-40.27	-64.12	98.89	42.32	82.41	-40.73	74.46	45.08
BRD-A16694057	CP	bisphenol-a	synthetic compound with hormone-like properties	AR, ESR2, ESRRG, PPARG		0.00, 0.00	0.36, 0.09	-92.22	46.25	-57.67	-28.05	38.16	-28.35	-12.32	59.64	60.77	36.55
BRD-A80017228	CP	bendroflumethiazide	sodium/potassium/chloride transporter inhibitor, thiazide diuretic	SLC12A3, CA1, CA2, CA4, KCNMA1, SLC12A1		0.00, 0.00	0.55, 0.09	26.11	-99.96	-91.44	88.86	-17.59	-73.78	-99.94	-63.49	61.11	-83.02
BRD-K70327191	CP	benzoxiquine	topical anti-infective			0.00, 0.00	0.22, 0.07	11.87	-46.61	-55.61	31.06	-97.35	13.95	-99.11	-96.78	-87.45	-94.33
BRD-A02180903	CP	betamethasone	corticosteroid agonist, glucocorticoid receptor agonist	NR3C1	Glucocorticoid receptor agonist	0.00, 0.00	1.63, 0.90	72.05	-66.10	29.05	-81.35	14.18	-98.44	65.44	60.87	78.19	61.89
BRD-A92177080	CP	betamethasone	corticosteroid agonist, glucocorticoid receptor agonist	NR3C1	Glucocorticoid receptor agonist	10.00, 10.00	1.30, 0.82	15.93	-34.75	11.38	-61.02	-81.18	-98.50	99.98	55.57	24.86	-28.41
BRD-A71799696	CP	BH3I-1	BCL inhibitor	BCL2		11.11, 11.11	1.03, 0.19	-27.49	-23.53	99.49	11.81	60.83	88.81	-10.24	3.33	NaN	23.08
BRD-K49294207	CP	BIBU-1361	EGFR inhibitor	EGFR	EGFR inhibitor	0.00, 0.00	1.69, 0.69	-98.69	-94.92	-99.19	-86.02	-24.96	40.97	-96.68	-99.19	NaN	-96.58
BRD-K70914287	CP	BIBX-1382	EGFR inhibitor, tyrosine kinase inhibitor	EGFR, ERBB2	EGFR inhibitor	0.00, 0.00	1.45, 0.41	-49.73	-94.56	-98.66	-63.80	-24.86	-96.57	67.95	-98.86	-26.84	-94.89
BRD-A00546892	CP	biperiden	anticholinergic	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, CHRNA2		0.00, 0.00	0.61, 0.15	88.60	-13.84	68.57	-63.42	-34.42	63.70	70.97	-28.75	-54.34	36.50
BRD-K39987650	CP	bisacodyl	stimulant laxative			0.00, 0.00	0.64, 0.26	-9.55	-72.29	-24.46	13.01	79.74	-19.02	8.45	-83.96	29.18	-6.11
BRD-A89175223	CP	bisoprolol	adrenergic receptor antagonist	ADRB1, ADRB2		10.00, 10.00	0.41, 0.05	94.35	16.42	-52.44	100.00	80.90	49.84	-67.82	-54.85	-26.68	67.72
BRD-K39120595	CP	bithionol	autotaxin inhibitor	ESR1, ESR2, MCL1		0.00, 0.00	1.89, 0.60	-98.86	61.35	-95.61	65.09	-99.45	-99.59	-95.54	-95.55	-78.41	-97.47
BRD-K56509348	CP	BMS-182874	endothelin receptor antagonist	EDNRA		22.22, 11.11	1.15, 0.31	38.78	99.74	13.36	95.29	82.80	-69.75	-24.36	48.65	NaN	66.69
BRD-K84895041	CP	BMY-45778	IP1 prostacyclin receptor agonist	PTGIR		0.00, 0.00	1.58, 0.56	-79.44	80.16	-98.75	-98.70	-99.44	-61.41	11.92	-91.33	NaN	-96.09
BRD-A55484088	CP	BNTX	opioid receptor antagonist	OPRD1, OPRK1, OPRM1		0.00, 0.00	2.36, 0.59	-99.21	-97.92	-97.90	-40.20	-98.45	-98.81	-97.83	-96.77	NaN	-96.39
BRD-A83326220	CP	brazilin	nitric oxide production inhibitor, nitric oxide synthase expression inhibitor, telomerase inhibitor			0.00, 0.00	1.50, 0.50	-75.04	-78.97	-98.85	-99.47	-88.65	34.77	47.66	-98.79	-49.26	-91.71
BRD-A37347161	CP	BRL-52537	opioid receptor agonist	OPRK1		0.00, 0.00	1.23, 0.41	24.67	-36.36	65.71	-65.37	26.25	44.27	-76.87	72.12	NaN	9.24
BRD-K47631482	CP	bromhexine	mucolytic			0.00, 0.00	0.56, 0.09	54.99	-49.07	-31.88	33.91	-27.82	-96.16	22.33	-8.85	-27.16	-11.63
BRD-A80151636	CP	bromocriptine	dopamine receptor agonist, dopamine receptor antagonist, prolactin secretion inhibitor	DRD2, ADRA2A, ADRA2B, ADRA2C, DRD1, DRD3, DRD4, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, ADRA1A, ADRA1B, ADRA1D, HTR6, HTR7, PRL		0.00, 0.00	0.98, 0.35	53.13	29.25	-92.70	15.09	38.03	-57.43	15.99	-85.36	37.58	9.70
BRD-A41995253	CP	brucine	glycine receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5		20.00, 20.00	0.60, 0.14	-9.93	74.50	76.34	-51.02	97.59	99.87	-23.07	92.50	21.62	90.14
BRD-K55344148	CP	BU-224	imidazoline receptor ligand	MAOA, MAOB	Imidazoline ligand	22.22, 22.22	1.20, 0.35	42.23	98.08	99.93	66.05	6.21	39.98	61.50	75.97	NaN	73.02
BRD-K56115039	CP	BU-226	imidazoline 2 receptor ligand		Imidazoline ligand	0.00, 0.00	1.64, 0.49	14.86	-37.81	88.94	52.03	-92.63	-95.51	33.17	14.64	NaN	14.35
BRD-A60571864	CP	budesonide	glucocorticoid receptor agonist, glucocordicoid receptor antagonist, immunosuppressant	NR3C1, CYP3A5, CYP3A7		0.00, 0.00	1.51, 0.75	16.36	12.61	89.32	-94.57	-79.94	-98.64	53.73	29.73	28.93	2.92
BRD-A05186015	CP	bupropion	dopamine reuptake inhibitor, adrenergic transmitter uptake inhibitor, dopamine transporter inhibitor, norepinephrine transporter inhibitor, norepinephrine/dopamine dual reuptake inhibitor	SLC6A2, SLC6A3, CHRNA3, CYP2B6		0.00, 0.00	0.61, 0.08	78.66	31.05	-22.34	-83.34	-36.50	81.12	-48.56	56.56	-40.61	18.78
BRD-K08287586	CP	butylparaben	antimicrobial preservative			10.00, 10.00	0.50, 0.10	18.98	37.78	-51.42	-43.85	51.24	-27.07	-9.97	-14.35	98.01	5.11
BRD-A22713669	CP	BVT-948	tyrosine phosphatase inhibitor	PTPN1, PTPN11, PTPN2		0.00, 0.00	2.32, 0.45	-99.63	-66.03	-93.54	-99.09	-85.46	-98.01	7.99	-99.14	NaN	-96.60
BRD-A55946879	CP	BW-B70C	lipoxygenase inhibitor	ALOX5		0.00, 0.00	1.08, 0.33	-18.06	-4.62	19.24	-97.91	-69.89	-96.70	-75.10	-96.28	NaN	-90.28
BRD-K43468059	CP	byssochlamic-acid	mycotoxin			22.22, 22.22	1.36, 0.40	16.90	-14.99	-31.85	98.02	-60.67	98.93	48.95	-34.68	NaN	-12.13
BRD-A15131297	CP	benazepril	angiotensin converting enzyme inhibitor	ACE		0.00, 0.00	0.78, 0.15	51.54	58.21	-44.25	-25.02	89.93	12.52	32.03	27.24	-90.15	17.78
BRD-K97688263	CP	benzamil	epithelial sodium channel blocker	PKD2L1, SCNN1A, SCNN1B, SCNN1G, ASIC1, SCNN1D, SLC8A1		0.00, 0.00	1.43, 0.50	93.24	-83.14	-33.64	-25.12	55.49	-32.06	-33.46	47.26	NaN	-10.27
BRD-K14221570	CP	benzopurpurin-4b	binds HIV gp120 and inhibits HIV-1 entry into the neural cell line SK-N-MC			0.00, 0.00	1.14, 0.40	-31.73	-52.31	16.16	20.59	49.56	-12.64	72.55	62.63	9.27	8.66
BRD-A15034104	CP	bergenin	anti-arthritic compound that modulates Th1/Th2 cytokine balance	PTPN1		11.11, 11.11	1.19, 0.32	94.53	-97.85	5.36	98.93	-34.03	-46.12	-36.06	-70.43	NaN	-40.95
BRD-K49448285	CP	bisindolylmaleimide	CDK inhibitor, PKC inhibitor, leucine rich repeat kinase inhibitor	CCND1, CDK4, LRRK2, PDPK1, PIM1, PRKCA, PRKCB, PRKCI, PRKCZ	PKC inhibitor	0.00, 0.00	0.73, 0.14	-97.76	4.97	-23.95	-90.54	-82.18	-43.08	64.93	-99.27	NaN	-93.09
BRD-A60274948	CP	bromocriptine	dopamine receptor agonist, dopamine receptor antagonist, prolactin secretion inhibitor	DRD2, ADRA2A, ADRA2B, ADRA2C, DRD1, DRD3, DRD4, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, ADRA1A, ADRA1B, ADRA1D, HTR6, HTR7, PRL		0.00, 0.00	0.88, 0.26	-20.93	-99.93	-67.19	-62.99	84.51	-84.30	-98.74	-72.17	NaN	-77.59
BRD-A15070535	CP	bucladesine	adenosine receptor agonist, cAMP stimulant, vasodilator	PRKACA		11.11, 0.00	1.11, 0.24	42.66	96.14	76.20	-15.60	-70.15	-93.71	37.69	-52.44	NaN	-27.95
BRD-A82238138	CP	budesonide	glucocorticoid receptor agonist, glucocordicoid receptor antagonist, immunosuppressant	NR3C1, CYP3A5, CYP3A7	Glucocorticoid receptor agonist	0.00, 0.00	1.40, 0.83	9.16	49.66	-72.56	-70.11	38.46	-98.14	-54.18	-57.76	NaN	-51.56
BRD-K41707108	CP	ceramide	nitric oxide production inhibitor, phosphoenolpyruvate carboxylase activator, serine/threonine protein phosphatase activator			0.00, 0.00	1.00, 0.25	51.65	6.11	18.39	38.16	44.87	-88.32	-87.03	19.99	NaN	12.89
BRD-A56020723	CP	CA-074-Me	cathepsin inhibitor, antiamyloidogenic agent	CTSB		0.00, 0.00	2.63, 0.91	69.17	-92.85	-92.54	81.05	-91.32	-64.58	-29.78	-44.57	NaN	-86.46
BRD-K02404261	CP	caffeine	adenosine receptor antagonist, ATM kinase inhibitor, ATR kinase inhibitor	ADORA1, ADORA2A, ADORA2B, ATM, ITPR1, RYR1, ADORA3, ATR, ITPR2, ITPR3, PDE10A, PDE11A, PDE1A, PDE1B, PDE1C, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A, PDE6A, PDE6B, PDE6C, PDE7A, PDE7B, PDE8A, PDE8B, PDE9A, PIK3CA, PIK3CB, PIK3CD, PRKDC, RYR2, RYR3		0.00, 0.00	0.43, 0.13	28.87	92.31	19.49	50.28	-18.58	62.75	-29.38	68.64	36.50	32.58
BRD-A65671304	CP	candesartan	angiotensin receptor antagonist	AGTR1, AGTR2	Angiotensin receptor antagonist	0.00, 0.00	0.53, 0.10	-98.78	-33.55	-99.38	31.32	-72.22	29.51	-52.90	-30.15	-29.73	-31.27
BRD-A29322418	CP	canrenoic-acid	aldosterone antagonist			10.00, 10.00	0.70, 0.19	14.85	43.69	-37.86	27.51	24.50	99.73	69.95	94.40	-9.11	35.30
BRD-A29426959	CP	carbinoxamine	histamine receptor antagonist, L-type calcium channel blocker	HRH1		0.00, 0.00	1.30, 0.38	-10.64	61.58	-95.46	-40.39	61.99	61.70	50.36	15.95	76.12	39.85
BRD-A10977446	CP	carvedilol	adrenergic receptor antagonist, reducing agent, ryanodine receptor channel modulator	ADRB1, ADRB2, ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB3, CYP2C19, CYP2E1, GJA1, HIF1A, KCNH2, NDUFC2, NPPB, RYR2, SELE, VCAM1, VEGFA		0.00, 0.00	0.88, 0.16	-96.53	-96.87	-83.45	-36.23	-76.17	7.56	-18.90	-80.58	-57.78	-71.91
BRD-A55369275	CP	CGP-54626	GABA receptor antagonist	GABBR1, GABBR2, KCTD12, KCTD16, KCTD8		22.22, 22.22	1.74, 0.64	99.89	64.74	52.22	-19.65	97.81	-41.27	20.43	-15.53	NaN	40.52
BRD-K42500029	CP	CGP-57380	MAP kinase inhibitor, MAPK-interacting kinase inhibitor	AURKB, LCK, MKNK1, MKNK2, SGK1		10.00, 10.00	1.36, 0.49	-33.07	-16.02	40.27	-27.50	-6.24	-66.37	24.79	-78.17	97.78	-6.55
BRD-K49049886	CP	CGS-15943	adenosine receptor antagonist	ADORA1, ADORA2A, ADORA2B, ADORA3		0.00, 0.00	1.56, 0.28	-84.56	-91.07	-96.42	-44.58	-46.03	-97.77	-76.98	-99.35	NaN	-96.90
BRD-A01593789	CP	chlormadinone	progesterone receptor agonist	PGR		20.00, 10.00	0.64, 0.23	-12.33	-84.72	-32.36	98.14	-15.24	-88.67	-85.75	96.27	-25.75	-47.23
BRD-A91699651	CP	chloroquine	antimalarial agent	CYP2C8, GSTA2, MRGPRX1, TLR9, TNF		20.00, 0.00	0.83, 0.11	54.05	-44.45	-44.84	57.23	89.04	-83.32	95.03	97.31	68.88	77.60
BRD-K17075857	CP	chloroxine	opioid receptor inhibitor	OPRK1		0.00, 0.00	1.31, 0.13	-96.73	24.55	-97.74	-67.75	-95.54	-93.09	-27.51	-66.63	-76.46	-91.26
BRD-K89595132	CP	chlorphenamine	histamine receptor antagonist	HRH1, SLC6A2, SLC6A3, SLC6A4		20.00, 10.00	0.45, 0.09	95.13	-10.84	-92.02	98.09	-11.79	63.56	-53.02	-75.82	-11.58	-6.74
BRD-K59058766	CP	chlorprothixene	dopamine receptor, dopamine receptor antagonist	DRD2, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD3, HRH1, HTR2A, HTR2B, HTR2C	Dopamine receptor antagonist	0.00, 0.00	1.59, 0.57	-16.27	-74.33	77.49	-51.85	-38.29	-99.20	-28.74	-77.65	-16.14	-55.31
BRD-K67017579	CP	cilostazol	phosphodiesterase inhibitor, platelet aggregation inhibitor	PDE3A, CYP2C19, CYP3A5, PDE3B		0.00, 0.00	1.17, 0.38	-9.00	74.99	37.10	40.38	-51.22	85.00	27.45	-14.48	-52.79	12.31
BRD-K34157611	CP	cimetidine	histamine receptor antagonist, histamine receptor inhibitor	HRH2, SLC29A4, SLC47A1, SLC47A2		20.00, 20.00	0.44, 0.13	98.53	-27.42	-71.19	15.34	89.73	-54.07	6.91	-64.65	99.80	22.21
BRD-K40901640	CP	cinanserin	serotonin receptor antagonist	HTR2A		0.00, 0.00	0.48, 0.09	93.87	52.35	-40.64	69.79	-43.02	54.49	27.81	-26.73	NaN	24.28
BRD-K14693417	CP	cinchonine	antimalarial agent	CYP2D6		50.00, 30.00	0.74, 0.19	-79.50	-71.78	96.68	22.61	65.36	95.28	99.20	98.25	54.77	98.91
BRD-K53263234	CP	CITCO	constitutive androstane receptor (CAR) agonist	NR1I3		0.00, 0.00	1.18, 0.35	10.18	58.95	40.55	-49.26	-98.05	29.69	-8.45	-19.30	NaN	-4.09
BRD-K30240666	CP	clemastine	histamine receptor antagonist	HRH1	HRH1 antagonist	0.00, 0.00	1.03, 0.26	-17.65	-60.23	-40.46	-29.47	-45.92	-15.71	76.23	-75.31	22.95	-11.56
BRD-A26095496	CP	clobetasol	glucocorticoid receptor agonist	NR3C1, PLA2G1B	Glucocorticoid receptor agonist	0.00, 0.00	1.44, 0.73	89.87	14.44	25.16	-98.62	17.15	-98.33	-19.89	48.15	90.17	16.34
BRD-K45252063	CP	clofibrate	PPAR receptor agonist	PPARA, LPL		10.00, 10.00	0.58, 0.24	82.40	67.28	-69.84	13.27	90.86	57.82	99.96	-11.75	-17.92	87.72
BRD-K54095730	CP	CMPD-1	p38 MAPK inhibitor	GNRHR, MAPK14		0.00, 0.00	2.41, 0.70	-88.23	69.10	-93.88	-73.02	-92.43	-68.11	-25.90	-99.90	NaN	-92.88
BRD-K53545112	CP	CNQX	glutamate receptor antagonist, unidentified pharmacological activity	GRIA1, GRIA2, GRIA3, GRIA4		11.11, 11.11	1.25, 0.32	99.98	14.63	8.26	-25.14	52.42	-61.93	-24.27	60.64	NaN	22.79
BRD-A55416093	CP	colforsin	adenylyl cyclase activator, Adenylate cyclase stimulant, growth hormone receptor agonist, phosphokinase stimulant	ADCY2, ADCY5, GNAS		20.00, 10.00	0.95, 0.47	96.26	-69.96	-3.93	81.29	99.75	-82.79	-33.08	-98.12	87.86	85.26
BRD-A54487287	CP	cortisone	glucocorticoid receptor agonist	NR3C1		10.00, 0.00	0.72, 0.15	-22.33	32.63	35.21	-29.12	25.04	4.88	-26.67	93.50	96.11	9.64
BRD-K23913458	CP	coumarin	vitamin antagonist	CA1, CA12, CA14, CA2, CA4, CA6, CA9, CYP2A6		40.00, 20.00	0.68, 0.25	97.37	76.85	-58.61	48.45	99.79	95.42	51.07	54.42	-41.34	97.60
BRD-A64933752	CP	CV-1808	adenosine receptor agonist	ADORA2A, ADORA2B	Adenosine receptor agonist	0.00, 0.00	1.07, 0.36	44.59	-16.21	-71.86	-11.02	38.42	72.62	-31.73	-81.07	NaN	-11.85
BRD-K40965114	CP	cyanopindolol	adrenergic receptor antagonist	HTR1D		0.00, 0.00	1.40, 0.47	-23.77	33.44	16.47	50.70	-37.85	-33.80	-5.82	-29.64	NaN	-2.96
BRD-K36055864	CP	cycloheximide	glycogen synthase kinase inhibitor, protein synthesis inhibitor	GSK3B, RPL3		10.00, 0.00	2.15, 0.60	-18.64	-99.52	-97.61	-63.65	96.85	70.19	-45.01	75.61	-22.86	-61.18
BRD-A26787626	CP	cyclopiazonic-acid	ATPase inhibitor	ATP2A1		0.00, 0.00	0.97, 0.17	56.68	-73.22	-61.80	-55.52	-69.25	32.11	18.64	14.45	NaN	-36.36
BRD-A69815203	CP	cyclosporin-a	calcineurin inhibitor, cyclophilin inhibitor, immunosuppressant, insulin expression inhibitor, T cell inhibitor	PPIA, ABCB11, CAMLG, CYP3A5, CYP3A7, FPR1, PPID, PPIF, PPP3CA, PPP3R2, SLC10A1, SLCO1B1, SLCO1B3		0.00, 0.00	1.84, 0.53	-99.10	-98.07	-98.87	-97.21	-85.98	-64.61	-62.27	-99.45	-41.10	-96.70
BRD-K56429665	CP	calcipotriol	vitamin D receptor agonist	VDR	Vitamin D receptor agonist	0.00, 0.00	1.07, 0.26	-68.70	-65.96	-84.43	-93.57	-33.56	-62.50	-68.29	-95.54	NaN	-82.83
BRD-A53416814	CP	ceramide	nitric oxide production inhibitor, phosphoenolpyruvate carboxylase activator, serine/threonine protein phosphatase activator			11.11, 11.11	0.91, 0.20	21.32	72.56	-5.60	-88.91	33.70	98.55	71.21	-88.62	NaN	32.77
BRD-K51290057	CP	SA-792709	retinoid receptor agonist	RARA, RARB		0.00, 0.00	1.50, 0.55	-99.52	-34.45	-99.60	-99.94	-78.61	56.62	-95.21	-99.34	-98.42	-98.94
BRD-K32828673	CP	chelidonine	tubulin polymerization inhibitor		Tubulin inhibitor	11.11, 11.11	1.86, 0.72	24.44	99.93	-72.66	-42.25	30.94	70.87	-60.27	-71.78	NaN	-65.23
BRD-A41555725	CP	chlortetracycline	protein synthesis inhibitor			0.00, 0.00	1.30, 0.49	81.36	32.35	57.48	15.61	18.90	-98.96	87.75	21.60	NaN	27.52
BRD-A83695761	CP	chromanol	potassium channel blocker		Potassium channel blocker	0.00, 0.00	1.01, 0.31	34.87	23.89	53.30	-38.89	-30.98	46.29	6.15	8.55	NaN	4.31
BRD-A65440446	CP	cimaterol	adrenergic receptor agonist		Beta-adrenergic receptor agonist	11.11, 11.11	0.82, 0.26	89.16	-57.51	98.58	73.25	21.89	68.45	-50.34	-54.80	NaN	52.19
BRD-K06895174	CP	cisapride	acetylcholine receptor agonist, serotonin receptor agonist	HTR4, KCNH2, CYP2B6, CYP2C8, CYP3A5, CYP3A7, HTR2A, HTR3A	Serotonin receptor agonist	40.00, 10.00	0.73, 0.13	-49.91	35.94	-61.21	96.35	99.92	97.07	93.07	-65.72	30.20	97.42
BRD-K59163477	CP	cisapride	acetylcholine receptor agonist, serotonin receptor agonist	HTR4, KCNH2, CYP2B6, CYP2C8, CYP3A5, CYP3A7, HTR2A, HTR3A		11.11, 11.11	0.98, 0.18	-61.97	-23.25	35.32	99.94	16.61	68.73	80.35	-11.82	NaN	23.96
BRD-K17294426	CP	clebopride	dopamine receptor antagonist	DRD2, ACHE		22.22, 22.22	1.03, 0.31	98.64	31.27	79.32	44.76	-56.98	98.46	-11.68	-12.95	NaN	53.89
BRD-K09255212	CP	clioquinol	chelating agent, antiamyloidogenic agent, beta amyloid antagonist, carbonic anhydrase inhibitor	OPRK1		11.11, 11.11	0.92, 0.15	-21.01	87.77	99.20	39.41	24.71	-44.46	-35.78	-95.68	NaN	17.91
BRD-K55677650	CP	CO-101244	ionotropic glutamate receptor antagonist	GRIN2B		11.11, 0.00	0.97, 0.23	64.25	-43.73	-96.30	96.54	-99.33	-99.06	-96.11	-96.47	NaN	-98.77
BRD-K43736954	CP	cortisone	glucocorticoid receptor agonist	NR3C1		0.00, 0.00	1.11, 0.26	-75.68	17.51	-29.61	92.26	-63.30	36.25	-43.43	62.71	31.98	-21.65
BRD-K06467078	CP	corynanthine	alpha adrenergic receptor antagonist			0.00, 0.00	1.27, 0.38	21.94	84.52	-91.50	-79.25	-99.80	-84.37	14.53	-26.29	NaN	-51.97
BRD-A62184259	CP	cycloheximide	glycogen synthase kinase inhibitor, protein synthesis inhibitor	GSK3B, RPL3	Protein synthesis inhibitor	0.00, 0.00	2.40, 0.60	-98.73	-99.12	-99.45	-84.48	86.32	-75.18	-95.69	-57.63	-27.24	-97.74
BRD-A92537424	CP	danazol	estrogen receptor antagonist, luteinizing hormone releasing hormone antagonist, progesterone receptor agonist, steroid derivative with antigonadotropic and anti-estrogenic activities, tumor necrosis factor modulator	ESR1, GNRHR, AR, CCL2, CYP2C8, GNRHR2, PGR, TNF		20.00, 20.00	1.02, 0.32	71.18	-97.06	19.87	-25.74	99.46	99.04	60.71	-99.66	-25.32	61.25
BRD-K43389675	CP	daunorubicin	RNA synthesis inhibitor, topoisomerase inhibitor, DNA synthesis inhibitor, radical formation stimulant	TOP2A, TOP2B	Topoisomerase inhibitor	0.00, 0.00	2.67, 0.82	-87.50	24.76	-85.21	-91.22	-99.16	-84.31	-98.98	-99.23	-90.99	-98.27
BRD-A39255369	CP	DCPIB	chloride channel blocker, gap junction modulator, glutamate transporter inhibitor, membrane permeability inhibitor	SLC1A2		10.00, 10.00	0.65, 0.24	-96.52	14.53	-58.68	-61.50	-20.39	-24.50	-95.12	62.75	99.77	-27.79
BRD-A17819071	CP	gedunin	HSP inhibitor	HSP90AA1		0.00, 0.00	1.02, 0.28	-24.24	50.97	-49.14	NaN	26.84	56.76	35.97	-25.29	-85.80	-13.61
BRD-K68558722	CP	deracoxib	cyclooxygenase inhibitor	PTGS2		10.00, 0.00	0.60, 0.18	-63.20	-96.62	-98.48	96.95	-45.83	-96.78	-79.14	50.02	35.41	-96.95
BRD-A49447682	CP	desoximetasone	glucocorticoid receptor agonist	NR3C1, PLA2G1B		0.00, 0.00	1.03, 0.19	5.34	21.56	-42.36	-89.19	-82.54	-34.41	58.10	20.36	-11.73	-16.05
BRD-K13819402	CP	desoxypeganine	acetylcholinesterase inhibitor, monoamine oxidase inhibitor	ACHE, MAOA		10.00, 10.00	0.45, 0.10	-96.60	58.88	-22.77	84.49	50.11	99.71	50.69	53.76	-88.81	51.88
BRD-A10188456	CP	dexamethasone	glucocorticoid receptor agonist, corticosteroid agonist, immunosuppressant	ANXA1, CYP3A4, CYP3A5, NOS2, NR0B1, NR3C1, NR3C2		10.00, 10.00	1.20, 0.67	99.18	76.19	53.36	-97.75	-91.72	-98.76	93.07	-66.19	40.53	-86.79
BRD-A93424738	CP	dexamethasone	glucocorticoid receptor agonist, corticosteroid agonist, immunosuppressant	ANXA1, CYP3A4, CYP3A5, NOS2, NR0B1, NR3C1, NR3C2	Glucocorticoid receptor agonist	0.00, 0.00	1.25, 0.52	-36.63	58.87	-28.84	-96.76	56.96	-95.21	75.53	-74.24	89.17	-55.72
BRD-A04553218	CP	chlorphenamine	histamine receptor antagonist	HRH1, SLC6A2, SLC6A3, SLC6A4		10.00, 0.00	0.41, 0.08	9.44	47.50	-90.37	-53.57	27.57	31.50	97.47	23.36	31.64	6.80
BRD-K24053527	CP	dextromethorphan	glutamate receptor antagonist, sigma receptor agonist	SIGMAR1, CHRNA2, CHRNA3, CHRNA4, CHRNA7, CHRNB2, CHRNB4, CYBA, CYBB, CYP3A5, GRIN1, GRIN3A, NCF1, NCF2, NCF4, OPRD1, OPRK1, OPRM1, PGRMC1, RAC1, RAC2, SLC6A2, SLC6A4		0.00, 0.00	0.45, 0.15	17.29	-80.65	-43.05	34.68	-67.00	48.71	-68.32	-31.24	23.24	-29.69
BRD-K01555864	CP	dibenzoylmethane	tumorigenesis inhibitor			11.11, 0.00	0.65, 0.11	-57.71	38.86	-74.11	97.00	85.06	39.47	26.14	20.36	NaN	18.08
BRD-K08252256	CP	diclofenac	cyclooxygenase inhibitor	PTGS1, PTGS2, AKR1C3, ALOX5, ASIC1, ASIC3, CYP2C8, KCNQ2, KCNQ3, PLA2G2A, PPARG, SCN4A		0.00, 0.00	0.78, 0.19	16.96	35.76	-24.01	-41.76	-45.62	66.52	-88.16	33.28	33.62	9.84
BRD-K95309561	CP	dienestrol	estrogen receptor agonist	ESR1	Estrogen receptor agonist	80.00, 60.00	0.34, 0.25	99.04	96.94	99.92	97.45	93.12	99.88	76.22	99.96	99.97	99.86
BRD-K45542189	CP	diethylcarbamazine	lipoxygenase inhibitor	ALOX5, PTGS1		10.00, 10.00	0.70, 0.16	-59.98	-61.69	49.37	44.11	99.88	81.07	84.21	-57.48	-63.47	-49.84
BRD-K45330754	CP	diethylstilbestrol	estrogen receptor agonist, chloride channel blocker	ESR1, ESR2, ESRRG, ESRRB	Estrogen receptor agonist	60.00, 60.00	0.41, 0.31	99.86	-12.91	99.89	86.16	-41.56	94.48	99.94	99.96	99.88	99.75
BRD-A93236127	CP	digitoxin	ATPase inhibitor	ATP1A1	ATPase inhibitor	0.00, 0.00	2.18, 0.56	-35.23	42.48	-93.10	-41.67	-66.96	-14.76	-95.32	63.14	40.30	-58.74
BRD-A94756469	CP	digoxin	ATPase inhibitor, ROR antagonist	ATP1A1, ABCB1, RORC, SLCO1B3	ATPase inhibitor	0.00, 0.00	2.18, 0.59	23.77	-98.77	-99.26	29.43	-82.29	32.93	-94.61	60.20	-54.66	-93.61
BRD-K20152659	CP	gamma-homolinolenic-acid	cholesterol inhibitor, platelet aggregation inhibitor, prostaglandin G/H synthase 1, prostanoid receptor stimulant	PTGS1, PTGS2		0.00, 0.00	1.63, 0.60	18.90	-98.03	-15.22	-78.70	-63.17	90.38	-51.00	-44.38	NaN	-59.02
BRD-A47144777	CP	dihydro-7-desacetyldeoxygedunin	HSP90 inhibitor	HSP90AA1		11.11, 0.00	1.03, 0.27	11.02	14.05	-23.64	9.25	95.64	-58.82	-55.00	-99.85	NaN	-22.60
BRD-A02713983	CP	dihydrodeoxygedunin	growth factor receptor activator	NTRK2		11.11, 11.11	1.14, 0.33	86.80	-33.04	93.90	93.81	20.93	39.02	21.49	99.82	NaN	94.68
BRD-A65076780	CP	dihydroergocristine	adrenergic receptor antagonist, prolactin inhibitor, adrenergic receptor partial agonist, dopamine receptor agonist, dopamine receptor partial agonist, dopamine receptor partial antagonist, serotonin receptor antagonist	HTR2A, ADRA1A, ADRB1, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR3A, HTR4, HTR5A, HTR6, HTR7		0.00, 0.00	1.34, 0.35	40.43	-95.62	-95.16	-21.59	-35.66	-85.14	-34.79	-82.99	NaN	-71.39
BRD-K72166146	CP	dihydroergotamine	serotonin receptor agonist, adrenergic receptor partial agonist, dopamine receptor agonist	HTR1D, HTR1B, ADRA2A, DRD2, HTR1E, HTR1F, HTR2B, HTR7		0.00, 0.00	0.65, 0.16	-21.85	-42.79	-99.74	12.28	37.22	-19.96	65.35	86.89	-26.90	-10.61
BRD-K63945320	CP	dihydrosamidin	nitric oxide production inhibitor, phospholipase inhibitor, platelet activating factor receptor antagonist			0.00, 0.00	0.44, 0.09	43.80	-11.24	-90.65	86.40	-85.91	-77.86	-99.98	46.04	-64.43	-81.04
BRD-K10974103	CP	diloxanide	unidentified pharmacological activity			10.00, 0.00	0.47, 0.09	43.08	-90.63	-38.90	-46.74	96.68	71.17	-84.77	-36.87	-13.31	-16.48
BRD-A69636825	CP	diltiazem	L-type calcium channel blocker, calcium channel antagonist, calcium channel blocker	CACNA1C, CACNA1S, CACNA2D1, CACNG1, CYP3A5, CYP3A7, HTR3A, KCNA5		0.00, 0.00	0.91, 0.31	20.76	-46.70	69.06	14.84	-71.95	48.29	-76.58	-44.14	18.57	-36.47
BRD-K82577285	CP	dipropyl-dopamine	dopamine receptor agonist			0.00, 0.00	2.07, 0.69	-19.73	-92.43	-61.42	-18.54	63.98	-60.88	9.81	-90.57	NaN	-77.45
BRD-K86301799	CP	dipyridamole	phosphodiesterase inhibitor, cyclooxygenase inhibitor, platelet aggregation inhibitor	ADA, PDE5A, PDE10A, PDE4A, PDE7B, PDE8A, PDE8B, SLC29A1		10.00, 0.00	0.55, 0.09	96.31	44.20	52.23	-50.71	-39.52	43.75	-33.76	38.05	-13.05	14.17
BRD-K96084870	CP	DMBI	platelet-derived growth factor receptor (PDGFR) inhibitor, tyrosine kinase inhibitor, vascular endothelial growth factor receptor (VEGFR) inhibitor	PDGFRB		0.00, 0.00	0.66, 0.17	25.45	-10.25	17.07	-93.70	-17.89	-99.90	-96.25	-99.96	51.90	-97.63
BRD-K38305202	CP	domperidone	dopamine receptor antagonist, breast cancer resistance protein inhibitor	DRD2, DRD3, ABCG2, CYP3A5		0.00, 0.00	0.81, 0.09	17.83	-25.26	-62.78	11.60	28.17	72.13	36.14	-39.12	80.66	10.40
BRD-A49160188	CP	donepezil	acetylcholinesterase inhibitor	ACHE, HTR2A		0.00, 0.00	1.13, 0.32	22.15	84.27	23.80	-49.08	-38.48	-96.96	-37.17	-90.42	-10.67	-6.37
BRD-K37694030	CP	doxepin	histamine receptor antagonist, adrenergic transmitter uptake inhibitor, histamine receptor inhibitor, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, tricyclic antidepressant	HRH1, HRH2, SLC6A2, SLC6A4, ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, CYP2C19, DRD2, HRH4, HTR1A, HTR2A, HTR2B, HTR2C, HTR6, KCNH2, SLC6A3		0.00, 0.00	0.38, 0.06	52.88	31.26	-9.74	-30.07	-51.45	36.43	54.74	-16.30	-62.70	-4.02
BRD-A52530684	CP	doxorubicin	topoisomerase inhibitor, DNA intercalating drug	TOP2A		0.00, 0.00	1.58, 0.51	-99.39	-12.99	-99.08	-99.93	-99.18	-26.34	90.56	-99.28	-97.10	-97.85
BRD-K99922388	CP	DPO-1	potassium channel blocker	KCNA5	Potassium channel blocker	0.00, 0.00	1.20, 0.36	12.95	-54.90	-38.18	-5.10	62.83	-34.41	-87.11	5.27	NaN	-4.78
BRD-K97158071	CP	droperidol	dopamine receptor antagonist, dopamine receptor	DRD2, ADRA1A	Dopamine receptor antagonist	20.00, 10.00	0.52, 0.11	-19.08	-69.67	51.36	98.08	26.28	95.24	-70.58	29.11	-13.11	17.85
BRD-K71103788	CP	duloxetine	norepinephrine reuptake inhibitor, serotonin reuptake inhibitor, adrenergic transmitter uptake inhibitor, norepinephrine transporter inhibitor, serotonin transporter (SERT) inhibitor, serotonin uptake inhibitor	SLC6A2, SLC6A4, SLC6A3, HTR2A, HTR2C, HTR6		0.00, 0.00	0.49, 0.14	-39.47	-99.28	64.75	41.59	-98.68	-60.70	-92.94	-57.51	-30.18	-86.38
BRD-K60274257	CP	dephostatin	tyrosine phosphatase inhibitor	PTPN1, PTPN6		0.00, 0.00	1.38, 0.31	-64.78	-85.55	-2.05	19.08	-98.56	-90.53	-27.25	34.48	-59.16	-80.92
BRD-K47635719	CP	dexamethasone	glucocorticoid receptor agonist, corticosteroid agonist, immunosuppressant	ANXA1, CYP3A4, CYP3A5, NOS2, NR0B1, NR3C1, NR3C2		0.00, 0.00	1.20, 0.78	-95.46	55.60	62.10	-92.76	-86.07	-99.23	16.49	54.70	-18.24	-91.54
BRD-A04706586	CP	bucladesine	adenosine receptor agonist, cAMP stimulant, vasodilator	PRKACA		20.00, 10.00	0.68, 0.18	79.42	84.99	99.98	83.45	96.93	32.29	9.93	-43.73	-39.96	79.03
BRD-K18518344	CP	digitoxigenin	ATPase inhibitor	ATP1A1	ATPase inhibitor	0.00, 0.00	2.61, 0.56	-55.64	-47.28	-99.21	-80.75	-30.70	40.75	-77.25	33.95	NaN	-82.69
BRD-A99164655	CP	dihydrexidine	dopamine receptor agonist	DRD1, DRD2, DRD3, DRD4, DRD5		0.00, 0.00	1.25, 0.32	-20.41	39.82	20.41	91.73	34.15	-91.71	-10.07	-55.38	NaN	5.43
BRD-A44701612	CP	dihydroergocristine	adrenergic receptor antagonist, prolactin inhibitor, adrenergic receptor partial agonist, dopamine receptor agonist, dopamine receptor partial agonist, dopamine receptor partial antagonist, serotonin receptor antagonist	HTR2A, ADRA1A, ADRB1, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR3A, HTR4, HTR5A, HTR6, HTR7		0.00, 0.00	1.11, 0.32	-99.40	-38.50	-99.17	-3.86	65.55	-61.41	21.71	-94.83	NaN	-92.58
BRD-A54845972	CP	dihydroergotamine	serotonin receptor agonist, adrenergic receptor partial agonist, dopamine receptor agonist	HTR1D, HTR1B, ADRA2A, DRD2, HTR1E, HTR1F, HTR2B, HTR7		0.00, 0.00	1.47, 0.50	47.43	20.11	-49.91	28.96	-18.50	45.46	51.02	-86.08	NaN	4.76
BRD-K48722258	CP	dilazep	adenosine reuptake inhibitor, calcium channel antagonist, platelet aggregation inhibitor	SLC29A1, CACNA1C		0.00, 0.00	1.32, 0.44	-73.64	58.35	75.26	74.51	-44.67	-54.15	-97.23	35.99	NaN	61.36
BRD-K93441486	CP	diphemanil	acetylcholine receptor antagonist	CHRM3		44.44, 11.11	0.84, 0.31	51.93	4.16	-93.90	14.62	97.10	-56.86	97.24	97.74	NaN	96.61
BRD-K54233340	CP	dorsomorphin	AMPK inhibitor, DNA damaging, TGF beta receptor inhibitor	ACVR1, BMPR1A, BMPR1B, EPHA2, FKBP1A, FLT1, FLT3, KDR, LCK, MKNK1, PRKAA1, RPS6KA1, SRC		0.00, 0.00	1.16, 0.24	-99.27	-99.78	-99.16	-97.38	-91.11	-98.91	-99.54	-93.28	-98.90	-98.01
BRD-A76941896	CP	doxorubicin	topoisomerase inhibitor, DNA intercalating drug	TOP2A		0.00, 0.00	2.36, 0.74	-99.48	-68.31	-94.50	-88.03	-99.63	-99.37	-53.11	-98.98	NaN	-98.38
BRD-A99571536	CP	dubinidine	anticonvulsant that reduces motor activity			11.11, 11.11	2.11, 0.59	98.83	-80.13	-95.23	-53.38	-68.97	51.40	-12.23	-55.54	NaN	-72.16
BRD-K41713976	CP	E-4031	polarization inhibitor, potassium channel antagonist, potassium channel blocker	KCNH2, KCNH1		10.00, 10.00	0.72, 0.18	18.06	54.85	-31.04	28.56	81.62	76.58	99.70	-43.48	29.57	35.44
BRD-K50464341	CP	berbamine	calmodulin antagonist	CALM1	Calmodulin antagonist	0.00, 0.00	1.76, 0.69	-18.67	-90.26	-95.95	-98.51	11.74	49.49	-92.99	-94.63	NaN	-95.24
BRD-K80325895	CP	eicosadienoic-acid	in touchstone			11.11, 0.00	1.49, 0.41	-7.66	37.78	-50.66	29.86	-88.64	-34.23	46.60	95.06	NaN	15.82
BRD-K47192521	CP	icosapent	fatty acid with anti-inflammatory, antithrombotic and immunomodulatory properties	PTGS1, PTGS2, ACSL3, ACSL4, FADS1, FFAR1, PPARD, PPARG, SLC8A1, TRPV1		0.00, 0.00	1.13, 0.30	82.63	-13.34	-18.65	13.66	72.56	49.84	-13.82	8.40	NaN	9.10
BRD-K47659338	CP	EMD-386088	serotonin receptor agonist	HTR6	Serotonin receptor agonist	0.00, 0.00	0.47, 0.09	-47.56	-42.08	-54.50	30.14	-35.06	-84.04	-47.94	-42.59	50.48	-18.76
BRD-A25687296	CP	emetine	protein synthesis inhibitor	RPS2	Protein synthesis inhibitor	11.11, 11.11	2.92, 0.68	21.29	NaN	-99.32	-71.24	99.03	-59.61	-98.64	-94.28	-47.79	-95.07
BRD-A98431941	CP	ephedrine	adrenergic receptor agonist	ACHE, ADRA1A, ADRB2, SLC18A2, SLC6A2		11.11, 11.11	1.33, 0.41	55.50	54.33	88.18	4.95	43.55	-96.35	99.35	82.56	NaN	70.31
BRD-K50660797	CP	epicatechin	beta amyloid protein neurotoxicity inhibitor, beta secretase inhibitor, cyclooxygenase inhibitor, DNA gyrase inhibitor, DNA polymerase beta inhibitor, fatty acid synthase inhibitor, HCV inhibitor, sodium/glucose cotransporter inhibitor	FASN, APP, BACE1, SLC5A1		10.00, 10.00	1.01, 0.33	99.70	-36.97	-69.31	68.05	49.60	-10.55	-63.51	-53.66	35.96	-31.17
BRD-K04548931	CP	pidorubicine	topoisomerase inhibitor, DNA intercalating drug	TOP2A	Topoisomerase inhibitor	0.00, 0.00	2.40, 0.72	-98.45	-83.18	-98.57	-69.55	-94.83	-98.05	-99.43	-98.83	-95.17	-98.20
BRD-A88080608	CP	equilin	estrogen receptor agonist	HSD17B1		10.00, 0.00	0.65, 0.18	88.71	53.50	25.86	-20.23	71.23	96.22	13.55	20.75	70.40	64.21
BRD-K39746403	CP	erythromycin	NFkB pathway inhibitor, 50S ribosomal subunit inhibitor, motilin receptor agonist, RPLV inhibitor	CYP3A4, MLNR		0.00, 0.00	0.74, 0.14	60.61	22.81	-81.36	41.13	-99.01	53.72	17.48	-36.53	10.77	8.21
BRD-K51677086	CP	erythromycin	NFkB pathway inhibitor, 50S ribosomal subunit inhibitor, motilin receptor agonist, RPLV inhibitor	CYP3A4, MLNR		10.00, 10.00	1.31, 0.32	50.98	-77.69	-60.20	28.74	98.79	77.17	38.26	90.49	13.60	59.40
BRD-K14920963	CP	erythrosine	food coloring agent			0.00, 0.00	0.68, 0.19	-6.84	-10.78	21.68	26.49	24.06	77.71	-75.94	-61.00	-23.04	4.19
BRD-K70301876	CP	escitalopram	selective serotonin reuptake inhibitor (SSRI), serotonin reuptake inhibitor	SLC6A4, ADRA1A, CHRM1, CYP2C19, HRH1, SLC6A2, SLC6A3		10.00, 10.00	0.45, 0.13	39.37	26.14	36.91	-25.04	98.58	54.19	-36.76	-18.00	-89.16	15.89
BRD-A18917088	CP	estradiol	estrogen receptor agonist	ESR1, ESR2, NR1I2, CYP2B6, CYP2C19, CYP2C8, CYP2E1, CYP3A5, CYP3A7, GPER1, KCNMA1	Estrogen receptor agonist	10.00, 10.00	0.52, 0.15	25.36	-51.09	18.22	23.66	98.69	89.12	-52.28	-77.08	-25.09	-14.31
BRD-A36066264	CP	estradiol-benzoate	contraceptive agent	ESR1	Estrogen receptor agonist	20.00, 20.00	0.39, 0.10	4.41	-98.36	-20.42	6.85	99.94	99.88	-10.99	-33.16	-90.01	-2.26
BRD-A91452556	CP	estradiol-cypionate	estrogen receptor agonist	ESR1	Estrogen receptor agonist	0.00, 0.00	1.38, 0.34	12.81	-99.63	29.33	25.21	-96.09	29.39	-57.34	76.68	25.25	5.76
BRD-A37959677	CP	estrone	estrogen receptor agonist, estrogenic hormone	ESR1, ESR2		0.00, 0.00	0.68, 0.22	-34.23	36.90	78.42	-32.59	38.97	47.27	-99.81	-74.78	NaN	21.21
BRD-A22143024	CP	estropipate	estrogen receptor agonist	ESR1, ESR2	Estrogen receptor agonist	0.00, 0.00	0.61, 0.10	15.15	16.87	20.04	62.09	-51.54	19.56	79.71	67.88	94.96	66.38
BRD-K08556791	CP	ethoprop	acetylcholinesterase inhibitor	ACHE		11.11, 0.00	1.47, 0.39	95.86	-24.05	93.47	48.27	23.63	67.70	-97.30	60.20	NaN	50.93
BRD-A74667430	CP	etodolac	cyclooxygenase inhibitor, TRPV agonist	PTGS2, PTGS1, RXRA, TRPV1	Cyclooxygenase inhibitor	10.00, 10.00	0.91, 0.24	87.49	-40.58	-58.92	62.85	87.55	80.23	99.53	-15.97	22.95	83.76
BRD-A54880345	CP	etomidate	membrane integrity inhibitor, membrane permeability inhibitor	GABRA1, ADRA2B, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ		0.00, 0.00	0.56, 0.16	19.55	72.59	-93.15	-34.97	-75.18	24.06	-41.16	46.07	7.47	8.95
BRD-K32977963	CP	eugenol	androgen receptor (AR) inhibitor, free radical scavenger, monoamine oxidase inhibitor, quorum sensing signaling modulator	AR, MAOA		11.11, 0.00	0.91, 0.25	-55.84	46.41	57.88	95.52	-73.44	58.09	-43.52	68.98	NaN	54.57
BRD-A73741725	CP	exemestane	aromatase inhibitor	CYP19A1	Aromatase inhibitor	20.00, 10.00	1.02, 0.35	-27.15	-94.90	-30.13	96.61	-51.44	99.16	-65.76	-37.41	-20.49	-23.76
BRD-A41519720	CP	ezetimibe	cholesterol absorption inhibitor, Niemann-Pick C1-like 1 protein antagonist, liver bile acid transporter inhibitor, Niemann-Pick C1-like 1 protein inhibitior	NPC1L1, ANPEP, SOAT1		0.00, 0.00	0.97, 0.18	-28.87	-71.98	-30.92	-65.74	-62.62	-73.17	-10.42	-99.30	-82.49	-67.59
BRD-K40227168	CP	vinburnine	adrenergic receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4		33.33, 22.22	0.76, 0.22	82.55	99.96	-72.99	95.10	54.59	99.05	-66.14	-81.90	NaN	94.86
BRD-K74212935	CP	ergocryptine	dopamine agonist			0.00, 0.00	0.64, 0.14	-39.90	-81.51	-63.09	93.88	-53.79	-9.34	21.17	79.23	-17.68	-29.18
BRD-K51095933	CP	estropipate	estrogen receptor agonist	ESR1, ESR2		0.00, 0.00	0.74, 0.14	-23.58	-86.96	71.56	-28.28	-83.73	-80.81	-74.04	-18.81	NaN	-68.44
BRD-K64755930	CP	etazolate	phosphodiesterase inhibitor, alpha secretase activator, GABA receptor modulator	GABRB3, PDE4A		22.22, 11.11	1.39, 0.44	-12.45	-38.10	95.72	98.83	59.84	-93.48	-87.23	18.66	NaN	19.68
BRD-K45033733	CP	famciclovir	DNA polymerase inhibitor, DNA directed DNA polymerase inhibitor		DNA polymerase inhibitor	0.00, 0.00	0.38, 0.10	-21.87	79.70	26.53	81.42	-70.15	-11.06	-48.65	-21.66	31.22	6.51
BRD-A97104540	CP	fenoterol	adrenergic receptor agonist	ADRB2, ADRB1, ADRB3	Beta-adrenergic receptor agonist	30.00, 20.00	0.97, 0.36	99.68	77.86	93.86	33.03	-15.21	87.45	-61.13	97.94	19.94	95.42
BRD-K66093087	CP	FGIN-1-43	benzodiazepine receptor ligand	TSPO		11.11, 0.00	1.50, 0.53	96.70	86.42	-60.00	42.36	-88.39	55.61	13.51	57.25	NaN	43.96
BRD-A50675702	CP	fipronil	GABA gated chloride channel blocker, glutamate gated chloride channel blocker			0.00, 0.00	0.72, 0.19	-86.31	-92.90	-39.59	-99.03	-99.54	-46.18	22.99	-99.51	-98.28	-99.51
BRD-A38749782	CP	fludrocortisone	glucocorticoid receptor agonist, mineralocorticoid receptor agonist	NR3C2, AR, NR3C1	Glucocorticoid receptor agonist	0.00, 0.00	1.64, 0.57	-25.67	-27.86	60.15	-93.79	37.85	42.41	18.16	-33.85	NaN	-13.56
BRD-K29582677	CP	flunarizine	calcium channel blocker, T-type calcium channel blocker	CACNA1G, CACNA1H, CACNA1I, CALM1, CYP2J2, HRH1		10.00, 10.00	0.92, 0.23	-17.34	-93.19	42.79	94.83	99.78	31.91	-22.02	35.41	-33.96	22.43
BRD-A77824596	CP	fluocinolone	corticosteroid agonist, glucocorticoid receptor agonist	NR3C1, SERPINA6		0.00, 0.00	1.51, 0.42	-69.74	-59.54	-51.95	-95.66	-27.61	-66.01	-45.92	-41.30	NaN	-82.04
BRD-A15297126	CP	fluocinonide	corticosteroid agonist, corticosteroid hormone receptor agonist	NR3C1, SERPINA6, SMO	Glucocorticoid receptor agonist	0.00, 0.00	1.74, 0.78	-48.35	25.28	-46.99	-97.48	-82.99	-61.57	-84.20	64.75	NaN	-73.01
BRD-K28307902	CP	flutamide	androgen receptor antagonist	AR, AHR, CYP2C19		0.00, 0.00	0.97, 0.23	64.92	-98.95	-5.23	-32.89	51.44	-97.05	69.37	46.68	-72.49	27.15
BRD-K66296774	CP	fluvastatin	HMGCR inhibitor	HMGCR, CYP2C8	HMGCR inhibitor	0.00, 0.00	0.69, 0.13	-89.44	-89.41	-34.09	-90.79	-35.67	-97.87	-9.35	-86.43	13.79	-93.89
BRD-K76587808	CP	fraxetin	anti-oxidative and anti-apoptotic agent			0.00, 0.00	0.65, 0.08	6.19	45.02	63.89	-87.07	36.20	81.32	-38.74	57.16	-36.38	18.83
BRD-K77947974	CP	fluspirilene	dopamine receptor, dopamine receptor antagonist	DRD2, HTR2A, CACNG1, HRH1, HTR1A, HTR1D, HTR1E	Dopamine receptor antagonist	0.00, 0.00	0.94, 0.14	-22.87	-98.40	51.50	88.70	-64.83	-22.15	-78.01	-94.99	-31.04	-63.99
BRD-K09602097	CP	forskolin	adenylyl cyclase activator, Adenylate cyclase stimulant, growth hormone receptor agonist, phosphokinase stimulant	ADCY2, ADCY5, GNAS		30.00, 20.00	1.14, 0.35	13.61	34.54	99.27	-51.87	99.77	-81.44	71.32	-77.00	96.84	88.69
BRD-A71157293	CP	fursultiamine	thiamine deriviative			11.11, 0.00	1.40, 0.47	34.41	95.40	14.53	15.11	13.46	-66.03	20.22	11.67	NaN	3.56
BRD-K31342827	CP	bisindolylmaleimide	CDK inhibitor, PKC inhibitor, leucine rich repeat kinase inhibitor	CCND1, CDK4, LRRK2, PDPK1, PIM1, PRKCA, PRKCB, PRKCI, PRKCZ		0.00, 0.00	1.35, 0.41	-85.03	-99.37	-99.51	-85.48	-50.35	-57.38	-82.48	-97.60	-82.36	-96.30
BRD-A29082194	CP	gitoxigenin	ATPase inhibitor	ATP1A1	ATPase inhibitor	30.00, 20.00	0.82, 0.30	95.60	16.21	16.93	-35.50	99.37	-17.82	-20.03	99.17	15.22	80.85
BRD-K51662849	CP	ilomastat	matrix metalloprotease inhibitor	ACAN, ADAM28, MMP1, MMP12, MMP13, MMP14, MMP2, MMP3, MMP8, MMP9		0.00, 0.00	0.91, 0.33	-30.79	-94.03	48.27	14.38	54.05	-52.00	-43.64	-99.31	-11.45	-27.88
BRD-A33084410	CP	5'-guanidinonaltrindole	opioid receptor antagonist			0.00, 0.00	1.44, 0.57	88.89	43.96	92.38	-18.98	-85.36	47.46	2.37	-80.18	NaN	23.42
BRD-K50891186	CP	GR-103691	dopamine receptor antagonist		Dopamine receptor antagonist	0.00, 0.00	1.63, 0.51	-46.69	56.70	40.07	15.39	-64.04	50.45	-61.42	-99.96	NaN	-41.69
BRD-K49945136	CP	GR-113808	serotonin receptor antagonist	HTR4		0.00, 0.00	0.91, 0.32	77.26	36.10	37.39	39.26	51.88	-59.08	9.02	55.18	21.89	44.50
BRD-K83023055	CP	GR-135531	melatonin receptor agonist			44.44, 22.22	1.18, 0.34	90.73	70.99	97.15	-26.05	99.77	-47.34	12.80	99.95	NaN	96.55
BRD-A90515964	CP	guaifenesin	expectorant			11.11, 11.11	1.19, 0.38	-50.80	-26.23	98.75	49.82	-78.45	-81.07	-35.83	-27.63	NaN	-45.32
BRD-K56800335	CP	guanabenz	adrenergic receptor agonist	ADRA2A, ADRA2B, ADRA2C		0.00, 0.00	0.78, 0.25	-76.02	-89.51	-61.17	-16.65	93.84	-52.54	20.32	17.00	NaN	-45.67
BRD-K32830106	CP	guanfacine	adrenergic receptor agonist, HCN (hyperpolarization activated cyclic nucleotide gated) channel blocker	ADRA2A, ADRA2B, ADRA2C, CYP3A5, HCN1, HCN2, HCN3, HCN4		10.00, 10.00	0.63, 0.09	22.86	97.99	16.64	55.70	76.66	86.27	27.46	-40.44	-82.15	67.13
BRD-A15415227	CP	GW-1929	PPAR receptor agonist, insulin sensitizer	INS, PPARG	PPAR receptor agonist	0.00, 0.00	1.10, 0.28	-88.73	-40.80	-98.48	63.92	9.25	15.24	66.66	-55.81	70.79	-38.18
BRD-K33818169	CP	GW-3965	LXR agonist, ABC transporter expression enhancer	NR1H2, NR1H3, ABCA1		0.00, 0.00	0.90, 0.35	-76.78	-70.84	-77.66	4.71	-14.45	19.76	-96.18	63.69	-87.81	-66.81
BRD-K64245000	CP	GW-4064	FXR agonist	NR1H4		0.00, 0.00	0.41, 0.08	-89.69	-62.15	28.21	36.63	-84.15	-72.52	-11.14	77.66	40.42	-50.39
BRD-K39520573	CP	GW-5074	RAF inhibitor, leucine rich repeat kinase inhibitor	LRRK1, LRRK2, NTRK1, RAF1	RAF inhibitor	0.00, 0.00	0.77, 0.22	-23.08	73.24	-97.71	-65.25	94.62	-51.19	-25.83	-86.67	NaN	-36.11
BRD-K96263742	CP	GW-7647	PPAR receptor agonist	PPARA	PPAR receptor agonist	0.00, 0.00	0.85, 0.20	-90.58	-49.17	23.50	60.99	-94.48	66.98	-77.25	42.02	55.89	-67.88
BRD-A49148672	CP	galantamine	acetylcholinesterase inhibitor, acetylcholine receptor agonist, butyrylcholinesterase inhibitors	ACHE, BCHE, CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG		55.56, 22.22	1.36, 0.45	99.75	5.12	95.36	97.15	51.54	-65.46	98.48	42.32	NaN	97.08
BRD-A17535965	CP	gelsemine	acetylcholine receptor antagonist, glycine receptor antagonist	GLRA3		0.00, 0.00	0.97, 0.31	23.44	-88.02	-32.00	-31.81	15.29	-97.04	12.93	-15.04	NaN	-10.94
BRD-K54771420	CP	glycocholic-acid	cholesterol inhibitor	FABP6		10.00, 10.00	0.50, 0.11	4.50	-43.64	56.38	13.65	45.68	36.81	76.70	-66.30	99.95	12.92
BRD-K62736196	CP	guanabenz	adrenergic receptor agonist	ADRA2A, ADRA2B, ADRA2C		0.00, 0.00	0.53, 0.08	-23.63	90.53	9.53	78.23	51.03	85.22	-58.09	50.12	-11.77	57.42
BRD-K67847053	CP	guanabenz	adrenergic receptor agonist	ADRA2A, ADRA2B, ADRA2C		0.00, 0.00	0.84, 0.23	65.46	-22.25	-80.02	78.94	65.35	-11.80	-77.11	-28.73	-75.33	-41.64
BRD-K77793136	CP	hydroxyfasudil	ROCK inhibitor	ROCK1, PKIA, PRKACA, ROCK2	Rho associated kinase inhibitor	0.00, 0.00	1.35, 0.39	18.24	-79.05	-17.46	-73.22	-21.22	50.99	24.15	94.02	NaN	13.99
BRD-K99946902	CP	hexylresorcinol	polyphenol oxidase inhibitor	TYR		0.00, 0.00	1.05, 0.36	-92.68	-64.31	-64.56	-38.04	54.88	-88.90	-41.31	-66.01	NaN	-77.42
BRD-A65767837	CP	hydrocortisone	corticosteroid agonist, glucocorticoid receptor agonist, immunosuppressant, interleukin receptor antagonist	ANXA1, NOS2, NR3C1, NR3C2	Glucocorticoid receptor agonist	0.00, 0.00	1.58, 0.39	-80.14	-70.86	-72.43	-98.00	-32.79	-77.39	-76.50	37.70	NaN	-80.90
BRD-A07000685	CP	hydrocortisone	corticosteroid agonist, glucocorticoid receptor agonist, immunosuppressant, interleukin receptor antagonist	ANXA1, NOS2, NR3C1, NR3C2	Glucocorticoid receptor agonist	11.11, 11.11	1.55, 0.57	57.92	97.92	-55.86	-98.38	-95.99	-98.20	-98.03	37.74	NaN	-98.01
BRD-A46186775	CP	hydrocortisone	corticosteroid agonist, glucocorticoid receptor agonist, immunosuppressant, interleukin receptor antagonist	ANXA1, NOS2, NR3C1, NR3C2	Glucocorticoid receptor agonist	0.00, 0.00	1.44, 0.70	-11.55	89.09	28.70	-97.19	-72.80	43.57	-99.95	35.66	NaN	-47.92
BRD-K29673530	CP	hypericin	PKC inhibitor, tyrosine kinase inhibitor, unidentified pharmacological activity			0.00, 0.00	0.75, 0.20	-29.89	-43.16	-58.54	21.77	-18.11	-56.43	-86.03	-55.46	19.05	-52.94
BRD-A08709697	CP	heliotrine	in touchstone			11.11, 11.11	1.08, 0.38	24.36	42.57	-8.80	-33.47	39.83	98.27	-74.80	-10.84	NaN	-8.41
BRD-A74975734	CP	homatropine	acetylcholine receptor antagonist	CES1, CHRM1		11.11, 0.00	1.07, 0.39	75.01	20.64	95.97	-30.75	57.18	93.43	29.06	8.94	NaN	81.87
BRD-A22769835	CP	homochlorcyclizine	antihistamine	HRH1		22.22, 22.22	0.95, 0.22	45.62	99.91	21.80	45.15	98.31	69.57	-92.45	-99.50	NaN	47.42
BRD-K37447567	CP	hydrocotarnine	non-narcotic opium alkaloid used in cancer pain treatment			11.11, 11.11	1.43, 0.45	61.20	37.03	-26.29	99.87	65.73	64.76	-66.21	-68.26	NaN	47.84
BRD-A78295502	CP	hydroquinine	anti-arrhythmia agent			0.00, 0.00	1.10, 0.39	-21.62	-68.67	36.78	-99.13	-78.02	-80.01	-15.57	-54.64	NaN	-56.95
BRD-K35377380	CP	I-OMe-AG-538	inhibitor of insulin growth factor 1 receptor protein tyrosine kinase			11.11, 0.00	1.02, 0.26	80.90	13.56	-50.50	95.40	-86.54	-45.78	56.97	-86.10	NaN	58.79
BRD-A48809242	CP	IB-MECA	adenosine receptor agonist, granulocyte colony stimulating factor agonist	ADORA3, ADORA1, ADORA2A, ADORA2B	Adenosine receptor agonist	0.00, 0.00	0.89, 0.24	24.66	90.54	-32.21	-31.05	35.74	-39.71	-32.64	-54.52	NaN	-13.66
BRD-K65639003	CP	icariin	neuromedin receptor agonist, sorbitol dehydrogenase inhibitor	NMUR2, PDE5A, SORD		0.00, 0.00	0.50, 0.07	23.57	-20.58	-33.24	40.57	-40.72	-16.79	-45.32	-14.81	21.02	-8.19
BRD-K52219182	CP	BRD-K52219182	phosphodiesterase inhibitor			10.00, 0.00	0.65, 0.14	-9.34	91.19	97.40	18.73	54.09	-69.76	-20.12	64.63	-42.80	30.35
BRD-A78942461	CP	ICI-118551	adrenergic receptor antagonist			0.00, 0.00	1.08, 0.27	-8.20	-51.47	-14.21	26.08	14.62	-70.45	-39.64	-47.91	NaN	-12.38
BRD-K33308633	CP	INCA-6	calcineurin inhibitor, Inhibitor of interaction between calcineurin and its substrate nuclear factor of activated T cells (NFAT)	NFATC1		0.00, 0.00	0.63, 0.18	-5.03	-7.00	-56.45	-31.40	-95.49	59.82	29.70	-92.61	60.88	-9.77
BRD-K17894950	CP	indirubin	CDK inhibitor, glycogen synthase kinase inhibitor, cyclin-dependent kinase inhibitor, PKC inhibitor	CDK1, CDK5, CCNE1, CDK2, CDK4, CDK5R1, CDK9, GSK3A, GSK3B, LCK, LRRK1, LRRK2		0.00, 0.00	1.08, 0.34	45.86	38.16	-13.27	-73.84	-37.52	-33.38	-57.17	-91.47	NaN	-17.17
BRD-K57222227	CP	indometacin	cyclooxygenase inhibitor	PTGS1, PTGS2, PPARG, PTGDR2, GLO1, PLA2G2A, PPARA, PTGR2, SLC46A1		0.00, 0.00	1.18, 0.33	-29.28	-15.82	10.45	-44.03	33.69	90.34	-54.34	-50.99	NaN	-11.85
BRD-K60038276	CP	irbesartan	angiotensin receptor antagonist, liver bile acid transporter inhibitor	AGTR1, JUN, SLC10A1	Angiotensin receptor antagonist	0.00, 0.00	0.58, 0.17	-99.11	81.44	-72.21	-70.61	-41.42	62.80	-25.27	78.50	24.71	-25.51
BRD-K48869804	CP	icilin	TRPA1 agonist, TRPM8 agonist	TRPA1, TRPM8		10.00, 0.00	0.57, 0.14	-64.74	88.37	-37.20	96.76	27.16	49.20	-30.60	-36.71	-97.07	-10.63
BRD-A10903566	CP	imiloxan	adrenergic receptor antagonist	ADRA2B		0.00, 0.00	1.17, 0.44	87.22	21.45	42.16	-91.66	46.15	-65.39	-28.03	-6.54	NaN	26.08
BRD-K49519092	CP	immethridine	histamine receptor agonist	HRH3		0.00, 0.00	0.53, 0.11	-46.23	78.05	12.11	13.48	12.71	44.16	78.01	16.52	-28.43	10.75
BRD-K53959060	CP	indirubin	CDK inhibitor, glycogen synthase kinase inhibitor, cyclin-dependent kinase inhibitor, PKC inhibitor	CDK1, CDK5, CCNE1, CDK2, CDK4, CDK5R1, CDK9, GSK3A, GSK3B, LCK, LRRK1, LRRK2	Glycogen synthase kinase inhibitor	0.00, 0.00	1.80, 0.53	-99.45	-39.63	-98.04	-95.26	-42.42	-95.74	-43.68	-99.64	NaN	-98.59
BRD-K19136521	CP	indirubin	CDK inhibitor, glycogen synthase kinase inhibitor, cyclin-dependent kinase inhibitor, PKC inhibitor	CDK1, CDK5, CCNE1, CDK2, CDK4, CDK5R1, CDK9, GSK3A, GSK3B, LCK, LRRK1, LRRK2	CDK inhibitor, Glycogen synthase kinase inhibitor	10.00, 0.00	1.20, 0.28	-91.91	-3.34	-93.68	-26.57	61.40	-93.60	96.89	-94.62	-46.67	-93.20
BRD-A37432947	CP	ipratropium	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5		0.00, 0.00	1.15, 0.15	-44.91	70.13	-10.72	-42.46	-18.60	76.81	4.97	39.18	NaN	-5.11
BRD-K90574421	CP	ipsapirone	serotonin receptor agonist	HTR1A		0.00, 0.00	1.03, 0.32	-22.52	49.84	42.74	-45.80	-32.18	37.59	-15.72	-30.18	NaN	-10.50
BRD-A90799790	CP	isradipine	calcium channel blocker, L-type calcium channel blocker	CACNA1C, CACNA1D, CACNA2D1, CACNA1F, CACNA1H, CACNA1S, CACNA2D2, CACNB2		11.11, 11.11	1.30, 0.35	-15.00	37.36	12.19	-96.43	-81.81	99.02	-93.16	-63.63	NaN	-75.43
BRD-A40639672	CP	ketorolac	cyclooxygenase inhibitor	PTGS1, PTGS2		0.00, 0.00	0.77, 0.16	-55.69	-11.29	-30.50	71.15	-85.73	-98.79	-47.61	-19.81	53.72	-27.12
BRD-K28936863	CP	ketotifen	histamine receptor ligand, leukotriene antagonist, phosphodiesterase inhibitor	HRH1, PDE4A, PDE4B, PDE4C, PDE4D, PDE7A, PDE7B, PDE8A, PDE8B, PGD		0.00, 0.00	0.52, 0.07	46.89	83.32	19.39	63.80	13.09	39.32	70.32	28.57	-25.54	44.45
BRD-A43849199	CP	karakoline	phytotoxin			0.00, 0.00	1.60, 0.55	-54.21	-80.88	-66.84	-20.04	-84.12	40.09	20.00	-63.29	NaN	-66.30
BRD-K09497549	CP	kawain	calcium channel modulator, mTOR inhibitor, Sodium Channel  Blockers	MTOR		11.11, 0.00	1.07, 0.28	58.92	11.44	-14.54	81.00	95.29	-85.46	76.67	-54.16	NaN	35.90
BRD-K47150025	CP	KI-8751	PDGFR alpha and c-Kit inhibitor, vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor, VEGFR inhibitor	KDR	PDGFR/KIT inhibitor	0.00, 0.00	2.49, 0.72	-98.57	35.23	-95.05	-98.59	-90.85	60.29	-69.67	-99.89	NaN	-98.52
BRD-K39733634	CP	L-161982	prostanoid receptor antagonist, angiotensin receptor antagonist	PTGER4		10.00, 10.00	0.86, 0.34	25.65	-55.07	-21.42	98.93	-77.86	-99.81	18.51	-43.73	91.09	-25.33
BRD-A85472596	CP	L-670596	prostanoid receptor antagonist			11.11, 11.11	1.40, 0.35	73.26	-44.09	-17.95	20.66	93.27	99.94	-6.59	11.51	NaN	54.79
BRD-A93206962	CP	L-755507	adrenergic receptor agonist, adrenergic receptor partial agonist	ADRB3, ADRB1, ADRB2		0.00, 0.00	0.58, 0.15	-15.02	-62.43	-81.29	-8.59	-96.79	-99.40	-29.89	-86.27	-44.25	-85.61
BRD-K18036262	CP	L-168049	glucagon receptor antagonist, human glucagon receptor antagonist	GCGR		0.00, 0.00	1.31, 0.35	-93.94	-5.55	-80.82	-99.93	-86.55	47.95	-99.70	-99.68	NaN	-99.75
BRD-A84389091	CP	L-655708	GABA receptor inverse agonist	GABRA5, GABRA1, GABRA2, GABRA3, GABRG2		11.11, 11.11	0.99, 0.30	46.40	98.29	-71.66	-4.67	93.48	43.80	-58.24	-85.48	NaN	-52.71
BRD-K08109516	CP	L-701324	glutamate receptor antagonist	GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D		20.00, 10.00	0.68, 0.17	-71.27	99.19	-25.29	96.59	39.60	35.40	56.06	64.51	-7.69	59.12
BRD-A71203467	CP	l-stepholidine	dopamine receptor antagonist, dopamine receptor agonist	DRD2, DRD1		11.11, 11.11	1.03, 0.30	-9.81	-30.30	99.92	11.79	14.43	45.00	4.43	10.56	NaN	2.68
BRD-A72711497	CP	lasalocid	ionophore antibiotic			0.00, 0.00	2.03, 0.66	-96.85	-99.07	-99.22	-99.61	-95.73	53.99	-97.67	-99.06	NaN	-97.96
BRD-A32836748	CP	leu-enkephalin	opioid receptor agonist	OPRD1, OPRM1		0.00, 0.00	1.40, 0.56	-48.71	27.28	21.47	-88.61	-91.67	-39.88	-74.06	85.52	NaN	-67.29
BRD-K08973992	CP	linoleic-acid	oxidative stress inducer	FABP4, FFAR1, FFAR4, HNF4A, KCNB1, PPARG, TRPM8		44.44, 33.33	1.27, 0.38	86.20	29.75	-57.74	97.07	98.58	98.72	81.69	50.48	NaN	97.92
BRD-K88849294	CP	lobaric-acid	tyrosine phosphatase inhibitor	PTPN1		0.00, 0.00	1.53, 0.39	90.49	48.18	67.85	24.33	-82.83	-60.92	-42.31	34.97	NaN	36.87
BRD-K15834839	CP	lobendazole	anthelmintic agent			0.00, 0.00	1.11, 0.27	-15.66	67.96	-28.25	6.66	-32.26	36.89	65.27	-90.88	32.88	-7.02
BRD-K39915878	CP	loxapine	dopamine receptor antagonist, serotonin receptor antagonist, dopamine receptor ligand	DRD2, DRD3, DRD4, DRD1, HRH1, HTR2A, HTR2C, HTR6, ADRA1A, ADRA1B, ADRA2A, ADRA2B, ADRA2C, ADRB1, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD5, HRH2, HRH4, HTR1A, HTR1B, HTR1D, HTR1E, HTR3A, HTR5A, HTR7, SLC6A2, SLC6A3, SLC6A4		10.00, 10.00	0.76, 0.16	51.20	-13.64	30.32	35.44	88.01	99.29	-28.81	69.28	46.88	41.41
BRD-A92826379	CP	lupanine	ATP channel blocker, insulin secretagogue, Sodium Channel  Blockers, sodium channel blocker	INS	Sodium channel blocker	0.00, 0.00	0.91, 0.24	-12.69	39.14	79.47	-91.91	39.28	87.02	55.01	41.57	16.29	35.98
BRD-K95899059	CP	LY-344864	serotonin receptor agonist	HTR1F, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR7		0.00, 0.00	1.18, 0.20	14.78	10.74	56.94	-27.22	-41.28	-90.38	-43.49	16.43	NaN	-20.11
BRD-K74765201	CP	tomelukast	leukotriene receptor antagonist	CYSLTR1		11.11, 11.11	0.76, 0.10	99.80	-22.18	70.48	40.82	44.68	83.34	-47.07	64.96	NaN	82.66
BRD-K27305650	CP	LY-294002	PI3K inhibitor, mTOR inhibitor, DNA dependent protein kinase inhibitor, phosphodiesterase inhibitor, PLK inhibitor	MTOR, PIK3CD, PIK3CG, PIK3CA, PIK3CB, PLK1, PRKDC, AKT1, CHEK1, GSK3B, LCK, MAPK1, MAPK11, MAPK12, MAPK14, MAPK8, PDE2A, PRKCA, ROCK1, RPS6KB1, SGK1	Bromodomain Inhibitor, MTOR inhibitor, PI3K inhibitor	0.00, 0.00	1.16, 0.51	92.29	-84.27	-41.31	66.74	-49.56	-56.34	-81.40	50.75	NaN	-31.08
BRD-K62792802	CP	LY-83583	inhibitor of soluble guanylyl cyclase, leukotriene synthesis inhibitor	GUCY1A2		22.22, 11.11	2.01, 0.45	-11.52	-26.05	96.29	NaN	37.46	99.17	-79.77	21.31	-27.15	16.48
BRD-A24817035	CP	laudanosine	central nervous system agent			0.00, 0.00	1.32, 0.27	-40.40	11.53	-22.90	-6.36	51.06	-52.58	-30.00	76.68	NaN	-12.69
BRD-K96119599	CP	leucodin	melanin synthesis inhibitor			10.00, 10.00	0.83, 0.19	-11.42	44.64	-18.63	-75.56	15.59	43.96	39.40	48.87	97.93	26.03
BRD-K59332007	CP	linopirdine	acetylcholine release enhancer, acetylcholine release stimulant, neurotransmitter agonist, voltage-gated potassium channel blocker	KCNQ2, KCNQ3, KCNQ4, KCNQ5		0.00, 0.00	0.66, 0.20	32.25	-8.05	-11.50	-20.62	23.99	-40.68	-99.64	20.90	-35.40	-0.92
BRD-K36377456	CP	marmesin	precursor in psoralen			11.11, 11.11	1.34, 0.44	-30.05	37.42	42.63	99.82	70.32	92.25	-14.36	71.55	NaN	61.50
BRD-K64746805	CP	MBCQ	phosphodiesterase inhibitor	PDE5A		0.00, 0.00	1.13, 0.39	-98.26	-84.49	-42.45	-99.62	-96.11	-72.10	-78.64	-99.27	NaN	-99.03
BRD-A62057054	CP	MDL-11939	serotonin receptor antagonist	HTR2A, HTR2B, HTR2C		11.11, 11.11	1.39, 0.53	99.52	-19.87	-60.65	-98.67	77.26	93.59	-96.61	73.84	NaN	74.09
BRD-K59753853	CP	MDL-29951	glutamate receptor antagonist, fructose biphosphate inhibitor, UDP/CysLT (GPR17, P2Y-like) Agonists	FBP1, GPR17		0.00, 0.00	1.28, 0.45	24.55	-89.96	-10.67	89.27	-97.46	24.01	31.27	74.69	-14.31	10.85
BRD-A09467419	CP	mebeverine	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4		10.00, 10.00	0.85, 0.23	54.32	86.49	-19.30	-10.95	-63.33	83.00	74.92	99.94	92.25	82.55
BRD-A84174393	CP	meloxicam	cyclooxygenase inhibitor, prostanoid receptor inhibitor	PTGS2, PTGS1		0.00, 0.00	1.10, 0.35	46.19	73.16	-35.49	85.25	72.03	-67.51	-68.48	-11.66	30.42	38.30
BRD-K18194590	CP	mephentermine	adrenergic receptor agonist	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3		0.00, 0.00	0.98, 0.26	72.72	-56.66	-98.05	-9.97	28.36	-30.17	94.49	-46.20	77.97	42.08
BRD-K91336023	CP	mesulergine	dopamine receptor agonist	HTR2A, HTR2C, HTR7, HTR2B, HTR3A, HTR3B, HTR6		11.11, 0.00	0.94, 0.19	73.04	29.65	66.80	53.29	-86.53	97.39	-16.19	-27.29	NaN	21.33
BRD-A02189320	CP	met-leu-phe	in touchstone			11.11, 11.11	1.18, 0.31	65.43	-25.08	-3.06	46.44	21.72	98.13	-28.61	31.87	NaN	12.86
BRD-K34685430	CP	methylergometrine	dopamine receptor antagonist, partial serotonin receptor agonist	DRD1, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C		0.00, 0.00	0.91, 0.26	-41.77	-21.38	-46.03	19.17	-15.63	-63.08	-95.89	28.38	NaN	-23.54
BRD-K35941380	CP	methysergide	serotonin receptor antagonist	HTR2C, HTR1B, HTR1E, HTR1F, HTR2A, HTR2B, HTR7, HTR1A, HTR1D, HTR5A, HTR6		0.00, 0.00	0.81, 0.24	5.61	-7.80	12.88	61.74	-55.95	35.54	18.32	71.62	67.16	21.84
BRD-A61793559	CP	metolazone	carbonic anhydrase inhibitor, quinazoline diuretic, inhibitor of sodium chloride symporters	SLC12A3, CA2, CA7		20.00, 20.00	0.48, 0.10	-22.24	53.52	70.17	99.98	-31.47	-25.12	-70.68	97.63	80.06	65.89
BRD-A79981887	CP	midodrine	adrenergic receptor agonist	ADRA1A, ADRA1B, ADRA1D		0.00, 0.00	0.78, 0.14	65.67	66.16	-20.45	-42.59	92.51	94.16	-59.92	67.65	-87.76	71.50
BRD-A48237631	CP	mitomycin-c	DNA alkylating drug, DNA inhibitor, DNA synthesis inhibitor		DNA synthesis inhibitor	0.00, 0.00	1.81, 0.56	-22.77	-97.88	-98.98	-56.26	-98.97	-79.57	-97.90	-98.91	-93.50	-97.92
BRD-A31204924	CP	mitotane	antineoplastic agent	CYP11B1, CYP11A1, CYP3A4, ESR1, FDX1		0.00, 0.00	0.66, 0.11	-30.02	-36.82	-98.29	-29.90	77.54	-53.82	-15.75	-45.61	-40.55	-30.08
BRD-K19554809	CP	MK-212	serotonin receptor agonist	HTR2A, HTR2B, HTR2C		11.11, 11.11	2.21, 0.98	82.82	-67.64	99.59	31.35	-91.67	-68.72	-85.78	-28.26	NaN	-76.26
BRD-K68402494	CP	ML-9	myosin light chain kinase inhibitor	MLCK, TRPC6, PKA, PKC		0.00, 0.00	1.17, 0.38	40.08	-95.94	-86.63	-84.43	-99.54	-55.51	-98.49	-55.76	NaN	-97.82
BRD-A06784547	CP	MRS-1334	adenosine receptor antagonist			0.00, 0.00	0.56, 0.14	25.17	14.84	-55.95	-98.21	-47.69	-32.90	-63.82	40.10	-99.63	-33.77
BRD-K03319035	CP	maprotiline	norepinephrine reputake inhibitor, tricyclic antidepressant (TCA)	SLC6A2, ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD2, HRH1, HTR2A, HTR2C, HTR7	Norepinephrine reuptake inhibitor, Tricyclic antidepressant	11.11, 0.00	1.05, 0.35	-37.40	71.57	-39.62	63.29	-18.04	95.58	-89.15	-94.36	NaN	-15.37
BRD-A66563878	CP	medetomidine	adrenergic receptor agonist, MAP kinase inhibitor	ADRA2A, ADRA2B, ADRA2C, ADRA1A, ADRA1B, ADRA1D		0.00, 0.00	1.22, 0.45	56.83	65.91	5.80	-76.94	-10.78	64.26	-62.15	71.03	NaN	36.84
BRD-K19507340	CP	megestrol	progesterone receptor agonist, DNA inhibitor, HegG2 inhibitor	PGR		22.22, 11.11	1.00, 0.32	-27.42	-98.81	9.16	-45.31	95.27	-45.79	99.94	-65.06	NaN	-7.89
BRD-A42346008	CP	metanephrine	epinephrine metabolite, levels are diagnostic for the neoplasm pheochromocytoma			11.11, 0.00	1.57, 0.50	16.15	-50.88	74.37	97.12	9.29	71.95	42.04	26.06	NaN	43.73
BRD-K88741031	CP	methyl-2,5-dihydroxycinnamate	EGFR inhibitor, tyrosine kinase inhibitor	EGFR		20.00, 20.00	1.06, 0.33	-49.14	99.69	21.65	-11.93	47.96	97.92	61.66	60.72	-21.28	37.11
BRD-A33711280	CP	metixene	acetylcholine receptor antagonist	CHRM5, CHRM1, CHRM2, CHRM3, CHRM4		0.00, 0.00	0.91, 0.25	-70.41	5.53	-65.77	67.75	-20.16	-90.68	-95.67	-28.98	NaN	-76.86
BRD-K46862739	CP	metyrapone	cytochrome P450 inhibitor, 11-beta hydroxysteroid dehydrogenase inhibitor, mineralocorticoid receptor antagonist	CYP11B1, HSD11B1, NR3C2		0.00, 0.00	0.67, 0.19	81.30	92.92	42.79	67.83	73.00	70.76	-51.77	-31.58	NaN	76.82
BRD-A64977602	CP	mirtazapine	adrenergic receptor antagonist, serotonin receptor antagonist	ADRA2A, HTR2A, HTR2C, ADRA2C, HTR3A, ADRA1A, ADRA1B, ADRA1D, ADRA2B, ADRB1, ADRB2, DRD1, DRD2, DRD3, DRD5, HRH1, HRH3, HTR2B, HTR7, OPRK1, SLC6A2, SLC6A3, SLC6A4		0.00, 0.00	0.50, 0.14	92.45	-37.59	71.20	94.32	-36.93	66.40	-75.34	70.62	42.21	63.31
BRD-K31542390	CP	mycophenolic-acid	dehydrogenase inhibitor, immunosuppressant, IMPDH inhibitor, inosine monophosphate dehydrogenase inhibitor	IMPDH1, IMPDH2	IMPDH inhibitor	0.00, 0.00	0.92, 0.33	-82.37	-50.00	-96.81	-98.77	10.36	-44.35	-99.72	-99.79	-99.56	-99.37
BRD-K51557114	CP	BRD-K51557114	GlyT-2 inhibitor	GPR18, LPAR5, SLC6A5		22.22, 0.00	0.81, 0.26	-13.06	96.91	60.55	96.33	-40.25	-79.24	-51.36	79.35	NaN	71.17
BRD-K98297262	CP	BRD-K98297262	1,3-beta-glucan synthase inhibitor	CLC		11.11, 11.11	1.30, 0.36	50.21	-86.52	-16.88	99.23	-76.34	66.22	-82.14	-50.31	NaN	-60.16
BRD-A61470182	CP	n-formylmethionylalanine	macrophage activator			11.11, 11.11	1.38, 0.47	72.71	-10.82	99.93	24.04	-18.42	-38.33	-74.52	-78.23	NaN	-12.12
BRD-A85234536	CP	N6-cyclopentyladenosine	adenosine receptor agonist	ADORA1, ADORA2A, ADORA2B, ADORA3, SLC29A1	Adenosine receptor agonist	22.22, 11.11	1.27, 0.39	91.98	79.49	99.02	30.14	-39.15	38.28	13.21	95.29	NaN	86.07
BRD-K65146499	CP	nabumetone	cyclooxygenase inhibitor, 3alpha hydroxysteroid dehydrogenase inhibitor	PTGS2, AKR1C3, CYP2B6, CYP2C19, CYP2E1, PTGS1	Cyclooxygenase inhibitor	22.22, 22.22	1.57, 0.33	99.46	56.50	40.57	5.89	80.58	99.91	16.51	33.33	NaN	78.35
BRD-A67862938	CP	naftidrofuryl	adrenergic receptor antagonist			10.00, 10.00	1.30, 0.57	33.68	12.19	-64.79	-98.02	-85.05	-80.08	99.43	34.25	75.59	-70.76
BRD-A66559694	CP	naltrexone	opioid receptor antagonist, opioid receptor ligand	OPRK1, OPRM1, OPRD1, SIGMAR1		10.00, 0.00	1.40, 0.47	-69.29	95.50	67.53	-58.70	86.94	-96.54	17.12	-99.90	73.11	58.25
BRD-K34014345	CP	naproxol	antiinflammatory agent	PTGS1, PTGS2		10.00, 10.00	0.80, 0.20	15.95	99.06	57.52	-98.97	-9.98	-87.15	-23.33	-99.28	58.84	-23.26
BRD-K47717570	CP	NBQX	glutamate receptor antagonist, kainate receptor antagonist	GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIN1, GRIN2A, GRIN2B		10.00, 10.00	0.85, 0.19	98.54	-12.50	14.83	90.63	-78.03	15.37	-17.20	22.22	55.32	8.66
BRD-A85025557	CP	NCS-382	GABA receptor antagonist	GABBR1, GABBR2, SLC52A2	GABA receptor antagonist	0.00, 0.00	0.59, 0.10	38.24	37.95	-92.15	43.70	27.91	75.56	19.65	-31.29	87.19	34.85
BRD-K76810206	CP	nicergoline	adrenergic receptor antagonist	ADRA1A		0.00, 0.00	0.76, 0.16	-81.06	94.96	-98.64	-33.98	44.48	-63.99	-39.38	-99.15	57.69	-73.51
BRD-K79092138	CP	nitrofural	POXB inhibitor			0.00, 0.00	1.19, 0.31	23.49	-16.45	-99.98	-97.75	54.33	-46.53	4.09	-52.24	NaN	-28.58
BRD-A09349126	CP	norethindrone	ovulation inhibitor, progesterone receptor agonist	PGR		0.00, 0.00	1.01, 0.27	6.88	-97.01	14.45	-90.38	21.81	-82.76	49.99	67.83	NaN	-19.34
BRD-A04756508	CP	norgestimate	progesterone receptor agonist	PGR, ESR1	Progesterone receptor agonist	0.00, 0.00	0.41, 0.15	-9.50	80.17	-45.17	9.96	71.97	54.39	-97.21	-99.70	-79.13	-38.39
BRD-K54210043	CP	NS-1619	calcium channel activator, large conductance potassium channel activator	KCNMA1, KCNT1, KCNT2, KCNU1		0.00, 0.00	0.84, 0.17	7.07	-60.28	-71.93	-22.24	-25.19	-15.51	-37.67	-55.58	-18.65	-28.66
BRD-K59637651	CP	NSC-119889	botulin neurotoxin inhibitor, mur synthetase inhibitor			11.11, 11.11	1.03, 0.30	-73.42	-30.87	98.94	46.70	-73.41	-51.29	-82.05	-37.25	NaN	-64.90
BRD-K03109492	CP	NSC-663284	CDC inhibitor	CDC25A, CDC25B, CDC25C		0.00, 0.00	1.94, 0.48	-99.98	-6.55	-79.90	-79.50	-99.49	-99.51	-52.59	-98.81	-99.69	-98.70
BRD-K09537769	CP	NU-7026	DNA dependent protein kinase inhibitor, mTOR inhibitor, PI3K inhibitor	PRKDC	DNA dependent protein kinase inhibitor, MTOR inhibitor, PI3K inhibitor	0.00, 0.00	1.02, 0.35	-66.07	-29.59	-38.40	88.05	-26.92	-97.41	87.87	-89.61	18.63	-45.84
BRD-K50311478	CP	tosyl-phenylalanyl-chloromethyl-ketone	chymotrypsin inhibitor, serine protease inhibitor			0.00, 0.00	1.01, 0.35	-82.48	-73.93	-99.00	69.22	-80.22	41.50	-83.86	-52.33	-99.26	-84.13
BRD-K66404838	CP	nalbuphine	opioid receptor agonist, opioid receptor antagonist	OPRD1, OPRK1, OPRM1		0.00, 0.00	1.23, 0.38	85.01	-98.39	28.37	-84.81	83.82	85.03	-89.48	58.90	NaN	55.23
BRD-A37541666	CP	naloxone	opioid receptor antagonist	OPRM1, OPRK1, OPRD1, CREB1, ESR1, TLR4		22.22, 22.22	1.08, 0.28	51.10	-20.22	82.09	98.86	98.09	-37.46	15.65	-23.61	NaN	77.37
BRD-A83855350	CP	naltrexone	opioid receptor antagonist, opioid receptor ligand	OPRK1, OPRM1, OPRD1, SIGMAR1		0.00, 0.00	1.51, 0.63	-39.36	12.44	59.07	-92.27	12.49	43.73	-32.23	56.38	NaN	14.27
BRD-A94669766	CP	naringenin	aromatase inhibitor, estrogen receptor agonist, quorum sensing signaling modulator, TRPM3 antagonist	CYP19A1, ESR2, CYP1B1, GLO1, HSD17B1		0.00, 0.00	1.16, 0.26	-9.61	77.96	29.30	-19.13	52.47	13.22	4.21	29.28	10.91	7.23
BRD-K02953697	CP	naringin	cytochrome P450 inhibitor	SLCO1A2		0.00, 0.00	1.26, 0.47	39.93	85.84	-16.27	-82.06	65.25	70.55	-16.65	44.65	NaN	45.99
BRD-K53123955	CP	niridazole	oogenesis inhibitor, spermatogenesis inhibitor			0.00, 0.00	0.78, 0.26	68.36	-41.79	-76.91	33.58	16.70	-75.33	18.07	46.40	NaN	16.42
BRD-K78485176	CP	olmesartan	angiotensin receptor antagonist, angiotensin antagonist	AGTR1	Angiotensin receptor antagonist	0.00, 0.00	0.98, 0.26	-16.07	71.21	-11.90	77.51	-87.78	92.60	36.23	27.17	25.63	22.71
BRD-A68930007	CP	ouabain	ATPase inhibitor, alpha subunit binder	ATP1A1, ATP1A2, ATP1A3, ATP1A4, ATP1B1, ATP1B2, ATP1B3, ATP1B4, FXYD2	ATPase inhibitor	0.00, 0.00	2.09, 0.56	-50.12	-89.22	-97.43	-67.58	-65.40	-57.04	-97.16	70.73	94.53	-83.47
BRD-K66019333	CP	oxantel	fumarate reductase inhibitor			0.00, 0.00	0.78, 0.15	77.43	45.78	77.92	-96.91	-87.62	32.05	-14.68	62.62	-99.66	44.17
BRD-K25394294	CP	oxaprozin	cyclooxygenase inhibitor	PTGS1, PTGS2		10.00, 10.00	0.91, 0.16	99.39	-91.52	-56.63	64.19	88.43	76.29	24.40	-14.07	-47.44	41.38
BRD-K52075715	CP	oxibendazole	DNA polymerase inhibitor, tubulin inhibitor	TUBB, TUBB4B	Tubulin inhibitor	40.00, 40.00	1.08, 0.47	63.18	99.98	-13.18	73.67	-33.14	99.88	99.51	-39.44	-64.20	98.63
BRD-K21936341	CP	oxotremorine	acetylcholine receptor agonist	CHRM2, CHRM1, CHRM3, CHRM4		0.00, 0.00	1.61, 0.50	69.00	29.84	39.44	49.16	-47.27	-99.20	-20.81	17.25	NaN	13.24
BRD-K31987754	CP	oleylethanolamide	Glucose-Dependent Insulinotropic Receptor (GDIR, GPR119)  Agonists, potassium channel blocker	GPR119, CNR1, GPR55, KCND3, PPARA		44.44, 22.22	0.98, 0.31	-78.41	98.69	27.60	20.95	-14.73	99.62	-74.93	96.99	NaN	96.86
BRD-A46747628	CP	ouabain	ATPase inhibitor, alpha subunit binder	ATP1A1, ATP1A2, ATP1A3, ATP1A4, ATP1B1, ATP1B2, ATP1B3, ATP1B4, FXYD2		20.00, 10.00	1.91, 0.52	-43.44	-28.06	-82.63	-38.22	-84.11	-87.10	-97.14	99.38	95.34	-90.29
BRD-A43671941	CP	oxprenolol	adrenergic receptor antagonist	ADRB1, ADRB2		0.00, 0.00	0.88, 0.22	83.15	88.54	60.75	84.84	-44.17	74.25	54.16	-49.86	NaN	83.27
BRD-K53061490	CP	ozagrel	thromboxane synthase inhibitor, platelet aggregation inhibitor, selective thromboxane synthetase inhibitor	TBXAS1		11.11, 0.00	1.00, 0.19	21.73	54.23	45.65	42.39	96.45	94.44	20.63	18.64	NaN	47.21
BRD-A28746609	CP	paclitaxel	tubulin inhibitor, microtubule stabilizing agent, microtubule stimulant, P glycoprotein inhibitor, taxane	TUBB, NR1I2, ABCB1, BCL2, CYP2C8, MAP2, MAP4, MAPT, TLR4, TUBB1	Tubulin inhibitor	20.00, 20.00	0.64, 0.27	66.59	99.87	84.79	34.41	88.03	29.39	99.60	-56.73	9.21	90.37
BRD-K48735772	CP	PD-158780	EGFR inhibitor, epidermal growth factor receptor (EGFR) inhibitor	EGFR	EGFR inhibitor	0.00, 0.00	1.63, 0.51	-15.01	-90.89	-84.32	-19.66	83.52	-70.23	60.47	-99.67	NaN	-70.34
BRD-A43150328	CP	penicillic-acid	bacterial quorum sensing inhibitor, caspase inhibitor			0.00, 0.00	1.40, 0.55	-83.30	-98.83	28.46	89.20	24.40	-79.86	24.15	-61.17	NaN	-72.17
BRD-K55191674	CP	benzylpenicillin	PBP3 inhibitor			10.00, 10.00	2.00, 0.72	47.68	7.29	76.86	36.39	83.00	-17.92	-70.82	72.12	98.53	69.92
BRD-K03842655	CP	penitrem-a	potassium channel blocker	KCNMA1		0.00, 0.00	0.89, 0.24	-25.36	-32.54	32.81	-69.55	-95.92	27.42	-54.61	-45.75	-9.54	-16.54
BRD-A44448661	CP	pentobarbital	GABA receptor modulator	GABRA1, CHRNA4, CHRNA7, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA2, GRIK2, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B		0.00, 0.00	1.23, 0.52	-14.03	-94.25	-68.68	-75.71	-52.39	72.29	29.25	84.80	NaN	-56.31
BRD-K60770992	CP	pergolide	dopamine receptor agonist, calcium-activated potassium channel blocker, potassium channel blocker, prolactin inhibitor	DRD1, DRD2, ADRA2A, ADRA2B, ADRA2C, DRD3, DRD4, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, ADRA1A, ADRA1B, ADRA1D, KCNA5		0.00, 0.00	0.58, 0.14	-20.59	37.29	42.45	-18.79	-37.26	66.37	85.94	-85.70	14.78	17.06
BRD-K92731339	CP	perindopril	angiotensin converting enzyme inhibitor	ACE		10.00, 0.00	0.61, 0.22	13.36	-16.30	-17.20	-36.96	58.60	82.56	-66.64	95.36	79.10	44.96
BRD-A45333398	CP	periplocymarin	apoptosis inducer			11.11, 0.00	2.74, 0.73	15.10	78.47	-90.29	-47.02	80.55	58.78	-37.79	96.42	NaN	77.32
BRD-A93477898	CP	PETCM	caspase activator	CASP3		0.00, 0.00	0.94, 0.27	10.32	34.31	-10.49	94.03	-54.94	-78.90	-72.38	30.91	NaN	-21.34
BRD-A48257147	CP	PHCCC	glutamate receptor agonist, glutamate receptor modulator	GRM1, GRM4		0.00, 0.00	1.11, 0.30	47.67	33.93	-94.34	-94.70	-98.48	-68.02	-88.33	-98.74	NaN	-99.14
BRD-K38323065	CP	phenacetin	cyclooxygenase inhibitor	PTGS1	Cyclooxygenase inhibitor	20.00, 20.00	0.81, 0.15	-40.72	3.78	91.13	99.98	58.86	94.99	98.35	50.48	76.54	91.56
BRD-K21350491	CP	phenamil	acid sensing ion channel blocker, Sodium Channel  Blockers, TRPP3 channel inhibitor, TRPV modulator	PKD2L1		0.00, 0.00	0.80, 0.23	-74.11	69.77	-41.98	-83.09	-41.15	-88.43	-82.13	-59.51	NaN	-83.14
BRD-K19227686	CP	phenolphthalein	weak acid used as a pH indicator			0.00, 0.00	1.25, 0.52	-65.08	-47.57	-86.06	26.47	-16.89	-33.45	-48.41	-54.41	-24.15	-29.42
BRD-K96319534	CP	phentermine	adrenergic transmitter uptake inhibitor, dopamine transmitter uptake inhibitor, serotonin uptake inhibitor	MAOA, MAOB, SLC6A2, SLC6A3, SLC6A4		0.00, 0.00	0.49, 0.08	-48.34	12.23	-80.46	-14.13	38.92	-29.39	-9.90	-53.26	-28.54	-12.92
BRD-K25650355	CP	physostigmine	acetylcholinesterase inhibitor, cholinesterase inhibitor	ACHE, BCHE		0.00, 0.00	0.57, 0.17	65.89	6.17	94.57	57.04	61.01	18.38	-13.42	37.91	39.14	43.08
BRD-K14536225	CP	piceid	glucosidase inhibitor, ICAM1 expression inhibitor, VCAM expression inhibitor, xanthine oxidase inhibitor	GAA, XDH		22.22, 22.22	1.11, 0.41	98.57	97.94	88.10	70.24	4.97	-34.42	55.36	93.81	NaN	94.31
BRD-K26801045	CP	pipamperone	dopamine receptor, dopamine receptor antagonist, serotonin receptor antagonist	DRD2, HTR2A, HRH1, HTR1A, HTR1B, HTR1D	Dopamine receptor antagonist	10.00, 10.00	1.05, 0.34	-56.69	-37.07	-20.20	-39.93	-41.63	41.21	-39.13	-35.86	99.84	-23.64
BRD-A97479839	CP	piperidolate	acetylcholine receptor antagonist	CHRM1		0.00, 0.00	1.19, 0.31	-30.87	25.85	-51.12	92.86	-94.32	13.87	45.16	-11.48	89.99	11.94
BRD-K59522102	CP	piperine	monoamine oxidase inhibitor, ACAT inhibitor	MAOA, MAOB, TRPV1		10.00, 10.00	0.70, 0.17	54.06	16.98	-46.19	97.69	63.64	-56.34	46.08	-45.57	24.53	29.47
BRD-K24132293	CP	piperlongumine	glutathione transferase inhibitor			0.00, 0.00	2.11, 0.70	-96.98	-81.46	-97.27	-98.65	-72.81	-89.87	-83.58	-43.19	-35.17	-90.72
BRD-K25224017	CP	pirenperone	serotonin receptor antagonist	HTR2A, HTR7		0.00, 0.00	0.50, 0.07	22.57	-99.72	-23.76	24.48	-45.49	83.64	69.34	-16.65	-54.47	-6.97
BRD-A57382968	CP	piroxicam	cyclooxygenase inhibitor	PTGS2, PTGS1		0.00, 0.00	0.58, 0.16	-97.80	88.85	85.74	58.58	-64.49	-74.12	-37.04	-98.43	-23.46	-27.33
BRD-K75958195	CP	pizotifen	serotonin receptor antagonist	HTR2A, HTR1A, HTR2C	Serotonin receptor antagonist	0.00, 0.00	0.60, 0.09	58.52	-35.97	31.80	-90.07	-99.15	16.42	-63.44	-44.85	-9.80	-27.88
BRD-K57304726	CP	PRE-084	alpha receptor agonist, sigma receptor agonist	SIGMAR1		10.00, 10.00	0.73, 0.20	59.56	-61.90	-80.28	44.04	-87.83	-41.64	-56.56	-98.60	99.92	-69.48
BRD-A27887842	CP	prednisolone	glucocorticoid receptor agonist	NR3C1, NR3C2, SERPINA6	Glucocorticoid receptor agonist	10.00, 0.00	1.15, 0.44	-59.29	10.85	-12.51	-82.19	-64.56	-98.79	-79.84	-46.85	97.29	-63.64
BRD-A01643550	CP	prednisolone	glucocorticoid receptor agonist	NR3C1, NR3C2, SERPINA6	Glucocorticoid receptor agonist	0.00, 0.00	0.86, 0.39	-79.02	31.07	16.68	6.90	-84.77	-30.86	58.89	-22.26	-18.69	-6.50
BRD-A78391468	CP	prednisolone	glucocorticoid receptor agonist	NR3C1, NR3C2, SERPINA6	Glucocorticoid receptor agonist	0.00, 0.00	1.53, 0.75	52.96	92.16	-91.33	-89.31	-15.15	-98.10	54.67	-41.74	94.82	-60.88
BRD-A62525898	CP	prednisone	glucocorticoid receptor agonist	NR3C1, HSD11B1		0.00, 0.00	0.74, 0.22	-31.17	67.15	-75.85	10.62	-86.26	-47.77	-43.23	83.73	38.47	-10.12
BRD-A35912562	CP	pregnenolone	acetylcholine release enhancer, dopamine release enhancer, GABA receptor negative allosteric modulator, glutamate receptor modulator, progesterone receptor agonist, steroid hormone inhibitor of CYP17A1 and SULT2B1	CYP17A1, PGR, SULT2B1		10.00, 0.00	1.01, 0.36	-94.78	-41.51	-49.23	96.79	49.28	-97.31	-96.56	45.12	70.38	-83.77
BRD-A55913614	CP	primaquine	antimalarial agent, DNA inhibitor	KRT7, NQO2		0.00, 0.00	0.57, 0.14	-43.88	-20.03	-82.01	46.73	-47.31	-89.92	-61.40	-39.79	20.96	-42.10
BRD-K46317332	CP	proadifen	nitric oxide synthase inhibitor, cytochrome P450 inhibitor, potassium channel blocker	NOS1		10.00, 0.00	0.60, 0.16	46.38	97.40	9.87	-20.62	27.51	73.72	-67.46	-14.82	76.48	46.40
BRD-K19352500	CP	prochlorperazine	dopamine receptor antagonist, dopamine receptor	DRD2, DRD1, DRD3, DRD4	Dopamine receptor antagonist	10.00, 10.00	0.93, 0.16	-48.58	-46.36	66.44	-50.96	-62.72	-48.82	97.71	-16.22	50.20	-46.32
BRD-A67479912	CP	progesterone	progesterone receptor agonist	PGR, CYP17A1, NR3C2, CATSPER1, CATSPER2, CATSPER3, CATSPER4, CYP2C19, ESR1, OPRK1, TRPC5		11.11, 11.11	0.44, 0.11	23.59	-90.59	-14.25	97.56	-95.98	-21.13	-25.55	9.33	NaN	-13.99
BRD-K06980535	CP	promazine	dopamine receptor, dopamine receptor antagonist	CHRM5, DRD2, ADRA1A, ADRA1B, ADRA1D, CHRM1, CHRM2, CHRM3, CHRM4, DRD1, DRD3, DRD4, HRH1, HTR2A, HTR2C	Dopamine receptor antagonist	20.00, 10.00	1.41, 0.49	48.31	-89.98	-16.16	-15.25	-88.03	96.21	98.64	-51.44	48.44	15.82
BRD-K59273480	CP	propentofylline	acetylcholinesterase inhibitor, adenosine reuptake inhibitor, adenosine uptake inhibitor, phosphodiesterase inhibitor	ACHE		0.00, 0.00	0.77, 0.18	47.05	91.52	-15.35	91.01	26.86	94.64	-93.40	26.70	NaN	76.82
BRD-K42098891	CP	protriptyline	tricyclic antidepressant (TCA)	SLC6A2, SLC6A4	Tricyclic antidepressant	0.00, 0.00	1.17, 0.33	-26.59	-83.28	-35.03	46.53	44.90	-67.50	-70.72	-12.24	-52.12	-57.88
BRD-K71266197	CP	PSB-06126	NTPDase inhibitor	ENTPD3		0.00, 0.00	0.70, 0.15	-55.15	-40.11	-20.09	-18.36	-37.63	-59.95	-22.92	-29.47	14.32	-16.24
BRD-K79366068	CP	PSB-069	NTPDase inhibitor	ENTPD1, ENTPD2, ENTPD3		20.00, 20.00	0.90, 0.22	29.08	10.75	-16.41	54.09	59.36	99.31	99.48	68.92	38.15	65.69
BRD-K49027941	CP	PSB-1115	adenosine receptor antagonist	ADORA2B, ADORA1, ADORA3		11.11, 11.11	1.13, 0.34	39.36	23.01	98.65	16.00	83.44	-29.82	15.01	43.96	NaN	20.52
BRD-K38251852	CP	paxilline	ABC transporter expression enhancer, high conductance calcium activated potassium blocker, LXR agonist	ABCA1, KCNMA1, NR1H3	Potassium channel blocker	0.00, 0.00	0.91, 0.25	33.82	-28.31	-41.30	28.38	-33.30	-37.71	-50.17	-80.21	NaN	-15.23
BRD-K96799727	CP	pifithrin-mu	HSP inhibitor	HSPA1A, TP53		10.00, 10.00	1.05, 0.24	78.45	99.23	-58.59	26.23	90.29	72.72	-40.16	88.68	-68.46	90.55
BRD-K47936004	CP	piribedil	dopamine receptor agonist, adrenergic receptor antagonist	DRD2, DRD3, ADRA1A, ADRA2A, ADRA2C, DRD4, HTR1A, HTR2B		0.00, 0.00	0.93, 0.11	43.45	-34.19	-27.06	91.41	79.20	34.98	-24.95	43.65	NaN	15.36
BRD-A54490543	CP	pirlindole	monoamine oxidase inhibitor	MAOA, SLC6A2, SLC6A4		0.00, 0.00	0.98, 0.24	42.61	38.60	48.79	41.95	-18.34	44.20	-16.69	41.58	NaN	17.50
BRD-K67100011	CP	pivmecillinam	cell wall synthesis inhibitor			0.00, 0.00	1.03, 0.27	-8.55	78.25	15.79	-75.46	73.39	39.56	93.27	-65.97	13.19	28.89
BRD-A41304429	CP	practolol	adrenergic receptor antagonist	ADRB1		10.00, 10.00	0.95, 0.31	15.87	99.04	-23.42	82.36	-89.21	82.21	90.68	79.52	34.82	79.80
BRD-K46137903	CP	prednicarbate	corticosteroid agonist, immunosuppressant, phospholipase activator	NR3C1, PLA2G1B	Glucocorticoid receptor agonist	0.00, 0.00	1.38, 0.64	-23.43	33.90	-54.92	-44.52	-30.75	-98.56	-97.78	-51.86	89.17	-27.55
BRD-A34806832	CP	proscillaridin	ATPase inhibitor	ATP1A1	ATPase inhibitor	0.00, 0.00	2.23, 0.53	-21.57	-31.04	-99.04	-85.30	-78.50	-89.74	-96.54	91.94	21.70	-90.98
BRD-K02581333	CP	protein-tyrosine-phosphatase-inhibitor-IV	tyrosine phosphatase inhibitor	PTPN1, PTPN11		20.00, 20.00	1.25, 0.42	-87.23	-38.27	-99.41	70.72	99.45	-85.15	98.90	-43.06	44.10	-74.23
BRD-K83302049	CP	protopine	acetylcholinesterase inhibitor, norepinephrine transporter inhibitor, serotonin transporter (SERT) inhibitor	ACHE, SLC6A2, SLC6A4		11.11, 0.00	0.68, 0.18	16.60	-65.46	64.01	-22.00	15.82	96.37	-33.06	-16.58	NaN	-6.11
BRD-K50836978	CP	purvalanol-a	CDK inhibitor, dual specificity tyrosine-(Y)-phosphorylation regulated kinase inhibitor	CDK1, CDK2, CDK4, CDK5, CCND1, CCNE1, CSNK1G3, RPS6KA1, SRC	CDK inhibitor	0.00, 0.00	2.88, 0.41	-99.83	-99.91	-99.96	-99.95	-99.95	-99.97	-99.98	-99.94	NaN	-99.86
BRD-K41564320	CP	purvalanol-b	tyrosine kinase inhibitor	CDK2, CDK4, MAPK1, MAPK3, CDK5, SRPK2		0.00, 0.00	1.24, 0.31	-24.59	37.00	26.77	17.79	78.96	62.24	-25.69	39.14	NaN	17.88
BRD-K68867920	CP	quetiapine	dopamine receptor antagonist, serotonin receptor antagonist, adrenergic receptor antagonist, histamine receptor antagonist	DRD2, HTR1A, HTR2A, DRD1, HRH1, HTR1D, HTR1E, ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD3, DRD4, DRD5, HTR1B, HTR1F, HTR2C, HTR3A, HTR6, HTR7, SLC6A2		0.00, 0.00	1.34, 0.48	-66.89	9.63	-98.71	40.90	88.10	-99.88	54.86	-73.12	14.86	-70.97
BRD-K72222507	CP	quinapril	angiotensin converting enzyme inhibitor	ACE		0.00, 0.00	0.57, 0.11	29.29	82.18	-53.86	-19.34	-52.42	21.14	15.21	32.41	-74.66	-5.62
BRD-K40782193	CP	QX-222	sodium channel blocker			0.00, 0.00	1.09, 0.33	94.27	-14.88	48.00	65.29	-21.77	40.40	9.89	21.94	NaN	20.66
BRD-K54665485	CP	R-59022	diacylglycerol kinase inhibitor, protein kinase inhibitor	DGKA		0.00, 0.00	1.57, 0.51	5.51	-89.74	-13.19	-31.67	-40.14	-97.67	-85.09	-54.17	NaN	-88.93
BRD-K16604360	CP	BRD-K16604360	antiamyloidogenic agent, dopamine receptor agonist			30.00, 20.00	0.63, 0.16	-76.48	-13.09	23.66	99.61	-23.29	96.94	79.39	-88.17	99.87	87.62
BRD-K13544237	CP	r(-)-propylnorapomorphine	dopamine receptor agonist, antiamyloidogenic agent	DRD2, DRD1, DRD3		0.00, 0.00	0.68, 0.19	75.78	80.86	-58.73	56.03	-99.31	45.66	90.46	-79.85	-97.81	53.85
BRD-A54236247	CP	racephedrine	adrenergic receptor agonist			0.00, 0.00	1.25, 0.33	57.30	61.22	93.50	56.12	18.79	-99.99	10.98	-32.24	NaN	43.91
BRD-K85603128	CP	resorcinol	phosphodiesterase inhibitor	CA12, CA14, CA2, PTGS1		0.00, 0.00	1.27, 0.31	-5.15	38.98	-88.23	70.78	31.48	73.35	52.88	-51.40	-68.27	28.10
BRD-K37206356	CP	rhamnetin	aldose reductase inhibitor, JNK inhibitor, lipoxygenase inhibitor, nitric oxide production inhibitor, p38 MAPK inhibitor	ALOX5, MAPK8		0.00, 0.00	0.80, 0.28	-34.35	27.93	-80.53	94.99	-99.95	-54.46	15.65	-99.22	-60.76	-65.29
BRD-K10098805	CP	rhapontin	apoptosis inducer			11.11, 11.11	1.17, 0.34	63.38	31.96	64.11	67.04	28.29	-98.03	98.97	-53.08	NaN	49.69
BRD-K13725475	CP	rhodomyrtoxin	cytotoxic, DNA intercalator			0.00, 0.00	1.24, 0.32	9.51	24.90	-34.28	14.58	-97.03	-85.49	-99.61	-84.33	NaN	-93.00
BRD-A08003242	CP	rhodomyrtoxin-b	cytotoxic, DNA intercalator			0.00, 0.00	1.80, 0.58	-97.42	-34.76	-99.61	-99.15	-99.37	-64.94	-99.66	-97.24	NaN	-98.56
BRD-K40887525	CP	ritanserin	serotonin receptor antagonist	HTR2A, HTR2C, HTR2B, ADRA1A, ADRA1B, ADRA1D, HTR1A, HTR1B, HTR1D, HTR5A, HTR6, HTR7		10.00, 10.00	0.77, 0.20	82.93	-52.24	4.98	-28.22	20.26	-85.54	99.11	-68.94	-18.76	-16.38
BRD-K75699339	CP	rizatriptan	serotonin receptor agonist	HTR1D, HTR1B, HTR1F, HTR1A, HTR1E		20.00, 20.00	0.34, 0.08	41.65	100.00	38.46	-52.93	-50.09	99.38	80.47	-25.86	-26.89	54.73
BRD-A77349281	CP	RK-682	heparanase inhibitor, tyrosine phosphatase inhibitor	HPSE, PTPN1		0.00, 0.00	0.58, 0.30	30.12	-25.81	46.12	-35.40	-62.27	-97.80	-91.69	-80.15	90.53	-67.39
BRD-K43796186	CP	benzyl-quinazolin-4-yl-amine	epidermal growth factor receptor (EGFR) inhibitor	EGFR		0.00, 0.00	0.90, 0.36	-29.38	25.94	-94.38	-94.34	-99.07	-41.21	-49.88	-96.99	NaN	-93.27
BRD-K43290182	CP	Ro-04-6790	serotonin receptor antagonist, serotonin receptor inhibitor	HTR6		0.00, 0.00	0.85, 0.27	-56.77	9.75	22.90	54.66	-96.51	51.18	16.43	89.87	-27.07	10.73
BRD-K54411430	CP	robustic-acid	cAMP inhibitor			11.11, 11.11	0.97, 0.15	15.93	6.58	-31.11	NaN	23.92	78.55	72.64	35.03	99.97	46.67
BRD-K21733600	CP	rofecoxib	cyclooxygenase inhibitor	PTGS2, CYP3A4, ELN		20.00, 20.00	0.57, 0.15	99.98	22.15	-39.10	-22.09	73.68	-18.13	71.71	32.38	99.59	48.91
BRD-A34255068	CP	rolipram	phosphodiesterase inhibitor, interleukin receptor antagonist	PDE4A, PDE4B, PDE4D, PDE4C, PDE5A		20.00, 10.00	0.74, 0.10	47.92	68.22	98.51	96.59	59.26	-30.77	38.78	59.67	-89.18	56.81
BRD-K82941592	CP	rosuvastatin	HMGCR inhibitor	HMGCR	HMGCR inhibitor	0.00, 0.00	0.58, 0.19	-82.60	-16.10	-41.43	94.82	54.85	-51.44	-47.89	-47.33	-18.53	-24.23
BRD-K83063356	CP	RS-102895	CC chemokine receptor antagonist, CCR antagonist	CCR2		0.00, 0.00	1.01, 0.33	32.63	93.44	19.90	-52.12	18.28	38.55	-91.21	-81.04	NaN	6.69
BRD-K20742498	CP	RS-39604	serotonin receptor antagonist	HTR4	Serotonin receptor antagonist	0.00, 0.00	1.50, 0.55	-98.51	-94.13	-8.02	-22.43	-99.38	86.50	-85.18	-99.56	-91.43	-95.81
BRD-A65597028	CP	RX-821002	adrenergic receptor antagonist	ADRA2A, ADRA2B, ADRA2C, ADRA1A, ADRA1B, ADRA1D		11.11, 11.11	1.51, 0.50	66.80	53.89	-34.65	99.04	12.35	48.99	-10.75	38.83	NaN	29.70
BRD-K07859598	CP	GW-5074	RAF inhibitor, leucine rich repeat kinase inhibitor	LRRK1, LRRK2, NTRK1, RAF1		0.00, 0.00	0.53, 0.17	-82.08	-48.64	90.48	63.79	-87.97	-50.09	-17.72	75.23	59.62	-50.80
BRD-K82846253	CP	repaglinide	insulin secretagogue, ATP-sensitive potassium channel antagonist, cytochrome P450 inhibitor, meglitinide	ABCC8, CYP2C8, CYP3A5, INS, KCNJ11, PPARG		11.11, 0.00	0.43, 0.09	-52.57	-23.77	71.15	-29.31	-52.03	68.54	96.54	-43.39	NaN	-23.13
BRD-A71765365	CP	mepireserpate	catecholamine depleting sympatholytic	SLC18A2, SLC18A1		11.11, 11.11	1.89, 0.67	24.58	-31.14	-44.60	-93.26	48.23	98.15	-50.96	-87.46	NaN	-75.76
BRD-A83431637	CP	resmethrin	cytochrome P450 inhibitor			0.00, 0.00	0.97, 0.31	-86.90	-85.66	-84.37	-20.21	-70.02	70.43	6.10	-11.33	NaN	-62.86
BRD-K42142750	CP	retrorsine	mutagenic, antimitotic, cytotoxic			11.11, 11.11	0.97, 0.31	99.54	84.49	-59.29	-21.55	23.20	73.06	-36.21	6.97	NaN	18.67
BRD-K46678324	CP	RHO-kinase-inhibitor-II	ROCK inhibitor		Rho associated kinase inhibitor	0.00, 0.00	0.91, 0.23	17.50	-9.84	-13.71	-15.08	46.77	47.23	58.15	29.00	NaN	7.45
BRD-K92760278	CP	riboflavin	vitamin B2, required for flavoprotein enzyme reactions			0.00, 0.00	0.76, 0.19	24.29	27.53	36.12	-24.77	26.32	60.08	24.69	26.47	-36.04	10.25
BRD-K82561139	CP	ricinine	casein kinase inhibitor			0.00, 0.00	0.94, 0.19	-5.61	-20.48	-54.50	90.58	-97.10	92.14	-15.42	58.04	-34.37	-6.20
BRD-K51465424	CP	ritodrine	adrenergic receptor agonist	ADRB2		0.00, 0.00	1.01, 0.30	71.06	-52.75	82.70	-78.63	45.11	69.40	-55.54	54.61	NaN	31.43
BRD-K51541829	CP	RO-25-6981	ionotropic glutamate receptor antagonist, monamine transporter modulator	GRIN2B, SLC18A2		0.00, 0.00	1.07, 0.26	16.49	-6.07	-45.16	79.33	28.88	44.91	47.43	-5.55	NaN	6.60
BRD-K06543683	CP	bisindolylmaleimide-ix	PKC inhibitor, glycogen synthase kinase inhibitor, leucine rich repeat kinase inhibitor, SIRT inhibitor	SIRT1, AKT1, GSK3B, LCK, LRRK2, MAPK1, MAPK11, MAPK12, MAPK14, MAPK8, PRKCA, ROCK1, RPS6KB1, SIRT2		0.00, 0.00	2.49, 0.91	-98.15	-55.18	-99.07	-75.33	-99.51	-91.35	-99.67	-93.08	-86.43	-98.31
BRD-K58299615	CP	RO-90-7501	amyloid precursor protein inhibitor, beta amyloid aggregation inhibitor	APP		11.11, 11.11	1.18, 0.27	-99.98	14.07	21.98	99.96	-30.15	34.36	-30.88	-99.30	NaN	-22.87
BRD-K39256324	CP	rottlerin	large conductance potassium channel activator, MAP kinase inhibitor, PKC inhibitor, protein kinase inhibitor, tissue transglutaminase inhibitor	KCNH2, PRKCD, TGM2		0.00, 0.00	1.28, 0.32	-99.39	-47.93	-80.00	-93.88	-99.85	-99.68	-96.89	-95.78	-98.15	-99.44
BRD-K46766488	CP	S-14506	serotonin receptor agonist	HTR1A, DRD2, HTR2C	Serotonin receptor agonist	11.11, 0.00	0.92, 0.26	-42.16	-71.04	-46.62	96.47	-34.44	-71.44	44.94	-93.75	NaN	-44.54
BRD-K64614248	CP	salicin	antiinflammatory agent			0.00, 0.00	1.13, 0.30	-7.32	14.84	66.67	70.17	37.14	-62.22	-46.53	-26.20	17.76	6.78
BRD-K03557653	CP	sappanone-a	melanogenesis inhibitor, tyrosinase inhibitor			0.00, 0.00	1.13, 0.48	-85.81	-10.64	-97.56	-32.37	67.58	32.31	-15.77	-99.04	-96.89	-90.75
BRD-K36395411	CP	SB-206553	serotonin receptor antagonist, serotonin receptor partial agonist	HTR2B, HTR2C, HTR1A, HTR2A		11.11, 11.11	1.20, 0.42	-12.24	34.59	-83.12	-23.05	85.59	98.00	-78.20	-31.23	NaN	-14.82
BRD-K30867024	CP	SB-216641	serotonin receptor antagonist	HTR1B, HTR1D, HTR1A, HTR2A, HTR2B, HTR2C	Serotonin receptor antagonist	10.00, 10.00	0.78, 0.13	-41.49	-35.46	-91.16	-25.22	-63.38	-80.77	41.09	-51.58	98.78	-46.67
BRD-A06352508	CP	SB-218078	CHK inhibitor, PKC inhibitor	CHEK1		0.00, 0.00	1.43, 0.60	-98.12	65.30	-99.19	62.83	-14.87	-96.06	-93.41	-99.32	-37.17	-96.00
BRD-K80639402	CP	SB-258585	serotonin receptor antagonist	HTR6		0.00, 0.00	0.99, 0.26	45.55	-88.93	-19.83	-62.18	-98.91	94.32	-81.82	-75.96	NaN	-90.32
BRD-K52512893	CP	SC-19220	prostanoid receptor antagonist	PTGER1		0.00, 0.00	1.01, 0.36	37.46	-14.56	-54.12	-93.12	-46.39	92.25	65.67	67.86	NaN	44.41
BRD-A92161634	CP	scopoline	acetylcholine receptor antagonist			11.11, 0.00	0.73, 0.14	95.63	55.27	-7.17	-28.09	52.90	74.51	-16.96	40.75	NaN	34.53
BRD-K91904471	CP	SD-169	p38 MAPK inhibitor	MAPK14		11.11, 11.11	1.19, 0.34	50.68	-20.09	32.58	99.51	-97.12	-55.81	64.13	-80.77	NaN	25.03
BRD-A58564983	CP	selamectin	nematocide			0.00, 0.00	1.74, 0.50	-98.62	-92.37	-99.85	-97.83	-56.62	-98.17	-81.58	-94.71	-83.09	-97.29
BRD-K82036761	CP	sertraline	serotonin receptor antagonist, serotonin reuptake inhibitor, serotonin uptake inhibitor	SLC6A4, CYP2C19, SLC6A3	Serotonin receptor antagonist	0.00, 0.00	1.59, 0.59	-99.76	-100.00	-21.98	-78.12	-91.67	-74.05	-91.46	-92.92	-93.79	-91.57
BRD-K67439147	CP	SIB-1893	glutamate receptor antagonist	GRM5, GRM4		20.00, 10.00	1.10, 0.41	-95.63	97.39	85.77	-99.93	34.30	99.26	83.87	-99.37	-67.59	-95.43
BRD-K79759585	CP	sildenafil	phosphodiesterase inhibitor	PDE5A, PDE6G, PDE6H, SLCO1B1, SLCO1B3		10.00, 10.00	0.58, 0.10	31.46	-6.06	34.29	-59.95	45.85	98.46	-19.73	-54.09	-14.71	6.37
BRD-K22134346	CP	simvastatin	HMGCR inhibitor	HMGCR, CYP2C8, CYP3A4, CYP3A5, ITGB2		10.00, 10.00	1.15, 0.24	44.46	-45.93	-76.38	98.10	-96.82	-99.97	62.84	-52.98	46.05	-60.79
BRD-A52588987	CP	SKF-83566	dopamine receptor antagonist	DRD1, DRD5		0.00, 0.00	0.19, 0.01	-24.39	-22.23	-60.43	-33.42	-99.19	-87.23	-29.46	40.20	NaN	-15.21
BRD-A72703248	CP	SKF-96365	calcium channel blocker, cytochrome P450 inhibitor	CYP3A4, TRPC1, PKD2, TRPC3, TRPC4, TRPC5, TRPV2		50.00, 40.00	0.49, 0.23	-95.81	99.94	99.82	-99.86	89.44	98.35	57.55	95.03	82.93	99.26
BRD-A64125466	CP	dehydrocholic-acid	gastrointestinal agent that stimulates bile production or the flow of bile into the duodenum			30.00, 20.00	0.50, 0.16	-6.22	-30.42	19.99	5.34	99.40	98.88	20.48	72.66	96.05	93.88
BRD-A54596827	CP	solifenacin	acetylcholine receptor antagonist	CHRM3, CHRM1, CHRM2, CHRM4, CHRM5		0.00, 0.00	1.32, 0.39	27.61	-99.02	-97.76	79.03	-44.17	-30.13	-21.42	-98.40	NaN	-94.59
BRD-K55468218	CP	spiperone	dopamine receptor antagonist	ADRA1A, DRD2, DRD3, DRD4, HTR1A, HTR2A, HTR7, ADRA1B, ADRA1D, DRD1, DRD5, HTR1D, HTR2B, HTR2C, HTR6		0.00, 0.00	0.64, 0.16	-42.98	-44.72	-64.12	20.42	-14.50	84.06	-38.15	-54.27	-37.97	-18.11
BRD-A91866971	CP	SQ-29548	thromboxane receptor antagonist			0.00, 0.00	0.80, 0.14	-55.62	46.69	89.79	75.08	-96.24	49.23	61.22	-7.45	NaN	25.16
BRD-A72066420	CP	mifobate	cholesterol inhibitor, PPAR receptor antagonist, renin inhibitor	PPARG, REN		0.00, 0.00	1.33, 0.49	-10.45	49.19	82.13	-18.44	17.54	40.84	-38.28	17.67	NaN	10.93
BRD-K79905821	CP	gabazine	GABA receptor antagonist	GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRG2		33.33, 22.22	1.08, 0.27	-16.53	73.56	98.52	58.86	94.58	99.99	-72.08	31.41	NaN	97.06
BRD-K51476772	CP	ST-638	tyrosine kinase inhibitor			11.11, 11.11	0.95, 0.25	99.24	-22.44	4.55	-23.92	-74.98	-43.42	-9.58	40.98	NaN	-3.84
BRD-K99595596	CP	salsolinol	monoamine oxidase inhibitor, tyrosine hydroxylase inhibitor	DRD2		0.00, 0.00	1.18, 0.36	37.90	-8.53	10.45	86.91	19.78	-46.92	-10.66	-17.45	-45.94	4.90
BRD-A77299732	CP	salubrinal	eukaryotic translation initiation factor inhibitor, GlyT-1 inhibitor	EIF2S1, SLC6A9		0.00, 0.00	1.56, 0.45	-14.62	44.67	-45.95	-49.27	-13.59	57.42	-91.04	-87.76	NaN	-59.94
BRD-A81772229	CP	simvastatin	HMGCR inhibitor	HMGCR, CYP2C8, CYP3A4, CYP3A5, ITGB2	HMGCR inhibitor	0.00, 0.00	2.36, 0.61	-96.17	-91.69	-98.22	-97.32	-82.55	-35.27	-97.72	-97.45	NaN	-98.00
BRD-A33168282	CP	sotalol	adrenergic receptor antagonist, polarization inhibitor, potassium channel antagonist	ADRB1, ADRB2, KCNH2		0.00, 0.00	0.82, 0.20	83.79	-85.67	25.51	42.69	-84.37	81.58	-64.47	-22.80	NaN	-49.21
BRD-A72483914	CP	spiroxatrine	serotonin receptor antagonist	HTR1A, ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, HTR2B		11.11, 0.00	1.03, 0.24	69.68	-31.80	80.84	-62.80	96.81	87.53	-88.75	-20.55	NaN	78.40
BRD-K27710560	CP	splitomycin	SIRT inhibitor	SIRT1, SIRT2		22.22, 22.22	1.26, 0.49	-15.06	44.14	65.68	98.65	-62.32	47.34	-54.97	99.96	NaN	52.80
BRD-K50495309	CP	SRC-kinase-inhibitor-I	src inhibitor	CSK, LCK, RIPK2		11.11, 11.11	0.85, 0.39	-38.43	-83.95	-80.86	-26.21	-53.66	98.57	-57.95	-82.71	NaN	-67.72
BRD-K42635745	CP	suloctidil	adrenergic receptor antagonist, platelet aggregation inhibitor, vasodilator			0.00, 0.00	0.72, 0.09	19.27	6.87	-56.88	16.60	-45.06	66.61	-40.62	-88.78	9.10	-6.95
BRD-K69608737	CP	tacrolimus	calcineurin inhibitor, FK506-binding protein inhibitor, immunosuppressant, insulin expression inhibitor, interleukin receptor antagonist, macrolide calcineurin inhibitor, rotamase inhibitor, T cell inhibitor	FKBP1A, CYP3A5, CYP3A7		0.00, 0.00	0.59, 0.07	-90.78	-99.67	53.87	-9.71	-52.55	-63.28	-79.98	-99.32	-46.77	-88.44
BRD-K93645900	CP	tadalafil	phosphodiesterase inhibitor	PDE5A, PDE11A		20.00, 20.00	0.43, 0.08	23.76	56.90	-55.30	-43.95	99.78	98.23	39.10	55.60	93.60	85.94
BRD-K55454768	CP	TAS-301	voltage-independent calcium influx blocker	CAMK2A		0.00, 0.00	1.10, 0.27	19.29	-13.11	32.04	40.31	-66.91	77.38	-42.17	-89.00	NaN	-46.37
BRD-K81376179	CP	TCS-359	FLT3 inhibitor	FLT3		0.00, 0.00	1.22, 0.43	23.67	57.83	18.96	92.47	-15.45	38.72	-29.23	30.74	NaN	18.89
BRD-K34820100	CP	tebuthiuron	photosynthesis inhibitor			10.00, 10.00	0.59, 0.14	-5.52	-10.67	-14.18	35.80	46.55	-20.95	11.56	99.03	77.76	15.40
BRD-A22844106	CP	tenoxicam	cyclooxygenase inhibitor, prostanoid receptor inhibitor	PTGS2, PTGS1		0.00, 0.00	0.67, 0.11	87.44	65.52	70.86	13.68	-89.12	33.15	13.32	59.60	-27.93	43.40
BRD-A06352418	CP	terfenadine	histamine receptor antagonist	HRH1, KCNH2, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, KCNH1		0.00, 0.00	1.94, 0.60	-79.86	-99.32	-98.43	-73.30	-98.67	-99.64	83.86	12.47	-74.58	-98.07
BRD-A42831637	CP	tetrahydrocannabinol-7-oic-acid	analgesic, anti-inflammatory			0.00, 0.00	1.08, 0.25	-77.83	-58.68	52.05	-16.57	17.43	35.44	-37.75	13.15	NaN	-46.48
BRD-A43940795	CP	tetrahydropalmatine	serotonin release inhibitor			0.00, 0.00	0.50, 0.14	-28.49	-30.96	-15.30	-88.82	-98.74	-20.75	-41.37	-55.54	-28.35	-42.21
BRD-A28856712	CP	tetryzoline	adrenergic receptor agonist			11.11, 11.11	1.32, 0.22	20.27	-19.28	-46.63	99.81	-90.20	-80.27	-71.79	-31.37	NaN	-44.52
BRD-K69023402	CP	thapsigargin	ATPase inhibitor, calcium channel blocker, PKC activator	ATP2A1		0.00, 0.00	1.59, 0.48	-30.70	-24.40	-98.84	-99.89	-99.88	34.01	-99.98	4.70	NaN	-99.89
BRD-K09631521	CP	thiotepa	cytochrome P450 inhibitor	CYP2B6		0.00, 0.00	1.48, 0.39	-25.89	-13.94	78.09	30.41	-15.82	-21.76	-6.63	-62.83	91.91	-2.92
BRD-K00603606	CP	ticlopidine	purinergic receptor antagonist, platelet aggregation inhibitor	P2RY12, CYP2B6, CYP2C19		0.00, 0.00	1.24, 0.18	44.59	83.51	-37.25	21.76	-27.50	10.67	-42.05	-67.99	88.54	9.89
BRD-K82562631	CP	tolmetin	cyclooxygenase inhibitor	PTGS2, PTGS1	Cyclooxygenase inhibitor	10.00, 10.00	0.64, 0.18	76.87	-27.00	-12.42	98.78	25.48	79.53	90.68	54.56	5.75	56.77
BRD-K64514229	CP	toltrazuril	anti-protozoal			20.00, 20.00	0.67, 0.16	87.64	20.81	55.21	43.67	99.98	99.26	-79.73	30.30	11.34	69.55
BRD-K51350053	CP	toremifene	selective estrogen receptor modulator (SERM), estrogen receptor antagonist	ESR1, CYP3A5		0.00, 0.00	1.08, 0.33	-12.53	-26.03	-14.94	-94.74	-75.53	-27.05	-33.95	-99.87	32.41	-12.08
BRD-A43974575	CP	tranylcypromine	cytochrome P450 inhibitor, histone lysine demethylase inhibitor, monoamine oxidase inhibitor	MAOA, MAOB, KDM1A, CYP2A6		0.00, 0.00	1.14, 0.30	62.74	-22.29	-7.96	8.19	49.32	-33.90	-15.34	53.37	NaN	12.66
BRD-K70778732	CP	trazodone	adrenergic receptor antagonist, serotonin receptor antagonist, serotonin reuptake inhibitor, histamine receptor antagonist, serotonin uptake inhibitor	HTR2A, HTR2C, SLC6A4, ADRA1A, ADRA2A, HRH1, HTR1A, HTR2B		0.00, 0.00	0.77, 0.15	-31.09	29.45	25.45	-34.18	56.73	85.19	52.65	-10.88	-16.57	15.00
BRD-A37780065	CP	triamcinolone	antiinflammatory agent, corticosteroid agonist, corticosteroid binding globulin binder, corticosteroid hormone receptor agonist, cytochrome P450 inhibitor, glucocorticoid receptor agonist, immunosuppressant, immunosuppressive agent	NR3C1, CYP3A5, CYP3A7, SERPINA6		0.00, 0.00	1.38, 0.73	81.28	-13.09	-22.64	-98.54	-92.65	-98.70	-74.99	-22.90	NaN	-91.65
BRD-A92439610	CP	triamcinolone	antiinflammatory agent, corticosteroid agonist, corticosteroid binding globulin binder, corticosteroid hormone receptor agonist, cytochrome P450 inhibitor, glucocorticoid receptor agonist, immunosuppressant, immunosuppressive agent	NR3C1, CYP3A5, CYP3A7, SERPINA6	Glucocorticoid receptor agonist	0.00, 0.00	1.18, 0.77	65.54	32.47	-22.95	-97.92	-93.40	-97.60	10.25	93.69	NaN	-85.22
BRD-K80431395	CP	triciribine	AKT inhibitor	AKT1, AKT2, AKT3		0.00, 0.00	1.44, 0.15	-99.89	-99.39	-88.30	-7.96	-31.66	-99.54	80.45	-99.84	-53.83	-99.05
BRD-A49225603	CP	alimemazine	histamine receptor ligand	HRH1		0.00, 0.00	1.67, 0.66	-25.71	38.30	-93.58	-90.11	-57.52	-39.98	-97.02	-30.77	NaN	-80.45
BRD-K53220666	CP	trimetozine	compound with mild tranquilizing effects			0.00, 0.00	1.00, 0.33	-5.33	19.65	-24.05	52.58	-83.41	8.00	30.57	44.12	58.06	14.76
BRD-A10303790	CP	talampicillin	antibiotic			0.00, 0.00	0.80, 0.17	-52.11	19.96	-16.30	50.14	14.38	92.22	-17.04	24.27	-26.80	8.74
BRD-K04210847	CP	tamoxifen	estrogen receptor antagonist, selective estrogen receptor modulator (SERM), estrogen receptor agonist, estrogen receptor modulator, PKC inhibitor	ESR1, ESR2, CYP3A5, EBP, GPER1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PRKCI, PRKCQ, PRKCZ	Estrogen receptor antagonist	0.00, 0.00	1.98, 0.59	-32.99	-26.91	-99.71	-90.90	-81.22	-90.07	-98.68	-99.93	NaN	-96.23
BRD-K95739795	CP	tetrabenazine	vesicular monoamine transporter inhibitor	SLC18A2, DRD2, SLC18A1		33.33, 22.22	1.45, 0.44	99.18	44.10	89.98	91.75	99.74	93.28	8.16	-27.05	NaN	97.45
BRD-A52660433	CP	tetrindole	monoamine oxidase inhibitor	MAOA		0.00, 0.00	1.74, 0.63	-28.17	-39.79	-98.70	-50.17	-75.91	29.29	-99.03	-86.95	NaN	-88.89
BRD-K69600043	CP	thiethylperazine	dopamine receptor antagonist	DRD1, DRD2, DRD4	Dopamine receptor antagonist	10.00, 10.00	0.92, 0.26	-63.67	32.82	-43.60	-53.80	49.95	-8.31	99.61	-99.60	-43.03	-24.23
BRD-A56012032	CP	thiorphan	membrane metalloendopeptidase inhibitor	MME		0.00, 0.00	1.03, 0.25	-14.16	-60.43	-13.50	-90.51	39.38	85.82	-44.00	-37.18	-99.17	-35.63
BRD-A53077924	CP	tianeptine	selective serotonin reuptake enhancer (SSRE), serotonin reuptake enhancer, serotonin uptake enhancer	SLC6A4		11.11, 11.11	1.05, 0.33	-69.24	34.91	-26.04	-28.11	-56.29	99.93	8.79	-8.15	NaN	-14.07
BRD-A72988804	CP	tiaprofenic-acid	cyclooxygenase inhibitor	PTGS2, PTGS1		0.00, 0.00	1.32, 0.48	52.79	30.42	-68.28	90.47	-46.70	77.27	-48.80	18.06	NaN	29.03
BRD-K30480208	CP	torasemide	cytochrome P450 antagonist, diuretic, electrolyte reabsorption inhibitor, thromboxane receptor antagonist	SLC12A1, CYP2C8, SLC12A2		0.00, 0.00	0.84, 0.23	78.13	76.54	56.78	-47.74	-90.62	36.55	-32.29	61.43	NaN	60.59
BRD-K84663978	CP	trequinsin	phosphodiesterase inhibitor, platelet aggregation inhibitor, potassium channel blocker	PDE4A, PDE4B, PDE4C, PDE4D, PDE5A, PTGIR		20.00, 20.00	0.55, 0.36	87.97	40.20	98.93	37.65	92.59	92.77	-99.54	91.49	46.93	98.56
BRD-A60294240	CP	tribenoside	vasoprotective agent			11.11, 0.00	1.05, 0.33	-65.24	7.46	-19.74	23.47	-79.52	96.01	-63.68	-91.39	NaN	-37.61
BRD-A79226577	CP	tropisetron	serotonin receptor antagonist, polarization inhibitor, sodium channel blocker	HTR3A, GLRA1, GLRA2, GLRB, HTR4		0.00, 0.00	0.90, 0.24	30.00	-7.89	77.58	-40.80	39.17	-77.92	-86.43	-77.03	NaN	-44.49
BRD-K20995441	CP	U-54494A	kappa opioid agonist			0.00, 0.00	1.33, 0.44	51.98	-9.01	-23.53	80.92	93.29	44.03	-48.64	-82.54	NaN	23.42
BRD-K51018020	CP	VAMA-37	DNA dependent protein kinase, DNA dependent protein kinase inhibitor, PI3K inhibitor	PRKDC	DNA dependent protein kinase inhibitor	0.00, 0.00	1.39, 0.48	-99.84	-75.37	-82.34	-22.51	-99.78	-43.67	-96.86	-99.38	NaN	-99.65
BRD-K95655893	CP	MAZ-51	VEGFR inhibitor	FLT4		22.22, 11.11	2.05, 0.74	95.59	99.96	-98.61	-98.69	20.26	39.36	26.37	-99.67	NaN	-93.65
BRD-M45964048	CP	verteporfin	apoptosis stimulant, photosensitizing agent, radical formation stimulant			0.00, 0.00	0.91, 0.30	-92.70	-9.49	-54.45	-97.02	14.86	-49.18	-22.14	-91.91	66.18	-79.89
BRD-K41868777	CP	W-5	calmodulin antagonist			11.11, 11.11	1.07, 0.31	-10.75	-13.42	-44.93	46.20	99.48	24.91	75.04	-35.90	NaN	9.71
BRD-A62021152	CP	WAY-161503	serotonin receptor agonist	HTR2C		0.00, 0.00	1.43, 0.45	-54.41	13.21	-57.38	9.00	10.53	-73.24	-17.75	-20.74	NaN	-26.37
BRD-K55430733	CP	WAY-629	serotonin receptor agonist	HTR2C		11.11, 11.11	1.16, 0.34	98.44	63.08	-11.87	48.94	78.71	47.54	82.17	-72.93	NaN	57.66
BRD-A11678676	CP	wortmannin	PI3K inhibitor, ATM kinase inhibitor, ATR kinase inhibitor, DNA dependent protein kinase inhibitor, mTOR inhibitor, Phosphatidylinositol 3-kinase (PI3K) inhibitor, PLK inhibitor	PIK3CA, PIK3CG, PLK1, ATM, ATR, MTOR, PI4KA, PI4KB, PIK3CD, PIK3R1, PLK3, PRKDC	PI3K inhibitor	0.00, 0.00	1.52, 0.50	-99.94	-99.96	-89.55	-99.98	-93.61	-99.76	-95.18	-98.92	-99.82	-99.54
BRD-K42748308	CP	XE-991	acetylcholine release enhancer, potassium channel blocker, voltage-gated potassium channel blocker	KCNQ1, KCNQ2, KCNQ3, KCNQ4, KCNQ5		0.00, 0.00	0.73, 0.24	-32.63	-35.35	68.09	65.35	20.98	42.63	46.61	-36.96	-13.74	25.22
BRD-K42679050	CP	Y-27152	potassium channel activator, potassium channel agonist	ABCC9, KCNJ8		10.00, 10.00	0.83, 0.25	-34.94	99.72	25.36	20.87	-65.74	37.99	-11.08	57.59	-10.01	10.69
BRD-K44084986	CP	Y-27632	ROCK inhibitor, calcium sensitizer, leucine rich repeat kinase inhibitor	ROCK1, ROCK2, LRRK2, PKIA, PKN2, PRKACA, PRKCE	Rho associated kinase inhibitor	11.11, 11.11	1.06, 0.25	-12.26	68.21	-17.94	82.25	83.37	-34.50	59.19	99.33	NaN	74.79
BRD-K48059230	CP	YM-298198	glutamate receptor antagonist	GRM1		0.00, 0.00	1.25, 0.25	67.47	-31.23	40.33	91.40	61.72	94.25	-80.97	92.61	NaN	84.38
BRD-K06712146	CP	YM-90709	IL5 inhibitor, interleukin receptor antagonist	CSF2RB, IL5RA		0.00, 0.00	1.00, 0.31	7.50	38.90	-26.33	76.91	-96.59	-38.56	-61.86	-99.93	-82.87	-59.48
BRD-A87445400	CP	yohimbine	adrenergic receptor antagonist	ADRA2A, ADRA2C, ADRA2B, HTR1A, HTR1B, HTR1D, HTR2B, DRD2, DRD3, HTR1E, HTR1F, HTR2A, HTR2C, HTR5A, HTR7, KCNJ1, KCNJ10, KCNJ11, KCNJ12, KCNJ14, KCNJ15, KCNJ8		10.00, 10.00	0.36, 0.11	99.21	91.88	-91.85	29.67	-18.89	50.94	52.88	-41.42	10.83	31.89
BRD-K35586044	CP	yohimbine	adrenergic receptor antagonist	ADRA2A, ADRA2C, ADRA2B, HTR1A, HTR1B, HTR1D, HTR2B, DRD2, DRD3, HTR1E, HTR1F, HTR2A, HTR2C, HTR5A, HTR7, KCNJ1, KCNJ10, KCNJ11, KCNJ12, KCNJ14, KCNJ15, KCNJ8		11.11, 11.11	1.60, 0.52	35.84	98.98	36.38	94.25	-69.60	-34.74	53.40	32.55	NaN	23.82
BRD-K45296539	CP	ZD-7114	adrenergic receptor agonist	ADRB3		10.00, 10.00	0.56, 0.18	25.78	-58.41	48.07	54.70	-58.49	61.20	-61.41	-23.05	98.40	24.79
BRD-K56403959	CP	ZK-756326	CC chemokine receptor ligand	CCR8		0.00, 0.00	1.11, 0.35	-59.36	61.38	-29.17	-72.70	54.95	30.60	47.98	-58.52	NaN	-32.24
BRD-K40624912	CP	ZM-39923	JAK inhibitor	JAK1, JAK3		11.11, 11.11	1.75, 0.43	99.40	-91.29	-79.78	89.61	68.81	60.04	-80.06	-17.20	NaN	-67.47
BRD-K66353228	CP	zoxazolamine	IKCa channel activator			0.00, 0.00	0.56, 0.11	17.77	-85.56	10.14	44.48	-98.46	-20.91	-68.87	-41.60	-23.71	-37.37
BRD-A65615053	CP	zacopride	serotonin receptor antagonist, serotonin receptor agonist	HTR3A, HTR4, HTR3B, HTR5A		11.11, 0.00	0.26, 0.05	-88.48	32.65	95.71	82.34	84.75	-92.16	-29.36	-29.59	NaN	53.32
BRD-K80451230	CP	zamifenacin	acetylcholine receptor antagonist	CHRM3		0.00, 0.00	1.13, 0.31	-60.40	-15.47	-95.37	-33.28	69.70	-48.23	-72.72	49.79	NaN	-40.89
BRD-K48300629	CP	zonisamide	GABA receptor agonist, Sodium Channel  Blockers, T-type calcium channel blocker	CA1, CA12, CA7, SCN1A, CA10, CA11, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA8, CA9, CACNA1G, CACNA1H, CACNA1I, MAOA, MAOB, SCN11A, SCN1B, SCN2A, SCN2B, SCN3A, SCN3B, SCN4A, SCN4B, SCN5A, SCN9A		0.00, 0.00	0.80, 0.19	77.51	41.29	82.59	-29.38	-58.93	-30.14	94.45	-24.14	NaN	71.52
BRD-K17110974	CP	aristolochic-acid	phospholipase inhibitor			0.00, 0.00	0.75, 0.11	7.38	-10.37	-51.50	-56.77	54.52	40.13	-99.19	-35.82	-99.95	-47.35
BRD-A78360835	CP	cercosporin	photoactivated to produce toxic reactive oxygen species, PKC inhibitor			0.00, 0.00	2.96, 0.78	-99.22	-68.96	-96.55	-98.97	-58.25	-88.42	-86.15	-98.72	NaN	-96.84
BRD-A39268308	CP	epibatidine	acetylcholine receptor agonist	CHRFAM7A, CHRNA2, CHRNA3, CHRNA4, CHRNA7		0.00, 0.00	1.85, 0.45	13.68	-42.24	28.61	16.33	-35.25	-67.82	31.15	77.01	NaN	7.63
BRD-K25836724	CP	epitestosterone	inactive testosterone analog	AKR1C1, AKR1C2, AR		10.00, 10.00	0.53, 0.11	74.12	-98.82	72.29	-18.98	13.60	98.86	77.30	-33.04	29.55	51.17
BRD-K77830450	CP	forskolin	adenylyl cyclase activator, Adenylate cyclase stimulant, growth hormone receptor agonist, phosphokinase stimulant	ADCY2, ADCY5, GNAS		20.00, 20.00	0.85, 0.43	92.89	48.36	-22.35	72.37	97.85	31.76	-62.57	-94.98	98.18	92.59
BRD-A90490067	CP	fulvestrant	estrogen receptor antagonist, DNA directed DNA polymerase inhibitor, soluble epoxide hydrolase inhibitor	ESR1, EPHX2, ESR2, GPER1		0.00, 0.00	0.42, 0.17	-39.86	-95.01	-31.56	15.75	-99.10	-90.20	-57.83	-100.00	-13.03	-98.87
BRD-K78599730	CP	manumycin-a	farnesyltransferase inhibitor, NFkB pathway inhibitor, ras farnesyltransferase inhibitor	FNTA, IKBKB	NFkB pathway inhibitor	0.00, 0.00	2.32, 0.57	-99.62	-99.25	-99.19	-99.86	-99.30	-95.03	-68.69	-99.42	-91.23	-99.26
BRD-A11135865	CP	nor-binaltorphimine	opioid receptor antagonist			11.11, 11.11	0.80, 0.19	11.58	87.58	94.31	99.53	58.89	50.28	-52.00	33.08	NaN	85.21
BRD-K46384212	CP	o-3M3FBS	phospholipase activator			0.00, 0.00	0.64, 0.14	10.09	30.64	-54.48	92.75	59.18	-31.10	69.77	-25.09	65.79	47.20
BRD-K87343924	CP	wortmannin	PI3K inhibitor, ATM kinase inhibitor, ATR kinase inhibitor, DNA dependent protein kinase inhibitor, mTOR inhibitor, Phosphatidylinositol 3-kinase (PI3K) inhibitor, PLK inhibitor	PIK3CA, PIK3CG, PLK1, ATM, ATR, MTOR, PI4KA, PI4KB, PIK3CD, PIK3R1, PLK3, PRKDC		0.00, 0.00	1.68, 0.48	-99.87	-99.89	-99.70	NaN	-84.89	-99.82	-68.38	-80.22	-77.40	-99.22
BRD-K26548821	CP	quinpirole	dopamine receptor agonist	DRD2, DRD3, DRD4, DRD1, HTR1A, HTR2A, HTR2B, HTR2C		0.00, 0.00	0.86, 0.13	-71.60	-91.24	-53.72	-34.58	11.67	-21.55	-70.87	72.14	75.61	-45.05
BRD-A95445494	CP	maackiain	interleukin synthesis inhibitor, sodium/glucose cotransporter inhibitor	SLC5A2		0.00, 0.00	1.69, 0.55	-10.68	28.10	-35.22	-25.68	71.63	-87.06	-36.63	-13.81	59.69	-7.50
BRD-K05906022	CP	limonin	HIV protease inhibitor			10.00, 10.00	0.82, 0.22	79.41	64.81	-33.47	97.52	13.17	41.69	-27.29	-17.13	-27.45	22.71
BRD-K78294846	CP	osthol	ACAT inhibitor, GABA receptor modulator			10.00, 10.00	0.73, 0.13	-13.57	34.07	10.94	99.14	-63.34	55.94	93.78	64.53	-46.61	33.16
BRD-K80348542	CP	cephaeline	protein synthesis inhibitor	RPS2	Protein synthesis inhibitor	11.11, 0.00	3.33, 0.78	-33.19	NaN	-99.32	-59.82	97.26	-57.35	-99.21	-79.37	-80.37	-91.62
BRD-K87991767	CP	umbelliferone	carbonic anhydrase inhibitor, cyclooxygenase inhibitor	CA9, CA12, PTGS2		0.00, 0.00	0.61, 0.16	-41.59	18.95	22.47	-28.10	58.09	32.16	-42.97	-57.13	-54.77	-18.22
BRD-K94841585	CP	emodic-acid	laxative, free radical generator			0.00, 0.00	0.76, 0.18	-35.99	32.43	62.61	-63.07	86.81	77.34	94.36	-99.36	22.60	24.40
BRD-K49657628	CP	tyrphostin-AG-18	epidermal growth factor receptor (EGFR) inhibitor, tyrosine kinase inhibitor	EGFR		0.00, 0.00	0.65, 0.17	-44.54	31.25	-72.79	-20.08	-94.83	60.69	-91.54	-12.37	-99.47	-87.95
BRD-K12357156	CP	AG-490	epidermal growth factor receptor (EGFR) inhibitor, ErbB2 and JAK2 inhibitor, JAK inhibitor	JAK2, JAK3, EGFR, STAT3		0.00, 0.00	1.31, 0.45	-44.18	-36.19	-99.44	23.67	-51.81	-90.41	-36.34	-92.84	43.65	-82.00
BRD-K34533029	CP	tyrphostin-AG-494	epidermal growth factor receptor (EGFR) inhibitor, tyrosine kinase inhibitor	EGFR		0.00, 0.00	0.81, 0.25	-88.72	82.79	-11.96	-25.09	-98.84	31.80	-51.09	-87.70	-46.98	-45.27
BRD-K81209512	CP	AG-494	epidermal growth factor receptor (EGFR) inhibitor, tyrosine kinase inhibitor	EGFR		10.00, 0.00	0.85, 0.26	6.85	95.66	-99.23	17.92	-99.18	78.35	-74.17	-38.99	-63.18	-43.29
BRD-K07888196	CP	tyrphostin-AG-538	insulin growth factor receptor inhibitor, tyrosine kinase inhibitor	EGFR		0.00, 0.00	0.94, 0.26	10.75	90.29	-37.67	-48.53	-87.26	67.77	87.10	-86.52	65.77	58.00
BRD-K72783841	CP	tyrphostin-AG-555	CDK inhibitor, epidermal growth factor receptor (EGFR) inhibitor, tyrosine kinase inhibitor	CDK2, EGFR		0.00, 0.00	1.20, 0.32	-54.22	13.63	-98.57	75.73	-95.82	-48.59	-14.12	-40.79	45.77	-24.59
BRD-K14441456	CP	tyrphostin-AG-556	epidermal growth factor receptor (EGFR) inhibitor, tyrosine kinase inhibitor	EGFR		10.00, 0.00	1.13, 0.40	45.25	-50.92	-20.02	-96.22	-99.52	96.66	-37.09	-99.90	-39.72	-76.83
BRD-K89930444	CP	AG-592	tyrosine kinase inhibitor			0.00, 0.00	1.82, 0.48	-86.74	-98.52	-96.77	-99.24	-99.78	-99.17	-99.20	-98.77	-62.27	-98.31
BRD-K08132273	CP	tyrphostin	epidermal growth factor receptor (EGFR) inhibitor, receptor tyrosine protein kinase inhibitor	ERBB2		0.00, 0.00	1.00, 0.28	22.86	15.16	-38.05	-63.23	-47.14	-13.94	-96.67	36.53	-50.51	-26.14
BRD-K87919739	CP	tyrphostin-AG-825	receptor tyrosine protein kinase inhibitor	ERBB2		0.00, 0.00	1.22, 0.33	39.49	45.15	-98.77	-87.08	-70.31	90.34	-76.12	42.92	-8.28	-79.21
BRD-K41996876	CP	tyrphostin-1	epidermal growth factor receptor (EGFR) inhibitor	EGFR		40.00, 10.00	0.55, 0.13	99.94	24.67	47.95	84.51	-28.74	45.48	97.45	96.49	13.67	96.30
BRD-K76064317	CP	tyrphostin-AG-1296	FLT3 inhibitor	FLT3		0.00, 0.00	0.65, 0.23	63.60	-42.61	-38.42	83.97	87.47	-36.60	-59.88	73.84	-73.74	61.51
BRD-K68336408	CP	tyrphostin-AG-1478	EGFR inhibitor	EGFR, MAPK14	EGFR inhibitor	0.00, 0.00	1.60, 0.51	-99.06	-98.32	-96.12	-97.82	-98.75	-97.50	-96.08	-98.48	-98.08	-95.50
BRD-K33204703	CP	AG-370	PDGFR tyrosine kinase receptor inhibitor, tyrosine kinase inhibitor	PDGFRB		0.00, 0.00	1.31, 0.40	72.98	-35.77	37.74	-23.78	-45.21	-16.20	46.26	-19.69	49.62	11.26
BRD-K47105409	CP	AG-490	epidermal growth factor receptor (EGFR) inhibitor, ErbB2 and JAK2 inhibitor, JAK inhibitor	JAK2, JAK3, EGFR, STAT3		0.00, 0.00	0.70, 0.22	-94.79	66.69	-84.75	-40.33	-98.09	77.41	-86.08	-3.26	90.82	-88.93
BRD-K59469039	CP	AG-879	angiogenesis inhibitor, EGFR inhibitor, tyrosine kinase inhibitor, VEGFR inhibitor	ERBB2, KDR, NTRK1	EGFR inhibitor, VEGFR inhibitor	0.00, 0.00	2.11, 0.65	-99.03	-99.61	-98.92	-99.75	-98.67	-98.98	-79.33	-99.68	-97.58	-98.53
BRD-K89055274	CP	alverine	smooth muscle relaxant	HTR1A		0.00, 0.00	0.90, 0.28	-86.96	50.67	94.94	-48.61	-30.93	8.96	-32.07	53.39	-51.25	-13.45
BRD-K21667562	CP	AM-404	FAAH transport inhibitor, anandamide transport inhibitor, nucelar factor of activated T-cells inhibitor, TRPV agonist	TRPV1, CNR1, CNR2, FAAH		10.00, 0.00	1.23, 0.27	4.10	-23.85	-68.79	-61.39	-99.05	-67.94	57.91	31.83	96.94	-31.42
BRD-K63533170	CP	AM-630	cannabinoid receptor antagonist, cannabinoid receptor inverse agonist	CNR2, CNR1		0.00, 0.00	1.25, 0.43	32.88	-73.97	27.03	-39.50	36.06	-33.15	79.91	-13.10	78.72	11.17
BRD-A11813248	CP	AM-92016	glutamate receptor antagonist, ionotropic glutamate receptor antagonist, time-dependent delayed rectifier potassium current blocker	GRIN1, GRIN2B		0.00, 0.00	0.78, 0.19	71.91	-64.95	-61.25	12.65	47.96	31.36	86.17	-94.30	-47.58	-24.23
BRD-K06854232	CP	AM-580	RAR agonist, retinoid receptor agonist	RARA	Retinoid receptor agonist	10.00, 10.00	0.38, 0.13	99.94	15.82	-36.48	-55.17	-92.08	77.69	34.09	-82.31	26.64	8.39
BRD-K70330367	CP	amantadine	glutamate receptor antagonist, acetylcholine channel inhibitor, dopamine receptor agonist	DRD2, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A		0.00, 0.00	0.81, 0.13	62.94	-26.09	-55.99	68.77	71.13	-57.75	44.70	-63.45	26.97	37.17
BRD-K23335153	CP	AMN-082	glutamate receptor positive allosteric modulator	GRM7		0.00, 0.00	1.10, 0.32	-9.47	25.76	-64.13	78.11	30.89	55.71	-25.67	-11.78	-67.88	4.78
BRD-A28318179	CP	aminomethyltransferase	nitric oxide synthase inhibitor	NOS2		10.00, 10.00	1.30, 0.47	84.68	73.23	45.70	98.36	83.93	92.42	54.58	-67.67	-38.57	85.46
BRD-K87905482	CP	anandamide	cannabinoid receptor agonist, potassium channel blocker, TRPV agonist	CNR1, CNR2, TRPV1, CACNA1G, CACNA1H, CACNA1I, GLRA1, GPR119, GPR18, GPR55, KCNA2, KCND3, KCNK3, KCNK9, TRPM8		30.00, 20.00	0.73, 0.19	87.30	8.75	96.24	98.94	-73.61	99.97	-64.93	30.98	-26.49	92.10
BRD-K78280988	CP	anandamide	cannabinoid receptor agonist, potassium channel blocker, TRPV agonist	CNR1, CNR2, TRPV1, CACNA1G, CACNA1H, CACNA1I, GLRA1, GPR119, GPR18, GPR55, KCNA2, KCND3, KCNK3, KCNK9, TRPM8	Cannabinoid receptor agonist	20.00, 20.00	0.77, 0.25	21.35	93.88	-34.62	59.26	99.31	41.12	99.50	-59.74	-51.48	85.00
BRD-A95513702	CP	androsta-1,4-dien-3,17-dione	aromatase inhibitor	CYP19A1	Aromatase inhibitor	0.00, 0.00	0.66, 0.23	9.81	-94.81	-90.98	71.03	89.89	64.75	75.79	-40.54	-25.55	34.78
BRD-A32349859	CP	methyl-angolensate	apoptosis inhibitor	HTR2B		0.00, 0.00	1.50, 0.33	30.06	-85.72	NaN	NaN	-99.46	46.37	NaN	NaN	NaN	-85.77
BRD-A42649439	CP	triciribine	AKT inhibitor	AKT1, AKT2, AKT3		0.00, 0.00	1.63, 0.16	-96.04	-99.96	-53.21	-48.01	-99.67	-99.38	38.93	-99.92	-44.97	-99.58
BRD-K81729199	CP	AQ-RA741	acetylcholine receptor antagonist			0.00, 0.00	0.85, 0.20	-14.91	21.69	-55.64	-18.94	32.57	13.55	-14.65	25.29	42.54	2.89
BRD-K29555132	CP	arachidonamide	cannabinoid receptor agonist	CNR1, CNR2		10.00, 0.00	1.13, 0.35	-7.01	-66.09	84.40	-52.80	-45.51	-40.27	25.48	14.32	96.44	-19.86
BRD-K73395020	CP	SA-1478088	metalloproteinase inhibitor	MMP12, MMP14, MMP2, MMP8, MMP9		0.00, 0.00	2.35, 0.81	71.00	-94.78	-97.89	-94.44	-97.85	-92.86	-90.95	-94.41	-97.61	-91.47
BRD-K85013741	CP	auraptene	lipoxygenase inhibitor, monoamine oxidase inhibitor, nitric oxide production inhibitor, nitric oxide synthase expression inhibitor	MAOB		10.00, 10.00	1.27, 0.41	93.30	84.22	-33.78	34.59	-78.05	72.38	99.73	-38.26	59.74	74.49
BRD-K78838262	CP	austricine	hypolipidemic			20.00, 20.00	1.58, 0.44	99.54	-14.48	NaN	NaN	44.20	46.43	NaN	NaN	NaN	54.57
BRD-K03642198	CP	AY-9944	hedgehog pathway inhibitor			0.00, 0.00	1.05, 0.19	45.63	82.70	-27.48	-69.67	-65.51	-8.84	-30.71	-91.72	60.86	-17.17
BRD-K36258877	CP	AZ-10417808	caspase inhibitor	CASP3		10.00, 10.00	1.42, 0.40	-62.22	59.50	-37.87	-16.97	-57.09	-24.58	88.55	99.89	92.28	71.33
BRD-K51751936	CP	alfadolone	GABA receptor agonist			10.00, 0.00	1.16, 0.34	96.36	-11.00	-89.74	-39.58	18.04	-16.74	-69.00	-55.26	52.42	-31.26
BRD-K51276371	CP	aloisine	CDK inhibitor, CFTR channel activator, glycogen synthase kinase inhibitor, JNK inhibitor	CDK2, CDK5, CDK1, CDK5R1, CFTR, PTK2B, ZAP70		0.00, 0.00	0.74, 0.28	-97.34	-99.81	-43.19	13.57	-92.73	-67.01	-96.73	-86.22	-99.97	-99.05
BRD-K93658967	CP	aloisine	CDK inhibitor, CFTR channel activator, glycogen synthase kinase inhibitor, JNK inhibitor	CDK2, CDK5, CDK1, CDK5R1, CFTR, PTK2B, ZAP70	CDK inhibitor, Glycogen synthase kinase inhibitor	0.00, 0.00	0.94, 0.31	-95.31	20.38	-94.74	-91.30	87.23	-63.62	-18.83	-71.73	-45.25	-72.92
BRD-K52459643	CP	prostaglandin-e1	prostanoid receptor agonist, prostanoid receptor antagonist	PTGER1, PTGER2, CATSPER1, CATSPER2, CATSPER3, CATSPER4, PTGDR, PTGER4, PTGIR		20.00, 10.00	1.02, 0.34	19.08	-90.93	-40.32	43.03	19.54	95.74	76.99	25.89	98.84	57.45
BRD-K00610438	CP	altanserin	serotonin receptor antagonist, collagen stimulant	HTR2A, HTR2C		0.00, 0.00	0.55, 0.14	59.92	-37.95	-88.81	-34.82	25.74	-70.31	-22.08	-35.70	71.93	-18.30
BRD-K97181089	CP	amiloride	sodium channel blocker, diuretic, epithelial sodium channel blocker, sodium/hydrogen exchanger inhibitor	SCNN1A, ASIC1, ASIC2, SCNN1B, SCNN1G, AOC1, ASIC3, PKD2, PKD2L1, PLAU, SCNN1D, SLC9A1, TRPC7, TRPV2		10.00, 10.00	0.32, 0.06	98.56	53.91	-46.24	34.32	-88.59	-52.17	44.57	34.92	40.86	17.27
BRD-K04976539	CP	aminogenistein	PKC inhibitor, src inhibitor	LCK		0.00, 0.00	1.01, 0.20	59.38	17.59	49.78	-15.15	-40.84	82.12	87.73	-99.86	-38.37	41.48
BRD-K07762753	CP	aminopurvalanol-a	CDK inhibitor, tyrosine kinase inhibitor	CDK1, CDK2, CDK5, CDK6	CDK inhibitor	0.00, 0.00	1.91, 0.49	-99.95	-99.96	-99.92	-99.73	-99.75	-99.96	-99.98	-99.96	-99.31	-99.93
BRD-K39670393	CP	amthamine	histamine receptor agonist	HRH2		0.00, 0.00	0.82, 0.24	-26.81	-14.99	23.91	9.41	19.19	24.31	-90.41	25.67	43.79	4.16
BRD-K36638830	CP	anabasine	acetylcholine receptor agonist			0.00, 0.00	1.10, 0.19	83.30	10.79	-46.71	88.30	86.37	58.22	70.78	21.37	-31.76	75.22
BRD-K08502430	CP	angiogenesis-inhibitor	angiogenesis inhibitor	EGFR		0.00, 0.00	1.67, 0.48	-99.98	-90.59	-99.55	-89.35	-95.05	-99.93	-98.48	-99.09	-99.97	-99.93
BRD-K88611939	CP	aniracetam	glutamate receptor agonist	DRD2, GRIA1, GRIA2, GRIA3, HTR2A, GRIA4		10.00, 10.00	0.52, 0.08	99.96	17.41	-21.85	-93.96	-73.52	18.64	63.70	-18.07	-21.18	-5.11
BRD-K91370081	CP	anisomycin	DNA synthesis inhibitor	NHP2L1, RPL10L, RPL11, RPL13A, RPL15, RPL19, RPL23, RPL23A, RPL26L1, RPL3, RPL37, RPL8, RSL24D1		0.00, 0.00	3.61, 0.86	-99.41	NaN	-99.21	-84.70	43.08	-92.30	-98.75	-68.65	47.59	-96.76
BRD-K15164005	CP	apoptosis-activator-II	carboxylesterase inhibitor	BCHE, CES1		10.00, 10.00	1.08, 0.40	-38.48	99.61	-93.80	-14.94	-81.79	77.14	-27.01	-74.24	-32.04	-47.56
BRD-K53523901	CP	arctigenin	adiponectin receptor agonist, AP inhibitor, aryl hydrocarbon receptor antagonist, HIV integrase inhibitor, MEK inhibitor, NFkB pathway inhibitor, topoisomerase inhibitor	ADIPOR1, AHR, CHUK, MAP2K1		10.00, 10.00	0.69, 0.15	81.98	98.33	-95.73	-45.53	24.49	-54.90	-33.74	-85.90	-99.28	-86.71
BRD-K63792901	CP	arecaidine	acetylcholine receptor agonist	CHRM1, CHRM2, CHRM3, CHRM4		30.00, 20.00	0.78, 0.23	99.96	-10.35	69.66	13.32	32.04	99.87	-24.55	86.14	93.19	97.24
BRD-K23922020	CP	arecaidine	acetylcholine receptor agonist	CHRM1, CHRM2, CHRM3, CHRM4		0.00, 0.00	1.28, 0.36	-49.25	-86.78	93.42	45.39	-57.61	33.03	57.31	-56.03	-49.42	-42.14
BRD-K34092021	CP	arvanil	TRPV agonist, cannabinoid receptor agonist	CNR1, TRPV1		10.00, 0.00	0.99, 0.31	-91.83	-23.44	-55.13	26.70	-97.40	96.76	83.61	38.11	-33.41	-14.03
BRD-K64236792	CP	austricine	hypolipidemic			10.00, 0.00	1.40, 0.42	23.52	60.19	95.45	33.41	15.39	-21.93	67.43	47.45	-43.66	41.01
BRD-K75615183	CP	talipexole	adrenergic receptor agonist, dopamine receptor agonist, dopamine autoreceptor agonist, serotonin receptor antagonist	DRD2, HTR3A		10.00, 0.00	0.89, 0.22	95.53	-55.22	-25.98	10.37	-22.24	27.04	32.74	33.67	-27.91	2.92
BRD-A84189516	CP	baccatin-III	paclitaxel precursor			50.00, 40.00	1.48, 0.32	-20.34	99.93	-27.92	-93.19	-11.30	90.51	98.38	95.26	99.58	98.98
BRD-K40742111	CP	baeomycesic-acid	lipoxygenase inhibitor			0.00, 0.00	2.02, 0.40	-8.21	-77.90	NaN	NaN	35.13	40.66	NaN	NaN	NaN	15.96
BRD-K40919711	CP	BAPTA-AM	potassium channel blocker	KCNA3, KCNA5, KCNH2		0.00, 0.00	1.31, 0.26	37.89	-99.06	-84.69	-98.01	-60.73	-99.15	-75.25	-38.31	-64.44	-95.17
BRD-K54704028	CP	BAY-36-7620	glutamate receptor antagonist	GRM1		10.00, 0.00	1.14, 0.31	-6.88	52.64	-89.05	-39.91	95.73	50.50	-94.16	-29.11	-94.41	-36.35
BRD-K18799075	CP	BAY-59-3074	cannabinoid receptor partial agonist	CNR1, CNR2	Cannabinoid receptor agonist	0.00, 0.00	0.63, 0.17	24.78	-53.34	-43.91	42.26	-33.60	69.06	-55.56	79.45	-98.04	-20.60
BRD-K17008822	CP	BD-1008	sigma receptor antagonist		Sigma receptor antagonist	10.00, 10.00	1.15, 0.38	25.70	52.15	99.61	65.27	-98.57	49.68	-75.39	-58.09	36.59	28.98
BRD-K36864847	CP	BD-1047	alpha receptor antagonist, sigma receptor antagonist	SIGMAR1		0.00, 0.00	0.76, 0.19	46.03	17.99	55.36	-12.21	79.28	-85.68	-49.10	-13.66	-59.94	-9.33
BRD-K29668683	CP	BD-1063	sigma receptor antagonist	SIGMAR1	Sigma receptor antagonist	10.00, 10.00	1.31, 0.28	-93.20	-99.23	46.10	40.82	76.09	-23.05	98.97	14.57	75.80	25.08
BRD-K87158025	CP	benzamil	epithelial sodium channel blocker	PKD2L1, SCNN1A, SCNN1B, SCNN1G, ASIC1, SCNN1D, SLC8A1		10.00, 10.00	0.70, 0.20	-71.04	-97.83	-21.10	84.40	99.77	-53.81	-50.26	-89.20	34.44	-48.07
BRD-K76872913	CP	benzanthrone	aromatic hydrocarbon derivate with fluorescent and luminescent properties			20.00, 0.00	1.09, 0.34	96.67	75.24	NaN	NaN	84.43	88.41	NaN	NaN	NaN	82.71
BRD-K09668667	CP	benzo(a)pyrene	pro carcinogen that is metabolized to the DNA intercalating agent benzo(a)pyrene diol epoxide			0.00, 0.00	1.40, 0.43	-78.82	19.41	NaN	NaN	-92.90	-46.83	NaN	NaN	NaN	-75.84
BRD-K91315211	CP	betahistine	histamine receptor agonist, histamine receptor antagonist	HRH3, HRH1		10.00, 10.00	1.58, 0.39	-48.36	-95.32	97.92	68.94	-48.64	48.00	66.31	40.76	42.08	50.81
BRD-K46018455	CP	bezafibrate	PPAR receptor agonist, 11-beta hydroxysteroid dehydrogenase expression inhibitor, 11-beta hydroxysteroid dehydrogenase inhibitor, lipase clearing factor inhibitor	PPARA, PPARD, PPARG, HSD11B1, LPL	PPAR receptor agonist	10.00, 0.00	0.83, 0.24	85.57	30.57	54.71	96.64	81.16	-37.93	35.64	-38.13	-30.23	30.30
BRD-A38913120	CP	BH3I-1	BCL inhibitor	BCL2		0.00, 0.00	0.98, 0.30	93.45	56.97	-27.40	-84.42	65.78	-17.56	56.88	44.94	-60.36	49.31
BRD-K28075147	CP	biochanin-a	estrogen receptor agonist			20.00, 10.00	1.30, 0.38	22.31	52.18	73.98	-16.26	99.39	96.43	-26.76	-28.89	38.71	55.07
BRD-K94379058	CP	BML-190	cannabinoid receptor inverse agonist	CNR2		0.00, 0.00	0.73, 0.10	-62.65	-12.31	-22.19	-24.22	78.27	-37.93	-86.93	36.82	-30.27	-7.59
BRD-K32584078	CP	BML-257	AKT inhibitor, HCV NS5B RdRp inhibitor	AKT1		0.00, 0.00	0.93, 0.32	65.94	-59.50	-60.57	-39.98	-76.20	32.74	28.20	-49.69	-66.18	-36.52
BRD-A15435692	CP	BMY-14802	sigma receptor antagonist, glutamate receptor antagonist, serotonin receptor agonist	HTR1A, SIGMAR1	Sigma receptor antagonist	0.00, 0.00	0.85, 0.31	61.06	81.68	-24.76	-46.72	67.42	-66.60	72.66	-71.50	-98.33	36.06
BRD-K31054881	CP	BMY-7378	serotonin receptor antagonist, adrenergic receptor antagonist	HTR1A, ADRA1D, ADRA1A, ADRA1B		10.00, 10.00	1.25, 0.47	14.75	68.50	-96.77	16.19	-10.80	99.71	-94.73	-20.51	39.79	8.94
BRD-K45479396	CP	BP-554	serotonin receptor agonist	HTR1A		0.00, 0.00	1.53, 0.40	-87.68	-13.72	-32.62	56.04	-39.98	-42.57	50.52	-11.36	-34.71	-15.81
BRD-A51829654	CP	BRL-15572	serotonin receptor antagonist	HTR1D, HTR1A, HTR1B, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR6		10.00, 10.00	1.05, 0.30	16.88	12.89	46.72	99.77	14.22	12.59	-24.09	-35.73	-42.54	7.81
BRD-K07507905	CP	BRL-37344	adrenergic receptor agonist	ADRB3, ADRB1, ADRB2		10.00, 10.00	0.76, 0.25	99.57	68.50	-23.39	-35.86	71.47	-16.32	46.20	-17.13	44.21	39.71
BRD-K84266862	CP	BRL-50481	phosphodiesterase inhibitor	PDE7A, PDE7B		10.00, 0.00	0.89, 0.26	95.29	-87.54	79.22	87.68	91.79	54.37	39.85	54.16	84.38	89.64
BRD-K17868609	CP	BRL-54443	serotonin receptor agonist	HTR1E, HTR1F		0.00, 0.00	0.97, 0.26	-24.71	-17.18	29.13	-5.35	21.03	-21.15	44.73	17.10	-45.59	-5.64
BRD-K11696279	CP	BU-239	imidazoline receptor agonist, imidazoline receptor ligand		Imidazoline ligand	20.00, 20.00	1.22, 0.47	99.62	39.94	29.73	4.46	99.53	-71.57	84.31	-24.15	-30.53	59.85
BRD-A15931911	CP	bucladesine	adenosine receptor agonist, cAMP stimulant, vasodilator	PRKACA		0.00, 0.00	1.49, 0.35	24.89	-42.02	NaN	NaN	-84.63	-7.12	NaN	NaN	NaN	-43.10
BRD-K25905511	CP	buddleoflavonoloside	acetylcholinesterase inhibitor			10.00, 10.00	1.34, 0.43	42.49	68.18	43.38	63.10	-20.13	12.94	98.80	37.13	60.26	34.78
BRD-A16665823	CP	butoconazole	cell wall synthesis inhibitor, sterol demethylase inhibitor			10.00, 10.00	0.58, 0.18	18.82	-94.12	40.74	-33.25	32.12	99.16	74.83	-83.86	-89.67	-41.78
BRD-A17428743	CP	BW-723C86	serotonin receptor agonist	HTR2B, HTR2A, HTR2C		10.00, 10.00	0.78, 0.22	98.87	-21.16	-37.53	7.38	81.81	-66.21	-33.67	-11.40	55.40	6.87
BRD-A68891053	CP	BW-B70C	lipoxygenase inhibitor	ALOX5		0.00, 0.00	1.11, 0.35	71.44	29.39	-54.89	-73.61	76.02	-83.09	-26.36	-83.58	-36.53	-40.05
BRD-K15025317	CP	BAY-11-7821	NFkB pathway inhibitor	RELA	NFkB pathway inhibitor	10.00, 10.00	1.55, 0.50	-95.91	-74.34	-74.01	99.79	-97.68	-8.96	-26.00	10.65	-99.17	-94.11
BRD-K39111395	CP	BCL2-inhibitor	BCL inhibitor	BCL2	BCL inhibitor	0.00, 0.00	1.31, 0.45	-98.00	21.74	-99.15	67.52	-99.69	-92.65	-88.90	-95.21	-44.40	-97.74
BRD-K04185004	CP	oxybuprocaine	anesthetic	SCN10A		0.00, 0.00	0.92, 0.35	-34.98	76.04	-15.51	13.38	14.47	44.33	-39.44	27.11	-47.73	5.36
BRD-K59574735	CP	ubenimex	leukotriene hydrolase inhibitor, alanine aminopeptidase inhibitor, aminopeptidase B inhibitor, immunostimulant, peptidase inhibitor	LTA4H, ANPEP, RNPEP		10.00, 10.00	0.56, 0.08	-96.59	29.19	-99.12	-61.83	99.98	-57.50	9.93	25.75	-53.95	-73.93
BRD-K39188321	CP	betamethasone	corticosteroid agonist, glucocorticoid receptor agonist	NR3C1		10.00, 0.00	1.60, 0.66	63.78	95.82	31.66	-70.21	68.56	-93.49	-43.10	-10.22	20.35	16.04
BRD-A02759312	CP	betaxolol	adrenergic receptor antagonist	ADRB1, ADRB2		40.00, 10.00	0.85, 0.17	-31.15	95.54	-99.85	33.45	96.27	-16.07	98.59	44.73	89.25	95.56
BRD-K18779551	CP	bifemelane	acetylcholine release stimulant, adrenergic transmitter uptake inhibitor, reducing agent	SLC6A2		0.00, 0.00	0.88, 0.18	-80.71	-70.55	-23.00	-33.62	-83.95	-81.38	-41.97	-72.79	23.72	-62.39
BRD-K89210380	CP	biotin	vitamin cofactor for many metabolic reactions	ACACA, ACACB, HLCS, MCCC1, MCCC2, PC, PCCA, PCCB, SLC5A6		20.00, 20.00	1.50, 0.53	99.72	70.28	17.48	55.34	21.49	45.78	-70.10	-55.63	99.97	52.80
BRD-A36471396	CP	biperiden	anticholinergic	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, CHRNA2		0.00, 0.00	0.88, 0.26	75.73	-95.75	35.57	24.45	-58.84	-11.90	-31.58	84.56	37.76	17.60
BRD-K32906660	CP	bis-tyrphostin	EGFR inhibitor, dynamin GTPase inhibitor	DNM1, EGFR		0.00, 0.00	0.93, 0.33	-23.87	85.26	-65.59	81.06	-38.68	46.57	-26.46	12.61	29.84	10.04
BRD-K03440695	CP	boldine	acetylcholine receptor inhibitor, dopamine receptor antagonist	CHRNA4, CHRNB2, DRD1, DRD2		0.00, 0.00	0.75, 0.24	-62.19	-72.08	-46.27	40.16	74.41	-82.99	91.12	61.96	-57.65	-55.13
BRD-A17065207	CP	brefeldin-a	antibiotic that disrupts Golgi function, brefeldin A inhibited guanine nucleotide exchange protein inhibitors, golgi-specific brefeldin A-resistance guanine nucleotide exchange factor inhibitor, protein synthesis inhibitor	ARF1, ARFGEF1, ARFGEF2, CYTH2, GBF1, SAR1A	Protein synthesis inhibitor	0.00, 0.00	2.14, 0.78	-99.17	-93.16	-84.67	-99.89	-99.53	-99.00	-99.03	-98.71	-75.27	-98.98
BRD-K74913225	CP	brinzolamide	carbonic anhydrase inhibitor	CA2, CA1, CA7, CA12, CA14, CA4, CA5A, CYP2B6, CYP2C8		40.00, 10.00	0.66, 0.23	78.25	95.06	95.64	-16.97	82.06	32.77	38.38	56.03	99.58	95.30
BRD-A69960130	CP	bromocriptine	dopamine receptor agonist, dopamine receptor antagonist, prolactin secretion inhibitor	DRD2, ADRA2A, ADRA2B, ADRA2C, DRD1, DRD3, DRD4, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, ADRA1A, ADRA1B, ADRA1D, HTR6, HTR7, PRL		0.00, 0.00	1.01, 0.19	-98.48	-91.01	-85.42	94.63	-84.01	-97.09	-30.96	-95.86	-90.32	-96.60
BRD-A58157837	CP	butabindide	tripeptidyl peptidase inhibitor	TPP2		0.00, 0.00	0.98, 0.26	30.33	17.37	-39.53	-44.85	50.07	-91.24	30.06	91.12	-54.03	-24.52
BRD-K17497770	CP	butein	angiotensin converting enzyme inhibitor, epidermal growth factor receptor (EGFR) inhibitor, interleukin synthesis inhibitor, NFkB pathway inhibitor, SIRT activator, Src tyrosine kinase inhibitor, steroid 5alpha-reductase inhibitor, tumor necrosis factor production inhibitor	ACE, CXCL8, IL6, SIRT1, SRD5A1, SRD5A2, TNF		0.00, 0.00	1.52, 0.56	-32.77	74.72	-99.19	59.12	-92.20	19.42	39.06	-99.71	-99.66	-97.47
BRD-K27499107	CP	carbacyclin	IP receptor activator, PPARbeta receptor activator	PPARD, PTGDR, PTGER1, PTGER2, PTGER3, PTGER4, PTGFR, PTGIR, TBXA2R		0.00, 0.00	0.73, 0.19	-13.59	91.88	-70.79	24.66	-30.61	-40.56	-91.25	65.63	88.03	33.40
BRD-A98702003	CP	carbenoxolone	11-beta hydroxysteroid dehydrogenase inhibitor	HSD11B1, GJA1, GJA10, GJA3, GJA4, GJA5, GJA8, GJA9, GJB1, GJB2, GJB3, GJB4, GJB5, GJB6, GJB7, GJC1, GJC2, GJC3, GJD2, GJD3, GJD4, GJE1, PANX1, PANX2, PANX3		0.00, 0.00	0.97, 0.31	20.61	16.54	-41.17	14.67	-70.08	26.54	61.14	56.34	92.91	22.73
BRD-K53570330	CP	carbofuran	cholinesterase inhibitor			20.00, 20.00	0.91, 0.31	99.53	62.60	-99.12	70.53	-75.87	99.59	42.29	55.86	-52.23	60.18
BRD-A17411484	CP	carprofen	cyclooxygenase inhibitor, prostanoid receptor inhibitor	PTGS2, PTGS1		30.00, 30.00	0.85, 0.24	99.56	72.46	-25.57	-34.52	-35.32	99.04	99.98	-32.39	27.56	91.89
BRD-K03600606	CP	catechin	beta secretase inhibitor, fatty acid synthase inhibitor, free radical scavenger, immunostimulant, LDL antioxidants, quorum sensing signaling modulator, reducing agent, sodium channel blocker	BACE1, CA1, CA12, CA14, CA2, CA4, CA6, CA9, FASN, PTGS1, SCN5A		10.00, 0.00	1.31, 0.36	40.29	95.77	-95.98	13.57	73.42	87.06	-25.99	72.05	-21.21	55.50
BRD-K15616905	CP	CCCP	mitochondrial oxidative phosphorylation uncoupler			0.00, 0.00	2.15, 0.60	-98.42	-65.27	-97.37	-99.58	-93.00	-99.78	-97.53	-98.52	-44.76	-98.27
BRD-K06159959	CP	CCMQ	inhibitor of the binding of homoquinolinic acid to non-NMDA sensitive sites			10.00, 0.00	1.33, 0.48	96.78	63.67	-45.93	68.88	-4.90	44.62	-53.51	91.26	-25.45	57.51
BRD-K65503129	CP	HSP90-inhibitor	HSP inhibitor, HSP antagonist	HSP90AA1, HSP90AB1	HSP inhibitor	10.00, 10.00	0.94, 0.23	-99.94	-99.96	-85.31	73.80	66.24	-61.27	99.95	-82.92	42.28	-92.08
BRD-K10870738	CP	CDC	lipoxygenase inhibitor	ALOX12, ALOX5		0.00, 0.00	1.05, 0.38	-36.51	-95.10	-54.82	9.23	-80.13	-69.83	39.25	-59.66	80.11	-43.23
BRD-A08877921	CP	cephalotaxine	protein synthesis inhibitor			0.00, 0.00	1.22, 0.17	28.78	43.96	NaN	NaN	21.11	85.67	NaN	NaN	NaN	38.04
BRD-K64341947	CP	CFM-1571	guanylate cyclase activator			0.00, 0.00	0.94, 0.24	21.38	-98.10	33.60	9.81	-47.71	56.98	-27.59	80.57	62.86	12.09
BRD-A50737080	CP	CGK-733	ATM kinase inhibitor, ATR kinase inhibitor	ATM, ATR		0.00, 0.00	2.44, 0.64	-99.01	-99.31	-81.20	-51.13	-95.55	-99.48	-77.11	-99.50	-94.64	-97.76
BRD-A34706053	CP	CGP-12177	adrenergic receptor agonist	ADRB1, ADRB2, ADRB3		20.00, 10.00	0.94, 0.32	75.44	99.66	64.61	-31.27	35.90	53.91	96.15	77.02	-39.30	81.75
BRD-K95851186	CP	CGP-13501	GABA receptor modulator	GABBR1		10.00, 0.00	1.01, 0.28	-34.39	-46.91	51.32	97.05	-60.01	72.98	77.72	9.31	-55.88	43.66
BRD-A31575449	CP	CGP-20712	adrenergic receptor antagonist	ADRB1, ADRB3		0.00, 0.00	0.88, 0.32	-50.53	-11.91	53.05	52.34	-15.96	34.28	-89.54	-46.63	45.24	9.43
BRD-A35623999	CP	CGP-37157	L-type calcium channel blocker, mitochondrial Na+/Ca2+ exchanger antagonist, sodium/calcium exchange inhibitor	SLC8A1		10.00, 10.00	0.78, 0.25	99.02	-31.35	-34.64	-23.43	-19.66	-15.94	33.58	45.13	62.53	26.72
BRD-A04668240	CP	CGP-52432	GABA receptor antagonist	GABBR1, GABBR2	GABA receptor antagonist	0.00, 0.00	1.38, 0.45	94.33	43.32	75.02	37.41	92.32	77.30	94.52	74.54	68.46	90.53
BRD-K32292990	CP	CGP-53353	EGFR inhibitor, PKC inhibitor	EGFR, PRKCB	PKC inhibitor	0.00, 0.00	0.67, 0.11	20.15	-97.97	-83.55	-99.84	13.34	-33.36	-37.49	-97.14	-99.09	-98.61
BRD-A89672324	CP	CGP-55845	GABA receptor antagonist	GABBR1, GABBR2, KCTD12, KCTD16, KCTD8		0.00, 0.00	1.06, 0.30	-89.52	70.04	30.71	87.54	46.88	46.44	31.48	35.63	77.78	60.82
BRD-K31912990	CP	CGP-71683	neuropeptide receptor antagonist	NPY5R		0.00, 0.00	1.72, 0.61	-95.21	-99.96	-97.96	-92.91	-99.54	-99.37	-53.11	-99.08	-79.08	-98.45
BRD-K65786282	CP	CGP-7930	GABA receptor modulator, GABA receptor positive allosteric modulator	GABBR1		0.00, 0.00	1.00, 0.22	84.09	53.95	-61.29	-28.96	-64.52	-71.25	-33.25	-69.29	-78.42	-41.07
BRD-K18909381	CP	CGS-12066B	serotonin receptor agonist	HTR1B, HTR1A, HTR1D, HTR2A, HTR2B, HTR2C		0.00, 0.00	0.84, 0.18	-80.14	16.46	-95.05	-41.52	-90.36	17.67	34.71	40.71	-33.86	-46.53
BRD-K68103045	CP	CGS-20625	benzodiazepine receptor agonist, GABA benzodiazepine site receptor partial agonist	GABRA1, GABRA2, GABRA3, GABRA5		0.00, 0.00	0.89, 0.23	7.98	-90.54	-48.42	83.65	93.83	85.42	-53.31	64.10	-90.24	54.86
BRD-A81866333	CP	CGS-21680	adenosine receptor agonist	ADORA2A, ADORA1, ADORA2B, ADORA3	Adenosine receptor agonist	0.00, 0.00	0.98, 0.35	-11.06	9.92	78.07	76.41	86.19	-15.54	-52.27	21.96	-38.92	18.92
BRD-A26032986	CP	zaldaride	calmodulin antagonist, calmodulin inhibitor	CALM1		0.00, 0.00	0.61, 0.16	-50.64	-31.80	20.73	-74.19	-99.78	-59.28	-29.43	60.00	-54.70	-30.42
BRD-K67680372	CP	CI-966	GABA uptake inhibitor, GAT inhibitor	SLC6A1		10.00, 10.00	0.90, 0.19	-96.11	-36.79	32.79	33.30	98.59	38.15	24.21	-7.02	75.37	19.17
BRD-A93000692	CP	ciglitazone	PPAR receptor agonist, insulin sensitizer	PPARG, INS	PPAR receptor agonist	0.00, 0.00	0.66, 0.22	-27.25	-79.22	-76.12	-13.06	-64.31	-92.45	-53.37	-87.54	-98.95	-87.01
BRD-K00662280	CP	CL-218872	GABA receptor agonist	GABRA1, GABRA2, GABRA3, GABRA5, GABRB2, GABRG2		10.00, 0.00	1.31, 0.27	4.50	-93.31	25.52	97.07	-17.69	-37.86	-45.12	30.27	-34.49	-11.58
BRD-K00675675	CP	CL-82198	metalloproteinase inhibitor	MMP13		20.00, 10.00	1.17, 0.40	-74.30	-93.61	-46.17	-88.37	27.56	-32.51	95.04	-52.99	99.73	-42.07
BRD-K13642330	CP	cosmosiin	cytochrome P450 inhibitor			20.00, 20.00	1.77, 0.51	-52.13	-80.29	NaN	NaN	97.76	18.35	NaN	NaN	NaN	-41.20
BRD-K96271548	CP	coumaric-acid	antioxidant			0.00, 0.00	1.19, 0.32	30.32	-28.28	-91.06	-49.84	61.70	-63.69	-76.59	-57.04	-21.91	-47.82
BRD-A03816571	CP	CP-55940	cannabinoid receptor agonist, CC chemokine receptor antagonist	CNR1, CNR2, CXCR4, GPR55		20.00, 10.00	1.01, 0.33	95.33	-26.60	87.57	-21.66	99.68	-47.86	-54.96	-98.56	-77.18	-23.34
BRD-K81876028	CP	CP-93129	serotonin receptor agonist	HTR1A, HTR1B		0.00, 0.00	1.17, 0.32	72.76	-9.00	-25.19	68.63	46.45	-93.82	81.87	-66.51	42.18	38.19
BRD-K33860217	CP	CP-94253	serotonin receptor agonist	HTR1B		0.00, 0.00	1.03, 0.28	-36.14	-23.96	87.83	-36.29	-99.94	-67.42	-42.79	78.38	-66.87	-24.36
BRD-A18202423	CP	CPCCOEt	glutamate receptor antagonist	GRM1		0.00, 0.00	0.74, 0.25	45.65	68.71	-23.94	-13.12	-98.55	58.68	-31.44	93.87	34.49	35.81
BRD-K08547377	CP	irinotecan	topoisomerase inhibitor	TOP1, CYP3A5, TOP1MT	Topoisomerase inhibitor	0.00, 0.00	1.91, 0.52	-99.76	66.57	-96.14	-99.58	-99.29	62.11	-99.87	-99.87	-64.68	-99.40
BRD-K57179821	CP	crotamiton	scabicidal, antipruritic			0.00, 0.00	1.06, 0.17	-58.95	39.96	26.37	-20.13	85.22	13.11	5.06	-85.15	33.85	3.31
BRD-K79353516	CP	indolophenanthridine	CALY activator, dopamine receptor agonist	CALY, DRD1		0.00, 0.00	1.11, 0.25	-60.20	-99.50	-99.83	-54.78	88.59	-76.88	75.37	-99.94	-96.52	-99.19
BRD-A71459254	CP	cymarin	ATPase inhibitor	ATP1A1	ATPase inhibitor	0.00, 0.00	1.97, 0.57	-88.02	29.63	-93.80	32.01	-25.88	-29.37	-94.25	-40.81	-11.58	-73.31
BRD-A63043573	CP	cabergoline	dopamine receptor agonist, prolactin inhibitor, prolactin secretion inhibitor	DRD2, ADRA1A, ADRA2A, ADRA2B, ADRA2C, DRD1, DRD3, DRD4, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, ADRA1B, ADRA1D, ADRB1, ADRB2, HTR7, PRL		0.00, 0.00	1.43, 0.36	62.89	-40.89	-36.92	-8.83	56.44	-6.69	51.69	8.37	-41.97	2.63
BRD-K86882815	CP	cabergoline	dopamine receptor agonist, prolactin inhibitor, prolactin secretion inhibitor	DRD2, ADRA1A, ADRA2A, ADRA2B, ADRA2C, DRD1, DRD3, DRD4, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, ADRA1B, ADRA1D, ADRB1, ADRB2, HTR7, PRL		10.00, 10.00	0.84, 0.23	27.83	66.37	10.26	-69.78	-97.75	22.78	99.98	-11.50	-38.44	-5.20
BRD-K84709232	CP	caffeic-acid	lipoxygenase inhibitor, HIV integrase inhibitor, NFkB pathway inhibitor, nitric oxide production inhibitor, PPAR receptor modulator, tumor necrosis factor production inhibitor	ALOX5, MIF, RELA, TNF		10.00, 0.00	1.24, 0.43	-75.74	55.62	-70.81	-80.21	-99.77	97.25	-94.41	-99.83	-71.39	-89.97
BRD-K59851896	CP	calycanthine	GABA release inhibitor			0.00, 0.00	0.83, 0.23	79.93	36.56	-88.06	-39.87	41.39	51.86	49.94	93.13	57.13	34.63
BRD-A30437061	CP	camptothecin	topoisomerase inhibitor, beta amyloid synthesis inhibitor, hypoxia inducible factor inhibitor	TOP1, HIF1A	Topoisomerase inhibitor	0.00, 0.00	2.19, 0.69	-99.43	-23.58	-98.32	-99.90	-69.26	-76.46	-99.44	-98.54	-90.46	-97.92
BRD-K46556543	CP	canrenoic-acid	aldosterone antagonist			0.00, 0.00	1.34, 0.40	-93.44	39.30	-54.79	-58.94	-86.02	-72.69	-24.58	-20.20	-28.00	-74.12
BRD-K44849676	CP	capsazepine	TRPV agonist, TRPV antagonist	TRPV1, TRPV4		0.00, 0.00	1.49, 0.49	-93.00	-21.36	-99.85	-92.36	-94.47	-97.98	-46.17	-99.98	-99.44	-99.33
BRD-K12765235	CP	carbenoxolone	11-beta hydroxysteroid dehydrogenase inhibitor	HSD11B1, GJA1, GJA10, GJA3, GJA4, GJA5, GJA8, GJA9, GJB1, GJB2, GJB3, GJB4, GJB5, GJB6, GJB7, GJC1, GJC2, GJC3, GJD2, GJD3, GJD4, GJE1, PANX1, PANX2, PANX3		10.00, 10.00	1.07, 0.26	-70.64	-46.30	98.57	10.81	18.79	11.75	50.34	93.69	-72.88	12.86
BRD-K99174507	CP	cardiogenol-c	pyrimidine compound, induces embryonic stem cell ifferentiation into cardiomyocytes			10.00, 10.00	0.99, 0.17	87.24	99.44	41.67	11.63	-13.57	55.89	-49.74	-85.17	46.23	21.12
BRD-K82484965	CP	carmoxirole	dopamine receptor agonist	DRD2		10.00, 0.00	0.95, 0.26	24.15	32.14	44.60	64.23	72.42	20.84	47.59	95.98	44.63	34.53
BRD-A42167015	CP	carteolol	adrenergic receptor antagonist	ADRB1, ADRB2		0.00, 0.00	0.70, 0.17	66.95	17.17	-98.20	83.39	67.89	55.69	-81.06	41.67	41.40	43.97
BRD-A61899133	CP	catechin	beta secretase inhibitor, fatty acid synthase inhibitor, free radical scavenger, immunostimulant, LDL antioxidants, quorum sensing signaling modulator, reducing agent, sodium channel blocker	BACE1, CA1, CA12, CA14, CA2, CA4, CA6, CA9, FASN, PTGS1, SCN5A		0.00, 0.00	1.22, 0.33	86.96	-50.40	NaN	NaN	-11.75	94.86	NaN	NaN	NaN	82.90
BRD-K87932577	CP	CDK1-5-inhibitor	CDK inhibitor	CDK1, CDK5, GSK3B	CDK inhibitor, Glycogen synthase kinase inhibitor	0.00, 0.00	0.94, 0.28	-25.25	75.29	75.38	-28.33	-99.93	-98.42	-28.94	-55.82	-51.99	-36.69
BRD-K71860425	CP	CDK2-5-inhibitor	inhibitor of CDK2/cyclin E and CDK5/p25	CDK2, CDK5		0.00, 0.00	1.09, 0.31	90.89	-34.38	67.01	-20.24	32.02	52.78	-29.25	30.55	45.81	21.67
BRD-K71059170	CP	cefixime	cell wall synthesis inhibitor			0.00, 0.00	0.83, 0.23	33.52	-90.43	-20.35	-81.73	-97.33	-81.52	-24.10	-33.49	-96.26	-92.84
BRD-K37848908	CP	ceforanide	cell wall synthesis inhibitor, penicillin binding protein inhibitor			0.00, 0.00	0.76, 0.32	21.20	-64.21	63.73	67.76	-19.41	-58.98	-79.87	-31.58	-88.15	-57.28
BRD-K02275692	CP	cefotiam	cell wall synthesis inhibitor			10.00, 10.00	1.11, 0.27	14.65	38.32	-31.83	97.93	-21.19	74.14	80.18	20.47	24.29	32.55
BRD-K50422030	CP	clomethiazole	GABA receptor agonist, GABA receptor antagonist, GABA receptor modulator, p38 MAPK inhibitor	GABRA1		0.00, 0.00	0.74, 0.19	73.46	77.74	29.39	-26.41	-16.96	-23.22	70.24	67.05	51.13	48.19
BRD-A90311807	CP	cilastatin	dehydropeptidase inhibitor	DPEP1		10.00, 10.00	0.95, 0.34	78.95	-23.07	62.48	28.38	98.18	40.31	42.55	14.01	-50.08	37.94
BRD-A07875874	CP	cilnidipine	calcium channel blocker, L-type calcium channel blocker, N-type calcium channel blocker	CACNA1B, CACNA1C		0.00, 0.00	0.75, 0.28	-58.58	-79.20	-83.40	-40.47	40.92	-84.28	-37.02	-77.13	-92.28	-77.10
BRD-K28578425	CP	cilostamide	phosphodiesterase inhibitor	PDE3A, PDE3B		50.00, 40.00	0.36, 0.30	97.02	-10.25	85.05	80.25	33.59	-82.97	98.80	98.03	99.97	99.08
BRD-K18618618	CP	cimetidine	histamine receptor antagonist, histamine receptor inhibitor	HRH2, SLC29A4, SLC47A1, SLC47A2		10.00, 10.00	0.72, 0.26	97.60	28.47	36.90	-36.59	54.16	94.96	-34.44	-42.75	29.95	30.27
BRD-K72816382	CP	cinalukast	leukotriene receptor antagonist	CYSLTR1		0.00, 0.00	1.88, 0.63	-31.54	-95.52	37.91	44.23	43.09	-78.12	38.17	14.57	-50.79	-26.73
BRD-K15522385	CP	cinanserin	serotonin receptor antagonist	HTR2A		10.00, 10.00	0.77, 0.28	-23.21	84.12	72.03	-87.05	98.97	48.85	-48.52	81.72	-26.82	75.56
BRD-K07220430	CP	cinnarizine	calcium ion channel antagonist, histamine receptor antagonist	HRH1, CACNA1C, CACNA1D, CACNA1F, CACNA1G, CACNA1H, CACNA1I, CACNA1S, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD5		10.00, 10.00	1.07, 0.45	99.88	66.72	92.51	62.98	67.51	21.61	-56.10	23.87	80.94	80.67
BRD-A49358627	CP	ciprofibrate	PPAR receptor agonist, lipase clearing factor inhibitor	PPARA, LPL		20.00, 10.00	1.09, 0.34	-38.47	-81.52	55.33	-29.53	99.91	-18.40	97.20	88.35	40.36	49.48
BRD-K54142781	CP	cirazoline	alpha receptor agonist	ADRA1A		10.00, 0.00	1.07, 0.28	-19.81	96.57	34.60	-39.92	76.51	39.54	50.56	-72.36	-81.36	13.23
BRD-K71430621	CP	clobenpropit	histamine receptor antagonist, histamine receptor inverse agonist	HRH3, HRH4, HRH1, HRH2		0.00, 0.00	0.63, 0.18	-26.13	67.74	-96.63	-57.35	71.07	-13.30	-61.44	-80.78	-47.94	-35.85
BRD-A63894585	CP	clobetasol	glucocorticoid receptor agonist	NR3C1, PLA2G1B		0.00, 0.00	1.39, 0.81	-99.53	88.38	-42.62	-98.53	29.45	-99.16	-17.78	-67.00	55.57	-95.84
BRD-K38003476	CP	clocortolone	glucocorticoid receptor agonist	NR3C1, PLA2G1B	Glucocorticoid receptor agonist	20.00, 20.00	1.40, 0.59	99.34	98.76	70.97	-98.37	36.13	-98.72	78.31	44.95	-20.70	93.75
BRD-A82371568	CP	clofarabine	ribonucleoside reductase inhibitor, DNA polymerase inhibitor, DNA repair enzyme inhibitor, DNA synthesis inhibitor, ribonucleotide reductase inhibitor	RRM1, POLA1, RRM2, SLC22A8	Ribonucleotide reductase inhibitor	0.00, 0.00	2.16, 0.52	-99.53	-99.91	-98.64	-98.74	-69.49	-98.06	-96.88	-99.90	-99.96	-99.51
BRD-K04218075	CP	clomifene	estrogen receptor antagonist, estrogen receptor modulator, selective estrogen receptor modulator (SERM), testosterone receptor agonist	ESR1, AR		30.00, 20.00	0.50, 0.24	98.55	89.96	87.95	76.02	63.33	-31.64	-43.98	-88.30	99.97	97.15
BRD-K52989797	CP	clomipramine	serotonin transporter (SERT) inhibitor, dopamine transporter (DAT) inhibitor, norepinephrine transporter (NET) inhibitor	SLC6A4, SLC6A2, CYP2C19, GSTP1, HTR2A, HTR2B, HTR2C, SLC6A3	Tricyclic antidepressant	0.00, 0.00	0.86, 0.22	-58.05	-71.12	61.27	-37.18	-96.77	50.22	62.65	-47.08	-27.09	-51.12
BRD-K08890269	CP	CO-102862	sodium channel blocker	SCN2A, SCN4A, SCN9A		0.00, 0.00	0.98, 0.20	-21.20	-71.83	-16.19	83.96	-52.36	36.60	-28.33	-96.33	24.52	-13.59
BRD-A76093993	CP	cromakalim	ATP channel activator, potassium channel agonist	KCNJ8, ABCC9, KCNJ5		0.00, 0.00	1.11, 0.28	-37.10	60.55	-19.30	15.07	68.41	-27.67	-26.73	39.67	-57.94	-7.15
BRD-A49680073	CP	cucurbitacin-i	inhibitor of STAT3/JAK2 signaling, JAK inhbitor, lipocortin synthesis stimulant, STAT inhibitor	JAK2, STAT3		0.00, 0.00	2.09, 0.45	-99.88	-98.91	-74.69	-97.88	-94.84	-98.88	-99.14	-93.81	-96.97	-96.52
BRD-K89046952	CP	ciclacillin	cell wall synthesis inhibitor			10.00, 10.00	1.22, 0.27	54.40	-45.01	-92.50	85.93	-50.39	99.90	27.15	-30.38	73.42	51.44
BRD-K95992530	CP	Cyclo-[Arg-Gly-Asp-D-Phe-Val]	integrin antagonist	ITGAV, ITGB3		0.00, 0.00	0.75, 0.14	-76.50	-39.38	-33.54	26.03	14.43	46.79	50.87	72.63	26.35	12.14
BRD-A41250306	CP	cyclopenthiazide	diuretic, inhibitor of sodium chloride symporter			0.00, 0.00	0.52, 0.18	58.20	8.70	-20.56	48.95	29.62	-81.11	-47.62	40.83	-28.06	13.18
BRD-A10420615	CP	cyclopiazonic-acid	ATPase inhibitor	ATP2A1	ATPase inhibitor	0.00, 0.00	1.99, 0.56	-99.33	-91.07	-41.99	-13.53	-97.52	-22.81	-55.98	-98.54	-40.68	-93.66
BRD-A64290322	CP	cyclosporin-a	calcineurin inhibitor, cyclophilin inhibitor, immunosuppressant, insulin expression inhibitor, T cell inhibitor	PPIA, ABCB11, CAMLG, CYP3A5, CYP3A7, FPR1, PPID, PPIF, PPP3CA, PPP3R2, SLC10A1, SLCO1B1, SLCO1B3		0.00, 0.00	1.56, 0.48	-98.98	-98.26	-96.80	-99.92	-59.99	-79.98	-99.93	-99.83	-99.97	-99.82
BRD-K13533483	CP	cyclosporin-a	calcineurin inhibitor, cyclophilin inhibitor, immunosuppressant, insulin expression inhibitor, T cell inhibitor	PPIA, ABCB11, CAMLG, CYP3A5, CYP3A7, FPR1, PPID, PPIF, PPP3CA, PPP3R2, SLC10A1, SLCO1B1, SLCO1B3		0.00, 0.00	1.15, 0.44	-70.88	-99.18	24.84	-86.10	12.17	-57.32	-79.84	-95.80	-88.50	-92.56
BRD-A39290993	CP	cyproterone	androgen receptor antagonist, DNA directed DNA polymerase stimunlant, Estradiol 17 beta dehydrogenase stimulant, estrone sulfotransferase stimulant, progesterone receptor agonist, testosterone receptor antagonist	AR, ADORA1, ESR1	Androgen receptor modulator, Progesterone receptor antagonist	10.00, 0.00	1.01, 0.23	-41.57	-49.96	-73.39	50.13	97.01	-36.77	-48.02	-8.81	34.04	-22.01
BRD-K09132007	CP	D-4476	casein kinase inhibitor, TGF beta receptor inhibitor	CSNK1A1, CSNK1D, TGFB1	TGF beta receptor inhibitor	0.00, 0.00	1.18, 0.35	23.24	65.89	-29.01	-61.71	23.64	-10.36	88.85	-14.74	84.23	41.06
BRD-K26997899	CP	SA-792574	microtubule inhibitor, tubulin inhibitor	TUBB	Tubulin inhibitor	20.00, 10.00	0.97, 0.43	-82.40	99.89	41.24	-45.46	42.70	95.30	-87.53	-77.69	-55.43	-72.89
BRD-A73909368	CP	dactinomycin	DNA directed RNA polymerase inhibitor, nucleic acid syntheis inhibitor, protein synthesis inhibitor	POLR2A		0.00, 0.00	2.35, 0.80	-99.52	-34.32	-97.52	-78.15	-99.44	-98.42	-98.07	-99.49	-77.74	-98.41
BRD-K10065684	CP	dantron	stimulant laxative			0.00, 0.00	0.89, 0.15	-82.09	-39.06	-29.06	-77.32	14.88	39.37	34.54	-44.52	-96.06	-38.21
BRD-A68929948	CP	DAPT-GSI-IX	antiamyloidogenic agent, gamma secretase inhibitor		Gamma secretase inhibitor	0.00, 0.00	0.84, 0.23	38.78	-13.37	-99.69	-21.25	45.58	-91.67	-99.54	73.24	74.64	-34.03
BRD-K31633810	CP	DAU-5884	acetylcholine receptor antagonist	CHRM1, CHRM3		0.00, 0.00	1.02, 0.32	-26.60	-19.17	-75.26	-16.18	-28.60	75.45	-49.82	25.63	-31.51	-9.26
BRD-K74430258	CP	1,2-dichlorobenzene	hepatotoxicant that induces oxidative stress and inflammatory response			0.00, 0.00	0.97, 0.27	90.88	27.81	-37.52	40.32	85.02	87.51	37.92	-13.31	-99.68	52.52
BRD-K32526544	CP	DCEBIO	intermediate conductance potassium channel activator	KCNN2, KCNN3, KCNN4	Potassium channel activator	0.00, 0.00	0.80, 0.24	24.58	-11.67	62.40	-48.12	-10.51	5.46	94.89	-45.66	26.59	6.13
BRD-K61401890	CP	deguelin	NADH-ubiquinone oxidoreductase (Complex I) inhibitor, AKT inhibitor, cyclooxygenase inhibitor, NFkB pathway inhibitor, phorbol ester-induced ornithine decarboxylase (ODC) activity suppressor, PI3K inhibitor	AKT1, PTGS2		10.00, 10.00	1.01, 0.14	-66.24	99.98	-45.36	-99.35	-34.63	17.10	-38.00	-99.60	-82.37	-78.20
BRD-A75402480	CP	desoxycorticosterone	mineralocorticoid receptor agonist			0.00, 0.00	1.09, 0.35	12.59	-98.03	-38.42	42.98	-4.41	-31.89	50.53	48.12	-71.97	-8.48
BRD-K23623876	CP	decafluorobutane	ultrasound contrast agent	GRM5		20.00, 20.00	1.15, 0.30	-19.49	47.30	32.08	11.64	99.11	71.31	98.36	9.34	-45.02	46.45
BRD-K06014311	CP	DH-97	melatonin receptor antagonist	MTNR1B		10.00, 10.00	1.31, 0.50	5.60	15.63	99.86	13.31	-29.66	-16.27	78.19	-65.43	-27.37	0.88
BRD-K76133116	CP	benzydamine	membrane integrity inhibitor, prostanoid receptor inhibitor	PRSS1, PRSS2		0.00, 0.00	0.93, 0.26	34.51	9.05	11.42	46.59	11.00	-32.40	93.26	72.58	-55.09	14.55
BRD-K16508793	CP	diazepam	benzodiazepine receptor agonist, GABA benzodiazepine site receptor agonist	GABRA1, GABRA2, GABRA3, GABRA5, ADRA1A, CYP2C19, GABRA4, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GABRR1, GABRR2, GABRR3, TSPO		0.00, 0.00	0.45, 0.10	81.05	-37.85	-96.04	75.00	-45.28	91.57	-35.92	94.29	NaN	84.07
BRD-K12906962	CP	dichlorobenzamil	sodium/calcium exchange inhibitor		T-type calcium channel blocker	10.00, 0.00	1.47, 0.39	-93.52	-99.12	-94.23	50.24	-94.05	-99.97	-27.00	-98.51	95.47	-96.41
BRD-K29178788	CP	dictamnine	furoquinoline alkaloid that causes smooth muscle contraction			0.00, 0.00	1.32, 0.44	20.86	-18.37	NaN	NaN	90.52	-16.37	NaN	NaN	NaN	17.72
BRD-K81521265	CP	dicyclohexylurea	epoxide hydolase inhibitor	EPHX2		10.00, 10.00	1.08, 0.45	10.85	-34.57	87.15	98.13	-11.25	-27.15	26.43	-13.14	-45.79	-6.24
BRD-K94080537	CP	diethyltoluamide	DEET, activator of fly antenna ionotropic receptor IR40a			0.00, 0.00	0.78, 0.18	-12.31	90.70	61.33	89.25	-23.70	-51.87	-29.64	53.95	65.12	38.83
BRD-K96362535	CP	tubaic-acid	mitochondrial complex I inhibitor, NADH-ubiquinone oxidoreductase (Complex I) inhibitor	MT-ND1		0.00, 0.00	1.72, 0.74	-45.98	-82.13	NaN	NaN	-64.00	25.05	NaN	NaN	NaN	-64.02
BRD-K32645441	CP	dipropyl-5ct	serotonin receptor agonist	HTR1B, HTR1D, HTR1F, HTR7		10.00, 10.00	0.89, 0.16	46.35	-72.22	53.38	-89.99	-47.10	99.66	-39.42	-21.52	27.31	-29.52
BRD-K69032158	CP	diprotin-a	dipeptidyl peptidase inhibitor	DPP4		20.00, 0.00	1.52, 0.38	-70.24	17.01	NaN	NaN	95.30	-86.64	NaN	NaN	NaN	-65.25
BRD-K26573499	CP	DMAB-anabaseine	alpha receptor partial agonist	CHRNA7		0.00, 0.00	0.98, 0.41	-58.40	-11.74	-27.33	21.28	-57.81	-21.38	-95.68	41.37	32.40	-10.90
BRD-K89274813	CP	DMP-543	acetylcholine release enhancer			0.00, 0.00	0.77, 0.24	79.67	21.80	-45.78	-34.25	-46.16	-82.80	-26.56	56.75	27.82	-12.87
BRD-K31699485	CP	DMEOB	glutamate receptor modulator			0.00, 0.00	1.68, 0.51	14.01	-20.82	-32.14	94.06	66.61	34.82	92.65	-33.72	26.76	38.57
BRD-K85266041	CP	DNQX	glutamate receptor antagonist	GRIA1, GRIA2, GRIK1, GRIN1, GRIN2A, GRIN2B		10.00, 10.00	1.00, 0.22	64.43	-88.27	-40.60	-66.75	-24.24	19.37	28.56	90.24	99.86	32.65
BRD-K17378184	CP	prestwick-559	dopamine receptor agonist	DRD3, ADRA1A, ADRA1D, ADRA2A, DRD1, DRD2, DRD4, HTR1A, HTR2B		20.00, 10.00	0.68, 0.16	-50.80	96.47	-60.88	-31.58	99.75	-86.61	55.10	-81.96	-41.28	-30.15
BRD-K39965020	CP	doconexent	PPAR receptor agonist, unidentified pharmacological activity	FFAR1, PPARA, PTGS1, PTGS2	PPAR receptor agonist	0.00, 0.00	0.77, 0.27	22.51	-22.98	-15.90	-29.78	-11.88	91.76	-60.31	-19.08	-86.15	-6.52
BRD-K01624546	CP	docosatrienoic-acid	inhibitor of LTB4 binding to neutrophils			10.00, 10.00	1.52, 0.59	66.34	61.17	-83.58	-64.18	98.85	73.70	92.67	60.89	-43.61	76.60
BRD-A27143604	CP	DPN	estrogen receptor agonist	ESR2	Estrogen receptor agonist	10.00, 10.00	0.81, 0.28	85.69	-33.09	-23.67	-23.71	-71.22	99.79	31.92	24.11	-26.56	7.54
BRD-K80315159	CP	DPPE	histamine receptor antagonist	ABCB1, HRH1		0.00, 0.00	0.92, 0.18	-70.93	68.50	30.97	79.83	73.04	-72.38	-58.44	18.10	23.39	15.26
BRD-K94920105	CP	DR-2313	PARP inhibitor	PARP1, PARP3		10.00, 10.00	0.99, 0.15	39.15	-8.31	-9.68	47.65	-39.62	44.86	-21.24	98.79	-17.51	7.95
BRD-K33459542	CP	ditolylguanidine	sigma receptor agonist	GRIN1, GRIN2A, GRIN2B, SIGMAR1		0.00, 0.00	1.27, 0.42	-7.01	9.28	-49.45	-60.41	29.17	24.49	-26.06	-51.63	-34.38	-1.50
BRD-K62353524	CP	DY-131	estrogen-related receptor agonist	ESR2, ESRRB, ESRRG		40.00, 30.00	0.70, 0.22	96.17	99.96	68.11	-99.98	94.76	-59.10	99.39	-97.15	67.74	97.85
BRD-A20243730	CP	danazol	estrogen receptor antagonist, luteinizing hormone releasing hormone antagonist, progesterone receptor agonist, steroid derivative with antigonadotropic and anti-estrogenic activities, tumor necrosis factor modulator	ESR1, GNRHR, AR, CCL2, CYP2C8, GNRHR2, PGR, TNF		0.00, 0.00	0.89, 0.22	-59.16	-98.34	-69.51	11.64	-72.59	-21.08	-87.50	68.62	48.30	-82.72
BRD-K48970916	CP	danazol	estrogen receptor antagonist, luteinizing hormone releasing hormone antagonist, progesterone receptor agonist, steroid derivative with antigonadotropic and anti-estrogenic activities, tumor necrosis factor modulator	ESR1, GNRHR, AR, CCL2, CYP2C8, GNRHR2, PGR, TNF		0.00, 0.00	0.77, 0.20	-48.49	-98.03	-49.54	-39.67	-44.84	81.60	12.96	-17.27	-32.61	-12.74
BRD-A68009927	CP	daunorubicin	RNA synthesis inhibitor, topoisomerase inhibitor, DNA synthesis inhibitor, radical formation stimulant	TOP2A, TOP2B		0.00, 0.00	1.73, 0.60	-92.62	-67.69	-94.46	-97.86	-99.56	-95.73	-94.02	-99.45	-93.59	-98.20
BRD-K96527333	CP	dehydroisoandosterone	GABA receptor modulator			0.00, 0.00	0.83, 0.22	75.13	-88.25	-34.02	-15.64	-60.14	-61.72	46.90	18.39	-29.66	-37.10
BRD-A88282067	CP	delcorine	ganglioblocking, antiarrhythmic			10.00, 10.00	1.53, 0.42	90.29	99.96	83.56	-64.96	84.26	32.49	-31.13	87.30	-35.59	91.48
BRD-A99177642	CP	deltaline	acetylcholine receptor antagonist	CHRNA7		0.00, 0.00	0.77, 0.28	93.38	18.77	-43.46	-57.07	-89.20	64.14	56.10	45.77	52.02	36.57
BRD-K37792168	CP	denbufylline	phosphodiesterase inhibitor	PDE4A, PDE4B, PDE4D		20.00, 10.00	0.76, 0.24	96.58	-12.45	99.93	-41.89	-99.52	70.77	-89.05	35.84	-51.87	45.40
BRD-K98521173	CP	desoxycortone	mineralocorticoid receptor agonist	NR3C1, NR3C2		0.00, 0.00	1.17, 0.31	84.40	-27.19	79.82	-21.69	-42.05	-99.23	50.84	58.70	-25.37	41.73
BRD-K31238592	CP	devazepide	CCK receptor antagonist, gastrin inhibitor	CCKAR, CCKBR, GAST	CCK receptor antagonist	0.00, 0.00	1.43, 0.45	-96.66	-91.39	-60.60	-7.19	-99.95	-87.78	-95.96	-99.92	-84.33	-98.80
BRD-K33211335	CP	dextromethorphan	glutamate receptor antagonist, sigma receptor agonist	SIGMAR1, CHRNA2, CHRNA3, CHRNA4, CHRNA7, CHRNB2, CHRNB4, CYBA, CYBB, CYP3A5, GRIN1, GRIN3A, NCF1, NCF2, NCF4, OPRD1, OPRK1, OPRM1, PGRMC1, RAC1, RAC2, SLC6A2, SLC6A4		10.00, 10.00	0.61, 0.14	32.04	99.10	38.54	48.58	-28.21	91.81	-22.99	64.01	45.84	38.44
BRD-K71499074	CP	diclofenamide	carbonic anhydrase inhibitor	CA1, CA2, CA4, CA12, CA7		0.00, 0.00	0.74, 0.23	-14.60	52.90	77.45	27.64	-96.88	40.95	38.82	39.83	29.44	14.86
BRD-K17674993	CP	diflorasone	corticosteroid agonist, cytochrome P450 inhibitor, glucocorticoid receptor agonist, immunosuppressant	NR3C1, PLA2G1B	Glucocorticoid receptor agonist	0.00, 0.00	1.47, 0.31	-15.45	-74.01	-29.12	-80.86	-62.39	-98.81	36.55	-72.65	-34.95	-88.96
BRD-K18619710	CP	digoxigenin	ATPase inhibitor	ATP1A1		10.00, 10.00	1.19, 0.38	-29.35	-24.85	-54.43	12.69	38.97	-13.30	-28.98	26.47	97.54	-7.04
BRD-K23478508	CP	digoxin	ATPase inhibitor, ROR antagonist	ATP1A1, ABCB1, RORC, SLCO1B3		0.00, 0.00	2.17, 0.51	47.57	30.19	-97.43	-49.36	-49.89	-52.14	-95.36	73.78	-75.28	-75.73
BRD-K97440753	CP	dihydroergocristine	adrenergic receptor antagonist, prolactin inhibitor, adrenergic receptor partial agonist, dopamine receptor agonist, dopamine receptor partial agonist, dopamine receptor partial antagonist, serotonin receptor antagonist	HTR2A, ADRA1A, ADRB1, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR3A, HTR4, HTR5A, HTR6, HTR7		0.00, 0.00	0.55, 0.10	-15.92	26.66	-45.33	9.54	15.96	75.01	-45.33	-21.79	35.26	4.72
BRD-K73391359	CP	quinisocaine	anesthetic			20.00, 10.00	0.63, 0.11	-19.83	33.53	95.44	97.92	-51.91	56.14	83.24	29.65	-57.34	43.64
BRD-K65814004	CP	diphenyleneiodonium	nitric oxide synthase inhibitor, aldehyde dehydrogenase inhibitor, cytochrome P450 inhibitor, NADPH oxidase inhibitor, xanthine oxidase inhibitor	ALDH1A2, ALDH2, ALDH5A1, ALDH7A1, NOX3, XDH		20.00, 20.00	0.86, 0.14	99.95	76.30	22.32	-93.43	99.77	34.59	35.26	-93.64	-59.18	37.31
BRD-K54759182	CP	dosulepin	adrenergic transmitter uptake inhibitor, norepinephrine reuptake inhibitor, serotonin reuptake inhibitor, serotonin uptake inhibitor, tricyclic antidepressant	SLC6A2, SLC6A4, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, CYP2C19, HRH1		10.00, 10.00	1.30, 0.30	-23.96	15.12	-18.75	61.21	-14.53	42.62	-80.97	99.98	-76.23	-5.11
BRD-K92093830	CP	doxorubicin	topoisomerase inhibitor, DNA intercalating drug	TOP2A	Topoisomerase inhibitor	0.00, 0.00	1.56, 0.65	-96.95	-99.72	-96.73	-99.66	-99.58	-73.35	-98.17	-97.10	-99.00	-98.17
BRD-K06221026	CP	DUP-697	cyclooxygenase inhibitor	PTGS2		0.00, 0.00	0.72, 0.19	-23.03	-63.25	-70.08	-66.71	33.80	-42.12	14.07	18.67	-23.20	-24.33
BRD-K68620903	CP	dydrogesterone	progesterone receptor agonist	PGR		0.00, 0.00	0.98, 0.32	-11.58	-41.84	-12.57	-91.93	-74.63	64.25	82.95	-12.11	-42.75	-14.74
BRD-A96485169	CP	EBPC	aldose reductase inhibitor	AKR1B1		10.00, 0.00	0.77, 0.24	96.51	67.24	26.07	-46.46	22.98	92.99	61.74	-11.03	52.10	70.73
BRD-K16233984	CP	eriochrome-black-t	azo dye used in titrations to detect metal ions			10.00, 10.00	1.23, 0.38	32.45	99.78	-68.73	-35.63	-41.37	-56.59	47.67	-45.93	-39.69	-31.96
BRD-A51820102	CP	econazole	cell wall synthesis inhibitor, lanosterol demethylase inhibitor, sterol demethylase inhibitor	CYP51A1, NPY1R, NPY2R, TRPM2, TRPV5	Sterol demethylase inhibitor	0.00, 0.00	0.51, 0.15	43.88	-78.57	-44.37	7.84	-89.17	-99.96	-46.05	-95.00	-50.26	-71.84
BRD-K27450477	CP	EHNA	adenosine deaminase inhibitor	ADA, PDE2A, ADORA2A		20.00, 10.00	0.70, 0.22	99.98	15.14	-15.49	-81.74	80.60	12.15	31.09	-99.86	97.40	38.12
BRD-K63913457	CP	eicosatrienoic-acid	vasodilator			40.00, 20.00	1.28, 0.47	96.66	99.96	-92.81	42.38	98.16	86.62	-33.98	63.73	-92.08	97.43
BRD-K88759641	CP	EMD-66684	angiotensin receptor antagonist	AGTR1		0.00, 0.00	1.19, 0.43	24.30	-34.16	-25.21	8.92	-69.74	7.60	44.67	-29.24	66.33	-2.40
BRD-K57545991	CP	enalapril	angiotensin converting enzyme inhibitor, angiotensin receptor blocker	ACE		10.00, 10.00	0.73, 0.19	99.56	-16.49	-45.47	48.09	-22.95	53.61	47.03	39.77	-32.86	25.86
BRD-K76534306	CP	enrofloxacin	topoisomerase inhibitor		Bacterial DNA gyrase inhibitor	0.00, 0.00	1.13, 0.36	-54.42	-68.17	-27.39	-93.08	-26.01	-62.19	91.27	23.88	80.01	-47.47
BRD-K42452249	CP	EO-1428	p38 MAPK inhibitor	MAPK11, MAPK14		0.00, 0.00	1.26, 0.32	30.41	45.02	-44.73	69.30	-67.57	-34.56	36.13	-98.14	-25.45	-23.60
BRD-A53131506	CP	epitestosterone	inactive testosterone analog	AKR1C1, AKR1C2, AR		0.00, 0.00	0.63, 0.11	-20.14	-41.57	91.66	84.22	-46.93	84.55	57.00	11.08	-36.20	69.80
BRD-K11927976	CP	ER-27319	mediator release inhibitor, syk inhibitor	SYK		0.00, 0.00	3.42, 1.16	-94.68	25.93	-32.73	-72.41	-99.12	-78.33	-95.31	-93.55	-92.02	-97.82
BRD-K19360254	CP	ergocornine	dopamine receptor agonist	DRD2		10.00, 0.00	1.14, 0.24	-25.81	-30.68	-36.26	41.57	41.87	-45.28	36.91	68.78	96.30	32.67
BRD-A73581086	CP	ergometrine	adrenergic receptor stimulatant, serotonin receptor stimulant	ADRA1A, HTR1E, HTR2A		10.00, 10.00	0.98, 0.39	15.92	-45.59	-33.81	-29.44	-25.13	10.50	-22.59	-29.74	99.96	-6.91
BRD-A35033682	CP	eriodictyol	cytochrome P450 inhibitor, TRPM3 antagonist, xanthine oxidase inhibitor	CYP1B1, NFE2L2, XDH		0.00, 0.00	1.48, 0.51	43.88	67.38	-88.63	-70.27	-93.43	4.19	68.64	-69.77	-46.31	-48.58
BRD-A23226398	CP	estradiol	estrogen receptor agonist	ESR1, ESR2, NR1I2, CYP2B6, CYP2C19, CYP2C8, CYP2E1, CYP3A5, CYP3A7, GPER1, KCNMA1		0.00, 0.00	0.77, 0.14	-62.15	-87.17	84.21	-82.76	-93.79	-95.65	27.35	44.46	-56.10	-82.51
BRD-A39747742	CP	estradiol-valerate	estrogen receptor agonist	ESR1	Estrogen receptor agonist	0.00, 0.00	1.16, 0.43	-26.16	-98.18	-55.09	89.53	-92.15	-24.20	-24.23	13.96	-60.61	-32.90
BRD-A84205515	CP	estriol	estrogen receptor agonist, estrogen receptor antagonist	ESR1, ESR2		0.00, 0.00	0.95, 0.30	12.06	-90.06	51.55	15.60	28.09	50.96	-31.71	70.87	44.43	12.04
BRD-K49061529	CP	BRD-K49061529	GABA benzodiazepine site receptor inverse agonist	GABRA1, GABRG2		0.00, 0.00	1.45, 0.33	25.51	-86.26	-72.78	54.54	32.88	81.70	70.11	-5.24	87.73	52.98
BRD-K15842202	CP	eudesmic-acid	in touchstone			0.00, 0.00	1.62, 0.36	-66.01	-15.76	NaN	NaN	-45.45	-61.44	NaN	NaN	NaN	-45.44
BRD-K46068882	CP	eugenitol	androgen receptor (AR) inhibitor, free radical scavenger, monoamine oxidase inhibitor, quorum sensing signaling modulator	AR, MAOA		20.00, 10.00	1.18, 0.30	16.30	-35.64	78.37	-86.66	96.53	-32.92	-64.39	19.32	99.61	33.43
BRD-K86727142	CP	embelin	HCV inhibitor, XIAP inhibitor	XIAP		0.00, 0.00	0.69, 0.23	-82.96	38.79	-99.96	-40.08	87.38	-22.40	36.66	92.11	-75.14	-44.14
BRD-K39339537	CP	epirizole	cyclooxygenase inhibitor	PTGS1, PTGS2		10.00, 0.00	0.57, 0.10	-15.90	64.90	6.89	92.81	-44.32	83.74	95.72	-58.37	94.89	92.76
BRD-A39969961	CP	eplerenone	cytochrome P450 antagonist, mineralocorticoid receptor antagonist	NR3C2, CYP3A5		20.00, 10.00	1.35, 0.40	99.88	-78.93	-29.90	46.44	-69.18	-15.73	96.00	54.06	-21.52	41.16
BRD-K04046242	CP	equilin	estrogen receptor agonist	HSD17B1	Estrogen receptor agonist	50.00, 50.00	0.45, 0.36	98.12	56.90	99.81	-26.31	75.73	99.90	94.83	99.92	94.20	99.47
BRD-A99411506	CP	esculin	antioxidant, unidentified pharmacological activity			0.00, 0.00	0.77, 0.30	-79.88	-7.33	37.71	-43.64	40.62	29.06	-82.58	-83.05	-99.95	-67.91
BRD-K17016787	CP	estriol	estrogen receptor agonist, estrogen receptor antagonist	ESR1, ESR2		60.00, 50.00	0.40, 0.35	95.59	-51.20	99.88	99.79	85.67	97.92	65.63	99.96	60.53	99.30
BRD-K81839095	CP	estrone	estrogen receptor agonist, estrogenic hormone	ESR1, ESR2	Estrogen receptor agonist	50.00, 40.00	0.52, 0.35	96.93	-37.68	99.41	63.28	92.54	93.11	93.20	99.98	99.85	99.33
BRD-K03981224	CP	ethisterone	androgen receptor agonist	TYR		0.00, 0.00	0.73, 0.25	71.41	-98.73	-58.48	-71.80	32.63	87.87	-30.26	-22.51	-41.72	-31.20
BRD-K31920458	CP	mestranol	estrogen receptor agonist	ESR1		30.00, 20.00	0.48, 0.06	31.05	60.71	-11.16	-23.74	95.67	97.67	26.80	-14.89	99.62	84.36
BRD-K47693913	CP	evoxine	antagonist of strychnine and pentylenetrazole; enhances effects of narcotics			0.00, 0.00	0.94, 0.32	92.97	23.45	-99.85	93.70	69.01	-31.58	-54.89	12.78	60.49	65.22
BRD-K78633253	CP	EXO-1	ARF inhibitor			10.00, 10.00	0.30, 0.06	-28.88	-15.81	98.56	51.54	-76.59	29.06	73.78	-17.93	-26.49	23.00
BRD-K63089472	CP	farnesylthioacetic-acid	inhibitor of methyl esterification of farnesylated proteins			20.00, 20.00	1.24, 0.35	13.94	-71.46	40.65	-35.69	-26.56	88.44	97.71	-76.21	99.62	39.35
BRD-K14821540	CP	FCCP	mitochondrial oxidative phosphorylation uncoupler			0.00, 0.00	1.90, 0.72	-99.53	-99.82	-90.38	-80.15	-99.50	-99.23	-81.99	-99.27	-96.76	-98.96
BRD-K48367671	CP	febuxostat	xanthine oxidase inhibitor	XDH		20.00, 20.00	0.91, 0.20	12.96	-5.63	-98.37	76.29	-49.20	99.02	99.57	-45.88	-10.84	36.96
BRD-K51318897	CP	fenbendazole	cytochrome P450 inhibitor, tubulin inhibitor	CYP2C19, CYP2D6, CYP2J2, CYP3A4, TUBB	Tubulin inhibitor	50.00, 50.00	0.88, 0.42	54.29	99.91	60.52	51.10	-86.20	99.84	99.56	94.15	98.75	99.26
BRD-A83081521	CP	finasteride	5 alpha reductase inhibitor, androgen receptor antagonist, steroid 5alpha-reductase inhibitor	SRD5A2, SRD5A1, AKR1D1, AR		0.00, 0.00	1.23, 0.25	11.94	53.13	-45.01	23.45	75.78	18.68	28.25	5.75	90.55	22.61
BRD-K17896185	CP	FIT	opioid receptor agonist	OPRD1		0.00, 0.00	1.44, 0.51	51.09	56.96	-70.67	-87.43	-95.89	-92.28	-34.62	-90.38	-65.64	-90.23
BRD-K83508485	CP	FK-888	tachykinin antagonist	TACR1, TACR2	Tachykinin antagonist	0.00, 0.00	1.00, 0.35	61.89	-98.80	21.13	-78.71	68.11	-88.85	-99.68	-97.91	-97.47	-99.54
BRD-K30296925	CP	flavokavain-b	carcinoma cell growth inhibitor, hypoxia inducible factor inhibitor	HIF1A		0.00, 0.00	1.49, 0.66	-93.20	41.42	-95.85	-97.45	-27.37	66.70	-78.00	-98.05	-67.19	-95.31
BRD-K44067360	CP	flufenamic-acid	calcium activated chloride channel inhibitor	AKR1C3, AR, PTGS1, PTGS2, ANO1, GJA1, GJA10, GJA3, GJA4, GJA5, GJA8, GJA9, GJB1, GJB2, GJB3, GJB4, GJB5, GJB6, GJB7, GJC1, GJC2, GJC3, GJD2, GJD3, GJD4, GJE1, PANX1, PANX2, PANX3, PKD2L1, TRPC5, TRPM2, TRPM5		0.00, 0.00	1.31, 0.34	-99.28	-99.89	45.25	-41.90	-35.76	-16.10	-68.76	32.89	69.63	-45.30
BRD-A01346607	CP	flumetasone	glucocorticoid receptor agonist	NR3C1, PLA2G1B	Glucocorticoid receptor agonist	0.00, 0.00	1.31, 0.76	88.37	81.25	93.00	-64.15	-97.19	-98.73	27.82	92.43	53.01	82.78
BRD-A65449987	CP	flunisolide	cytochrome P450 inhibitor, corticosteroid agonist, corticosteroid hormone receptor agonist, glucocorticoid receptor agonist, immunosuppressant	NR3C1	Glucocorticoid receptor agonist	0.00, 0.00	1.23, 0.76	-85.71	-26.29	89.11	-79.16	62.28	-93.14	-53.08	29.20	-33.85	-40.27
BRD-K15715913	CP	fluperlapine	dopamine receptor antagonist, serotonin receptor antagonist	DRD2, HTR2A, HTR6, HTR7		10.00, 10.00	0.52, 0.17	-22.51	25.67	73.38	-45.97	-49.25	-33.45	-15.14	99.81	35.05	6.09
BRD-K31611373	CP	fluprostenol	prostaglandin F receptor agonist	PTGER3, PTGFR, TBXA2R		10.00, 0.00	0.72, 0.15	51.37	-74.04	-34.03	71.27	-85.66	97.36	64.60	2.72	49.75	31.16
BRD-A49765801	CP	fludroxycortide	corticosteroid, glucocorticoid receptor agonist	NR3C1, SERPINA6	Glucocorticoid receptor agonist	10.00, 0.00	1.34, 0.80	16.58	60.32	28.53	-79.66	-80.35	-98.50	76.30	97.41	-21.81	-16.55
BRD-A96456596	CP	FPL-55712	leukotriene receptor antagonist, leukotriene synthesis inhibitor			0.00, 0.00	1.09, 0.26	31.87	-17.69	51.16	83.12	61.56	87.95	-29.34	-8.45	-46.55	25.54
BRD-K30990140	CP	FR-122047	cyclooxygenase inhibitor			0.00, 0.00	0.48, 0.23	-51.77	-98.58	-94.21	-41.21	-98.63	-40.53	-39.97	78.76	-73.98	-97.21
BRD-A80641450	CP	FR-139317	endothelin receptor antagonist	EDNRA		10.00, 0.00	1.18, 0.40	-41.94	29.14	-32.90	40.78	-62.60	96.29	-17.25	56.92	79.04	20.75
BRD-K66944906	CP	fraxidin	carbonic anhydrase inhibitor	CA1		0.00, 0.00	1.30, 0.40	12.39	31.77	68.51	49.98	-44.20	-94.77	84.00	-87.84	41.46	28.95
BRD-K96402602	CP	farnesylthiotriazole	prenylated protein methyltransferase (PPMTase) inhibitor			0.00, 0.00	1.00, 0.34	30.95	-37.68	-25.08	-57.17	14.85	-33.67	36.16	-78.00	20.31	-11.47
BRD-K08998509	CP	fananserin	dopamine receptor antagonist, serotonin receptor antagonist	HTR2A, DRD4		30.00, 20.00	1.20, 0.42	85.44	89.73	93.19	-8.39	98.05	63.47	99.98	50.67	93.28	97.27
BRD-K76617868	CP	fasudil	ROCK inhibitor, calcium sensitizer, PKA inhibitor, protein kinase inhibitor, rho associated kinase inhibitor	ROCK1, ROCK2, PKIA, PRKACA	PKA inhibitor, Rho associated kinase inhibitor	0.00, 0.00	0.91, 0.25	-63.52	50.54	-74.51	-26.82	-85.52	-80.24	-98.34	-42.47	-69.03	-86.46
BRD-K99107520	CP	felbamate	carbonic anhydrase inhibitor, GABA receptor modulator, glutamate receptor blocker	GRIN2A, GRIN2B, GRIN3A		0.00, 0.00	0.57, 0.11	-28.43	27.06	74.01	19.96	86.35	64.35	-42.86	47.50	92.99	43.77
BRD-A30815329	CP	felodipine	calcium channel blocker, L-type calcium channel blocker	CACNA1C, CACNA1D, CACNA1H, CACNA1S, CACNA2D1, CACNA2D2, CACNB2, CALM1, CFTR, NR3C2, PDE1A, PDE1B, TNNC1, TNNC2		0.00, 0.00	0.97, 0.16	-55.48	74.29	-31.06	24.31	-61.59	68.13	-8.42	90.35	-99.25	18.56
BRD-K41160163	CP	fenobam	glutamate receptor antagonist	GRM5		20.00, 20.00	0.82, 0.31	-24.85	-93.42	-33.99	8.98	99.25	22.19	99.34	10.01	-26.58	6.80
BRD-A50684349	CP	fenoldopam	dopamine receptor agonist	DRD1, ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, DRD4, DRD5		0.00, 0.00	0.40, 0.10	-23.17	47.74	8.79	76.27	84.28	67.21	11.15	-55.72	66.33	40.57
BRD-K28168037	CP	fenretinide	apoptosis stimulant, retinoid receptor agonist, RAR agonist	CYP2C8, CYP3A5, RARA, RARG	Retinoid receptor agonist	0.00, 0.00	0.82, 0.16	-91.16	-99.50	-66.13	-95.67	-85.07	-22.77	34.99	-97.78	-96.03	-96.68
BRD-K34170797	CP	fexaramine	FXR agonist	NR1H4		10.00, 10.00	1.27, 0.36	-12.62	20.56	99.87	-6.72	40.25	35.05	61.63	-76.88	-82.58	9.73
BRD-K28667196	CP	fillalbin	increases arterial blood pressure			40.00, 30.00	0.75, 0.22	17.87	98.39	47.16	-46.31	98.10	85.87	29.49	97.30	-48.78	97.79
BRD-K01095011	CP	finasteride	5 alpha reductase inhibitor, androgen receptor antagonist, steroid 5alpha-reductase inhibitor	SRD5A2, SRD5A1, AKR1D1, AR		10.00, 10.00	0.77, 0.14	99.64	-89.39	27.42	-44.65	39.33	-11.76	-40.23	50.32	-40.38	9.99
BRD-A13650332	CP	flucloxacillin	antibiotic of the penicillin class			0.00, 0.00	1.03, 0.22	-19.90	-16.96	30.66	87.54	-28.00	-46.03	41.44	66.92	-38.22	-11.21
BRD-K98769987	CP	flumazenil	benzodiazepine receptor antagonist, GABA benzodiazepine site receptor antagonist	GABRA1, GABRA2, GABRA3, GABRA5, GABRA4, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ		0.00, 0.00	1.15, 0.22	-27.26	32.47	-36.87	63.27	-49.60	92.07	-12.36	50.43	-66.27	31.10
BRD-K61496577	CP	flumetasone	glucocorticoid receptor agonist	NR3C1, PLA2G1B		0.00, 0.00	1.30, 0.63	86.69	19.75	53.34	-79.08	80.68	-98.32	67.64	-27.63	29.04	41.19
BRD-K12184470	CP	flunarizine	calcium channel blocker, T-type calcium channel blocker	CACNA1G, CACNA1H, CACNA1I, CALM1, CYP2J2, HRH1		0.00, 0.00	0.95, 0.27	38.55	-28.66	19.54	13.39	44.43	-87.23	-29.31	-38.83	-52.30	-5.31
BRD-K49577446	CP	flunisolide	cytochrome P450 inhibitor, corticosteroid agonist, corticosteroid hormone receptor agonist, glucocorticoid receptor agonist, immunosuppressant	NR3C1		0.00, 0.00	1.41, 0.75	-57.99	-27.32	-8.30	-98.01	90.80	-98.54	-94.98	60.81	-10.56	-93.75
BRD-K53987533	CP	fluphenazine	dopamine receptor antagonist, acetylcholine receptor ligand, dopamine receptor, histamine receptor antagonist, serotonin receptor antagonist	DRD2, DRD1, CALM1, CHRNA7, DRD5, HRH1, HTR2A, HTR6, HTR7		0.00, 0.00	1.01, 0.23	-8.31	13.82	-99.27	-53.30	-88.32	-25.06	-95.10	-89.45	-99.56	-92.68
BRD-K00824317	CP	fludroxycortide	corticosteroid, glucocorticoid receptor agonist	NR3C1, SERPINA6		0.00, 0.00	1.44, 0.72	43.52	13.79	84.73	-79.39	49.14	-98.92	27.67	51.28	93.39	25.72
BRD-K67445247	CP	flurofamide	bacterial urease inhibitor			0.00, 0.00	1.14, 0.33	22.87	-87.50	81.12	-41.43	-60.04	50.15	78.95	27.22	69.34	64.59
BRD-A59943784	CP	fluticasone	glucocorticoid receptor agonist	NR3C1, CYP3A5, CYP3A7, NR3C2, PGR, PLA2G4A		0.00, 0.00	1.30, 0.74	-32.64	-37.40	-33.01	-85.16	-37.07	-98.92	20.62	63.14	-22.92	-9.27
BRD-K62310379	CP	fluticasone	glucocorticoid receptor agonist	NR3C1, CYP3A5, CYP3A7, NR3C2, PGR, PLA2G4A	Glucocorticoid receptor agonist	20.00, 20.00	1.31, 0.69	32.93	99.61	-96.69	-97.79	-48.27	-98.41	54.22	-20.99	99.55	-55.03
BRD-K72676686	CP	fluvoxamine	selective serotonin reuptake inhibitor (SSRI), serotonin reuptake inhibitor, serotonin uptake inhibitor	SLC6A4, CYP2C19		10.00, 10.00	0.50, 0.10	-74.90	-99.30	-97.80	22.38	99.98	51.45	-52.80	-11.12	40.43	-39.49
BRD-A49734948	CP	foliosidine	anticonvulsant			0.00, 0.00	0.94, 0.30	13.96	-43.13	91.88	-97.09	4.70	24.91	54.74	84.40	-93.89	14.19
BRD-M00539986	CP	formoterol	adrenergic receptor agonist	ADRB2, CYP2C19	Beta-adrenergic receptor agonist	10.00, 0.00	0.57, 0.16	93.63	89.23	95.08	11.94	-13.83	12.02	-33.13	86.25	-21.40	91.53
BRD-K03015355	CP	forskolin	adenylyl cyclase activator, Adenylate cyclase stimulant, growth hormone receptor agonist, phosphokinase stimulant	ADCY2, ADCY5, GNAS		20.00, 10.00	0.95, 0.41	51.92	77.05	59.95	-55.25	99.91	97.31	-86.81	-98.15	83.54	92.65
BRD-K87049188	CP	fusaric-acid	chelating agent, dopamine beta hydroxylase inhibitor	DBH		10.00, 10.00	1.02, 0.35	-71.50	44.92	21.52	12.65	-71.91	99.68	46.56	-18.76	-41.06	-18.87
BRD-K18059238	CP	gamma-linolenic-acid	cyclooxygenase inhibitor, prostanoid receptor stimulant, thromboxane synthase stimulant	TBXAS1		0.00, 0.00	1.66, 0.52	-89.10	-98.53	-31.31	-77.63	-31.28	-66.21	-79.09	-32.82	-25.31	-85.65
BRD-K77998258	CP	ganglioside	src activator			0.00, 0.00	0.86, 0.34	91.89	33.80	-37.72	-24.87	-67.56	-20.24	-61.25	38.95	51.64	24.87
BRD-K92015269	CP	GBR-12783	dopamine uptake inhibitor			0.00, 0.00	0.94, 0.19	22.22	-7.90	-22.69	-58.20	-64.61	56.68	20.99	-36.65	14.61	-2.08
BRD-K34034388	CP	GBR-12783	dopamine uptake inhibitor			10.00, 0.00	0.70, 0.15	-62.70	-29.77	96.74	-39.96	34.79	-88.11	56.58	-99.65	83.44	-31.82
BRD-K32501161	CP	vanoxerine	dopamine reuptake inhibitor, dopamine transporter inhibitor, monoamine oxidase inhibitor	SLC6A3, MAOA, MAOB		0.00, 0.00	1.47, 0.31	-58.96	-76.29	-100.00	-97.64	26.87	-98.61	-72.68	-84.42	-97.64	-98.77
BRD-K50135270	CP	GBR-12935	dopamine uptake inhibitor	AGTR1, SLC6A3		0.00, 0.00	1.25, 0.36	6.65	37.22	48.21	-20.85	6.90	31.05	-98.94	-13.38	-36.68	0.81
BRD-K92577649	CP	GBR-13069	dopamine uptake inhibitor	SLC6A3		0.00, 0.00	2.94, 1.12	65.32	-45.87	NaN	NaN	9.45	38.55	NaN	NaN	NaN	18.46
BRD-K11634954	CP	GBR-13069	dopamine uptake inhibitor	SLC6A3		0.00, 0.00	0.97, 0.26	-79.43	39.43	-94.12	-29.88	-96.12	73.67	-60.53	-64.36	-30.84	-70.38
BRD-K65285700	CP	BRD-K65285700	cannabinoid receptor agonist	CNR2	Cannabinoid receptor agonist	0.00, 0.00	0.86, 0.26	-40.78	62.08	-28.49	-6.03	89.69	-9.50	-97.69	-88.71	61.08	-14.13
BRD-K34608650	CP	BRD-K34608650	cannabinoid receptor agonist	CNR2		10.00, 0.00	1.24, 0.35	-51.98	-81.74	-85.70	52.43	-96.52	-19.34	-32.66	-40.71	95.34	-63.26
BRD-K11911061	CP	GR-127935	serotonin receptor antagonist	HTR1B, HTR1D, HTR1A, HTR2A, HTR2C, HTR1E, HTR1F, HTR2B, HTR6	Serotonin receptor antagonist	0.00, 0.00	1.34, 0.19	-93.07	-84.89	-68.45	-98.18	16.25	-99.37	29.85	-99.27	-98.46	-96.75
BRD-K12120659	CP	GR-144053	integrin antagonist	ITGB3, ITGA2B		20.00, 20.00	1.01, 0.33	74.01	81.95	-36.35	30.25	-53.85	98.67	99.21	62.95	-37.62	75.04
BRD-K52394958	CP	GR-159897	tachykinin antagonist	TACR2, TAC1	Tachykinin antagonist	0.00, 0.00	1.24, 0.28	-49.50	-96.77	-38.45	65.80	-52.44	-73.37	43.18	-81.84	33.73	-71.90
BRD-K02283807	CP	GR-32191	thromboxane receptor antagonist, prostanoid receptor antagonist	TBXA2R	Thromboxane receptor antagonist	0.00, 0.00	0.80, 0.28	-50.32	-19.74	59.46	-32.45	42.86	-89.11	88.21	-25.84	-34.29	-10.84
BRD-K68190965	CP	GR-46611	serotonin receptor agonist	HTR1D		0.00, 0.00	0.63, 0.13	89.64	-83.44	-79.11	-23.47	57.78	-63.87	-21.29	60.90	-49.73	-39.84
BRD-K46441700	CP	GR-55562	serotonin receptor antagonist	HTR1B, HTR1D	Serotonin receptor antagonist	0.00, 0.00	0.80, 0.25	65.18	-97.59	72.38	-12.87	81.88	38.22	39.82	-99.89	-32.70	32.08
BRD-K40578143	CP	GR-79236	adenosine receptor agonist	ADORA1, ADORA2A	Adenosine receptor agonist	20.00, 10.00	1.09, 0.34	37.22	54.98	93.58	43.69	-93.15	96.27	-54.74	91.06	97.64	93.95
BRD-A93659613	CP	GR-89696	opioid receptor agonist	OPRK1		0.00, 0.00	0.76, 0.16	-15.25	-91.78	4.43	81.69	-93.44	76.70	10.57	24.61	-20.32	2.94
BRD-K75478907	CP	GS-39783	GABA receptor modulator, GABA receptor positive allosteric modulator	GABBR1		0.00, 0.00	0.49, 0.17	-36.44	91.51	-46.27	-27.79	50.94	-33.95	35.07	-50.50	-93.88	-21.24
BRD-K67860401	CP	AR-A014418	glycogen synthase kinase inhibitor	GSK3B	Glycogen synthase kinase inhibitor	10.00, 10.00	0.88, 0.19	-18.80	-66.89	-45.45	99.96	-54.07	-79.38	-39.52	33.09	-29.43	-33.91
BRD-K16664969	CP	GTP-14564	FLT3 inhibitor, tyrosine kinase receptor inhibitor	FLT3, CSF1R, KIT, PDGFRB		0.00, 0.00	0.93, 0.17	34.56	-33.52	-44.38	-7.87	-20.94	-99.91	21.75	-93.52	30.72	-7.80
BRD-K82983861	CP	GW-0742	PPAR receptor agonist, insulin sensitizer	INS, PPARD	PPAR receptor agonist	0.00, 0.00	1.32, 0.43	-12.27	-15.04	90.77	-14.21	41.79	-41.82	-32.28	40.59	76.71	29.06
BRD-A38898897	CP	GW-311616	leukocyte elastase inhibitor	ELANE		20.00, 20.00	1.43, 0.49	8.97	17.39	99.50	99.71	-39.27	24.68	48.33	71.77	-46.19	52.42
BRD-K10705233	CP	GW-405833	cannabinoid receptor agonist	CNR2	Cannabinoid receptor agonist	10.00, 10.00	0.10, 0.01	-82.58	98.73	-99.81	-97.71	-99.89	-100.00	-99.83	-91.57	-98.45	-99.37
BRD-K04146668	CP	GW-441756	growth factor receptor inhibitor, leucine rich repeat kinase inhibitor	LRRK2, NTRK1		10.00, 10.00	1.23, 0.33	99.42	-99.21	84.73	-25.42	-20.19	-89.56	-24.50	-50.00	-38.65	-17.00
BRD-K79930101	CP	GW-583340	EGFR inhibitor, epidermal growth factor receptor (EGFR) inhibitor, ErbB2 tyrosine kinase inhibitor, receptor tyrosine protein kinase inhibitor	EGFR, ERBB2		10.00, 0.00	0.94, 0.33	95.47	49.68	-92.78	-79.32	-42.28	-84.75	72.31	30.46	27.85	-38.64
BRD-A72596465	CP	GW-6471	PPAR receptor antagonist	PPARA		0.00, 0.00	0.81, 0.17	-59.66	28.36	-91.14	10.34	66.40	16.72	69.91	-73.03	-97.92	-61.47
BRD-K90382497	CP	GW-843682X	PLK inhibitor	PLK1, PLK3		20.00, 20.00	0.77, 0.28	-81.96	99.96	-39.39	-62.27	-84.56	99.96	-92.40	-85.19	-93.24	-90.75
BRD-K71534238	CP	GW-9508	Free Fatty Acid Receptor 1 (FFAR1;  GPR40) Agonists, G protein coupled receptor agonist, G-protein coupled receptor agonist	FFAR4, FFAR1		10.00, 10.00	0.51, 0.08	-10.33	-33.43	34.49	52.66	99.96	-46.44	-45.49	19.78	72.15	8.13
BRD-K93258693	CP	GW-9662	PPAR receptor antagonist	PPARG, NCOA2, RXRA		40.00, 30.00	1.00, 0.25	-75.66	18.63	-35.01	91.86	99.96	-63.77	96.84	99.89	-34.95	99.54
BRD-K24240364	CP	GYKI-52466	glutamate receptor antagonist, kainate receptor antagonist	GRIA1, GRIA2, GRIA3, GRIA4		20.00, 20.00	1.10, 0.34	99.80	99.58	72.27	-80.26	4.80	27.04	-51.38	54.01	35.72	42.68
BRD-K59256312	CP	gabexate	serine protease inhibitor, AP inhibitor, NFkB pathway inhibitor, peptidase inhibitor, protease inhibitor	PRSS1, TPSAB1		0.00, 0.00	1.23, 0.36	91.49	45.74	-84.95	29.18	73.49	-30.82	9.23	-32.25	-48.10	17.05
BRD-K49890030	CP	gavestinel	glutamate receptor antagonist, glycine receptor antagonist	GLRB		0.00, 0.00	1.19, 0.34	-26.27	-11.53	85.31	-80.72	-11.38	19.38	-23.90	85.74	-67.74	-5.11
BRD-A36151937	CP	genistein	tyrosine kinase inhibitor, angiogenesis inhibitor, CFTR channel activator, EGFR inhibitor, estrogen receptor agonist, histidine kinase inhibitor, immunosuppressant, isoflavone agonist, protein tyrosine kinase inhibitor, reducing agent, topoisomerase inhibitor	CFTR, ESR2, EGFR, ESR1, ESRRA, ESRRB, ESRRG, NCOA1, NCOA2, PPARG, PTK2B, TOP2A, TRPC5		0.00, 0.00	1.30, 0.41	-60.95	-49.50	73.53	90.80	-18.45	-55.32	-68.50	53.30	-28.02	-42.45
BRD-K92758126	CP	gibberellic-acid	NFkB pathway modulator	AADACL2		0.00, 0.00	0.84, 0.18	-23.77	-43.52	-41.74	-13.40	62.91	30.84	-40.40	74.16	78.87	33.93
BRD-K34776109	CP	glimepiride	insulin secretagogue, ATP channel blocker, ATP-sensitive potassium channel antagonist, insulinotropin agonist, sulfonylurea	ABCC8, KCNJ11, KCNJ1	KCNJ11 modulator	0.00, 0.00	0.68, 0.13	27.05	-16.38	-19.56	29.17	-97.82	45.87	-37.53	27.66	85.44	13.69
BRD-K42693031	CP	glimepiride	insulin secretagogue, ATP channel blocker, ATP-sensitive potassium channel antagonist, insulinotropin agonist, sulfonylurea	ABCC8, KCNJ11, KCNJ1		0.00, 0.00	0.80, 0.24	59.11	-11.68	51.63	93.34	-89.09	-58.45	-52.08	81.83	93.31	61.00
BRD-A86109770	CP	guggulsterone	estrogen receptor agonist, FXR antagonist, progesterone receptor agonist, cholesterol inhibitor, IKK inhibitor, PXR agonist	NR1H4, PGR, AR, ESR1, IKBKB, NR1I2, NR3C1, NR3C2		0.00, 0.00	0.94, 0.31	48.93	-73.64	-87.55	34.40	-44.06	63.23	-41.13	-15.98	-82.63	-51.30
BRD-K27737647	CP	H-89	AKT inhibitor, cAMP dependent protein kinase inhibitor, PKA inhibitor, voltage-gated potassium channel blocker	PRKACA, GSG2, KCNA2, KCNA3, KCNA5, KCNAB2, KCNC1, KCNC2, KCNC3, KCNE1, KCNE2, KCNE3, KCNE4, KCNH1, KCNH2, KCNQ1, KCNQ2, KCNQ3, KCNQ5, KCNS3, PKIA	PKA inhibitor	0.00, 0.00	1.58, 0.55	-96.57	-93.97	-36.41	-59.31	-65.22	-99.07	-72.53	-91.33	-89.51	-91.65
BRD-K18742343	CP	H-8	PKA inhibitor	PKIA, PRKACA	PKA inhibitor	20.00, 20.00	1.00, 0.30	-59.93	99.43	-90.46	-40.50	-56.87	-23.20	-34.91	98.19	42.88	-47.47
BRD-K70577657	CP	H-9	cAMP dependent protein kinase inhibitor, PKA inhibitor	PRKACA	PKA inhibitor	0.00, 0.00	0.55, 0.11	-77.69	-5.21	-33.95	20.89	-52.97	-99.30	73.82	70.88	49.26	21.23
BRD-K05434375	CP	HA-1004	calcium channel blocker			10.00, 0.00	0.84, 0.19	95.81	73.52	-84.90	-20.26	51.28	-79.43	-30.00	-51.44	83.57	55.90
BRD-A24429032	CP	HEAT	adrenergic receptor antagonist	ADRA1A		0.00, 0.00	1.06, 0.27	40.97	60.98	-21.93	79.18	92.38	69.57	83.68	-24.57	-79.35	61.46
BRD-A00267231	CP	hemado	adenosine receptor agonist	ADORA3, ADORA1, ADORA2A, ADORA2B		10.00, 0.00	0.85, 0.32	42.51	-24.17	-18.79	93.35	-83.08	-82.52	74.14	-84.36	95.02	39.10
BRD-K81209159	CP	herniarin	acetylcholinesterase inhibitor	ACHE, CA1, CA12, CA14, CA4, CA6, CA9		10.00, 0.00	1.57, 0.36	-60.49	-94.15	-20.67	96.06	24.42	-62.19	26.38	25.96	-83.90	-47.80
BRD-K95885906	CP	quercetagetin	Pim kinase inhibitor	PIM1		0.00, 0.00	0.70, 0.18	-22.10	-14.31	-35.28	30.47	79.66	-89.80	80.59	-32.61	-69.48	-6.52
BRD-A34751532	CP	homosalate	HSP activator			0.00, 0.00	0.73, 0.31	71.30	-40.05	42.37	-98.53	-93.86	9.32	-45.84	-49.56	37.41	-38.91
BRD-K02715688	CP	hydrastine	GABA receptor antagonist			10.00, 10.00	1.48, 0.45	20.08	87.67	-70.08	-50.66	44.92	88.10	99.98	67.80	40.63	81.03
BRD-A75172220	CP	hydrocortisone	corticosteroid agonist, glucocorticoid receptor agonist, immunosuppressant, interleukin receptor antagonist	ANXA1, NOS2, NR3C1, NR3C2		20.00, 10.00	1.34, 0.39	88.74	99.91	95.93	-30.88	7.20	-91.93	49.67	62.90	-80.96	80.20
BRD-A25143711	CP	hydrocortisone	corticosteroid agonist, glucocorticoid receptor agonist, immunosuppressant, interleukin receptor antagonist	ANXA1, NOS2, NR3C1, NR3C2	Glucocorticoid receptor agonist	0.00, 0.00	1.27, 0.64	-63.36	91.22	-97.20	-92.45	-20.59	-92.78	75.50	-28.68	-27.83	-78.91
BRD-A06390036	CP	hydroquinidine	anti-arrhythmia agent			20.00, 10.00	0.61, 0.22	-43.24	73.55	85.52	-16.52	-21.76	22.61	54.25	95.70	98.49	80.62
BRD-K81709173	CP	halcinonide	glucocorticoid receptor agonist	NR3C1	Glucocorticoid receptor agonist	0.00, 0.00	1.38, 0.75	92.29	46.37	-48.30	-94.29	11.91	-98.59	88.69	-46.29	56.61	44.77
BRD-K07996107	CP	harpagoside	acetylcholinesterase inhibitor	ACHE		0.00, 0.00	0.94, 0.26	5.70	-27.14	74.11	-34.85	-52.35	55.51	31.82	-10.42	55.12	24.80
BRD-K38903228	CP	hesperidin	free radical scavenger	CACNA1B		0.00, 0.00	1.34, 0.50	84.00	14.11	66.94	39.86	22.74	90.42	-36.26	-27.93	-55.88	45.88
BRD-A97730597	CP	hexylcaine	sodium channel blocker	SCN5A, SCN10A		0.00, 0.00	0.56, 0.14	20.36	-90.98	-20.21	-33.25	22.80	-42.96	29.16	37.29	37.41	5.95
BRD-K37691127	CP	hinokitiol	tyrosinase inhibitor	TYR		0.00, 0.00	1.36, 0.45	-85.91	-99.67	-38.17	-62.99	-95.37	-92.12	-93.65	-96.94	-44.70	-96.73
BRD-K71003802	CP	hippeastrine	plant alkaloid with cytotoxic effects on some human tumor cell lines			0.00, 0.00	0.90, 0.28	-20.70	24.19	-43.82	55.35	-11.47	-8.26	89.48	8.78	69.40	14.51
BRD-K07325606	CP	hispidin	beta secretase inhibitor, cyclooxygenase inhibitor, HIV integrase inhibitor, PKC inhibitor, prolyl endopeptidase inhibitor, xanthine oxidase inhibitor	PREP, PRKCB, PTGS2, XDH		0.00, 0.00	1.05, 0.34	8.43	68.68	67.04	91.00	-99.72	74.55	34.47	-32.96	-60.00	40.78
BRD-K08554278	CP	bisbenzimide	BCL inhibitor, DNA binding, topoisomerase inhibitor	BCL2L1, TOP1		0.00, 0.00	0.94, 0.38	-67.86	-90.60	74.03	54.40	-99.13	-86.68	-60.21	-22.17	91.25	-89.32
BRD-K76674262	CP	homoharringtonine	apoptosis stimulant, protein synthesis inhibitor	RPL3	Protein synthesis inhibitor	11.11, 0.00	2.88, 0.75	-97.61	NaN	-98.05	-81.04	97.35	-59.39	-84.94	-87.26	-35.54	-91.70
BRD-A77722753	CP	hydralazine	smooth muscle relaxant	AOC3, P4HA1		40.00, 20.00	0.98, 0.30	24.89	-20.35	-32.41	96.58	-36.89	88.51	98.24	95.48	51.51	97.91
BRD-K92726801	CP	hydrastinine	alkaloid with hemostatic properties			30.00, 20.00	1.15, 0.42	98.29	94.29	93.67	-54.71	80.19	97.32	45.04	-63.78	88.44	98.41
BRD-K40530731	CP	hyoscyamine	acetylcholine receptor inhibitor	CHRM1, CHRM2, CHRM3, CHRM4		0.00, 0.00	0.85, 0.27	10.83	27.40	42.29	-26.92	85.90	29.09	-49.21	-16.44	-51.28	-9.56
BRD-K85383046	CP	IAA-94	chloride channel blocker			0.00, 0.00	1.01, 0.19	22.00	-19.36	66.46	-40.70	30.87	-57.46	-31.48	-35.64	82.21	-8.40
BRD-A20527803	CP	IB-MECA	adenosine receptor agonist, granulocyte colony stimulating factor agonist	ADORA3, ADORA1, ADORA2A, ADORA2B		0.00, 0.00	0.94, 0.30	14.85	10.85	83.37	34.38	58.34	-36.90	-77.24	82.45	-37.36	14.75
BRD-K15196155	CP	IBC-293	hydroxycarboxylic acid receptor agonist	HCAR3		20.00, 20.00	1.02, 0.26	87.62	20.84	-26.18	33.62	99.98	-46.58	98.99	71.59	-23.47	66.94
BRD-K09638361	CP	SA-63133	casein kinase inhibitor, tubulin inhibitor	CSNK1E, CSNK1A1, CSNK1D, CSNK1G2	Tubulin inhibitor	10.00, 10.00	1.23, 0.53	-63.76	99.96	33.26	-37.22	-44.91	-86.42	89.48	-59.93	78.60	-50.73
BRD-A89208012	CP	BRD-A89208012	prostanoid receptor antagonist, thromboxane receptor antagonist	TBXA2R		0.00, 0.00	1.56, 0.58	-51.74	71.62	-39.27	-27.79	-83.83	18.33	-42.50	-14.88	-24.59	-18.15
BRD-K66782112	CP	BRD-K66782112	histamine receptor antagonist	HRH2		0.00, 0.00	1.41, 0.41	-21.74	-83.76	35.50	-28.53	-52.34	-56.73	22.91	9.48	42.30	-26.86
BRD-A51929314	CP	BRD-A51929314	prostanoid receptor antagonist, thromboxane receptor antagonist			0.00, 0.00	1.25, 0.40	-48.70	-57.09	-37.14	26.58	-36.52	-32.27	52.29	20.63	40.12	-16.12
BRD-K73290745	CP	ICI-199441	opioid receptor agonist	OPRK1, CYP2D6, OPRD1, OPRM1, UTS2R		0.00, 0.00	1.42, 0.38	-87.84	-36.42	-25.36	-24.18	71.75	-86.76	-62.65	-99.58	-83.83	-81.07
BRD-A03359064	CP	ICI-89406	adrenergic receptor antagonist	ADRB1, ADRB2		20.00, 10.00	1.63, 0.44	96.82	92.79	-57.54	-36.81	99.58	-80.83	-27.07	-33.49	45.67	49.94
BRD-K14618467	CP	IKK-16	IKK inhibitor	IKBKB	IKK inhibitor	0.00, 0.00	1.49, 0.32	-99.94	-99.91	-55.64	-99.69	-95.90	-99.54	-69.67	-99.48	-95.40	-99.58
BRD-K74305673	CP	IKK-2-inhibitor-V	IKK inhibitor, NFkB pathway inhibitor, protein kinase inhibitor	IKBKB	IKK inhibitor, NFkB pathway inhibitor	0.00, 0.00	1.99, 0.72	-84.83	-99.93	-85.64	-98.58	-99.31	-99.66	-96.96	-84.88	-96.44	-96.58
BRD-K07117950	CP	imperatorin	acetylcholinesterase inhibitor, nitric oxide production inhibitor, Sodium Channel  Blockers	ACHE, HTR7		20.00, 10.00	0.82, 0.20	62.73	-27.97	67.12	38.91	99.96	-27.11	-31.39	97.34	-96.11	61.83
BRD-K01815685	CP	indole	aryl hydrocarbon receptor agonist, indoleamine 2,3-dioxygenase inhibitor	AHR, IDO1		0.00, 0.00	0.92, 0.18	-69.24	-40.23	-24.90	28.92	8.82	15.86	63.55	-91.05	-98.47	-32.91
BRD-A07029265	CP	ipratropium	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5		20.00, 10.00	1.26, 0.40	-72.99	59.39	59.59	34.76	89.99	37.77	97.90	96.96	30.85	81.42
BRD-K92678294	CP	irilin-a	isoflavone			0.00, 0.00	0.70, 0.23	74.82	72.53	91.49	-15.00	-65.18	92.64	-67.89	51.01	35.60	64.12
BRD-A54029483	CP	IRL-2500	endothelin receptor antagonist	EDNRB		10.00, 10.00	1.14, 0.35	81.70	-28.11	77.23	59.02	73.56	54.63	-30.17	-93.89	99.13	81.31
BRD-A26845397	CP	isamoltan	adrenergic receptor antagonist	ADRB1, ADRB2		10.00, 10.00	0.98, 0.34	99.43	83.06	-84.12	-86.83	27.79	50.98	84.19	-37.48	-55.85	47.60
BRD-K05737787	CP	isoeugenol	nitric oxide production inhibitor			0.00, 0.00	1.83, 0.56	9.66	-97.97	NaN	NaN	-51.19	-85.68	NaN	NaN	NaN	-69.54
BRD-K37080523	CP	isoreserpine	vesicular monoamine transporter inhibitor	SLC18A2, SLC18A1, SIAH1		0.00, 0.00	0.78, 0.17	-72.38	-97.16	-91.60	-47.39	-79.14	-99.03	75.78	-91.32	-43.84	-99.33
BRD-K06198550	CP	isorotenone	mitochondrial complex I inhibitor, NADH-ubiquinone oxidoreductase (Complex I) inhibitor	MT-ND1		20.00, 10.00	1.10, 0.23	-16.74	18.23	-36.21	-86.02	97.89	95.34	44.77	-96.25	-42.09	8.14
BRD-K60298136	CP	ITE	aryl hydrocarbon receptor agonist, aryl hydrocarbon receptor ligand	AHR		10.00, 10.00	1.24, 0.36	37.12	-89.39	-22.78	-18.28	-33.15	-5.52	-25.34	-99.59	99.77	-10.87
BRD-A48570745	CP	ivermectin	GABA receptor agonist, acetylcholine receptor allosteric modulator, GABA release stimulant, purinergic receptor allosteric modulator	CHRNA7, GABRB3, GLRA3, P2RX7		0.00, 0.00	1.89, 0.43	-97.41	-99.63	-95.28	-98.83	-92.00	-99.97	-80.27	-99.79	-97.26	-97.76
BRD-K16444452	CP	ibudilast	phosphodiesterase inhibitor, leukotriene receptor antagonist, toll-like receptor antagonist, macrophage migration inhibiting factor inhibitor, macrophage migration inhibiting factor modulator, mediator release inhibitor, nitric oxide synthase inhibitor	PDE4A, PDE4B, PDE4C, MIF, PDE10A, PDE3A, PDE4D, TLR4, CYSLTR1, IL1B, IL6, PDE11A, PDE5A		20.00, 20.00	0.76, 0.13	-49.29	99.54	-78.32	20.86	-92.93	98.91	68.49	-78.22	-67.72	-55.39
BRD-K25906698	CP	immepip	histamine receptor agonist	HRH3, HRH4		0.00, 0.00	1.00, 0.33	47.59	-24.87	-37.46	28.80	-14.96	94.23	-77.71	-50.51	-54.47	-26.87
BRD-K43860855	CP	iobenguane	radiopharmaceutical and antineoplastic agent			10.00, 10.00	1.20, 0.38	-71.91	-72.26	68.78	85.95	-87.80	-87.08	-59.08	-18.36	98.16	-78.60
BRD-K51918615	CP	iodophenpropit	histamine receptor antagonist, histamine receptor inhibitor, ionotropic glutamate receptor antagonist	HRH3, HRH4, GRIN2B		10.00, 10.00	1.10, 0.33	-49.92	-73.21	-30.54	-27.43	93.81	-75.64	99.88	-34.35	50.46	-21.06
BRD-K79124250	CP	ioxaglic-acid	iodine contrast agent			0.00, 0.00	1.26, 0.44	11.87	-50.60	-27.61	83.80	94.16	52.85	-34.48	94.28	-50.59	52.61
BRD-K74195153	CP	irsogladine	diuretic, phosphodiesterase inhibitor	PDE4A		0.00, 0.00	0.74, 0.16	-10.99	63.20	89.57	54.19	86.60	36.34	-16.71	38.33	60.74	67.61
BRD-K93332168	CP	isocarboxazid	monoamine oxidase inhibitor	MAOA, MAOB		0.00, 0.00	1.28, 0.35	-48.73	-82.83	-45.84	-68.58	59.61	58.44	28.79	63.25	30.71	10.19
BRD-K29173907	CP	isoflupredone	glucocorticoid receptor agonist	NR3C1	Glucocorticoid receptor agonist	0.00, 0.00	1.57, 0.72	-40.07	7.11	35.57	-20.95	-97.90	-96.84	17.95	77.41	33.50	-19.93
BRD-A41722204	CP	sulmazole	calcium sensitizer, phosphodiesterase inhibitor			0.00, 0.00	0.52, 0.11	-18.45	-26.90	42.57	30.10	65.96	-82.10	86.42	23.46	37.61	16.53
BRD-A74269027	CP	isoxsuprine	adrenergic receptor agonist	ADRB2		10.00, 0.00	0.93, 0.30	40.68	44.58	-71.01	85.79	26.07	56.69	60.56	-95.94	95.07	35.42
BRD-K64402243	CP	ivachtin	caspase inhibitor	CASP3		10.00, 10.00	1.60, 0.39	30.87	-59.77	-29.15	-13.28	68.58	39.76	-87.41	84.36	99.04	60.39
BRD-K26429091	CP	J-104129	acetylcholine receptor antagonist	CHRM3		0.00, 0.00	1.17, 0.33	55.64	-39.21	-29.27	-13.21	5.87	34.02	-73.62	-75.70	55.35	4.51
BRD-K72541103	CP	JAK3-inhibitor-I	JAK inhibitor	JAK3	JAK inhibitor	0.00, 0.00	0.73, 0.20	-90.25	48.18	-85.44	57.47	-21.70	-99.44	24.03	8.40	36.49	-33.22
BRD-K52850071	CP	JAK3-Inhibitor-II	JAK inhibitor, ALK tyrosine kinase receptor inhibitor, EGFR inhibitor	EGFR, ALK, JAK1, JAK2, JAK3	JAK inhibitor	0.00, 0.00	1.22, 0.42	-52.18	-57.06	-98.87	28.24	-15.29	-99.82	-76.39	-28.29	-79.86	-63.36
BRD-K95676198	CP	JAK3-inhibitor-V	JAK inhibitor	JAK3		0.00, 0.00	1.39, 0.28	-24.47	-41.83	36.58	-7.49	36.88	-7.38	33.80	41.53	-92.23	1.78
BRD-K04546108	CP	JAK3-inhibitor-VI	JAK inhibitor	JAK3	JAK inhibitor	0.00, 0.00	1.86, 0.65	-99.93	-98.89	-99.86	-99.93	-99.92	-99.75	-99.81	-99.93	-99.43	-99.68
BRD-K22010301	CP	JLK-6	gamma secretase inhibitor, antiamyloidogenic agent	PSEN1	Gamma secretase inhibitor	0.00, 0.00	1.88, 0.56	-60.53	67.82	-98.57	-42.14	92.27	-66.02	-99.51	-99.53	-96.94	-98.80
BRD-K15086322	CP	JNJ-10191584	histamine receptor antagonist, histamine receptor silent antagonist	HRH4		0.00, 0.00	0.93, 0.32	7.91	-35.03	55.66	-26.33	-45.79	80.91	46.05	72.59	-33.28	16.53
BRD-K64670467	CP	JNJ-16259685	glutamate receptor antagonist	GRM1		0.00, 0.00	1.05, 0.33	55.21	17.40	-52.43	-36.34	-27.45	-40.38	74.07	12.82	29.36	8.92
BRD-K43330982	CP	JTE-013	lysophospholipid receptor antagonist	S1PR2, P2RY10		0.00, 0.00	0.72, 0.19	-13.00	-90.27	-31.10	-99.62	37.26	-22.82	-51.00	-99.73	-91.04	-98.92
BRD-K63150726	CP	JTE-907	cannabinoid receptor inverse agonist	CNR2	Cannabinoid receptor agonist	0.00, 0.00	1.17, 0.34	-62.49	-5.80	-22.87	80.48	24.17	-42.87	-66.39	-55.62	-58.79	-18.91
BRD-K17796732	CP	JWH-015	cannabinoid receptor agonist	CNR2, GPR55	Cannabinoid receptor agonist	0.00, 0.00	1.25, 0.41	-98.99	55.12	-32.71	13.33	6.99	-20.59	63.52	-43.03	-25.70	-3.07
BRD-K05464208	CP	JX-401	p38 MAPK inhibitor	MAPK14		0.00, 0.00	1.08, 0.38	-65.91	33.03	-84.89	-37.25	-8.86	26.26	-27.37	-86.92	43.43	-33.27
BRD-A75455249	CP	kavain	calcium channel modulator, mTOR inhibitor, Sodium Channel  Blockers	MTOR		0.00, 0.00	0.56, 0.16	75.48	46.77	73.36	67.55	-20.39	10.61	43.76	-47.26	29.48	39.70
BRD-K17743697	CP	KB-R7943	sodium/calcium exchange inhibitor	SLC8A1, TRPC3, TRPC5, TRPC6	T-type calcium channel blocker	10.00, 10.00	1.43, 0.42	-28.20	-93.25	-30.35	-50.85	-40.06	39.88	97.58	-91.06	31.36	-26.56
BRD-A54927599	CP	KF-38789	P selectin inhibitor	SELP		10.00, 10.00	2.00, 0.59	-80.30	99.96	-44.42	39.83	-87.34	-95.56	-38.41	-95.12	34.58	-82.08
BRD-A81177136	CP	KN-62	calcium/calmodulin dependent protein kinase inhibitor, purinergic receptor antagonist, calmodulin antagonist	AKT1, CAMK2A, CHEK1, LCK, MAPK1, MAPK11, MAPK12, MAPK14, MAPK8, P2RX7, PRKCA, ROCK1, RPS6KB1, SGK1		0.00, 0.00	0.81, 0.14	-99.90	-27.85	36.42	-98.59	-90.98	-46.14	22.54	-99.67	52.04	-96.41
BRD-K93480852	CP	KN-93	calcium/calmodulin dependent protein kinase inhibitor	CAMK2A		0.00, 0.00	0.61, 0.08	-87.00	-28.11	-30.33	-49.43	-95.36	-93.85	-62.38	-99.19	-81.55	-87.88
BRD-A38747044	CP	KU-14R	pancreatic β-cell I3 binding site antagonist			10.00, 10.00	0.89, 0.27	33.36	16.21	-62.76	-81.99	87.54	51.60	40.94	12.41	99.80	17.90
BRD-A31227688	CP	kynuramine	aryl hydrocarbon receptor activator			10.00, 10.00	0.94, 0.28	99.95	-14.16	28.27	12.77	-24.68	25.24	-85.46	-68.73	-45.77	-4.75
BRD-K37312348	CP	kenpaullone	CDK inhibitor, glycogen synthase kinase inhibitor, src inhibitor	GSK3B, CDK1, CDK5, CCNB1, CDK2, LCK	CDK inhibitor, Glycogen synthase kinase inhibitor	0.00, 0.00	0.88, 0.39	-60.24	-61.00	-97.61	-74.30	-63.92	-86.08	-77.83	-99.53	-65.04	-94.19
BRD-K49671696	CP	ketanserin	serotonin receptor antagonist, collagen stimulant	HTR2A, HTR2C, ADRA1A, ADRA1B, ADRA1D, DRD1, DRD5, HTR1A, HTR1B, HTR1D, HTR2B, HTR5A, HTR7, SLC18A1, SLC18A2		0.00, 0.00	0.76, 0.25	-46.99	-56.80	-86.69	87.99	-17.43	11.83	40.10	20.81	85.24	13.08
BRD-A43930669	CP	L-368899	oxytocin receptor antagonist	OXTR, AVPR1A, AVPR2, OXT		0.00, 0.00	1.28, 0.47	32.51	-23.03	66.09	-26.71	43.57	14.86	94.82	-40.29	52.11	15.60
BRD-K89402695	CP	L-655240	platelet aggregation inhibitor, prostanoid receptor antagonist, thromboxane receptor antagonist	PTGES	Thromboxane receptor antagonist	0.00, 0.00	0.91, 0.27	-12.62	-50.66	-87.33	69.79	-14.01	-40.65	-16.07	15.83	-49.28	-17.00
BRD-K14765469	CP	vesamicol	acetylcholine transport inhibitor	SLC18A3		10.00, 0.00	0.59, 0.17	96.83	40.09	-9.94	44.92	-33.62	50.06	-19.73	41.93	-27.87	18.05
BRD-A42553870	CP	L-152804	neuropeptide receptor antagonist	NPY5R		10.00, 10.00	0.95, 0.26	56.72	32.65	56.32	-73.80	-63.08	99.97	88.97	-17.21	-23.85	30.22
BRD-K40656405	CP	L-165041	PPAR receptor agonist	PPARD	PPAR receptor agonist	0.00, 0.00	0.86, 0.30	-41.80	-63.91	-79.28	40.34	43.54	-22.54	-98.43	77.22	92.05	-56.10
BRD-A28422058	CP	L-689560	glutamate receptor antagonist	GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D		0.00, 0.00	0.76, 0.18	-17.13	80.59	-61.40	70.80	76.64	38.35	54.89	21.15	-78.72	48.16
BRD-K74284736	CP	L-689560	glutamate receptor antagonist	GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D		0.00, 0.00	1.13, 0.25	58.66	43.76	-28.27	66.46	14.60	-47.06	76.26	60.48	85.09	71.30
BRD-K70241288	CP	L-692585	growth hormone releasing peptide ligand agonist, growth hormone secretagogue	GH1, GHSR		10.00, 10.00	1.06, 0.24	14.66	-91.40	-34.88	15.72	85.94	46.36	-47.31	90.75	97.62	33.17
BRD-K83322645	CP	L-693403	sigma receptor antagonist, sigma receptor ligand	DRD2, SIGMAR1		10.00, 0.00	1.06, 0.28	-10.48	68.13	35.74	-25.65	96.90	59.59	-13.64	17.59	40.71	18.30
BRD-K18816859	CP	L-694247	serotonin receptor agonist	HTR1D, HTR1A, HTR1B		0.00, 0.00	0.72, 0.08	-20.50	-14.34	7.21	-12.56	52.80	40.54	44.38	-12.66	23.40	4.16
BRD-K10176267	CP	L-701252	glutamate receptor antagonist	GRIN1		0.00, 0.00	1.18, 0.38	39.45	-48.03	68.83	90.99	36.64	53.74	-47.07	75.72	35.19	54.97
BRD-A96882008	CP	L-732138	tachykinin antagonist	TACR1, TACR2		0.00, 0.00	1.41, 0.35	68.71	-55.27	-31.19	-32.18	-9.42	92.97	36.24	94.22	-47.42	19.96
BRD-K15791587	CP	L-733060	tachykinin antagonist	TACR1	Tachykinin antagonist	10.00, 10.00	1.56, 0.66	-71.00	57.61	-26.28	-26.32	98.53	51.73	48.17	-91.72	25.92	16.71
BRD-K05181463	CP	L-741626	dopamine receptor, dopamine receptor antagonist	DRD2, DRD3, DRD4, HTR2A, HTR2B	Dopamine receptor antagonist	0.00, 0.00	1.27, 0.42	-97.28	-99.56	66.91	-17.85	-88.69	-97.65	-26.21	-66.23	-73.83	-93.91
BRD-K05528470	CP	L-745870	dopamine receptor antagonist	DRD4, DRD1, DRD2, DRD3, HTR1A, HTR2A, HTR6, HTR7		0.00, 0.00	0.74, 0.18	-6.65	71.56	-26.23	16.44	-88.42	86.49	-34.48	-13.41	-24.83	-2.75
BRD-K28806945	CP	L-750667	dopamine receptor antagonist	DRD4		0.00, 0.00	0.98, 0.35	-40.79	-27.11	-62.62	-81.91	-98.78	-44.19	92.27	-37.08	-23.77	-36.51
BRD-A35511923	CP	L-803087	somatostatin receptor agonist	SSTR4		0.00, 0.00	1.28, 0.50	-3.92	-45.02	31.58	-8.84	-43.61	12.88	-37.32	-56.80	45.79	-7.43
BRD-K81029756	CP	diltiazem	L-type calcium channel blocker, calcium channel antagonist, calcium channel blocker	CACNA1C, CACNA1S, CACNA2D1, CACNG1, CYP3A5, CYP3A7, HTR3A, KCNA5		0.00, 0.00	0.90, 0.26	65.03	-44.11	-16.35	54.42	-64.08	-51.95	72.55	-35.21	70.05	28.82
BRD-K23583188	CP	lavendustin-a	EGFR inhibitor, tyrosine kinase inhibitor	EGFR, LCK		10.00, 10.00	1.42, 0.33	18.43	-83.73	61.65	67.06	99.81	-21.37	12.62	-69.86	43.16	17.43
BRD-K66707493	CP	lawsone	coloring agent			0.00, 0.00	0.91, 0.26	30.69	-99.20	-87.63	-23.17	-97.59	-75.94	-31.16	-83.17	36.06	-88.64
BRD-K01648091	CP	LE-300	dopamine receptor antagonist, dopamine receptor ligand, serotonin receptor ligand	DRD5, DRD1, HTR2A		40.00, 40.00	0.65, 0.20	98.78	53.61	90.89	99.29	32.61	-22.48	-33.72	-68.29	98.98	97.50
BRD-A44551378	CP	LFM-A12	EGFR inhibitor, epidermal growth factor receptor (EGFR) inhibitor	EGFR		0.00, 0.00	1.40, 0.35	-84.55	-33.69	NaN	NaN	49.87	-79.05	NaN	NaN	NaN	-71.00
BRD-A30655177	CP	LFM-A13	Bruton's tyrosine kinase (BTK) inhibitor	BTK		10.00, 10.00	0.69, 0.13	71.73	99.12	91.23	21.08	-10.62	-20.75	51.80	55.17	24.63	58.46
BRD-K52662033	CP	lidocaine	histamine receptor agonist, voltage-gated sodium channel modulator	SCN5A, EGFR, SCN10A, SCN9A		0.00, 0.00	0.90, 0.19	64.94	-38.25	-73.12	57.81	39.28	69.33	93.78	47.37	60.15	49.99
BRD-K64044582	CP	linoleamide	ACAT inhibitor	SOAT1, SOAT2		10.00, 10.00	1.16, 0.32	38.50	-34.75	98.29	26.60	79.19	83.24	-40.71	68.99	27.09	65.44
BRD-K33396764	CP	alpha-linolenic-acid	omega-3 fatty acid	ELOVL4, FADS1, FADS2, FFAR1, FFAR4, PTGS2, SLC8A1, TRPV1		0.00, 0.00	1.28, 0.33	47.33	-59.46	44.83	3.91	46.55	-53.01	-78.95	57.93	93.69	31.63
BRD-K96670504	CP	lonidamine	glucokinase inhibitor, protein synthesis inhibitor	GCK		0.00, 0.00	0.76, 0.18	82.53	81.09	27.71	22.05	68.46	92.29	32.72	58.75	-29.97	59.38
BRD-K09416995	CP	lovastatin	HMGCR inhibitor	HMGCR, CYP3A5, HDAC2, ITGAL, NR1I2	HMGCR inhibitor	0.00, 0.00	0.77, 0.16	-92.87	-84.16	-92.16	-75.00	48.97	-91.28	-24.02	-91.38	45.36	-93.23
BRD-K33864865	CP	LY-225910	CCK receptor antagonist	CCKBR	CCK receptor antagonist	0.00, 0.00	0.90, 0.19	-93.44	39.77	47.42	-30.40	6.45	-50.46	-92.28	-91.62	-43.75	-73.88
BRD-K24675965	CP	LY-288513	CCK receptor antagonist	CCKBR		0.00, 0.00	0.94, 0.19	23.34	-8.40	-43.97	-18.83	-18.32	-97.88	49.34	-14.73	58.25	-3.42
BRD-K22385716	CP	LY-303511	casein kinase inhibitor, mTOR inhibitor, PI3K inhibitor	CSNK2A1, CSNK2A2, CSNK2B, MTOR	Bromodomain Inhibitor	10.00, 0.00	0.97, 0.42	-22.71	41.83	97.32	22.92	53.73	-99.97	68.27	-98.76	-70.47	-46.95
BRD-K78637815	CP	LY-320135	cannabinoid receptor antagonist	CNR1		0.00, 0.00	1.63, 0.51	27.95	42.11	72.31	49.81	92.85	53.41	-32.37	18.23	94.61	47.49
BRD-K69763916	CP	LY-341495	glutamate receptor antagonist	GRM2, GRM3		0.00, 0.00	1.00, 0.32	49.36	64.36	-61.76	47.02	-20.70	44.45	43.09	-77.95	36.96	16.71
BRD-K06234293	CP	LY-364947	TGF beta receptor inhibitor, p38 MAPK inhibitor	TGFBR1	P38 MAPK inhibitor, TGF beta receptor inhibitor	10.00, 0.00	1.06, 0.28	84.17	87.17	74.45	-17.83	66.82	95.93	-55.40	84.39	-32.26	81.23
BRD-K13261168	CP	LY-16350	dopamine receptor agonist, dopamine receptor antagonist	DRD2, DRD3		0.00, 0.00	1.34, 0.36	42.74	-62.08	41.63	74.25	17.00	-8.47	-68.14	75.14	27.23	18.14
BRD-K14282469	CP	LY-165163	serotonin receptor antagonist	HTR1A, HTR1D	Serotonin receptor antagonist	0.00, 0.00	0.91, 0.23	72.28	71.69	-44.75	-65.58	-93.55	-84.24	40.98	18.24	-96.37	-50.76
BRD-A12016240	CP	LY-278584	serotonin receptor antagonist	HTR3A		0.00, 0.00	0.68, 0.18	88.74	-60.44	34.59	-40.66	30.09	62.46	72.46	48.62	-65.82	31.08
BRD-K92492521	CP	LY-255283	leukotriene receptor antagonist	LTB4R, LTB4R2		10.00, 0.00	1.02, 0.32	-54.69	97.28	88.60	65.74	58.71	60.40	-30.78	37.82	33.75	41.39
BRD-K47328134	CP	lysylphenylalanyl-tyrosine	heparin activation inhibitor			0.00, 0.00	1.41, 0.44	-22.82	5.10	NaN	NaN	56.35	71.75	NaN	NaN	NaN	59.21
BRD-K93460210	CP	lamotrigine	glutamate release inhibitor, serotonin receptor inhibitor, Sodium Channel  Blockers, sodium channel blocker, voltage-gated sodium channel blocker	SCN1A, SCN2A, SCN3A		0.00, 0.00	0.76, 0.11	19.93	-22.85	86.26	66.30	63.67	-72.25	27.27	22.20	-96.65	25.42
BRD-K10207760	CP	lasalocid	ionophore antibiotic			0.00, 0.00	1.80, 0.35	-88.87	-99.96	-86.47	-92.12	-99.54	-99.38	-76.98	-98.30	31.49	-98.80
BRD-K78692225	CP	leflunomide	dihydroorotate dehydrogenase inhibitor, PDGFR tyrosine kinase receptor inhibitor, disease modifying antirheumatic drug, immunosuppressant, JAK inhibitor, STAT inhibitor	DHODH, AHR, CYP2C19, JAK3, PTK2B, STAT6		20.00, 20.00	0.52, 0.18	97.68	-59.13	51.73	-91.89	-40.40	-89.95	-26.45	-54.82	99.69	-65.37
BRD-K24526313	CP	levcromakalim	potassium channel activator, potassium channel agonist	KCNJ8, ABCC9, KCNJ5	Potassium channel activator	0.00, 0.00	0.81, 0.26	-17.86	31.98	-50.00	-94.09	-37.99	-74.13	49.02	-37.89	36.40	-16.08
BRD-K62996583	CP	lidoflazine	calcium channel antagonist	SCN1A, SCN3A, SLC29A1		0.00, 0.00	0.60, 0.09	86.76	-60.58	20.48	-46.71	-72.18	13.28	-8.79	-86.23	-34.52	-9.57
BRD-K03384561	CP	roquinimex	T cell inhibitor, T cell stimulant, tumor necrosis factor receptor antagonist			10.00, 10.00	0.91, 0.33	66.67	-54.40	-19.35	-32.95	31.85	99.97	-43.09	-17.15	-60.47	-12.97
BRD-A59215453	CP	lobelanidine	acetylcholine receptor antagonist, dopamine receptor modulator, opioid receptor antagonist, vesicular monoamine transporter ligand	SLC18A2, CHRNA10, CHRNA4, CHRNA9, CHRNB2, OPRM1		10.00, 10.00	1.27, 0.51	-64.77	-81.72	42.89	93.94	-56.83	-62.34	50.28	97.93	-27.69	41.00
BRD-K28137194	CP	loreclezole	GABA receptor agonist	GABRB2, GABRB3		0.00, 0.00	0.78, 0.26	53.01	-20.93	-47.65	-5.55	19.37	-58.17	-26.55	20.74	32.05	-8.98
BRD-K99411983	CP	lumicolchicine	colchicine isomer, non-binder of microtubules			0.00, 0.00	0.51, 0.16	-22.44	31.74	-40.97	70.43	-14.85	93.42	85.96	86.69	84.86	80.64
BRD-K67013324	CP	luzindole	melatonin receptor antagonist	MTNR1B, MTNR1A		10.00, 0.00	1.06, 0.34	96.71	42.29	-59.62	26.16	-87.10	-88.98	-30.19	73.19	36.24	31.33
BRD-K62289640	CP	lylamine	cannabinoid receptor agonist	CNR1		0.00, 0.00	1.65, 0.63	-87.19	-98.36	-85.79	-21.45	-89.66	-96.96	-41.79	-93.32	-95.14	-92.89
BRD-K27871032	CP	lysergol	ergoline alkaloid	HTR1B, HTR1D, HTR1E		0.00, 0.00	1.22, 0.39	8.00	-39.23	-44.20	-55.17	58.73	-48.26	41.40	74.70	-71.26	-16.60
BRD-K92138166	CP	mammea-a	cytotoxic, antibacterial			10.00, 10.00	0.55, 0.08	-84.95	99.87	-90.71	-70.34	-29.33	-99.76	20.22	-18.32	-84.37	-84.22
BRD-K76274772	CP	MAPP-D-erythro	ceramidase inhibitor			0.00, 0.00	1.14, 0.49	35.46	-54.21	-40.77	-58.05	63.74	7.31	-91.03	13.84	62.44	-19.92
BRD-K09635134	CP	l-erythro-MAPP	ceramidase inhibitor, negative control for D-erythro-MAPP			20.00, 10.00	0.80, 0.34	96.80	-6.86	44.28	99.10	87.76	-17.25	35.47	24.03	-47.84	64.19
BRD-K25433859	CP	maprotiline	norepinephrine reputake inhibitor, tricyclic antidepressant (TCA)	SLC6A2, ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD2, HRH1, HTR2A, HTR2C, HTR7		0.00, 0.00	1.39, 0.55	-10.99	-97.31	-8.40	-77.85	-60.84	-97.23	-13.60	-98.16	30.07	-91.75
BRD-A85587465	CP	bemesetron	serotonin receptor antagonist	HTR3A, HTR3B	Serotonin receptor antagonist	10.00, 10.00	0.69, 0.13	-90.98	-82.63	48.46	-49.18	20.94	-64.66	-98.64	-45.41	99.26	-68.27
BRD-A17453586	CP	MDL-72832	serotonin receptor agonist	HTR1A		0.00, 0.00	0.91, 0.24	-15.99	-12.90	-35.06	20.02	-63.93	-23.36	-71.72	-64.56	36.62	-22.32
BRD-K43245338	CP	MDL-28170	calpain inhibitor, cathepsin inhibitor	CAPN1, CTSB, CTSL		0.00, 0.00	1.06, 0.32	51.30	-87.08	-62.36	64.24	-67.95	-54.77	-54.30	-55.63	-50.00	-54.21
BRD-K84987553	CP	MDM2-inhibitor	MDM inhibitor	MDM2	MDM inhibitor	0.00, 0.00	1.22, 0.52	-88.94	-6.73	-66.67	-33.00	64.62	-74.49	48.23	-49.17	81.28	-39.19
BRD-K96144918	CP	mead-acid	KPL-1 tumor suppressor			10.00, 10.00	1.18, 0.35	72.38	80.32	-34.67	12.57	99.17	-25.02	41.92	-68.27	-26.90	57.69
BRD-K09764130	CP	mead-ethanolamide	cannabinoid receptor agonist			10.00, 10.00	0.76, 0.18	90.64	99.96	36.96	-25.24	-94.75	-67.96	28.71	-11.33	34.88	7.40
BRD-A20126139	CP	medrysone	corticosteroid hormone receptor agonist, glucocorticoid receptor agonist	NR3C1	Glucocorticoid receptor agonist	10.00, 10.00	1.15, 0.48	64.88	-98.82	42.89	-58.26	-87.74	-97.54	90.45	99.55	45.45	-71.24
BRD-A35989968	CP	megestrol	progesterone receptor agonist, DNA inhibitor, HegG2 inhibitor	PGR	Progesterone receptor agonist	0.00, 0.00	1.46, 0.42	52.07	-99.87	NaN	NaN	27.36	-94.58	NaN	NaN	NaN	-96.21
BRD-K12244279	CP	MEK1-2-inhibitor	MEK inhibitor	MAP2K1, MAP2K2	MEK inhibitor	20.00, 20.00	1.14, 0.49	21.28	18.43	63.87	32.95	-26.93	-23.81	98.40	-19.69	97.60	22.61
BRD-A14395271	CP	mesoridazine	dopamine receptor antagonist	DRD2, HTR2A		0.00, 0.00	0.33, 0.07	25.18	-46.32	46.21	-89.90	-26.19	74.30	83.89	39.23	64.06	20.81
BRD-A14798026	CP	mestranol	estrogen receptor agonist	ESR1	Estrogen receptor agonist	0.00, 0.00	0.83, 0.28	88.53	52.21	-37.29	-38.69	-17.55	-29.69	58.73	-51.07	-31.40	-8.87
BRD-A94709349	CP	metaxalone	muscle relaxant			0.00, 0.00	0.88, 0.30	-75.08	6.37	-97.95	7.92	-35.50	75.05	27.50	21.75	-93.61	-25.63
BRD-A41145729	CP	methoprene-acid	RXR agonist	NCOA2, NR1H3, RXRA, RXRB		0.00, 0.00	1.06, 0.35	61.12	89.23	-88.62	70.65	-99.29	37.54	-88.50	76.80	21.24	43.85
BRD-K14844937	CP	BRD-K14844937	GABA benzodiazepine site receptor inverse agonist	GABRA1, GABRA2, GABRA3, GABRA5		0.00, 0.00	0.85, 0.24	-26.45	25.66	37.90	51.17	32.72	63.42	-42.16	-87.74	-29.01	-8.94
BRD-K28680267	CP	BRD-K28680267	CCK receptor antagonist	CCKAR, GABRA1, GABRB2, GABRG2		0.00, 0.00	0.89, 0.26	-14.51	9.57	51.71	46.37	27.86	-72.14	-61.27	-99.04	-58.66	-40.29
BRD-K33193182	CP	methylnorlichexanthone	Aurora kinase inhibitor, Pim kinase inhibitor, VEGFR inhibitor	AURKB, KDR, PIM1		20.00, 0.00	0.85, 0.25	20.66	80.70	NaN	NaN	96.88	63.43	NaN	NaN	NaN	86.49
BRD-K75641298	CP	metoclopramide	dopamine receptor antagonist, serotonin receptor antagonist, serotonin receptor agonist	DRD2, HTR3A, HTR4, CHRM1, HTR3B		0.00, 0.00	0.95, 0.27	93.47	-98.71	-31.61	23.16	49.63	-6.05	83.17	-77.78	51.82	34.64
BRD-A03623303	CP	metoprolol	adrenergic receptor antagonist	ADRB1, ADRB2		10.00, 10.00	0.89, 0.38	8.32	-28.10	98.78	53.99	11.91	60.16	94.93	13.63	-29.28	29.77
BRD-K60230970	CP	MG-132	proteasome inhibitor	PSMB1	Proteasome inhibitor	0.00, 0.00	2.30, 0.69	-99.39	-97.81	-87.22	-99.31	-99.71	-99.32	-54.88	-99.48	-99.82	-98.70
BRD-K06902185	CP	minoxidil	antialopecia agent, ATP channel activator, ATP-sensitive potassium channel agonist, KATP activator, Kir6 channel (KATP) activator, polarization activator, renin secretion stimulant	KCNJ8, ABCC9, KCNJ1, KCNJ10, KCNJ11, PTGS1, REN		20.00, 20.00	0.95, 0.23	98.94	-11.87	-88.79	66.20	97.69	-19.16	69.59	74.67	47.52	80.64
BRD-K95202259	CP	ML-3163	p38 MAPK inhibitor	CYP2D6, CYP3A4, MAPK11, MAPK12, MAPK14	P38 MAPK inhibitor	0.00, 0.00	0.93, 0.22	8.57	73.66	69.53	-32.79	-71.47	-68.44	79.63	8.84	52.42	17.31
BRD-K93201660	CP	ML-7	myosin light chain kinase inhibitor	MYLK		0.00, 0.00	0.94, 0.22	-44.96	-64.72	-26.81	-54.14	-34.04	-17.68	47.07	83.72	52.78	-31.15
BRD-K53878242	CP	MMPX	phosphodiesterase inhibitor			10.00, 0.00	0.97, 0.36	74.78	-34.25	-39.37	55.83	27.83	-40.84	28.23	10.94	95.56	29.12
BRD-K63151507	CP	MNITMT	lymphocyte inhibitor			20.00, 20.00	1.07, 0.26	98.60	35.00	89.60	-53.40	-38.57	98.51	-44.79	-15.10	-94.03	45.48
BRD-A16332958	CP	modafinil	adrenergic receptor agonist, dopamine receptor reuptake inhibitor	ADRA1B, CYP1A2, CYP2B6, CYP2C19, CYP3A4, CYP3A5, SLC6A3		0.00, 0.00	0.72, 0.18	-17.25	-46.55	42.92	-49.65	-46.55	-15.05	-55.34	43.20	50.32	-22.87
BRD-K87696786	CP	LY-456236	glutamate receptor antagonist	GRM1		0.00, 0.00	0.98, 0.27	54.86	74.39	35.61	-22.91	-19.34	49.78	66.94	13.24	-42.94	17.77
BRD-A30590053	CP	MR-16728	acetylcholine release enhancer			10.00, 0.00	0.59, 0.23	95.40	44.46	-24.31	-24.75	81.99	49.34	91.65	44.55	-50.97	43.17
BRD-K37618799	CP	MRS-1220	adenosine receptor antagonist	ADORA2B, ADORA3		0.00, 0.00	0.77, 0.31	16.41	57.43	-33.17	-29.71	78.25	-97.39	-54.33	-89.56	-50.16	-28.22
BRD-K72024482	CP	MRS-1754	adenosine receptor antagonist	ADORA2B, ADORA1, ADORA2A, ADORA3		10.00, 10.00	0.80, 0.20	43.62	-45.98	-77.95	-53.77	99.60	78.48	82.11	90.06	39.64	72.88
BRD-A32949107	CP	MRS-1845	calcium channel blocker	ORAI1		0.00, 0.00	1.08, 0.34	92.99	27.61	-50.75	14.56	-96.92	-41.11	23.49	-81.57	30.01	-12.07
BRD-A99449986	CP	MT-21	adenine nucleotide translocase inhibitor, caspase activator, neurotrophic agent	CYCS, SLC25A4		0.00, 0.00	0.67, 0.20	-99.93	-96.29	48.90	-94.76	-15.96	-98.75	-93.93	-64.85	-60.93	-99.68
BRD-K90524085	CP	MY-5445	phosphodiesterase inhibitor, platelet aggregation inhibitor	PDE5A		0.00, 0.00	0.70, 0.18	-91.20	83.47	-82.97	16.94	-55.14	-15.46	-55.05	-96.93	-99.97	-85.50
BRD-K92428153	CP	mycophenolate-mofetil	dehydrogenase inhibitor, hydroxycarboxylic acid receptor agonist, immunosuppressant, IMPDH inhibitor, inosine monophosphate dehydrogenase inhibitor	IMPDH1, IMPDH2, HCAR2	IMPDH inhibitor	0.00, 0.00	1.16, 0.33	-99.75	-87.41	-99.08	-74.31	-88.97	-92.03	-99.85	-99.68	-93.86	-99.54
BRD-K38477985	CP	malonoben	protein tyrosine kinase inhibitor, tyrosine kinase inhibitor	EGFR		0.00, 0.00	1.84, 0.60	-99.25	-99.54	-96.14	-98.51	-98.02	-98.35	-89.94	-97.97	-99.18	-97.60
BRD-A45140972	CP	meclocycline	tetracycline antibiotic		Bacterial 30S ribosomal subunit inhibitor	10.00, 10.00	0.55, 0.11	-34.21	99.96	87.43	-21.39	68.54	31.24	52.36	48.95	-53.16	38.18
BRD-K92984783	CP	melperone	dopamine receptor antagonist, serotonin receptor antagonist	DRD2, HTR1A, HTR2A		40.00, 30.00	0.91, 0.20	100.00	96.29	35.54	99.02	63.85	87.68	-53.38	-86.43	-30.15	97.64
BRD-A02710418	CP	meptazinol	opioid receptor agonist	BCHE		0.00, 0.00	1.05, 0.41	71.53	57.79	-30.21	-36.09	9.12	-41.99	32.82	-85.65	37.60	5.50
BRD-K56699285	CP	metergoline	dopamine receptor agonist, serotonin receptor antagonist, prolactin inhibitor	DRD2, HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR5A, HTR6, HTR7		0.00, 0.00	1.22, 0.31	34.05	-47.99	-20.33	29.82	-91.81	33.90	22.09	28.45	-28.44	3.42
BRD-K09859624	CP	methantheline	acetylcholine receptor antagonist	CHRM1, HRH2		10.00, 10.00	1.14, 0.23	99.26	35.86	80.98	80.29	25.30	74.43	46.43	28.10	54.24	70.97
BRD-A63667919	CP	methylergometrine	dopamine receptor antagonist, partial serotonin receptor agonist	DRD1, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C		0.00, 0.00	0.78, 0.28	83.51	-24.63	39.76	-12.07	-99.98	44.99	66.53	11.29	-30.97	19.94
BRD-A32164164	CP	methyllycaconitine	acetylcholine receptor antagonist	CHRNA7		10.00, 10.00	1.06, 0.31	88.50	16.24	-54.10	98.16	-35.00	-70.49	65.02	44.63	-81.95	33.75
BRD-A98725278	CP	methysergide	serotonin receptor antagonist	HTR2C, HTR1B, HTR1E, HTR1F, HTR2A, HTR2B, HTR7, HTR1A, HTR1D, HTR5A, HTR6		0.00, 0.00	1.01, 0.30	66.46	56.06	-64.31	13.35	38.43	-37.10	-33.85	-56.09	93.67	16.81
BRD-K94441233	CP	mevastatin	HMGCR inhibitor	HMGCR	HMGCR inhibitor	0.00, 0.00	1.23, 0.18	-98.24	25.60	-71.03	-52.63	51.18	-97.53	-99.39	-99.57	26.69	-99.22
BRD-A19661776	CP	mianserin	serotonin receptor antagonist, tetracyclic antidepressant	HTR2A, HTR2C, ADRA1A, ADRA1B, ADRA1D, HRH1, HTR2B, HTR6, HTR7, ADRA2A, ADRA2B, ADRA2C, DRD1, DRD2, DRD3, DRD5, HRH2, HRH4, HTR1A, HTR1F, OPRK1, SLC6A2, SLC6A3, SLC6A4		0.00, 0.00	1.14, 0.30	44.98	-6.26	-45.89	42.19	-10.43	15.12	-94.79	-49.07	79.83	-15.83
BRD-K09549677	CP	mibefradil	T-type calcium channel blocker, angiogenesis inhibitor, calcium channel blocker, calcium channel inhibitor, L-type calcium channel blocker, sodium channel blocker	CACNA1G, CACNA1H, CACNA1C, CACNA1I, ANO1, CACNA1D, CACNA1F, CACNA1S, CACNB1, CACNB2, CACNB3, CACNB4, CATSPER1, CATSPER2, CATSPER3, CATSPER4, CYP3A5, CYP3A7, SCN2A, SCN4A, SCN5A, SCN9A	T-type calcium channel blocker	0.00, 0.00	1.64, 0.48	-77.03	-37.27	-93.19	-99.55	-85.53	-99.50	-29.06	-99.54	-56.76	-94.33
BRD-A44780397	CP	mifepristone	glucocorticoid receptor antagonist, progesterone receptor antagonist, androgen receptor ligand, internal ribosomal entry site inhibitor	PGR, NR3C1, AR, CYP2B6, CYP2C8, CYP3A5, CYP3A7, NR1I2	Progesterone receptor antagonist	0.00, 0.00	0.90, 0.16	-80.58	-96.75	-98.71	-14.62	-90.77	-99.82	-56.28	-96.76	-75.84	-99.44
BRD-K37270826	CP	mifepristone	glucocorticoid receptor antagonist, progesterone receptor antagonist, androgen receptor ligand, internal ribosomal entry site inhibitor	PGR, NR3C1, AR, CYP2B6, CYP2C8, CYP3A5, CYP3A7, NR1I2		0.00, 0.00	0.69, 0.16	-96.92	-99.91	-41.02	-67.77	-35.76	-90.89	-99.96	-65.35	-60.39	-97.20
BRD-K34441861	CP	moexipril	angiotensin converting enzyme inhibitor, phosphodiesterase inhibitor	ACE, ACE2		20.00, 20.00	1.23, 0.51	-17.67	46.11	-43.53	30.09	99.92	98.28	85.75	-59.32	25.37	62.86
BRD-K60640630	CP	mometasone	glucocorticoid receptor agonist, immunosuppressant	NR3C1	Glucocorticoid receptor agonist	0.00, 0.00	1.19, 0.64	47.29	-34.32	-51.99	-95.53	-36.89	-98.89	74.33	-73.89	63.31	-48.45
BRD-A78377521	CP	monastrol	kinesin-like spindle protein inhibitor	KIF11		10.00, 10.00	0.77, 0.18	44.64	53.69	27.67	75.86	-42.08	-22.15	98.98	10.53	-34.09	28.54
BRD-K77771411	CP	moxonidine	imidazoline receptor agonist, adrenergic receptor agonist	NISCH, ADRA2A, ADRA2B, ADRA2C		10.00, 10.00	0.56, 0.11	98.81	-23.77	-13.95	76.37	-56.97	23.18	-56.49	-54.20	29.05	-13.42
BRD-K40990712	CP	hexamethyleneamiloride	gonadotropin releasing factor hormone receptor antagonist, sodium/hydrogen antiport inhibitor, sodium/hydrogen exchanger inhibitor, urokinase inhibitor	GNRHR, ADRA2A, GNRH1, PLAU, SLC9A1		10.00, 10.00	0.89, 0.19	-58.05	-99.93	-35.23	-48.57	-99.88	-93.01	98.00	38.24	-36.23	-88.52
BRD-K44899736	CP	RO-16-6941	monoamine oxidase inhibitor			0.00, 0.00	1.00, 0.28	-21.16	-7.73	-39.35	-32.27	30.22	44.30	-39.23	38.27	-52.83	-8.75
BRD-K06024458	CP	n-arachidonyl-GABA	arachidonyl amino acid that inhibits pain			10.00, 10.00	1.06, 0.38	-9.14	99.96	23.99	35.90	73.14	90.50	93.51	26.12	79.41	88.18
BRD-K10042277	CP	desmethylclozapine	acetylcholine receptor agonist, dopamine receptor agonist, dopamine receptor antagonist, dopamine receptor partial agonist, serotonin receptor antagonist, serotonin receptor inverse agonist	CHRM1, DRD2, DRD3, HTR2A		0.00, 0.00	0.95, 0.25	64.83	-94.11	-25.66	-7.52	-79.79	-95.70	-68.43	-95.82	-28.18	-90.04
BRD-K60060639	CP	methyllidocaine	antiarrhythmic, phosphatidyl-inositol activator			0.00, 0.00	0.88, 0.19	16.25	-15.11	42.04	-36.68	29.26	-4.50	-53.34	39.24	72.21	12.76
BRD-K17693482	CP	BRD-K17693482	potassium channel activator			0.00, 0.00	0.69, 0.17	25.29	-53.18	50.48	32.42	86.30	14.10	-44.00	-96.87	-33.24	-9.38
BRD-K71726959	CP	BRD-K71726959	CDK inhibitor	CDK1, CDK5		0.00, 0.00	0.63, 0.30	-99.84	-34.26	-55.27	66.77	-98.63	-99.94	-96.44	-98.27	69.60	-99.19
BRD-A92651262	CP	nalbuphine	opioid receptor agonist, opioid receptor antagonist	OPRD1, OPRK1, OPRM1		0.00, 0.00	1.08, 0.34	-5.02	-35.61	86.48	-8.86	28.33	-3.14	-26.06	83.09	69.32	13.67
BRD-A70461345	CP	naloxone	opioid receptor antagonist	OPRM1, OPRK1, OPRD1, CREB1, ESR1, TLR4		10.00, 10.00	0.89, 0.30	51.07	32.23	-54.07	70.12	-45.72	-36.15	-58.01	99.75	55.80	46.98
BRD-K69195780	CP	NAN-190	serotonin receptor agonist	HTR1A, ADRA1A, ADRA1B, ADRA1D, HTR1F		0.00, 0.00	1.16, 0.38	42.81	37.24	72.16	77.57	79.11	-12.35	-78.39	-56.06	-86.50	27.37
BRD-A23683907	CP	NAS-181	serotonin receptor antagonist	HTR1B		0.00, 0.00	0.82, 0.19	36.77	40.89	-36.99	56.61	-41.06	86.34	-30.81	56.40	-36.86	23.79
BRD-K84658672	CP	nateglinide	insulin secretagogue, ATP-sensitive potassium channel antagonist, meglitinide, sulphonylurea receptor activator	ABCC8, KCNJ11, CYP3A4, INS, KCNJ10, PPARG		0.00, 0.00	0.84, 0.27	38.47	-87.04	51.86	-52.24	-99.61	94.49	62.66	36.70	-74.69	-33.97
BRD-K61177364	CP	NBI-27914	CRF receptor antagonist	CRHR1		20.00, 10.00	0.73, 0.13	95.80	-92.12	98.89	-57.93	71.11	-63.37	-34.29	12.82	-91.45	-61.21
BRD-A67433117	CP	NCS-382	GABA receptor antagonist	GABBR1, GABBR2, SLC52A2		0.00, 0.00	0.91, 0.31	16.31	-42.67	-48.03	-19.53	92.46	70.97	25.65	13.78	-80.69	-3.39
BRD-A35338386	CP	NECA	adenosine receptor agonist	ADORA1, ADORA2A, ADORA2B, ADORA3, HSP90B1	Adenosine receptor agonist	50.00, 30.00	0.91, 0.36	95.63	96.61	99.79	30.41	88.03	99.28	-32.77	80.17	64.04	99.12
BRD-A78877355	CP	nefopam	cyclooxygenase inhibitor, prostanoid receptor inhibitor			10.00, 10.00	1.00, 0.24	80.35	30.06	33.36	98.24	-47.66	-64.22	-45.66	20.47	31.36	15.78
BRD-K05181084	CP	NGB-2904	dopamine receptor antagonist	DRD3		0.00, 0.00	0.70, 0.27	31.37	23.20	-65.78	-38.60	-40.22	-72.75	24.73	-60.57	-60.10	-31.70
BRD-A62336480	CP	niguldipine	adrenergic receptor antagonist, calcium channel blocker, calcium channel antagonist, calcium channel inhibitor	ADRA1A, CACNA1C, ADRA1B, ADRA1D		0.00, 0.00	1.43, 0.32	-99.70	-99.43	-41.88	-98.76	-91.45	-90.22	-79.89	-99.56	-99.22	-98.22
BRD-K23566484	CP	nilutamide	androgen receptor antagonist, RNA directed RNA polymerase inhibitor	AR, CYP2C19		10.00, 10.00	0.66, 0.20	-20.12	-8.82	69.45	47.22	99.96	-97.19	-29.29	-39.58	-50.99	-14.06
BRD-K73589491	CP	nizatidine	histamine receptor antagonist	HRH2		10.00, 10.00	0.59, 0.14	-88.38	56.69	13.28	-61.16	64.63	98.44	85.44	-14.02	68.06	44.46
BRD-K85015012	CP	NNC-05-2090	GABA uptake inhibitor, GAT inhibitor	SLC6A11, SLC6A12, SLC6A13		0.00, 0.00	1.48, 0.51	-95.02	94.52	-96.54	-97.59	-72.86	-99.88	-89.58	-87.15	-57.62	-93.00
BRD-K08438429	CP	BRD-K08438429	glucosylceramidase inhibitor, somatostatin receptor agonist	GBA, SSTR4		0.00, 0.00	0.83, 0.16	-99.15	-77.25	-93.81	-63.60	-73.08	-99.59	-57.59	-86.76	-99.51	-97.04
BRD-K78122587	CP	NNC-55-0396	T-type calcium channel blocker	CATSPER1, CATSPER2, CATSPER3, CATSPER4	T-type calcium channel blocker	0.00, 0.00	1.65, 0.48	-99.62	-98.79	-95.58	-99.01	-96.29	-99.75	-85.71	-95.03	-99.73	-98.98
BRD-K36009368	CP	NNC-63-0532	opioid receptor agonist	OPRL1		10.00, 10.00	0.88, 0.19	-42.21	54.81	97.77	-29.12	-46.86	-65.27	-57.78	90.19	-9.52	-21.54
BRD-K42221274	CP	NNC-711	GAT inhibitor	SLC6A1, SIGMAR1		0.00, 0.00	0.90, 0.24	-10.69	66.89	-55.67	28.74	33.61	-72.81	35.80	-13.48	-57.53	-10.06
BRD-K06753942	CP	nobiletin	MEK phosphorylation inhibitor, nitric oxide synthase expression inhibitor, P glycoprotein inhibitor, tyrosinase inhibitor	ABCB1, MAP2K1, TYR		0.00, 0.00	0.42, 0.13	-69.18	27.81	-13.82	-55.25	-73.30	-91.74	-31.37	-94.55	-91.55	-76.39
BRD-A09161221	CP	nomilin	HSP inhibitor			60.00, 40.00	2.02, 0.62	10.90	-29.76	NaN	NaN	99.66	98.23	NaN	NaN	NaN	95.67
BRD-K88625236	CP	nonoxynol-9	interacts with the lipids in the membranes of the acrosome and the midpiece of the sperm			0.00, 0.00	1.23, 0.22	-84.70	-98.97	-81.28	-86.68	-36.05	-99.75	-55.72	-99.89	-98.77	-97.26
BRD-K32696739	CP	noreleagnine	imidazoline receptor ligand, serotonin receptor ligand	ADRA2A, ADRA2B, ADRA2C, HTR2A, MAOA, MAOB		10.00, 10.00	1.11, 0.23	68.54	98.03	-20.84	-10.85	29.38	-47.58	36.96	-97.62	44.23	20.76
BRD-A39415247	CP	norethisterone	ovulation inhibitor	PGR	Progesterone receptor agonist	0.00, 0.00	0.76, 0.27	11.18	-97.68	50.20	46.03	-65.69	89.04	-65.06	51.94	-39.69	-28.79
BRD-A00758722	CP	noretynodrel	progestogen steroid hormone	PGR		10.00, 10.00	0.88, 0.28	73.22	-93.06	-27.17	-45.28	46.88	18.60	-96.50	97.65	-30.58	14.87
BRD-A50928468	CP	norgestrel	progesterone receptor agonist	CYP2E1, PGR	Progesterone receptor agonist	10.00, 10.00	1.06, 0.30	-15.05	-96.46	-32.30	-98.44	43.12	-31.80	77.15	99.38	72.98	34.59
BRD-K91301684	CP	noscapine	bradykinin receptor antagonist, tubulin polymerization inhibitor, apoptosis stimulant, microtubule inhibitor, tubulin inhibitor	BDKRB2, SIGMAR1		10.00, 10.00	0.91, 0.34	86.06	37.51	-81.99	22.39	-63.75	99.06	52.15	-77.00	20.90	17.74
BRD-A47633927	CP	NPC-15199	ICAM 1 antagonist, increases intracellular calcium levels	ICAM1, PPARG		0.00, 0.00	0.97, 0.19	60.73	-67.49	15.66	55.42	15.05	-72.77	-29.06	26.27	43.68	6.05
BRD-K13169950	CP	NSC-3852	HDAC inhibitor	HDAC1	HDAC inhibitor	0.00, 0.00	2.16, 0.67	-99.00	63.54	-98.35	-99.94	-99.06	-98.48	-99.26	-99.21	-99.97	-99.37
BRD-K37392901	CP	NSC-632839	ubiquitin hydrolase inhibitor, ubiquitin isopeptidase inhibitor	USP2, USP7, SENP2, USP1		0.00, 0.00	2.25, 0.61	-98.56	-99.80	-98.78	-99.73	-99.17	-98.69	-95.74	-87.18	-99.61	-97.74
BRD-K31268420	CP	NSC-693868	CDK inhibitor, glycogen synthase kinase inhibitor	CDK1, CDK5, GSK3A, GSK3B		10.00, 0.00	1.16, 0.28	-78.54	96.70	-33.16	-34.95	-68.58	-98.41	57.12	-35.64	94.00	-34.20
BRD-A94413429	CP	NTNCB	neuropeptide receptor antagonist	NPY5R		0.00, 0.00	1.69, 0.73	17.38	-48.69	-38.08	-32.52	-84.33	-99.18	72.04	-99.21	49.79	-77.69
BRD-K10136726	CP	tosyllysyl-chloromethyl-ketone	chymotrypsin inhibitor			10.00, 0.00	0.97, 0.38	13.01	-27.92	52.87	95.13	-25.02	13.45	-30.03	-61.92	46.14	6.53
BRD-A97454584	CP	nadolol	adrenergic receptor antagonist	ADRB1, ADRB2, ADRB3		10.00, 10.00	1.47, 0.59	98.48	93.05	85.19	19.34	73.25	93.41	-63.83	43.54	73.27	81.83
BRD-A71262238	CP	nafadotride	dopamine receptor antagonist	DRD3, DRD2, HTR1A		20.00, 10.00	0.90, 0.17	97.69	-21.21	29.74	95.71	-37.10	74.76	-57.71	-23.30	66.97	62.54
BRD-K18574842	CP	nafcillin	antibiotic	CYP3A4	Bacterial cell wall synthesis inhibitor	10.00, 10.00	0.88, 0.30	89.82	44.76	13.60	-42.62	81.10	-39.24	-20.48	99.92	-45.64	43.32
BRD-K74141488	CP	naftifine	squalene epoxidase inhibitor, steroid sulfatase inhibitor	SQLE		10.00, 10.00	0.83, 0.30	37.67	59.95	-56.76	97.56	94.66	32.63	77.22	82.16	-35.96	83.25
BRD-A41833852	CP	naloxone	opioid receptor antagonist	OPRM1, OPRK1, OPRD1, CREB1, ESR1, TLR4		0.00, 0.00	1.11, 0.22	-26.34	-53.87	43.18	-57.67	-94.46	62.54	-73.54	30.16	-63.76	-24.49
BRD-A21723284	CP	naltriben	opioid receptor antagonist	OPRD1, OPRK1, OPRM1		20.00, 20.00	1.01, 0.31	98.85	99.96	33.77	30.38	85.07	67.58	-36.95	-44.87	53.38	68.61
BRD-A82656074	CP	naltrindole	opioid receptor antagonist	OPRD1, OPRK1, OPRM1		0.00, 0.00	0.94, 0.36	-75.68	-21.62	63.74	-97.39	-26.17	-99.60	92.42	-54.17	-63.47	-69.25
BRD-A87719232	CP	naproxen	cyclooxygenase inhibitor	PTGS2, PTGS1		10.00, 10.00	1.25, 0.35	98.53	38.40	22.24	-45.96	-33.99	73.45	-46.06	-22.98	23.91	17.00
BRD-A36318220	CP	necrostatin-1	RIPK inhibitor, indoleamine 2,3-dioxygenase inhibitor	IDO1, KRR1, RIPK1		10.00, 0.00	0.58, 0.11	-31.17	18.82	-55.81	-28.31	76.79	-99.69	95.88	-99.62	-20.71	-19.00
BRD-K90789829	CP	nefazodone	serotonin receptor antagonist, serotonin reuptake inhibitor, adrenergic transmitter uptake inhibitor, norepinephrine reuptake inhibitor, serotonin uptake inhibitor	HTR2A, SLC6A4, HTR2C, SLC6A2, ADRA1A, ADRA1B, ADRA2A, CYP3A4, CYP3A5, CYP3A7, HTR1A, SLC6A3		0.00, 0.00	0.60, 0.16	-96.60	-90.78	-85.63	-27.74	-90.95	-99.97	-90.77	-59.80	-87.96	-98.94
BRD-A66927094	CP	nemonapride	dopamine receptor antagonist, serotonin receptor agonist	DRD2, DRD3, DRD4		0.00, 0.00	0.98, 0.38	71.25	-32.62	21.31	45.47	-46.05	-34.63	-75.90	49.31	-23.44	-15.79
BRD-A00100033	CP	nifurtimox	DNA inhibitor			0.00, 0.00	0.97, 0.34	24.76	-85.31	24.96	15.96	-49.12	14.01	-52.50	-58.05	-42.45	-24.73
BRD-K76775527	CP	nimesulide	cyclooxygenase inhibitor, matrix metalloprotease inhibitor, prostanoid receptor inhibitor	PTGS2, LTF, PLA2G2E, PTGS1		0.00, 0.00	1.30, 0.38	-36.52	-64.65	35.80	74.49	-59.50	-99.31	-37.18	25.11	52.20	-32.84
BRD-A95696066	CP	nisoxetine	dopamine transporter inhibitor, norepinephrine transporter inhibitor, serotonin transporter (SERT) inhibitor	SLC6A2, SLC6A3, SLC6A4		0.00, 0.00	0.66, 0.16	81.28	42.39	-29.79	-31.12	27.74	-52.61	47.56	78.01	-25.57	32.19
BRD-K28453807	CP	nitrocaramiphen	acetylcholine receptor antagonist			30.00, 30.00	0.66, 0.20	69.23	-38.44	98.42	99.48	76.04	94.26	-37.82	45.93	55.47	98.34
BRD-K46652470	CP	nizatidine	histamine receptor antagonist	HRH2		0.00, 0.00	1.34, 0.35	-56.06	-83.26	89.48	20.36	-29.52	-89.13	77.48	-12.30	-28.00	-38.32
BRD-K27351809	CP	nomegestrol	progesterone receptor agonist	PGR	Progesterone receptor agonist	0.00, 0.00	1.19, 0.25	-49.63	-62.68	-33.63	-34.03	-67.38	81.55	-64.66	76.24	63.04	-39.12
BRD-K63165456	CP	norcyclobenzaprine	adrenergic receptor ligand, serotonin receptor ligand	HTR2A	Serotonin receptor antagonist	0.00, 0.00	0.90, 0.20	76.97	-81.88	-56.71	10.66	85.67	79.78	-26.32	26.66	-46.15	20.01
BRD-K80334323	CP	noretynodrel	progestogen steroid hormone	PGR		0.00, 0.00	0.88, 0.20	-31.54	-97.97	-33.45	13.65	-85.61	-31.25	12.75	54.12	-13.74	-9.04
BRD-K35189033	CP	levonorgestrel	estrogen receptor agonist, glucocorticoid receptor antagonist, progesterone receptor agonist, progesterone receptor antagonist	PGR, AR, CYP2E1, ESR1, SRD5A1		10.00, 10.00	0.92, 0.31	37.22	-96.63	-19.51	99.61	-82.59	43.88	-22.72	-20.81	45.26	-7.46
BRD-A10355991	CP	norketamine	glutamate receptor antagonist	CYP2B6, CYP2C19, CYP3A5, GRIN1		0.00, 0.00	1.31, 0.39	26.16	29.24	-15.54	33.07	-55.42	-55.90	-32.79	45.99	63.27	13.43
BRD-A51393488	CP	noscapine	bradykinin receptor antagonist, tubulin polymerization inhibitor, apoptosis stimulant, microtubule inhibitor, tubulin inhibitor	BDKRB2, SIGMAR1		20.00, 10.00	0.63, 0.10	-22.66	94.33	-41.61	94.20	17.70	-15.36	-76.60	85.80	99.78	96.01
BRD-K18316707	CP	O-1918	cannabinoid receptor antagonist			10.00, 0.00	0.81, 0.30	95.44	-13.25	-68.25	-93.19	10.67	20.64	-46.66	63.80	-99.84	-12.03
BRD-K02590140	CP	O-2050	cannabinoid receptor antagonist	CNR1		0.00, 0.00	1.14, 0.42	-21.20	-47.52	-19.20	-60.42	-20.99	16.62	71.39	-83.73	-74.76	-38.74
BRD-K48029790	CP	OBAA	phospholipase inhibitor	PLA2G1B		0.00, 0.00	1.43, 0.38	-35.94	-99.26	-23.33	65.27	68.44	44.30	-32.63	-47.63	-33.82	-18.36
BRD-K85318537	CP	OBAA	phospholipase inhibitor	PLA2G1B		10.00, 10.00	0.73, 0.30	18.81	-51.78	-42.38	-17.86	-17.82	-56.85	-30.77	98.88	47.97	-7.07
BRD-K26015241	CP	ODQ	guanylyl cyclase inhibitor, inhibitor of soluble guanylyl cyclase, potassium channel blocker	GUCY1A2, GUCY1A3, GUCY1B3		10.00, 10.00	1.08, 0.33	62.91	98.12	23.07	-75.60	71.92	63.94	-38.43	49.34	-55.08	42.41
BRD-A41112154	CP	oleanolic-acid	antitumor agent			0.00, 0.00	2.12, 0.63	29.25	90.66	NaN	NaN	91.49	16.73	NaN	NaN	NaN	76.49
BRD-A39522003	CP	OMDM-2	FAAH reuptake inhibitor	GPR119		0.00, 0.00	1.06, 0.41	-53.05	12.51	36.78	62.50	-99.71	76.32	-55.18	-99.15	-46.86	-25.88
BRD-A55962179	CP	omeprazole	ATPase inhibitor, ABC transporter expression enhancer	ATP4A, CLCN2, CYP1A2, CYP2C19		0.00, 0.00	1.30, 0.36	-25.03	38.80	38.63	-29.24	84.83	-44.02	65.86	-22.11	17.43	20.27
BRD-A53576514	CP	orphenadrine	acetylcholine receptor antagonist	CYP2B6, GRIN1, GRIN2D, GRIN3A, GRIN3B, HRH1, SCN10A, SLC6A2		0.00, 0.00	0.95, 0.28	-22.25	-73.53	34.02	75.75	75.65	-48.97	49.37	78.46	35.00	36.34
BRD-K59037100	CP	oxybenzone	lipase inhibitor	LIPE		10.00, 10.00	1.25, 0.38	84.63	-69.59	53.86	15.09	-65.00	-12.38	99.55	74.78	49.92	48.44
BRD-K82731415	CP	olomoucine	CDK inhibitor	CDK1, CDK2, CDK5, MAPK1		10.00, 10.00	0.93, 0.22	18.71	99.96	-66.49	25.29	-43.11	-29.22	-95.68	-50.17	-26.67	-24.85
BRD-K86958018	CP	olvanil	TRPV agonist	TRPV1, CNR1, GPR119	Cannabinoid receptor agonist	0.00, 0.00	0.86, 0.20	-29.80	-96.09	-99.43	25.11	-99.67	-33.80	21.08	-95.54	88.41	-94.15
BRD-K51816706	CP	oxindole-I	protein kinase inhibitor, vascular endothelial growth factor receptor (VEGFR) inhibitor	AKT1, KDR, PDPK1, RET		0.00, 0.00	1.02, 0.25	-44.21	-78.68	-69.06	-53.08	28.02	-75.57	-48.67	-98.10	-51.79	-65.93
BRD-K16195444	CP	oxymetazoline	adrenergic receptor agonist, unidentified pharmacological activity	ADRA1A, ADRA2A, ADRA1B, ADRA1D, ADRA2B, ADRA2C, CYP2C19, HTR1B, HTR1D, HTR2C		0.00, 0.00	1.47, 0.35	-38.55	-89.21	43.36	37.47	-48.75	-37.59	29.29	-57.80	-32.24	-38.10
BRD-K19525698	CP	ozagrel	thromboxane synthase inhibitor, platelet aggregation inhibitor, selective thromboxane synthetase inhibitor	TBXAS1		0.00, 0.00	1.06, 0.34	89.49	64.11	32.57	-40.20	-15.59	80.58	37.19	52.02	-41.18	60.42
BRD-K00206590	CP	P-1075	ATP channel activator, potassium channel agonist	KCNJ8	KCNJ11 modulator, Potassium channel activator	0.00, 0.00	1.06, 0.25	17.46	30.79	82.80	45.27	-59.50	-31.99	87.02	-50.16	-57.46	25.32
BRD-A22380646	CP	pantoprazole	ATPase inhibitor	ATP4A, CYP2C19, CYP3A4		20.00, 20.00	0.58, 0.15	-11.87	-18.14	69.39	54.91	97.76	-65.46	76.97	60.04	98.88	67.06
BRD-K15567136	CP	papaverine	phosphodiesterase inhibitor	PDE10A, PDE4B, PDE5A		0.00, 0.00	0.84, 0.20	-27.56	-30.31	-28.55	11.30	-12.53	-90.65	-29.67	-90.65	-98.35	-47.80
BRD-K40992116	CP	parachlorophenol	disinfectant			10.00, 10.00	1.11, 0.33	-43.70	-64.96	97.61	80.79	-34.76	-47.95	-51.15	-47.76	-7.96	-19.56
BRD-K83597974	CP	pargyline	monoamine oxidase inhibitor	MAOB, MAOA		10.00, 0.00	0.91, 0.28	41.37	-7.94	-53.12	-46.95	97.24	69.28	-62.86	45.73	72.86	41.06
BRD-A29289453	CP	PCA-4248	platelet activating factor receptor antagonist	PTAFR		0.00, 0.00	0.76, 0.15	-97.94	43.95	-59.39	-98.30	54.06	-99.24	-80.57	-84.67	-95.58	-97.90
BRD-K52721684	CP	PCO-400	potassium channel activator, potassium channel agonist	ABCC9, KCNJ8	Potassium channel activator	10.00, 10.00	1.10, 0.33	90.57	17.76	-21.42	81.55	99.76	-11.82	-29.04	-49.56	-33.04	38.67
BRD-A89337244	CP	PD-102807	acetylcholine receptor antagonist	CHRM4		0.00, 0.00	1.00, 0.10	-93.74	-97.86	24.22	-99.77	-70.28	-99.90	-64.82	-98.53	-97.07	-98.70
BRD-A63836183	CP	PD-123319	angiotensin antagonist	AGTR2		0.00, 0.00	0.80, 0.24	79.21	86.98	43.96	86.46	19.49	-83.49	28.56	74.43	43.88	83.09
BRD-K12079898	CP	PD-160170	neuropeptide receptor antagonist	NPY1R		0.00, 0.00	1.17, 0.32	17.12	-5.29	-96.48	-47.97	-35.11	46.48	-63.75	-72.05	32.68	-46.85
BRD-A75478957	CP	PD-166793	collagenase inhibitor, metalloproteinase inhibitor, stromelysin inhibitor	MMP13, MMP2, MMP3		10.00, 10.00	1.16, 0.31	-22.39	-71.98	-38.15	97.58	-12.56	-38.74	40.18	16.52	20.68	-13.66
BRD-K77133231	CP	PD-169316	p38 MAPK inhibitor	ALOX5	P38 MAPK inhibitor	0.00, 0.00	1.29, 0.28	88.32	20.42	NaN	NaN	-90.95	83.58	NaN	NaN	NaN	73.33
BRD-K88677950	CP	PD-198306	MAP kinase inhibitor, MEK inhibitor	MAP2K1, MAP2K2, MAPK1, MAPK3	MEK inhibitor	10.00, 0.00	1.14, 0.31	-99.43	-44.55	-76.08	-99.42	-99.19	-70.70	95.11	-98.51	-89.31	-97.85
BRD-K82823804	CP	SA-792987	PKC inhibitor	WEE1	PKC inhibitor	10.00, 10.00	1.32, 0.30	-98.73	-95.93	29.04	-97.25	-75.33	-95.97	99.08	-99.98	85.04	-95.88
BRD-K27665173	CP	D-64406	PDGFR tyrosine kinase receptor inhibitor	FLT3, PDGFRA, PDGFRB	PDGFR/KIT inhibitor	10.00, 10.00	1.03, 0.28	-73.04	98.77	-72.21	79.16	-99.82	-96.51	81.51	-98.41	-95.43	-96.86
BRD-K15409150	CP	penfluridol	dopamine receptor antagonist, T-type calcium channel blocker	CACNA1G, DRD1, DRD2	T-type calcium channel blocker	0.00, 0.00	1.57, 0.35	-99.57	-89.80	-95.33	-76.68	-98.95	-97.82	-87.71	-95.71	-93.23	-95.49
BRD-K57569181	CP	pentoxifylline	phosphodiesterase inhibitor, acetylcholinesterase inhibitor, chitinase inhibitor, tumor necrosis factor production inhibitor	TNF, ACHE, ADORA1, ADORA2A, ADRA2B, CHIA, NT5E, PDE4A, PDE4B, PDE5A		20.00, 10.00	0.63, 0.14	96.85	77.03	12.22	20.72	23.55	48.76	35.91	98.20	-61.60	53.30
BRD-K57718010	CP	pentylenetetrazol	GABA receptor antagonist		GABA receptor antagonist	0.00, 0.00	1.01, 0.26	-59.56	48.31	-26.10	-10.95	-36.80	-33.65	48.74	-76.80	76.16	-17.79
BRD-K72034655	CP	peucedanin	apoptosis inducer, antileukemic			80.00, 20.00	1.21, 0.50	-26.14	95.93	NaN	NaN	96.47	99.44	NaN	NaN	NaN	97.42
BRD-A70268693	CP	PG-9	presynaptic cholinergic modulator			0.00, 0.00	0.75, 0.31	63.17	-36.63	-48.70	-14.76	-76.80	-73.53	32.97	10.55	60.33	-32.48
BRD-K95435023	CP	PHA-665752	c-Met inhibitor, hepatocyte growth factor receptor inhibitor	MET		0.00, 0.00	1.49, 0.38	-43.98	-95.50	-97.91	-83.36	-74.07	-97.34	-94.45	-47.71	-97.37	-97.61
BRD-K90333595	CP	phentolamine	adrenergic receptor antagonist	ADRA1A, ADRA2A, ADRA1B, ADRA1D, ADRA2B, ADRA2C		20.00, 10.00	0.94, 0.23	57.42	10.61	29.58	26.31	-26.53	99.97	96.71	21.58	-81.09	21.15
BRD-K74112339	CP	acetohydroxamic-acid	inhibitor of bacterial and plant urease			0.00, 0.00	1.71, 0.42	31.80	42.75	NaN	NaN	47.45	81.11	NaN	NaN	NaN	30.98
BRD-K10843433	CP	phenylbutazone	cyclooxygenase inhibitor, platelet aggregation inhibitor, prostanoid receptor inhibitor	PTGS2, PTGS1, PTGIS		10.00, 10.00	0.66, 0.13	99.93	-84.87	-99.91	43.33	-37.31	-10.18	-55.03	58.45	56.07	-30.07
BRD-K76568384	CP	PHTPP	estrogen receptor antagonist	ESR2		0.00, 0.00	1.22, 0.45	-50.66	-8.60	65.48	-17.15	14.15	-68.22	-40.11	-11.70	-95.47	-16.48
BRD-K97365803	CP	PI-828	PI3K inhibitor		PI3K inhibitor	0.00, 0.00	1.73, 0.70	-97.74	-98.38	-23.46	-99.71	-57.73	-99.88	41.66	-99.83	-24.18	-98.52
BRD-K91509126	CP	piceatannol	syk inhibitor, cyclooxygenase inhibitor, nitric oxide synthase inhibitor, SIRT activator, tyrosinase inhibitor, tyrosine kinase inhibitor	ATP5A1, ATP5B, ATP5C1, IRF3, PTGS2, SIRT1, SYK, TYR		0.00, 0.00	0.63, 0.10	-28.11	-41.33	-80.66	-89.19	-99.84	-95.02	-56.12	-66.33	-96.89	-87.38
BRD-A43882281	CP	pinacidil	ATP channel activator, potassium channel agonist	ABCC9, KCNJ8		10.00, 10.00	0.66, 0.19	-32.56	93.38	-18.27	55.23	14.44	99.97	60.78	-67.52	79.71	56.75
BRD-K94689771	CP	pinocembrin	androgen receptor ligand, CYP1B1 inhibitor, reducing agent, steroid 5alpha-reductase inhibitor	AR, CYP1B1, SRD5A1, SRD5A2		10.00, 10.00	0.90, 0.34	-94.01	63.03	-36.94	-33.27	-46.54	91.14	-75.92	98.85	-28.13	-21.67
BRD-K89375097	CP	pirenzepine	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5		10.00, 10.00	1.38, 0.34	94.86	81.18	-76.84	44.14	-17.80	60.36	-38.97	99.32	74.95	89.40
BRD-K43978949	CP	PIT	purinergic receptor antagonist	P2RY1		10.00, 10.00	0.84, 0.32	80.53	88.53	99.30	89.75	53.49	53.12	-52.85	-27.73	70.88	92.44
BRD-A41451487	CP	PK-11195	benzodiazepine receptor antagonist, constitutive androstane receptor (CAR) antagonist, PXR agonist, translocator protein antagonist	TSPO, NR1I2, NR1I3		0.00, 0.00	0.45, 0.03	29.45	-74.81	-98.81	-31.43	-97.59	-52.76	-92.86	-99.34	-40.71	-98.80
BRD-K13646352	CP	midostaurin	FLT3 inhibitor, KIT inhibitor, PKC inhibitor, angiogenesis inhibitor, cell cycle inhibitor, cyclin inhibitor, histamine release inhibitor, multi targeted kinase inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR antagonist, VEGFR inhibitor	FLT3, KIT, CCNB1, FLT1, KDR, PDGFRB, PRKCA, PRKCG, VEGFA	FLT3 inhibitor, PDGFR/KIT inhibitor, PKC inhibitor, VEGFR inhibitor	0.00, 0.00	1.35, 0.26	-98.21	18.85	-45.56	-97.37	-16.73	-99.90	93.06	-99.83	-51.62	-98.06
BRD-K71731651	CP	PNU-120596	acetylcholine receptor modulator, acetylcholine receptor positive allosteric modulator	CHRNA7		10.00, 10.00	1.24, 0.47	-79.48	59.70	21.39	-35.24	-61.61	94.50	99.07	-50.20	57.46	61.59
BRD-K16551401	CP	PNU-22394	serotonin receptor agonist	MAOA, MAOB		10.00, 10.00	0.97, 0.28	-12.57	12.38	36.88	87.20	27.05	5.65	65.62	82.52	99.86	47.94
BRD-K28863208	CP	PNU-282987	acetylcholine receptor antagonist	CHRNA7		10.00, 10.00	0.78, 0.19	85.69	65.04	-59.25	-43.95	-53.08	51.47	98.95	79.24	-55.60	57.76
BRD-A95096829	CP	PNU-96415E	dopamine receptor antagonist			0.00, 0.00	0.91, 0.20	-26.66	-23.49	-37.89	-37.14	93.36	12.48	-85.82	86.72	33.79	-14.28
BRD-K47598052	CP	PP-1	src inhibitor, Abl kinase inhibitor	HCK, RET, SRC	SRC inhibitor	0.00, 0.00	1.75, 0.64	-98.25	-95.51	-40.89	-11.16	-60.34	-96.95	64.53	-98.65	-83.58	-96.19
BRD-K95785537	CP	PP-2	src inhibitor	SRC, LCK, ABL1, LYN, RIPK2	SRC inhibitor	10.00, 0.00	1.60, 0.53	-99.34	-30.53	-96.84	-93.99	96.39	-98.73	55.33	-99.75	-42.52	-97.82
BRD-K16977723	CP	PP-3	EGFR kinase inhibitor			0.00, 0.00	0.85, 0.35	73.34	-26.16	81.60	65.98	-97.87	-70.57	83.78	-31.93	86.28	76.38
BRD-K00312224	CP	PPT	estrogen receptor agonist	ESR1	Estrogen receptor agonist	0.00, 0.00	0.85, 0.16	-79.95	-78.14	31.02	-98.49	-38.68	-33.55	-36.81	74.95	77.29	-51.14
BRD-K67537649	CP	PQ-401	insulin growth factor receptor inhibitor	IGF1R		0.00, 0.00	0.66, 0.06	-99.81	-92.86	-20.64	-42.57	-89.15	-99.93	17.06	-97.67	-99.88	-99.72
BRD-A71816415	CP	pravastatin	HMGCR inhibitor	HMGCR, SLCO1B1		20.00, 10.00	0.97, 0.33	51.12	-97.59	-31.68	97.26	-49.20	10.01	56.80	13.89	97.94	28.10
BRD-K72029282	CP	probucol	atherogenesis inhibitor, cholesterol inhibitor, reducing agent	ABCA1, ABCB11, CES1		0.00, 0.00	1.40, 0.43	59.97	-68.17	72.13	69.19	-58.71	86.70	-34.20	-17.97	40.11	38.78
BRD-K99029477	CP	prometon	photosynthesis inhibitor			20.00, 20.00	2.05, 0.64	-13.65	-28.38	NaN	NaN	99.96	8.25	NaN	NaN	NaN	-4.98
BRD-A26334849	CP	propafenone	antiarrhythmic medication, potassium channel blocker, voltage-gated sodium channel blocker	KCNH2, SCN5A, ADRB1, ADRB2, KCNA5, KCNK2, KCNK3		0.00, 0.00	0.89, 0.17	-72.50	-15.66	9.84	45.94	61.43	-57.46	-34.25	-68.15	-24.85	-13.51
BRD-K82255054	CP	propofol	membrane integrity inhibitor, membrane permeability inhibitor, TRPV agonist	CYP2B6, FAAH, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, SCN2A, SCN4A, TRPV1		0.00, 0.00	0.66, 0.17	-35.16	75.01	-34.06	54.80	-66.41	-52.52	-33.18	35.66	29.56	-20.59
BRD-K85242180	CP	beta-CCP	indoleamine 2,3-dioxygenase inhibitor	GABRA1, GABRG2, IDO1		10.00, 10.00	0.94, 0.25	98.23	74.10	82.96	23.51	47.12	14.00	14.12	15.65	43.14	41.23
BRD-K04010869	CP	prostaglandin-a1	HSP inducer, NFKB pathway inhibitor			50.00, 50.00	0.63, 0.16	99.72	100.00	65.96	90.21	99.74	56.43	78.44	100.00	27.85	99.89
BRD-K82865713	CP	prostaglandin-b2	cAMP inhibitor			20.00, 20.00	0.77, 0.26	35.79	99.89	-20.64	-65.46	61.64	3.52	-60.69	-9.03	99.59	13.61
BRD-K97863768	CP	prothionamide	mycobacterium tuberculosis enoyl-[acyl-carrier-protein] reductase [NADH] (inhA) inhibitor			0.00, 0.00	1.07, 0.39	68.63	39.43	-85.38	8.77	-54.64	45.76	47.13	-85.00	42.93	30.68
BRD-K57546357	CP	prunetin	breast cancer resistance protein inhibitor	ABCG2, ALDH2		0.00, 0.00	1.04, 0.31	-63.33	-50.51	NaN	NaN	-91.16	77.25	NaN	NaN	NaN	-53.70
BRD-K10177585	CP	PSB-11	adenosine receptor antagonist	ADORA3, ADORA1, ADORA2A		0.00, 0.00	1.27, 0.49	55.49	31.57	-95.30	-79.51	28.02	33.65	32.23	-97.17	-53.92	-66.70
BRD-K84175871	CP	pseudoephedrine	histamine receptor antagonist, interleukin expression inhibitor, tumor necrosis factor expression inhibitor	ADRA1A, ADRA2A, ADRB1, ADRB2, ATF1, ATF2, ATF3, ATF4, ATF5, ATF6, ATF7, CXCL8, FOS, HRH1, IL2, JDP2, JUN, NFATC1, SLC6A2, SLC6A3, SLC6A4, TNF		10.00, 10.00	1.17, 0.32	83.18	-12.36	73.10	16.44	-89.36	98.69	-24.62	87.81	37.34	80.91
BRD-K04170657	CP	psoromic-acid	Rab-Prenylation Inhibitor			0.00, 0.00	1.73, 0.28	56.89	-80.54	NaN	NaN	22.07	60.59	NaN	NaN	NaN	36.34
BRD-A28970875	CP	puromycin	adenosine receptor agonist, protein synthesis inhibitor	NHP2L1, RPL10L, RPL11, RPL13A, RPL15, RPL19, RPL23, RPL23A, RPL26L1, RPL3, RPL37, RPL8, RSL24D1	Protein synthesis inhibitor	0.00, 0.00	2.40, 0.51	-99.65	-99.82	-98.35	-98.37	-91.97	-94.72	-99.25	-64.28	-99.69	-98.63
BRD-K97564742	CP	mepyramine	histamine receptor antagonist	HRH1		0.00, 0.00	0.50, 0.14	46.61	68.11	40.61	42.18	-55.54	-89.59	93.80	93.69	56.89	49.02
BRD-K88429204	CP	pyrimethamine	dihydrofolate reductase inhibitor, hexosaminidase stimulant, pharmacological chaperone, STAT inhibitor	DHFR, DHFRP1, HEXA, SLC47A1, STAT3	Dihydrofolate reductase inhibitor	0.00, 0.00	0.51, 0.06	-99.98	-94.31	-99.95	-97.64	-73.86	-92.21	-99.64	-96.44	-99.95	-99.93
BRD-K68095457	CP	palmitoylethanolamide	cannabinoid receptor agonist, Glucose-Dependent Insulinotropic Receptor (GDIR, GPR119)  Agonists, unidentified pharmacological activity	CNR2, GPR119, GPR55	Cannabinoid receptor agonist	10.00, 10.00	0.83, 0.24	-52.37	45.62	-39.13	42.85	-9.81	97.79	-55.79	-38.29	-43.19	-14.01
BRD-K11163873	CP	phenanthridone	PARP inhibitor	PARP1	PARP inhibitor	0.00, 0.00	1.27, 0.39	46.24	-19.75	-41.42	90.47	22.20	-90.25	-28.75	78.19	-54.74	6.54
BRD-K11399644	CP	phenformin	AMPK activator	KCNJ8, PRKAA1		20.00, 20.00	0.83, 0.18	-87.67	-94.85	65.17	-15.00	-76.05	99.54	99.62	91.91	-78.65	78.55
BRD-K68873215	CP	phosphodiesterase-V-inhibitor-II	phosphodiesterase inhibitor	PDE5A		0.00, 0.00	0.68, 0.23	-80.11	-82.59	-99.72	-29.47	-91.73	-98.86	-68.65	-99.66	33.22	-98.40
BRD-K26241953	CP	piceatannol	syk inhibitor, cyclooxygenase inhibitor, nitric oxide synthase inhibitor, SIRT activator, tyrosinase inhibitor, tyrosine kinase inhibitor	ATP5A1, ATP5B, ATP5C1, IRF3, PTGS2, SIRT1, SYK, TYR		10.00, 10.00	1.05, 0.30	-26.71	41.29	-83.03	-42.13	-99.66	98.48	-68.76	-93.98	-99.81	-86.28
BRD-K67277431	CP	picotamide	prostanoid receptor antagonist, thromboxane receptor antagonist, thromboxane synthase inhibitor	TBXA2R, TBXAS1	Thromboxane receptor antagonist	10.00, 10.00	0.80, 0.22	99.43	19.95	27.53	34.97	-18.18	44.63	-66.66	70.90	-37.02	14.80
BRD-A37817666	CP	picrotoxin	GABA receptor antagonist	GABRA1, GLRA2, GLRA3, GABRR1, GLRA1, GLRB, HTR3A, HTR3B		0.00, 0.00	1.11, 0.36	-9.47	20.20	79.44	-19.52	-52.30	81.04	20.10	54.63	93.33	59.36
BRD-K66874953	CP	pifithrin-alpha	TP53 inhibitor	TP53		10.00, 0.00	0.52, 0.11	90.39	86.90	28.29	-18.12	96.12	-70.53	-47.29	-97.69	-92.64	48.84
BRD-K31792052	CP	pifithrin	interleukin receptor antagonist			0.00, 0.00	0.73, 0.20	51.36	17.44	69.50	44.13	-94.69	-85.14	87.84	-99.68	-36.07	29.13
BRD-A58207013	CP	pinacidil	ATP channel activator, potassium channel agonist	ABCC9, KCNJ8		0.00, 0.00	1.03, 0.25	18.06	-67.09	-27.07	9.96	26.09	65.43	-61.88	-13.94	-86.95	-11.64
BRD-K16277217	CP	piperacetazine	antipsychotic			20.00, 10.00	1.14, 0.31	54.10	-13.90	-37.15	65.83	47.72	96.77	-37.13	99.96	38.21	63.90
BRD-K87990216	CP	piretanide	diuretic, glucocorticoid receptor agonist	SLC12A1, SLC12A2		0.00, 0.00	1.20, 0.41	-23.39	-74.02	21.28	-59.27	-89.45	-17.78	70.17	46.95	-28.58	-24.86
BRD-K96862998	CP	pirfenidone	FGFR antagonist, p38 MAPK inhibitor, TGF beta receptor antagonist, TGF beta receptor inhibitor, tumor necrosis factor production inhibitor, tumor necrosis factor receptor antagonist	TNF, FURIN, MAPK14, TNFRSF1A		10.00, 10.00	1.26, 0.27	58.34	86.55	-20.74	46.12	99.69	24.71	90.09	58.44	-95.73	81.25
BRD-K60511616	CP	pravastatin	HMGCR inhibitor	HMGCR, SLCO1B1		0.00, 0.00	0.49, 0.17	83.72	-9.69	-74.27	29.58	-38.42	25.58	32.94	94.92	63.27	24.59
BRD-K39356024	CP	pregnenolone	acetylcholine release enhancer, dopamine release enhancer, GABA receptor negative allosteric modulator, glutamate receptor modulator, progesterone receptor agonist, steroid hormone inhibitor of CYP17A1 and SULT2B1	CYP17A1, PGR, SULT2B1		30.00, 10.00	0.77, 0.25	-38.62	51.55	95.39	57.65	95.85	77.39	29.34	98.42	35.98	82.57
BRD-A22684332	CP	procaterol	adrenergic receptor agonist	ADRB2	Beta-adrenergic receptor agonist	0.00, 0.00	0.94, 0.36	-19.67	79.46	-88.17	-42.20	21.91	87.36	36.07	-9.12	-52.24	12.76
BRD-K64994968	CP	progesterone	progesterone receptor agonist	PGR, CYP17A1, NR3C2, CATSPER1, CATSPER2, CATSPER3, CATSPER4, CYP2C19, ESR1, OPRK1, TRPC5	Progesterone receptor agonist	0.00, 0.00	0.45, 0.11	-58.95	-50.75	-48.48	35.14	-98.87	-39.33	73.60	34.48	-72.06	-54.05
BRD-K18250272	CP	propoxycaine	anesthetic			10.00, 10.00	0.56, 0.15	-67.60	82.79	74.25	-81.25	57.22	45.21	80.86	98.01	-89.45	69.42
BRD-K26521938	CP	dinoprostone	prostanoid receptor agonist	PTGER2, PTGER1, PTGER3, PTGER4, CATSPER1, CATSPER2, CATSPER3, CATSPER4, PTGDR, PTGDR2, PTGFR, TBXA2R		20.00, 10.00	0.90, 0.27	99.03	-85.27	-38.79	43.58	85.29	75.62	-47.44	95.19	-31.27	78.42
BRD-K77171813	CP	proxyfan	histamine receptor modulator	HRH3		10.00, 0.00	0.90, 0.24	81.55	81.83	92.49	7.04	37.07	43.04	56.38	96.89	-26.18	86.67
BRD-A19053259	CP	pseudopelletierine	stimulant reflex trigger used as an anthelmintic and anti-amoeboid			0.00, 0.00	0.86, 0.25	-39.50	-41.37	-30.39	-11.67	48.20	-23.51	60.34	91.82	50.85	26.55
BRD-K73397362	CP	purmorphamine	smoothened receptor agonist	SMO, DHH, IHH, PTCH1		0.00, 0.00	0.73, 0.19	-17.14	47.42	-24.99	-55.74	-49.75	-85.46	-71.83	-58.36	87.92	-43.19
BRD-K36007650	CP	puromycin	adenosine receptor agonist, protein synthesis inhibitor	NHP2L1, RPL10L, RPL11, RPL13A, RPL15, RPL19, RPL23, RPL23A, RPL26L1, RPL3, RPL37, RPL8, RSL24D1		0.00, 0.00	2.26, 0.58	-99.74	-99.23	-98.47	-84.82	-99.35	-99.69	-96.26	82.01	-98.49	-98.80
BRD-K80970344	CP	pyrrolidine-dithiocarbamate	NFkB pathway inhibitor	HSD11B1, RELA	NFkB pathway inhibitor	10.00, 10.00	1.64, 0.73	16.37	-95.03	-73.89	98.55	-98.87	11.84	-84.71	-99.87	34.46	-91.64
BRD-K59632282	CP	quinidine	cytochrome P450 inhibitor, P glycoprotein inhibitor, sodium current blocker	SCN5A, ABCB1, CYP2D6, KCNA5, KCNA7, KCNH1, KCNH2, KCNH5, KCNK1, KCNK6, SLC29A4		10.00, 0.00	0.77, 0.24	-16.79	-97.73	46.28	96.86	86.45	30.92	47.32	93.46	-35.06	66.63
BRD-K56596464	CP	QX-314	sodium channel blocker	MAPK14, TGFBR1		40.00, 40.00	1.15, 0.30	99.94	76.77	-41.99	77.41	60.65	-33.08	99.96	-20.74	99.58	99.47
BRD-K97399794	CP	quercetin	aldose reductase inhibitor, cytokine production inhibitor, EGFR inhibitor, glucosidase inhibitor, monoamine oxidase inhibitor, polar auxin transport inhibitor, quorum sensing signaling modulator, SIRT activator, sodium channel blocker, tyrosine phosphatase inhibitor, xanthine oxidase inhibitor	PIK3CG, AKR1B1, ATP5A1, ATP5B, ATP5C1, CYP2C8, EGFR, GAA, HCK, HIBCH, MAOA, PIM1, PTPN1, SCN5A, SIRT1, STK17B, UGT3A1, XDH		0.00, 0.00	0.98, 0.30	64.54	84.39	35.67	-96.52	-88.47	24.35	-97.51	-97.27	-93.16	-96.65
BRD-K70799801	CP	quinidine	cytochrome P450 inhibitor, P glycoprotein inhibitor, sodium current blocker	SCN5A, ABCB1, CYP2D6, KCNA5, KCNA7, KCNH1, KCNH2, KCNH5, KCNK1, KCNK6, SLC29A4		0.00, 0.00	1.08, 0.32	16.03	-16.13	-20.83	-49.42	-41.96	78.01	78.50	7.52	41.12	7.31
BRD-K84421793	CP	BRD-K84421793	dopamine receptor agonist	DRD1		0.00, 0.00	1.16, 0.23	-99.62	55.81	-17.96	-96.85	-99.10	81.52	-87.25	-94.14	-79.82	-95.31
BRD-K39187410	CP	BRD-K39187410	antiamyloidogenic agent			0.00, 0.00	0.81, 0.28	12.16	80.05	49.46	59.72	25.95	-61.86	-47.24	-96.06	-94.62	-33.14
BRD-K32412559	CP	morphothebaine	adrenergic receptor inhibitor			10.00, 10.00	0.58, 0.15	-37.76	-31.63	38.26	-71.13	97.92	-50.06	44.96	22.48	-25.86	-22.04
BRD-K15588452	CP	R-96544	serotonin receptor antagonist	HTR2A	Serotonin receptor antagonist	0.00, 0.00	1.30, 0.28	13.18	-17.01	83.77	53.42	-9.11	-19.35	58.09	-83.16	82.00	34.09
BRD-K70505054	CP	ranitidine	histamine receptor antagonist	HRH2, SLC22A2		10.00, 10.00	1.10, 0.44	-82.64	92.59	-48.22	14.03	80.16	98.43	-38.43	-97.25	-27.23	46.49
BRD-A97674275	CP	ranolazine	fatty acid oxidation partial inhibitor, Sodium Channel  Blockers, sodium channel blocker	SCN9A, SCN10A, SCN5A, SLC22A2		0.00, 0.00	0.36, 0.02	91.46	-50.24	20.44	-65.05	-66.88	-15.71	-41.33	28.20	62.79	-22.49
BRD-K95921201	CP	reserpine	vesicular monoamine transporter inhibitor	SLC18A2, SLC18A1		0.00, 0.00	1.59, 0.30	-96.32	67.46	-65.92	-94.65	-98.67	-98.26	-43.31	-99.70	-64.30	-98.09
BRD-A68281735	CP	REV-5901	leukotriene receptor antagonist, lipoxygenase inhibitor	ALOX5		0.00, 0.00	0.92, 0.35	30.63	66.36	37.76	-27.52	-98.08	-60.69	-81.12	-96.43	68.19	-54.49
BRD-K82688027	CP	RG-13022	EGFR inhibitor, PDGFR tyrosine kinase receptor inhibitor	EGFR, PDGFRA, PDGFRB		10.00, 10.00	0.88, 0.32	51.52	-99.52	55.29	-16.09	94.68	-46.66	-29.85	-98.55	99.29	23.73
BRD-K21853356	CP	RG-14620	EGFR inhibitor	EGFR		0.00, 0.00	1.09, 0.33	-21.18	-8.31	-97.41	37.12	-72.70	-12.01	-61.38	-76.06	27.43	-51.75
BRD-K56047318	CP	RHC-80267	triacylglycerol lipase inhibitor	DAGLA, DAGLB, LIPC, LIPE, LIPG		0.00, 0.00	0.72, 0.19	-39.06	-12.94	-18.65	22.64	59.10	11.35	-85.36	79.15	-58.72	-5.97
BRD-A59174698	CP	ritodrine	adrenergic receptor agonist	ADRB2	Beta-adrenergic receptor agonist	10.00, 0.00	1.26, 0.45	32.54	-37.67	33.88	-59.84	36.15	-88.25	-64.14	96.17	-25.95	-36.42
BRD-K34330170	CP	rotenonic-acid	RAR antagonist			0.00, 0.00	0.84, 0.23	85.31	-26.05	27.52	-19.94	13.46	32.47	-48.32	-43.33	-87.12	-15.16
BRD-K08640512	CP	RS-100329	adrenoceptor antagonist	ADRA1A, ADRA1D		0.00, 0.00	0.98, 0.36	75.59	-11.27	80.84	74.26	92.83	22.69	-35.51	80.38	88.01	81.23
BRD-K87048468	CP	RS-102221	serotonin receptor antagonist	HTR2C, HTR2A, HTR2B		0.00, 0.00	1.13, 0.25	14.97	34.83	42.76	73.83	61.34	20.35	-85.31	59.01	46.87	32.25
BRD-K80725821	CP	RS-16566	(R)-zacopride ligand			10.00, 10.00	1.03, 0.33	-65.42	-34.07	-32.47	-50.24	92.66	-50.56	-25.76	89.13	99.61	-26.57
BRD-K76840893	CP	RS-17053	adrenergic receptor antagonist	ADRA1A, ADRA1D		0.00, 0.00	1.68, 0.52	-99.98	-95.43	-22.21	-98.33	-89.28	-97.05	87.29	-98.21	-98.70	-95.26
BRD-K26160755	CP	RS-45041-190	imidazoline receptor agonist			0.00, 0.00	0.84, 0.15	-27.02	40.32	40.30	46.90	-52.63	28.45	-36.55	-78.53	79.11	18.02
BRD-K87510569	CP	RS-504393	CC chemokine receptor antagonist	CCR2, CCL2		0.00, 0.00	1.22, 0.15	-99.06	-99.56	48.90	-67.76	-90.82	-54.10	-32.36	19.12	-49.21	-86.38
BRD-K20714604	CP	RS-56812	serotonin receptor antagonist, serotonin receptor partial agonist	HTR3A		0.00, 0.00	0.95, 0.38	92.99	77.29	39.10	53.74	-29.72	15.95	22.77	-16.15	68.58	62.10
BRD-K46142322	CP	RS-67333	serotonin receptor partial agonist	HTR4		0.00, 0.00	1.17, 0.35	24.46	4.94	-33.00	-39.03	11.75	87.86	-35.57	20.32	71.88	4.81
BRD-K50018155	CP	RS-67506	serotonin receptor partial agonist	HTR4		20.00, 20.00	0.85, 0.16	-45.88	52.48	-59.99	80.27	-15.75	99.68	-32.26	-25.62	98.16	53.54
BRD-A29437505	CP	RWJ-21757	toll-like receptor ligand	TLR7		20.00, 10.00	0.69, 0.20	55.52	-35.48	36.17	77.33	-22.69	96.78	-36.17	20.06	97.97	65.39
BRD-K69556541	CP	ryanodine	calcium channel inhibitor	RYR1, RYR2, RYR3		0.00, 0.00	1.49, 0.45	18.16	54.84	-90.90	62.95	69.98	77.66	69.04	32.01	93.21	68.19
BRD-K04111260	CP	raclopride	dopamine receptor antagonist	DRD2, DRD3, HTR1A		0.00, 0.00	0.45, 0.08	-38.93	-25.63	-99.98	74.81	-63.67	-6.28	62.20	-33.56	-80.76	-18.50
BRD-K14204120	CP	ranitidine	histamine receptor antagonist	HRH2, SLC22A2		0.00, 0.00	1.24, 0.33	-48.41	18.25	48.07	-41.56	23.40	40.73	-59.48	-14.14	-49.31	-13.98
BRD-A43974499	CP	reboxetine	adrenergic receptor antagonist, adrenergic transmitter uptake inhibitor, norepinephrine reputake inhibitor, norepinephrine transporter inhibitor	SLC6A2		10.00, 10.00	1.36, 0.47	9.65	-90.94	-60.95	-29.31	99.40	14.37	78.09	29.52	-45.64	-13.01
BRD-K54094468	CP	remoxipride	dopamine receptor antagonist	DRD2, DRD3, DRD4, HTR2A, SIGMAR1		0.00, 0.00	0.72, 0.16	50.79	-32.20	90.41	7.37	-14.85	-62.66	59.10	-47.24	-50.64	-21.74
BRD-K52930707	CP	rescinnamine	angiotensin converting enzyme inhibitor	ACE		0.00, 0.00	1.10, 0.27	-24.89	-82.12	-89.40	33.89	16.00	-41.88	41.27	-81.65	42.36	-51.70
BRD-K32755366	CP	reserpic-acid	norepinephrine transporter inhibitor			20.00, 10.00	0.93, 0.38	-15.03	-49.18	96.95	67.27	15.10	66.06	-98.96	97.67	-63.13	73.29
BRD-K25591257	CP	resveratrol	apolipoprotein expression enhancer, beta-secretase inhibitor, cyclooxygenase inhibitor, cytochrome P450 inhibitor, lipid peroxidase inhibitor, MAP kinase inhibitor, monoamine oxidase inhibitor, NFkB pathway modulator, SIRT activator, SIRT pathway, SIRT stimulant, sodium channel blocker, thioredoxin reductase inhibitor, topoisomerase inhibitor, xanthine oxidase inhibitor	PTGS1, PTGS2, SIRT1, APOA1, BACE1, CSNK2A1, MAOA, NQO2, SCN5A, TXNRD1, TXNRD2, XDH		0.00, 0.00	0.88, 0.31	-77.88	84.77	-99.57	-89.04	-98.98	23.94	23.24	-99.75	-88.99	-98.86
BRD-M62162320	CP	rilmenidine	adrenergic receptor agonist, imidazoline receptor agonist	NISCH		0.00, 0.00	0.84, 0.20	88.25	-96.62	-96.05	24.10	-18.95	-44.66	-45.82	32.74	-41.58	-15.53
BRD-K21283037	CP	riluzole	glutamate release inhibitor, dopamine receptor agonist, glutamate receptor antagonist, potassium channel blocker, Sodium Channel  Blockers, sodium channel blocker	KCND3, KCNK10, KCNK2, KCNK4, KCNN4, SCN5A, SLC7A11		0.00, 0.00	0.35, 0.05	39.58	-59.17	4.65	-37.22	-71.70	25.46	9.24	-66.72	69.82	-40.26
BRD-A63346720	CP	rimcazole	sigma receptor antagonist, dopamine reuptake inhibitor	SIGMAR1		10.00, 10.00	1.45, 0.64	-97.94	-43.46	-51.16	-48.40	-82.83	-64.69	35.39	-16.23	98.10	-43.61
BRD-K31627533	CP	rimexolone	glucocorticoid receptor agonist, immunosuppressant, mineralocorticoid receptor agonist	NR3C1, SERPINA6	Glucocorticoid receptor agonist	0.00, 0.00	1.19, 0.47	12.80	-33.15	39.60	-85.51	-77.05	-94.88	48.77	-43.61	-35.83	-43.21
BRD-A63546914	CP	RO-04-5595	ionotropic glutamate receptor antagonist			0.00, 0.00	0.98, 0.31	74.26	-97.93	34.03	-88.65	83.12	-46.98	86.24	-59.12	86.29	77.81
BRD-K00486786	CP	RO-08-2750	nerve growth factor receptor ligand, NGF binding inhibitor	NGFR, NGF		0.00, 0.00	1.11, 0.30	25.68	-31.01	-94.79	11.90	-99.51	24.62	-66.08	-96.36	-98.30	-98.70
BRD-K79684402	CP	RO-10-5824	dopamine receptor partial agonist	DRD4		0.00, 0.00	1.47, 0.36	-60.03	-68.89	-28.21	30.96	-32.26	46.30	82.73	70.85	91.05	68.78
BRD-K82823076	CP	RO-15-4513	GABA benzodiazepine site receptor inverse agonist	GABRA1, GABRA2, GABRA3, GABRA5, GABRA4, GABRA6, GABRB2, GABRG2		0.00, 0.00	0.78, 0.16	11.61	84.18	34.81	50.87	56.93	14.48	25.32	-25.80	91.31	23.53
BRD-K80778372	CP	RO-19-4605	GABA benzodiazepine site receptor inverse agonist	GABRA1, GABRA2, GABRA3, GABRA5		20.00, 20.00	0.72, 0.19	88.59	11.54	35.23	-43.54	37.42	20.08	99.79	-88.00	99.97	63.79
BRD-A49370193	CP	RO-60-0175	serotonin receptor agonist	HTR2C, HTR2A, HTR2B	Serotonin receptor agonist	0.00, 0.00	0.97, 0.23	10.27	-56.02	-42.98	-33.54	-14.68	91.77	91.24	-83.89	-86.86	-50.33
BRD-K20313525	CP	rosmarinic-acid	antioxidant	MCL1, TYR		20.00, 0.00	0.98, 0.19	39.34	45.84	89.86	97.19	76.21	97.20	55.64	19.41	-48.56	84.36
BRD-K06426971	CP	ryuvidine	histone lyinse methyltransferase inhibitor	CDK4, CDK2		0.00, 0.00	1.86, 0.38	-83.83	-99.52	-82.04	-69.43	37.55	-79.14	-98.72	-88.25	-85.20	-91.01
BRD-K05901394	CP	terguride	adrenergic receptor antagonist, dopamine autoreceptor agonist, dopamine receptor agonist, dopamine receptor partial agonist, platelet aggregation inhibitor, prolactin secretion inhibitor, serotonin receptor antagonist	DRD2, HTR2A, HTR2B, ADRA1A, ADRA2A, ADRA2B, ADRA2C, DRD3, DRD4, HTR1A, HTR1B, HTR1D, HTR2C, PRL		40.00, 30.00	1.16, 0.42	94.35	98.29	39.51	-6.93	99.22	97.83	-29.64	18.50	-67.95	96.99
BRD-K88871508	CP	lisuride	dopamine receptor agonist, prolactin inhibitor, serotonin receptor antagonist, serotonin receptor ligand	DRD2, HTR2B, HTR2C, ADRA2A, ADRA2B, ADRA2C, DRD1, DRD3, DRD4, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, ADRA1A, HRH1, HTR6		10.00, 10.00	1.01, 0.27	9.50	12.67	-84.29	-51.40	-3.16	99.97	-50.37	-35.81	-61.93	-16.19
BRD-K14965640	CP	ibuprofen	cyclooxygenase inhibitor, NFkB pathway inhibitor	PTGS2, PTGS1, ASIC1, BCL2, CFTR, CYP2C8, FABP2, PLAT, PPARG, SLC5A8, THBD		10.00, 0.00	0.76, 0.26	68.75	63.57	81.75	-60.06	79.31	13.33	95.06	-32.60	-30.69	55.63
BRD-K19284129	CP	salvinorin-a	opioid receptor agonist	OPRK1, OPRD1, OPRM1		20.00, 20.00	0.56, 0.23	69.14	-21.73	99.77	-50.31	99.65	-13.66	58.49	75.30	-65.41	55.69
BRD-K83637872	CP	SANT-1	smoothened receptor antagonist	DHH, IHH, PTCH1, SMO		0.00, 0.00	0.78, 0.17	-38.09	12.23	30.28	-34.81	80.21	27.99	-41.26	7.72	64.75	6.66
BRD-A89434049	CP	sarmentogenin	ATPase inhibitor	ATP1A1	ATPase inhibitor	0.00, 0.00	2.40, 0.72	-15.41	-22.03	NaN	NaN	87.20	-16.04	NaN	NaN	NaN	-6.04
BRD-K77677632	CP	SB-200646	serotonin receptor antagonist	HTR2B, HTR2C		10.00, 0.00	0.74, 0.20	14.69	-64.50	95.27	-12.45	9.64	-35.83	-31.36	80.39	31.11	8.41
BRD-K54330070	CP	SB-202190	p38 MAPK inhibitor, interleukin inhibitor, stress activated protein kinase inhibitor	MAPK14, AKT1, ALOX5, CHEK1, GSK3B, LCK, MAPK1, MAPK11, MAPK12, MAPK8, PRKCA, ROCK1, RPS6KB1, SGK1	Bromodomain Inhibitor, P38 MAPK inhibitor	0.00, 0.00	1.02, 0.23	35.03	66.41	-99.65	-18.45	-97.34	26.20	31.69	-98.82	-99.93	-98.77
BRD-A37704979	CP	SB-203580	p38 MAPK inhibitor, calcium channel activator, interleukin inhibitor, stress activated protein kinase inhibitor	MAPK14, MAPK1, MAPK11, AKT1, ALOX5, CHEK1, CYP2D6, CYP3A4, GAK, GSK3B, LCK, MAPK10, MAPK12, MAPK8, MAPK9, PRKCA, RAF1, RIPK2, ROCK1, RPS6KB1, SGK1, SRC, TNF		0.00, 0.00	0.82, 0.24	-11.82	-25.76	62.18	34.94	52.07	44.25	43.40	65.69	47.01	20.68
BRD-A22707317	CP	SB-205384	GABA receptor modulator	GABRA3, GABRA5, GABRA6		10.00, 10.00	0.75, 0.10	66.12	99.85	-82.31	-63.43	81.35	93.41	71.27	30.31	-93.35	76.38
BRD-A11609859	CP	SB-205607	delta 1 opioid receptor agonist, opioid receptor agonist	OPRD1, OPRK1, OPRM1		0.00, 0.00	0.97, 0.34	52.40	-53.69	54.55	54.83	79.57	19.26	-70.84	86.37	37.36	36.07
BRD-K61097567	CP	SB-218795	tachykinin antagonist	TACR3		10.00, 10.00	1.00, 0.34	37.31	49.44	52.35	10.05	59.99	98.87	31.38	89.47	-87.60	38.43
BRD-K14807180	CP	SB-221284	serotonin receptor antagonist	HTR2B, HTR2C, HTR2A		0.00, 0.00	0.81, 0.22	49.73	-85.40	49.58	-93.63	-70.96	24.21	-82.22	71.96	-40.58	-72.08
BRD-K04414442	CP	SB-222200	tachykinin antagonist	TACR3		0.00, 0.00	1.33, 0.55	20.63	-16.44	-33.03	38.06	-22.27	-77.90	41.15	-82.98	78.95	-4.57
BRD-K61323504	CP	SB-225002	CC chemokine receptor antagonist, Chemokine CXCR2  (IL-8 beta Receptor) Antagonists	CXCR2		30.00, 20.00	1.27, 0.60	66.32	100.00	-24.39	93.38	86.65	99.93	70.44	-65.54	-45.95	95.54
BRD-K98143437	CP	SB-239063	p38 MAPK inhibitor, interleukin inhibitor, tumor necrosis factor production inhibitor	MAPK11, MAPK14, PTGS2, TNF		10.00, 0.00	1.15, 0.27	-78.01	95.65	-86.26	-46.59	-80.22	87.92	-77.89	-98.78	-42.01	-86.36
BRD-K24201553	CP	SB-269970	serotonin receptor antagonist	HTR7		0.00, 0.00	0.86, 0.31	86.91	26.68	-54.30	46.23	-36.85	94.61	42.58	-12.80	55.74	44.99
BRD-K41567364	CP	SB-334867	orexin receptor antagonist	HCRTR1, HCRTR2		10.00, 0.00	1.28, 0.47	-17.46	-13.29	37.69	87.45	-35.45	21.57	95.20	62.72	86.69	66.27
BRD-K59331372	CP	SB-366791	TRPV antagonist	TRPV1		10.00, 10.00	0.92, 0.26	-22.52	-95.96	49.39	12.76	98.09	14.84	63.18	18.42	44.04	28.68
BRD-K53913732	CP	SB-408124	orexin receptor antagonist, orexin type 1 receptor antagonist	HCRTR1, HCRTR2		10.00, 10.00	0.93, 0.22	-98.09	51.71	36.39	35.00	-99.98	17.24	99.10	-93.88	-78.22	-95.85
BRD-K76805682	CP	SB-415286	glycogen synthase kinase inhibitor	GSK3B, GSK3A, RPS6KB1	Glycogen synthase kinase inhibitor	0.00, 0.00	0.70, 0.20	-99.96	-99.34	-84.96	-99.77	-11.77	-97.16	-82.18	-95.26	-98.26	-99.58
BRD-K67298865	CP	SB-431542	TGF beta receptor inhibitor, ALK inhibitor	TGFBR1, ACVR1C, ACVR1B	TGF beta receptor inhibitor	10.00, 0.00	1.23, 0.48	25.88	40.90	49.03	21.30	42.95	-55.43	70.98	-88.32	96.05	29.00
BRD-K14767410	CP	SC-560	cyclooxygenase inhibitor	PTGS1		0.00, 0.00	0.90, 0.25	58.37	-81.13	47.38	-68.47	30.89	-67.68	-44.78	-47.64	56.45	-41.56
BRD-K26373640	CP	IKK-2-inhibitor	IKK inhibitor, syk inhibitor	IKBKB		10.00, 10.00	0.81, 0.20	-98.29	-25.13	-39.22	-16.36	31.23	99.56	78.46	27.99	55.82	29.08
BRD-K85871428	CP	SC-68376	p38 MAPK inhibitor	MAPK14		0.00, 0.00	0.84, 0.26	43.68	-43.50	65.69	52.39	26.78	-16.43	-16.96	8.77	-53.92	13.82
BRD-K25875056	CP	SC-9	protein kinase C activator			10.00, 0.00	1.23, 0.36	95.99	56.51	88.68	-82.86	-83.68	87.80	28.76	42.83	40.43	84.29
BRD-K81847782	CP	scandenin	plant compound with antimicrobiial activity			0.00, 0.00	0.79, 0.17	-99.70	-17.97	NaN	NaN	-38.06	50.79	NaN	NaN	NaN	-40.87
BRD-K45435259	CP	SCH-23390	dopamine receptor antagonist	DRD1, DRD5, HTR2C, KCNJ4, KCNJ6		10.00, 10.00	1.02, 0.28	-51.59	86.77	12.77	99.05	-61.22	-42.75	-31.31	42.03	78.40	51.23
BRD-K94270326	CP	ecopipam	dopamine receptor antagonist	DRD1, DRD5, DRD2		20.00, 0.00	0.76, 0.11	-21.05	-59.11	-45.75	71.19	95.31	-27.83	-33.72	97.09	-19.09	-3.10
BRD-K46469693	CP	SCH-442416	adenosine receptor antagonist	ADORA1, ADORA2A, ADORA2B, ADORA3		0.00, 0.00	0.95, 0.22	-47.58	-49.80	-44.24	16.42	17.79	-43.92	-68.22	-86.40	-85.54	-70.33
BRD-K81225797	CP	SCH-58261	adenosine receptor antagonist	ADORA2A, ADORA1, ADORA2B, ADORA3		0.00, 0.00	1.01, 0.42	-57.43	-91.79	80.14	-57.94	61.30	-93.02	-24.91	-15.79	-26.19	-55.95
BRD-A62035778	CP	scopolamine	acetylcholine receptor antagonist	CHRM2, CHRM1, CHRM3, CHRM4, CHRM5, SI		20.00, 20.00	0.86, 0.33	87.32	-19.79	36.92	98.89	27.31	68.28	-62.99	61.66	99.66	74.44
BRD-K15868788	CP	SDZ-205-557	serotonin receptor antagonist	HTR3A, HTR3B, HTR4		0.00, 0.00	0.76, 0.10	51.72	35.71	67.68	-70.58	79.81	51.23	-98.54	16.49	76.02	39.75
BRD-A15530910	CP	carpindolol	adrenergic receptor antagonist, serotonin receptor antagonist		Serotonin receptor antagonist	0.00, 0.00	1.11, 0.32	82.98	32.48	41.70	-95.48	89.98	-96.35	48.62	-97.56	40.42	31.65
BRD-A82590476	CP	SDZ-NKT-343	tachykinin antagonist	TACR1	Tachykinin antagonist	0.00, 0.00	0.82, 0.22	-97.87	-90.28	-43.41	-85.15	-88.54	-78.40	59.01	-31.66	69.66	-95.02
BRD-A31007383	CP	SDZ-WAG-994	adenosine receptor agonist	ADORA1		0.00, 0.00	1.30, 0.43	26.54	-93.39	-76.47	-22.82	23.97	26.63	-20.66	32.59	81.25	9.36
BRD-K07212038	CP	selinidin	cumarin derivative with antiallergic properties			0.00, 0.00	2.61, 0.97	-15.60	-97.17	NaN	NaN	-30.57	-16.91	NaN	NaN	NaN	-28.95
BRD-K15601958	CP	SEW-2871	lysophospholipid receptor agonist	S1PR1		10.00, 10.00	1.19, 0.39	-87.44	60.63	-76.01	99.51	75.07	-24.13	-31.39	34.27	-97.54	-34.69
BRD-K98157055	CP	SIB-1757	glutamate receptor antagonist	GRM5		10.00, 10.00	1.11, 0.28	98.62	-69.32	-19.08	-34.14	-58.79	53.41	-86.56	-18.01	-39.71	-32.26
BRD-K84996949	CP	sinensetin	cyclooxygenase inhibitor			20.00, 20.00	1.10, 0.38	-75.99	86.62	20.92	43.05	-64.01	99.35	98.25	-90.02	79.68	88.62
BRD-K73824630	CP	skatole	thrombin inhibitor	F2		0.00, 0.00	0.92, 0.19	43.95	-93.04	-58.32	-23.64	-87.87	-46.86	57.70	-38.02	-38.12	-37.55
BRD-A64227845	CP	SKF-77434	dopamine receptor agonist, dopamine receptor partial agonist	DRD1		40.00, 30.00	0.84, 0.34	94.73	98.36	30.73	99.91	-59.33	-87.24	33.77	17.69	95.37	98.24
BRD-A09828896	CP	SKF-81297	dopamine receptor agonist	DRD1, DRD5		0.00, 0.00	0.83, 0.23	37.39	-75.71	-24.57	-80.61	10.87	-45.80	31.79	-95.78	-85.26	-63.63
BRD-K96809896	CP	SKF-86002	p38 MAPK inhibitor	ALOX5, MAPK14	P38 MAPK inhibitor	0.00, 0.00	1.01, 0.36	6.49	-62.73	-81.13	-9.85	-60.36	-98.30	-25.19	-88.26	53.25	-46.97
BRD-A49046702	CP	SKF-89976A	GABA uptake inhibitor	SLC6A1		0.00, 0.00	0.89, 0.27	73.42	67.89	59.95	-68.46	32.45	-26.37	-29.11	-43.87	32.88	25.74
BRD-K01567962	CP	pyrazolanthrone	JNK inhibitor, AP inhibitor, dual specificity protein kinase inhibitor, leucine rich repeat kinase inhibitor	MAPK10, MAPK8, MAPK9, TTK, LRRK2, MAPK8IP1		0.00, 0.00	0.68, 0.16	7.68	-90.76	-36.34	-14.45	-6.34	-50.77	60.59	-17.52	-41.96	-4.51
BRD-A56987319	CP	SQ-22536	adenylyl cyclase inhibitor	ADCY1, ADCY5		0.00, 0.00	1.06, 0.40	32.64	7.12	-29.71	-34.49	-43.04	-39.16	-60.55	-28.95	42.62	-14.31
BRD-K91243525	CP	SR-142948	neurotensin receptor antagonist	NTSR1		10.00, 10.00	1.27, 0.38	99.90	-52.04	89.02	34.32	-49.43	94.34	46.16	-88.41	30.87	69.77
BRD-K35629949	CP	SR-27897	CCK receptor antagonist	CCKAR	CCK receptor antagonist	10.00, 10.00	0.99, 0.31	98.12	6.68	50.10	-51.65	11.34	16.81	93.52	80.35	-63.80	41.53
BRD-K96720755	CP	relcovaptan	vasopressin receptor antagonist	AVPR1A, AVPR1B, AVPR2, OXTR		0.00, 0.00	1.09, 0.28	-70.19	-81.07	25.82	10.93	24.10	-47.29	67.56	-79.87	-31.96	-28.88
BRD-K09397065	CP	SR-57227A	serotonin receptor agonist, serotonin release enhancer	HTR3A		20.00, 10.00	0.53, 0.13	11.62	61.98	-86.50	-28.21	-26.41	13.22	83.85	96.84	99.88	56.95
BRD-K35430135	CP	SR-59230A	adrenergic receptor antagonist	ADRB3, ADRB1, ADRB2		0.00, 0.00	0.66, 0.16	-34.47	12.85	-33.94	-42.28	-7.65	-97.44	-42.86	-45.13	-39.63	-10.88
BRD-K19309090	CP	SR-95639A	acetylcholine receptor agonist	CHRM1		0.00, 0.00	0.89, 0.15	70.27	24.75	45.28	-27.73	29.15	82.95	37.99	-44.59	-28.46	13.85
BRD-K72895815	CP	SSR-69071	leukocyte elastase inhibitor	ELANE		0.00, 0.00	2.18, 0.52	-99.01	-95.73	-99.78	-96.79	-98.79	-80.28	-75.38	-90.61	-60.36	-97.25
BRD-K18905250	CP	ST-91	adrenergic receptor agonist			30.00, 30.00	1.31, 0.35	99.21	-44.15	93.76	40.51	94.99	49.50	99.91	65.05	-98.16	98.73
BRD-K52620403	CP	STO-609	calcium/calmodulin dependent protein kinase inhibitor, calmodulin inhibitor	CAMKK1, CAMKK2		10.00, 0.00	1.22, 0.38	82.01	57.51	-40.12	97.12	92.15	41.46	-43.38	-48.34	-34.75	76.44
BRD-K20287671	CP	SU-4312	platelet-derived growth factor receptor (PDGFR) inhibitor, tyrosine kinase inhibitor, vascular endothelial growth factor receptor (VEGFR) inhibitor, vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor	KDR, PDGFRB	VEGFR inhibitor	0.00, 0.00	0.88, 0.31	66.00	-54.62	94.57	68.77	-53.87	-92.82	-38.37	-99.95	57.05	-40.65
BRD-K60487568	CP	SU-4312	platelet-derived growth factor receptor (PDGFR) inhibitor, tyrosine kinase inhibitor, vascular endothelial growth factor receptor (VEGFR) inhibitor, vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor	KDR, PDGFRB		0.00, 0.00	0.80, 0.24	-97.39	-49.29	-28.78	19.27	-44.66	-94.93	65.20	-96.47	-37.64	-88.21
BRD-K63504947	CP	semaxanib	VEGFR inhibitor, angiogenesis inhibitor, FLT3 inhibitor, hepatocyte growth factor receptor inhibitor, vascular endothelial growth factor receptor (VEGFR) inhibitor, VEGFR antagonist	KDR, FLT1, KIT, PDGFRB, FGFR1, FLT3, MET, PDGFRA, RET		20.00, 20.00	1.01, 0.31	36.64	-86.03	53.52	38.86	-42.60	-87.69	99.98	-66.53	99.13	-45.61
BRD-K34995470	CP	SU-1498	receptor tyrosine protein kinase inhibitor, vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor, VEGFR inhibitor	ERBB2, KDR		0.00, 0.00	0.81, 0.25	-97.70	-20.00	-62.53	-36.84	-14.07	-99.15	52.76	-96.95	-95.33	-99.58
BRD-K97354755	CP	SU-6656	src inhibitor	LYN, AURKB, AURKC, BRSK2, CALM1, CAMK2D, LCK, RET, SRC, YES1		0.00, 0.00	1.23, 0.32	36.05	-37.83	NaN	NaN	-52.50	70.65	NaN	NaN	NaN	-22.63
BRD-A70649075	CP	sulconazole	sterol demethylase inhibitor, cell wall synthesis inhibitor			0.00, 0.00	0.64, 0.11	-98.99	-24.08	-99.95	-59.67	-99.14	-99.78	-85.15	-98.79	-25.25	-99.65
BRD-A10715913	CP	sulpiride	carbonic anhydrase inhibitor, dopamine receptor, dopamine receptor antagonist	DRD2, CA7, DRD3, CA1, CA12		0.00, 0.00	2.13, 0.63	-55.41	-89.09	-48.92	78.57	-53.21	-25.92	-40.29	13.23	92.87	-50.52
BRD-A24122750	CP	saclofen	GABA receptor antagonist	GABBR1, GABBR2, KCTD12, KCTD16, KCTD8	GABA receptor antagonist	10.00, 10.00	0.99, 0.32	9.36	53.42	-94.97	-60.94	98.62	19.14	-85.48	-90.61	32.53	-49.49
BRD-K09963420	CP	saquinavir	HIV protease inhibitor, peptidase inhibitor	CYP3A4, CYP3A5		0.00, 0.00	1.15, 0.35	-14.19	-99.91	-26.80	64.63	-82.56	19.89	30.95	-32.37	-99.03	-46.66
BRD-A49906757	CP	scopolamine	acetylcholine receptor antagonist	CHRM2, CHRM1, CHRM3, CHRM4, CHRM5, SI		10.00, 10.00	0.82, 0.25	15.63	52.43	-82.18	99.29	-54.36	93.28	29.12	71.16	93.92	91.06
BRD-A14566392	CP	scopolamine	acetylcholine receptor antagonist	CHRM2, CHRM1, CHRM3, CHRM4, CHRM5, SI		0.00, 0.00	1.14, 0.47	5.87	-77.57	-71.99	48.68	49.45	6.49	-23.28	-23.76	89.20	6.33
BRD-K62609077	CP	scoulerine	adrenergic receptor antagonist, GABA receptor antagonist, serotonin receptor antagonist	ADRA1D, ADRA2A, GABRA1		40.00, 40.00	0.44, 0.09	69.88	99.96	83.19	-95.64	99.93	99.96	-68.79	-99.98	85.32	99.54
BRD-K22503835	CP	scriptaid	HDAC inhibitor	HDAC1, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9	HDAC inhibitor	0.00, 0.00	1.80, 0.59	-99.58	-76.91	-92.31	-95.75	-94.92	-99.53	-99.59	-97.93	-70.69	-98.56
BRD-A25775766	CP	securinine	GABA receptor antagonist, TP53 activator	GABRA1		10.00, 0.00	1.26, 0.41	85.36	75.62	-58.52	91.61	-26.97	-99.10	95.08	-37.08	-34.04	77.73
BRD-K38449220	CP	seneciphylline	cytochrome P450 inhibitor			10.00, 10.00	0.83, 0.28	99.72	-9.74	29.88	41.69	-20.84	88.41	43.38	23.05	-31.50	14.95
BRD-K25741894	CP	skimmianine	acetylcholinesterase inhibitor			20.00, 10.00	0.93, 0.18	98.82	80.70	54.02	96.50	7.14	14.27	20.59	62.24	-91.82	57.30
BRD-K70881766	CP	solanine	acetylcholinesterase inhibitor			0.00, 0.00	0.63, 0.15	63.55	38.31	-34.88	68.63	-44.25	-29.02	-78.06	-20.43	48.07	39.41
BRD-K97330509	CP	SRC-kinase-inhibitor-II	src inhibitor			0.00, 0.00	0.99, 0.26	91.47	20.05	33.30	-63.71	-83.76	50.18	37.93	-23.23	44.19	12.91
BRD-K68332390	CP	ponalrestat	aldose reductase inhibitor, reductase inhibitor	AKR1B1		10.00, 10.00	1.34, 0.30	-21.74	90.33	-23.30	86.08	70.97	-55.55	-69.72	98.98	-34.33	81.77
BRD-K84595254	CP	strophanthidin	ATPase inhibitor	ATP1A1, ATP1A2, ATP1A3, ATP1A4, ATP1B1, ATP1B2, ATP1B3, ATP1B4, FXYD2	ATPase inhibitor	0.00, 0.00	1.91, 0.48	-16.46	-19.56	-94.80	-51.17	13.32	-89.19	-76.32	37.74	32.84	-64.27
BRD-K35708212	CP	ouabain	ATPase inhibitor, alpha subunit binder	ATP1A1, ATP1A2, ATP1A3, ATP1A4, ATP1B1, ATP1B2, ATP1B3, ATP1B4, FXYD2		0.00, 0.00	2.21, 0.51	-58.77	93.93	-88.17	-50.60	-66.50	-52.84	-88.47	70.14	-33.65	-81.00
BRD-K30189597	CP	SYK-inhibitor	syk inhibitor	SYK		0.00, 0.00	0.99, 0.24	-59.01	-60.10	37.34	16.96	92.15	-99.85	41.66	54.28	-39.09	15.39
BRD-K14200658	CP	syrosingopine	vesicular monoamine transporter inhibitor	SLC18A2, SLC18A1		0.00, 0.00	0.92, 0.30	54.65	43.80	-61.32	-99.85	-99.98	23.92	24.50	-90.24	-55.47	-74.38
BRD-K31843556	CP	T-0070907	PPAR receptor anatagonist, PPAR receptor antagonist	PPARG		0.00, 0.00	0.45, 0.10	-52.26	42.10	-38.88	35.07	93.30	90.09	75.47	-99.47	-55.51	44.63
BRD-K63516691	CP	T-0156	phosphodiesterase inhibitor	PDE5A		20.00, 20.00	1.10, 0.40	99.39	97.57	31.61	80.82	16.62	48.66	-22.70	-72.64	-41.01	60.14
BRD-K23383398	CP	T-0901317	LXR agonist, ABC transporter expression enhancer, ROR inverse agonist	NR1H3, NR1H2, ABCA1, NCOA1, NCOA2, NR1I2, RORA, RORC, RXRB		0.00, 0.00	0.77, 0.18	-23.77	-33.83	28.04	-30.39	-92.35	-72.37	-52.60	-89.88	48.57	-48.81
BRD-K62221994	CP	T-98475	gonadotropin releasing factor hormone receptor antagonist	GNRH1, GNRHR		0.00, 0.00	1.59, 0.49	-98.70	-98.67	-85.84	-41.38	-75.28	-98.24	-69.76	-99.93	-42.07	-96.19
BRD-K25186396	CP	tangeritin	cell cycle inhibitor			0.00, 0.00	0.98, 0.23	33.38	-22.70	89.89	7.80	34.86	-59.85	37.05	-89.28	-27.52	5.08
BRD-K97118047	CP	4,5,6,7-tetrabromobenzotriazole	casein kinase inhibitor	CSNK2A1, AKT1, CHEK1, CSNK2A2, CSNK2B, GSK3B, LCK, MAP2K1, MAPK1, MAPK11, MAPK12, MAPK14, MAPK8, PRKCA, ROCK1, RPS6KB1, SGK1		0.00, 0.00	0.66, 0.16	60.16	-59.87	39.21	-71.60	64.67	13.42	38.42	-56.92	31.48	9.26
BRD-K67352070	CP	TC-2559	acetylcholine receptor agonist, acetylcholine receptor ligand	CHRNA4		0.00, 0.00	1.17, 0.38	-64.62	-95.17	-23.41	-61.85	-32.20	-67.56	-25.36	-13.41	-25.38	-43.84
BRD-A31195449	CP	TCB2	serotonin receptor agonist	HTR2A		20.00, 10.00	1.26, 0.40	21.29	-14.88	-26.00	11.57	5.29	96.04	-34.77	-36.30	99.54	3.55
BRD-K73999723	CP	telmisartan	angiotensin receptor antagonist, PPAR receptor agonist, PPAR receptor modulator, PPAR receptor partial agonist	AGTR1, PPARG, CYP2C19, CYP2J2, PPARA		0.00, 0.00	0.75, 0.19	-76.98	-20.88	80.32	57.48	-38.28	8.23	-85.92	53.02	52.23	21.66
BRD-K51805276	CP	temefos	cholinesterase inhibitor			0.00, 0.00	0.72, 0.23	50.32	-22.99	-33.28	9.72	33.65	37.16	-32.86	-49.89	-20.50	-8.63
BRD-A33833419	CP	TER-14687	inhibitor of translocation of PKCq in T cells	PRKCQ		0.00, 0.00	1.09, 0.28	-95.80	-22.99	-99.36	-16.68	-34.52	-94.76	-14.89	74.60	-46.79	-78.42
BRD-A48720949	CP	testosterone	androgen receptor (AR) agonist, androgen receptor agonist, testosterone receptor agonist	AR, CYP19A1, CYP2C19, CYP2C8, CYP3A5	Androgen receptor modulator	0.00, 0.00	0.82, 0.19	80.02	-99.04	-33.39	-35.04	-14.58	13.28	-21.96	46.76	42.83	9.79
BRD-K97309399	CP	thiothixene	dopamine receptor, dopamine receptor antagonist	HTR2A, DRD1, DRD2, HRH1	Dopamine receptor antagonist	0.00, 0.00	1.48, 0.45	-47.84	32.84	-77.29	-81.84	-67.23	-99.03	-52.80	-99.44	27.34	-85.07
BRD-K12867552	CP	THM-I-94	HDAC inhibitor, apoptosis stimulant, cell cycle inhibitor	HDAC1, HDAC10, HDAC2, HDAC3, HDAC6, HDAC8	HDAC inhibitor	0.00, 0.00	1.81, 0.57	-99.63	-99.43	-85.33	-98.86	-99.67	-99.50	-99.74	-99.44	-98.52	-98.94
BRD-K45988865	CP	tetramethylsilane	organosilicon compound used as an internal standard in NMR spectroscopy			30.00, 20.00	1.18, 0.18	99.19	99.98	-41.79	-22.95	96.85	92.08	-18.78	-18.44	-27.42	89.97
BRD-K51033547	CP	tramadol	opioid receptor agonist, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, adrenergic transmitter uptake inhibitor, OP3 receptor agonist, serotonin uptake inhibitor	OPRM1, SLC6A2, SLC6A4, CHRFAM7A, CHRM3, CYP2B6, GRIN3A, HTR2C, OPRD1, OPRK1		0.00, 0.00	0.81, 0.17	-21.63	82.32	30.65	33.20	38.57	-22.60	42.55	20.16	93.53	51.59
BRD-A01295252	CP	trans-7-hydroxy-pipat	dopamine receptor ligand			0.00, 0.00	0.77, 0.33	-13.99	85.38	51.42	-30.17	86.53	39.16	52.44	-63.84	-37.07	19.84
BRD-K34415467	CP	trimethobenzamide	histamine receptor antagonist	DRD2		0.00, 0.00	0.81, 0.31	44.88	-19.55	-73.59	-14.31	61.32	-51.72	77.54	-44.34	-30.82	-15.06
BRD-K54790157	CP	trioxsalen	DNA synthesis inhibitor			20.00, 20.00	1.02, 0.31	67.47	99.96	76.75	-30.93	51.23	92.62	43.46	-18.78	98.44	93.30
BRD-K57033106	CP	tripelennamine	histamine receptor antagonist	HRH1		10.00, 10.00	0.50, 0.18	99.69	-42.41	-9.92	79.39	-55.40	-89.98	90.82	46.70	56.49	62.81
BRD-K00959089	CP	thenoyltrifluoroacetone	PPAR receptor ligand	CES1, PPARA, SDHA		10.00, 0.00	1.36, 0.39	-40.18	62.82	-72.92	96.33	-35.74	61.33	-39.78	60.21	-46.78	42.36
BRD-K68246049	CP	TTNPB	RAR agonist, retinoid receptor agonist	RARB, RARA, RARG	Retinoid receptor agonist	40.00, 40.00	1.40, 0.33	83.01	99.96	-61.95	-62.76	74.76	99.88	51.71	-97.73	99.73	98.41
BRD-A02176148	CP	tubaic-acid	mitochondrial complex I inhibitor, NADH-ubiquinone oxidoreductase (Complex I) inhibitor	MT-ND1		0.00, 0.00	1.09, 0.36	72.77	67.62	86.96	-44.56	-55.02	9.41	-99.49	-48.16	-69.04	-35.63
BRD-K94176593	CP	TWS-119	glycogen synthase kinase inhibitor	GSK3B, JUN, MYC	Glycogen synthase kinase inhibitor	20.00, 10.00	1.14, 0.41	-84.73	99.82	-61.57	91.68	68.67	-75.45	96.74	49.83	42.21	94.03
BRD-K60184833	CP	tyrphostin-46	tyrosine kinase inhibitor	EGFR		0.00, 0.00	0.92, 0.27	-31.22	-61.28	25.47	77.51	-92.88	70.69	40.11	-79.85	-34.70	-32.89
BRD-K96778649	CP	tyrphostin-47	EGFR inhibitor, epidermal growth factor receptor (EGFR) inhibitor	EGFR		0.00, 0.00	1.05, 0.30	-54.96	58.81	69.66	-14.12	-65.89	-59.08	-76.51	-31.43	-78.20	-54.29
BRD-K11158509	CP	tyrphostin-B44	EGFR inhibitor			10.00, 10.00	1.33, 0.44	90.71	-98.23	37.57	44.82	13.58	88.38	99.96	51.31	-36.46	74.28
BRD-A98378129	CP	talniflumate	cyclooxygenase inhibitor, calcium channel blocker, calcium-activated chloride channel blocker, mucin production inhibitor	CLCA1		0.00, 0.00	1.20, 0.51	87.76	62.94	-44.09	91.62	48.51	42.58	-61.20	-54.33	76.98	63.59
BRD-K43744935	CP	tamoxifen	estrogen receptor antagonist, selective estrogen receptor modulator (SERM), estrogen receptor agonist, estrogen receptor modulator, PKC inhibitor	ESR1, ESR2, CYP3A5, EBP, GPER1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PRKCI, PRKCQ, PRKCZ		0.00, 0.00	0.91, 0.18	-94.28	-82.99	-17.96	73.31	41.94	72.33	65.95	-99.87	-39.17	-48.99
BRD-A23723433	CP	paclitaxel	tubulin inhibitor, microtubule stabilizing agent, microtubule stimulant, P glycoprotein inhibitor, taxane	TUBB, NR1I2, ABCB1, BCL2, CYP2C8, MAP2, MAP4, MAPT, TLR4, TUBB1		30.00, 30.00	1.08, 0.30	-24.75	99.93	-40.11	67.23	75.23	98.53	99.73	65.36	-41.85	94.34
BRD-K06147391	CP	telenzepine	acetylcholine receptor antagonist	CHRM1		0.00, 0.00	0.53, 0.17	78.60	82.28	19.73	-10.59	-75.68	81.06	-22.44	-20.84	-24.95	25.95
BRD-A87479750	CP	tenidap	cyclooxygenase inhibitor, lipoxygenase inhibitor, prostanoid receptor antagonist	ALOX5, KCNJ4, PTGS1		0.00, 0.00	0.78, 0.24	-31.63	-26.07	-36.59	28.80	34.81	-20.69	32.24	-9.32	-40.97	-6.59
BRD-K90553655	CP	testosterone	androgen receptor (AR) agonist, androgen receptor agonist, testosterone receptor agonist	AR, CYP19A1, CYP2C19, CYP2C8, CYP3A5		0.00, 0.00	0.67, 0.25	-13.30	-98.51	68.93	34.90	-13.14	58.11	-39.58	84.67	-25.66	31.40
BRD-A11605036	CP	thiocolchicoside	GABA receptor antagonist	GABRA1, GABRB2, GABRG2, GLRA1, GLRB		10.00, 10.00	1.44, 0.57	-7.63	20.14	-37.60	54.16	93.01	-39.83	-49.40	98.50	42.56	17.69
BRD-A85424553	CP	thioperamide	histamine receptor antagonist, histamine receptor inverse agonist	HRH3, HRH4		10.00, 0.00	1.02, 0.32	-20.22	22.70	95.48	11.36	-13.16	13.45	-50.21	-23.36	-60.96	-5.44
BRD-K63874012	CP	thioperamide	histamine receptor antagonist, histamine receptor inverse agonist	HRH3, HRH4		10.00, 10.00	0.66, 0.16	-24.04	91.60	-33.80	-75.08	44.86	99.93	76.87	-34.41	30.32	33.69
BRD-K08619574	CP	thioproperazine	dopamine receptor antagonist	ADRA1A, ADRA1B, DRD1, DRD2, HTR1A, HTR2A	Dopamine receptor antagonist	20.00, 10.00	0.81, 0.30	97.33	-89.73	-63.47	24.79	-63.58	98.85	93.38	-43.50	50.10	81.27
BRD-K11107424	CP	tiotidine	histamine receptor antagonist	HRH2		10.00, 10.00	0.97, 0.36	85.84	-99.08	-70.43	-49.62	24.62	26.24	81.37	-39.21	98.49	48.75
BRD-K20141153	CP	atomoxetine	norepinephrine transporter inhibitor, adrenergic transmitter uptake inhibitor	SLC6A2, SLC6A3, SLC6A4, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B		10.00, 10.00	0.63, 0.11	74.01	-26.22	-40.33	-26.21	27.39	-28.82	98.86	31.08	-50.62	10.61
BRD-K34154330	CP	tracazolate	GABA receptor agonist, GABA receptor modulator	GABRA1		20.00, 10.00	0.61, 0.17	99.23	-97.22	42.10	-31.10	70.18	-76.21	-66.77	-25.29	95.86	24.17
BRD-K19533706	CP	tranilast	angiogenesis inhibitor, histamine receptor antagonist, histamine release inhibitor, indoleamine 2,3-dioxygenase activator, interferon gamma synthesis inhibitor, interleukin receptor modulator, interleukin synthesis enhancer, interleukin synthesis inhibitor, TGF beta receptor antagonist, TRPV antagonist, tumor necrosis factor production inhibitor, urate transporter inhibitor	HPGDS, HRH1, IDO1, IFNG, IL10, IL2, IL4, SLC22A12, TGFB1, TNF, TRPV2		0.00, 0.00	0.76, 0.17	-83.20	29.91	90.18	93.34	-82.22	-54.78	83.50	78.31	54.19	80.38
BRD-K69837166	CP	trap-101	nociceptin/orphanin FQ (NOP) receptor antagonist, opioid receptor antagonist	OPRL1		10.00, 10.00	0.89, 0.22	-12.44	-65.85	90.39	-33.72	99.98	79.60	45.28	-95.95	-21.06	55.05
BRD-K95763993	CP	trapidil	calcium channel antagonist, PDGFR tyrosine kinase receptor inhibitor, platelet aggregation inhibitor, protein kinase activator	PDGFRA		0.00, 0.00	0.72, 0.22	69.57	-23.07	41.51	-19.60	10.07	-87.13	49.78	-32.36	-35.55	-11.32
BRD-K08619838	CP	tremorine	acetylcholine receptor agonist			20.00, 10.00	1.05, 0.24	95.86	-11.11	-78.77	97.92	-7.78	62.05	-55.12	60.89	-28.78	28.77
BRD-K77554836	CP	triamcinolone	antiinflammatory agent, corticosteroid agonist, corticosteroid binding globulin binder, corticosteroid hormone receptor agonist, cytochrome P450 inhibitor, glucocorticoid receptor agonist, immunosuppressant, immunosuppressive agent	NR3C1, CYP3A5, CYP3A7, SERPINA6		0.00, 0.00	1.30, 0.67	62.58	-74.38	30.56	-54.14	-66.63	-98.50	-26.71	-36.02	-22.25	-41.67
BRD-A84389633	CP	tropanyl-3,5-dimethylbenzoate	serotonin receptor antagonist			0.00, 0.00	0.81, 0.18	36.15	-95.60	43.88	-22.17	-88.53	-21.31	94.02	9.14	25.48	7.58
BRD-A83859836	CP	tropisetron	serotonin receptor antagonist, polarization inhibitor, sodium channel blocker	HTR3A, GLRA1, GLRA2, GLRB, HTR4		0.00, 0.00	0.98, 0.26	71.72	-90.06	-55.14	83.03	93.00	41.65	72.66	-8.23	88.81	82.45
BRD-K02607075	CP	tubocurarine	acetylcholine receptor antagonist	CHRNA2, HTR3A, ACHE, HTR3B, KCNN1, KCNN2, KCNN3, ZACN		0.00, 0.00	1.13, 0.40	13.12	-12.55	-69.02	-76.76	-77.12	-17.06	75.83	23.07	61.91	-20.13
BRD-K17415526	CP	tyrphostin-AG-835	protein tyrosine kinase inhibitor	EGFR		0.00, 0.00	0.81, 0.25	21.75	-23.94	-41.89	57.07	-99.08	-29.37	-66.16	12.31	-29.45	-6.23
BRD-A81795050	CP	U-18666A	oxidosqualene cyclase inhibitor			0.00, 0.00	1.19, 0.26	-68.90	21.87	-96.63	-45.17	66.82	-92.33	-98.62	-91.21	-35.45	-93.14
BRD-K70281171	CP	U-99194	dopamine receptor antagonist	DRD3		20.00, 10.00	1.11, 0.27	72.85	-74.13	-25.14	-86.03	11.36	37.49	95.19	29.97	98.38	21.82
BRD-K18787491	CP	U-0126	MEK inhibitor, JAK inhibitor, MAP kinase inhibitor	AKT1, CHEK1, GSK3B, JAK2, LCK, MAP2K1, MAP2K2, MAP2K7, MAPK1, MAPK11, MAPK12, MAPK14, MAPK8, PRKCA, RAF1, ROCK1, RPS6KB1, SGK1	MEK inhibitor	10.00, 0.00	1.06, 0.43	-98.84	-99.56	-51.14	-85.62	-85.61	-99.79	97.18	-99.89	34.03	-99.05
BRD-K18757346	CP	U-46619	thromboxane receptor agonist	PTGDR, PTGDR2, PTGER1, PTGER2, PTGER3, PTGER4, PTGFR, PTGIR, TBXA2R		0.00, 0.00	0.91, 0.20	11.91	-95.11	89.74	-33.67	-66.46	18.93	-31.74	18.26	75.45	-10.43
BRD-A96897502	CP	U-74389F	lipid peroxidase inhibitor			0.00, 0.00	0.85, 0.34	87.59	-85.12	-38.22	50.73	14.55	-23.20	-28.63	19.60	54.66	9.05
BRD-K46419649	CP	U0126	MEK inhibitor, JAK inhibitor, MAP kinase inhibitor	JAK2, MAP2K1, MAP2K2, MAP3K1, MAP3K2		10.00, 10.00	1.44, 0.51	-26.16	-48.77	-40.17	-94.43	-94.79	-97.23	99.74	-99.87	30.12	-97.15
BRD-A14574269	CP	UB-165	acetylcholine receptor agonist	CHRNA3, CHRNA4, CHRNB2		10.00, 0.00	1.14, 0.43	-53.06	50.94	-13.77	48.27	21.62	84.24	-33.69	-38.47	96.82	34.56
BRD-A45499626	CP	UBP-302	glutamate receptor antagonist	GRIK1		0.00, 0.00	0.94, 0.34	10.39	-34.45	-36.42	-17.49	-72.85	73.20	68.82	91.01	47.41	33.75
BRD-K50325075	CP	UCL-2077	potassium channel blocker, slow afterhyperpolarization channel blocker			0.00, 0.00	0.83, 0.24	27.81	-58.79	83.73	-89.68	13.87	23.07	-37.99	14.58	-67.95	-28.11
BRD-K45158365	CP	valsartan	angiotensin receptor antagonist	AGTR1		20.00, 20.00	0.73, 0.22	98.16	98.16	13.36	-63.07	75.52	74.25	53.32	21.86	34.11	54.88
BRD-K13926615	CP	vardenafil	phosphodiesterase inhibitor	PDE5A, CYP2C19, CYP2C8, CYP3A5, PDE6G, PDE6H		0.00, 0.00	0.99, 0.28	37.52	67.57	-11.47	41.98	47.40	48.86	15.42	53.27	15.08	33.69
BRD-K61737877	CP	VEGF-receptor-2-kinase-inhibitor-IV	VEGFR inhibitor	KDR		80.00, 60.00	0.90, 0.31	99.86	96.35	NaN	NaN	99.85	93.08	NaN	NaN	NaN	99.93
BRD-K60923938	CP	veratridine	sodium channel activator	SCN1A, SCN3A, SCN8A, SCN9A		10.00, 10.00	1.07, 0.30	65.69	-95.51	50.34	-79.88	54.24	18.70	54.04	40.02	99.92	44.85
BRD-A55594068	CP	vinblastine	microtubule formation inhibitor, tubulin inhibitor, tubulin polymerisation inhibitor	TUBB, JUN, TUBA1A, TUBD1, TUBE1, TUBG1	Tubulin inhibitor	20.00, 10.00	1.43, 0.39	91.38	95.93	-76.10	98.78	64.00	84.04	-74.43	-85.09	-94.19	86.32
BRD-A60414806	CP	vincristine	tubulin inhibitor, microtubule inhibitor, microtubule polymerization inhibitor, tubulin polymerisation inhibitor, vinca alkaloid	TUBB, TUBA4A		10.00, 10.00	1.41, 0.49	60.92	99.58	-36.08	82.90	-84.86	94.97	-71.67	43.20	-90.87	83.33
BRD-K62206109	CP	VUF-5681	histamine receptor antagonist	HRH3		20.00, 0.00	0.89, 0.35	89.43	46.60	25.62	-23.77	87.91	-35.50	47.39	95.21	96.06	89.46
BRD-A22783572	CP	vinblastine	microtubule formation inhibitor, tubulin inhibitor, tubulin polymerisation inhibitor	TUBB, JUN, TUBA1A, TUBD1, TUBE1, TUBG1		0.00, 0.00	1.72, 0.49	-95.63	58.68	-17.80	-49.74	-53.48	-18.70	-96.41	-86.05	-88.71	-91.32
BRD-K40902647	CP	vincamine	adrenergic receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4		0.00, 0.00	0.98, 0.38	-18.46	19.05	35.87	-13.70	-23.85	-50.61	-29.99	-76.25	-30.94	-7.47
BRD-A76528577	CP	vincristine	tubulin inhibitor, microtubule inhibitor, microtubule polymerization inhibitor, tubulin polymerisation inhibitor, vinca alkaloid	TUBB, TUBA4A		0.00, 0.00	1.67, 0.57	71.57	94.81	-94.20	82.67	10.07	-23.07	-75.77	51.72	-83.63	-48.85
BRD-A19374631	CP	vinpocetine	phosphodiesterase inhibitor, sodium channel blocker, voltage-sensitive sodium channel inhibitor	PDE1A, PDE1C, SCN10A		0.00, 0.00	0.94, 0.38	-42.75	24.65	90.76	80.11	47.90	38.33	21.19	39.28	-24.29	13.02
BRD-K53318339	CP	vinpocetine	phosphodiesterase inhibitor, sodium channel blocker, voltage-sensitive sodium channel inhibitor	PDE1A, PDE1C, SCN10A		10.00, 10.00	0.94, 0.25	92.48	43.55	47.79	-61.95	-11.79	98.18	80.94	21.46	-63.41	58.94
BRD-A41941932	CP	vitexin	antioxidant			0.00, 0.00	1.34, 0.58	78.80	-33.53	46.62	13.89	-77.10	-64.59	45.36	17.76	31.48	6.62
BRD-K78084463	CP	W-12	calmodulin antagonist			0.00, 0.00	1.39, 0.38	-11.08	19.36	NaN	NaN	-68.00	-96.35	NaN	NaN	NaN	-78.24
BRD-K45068323	CP	W-13	calmodulin antagonist	CALM1, MYLK, PDE1A	Calmodulin antagonist	0.00, 0.00	0.83, 0.13	76.50	58.75	31.78	49.76	-90.08	-69.54	-76.93	-87.59	-99.60	-67.98
BRD-K90259198	CP	W-7	calmodulin antagonist, potassium channel blocker, squalene monooxygenase channel blocker	CALM1, CALM2, KCNA5, KCNH2, TNNC1, TNNI3		0.00, 0.00	1.80, 0.43	43.65	-72.45	-77.43	-48.92	69.81	-76.95	-48.60	-27.02	-61.58	-64.94
BRD-K68341547	CP	W-9	calmodulin antagonist	CALM2	Calmodulin antagonist	0.00, 0.00	0.93, 0.22	74.64	85.02	-27.68	-18.50	-13.46	37.54	92.95	-14.48	-50.09	31.55
BRD-K36198571	CP	WAY-170523	metalloproteinase inhibitor	MMP13		0.00, 0.00	1.30, 0.38	-68.18	18.68	-99.55	-92.21	-66.12	-51.36	-97.46	-98.77	-96.06	-95.56
BRD-A20968261	CP	WAY-213613	glutamate transporter inhibitor	SLC1A2		10.00, 10.00	0.76, 0.27	70.96	99.72	59.45	20.57	64.74	34.09	38.44	49.03	-71.34	41.75
BRD-K28115081	CP	apafant	platelet activating factor receptor antagonist	PTAFR		0.00, 0.00	1.13, 0.28	-20.61	48.10	47.38	21.05	24.85	78.55	-52.70	-21.69	-96.04	12.68
BRD-K26669427	CP	WR-216174	CDK inhibitor, PFMRK inhibitor			0.00, 0.00	1.34, 0.45	-99.92	-99.32	-97.36	-68.28	-98.27	-99.66	62.91	-92.64	-96.45	-99.33
BRD-K01902415	CP	pirinixic-acid	PPAR receptor agonist	PPARA	PPAR receptor agonist	10.00, 10.00	1.06, 0.30	12.89	-28.68	99.82	7.98	25.25	12.37	73.83	51.27	89.68	59.45
BRD-K12260308	CP	xanthoxyline	plant-derived antifungal			0.00, 0.00	0.93, 0.28	-13.08	-99.96	-48.31	68.56	-55.24	-41.04	50.70	-12.11	-28.66	-25.35
BRD-K21565985	CP	xylazine	adrenergic receptor agonist	ADRA2A, ADRA2B, ADRA2C		10.00, 10.00	1.05, 0.38	-44.93	99.80	36.89	85.36	10.53	-98.85	33.55	-41.13	42.33	7.82
BRD-K88358234	CP	xaliproden	serotonin receptor agonist, nerve growth factor agonist, neurotrophic factor enhancer	HTR1A		0.00, 0.00	0.72, 0.27	-17.87	-11.73	-48.81	-39.11	88.95	13.72	31.79	89.20	-49.21	7.90
BRD-K94832621	CP	Y-134	estrogen receptor antagonist, selective estrogen receptor modulator (SERM)	ESR1, ESR2	Estrogen receptor antagonist	0.00, 0.00	1.28, 0.23	-99.62	-98.37	-70.93	-80.47	-96.59	-98.41	-28.12	-97.98	-53.99	-97.74
BRD-A44133049	CP	azasetron	serotonin receptor antagonist	HTR3A, HTR3B		10.00, 10.00	0.66, 0.13	-29.26	-36.15	2.55	99.66	-28.24	94.70	-10.28	-14.19	-74.87	-4.83
BRD-K60476892	CP	YC-1	activator of soluble guanylyl cyclase, guanylate cyclase activator, hypoxia inducible factor inhibitor	HIF1A, GUCY1A2, GUCY1A3, GUCY1B3		10.00, 10.00	0.66, 0.16	70.85	-34.93	-47.49	-91.37	99.34	74.10	-99.96	-97.01	-92.83	-95.87
BRD-K59650319	CP	YM-298198	glutamate receptor antagonist	GRM1		30.00, 20.00	0.99, 0.30	98.89	51.69	48.61	99.27	34.56	90.64	66.49	-35.46	91.73	97.04
BRD-K12932420	CP	YM-976	phosphodiesterase inhibitor, tumor necrosis factor production inhibitor	PDE4A, PDE4B, PDE4C, PDE4D, TNF		10.00, 0.00	0.73, 0.27	36.05	-38.59	-53.16	44.98	92.22	-94.78	95.60	-13.47	47.50	13.75
BRD-K06208435	CP	YS-035	calcium channel blocker			20.00, 20.00	1.06, 0.41	14.65	18.74	89.90	91.42	99.88	-71.78	-26.65	46.47	99.69	82.00
BRD-A51410489	CP	yohimbine	adrenergic receptor antagonist	ADRA2A, ADRA2C, ADRA2B, HTR1A, HTR1B, HTR1D, HTR2B, DRD2, DRD3, HTR1E, HTR1F, HTR2A, HTR2C, HTR5A, HTR7, KCNJ1, KCNJ10, KCNJ11, KCNJ12, KCNJ14, KCNJ15, KCNJ8		0.00, 0.00	1.49, 0.53	70.49	-51.19	32.27	-8.06	5.94	-91.51	44.07	-52.89	24.73	-6.68
BRD-K15935639	CP	z-leu3-VS	PGPH inhibitor, proteasome inhibitor		Proteasome inhibitor	0.00, 0.00	3.00, 0.82	-99.68	-67.90	NaN	NaN	-98.75	-99.48	NaN	NaN	NaN	-98.89
BRD-K60174629	CP	z-prolyl-prolinal	prolyl endopeptidase inhibitor	PREP		10.00, 0.00	0.88, 0.26	61.80	-44.13	22.16	-97.39	23.90	20.38	96.28	52.29	27.32	12.59
BRD-K64157027	CP	ZD-2079	adrenergic receptor agonist, insulin sensitizer	ADRB3		0.00, 0.00	1.17, 0.34	-34.19	-63.63	82.14	72.33	-62.84	39.47	-30.25	80.91	94.09	74.86
BRD-K11373525	CP	ZD-7155	angiotensin receptor antagonist	AGTR1	Angiotensin receptor antagonist	0.00, 0.00	1.28, 0.45	-52.26	-43.21	-79.47	-65.76	-96.44	16.33	-26.00	-73.67	-98.20	-71.53
BRD-K18678457	CP	ZD-7288	HCN (hyperpolarization activated cyclic nucleotide gated) channel blocker, HCN channel antagonist, potassium channel antagonist, sodium channel blocker	HCN1, HCN2, HCN3, HCN4		10.00, 10.00	1.08, 0.36	55.67	-72.40	-46.09	78.85	61.33	-72.50	99.39	-59.82	94.40	75.89
BRD-K05151076	CP	ZK-164015	estrogen receptor antagonist	ESR1, ESR2	Estrogen receptor antagonist	10.00, 10.00	1.38, 0.18	-88.86	97.61	-86.61	-99.05	-97.67	-98.84	-32.51	-99.95	-98.71	-97.78
BRD-K33882852	CP	ZK-93423	benzodiazepine receptor agonist	GABRA1, GABRA2, GABRA3, GABRA5, GABRB2, GABRG2		0.00, 0.00	0.83, 0.20	41.60	-38.05	-88.36	-90.29	-91.35	-26.71	-38.40	-99.24	-96.71	-96.72
BRD-K68392338	CP	ZK-93426	benzodiazepine receptor agonist, benzodiazepine receptor antagonist, GABA benzodiazepine site receptor antagonist	GABRA1, GABRA2, GABRA3, GABRA5		0.00, 0.00	1.15, 0.33	41.26	20.61	87.96	-44.27	72.84	33.21	-47.16	-97.53	-26.72	15.39
BRD-K19605405	CP	ZM-241385	adenosine receptor antagonist	ADORA2A, ADORA2B, ADORA1, ADORA3		10.00, 10.00	0.63, 0.23	-55.48	50.74	98.10	-57.44	65.25	-87.68	-25.33	-97.56	-33.24	-52.01
BRD-K41337261	CP	ZM-306416	Src and Abl inhibitor, vascular endothelial growth factor receptor 1 (VEGFR1) inhibitor	FLT1, KDR, EGFR, FLT4	SRC inhibitor, VEGFR inhibitor	10.00, 10.00	0.83, 0.25	46.43	16.29	-90.90	-28.74	99.80	-96.09	-27.24	33.42	32.72	7.02
BRD-K67831364	CP	ZM-323881	vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor, VEGFR inhibitor	KDR	VEGFR inhibitor	10.00, 10.00	0.82, 0.20	-90.82	-99.21	84.71	53.03	29.18	10.31	30.03	97.66	-25.89	11.51
BRD-K54314721	CP	zolmitriptan	serotonin receptor agonist	HTR1B, HTR1D, HTR1A, HTR1F, HTR1E		10.00, 0.00	0.59, 0.14	53.82	63.02	-10.88	31.88	38.01	49.23	97.06	30.35	-86.46	23.92
BRD-K12516989	CP	zaprinast	phosphodiesterase inhibitor, histamine release inhibitor	PDE5A, GPR35, PDE1A, PDE4D, PDE9A		0.00, 0.00	1.01, 0.34	-47.93	-16.73	-44.78	25.69	-55.94	51.88	25.64	-7.66	63.48	12.33
BRD-K37561857	CP	zardaverine	phosphodiesterase inhibitor	PDE4D, PDE3A, PDE4A, PDE4B, PDE4C		0.00, 0.00	0.61, 0.11	-59.37	18.10	12.45	47.30	75.33	-55.97	80.55	44.23	68.95	43.12
BRD-K92446736	CP	zatebradine	HCN (hyperpolarization activated cyclic nucleotide gated) channel blocker, HCN channel antagonist, potassium channel antagonist, sodium channel blocker	HCN1, HCN2, HCN3, HCN4		0.00, 0.00	0.68, 0.17	86.43	69.27	-55.36	-37.81	14.02	-28.88	27.00	-13.78	-51.87	-11.48
BRD-K08996725	CP	zolantidine	histamine receptor antagonist			0.00, 0.00	1.06, 0.39	94.84	42.03	-28.27	70.80	-41.31	-36.49	94.93	-99.47	38.82	24.21
BRD-K28761384	CP	zuclopenthixol	dopamine receptor antagonist	DRD2, DRD1, ADRA1A, ADRA2A, DRD5, HRH1, HTR2A		0.00, 0.00	0.95, 0.25	-26.73	-16.34	36.26	23.63	-87.96	-96.58	-41.30	15.91	92.88	-8.02
BRD-K45401373	CP	betulinic-acid	apoptosis stimulant, caspase activator, diacylglycerol O acyltransferase inhibitor, HIV integrase inhibitor, NFkB pathway activator, NFKB pathway inhibitor, SARS coronavirus 3C-like protease inhibitor, topoisomerase inhibitor	CASP3, CASP8, GPBAR1, TOP1		20.00, 10.00	0.89, 0.25	77.96	-41.31	23.10	21.06	99.80	96.41	37.09	87.02	68.31	85.68
BRD-A41301928	CP	bongkrek-acid	mitochondrial ADP, ATP translocase inhibitor	SLC25A4		0.00, 0.00	1.39, 0.41	11.34	22.11	-22.97	19.90	-78.71	-54.06	32.97	-11.63	-42.94	-14.94
BRD-K63606607	CP	bufalin	ATPase inhibitor, chloride channel activator	ATP1A1	ATPase inhibitor	0.00, 0.00	2.18, 0.60	-66.64	-60.96	-99.08	-78.13	-54.46	-97.90	-94.51	57.43	-49.79	-93.34
BRD-A26097136	CP	bulleyaconitine-a	non-opiod analgesic			10.00, 10.00	1.14, 0.45	72.89	9.73	98.61	-29.39	15.08	11.02	-25.06	-20.13	55.76	16.51
BRD-K26134695	CP	calpeptin	calpain inhibitor, proteasome inhibitor, tyrosine phosphatase inhibitor			0.00, 0.00	1.59, 0.51	-45.88	46.28	-45.54	29.16	88.37	56.75	53.64	10.10	22.35	24.76
BRD-A80502530	CP	cinobufagin	ATPase inhibitor, chloride channel activator	ATP1A1, ATP1A2, ATP1A3, ATP1A4, ATP1B1, ATP1B2, ATP1B3, ATP1B4, FXYD2	ATPase inhibitor	0.00, 0.00	2.39, 0.55	-36.81	21.14	-84.99	-64.47	-31.73	-94.79	-98.27	23.75	-92.36	-92.76
BRD-K70487031	CP	flupentixol	dopamine receptor antagonist	DRD2, DRD1, ADRA1A, CHRM1, DRD3, DRD5, HTR2A		0.00, 0.00	1.06, 0.28	-85.33	-96.08	66.21	-91.39	26.19	-87.10	60.84	-69.28	-62.02	-84.89
BRD-K97509413	CP	coumestrol	AGE inhibitor, estrogen receptor agonist, estrogen receptor ligand	ESR1, ESR2	Estrogen receptor agonist	20.00, 20.00	1.31, 0.35	-26.00	41.56	49.34	99.07	-38.21	-42.98	-19.64	38.79	97.52	17.82
BRD-A82329351	CP	cycloheximide	glycogen synthase kinase inhibitor, protein synthesis inhibitor	GSK3B, RPL3		10.00, 10.00	1.01, 0.31	-41.10	45.93	49.00	89.18	92.64	92.96	-33.82	-88.81	99.97	92.80
BRD-K58938839	CP	cyclopamine	smoothened receptor antagonist, hedgehog pathway inhibitor	SMO, DHH, IHH, PTCH1		0.00, 0.00	0.88, 0.26	92.58	-58.01	-39.67	-26.05	11.60	-20.11	67.47	-78.64	-52.38	-21.08
BRD-K93325701	CP	damnacanthal	src inhibitor			20.00, 0.00	1.81, 0.50	89.90	27.02	NaN	NaN	85.83	96.83	NaN	NaN	NaN	94.09
BRD-A94624445	CP	bucladesine	adenosine receptor agonist, cAMP stimulant, vasodilator	PRKACA		0.00, 0.00	1.34, 0.39	-24.04	-6.55	48.09	72.02	-48.72	-31.51	-63.20	-25.05	74.83	-11.99
BRD-A06726973	CP	dibutyrylcyclic-gmp	cGMP analog			0.00, 0.00	0.98, 0.30	-39.83	19.69	39.10	47.28	13.42	-9.57	-76.87	70.59	80.50	36.20
BRD-K18910433	CP	estradiol	estrogen receptor agonist	ESR1, ESR2, NR1I2, CYP2B6, CYP2C19, CYP2C8, CYP2E1, CYP3A5, CYP3A7, GPER1, KCNMA1		70.00, 70.00	0.34, 0.25	45.30	-99.06	99.94	45.16	97.89	99.96	99.64	99.98	99.93	99.93
BRD-A31801025	CP	formestane	aromatase inhibitor	CYP19A1	Aromatase inhibitor	0.00, 0.00	0.95, 0.25	-94.47	-98.23	-24.46	7.68	86.55	-40.75	32.72	41.12	-91.64	-63.57
BRD-A65550283	CP	ginsenoside	steroidal receptor agonist			10.00, 10.00	1.13, 0.31	13.78	32.12	51.97	9.75	-72.58	-37.97	23.65	40.72	99.47	11.94
BRD-A73605923	CP	mocimycin	protein synthesis inhibitor			0.00, 0.00	0.90, 0.30	-82.81	-92.67	-38.18	91.93	38.00	-81.08	29.24	-20.76	-97.35	-65.51
BRD-K09635314	CP	M-3M3FBS	phospholipase activator	PLCB2, PLCB3, PLCD1, PLCG1, PLCG2		10.00, 10.00	0.63, 0.10	93.53	92.96	-18.33	-25.11	99.88	-26.89	-68.63	-43.68	-54.75	-14.81
BRD-K36965586	CP	m-chlorophenylbiguanide	serotonin receptor agonist	HTR3A, HTR3B		0.00, 0.00	1.09, 0.35	-39.41	34.58	50.16	75.37	-14.88	12.94	41.42	-21.16	59.93	13.08
BRD-K54708045	CP	nTZDpa	PPAR receptor partial agonist	PPARG	PPAR receptor agonist	0.00, 0.00	0.97, 0.24	-52.04	25.79	25.47	-59.77	33.74	-11.79	-45.99	-71.96	-38.84	-22.43
BRD-A34907681	CP	rutin	aldose reductase inhibitor, antioxidant, capillary stabilizing agent, nitric oxide scavenger, prolyl 4-hydroxylase inhibitor	AKR1C3, AKR1B1, F10		0.00, 0.00	0.91, 0.31	45.68	-30.55	45.92	60.08	-59.46	-11.88	78.87	-95.71	27.80	27.71
BRD-A62071884	CP	siguazodan	histamine receptor antagonist, phosphodiesterase inhibitor	PDE3A		0.00, 0.00	1.00, 0.30	71.53	-91.80	-45.90	17.21	-61.28	83.30	-49.57	-59.28	37.89	-40.32
BRD-A18579359	CP	wiskostatin	neural Wiskott-Aldrich syndrome protein inhibitor	WAS, WASL		0.00, 0.00	1.68, 0.72	-41.80	19.07	-19.91	-84.65	-37.59	-96.34	-97.70	-91.03	-44.68	-79.90
BRD-A34205397	CP	suloctidil	adrenergic receptor antagonist, platelet aggregation inhibitor, vasodilator			0.00, 0.00	2.07, 0.56	-99.76	-98.97	-96.36	-15.75	NaN	-98.47	46.85	-93.42	-35.47	-97.00
BRD-A60070924	CP	alpha-estradiol	estrogen receptor agonist	ESR1, ESR2, NR1I2, CYP2B6, CYP2C19, CYP2C8, CYP2E1, CYP3A5, CYP3A7, GPER1, KCNMA1		66.67, 55.56	0.41, 0.33	98.21	NaN	99.26	97.15	70.36	39.05	99.88	99.96	81.29	99.44
BRD-K43797669	CP	genistein	tyrosine kinase inhibitor, angiogenesis inhibitor, CFTR channel activator, EGFR inhibitor, estrogen receptor agonist, histidine kinase inhibitor, immunosuppressant, isoflavone agonist, protein tyrosine kinase inhibitor, reducing agent, topoisomerase inhibitor	CFTR, ESR2, EGFR, ESR1, ESRRA, ESRRB, ESRRG, NCOA1, NCOA2, PPARG, PTK2B, TOP2A, TRPC5		90.00, 80.00	0.38, 0.34	97.43	-98.52	99.70	99.72	99.20	98.16	99.28	99.94	99.78	99.33
BRD-K71879491	CP	tretinoin	RAR agonist, RAR receptor binder, retinoid receptor agonist, ROR ligand	RARG, RORB, ALDH1A1, ALDH1A2, GPRC5A, NR0B1, NR2C2, PPARD, RARA, RARB, RARRES1, RORC, RXRB, RXRG		0.00, 0.00	0.60, 0.19	32.03	86.24	-38.51	-29.50	79.06	40.69	53.72	-58.55	66.31	40.34
BRD-A13084692	CP	troglitazone	PPAR receptor agonist, insulin sensitizer, CCK ligand expression inhibitor, EGR1 expression enhancer, glycogen synthase kinase stimulant	PPARG, ACSL4, AKR1B1, CCL2, CYP3A4, ESRRA, ESRRG, INS, SERPINE1, SLC29A1, TRPM3	PPAR receptor agonist	20.00, 20.00	0.83, 0.27	-68.67	99.20	99.24	-36.34	88.74	19.16	-21.58	20.84	-41.23	50.41
BRD-K41260949	CP	valproic-acid	HDAC inhibitor, ABAT inhibitor, GABA receptor agonist, GABAergic transmission enhancer, voltage-gated sodium channel blocker	ABAT, HDAC1, SCN1A, SCN3A, ACADSB, ALDH5A1, HDAC2, HDAC9, OGDH, SCN10A, SCN11A, SCN1B, SCN2A, SCN2B, SCN3B, SCN4A, SCN4B, SCN5A, SCN7A, SCN8A, SCN9A		10.00, 10.00	0.66, 0.19	80.35	-25.43	77.97	98.54	-50.41	68.39	45.55	47.29	-70.50	70.98
BRD-K17705806	CP	JTC-801	opioid receptor antagonist	OPRL1		0.00, 0.00	2.92, 0.63	-99.84	-69.81	NaN	-94.95	NaN	NaN	-99.57	-89.91	NaN	-98.70
BRD-K14329163	CP	BAY-K8644	L-type calcium channel activator	CACNA1C		0.00, 0.00	1.02, 0.26	-87.46	-77.40	41.16	38.80	35.28	34.66	-80.43	82.23	77.79	22.29
BRD-A34817987	CP	itraconazole	cell wall synthesis inhibitor, cytochrome P450 inhibitor, sterol demethylase inhibitor, VEGFR inhibitor	CYP3A5, CYP3A7, CYP51A1, KDR		0.00, 0.00	0.97, 0.13	13.85	-98.95	-52.01	-40.24	51.86	77.91	-54.65	-66.23	-18.77	-20.83
BRD-A36630025	CP	SN-38	topoisomerase inhibitor	TOP1	Topoisomerase inhibitor	0.00, 0.00	3.27, 1.09	-87.49	-95.28	-92.83	-99.86	-98.18	35.48	-87.42	-99.28	-91.44	-98.56
BRD-A56359832	CP	zileuton	leukotriene synthesis inhibitor, lipoxygenase inhibitor	ALOX5		0.00, 0.00	0.57, 0.07	-32.13	37.38	94.26	44.04	-39.78	90.51	-25.43	36.23	73.79	48.47
BRD-A62809825	CP	thapsigargin	ATPase inhibitor, calcium channel blocker, PKC activator	ATP2A1	ATPase inhibitor	0.00, 0.00	1.76, 0.47	71.29	-79.45	-99.43	-99.88	-98.56	69.88	-99.30	72.25	-75.51	-99.12
BRD-K04430056	CP	7-nitroindazole	nitric oxide synthase inhibitor	NOS1, NOS2, NOS3		20.00, 10.00	0.81, 0.19	43.61	38.87	98.73	-27.84	76.81	-70.68	96.98	-11.26	17.33	47.70
BRD-K17140735	CP	SCH-79797	proteinase activated receptor antagonist	F2R		0.00, 0.00	3.38, 0.63	-98.09	-99.51	-97.66	-88.15	NaN	-98.57	-97.71	-94.30	-99.59	-97.53
BRD-K28907958	CP	CD-437	RAR agonist, retinoid receptor agonist	RARG		0.00, 0.00	3.42, 0.89	-99.80	-99.74	-98.18	-99.91	-97.31	-99.41	-99.44	-99.43	-100.00	-99.30
BRD-K41859756	CP	NVP-AUY922	HSP inhibitor	HSP90AA1, HSP90AA2, HSP90AB1	HSP inhibitor	0.00, 0.00	1.22, 0.41	-99.50	-86.68	-99.53	-36.42	92.02	-17.32	-73.45	-28.49	63.51	-83.40
BRD-K60219430	CP	serdemetan	MDM inhibitor, angiogenesis stimulant, apoptosis stimulant, oncogene inhibitor	MDM2		0.00, 0.00	1.31, 0.38	13.54	-94.79	-93.31	-77.93	-99.31	55.49	-99.70	-54.74	-99.17	-97.74
BRD-K66792149	CP	quinoclamine	algicide			0.00, 0.00	2.48, 0.58	-99.82	89.41	-98.93	-88.02	-93.95	-99.60	-95.96	-96.65	-97.82	-97.96
BRD-K73319509	CP	PF-04217903	c-Met inhibitor, hepatocyte growth factor receptor inhibitor	MET		10.00, 10.00	0.63, 0.16	18.47	-99.67	99.15	-31.92	77.05	23.18	28.88	-21.82	-56.81	-19.23
BRD-K92301463	CP	16,16-dimethylprostaglandin-e2	15-hydroxyprostaglandin dehydrogenase inhibitor, unidentified pharmacological activity	HPGD		10.00, 0.00	1.40, 0.40	77.71	-99.56	-70.21	96.48	16.43	86.94	26.28	-56.75	24.35	33.60
BRD-K93095519	CP	SJ-172550	MDM inhibitor	MDM4	MDM inhibitor	20.00, 20.00	2.57, 0.65	18.19	64.56	98.57	40.68	90.01	64.99	77.16	98.17	49.51	94.33
BRD-K99696746	CP	fatostatin	sterol regulatory element binding protein (SREBP) inhibitor	SREBF1, SREBF2		50.00, 20.00	0.88, 0.24	95.89	99.96	95.67	-83.92	38.04	99.97	50.27	26.54	68.03	97.43
BRD-K86682249	CP	BRD-K86682249	tyrosine phosphatase inhibitor	PTPN1, PTPN11		0.00, 0.00	0.90, 0.23	63.01	55.50	-9.15	-79.08	-46.59	-58.36	54.01	90.51	32.99	29.84
BRD-K14696368	CP	9-methyl-5H-6-thia-4,5-diaza-chrysene-6,6-dioxide	NFkB pathway inhibitor	RELA		30.00, 20.00	0.85, 0.25	66.36	-86.39	99.92	30.82	-27.20	95.98	99.01	63.97	40.15	91.22
BRD-K98404142	CP	BRD-K98404142	glucose 6 phosphate dehydrogenase inhibitor, immunostimulant	G6PD		10.00, 10.00	0.95, 0.34	12.13	-91.73	28.74	99.95	16.66	79.35	41.84	91.94	-34.05	66.07
BRD-A20131130	CP	2',5'-dideoxyadenosine	adenylyl cyclase inhibitor			10.00, 10.00	1.40, 0.35	24.63	63.09	81.62	99.98	61.98	49.56	83.92	33.60	30.15	74.40
BRD-K59962020	CP	CHEMBL-374350	NFkB pathway inhibitor			0.00, 0.00	1.70, 0.33	-65.46	-41.93	-18.43	-99.57	-43.25	-98.86	-96.66	-96.76	-99.65	-97.79
BRD-K61829047	CP	7b-cis	exportin antagonist	XPO1		0.00, 0.00	2.61, 0.70	-99.13	-97.32	-99.80	-99.47	-82.32	-99.97	-99.73	-99.88	-98.53	-99.68
BRD-K87142802	CP	veliparib	PARP inhibitor, DNA repair enzyme inhibitor	PARP1, PARP2	PARP inhibitor	0.00, 0.00	1.06, 0.25	30.33	74.88	40.32	14.92	-35.71	-37.61	25.53	33.24	76.86	22.22
BRD-K01192156	CP	tyrphostin-AG-112	protein tyrosine kinase inhibitor	EGFR		30.00, 20.00	1.78, 0.49	43.90	99.45	99.50	71.56	23.42	83.80	58.51	93.60	55.71	97.46
BRD-K00615600	CP	AG-14361	PARP inhibitor	PARP1	PARP inhibitor	10.00, 10.00	0.64, 0.20	-99.81	99.47	-95.99	17.09	-72.27	-99.04	-99.79	48.72	-85.59	-98.27
BRD-K02113016	CP	olaparib	PARP inhibitor, DNA repair enzyme inhibitor	PARP1, PARP2, PARP3	PARP inhibitor	0.00, 0.00	0.59, 0.13	-99.78	78.07	-94.64	61.82	-14.07	-56.15	-98.91	88.53	-88.87	-98.91
BRD-K28296557	CP	AKT-inhibitor-IV	AKT inhibitor	AKT1		0.00, 0.00	2.85, 0.60	-99.60	-94.04	-27.03	-61.51	66.15	-97.07	-95.04	-70.28	-72.49	-95.47
BRD-M86331534	CP	pyrvinium-pamoate	AKT inhibitor, androgen receptor (AR) inhibitor, androgen receptor antagonist	AR		0.00, 0.00	2.96, 0.81	-99.33	-99.58	-95.15	-99.89	-99.81	-99.37	-98.09	-98.71	-98.90	-99.22
BRD-K02950022	CP	BMS-299897	gamma secretase inhibitor, antiamyloidogenic agent		Gamma secretase inhibitor	20.00, 10.00	1.18, 0.15	6.90	98.34	24.51	50.41	55.56	16.26	12.22	25.91	97.23	43.41
BRD-K34581968	CP	BMS-536924	insulin growth factor receptor inhibitor, insulin receptor ligand	IGF1R, AKT1, CCNE1, CDK2, CYP3A4, ERBB2, INSR, KDR, LCK, MAPK1, MET, PDGFRA, PDGFRB	IGF-1 inhibitor	0.00, 0.00	2.15, 0.73	-12.73	-99.91	-99.56	-65.35	-37.53	-99.28	-94.67	55.66	-97.24	-98.87
BRD-K48923948	CP	BMS-641988	androgen receptor antagonist	AR		40.00, 40.00	2.52, 0.60	99.84	-94.64	99.86	99.09	50.43	33.92	91.79	36.10	88.44	99.44
BRD-K13049116	CP	BMS-754807	insulin growth factor receptor inhibitor	IGF1R, AKT1	IGF-1 inhibitor	0.00, 0.00	2.85, 0.90	27.79	-96.24	-94.36	-82.63	32.28	-99.52	-99.77	-99.83	-52.96	-98.38
BRD-K83289131	CP	CAY-10618	NAMPT inhibitor, niacinamide phosphoribosyltransferase inhibitor	NAMPT		0.00, 0.00	1.57, 0.45	-76.91	-82.67	81.05	-97.70	-63.10	-46.94	-94.16	-95.53	-96.35	-94.47
BRD-A84045418	CP	calpeptin	calpain inhibitor, proteasome inhibitor, tyrosine phosphatase inhibitor			20.00, 20.00	1.36, 0.52	42.21	99.93	37.57	-61.39	-18.25	13.00	98.42	-4.18	-22.53	16.87
BRD-K01779529	CP	fluoropyruvate	PDH inhibitor			40.00, 30.00	1.27, 0.24	29.08	73.11	99.94	31.07	86.71	96.49	20.26	97.65	67.84	98.38
BRD-K74402642	CP	NSC-632839	ubiquitin hydrolase inhibitor, ubiquitin isopeptidase inhibitor	USP2, USP7, SENP2, USP1		0.00, 0.00	3.01, 0.78	-99.65	-99.37	-99.00	55.29	-93.75	-99.51	-96.37	-62.56	-95.95	-98.34
BRD-K40892394	CP	AR-C133057XX	nitric oxide synthase inhibitor	NOS2, NOS1		60.00, 50.00	1.27, 0.33	99.74	98.92	97.61	96.93	29.34	92.99	-30.90	99.28	93.14	99.65
BRD-K80672993	CP	M2-PK-activator	pyruvate kinase isozyme activator	PKM		10.00, 0.00	0.49, 0.08	95.61	28.89	92.53	-82.62	93.51	41.13	-72.21	52.80	-99.86	82.29
BRD-K69690935	CP	curcumin	cyclooxygenase inhibitor, AP inhibitor, CCN expression inhibitor, DNA methyltransferase inhibitor, EGFR expression inhibitor, free radical scavenger, FtsZ inhibitor, glucose 6 phosphatase inhibitor, histone N-acetyltransferase inhibitor, HIV integrase inhibitor, lipoxygenase inhibitor, NFkB pathway inhibitor, tau aggregation inhibitor, unidentified pharmacological activity	PTGS1, PTGS2, APP, CA1, CA12, CA14, CA2, CA4, CA6, CA9, CCND1, CYP3A4, DNMT1, DNMT3B, EP300, G6PC, MAPT, MMP13, MMP9, NOS2, XDH		10.00, 10.00	1.56, 0.32	87.45	94.85	99.06	-41.03	94.37	19.14	-53.05	55.44	30.16	94.68
BRD-K86191271	CP	cytosporone-b	HMR receptor agonist	NR4A1		0.00, 0.00	0.92, 0.31	94.09	18.49	74.69	76.85	43.32	75.28	70.05	82.37	-66.60	81.36
BRD-K75532464	CP	FTI-276	farnesyltransferase inhibitor	FNTA, FNTB		0.00, 0.00	0.58, 0.22	69.77	-44.91	-21.27	74.03	-33.17	88.47	70.48	20.90	29.71	52.16
BRD-K64451768	CP	GANT-58	GLI antagonist	DHH, GLI1, IHH		10.00, 0.00	0.66, 0.23	-41.46	-11.79	62.75	69.19	21.13	16.40	96.39	-80.96	73.02	53.92
BRD-K69840642	CP	ISOX	HDAC inhibitor	HDAC6	HDAC inhibitor	0.00, 0.00	1.81, 0.60	-94.42	-60.75	-95.16	-96.12	-99.68	-99.48	-99.08	-94.59	-97.37	-98.56
BRD-K17349619	CP	HLI-373	MDM inhibitor	MDM2	MDM inhibitor	20.00, 20.00	0.85, 0.25	21.80	-97.70	38.05	99.68	79.20	99.97	91.65	26.44	-31.91	92.18
BRD-A02481876	CP	importazole	importin-ÃƒÅ½Ã‚Â² transport receptor inhibitor	KPNB1		0.00, 0.00	1.51, 0.24	-93.30	-75.28	-65.31	65.90	-28.11	-92.46	-56.88	36.06	-82.60	-85.65
BRD-A52650764	CP	ingenol	PKC activator	PRKCD, PRKCE	PKC activator	0.00, 0.00	3.22, 0.82	-73.07	76.06	89.38	-97.77	50.89	-99.43	-51.69	-97.13	-50.46	-92.71
BRD-K45446451	CP	JZL-184	monoacylglucerol lipase inhibitor	MGLL		10.00, 10.00	1.31, 0.39	94.68	56.43	18.19	24.09	-28.75	68.69	88.72	99.98	-17.38	68.51
BRD-A58955223	CP	sulforaphane	anticancer agent, aryl hydrocarbon receptor antagonist, nuclear factor erythroid derived, like (NRF2) activator	NFE2L2		70.00, 60.00	0.83, 0.22	99.95	98.01	99.76	71.61	60.28	97.10	97.98	98.48	71.79	99.05
BRD-K19796430	CP	erismodegib	hedgehog pathway inhibitor, smoothened receptor antagonist	SMO		0.00, 0.00	2.52, 0.73	18.28	-99.06	-56.23	-40.34	40.45	-23.82	-78.50	-50.85	-25.11	-63.31
BRD-A04352665	CP	maraviroc	CC chemokine receptor antagonist, CC chemokine receptor 5 (CCR5) antagonist, reverse transcriptase inhibitor	CCR5, CYP3A5		60.00, 50.00	1.38, 0.50	66.82	99.96	99.98	99.40	90.03	99.96	-45.32	95.91	-34.03	99.93
BRD-K16406336	CP	methylene-blue	guanylate cyclase inhibitor, monoamine oxidase inhibitor, nitric oxide production inhibitor, tau aggregation inhibitor	ACHE, MAPT		0.00, 0.00	2.94, 0.64	-82.54	-47.65	-94.28	-99.44	-60.21	-99.62	-84.26	-47.41	-89.57	-96.02
BRD-K68065987	CP	MK-2206	AKT inhibitor	AKT1, AKT2, AKT3		0.00, 0.00	1.82, 0.36	-90.34	-99.71	-90.09	-40.98	-31.17	-83.63	-99.95	-98.21	75.78	-94.43
BRD-K78659596	CP	MLN-2238	proteasome inhibitor	PSMB1	Proteasome inhibitor	0.00, 0.00	2.44, 0.85	-99.02	-98.99	-44.06	-99.04	-93.90	-98.64	-94.95	-99.39	-64.66	-97.46
BRD-K19894101	CP	MST-312	telomerase inhibitor	TERT		10.00, 10.00	1.36, 0.32	-76.73	99.85	-90.76	-90.13	-97.80	54.26	65.11	61.96	-38.11	-86.48
BRD-K36324071	CP	NF-449	purinergic receptor antagonist	P2RX1		50.00, 40.00	1.60, 0.48	27.50	92.30	56.00	35.57	99.08	99.73	98.13	95.19	84.96	99.47
BRD-K06792661	CP	narciclasine	coflilin signaling pathway activator, LIM kinase activator, ROCK activator	RHOA		0.00, 0.00	3.52, 0.82	-97.61	19.71	-96.65	-67.26	-15.12	-84.12	-61.05	84.67	-42.11	-84.87
BRD-K56700933	CP	phenethyl-isothiocyanate	cancer cell growth inhibitor, unidentified pharmacological activity	CYP2E1		0.00, 0.00	0.93, 0.19	-5.51	29.34	-98.54	30.07	-99.34	20.57	92.94	9.69	36.38	5.11
BRD-A19633847	CP	perhexiline	carnitine palmitoyltransferase binder, carnitine palmitoyltransferase inhibitor	CPT1A, CPT2		10.00, 0.00	2.63, 0.72	-78.57	43.09	-99.83	96.07	-97.31	-92.39	-98.41	83.96	-98.18	-95.48
BRD-K68997413	CP	PF-3845	FAAH inhibitor	FAAH		10.00, 0.00	0.69, 0.28	-58.95	68.44	71.12	-78.58	-71.59	10.50	-57.50	96.40	-98.86	-64.14
BRD-K67868012	CP	PI-103	PI3K inhibitor, mTOR inhibitor	PIK3CA, PIK3CG, MTOR, PIK3CB, PIK3CD, PRKDC	MTOR inhibitor, PI3K inhibitor	0.00, 0.00	1.93, 0.66	-95.35	-99.52	-99.58	-99.71	-57.34	-99.40	63.66	-36.15	-33.67	-98.80
BRD-K99818283	CP	PIK-90	PI3K inhibitor		PI3K inhibitor	0.00, 0.00	1.57, 0.61	-25.01	-99.80	-14.93	-45.91	25.43	-98.52	-99.27	-98.86	87.00	-98.13
BRD-K89687904	CP	PKCbeta-inhibitor	PKC inhibitor	PRKCB		40.00, 40.00	0.83, 0.27	23.62	98.22	71.02	85.43	99.47	99.87	29.10	28.87	71.88	97.82
BRD-K30677119	CP	PP-30	RAF inhibitor	RAF1		0.00, 0.00	1.25, 0.48	-57.75	-99.32	50.77	65.78	-85.67	-94.28	-13.45	-96.84	-32.80	-94.08
BRD-K49456190	CP	prima-1-met	thioredoxin inhibitor, TP53 activator	TP53		50.00, 40.00	1.36, 0.39	85.05	99.80	99.96	83.15	37.18	69.08	97.47	99.50	-99.58	99.86
BRD-A73680854	CP	PT-630	dipeptidyl peptidase inhibitor, fibroblast activation protein inhibitor	DPP4, FAP		50.00, 30.00	1.68, 0.49	99.48	46.23	99.98	59.68	93.90	73.06	79.40	96.00	96.33	99.40
BRD-K59597909	CP	phenothiazine	dopamine receptor antagonist			10.00, 10.00	0.60, 0.10	53.92	62.79	-30.43	99.89	91.39	86.40	-40.82	86.98	-45.15	93.59
BRD-K02526760	CP	QS-11	ARFGAP inhibitor	ARFGAP1		0.00, 0.00	1.27, 0.35	-56.44	-54.25	54.57	-75.30	40.28	6.59	14.81	-77.01	-30.97	-29.30
BRD-U94846492	CP	quinine	cytochrome P450 inhibitor, hemozoin biocrystallization inhibitor, P glycoprotein inhibitor	KCNN4, ABCB1, CYP2D6, GP9, KCNB2, SLC29A4		70.00, 50.00	2.16, 0.49	99.50	29.55	99.72	96.80	99.48	96.77	99.70	93.54	-46.56	99.86
BRD-K20285085	CP	fostamatinib	syk inhibitor, FLT3 inhibitor	SYK, FLT3, RET		0.00, 0.00	2.07, 0.75	66.53	46.10	-94.96	-84.67	11.33	30.50	-87.70	79.23	51.29	25.69
BRD-A23770159	CP	sirolimus	mTOR inhibitor, CCR expression inhibitor, cell cycle inhibitor, proteasome inhibitor, protein kinase inhibitor, T cell inhibitor	MTOR, FKBP1A, CCR5, FGF2		20.00, 10.00	1.42, 0.40	97.05	23.23	69.80	37.48	82.78	39.22	22.41	99.55	38.28	80.26
BRD-K08417745	CP	SID-26681509	cathepsin inhibitor	CTSL		0.00, 0.00	0.13, 0.02	-96.26	-90.97	-98.57	-13.88	-99.16	-51.03	-99.15	39.03	-99.97	-99.00
BRD-K60623809	CP	SU-11652	FGFR inhibitor, PDGFR tyrosine kinase receptor inhibitor, tyrosine kinase receptor & angiogenic inhibitor, VEGFR inhibitor	KDR, PDGFRB, CAMK1G, FGF2, FGFR1, FLT1, KIT, PDGFRA		0.00, 0.00	3.73, 0.84	-96.05	-80.02	-85.44	33.57	-51.09	-99.78	-94.15	-92.88	NaN	-96.93
BRD-K12502280	CP	TG-101348	JAK inhibitor, FLT3 inhibitor, RET tyrosine kinase inhibitor	JAK2, FLT3, BRD4, JAK1, JAK3, RET, TYK2	Bromodomain Inhibitor, FLT3 inhibitor, JAK inhibitor	20.00, 10.00	1.65, 0.56	-98.97	93.39	-99.74	-99.73	95.03	-97.62	-89.81	-71.25	98.30	-98.06
BRD-K32107296	CP	temozolomide	DNA alkylating drug, DNA damage inducer, DNA inhibitor, topoisomerase inhibitor	TOP2A		40.00, 40.00	0.50, 0.16	-30.15	53.35	90.67	98.56	-42.57	99.97	-78.69	31.07	99.81	98.47
BRD-K63195589	CP	tipifarnib	farnesyltransferase inhibitor, angiogenesis inhibitor, apoptosis stimulant	FNTA, FNTB		20.00, 10.00	0.66, 0.16	-25.85	-42.46	70.42	-28.75	97.10	99.96	-63.31	-53.68	-26.10	-9.77
BRD-K62965247	CP	tipifarnib-P2	farnesyltransferase inhibitor, angiogenesis inhibitor, apoptosis stimulant	FNTA, FNTB		10.00, 10.00	1.40, 0.33	60.27	79.31	-68.24	-77.68	92.85	-30.01	-96.34	-99.67	97.89	73.70
BRD-K57011718	CP	UK-356618	metalloproteinase inhibitor	MMP3, MMP13, MMP14, MMP2, MMP9		0.00, 0.00	0.81, 0.19	-96.97	-44.63	-15.50	-96.37	-89.73	-75.45	-99.74	-99.94	-52.40	-98.66
BRD-K32330832	CP	VER-155008	HSP inhibitor	HSPA1A		0.00, 0.00	0.98, 0.36	-60.35	-87.93	-97.46	16.38	80.76	-87.30	10.40	-64.56	-38.02	-85.43
BRD-A58280226	CP	Y-27632	ROCK inhibitor, calcium sensitizer, leucine rich repeat kinase inhibitor	ROCK1, ROCK2, LRRK2, PKIA, PKN2, PRKACA, PRKCE		20.00, 10.00	0.36, 0.13	24.56	-88.79	17.87	98.89	-17.64	-57.12	-71.57	96.52	-38.50	-33.99
BRD-A62182663	CP	YK-4279	apoptosis stimulant, binding of RNA helicase A to the transcription factor EWS-FLI1 inhibitor, EWS-FLI1 inhibitor	DHX9, EWSR1, FLI1		20.00, 20.00	1.40, 0.68	91.78	99.96	-23.17	-73.43	84.13	99.91	73.33	-71.62	68.82	90.83
BRD-A47829399	CP	artesunate	DNA synthesis inhibitor			0.00, 0.00	1.72, 0.51	-74.35	90.28	-33.12	-60.75	-20.84	-12.88	-70.34	-51.25	62.31	-49.34
BRD-A79465854	CP	auranofin	disease modifying antirheumatic drug, immunosuppressant, NFkB pathway inhibitor, prostanoid receptor inhibitor, thioredoxin reductase inhibitor	IKBKB, PRDX5, TRPA1, TXNRD1, TXNRD2	NFkB pathway inhibitor	0.00, 0.00	2.74, 0.50	-99.51	-99.30	-86.06	-99.55	-58.57	-99.72	-99.83	44.47	-54.54	-99.47
BRD-A28105619	CP	cucurbitacin-i	inhibitor of STAT3/JAK2 signaling, JAK inhbitor, lipocortin synthesis stimulant, STAT inhibitor	JAK2, STAT3		0.00, 0.00	2.92, 0.80	-99.96	-96.95	-96.35	-97.38	-49.46	-98.54	-84.74	-92.19	-40.60	-94.79
BRD-K61314889	CP	IWR-1-ENDO	PARP inhibitor	TNKS, TNKS2	PARP inhibitor	20.00, 20.00	0.58, 0.15	44.04	99.96	99.98	54.13	88.42	-96.34	-48.03	33.31	-31.44	71.53
BRD-A70449690	CP	forskolin	adenylyl cyclase activator, Adenylate cyclase stimulant, growth hormone receptor agonist, phosphokinase stimulant	ADCY2, ADCY5, GNAS		30.00, 20.00	1.24, 0.48	74.07	94.97	61.06	99.96	99.77	-95.65	89.16	18.69	-27.23	95.35
BRD-A77216878	CP	manumycin-a	farnesyltransferase inhibitor, NFkB pathway inhibitor, ras farnesyltransferase inhibitor	FNTA, IKBKB		10.00, 0.00	3.15, 0.77	-99.71	-99.19	-18.42	-99.50	-55.83	-50.84	96.02	-94.83	-95.28	-97.96
BRD-A76279427	CP	myriocin	sphingolipid biosynthesis inhibitor	AKT1, SPTLC1, SPTLC2, SPTLC3		10.00, 10.00	0.90, 0.24	44.55	-31.03	84.52	61.53	61.09	-25.71	98.66	11.35	-70.45	38.71
BRD-A43331270	CP	niguldipine	adrenergic receptor antagonist, calcium channel blocker, calcium channel antagonist, calcium channel inhibitor	ADRA1A, CACNA1C, ADRA1B, ADRA1D		0.00, 0.00	2.22, 0.72	-84.99	-83.46	-94.85	-96.47	-97.99	-99.03	-98.84	-99.71	-99.20	-96.41
BRD-A15079084	CP	phorbol-12-myristate-13-acetate	PKC activator, CD antagonist	CD4, KCNT2, PRKCA, TRPV4	PKC activator	0.00, 0.00	2.48, 0.49	-88.75	-96.37	85.12	-98.38	-46.49	-99.68	-90.73	-97.79	-60.89	-96.72
BRD-A01145011	CP	zebularine	DNA methyltransferase inhibitor, cytidine deaminase inhibitor	CDA, DNMT1		60.00, 60.00	0.63, 0.20	99.91	98.01	97.78	88.78	99.98	99.96	19.46	37.20	-58.10	99.93
BRD-K01638814	CP	rilmenidine	adrenergic receptor agonist, imidazoline receptor agonist	NISCH	Imidazoline ligand	50.00, 50.00	2.49, 0.59	99.98	98.18	73.41	98.50	15.73	92.57	92.96	99.96	73.66	99.30
BRD-A62025033	CP	temsirolimus	mTOR inhibitor, cell cycle inhibitor, immunosuppressant, protein kinase inhibitor	MTOR, PTEN	MTOR inhibitor	0.00, 0.00	1.08, 0.38	-91.82	-98.23	-99.66	-99.78	-51.27	-98.28	44.79	-96.81	-43.61	-97.19
BRD-K04853698	CP	LDN-193189	ALK inhibitor, serine/threonine protein kinase inhibitor	ACVR1, BMPR1A		0.00, 0.00	4.48, 1.43	-99.96	-72.36	NaN	-85.84	NaN	-99.04	-99.50	93.07	-86.58	-98.84
BRD-K91691979	CP	BRD-K91691979	glucosylceramidase inhibitor	GBA		11.11, 11.11	0.89, 0.25	-36.77	24.08	99.25	-51.73	-22.95	52.10	27.29	-13.33	NaN	-11.45
BRD-K76425766	CP	BRD-K76425766	metalloproteinase inhibitor			11.11, 11.11	1.22, 0.26	98.72	34.27	27.74	58.78	-91.49	-26.75	-46.95	-81.65	NaN	-17.34
BRD-K19059335	CP	BRD-K19059335	runt-related transcription factor inhibitor, tyrosine aminotransferase inhibitor	RUNX1		11.11, 11.11	1.36, 0.36	17.64	59.15	12.14	46.76	NaN	-31.25	99.96	-26.18	-53.39	31.93
BRD-K14609189	CP	BRD-K14609189	PPAR receptor partial agonist	PPARG		11.11, 11.11	1.17, 0.28	-15.74	-44.53	-45.34	99.86	NaN	-59.44	-53.25	-73.31	-43.61	-43.85
BRD-K11717138	CP	benzbromarone	calcium-activated chloride channel blocker, uric acid diuretic	ABCC1, SLC22A12		10.00, 10.00	0.52, 0.11	-23.02	-16.94	-99.61	52.07	90.27	58.99	-20.34	99.82	42.61	19.51
BRD-A28422330	CP	BRD-A28422330	CDC inhibitor			0.00, 0.00	0.83, 0.13	-17.41	-7.90	-7.70	-92.60	22.02	-19.38	-16.39	-50.40	NaN	-1.73
BRD-A12633378	CP	BRD-A12633378	voltage-gated potassium channel activator	KCNQ4, KCNQ2		0.00, 0.00	0.90, 0.18	23.73	-36.85	-74.23	-90.53	NaN	20.71	-30.69	46.79	-94.11	-25.06
BRD-K77690805	CP	BRD-K77690805	pyruvate kinase isozyme activator	PKM		20.00, 10.00	0.74, 0.14	-51.69	47.63	96.51	-60.85	24.86	-37.75	99.45	-25.58	-77.55	-21.85
BRD-K58033748	CP	BRD-K58033748	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5		44.44, 11.11	0.73, 0.18	95.95	-49.02	34.65	96.29	NaN	57.89	86.98	29.51	95.40	99.33
BRD-K45031696	CP	BRD-K45031696	cytohesin inhibitor			11.11, 11.11	0.55, 0.10	73.67	77.26	-54.09	74.04	98.09	-84.76	21.40	-75.71	NaN	74.57
BRD-K27074404	CP	BRD-K27074404	solute carrier family member inhibitor	SLC12A5		22.22, 22.22	0.93, 0.13	15.57	89.11	99.88	-61.70	99.90	-6.60	85.95	-85.88	NaN	77.80
BRD-A16820783	CP	BRD-A16820783	phosphodiesterase inhibitor			10.00, 10.00	1.20, 0.42	-15.92	99.96	-72.30	-93.92	-37.52	-99.81	-73.03	-37.42	-97.01	-92.75
BRD-K00313977	CP	BRD-K00313977	APEX inhibitor	APEX1		0.00, 0.00	1.91, 0.59	69.19	-93.59	60.09	-99.04	-93.84	-31.66	-74.77	-99.55	81.35	-94.95
BRD-K07872006	CP	BRD-K07872006	lipoxygenase inhibitor			0.00, 0.00	0.84, 0.17	17.31	89.02	-54.73	40.37	-66.98	45.21	41.68	86.89	-45.84	40.96
BRD-K11540476	CP	EMF-BCA1-64	caspase inhibitor	CASP3		10.00, 10.00	0.66, 0.09	34.53	5.74	-10.81	69.28	99.78	85.19	6.74	92.53	9.84	44.68
BRD-K11757396	CP	BRD-K11757396	neuropeptide receptor ligand	NPSR1		0.00, 0.00	0.76, 0.17	-96.70	-99.58	84.45	-97.66	-32.23	-44.33	38.43	11.78	75.67	-63.62
BRD-K12401458	CP	BRD-K12401458	lysophospholipid receptor agonist	S1PR4		0.00, 0.00	0.76, 0.22	22.00	18.04	-45.35	36.83	NaN	38.19	-99.47	68.48	-33.57	9.83
BRD-K14048378	CP	BRD-K14048378	lysophospholipid receptor agonist	S1PR3		0.00, 0.00	0.89, 0.23	-98.33	38.13	-23.22	-30.15	-63.74	-32.47	-29.25	-17.56	NaN	-10.15
BRD-K14236372	CP	BRD-K14236372	lysophospholipid receptor agonist	S1PR4		44.44, 44.44	1.22, 0.28	16.34	-97.51	-71.50	98.77	NaN	53.70	99.89	71.86	99.97	99.86
BRD-K16618170	CP	BRD-K16618170	lysophospholipid receptor agonist	S1PR4		11.11, 11.11	1.07, 0.24	-38.24	-13.66	-21.69	99.06	NaN	86.96	68.65	-30.40	41.40	85.12
BRD-K24538644	CP	KUC104502N	opioid receptor antagonist	OPRK1		0.00, 0.00	0.95, 0.19	56.21	12.82	-37.77	37.32	33.34	-42.33	76.26	64.81	-59.81	25.99
BRD-K36038115	CP	BRD-K36038115	neuropeptide receptor antagonist	NPBWR1		0.00, 0.00	1.09, 0.24	17.22	-39.36	-99.61	17.95	-60.51	-98.82	71.98	23.80	-70.22	-36.06
BRD-K51302260	CP	KU-C103871	GSP agonist	SMAD3		0.00, 0.00	1.35, 0.42	42.77	20.89	-21.67	12.45	-39.90	-34.58	17.04	23.21	-99.96	3.64
BRD-K60218670	CP	BRD-K60218670	lipoxygenase inhibitor			10.00, 10.00	1.28, 0.23	-28.82	-48.98	94.49	-45.21	-82.07	40.42	33.01	-9.71	97.66	18.89
BRD-K64314806	CP	BRD-K64314806	lipoxygenase inhibitor			0.00, 0.00	1.25, 0.23	-30.99	-22.21	64.37	-74.84	-32.80	-20.41	84.07	33.26	65.85	27.31
BRD-K64610608	CP	EMF-bca1-57	caspase inhibitor	CASP3		0.00, 0.00	0.90, 0.17	-27.63	-11.78	17.72	-54.61	-26.12	-18.77	-19.00	-27.32	58.26	-7.37
BRD-K68437527	CP	EMF-bca1-60	caspase inhibitor			0.00, 0.00	0.66, 0.17	30.38	31.62	67.94	25.74	-81.04	14.03	22.12	-40.08	86.76	16.59
BRD-K72817452	CP	BRD-K72817452	lipoxygenase inhibitor			10.00, 0.00	1.63, 0.41	-58.51	-90.17	-58.42	-12.42	96.96	87.36	41.66	73.43	71.69	79.93
BRD-K73285375	CP	BRD-K73285375	lipoxygenase inhibitor			10.00, 10.00	1.57, 0.51	-85.17	-95.70	-50.53	-23.47	-49.66	-38.12	-50.43	32.25	99.58	-44.03
BRD-K94919853	CP	10H-phenothiazin-10-yl)(p-tolyl)methanone	BCHE inhibitor	BCHE		11.11, 11.11	0.89, 0.24	75.70	47.90	67.78	99.98	-29.30	90.47	-26.97	74.38	NaN	70.14
BRD-A71657825	CP	2-(biphenyl-4-ylsulfonamido)pentanedioic-acid	matrix metalloprotease inhibitor	MMP13, MMP8, MMP9		0.00, 0.00	0.60, 0.11	29.90	20.73	31.01	-37.21	36.08	-40.90	53.70	31.29	NaN	17.92
BRD-K73709114	CP	BRD-K73709114	glucosylceramidase inhibitor	GBA		0.00, 0.00	0.76, 0.15	-73.82	-48.70	24.59	-28.61	69.43	35.42	-61.94	-33.05	NaN	-48.96
BRD-K77681376	CP	BRD-K77681376	casein kinase inhibitor, FLT3 inhibitor			0.00, 0.00	2.38, 0.72	-92.94	NaN	-91.29	-93.97	NaN	-99.50	-99.65	-99.08	-99.41	-98.34
BRD-K76211160	CP	BRD-K76211160	cytochrome P450 inhibitor	CYP11B2		11.11, 0.00	0.94, 0.32	-16.66	81.65	83.37	95.90	60.67	-91.52	-11.77	-64.83	NaN	81.81
BRD-K08219523	CP	5-nonyloxytryptamine	serotonin receptor agonist	HTR1B, HTR1D		0.00, 0.00	1.58, 0.38	-96.70	-99.93	-97.20	-96.54	-39.21	88.82	-59.92	-97.59	-98.65	-96.09
BRD-K91442916	CP	CAM-9-026	ADAM10 inhibitor			0.00, 0.00	1.27, 0.26	14.78	-98.84	23.25	93.08	NaN	-64.91	14.95	61.71	-32.56	21.89
BRD-K03067624	CP	emetine	protein synthesis inhibitor	RPS2		0.00, 0.00	3.28, 0.78	-70.86	NaN	-99.23	-62.61	83.96	-51.44	-79.24	-49.66	NaN	-84.21
BRD-A82096673	CP	KU-C103428N	CDC inhibitor, rho GTPase inhibitor	NFE2		0.00, 0.00	0.64, 0.17	-44.50	57.71	-95.09	-74.68	86.46	43.83	-93.96	-56.93	NaN	-69.89
BRD-A81402010	CP	KU-C103443N	CDC inhibitor, rho GTPase inhibitor			0.00, 0.00	0.75, 0.23	-18.43	-15.66	-89.65	25.87	-75.78	-73.20	-66.35	-96.71	NaN	-76.02
BRD-K36153907	CP	KU-C103885	cystic fibrosis transmembrane conductance regulator inhibitor			0.00, 0.00	1.35, 0.26	-38.39	-84.11	-63.30	-92.69	NaN	-90.27	20.51	-85.82	-43.98	-88.57
BRD-A53107311	CP	BRD-A53107311	mitotic kinesin inhibitor, Tubulin Polymerization Inhibitors			0.00, 0.00	0.99, 0.23	-64.92	-9.63	-93.88	62.30	-32.84	55.57	-7.87	31.87	NaN	-2.57
BRD-K48974000	CP	BRD-K48974000	CDC inhibitor			0.00, 0.00	0.70, 0.22	-99.62	-69.31	-26.39	81.07	-99.63	93.52	93.01	-18.73	NaN	-82.77
BRD-A69470004	CP	BRD-A69470004	XIAP inhibitor	XIAP		11.11, 11.11	0.66, 0.13	-53.41	99.69	56.59	-38.02	39.59	71.40	73.74	-10.43	NaN	39.98
BRD-A05680309	CP	BRD-A05680309	caspase activator, XIAP inhibitor	CASP8, XIAP		22.22, 11.11	1.26, 0.44	-32.70	97.41	71.97	-83.31	32.15	-40.25	-28.56	99.64	NaN	56.52
BRD-A97035593	CP	BRD-A97035593	XIAP inhibitor	XIAP		11.11, 11.11	0.83, 0.23	-42.25	28.37	99.96	-33.30	89.05	36.74	-65.79	13.03	NaN	11.32
BRD-K55186349	CP	BRD-K55186349	apelin receptor antagonist	APLNR		11.11, 11.11	0.91, 0.32	99.71	49.33	-58.07	62.71	NaN	-46.52	-34.17	51.97	89.98	42.29
BRD-K43149758	CP	myricetin	androgen receptor ligand, cytochrome P450 inhibitor	PIK3CG, AR, CYP3A4		66.67, 55.56	0.74, 0.16	13.24	97.84	99.98	98.24	32.01	95.10	99.79	83.52	NaN	99.72
BRD-K53780220	CP	BRD-K53780220	casein kinase inhibitor, FLT3 inhibitor			0.00, 0.00	2.82, 0.91	-71.15	-48.65	-89.85	33.81	NaN	-97.05	-99.83	-96.71	-99.39	-98.24
BRD-K56658166	CP	BRD-K56658166	N-type calcium channel blocker, Sodium Channel  Blockers	CACNA1B		0.00, 0.00	0.53, 0.09	22.30	90.55	-68.14	80.04	-16.44	-47.56	-16.18	80.62	NaN	52.45
BRD-K28452084	CP	BRD-K28452084	opioid receptor agonist	OPRK1		0.00, 0.00	0.92, 0.22	-29.44	24.32	56.25	13.12	-40.44	-93.16	-61.81	-54.28	NaN	-32.55
BRD-K97274161	CP	BRD-K97274161	beta-catenin inhibitor, opioid receptor antagonist	OPRK1		0.00, 0.00	1.31, 0.45	-33.28	29.98	-26.45	-90.00	-28.64	-45.62	-72.91	-92.18	NaN	-66.30
BRD-K20401833	CP	BRD-K20401833	ROR inverse agonist	RORA		0.00, 0.00	1.08, 0.23	-9.36	-20.31	-11.88	15.01	-30.99	94.54	-43.25	70.40	-90.30	-4.88
BRD-K70693222	CP	BRD-K70693222	CLK inhibitor, dual specificity tyrosine-(Y)-phosphorylation regulated kinase inhibitor	CLK1, CLK4, DYRK1A		10.00, 10.00	0.75, 0.11	27.24	-14.91	90.66	-72.29	71.18	40.11	97.63	74.62	70.79	68.91
BRD-K55703048	CP	latrepirdine	glutamate receptor antagonist, histamine receptor antagonist, serotonin receptor antagonist	HTR6, GRIN2B, HRH1		0.00, 0.00	1.57, 0.36	-73.70	91.15	-37.03	89.68	NaN	49.14	47.09	76.27	-99.81	74.11
BRD-K73610817	CP	BRD-K73610817	apoptosis protein inhibitor			0.00, 0.00	1.99, 0.45	-90.07	-42.42	-96.18	-99.48	-97.97	52.78	-85.89	-95.21	NaN	-96.31
BRD-K78883024	CP	BRD-K78883024	neuropeptide receptor antagonist	NPSR1		0.00, 0.00	0.82, 0.16	78.21	26.09	83.53	63.80	-65.79	76.85	-31.34	-24.00	NaN	58.34
BRD-K30351863	CP	BRD-K30351863	APEX inhibitor	APEX1		11.11, 0.00	1.64, 0.51	-35.85	-88.86	-89.89	-98.62	NaN	-99.50	-47.60	-99.14	95.45	-98.87
BRD-K37940862	CP	BRD-K37940862	neuropeptide receptor antagonist	NPSR1		0.00, 0.00	2.22, 0.74	-99.25	-96.81	-98.98	-98.31	-44.12	-79.57	-99.60	-59.77	NaN	-97.48
BRD-K68783079	CP	BRD-K68783079	CLK inhibitor, dual specificity tyrosine-(Y)-phosphorylation regulated kinase inhibitor	CLK1, CLK4, DYRK1A		0.00, 0.00	1.11, 0.16	8.37	-21.42	-27.39	-43.23	NaN	-32.94	18.34	16.44	92.64	-5.33
BRD-K88761633	CP	BRD-K88761633	glucosylceramidase inhibitor	GBA		0.00, 0.00	0.68, 0.22	-99.87	-84.71	-67.10	-52.06	NaN	-94.20	-98.98	-98.26	-94.66	-99.86
BRD-K06956503	CP	BRD-K06956503	glucosylceramidase inhibitor	GBA		11.11, 0.00	1.31, 0.48	96.57	-43.47	-99.58	-30.46	-97.64	-67.45	-11.31	-45.76	NaN	-52.80
BRD-A32917072	CP	BRD-A32917072	ROR antagonist	RORC		11.11, 11.11	0.67, 0.18	31.40	60.72	-13.20	63.61	NaN	98.02	-8.60	12.01	-97.15	17.12
BRD-A61599461	CP	BRD-A61599461	thyroid-stimulating hormone receptor inverse agonist	TSHR		0.00, 0.00	1.10, 0.30	24.63	-85.43	-62.51	43.80	NaN	-98.76	40.04	-23.76	-47.04	-51.62
BRD-A81377415	CP	BRD-A81377415	CLK inhibitor, dual specificity tyrosine-(Y)-phosphorylation regulated kinase inhibitor, dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1B inhibitor	CLK1, CLK4, DYRK1A, DYRK1B		0.00, 0.00	1.41, 0.33	55.44	83.90	-36.67	-39.54	NaN	35.42	70.59	-66.49	37.66	57.97
BRD-K89237706	CP	noscapine	bradykinin receptor antagonist, tubulin polymerization inhibitor, apoptosis stimulant, microtubule inhibitor, tubulin inhibitor	BDKRB2, SIGMAR1		22.22, 11.11	0.80, 0.13	-78.83	99.50	-51.10	95.07	68.78	15.05	90.49	19.10	NaN	94.72
BRD-K40213712	CP	SAL-1	adenosine receptor antagonist	ADORA2B, ADORA2A		0.00, 0.00	0.72, 0.13	65.26	-19.39	90.54	-18.76	34.22	93.03	-12.53	-18.64	NaN	48.17
BRD-A41630653	CP	BRD-A41630653	glutamate receptor antagonist, sigma receptor agonist	SIGMAR1, CHRNA2, CHRNA3, CHRNA4, CHRNA7, CHRNB2, CHRNB4, CYBA, CYBB, CYP3A5, GRIN1, GRIN3A, NCF1, NCF2, NCF4, OPRD1, OPRK1, OPRM1, PGRMC1, RAC1, RAC2, SLC6A2, SLC6A4		11.11, 0.00	0.51, 0.14	29.62	95.50	90.85	85.35	17.51	-63.16	39.70	34.48	NaN	57.57
BRD-A57457122	CP	VU-0400071-3	glutamate receptor modulator	GRM4		0.00, 0.00	1.52, 0.31	85.71	42.51	40.78	62.31	77.67	32.99	79.86	-36.50	-75.02	69.06
BRD-K84141129	CP	VU-0400193-3	glutamate receptor modulator	GRM4		10.00, 0.00	0.83, 0.27	19.49	58.71	-39.62	76.51	50.84	95.25	30.93	-30.70	82.87	76.83
BRD-K30570479	CP	VU-0400195-3	glutamate receptor modulator	GRM4		0.00, 0.00	1.07, 0.27	-11.93	-84.49	-19.16	-47.50	-36.28	46.99	-41.17	16.02	31.47	-20.67
BRD-A52172093	CP	VU-0413807-2	calcium channel blocker	CACNA1G, CACNA1H, CACNA1I		22.22, 11.11	1.13, 0.25	14.87	56.72	96.77	-91.90	NaN	-28.90	-31.66	-42.33	99.18	18.91
BRD-K76907295	CP	VU-0418947-2	hypoxia inducible factor activator		HIF activator	0.00, 0.00	1.82, 0.63	-95.60	-98.75	-96.83	-86.50	NaN	-77.98	-97.07	-96.45	-99.14	-96.30
BRD-K59633790	CP	VU-0420363-1	SARS coronavirus 3C-like protease inhibitor			0.00, 0.00	1.59, 0.39	-19.61	13.84	57.25	44.67	NaN	-56.36	-31.30	-17.86	28.40	18.09
BRD-K92817986	CP	BJM-CSC-19	compound cytotoxic to breast cancer stem cells			10.00, 10.00	0.58, 0.14	-83.59	-41.89	44.37	21.02	-42.83	78.82	81.84	99.96	47.24	62.29
BRD-A67981824	CP	cefotaxime	cell wall synthesis inhibitor		Bacterial cell wall synthesis inhibitor	0.00, 0.00	1.38, 0.35	-23.26	-73.52	-70.08	34.85	47.52	29.42	-33.54	49.32	-35.90	-19.27
BRD-A74500471	CP	ethambutol	bacterial arabinosyl transferase inhibitor		Bacterial cell wall synthesis inhibitor	10.00, 10.00	1.17, 0.41	-74.43	-63.75	-13.29	16.69	92.84	98.13	23.80	91.07	84.47	85.08
BRD-A10070317	CP	propranolol	adrenergic receptor antagonist	ADRB2, ADRB3, ADRB1, CYP2C19, HTR1A, HTR1B		10.00, 10.00	1.45, 0.47	-57.05	-94.60	-70.40	-30.38	-39.31	98.44	-74.25	-13.16	56.70	-64.02
BRD-K02992638	CP	lamivudine	nucleoside reverse transcriptase inhibitor, reverse transcriptase inhibitor			0.00, 0.00	0.59, 0.19	29.83	32.26	-24.63	70.29	80.77	73.41	-29.09	30.45	50.26	38.61
BRD-K35240538	CP	methylprednisolone	glucocorticoid receptor agonist	NR3C1	Glucocorticoid receptor agonist	0.00, 0.00	1.44, 0.60	-12.84	66.34	-19.18	-91.11	-50.89	-79.58	-26.00	90.63	-34.96	-21.48
BRD-A84702196	CP	penicillin	cell wall synthesis inhibitor		Bacterial cell wall synthesis inhibitor	10.00, 10.00	1.33, 0.38	-8.23	-11.65	23.86	64.01	70.25	49.16	-12.05	20.32	97.65	20.22
BRD-K87024524	CP	phenelzine	monoamine oxidase inhibitor	MAOB, AOC3, MAOA, ABAT, GAD2, GPT, GPT2, SLC6A2, SLC6A3, SLC6A4		0.00, 0.00	0.74, 0.17	92.97	-62.17	-36.40	-41.00	-81.84	75.48	-15.36	-16.75	78.06	-19.85
BRD-A96255180	CP	ribavirin	antiviral guanosine ribonucleoside analog, IMPDH inhibitor, inosine monophosphate dehydrogenase inhibitor	IMPDH1, ADK, ENPP1, IMPDH2, NT5C2		10.00, 10.00	1.03, 0.22	87.08	-30.20	-39.13	91.87	-47.77	38.23	-16.27	98.86	60.02	61.07
BRD-K28346421	CP	rifapentine	DNA directed RNA polymerase inhibitor, DNA directed DNA polymerase inhibitor	CYP2C8, CYP3A4		10.00, 10.00	1.13, 0.32	-22.52	60.01	22.23	69.77	98.19	35.29	-42.16	-92.59	-45.50	-7.10
BRD-K22878149	CP	SB-205607	delta 1 opioid receptor agonist, opioid receptor agonist	OPRD1, OPRK1, OPRM1		10.00, 10.00	1.65, 0.52	-26.35	29.12	-37.11	99.90	93.40	21.14	-28.93	36.79	-40.09	20.09
BRD-A22256192	CP	terazosin	adrenergic receptor antagonist	ADRA1D, ADRA1A, ADRA1B, KCNH2, KCNH6, KCNH7		10.00, 10.00	0.55, 0.11	58.05	87.65	-19.34	-18.99	89.81	-56.81	49.17	98.33	-35.65	75.91
BRD-K88304388	CP	dextrorphan	glutamate receptor antagonist, adrenergic transmitter release inhibitor, opioid receptor agonist, serotonin receptor antagonist	OPRM1, OPRK1, OPRD1, GRIN1, HTR1A, SLC6A2		12.50, 0.00	1.74, 0.72	95.44	91.23	-26.78	30.91	92.73	NaN	47.38	11.34	NaN	58.66
BRD-K94144010	CP	cotinine	nicotine metabolite			0.00, 0.00	1.89, 0.59	38.12	-99.91	-20.93	89.57	-41.17	NaN	-30.92	88.27	NaN	21.25
BRD-A17664363	CP	BRD-A17664363	steroidogenic factor antagonist	NR5A1		0.00, 0.00	0.78, 0.15	-38.58	-32.26	-99.98	-41.34	-11.64	38.73	28.45	-36.87	-89.48	-32.62
BRD-A54632525	CP	BRD-A54632525	lipoxygenase inhibitor	ALOX12		10.00, 10.00	0.95, 0.32	-90.27	-38.35	-46.14	-59.56	-98.30	77.60	99.87	-72.10	43.12	-64.79
BRD-A61189834	CP	BRD-A61189834	XIAP inhibitor	XIAP		0.00, 0.00	1.20, 0.36	-91.23	91.47	21.33	71.87	81.36	48.01	-98.07	52.47	-21.06	60.28
BRD-A71009679	CP	KUC103420N	rho GTPase inhibitor, CDC inhibitor			0.00, 0.00	1.64, 0.38	31.65	84.80	-50.40	-81.35	77.68	-36.62	16.50	-96.77	80.34	38.55
BRD-A89049230	CP	BRD-A89049230	thyroid-stimulating hormone receptor agonist	TSHR		0.00, 0.00	0.94, 0.27	-77.90	-13.26	-99.32	-14.70	-80.91	-22.49	90.39	-99.93	34.40	-90.14
BRD-A93048969	CP	BRD-A93048969	acetylcholine receptor antagonist	CHRM2, CHRM1, CHRM3, CHRM4, CHRM5, SI		0.00, 0.00	1.01, 0.28	-57.75	8.99	-37.72	93.14	-74.89	NaN	88.64	-16.41	NaN	-13.81
BRD-A94297859	CP	BRD-A94297859	XIAP inhibitor	XIAP		10.00, 10.00	1.56, 0.43	98.03	35.64	38.78	-6.09	40.85	-94.31	-99.12	17.77	-64.03	-16.37
BRD-K00256256	CP	BRD-K00256256	protein phosphatase inhibitor			10.00, 0.00	1.00, 0.28	90.34	78.85	-80.80	20.79	-32.18	-25.24	-69.70	96.31	-43.60	26.48
BRD-K01265221	CP	BRD-K01265221	BCL inhibitor	BCL2		0.00, 0.00	1.01, 0.25	37.47	33.89	-45.05	-26.16	93.87	-31.19	35.75	66.48	70.49	30.79
BRD-K06217810	CP	BRD-K06217810	CLK inhibitor, dual specificity tyrosine-(Y)-phosphorylation regulated kinase inhibitor, dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1B inhibitor	CLK1, CLK4, DYRK1A, DYRK1B		20.00, 20.00	1.18, 0.31	-75.93	99.80	97.73	-19.24	74.60	-32.22	36.19	-99.30	62.95	71.87
BRD-K11663430	CP	pyroxamide	HDAC inhibitor, cell cycle inhibitor	HDAC1	HDAC inhibitor	0.00, 0.00	1.53, 0.64	-99.22	43.87	-70.34	-66.76	-97.52	-88.00	-98.28	-99.67	-99.23	-98.87
BRD-K13810148	CP	givinostat	HDAC inhibitor, interleukin receptor antagonist, interleukin synthesis inhibitor, tumor necrosis factor receptor antagonist, tumor necrosis factor release inhibitor	HDAC2, HDAC1, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9, IL1B, IL1R2, IL6R, TNF	HDAC inhibitor	0.00, 0.00	1.35, 0.48	21.03	-17.27	-99.24	61.36	-99.44	-53.24	38.13	-98.10	NaN	-98.56
BRD-K19985802	CP	BRD-K19985802	protein phosphatase inhibitor			10.00, 10.00	1.06, 0.27	16.95	49.04	-42.91	58.41	97.95	-29.13	-39.41	17.94	49.82	34.20
BRD-K21009077	CP	BRD-K21009077	dual specificity protein phosphatase inhibitors			10.00, 0.00	1.00, 0.26	88.29	95.62	-38.67	86.01	45.20	-99.35	-97.56	10.08	-97.77	70.48
BRD-K22828899	CP	TUL-XXI039	serine/threonine kinase inhibitor			0.00, 0.00	1.26, 0.35	-5.53	-38.17	-35.91	77.25	37.33	-77.40	32.46	31.70	NaN	-16.35
BRD-K28143534	CP	cyproheptadine	histamine receptor antagonist, serotonin receptor antagonist	HRH1, ADRA1A, ADRA1B, ADRA1D, CHRM1, CHRM2, CHRM3, HTR2A, HTR2B, HTR2C, HTR6, HTR7		0.00, 0.00	1.19, 0.47	-45.28	-99.85	-8.16	-31.93	-43.11	-74.46	-98.93	-95.99	-96.03	-97.63
BRD-K29113274	CP	ketoconazole	14-alpha demethylase inhibitor, androgen receptor ligand, aromatase inhibitor, cell wall synthesis inhibitor, cortisol synthesis inhibitor, P glycoprotein inhibitor, sterol demethylase inhibitor	AR, CYP19A1, CYP21A2, CYP2C19, CYP3A5, CYP3A7, KCNA10	Sterol demethylase inhibitor	0.00, 0.00	0.83, 0.18	-97.29	-12.34	-42.34	70.18	30.49	NaN	-44.98	-95.60	NaN	-18.86
BRD-K32656671	CP	BRD-K32656671	mannose-6-phosphate isomerate inhibitor			0.00, 0.00	1.67, 0.41	32.18	-11.06	92.06	13.47	35.12	37.91	-43.41	86.81	-35.86	27.78
BRD-K33106058	CP	cytarabine	antimetabolite, DNA polymerase inhibitor, DNA synthesis inhibitor, ribonucleotide reductase inhibitor	POLB, POLA1	Ribonucleotide reductase inhibitor	0.00, 0.00	1.28, 0.45	-77.55	-95.54	-50.19	-99.82	-98.83	NaN	-62.48	-99.78	NaN	-97.14
BRD-K34508425	CP	KUC103898N	G protein coupled receptor			10.00, 10.00	1.42, 0.42	24.08	99.96	-40.21	-85.12	-20.16	63.10	-77.16	-97.53	30.39	-32.84
BRD-K37798499	CP	etoposide	topoisomerase inhibitor, cell cycle inhibitor, DNA inhibitor, DNA intercalating drug, DNA repair enzyme inhibitor	TOP2A, CYP2E1, CYP3A5, TOP2B	Topoisomerase inhibitor	0.00, 0.00	2.69, 0.78	-99.69	-97.40	-99.69	-99.79	-99.82	NaN	-99.93	-99.62	NaN	-99.47
BRD-K47278471	CP	diphenhydramine	histamine receptor antagonist	HRH1		0.00, 0.00	1.67, 0.52	82.49	83.80	-10.26	14.82	28.30	NaN	-23.57	54.37	NaN	50.52
BRD-K48115423	CP	2-(4-methoxybenzylthio)-6-methylpyrimidin-4-ol	matrix metalloprotease inhibitor	MMP13		0.00, 0.00	0.84, 0.20	-21.78	-7.26	-53.48	-29.37	-43.80	-43.71	34.85	52.07	-57.02	-15.12
BRD-K48969316	CP	BRD-K48969316	caspase inhibitor	CASP1		10.00, 10.00	1.26, 0.34	43.33	-20.92	38.18	99.85	-26.19	30.28	61.74	8.73	25.01	10.35
BRD-K52080565	CP	rilmenidine	adrenergic receptor agonist, imidazoline receptor agonist	NISCH		0.00, 0.00	1.17, 0.38	24.99	-98.29	-79.64	82.43	26.81	NaN	50.09	23.87	NaN	7.10
BRD-K61106942	CP	BRD-K61106942	pyruvate kinase isozyme activator	PKM		20.00, 20.00	1.02, 0.26	99.60	-74.12	-36.52	-50.97	-65.53	31.78	99.98	92.36	-47.53	52.74
BRD-K61217870	CP	n-(3-acetamidophenyl)-3-chlorobenzamide	glutamate receptor inhibitor	GRM5		20.00, 10.00	0.99, 0.22	45.35	66.50	22.64	60.47	60.80	-9.80	95.65	89.31	97.75	93.15
BRD-K64606589	CP	apicidin	HDAC inhibitor	HDAC1, HDAC10, HDAC11, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9	HDAC inhibitor	0.00, 0.00	1.56, 0.50	-98.71	-56.17	-99.91	-99.79	-99.72	-99.68	-99.31	-99.48	-99.78	-99.19
BRD-K64835161	CP	BRD-K64835161	CLK inhibitor, dual specificity tyrosine-(Y)-phosphorylation regulated kinase inhibitor, dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1B inhibitor	CLK1, CLK4, DYRK1B		10.00, 10.00	1.14, 0.42	-96.60	98.22	-65.49	21.60	35.54	-29.23	-70.40	-99.65	-68.21	-66.45
BRD-K65910366	CP	KUC103904N	opioid receptor antagonist			0.00, 0.00	0.86, 0.15	-80.61	-20.39	-47.55	-93.01	-43.38	-79.99	-33.51	-71.48	-99.88	-89.03
BRD-K70751730	CP	BRD-K70751730	histone lysine demethylase inhibitor	EGLN1, KDM3A, KDM4A, KDM4C, KDM6B		0.00, 0.00	1.35, 0.32	92.89	-14.14	82.02	58.99	74.84	-26.26	40.69	39.11	31.12	54.90
BRD-K72264770	CP	QW-BI-011	histone lyinse methyltransferase inhibitor	EHMT2		0.00, 0.00	1.02, 0.31	24.48	22.70	-65.03	-14.04	50.81	73.53	-39.63	-86.22	NaN	-23.87
BRD-K74761218	CP	WT-171	HDAC inhibitor	HDAC6		0.00, 0.00	1.70, 0.59	-85.83	-38.42	-91.19	-98.17	-99.54	-51.51	-98.79	-73.18	NaN	-98.13
BRD-K85853281	CP	BRD-K85853281	radical formation stimulant, RNA synthesis inhibitor, topoisomerase inhibitor	TOP2A		0.00, 0.00	2.38, 0.86	-96.70	-88.65	-61.44	-72.99	-45.87	-81.00	-99.53	-99.50	-96.87	-98.27
BRD-U37049823	CP	HG-6-64-01	RAF inhibitor, Abl kinase inhibitor, ephrin receptor inhibitor, KIT inhibitor, MAP kinase inhibitor, MEK inhibitor, p38 MAPK inhibitor, src inhibitor	ABL1, BRAF, CSF1R, EGFR, FGFR1, FLT3, KIT, MAPK11, PDGFRB, RET	PDGFR/KIT inhibitor, RAF inhibitor	0.00, 0.00	1.82, 0.35	-99.98	-13.06	-97.48	-99.98	-21.74	-76.92	-46.43	-80.41	-54.63	-91.71
BRD-U44700465	CP	HG-5-88-01	protein kinase inhibitor	ADCK4, EGFR		0.00, 0.00	2.00, 0.63	-95.02	-36.17	-68.57	29.45	33.47	-28.29	-30.41	-88.44	86.43	-47.20
BRD-U68942961	CP	JW-7-24-1	LCK Inhibitor	LCK		0.00, 0.00	2.46, 0.67	-99.88	51.45	-30.86	-99.62	-92.10	-96.84	-96.81	-97.16	-82.11	-96.92
BRD-U82589721	CP	HG-5-113-01	protein kinase inhibitor	ABL1, LTK, STK10		0.00, 0.00	1.97, 0.53	-99.93	-99.21	-94.00	-99.44	-99.96	-87.33	-99.91	-99.76	-72.20	-99.65
BRD-K26947839	CP	BRD-K26947839	NADPH oxidase inhibitor	NOX1		0.00, 0.00	0.69, 0.17	-98.50	84.50	-77.49	52.36	-40.64	93.03	-22.47	-65.67	-32.95	-28.92
BRD-K32795028	CP	1-benzylimidazole	thromboxane synthase inhibitor	CYP11B1, QPCT		10.00, 10.00	1.14, 0.38	57.26	-94.09	7.52	-62.31	39.47	17.28	36.56	99.81	-33.82	15.40
BRD-K78278890	CP	NM-PP1	calcium/calmodulin dependent protein kinase inhibitor, growth factor receptor inhibitor, MAP kinase inhibitor, mutant kinase inhibitor	CAMK2A, LCK, MAPK8, PRKACA, RIPK2, SRC		0.00, 0.00	1.14, 0.35	32.32	-29.64	-91.91	-43.59	-65.66	-29.57	-77.39	-89.77	-89.56	-88.53
BRD-A15010982	CP	HU-211	glutamate receptor antagonist, apoptosis stimulant, NFkB pathway inhibitor, reducing agent	CNR1, CNR2, GLRA1, GLRA2, GLRA3, GPR55, GRIN1, NFKB1		0.00, 0.00	2.10, 0.49	-17.24	37.40	-96.00	-98.10	-95.38	37.53	32.94	-79.91	NaN	-97.25
BRD-K87573634	CP	propylpyrazole	estrogen receptor agonist	ESR1		0.00, 0.00	1.33, 0.36	-27.61	7.29	-22.24	34.01	-34.11	-65.76	-38.18	75.54	NaN	-26.99
BRD-K54987996	CP	CAY-10578	casein kinase inhibitor			11.11, 0.00	1.03, 0.23	49.70	69.48	16.31	62.68	95.66	30.33	-65.33	56.53	NaN	37.20
BRD-A67438293	CP	treprostinil	prostacyclin analog	PTGIR, CYP2C8, P2RY12, PPARD, PTGDR, PTGER1, PTGER2, PTGER3, PTGER4		11.11, 11.11	0.99, 0.23	63.11	55.37	-27.58	99.91	30.47	66.65	-52.19	73.69	NaN	66.66
BRD-K40619305	CP	larixinic-acid	comopund that interacts with metal centers			0.00, 0.00	1.18, 0.39	85.49	-16.46	-86.19	-71.69	-44.34	-82.97	78.21	53.42	-46.93	-36.23
BRD-K66896231	CP	BRD-K66896231	acetylcholinesterase inhibitor	ACHE		12.50, 0.00	1.90, 0.75	86.12	96.64	-49.11	-18.33	-51.40	NaN	-14.49	16.19	NaN	9.64
BRD-K55055802	CP	BRD-K55055802	membrane integrity inhibitor, membrane permeability inhibitor	GABRA1, ADRA2B, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ		0.00, 0.00	2.01, 0.53	-45.48	-91.23	-49.36	62.30	-39.02	NaN	-14.22	47.23	NaN	-49.70
BRD-K20168484	CP	BRD-K20168484	lipoxygenase inhibitor, leukotriene synthesis inhibitor, PPAR receptor modulator	ALOX5AP		0.00, 0.00	1.44, 0.35	8.20	69.14	80.84	-98.61	46.16	NaN	13.53	12.98	NaN	22.22
BRD-K85925969	CP	zalcitabine	nucleoside reverse transcriptase inhibitor, reverse transcriptase inhibitor		Nucleoside reverse transcriptase inhibitor	12.50, 12.50	0.81, 0.27	-22.95	99.69	51.19	-32.81	51.26	NaN	-40.35	88.58	NaN	39.18
BRD-K99063460	CP	didanosine	nucleoside reverse transcriptase inhibitor, reverse transcriptase inhibitor	PNP	Nucleoside reverse transcriptase inhibitor	12.50, 12.50	0.86, 0.24	34.86	-20.05	99.94	40.81	-75.57	NaN	-49.64	29.44	NaN	22.84
BRD-K61993165	CP	niacin	vitamin agonist	HCAR2, HCAR3, ACHE, DGAT2, HCAR1, NNMT, PTGDR, QPRT		20.00, 10.00	1.23, 0.31	95.68	70.94	99.98	12.24	33.54	-33.99	87.80	74.59	-94.42	58.87
BRD-K79511609	CP	BRD-K79511609	adenosine receptor agonist	ADORA1, ADORA2A, ADORA2B		12.50, 12.50	1.13, 0.27	-82.27	99.89	-47.96	15.02	58.76	NaN	-58.11	-15.65	NaN	-20.86
BRD-K51941867	CP	LM-1685	cyclooxygenase inhibitor	PTGS2		11.11, 11.11	0.82, 0.22	99.64	51.18	-67.02	-45.69	41.85	-40.28	-48.56	-4.89	NaN	-22.61
BRD-K57954781	CP	BRD-K57954781	apoptosis stimulant, DNA inhibitor			62.50, 50.00	1.10, 0.58	-66.46	86.70	99.78	98.96	-90.95	NaN	96.78	97.69	NaN	99.01
BRD-K06878038	CP	deferiprone	chelating agent, cytochrome P450 inhibitor, iron absorption inhibitor, reducing agent	CYP4F2		12.50, 0.00	0.51, 0.17	53.64	95.88	-93.82	81.78	-92.46	NaN	-61.89	63.99	NaN	69.59
BRD-K09485525	CP	GANT-61	GLI antagonist	DHH, IHH		0.00, 0.00	0.76, 0.11	-10.66	-72.84	-32.80	-45.74	42.79	33.40	-40.95	-95.91	-37.20	-55.79
BRD-K92413528	CP	thiazolidinecarboxylic-acid	glutathione synthase stimulant, reducing agent			12.50, 12.50	2.32, 0.82	97.68	-46.03	-53.10	50.71	-35.71	NaN	-16.90	-43.86	NaN	-21.31
BRD-K28849549	CP	mesalazine	cyclooxygenase inhibitor, arylamine N-acetyltransferase inhibitor, beta catenin inhibitor, lipoxygenase inhibitor, prostanoid receptor inhibitor, protein phosphatase inhibitor, thromboxane receptor antagonist, thromboxane synthase inhibitor	PTGS1, PPARG, PTGS2, ALOX5, CHUK, CTNNB1, IKBKB, MPO, NAT1		12.50, 12.50	1.17, 0.58	-12.61	31.01	-31.07	99.48	79.82	NaN	88.31	20.25	NaN	44.36
BRD-K34437622	CP	BRD-K34437622	thymidylate synthase inhibitor	TYMS		12.50, 12.50	1.73, 0.50	99.51	-88.25	15.76	-37.95	-67.11	NaN	83.48	11.89	NaN	37.29
BRD-K82143716	CP	flucytosine	pyrimidine analog, inhibits fungal DNA synthesis	DNMT1		0.00, 0.00	0.98, 0.39	38.37	-94.90	31.03	15.28	54.09	NaN	50.73	-47.61	NaN	13.92
BRD-K30197592	CP	5-methoxytryptamine	serotonin receptor agonist	HTR2A, HTR6, HTR1B, HTR1D, HTR1E, HTR1F, HTR2C, HTR4, HTR7, TRPM8		0.00, 0.00	1.44, 0.44	88.06	23.83	34.51	-53.81	-30.82	56.86	-93.74	-27.68	65.03	42.48
BRD-K55591206	CP	epigallocatechin	AP inhibitor, aromatase inhibitor, bacterial efflux pump inhibitor, beta amyloid aggregation inhibitor, beta amyloid protein neurotoxicity inhibitor, beta secretase inhibitor, DNA gyrase inhibitor, dual specificity tyrosine-(Y)-phosphorylation regulated kinase inhibitor, enoyl-(acyl-carrier protein) reductase Fabl inhibitor, fatty acid synthase inhibitor, HCV inhibitor, indoleamine 2,3-dioxygenase inhibitor, NFkB pathway inhibitor, nitric oxide synthase inhibitor, PDGFR tyrosine kinase receptor inhibitor, PPAR receptor agonist, prolyl endopeptidase inhibitor, proteasome inhibitor, sodium/glucose cotransporter inhibitor, telomerase inhibitor, tumor NADH oxidase inhibitor, VEGFR inhibitor	FASN, APP, BACE1, CYP19A1, DYRK1A, ELANE, ENOX2, EP300, IDO1, KAT2B, KDR, MMP14, MMP2, PPARA, PREP, SLC5A1		0.00, 0.00	0.55, 0.10	-50.34	61.91	-70.98	36.32	-99.13	30.48	-21.50	78.47	NaN	27.24
BRD-K89626439	CP	sirolimus	mTOR inhibitor, CCR expression inhibitor, cell cycle inhibitor, proteasome inhibitor, protein kinase inhibitor, T cell inhibitor	MTOR, FKBP1A, CCR5, FGF2	MTOR inhibitor	0.00, 0.00	1.99, 0.56	-61.40	-99.96	-97.01	-46.12	-97.29	31.16	-43.45	-98.76	NaN	-96.23
BRD-K49372556	CP	mofezolac	cyclooxygenase inhibitor, cytochrome P450 inhibitor, platelet aggregation inhibitor			11.11, 0.00	1.19, 0.30	23.05	-75.69	-24.36	20.61	-83.71	54.15	17.86	95.83	NaN	8.38
BRD-K51066026	CP	aminoindazole	ionophore			0.00, 0.00	0.99, 0.36	12.61	78.66	-66.71	-5.63	-42.26	-64.79	-78.04	16.71	57.52	-10.79
BRD-K56745457	CP	azauridine	antiviral agent, blocks the conversion of orotic acid into UMP			10.00, 10.00	1.30, 0.32	-32.90	52.71	-6.87	-18.74	86.23	58.17	31.04	-98.91	97.96	25.11
BRD-K72238567	CP	fludarabine	DNA synthesis inhibitor, DNA repair enzyme inhibitor, purine antagonist, ribonucleotide reductase inhibitor	ADA, DCK, POLA1, RRM1, RRM2		0.00, 0.00	3.44, 1.00	-70.50	NaN	-48.79	-48.03	-31.24	-45.08	-70.80	-94.79	NaN	-73.77
BRD-A00520476	CP	otenzepad	acetylcholine receptor antagonist			0.00, 0.00	1.58, 0.58	39.77	59.69	-27.74	-63.23	75.96	NaN	24.40	-40.17	NaN	30.64
BRD-A61858259	CP	CAY-10415	insulin sensitizer	INS	PPAR receptor agonist	0.00, 0.00	0.77, 0.24	-29.40	16.49	34.16	-48.13	-99.11	-66.31	-99.81	53.21	NaN	-67.87
BRD-K15107389	CP	BRD-K15107389	ribosomal protein inhibitor	RPS6KA1, RPS6KA2, RPS6KA3		20.00, 10.00	1.64, 0.42	29.15	96.11	75.45	66.99	56.81	26.33	48.82	78.06	99.18	89.90
BRD-A74771556	CP	nikkomycin	chitinase inhibitor			44.44, 44.44	1.15, 0.34	25.16	34.03	-65.36	99.28	-56.45	99.94	98.52	93.17	NaN	99.44
BRD-K63954456	CP	BRD-K63954456	macrophage migration inhibiting factor inhibitor, nitric oxide production inhibitor, tumor necrosis factor production inhibitor	MIF, TNF		22.22, 22.22	2.57, 1.06	99.30	25.15	59.31	-35.08	99.19	40.84	63.86	33.05	NaN	49.49
BRD-K64310881	CP	MW-STK33-3B	large conductance potassium channel activator			11.11, 11.11	1.39, 0.25	-71.42	10.52	72.08	98.71	34.66	-51.65	-24.45	-66.54	NaN	-49.64
BRD-A07614565	CP	BRD-A07614565	botulin neurotoxin inhibitor			10.00, 10.00	1.35, 0.34	-91.97	99.78	-99.11	-96.56	-91.35	-36.05	-17.86	50.57	-18.25	-96.72
BRD-K82357231	CP	desloratadine	histamine receptor antagonist	HRH1		0.00, 0.00	0.78, 0.17	-96.39	15.43	-23.65	58.52	-49.60	NaN	-59.21	-66.87	NaN	-31.91
BRD-K26863634	CP	BIX-01338	histone methyltransferase inhibitor			0.00, 0.00	1.50, 0.34	-21.70	15.65	-48.12	12.58	-33.22	-76.49	-89.33	-77.96	NaN	-76.07
BRD-A47706533	CP	L-BSO	γ-glutamylcysteine synthetase inhibitor	GCLM		0.00, 0.00	0.60, 0.16	68.03	-10.25	74.44	-59.05	-48.08	-32.39	-79.92	58.31	57.55	49.85
BRD-K14550461	CP	doxercalciferol	vitamin D receptor agonist	VDR	Vitamin D receptor agonist	0.00, 0.00	1.52, 0.33	14.27	-19.00	73.01	11.79	59.85	87.21	-98.30	-25.03	NaN	50.65
BRD-K29359156	CP	ebselen	COX inihibitor, H+/K+-ATPase inhibitor, leukotriene receptor antagonist, NADPH oxidase inhibitor, nitric oxide synthase inhibitor, PKC inhibitor, prostanoid receptor antagonist, protein kinase C inhibitor, reducing agent	ALB, LTB4R, NOX3		0.00, 0.00	1.01, 0.25	62.51	-52.66	-89.41	-46.65	-56.91	61.51	-33.89	19.15	-67.17	-29.39
BRD-K65261396	CP	tacrolimus	calcineurin inhibitor, FK506-binding protein inhibitor, immunosuppressant, insulin expression inhibitor, interleukin receptor antagonist, macrolide calcineurin inhibitor, rotamase inhibitor, T cell inhibitor	FKBP1A, CYP3A5, CYP3A7		0.00, 0.00	1.06, 0.14	78.99	13.48	56.88	-53.12	44.82	-36.21	-97.60	-43.77	12.40	18.96
BRD-K14791739	CP	fluticasone	glucocorticoid receptor agonist	NR3C1, CYP3A5, CYP3A7, NR3C2, PGR, PLA2G4A	Glucocorticoid receptor agonist	0.00, 0.00	1.40, 0.78	58.25	-12.45	78.88	-23.64	-38.69	-63.66	65.25	20.61	-38.99	22.33
BRD-K15402119	CP	huperzine-a	acetylcholinesterase inhibitor, glutamate receptor antagonist	ACHE		0.00, 0.00	0.98, 0.39	46.60	63.68	-91.82	16.61	85.29	48.27	61.66	53.80	NaN	67.16
BRD-K49328571	CP	dasatinib	KIT inhibitor, src inhibitor, Bcr-Abl kinase inhibitor, ephrin receptor inhibitor, PDGFR tyrosine kinase receptor inhibitor, yes kinase inhibitor, Abl kinase inhibitor, Bruton's tyrosine kinase (BTK) inhibitor, discoidin domain containing receptor Inhibitor, lymphocyte specific tyrosine kinase inhibitor, tyrosine kinase inhibitor	ABL1, FYN, LCK, SRC, KIT, YES1, BCR, EPHA2, LYN, PDGFRB, ABL2, BTK, DDR1, DDR2, PDGFRA, STAT5B	SRC inhibitor	0.00, 0.00	1.44, 0.53	-91.09	84.83	-35.29	-95.46	-28.57	24.72	84.71	-90.94	73.32	-37.44
BRD-K76908866	CP	CP-724714	receptor tyrosine protein kinase inhibitor, EGFR inhibitor, tyrosine kinase inhibitor	ERBB2		0.00, 0.00	1.26, 0.22	-22.33	30.23	-24.17	90.40	17.68	11.13	-6.61	-37.90	-21.42	-2.83
BRD-K79090631	CP	CGP-60474	CDK inhibitor, PKC inhibitor	CDK1, CDK2		0.00, 0.00	3.50, 1.24	-99.46	-63.53	-99.54	-76.47	-63.80	-51.55	-99.66	-99.09	-78.47	-98.31
BRD-K13390322	CP	AT-7519	CDK inhibitor, cell cycle inhibitor	CDK2, CDK5, CDK1, CDK4, CDK6, CDK9	CDK inhibitor	0.00, 0.00	2.49, 0.85	-94.99	-31.01	-83.54	-60.54	-96.79	-73.77	-99.53	-92.90	-95.45	-98.13
BRD-A19248578	CP	latrunculin-b	actin destabilizer, unidentified pharmacological activity	ACTA1, MKL1, SPIRE2		0.00, 0.00	1.32, 0.42	-98.16	-94.97	-84.33	-99.82	-65.65	-75.99	-82.57	-96.19	NaN	-94.43
BRD-K54331210	CP	BRD-K54331210	alkaline phosphatase inhibitor	ALPL		0.00, 0.00	1.32, 0.35	92.87	51.84	86.32	17.15	78.96	91.25	7.05	88.39	78.52	89.57
BRD-K71427192	CP	BRD-K71427192	XIAP inhibitor	XIAP		10.00, 10.00	1.17, 0.19	26.89	-23.99	13.84	-61.70	-41.51	-31.96	-31.14	98.83	48.93	15.44
BRD-K91485395	CP	BRD-K91485395	dual specificity protein phosphatase inhibitors			0.00, 0.00	1.93, 0.38	42.27	82.88	-38.39	53.76	36.39	90.67	-40.88	59.99	NaN	66.43
BRD-A77050075	CP	heraclenol	furocoumarin compound with antiproliferative activity at G2/M phase			10.00, 0.00	1.02, 0.30	56.98	96.12	30.91	6.53	-76.82	44.30	85.13	93.52	55.64	79.18
BRD-K52640952	CP	BRD-K52640952	topoisomerase inhibitor	TOP1		0.00, 0.00	0.68, 0.23	-56.28	-16.09	18.07	17.74	79.35	50.00	90.92	14.93	-43.64	16.92
BRD-K97951054	CP	BRD-K97951054	Aurora kinase inhibitor, Pim kinase inhibitor, VEGFR inhibitor	AURKB, KDR, PIM1		11.11, 11.11	1.41, 0.43	72.94	50.26	99.96	-18.50	-34.23	81.57	69.01	21.69	NaN	69.22
BRD-K21971034	CP	OM-137	Aurora kinase inhibitor		Aurora kinase inhibitor	33.33, 33.33	0.95, 0.15	93.35	99.82	99.10	91.45	-40.55	25.80	42.90	7.22	NaN	97.87
BRD-K47761761	CP	PD-168077	dopamine receptor agonist	DRD2, DRD4		11.11, 11.11	1.06, 0.20	43.91	98.72	-71.80	-43.10	54.39	-25.84	68.46	-19.40	NaN	22.23
BRD-K18855837	CP	varenicline	acetylcholine receptor partial agonist	CHRNA4, CHRNA3, CHRNA6, CHRNA7, CHRNB2		11.11, 0.00	1.34, 0.34	-65.33	-52.91	-76.15	16.80	96.24	70.42	-44.84	21.12	NaN	-29.16
BRD-K28120222	CP	parthenolide	NFkB pathway inhibitor, adiponectin receptor agonist	ADIPOR2, IKBKB, RELA		10.00, 0.00	1.69, 0.69	-36.95	-25.02	-99.46	23.01	-34.58	-54.24	95.80	-80.59	-36.49	-32.82
BRD-K35483542	CP	alitretinoin	RXR agonist, ABC transporter expression enhancer, apoptosis stimulant, RAR agonist, retinoid receptor agonist	RARG, RARA, RARB, RXRA, RXRG, ABCA1, CYP2C8, CYP3A7, RXRB, VKORC1	Retinoid receptor agonist	20.00, 10.00	0.57, 0.24	-19.22	99.72	-18.00	-35.00	37.01	53.39	9.93	-23.48	96.23	17.00
BRD-K49810818	CP	sorafenib	RAF inhibitor, FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor, angiogenesis inhibitor, VEGFR antagonist	RET, BRAF, FLT3, KDR, RAF1, FLT1, FLT4, KIT, DDR2, FGFR1, PDGFRB, CYP2B6, CYP2C8, CYP3A5, PDGFB, SLCO1B3	FLT3 inhibitor, PDGFR/KIT inhibitor, RAF inhibitor, VEGFR inhibitor	0.00, 0.00	1.83, 0.52	-98.82	-87.96	-99.19	-99.12	-64.36	-41.74	-98.47	-46.47	-99.07	-98.45
BRD-K29905972	CP	axitinib	VEGFR inhibitor, PDGFR tyrosine kinase receptor inhibitor, angiogenesis inhibitor, KIT inhibitor, VEGFR antagonist	KDR, FLT1, FLT4, CSF1, CYP2C19, CYP3A5, KIT, PDGFRB, PLK4	VEGFR inhibitor	10.00, 10.00	0.99, 0.20	90.95	99.96	-14.71	-98.38	-26.83	-34.25	-7.83	-59.33	-33.20	-5.50
BRD-K66175015	CP	afatinib	EGFR inhibitor, receptor tyrosine protein kinase inhibitor, tyrosine kinase inhibitor	EGFR, ERBB2, ERBB4	EGFR inhibitor	0.00, 0.00	1.34, 0.32	-33.59	38.29	-21.93	-76.57	-94.77	-33.51	53.79	-35.43	25.76	-11.04
BRD-K05104363	CP	PD-184352	MEK inhibitor, MAP kinase inhibitor	MAP2K1, MAP2K2, MAP3K1, MAP3K2	MEK inhibitor	0.00, 0.00	1.43, 0.49	-25.36	64.69	-48.26	-99.75	-26.26	52.70	72.95	85.61	-17.66	38.59
BRD-M07438658	CP	lapatinib	EGFR inhibitor, EGFR antagonist, epidermal growth factor receptor (EGFR) inhibitor, receptor tyrosine protein kinase inhibitor, tyrosine kinase inhibitor	EGFR, ERBB2, CYP3A5		11.11, 0.00	0.85, 0.32	-26.59	-27.67	-88.00	14.57	-99.53	97.16	51.61	-38.41	NaN	-20.34
BRD-K05926469	CP	lenalidomide	angiogenesis inhibitor, cereblon inhibitor, tumor apoptosis inducer, tumor necrosis factor production inhibitor, tumor necrosis factor receptor antagonist	CRBN, TNF, CDH5, PTGS2, TNFSF11		0.00, 0.00	1.30, 0.36	67.48	-24.00	-76.76	17.28	-36.77	-40.51	88.82	49.52	85.54	50.93
BRD-K99616396	CP	motesanib	KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor, angiogenesis inhibitor, RET tyrosine kinase inhibitor, vascular endothelial growth factor receptor (VEGFR) inhibitor, VEGFR antagonist	FLT1, FLT4, KDR, KIT, PDGFRA, RET	PDGFR/KIT inhibitor	0.00, 0.00	0.64, 0.17	-14.34	-31.12	-97.89	-81.05	-15.57	13.25	12.20	-63.92	-99.17	-62.60
BRD-K23984367	CP	sorafenib	RAF inhibitor, FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor, angiogenesis inhibitor, VEGFR antagonist	RET, BRAF, FLT3, KDR, RAF1, FLT1, FLT4, KIT, DDR2, FGFR1, PDGFRB, CYP2B6, CYP2C8, CYP3A5, PDGFB, SLCO1B3		0.00, 0.00	1.13, 0.23	-87.74	-61.92	-80.91	-96.38	-94.10	-88.73	55.08	-98.16	-98.47	-95.53
BRD-K89162000	CP	tandutinib	FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor	FLT3, KIT, PDGFRA, PDGFRB, CSF1R, PDGFD	PDGFR/KIT inhibitor	0.00, 0.00	0.97, 0.28	26.41	69.34	-28.02	74.55	31.41	-80.05	91.34	-63.99	-40.26	24.52
BRD-K15600710	CP	obatoclax	BCL inhibitor, MCL1 inhibitor	BCL2, BCL2L1, MCL1	BCL inhibitor	0.00, 0.00	2.15, 0.70	-86.97	-75.69	-98.06	-87.88	76.79	-37.49	-83.77	-98.18	-99.12	-92.42
BRD-A13807286	CP	HA-14-1	BCL inhibitor	BCL2	BCL inhibitor	0.00, 0.00	1.30, 0.26	-96.79	41.73	-96.97	81.84	-99.82	-36.70	-41.96	79.41	-54.03	-93.95
BRD-K04833372	CP	GSK-1904529A	insulin growth factor receptor inhibitor, insulin receptor ligand	IGF1R, INSR		0.00, 0.00	1.94, 0.52	-99.60	23.17	-37.15	8.84	21.47	-33.58	-66.73	-31.17	21.00	-18.17
BRD-K24681473	CP	YM-155	survivin inhibitor, XIAP expression inhibitor	BIRC5		0.00, 0.00	2.30, 0.64	-91.63	-36.43	-51.03	-98.22	-79.26	-34.21	-96.84	-97.58	-88.47	-94.33
BRD-K82164249	CP	andarine	androgen receptor modulator	AR	Androgen receptor modulator	0.00, 0.00	1.08, 0.30	43.30	-97.79	-18.27	55.39	-89.38	47.84	-74.29	14.37	-82.71	-77.29
BRD-K63923597	CP	barasertib	Aurora kinase inhibitor, mitotic inhibitor, protein kinase inhibitor	AURKB, AURKC	Aurora kinase inhibitor	30.00, 10.00	0.64, 0.41	91.47	96.64	-72.42	-75.00	85.71	99.94	86.52	-99.84	-59.28	95.65
BRD-K42125900	CP	docetaxel	tubulin inhibitor, microtubule depolymerization inhibitor, microtubule stabilizing agent, microtubule stimulant, taxane	TUBB, BCL2, MAP2, MAP4, MAPT, NR1I2, TUBB1		20.00, 20.00	1.26, 0.36	66.69	99.93	-73.64	-99.88	79.01	-47.82	99.62	47.27	-14.27	82.68
BRD-K61192372	CP	capecitabine	dihydropyrimidine dehydrogenase inhibitor, DNA synthesis inhibitor, pyrimidine antagonist, RNA synthesis inhibitor, thymidylate synthase inhibitor	TYMS, DPYD	Thymidylate synthase inhibitor	0.00, 0.00	1.72, 0.45	7.92	-19.78	37.15	81.75	41.10	-32.52	-4.36	74.46	47.90	16.60
BRD-K16621777	CP	enobosarm	androgen receptor modulator, androgen receptor agonist	AR	Androgen receptor modulator, Progesterone receptor antagonist	10.00, 10.00	0.81, 0.18	-18.04	-59.71	-40.42	30.11	99.82	-59.92	-40.94	-6.88	-40.07	-23.51
BRD-K51967704	CP	BIIB021	HSP inhibitor	AOX1, HSP90AA1	HSP inhibitor	10.00, 10.00	1.28, 0.52	-98.74	-27.85	-42.03	-74.99	43.18	37.67	99.31	37.69	-97.69	-63.77
BRD-K17210248	CP	daunorubicin	RNA synthesis inhibitor, topoisomerase inhibitor, DNA synthesis inhibitor, radical formation stimulant	TOP2A, TOP2B		0.00, 0.00	2.84, 1.10	-97.36	-55.03	-58.57	-52.25	-83.53	-73.99	-98.79	-97.92	-99.21	-98.27
BRD-K11636097	CP	JNJ-7706621	CDK inhibitor, Aurora kinase inhibitor	CDK1, CDK2, AURKA, AURKB	CDK inhibitor	0.00, 0.00	4.50, 1.56	-98.75	26.84	-98.96	-99.75	-81.94	-36.92	-97.74	-96.67	-98.90	-98.10
BRD-A25569250	CP	KI-16425	lysophosphatidic acid receptor antagonist	LPAR1, LPAR3		0.00, 0.00	1.16, 0.22	-26.87	63.79	-5.72	75.23	-51.86	44.01	-19.49	81.47	-72.38	38.20
BRD-K64785675	CP	TG100-115	PI3K inhibitor	PIK3CG, PIK3CA, PIK3CB, PIK3CD		20.00, 10.00	1.30, 0.34	99.83	5.93	-24.70	-73.08	33.59	41.28	66.81	95.98	94.54	92.42
BRD-K48935217	CP	epothilone	inhibition of microtubulefunction, microtubule stabilizing agent, microtubule stimulant, tubulin inhibitor	TUBA1A, TUBA1B, TUBA1C, TUBA3C, TUBA4A, TUBA8, TUBB, TUBB1, TUBB3, TUBB4A, TUBB4B	Tubulin inhibitor	44.44, 44.44	1.24, 0.32	-95.13	99.96	99.94	-20.72	68.64	27.15	99.84	68.42	NaN	99.65
BRD-K56334280	CP	amonafide	topoisomerase inhibitor, DNA intercalating drug	TOP2A, TOP2B	Topoisomerase inhibitor	0.00, 0.00	1.61, 0.44	47.42	-99.30	-99.68	-99.80	-71.56	-97.50	-97.56	-97.36	-99.95	-99.51
BRD-K62982419	CP	cilomilast	phosphodiesterase inhibitor, interleukin synthesis inhibitor, tumor necrosis factor production inhibitor	PDE4A, PDE4B, PDE4D, IL12A, IL12B, IL1B, PDE4C, TNF		0.00, 0.00	1.22, 0.35	58.86	64.24	-38.59	79.16	87.45	-43.10	37.44	24.76	89.29	80.91
BRD-K05658747	CP	raltegravir	HIV integrase inhibitor			10.00, 10.00	0.99, 0.31	-26.49	-11.52	99.16	11.93	-72.39	-37.75	-32.90	84.00	-98.32	-14.79
BRD-A59985574	CP	topotecan	topoisomerase inhibitor	TOP1, TOP1MT	Topoisomerase inhibitor	0.00, 0.00	3.25, 0.84	-99.12	-41.42	-97.02	-99.63	-98.54	-94.69	-99.57	-93.34	NaN	-97.99
BRD-A20697603	CP	thiostrepton	downregulates FOXM1 expression, FOXM1 expression inhibitor, protein synthesis inhibitor	FOXM1	Protein synthesis inhibitor	0.00, 0.00	1.86, 0.31	-99.71	-91.60	-94.54	-99.64	-99.75	-97.77	-98.92	-97.11	-94.63	-98.38
BRD-K17849083	CP	tranilast	angiogenesis inhibitor, histamine receptor antagonist, histamine release inhibitor, indoleamine 2,3-dioxygenase activator, interferon gamma synthesis inhibitor, interleukin receptor modulator, interleukin synthesis enhancer, interleukin synthesis inhibitor, TGF beta receptor antagonist, TRPV antagonist, tumor necrosis factor production inhibitor, urate transporter inhibitor	HPGDS, HRH1, IDO1, IFNG, IL10, IL2, IL4, SLC22A12, TGFB1, TNF, TRPV2		0.00, 0.00	1.45, 0.63	15.69	68.34	-17.28	52.64	38.62	-43.38	-26.15	-37.78	81.05	34.99
BRD-A16444946	CP	acarbose	glucosidase inhibitor	GAA, MGAM, AMY2A, SI		0.00, 0.00	0.84, 0.13	27.45	-93.70	-27.71	-40.65	-41.33	NaN	32.10	72.94	75.72	-23.30
BRD-K33483813	CP	actarit	interleukin receptor agonist			0.00, 0.00	1.20, 0.30	35.58	25.95	55.82	-15.25	-42.09	NaN	-40.96	25.60	NaN	21.40
BRD-A73929928	CP	BRD-A73929928	adenosine receptor agonist	ADORA1, ADORA2A		0.00, 0.00	1.28, 0.32	-90.87	-65.20	-65.24	27.54	74.77	NaN	-37.32	31.57	NaN	-59.79
BRD-K46742498	CP	alosetron	serotonin receptor antagonist	HTR3A		0.00, 0.00	1.31, 0.35	-89.68	45.66	-98.35	91.65	-32.38	NaN	-83.32	-8.87	NaN	-89.40
BRD-K32398298	CP	alprazolam	GABA benzodiazepine site receptor agonist, benzodiazepine receptor agonist	GABRA1, GABRA2, GABRA3, GABRA5, CYP3A5, GABRA4, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ		12.50, 12.50	1.10, 0.50	-56.28	-39.24	99.89	32.47	54.04	NaN	-81.01	-42.47	NaN	-48.80
BRD-K55462201	CP	AM-404	FAAH transport inhibitor, anandamide transport inhibitor, nucelar factor of activated T-cells inhibitor, TRPV agonist	TRPV1, CNR1, CNR2, FAAH		0.00, 0.00	0.82, 0.23	-68.59	81.26	-80.29	-99.80	84.91	NaN	-43.86	-34.87	NaN	-62.96
BRD-K29530284	CP	amlexanox	histamine release inhibitor, mediator release inhibitor	FGF1, IL3, S100A12, S100A13		25.00, 25.00	1.24, 0.34	99.88	61.89	40.76	-72.64	99.95	NaN	-15.87	-7.64	NaN	61.86
BRD-A64297288	CP	amlodipine	breast cancer resistance protein inhibitor, calcium channel blocker, calcium channel inhibitor, L-type calcium channel blocker	CACNA1C, CACNA1D, CACNA2D1, ABCG2, CA1, CACNA1B, CACNA1S, CACNA2D3, CACNB1, CACNB2, SMPD1	Calcium channel blocker	0.00, 0.00	1.36, 0.33	-99.87	-99.15	-77.89	-29.96	-33.56	NaN	-19.32	13.58	NaN	-93.89
BRD-A39172021	CP	ampiroxicam	cyclooxygenase inhibitor	PTGS1, PTGS2		0.00, 0.00	1.59, 0.52	-4.27	49.34	-11.48	28.42	82.03	NaN	-49.83	11.17	NaN	2.02
BRD-K52172416	CP	anastrozole	aromatase inhibitor	CYP19A1		0.00, 0.00	1.05, 0.39	-27.65	-59.16	-26.99	-27.73	-71.28	55.90	-24.79	92.17	75.34	-7.15
BRD-A48261811	CP	argatroban	thrombin inhibitor, peptidase inhibitor, protease inhibitor	F2, CYP3A5		0.00, 0.00	0.98, 0.25	11.71	58.53	-63.17	14.63	-39.71	NaN	30.88	-83.66	NaN	-21.09
BRD-K70358946	CP	aripiprazole	serotonin receptor agonist, serotonin receptor antagonist, dopamine receptor agonist, dopamine receptor partial agonist, serotonin receptor partial agonist	DRD2, HTR1A, HTR2A, HRH1, HTR1B, HTR1D, HTR2C, ADRA1A, ADRA1B, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD3, DRD4, DRD5, HTR1E, HTR3A, HTR6, HTR7		0.00, 0.00	0.97, 0.19	-69.60	36.65	-17.03	-93.77	29.49	NaN	-24.68	-84.59	NaN	-80.42
BRD-K39621635	CP	artemether	antimalarial, interacts with heme and with COX3	ATP1A1, CYP2B6, CYP2C19, CYP3A5		0.00, 0.00	1.15, 0.26	-27.78	40.75	-32.56	49.75	-51.98	NaN	38.49	-63.61	NaN	-40.35
BRD-K79759031	CP	artesunate	DNA synthesis inhibitor			12.50, 12.50	0.98, 0.23	-83.30	-96.74	99.96	-83.66	-41.08	NaN	-31.31	79.08	NaN	-90.82
BRD-A75935363	CP	atracurium	acetylcholine receptor antagonist	CHRNA2		0.00, 0.00	1.17, 0.34	-31.60	87.30	-64.67	89.69	46.71	NaN	-96.47	20.44	NaN	-46.35
BRD-A68888262	CP	azelastine	histamine receptor antagonist, histamine release inhibitor, immunosuppressant	HRH1, CYP2C19		0.00, 0.00	1.81, 0.68	47.97	-92.58	-9.00	-59.86	48.69	NaN	22.92	55.63	NaN	9.60
BRD-A17448384	CP	beclometasone	glucocorticoid receptor agonist, corticosteroid hormone receptor agonist, immunosuppressant	NR3C1, CYP3A5, GPR97, SERPINA6	Glucocorticoid receptor agonist	10.00, 0.00	1.57, 0.56	36.77	35.31	-11.26	-54.11	-38.49	-51.43	47.43	96.15	-28.73	-16.00
BRD-K85030058	CP	benactyzine	acetylcholine receptor antagonist			0.00, 0.00	1.19, 0.39	-32.92	-22.08	-85.02	70.89	-33.48	NaN	61.93	-65.85	NaN	-37.43
BRD-K49807096	CP	benazepril	angiotensin converting enzyme inhibitor	ACE		0.00, 0.00	1.23, 0.41	88.68	37.84	-16.78	53.65	-48.77	NaN	74.67	-16.93	NaN	23.43
BRD-A35519318	CP	benidipine	calcium channel blocker, L-type calcium channel blocker	CACNA1C, CACNA1G, CYP3A5		25.00, 12.50	0.88, 0.27	-91.32	12.34	96.83	-28.73	59.28	NaN	87.88	99.50	NaN	91.15
BRD-A42423104	CP	benproperine	anti-tussive			0.00, 0.00	1.26, 0.35	-31.73	84.45	25.11	14.23	74.19	NaN	36.75	46.79	NaN	36.21
BRD-K31471398	CP	dihydrexidine	dopamine receptor agonist	DRD1, DRD2, DRD3, DRD4, DRD5		10.00, 10.00	1.32, 0.43	-27.98	-64.89	-20.41	20.50	-36.25	-33.84	99.98	-87.12	-87.91	-44.58
BRD-A94543220	CP	bifonazole	cell wall synthesis inhibitor, sterol demethylase inhibitor	CYP2B6		12.50, 0.00	1.10, 0.36	96.24	-21.64	-53.10	-99.95	-88.65	NaN	26.06	-51.06	NaN	-54.27
BRD-K68077509	CP	brucine	glycine receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5		30.00, 20.00	1.51, 0.45	-45.16	99.96	-57.99	96.66	17.98	-38.08	-48.05	36.59	97.99	59.57
BRD-K19462402	CP	buflomedil	adrenergic receptor antagonist, calcium channel antagonist	CACNA1C		0.00, 0.00	1.24, 0.35	45.09	-62.86	-59.44	21.15	-56.19	NaN	-39.63	71.98	NaN	-55.65
BRD-K16336526	CP	capsaicin	TRPV agonist, NFkB pathway inhibitor, tumor NADH oxidase inhibitor	TRPV1, CFTR, ENOX2		0.00, 0.00	1.43, 0.47	55.57	-96.32	-18.56	34.54	79.25	NaN	39.31	14.19	NaN	11.79
BRD-K11630072	CP	carmofur	thymidylate synthase inhibitor, pyrimidine antagonist	TYMS	Thymidylate synthase inhibitor	0.00, 0.00	1.19, 0.41	-84.79	-41.66	-59.73	-99.47	-48.27	NaN	-99.96	-98.40	NaN	-99.51
BRD-K20338176	CP	cefaclor	cell wall synthesis inhibitor			10.00, 10.00	0.98, 0.34	-60.81	73.66	91.99	75.65	99.22	-82.82	83.64	-36.65	34.12	91.57
BRD-M47937986	CP	cefatrizine	cell wall synthesis inhibitor			0.00, 0.00	0.83, 0.25	-29.23	-74.49	-50.69	14.67	-82.56	NaN	-40.16	18.16	NaN	-19.02
BRD-K52735702	CP	cefdinir	cell wall synthesis inhibitor	MPO	Bacterial cell wall synthesis inhibitor	0.00, 0.00	1.60, 0.41	-45.22	30.19	34.52	51.42	-17.33	57.96	-54.50	83.81	-68.11	35.93
BRD-K04993501	CP	cefixime	cell wall synthesis inhibitor		Bacterial cell wall synthesis inhibitor	0.00, 0.00	1.49, 0.43	41.95	31.81	-98.72	-76.89	-27.63	-22.53	-42.31	20.25	-89.82	-19.27
BRD-A87387433	CP	cefpodoxime	cell wall synthesis inhibitor			0.00, 0.00	1.22, 0.39	84.37	67.63	-84.17	-93.47	45.16	NaN	-47.43	-54.91	NaN	-80.60
BRD-K90733503	CP	cefalexin	cell wall synthesis inhibitor		Bacterial cell wall synthesis inhibitor	0.00, 0.00	1.35, 0.28	-83.59	-50.94	-47.71	49.11	-63.67	NaN	87.50	-42.85	NaN	-56.09
BRD-K81169441	CP	cerivastatin	HMGCR inhibitor	HMGCR, CYP2C8, CYP3A5	HMGCR inhibitor	0.00, 0.00	0.95, 0.18	-96.70	-43.36	53.17	-99.61	-65.45	NaN	-44.37	-76.17	NaN	-85.38
BRD-K48932581	CP	cetraxate	gastrin inhibitor, mucus protecting agent	GAST		0.00, 0.00	1.48, 0.39	-14.05	60.34	46.11	49.27	36.24	NaN	-41.03	-44.03	NaN	35.05
BRD-K86595100	CP	chlordiazepoxide	GABA benzodiazepine site receptor agonist	GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ		0.00, 0.00	1.38, 0.41	60.61	-34.18	-18.76	90.31	-32.21	45.48	-31.32	-32.29	82.14	-19.72
BRD-K85518562	CP	cilastatin	dehydropeptidase inhibitor	DPEP1		12.50, 0.00	1.33, 0.33	-15.08	97.14	-92.97	59.78	-98.08	NaN	16.35	93.31	NaN	54.77
BRD-K49668410	CP	clarithromycin	50S ribosomal subunit inhibitor	CYP2C19, CYP3A4, CYP3A5, CYP3A7		0.00, 0.00	1.41, 0.39	92.44	16.38	-26.52	-95.07	93.80	NaN	-39.73	-24.35	NaN	-55.18
BRD-K56614220	CP	clofazimine	GK0582 inhibitor			12.50, 12.50	0.64, 0.17	-98.80	98.23	-61.74	-20.47	32.49	NaN	-31.50	-31.24	NaN	-25.48
BRD-K15916496	CP	clotrimazole	cell wall synthesis inhibitor, cytochrome P450 inhibitor, imidazole inhibitor, intermediate conductance potassium channel activator, intermediate conductance potassium channel blocker, lanosterol demethylase inhibitor, sterol demethylase inhibitor	KCNN4, CYP3A4, CYP51A1, NR1I2, NR1I3, TRPM2, TRPM4, TRPM8		12.50, 12.50	1.44, 0.69	-98.49	-33.65	53.05	-86.51	99.46	NaN	25.88	-95.54	NaN	-91.49
BRD-K73589401	CP	corticosterone	mineralocorticoid receptor agonist	HSD11B1, NR3C2, NCOA1		0.00, 0.00	1.63, 0.55	-11.38	-45.63	-96.29	19.90	37.28	22.04	56.82	-56.30	64.57	12.81
BRD-K70578146	CP	dactinomycin	DNA directed RNA polymerase inhibitor, nucleic acid syntheis inhibitor, protein synthesis inhibitor	POLR2A		0.00, 0.00	2.80, 0.84	-94.88	11.23	-52.76	-72.26	-99.70	-82.54	-99.59	-99.47	-99.43	-98.48
BRD-K90976994	CP	dehydrocholic-acid	gastrointestinal agent that stimulates bile production or the flow of bile into the duodenum			10.00, 0.00	1.48, 0.41	50.02	-57.22	52.48	-25.30	-67.86	78.66	96.57	-46.08	10.02	47.46
BRD-K30697463	CP	desoximetasone	glucocorticoid receptor agonist	NR3C1, PLA2G1B	Glucocorticoid receptor agonist	0.00, 0.00	1.52, 0.51	-82.62	87.51	25.66	9.29	63.96	35.69	-39.82	44.22	33.55	6.82
BRD-K22947005	CP	dexbrompheniramine	histamine receptor antagonist	HRH1		0.00, 0.00	1.17, 0.30	-15.40	8.10	36.96	-62.96	-58.84	NaN	65.09	-12.24	NaN	-8.56
BRD-K39462424	CP	dexchlorpheniramine	histamine receptor antagonist			10.00, 10.00	1.17, 0.39	42.19	-16.53	-16.65	-54.30	50.34	67.95	99.96	-25.29	23.94	10.43
BRD-K13664374	CP	dichloroacetic-acid	pyruvate dehydrogenase kinase inhibitor, pyruvate dehydrogenase stimulant	PDK1		0.00, 0.00	1.33, 0.38	-45.50	91.41	-72.76	-88.89	-37.14	NaN	-76.79	-44.39	NaN	-73.10
BRD-K41903098	CP	diphenoxylate	opoid receptor agonist	OPRM1, OPRD1		0.00, 0.00	0.99, 0.19	-77.33	94.61	-98.57	-36.22	42.39	NaN	-99.54	-95.48	NaN	-99.51
BRD-K51730347	CP	diphencyprone	immunostimulant			0.00, 0.00	1.84, 0.66	-31.74	-87.97	-99.59	-97.51	-99.82	NaN	29.86	-55.42	NaN	-95.21
BRD-K63265447	CP	docetaxel	tubulin inhibitor, microtubule depolymerization inhibitor, microtubule stabilizing agent, microtubule stimulant, taxane	TUBB, BCL2, MAP2, MAP4, MAPT, NR1I2, TUBB1	Tubulin inhibitor	12.50, 12.50	1.02, 0.39	14.76	99.76	93.64	-75.72	57.24	NaN	-72.89	-29.57	NaN	88.49
BRD-K86887724	CP	dofetilide	polarization inhibitor, potassium channel antagonist, potassium channel blocker	KCNH2, KCNH1, KCNJ12, KCNK2		0.00, 0.00	1.25, 0.40	11.49	-48.04	44.66	70.77	38.16	NaN	-21.14	41.19	NaN	7.05
BRD-K28029915	CP	dolasetron	serotonin receptor antagonist	HTR3A		0.00, 0.00	1.38, 0.42	84.21	-42.02	-13.01	56.05	-49.29	41.17	-61.43	62.72	25.72	24.95
BRD-K40758068	CP	efavirenz	HIV reverse transcriptase inhibitor, non-nucleoside reverse transcriptase inhibitor, reverse transcriptase inhibitor	CYP2B6, CYP2C19, CYP2C8, CYP3A4, CYP3A5		25.00, 0.00	0.74, 0.20	-19.22	-54.89	-60.73	96.71	96.33	NaN	90.51	41.28	NaN	94.63
BRD-K99447003	CP	enalaprilat	angiotensin converting enzyme inhibitor	ACE		0.00, 0.00	1.80, 0.55	72.54	62.92	-8.13	-90.16	90.09	NaN	-99.20	-57.49	NaN	40.02
BRD-A07395371	CP	esmolol	adrenergic receptor antagonist	ADRB1		0.00, 0.00	0.56, 0.15	67.34	40.77	-73.54	65.22	63.95	NaN	64.94	-26.62	NaN	41.94
BRD-A56892734	CP	esomeprazole	ATPase inhibitor, ABC transporter expression enhancer	ATP4A, CYP2C19, CYP3A4		12.50, 12.50	1.60, 0.34	14.75	-95.20	11.02	16.75	-46.87	NaN	99.91	-86.70	NaN	-43.91
BRD-K47448802	CP	BRD-K47448802	acetylcholine receptor allosteric modulator	CHRM1		10.00, 10.00	1.60, 0.45	8.87	78.62	78.76	19.38	75.44	53.83	98.56	-20.84	74.80	84.03
BRD-K39391626	CP	ethylestrenol	anabolic steroid, has some progesterone-like activity	AR	Progesterone receptor agonist, Progesterone receptor antagonist	0.00, 0.00	1.59, 0.70	18.85	9.37	-13.85	93.15	-45.35	NaN	-36.71	-30.58	NaN	-8.92
BRD-K48195008	CP	ethinylestradiol	DNA directed DNA polymerase stimunlant, estrogen receptor agonist	ESR1, CYP2C8, ESR2, NR1I2		12.50, 12.50	1.73, 0.58	33.33	99.93	46.96	-72.33	-56.47	NaN	-25.10	14.08	NaN	16.29
BRD-K33425534	CP	exemestane	aromatase inhibitor	CYP19A1		0.00, 0.00	0.92, 0.28	76.73	-95.65	44.06	55.60	30.34	NaN	37.71	68.98	NaN	43.55
BRD-K42260897	CP	ezetimibe	cholesterol absorption inhibitor, Niemann-Pick C1-like 1 protein antagonist, liver bile acid transporter inhibitor, Niemann-Pick C1-like 1 protein inhibitior	NPC1L1, ANPEP, SOAT1		12.50, 0.00	1.59, 0.44	-28.40	-29.03	96.54	-53.66	43.29	NaN	72.07	-48.23	NaN	28.14
BRD-K00673382	CP	famotidine	histamine receptor antagonist	HRH2		12.50, 12.50	1.61, 0.40	-37.05	13.99	16.92	99.05	-40.96	NaN	22.20	46.17	NaN	12.56
BRD-K84566043	CP	fenpiverinium	acetylcholine receptor antagonist			12.50, 0.00	1.18, 0.35	95.43	-59.48	19.17	25.77	-67.28	NaN	48.24	37.37	NaN	34.66
BRD-K86003836	CP	flubendazole	acetylcholinesterase inhibitor, microtubule inhibitor, tubulin inhibitor	TUBB	Tubulin inhibitor	50.00, 25.00	0.89, 0.45	-75.62	96.43	98.75	-48.37	39.03	NaN	-97.45	97.17	NaN	97.96
BRD-K31534764	CP	fluvoxamine	selective serotonin reuptake inhibitor (SSRI), serotonin reuptake inhibitor, serotonin uptake inhibitor	SLC6A4, CYP2C19		12.50, 0.00	1.60, 0.43	95.47	-68.09	15.90	-53.64	43.63	NaN	-64.93	10.51	NaN	-23.17
BRD-K54006094	CP	formoterol	adrenergic receptor agonist	ADRB2, CYP2C19		0.00, 0.00	1.72, 0.67	-36.71	-25.55	-68.54	-99.29	-88.66	NaN	-14.72	-13.19	NaN	-81.76
BRD-A79903587	CP	tegafur	DNA synthesis inhibitor, thymidylate synthase inhibitor	TYMS		25.00, 12.50	0.58, 0.20	99.92	-97.88	91.28	-62.66	37.05	NaN	-60.09	87.60	NaN	96.05
BRD-K49481516	CP	galantamine	acetylcholinesterase inhibitor, acetylcholine receptor agonist, butyrylcholinesterase inhibitors	ACHE, BCHE, CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG		0.00, 0.00	1.66, 0.57	27.04	-21.64	-13.82	-35.46	-51.91	NaN	-25.47	46.31	NaN	-4.69
BRD-A62434282	CP	goserelin	gonadotropin releasing factor hormone receptor agonist, luteinizing hormone releasing hormone agonist	GNRHR, GNRH1, LHCGR		10.00, 0.00	1.14, 0.35	35.68	21.90	57.72	27.25	96.28	42.16	-71.73	71.98	-54.67	40.98
BRD-K10860596	CP	granisetron	serotonin receptor antagonist	HTR3A, CYP3A5		10.00, 0.00	1.49, 0.36	46.67	-18.57	-29.11	95.90	41.53	-34.87	47.38	-37.06	-26.66	-9.20
BRD-K33312228	CP	halometasone	cytochrome P450 inhibitor, glucocorticoid receptor agonist, immunosuppressant	NR3C1	Glucocorticoid receptor agonist	0.00, 0.00	1.69, 0.53	-15.82	-41.94	-66.89	-96.57	29.39	NaN	-28.30	-41.79	NaN	-43.17
BRD-A24643465	CP	homoharringtonine	apoptosis stimulant, protein synthesis inhibitor	RPL3		0.00, 0.00	2.46, 0.69	-99.10	-91.80	-72.93	-65.38	82.53	-60.09	-96.05	-60.30	-58.81	-95.59
BRD-K59570838	CP	homoveratrylamine	dopamine analog			0.00, 0.00	1.41, 0.34	53.46	85.44	45.92	-50.79	-65.85	73.55	31.93	9.21	-23.94	29.38
BRD-K98493452	CP	honokiol	AKT inhibitor, neurotrophic agent	ALOX5, PTGS1, PTGS2		0.00, 0.00	1.67, 0.49	-45.35	-92.37	-39.92	-51.30	-86.67	NaN	20.80	89.85	NaN	-29.09
BRD-K45888792	CP	huperzine-a	acetylcholinesterase inhibitor, glutamate receptor antagonist	ACHE		0.00, 0.00	1.68, 0.48	-85.09	51.68	-24.16	56.20	-59.52	NaN	-25.81	9.87	NaN	-15.53
BRD-K84955386	CP	hyperoside	glucosidase inhibitor, free radical scavenger	ACE, AKR1B1, GAA		0.00, 0.00	2.08, 0.76	57.14	-97.44	-16.94	76.06	64.97	NaN	-27.04	-71.95	NaN	-27.18
BRD-K69650333	CP	idarubicin	topoisomerase inhibitor, radical formation stimulant, RNA synthesis inhibitor	TOP2A	Topoisomerase inhibitor	0.00, 0.00	2.64, 0.69	-94.03	-77.29	-91.25	-71.41	-98.50	NaN	-75.42	-83.71	NaN	-93.51
BRD-K37516142	CP	idebenone	calcium channel modulator, reducing agent			12.50, 12.50	0.86, 0.18	98.48	37.62	-79.35	85.79	48.86	NaN	-89.93	-62.12	NaN	-65.94
BRD-A24191444	CP	ifenprodil	adrenergic receptor antagonist, glutamate receptor antagonist	GRIN1, GRIN2B		0.00, 0.00	0.90, 0.16	-17.41	90.62	25.90	74.15	81.27	NaN	-92.95	35.80	NaN	80.18
BRD-K01649396	CP	indatraline	norepinephrine transporter inhibitor, dopamine transporter inhibitor, dopamine uptake inhibitor, serotonin transporter (SERT) inhibitor, serotonin uptake inhibitor	SLC6A2, SLC6A3, SLC6A4		0.00, 0.00	1.58, 0.47	-92.84	-96.92	-45.42	37.58	88.34	NaN	90.23	-45.43	NaN	-64.92
BRD-K33226500	CP	indinavir	HIV protease inhibitor	CYP3A5	HIV protease inhibitor	0.00, 0.00	1.13, 0.28	21.93	-46.13	-62.10	86.41	71.96	NaN	-90.10	62.14	NaN	54.37
BRD-K93618743	CP	ipriflavone	bone resorption inhibitor			12.50, 12.50	1.25, 0.25	97.58	-50.68	-56.50	28.86	65.43	NaN	-35.17	-21.99	NaN	-14.24
BRD-K73991644	CP	isoquercetin	aldose reductase inhibitor, falcipain inhibitor	AKR1B1, ACE		0.00, 0.00	1.64, 0.66	69.74	36.92	-11.55	-55.69	46.93	NaN	47.48	17.61	NaN	18.18
BRD-A69927616	CP	isradipine	calcium channel blocker, L-type calcium channel blocker	CACNA1C, CACNA1D, CACNA2D1, CACNA1F, CACNA1H, CACNA1S, CACNA2D2, CACNB2		25.00, 12.50	1.82, 0.56	98.36	97.16	18.23	-42.53	-29.84	NaN	23.14	45.86	NaN	40.24
BRD-K30097969	CP	pitavastatin	HMGCR inhibitor, apolipoprotein expression enhancer, osteopontin expression inhibitor	HMGCR, APOA1, CYP2C8	HMGCR inhibitor	0.00, 0.00	2.19, 0.43	-97.31	63.75	-56.21	-99.44	85.23	-62.21	-45.45	-99.84	-26.68	-95.42
BRD-K96740444	CP	itopride	dopamine receptor antagonist, acetylcholinesterase inhibitor	DRD2, ACHE, CHRM3		0.00, 0.00	0.83, 0.28	-37.24	-5.51	-23.61	7.98	-81.63	NaN	-78.78	24.95	NaN	-35.78
BRD-K96134740	CP	kitasamycin	protein synthesis inhibitor			12.50, 12.50	1.08, 0.34	97.66	53.50	-6.22	-31.30	-37.01	NaN	-37.02	-75.38	NaN	-10.55
BRD-K59456551	CP	methotrexate	dihydrofolate reductase inhibitor, disease modifying antirheumatic drug, folate receptor antagonist, immunosuppressant, thymidylate synthase inhibitor	DHFR, AOX1, FOLR1, TYMS	Dihydrofolate reductase inhibitor	0.00, 0.00	0.97, 0.23	-99.92	-77.62	-94.83	-99.09	32.71	NaN	-99.19	-100.00	NaN	-99.72
BRD-K22227508	CP	targinine	nitric oxide synthase inhibitor	NOS2, NOS3		0.00, 0.00	2.35, 0.69	-56.78	32.49	-29.20	64.05	-35.50	NaN	-26.16	-20.11	NaN	-10.15
BRD-A52282606	CP	lacidipine	calcium channel blocker, L-type calcium channel blocker	CACNA1C	Calcium channel blocker	0.00, 0.00	0.85, 0.20	-80.69	12.67	-98.49	-80.58	51.04	NaN	-92.59	-25.32	NaN	-85.80
BRD-A49172652	CP	lansoprazole	ATPase inhibitor	ATP4A, CYP2C19, CYP3A4, CYP3A5		0.00, 0.00	1.35, 0.30	85.42	13.74	-10.33	14.73	-42.97	NaN	40.08	-97.91	NaN	-8.89
BRD-K10961822	CP	latanoprost	prostanoid receptor agonist	PTGFR		0.00, 0.00	1.78, 0.70	53.04	48.44	-29.43	28.56	93.68	NaN	-15.69	-44.22	NaN	15.02
BRD-K49404994	CP	levetiracetam	acetylcholine receptor agonist, N-type calcium channel blocker, synaptic vesicle glycoprotein ligand	SV2A, CACNA1B, SCN1A		12.50, 12.50	0.77, 0.24	99.56	-64.62	-36.93	-77.70	-75.62	NaN	-95.12	49.37	NaN	-70.62
BRD-K27184429	CP	levocetirizine	histamine receptor antagonist, interleukin expression inhibitor, tumor necrosis factor expression inhibitor	HRH1, CXCL8		12.50, 12.50	1.36, 0.36	98.14	11.35	-30.16	-51.28	-81.09	NaN	58.24	-73.40	NaN	-26.58
BRD-K09471561	CP	levofloxacin	topoisomerase inhibitor, DNA gyrase inhibitor	TOP2A		0.00, 0.00	1.83, 0.38	9.81	-41.69	-53.09	33.68	-99.32	NaN	-33.97	49.39	NaN	-25.33
BRD-K51671335	CP	sulpiride	carbonic anhydrase inhibitor, dopamine receptor, dopamine receptor antagonist	DRD2, CA7, DRD3, CA1, CA12	Dopamine receptor antagonist	0.00, 0.00	2.11, 0.84	14.89	24.04	-13.47	19.11	-50.53	NaN	-61.37	-37.56	NaN	-8.91
BRD-K66206289	CP	lobeline	acetylcholine receptor antagonist, dopamine receptor modulator, opioid receptor antagonist, vesicular monoamine transporter ligand	SLC18A2, CHRNA10, CHRNA4, CHRNA9, CHRNB2, OPRM1		25.00, 12.50	0.76, 0.28	98.78	39.26	70.79	-50.42	-37.94	NaN	95.38	-97.23	NaN	76.79
BRD-K82147103	CP	lofepramine	adrenergic transmitter uptake inhibitor, norepinephrine reuptake inhibitor, serotonin reuptake inhibitor, serotonin uptake inhibitor, tricyclic antidepressant	SLC6A2, SLC6A4		0.00, 0.00	1.72, 0.57	-20.29	-98.05	-52.71	29.56	-76.06	NaN	22.68	-62.10	NaN	-59.46
BRD-A02990301	CP	lofexidine	adrenergic receptor agonist	ADRA2A		0.00, 0.00	1.19, 0.33	-15.45	-17.51	77.71	-43.50	77.79	-38.79	-79.92	90.47	36.66	47.57
BRD-K62858456	CP	lomerizine	calcium channel antagonist, calcium channel blocker, P glycoprotein inhibitor	ABCB1, CACNA1B, SCN5A	Calcium channel blocker	0.00, 0.00	1.78, 0.67	49.44	11.38	-16.72	-56.80	-97.01	NaN	-28.22	-69.16	NaN	-39.55
BRD-K82795137	CP	loratadine	histamine receptor antagonist	HRH1, CYP2C19, CYP3A5	HRH1 antagonist	0.00, 0.00	1.14, 0.22	34.74	-17.40	-51.26	-71.60	35.48	NaN	-96.79	-46.90	NaN	-75.01
BRD-A11990600	CP	lorazepam	chloride channel agonist, GABA benzodiazepine site receptor agonist, GABA receptor agonist, potassium channel agonist	GABRA1, GABRA2, GABRA3, GABRA5, GABRA4, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, TSPO	Benzodiazepine receptor agonist	0.00, 0.00	1.08, 0.33	-86.72	61.19	-52.75	14.82	39.96	NaN	65.86	-17.14	NaN	-14.20
BRD-K66198023	CP	losartan	angiotensin receptor antagonist	AGTR1		12.50, 12.50	1.78, 0.38	19.06	-19.31	-81.81	94.36	29.69	NaN	-20.62	98.26	NaN	37.62
BRD-K39983086	CP	loteprednol	corticosteroid agonist, phospholipase inhibitor	NR3C1	Glucocorticoid receptor agonist	12.50, 12.50	1.67, 0.61	99.82	15.33	27.68	-95.49	-87.28	NaN	34.86	-83.38	NaN	-78.84
BRD-A43082555	CP	loxoprofen	cyclooxygenase inhibitor, platelet aggregation inhibitor, prostanoid receptor inhibitor	PTGS2		0.00, 0.00	0.88, 0.30	17.02	-49.27	-38.38	-50.43	-64.98	NaN	30.59	-14.84	NaN	-29.19
BRD-K41051431	CP	mecillinam	cell wall synthesis inhibitor			12.50, 12.50	1.16, 0.34	65.86	-56.19	-67.79	99.93	58.13	NaN	-48.62	-32.49	NaN	-41.14
BRD-K99615199	CP	medroxyprogesterone	progesterone receptor agonist	PGR, ESR1		0.00, 0.00	1.18, 0.40	14.03	-97.56	-11.21	-97.97	-43.97	35.05	78.51	-17.60	-26.07	-27.72
BRD-K91938660	CP	memantine	glutamate receptor antagonist, glutamate release inhibitor	GRIN1, CHRFAM7A, CYP2E1, DRD2, GRIN2A, GRIN2B, GRIN3A, HTR3A		0.00, 0.00	1.42, 0.47	-93.32	83.89	-97.51	-90.38	-32.69	NaN	54.75	-34.97	NaN	-94.60
BRD-A03216249	CP	mepivacaine	potassium channel antagonist, voltage-gated sodium channel blocker	SCN10A, SCN9A		0.00, 0.00	1.41, 0.36	-82.62	-49.47	73.18	-75.65	-67.39	43.52	-22.36	-42.56	21.67	-37.06
BRD-K18523449	CP	mestanolone	androgenic steroid		Androgen receptor modulator	0.00, 0.00	1.38, 0.44	-54.44	-98.08	-22.33	-29.93	-58.75	NaN	18.92	5.89	NaN	-27.56
BRD-K88679075	CP	methandriol	androgenic horomone		Androgen receptor modulator	0.00, 0.00	2.10, 0.76	-55.92	-97.69	-27.41	30.63	61.56	NaN	22.51	20.09	NaN	-35.59
BRD-K84036904	CP	testosterone	androgen receptor (AR) agonist, androgen receptor agonist, testosterone receptor agonist	AR, CYP19A1, CYP2C19, CYP2C8, CYP3A5		12.50, 12.50	1.01, 0.40	99.58	-61.01	-19.27	-95.88	92.72	NaN	86.81	43.76	NaN	88.83
BRD-K52020312	CP	metronidazole	DNA inhibitor	CYP2C8, CYP2E1, CYP3A5, CYP3A7		12.50, 12.50	1.66, 0.42	-99.89	-37.67	99.98	-44.66	-31.85	NaN	-24.73	24.12	NaN	-19.07
BRD-K00532621	CP	midazolam	benzodiazepine receptor agonist, GABA benzodiazepine site receptor agonist	CYP3A5, CYP3A7, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GABRR1, GABRR2, GABRR3	Benzodiazepine receptor agonist	12.50, 12.50	1.90, 0.82	53.44	-19.22	29.29	15.66	78.36	NaN	98.76	-18.26	NaN	65.15
BRD-K44779798	CP	miglitol	glucosidase inhibitor, sodium/glucose cotransporter activator	GAA, MGAM, GANAB, GANC, SLC5A4		0.00, 0.00	1.74, 0.57	93.41	-96.04	-9.34	-18.31	-39.95	NaN	57.92	87.68	NaN	75.02
BRD-K02227374	CP	milnacipran	serotonin reuptake inhibitor, adrenergic transmitter uptake inhibitor, norepinephrine reputake inhibitor, norepinephrine reuptake inhibitor, serotonin uptake inhibitor	SLC6A2, SLC6A4, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B		12.50, 0.00	1.49, 0.43	95.62	-73.89	-36.77	-99.78	-95.77	NaN	47.95	-82.82	NaN	-89.22
BRD-K69470111	CP	montelukast	leukotriene receptor antagonist	CYSLTR1, ALOX5, CYP2C8		0.00, 0.00	0.89, 0.22	72.84	77.45	-24.51	-28.35	34.64	NaN	-51.79	-31.51	NaN	-9.64
BRD-A39052811	CP	mosapride	serotonin receptor agonist, serotonin receptor antagonist	HTR4, HTR3A		0.00, 0.00	2.30, 0.74	-93.86	43.65	-75.42	-48.07	94.71	-23.79	-6.75	-64.52	26.59	-15.74
BRD-K04710043	CP	hexamethylenebisacetamide	differentiation inducer, NFKB inhibitor, AKT inhibitor			25.00, 25.00	2.07, 0.75	99.82	98.69	-10.40	77.38	-29.49	NaN	36.06	-7.54	NaN	79.84
BRD-A01787639	CP	naftopidil	adrenergic receptor antagonist, calcium channel antagonist	ADRA1A, ADRA1D		0.00, 0.00	0.68, 0.25	-98.75	-30.46	-67.59	-29.76	31.91	NaN	-34.56	-34.23	NaN	-27.90
BRD-A16934955	CP	nalbuphine	opioid receptor agonist, opioid receptor antagonist	OPRD1, OPRK1, OPRM1		0.00, 0.00	1.34, 0.40	26.02	-64.82	-58.53	42.33	-80.46	NaN	-28.82	-18.71	NaN	-51.35
BRD-A47342814	CP	naltrindole	opioid receptor antagonist	OPRD1, OPRK1, OPRM1		0.00, 0.00	0.95, 0.22	-12.26	-53.70	-12.51	-86.60	49.77	NaN	57.44	11.85	NaN	-13.23
BRD-K59197931	CP	naproxen	cyclooxygenase inhibitor	PTGS2, PTGS1		10.00, 10.00	2.05, 0.53	38.64	7.31	98.50	-66.64	-37.19	-90.27	69.43	80.14	-70.63	24.55
BRD-K44353683	CP	nateglinide	insulin secretagogue, ATP-sensitive potassium channel antagonist, meglitinide, sulphonylurea receptor activator	ABCC8, KCNJ11, CYP3A4, INS, KCNJ10, PPARG		0.00, 0.00	1.57, 0.31	56.78	-5.32	-59.85	-48.03	-86.26	NaN	47.19	13.63	NaN	-16.78
BRD-K74117820	CP	nelfinavir	HIV protease inhibitor, proteasome inhibitor	CYP2C19, CYP3A5, CYP3A7		0.00, 0.00	1.51, 0.41	-99.59	48.40	-99.85	85.24	-43.72	NaN	-96.05	-82.18	NaN	-97.96
BRD-A30977374	CP	nifedipine	calcium channel blocker, L-type calcium channel blocker	CACNA1C, CACNA1D, CACNA1S, CACNA2D1, CACNA1F, CACNA1H, CACNB2, CALM1, CYP3A5, GLRA1, GLRA3, GLRB, KCNA1, KCNA5, NR1I2, TRPM3		0.00, 0.00	1.26, 0.40	-95.76	50.31	-15.95	-26.97	-36.37	NaN	-86.62	27.29	NaN	-33.38
BRD-K32311154	CP	nifekalant	potassium channel antagonist, potassium channel blocker			0.00, 0.00	0.98, 0.32	91.83	92.20	-4.84	30.51	38.39	NaN	42.51	9.53	NaN	25.48
BRD-K70883034	CP	nimetazepam	chloride channel agonist, GABA receptor agonist, potassium channel agonist	GABRA1, GABRA2, GABRA3, GABRA5		25.00, 12.50	0.99, 0.27	96.73	-18.39	63.86	-68.98	25.44	NaN	98.83	-37.67	NaN	45.40
BRD-A24891640	CP	nimodipine	calcium channel blocker, L-type calcium channel blocker	CACNA1C, NR3C2, AHR, CACNA1D, CACNA1F, CACNA1S, CACNB1, CACNB2, CACNB3, CACNB4, CFTR		10.00, 0.00	1.00, 0.25	-49.84	18.32	-78.13	95.13	-28.91	-22.38	-73.10	-71.22	59.68	-38.19
BRD-A96107863	CP	nisoldipine	calcium channel blocker, L-type calcium channel blocker	CACNA1C, CACNA1D, CACNA1S, CACNA2D1, CACNB2, CYP3A5	Calcium channel blocker	0.00, 0.00	1.45, 0.64	-79.76	-95.58	-13.48	-91.54	-75.53	NaN	-49.31	-60.08	NaN	-80.10
BRD-K96471533	CP	nitazoxanide	pyruvate ferredoxin oxidoreductase inhibitor, pyruvate synthase inhibitor			0.00, 0.00	1.03, 0.27	-97.52	37.14	-40.91	-98.46	-93.04	NaN	-20.55	20.08	NaN	-89.09
BRD-K57930253	CP	nitrazepam	GABA benzodiazepine site receptor agonist	GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GABRR1, GABRR2, GABRR3, SCN1A	Benzodiazepine receptor agonist	0.00, 0.00	1.19, 0.33	-16.84	39.06	-11.98	44.26	37.11	NaN	-78.58	62.41	NaN	17.43
BRD-A12560204	CP	nitrendipine	calcium channel blocker, L-type calcium channel blocker	CACNA1C, CACNA1D, CACNA2D1, CACNA1H, CACNA1S, CACNA2D2, CACNB2, CACNG1, KCNN4	Calcium channel blocker	0.00, 0.00	1.74, 0.41	-12.95	-36.18	-25.30	12.82	32.24	NaN	-39.90	10.26	NaN	-15.40
BRD-A24543851	CP	nornicotine	acetylcholine receptor agonist			0.00, 0.00	0.83, 0.20	-71.26	16.14	42.13	77.09	35.97	NaN	41.69	46.30	NaN	20.78
BRD-K18895904	CP	olanzapine	dopamine receptor antagonist, serotonin receptor antagonist	DRD2, HTR2A, HTR2C, DRD1, DRD3, DRD4, HRH1, HTR1A, HTR1B, HTR1D, HTR1E, HTR6, HTR7, ADRA1A, ADRA1B, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, CYP2C8, DRD5, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, HRH2, HRH4, HTR1F, HTR2B, HTR3A, HTR5A		12.50, 12.50	0.57, 0.17	42.48	-98.86	49.05	-19.45	84.32	NaN	-54.69	99.28	NaN	41.40
BRD-K05350981	CP	oligomycin-c	ATP synthase inhibitor, regulatory volume decrease inhibitor	ATP5A1	ATP synthase inhibitor, ATPase inhibitor	0.00, 0.00	1.44, 0.43	-98.82	-99.89	-47.97	-78.03	-94.12	NaN	39.72	-95.16	NaN	-97.24
BRD-K83144676	CP	olmesartan	angiotensin receptor antagonist, angiotensin antagonist	AGTR1		25.00, 12.50	1.99, 0.48	78.94	98.19	95.80	-17.64	-37.74	NaN	14.05	-28.04	NaN	72.76
BRD-K63343048	CP	orlistat	cholesterol inhibitor, diacylglycerol lipase inhibitor, fatty acid synthase inhibitor, gastric triacylglycerol lipase inhibitor, Hypolipemic pancreatic, gastric and carboxylester lipase inhibitor, lipase inhibitor, pancreatic lipase inhibitor	PNLIP, DAGLA, FASN, LIPF, CNR1, DAGLB		0.00, 0.00	1.16, 0.32	-84.45	-86.93	-81.74	-28.32	89.03	NaN	-21.18	-55.22	NaN	-85.48
BRD-K25310650	CP	ormetoprim	antibiotic			0.00, 0.00	1.85, 0.74	42.02	16.78	-12.32	27.72	70.24	NaN	35.56	13.93	NaN	11.93
BRD-K23369905	CP	oxiconazole	cell wall synthesis inhibitor, sterol demethylase inhibitor			0.00, 0.00	1.25, 0.40	-99.96	-98.17	-40.26	35.50	-85.14	NaN	-77.11	-94.17	NaN	-98.86
BRD-A67552655	CP	etomoxir	carnitine palmitoyltransferase inhibitor, carnitine O-palmitoyltransferase inhibitor, fatty acid oxidation inhibitor	CPT1A, CPT1B		0.00, 0.00	1.90, 0.76	-37.95	-58.37	-26.65	-52.67	-42.49	NaN	-30.00	-25.13	NaN	-21.59
BRD-A23637604	CP	oxymetholone	androgen receptor agonist, synthetic hormone with anabolic and androgenic properties	AR	Androgen receptor modulator	12.50, 0.00	0.65, 0.24	41.39	-98.12	-41.61	52.19	96.68	NaN	87.93	-30.45	NaN	55.28
BRD-A14208071	CP	oxyphenonium	acetylcholine receptor antagonist	CHRM1		10.00, 10.00	1.41, 0.40	-11.09	15.47	-89.38	97.79	-98.77	-43.28	-35.44	12.86	-70.77	-47.13
BRD-K08924299	CP	palonosetron	serotonin receptor antagonist	HTR3A		10.00, 0.00	1.28, 0.34	53.81	-64.88	44.25	92.95	78.59	-80.73	95.22	74.39	78.07	91.78
BRD-A84134924	CP	pancuronium	acetylcholine receptor antagonist	CHRM2, CHRM3, CHRNA1, CHRNA2		0.00, 0.00	1.82, 0.60	83.57	34.02	-10.80	-62.73	-79.90	NaN	63.33	-9.91	NaN	17.39
BRD-K13800121	CP	parecoxib	cyclooxygenase inhibitor	LTF, PTGS2		0.00, 0.00	0.99, 0.30	-99.46	71.98	-27.56	9.86	-56.90	NaN	-38.55	-57.88	NaN	-57.05
BRD-K19277754	CP	paroxetine	cyclophilin inhibitor, norepinephrine reputake inhibitor, selective serotonin reuptake inhibitor (SSRI), serotonin reuptake inhibitor, serotonin uptake inhibitor	SLC6A4, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, HTR2A, SLC6A2		12.50, 0.00	0.93, 0.22	13.02	-22.95	-18.14	10.64	96.65	NaN	91.94	-10.90	NaN	5.50
BRD-K66412701	CP	pazufloxacin	topoisomerase inhibitor			0.00, 0.00	1.58, 0.75	84.12	-16.51	-40.69	-43.47	-61.13	NaN	-25.80	81.28	NaN	-21.01
BRD-K55034111	CP	pefloxacin	topoisomerase inhibitor	TOP2A		12.50, 0.00	1.27, 0.40	38.47	96.48	30.41	-48.02	-92.61	NaN	26.86	23.85	NaN	30.27
BRD-K47780086	CP	penciclovir	DNA directed DNA polymerase inhibitor			12.50, 12.50	1.18, 0.31	-67.35	15.29	38.80	46.72	97.71	NaN	17.45	-22.78	NaN	7.97
BRD-K85503079	CP	perospirone	dopamine receptor antagonist, serotonin receptor antagonist	DRD2, HTR2A, DRD3, DRD4, HTR2C		0.00, 0.00	0.90, 0.18	73.50	-73.93	-75.82	14.09	-83.28	NaN	-34.52	-46.03	NaN	-54.51
BRD-K22009844	CP	phenprobamate	skeletal muscle relaxant			25.00, 0.00	0.67, 0.23	-46.31	90.22	92.99	-16.19	-93.28	NaN	29.00	96.87	NaN	97.43
BRD-A37052580	CP	physostigmine	acetylcholinesterase inhibitor, cholinesterase inhibitor	ACHE, BCHE		0.00, 0.00	0.83, 0.26	54.39	-24.87	-87.93	-70.40	-36.56	NaN	65.98	26.94	NaN	-40.12
BRD-K43236057	CP	piceid	glucosidase inhibitor, ICAM1 expression inhibitor, VCAM expression inhibitor, xanthine oxidase inhibitor	GAA, XDH		0.00, 0.00	0.99, 0.28	84.42	-8.93	-58.37	54.80	-36.04	NaN	-39.67	44.61	NaN	23.21
BRD-M47793593	CP	picrotoxin	GABA receptor antagonist	GABRA1, GLRA2, GLRA3, GABRR1, GLRA1, GLRB, HTR3A, HTR3B		12.50, 0.00	1.74, 0.64	73.45	-29.26	59.07	-14.89	96.30	NaN	88.74	-11.03	NaN	59.74
BRD-K44442813	CP	pidotimod	interferon receptor agonist, interleukin receptor agonist, T cell stimulant			25.00, 25.00	1.86, 0.65	-59.02	-31.34	-9.54	98.64	99.63	NaN	-30.17	57.37	NaN	41.49
BRD-A22897758	CP	pinacidil	ATP channel activator, potassium channel agonist	ABCC9, KCNJ8		10.00, 0.00	1.16, 0.40	76.76	87.30	24.08	79.56	96.30	32.55	55.59	94.44	27.52	80.87
BRD-K92870997	CP	pterostilbene	cyclooxygenase inhibitor, FAAH inhibitor, MAP kinase inhibitor, PPAR receptor agonist	FAAH, PPARA, PTGS1, PTGS2		0.00, 0.00	1.94, 0.63	-35.77	39.52	-14.17	-77.79	-99.98	NaN	-51.11	-72.20	NaN	-59.05
BRD-A56245458	CP	reichstein	androgen receptor antagonist	AR		10.00, 10.00	1.27, 0.35	-21.28	-7.11	13.96	99.14	29.04	29.85	62.73	50.88	-33.82	35.91
BRD-K30563334	CP	rifabutin	DNA directed DNA polymerase inhibitor, DNA directed RNA polymerase inhibitor, protein synthesis inhibitor	CYP3A4, HSP90AA1, HSP90B1		0.00, 0.00	1.76, 0.69	-18.11	-99.52	-8.78	-41.90	53.19	NaN	-26.12	-39.43	NaN	-25.19
BRD-K55889443	CP	rifapentine	DNA directed RNA polymerase inhibitor, DNA directed DNA polymerase inhibitor	CYP2C8, CYP3A4		0.00, 0.00	0.81, 0.27	28.29	73.73	-80.15	-18.16	-83.65	NaN	59.91	-40.02	NaN	-37.21
BRD-K89708791	CP	rifaximin	50S ribosomal subunit inhibitor, DNA directed DNA polymerase inhibitor, PXR agonist, RNA synthesis inhibitor	NR1I2, CYP3A4		0.00, 0.00	1.88, 0.56	64.67	65.20	-47.55	61.38	44.23	NaN	-20.34	-73.39	NaN	42.46
BRD-K70490179	CP	rimcazole	sigma receptor antagonist, dopamine reuptake inhibitor	SIGMAR1		0.00, 0.00	1.94, 0.53	-66.62	-97.17	-73.26	-94.96	87.13	93.95	-98.68	-93.34	67.88	-93.83
BRD-K51485625	CP	ritonavir	HIV protease inhibitor, cytochrome P450 inhibitor	CYP3A4, CYP1A2, CYP2B6, CYP2C19, CYP3A5, CYP3A7	HIV protease inhibitor	0.00, 0.00	0.77, 0.18	-86.86	-99.52	-70.07	-80.62	-70.36	NaN	-45.00	64.53	NaN	-88.04
BRD-A27489425	CP	rolitetracycline	antibiotic			0.00, 0.00	1.91, 0.49	-53.92	36.94	-62.39	42.43	19.15	-89.66	-26.34	-38.88	83.73	-37.37
BRD-K50938786	CP	ropivacaine	membrane integrity inhibitor, potassium channel antagonist, sodium channel blocker	SCN10A, SCN9A		0.00, 0.00	1.15, 0.35	-12.34	30.63	-18.64	14.60	-54.91	-50.54	9.37	84.09	-25.73	-3.11
BRD-K81855038	CP	roxatidine	histamine receptor antagonist	HRH2		0.00, 0.00	0.94, 0.23	86.58	62.73	49.27	31.78	42.54	NaN	23.82	61.97	NaN	67.93
BRD-K62374253	CP	rufloxacin	topoisomerase inhibitor		Bacterial DNA gyrase inhibitor	0.00, 0.00	1.00, 0.24	-5.52	84.90	-85.37	-15.53	-27.66	NaN	-33.33	-17.59	NaN	-2.47
BRD-A88254928	CP	salbutamol	adrenergic receptor agonist	ADRB2, ADRB1		0.00, 0.00	1.44, 0.41	36.81	-97.99	55.61	-28.33	-78.74	NaN	25.38	33.96	NaN	-17.29
BRD-K91733562	CP	secoisolariciresinol	antioxidant			0.00, 0.00	1.17, 0.33	-9.58	21.88	17.49	17.30	62.05	34.79	37.52	81.78	20.35	10.38
BRD-A23359898	CP	sibutramine	serotonin reuptake inhibitor, adrenergic transmitter uptake inhibitor, dopamine reuptake inhibitor, norepinephrine reuptake inhibitor, norepinephrine transporter inhibitor, serotonin uptake inhibitor	SLC6A2, SLC6A4, SLC6A3, CYP2B6, CYP2C19, CYP3A5		0.00, 0.00	0.98, 0.30	-48.35	44.90	-14.31	74.79	-20.44	NaN	-43.34	28.44	NaN	11.65
BRD-A72441487	CP	stiripentol	GABA aminotransferase inhibitor, GABA reuptake inhibitor, sodium channel blocker	ABAT, SCN1A, SCN3A		20.00, 20.00	1.07, 0.35	38.22	24.21	-11.92	-40.78	-84.81	99.17	-62.26	-61.18	98.12	12.24
BRD-K10670311	CP	sulfasalazine	cyclooxygenase inhibitor, disease modifying antirheumatic drug, lipoxygenase inhibitor, NFkB pathway inhibitor, prostanoid receptor inhibitor, thromboxane receptor antagonist	PTGS1, PTGS2, ACAT1, ALOX5, CHUK, IKBKB, PLA2G1B, PPARG, SLC46A1, SLC7A11, TBXAS1		12.50, 12.50	1.00, 0.25	-11.91	50.11	-47.67	33.62	-65.40	NaN	99.27	-58.67	NaN	-18.14
BRD-A04327189	CP	synephrine	adrenergic receptor agonist, L-type calcium channel activator	ADRA1A		0.00, 0.00	1.10, 0.23	60.23	61.74	21.35	74.29	60.13	43.38	72.85	57.34	-41.17	46.15
BRD-K44094599	CP	tacrolimus	calcineurin inhibitor, FK506-binding protein inhibitor, immunosuppressant, insulin expression inhibitor, interleukin receptor antagonist, macrolide calcineurin inhibitor, rotamase inhibitor, T cell inhibitor	FKBP1A, CYP3A5, CYP3A7		12.50, 12.50	1.22, 0.44	-47.22	20.02	34.16	-91.22	-96.02	NaN	99.94	19.92	NaN	-44.24
BRD-K94649603	CP	taxifolin	apolipoprotein secretion inhibitor, beta amyloid aggregation inhibitor, cholesterol biosynthesis inhibitor, HMGCR inhibitor, NFkB pathway modulator, opioid receptor antagonist, reverse transcriptase inhibitor	APOB, APP, HMGCR		0.00, 0.00	2.00, 0.70	26.37	-62.16	-18.65	29.73	45.10	NaN	-24.33	25.23	NaN	9.77
BRD-K95808480	CP	taxifolin	apolipoprotein secretion inhibitor, beta amyloid aggregation inhibitor, cholesterol biosynthesis inhibitor, HMGCR inhibitor, NFkB pathway modulator, opioid receptor antagonist, reverse transcriptase inhibitor	APOB, APP, HMGCR		0.00, 0.00	1.88, 0.76	-25.92	-98.07	-10.59	-10.77	-32.95	NaN	-39.86	-21.01	NaN	-11.51
BRD-K21806131	CP	tegaserod	serotonin receptor partial agonist, serotonin receptor agonist	HTR4, HTR2B, HTR2A, HTR2C		0.00, 0.00	1.69, 0.63	-89.15	-96.23	-16.24	-96.86	NaN	NaN	-97.57	-96.62	NaN	-94.54
BRD-K32744045	CP	disulfiram	aldehyde dehydrogenase inhibitor, DNA methyltransferase inhibitor, TRPA1 agonist	ALDH2, ALDH1A2, ALDH5A1, ALDH7A1, CYP2E1, DBH, DNMT1, TRPA1		0.00, 0.00	1.80, 0.52	56.28	-93.72	24.11	-81.82	61.96	NaN	-33.28	-86.49	NaN	-79.03
BRD-K94887716	CP	TFMPP	serotonin receptor agonist, serotonin receptor antagonist			0.00, 0.00	1.41, 0.39	8.13	15.38	-92.36	53.69	89.94	NaN	-34.43	-75.21	NaN	-49.54
BRD-K60160658	CP	tiagabine	GABA uptake inhibitor, GAT inhibitor	SLC6A1, CYP2C19		12.50, 0.00	1.98, 0.76	95.31	-23.01	-48.85	-58.24	82.05	NaN	-19.94	-30.55	NaN	-15.44
BRD-K10467831	CP	tibolone	estrogen receptor agonist, androgen receptor agonist, progesterone receptor agonist, selective estrogen receptor modulator (SERM), steryl sulfatase inhibitor	AR, ESR1, PGR, STS	Androgen receptor modulator	10.00, 0.00	1.91, 0.58	71.41	-78.00	-26.47	-54.50	35.41	-48.74	-46.37	97.22	-21.21	-26.57
BRD-K89125793	CP	tinidazole	anti-protozoal			20.00, 10.00	0.77, 0.15	-17.17	72.86	-9.42	84.81	-40.11	38.04	99.12	83.67	95.95	89.93
BRD-K54316499	CP	tolterodine	acetylcholine receptor antagonist	CHRM2, CHRM3, CHRM1, CHRM4, CHRM5		0.00, 0.00	1.59, 0.44	64.49	15.13	90.30	-97.51	47.94	NaN	-19.90	-71.69	NaN	31.71
BRD-K29653726	CP	topiramate	carbonic anhydrase inhibitor, glutamate receptor antagonist, kainate receptor antagonist, GABA receptor agonist, Sodium Channel  Blockers, voltage-gated sodium channel blocker	CA2, CA4, GRIK1, CA1, CA12, CA7, CYP2C19, CYP3A4, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA1, SCN1A, SCN5A		12.50, 12.50	0.97, 0.22	83.01	-16.69	99.91	-71.53	-33.60	NaN	-38.29	83.01	NaN	85.92
BRD-K55696337	CP	topotecan	topoisomerase inhibitor	TOP1, TOP1MT		0.00, 0.00	2.99, 0.69	-99.68	-64.79	-99.74	-99.74	-63.03	NaN	-99.93	-91.15	NaN	-99.51
BRD-A41450521	CP	tosufloxacin	topoisomerase inhibitor			0.00, 0.00	1.20, 0.28	-20.25	90.01	-13.04	-69.20	-17.04	NaN	-85.66	16.19	NaN	-10.85
BRD-K04412738	CP	tramadol	opioid receptor agonist, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, adrenergic transmitter uptake inhibitor, OP3 receptor agonist, serotonin uptake inhibitor	OPRM1, SLC6A2, SLC6A4, CHRFAM7A, CHRM3, CYP2B6, GRIN3A, HTR2C, OPRD1, OPRK1		10.00, 0.00	1.77, 0.44	45.92	-5.62	-15.90	52.55	89.37	-33.54	96.39	20.60	-51.52	31.28
BRD-A61856038	CP	tremulacin	5-lipoxygenase inhibitor			0.00, 0.00	1.53, 0.52	-88.32	71.89	-21.91	-69.12	-66.42	-54.77	-12.80	-99.95	46.15	-65.68
BRD-K68202742	CP	trichostatin-a	HDAC inhibitor, CDK expression enhancer, ID1 expression inhibitor	HDAC7, HDAC8, HDAC1, HDAC10, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC9	HDAC inhibitor	0.00, 0.00	1.69, 0.59	-99.58	-85.47	-98.69	-99.36	-96.19	-89.48	-99.64	-97.65	-93.30	-98.03
BRD-K81916719	CP	triclabendazole	acetylcholinesterase inhibitor, DNA methyltransferase inhibitor, microtubule inhibitor	DNMT1		0.00, 0.00	0.83, 0.25	-85.35	50.08	47.99	-99.32	36.08	NaN	80.83	-99.98	NaN	-86.29
BRD-K04196797	CP	oxcarbazepine	voltage-gated sodium channel blocker, Sodium Channel  Blockers	CYP2C19, CYP3A4, CYP3A5, SCN1A, SCN3A, SCN5A		0.00, 0.00	1.35, 0.35	51.46	-25.05	-27.67	80.55	46.20	NaN	64.22	-39.32	NaN	32.87
BRD-A92630576	CP	trimebutine	opioid receptor agonist, acetylcholine receptor antagonist, Sodium Channel  Blockers	CHRM1, CHRM2, CHRM3, CHRM4		12.50, 12.50	1.00, 0.30	-32.93	80.12	-32.41	11.57	99.98	NaN	-64.95	72.89	NaN	-39.10
BRD-K39484304	CP	triptolide	RNA polymerase inhibitor	CYP2C19, RELA		0.00, 0.00	1.88, 0.72	-99.53	-25.92	-99.34	-99.68	-99.68	NaN	-99.82	-99.33	NaN	-99.07
BRD-K50866992	CP	tropisetron	serotonin receptor antagonist, polarization inhibitor, sodium channel blocker	HTR3A, GLRA1, GLRA2, GLRB, HTR4		0.00, 0.00	1.88, 0.47	-69.47	-94.88	-53.01	-52.91	-37.77	NaN	26.15	-22.30	NaN	-56.49
BRD-A68589262	CP	troxipide	glucosamine synthetase stimulant			12.50, 12.50	1.55, 0.52	-56.72	-78.42	-93.89	98.59	-99.88	NaN	47.08	31.55	NaN	-94.30
BRD-K46435977	CP	valaciclovir	DNA directed DNA polymerase inhibitor, DNA polymerase inhibitor		DNA polymerase inhibitor	12.50, 0.00	1.90, 0.66	95.64	82.86	-30.78	89.96	29.10	NaN	17.96	-14.40	NaN	81.69
BRD-K20168442	CP	vecuronium	acetylcholine receptor antagonist	CHRNA2		10.00, 0.00	1.81, 0.50	32.46	19.95	70.07	13.12	-57.90	31.50	64.18	82.66	96.31	49.12
BRD-K82109576	CP	vincristine	tubulin inhibitor, microtubule inhibitor, microtubule polymerization inhibitor, tubulin polymerisation inhibitor, vinca alkaloid	TUBB, TUBA4A	Tubulin inhibitor	12.50, 12.50	1.57, 0.50	-81.35	99.87	-84.73	12.60	-54.03	NaN	-99.49	-27.62	NaN	-85.63
BRD-K59753975	CP	vindesine	tubulin inhibitor, microtubule inhibitor, vinca alkaloid	TUBB, TUBB1	Tubulin inhibitor	12.50, 12.50	1.41, 0.49	-62.18	99.96	-44.82	67.75	-48.55	NaN	-84.59	-70.17	NaN	-69.21
BRD-K97514127	CP	vinorelbine	tubulin inhibitor, apoptosis stimulant, microtubule inhibitor, mitosis inhibitor, mitotic inhibitor, tubulin polymerisation inhibitor, vinca alkaloid	TUBB		12.50, 12.50	2.16, 0.73	-38.12	99.93	-80.14	-75.75	-23.44	NaN	-68.56	36.10	NaN	-74.78
BRD-K06557128	CP	voriconazole	cell wall synthesis inhibitor, cytochrome P450 inhibitor, lanosterol demethylase inhibitor	CYP2C19, CYP51A1		0.00, 0.00	1.18, 0.43	44.60	35.51	-13.07	91.23	88.13	NaN	33.86	-16.63	NaN	31.10
BRD-A24381660	CP	zeranol	estrogen receptor agonist			12.50, 12.50	1.49, 0.59	-12.22	39.02	-13.96	40.52	99.32	NaN	26.86	-57.82	NaN	14.40
BRD-K44876623	CP	zolpidem	benzodiazepine receptor agonist, GABA benzodiazepine site receptor agonist, non-benzodiazepine hypnotic	GABRA1, GABRA2, GABRA3	Benzodiazepine receptor agonist	0.00, 0.00	0.75, 0.16	14.53	-28.75	17.18	-79.71	29.05	88.03	-63.23	27.03	NaN	6.10
BRD-A60245366	CP	AS-601245	JNK inhibitor	GSK3B, MAPK10, MAPK8, MAPK9, PIM1		0.00, 0.00	1.81, 0.65	-90.74	-87.93	-98.46	-15.87	-70.66	-98.04	-99.40	-98.28	-99.01	-98.10
BRD-K01436366	CP	XMD-1150	leucine rich repeat kinase inhibitor	LRRK2	Leucine rich repeat kinase inhibitor	10.00, 10.00	1.33, 0.56	-99.06	84.27	42.55	-93.78	-96.64	-74.52	-21.80	-43.92	98.13	-80.07
BRD-K19220233	CP	JNK-9L	JNK inhibitor	MAPK8		0.00, 0.00	1.32, 0.67	-94.32	-8.26	-95.85	-41.86	-64.61	-87.00	-99.46	-66.73	-99.28	-98.20
BRD-K24859147	CP	KIN001-242	protein kinase inhiibor	RPS6KA3		0.00, 0.00	0.97, 0.26	51.98	-99.76	-64.82	37.07	30.84	-91.97	65.56	73.19	-39.10	32.87
BRD-K38615104	CP	A-443644	AKT inhibitor	AKT1, AKT2, AKT3, CDC42BPB, GSK3B, PHKG1, PKIA, PRKACA		0.00, 0.00	2.41, 0.84	-72.70	-27.57	30.16	-34.95	-85.86	-99.56	-84.96	-94.38	-92.63	-94.08
BRD-K40175214	CP	torin-1	mTOR inhibitor, PI3K inhibitor	MTOR, PIK3CA	MTOR inhibitor, PI3K inhibitor	0.00, 0.00	1.67, 0.61	-99.74	-97.83	-25.95	-99.63	64.85	-89.69	-82.63	-93.71	-54.67	-95.70
BRD-K56957086	CP	dacinostat	HDAC inhibitor	HDAC1, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9	HDAC inhibitor	0.00, 0.00	1.48, 0.63	-98.51	-60.90	-84.21	-90.10	-93.51	-72.33	-99.31	-97.72	-78.93	-98.10
BRD-K64857848	CP	XMD-885	leucine rich repeat kinase inhibitor, MAP kinase inhibitor	LRRK2, MAPK7	Leucine rich repeat kinase inhibitor	10.00, 10.00	1.08, 0.56	-83.34	85.37	49.98	67.52	-41.86	-44.85	98.47	33.95	92.71	92.36
BRD-K68174511	CP	torin-2	mTOR inhibitor	MTOR	MTOR inhibitor	0.00, 0.00	1.56, 0.48	-99.90	-79.94	-67.68	-69.13	-45.70	-43.99	-88.96	-96.82	51.24	-90.12
BRD-K72420232	CP	WZ-4002	EGFR inhibitor	EGFR, ERBB2	EGFR inhibitor	0.00, 0.00	1.35, 0.40	83.29	86.97	-10.82	57.74	-7.76	-68.52	-6.08	-43.01	-81.55	-6.75
BRD-K83972459	CP	JWE-035	Aurora kinase inhibitor	AURKA	Aurora kinase inhibitor	0.00, 0.00	1.50, 0.56	-70.99	24.35	-83.20	-99.34	-9.22	-39.24	-30.81	-26.37	-92.69	-79.59
BRD-K84085265	CP	CG-930	JNK inhibitor	MAPK8		40.00, 40.00	0.86, 0.28	98.94	77.12	-95.41	99.90	77.89	46.69	99.95	57.17	65.05	98.12
BRD-U25771771	CP	WZ-4-145	EGFR inhibitor	CSF1R, DDR1, EGFR, PDGFRA, TIE1	EGFR inhibitor	0.00, 0.00	1.70, 0.58	-98.71	-84.08	-99.96	-99.94	-88.20	-95.25	-25.73	-99.26	-99.93	-99.12
BRD-U33728988	CP	QL-X-138	mTOR inhibitor	BTK, JAK3, MKNK2, MTOR, PRKDC	MTOR inhibitor	0.00, 0.00	1.47, 0.68	50.26	34.70	-40.57	-97.75	68.68	-39.59	93.99	80.16	32.20	63.34
BRD-U44618005	CP	WH-4023	src inhibitor	ABL1, LCK, SRC	SRC inhibitor	20.00, 20.00	1.25, 0.47	40.33	-44.90	-67.14	-12.60	86.39	97.92	99.93	-25.00	62.21	79.09
BRD-U51951544	CP	ZG-10	JNK inhibitor	MAPK8		0.00, 0.00	1.19, 0.61	-99.13	-99.61	-99.56	-90.11	-99.64	-99.44	-99.40	-99.36	-99.22	-98.34
BRD-U73238814	CP	QL-XI-92	DDR1 inhibitor	DDR1		0.00, 0.00	1.31, 0.35	-98.75	-99.50	-96.95	-98.62	-95.42	-65.38	91.73	-26.58	-80.08	-96.53
BRD-U86922168	CP	QL-XII-47	BMX inhibitor, Bruton's tyrosine kinase (BTK) inhibitor, bruton's tyrosine kinase inhibitor, cytoplasmic tyrosine protein kinase BMX inhibitor	BMX, BTK		0.00, 0.00	2.59, 0.67	-98.76	-19.86	-47.07	25.26	60.42	79.07	-62.34	-44.57	49.12	-58.06
BRD-K14681867	CP	somatostatin	somatostatin receptor agonist, growth hormone receptor antagonist, growth hormone release inhibitor, somatostatin receptor ligand	SSTR1, SSTR2, SSTR3, SSTR4, SSTR5, GH1, GHR, OPRD1, OPRM1		10.00, 10.00	0.93, 0.34	-71.73	-15.16	63.22	-99.96	76.36	51.29	99.68	85.83	-29.37	50.16
BRD-K63915849	CP	AS-604850	Phosphatidylinositol 3-kinase (PI3K) inhibitor, PI3K inhibitor	PIK3CG, PIK3CA		20.00, 10.00	1.13, 0.32	25.03	73.56	-89.41	-79.83	97.94	-53.83	33.00	82.63	97.47	90.59
BRD-K88551539	CP	CAY-10585	hypoxia inducible factor inhibitor	HIF1A		10.00, 10.00	1.76, 0.75	46.53	11.38	-92.20	9.97	44.28	43.37	26.30	99.59	-88.52	20.10
BRD-K31484631	CP	rifabutin	DNA directed DNA polymerase inhibitor, DNA directed RNA polymerase inhibitor, protein synthesis inhibitor	CYP3A4, HSP90AA1, HSP90B1		0.00, 0.00	0.94, 0.24	22.98	-73.60	-24.33	-49.69	-45.96	-42.60	-60.67	22.32	27.60	-13.48
BRD-K22631935	CP	neurodazine	neurogenesis of non-pluripotent C2C12 myoblast inducer			20.00, 10.00	1.91, 0.64	10.29	27.75	33.03	34.45	80.52	98.70	95.80	-56.19	-59.52	56.95
BRD-K76698671	CP	HNHA	HDAC inhibitor	HDAC1		10.00, 10.00	0.94, 0.40	42.23	41.18	-35.72	10.78	38.00	98.91	-86.51	-47.28	-99.55	-12.62
BRD-A80574334	CP	oxalomalic-acid	isocitrate dehydrogenase inhibitor	ACO1, IDH1		20.00, 20.00	1.95, 0.58	26.41	-18.54	89.61	19.09	43.41	99.60	99.70	24.12	37.30	69.10
BRD-A11702965	CP	chromomycin-a3	DNA binding			0.00, 0.00	1.43, 0.64	-99.33	26.47	-94.97	-40.97	-99.59	-98.82	-74.13	-98.82	-99.16	-98.24
BRD-A52193669	CP	withaferin-a	acetylcholinesterase inhibitor, butyrylcholinesterase inhibitors, IKK inhibitor, NFkB pathway inhibitor, PKC inhibitor	ACHE, BCHE, IKBKB	IKK inhibitor	0.00, 0.00	1.85, 0.40	-94.23	-59.99	-17.39	-30.88	-77.25	-99.36	-42.68	-92.42	-83.73	-84.74
BRD-K04923131	CP	GSK-3-inhibitor-IX	glycogen synthase kinase inhibitor, lipoxygenase inhibitor, PKC inhibitor	ALOX5, GSK3A, GSK3B	Glycogen synthase kinase inhibitor, PKC inhibitor	0.00, 0.00	1.55, 0.44	-82.72	-98.74	-99.70	-91.69	-29.16	-98.30	-93.65	-97.83	-99.89	-98.94
BRD-A80960055	CP	celastrol	anti-inflammatory agent, antioxidant, HSP90 Inhibitor, NFKB pathway inhibitor, topoisomerase inhibitor	IL1B, TNF	Topoisomerase inhibitor	0.00, 0.00	1.88, 0.49	-85.57	-75.82	-99.30	-32.08	-33.53	64.03	-75.55	-61.16	-58.62	-89.58
BRD-K39944607	CP	ochratoxin-a	phenylalanyl tRNA synthetase inhibitor	SLC22A6		0.00, 0.00	1.39, 0.57	-41.38	-78.66	38.73	-76.21	-53.10	61.11	-24.74	75.75	45.27	-18.58
BRD-K14880289	CP	GW-501516	PPAR receptor agonist, insulin sensitizer	PPARD, INS, PPARA	PPAR receptor agonist	10.00, 10.00	0.93, 0.31	-43.51	79.27	-30.70	-34.24	-41.14	94.61	98.43	-14.19	-96.17	-12.75
BRD-A31374339	CP	fludarabine	DNA synthesis inhibitor, DNA repair enzyme inhibitor, purine antagonist, ribonucleotide reductase inhibitor	ADA, DCK, POLA1, RRM1, RRM2		0.00, 0.00	1.49, 0.42	-74.12	-46.89	-35.16	-52.71	24.35	42.39	-50.22	22.45	17.09	-22.60
BRD-K05977823	CP	tenovins	SIRT inhibitor, TP53 activator	SIRT1, SIRT2		0.00, 0.00	1.14, 0.36	-94.39	57.20	-89.88	-99.95	-47.59	85.01	87.00	-96.20	56.74	-96.86
BRD-K91701654	CP	U-0126	MEK inhibitor, JAK inhibitor, MAP kinase inhibitor	AKT1, CHEK1, GSK3B, JAK2, LCK, MAP2K1, MAP2K2, MAP2K7, MAPK1, MAPK11, MAPK12, MAPK14, MAPK8, PRKCA, RAF1, ROCK1, RPS6KB1, SGK1		0.00, 0.00	1.67, 0.53	-28.99	-20.49	78.68	-15.02	35.28	37.21	23.21	-99.89	-41.98	-5.92
BRD-A59808129	CP	guggulsterone	estrogen receptor agonist, FXR antagonist, progesterone receptor agonist, cholesterol inhibitor, IKK inhibitor, PXR agonist	NR1H4, PGR, AR, ESR1, IKBKB, NR1I2, NR3C1, NR3C2	FXR antagonist	10.00, 0.00	1.39, 0.27	96.13	48.56	-97.50	-14.11	88.47	55.07	47.88	12.71	50.38	47.05
BRD-A84327315	CP	calcitriol	vitamin D receptor agonist, hypercalcaemic agent	VDR, CYP3A5	Vitamin D receptor agonist	10.00, 10.00	0.84, 0.27	18.10	-97.16	99.19	68.58	69.23	39.36	-32.33	-11.76	80.25	55.79
BRD-K61341215	CP	vecuronium	acetylcholine receptor antagonist	CHRNA2		20.00, 20.00	0.75, 0.28	89.08	80.30	-57.73	72.05	46.01	-40.62	99.12	-13.91	99.82	91.86
BRD-A01317026	CP	7,8-dihydro-L-biopterin	dihydroneopterin aldolase inhibitor	NOS2, TPH1		10.00, 0.00	0.86, 0.26	48.29	-14.94	29.19	-39.19	-52.79	-38.17	-98.28	95.00	-46.60	-14.35
BRD-K84937637	CP	sirolimus	mTOR inhibitor, CCR expression inhibitor, cell cycle inhibitor, proteasome inhibitor, protein kinase inhibitor, T cell inhibitor	MTOR, FKBP1A, CCR5, FGF2		10.00, 10.00	1.08, 0.47	36.42	-78.66	-58.22	-53.88	87.33	-99.82	97.65	-83.83	-51.13	-83.02
BRD-K74733595	CP	APHA-compound-8	HDAC inhibitor	HDAC8	HDAC inhibitor	0.00, 0.00	1.50, 0.48	-25.54	-40.94	-96.87	-77.56	-51.79	-68.82	-46.18	-98.83	-42.65	-59.13
BRD-K01493881	CP	apigenin	casein kinase inhibitor, cell proliferation inhibitor, cytochrome P450 inhibitor, GABA receptor antagonist, glutamate receptor antagonist, monoamine oxidase inhibitor, nitric oxide production inhibitor, ornithine decarboxylase inhibitor, quorum sensing signaling modulator, VEGF expression inhibitor, xanthine oxidase inhibitor	AKR1B1, AR, CDK6, CFTR, CYP19A1, CYP1A2, CYP1B1, HSD17B1, MAOA, ODC1, XDH		0.00, 0.00	0.91, 0.41	83.47	-90.89	-66.98	-35.71	12.10	38.46	12.42	-57.59	-95.70	-66.49
BRD-A52886023	CP	antimycin-a	antibiotic, electron transfer inhibitor	CYCS		10.00, 10.00	1.01, 0.33	-23.66	23.59	-90.81	-75.96	40.33	99.56	-69.39	-37.97	-51.00	-49.06
BRD-K57926513	CP	tyrphostin-AG-1295	FLT3 inhibitor, PDGFR tyrosine kinase receptor inhibitor	FLT3, KDR, PDGFRA, PDGFRB		20.00, 10.00	1.66, 0.44	92.59	91.79	35.98	65.77	98.14	84.15	34.32	11.25	35.79	96.51
BRD-A50454580	CP	PD-0325901	MEK inhibitor, MAP kinase inhibitor, protein kinase inhibitor	MAP2K1, MAP2K2		30.00, 10.00	1.50, 0.58	82.85	-81.98	94.98	-98.45	-44.87	92.90	96.33	98.83	-31.29	97.06
BRD-K73982490	CP	BI-78D3	JNK inhibitor	MAPK8		0.00, 0.00	1.74, 0.51	-9.92	-55.70	-50.35	46.80	49.91	-24.27	-40.14	-11.53	35.70	-4.67
BRD-A11007541	CP	BCI-hydrochloride	MAP kinase phosphatase inhibitor, protein phosphatase inhibitor	DUSP1, DUSP6		10.00, 0.00	2.47, 0.52	-99.36	-76.55	-69.00	-64.37	95.66	-91.48	-91.64	-96.44	-71.51	-92.60
BRD-K22429181	CP	retinol	RAR receptor binder	ALDH1A1, ALDH1A2, ALDH1A3, DHRS3, DHRS4, LRAT, NR2C2, RBP1, RBP3, RDH11, RDH12, RDH13, RDH14, RDH5, RDH8, RETSAT, RHO, RLBP1, RXRA, RXRB, RXRG		0.00, 0.00	1.42, 0.49	45.20	26.31	-99.32	65.38	70.64	93.78	-33.96	-13.50	92.41	79.13
BRD-K13927029	CP	retinol	RAR receptor binder	ALDH1A1, ALDH1A2, ALDH1A3, DHRS3, DHRS4, LRAT, NR2C2, RBP1, RBP3, RDH11, RDH12, RDH13, RDH14, RDH5, RDH8, RETSAT, RHO, RLBP1, RXRA, RXRB, RXRG		10.00, 10.00	1.06, 0.43	82.11	-94.18	-93.73	82.98	-36.80	-48.76	41.42	-99.04	97.98	67.89
BRD-K65331431	CP	retinyl	vitamin analog			10.00, 10.00	1.38, 0.39	85.44	-97.37	-31.06	93.46	88.81	-48.58	-25.67	98.23	75.87	89.03
BRD-K43164539	CP	cholic-acid	ferrochelatase inhibitor, unidentified pharmacological activity	CES1, FECH, PLA2G1B, ADH1C, COX4I1, COX5A, COX5B, COX6A2, COX6B1, COX6C, COX7A1, COX7B, COX7C, COX8A, ESRRG, FABP6, GPBAR1, MT-CO1, MT-CO2, MT-CO3	Bile acid	40.00, 40.00	1.40, 0.41	12.94	-25.42	-48.56	62.28	59.99	99.75	-30.11	99.98	99.97	99.37
BRD-K41170226	CP	deoxycholic-acid	biliverdin reductase A activator, G protein coupled receptor agonist, unidentified pharmacological activity	GPBAR1, EFTUD1, FPR1		0.00, 0.00	0.91, 0.28	42.42	81.89	-26.50	-24.82	-29.05	-99.09	-46.32	81.01	91.25	47.64
BRD-K18135438	CP	chenodeoxycholic-acid	11-beta hydroxysteroid dehydrogenase inhibitor, FXR agonist	HSD11B1, NR1H4		10.00, 10.00	1.22, 0.45	99.77	47.45	-57.99	79.89	49.52	58.14	-26.82	48.05	77.86	55.21
BRD-K68144790	CP	glycodeoxycholic-acid	apoptosis activator			20.00, 10.00	1.36, 0.38	97.18	97.99	-19.19	87.90	-35.38	-72.80	53.90	27.73	-54.03	74.35
BRD-K81062487	CP	taurocholic-acid	bile acid	CEL, FXR, NR1H4, FABP6, SLCO1C1	Bile acid	20.00, 0.00	0.78, 0.30	97.47	92.86	34.09	70.53	-99.03	45.12	71.39	92.39	87.71	96.35
BRD-K33572481	CP	taurodeoxycholic-acid	bile acid		Bile acid	10.00, 10.00	1.15, 0.38	99.54	88.29	-82.14	-61.23	-40.70	-45.05	-25.80	18.14	54.94	24.35
BRD-K30743633	CP	TCPOBOP	constitutive androstane receptor (CAR) agonist	NR1I3		10.00, 10.00	1.01, 0.31	42.18	93.04	7.24	87.27	-37.79	62.50	38.56	98.43	35.40	68.63
BRD-K20986251	CP	lithocholic-acid	FXR antagonist, MDM inhibitor, PXR ligand, tyrosine phosphatase inhibitor, vitamin D receptor ligand	NR1I2, VDR, GPBAR1, MDM2, MDM4, NR1H4, PTPN1	Bile acid, FXR antagonist, Vitamin D receptor agonist	0.00, 0.00	1.42, 0.32	50.62	-84.29	-68.44	37.68	-59.95	55.74	-25.90	7.90	-56.71	-26.96
BRD-K24656285	CP	farnesol	amine oxidase B inhibitor, FXR agonist	MAOB, MVK, NR1H4		0.00, 0.00	2.13, 0.48	92.36	-21.70	-42.08	51.15	53.26	32.81	24.92	89.90	65.44	67.84
BRD-U66370498	CP	androstanol	constitutive androstane receptor (CAR) inhibitor	NR1I3		10.00, 10.00	0.99, 0.40	-74.15	21.23	75.77	55.43	99.98	52.49	-36.09	62.70	39.02	49.20
BRD-K43880410	CP	pregnenolone	acetylcholine release enhancer, dopamine release enhancer, GABA receptor negative allosteric modulator, glutamate receptor modulator, progesterone receptor agonist, steroid hormone inhibitor of CYP17A1 and SULT2B1	CYP17A1, PGR, SULT2B1		0.00, 0.00	1.89, 0.58	44.64	17.76	-33.26	79.63	50.79	82.83	-28.51	68.61	22.87	43.72
BRD-K32610195	CP	androstenedione	cytochrome P450 inhibitor	AKR1C3, HSD17B1, HSD3B1		10.00, 0.00	1.32, 0.38	87.48	-98.01	40.61	77.96	96.44	84.89	-53.62	-85.83	41.32	90.86
BRD-A77118605	CP	BML-ST330	phospholipase inhibitor, DNA inhibitor, RNA synthesis inhibitor			0.00, 0.00	0.82, 0.33	-85.82	-28.79	-95.17	-86.76	-71.78	-95.55	39.70	15.73	51.24	-89.51
BRD-K35128472	CP	2-aminopurine	serine/threonine protein kinase inhibitor			10.00, 10.00	1.43, 0.39	-72.86	99.33	-89.41	-74.79	-42.50	51.67	-40.30	58.86	46.03	-53.30
BRD-K53972329	CP	ruxolitinib	JAK inhibitor, tyrosine kinase inhibitor	JAK1, JAK2, TYK2, JAK3		10.00, 0.00	0.56, 0.17	85.52	88.08	53.12	74.58	37.13	49.70	96.34	63.64	-63.80	90.83
BRD-K13087974	CP	4,5-dianilinophthalimide	EGFR inhibitor, epidermal growth factor receptor (EGFR) inhibitor	EGFR	EGFR inhibitor	0.00, 0.00	0.84, 0.35	37.94	69.85	-82.27	-98.37	-74.26	-84.07	-36.95	37.99	-74.20	-77.28
BRD-K64935403	CP	ebelactone-b	pancreatic lipase inhibitor	PNLIP		10.00, 10.00	1.40, 0.40	9.82	75.87	-94.12	72.92	47.45	-43.10	-41.27	98.79	-35.79	46.72
BRD-K77625572	CP	etomoxir	carnitine palmitoyltransferase inhibitor, carnitine O-palmitoyltransferase inhibitor, fatty acid oxidation inhibitor	CPT1A, CPT1B		10.00, 10.00	0.90, 0.38	73.25	62.19	78.07	98.15	-63.79	-54.64	86.22	85.50	31.80	87.38
BRD-K85985071	CP	ellipticine	topoisomerase inhibitor, DNA intercalating drug	TOP2A, TOP2B	Topoisomerase inhibitor	0.00, 0.00	1.99, 0.44	-87.53	-95.43	-96.14	-92.34	-80.18	-74.59	-94.59	-72.50	-49.50	-95.88
BRD-A55756846	CP	H-7	PKA inhibitor	PKIA, PRKACA, PRKAR1A	PKA inhibitor	0.00, 0.00	1.09, 0.32	-61.16	12.15	-83.95	-78.31	48.51	-70.25	68.36	35.97	-49.97	-50.28
BRD-K62959606	CP	sphingosine	ceramidase inhibitor	GLTP, PVR, TRPM3		0.00, 0.00	0.88, 0.15	-8.31	-56.99	-79.23	11.17	-99.46	40.93	6.65	24.09	-99.95	-38.44
BRD-K70549064	CP	staurosporine	PKC inhibitor, AKT inhibitor, BMX inhibitor, CDK inhibitor, CHK inhibitor, G protein coupled receptor agonist, glycogen synthase kinase inhibitor, leucine rich repeat kinase inhibitor, ribosomal protein inhibitor, sodium/hydrogen exchanger inhibitor	CDK2, GSK3B, CAMK2B, CDK1, CDK5, CHEK1, CHRM1, CHRM2, CHRM4, CSK, DAPK1, GPR35, IKBKB, ITK, LCK, LRRK2, MAP2K4, MAP2K6, MAPKAPK2, PAK2, PDPK1, PHKG2, PIK3CG, PIM1, PKN1, PRKACB, PRKCI, PRKCQ, RPS6KA1, STK3, SYK, TNIK, ZAP70		0.00, 0.00	3.22, 0.84	-93.23	-18.89	-45.92	-28.88	-71.98	-86.14	-98.20	-90.82	-87.38	-95.86
BRD-K47943470	CP	tyrphostin-51	EGFR inhibitor			0.00, 0.00	1.35, 0.39	-38.94	14.59	-21.20	-19.85	-47.36	94.58	-21.91	6.75	-94.94	-8.69
BRD-K09790412	CP	H-9	cAMP dependent protein kinase inhibitor, PKA inhibitor	PRKACA		30.00, 30.00	0.57, 0.23	-99.95	-72.68	-31.26	-91.95	98.44	42.55	99.36	25.24	99.26	94.86
BRD-K43764301	CP	dexketoprofen	cyclooxygenase inhibitor	CXCR1, PTGS1, PTGS2, SLC5A8		0.00, 0.00	0.97, 0.20	-66.68	39.42	-96.44	70.79	-42.83	-45.37	68.35	-41.96	-99.97	-42.27
BRD-A74904029	CP	EI-231	casein kinase inhibitor	CSNK2A1, CSNK2A2, CSNK2B		0.00, 0.00	1.39, 0.43	21.42	82.84	59.80	14.15	-70.97	84.06	-36.18	-42.54	91.36	55.52
BRD-K80725632	CP	lavendustin-c	epidermal growth factor receptor (EGFR) inhibitor	CAMK2A, EGFR, SRC		0.00, 0.00	1.09, 0.26	57.11	48.05	-50.41	-95.12	62.25	71.00	-44.51	-4.62	-35.55	18.87
BRD-K32710582	CP	EI-247	insulin growth factor receptor inhibitor	INSR		10.00, 10.00	1.22, 0.30	36.75	27.82	56.97	89.88	92.63	60.43	11.06	81.26	99.80	81.39
BRD-K67506692	CP	tyrphostin-AG-126	ERK1 and ERK2 phosphorylation inhibitor, tyrosine kinase inhibitor			20.00, 0.00	1.78, 0.40	85.00	81.62	-90.73	95.45	95.99	-32.61	5.35	-11.36	-96.63	87.00
BRD-K56064827	CP	EI-273	PKC inhibitor	PRKCA, PRKCG		0.00, 0.00	2.13, 0.88	65.32	27.16	79.84	-67.25	44.37	-59.20	58.56	-52.96	74.12	64.91
BRD-K99291625	CP	SB-203580	p38 MAPK inhibitor, calcium channel activator, interleukin inhibitor, stress activated protein kinase inhibitor	MAPK14, MAPK1, MAPK11, AKT1, ALOX5, CHEK1, CYP2D6, CYP3A4, GAK, GSK3B, LCK, MAPK10, MAPK12, MAPK8, MAPK9, PRKCA, RAF1, RIPK2, ROCK1, RPS6KB1, SGK1, SRC, TNF	P38 MAPK inhibitor	10.00, 10.00	1.74, 0.34	98.57	94.93	-17.06	87.26	-60.03	23.35	-35.41	-19.56	-98.65	27.61
BRD-A18497530	CP	5-iodotubercidin	adenosine kinase inhibitor, nucleoside transporter inhibitor	MAPK3, ADK, CSNK1G2, GSG2, LRRK2		0.00, 0.00	4.91, 1.55	-94.71	35.38	-99.17	-41.50	-85.20	-85.86	-99.46	-53.44	-21.67	-97.39
BRD-A64228451	CP	terreic-acid	Bruton's tyrosine kinase (BTK) inhibitor	BTK		20.00, 10.00	1.56, 0.52	45.25	96.06	-79.52	99.95	-94.73	28.90	-46.08	-92.62	-99.16	-92.51
BRD-A11706664	CP	triciribine	AKT inhibitor	AKT1, AKT2, AKT3		0.00, 0.00	0.97, 0.24	-47.34	-99.87	-99.87	-65.87	-35.59	50.91	-25.60	-95.10	-89.13	-96.65
BRD-K08115555	CP	tyrphostin-AG-1288	catechol O methyltransferase inhibitor, tumor necrosis factor inhibitor	COMT		10.00, 10.00	1.44, 0.39	97.61	-62.54	67.31	75.21	-46.91	-59.88	28.26	33.95	-43.65	27.89
BRD-U08759356	CP	EI-346-erlotinib-analog	epidermal growth factor receptor (EGFR) inhibitor	EGFR		10.00, 10.00	1.74, 0.51	-7.23	29.91	-99.08	-34.19	69.89	97.51	48.08	-63.46	-91.72	-42.26
BRD-K50720187	CP	flupirtine	glutamate receptor antagonist, apoptosis inhibitor, opioid receptor agonist, potassium channel agonist	KCNQ2, ADRA2A, KCNQ1, KCNQ3		10.00, 10.00	1.90, 0.58	26.30	7.25	-59.45	84.93	83.34	99.54	-56.92	-73.76	-46.54	50.25
BRD-K79437791	CP	acetyl-farnesyl-cysteine	inhibitor of methylation of endogenous isoprenylated proteins	PPARG		20.00, 20.00	1.23, 0.43	98.68	-37.52	49.70	14.74	-42.67	33.76	46.68	98.35	61.34	46.74
BRD-K75181824	CP	acetyl-geranygeranyl-cysteine	inhibitor of methyl esterification of geranylgeranylated proteins			10.00, 10.00	1.10, 0.38	86.75	39.87	-31.42	52.56	-78.74	-77.74	80.50	97.99	94.45	93.08
BRD-U01690642	CP	acetyl-geranyl-cysteine	Ras carboxyl methylation inhibitor			0.00, 0.00	1.15, 0.40	-30.27	-78.00	93.18	-98.17	63.86	77.73	79.71	-58.25	23.45	66.22
BRD-K95402279	CP	geranylgeraniol	farnesyltransferase inhibitor			20.00, 20.00	1.39, 0.45	80.76	11.49	-54.10	30.04	97.95	66.82	-30.03	16.78	98.08	67.12
BRD-K28178212	CP	GW-441756	growth factor receptor inhibitor, leucine rich repeat kinase inhibitor	LRRK2, NTRK1		0.00, 0.00	1.40, 0.31	32.51	-99.87	17.02	-18.33	65.33	-44.57	-29.33	-11.82	46.04	10.84
BRD-K98684188	CP	GSK-0660	PPAR receptor inhibitor	PPARD		0.00, 0.00	1.11, 0.32	33.87	-65.48	-73.98	57.34	-34.40	55.27	-43.76	-53.15	86.53	-34.82
BRD-K89085489	CP	fenretinide	apoptosis stimulant, retinoid receptor agonist, RAR agonist	CYP2C8, CYP3A5, RARA, RARG		0.00, 0.00	0.78, 0.20	-98.46	-65.46	-92.60	-76.18	70.85	75.38	-62.49	-69.52	-66.22	-75.83
BRD-K49685476	CP	TTNPB	RAR agonist, retinoid receptor agonist	RARB, RARA, RARG		0.00, 0.00	0.66, 0.27	66.65	27.47	-58.69	24.60	62.73	89.49	-34.35	49.90	53.69	50.04
BRD-K62012036	CP	acitretin	retinoid receptor agonist, microbial collagenase inhibitor, protein synthesis inhibitor	RARA, RARB, RARG, RBP1, RXRA, RXRB, RXRG, STAT3	Retinoid receptor agonist	0.00, 0.00	1.64, 0.48	-76.26	73.16	86.87	-42.64	26.09	51.56	-33.10	-39.38	16.80	15.13
BRD-A96799240	CP	4-hydroxyretinoic-acid	retinoic acid metabolite			0.00, 0.00	1.15, 0.31	-54.73	-17.47	31.78	53.81	-46.08	30.10	22.42	-80.49	52.57	24.12
BRD-K00184207	CP	GR-206	aryl hydrocarbon receptor ligand			10.00, 0.00	0.97, 0.31	67.18	-67.35	-6.64	95.86	83.51	-55.06	-46.89	-23.55	83.55	68.14
BRD-K37846922	CP	3,3'-diindolylmethane	androgen receptor antagonist, aryl hydrocarbon receptor agonist, beta glucuronidase inhibitor, CHK inhibitor, cytochrome P450 activator, indoleamine 2,3-dioxygenase inhibitor	AHR, AR, CYP1A2, GUSB, IDO1		0.00, 0.00	1.33, 0.39	23.01	-55.63	-13.88	23.08	92.53	-33.35	93.18	-90.83	79.29	59.13
BRD-A36707673	CP	hydroxycholesterol	LXR agonist, ABC transporter expression enhancer, alpha secretase activator, beta secretase inhibitor, glutamate receptor modulator	ABCA1, NR1H2, NR1H3		0.00, 0.00	0.92, 0.36	47.39	76.61	37.64	-28.34	78.93	-41.77	86.84	31.61	-64.85	61.88
BRD-K61480498	CP	epoxycholesterol	LXR agonist	NR1H2, NR1H3		0.00, 0.00	1.11, 0.42	-99.66	-82.33	41.89	-93.95	63.31	-77.86	76.90	-87.94	-80.47	-88.76
BRD-K26674531	CP	GR-235	FXR antagonist, cholesterol inhibitor, estrogen receptor agonist, IKK inhibitor, progesterone receptor agonist, PXR agonist	ESR1, IKBKB, NR1H4, NR1I2, PGR	FXR antagonist	20.00, 10.00	1.27, 0.40	93.70	97.75	71.33	96.58	49.39	67.95	-19.83	78.29	-99.96	92.89
BRD-K47539947	CP	tetradecylthioacetic-acid	lipid peroxidase inhibitor			0.00, 0.00	0.93, 0.40	71.74	51.70	-35.13	15.79	55.84	63.38	34.82	35.41	13.64	33.55
BRD-A80775386	CP	hyperforin	cyclooxygenase inhibitor, dopamine reuptake inhibitor, interleukin receptor antagonist, lipoxygenase inhibitor, serotonin uptake inhibitor	NR1I2, ALOX5, PTGS1, TRPC6		0.00, 0.00	1.53, 0.48	-86.87	29.32	-63.02	-44.27	-79.62	35.42	-57.22	-96.13	-99.70	-88.52
BRD-K61463582	CP	BRD-K61463582	aryl hydrocarbon receptor agonist	AHR, CYP1A2		20.00, 10.00	1.20, 0.42	27.21	96.46	38.77	-35.67	99.16	-40.17	-30.35	-90.28	36.61	20.79
BRD-A39646320	CP	HC-toxin	HDAC inhibitor	HDAC1	HDAC inhibitor	0.00, 0.00	1.55, 0.53	-98.36	-90.00	-99.48	-92.74	-99.58	-81.32	-99.22	-85.34	-95.41	-98.73
BRD-K86465814	CP	HO-013	PPAR receptor agonist	PPARG	PPAR receptor agonist	10.00, 10.00	1.10, 0.34	14.65	-99.78	99.22	-26.99	79.27	84.75	93.26	-99.77	46.11	93.99
BRD-K81528515	CP	nilotinib	Bcr-Abl kinase inhibitor, Abl kinase inhibitor, discoidin domain containing receptor inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor	ABL1, KIT, BCR, CYP2B6, CYP2C8, DDR1, DDR2, PDGFRA	FLT3 inhibitor	60.00, 50.00	0.60, 0.17	96.22	-72.66	99.69	99.84	39.75	41.08	98.10	70.17	99.75	99.58
BRD-K58772419	CP	AZD-6482	PI3K inhibitor	PIK3CD, PIK3CG, PIK3CA, PIK3CB	PI3K inhibitor	10.00, 10.00	1.38, 0.60	-21.43	-100.00	-27.97	99.78	75.28	43.51	-29.26	-86.33	27.83	13.76
BRD-K52751261	CP	TAK-715	p38 MAPK inhibitor, tumor necrosis factor production inhibitor	MAPK14, TNF	P38 MAPK inhibitor	0.00, 0.00	0.60, 0.20	-29.26	15.89	-61.05	56.53	-92.08	-49.86	-27.67	-22.19	33.71	-19.39
BRD-K99545815	CP	PF-562271	focal adhesion kinase inhibitor, angiogenesis inhibitor, apoptosis stimulant	PTK2, PTK2B		0.00, 0.00	2.69, 1.02	-98.06	NaN	-99.48	-54.90	-99.54	-99.41	-98.13	-88.60	-68.87	-98.24
BRD-K13566078	CP	BMS-345541	IKK inhibitor	IKBKB, CHUK		0.00, 0.00	0.90, 0.55	-98.29	-99.30	-54.92	-93.10	-99.61	-99.41	-91.52	84.40	-98.15	-98.34
BRD-K01253243	CP	SB-590885	RAF inhibitor	BRAF	RAF inhibitor	0.00, 0.00	0.90, 0.41	-47.17	81.53	-19.71	18.84	-89.85	-53.99	57.96	-57.48	-32.68	-21.58
BRD-K64800655	CP	PHA-793887	CDK inhibitor	CDK1, CDK2, CDK4, CDK5, CCND1, CCNE1, CDK7, CDK9	CDK inhibitor	0.00, 0.00	1.55, 0.68	-99.63	-55.14	-73.88	-99.98	-99.18	-99.71	-99.57	-99.42	-99.54	-98.94
BRD-K05804044	CP	AZ-628	RAF inhibitor	BRAF, RAF1	RAF inhibitor	0.00, 0.00	1.76, 0.56	-75.84	80.19	-40.98	-79.03	73.13	45.01	-41.96	44.70	-39.62	-36.91
BRD-K00337317	CP	NU-7441	DNA dependent protein kinase, DNA dependent protein kinase inhibitor, P glycoprotein inhibitor	PRKDC, ABCB1	DNA dependent protein kinase inhibitor	10.00, 10.00	1.41, 0.63	-99.27	-73.39	-20.35	-99.64	-72.68	-97.26	98.54	-99.03	-39.83	-96.21
BRD-K82091397	CP	SB-239063	p38 MAPK inhibitor, interleukin inhibitor, tumor necrosis factor production inhibitor	MAPK11, MAPK14, PTGS2, TNF	P38 MAPK inhibitor	10.00, 10.00	0.83, 0.35	55.80	94.73	-28.19	97.86	-39.68	-94.54	-29.21	-89.33	34.07	16.70
BRD-K78431006	CP	crizotinib	ALK tyrosine kinase receptor inhibitor, c-Met inhibitor, hepatocyte growth factor receptor inhibitor, tyrosine kinase inhibitor	ALK, MET, CYP2B6, CYP3A5, MST1R, ROS1		0.00, 0.00	0.97, 0.19	-96.05	-30.63	-53.23	-99.63	72.35	-21.58	-99.60	-78.05	-99.58	-97.29
BRD-K70401845	CP	erlotinib	EGFR inhibitor, epidermal growth factor receptor (EGFR) inhibitor, tyrosine kinase inhibitor	EGFR, NR1I2	EGFR inhibitor	0.00, 0.00	1.18, 0.40	59.35	-63.42	-97.56	-18.00	-78.71	36.91	77.45	41.69	-72.32	-45.95
BRD-K19687926	CP	lapatinib	EGFR inhibitor, EGFR antagonist, epidermal growth factor receptor (EGFR) inhibitor, receptor tyrosine protein kinase inhibitor, tyrosine kinase inhibitor	EGFR, ERBB2, CYP3A5		20.00, 10.00	1.16, 0.26	43.28	27.30	21.20	32.41	33.76	98.50	79.06	95.52	63.58	56.22
BRD-A67748489	CP	K3644	Kinesin-Like Spindle Protein  KIF11 (KSP, Eg5) Inhibitors, mitotic kinesin inhibitor	KIF11		20.00, 20.00	1.23, 0.36	-50.64	99.14	26.71	82.20	55.94	47.18	87.61	77.97	97.97	92.21
BRD-K23192422	CP	lestaurtinib	FLT3 inhibitor, growth factor receptor inhibitor, JAK inhibitor, apoptosis stimulant	FLT3, NTRK1, JAK2, NTRK2, NTRK3	FLT3 inhibitor, JAK inhibitor	0.00, 0.00	3.09, 0.86	-99.83	-99.74	-99.98	-95.35	-50.53	-98.67	-99.49	-95.62	-99.32	-98.24
BRD-K98372770	CP	L-2167	PPAR receptor agonist	PPARD		10.00, 10.00	1.02, 0.34	-51.99	99.96	39.55	16.80	-96.81	86.06	-95.71	12.98	55.19	27.42
BRD-K99451608	CP	lopinavir	HIV protease inhibitor		HIV protease inhibitor	0.00, 0.00	1.15, 0.41	42.64	-14.13	-83.00	-28.88	89.42	67.22	-28.35	32.89	66.62	49.04
BRD-K55420858	CP	mirin	inhibitor of MRE11A exonuclease activity	MRE11A		20.00, 0.00	1.16, 0.47	-56.75	74.18	-45.46	56.61	56.37	95.61	23.46	96.94	-26.62	68.34
BRD-K67258146	CP	BRD-K67258146	mannose-6-phosphate isomerate inhibitor			0.00, 0.00	1.51, 0.43	37.49	77.38	-38.63	26.80	45.18	-34.50	35.43	12.27	-19.51	13.78
BRD-K36529613	CP	PU-H71	HSP inhibitor	HSP90AA1	HSP inhibitor	10.00, 10.00	1.07, 0.36	-99.02	-99.80	-25.15	-46.40	-41.47	48.10	93.76	99.84	36.79	-15.72
BRD-K09436313	CP	prostaglandin	prostanoid receptor antagonist	AKR1C3, PTGDR, PTGDR2, PTGER1, PTGER2, PTGER4, PTGFR		0.00, 0.00	1.19, 0.49	18.77	-98.30	-89.18	86.60	92.48	43.25	-39.42	29.84	39.29	15.97
BRD-K83794624	CP	pirarubicin	topoisomerase inhibitor	TOP2A	Topoisomerase inhibitor	0.00, 0.00	3.16, 0.95	-73.92	-67.68	-83.02	-46.80	-90.10	-99.41	-98.83	-82.59	-70.66	-95.51
BRD-K46212057	CP	voriconazole	cell wall synthesis inhibitor, cytochrome P450 inhibitor, lanosterol demethylase inhibitor	CYP2C19, CYP51A1		10.00, 10.00	1.43, 0.45	66.18	80.12	-25.92	58.95	50.87	-37.24	99.31	53.99	-68.60	68.54
BRD-K60460488	CP	nelfinavir	HIV protease inhibitor, proteasome inhibitor	CYP2C19, CYP3A5, CYP3A7	HIV protease inhibitor	0.00, 0.00	1.32, 0.41	-84.02	7.74	20.40	-75.23	-52.29	93.70	-14.25	-3.58	35.00	-5.16
BRD-K33551950	CP	radicicol	HSP inhibitor, ATP citrase lyase inhibitor, MAP kinase inhibitor, opioid receptor ligand, pyruvate dehydrogenase kinase inhibitor	ACLY, DLAT, HSP90AB1, HSP90B1, MAP3K7, OPRM1, PDK3	HSP inhibitor	0.00, 0.00	2.09, 0.76	-92.06	-69.01	-99.36	-39.22	47.90	-89.24	-66.41	-97.74	-99.13	-94.53
BRD-K77286328	CP	reversine	Aurora kinase inhibitor, adenosine receptor antagonist	AURKB, ADORA3, AURKA, INCENP, MAP2K1	Aurora kinase inhibitor	0.00, 0.00	1.58, 0.56	-32.35	-53.32	-35.29	-99.98	-42.51	44.85	-69.29	-95.51	-54.00	-62.21
BRD-K93331255	CP	lypressin	vasopressin receptor agonist	AVPR1A, AVPR1B, AVPR2		20.00, 10.00	0.77, 0.24	-90.64	96.59	-75.53	-78.13	-73.22	88.18	97.98	-43.01	-96.89	-69.10
BRD-K99749624	CP	linifanib	PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor, angiogenesis inhibitor, colony stimulating factor receptor antagonist, colony stimulating factor receptor inhibitor, FLT3 inhibitor, macrophage colony stimulating factor antagonist, MAP kinase inhibitor, PARP inhibitor, receptor tyrosine kinase inhibitor, STAT inhibitor, VEGFR antagonist	CSF1R, KDR, PDGFRB, FLT1, FLT3, FLT4, CSF1, KIT, PDGFRA, RET, TEK		10.00, 10.00	1.02, 0.49	-44.71	-31.94	-96.28	44.51	-45.09	98.92	-39.20	-46.80	-47.26	-39.40
BRD-K99964838	CP	bosutinib	src inhibitor, Abl kinase inhibitor, Bcr-Abl kinase inhibitor, apoptosis stimulant, STAT inhibitor	ABL1, SRC, BCR, CAMK2G, LYN, CAMK1D, CDK2, FRK, FYN, HCK, MAP2K1, MAP2K2, MAP3K2, MAP4K5, STK10, STK24, STK4, TNK2, TXK	SRC inhibitor	20.00, 20.00	1.28, 0.45	-40.74	42.11	-16.42	-93.90	-99.71	99.87	98.87	-90.52	89.43	-74.27
BRD-K86930074	CP	cediranib	VEGFR inhibitor, KIT inhibitor, angiogenesis inhibitor, VEGFR antagonist	KDR, FLT1, FLT4, KIT, PDGFRB, CSF1R, FLT3, PDGFRA	PDGFR/KIT inhibitor, VEGFR inhibitor	30.00, 20.00	1.56, 0.56	-93.65	-96.87	-27.03	-92.44	97.10	99.43	98.72	48.83	-56.65	92.10
BRD-K85402309	CP	dovitinib	EGFR inhibitor, FGFR inhibitor, FLT3 inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor, angiogenesis inhibitor, FGFR antagonist, KIT inhibitor, VEGFR antagonist	EGFR, FGFR3, PDGFRB, CSF1R, FGFR1, FGFR2, FLT1, FLT3, FLT4, INSR, KDR, KIT, PDGFRA	EGFR inhibitor, FGFR inhibitor, VEGFR inhibitor	10.00, 10.00	0.99, 0.19	48.29	-98.56	-98.90	21.35	97.59	47.84	-68.36	73.52	69.28	34.49
BRD-K50168500	CP	canertinib	EGFR inhibitor, EGFR antagonist, receptor tyrosine protein kinase inhibitor, tyrosine kinase inhibitor	EGFR, ERBB2, ERBB4, AKT1	EGFR inhibitor	0.00, 0.00	1.59, 0.39	-98.75	-53.76	-85.45	-96.37	84.11	-86.69	76.39	-61.10	-99.78	-89.68
BRD-K74514084	CP	pazopanib	VEGFR inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, angiogenesis inhibitor, RAF inhibitor, tyrosine kinase inhibitor, VEGFR antagonist	KDR, KIT, FLT1, FLT4, PDGFRB, PDGFRA, BRAF, CSF1R, CYP2B6, CYP2C8, CYP2E1, DDR2, FGF1, FGFR1, FGFR3, ITK, SH2B3	PDGFR/KIT inhibitor, VEGFR inhibitor	10.00, 10.00	0.81, 0.33	99.78	-68.22	52.58	41.05	-35.80	-56.63	-24.11	-64.09	-99.51	-46.34
BRD-K71035033	CP	masitinib	KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, src inhibitor, c-kit inhibitor, FGFR antagonist, FGFR inhibitor, tyrosine kinase inhibitor	KIT, FGFR3, LYN, PDGFRA, PDGFRB	PDGFR/KIT inhibitor	0.00, 0.00	0.80, 0.24	-66.84	-82.92	37.09	-99.98	-66.92	-76.30	-62.34	21.66	-72.68	-62.85
BRD-K02965346	CP	SU-11274	hepatocyte growth factor receptor inhibitor, tyrosine kinase inhibitor	MET		0.00, 0.00	1.42, 0.56	-11.84	-93.68	-98.37	26.33	75.18	-28.88	19.12	-99.98	-57.79	-67.77
BRD-K28428262	CP	brivanib	alcohol dehydrogenase inhibitor, FGFR inhibitor, fibroblast growth factor receptor (FGFR) inhibitor, vascular endothelial growth factor receptor (VEGFR) inhibitor, VEGFR inhibitor	FGFR1, KDR, FLT1, CYP3A4, FGFR2, FGFR3, FLT4, KCNH2	FGFR inhibitor	10.00, 10.00	0.83, 0.31	-42.38	-28.69	-89.75	11.53	48.44	99.88	-63.24	-16.56	54.55	-30.09
BRD-K67578145	CP	GDC-0879	RAF inhibitor	BRAF	RAF inhibitor	0.00, 0.00	1.20, 0.40	-28.58	-71.24	-99.79	34.61	-37.57	94.03	30.14	54.50	-40.88	-8.54
BRD-K95901403	CP	XL-147	Phosphatidylinositol 3-kinase (PI3K) inhibitor, PI3K inhibitor	PIK3CA, PIK3CD, PIK3CG		0.00, 0.00	2.02, 0.58	-99.52	-8.31	-47.72	-67.53	-40.27	-36.65	-48.25	-18.27	-90.85	-66.30
BRD-K13514097	CP	everolimus	mTOR inhibitor, angiogenesis inhibitor, cell cycle inhibitor, immunosuppressant, protein kinase inhibitor, rotamase inhibitor	MTOR, CYP3A5, FKBP1A		0.00, 0.00	1.93, 0.51	13.25	-29.20	-66.54	12.94	-24.55	-64.81	-87.49	-20.11	32.42	-18.20
BRD-K16485616	CP	mocetinostat	HDAC inhibitor, cell cycle inhibitor	HDAC1, HDAC2, HDAC3, HDAC11	HDAC inhibitor	0.00, 0.00	1.90, 0.51	-88.47	-25.73	-91.20	-28.38	-73.73	-67.19	-99.81	-60.65	40.47	-93.08
BRD-A41692738	CP	TGX-221	PI3K inhibitor	PIK3CB, PIK3CD	PI3K inhibitor	0.00, 0.00	0.98, 0.31	-71.96	-95.69	-59.20	-74.57	-68.39	61.92	-30.45	-38.55	36.71	-84.31
BRD-K73293050	CP	WZ-3146	EGFR inhibitor, epidermal growth factor receptor (EGFR) inhibitor	EGFR		20.00, 10.00	1.74, 0.50	-96.46	67.69	-35.06	-99.16	95.81	20.46	98.72	-97.35	20.60	-83.60
BRD-K83837640	CP	JNJ-26854165	HDAC inhibitor, MDM inhibitor	HDAC1, HDAC10, HDAC11, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9, MDM2		0.00, 0.00	1.40, 0.39	-98.18	-99.96	-99.37	-87.40	-99.75	-96.66	-91.45	-99.76	-29.32	-99.47
BRD-K99498722	CP	NPI-2358	tubulin inhibitor, angiogenesis inhibitor, tubulin polymerisation inhibitor		Tubulin inhibitor	0.00, 0.00	1.63, 0.59	-47.57	13.11	-21.67	-35.51	41.40	42.87	-91.60	-89.49	-97.81	-83.23
BRD-K17306061	CP	aprepitant	tachykinin antagonist	TACR1, CYP2C19		10.00, 10.00	1.22, 0.30	-23.49	98.04	26.57	67.52	43.71	-45.81	37.03	-4.10	32.77	11.67
BRD-M16762496	CP	PIK-75	DNA protein kinase inhibitor, P110 inhibitor, Phosphatidylinositol 3-kinase (PI3K) inhibitor, PI3K inhibitor	PIK3CA, PIK3CB, PIK3CD, PIK3CG, PRKDC	PI3K inhibitor	0.00, 0.00	1.86, 0.69	-90.80	79.30	-99.55	-36.64	-57.61	-95.78	-96.53	-99.36	-92.06	-98.06
BRD-K07265709	CP	razoxane	topoisomerase inhibitor, chelating agent	TOP2A, TOP2B		0.00, 0.00	0.93, 0.33	-98.66	-68.16	-30.87	-99.98	89.43	90.92	78.91	-98.84	64.59	-96.75
BRD-K73838513	CP	cinacalcet	calcimimetic that activates calcium-sensing receptors	CASR		0.00, 0.00	1.19, 0.41	-45.96	20.20	-34.99	-41.93	52.07	-52.48	-31.38	-10.20	36.98	-14.41
BRD-K99260425	CP	etodolac	cyclooxygenase inhibitor, TRPV agonist	PTGS2, PTGS1, RXRA, TRPV1		0.00, 0.00	1.28, 0.34	51.03	92.34	-95.67	11.28	-60.78	43.81	34.23	61.00	-62.69	34.59
BRD-K91900765	CP	VX-745	p38 MAPK inhibitor	MAPK14, MAPK11, MAPK12	P38 MAPK inhibitor	0.00, 0.00	0.86, 0.30	6.86	35.80	37.25	39.33	62.00	-83.82	41.25	79.85	-50.03	25.51
BRD-K91696562	CP	orantinib	PDGFR tyrosine kinase receptor inhibitor, FGFR inhibitor, VEGFR inhibitor, angiogenesis inhibitor, apoptosis stimulant, Aurora kinase inhibitor, FGFR antagonist, fibroblast growth factor receptor (FGFR) antagonist, fibroblast growth factor receptor inhibitor, kinase insert domain receptor inhibitor, platelet-derived growth factor receptor (PDGFR) inhibitor, serine/threonine kinase inhibitor, vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor, VEGFR antagonist	PDGFRB, AURKA, AURKB, KDR, EGFR, FGFR1, FGFR2, PDGFRA, TBK1	FGFR inhibitor	0.00, 0.00	0.91, 0.41	12.75	-18.46	43.39	-22.86	-50.30	73.97	-33.09	42.54	-52.56	-12.50
BRD-K84639753	CP	safinamide	dopamine reuptake inhibitor, glutamate release inhibitor, monoamine oxidase inhibitor, calcium channel antagonist, calcium channel modulator, Sodium Channel  Blockers, sodium channel blocker	MAOB, SLC6A3		10.00, 0.00	1.69, 0.50	44.35	94.75	54.02	69.19	31.79	95.79	91.05	66.31	78.24	87.91
BRD-K89014967	CP	AS-703026	MEK inhibitor	MAP2K1, MAP2K2	MEK inhibitor	0.00, 0.00	1.41, 0.55	-13.11	70.57	68.34	-91.93	59.28	40.67	91.90	-5.52	93.45	73.99
BRD-K81783531	CP	VX-222	HCV inhibitor, RNA-directed RNA polymerase inhibitor			0.00, 0.00	0.59, 0.25	29.70	32.08	-89.86	57.52	32.88	-50.78	-40.81	-40.61	-35.31	14.95
BRD-K70557564	CP	zosuquidar	P glycoprotein inhibitor, P glycoprotein modulator	ABCB1, ABCB4		0.00, 0.00	0.98, 0.31	40.55	85.09	-73.48	-20.55	-98.84	-34.57	-64.02	-60.61	-99.02	-79.63
BRD-K48722833	CP	iloperidone	dopamine receptor antagonist, serotonin receptor antagonist	DRD2, HTR2A, HTR1A, HTR6, HTR7, ADRA1A, ADRA2C, DRD1, DRD3, DRD4, HRH1		0.00, 0.00	1.19, 0.39	82.83	30.14	-70.57	33.73	75.31	90.45	-36.75	-75.37	92.09	77.41
BRD-K70511574	CP	sunitinib	FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor, angiogenesis inhibitor, colony stimulating factor receptor antagonist, colony stimulating factor receptor inhibitor, platelet-derived growth factor receptor (PDGFR) inhibitor, vascular endothelial growth factor receptor (VEGFR) inhibitor, vascular endothelial growth factor receptor 1 (VEGFR1) inhibitor, vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor, VEGFR antagonist	FLT3, KDR, KIT, FLT4, FLT1, PDGFRA, PDGFRB, RET, CSF1R, FGFR1		20.00, 20.00	1.27, 0.45	-19.44	99.96	-18.09	99.83	67.13	70.89	37.72	-99.79	77.09	74.25
BRD-K10916986	CP	vinorelbine	tubulin inhibitor, apoptosis stimulant, microtubule inhibitor, mitosis inhibitor, mitotic inhibitor, tubulin polymerisation inhibitor, vinca alkaloid	TUBB		10.00, 10.00	1.51, 0.51	-64.97	99.96	-82.10	61.35	-81.47	-61.13	-87.50	19.98	-34.89	-69.37
BRD-K54472332	CP	elvitegravir	HIV integrase inhibitor, HIV inhibitor			0.00, 0.00	1.10, 0.33	-55.23	72.10	-91.32	-6.49	34.83	-28.44	-39.40	-14.07	69.78	-7.93
BRD-M72442222	CP	vicriviroc	CC chemokine receptor antagonist, CC chemokine receptor 5 (CCR5) antagonist	CCR5		0.00, 0.00	0.97, 0.15	7.30	-17.61	-37.59	76.43	91.76	-32.27	27.40	11.59	37.23	9.42
BRD-K37130656	CP	rivaroxaban	coagulation factor inhibitor, coagulation inhibitor, serine protease inhibitor	F10, CYP2J2, CYP3A5		30.00, 20.00	0.91, 0.38	80.86	99.15	-87.80	94.54	-62.38	87.66	99.65	-26.46	49.14	96.72
BRD-K07736136	CP	VX-702	p38 MAPK inhibitor	MAPK14, MAPK11, MAPK12	P38 MAPK inhibitor	0.00, 0.00	1.49, 0.30	76.94	24.46	-30.48	16.36	-81.29	85.62	79.06	-18.43	37.19	28.98
BRD-K37720887	CP	SB-525334	TGF beta receptor inhibitor	TGFBR1	TGF beta receptor inhibitor	10.00, 10.00	1.60, 0.44	65.13	28.24	-51.05	19.41	56.74	70.48	37.26	100.00	53.98	68.67
BRD-K66956375	CP	oleoylethanolamide	Glucose-Dependent Insulinotropic Receptor (GDIR, GPR119)  Agonists, potassium channel blocker, PPAR receptor agonist	CNR1, GPR119, GPR55, KCND3, PPARA		20.00, 10.00	1.34, 0.52	-54.47	96.76	-80.97	-98.61	-51.77	-72.25	98.47	23.86	63.24	-41.55
BRD-K15891719	CP	tenofovir	reverse transcriptase inhibitor, nucleoside reverse transcriptase inhibitor, nucleotide reverse transcriptase inhibitor			0.00, 0.00	3.25, 0.93	-38.66	-10.48	-68.70	36.29	92.53	92.44	-85.85	43.30	-25.27	40.73
BRD-U97083655	CP	teicoplanin	bacterial cell wall synthesis inhibitor			20.00, 20.00	1.33, 0.49	-18.70	98.43	77.87	76.23	-44.50	98.07	32.38	-18.51	40.18	75.51
BRD-K36627727	CP	tamibarotene	retinoid receptor agonist, RAR agonist	RARA, RARB	Retinoid receptor agonist	0.00, 0.00	0.98, 0.31	-98.30	42.38	-29.03	-54.77	-45.38	-49.51	-36.25	-95.77	-89.10	-58.77
BRD-K25991148	CP	warfarin	cytochrome P450 inhibitor, vitamin inhibitor, vitamin K epoxide reductase inhibitor	VKORC1, CYP2C19, CYP2C8, CYP4F2		30.00, 20.00	1.11, 0.39	70.00	59.31	-38.49	94.10	-50.26	99.93	-26.17	99.17	82.19	95.26
BRD-M30523314	CP	vinorelbine	tubulin inhibitor, apoptosis stimulant, microtubule inhibitor, mitosis inhibitor, mitotic inhibitor, tubulin polymerisation inhibitor, vinca alkaloid	TUBB	Tubulin inhibitor	10.00, 10.00	1.24, 0.56	-27.62	99.96	-69.69	80.52	54.51	-97.89	-67.47	-60.88	-64.68	-52.16
BRD-A26002865	CP	verrucarin-a	protein synthesis inhibitor		Protein synthesis inhibitor	0.00, 0.00	2.76, 0.81	-83.20	-34.76	-98.56	-73.76	94.11	-39.85	-97.22	-16.49	-95.62	-95.17
BRD-K77390737	CP	xanthohumol	aromatase inhibitor, diacylglycerol O acyltransferase inhibitor, valosin containing protein inhibitor	CYP19A1, VCP		0.00, 0.00	1.35, 0.38	-15.09	58.82	39.44	74.93	-31.36	94.43	-41.35	27.20	-52.67	22.69
BRD-K29582115	CP	ziprasidone	dopamine receptor antagonist, serotonin receptor antagonist, norepinephrine reuptake inhibitor, serotonin receptor agonist, serotonin reuptake inhibitor	DRD2, HTR2A, HTR1A, HTR1D, HRH1, HTR1B, HTR1E, HTR2C, HTR7, ADRA1A, ADRA1B, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD3, DRD4, DRD5, HTR3A, HTR6, SLC6A4		20.00, 10.00	1.74, 0.64	-33.62	-75.30	-43.86	96.71	81.94	-35.17	-85.33	22.37	99.63	46.37
BRD-A98283014	CP	calmidazolium	calcium channel blocker, calmodulin antagonist	ATP2B1, PDE1A		0.00, 0.00	2.63, 0.69	-58.22	-68.55	NaN	-97.15	NaN	-44.54	51.00	-61.58	-34.23	-65.78
BRD-A03323675	CP	ritonavir	HIV protease inhibitor, cytochrome P450 inhibitor	CYP3A4, CYP1A2, CYP2B6, CYP2C19, CYP3A5, CYP3A7		0.00, 0.00	1.03, 0.26	-98.62	-93.63	84.28	23.13	-55.23	-23.87	78.94	-43.95	NaN	-38.45
BRD-A09495397	CP	bicuculline	GABA receptor antagonist	GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, KCNN1	GABA receptor antagonist	0.00, 0.00	1.27, 0.46	NaN	NaN	-52.59	-32.20	NaN	NaN	56.29	-16.94	87.65	-21.61
BRD-A11170096	CP	pravastatin	HMGCR inhibitor	HMGCR, SLCO1B1		0.00, 0.00	1.28, 0.39	11.47	-29.32	43.37	-42.21	50.81	36.94	-78.00	-8.90	NaN	-6.82
BRD-A14792000	CP	valsartan	angiotensin receptor antagonist	AGTR1		11.11, 0.00	1.47, 0.63	-10.63	34.94	37.28	96.35	41.61	89.27	34.91	27.60	NaN	24.63
BRD-A14985772	CP	ascorbyl-palmitate	antioxidant			0.00, 0.00	1.15, 0.44	16.39	93.35	-70.46	-40.72	-84.55	-32.19	64.41	65.34	-47.85	-33.44
BRD-A15914070	CP	4-hydroxy-2-nonenal	cytotoxic lipid peroxidation product	IKBKB		0.00, 0.00	1.76, 0.58	NaN	NaN	-99.40	-29.24	NaN	NaN	26.16	-76.67	77.92	-54.86
BRD-A20589515	CP	dihydroxyphenylglycine	glutamate receptor agonist	GRM1		16.67, 16.67	1.77, 0.52	NaN	NaN	-51.37	97.54	NaN	NaN	70.66	-59.27	-37.62	-20.54
BRD-A29731977	CP	17-hydroxyprogesterone-caproate	progesterone receptor agonist	CYP1A2, CYP2B6, CYP3A5, PGR	Progesterone receptor agonist	20.00, 0.00	0.80, 0.18	-7.38	96.46	46.80	-22.91	-36.29	35.67	85.35	96.35	59.97	75.71
BRD-A62890442	CP	3-methyl-GABA	GABA aminotransferase activator			0.00, 0.00	2.52, 0.88	NaN	NaN	43.42	17.02	NaN	NaN	62.48	38.72	72.74	57.30
BRD-A79314293	CP	cephalosporanic-acid	core structure for synthesis of cephalosporin antibiotics			16.67, 16.67	1.76, 0.66	NaN	NaN	63.91	44.00	NaN	NaN	-92.92	99.58	76.59	75.95
BRD-A80383043	CP	BRD-A80383043	glutamate receptor agonist, glutamate receptor antagonist	GRM1, GRM2		0.00, 0.00	2.20, 0.90	NaN	NaN	42.37	88.82	NaN	NaN	58.20	17.38	92.45	77.09
BRD-A80928489	CP	1-monopalmitin	P glycoprotein inhibitor	ABCB1		16.67, 0.00	1.44, 0.56	NaN	NaN	-31.48	96.97	NaN	NaN	50.40	64.10	78.93	79.84
BRD-A83892713	CP	rifampicin	DNA directed RNA polymerase inhibitor, enzyme inducer	NR1I2, ABCB1, CYP2B6, CYP2C19, CYP2C8, CYP3A4, CYP3A5, SLCO1A2, SLCO1B1, SLCO1B3		0.00, 0.00	1.26, 0.34	-51.80	-74.37	-25.62	-30.52	70.52	-61.70	-20.35	-78.07	NaN	-57.65
BRD-A87125127	CP	3-matida	glutamate receptor antagonist	GRM1		16.67, 16.67	1.87, 0.60	NaN	NaN	37.54	99.98	NaN	NaN	-28.85	83.23	-61.60	70.45
BRD-A95696820	CP	acadesine	adenosine release stimulant, AMPK activator, AMPK stimulant			16.67, 16.67	2.15, 0.51	NaN	NaN	20.48	-21.40	NaN	NaN	64.30	97.82	-80.85	46.71
BRD-K04466929	CP	Merck60	HDAC inhibitor	HDAC1, HDAC2		0.00, 0.00	0.11, 0.02	57.36	-56.63	31.67	-96.19	57.88	55.52	72.41	88.95	-90.79	68.06
BRD-K06750613	CP	GSK-1059615	PI3K inhibitor, mTOR inhibitor	PIK3CA, PIK3CG	MTOR inhibitor, PI3K inhibitor	0.00, 0.00	1.64, 0.68	-99.95	-97.04	36.96	-48.43	-79.37	84.80	-43.64	-99.67	NaN	-92.78
BRD-K06817181	CP	BRD-K06817181	JAK inhibitor	JAK2		0.00, 0.00	1.34, 0.46	NaN	NaN	-38.33	-30.72	NaN	NaN	-97.87	82.44	-86.95	-67.10
BRD-K13872703	CP	BRD-K13872703	chlorine/bicarbinate exchanger inhibitor, purinergic receptor antagonist	ANO1, CLCN6, CLCN7, CLCNKA, CLCNKB, P2RY2		0.00, 0.00	1.48, 0.40	NaN	NaN	-68.01	26.92	NaN	NaN	61.02	94.48	-47.85	46.92
BRD-K14643723	CP	4-(2-Amino-ethyl)-benzenesulfonamide	carbonic anhydrase inhibitor	CA2, CA1, CA9, CA12, CA14, CA4		30.00, 20.00	1.06, 0.16	98.44	59.87	95.45	50.30	99.77	64.43	62.08	-28.63	-64.93	93.83
BRD-K15519488	CP	CS-110266	dopamine receptor agonist	SLC6A3		0.00, 0.00	3.87, 1.32	NaN	NaN	-19.21	61.45	NaN	NaN	52.83	-28.03	NaN	39.95
BRD-K17953061	CP	staurosporine	PKC inhibitor, AKT inhibitor, BMX inhibitor, CDK inhibitor, CHK inhibitor, G protein coupled receptor agonist, glycogen synthase kinase inhibitor, leucine rich repeat kinase inhibitor, ribosomal protein inhibitor, sodium/hydrogen exchanger inhibitor	CDK2, GSK3B, CAMK2B, CDK1, CDK5, CHEK1, CHRM1, CHRM2, CHRM4, CSK, DAPK1, GPR35, IKBKB, ITK, LCK, LRRK2, MAP2K4, MAP2K6, MAPKAPK2, PAK2, PDPK1, PHKG2, PIK3CG, PIM1, PKN1, PRKACB, PRKCI, PRKCQ, RPS6KA1, STK3, SYK, TNIK, ZAP70		0.00, 0.00	4.04, 1.01	-96.11	NaN	-99.88	-64.11	-74.06	-96.05	-86.80	-83.68	-93.69	-96.79
BRD-K20197062	CP	SA-94315	caspase inhibitor	CASP3		10.00, 10.00	0.63, 0.11	43.69	84.60	-35.49	21.90	26.20	98.16	-36.29	56.79	83.90	66.82
BRD-K31491153	CP	1-phenylbiguanide	serotonin receptor agonist	HTR3A, HTR3B		0.00, 0.00	1.35, 0.42	NaN	NaN	-56.78	57.20	NaN	NaN	62.80	84.89	-92.32	56.78
BRD-K37814297	CP	acepromazine	dopamine receptor antagonist	ADRA1A, ADRA1B, DRD1, DRD2, HTR1A, HTR2A	Dopamine receptor antagonist	0.00, 0.00	1.01, 0.24	-90.35	NaN	-64.99	-21.85	NaN	NaN	36.90	72.49	62.09	-27.65
BRD-K50384076	CP	7,4'-dihydroxyflavone	opioid receptor antagonist	CYP19A1		0.00, 0.00	2.32, 0.66	NaN	NaN	-47.48	31.87	NaN	NaN	45.38	14.32	39.87	29.18
BRD-K56450366	CP	NSC-94258	antitumor agent	AKR1B1, CYP19A1, HSD17B1		50.00, 50.00	1.42, 0.42	NaN	NaN	75.93	98.47	NaN	NaN	83.25	-30.28	97.62	98.11
BRD-K60690191	CP	MPEP	glutamate receptor antagonist	GRM5, GRM1, GRM4		0.00, 0.00	1.56, 0.49	NaN	NaN	-51.77	39.26	NaN	NaN	67.63	-81.81	44.11	46.35
BRD-K63784565	CP	BRD-K63784565	beta amyloid synthesis inhibitor, topoisomerase inhibitor	TOP1		0.00, 0.00	1.88, 0.51	NaN	NaN	-61.98	83.30	NaN	NaN	55.34	57.63	44.24	38.30
BRD-K67977190	CP	eprosartan	angiotensin receptor antagonist	AGTR1		44.44, 44.44	1.65, 0.47	99.60	99.87	-48.67	36.60	36.38	67.29	-50.88	99.83	NaN	99.58
BRD-K83636919	CP	entacapone	catechol O methyltransferase inhibitor	COMT		44.44, 44.44	1.48, 0.48	-30.80	99.91	64.41	47.19	83.25	99.21	99.68	-15.34	NaN	99.72
BRD-K88701661	CP	dimercaptosuccinic-acid	chelating agent, DNA methyltransferase inhibitor	DNMT1	HIF activator	16.67, 16.67	1.56, 0.50	NaN	NaN	-36.93	45.08	NaN	NaN	32.84	60.68	99.80	47.65
BRD-K90864987	CP	cobalt(II)-chloride	HSP agonist	HIF1A	HIF activator	22.22, 22.22	1.67, 0.59	54.94	26.28	-46.93	-43.13	99.09	98.83	31.66	-45.08	NaN	49.40
BRD-K91145395	CP	prostratin	NFkB pathway activator, PKC activator	PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PRKCH, PRKCQ	PKC activator	0.00, 0.00	3.63, 1.03	-62.27	27.40	-41.47	-91.29	56.24	-77.66	-58.37	-99.18	-41.58	-78.35
BRD-K91781484	CP	BRD-K91781484	nuclear factor erythroid derived, like (NRF2) activator	NFE2L2		0.00, 0.00	1.51, 0.56	NaN	NaN	-52.63	24.75	NaN	NaN	-31.11	10.19	-38.73	-5.35
BRD-K98824517	CP	BRD-K98824517	tyrosine phosphatase inhibitor			0.00, 0.00	2.49, 0.73	-13.35	-53.31	-98.34	-99.71	36.51	-81.32	-93.44	-99.93	-98.54	-96.77
BRD-M41783010	CP	acamprosate	glutamate receptor antagonist, excitatory amino acid receptor antagonist, GABA receptor agonist, glutamate receptor modulator	GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B, GRM5		0.00, 0.00	1.35, 0.39	62.91	NaN	29.76	-9.77	NaN	NaN	28.37	-26.50	-77.14	9.02
BRD-K66766661	CP	17-beta-estradiol	estrogen receptor agonist	ESR1	Estrogen receptor agonist	0.00, 0.00	1.56, 0.55	-11.57	NaN	65.14	-82.82	-85.18	-29.41	54.21	18.52	NaN	-19.10
BRD-K54529596	CP	captopril	angiotensin converting enzyme inhibitor	ACE, LTA4H, MMP2, MMP9		0.00, 0.00	1.42, 0.42	-31.66	-12.52	86.77	-39.79	-31.86	80.14	88.01	83.98	NaN	80.15
BRD-A63445921	CP	nicardipine	calcium channel blocker, L-type calcium channel blocker	CACNA1C, ADORA3, ADRA1A, ADRA1B, ADRA1D, CACNA1D, CACNA2D1, CACNB2, CALM1, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, PDE1A, PDE1B		0.00, 0.00	1.92, 0.56	-52.49	70.31	-40.10	-31.20	-34.83	-39.13	-78.42	-64.51	NaN	-57.24
BRD-A51182606	CP	chloramphenicol	30S ribosomal protein inhibitor, 50S ribosomal subunit inhibitor, antibacterial agent	CD55, CYP2C19		0.00, 0.00	1.82, 0.47	41.13	22.19	-75.40	-31.41	69.25	-41.27	-21.06	-64.36	NaN	-11.78
BRD-K94070024	CP	depomedrol	glucocorticoid receptor agonist		Glucocorticoid receptor agonist	0.00, 0.00	1.47, 0.75	87.94	69.29	48.02	-94.86	-53.89	-60.71	53.33	-53.92	NaN	-45.57
BRD-A75144621	CP	digoxin	ATPase inhibitor, ROR antagonist	ATP1A1, ABCB1, RORC, SLCO1B3		0.00, 0.00	2.00, 0.58	61.99	-80.77	-90.34	-92.96	37.38	-76.96	-91.65	27.28	NaN	-92.71
BRD-K82216340	CP	medroxyprogesterone	progesterone receptor agonist	PGR, ESR1	Progesterone receptor agonist	11.11, 11.11	1.81, 0.60	97.90	-99.60	-64.64	-76.27	88.20	-27.49	-61.47	-23.42	NaN	-64.74
BRD-K13356952	CP	methazolamide	carbonic anhydrase inhibitor, insulin sensitizer	CA1, CA2, CA4, CA7, CA12, CA14, INS		11.11, 11.11	1.56, 0.56	34.31	23.18	-65.40	-35.45	49.23	98.87	43.43	-22.59	NaN	23.20
BRD-K54416256	CP	methimazole	antithyroid Drugs	TPO		11.11, 11.11	0.90, 0.34	80.05	80.47	-24.83	-39.07	-88.29	-74.13	97.96	54.87	NaN	69.43
BRD-K86873305	CP	piperacillin	cell wall synthesis inhibitor			11.11, 11.11	1.52, 0.67	-10.86	23.97	97.69	-79.33	88.37	89.03	-90.78	-28.61	NaN	86.40
BRD-K28667793	CP	pyrazinamide	fatty acid synthase inhibitor	FASN		11.11, 11.11	1.74, 0.56	80.33	38.60	47.81	99.86	92.59	33.03	40.15	-71.51	NaN	71.60
BRD-A15493168	CP	tetracycline	30S ribosomal protein inhibitor, 30S ribosomal subunit inhibitor, protein arginine deiminase inhibitor	PRNP	Bacterial 30S ribosomal subunit inhibitor	11.11, 11.11	2.18, 0.53	45.70	33.86	75.72	-26.53	35.55	97.88	57.28	-43.28	NaN	53.89
BRD-K97799481	CP	theophylline	adenosine receptor antagonist, chitinase inhibitor, GABA receptor antagonist, phosphodiesterase inhibitor	ADORA1, ADORA2A, ADORA2B, ADORA3, CHIA, CYP2E1, CYP3A4, HDAC2, PDE3A, PDE4A, PDE4B, PDE5A		55.56, 44.44	1.84, 0.49	97.38	99.80	-41.77	86.03	23.79	98.07	-33.56	98.87	NaN	98.66
BRD-K69688083	CP	mestinon	cholinesterase inhibitor	ACHE, BCHE		0.00, 0.00	2.26, 0.53	79.35	29.16	NaN	-50.39	-42.14	42.62	36.18	-43.06	NaN	-29.63
TRCN0000208001	CTRL	EMPTY_VECTOR	Empty vector control			40.00, 30.00	0.01, 0.00	98.60	99.36	95.65	94.91	75.30	79.18	94.13	92.18	89.89	98.12
BRD-K59773493	CP	benzohydroxamic-acid	metal chelator, anti bacterial			55.56, 55.56	0.43, 0.34	99.40	NaN	99.24	93.66	99.93	63.65	99.73	60.26	87.23	99.44
ccsbBroad304_00003	OE	ABAT	GABA turnover, 4-aminobutyrate aminotransferase			10.00, 0.00	1.01, 0.40	-59.53	54.84	97.04	-28.92	28.55	-42.35	-55.22	-99.85	-96.61	-22.81
ccsbBroad304_05471	OE	ABCB5	ATP binding cassette transporters / subfamily B, ATP-binding cassette, sub-family B (MDR/TAP), member 5			10.00, 10.00	0.93, 0.27	99.31	84.32	-16.33	37.94	-37.35	43.65	-97.39	-99.98	-46.57	-9.00
ccsbBroad304_07542	OE	ABCF2	ATP binding cassette transporters / subfamily F, ATP-binding cassette, sub-family F (GCN20), member 2			11.11, 11.11	0.97, 0.28	-60.98	99.87	-33.74	NaN	-44.04	-40.35	-11.91	-31.74	68.20	-4.57
ccsbBroad304_05756	OE	ACAA1	acetyl-CoA acyltransferase 1			10.00, 10.00	1.31, 0.39	-69.77	-84.06	-78.64	-65.11	32.49	98.23	-32.62	-57.89	-43.79	-34.76
ccsbBroad304_00006	OE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain			0.00, 0.00	1.14, 0.24	41.87	23.76	-89.84	-37.43	-46.26	39.63	45.56	90.71	29.30	10.39
ccsbBroad304_05759	OE	ACAT2	Lanosterol biosynthesis pathway, acetyl-CoA acetyltransferase 2			22.22, 11.11	1.43, 0.48	99.98	97.07	-10.06	NaN	-96.59	-49.79	18.90	-35.11	58.71	38.04
ccsbBroad304_00009	OE	ACLY	ATP citrate lyase			0.00, 0.00	0.98, 0.30	-33.75	-41.80	21.49	28.63	-72.16	-63.38	69.33	92.74	68.34	-23.51
ccsbBroad304_00016	OE	ACTN4	EF-hand domain containing, actinin, alpha 4			10.00, 10.00	0.92, 0.24	36.16	72.32	-68.61	99.83	-81.90	-48.28	-41.00	62.59	-46.47	34.87
ccsbBroad304_02313	OE	ACTR3	ARP3 actin-related protein 3 homolog (yeast)			0.00, 0.00	0.97, 0.39	30.70	30.53	75.53	-95.44	-99.69	-54.38	36.22	69.22	43.69	22.88
ccsbBroad304_05767	OE	ACVR1	Type I receptor serine/threonine kinases, activin A receptor, type I			10.00, 10.00	1.05, 0.28	90.46	-97.18	-89.58	-32.46	-84.75	63.33	-60.65	99.98	29.67	-81.37
ccsbBroad304_00020	OE	ACY1	aminoacylase 1			0.00, 0.00	1.28, 0.30	-28.58	-93.56	-96.17	-58.22	86.92	-96.52	45.56	-60.25	-31.85	-79.24
ccsbBroad304_00023	OE	ADA	Adenosine turnover, adenosine deaminase			0.00, 0.00	0.99, 0.31	77.74	-37.73	94.30	-57.08	-51.77	-50.66	83.58	-31.15	-41.69	-10.62
ccsbBroad304_02789	OE	ADAT1	adenosine deaminase, tRNA-specific 1			0.00, 0.00	1.03, 0.23	50.43	NaN	-85.97	41.02	-93.25	51.22	-21.57	-82.44	83.89	-39.72
ccsbBroad304_00024	OE	ADCY3	Adenylyl cyclases, adenylate cyclase 3			10.00, 0.00	1.06, 0.42	-94.88	-22.12	-18.18	97.12	55.89	55.08	-98.37	-35.29	89.84	24.70
ccsbBroad304_00028	OE	ADH5	Alcohol dehydrogenases, alcohol dehydrogenase 5 (class III), chi polypeptide			0.00, 0.00	0.86, 0.22	-79.10	57.13	-14.70	-22.77	-80.51	58.15	14.83	-33.27	29.05	-3.19
ccsbBroad304_03565	OE	ADI1	acireductone dioxygenase 1			10.00, 0.00	1.17, 0.38	14.08	39.13	97.40	62.53	-83.41	55.18	80.87	-60.67	18.44	10.90
ccsbBroad304_05782	OE	ADORA2A	GPCR / Class A : Adenosine receptors, adenosine A2a receptor		GPCR Subset GOF	40.00, 40.00	1.09, 0.35	100.00	41.49	98.22	34.84	63.18	27.16	-36.43	68.67	99.47	97.57
ccsbBroad304_00030	OE	ADORA2B	GPCR / Class A : Adenosine receptors, adenosine A2b receptor			10.00, 0.00	1.07, 0.34	62.55	-99.91	-98.28	93.92	-41.85	-86.89	77.00	-35.77	97.33	-83.58
ccsbBroad304_05786	OE	ADRB2	GPCR / Class A : Adrenoceptors : beta, adrenergic, beta-2-, receptor, surface			33.33, 33.33	2.11, 0.67	57.54	99.96	-35.57	NaN	-40.23	-40.34	94.21	-36.29	99.97	99.44
ccsbBroad304_00032	OE	ADSL	adenylosuccinate lyase			0.00, 0.00	1.58, 0.41	-51.07	82.84	7.20	-65.08	-59.38	41.18	72.48	-29.50	-41.96	-8.16
ccsbBroad304_00033	OE	ADSS	adenylosuccinate synthase			11.11, 11.11	1.08, 0.47	-34.59	55.36	-91.42	NaN	99.46	-98.67	-63.85	-41.46	83.06	-44.91
ccsbBroad304_00034	OE	AES	amino-terminal enhancer of split			20.00, 20.00	0.89, 0.19	99.94	30.03	-35.16	68.50	56.88	99.88	34.69	-40.12	31.88	68.77
ccsbBroad304_00036	OE	AFP	alpha-fetoprotein			40.00, 30.00	1.43, 0.45	-32.04	90.73	90.02	99.47	-32.77	99.97	-96.33	97.21	-32.35	99.03
ccsbBroad304_02467	OE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferases, 1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)			0.00, 0.00	2.34, 0.58	-98.79	NaN	-78.08	29.34	-40.68	-99.97	-98.98	-99.81	88.84	-99.31
ccsbBroad304_07634	OE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferases, 1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)			20.00, 20.00	0.67, 0.16	-9.60	50.57	92.03	99.91	-61.13	-56.61	-48.27	-54.92	99.17	57.12
ccsbBroad304_05792	OE	AGTR1	Angiotensin receptors, angiotensin II receptor, type 1			0.00, 0.00	0.91, 0.30	42.42	-76.93	-26.35	-89.35	-74.48	40.06	51.51	30.49	57.56	-13.69
ccsbBroad304_05796	OE	AK1	Adenylate kinases, adenylate kinase 1			0.00, 0.00	0.98, 0.36	71.86	-83.91	41.91	36.46	-54.29	60.93	-99.88	-50.71	37.63	-25.76
ccsbBroad304_00044	OE	AK2	Adenylate kinases, adenylate kinase 2			0.00, 0.00	1.00, 0.24	31.17	-35.09	-97.00	45.16	43.80	-97.86	-30.19	-25.40	-75.24	-33.66
ccsbBroad304_00429	OE	AKR1C2	Aldo-keto reductases, aldo-keto reductase family 1, member C2 (dihydrodiol dehydrogenase 2; bile acid binding protein; 3-alpha hydroxysteroid dehydrogenase, type III)			0.00, 0.00	0.95, 0.31	-75.62	75.19	-90.35	-54.44	93.73	64.27	-89.90	-41.92	19.26	-20.78
ccsbBroad304_00046	OE	AKT1	Akt (Protein kinase B), v-akt murine thymoma viral oncogene homolog 1		Akt Signaling GOF	30.00, 20.00	1.74, 0.57	-83.41	69.91	33.54	-78.08	99.98	84.93	99.49	-99.90	95.79	93.84
ccsbBroad304_00048	OE	ALDH1A1	Aldehyde dehydrogenases, aldehyde dehydrogenase 1 family, member A1			10.00, 0.00	1.22, 0.47	27.57	-85.11	95.69	-74.92	45.22	58.41	53.91	-70.72	57.82	42.40
ccsbBroad304_05801	OE	ALDH3A1	Aldehyde dehydrogenases, aldehyde dehydrogenase 3 family, member A1			10.00, 10.00	0.75, 0.33	-80.70	49.51	-83.45	99.98	-52.99	91.37	88.93	55.36	66.01	81.98
ccsbBroad304_00052	OE	ALDH3A2	Aldehyde dehydrogenases, aldehyde dehydrogenase 3 family, member A2			11.11, 11.11	1.28, 0.34	-88.93	NaN	24.64	99.98	58.38	83.38	-32.41	-97.48	47.52	48.36
ccsbBroad304_05803	OE	ALDH3B2	Aldehyde dehydrogenases, aldehyde dehydrogenase 3 family, member B2			0.00, 0.00	0.72, 0.24	-40.99	35.90	-64.67	58.15	62.11	38.01	88.65	-52.34	-93.23	20.69
ccsbBroad304_00054	OE	ALDOC	aldolase C, fructose-bisphosphate			0.00, 0.00	0.94, 0.28	42.59	-41.61	-60.37	-62.61	-22.02	-24.94	20.84	48.72	-37.94	-1.44
ccsbBroad304_08128	OE	ALG5	Glycosyltransferase family 2 domain containing, asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)			20.00, 0.00	1.27, 0.31	-62.86	95.52	-60.96	95.04	-87.47	-99.93	-39.31	23.11	51.84	-42.37
ccsbBroad304_00060	OE	AMBP	Lipocalins, alpha-1-microglobulin/bikunin precursor			11.11, 11.11	0.88, 0.22	-83.34	39.77	66.36	NaN	-24.69	-44.26	-99.61	99.96	92.91	25.23
ccsbBroad304_00066	OE	ANG	Ribonucleases, RNase A, angiogenin, ribonuclease, RNase A family, 5			10.00, 10.00	1.01, 0.33	31.72	-66.90	59.67	-82.60	-99.96	99.97	-74.11	-64.27	76.14	-60.54
ccsbBroad304_03532	OE	ANKZF1	Ankyrin repeat domain containing, ankyrin repeat and zinc finger domain containing 1			0.00, 0.00	0.93, 0.28	36.55	34.15	-96.41	NaN	37.02	25.80	-53.45	-39.11	-95.20	-22.91
ccsbBroad304_00072	OE	ANXA7	Annexins, annexin A7			0.00, 0.00	1.44, 0.49	-31.24	-96.85	-10.01	NaN	90.88	-92.17	-50.63	-36.18	-36.78	-18.81
ccsbBroad304_06008	OE	AP2M1	adaptor-related protein complex 2, mu 1 subunit			30.00, 30.00	1.69, 0.41	-36.03	99.96	64.51	99.63	-66.12	67.90	98.48	-75.78	-30.54	92.72
ccsbBroad304_00077	OE	APEX1	APEX nuclease (multifunctional DNA repair enzyme) 1			10.00, 0.00	1.03, 0.44	83.58	97.37	-68.65	-77.00	46.02	60.51	-30.77	58.23	-69.09	32.49
ccsbBroad304_00079	OE	APOA1	Apolipoproteins, apolipoprotein A-I			0.00, 0.00	1.24, 0.31	69.07	NaN	68.91	38.01	-61.26	88.42	12.13	-58.33	-34.47	36.46
ccsbBroad304_00080	OE	APOA2	Apolipoproteins, apolipoprotein A-II			0.00, 0.00	0.93, 0.27	17.07	60.98	-46.44	-98.38	-99.33	66.31	-89.00	60.69	39.56	-59.35
ccsbBroad304_05838	OE	APOC2	Apolipoproteins, apolipoprotein C-II			0.00, 0.00	0.72, 0.17	38.82	-79.99	-7.10	34.70	-99.95	94.13	-99.89	-61.54	43.07	-42.84
ccsbBroad304_00081	OE	APOC3	Apolipoproteins, apolipoprotein C-III			0.00, 0.00	0.88, 0.26	63.65	-50.28	90.04	-42.64	-99.98	-61.00	63.67	45.54	-18.59	-27.32
ccsbBroad304_00084	OE	APOH	Apolipoproteins, apolipoprotein H (beta-2-glycoprotein I)			11.11, 11.11	0.99, 0.28	-92.92	-30.46	28.23	NaN	45.29	98.55	-72.55	-41.72	-33.46	-13.13
ccsbBroad304_00099	OE	ARG2	Arginase, arginase, type II			0.00, 0.00	1.42, 0.38	-58.56	-50.48	-37.24	-99.50	78.56	-86.17	-99.91	-61.15	-68.93	-72.37
ccsbBroad304_02321	OE	ARL4C	ADP-ribosylation factors, ADP-ribosylation factor-like 4C			40.00, 40.00	1.02, 0.24	98.81	99.87	74.01	70.01	99.93	-95.50	27.99	-92.08	71.60	97.58
ccsbBroad304_00105	OE	ARNTL	Basic helix-loop-helix proteins, aryl hydrocarbon receptor nuclear translocator-like			0.00, 0.00	1.94, 0.53	39.08	35.21	-37.31	32.60	-72.37	37.58	-42.85	-57.68	37.31	10.79
ccsbBroad304_02466	OE	ARPC1A	Actin related protein 2/3 complex subunits, actin related protein 2/3 complex, subunit 1A, 41kDa			0.00, 0.00	1.09, 0.40	50.32	37.51	-96.86	34.18	-48.28	31.39	-99.94	-41.83	-99.90	-75.32
ccsbBroad304_02312	OE	ARPC1B	Actin related protein 2/3 complex subunits, actin related protein 2/3 complex, subunit 1B, 41kDa			0.00, 0.00	1.16, 0.36	72.08	-98.15	94.78	62.98	-92.56	-36.14	52.79	-44.75	-99.97	-41.25
ccsbBroad304_05856	OE	ASAH1	Acid ceramidase, N-acylsphingosine amidohydrolase (acid ceramidase) 1			10.00, 10.00	0.83, 0.28	-24.89	-44.38	5.62	98.82	-91.42	29.68	-98.79	-86.76	-80.07	-49.35
ccsbBroad304_02869	OE	ASF1A	ASF1 anti-silencing function 1 homolog A (S. cerevisiae)			0.00, 0.00	1.33, 0.35	74.10	-95.59	87.18	-95.56	-51.18	-47.28	-99.85	-32.81	27.26	-76.08
ccsbBroad304_03641	OE	ASF1B	ASF1 anti-silencing function 1 homolog B (S. cerevisiae)			0.00, 0.00	1.02, 0.33	-25.46	-45.44	-37.30	42.04	-66.26	-41.54	57.03	-40.92	65.94	-10.36
ccsbBroad304_00110	OE	ASGR2	C-type lectin domain containing, asialoglycoprotein receptor 2			10.00, 10.00	1.13, 0.43	78.55	53.52	99.13	41.96	-32.67	-61.04	35.13	-36.94	81.12	58.24
ccsbBroad304_07354	OE	ASH2L	Zinc fingers, PHD-type, ash2 (absent, small, or homeotic)-like (Drosophila)			10.00, 10.00	1.17, 0.33	92.62	58.89	98.31	-88.44	40.25	15.48	40.06	-34.50	-33.00	17.22
ccsbBroad304_07273	OE	ASMTL	Pseudoautosomal regions / PAR1, acetylserotonin O-methyltransferase-like			10.00, 10.00	1.26, 0.39	75.62	-30.92	-38.26	-40.01	99.87	-49.17	-51.52	-33.73	42.83	-20.56
ccsbBroad304_00113	OE	ASNS	asparagine synthetase (glutamine-hydrolyzing)			0.00, 0.00	1.32, 0.32	26.65	34.06	77.63	-55.46	44.88	-70.17	-34.75	-81.70	56.68	-40.02
ccsbBroad304_00116	OE	ASS1	argininosuccinate synthase 1			0.00, 0.00	1.07, 0.38	-93.78	-40.97	-46.04	NaN	-92.16	-30.78	50.62	-30.58	35.04	-21.80
ccsbBroad304_00117	OE	ATF4	basic leucine zipper proteins, activating transcription factor 4 (tax-responsive enhancer element B67)			10.00, 10.00	1.16, 0.33	37.70	47.71	-12.68	99.90	30.82	-99.63	76.89	62.64	44.90	21.91
ccsbBroad304_04294	OE	ATG10	ATG10 autophagy related 10 homolog (S. cerevisiae)			0.00, 0.00	1.03, 0.36	-84.32	34.56	-81.50	-98.09	-71.16	94.73	-96.55	74.57	-22.91	-61.69
ccsbBroad304_04675	OE	ATG4A	ATG4 autophagy related 4 homolog A (S. cerevisiae)			20.00, 10.00	1.66, 0.38	98.80	-72.88	90.69	37.72	-24.10	95.19	-93.80	-99.01	-46.33	-39.85
ccsbBroad304_02173	OE	ATG5	ATG5 autophagy related 5 homolog (S. cerevisiae)			20.00, 20.00	0.98, 0.32	99.98	-75.15	49.18	-32.58	-38.84	23.42	-88.92	55.38	98.82	14.49
ccsbBroad304_00118	OE	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase			0.00, 0.00	1.11, 0.28	89.78	30.06	46.18	NaN	-49.30	-88.74	77.71	-93.77	-24.82	-18.63
ccsbBroad304_00120	OE	ATOX1	ATX1 antioxidant protein 1 homolog (yeast)			0.00, 0.00	1.15, 0.18	-26.45	-37.91	-39.58	-31.40	-95.74	-91.63	-60.19	92.08	27.98	-23.50
ccsbBroad304_00122	OE	ATP1B1	ATPases / P-type, ATPase, Na+/K+ transporting, beta 1 polypeptide			0.00, 0.00	1.39, 0.52	52.10	NaN	-92.89	-99.30	-99.91	46.26	-21.37	-72.61	-44.96	-99.03
ccsbBroad304_00127	OE	ATP5B	ATPases / F-type, ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide			0.00, 0.00	0.82, 0.25	72.82	45.49	93.39	-91.75	-33.60	-36.11	51.46	92.28	83.28	68.80
ccsbBroad304_00129	OE	ATP5D	ATPases / F-type, ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit			22.22, 22.22	1.60, 0.50	-75.87	-99.96	-25.36	NaN	-94.65	99.00	-99.27	-91.55	99.96	-91.39
ccsbBroad304_02447	OE	ATP5H	ATPases / F-type, ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d			10.00, 10.00	1.14, 0.39	-87.18	-79.24	-31.18	49.17	35.80	99.65	50.63	59.05	-56.33	-24.46
ccsbBroad304_07657	OE	ATP5L	ATPases / F-type, ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G			0.00, 0.00	0.65, 0.14	-32.86	55.86	48.24	-99.98	-95.69	-37.52	-28.39	-97.25	41.06	-62.14
ccsbBroad304_08055	OE	ATP5S	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit s (factor B)			0.00, 0.00	1.00, 0.24	78.58	-89.69	-76.47	NaN	-79.98	24.18	-66.01	-43.78	49.45	-56.30
ccsbBroad304_00140	OE	ATP6V0A1	ATPases / V-type, ATPase, H+ transporting, lysosomal V0 subunit a1			0.00, 0.00	1.20, 0.48	56.65	-36.25	43.78	-92.04	-80.94	31.74	70.00	-70.59	30.35	-25.37
ccsbBroad304_00138	OE	ATP6V0B	ATPases / V-type, ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b			0.00, 0.00	1.05, 0.33	66.85	-68.38	92.55	58.52	-23.78	88.41	-52.06	46.39	40.99	41.95
ccsbBroad304_00135	OE	ATP6V0C	ATPases / V-type, ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c			22.22, 11.11	1.06, 0.39	-65.83	77.45	99.86	NaN	-95.47	-34.22	97.46	93.14	-41.01	86.00
ccsbBroad304_02131	OE	ATP6V1F	ATPases / V-type, ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F			0.00, 0.00	0.81, 0.26	53.93	-98.45	-59.65	41.06	-44.23	-46.25	-95.87	-41.90	-95.23	-84.46
ccsbBroad304_05876	OE	AZGP1	Immunoglobulin superfamily / C1-set domain containing, alpha-2-glycoprotein 1, zinc-binding			10.00, 10.00	1.00, 0.36	44.06	50.89	-76.70	79.44	89.64	98.73	55.35	50.71	-68.18	64.00
ccsbBroad304_00144	OE	B2M	Immunoglobulin superfamily / C1-set domain containing, beta-2-microglobulin			10.00, 10.00	1.09, 0.42	26.58	57.40	25.82	-54.12	-77.53	-27.75	26.68	99.87	94.67	13.40
ccsbBroad304_02604	OE	B3GNT1	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 1			10.00, 10.00	1.59, 0.40	-68.99	99.58	37.06	-24.65	-22.69	-99.87	-39.99	-84.17	28.76	-40.39
ccsbBroad304_00146	OE	BAD	BCL2-associated agonist of cell death			20.00, 20.00	1.06, 0.31	38.22	78.85	57.67	99.23	-99.98	28.49	-65.45	-48.77	99.55	49.17
ccsbBroad304_00147	OE	BAG1	BCL2-associated athanogene			55.56, 55.56	1.30, 0.55	-95.16	99.85	-98.82	NaN	76.39	99.50	99.95	-80.88	98.08	99.58
ccsbBroad304_03599	OE	BATF3	basic leucine zipper proteins, basic leucine zipper transcription factor, ATF-like 3			10.00, 10.00	1.13, 0.30	90.48	46.54	84.60	26.64	-53.29	-76.17	32.67	-98.03	99.89	52.64
ccsbBroad304_00150	OE	BAX	BCL2-associated X protein			0.00, 0.00	0.97, 0.31	-36.11	48.49	26.52	-36.12	29.23	43.12	-13.55	43.06	-59.92	4.95
ccsbBroad304_00152	OE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial			0.00, 0.00	0.97, 0.26	-46.06	-31.93	-23.05	-32.55	-90.09	-70.92	-97.02	-64.26	29.64	-37.58
ccsbBroad304_08645	OE	BCCIP	BRCA2 and CDKN1A interacting protein			20.00, 20.00	0.83, 0.25	49.93	48.17	99.96	69.61	-94.66	-58.54	-25.61	74.89	99.06	52.53
ccsbBroad304_02391	OE	BCKDK	Pyruvate dehydrogenase kinase (PDHK) family, branched chain ketoacid dehydrogenase kinase			10.00, 10.00	1.58, 0.41	98.80	-93.21	-99.96	43.67	-48.49	-95.75	88.23	59.39	-99.32	-94.83
ccsbBroad304_00156	OE	BCL2L1	Serine/threonine phosphatases / Protein phosphatase 1, regulatory subunits, BCL2-like 1			0.00, 0.00	1.09, 0.31	78.50	63.20	49.67	-62.91	75.56	-35.45	36.08	-56.60	73.33	46.59
ccsbBroad304_05881	OE	BCL2L2	Serine/threonine phosphatases / Protein phosphatase 1, regulatory subunits, BCL2-like 2			11.11, 0.00	1.25, 0.35	-26.59	-89.22	37.52	NaN	-91.29	-36.68	95.84	-92.05	59.85	-48.14
ccsbBroad304_00161	OE	BID	Endogenous ligands, BH3 interacting domain death agonist			44.44, 33.33	2.10, 0.59	-97.82	95.41	-32.70	NaN	92.71	97.52	-77.63	-13.78	99.35	97.78
ccsbBroad304_05836	OE	BIRC5	Inhibitors of apoptosis (IAP) protein family, baculoviral IAP repeat containing 5			0.00, 0.00	1.05, 0.27	79.78	42.81	-99.92	NaN	-89.41	-40.43	76.89	48.49	47.62	25.47
ccsbBroad304_00164	OE	BLMH	bleomycin hydrolase			10.00, 10.00	1.24, 0.35	-43.46	37.05	-82.79	-48.44	99.70	78.84	81.16	-28.54	76.63	79.04
ccsbBroad304_01951	OE	BLZF1	basic leucine zipper nuclear factor 1			10.00, 0.00	1.53, 0.25	-37.94	-78.47	-12.34	-99.91	34.51	-46.41	-41.19	-21.17	95.00	-26.20
ccsbBroad304_00165	OE	BMI1	Polycomb group ring fingers, BMI1 polycomb ring finger oncogene			20.00, 10.00	1.07, 0.28	-97.19	73.98	45.38	-66.70	71.76	-91.44	99.98	-99.82	96.70	-68.85
ccsbBroad304_00170	OE	BNIP1	BCL2/adenovirus E1B 19kDa interacting protein 1			10.00, 10.00	0.89, 0.28	-64.87	-63.39	-85.47	47.53	62.93	-55.23	-83.34	-54.64	99.97	-62.07
ccsbBroad304_05902	OE	BNIP3	BCL2/adenovirus E1B 19kDa interacting protein 3			10.00, 10.00	1.08, 0.31	-67.26	-46.36	-99.73	-99.85	-40.10	-99.97	-67.56	-52.02	99.20	-98.20
ccsbBroad304_00171	OE	BNIP3L	BCL2/adenovirus E1B 19kDa interacting protein 3-like			11.11, 0.00	1.09, 0.26	61.30	NaN	-46.51	60.38	72.99	79.07	96.03	33.03	-76.44	62.91
ccsbBroad304_00179	OE	BTG1	B-cell translocation gene 1, anti-proliferative			20.00, 20.00	1.08, 0.27	-94.68	36.02	-99.69	99.98	51.22	92.88	-41.27	99.84	-37.58	81.80
ccsbBroad304_02569	OE	BTG3	BTG family, member 3			11.11, 11.11	0.98, 0.26	99.72	76.26	34.17	NaN	29.54	-98.40	-68.09	-37.52	-72.51	-29.34
ccsbBroad304_03047	OE	BZW2	basic leucine zipper and W2 domains 2			11.11, 0.00	1.14, 0.30	59.54	51.19	29.82	NaN	-70.34	62.04	95.39	-96.18	-43.85	30.70
ccsbBroad304_03696	OE	C19ORF10	chromosome 19 open reading frame 10			44.44, 44.44	1.40, 0.32	-45.34	99.87	-97.03	NaN	99.32	35.57	-46.47	-88.31	99.96	98.29
ccsbBroad304_02367	OE	CALCOCO2	calcium binding and coiled-coil domain 2			10.00, 10.00	0.82, 0.24	83.41	30.51	-79.71	99.93	-56.21	-54.67	-98.91	43.63	-22.05	-34.15
ccsbBroad304_00207	OE	CALM2	EF-hand domain containing, calmodulin 2 (phosphorylase kinase, delta)			0.00, 0.00	0.99, 0.25	29.32	30.44	-10.29	NaN	-97.03	82.66	84.42	70.72	-99.97	41.93
ccsbBroad304_13822	OE	CALM3	EF-hand domain containing, calmodulin 3 (phosphorylase kinase, delta)			11.11, 11.11	0.97, 0.35	50.89	-44.81	-44.78	NaN	-37.37	-99.78	99.89	74.29	-99.96	-13.32
ccsbBroad304_01949	OE	CAMK1	CAMK1 family, calcium/calmodulin-dependent protein kinase I			30.00, 30.00	0.98, 0.34	99.98	99.28	-8.70	99.98	-72.31	-62.37	26.35	49.28	-38.45	71.76
ccsbBroad304_00212	OE	CAMLG	calcium modulating ligand			22.22, 11.11	1.23, 0.41	96.27	64.61	99.92	NaN	-47.20	59.35	-86.87	-87.82	-99.89	-62.75
ccsbBroad304_04786	OE	CANT1	calcium activated nucleotidase 1			0.00, 0.00	1.17, 0.24	-45.57	35.06	-29.40	NaN	-57.44	-98.39	-61.06	-99.59	67.65	-44.03
ccsbBroad304_05931	OE	CAPG	capping protein (actin filament), gelsolin-like			10.00, 10.00	1.19, 0.39	25.57	-99.65	86.23	78.26	99.91	68.07	39.44	-46.09	38.29	68.63
ccsbBroad304_03933	OE	CARD9	caspase recruitment domain family, member 9			10.00, 10.00	1.40, 0.43	-37.55	41.87	-87.50	-88.33	-53.06	83.01	99.36	-41.50	-90.71	-55.05
ccsbBroad304_00221	OE	CASP3	Caspases, caspase 3, apoptosis-related cysteine peptidase			10.00, 10.00	1.51, 0.38	-53.04	26.55	-82.57	-44.38	-25.32	30.09	99.22	87.74	61.72	18.81
ccsbBroad304_00222	OE	CASP6	Caspases, caspase 6, apoptosis-related cysteine peptidase			11.11, 11.11	0.95, 0.39	33.14	-75.99	-84.14	NaN	99.95	82.10	79.82	-44.75	48.07	63.38
ccsbBroad304_00223	OE	CASP9	Caspases, caspase 9, apoptosis-related cysteine peptidase			11.11, 11.11	1.16, 0.38	23.86	-69.63	-85.65	NaN	76.03	-90.04	98.67	68.70	-54.58	42.81
ccsbBroad304_00226	OE	CAV1	caveolin 1, caveolae protein, 22kDa			0.00, 0.00	0.81, 0.28	55.42	-34.27	-99.75	90.30	31.99	-27.23	-95.88	72.51	69.58	32.40
ccsbBroad304_00231	OE	CBFB	core-binding factor, beta subunit			10.00, 10.00	1.06, 0.31	58.87	42.94	50.75	37.64	-86.64	99.90	-84.15	34.75	41.84	8.35
ccsbBroad304_05939	OE	CBLB	RING-type (C3HC4) zinc fingers, Cas-Br-M (murine) ecotropic retroviral transforming sequence b			0.00, 0.00	0.89, 0.27	67.56	80.02	35.31	-50.78	92.85	-23.32	-53.42	-25.77	45.90	33.60
ccsbBroad304_07918	OE	CBLC	RING-type (C3HC4) zinc fingers, Cas-Br-M (murine) ecotropic retroviral transforming sequence c			0.00, 0.00	0.98, 0.27	53.74	37.00	-26.56	27.81	-53.77	-81.09	86.48	-43.93	-96.69	-21.50
ccsbBroad304_05941	OE	CBR3	Short chain dehydrogenase/reductase superfamily / Classical SDR fold cluster 1, carbonyl reductase 3			0.00, 0.00	1.07, 0.28	29.11	48.36	-74.69	-64.51	-98.96	31.03	27.68	-59.21	-99.82	-36.89
ccsbBroad304_05942	OE	CBS	Hydrogen sulphide synthesis, cystathionine-beta-synthase			10.00, 0.00	0.99, 0.33	-40.22	96.27	-23.55	-67.84	-30.65	-99.71	69.24	-48.03	-32.13	-14.13
ccsbBroad304_07888	OE	CBX6	chromobox homolog 6			10.00, 10.00	1.18, 0.33	-43.08	55.80	35.97	46.85	-56.92	-38.28	-99.65	-70.45	99.95	-29.22
ccsbBroad304_07890	OE	CBX7	chromobox homolog 7			40.00, 20.00	1.45, 0.43	96.65	45.69	99.98	96.83	-51.57	94.09	66.08	-99.37	37.86	98.98
ccsbBroad304_05944	OE	CCBL1	Hydrogen sulphide synthesis, cysteine conjugate-beta lyase, cytoplasmic			0.00, 0.00	1.09, 0.41	-93.42	-98.24	-82.75	-39.70	84.06	-37.86	-24.70	38.84	40.70	-43.11
ccsbBroad304_04190	OE	CCDC92	coiled-coil domain containing 92			0.00, 0.00	1.25, 0.39	40.48	-91.14	-29.19	-56.78	-74.64	-28.31	-93.21	-32.16	63.21	-65.42
ccsbBroad304_01495	OE	CCL2	Chemokine ligands, chemokine (C-C motif) ligand 2			10.00, 0.00	0.58, 0.24	-27.42	-25.14	48.00	38.99	65.98	95.90	-62.74	73.60	34.70	17.04
ccsbBroad304_05947	OE	CCNC	cyclin C			11.11, 11.11	1.09, 0.34	44.69	-27.17	-99.96	NaN	-99.56	-64.07	98.03	32.07	-53.11	-62.99
ccsbBroad304_00237	OE	CCND3	cyclin D3			22.22, 0.00	2.03, 0.60	-72.05	-50.30	96.40	NaN	82.53	-35.28	97.38	76.23	79.34	89.68
ccsbBroad304_00240	OE	CCNH	General transcription factor IIH complex subunits, cyclin H			0.00, 0.00	1.14, 0.34	27.98	36.25	-86.46	52.21	66.63	78.48	-29.90	88.06	-18.16	27.66
ccsbBroad304_03772	OE	CCNL1	cyclin L1			0.00, 0.00	0.83, 0.18	85.81	-85.71	-94.23	-99.98	63.62	31.09	-80.15	64.34	-78.21	-96.42
ccsbBroad304_07478	OE	CCP110	centriolar coiled coil protein 110kDa			0.00, 0.00	1.19, 0.44	-27.15	62.61	67.64	91.25	24.98	-85.15	57.77	73.39	-40.47	45.22
ccsbBroad304_00249	OE	CD14	CD molecules, CD14 molecule			0.00, 0.00	1.58, 0.45	-98.82	54.17	-97.18	-79.45	-91.16	69.40	-41.60	-39.92	58.87	-91.15
ccsbBroad304_00250	OE	CD19	CD molecules, CD19 molecule			10.00, 10.00	1.11, 0.31	-79.34	35.45	-45.23	62.28	-99.94	61.60	-99.98	98.42	79.62	-33.23
ccsbBroad304_03269	OE	CD320	CD molecules, CD320 molecule			10.00, 10.00	0.72, 0.22	29.60	63.28	99.81	-89.89	-81.61	84.63	-72.83	64.64	-34.00	44.82
ccsbBroad304_00259	OE	CD40	Tumour necrosis factor (TNF) receptor family, CD40 molecule, TNF receptor superfamily member 5		NFKB Activation GOF	0.00, 0.00	4.50, 1.35	-35.51	-81.02	-98.46	-40.83	-91.73	-99.75	-95.65	-92.77	-34.22	-98.98
ccsbBroad304_00418	OE	CD55	CD molecules, CD55 molecule, decay accelerating factor for complement (Cromer blood group)			10.00, 0.00	0.77, 0.13	87.25	77.86	-56.36	-78.39	95.28	63.45	51.78	-41.13	78.82	67.87
ccsbBroad304_00262	OE	CD59	CD molecules, CD59 molecule, complement regulatory protein			0.00, 0.00	0.85, 0.24	-36.69	42.71	-24.45	NaN	-60.22	-31.91	-44.85	-39.33	-73.36	-10.56
ccsbBroad304_00268	OE	CD81	CD molecules, CD81 molecule			10.00, 0.00	1.52, 0.49	89.73	53.51	-28.78	-40.59	43.44	77.10	95.63	62.38	-46.92	61.32
ccsbBroad304_02133	OE	CD83	CD molecules, CD83 molecule			0.00, 0.00	1.53, 0.43	69.74	23.23	-35.98	43.95	-40.43	-84.38	24.59	-60.15	34.50	-6.47
ccsbBroad304_05970	OE	CDC20	WD repeat domain containing, cell division cycle 20 homolog (S. cerevisiae)			0.00, 0.00	1.06, 0.31	75.69	-87.40	-47.59	93.89	-94.07	93.39	-98.99	66.38	76.80	66.73
ccsbBroad304_00272	OE	CDC25A	Protein tyrosine phosphatases / Class III Cys-based PTPs, cell division cycle 25 homolog A (S. pombe)			20.00, 0.00	1.25, 0.44	51.28	97.24	-98.24	-77.68	-30.69	-60.36	97.26	-99.90	-53.21	-61.06
ccsbBroad304_03746	OE	CDC42SE1	CDC42 small effector 1			20.00, 20.00	1.32, 0.23	-99.84	49.04	30.58	-74.32	-58.69	-97.61	-83.01	99.33	99.84	-64.08
ccsbBroad304_03533	OE	CDCA8	cell division cycle associated 8			10.00, 10.00	1.07, 0.38	55.41	67.57	91.92	99.44	74.33	-61.21	59.06	-40.89	22.91	79.70
ccsbBroad304_02425	OE	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase			10.00, 10.00	1.24, 0.43	98.98	90.17	-80.46	-33.84	60.49	-99.76	-46.35	-60.24	-34.74	-47.32
ccsbBroad304_00277	OE	CDK4	Cyclin-dependent kinases, CDK4 subfamily, cyclin-dependent kinase 4			44.44, 44.44	1.15, 0.36	-65.53	NaN	-50.29	99.98	85.26	99.82	-50.40	-30.31	99.97	99.91
ccsbBroad304_00279	OE	CDK6	Cyclin-dependent kinases, CDK4 subfamily, cyclin-dependent kinase 6			77.78, 77.78	2.05, 0.64	99.20	99.80	98.16	NaN	92.60	99.48	-28.60	99.69	99.97	99.91
ccsbBroad304_05979	OE	CDK9	Cyclin-dependent kinases, CDK9 subfamily, cyclin-dependent kinase 9			0.00, 0.00	1.02, 0.39	41.17	86.39	-45.73	43.02	49.67	-42.52	-27.57	-54.31	68.93	10.10
ccsbBroad304_00282	OE	CDKN1A	cyclin-dependent kinase inhibitor 1A (p21, Cip1)		Cell Cycle Inhibition GOF	0.00, 0.00	3.07, 1.05	-98.63	83.32	-99.93	NaN	-84.22	-99.94	-77.15	-99.92	-99.97	-99.91
ccsbBroad304_05980	OE	CDKN1B	cyclin-dependent kinase inhibitor 1B (p27, Kip1)		Cell Cycle Inhibition GOF	0.00, 0.00	4.74, 1.69	-97.37	-99.12	-94.42	-99.98	-99.93	-99.82	-99.82	-99.95	-28.03	-99.86
ccsbBroad304_05982	OE	CDX2	Homeoboxes / ANTP class : HOXL subclass, caudal type homeobox 2			0.00, 0.00	4.90, 1.69	-99.47	-98.95	-99.98	NaN	-26.12	-96.80	-99.54	-98.57	-45.28	-99.77
ccsbBroad304_00290	OE	CEBPG	basic leucine zipper proteins, CCAAT/enhancer binding protein (C/EBP), gamma			11.11, 0.00	1.00, 0.24	-27.64	96.04	-87.11	NaN	48.93	-41.49	38.15	-69.71	42.36	19.45
ccsbBroad304_03640	OE	CEP72	centrosomal protein 72kDa			0.00, 0.00	1.61, 0.33	94.13	47.18	-27.10	29.96	32.44	-61.24	-44.57	94.04	-83.55	-30.78
ccsbBroad304_03117	OE	CERS2	Homeoboxes / CERS class, ceramide synthase 2			10.00, 10.00	1.76, 0.45	-26.22	-44.89	-9.65	33.45	31.64	62.35	63.99	-68.00	98.00	3.84
ccsbBroad304_09831	OE	CERS3	Homeoboxes / CERS class, ceramide synthase 3			10.00, 0.00	1.09, 0.35	31.76	96.03	93.90	-69.28	-60.81	-31.14	28.88	-57.83	47.21	-17.90
ccsbBroad304_05985	OE	CFL1	cofilin 1 (non-muscle)			11.11, 11.11	1.63, 0.39	-99.98	-49.54	66.35	NaN	-59.97	-41.65	-98.13	-56.26	99.15	-55.20
ccsbBroad304_07667	OE	CGRRF1	RING-type (C3HC4) zinc fingers, cell growth regulator with ring finger domain 1			0.00, 0.00	0.83, 0.25	85.14	94.55	-25.84	-99.74	38.02	-77.02	77.08	54.16	38.42	53.55
ccsbBroad304_01870	OE	CHAF1B	WD repeat domain containing, chromatin assembly factor 1, subunit B (p60)			11.11, 11.11	1.23, 0.33	-94.12	NaN	82.39	-97.44	-35.70	-95.47	39.60	99.07	67.86	-84.45
ccsbBroad304_04055	OE	CHCHD7	Coiled-coil-helix-coiled-coil-helix domain containing, coiled-coil-helix-coiled-coil-helix domain containing 7			22.22, 22.22	1.13, 0.31	-41.94	78.97	-22.79	NaN	-29.47	98.95	98.49	69.50	-27.67	63.35
ccsbBroad304_03071	OE	CHMP4A	Charged multivesicular body proteins, charged multivesicular body protein 4A			0.00, 0.00	1.41, 0.34	90.00	-41.75	-99.56	-39.23	-91.25	-99.94	-31.73	-54.15	24.72	-79.35
ccsbBroad304_04095	OE	CHMP6	Charged multivesicular body proteins, charged multivesicular body protein 6			10.00, 10.00	1.20, 0.32	97.97	-96.61	-92.21	-34.95	-34.92	-99.71	34.26	-42.13	80.91	-63.43
ccsbBroad304_00303	OE	CHN1	Rho GTPase activating proteins, chimerin (chimaerin) 1			0.00, 0.00	0.86, 0.32	-75.48	-82.33	-50.57	NaN	69.41	-87.83	-51.85	-83.65	76.81	-82.12
ccsbBroad304_03405	OE	CHRAC1	chromatin accessibility complex 1			11.11, 11.11	1.34, 0.36	40.63	92.18	98.91	NaN	-37.57	54.29	63.67	-31.32	-72.66	44.19
ccsbBroad304_03773	OE	CIAPIN1	cytokine induced apoptosis inhibitor 1			0.00, 0.00	1.24, 0.40	-71.70	43.15	-89.51	NaN	-92.22	-37.41	-27.15	-61.30	-32.84	-56.74
ccsbBroad304_00312	OE	CIRBP	RNA binding motif (RRM) containing, cold inducible RNA binding protein			11.11, 11.11	0.89, 0.26	-93.59	27.32	-78.47	NaN	47.82	-70.75	-25.08	-92.17	99.31	-74.56
ccsbBroad304_03666	OE	CISD1	CDGSH iron sulfur domain containing, CDGSH iron sulfur domain 1			0.00, 0.00	0.74, 0.25	93.96	-91.42	-13.35	-98.95	-53.54	59.07	47.11	-59.60	-97.13	-82.95
ccsbBroad304_06007	OE	CISH	SH2 domain containing, cytokine inducible SH2-containing protein		Supressors of cytokine signaling GOF	0.00, 0.00	1.23, 0.41	-38.64	84.28	7.06	-30.42	34.99	55.86	28.67	-51.44	-52.16	-3.61
ccsbBroad304_06004	OE	CKB	creatine kinase, brain			10.00, 0.00	0.82, 0.20	35.03	-99.41	-96.81	-45.85	-98.69	56.59	9.36	-54.79	95.58	-79.47
ccsbBroad304_00316	OE	CKS1B	CDC28 protein kinase regulatory subunit 1B			50.00, 40.00	1.33, 0.44	97.34	90.64	98.90	26.50	-56.17	99.96	99.84	-48.48	38.42	99.72
ccsbBroad304_00322	OE	CLCN5	Ion channels / Chloride channels : Voltage-sensitive, chloride channel 5			11.11, 11.11	0.98, 0.34	-50.77	77.34	68.36	NaN	-71.18	94.44	90.78	-46.07	99.97	88.22
ccsbBroad304_02887	OE	CLIC4	Ion channels / Chloride channels : Intracellular, chloride intracellular channel 4			0.00, 0.00	1.09, 0.36	-95.85	31.46	-52.48	29.64	70.60	-56.18	58.52	-74.21	32.95	-27.57
ccsbBroad304_00328	OE	CLK3	CDC-like kinases, CDC-like kinase 3			10.00, 10.00	1.24, 0.19	64.76	58.22	-46.49	-89.73	99.93	-58.11	-99.98	34.40	29.58	-43.92
ccsbBroad304_02201	OE	CLOCK	Histone acetyltransferases, clock homolog (mouse)			11.11, 11.11	0.86, 0.32	-21.40	48.89	-56.58	NaN	38.17	93.68	-17.77	-97.37	99.68	5.22
ccsbBroad304_06013	OE	CLPTM1	cleft lip and palate associated transmembrane protein 1			0.00, 0.00	2.02, 0.58	41.15	NaN	-26.60	87.24	67.38	-40.25	51.15	32.46	79.10	47.21
ccsbBroad304_00329	OE	CLTA	clathrin, light chain A			10.00, 10.00	1.19, 0.36	-63.91	-46.47	87.56	-87.15	-67.29	99.87	-20.35	-61.16	57.00	-44.21
ccsbBroad304_08339	OE	CMPK1	cytidine monophosphate (UMP-CMP) kinase 1, cytosolic			10.00, 10.00	0.77, 0.24	33.08	99.58	-99.02	-56.17	-99.70	-98.00	-71.12	44.16	-99.95	-99.91
ccsbBroad304_03097	OE	CNOT7	CCR4-NOT transcription complex, subunit 7			0.00, 0.00	1.22, 0.30	44.35	26.58	93.43	92.57	-99.05	-34.34	81.17	-81.99	-12.48	29.61
ccsbBroad304_02143	OE	CNOT8	CCR4-NOT transcription complex, subunit 8			0.00, 0.00	0.77, 0.19	-19.28	70.98	-53.62	NaN	79.34	87.92	32.81	40.26	-79.48	35.29
ccsbBroad304_09035	OE	COASY	CoA synthase			11.11, 11.11	1.65, 0.35	99.53	88.09	58.15	NaN	-37.14	-88.40	45.96	-35.66	36.67	46.52
ccsbBroad304_02136	OE	COPS2	COP9 constitutive photomorphogenic homolog subunit 2 (Arabidopsis)			20.00, 10.00	1.19, 0.35	-42.46	32.07	48.29	96.14	77.49	-42.44	-16.79	99.96	34.08	34.29
ccsbBroad304_02589	OE	COPS5	COP9 constitutive photomorphogenic homolog subunit 5 (Arabidopsis)			0.00, 0.00	1.14, 0.30	-31.12	84.32	-42.90	-38.95	-36.91	52.93	-54.87	-62.60	40.71	-10.78
ccsbBroad304_08346	OE	COQ3	coenzyme Q3 homolog, methyltransferase (S. cerevisiae)			20.00, 10.00	1.10, 0.33	98.95	97.07	64.98	-99.17	44.11	63.85	-20.41	-74.55	-83.12	74.32
ccsbBroad304_00349	OE	COX4I1	Mitochondrial respiratory chain complex, cytochrome c oxidase subunit IV isoform 1			11.11, 11.11	1.31, 0.32	-94.69	NaN	98.64	44.12	-54.82	-38.27	-17.91	64.47	62.55	44.04
ccsbBroad304_02154	OE	COX5A	Mitochondrial respiratory chain complex, cytochrome c oxidase subunit Va			0.00, 0.00	0.77, 0.28	-80.54	-36.37	-26.80	30.70	-33.46	86.26	52.60	-47.11	-95.54	-14.61
ccsbBroad304_00350	OE	COX5B	Mitochondrial respiratory chain complex, cytochrome c oxidase subunit Vb			0.00, 0.00	1.18, 0.39	-98.54	-90.94	-92.32	NaN	69.78	-39.16	-37.40	-99.90	81.25	-96.11
ccsbBroad304_06035	OE	CRABP1	Fatty acid-binding proteins, cellular retinoic acid binding protein 1			0.00, 0.00	1.64, 0.38	21.24	NaN	15.37	-33.99	-17.79	81.50	67.68	26.20	24.47	1.02
ccsbBroad304_03023	OE	CRCP	CGRP receptor component			11.11, 11.11	1.11, 0.25	-32.14	NaN	-31.20	9.23	94.12	99.97	-42.72	82.71	80.82	64.14
ccsbBroad304_02455	OE	CREB3	basic leucine zipper proteins, cAMP responsive element binding protein 3			0.00, 0.00	0.65, 0.15	90.69	-76.39	-99.86	87.19	40.83	-99.88	-94.49	-43.45	-99.18	-99.66
ccsbBroad304_09309	OE	CREB3L1	basic leucine zipper proteins, cAMP responsive element binding protein 3-like 1			0.00, 0.00	1.64, 0.48	-57.75	44.50	42.09	37.08	62.17	-58.68	-60.54	-92.35	57.96	-39.51
ccsbBroad304_05012	OE	CREB3L4	basic leucine zipper proteins, cAMP responsive element binding protein 3-like 4			0.00, 0.00	0.72, 0.28	94.75	-28.73	-70.34	38.36	-99.88	-86.95	91.90	-93.24	-36.50	-77.02
ccsbBroad304_06038	OE	CRK	SH2 domain containing, v-crk sarcoma virus CT10 oncogene homolog (avian)			11.11, 11.11	2.26, 0.68	-17.48	NaN	-46.67	99.91	-92.44	-99.97	-85.93	-90.17	-94.50	-97.87
ccsbBroad304_10240	OE	CROT	carnitine O-octanoyltransferase			0.00, 0.00	1.09, 0.30	34.24	-91.28	-56.53	NaN	-30.97	17.06	58.42	-99.89	-30.56	-23.69
ccsbBroad304_00370	OE	CS	citrate synthase			0.00, 0.00	1.24, 0.39	-92.58	81.40	-75.46	46.41	-36.09	50.40	29.23	37.49	72.35	18.17
ccsbBroad304_00382	OE	CSNK2A2	Casein kinase 2 (CK2) family, casein kinase 2, alpha prime polypeptide			0.00, 0.00	1.48, 0.40	93.60	NaN	48.10	-75.40	63.78	-26.85	-28.15	-98.75	22.79	18.04
ccsbBroad304_00389	OE	CTBP1	C-terminal binding protein 1			0.00, 0.00	3.60, 1.01	-99.33	-46.76	-68.37	NaN	-99.86	-99.59	-99.98	-97.52	61.90	-99.81
ccsbBroad304_10758	OE	CTBP2	C-terminal binding protein 2			10.00, 10.00	1.11, 0.38	38.77	64.94	77.35	99.58	-99.00	-99.28	79.73	-72.56	-99.32	-96.47
ccsbBroad304_00391	OE	CTH	Hydrogen sulphide synthesis, cystathionase (cystathionine gamma-lyase)			11.11, 11.11	1.33, 0.35	-43.36	30.01	-61.62	NaN	54.05	-95.87	98.98	38.23	51.97	-7.59
ccsbBroad304_03769	OE	CTNNBIP1	Catenins, catenin, beta interacting protein 1			0.00, 0.00	0.98, 0.25	72.12	45.22	-88.85	-31.30	-43.33	-33.44	-85.96	79.00	31.18	-13.58
ccsbBroad304_00394	OE	CTSD	Cathepsins, cathepsin D			10.00, 10.00	1.08, 0.28	17.67	-93.26	-56.77	-43.77	-25.00	99.69	-99.91	-38.12	-28.24	-26.66
ccsbBroad304_00397	OE	CTSK	Cathepsins, cathepsin K			10.00, 10.00	1.14, 0.30	99.64	59.00	19.09	-73.70	-42.76	60.09	-99.14	76.24	-28.21	35.25
ccsbBroad304_06066	OE	CTSL1	cathepsin L1			0.00, 0.00	1.22, 0.35	-74.98	-84.24	-7.08	71.17	-55.90	-25.80	35.71	74.14	63.32	12.09
ccsbBroad304_00398	OE	CTSL2	cathepsin L2			0.00, 0.00	1.03, 0.27	68.72	57.67	-20.73	-66.25	45.64	-53.27	59.65	59.73	-92.85	15.27
ccsbBroad304_06068	OE	CXADR	Immunoglobulin superfamily / Immunoglobulin-like domain containing, coxsackie virus and adenovirus receptor			10.00, 10.00	1.17, 0.45	99.81	38.34	-97.30	-43.13	-45.34	-24.92	-30.88	30.26	29.98	-8.30
ccsbBroad304_00695	OE	CXCL1	Endogenous ligands, chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)			0.00, 0.00	1.59, 0.56	-94.27	-42.01	48.86	-42.24	-42.46	-83.49	-99.82	-73.62	41.92	-74.89
ccsbBroad304_00696	OE	CXCL2	Endogenous ligands, chemokine (C-X-C motif) ligand 2			11.11, 11.11	1.18, 0.27	99.35	-88.23	63.10	NaN	-45.96	-29.69	-30.49	-54.30	29.23	-17.05
ccsbBroad304_08684	OE	CXCR7	chemokine (C-X-C motif) receptor 7			10.00, 10.00	1.40, 0.45	44.88	-42.41	-24.41	40.83	99.95	-50.76	80.06	50.37	-65.11	29.92
ccsbBroad304_00402	OE	CYB561	Cytochrome b genes, cytochrome b-561			10.00, 10.00	0.85, 0.28	21.69	-59.08	-6.03	99.98	-63.56	-90.81	-70.00	54.99	-99.41	-58.89
ccsbBroad304_08365	OE	CYCS	cytochrome c, somatic			0.00, 0.00	0.99, 0.38	-30.04	58.55	-23.49	-97.08	84.55	-80.31	-63.13	42.03	78.98	-43.08
ccsbBroad304_00406	OE	CYP1A1	Cytochrome P450s, cytochrome P450, family 1, subfamily A, polypeptide 1			0.00, 0.00	1.31, 0.44	86.38	-46.42	34.79	-73.77	69.03	60.39	28.93	-94.28	-41.40	18.83
ccsbBroad304_08724	OE	CYP20A1	Cytochrome P450s, cytochrome P450, family 20, subfamily A, polypeptide 1			0.00, 0.00	0.95, 0.28	41.36	-38.06	74.70	-40.33	-91.82	51.03	65.28	-70.99	-99.85	-39.99
ccsbBroad304_00415	OE	CYP24A1	Cytochrome P450s, cytochrome P450, family 24, subfamily A, polypeptide 1			0.00, 0.00	0.90, 0.16	-73.62	46.88	-20.90	64.51	-99.70	-44.23	-59.67	-43.46	36.92	-23.52
ccsbBroad304_00412	OE	CYP3A5	Cytochrome P450s, cytochrome P450, family 3, subfamily A, polypeptide 5			0.00, 0.00	0.95, 0.38	-48.78	29.10	91.29	51.82	61.39	36.60	41.65	63.78	-30.46	24.72
ccsbBroad304_06079	OE	CYP51A1	Cytochrome P450s, cytochrome P450, family 51, subfamily A, polypeptide 1			20.00, 0.00	1.32, 0.38	-28.11	48.71	84.72	-40.64	-85.36	96.28	59.30	-49.28	96.19	60.50
ccsbBroad304_00420	OE	DAP	death-associated protein			0.00, 0.00	1.27, 0.36	-47.26	-55.10	-91.95	NaN	-41.83	-51.79	71.68	-33.05	41.90	-50.00
ccsbBroad304_00421	OE	DAPK1	Death-associated kinase (DAPK) family, death-associated protein kinase 1			0.00, 0.00	1.22, 0.30	-18.32	-71.82	-90.09	-27.67	89.87	50.06	-97.25	71.98	27.75	-36.88
ccsbBroad304_00422	OE	DARS	Aminoacyl tRNA synthetases / Class II, aspartyl-tRNA synthetase			0.00, 0.00	0.91, 0.19	77.27	86.97	-42.13	-98.83	-82.80	76.13	23.53	67.49	-97.42	-68.50
ccsbBroad304_00423	OE	DAXX	death-domain associated protein			10.00, 0.00	1.03, 0.41	96.98	85.97	-6.62	-98.59	-21.73	-96.36	57.73	68.05	-99.97	-43.31
ccsbBroad304_03980	OE	DCLRE1B	DNA cross-link repair 1B			10.00, 0.00	0.94, 0.28	95.02	-82.80	21.70	-99.44	-86.93	56.15	-97.33	-51.93	28.16	-89.56
ccsbBroad304_08093	OE	DCPS	decapping enzyme, scavenger			10.00, 10.00	0.74, 0.19	-94.73	-63.38	65.48	60.16	-94.74	56.06	98.21	-89.00	56.73	-73.89
ccsbBroad304_06087	OE	DDB2	WD repeat domain containing, damage-specific DNA binding protein 2, 48kDa			20.00, 20.00	0.84, 0.33	99.42	43.31	-23.46	-39.05	92.17	59.99	-59.77	38.63	99.97	79.23
ccsbBroad304_06090	OE	DDOST	dolichyl-diphosphooligosaccharide--protein glycosyltransferase			0.00, 0.00	1.16, 0.48	-30.06	-49.06	16.63	-46.81	33.05	59.14	21.42	34.72	-39.92	3.66
ccsbBroad304_05923	OE	DDR1	Type XVI RTKs: DDR (collagen receptor) family, discoidin domain receptor tyrosine kinase 1			11.11, 11.11	1.00, 0.32	98.04	53.38	-54.80	NaN	30.76	-88.69	-39.01	43.07	45.65	23.01
ccsbBroad304_03437	OE	DDX49	DEAD-boxes, DEAD (Asp-Glu-Ala-Asp) box polypeptide 49			10.00, 10.00	0.88, 0.26	47.79	99.83	-70.03	-37.61	32.32	-52.02	-66.94	-88.28	-60.33	-30.73
ccsbBroad304_06094	OE	DFFA	DNA fragmentation factor, 45kDa, alpha polypeptide			0.00, 0.00	0.95, 0.31	19.69	46.31	-76.66	46.74	62.19	52.99	-64.88	56.03	32.06	19.52
ccsbBroad304_06081	OE	DGKA	EF-hand domain containing, diacylglycerol kinase, alpha 80kDa			0.00, 0.00	0.97, 0.32	65.03	-92.99	32.53	-89.07	-99.44	91.18	29.56	-80.06	-18.06	-83.02
ccsbBroad304_06098	OE	DHCR24	24-dehydrocholesterol reductase			10.00, 0.00	1.27, 0.35	29.08	-38.65	-33.48	84.38	-41.17	95.69	-40.99	-69.19	35.12	22.91
ccsbBroad304_00443	OE	DHFR	Oxidoreductases, dihydrofolate reductase			20.00, 20.00	0.81, 0.34	65.04	-31.68	-61.53	81.33	85.85	99.78	99.96	-76.76	81.15	92.53
ccsbBroad304_07379	OE	DHRS3	Short chain dehydrogenase/reductase superfamily / Classical SDR fold cluster 3, dehydrogenase/reductase (SDR family) member 3			0.00, 0.00	1.45, 0.35	30.37	NaN	-87.30	-87.97	27.31	-28.51	-95.08	-99.90	17.28	-97.08
ccsbBroad304_03351	OE	DHRS7	Short chain dehydrogenase/reductase superfamily / Classical SDR fold cluster 3, dehydrogenase/reductase (SDR family) member 7			0.00, 0.00	0.85, 0.19	18.48	-32.87	-69.78	78.44	39.76	-69.19	-97.92	-62.44	30.97	-13.94
ccsbBroad304_08389	OE	DHX29	DEAH-boxes, DEAH (Asp-Glu-Ala-His) box polypeptide 29			0.00, 0.00	1.41, 0.33	-24.99	-43.13	-19.24	NaN	62.46	92.49	-28.97	-34.64	-48.45	-9.88
ccsbBroad304_10427	OE	DHX8	DEAH-boxes, DEAH (Asp-Glu-Ala-His) box polypeptide 8			11.11, 11.11	1.51, 0.33	-19.12	NaN	92.40	57.65	99.98	33.05	75.55	-16.95	-87.09	48.00
ccsbBroad304_07596	OE	DLC1	Rho GTPase activating proteins, deleted in liver cancer 1			11.11, 0.00	1.50, 0.44	-99.82	97.16	-99.94	NaN	-35.19	-33.61	-36.96	-24.76	48.93	-11.73
ccsbBroad304_00447	OE	DLD	dihydrolipoamide dehydrogenase			11.11, 11.11	1.34, 0.41	-27.78	98.73	72.67	NaN	-55.02	-41.29	-66.33	30.72	-17.20	-7.69
ccsbBroad304_06102	OE	DLX3	Homeoboxes / ANTP class : NKL subclass, distal-less homeobox 3		Homeobox Gene GOF	10.00, 0.00	1.77, 0.63	94.96	-35.68	-96.81	47.76	-76.21	-99.87	97.43	-96.82	-49.03	-95.02
ccsbBroad304_06103	OE	DMD	dystrophin			0.00, 0.00	1.23, 0.41	-99.48	NaN	-60.22	-97.24	37.19	-49.89	-5.87	-84.11	-68.87	-88.54
ccsbBroad304_07528	OE	DMTF1	cyclin D binding myb-like transcription factor 1			0.00, 0.00	1.07, 0.25	-61.73	42.18	-13.22	NaN	-46.00	-48.21	51.55	46.94	53.68	5.74
ccsbBroad304_00796	OE	DNAJB2	Heat shock proteins / DNAJ (HSP40), DnaJ (Hsp40) homolog, subfamily B, member 2			10.00, 0.00	0.90, 0.24	96.71	88.02	-95.97	64.83	93.01	68.36	69.67	-30.68	25.68	86.83
ccsbBroad304_00990	OE	DNAJB9	Heat shock proteins / DNAJ (HSP40), DnaJ (Hsp40) homolog, subfamily B, member 9			0.00, 0.00	1.15, 0.35	-89.65	42.97	33.37	44.36	66.18	76.10	64.14	-43.89	-48.25	36.23
ccsbBroad304_03113	OE	DSE	dermatan sulfate epimerase			0.00, 0.00	1.22, 0.45	27.43	70.59	54.59	-58.46	-39.26	52.37	53.95	-90.60	40.25	26.55
ccsbBroad304_09391	OE	DTX2	RING-type (C3HC4) zinc fingers, deltex homolog 2 (Drosophila)			10.00, 10.00	1.15, 0.38	40.61	44.24	99.98	39.92	-26.53	-84.41	-42.07	-81.02	-66.54	-27.62
ccsbBroad304_02612	OE	DUSP14	Protein tyrosine phosphatases / Class I Cys-based PTPs : Atypical dual specificity phosphatases, dual specificity phosphatase 14			10.00, 10.00	0.95, 0.31	-57.56	53.20	34.65	-26.22	-52.42	68.48	47.66	99.69	21.21	35.10
ccsbBroad304_08670	OE	DUSP22	Protein tyrosine phosphatases / Class I Cys-based PTPs : Atypical dual specificity phosphatases, dual specificity phosphatase 22			0.00, 0.00	0.77, 0.17	-61.60	-90.02	-21.98	-92.57	-79.73	47.26	-82.22	83.65	65.13	-73.49
ccsbBroad304_13847	OE	DUSP3	Protein tyrosine phosphatases / Class I Cys-based PTPs : Atypical dual specificity phosphatases, dual specificity phosphatase 3			0.00, 0.00	0.98, 0.35	31.35	40.91	-49.06	-23.54	-28.85	43.56	-95.24	-77.90	-32.81	-6.28
ccsbBroad304_06130	OE	DUSP4	Protein tyrosine phosphatases / Class I Cys-based PTPs : MAP kinase phosphatases, dual specificity phosphatase 4			40.00, 20.00	2.10, 0.89	99.98	48.94	-99.85	68.44	-99.92	-87.76	-43.34	96.50	98.95	96.56
ccsbBroad304_06131	OE	DUSP6	Protein tyrosine phosphatases / Class I Cys-based PTPs : MAP kinase phosphatases, dual specificity phosphatase 6			10.00, 10.00	2.56, 0.65	31.05	-44.58	-99.98	-49.78	-94.36	-97.04	-44.51	-51.48	98.79	-86.00
ccsbBroad304_00469	OE	DUT	deoxyuridine triphosphatase			10.00, 10.00	0.92, 0.30	55.76	-33.87	-52.75	-33.00	-60.01	99.97	87.20	65.15	-67.94	24.78
ccsbBroad304_00470	OE	DVL2	Dishevelled homologs, dishevelled, dsh homolog 2 (Drosophila)			20.00, 20.00	0.81, 0.25	-97.54	-22.16	30.53	83.50	93.37	99.88	-64.87	-45.19	99.44	93.47
ccsbBroad304_04947	OE	DYNLL2	Cytoplasmic dyneins, dynein, light chain, LC8-type 2			10.00, 10.00	1.05, 0.22	90.19	-46.90	-57.02	-97.09	98.44	-68.35	13.94	-91.66	-45.68	-53.25
ccsbBroad304_01655	OE	DYNLT3	Cytoplasmic dyneins, dynein, light chain, Tctex-type 3			0.00, 0.00	1.01, 0.38	-19.03	83.70	-99.01	-98.05	58.87	89.80	-79.62	-31.68	-98.76	-95.31
ccsbBroad304_08596	OE	EAPP	E2F-associated phosphoprotein			0.00, 0.00	0.93, 0.27	-78.76	-31.90	-90.98	-99.98	-96.77	59.11	-60.78	-25.37	62.31	-79.86
ccsbBroad304_02578	OE	EBNA1BP2	EBNA1 binding protein 2			0.00, 0.00	0.95, 0.25	92.91	-76.24	-92.24	NaN	78.58	-45.84	-60.43	-97.34	-47.72	-68.59
ccsbBroad304_02671	OE	ECD	ecdysoneless homolog (Drosophila)			0.00, 0.00	1.33, 0.38	15.01	31.99	-50.47	NaN	-99.96	24.60	-99.06	-36.88	70.11	-9.78
ccsbBroad304_06134	OE	ECH1	enoyl CoA hydratase 1, peroxisomal			0.00, 0.00	1.41, 0.36	16.39	-45.96	-33.39	-51.29	35.37	35.28	-30.12	-87.26	30.81	-11.85
ccsbBroad304_06136	OE	ECHS1	enoyl CoA hydratase, short chain, 1, mitochondrial			0.00, 0.00	2.02, 0.63	-85.51	-28.04	-93.71	NaN	-92.28	-32.55	-92.15	-41.45	43.70	-92.71
ccsbBroad304_09054	OE	EGFL8	EGF-like-domain, multiple 8			0.00, 0.00	1.39, 0.48	-81.85	81.68	-82.07	-78.08	-94.75	-34.92	38.16	85.68	-32.67	-67.87
ccsbBroad304_04626	OE	EGLN3	egl nine homolog 3 (C. elegans)			10.00, 10.00	0.80, 0.26	86.46	98.51	-16.17	-69.70	94.24	-67.58	48.98	-29.81	19.97	66.33
ccsbBroad304_02956	OE	EHF	ets homologous factor			0.00, 0.00	0.93, 0.23	-58.23	26.21	-83.45	-63.90	-24.90	84.52	-99.91	-44.68	-14.20	-29.16
ccsbBroad304_00489	OE	EHHADH	enoyl-CoA, hydratase/3-hydroxyacyl CoA dehydrogenase			0.00, 0.00	1.28, 0.36	-84.45	-40.69	-99.76	-54.88	-99.98	41.73	33.75	-35.04	-66.74	-64.70
ccsbBroad304_02386	OE	EIF1B	eukaryotic translation initiation factor 1B			0.00, 0.00	1.11, 0.25	-95.94	47.03	-97.64	-38.60	-99.98	-44.56	-79.26	-39.44	81.14	-82.49
ccsbBroad304_08054	OE	EIF2AK1	Other PEK family kinases, eukaryotic translation initiation factor 2-alpha kinase 1			0.00, 0.00	1.11, 0.40	26.99	93.40	91.23	NaN	-30.77	-43.70	70.17	-52.99	-63.20	21.89
ccsbBroad304_07326	OE	EIF2B2	eukaryotic translation initiation factor 2B, subunit 2 beta, 39kDa			10.00, 0.00	1.36, 0.56	-34.25	56.52	97.03	93.13	61.61	48.41	-36.76	-91.71	-50.40	32.91
ccsbBroad304_02044	OE	EIF2S2	Serine/threonine phosphatases / Protein phosphatase 1, regulatory subunits, eukaryotic translation initiation factor 2, subunit 2 beta, 38kDa			10.00, 10.00	1.09, 0.28	89.55	-21.21	-95.00	-47.83	-79.02	69.07	98.52	35.95	22.12	32.44
ccsbBroad304_01985	OE	EIF3H	eukaryotic translation initiation factor 3, subunit H			10.00, 0.00	0.98, 0.31	96.74	87.91	20.52	-94.98	-76.02	34.87	31.30	81.76	58.01	57.39
ccsbBroad304_00490	OE	EIF4EBP1	eukaryotic translation initiation factor 4E binding protein 1			0.00, 0.00	1.49, 0.43	61.40	37.62	-94.88	-46.93	-89.33	-69.59	-70.62	-97.73	-91.25	-97.13
ccsbBroad304_00491	OE	EIF4EBP2	eukaryotic translation initiation factor 4E binding protein 2			0.00, 0.00	1.55, 0.30	39.47	43.22	-99.89	NaN	-46.98	39.09	-99.98	-32.26	-29.08	-37.95
ccsbBroad304_00492	OE	EIF5A	eukaryotic translation initiation factor 5A			20.00, 20.00	1.23, 0.32	-33.34	98.18	99.16	-72.28	88.70	-75.30	-67.46	-41.01	-35.80	-31.16
ccsbBroad304_08802	OE	ELAC2	elaC homolog 2 (E. coli)			11.11, 11.11	1.47, 0.32	-72.70	98.24	48.58	NaN	-54.33	-96.01	-93.29	-99.98	62.32	-94.80
ccsbBroad304_06155	OE	ELF1	ETS Transcription Factors, E74-like factor 1 (ets domain transcription factor)			22.22, 11.11	0.84, 0.23	42.63	NaN	30.28	-63.75	-98.70	-89.23	49.52	99.98	97.06	66.50
ccsbBroad304_00496	OE	ELF4	ETS Transcription Factors, E74-like factor 4 (ets domain transcription factor)			0.00, 0.00	1.14, 0.25	-55.00	NaN	-28.31	65.68	-50.60	-99.82	-13.35	-49.79	-81.04	-48.40
ccsbBroad304_00498	OE	ELK1	ETS Transcription Factors, ELK1, member of ETS oncogene family			0.00, 0.00	2.10, 0.51	-16.79	-64.15	22.67	NaN	94.66	33.94	-24.48	-98.36	53.19	-10.71
ccsbBroad304_00510	OE	EPHX2	epoxide hydrolase 2, cytoplasmic			20.00, 20.00	1.17, 0.34	62.04	97.81	36.56	76.14	99.88	91.05	-66.49	32.93	-31.27	94.74
ccsbBroad304_00513	OE	ERCC3	General transcription factors, excision repair cross-complementing rodent repair deficiency, complementation group 3 (xeroderma pigmentosum group B complementing)			11.11, 11.11	1.22, 0.44	-26.78	-44.64	99.53	NaN	62.63	33.91	35.00	-78.79	81.13	18.96
ccsbBroad304_06178	OE	ERCC5	excision repair cross-complementing rodent repair deficiency, complementation group 5			0.00, 0.00	1.30, 0.27	-98.91	-51.50	-93.58	NaN	-39.77	-62.32	-15.35	-68.49	33.06	-46.22
ccsbBroad304_06179	OE	ERG	ETS Transcription Factors, v-ets erythroblastosis virus E26 oncogene homolog (avian)			0.00, 0.00	3.42, 0.76	26.80	64.77	-72.47	-97.27	-34.17	-98.74	-50.55	-77.02	-29.80	-89.96
ccsbBroad304_03266	OE	ERGIC2	ERGIC and golgi 2			0.00, 0.00	1.34, 0.45	-68.35	-30.18	-35.59	-96.49	45.58	-44.52	-89.96	-58.74	42.17	-79.86
ccsbBroad304_00515	OE	ERH	enhancer of rudimentary homolog (Drosophila)			0.00, 0.00	1.59, 0.48	32.84	-76.03	11.71	NaN	-35.73	80.05	33.40	39.34	-55.32	3.06
ccsbBroad304_03129	OE	ERO1L	ERO1-like (S. cerevisiae)			10.00, 10.00	1.09, 0.38	57.57	99.96	-84.44	58.62	-72.54	65.42	-90.59	46.30	-44.42	34.19
ccsbBroad304_10428	OE	ETS2	ETS Transcription Factors, v-ets erythroblastosis virus E26 oncogene homolog 2 (avian)			10.00, 10.00	1.16, 0.39	-35.20	-42.85	-18.48	99.74	42.56	-89.94	33.16	-98.49	37.38	-10.29
ccsbBroad304_00521	OE	ETV5	ETS Transcription Factors, ets variant 5			10.00, 10.00	1.76, 0.51	-65.96	-18.45	-48.09	27.19	98.76	56.24	-46.85	55.65	-89.39	-23.84
ccsbBroad304_03311	OE	EVL	Enah/Vasp-like			0.00, 0.00	1.24, 0.33	-84.76	84.41	-84.70	NaN	-46.20	-84.74	-26.95	-73.37	-96.38	-81.84
ccsbBroad304_06183	OE	EWSR1	RNA binding motif (RRM) containing, Ewing sarcoma breakpoint region 1			0.00, 0.00	1.08, 0.33	-99.63	86.66	20.79	47.87	-73.81	-80.19	91.85	-72.18	91.12	-51.73
ccsbBroad304_03652	OE	EXOC2	exocyst complex component 2			11.11, 11.11	1.23, 0.34	99.41	90.09	84.68	NaN	-15.00	-94.62	7.86	41.38	49.34	60.63
ccsbBroad304_00526	OE	EZH2	Chromatin-modifying enzymes / K-methyltransferases, enhancer of zeste homolog 2 (Drosophila)			20.00, 10.00	1.17, 0.35	95.37	86.38	99.79	-94.08	36.33	-57.41	52.54	-37.03	-31.35	65.40
ccsbBroad304_06188	OE	F10	Chymotrypsin, coagulation factor X			0.00, 0.00	1.13, 0.35	28.73	-46.27	-62.86	17.13	-96.55	-85.10	85.31	-59.61	-58.60	-21.42
ccsbBroad304_00532	OE	F11	Chymotrypsin, coagulation factor XI			10.00, 10.00	1.03, 0.34	-30.34	70.99	67.78	68.15	-39.16	74.35	99.98	-24.54	-96.00	72.61
ccsbBroad304_06186	OE	F2R	Protease activated receptors, coagulation factor II (thrombin) receptor			0.00, 0.00	1.32, 0.52	-76.88	65.60	-45.82	NaN	-91.84	31.91	35.15	65.45	54.45	47.26
ccsbBroad304_00527	OE	F2RL1	GPCR / Class A : Protease activated receptors, coagulation factor II (thrombin) receptor-like 1			0.00, 0.00	0.97, 0.32	78.61	-98.08	32.61	35.00	84.78	-57.11	-32.45	-91.44	-28.76	-10.89
ccsbBroad304_00529	OE	F3	CD molecules, coagulation factor III (thromboplastin, tissue factor)			20.00, 20.00	0.78, 0.19	93.72	34.92	97.66	99.64	40.88	-95.74	28.42	-38.51	48.27	54.58
ccsbBroad304_00534	OE	FABP1	Fatty acid-binding proteins, fatty acid binding protein 1, liver			0.00, 0.00	1.13, 0.38	-37.64	50.14	23.15	55.47	24.02	91.99	-46.41	-72.79	54.23	23.20
ccsbBroad304_06528	OE	FADS3	Fatty acid desaturases, fatty acid desaturase 3			10.00, 0.00	1.05, 0.24	16.56	-85.86	-96.48	-28.02	-27.71	95.83	-58.52	-70.58	-41.97	-33.59
ccsbBroad304_03544	OE	FAIM	Fas apoptotic inhibitory molecule			0.00, 0.00	0.82, 0.20	-85.04	41.76	-10.08	-64.67	-97.07	67.61	61.20	83.08	34.59	-9.12
ccsbBroad304_02270	OE	FAM20B	family with sequence similarity 20, member B			11.11, 11.11	1.09, 0.26	34.53	-61.27	-87.64	NaN	-97.85	-24.32	-23.23	-37.89	99.86	-43.37
ccsbBroad304_02438	OE	FAM3C	family with sequence similarity 3, member C			10.00, 10.00	1.07, 0.33	43.12	-96.96	99.41	-36.70	26.99	40.05	-97.90	92.97	28.29	6.28
ccsbBroad304_00539	OE	FANCG	Fanconi anemia, complementation groups, Fanconi anemia, complementation group G			0.00, 0.00	0.86, 0.18	-49.27	-77.36	-13.71	NaN	12.34	73.79	44.32	-99.79	91.43	8.01
ccsbBroad304_00087	OE	FAS	Tumour necrosis factor (TNF) receptor family, Fas (TNF receptor superfamily, member 6)			0.00, 0.00	1.98, 0.70	-41.79	88.85	20.27	-33.44	37.49	56.66	-98.09	60.31	43.01	41.23
ccsbBroad304_08418	OE	FBXL12	F-boxes / Leucine-rich repeats, F-box and leucine-rich repeat protein 12			0.00, 0.00	1.89, 0.38	73.12	-26.52	-89.06	-47.60	-44.86	-88.26	-85.23	-44.04	-52.40	-77.47
ccsbBroad304_08010	OE	FBXO5	F-boxes / other, F-box protein 5			10.00, 10.00	0.99, 0.24	-97.93	54.98	-94.98	98.20	-75.95	-99.94	-62.00	-39.32	-44.25	-90.11
ccsbBroad304_07941	OE	FBXO7	F-boxes / other, F-box protein 7			11.11, 0.00	0.98, 0.19	95.38	NaN	41.40	-86.23	-97.91	-30.77	53.64	-66.39	65.67	-32.38
ccsbBroad304_03574	OE	FBXW7	F-boxes / WD-40 domains, F-box and WD repeat domain containing 7			11.11, 0.00	1.81, 0.49	47.35	-65.99	-21.20	NaN	96.97	-55.06	-99.95	-99.98	31.82	-53.32
ccsbBroad304_06198	OE	FCGR2A	CD molecules, Fc fragment of IgG, low affinity IIa, receptor (CD32)			20.00, 20.00	0.77, 0.32	50.55	-28.49	97.85	71.71	-23.18	-95.84	61.51	-50.26	100.00	38.36
ccsbBroad304_06204	OE	FDFT1	Lanosterol biosynthesis pathway, farnesyl-diphosphate farnesyltransferase 1			0.00, 0.00	0.75, 0.28	23.82	56.96	20.25	-95.15	-34.39	-32.15	-95.99	61.82	60.24	10.92
ccsbBroad304_00548	OE	FDPS	Lanosterol biosynthesis pathway, farnesyl diphosphate synthase			30.00, 10.00	0.84, 0.18	95.47	51.97	95.63	58.55	99.33	-50.37	47.33	-24.09	78.45	92.80
ccsbBroad304_00550	OE	FDXR	ferredoxin reductase			20.00, 20.00	0.92, 0.19	74.64	99.93	31.70	93.02	83.15	-35.19	99.98	-93.72	39.94	91.37
ccsbBroad304_00552	OE	FEN1	flap structure-specific endonuclease 1			0.00, 0.00	1.15, 0.28	80.48	85.29	-98.48	34.93	-39.69	-52.83	-53.27	-99.94	-65.66	-61.74
ccsbBroad304_00561	OE	FGFR1	Type V RTKs: FGF (fibroblast growth factor) receptor family, fibroblast growth factor receptor 1		Targets of VEGFR inhibitors GOF	11.11, 11.11	1.28, 0.44	60.29	-92.34	99.91	NaN	-94.88	-37.13	-91.86	-45.02	39.90	-81.32
ccsbBroad304_03396	OE	FGFRL1	Immunoglobulin superfamily / I-set domain containing, fibroblast growth factor receptor-like 1			0.00, 0.00	1.23, 0.39	-51.80	72.29	32.18	27.58	-98.88	-99.82	-29.34	34.21	-33.09	-9.12
ccsbBroad304_00563	OE	FGG	Endogenous ligands, fibrinogen gamma chain			0.00, 0.00	1.52, 0.45	-99.90	-99.47	-99.98	-62.62	92.70	47.30	-35.43	-86.62	-98.84	-99.26
ccsbBroad304_00568	OE	FHL2	four and a half LIM domains 2			0.00, 0.00	1.20, 0.40	-40.47	-51.83	20.27	35.36	-67.28	49.31	-74.53	68.45	-83.28	-41.90
ccsbBroad304_02094	OE	FIBP	fibroblast growth factor (acidic) intracellular binding protein			10.00, 0.00	1.11, 0.41	-39.45	-41.12	-9.77	96.46	72.46	-81.49	58.56	-29.53	92.43	60.24
ccsbBroad304_00570	OE	FIGF	c-fos induced growth factor (vascular endothelial growth factor D)			0.00, 0.00	1.25, 0.42	-77.99	NaN	32.23	36.84	-41.94	90.38	-27.57	27.49	68.06	11.51
ccsbBroad304_03177	OE	FIS1	fission 1 (mitochondrial outer membrane) homolog (S. cerevisiae)			0.00, 0.00	1.47, 0.33	-11.17	-42.20	-99.70	NaN	-83.83	-67.89	-66.26	-92.78	63.76	-90.22
ccsbBroad304_00572	OE	FKBP3	FK506 binding protein 3, 25kDa			0.00, 0.00	0.93, 0.28	-86.92	42.69	75.83	-74.53	51.66	76.65	64.21	-99.70	-45.51	53.75
ccsbBroad304_00578	OE	FLI1	ETS Transcription Factors, Friend leukemia virus integration 1			10.00, 10.00	1.85, 0.44	72.40	93.48	-21.55	99.79	-40.69	-81.63	-97.60	-93.47	90.86	83.07
ccsbBroad304_06220	OE	FOS	basic leucine zipper proteins, FBJ murine osteosarcoma viral oncogene homolog		FOS transcription factor family GOF	0.00, 0.00	1.22, 0.31	-99.80	44.18	-99.39	30.02	-48.80	-27.41	-39.33	-96.94	92.06	-87.87
ccsbBroad304_01858	OE	FOSL1	basic leucine zipper proteins, FOS-like antigen 1		FOS transcription factor family GOF	11.11, 11.11	1.15, 0.28	28.34	-56.20	-76.49	NaN	-88.00	63.80	92.09	-95.51	99.80	-60.58
ccsbBroad304_00762	OE	FOXA3	Forkhead boxes, forkhead box A3			0.00, 0.00	1.02, 0.27	-49.48	-37.16	83.70	-29.98	-25.99	-77.45	-80.58	46.44	43.71	-13.77
ccsbBroad304_03161	OE	FOXP3	Forkhead boxes, forkhead box P3			0.00, 0.00	0.97, 0.23	56.16	71.92	93.55	NaN	92.06	93.31	-50.19	-75.66	-33.15	79.93
ccsbBroad304_09429	OE	FOXP4	Forkhead boxes, forkhead box P4			0.00, 0.00	1.17, 0.34	-78.05	42.62	-50.72	NaN	38.19	34.88	-34.64	-40.00	53.36	-6.43
ccsbBroad304_05348	OE	FOXR1	Forkhead boxes, forkhead box R1			0.00, 0.00	1.50, 0.39	80.40	86.07	-84.60	53.70	38.13	-50.31	-65.82	69.02	-39.65	53.55
ccsbBroad304_06226	OE	FTL	ferritin, light polypeptide			20.00, 10.00	0.95, 0.33	79.05	99.04	-7.80	-99.75	-42.35	66.22	96.31	-39.37	44.68	38.48
ccsbBroad304_00125	OE	FXYD2	Ion transport regulator, FXYD domain containing ion transport regulator 2			0.00, 0.00	0.84, 0.23	61.23	42.78	-84.34	-93.38	-30.29	91.47	-26.48	-86.15	-73.35	-73.16
ccsbBroad304_03614	OE	G2E3	Zinc fingers, PHD-type, G2/M-phase specific E3 ubiquitin protein ligase			22.22, 22.22	1.30, 0.43	-59.14	NaN	92.52	-37.57	-80.01	-48.83	99.09	98.54	-45.98	29.22
ccsbBroad304_02330	OE	G3BP1	RNA binding motif (RRM) containing, GTPase activating protein (SH3 domain) binding protein 1			0.00, 0.00	0.85, 0.25	-35.15	-75.11	-98.95	NaN	-30.68	-61.63	-51.66	-29.98	68.45	-26.94
ccsbBroad304_02268	OE	G3BP2	RNA binding motif (RRM) containing, GTPase activating protein (SH3 domain) binding protein 2			0.00, 0.00	1.11, 0.36	32.41	NaN	-99.94	51.84	-37.01	72.05	6.52	89.47	79.43	48.92
ccsbBroad304_06235	OE	G6PD	glucose-6-phosphate dehydrogenase			0.00, 0.00	0.89, 0.19	28.67	-70.64	74.25	-99.68	75.96	-61.26	60.40	-57.54	-79.60	-46.42
ccsbBroad304_02834	OE	GABARAPL1	GABA(A) receptor-associated protein like 1			10.00, 10.00	1.61, 0.42	-53.96	-71.11	-17.92	-71.62	-53.06	42.74	99.00	80.25	-65.44	-35.72
ccsbBroad304_04817	OE	GABPB2	Ankyrin repeat domain containing, GA binding protein transcription factor, beta subunit 2			10.00, 0.00	0.97, 0.33	-95.35	93.39	94.18	-33.70	97.13	-99.66	-50.94	-82.31	35.51	-51.69
ccsbBroad304_00430	OE	GADD45A	growth arrest and DNA-damage-inducible, alpha			0.00, 0.00	4.57, 1.18	-95.26	NaN	-46.27	-97.85	-93.39	-99.96	-95.80	-95.99	-99.93	-99.72
ccsbBroad304_00611	OE	GALE	Short chain dehydrogenase/reductase superfamily / Extended SDR fold, UDP-galactose-4-epimerase			0.00, 0.00	1.13, 0.28	-64.45	-47.89	-46.84	-74.13	-45.00	-26.63	-72.14	-51.08	-81.69	-51.59
ccsbBroad304_00612	OE	GALNS	Arylsulfatase family, galactosamine (N-acetyl)-6-sulfate sulfatase			10.00, 10.00	1.17, 0.41	79.48	90.83	-98.57	43.67	-78.95	85.84	99.93	47.04	-58.09	76.02
ccsbBroad304_00615	OE	GAPDH	glyceraldehyde-3-phosphate dehydrogenase			10.00, 10.00	1.31, 0.39	-16.12	98.51	57.42	-87.32	-81.92	62.52	-62.93	-56.80	64.51	-53.88
ccsbBroad304_01948	OE	GAS7	growth arrest-specific 7			20.00, 20.00	1.07, 0.35	33.61	-50.60	-99.91	33.43	-78.98	98.92	-65.50	97.69	-93.60	-71.67
ccsbBroad304_06257	OE	GATA2	GATA zinc finger domain containing, GATA binding protein 2			0.00, 0.00	1.08, 0.28	-94.16	-27.63	-94.09	-55.80	-71.23	-99.59	21.05	83.65	62.41	-82.57
ccsbBroad304_06260	OE	GATA3	GATA zinc finger domain containing, GATA binding protein 3			0.00, 0.00	1.66, 0.43	-90.80	-96.81	-13.77	33.23	-51.49	-99.94	-95.32	-30.07	-75.86	-96.18
ccsbBroad304_03822	OE	GATAD2B	GATA zinc finger domain containing, GATA zinc finger domain containing 2B			0.00, 0.00	1.43, 0.31	94.65	40.27	82.46	NaN	79.23	50.61	33.11	-99.93	-99.90	59.82
ccsbBroad304_00620	OE	GCDH	glutaryl-CoA dehydrogenase			0.00, 0.00	1.05, 0.34	89.72	42.28	-98.85	-37.75	-89.20	41.01	82.88	44.78	-50.64	-26.51
ccsbBroad304_00624	OE	GCK	Hexokinases, glucokinase (hexokinase 4)			0.00, 0.00	1.57, 0.42	-72.55	39.68	-48.74	-27.41	-27.01	-27.61	-99.93	-75.75	93.22	-51.71
ccsbBroad304_00644	OE	GCLC	glutamate-cysteine ligase, catalytic subunit			11.11, 11.11	0.97, 0.36	59.97	94.05	-12.15	NaN	79.52	42.31	99.92	47.51	-63.37	73.99
ccsbBroad304_00645	OE	GCLM	glutamate-cysteine ligase, modifier subunit			0.00, 0.00	1.00, 0.34	-34.28	-29.97	-36.29	29.04	25.26	72.59	-92.85	87.34	-30.89	-5.59
ccsbBroad304_00626	OE	GDI1	GDP dissociation inhibitor 1			10.00, 0.00	1.88, 0.56	-25.73	-23.85	-61.63	58.62	-79.52	-83.91	-96.60	-31.24	95.00	-47.40
ccsbBroad304_14291	OE	GDPD5	glycerophosphodiester phosphodiesterase domain containing 5			10.00, 0.00	1.17, 0.27	69.53	-99.96	-88.02	-44.11	-97.94	95.53	-38.48	-89.54	86.12	-93.36
ccsbBroad304_07515	OE	GFPT2	glutamine-fructose-6-phosphate transaminase 2			0.00, 0.00	0.85, 0.24	-93.44	32.03	13.14	-67.92	-37.43	68.55	-87.33	-34.18	76.43	-13.07
ccsbBroad304_07834	OE	GGA2	golgi-associated, gamma adaptin ear containing, ARF binding protein 2			11.11, 11.11	2.63, 0.86	-94.29	-99.96	-99.08	NaN	31.82	-50.92	-99.11	-99.98	99.81	-99.86
ccsbBroad304_00632	OE	GGCX	Carboxylases, gamma-glutamyl carboxylase			10.00, 10.00	0.95, 0.40	-67.91	-33.41	93.15	-95.92	45.65	67.00	89.47	-71.70	99.96	79.75
ccsbBroad304_02168	OE	GGPS1	Lanosterol biosynthesis pathway, geranylgeranyl diphosphate synthase 1			0.00, 0.00	0.99, 0.25	-99.98	-58.20	-15.34	36.01	-63.53	83.23	-52.05	91.63	-95.58	-40.28
ccsbBroad304_06274	OE	GJA1	Ion channels / Gap junction proteins (connexins), gap junction protein, alpha 1, 43kDa			10.00, 10.00	1.17, 0.33	53.65	33.14	-90.46	-28.54	33.52	99.44	-31.38	71.10	-38.36	10.89
ccsbBroad304_06278	OE	GK	Glycerol kinases, glycerol kinase			20.00, 20.00	1.18, 0.27	58.82	-41.09	97.75	-47.02	-49.69	-31.58	98.59	52.72	-49.09	30.37
ccsbBroad304_03182	OE	GLOD4	glyoxalase domain containing 4			22.22, 11.11	0.98, 0.30	-34.36	97.13	-56.84	NaN	59.60	31.05	-96.95	-65.23	99.86	32.91
ccsbBroad304_00648	OE	GLRX	glutaredoxin (thioltransferase)			0.00, 0.00	0.94, 0.23	-53.19	-80.00	30.84	NaN	-45.92	-68.53	48.76	-36.61	31.34	-22.57
ccsbBroad304_06286	OE	GLUL	glutamate-ammonia ligase			0.00, 0.00	1.20, 0.38	60.70	69.71	48.79	-36.88	38.59	-97.65	83.48	-41.91	23.47	16.52
ccsbBroad304_06287	OE	GM2A	GM2 ganglioside activator			10.00, 10.00	0.88, 0.25	94.11	39.47	12.17	-36.73	32.22	60.78	47.73	-45.64	97.60	19.95
ccsbBroad304_06288	OE	GMDS	Short chain dehydrogenase/reductase superfamily / Extended SDR fold, GDP-mannose 4,6-dehydratase			0.00, 0.00	2.52, 0.60	-32.66	-84.27	-99.69	-40.67	-74.29	-99.93	63.85	-83.16	29.24	-93.12
ccsbBroad304_02509	OE	GMEB1	glucocorticoid modulatory element binding protein 1			11.11, 11.11	1.30, 0.23	99.98	-99.91	-65.75	NaN	-98.54	-99.82	-71.74	-92.28	-75.30	-99.11
ccsbBroad304_03186	OE	GMNN	geminin, DNA replication inhibitor			10.00, 10.00	1.17, 0.25	45.49	98.05	-97.67	-98.95	-81.90	-95.53	83.00	-39.71	91.90	-89.26
ccsbBroad304_03268	OE	GMPR2	guanosine monophosphate reductase 2			10.00, 10.00	1.19, 0.28	-96.64	66.31	-98.42	98.07	36.49	68.45	90.99	-65.07	30.74	48.10
ccsbBroad304_02502	OE	GNA13	guanine nucleotide binding protein (G protein), alpha 13			30.00, 10.00	1.14, 0.43	97.36	66.95	-13.86	-46.31	97.79	97.09	-99.95	-49.88	-41.09	86.97
ccsbBroad304_06290	OE	GNA15	guanine nucleotide binding protein (G protein), alpha 15 (Gq class)			20.00, 20.00	1.08, 0.28	83.23	-47.56	-80.45	99.85	99.98	85.89	-21.24	-82.46	-65.03	78.87
ccsbBroad304_06291	OE	GNAI1	guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1			22.22, 22.22	1.63, 0.38	56.50	NaN	99.83	82.75	99.98	-45.07	70.26	-63.26	53.25	90.77
ccsbBroad304_06292	OE	GNAI2	guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2			0.00, 0.00	0.88, 0.31	46.22	-91.37	-71.32	58.93	-73.66	76.09	-34.83	-41.66	50.96	22.12
ccsbBroad304_00652	OE	GNAS	GNAS complex locus			10.00, 10.00	0.80, 0.25	-90.42	90.22	60.23	-76.62	99.84	-36.37	-99.90	-40.67	23.14	-50.58
ccsbBroad304_06294	OE	GNAZ	guanine nucleotide binding protein (G protein), alpha z polypeptide			10.00, 10.00	1.56, 0.42	53.48	66.53	99.83	42.41	36.57	-72.43	-67.36	-51.53	56.43	40.99
ccsbBroad304_03439	OE	GNB1L	WD repeat domain containing, guanine nucleotide binding protein (G protein), beta polypeptide 1-like			0.00, 0.00	1.09, 0.39	-99.84	-27.33	-97.36	-46.93	-60.70	-34.42	39.70	-53.22	-33.93	-34.77
ccsbBroad304_00655	OE	GNB2	WD repeat domain containing, guanine nucleotide binding protein (G protein), beta polypeptide 2			10.00, 10.00	0.97, 0.38	-33.67	-65.33	39.50	71.46	89.17	-37.75	56.31	-70.49	97.54	50.91
ccsbBroad304_00657	OE	GNG4	guanine nucleotide binding protein (G protein), gamma 4			10.00, 10.00	2.80, 0.77	-76.34	-23.52	-62.72	-71.53	-25.94	-37.11	-22.79	-59.87	99.97	-38.54
ccsbBroad304_00661	OE	GNGT2	guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 2			0.00, 0.00	1.28, 0.28	-11.78	-39.85	-29.83	NaN	-20.44	77.47	-46.41	-37.74	74.24	-3.56
ccsbBroad304_02287	OE	GNPDA1	glucosamine-6-phosphate deaminase 1			0.00, 0.00	1.15, 0.30	34.50	86.89	-38.84	50.22	48.30	78.91	-38.94	50.68	84.54	57.19
ccsbBroad304_00665	OE	GOT1	glutamic-oxaloacetic transaminase 1, soluble (aspartate aminotransferase 1)			0.00, 0.00	1.08, 0.36	61.20	81.11	-31.39	NaN	88.38	63.49	-75.56	52.04	35.26	32.79
ccsbBroad304_06318	OE	GPER	G protein-coupled estrogen receptor 1			10.00, 10.00	1.61, 0.53	99.71	-81.36	46.47	-40.88	-39.83	-99.94	-28.98	-97.69	-82.69	-77.43
ccsbBroad304_05253	OE	GPR114	Adhesion Class GPCRs, G protein-coupled receptor 114			10.00, 10.00	0.95, 0.36	99.87	-85.15	-53.80	37.82	-43.57	86.10	45.14	-67.93	88.27	48.01
ccsbBroad304_04933	OE	GPR119	GPCR / Class A : Orphans, G protein-coupled receptor 119		GPCR Subset GOF	20.00, 20.00	0.91, 0.31	73.81	-97.90	-57.55	-42.57	99.46	-65.35	-32.70	-84.15	99.92	-51.07
ccsbBroad304_09233	OE	GPR128	Adhesion Class GPCRs, G protein-coupled receptor 128			10.00, 10.00	1.06, 0.24	61.57	-95.67	99.50	-32.20	-40.05	67.17	93.86	62.67	-59.97	41.91
ccsbBroad304_04678	OE	GPR146	GPCR / Class A : Orphans, G protein-coupled receptor 146			10.00, 10.00	1.61, 0.48	-98.88	-33.83	91.69	-33.40	99.21	-93.00	-37.61	-96.52	47.80	-79.32
ccsbBroad304_09761	OE	GPR156	GPCR / Class C : Orphans, G protein-coupled receptor 156			0.00, 0.00	1.07, 0.31	30.59	32.18	-94.98	-81.36	-99.98	47.67	-34.87	-99.91	-99.23	-98.70
ccsbBroad304_02766	OE	GPR161	GPCR / Class A : Orphans, G protein-coupled receptor 161			10.00, 10.00	1.77, 0.42	51.61	-99.96	-11.76	-39.42	-35.16	39.94	-42.66	-75.85	99.85	-9.05
ccsbBroad304_04082	OE	SLC52A2	SLC52 family of riboflavin transporters, solute carrier family 52 (riboflavin transporter), member 2			10.00, 10.00	0.85, 0.31	78.53	60.20	-47.10	90.28	-98.75	99.96	-71.65	-34.52	-36.60	68.90
ccsbBroad304_06319	OE	GPR35	GPCR / Class A : Orphans, G protein-coupled receptor 35			0.00, 0.00	2.15, 0.51	-48.29	-26.39	17.38	-40.65	-79.41	-99.97	50.32	-97.69	-73.17	-85.73
ccsbBroad304_02128	OE	GPR55	GPCR / Class A : Orphans, G protein-coupled receptor 55			0.00, 0.00	0.88, 0.34	-17.49	60.84	60.73	88.94	52.97	-94.75	63.21	-34.16	-43.32	35.32
ccsbBroad304_07244	OE	GPR65	GPCR / Class A : Orphans, G protein-coupled receptor 65			10.00, 0.00	1.36, 0.32	-98.93	-99.89	-39.63	-25.33	-62.34	96.33	-74.48	-97.49	-87.24	-94.40
ccsbBroad304_03368	OE	GPRC5B	GPCR / Class C : Orphans, G protein-coupled receptor, family C, group 5, member B			10.00, 10.00	1.72, 0.42	-87.27	31.62	-97.24	-64.89	-37.22	-99.94	-93.08	-65.40	99.37	-87.16
ccsbBroad304_06324	OE	GPX7	glutathione peroxidase 7			0.00, 0.00	1.05, 0.32	60.00	74.10	64.98	29.05	-74.71	-56.84	54.26	92.89	-66.23	50.06
ccsbBroad304_00688	OE	GRB2	SH2 domain containing, growth factor receptor-bound protein 2			20.00, 10.00	1.00, 0.36	99.98	-36.16	-31.23	30.05	96.35	-38.70	-12.41	-61.56	-26.77	-2.45
ccsbBroad304_00682	OE	GRK6	GRK1/3 subfamily, G protein-coupled receptor kinase 6			0.00, 0.00	1.16, 0.24	-80.59	-30.70	-37.55	NaN	39.43	-42.58	-62.44	39.05	85.67	-16.95
ccsbBroad304_06332	OE	GSTM2	Glutathione S-transferases / Soluble, glutathione S-transferase mu 2 (muscle)			0.00, 0.00	0.95, 0.26	57.45	72.72	-98.98	60.14	-60.00	-79.08	-48.33	-65.64	28.22	-40.22
ccsbBroad304_00704	OE	GSTZ1	Glutathione S-transferases / Soluble, glutathione transferase zeta 1			10.00, 0.00	1.22, 0.38	96.63	40.93	-71.12	-38.88	-67.89	43.23	44.58	-28.67	23.90	-10.05
ccsbBroad304_00705	OE	GTF2A1	General transcription factors, general transcription factor IIA, 1, 19/37kDa			10.00, 10.00	1.25, 0.26	-40.00	64.87	-38.75	-50.88	-99.95	-92.05	99.95	36.46	-36.06	-30.80
ccsbBroad304_00706	OE	GTF2B	General transcription factors, general transcription factor IIB			0.00, 0.00	1.75, 0.56	56.25	-88.38	-92.70	NaN	-30.21	-72.20	-58.52	76.12	76.78	-47.33
ccsbBroad304_00725	OE	HADHA	hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein), alpha subunit			22.22, 22.22	0.99, 0.28	49.42	NaN	45.24	-50.94	86.71	99.90	99.27	-41.49	83.66	84.85
ccsbBroad304_06349	OE	HAGH	hydroxyacylglutathione hydrolase			20.00, 10.00	1.07, 0.33	35.33	-80.20	-98.51	67.24	91.10	84.28	-30.78	97.81	96.64	90.73
ccsbBroad304_11277	OE	HAT1	Histone acetyltransferases (HATs), histone acetyltransferase 1			0.00, 0.00	1.06, 0.31	-99.30	-69.18	-16.64	-36.85	-99.63	-75.57	40.54	-95.55	-33.43	-84.43
ccsbBroad304_02974	OE	HAVCR1	Immunoglobulin superfamily / V-set domain containing, hepatitis A virus cellular receptor 1			10.00, 10.00	1.22, 0.42	92.35	88.16	-90.57	-31.10	80.59	99.33	86.71	-53.39	37.55	89.25
ccsbBroad304_02443	OE	HAX1	HCLS1 associated protein X-1			0.00, 0.00	0.93, 0.31	36.21	58.47	-92.33	90.19	51.79	91.40	-39.45	-45.28	40.56	37.31
ccsbBroad304_00728	OE	HBE1	hemoglobin, epsilon 1			22.22, 22.22	1.19, 0.23	99.63	-95.65	-14.37	NaN	21.62	79.62	99.50	48.62	-90.63	49.77
ccsbBroad304_00734	OE	HDAC1	Histone deacetylases, histone deacetylase 1			0.00, 0.00	1.57, 0.51	64.95	-38.67	-99.72	-52.83	-97.81	-41.11	-94.47	-79.31	24.42	-91.25
ccsbBroad304_04146	OE	HDAC11	Histone deacetylases, histone deacetylase 11			0.00, 0.00	1.24, 0.43	29.23	36.22	-97.00	-55.55	27.63	-76.59	42.80	73.02	-56.74	-55.03
ccsbBroad304_07311	OE	HDAC3	Histone deacetylases, histone deacetylase 3			20.00, 20.00	0.81, 0.17	99.69	99.93	-53.62	33.98	91.36	-53.87	-46.74	77.03	51.22	69.45
ccsbBroad304_02230	OE	HERPUD1	homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1			10.00, 10.00	0.94, 0.27	-58.68	-98.56	99.94	-76.52	-95.64	-28.04	-98.12	-94.12	-48.62	-96.25
ccsbBroad304_06348	OE	HIST1H2BD	Histones / Replication-dependent, histone cluster 1, H2bd			0.00, 0.00	1.08, 0.27	-16.16	-62.32	-24.17	-94.10	-23.68	67.67	-51.43	-44.43	61.41	-11.66
ccsbBroad304_04472	OE	HIST1H2BK	Histones / Replication-dependent, histone cluster 1, H2bk			0.00, 0.00	1.07, 0.30	31.85	-41.40	-34.26	NaN	60.20	41.22	83.76	-99.82	-93.54	-9.89
ccsbBroad304_01903	OE	HIST2H2BE	Histones / Replication-dependent, histone cluster 2, H2be			0.00, 0.00	1.02, 0.16	-44.04	87.00	10.44	NaN	-48.57	-63.91	-91.69	-67.67	88.56	-44.06
ccsbBroad304_06367	OE	HK1	hexokinase 1			10.00, 0.00	1.00, 0.35	97.48	67.94	-47.22	48.29	53.48	-28.77	-40.53	-62.12	-99.16	21.50
ccsbBroad304_13869	OE	HLA-A	Immunoglobulin superfamily / C1-set domain containing, major histocompatibility complex, class I, A			0.00, 0.00	1.10, 0.48	56.61	-44.73	-95.24	38.33	-40.66	-21.01	24.26	63.53	67.89	9.17
ccsbBroad304_06374	OE	HLA-DRA	Immunoglobulin superfamily / C1-set domain containing, major histocompatibility complex, class II, DR alpha			20.00, 20.00	0.90, 0.41	97.60	-51.61	43.56	45.02	-95.11	30.96	-75.43	-33.37	98.04	14.12
ccsbBroad304_10882	OE	HLA-DRB1	Immunoglobulin superfamily / C1-set domain containing, major histocompatibility complex, class II, DR beta 1			0.00, 0.00	1.25, 0.41	52.16	NaN	-63.73	-83.49	-57.59	-62.37	-44.01	88.57	-27.09	-47.20
ccsbBroad304_00747	OE	HLF	hepatic leukemia factor			11.11, 0.00	1.66, 0.33	-65.56	95.67	-79.51	NaN	-50.24	-99.94	-66.67	-53.79	41.11	-61.77
ccsbBroad304_00757	OE	HMGA1	High-mobility group / Canonical, high mobility group AT-hook 1			0.00, 0.00	0.93, 0.27	57.51	69.78	-99.94	65.12	-82.43	71.20	-99.14	-99.98	-40.41	-97.62
ccsbBroad304_06381	OE	HMGB1	High-mobility group / Canonical, high mobility group box 1			0.00, 0.00	1.00, 0.33	-29.19	-28.11	-38.78	-88.65	37.32	37.23	-17.86	-68.11	-55.36	-16.01
ccsbBroad304_00751	OE	HMGB2	High-mobility group / Canonical, high mobility group box 2			0.00, 0.00	1.03, 0.31	-77.93	62.60	-35.46	-69.11	-99.94	41.40	-35.85	37.28	-16.20	-26.77
ccsbBroad304_09508	OE	HMGB4	High-mobility group / Canonical, high mobility group box 4			20.00, 10.00	0.98, 0.32	95.71	-88.75	62.51	-99.78	55.74	53.71	98.56	-87.97	-40.75	46.69
ccsbBroad304_00755	OE	HMGCR	Lanosterol biosynthesis pathway, 3-hydroxy-3-methylglutaryl-CoA reductase			10.00, 10.00	1.13, 0.31	-84.10	-30.73	52.15	49.25	91.42	25.72	-99.93	-43.25	99.97	29.83
ccsbBroad304_02139	OE	HMGN3	High-mobility group / Canonical, high mobility group nucleosomal binding domain 3			30.00, 30.00	1.11, 0.28	99.98	-53.46	-82.61	36.38	-33.95	-48.84	-55.30	99.12	98.22	59.31
ccsbBroad304_07617	OE	HMGN4	High-mobility group / Canonical, high mobility group nucleosomal binding domain 4			0.00, 0.00	1.27, 0.36	23.90	-81.36	-33.07	NaN	-70.55	-31.43	-56.61	78.41	68.52	-23.20
ccsbBroad304_06384	OE	HMOX1	Haem oxygenase, heme oxygenase (decycling) 1			10.00, 10.00	1.07, 0.34	-63.07	57.21	-97.95	30.42	-77.67	-80.48	98.71	-99.83	53.12	-92.50
ccsbBroad304_00759	OE	HMOX2	Haem oxygenase, heme oxygenase (decycling) 2			11.11, 0.00	1.10, 0.38	89.71	NaN	-99.95	96.89	-98.55	-65.42	5.59	-37.26	84.95	61.02
ccsbBroad304_06386	OE	HNMT	histamine N-methyltransferase			0.00, 0.00	1.67, 0.48	50.22	-78.71	18.64	NaN	-36.90	-91.23	69.79	-40.15	-34.44	-11.67
ccsbBroad304_08137	OE	HOOK2	hook homolog 2 (Drosophila)			0.00, 0.00	1.39, 0.28	39.08	NaN	14.91	47.25	-97.33	-24.94	12.77	-40.85	-79.44	4.21
ccsbBroad304_09198	OE	HOPX	Homeoboxes / PRD class, HOP homeobox			10.00, 10.00	0.64, 0.18	-34.35	88.18	86.62	5.16	-87.66	48.23	98.16	-51.02	-85.40	26.57
ccsbBroad304_05038	OE	HORMAD2	HORMA domain containing 2			0.00, 0.00	0.92, 0.34	36.33	83.85	-17.25	NaN	-73.97	-90.03	-98.49	-52.88	-93.01	-91.66
ccsbBroad304_00769	OE	HOXA1	Homeoboxes / ANTP class : HOXL subclass, homeobox A1			20.00, 10.00	1.08, 0.33	-62.08	-24.21	-99.79	99.58	-42.61	-92.10	-35.73	-32.62	96.09	-22.96
ccsbBroad304_00771	OE	HOXA5	Homeoboxes / ANTP class : HOXL subclass, homeobox A5			22.22, 22.22	2.30, 0.63	-82.64	99.91	-44.99	NaN	-99.54	-33.72	99.98	-97.80	91.18	-85.90
ccsbBroad304_00773	OE	HOXA9	Homeoboxes / ANTP class : HOXL subclass, homeobox A9		Homeobox Gene GOF	0.00, 0.00	2.32, 0.65	-86.35	-30.46	-95.63	NaN	-96.11	-99.85	-44.99	-99.59	28.90	-98.52
ccsbBroad304_02451	OE	HOXB13	Homeoboxes / ANTP class : HOXL subclass, homeobox B13			0.00, 0.00	4.59, 0.94	-32.89	NaN	-99.08	25.60	-98.72	-99.90	-73.59	-99.94	21.59	-99.44
ccsbBroad304_00775	OE	HOXB5	Homeoboxes / ANTP class : HOXL subclass, homeobox B5			20.00, 20.00	1.18, 0.36	-26.20	-36.36	41.72	56.07	-57.60	-92.22	98.37	99.78	39.26	23.13
ccsbBroad304_06398	OE	HPN	Serine peptidases / Transmembrane, hepsin		Serine proteases GOF	0.00, 0.00	1.68, 0.56	-46.75	49.67	-35.11	NaN	-47.71	-99.43	-35.42	-99.90	-49.32	-35.73
ccsbBroad304_00789	OE	HSBP1	heat shock factor binding protein 1			0.00, 0.00	1.30, 0.35	-38.11	92.36	-97.07	NaN	37.68	-45.33	-34.31	-29.60	-99.57	-44.05
ccsbBroad304_08239	OE	HSD17B11	Short chain dehydrogenase/reductase superfamily / Classical SDR fold cluster 3, hydroxysteroid (17-beta) dehydrogenase 11			0.00, 0.00	1.05, 0.32	-66.19	36.23	-95.28	-31.76	38.30	48.64	28.37	-46.16	67.84	-6.44
ccsbBroad304_00792	OE	HSD17B2	Short chain dehydrogenase/reductase superfamily / Classical SDR fold cluster 2, hydroxysteroid (17-beta) dehydrogenase 2			0.00, 0.00	1.17, 0.41	-87.34	-96.54	73.00	-99.63	45.41	55.70	-94.45	-62.93	-26.34	-95.85
ccsbBroad304_00793	OE	HSD17B4	Short chain dehydrogenase/reductase superfamily / Classical SDR fold cluster 3, hydroxysteroid (17-beta) dehydrogenase 4			0.00, 0.00	1.09, 0.33	40.07	28.59	83.01	-24.21	-51.44	34.76	-50.46	-71.69	-80.83	-35.01
ccsbBroad304_01844	OE	HSD17B8	Short chain dehydrogenase/reductase superfamily / Classical SDR fold cluster 1, hydroxysteroid (17-beta) dehydrogenase 8			0.00, 0.00	0.82, 0.27	45.07	-58.25	-52.35	27.28	34.80	62.39	-70.72	-62.42	62.18	-19.74
ccsbBroad304_00797	OE	HSPA2	Heat shock proteins / HSP70, heat shock 70kDa protein 2			22.22, 11.11	1.02, 0.35	-42.11	99.96	46.77	NaN	-92.02	62.71	97.14	-43.51	-97.45	-43.99
ccsbBroad304_06410	OE	HSPA8	Heat shock proteins / HSP70, heat shock 70kDa protein 8			0.00, 0.00	0.88, 0.19	28.09	35.98	-21.96	-88.55	-40.85	-60.22	-43.42	-33.72	66.06	-6.16
ccsbBroad304_00800	OE	HSPD1	Heat Shock Proteins / Chaperonins, heat shock 60kDa protein 1 (chaperonin)			20.00, 20.00	1.00, 0.30	98.67	-36.68	17.76	87.74	-39.24	99.97	-78.91	-30.75	72.46	67.44
ccsbBroad304_07633	OE	HTATIP2	Short chain dehydrogenase/reductase superfamily / Atypical members, HIV-1 Tat interactive protein 2, 30kDa			22.22, 11.11	1.14, 0.26	-43.37	99.87	17.76	NaN	-32.48	-23.61	96.35	73.18	-37.54	42.38
ccsbBroad304_07287	OE	HYAL2	hyaluronoglucosaminidase 2			10.00, 10.00	0.77, 0.27	99.78	73.20	-48.20	72.38	-96.58	78.27	-56.21	-65.10	-23.18	51.45
ccsbBroad304_06422	OE	ID3	Basic helix-loop-helix proteins, inhibitor of DNA binding 3, dominant negative helix-loop-helix protein			11.11, 11.11	1.00, 0.26	-26.39	-99.96	-98.50	NaN	-93.07	45.90	99.62	-33.34	-32.17	-74.51
ccsbBroad304_00816	OE	IDE	Pitrilysin, insulin-degrading enzyme			40.00, 30.00	0.75, 0.14	-95.14	99.93	96.12	-73.48	-27.32	45.81	88.55	80.38	99.93	98.79
ccsbBroad304_00817	OE	IDH2	isocitrate dehydrogenase 2 (NADP+), mitochondrial			0.00, 0.00	1.38, 0.25	46.53	65.02	-88.57	37.95	-97.89	-20.05	-74.93	-36.19	32.72	-54.84
ccsbBroad304_00819	OE	IDH3B	isocitrate dehydrogenase 3 (NAD+) beta			0.00, 0.00	1.44, 0.43	-42.97	-73.28	-13.03	-47.59	50.91	-34.05	-68.20	-99.06	-96.13	-70.01
ccsbBroad304_08839	OE	IFIH1	interferon induced with helicase C domain 1			20.00, 10.00	0.84, 0.25	97.90	-42.56	-22.80	24.95	-36.12	-85.27	-26.01	35.41	97.30	4.07
ccsbBroad304_07935	OE	IFIT5	Tetratricopeptide (TTC) repeat domain containing, interferon-induced protein with tetratricopeptide repeats 5			20.00, 10.00	1.18, 0.31	94.22	-37.65	-91.60	59.23	99.42	96.12	-27.02	73.23	61.94	81.67
ccsbBroad304_00832	OE	IFNB1	Interferons, interferon, beta 1, fibroblast			0.00, 0.00	4.36, 1.22	-89.05	-89.59	-99.98	-87.09	-99.39	-99.69	-99.76	-99.98	36.20	-99.86
ccsbBroad304_00834	OE	IFNGR1	Interferon receptor family, interferon gamma receptor 1			0.00, 0.00	1.49, 0.49	67.56	-33.67	-79.10	-76.29	57.56	87.57	-95.18	-96.48	25.96	-78.56
ccsbBroad304_10901	OE	IGF1R	Type II RTKs: Insulin receptor family, insulin-like growth factor 1 receptor			20.00, 10.00	1.10, 0.30	73.52	84.55	-85.45	-74.51	-29.45	95.44	59.21	-95.85	98.37	72.27
ccsbBroad304_00836	OE	IGF2	insulin-like growth factor 2 (somatomedin A)			10.00, 10.00	1.22, 0.27	41.94	79.20	99.94	33.01	57.42	84.10	-42.97	60.19	-83.08	69.62
ccsbBroad304_07663	OE	IGF2BP3	RNA binding motif (RRM) containing, insulin-like growth factor 2 mRNA binding protein 3			0.00, 0.00	1.07, 0.32	79.69	69.22	-85.32	NaN	-13.67	35.36	-44.99	82.85	-99.69	18.60
ccsbBroad304_00838	OE	IGFBP5	insulin-like growth factor (IGF) binding proteins, insulin-like growth factor binding protein 5			0.00, 0.00	1.80, 0.53	34.64	-86.24	-45.59	NaN	-89.39	-72.70	-99.64	-94.74	37.57	-83.97
ccsbBroad304_09354	OE	IGSF8	CD molecules, immunoglobulin superfamily, member 8			11.11, 11.11	1.01, 0.36	-74.97	-99.87	50.39	NaN	93.51	32.68	25.04	59.30	99.96	25.43
ccsbBroad304_04752	OE	IKBIP	IKBKB interacting protein			10.00, 0.00	1.14, 0.33	-97.73	88.15	7.59	-98.49	37.28	95.03	-99.01	-30.49	-30.85	-59.80
ccsbBroad304_01945	OE	IKBKG	Zinc fingers, C2HC-type containing, inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma			10.00, 10.00	0.99, 0.17	11.56	69.14	-77.82	99.98	-58.42	-80.15	-16.42	38.95	-99.97	-31.63
ccsbBroad304_00862	OE	IL13RA2	IL-2 receptor family, interleukin 13 receptor, alpha 2			0.00, 0.00	0.89, 0.35	68.14	56.76	-13.42	-62.37	-29.39	89.06	-65.15	46.96	-87.12	14.98
ccsbBroad304_00843	OE	IL1B	Interleukins and interleukin receptors, interleukin 1, beta			11.11, 11.11	1.05, 0.32	53.50	-97.64	-91.17	NaN	-67.23	48.02	99.96	-35.37	29.66	-44.04
ccsbBroad304_00844	OE	IL1R1	Interleukins and interleukin receptors, interleukin 1 receptor, type I			0.00, 0.00	1.38, 0.31	-86.42	-98.12	38.10	-96.72	-60.23	-72.24	-99.98	-99.98	-27.62	-99.72
ccsbBroad304_01833	OE	IL1R2	Immunoglobulin-like family of IL-1 receptors, interleukin 1 receptor, type II			0.00, 0.00	0.88, 0.26	94.08	-96.67	64.03	-72.56	-74.29	-88.01	-33.57	54.20	37.38	-55.08
ccsbBroad304_06438	OE	IL2RB	IL-2 receptor family, interleukin 2 receptor, beta			10.00, 0.00	1.63, 0.50	95.47	44.62	-25.12	-49.31	-64.84	-99.69	-14.09	-64.49	41.31	-27.64
ccsbBroad304_00853	OE	IL7R	IL-2 receptor family, interleukin 7 receptor			20.00, 10.00	0.93, 0.23	99.75	-49.33	-50.33	47.38	-95.43	-36.94	96.01	47.18	-91.16	-25.55
ccsbBroad304_00854	OE	IL8	interleukin 8			11.11, 0.00	0.80, 0.32	-26.68	36.34	-98.82	NaN	29.10	96.20	-96.78	-39.70	70.56	-25.96
ccsbBroad304_06450	OE	ILK	Ankyrin repeat domain containing, integrin-linked kinase			20.00, 20.00	0.90, 0.31	-94.14	-64.63	-71.90	92.07	-53.20	99.97	-33.89	99.85	35.76	60.14
ccsbBroad304_00867	OE	IMPDH2	Oxidoreductases, IMP (inosine 5'-monophosphate) dehydrogenase 2			0.00, 0.00	1.10, 0.39	87.49	73.11	-43.76	-78.44	-91.60	78.95	-25.67	23.53	34.32	23.07
ccsbBroad304_12059	OE	ING3	Zinc fingers, PHD-type, inhibitor of growth family, member 3			0.00, 0.00	0.81, 0.22	-47.63	59.57	48.17	NaN	-47.24	42.74	-73.61	45.36	-90.97	-42.34
ccsbBroad304_04292	OE	INHBE	inhibin, beta E			0.00, 0.00	1.93, 0.73	-71.41	NaN	-45.05	-81.10	74.98	35.39	-99.93	28.09	92.07	-62.37
ccsbBroad304_00873	OE	INPP1	Inositol polyphosphate phosphatases, inositol polyphosphate-1-phosphatase			0.00, 0.00	1.26, 0.31	54.69	41.78	38.68	40.21	93.95	83.66	16.26	-74.22	-98.16	23.13
ccsbBroad304_00874	OE	INS	insulin			10.00, 0.00	0.94, 0.18	96.68	56.20	-37.07	-54.03	-67.34	-44.50	-66.05	-46.50	-68.86	-34.04
ccsbBroad304_03785	OE	INTS12	Zinc fingers, PHD-type, integrator complex subunit 12			11.11, 11.11	1.26, 0.31	-38.99	99.82	-99.23	NaN	-98.67	-56.16	-96.13	-56.03	25.35	-94.58
ccsbBroad304_07491	OE	IP6K1	inositol hexakisphosphate kinase 1			20.00, 10.00	0.81, 0.25	59.93	-78.33	59.01	-93.05	-81.96	96.86	-70.47	-77.89	99.62	-79.29
ccsbBroad304_00880	OE	IRF2	interferon regulatory factor 2			0.00, 0.00	1.11, 0.33	-42.41	-29.75	53.41	-98.96	-65.21	-89.42	93.73	94.00	-79.95	-65.90
ccsbBroad304_06458	OE	IRF3	interferon regulatory factor 3			20.00, 0.00	1.34, 0.50	39.22	26.42	20.22	96.67	31.59	96.74	65.31	-41.17	79.78	54.44
ccsbBroad304_02414	OE	IRF9	interferon regulatory factor 9			20.00, 10.00	0.99, 0.27	-75.35	26.97	95.11	40.19	-97.74	99.21	-54.20	-67.06	-36.28	-40.74
ccsbBroad304_09316	OE	ISX	Homeoboxes / PRD class, intestine-specific homeobox			11.11, 11.11	1.25, 0.35	-96.08	43.16	98.26	NaN	80.61	71.92	-56.57	-99.98	-87.22	-87.60
ccsbBroad304_06462	OE	ITGAE	Integrins, integrin, alpha E (antigen CD103, human mucosal lymphocyte antigen 1; alpha polypeptide)			0.00, 0.00	1.00, 0.25	75.02	83.77	43.42	91.01	59.23	-72.11	-78.37	41.66	-50.65	47.66
ccsbBroad304_00888	OE	ITPK1	inositol-tetrakisphosphate 1-kinase			10.00, 10.00	0.93, 0.31	99.09	-54.77	-20.01	62.84	-72.50	-46.17	68.68	-40.07	-93.02	-37.71
ccsbBroad304_02737	OE	JMJD6	jumonji domain containing 6			0.00, 0.00	0.98, 0.25	43.88	-32.42	-18.31	NaN	-42.89	-64.93	-97.99	58.84	32.81	-4.95
ccsbBroad304_00889	OE	JUNB	basic leucine zipper proteins, jun B proto-oncogene			0.00, 0.00	0.98, 0.19	-58.20	-76.66	-99.75	47.29	-36.46	-87.18	89.99	-99.94	38.48	-88.05
ccsbBroad304_06469	OE	KARS	Aminoacyl tRNA synthetases / Class II, lysyl-tRNA synthetase			0.00, 0.00	1.42, 0.49	23.25	-33.88	-60.05	NaN	69.89	-66.10	-89.65	-99.23	51.79	-34.24
ccsbBroad304_00902	OE	KCNN4	Calcium-activated potassium channels, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4			10.00, 10.00	1.65, 0.56	-36.14	-91.62	-54.11	44.62	98.47	21.03	-72.93	-33.96	-32.67	-23.35
ccsbBroad304_07724	OE	KDELR2	KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 2			10.00, 10.00	0.97, 0.32	98.68	81.16	9.30	76.81	61.01	-39.07	31.44	-62.96	5.49	35.76
ccsbBroad304_02596	OE	KDELR3	KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 3			0.00, 0.00	0.97, 0.34	56.68	83.76	45.35	52.04	-97.98	-27.06	91.18	89.33	38.66	48.68
ccsbBroad304_02318	OE	KIF20A	Kinesins, kinesin family member 20A			11.11, 11.11	0.86, 0.23	-73.87	59.47	-67.25	NaN	40.02	40.75	99.82	-34.67	76.38	16.06
ccsbBroad304_08840	OE	KIF9	Kinesins, kinesin family member 9			0.00, 0.00	0.69, 0.13	60.52	-99.82	67.47	36.81	-81.29	56.22	61.54	-61.47	84.38	25.46
ccsbBroad304_08267	OE	KLF3	Kruppel-like transcription factors, Kruppel-like factor 3 (basic)			11.11, 11.11	3.35, 0.75	-39.82	98.67	-71.74	NaN	-46.55	-82.18	-88.24	-54.22	-24.42	-87.48
ccsbBroad304_02804	OE	KLHDC2	kelch domain containing 2			0.00, 0.00	0.69, 0.19	40.50	77.58	-17.78	NaN	-46.32	-35.83	-23.35	-51.43	-31.53	-3.52
ccsbBroad304_09503	OE	KLHDC9	kelch domain containing 9			10.00, 10.00	1.48, 0.41	-28.13	-27.65	-86.35	-31.19	91.18	-87.61	-45.96	99.79	43.25	-27.67
ccsbBroad304_06496	OE	KNG1	Endogenous ligands, kininogen 1			0.00, 0.00	1.84, 0.60	-44.84	-96.46	-69.40	65.56	-36.10	91.88	-87.44	-54.64	32.54	-52.91
ccsbBroad304_13499	OE	KSR2	RAF family, kinase suppressor of ras 2			30.00, 10.00	1.25, 0.39	18.04	-53.59	81.68	99.79	59.59	-72.73	96.79	-36.25	95.47	93.57
ccsbBroad304_02052	OE	KYNU	kynureninase			11.11, 11.11	1.07, 0.30	-53.53	-76.42	99.48	NaN	-28.16	83.96	37.17	-56.22	-31.52	-21.20
ccsbBroad304_02398	OE	LANCL1	LanC lantibiotic synthetase component C-like 1 (bacterial)			10.00, 10.00	2.09, 0.67	-98.37	-18.92	-40.59	-53.30	93.29	27.02	-84.02	66.81	97.99	44.43
ccsbBroad304_08203	OE	LAP3	Leucyl aminopeptidase, leucine aminopeptidase 3			0.00, 0.00	1.02, 0.30	64.77	34.53	-65.42	NaN	-87.83	64.81	39.27	-95.94	-94.18	-76.82
ccsbBroad304_06518	OE	LDHA	lactate dehydrogenase A			0.00, 0.00	1.24, 0.33	-33.46	33.03	24.61	NaN	60.21	-58.26	73.55	-39.18	55.54	12.03
ccsbBroad304_00936	OE	LGALS1	Endogenous ligands, lectin, galactoside-binding, soluble, 1			0.00, 0.00	0.66, 0.19	-94.21	-99.96	79.22	NaN	-99.41	-58.54	-61.96	52.62	-85.52	-96.73
ccsbBroad304_10438	OE	LGALS8	Lectins, galactoside-binding, lectin, galactoside-binding, soluble, 8			0.00, 0.00	0.78, 0.19	-85.55	28.29	22.28	-36.31	-95.15	44.83	52.49	-27.69	-95.45	-23.31
ccsbBroad304_06783	OE	LGMN	Legumain, legumain			0.00, 0.00	1.66, 0.34	35.60	-70.75	-30.95	53.64	-46.80	31.68	-30.31	-28.23	65.09	-6.53
ccsbBroad304_04496	OE	LHX4	Homeoboxes / LIM class, LIM homeobox 4		Homeobox Gene GOF, LIM class homeoboxes GOF	0.00, 0.00	1.02, 0.33	68.19	-93.50	-50.21	58.23	-94.64	43.32	-48.28	-99.79	-45.46	-88.35
ccsbBroad304_10157	OE	LHX8	Homeoboxes / LIM class, LIM homeobox 8		LIM class homeoboxes GOF	11.11, 11.11	1.08, 0.28	-55.61	-30.19	-67.96	NaN	-24.12	-94.26	-71.08	-72.91	99.02	-74.11
ccsbBroad304_00941	OE	LIG3	ligase III, DNA, ATP-dependent			0.00, 0.00	1.17, 0.33	-90.55	-52.78	67.80	NaN	64.97	75.84	86.75	-43.85	-47.11	51.62
ccsbBroad304_08325	OE	LIPT1	lipoyltransferase 1			20.00, 20.00	0.86, 0.33	67.96	-23.76	98.63	-98.31	-35.44	46.32	48.02	92.89	99.90	68.99
ccsbBroad304_00477	OE	LPAR1	GPCR / Class A : Lysophospholipid receptors : Lysophosphatidic acid, lysophosphatidic acid receptor 1			20.00, 20.00	2.77, 0.99	32.33	-64.49	98.23	13.34	53.97	64.71	99.54	-95.73	-99.96	47.65
ccsbBroad304_02271	OE	LPGAT1	lysophosphatidylglycerol acyltransferase 1			0.00, 0.00	1.00, 0.33	77.42	-88.38	-99.30	51.57	-30.59	92.15	-66.13	-38.96	88.44	46.92
ccsbBroad304_07411	OE	LPXN	leupaxin			20.00, 20.00	0.88, 0.17	99.98	99.60	-55.43	-85.47	-94.96	-46.11	-98.15	64.34	-34.28	-72.39
ccsbBroad304_03853	OE	LSM2	LSM2 homolog, U6 small nuclear RNA associated (S. cerevisiae)			20.00, 20.00	0.92, 0.33	99.80	42.59	-43.05	-41.43	-31.65	99.45	40.58	-47.65	54.95	38.64
ccsbBroad304_02633	OE	LSM6	LSM6 homolog, U6 small nuclear RNA associated (S. cerevisiae)			20.00, 10.00	1.17, 0.31	28.31	-99.21	-28.87	-98.66	96.65	99.91	-53.51	55.79	-90.57	-82.86
ccsbBroad304_06538	OE	LSP1	lymphocyte-specific protein 1			10.00, 10.00	0.90, 0.23	-32.05	-51.33	-65.76	-91.82	98.55	39.20	-83.03	80.12	32.05	-48.26
ccsbBroad304_00956	OE	LYZ	lysozyme			0.00, 0.00	1.19, 0.34	45.10	-25.03	-54.06	NaN	-22.80	28.89	94.37	-84.07	-41.65	-19.30
ccsbBroad304_00957	OE	M6PR	mannose-6-phosphate receptor (cation dependent)			0.00, 0.00	1.68, 0.47	-95.13	-86.26	-27.76	NaN	77.16	91.78	-37.71	-74.32	-74.17	-70.35
ccsbBroad304_02203	OE	MAD2L1BP	MAD2L1 binding protein			0.00, 0.00	0.98, 0.27	71.34	35.68	-99.93	NaN	-99.98	-39.53	-26.56	51.11	-51.59	-12.79
ccsbBroad304_02175	OE	MAGED1	melanoma antigen family D, 1			22.22, 22.22	1.55, 0.43	-99.89	-66.82	-93.05	NaN	48.41	98.31	-54.39	36.83	98.69	-75.36
ccsbBroad304_06557	OE	MAOA	Catecholamine turnover, monoamine oxidase A			22.22, 22.22	2.16, 0.58	99.98	NaN	56.70	42.66	-95.70	-15.88	56.82	99.96	-42.77	34.34
ccsbBroad304_06558	OE	MAOB	Catecholamine turnover, monoamine oxidase B			10.00, 10.00	0.99, 0.31	88.89	61.69	42.30	-97.05	-82.24	-99.85	-63.48	99.68	92.44	75.46
ccsbBroad304_01290	OE	MAP2K5	MAPKK:STE7 family, mitogen-activated protein kinase kinase 5			20.00, 20.00	1.75, 0.57	-39.34	-42.16	97.79	99.55	-70.57	-25.01	-37.43	91.68	22.42	34.35
ccsbBroad304_07349	OE	MAP7	microtubule-associated protein 7			11.11, 11.11	1.66, 0.43	-66.62	NaN	-40.38	-47.05	-46.58	99.93	71.07	-99.82	-98.71	-54.56
ccsbBroad304_06911	OE	MAPK12	MAPK:p38 subfamily, mitogen-activated protein kinase 12			0.00, 0.00	1.08, 0.43	93.32	-82.76	-66.06	-82.64	92.91	-94.21	34.17	55.21	25.93	-35.58
ccsbBroad304_01289	OE	MAPK13	MAPK:p38 subfamily, mitogen-activated protein kinase 13			10.00, 10.00	1.15, 0.32	84.32	-34.42	75.00	-21.32	99.96	56.38	36.23	90.77	91.48	89.95
ccsbBroad304_01287	OE	MAPK8	MAPK:JNK subfamily, mitogen-activated protein kinase 8			11.11, 11.11	1.11, 0.36	86.40	99.10	-25.18	NaN	-98.78	-42.43	-28.90	-23.46	-48.85	-6.92
ccsbBroad304_01836	OE	MAPKAPK3	MAPKAPK subfamily, mitogen-activated protein kinase-activated protein kinase 3			10.00, 10.00	1.11, 0.32	71.69	-76.24	76.71	67.64	-33.06	-39.96	-98.17	-80.13	99.93	37.34
ccsbBroad304_06562	OE	MAT1A	methionine adenosyltransferase I, alpha			20.00, 20.00	1.65, 0.49	28.83	-29.18	-90.77	31.90	99.94	82.18	-57.80	-47.84	99.93	40.60
ccsbBroad304_00975	OE	MAT2A	methionine adenosyltransferase II, alpha			0.00, 0.00	0.92, 0.34	-51.44	-34.55	49.85	72.75	-42.92	21.93	47.21	-35.75	5.55	5.06
ccsbBroad304_08089	OE	MAT2B	Short chain dehydrogenase/reductase superfamily / Extended SDR fold, methionine adenosyltransferase II, beta			0.00, 0.00	0.75, 0.30	41.46	87.34	21.33	-81.55	-29.91	-87.95	91.51	-99.27	12.91	-18.55
ccsbBroad304_00977	OE	MAX	Basic helix-loop-helix proteins, MYC associated factor X			20.00, 10.00	1.05, 0.26	-59.16	-45.83	-30.85	95.80	98.36	-60.11	29.24	-99.85	56.54	35.62
ccsbBroad304_06565	OE	MB	myoglobin			0.00, 0.00	0.99, 0.30	76.60	NaN	-93.81	-41.97	-98.46	-95.34	-50.56	-84.68	-98.84	-99.54
ccsbBroad304_00985	OE	MCL1	myeloid cell leukemia sequence 1 (BCL2-related)			11.11, 11.11	1.08, 0.26	32.06	-36.72	-72.97	NaN	-47.69	93.03	-34.99	51.29	99.24	15.35
ccsbBroad304_00986	OE	MCM2	minichromosome maintenance complex component 2			0.00, 0.00	1.33, 0.32	-45.53	-43.45	-56.05	NaN	94.18	91.41	81.79	-97.27	-90.10	-65.42
ccsbBroad304_09195	OE	MCM8	minichromosome maintenance complex component 8			11.11, 11.11	1.09, 0.27	27.34	-82.05	-98.99	NaN	43.72	-53.58	68.74	-29.70	99.14	7.63
ccsbBroad304_03806	OE	MCOLN1	Voltage-gated ion channels / Transient receptor potential cation channels, mucolipin 1			0.00, 0.00	1.59, 0.40	-97.32	-35.48	-99.80	NaN	28.43	-97.54	39.09	-82.95	-30.14	-98.43
ccsbBroad304_03056	OE	MCTS1	malignant T cell amplified sequence 1			10.00, 10.00	1.20, 0.33	98.66	78.90	-42.60	69.12	-41.01	23.53	17.51	62.31	71.03	58.25
ccsbBroad304_00991	OE	MDH1	malate dehydrogenase 1, NAD (soluble)			11.11, 11.11	1.09, 0.24	99.96	32.44	83.46	NaN	29.15	-32.90	-30.55	-82.75	52.48	23.76
ccsbBroad304_00995	OE	MECP2	methyl CpG binding protein 2 (Rett syndrome)			20.00, 10.00	1.02, 0.20	43.17	-38.58	66.10	24.47	82.75	99.97	97.13	60.96	22.74	73.48
ccsbBroad304_04202	OE	MED28	mediator complex subunit 28			0.00, 0.00	1.11, 0.27	52.03	NaN	-86.35	-99.98	-86.70	74.16	20.07	35.10	-61.23	-81.44
ccsbBroad304_08104	OE	MED4	mediator complex subunit 4			22.22, 0.00	1.10, 0.32	71.81	96.60	-74.96	NaN	24.74	95.60	-50.48	41.78	-51.96	77.61
ccsbBroad304_02285	OE	MED6	mediator complex subunit 6			11.11, 0.00	1.01, 0.28	79.02	24.71	-64.80	NaN	93.40	-24.48	-40.74	42.58	95.83	33.95
ccsbBroad304_02163	OE	MED7	mediator complex subunit 7			0.00, 0.00	1.27, 0.34	83.43	-27.28	-37.11	-77.00	-76.37	-41.85	-50.78	57.03	54.05	-28.81
ccsbBroad304_00998	OE	MEIS2	Homeoboxes / TALE class, Meis homeobox 2			0.00, 0.00	1.72, 0.43	-77.82	-85.67	-99.72	-97.62	-73.23	-99.96	-56.75	-99.84	45.26	-97.61
ccsbBroad304_11503	OE	MERTK	Type XI RTKs: TAM (TYRO3-, AXL- and MER-TK) receptor family, c-mer proto-oncogene tyrosine kinase			10.00, 0.00	0.95, 0.18	-35.63	-89.62	12.11	-32.46	-97.56	88.53	93.46	97.32	34.92	26.10
ccsbBroad304_01001	OE	MEST	mesoderm specific transcript homolog (mouse)			10.00, 10.00	0.94, 0.32	-33.32	66.00	90.05	-46.04	94.07	-99.69	-72.75	-31.77	99.96	73.31
ccsbBroad304_01002	OE	METTL1	methyltransferase like 1			0.00, 0.00	1.03, 0.24	12.23	81.82	-43.92	38.91	33.29	-48.19	-76.34	-88.00	-15.14	-5.68
ccsbBroad304_03848	OE	METTL14	methyltransferase like 14			10.00, 0.00	1.13, 0.32	-34.73	96.15	-50.70	50.01	-43.10	77.77	93.32	-39.94	-55.90	29.61
ccsbBroad304_02361	OE	MFSD10	major facilitator superfamily domain containing 10			0.00, 0.00	0.86, 0.31	-97.53	29.01	-98.78	-63.86	40.86	-31.06	69.84	-36.65	8.03	-11.55
ccsbBroad304_02681	OE	MGLL	Endocannabinoid turnover, monoglyceride lipase			11.11, 11.11	1.20, 0.31	46.13	-38.84	-29.99	NaN	-44.98	76.17	-81.67	99.59	-46.46	-12.95
ccsbBroad304_10857	OE	MKNK2	MKN subfamily, MAP kinase interacting serine/threonine kinase 2			22.22, 11.11	1.15, 0.31	45.30	99.82	16.20	NaN	97.14	-55.99	87.05	-39.55	-99.97	83.03
ccsbBroad304_09934	OE	MKX	Homeoboxes / TALE class, mohawk homeobox			10.00, 0.00	1.01, 0.38	94.06	-41.07	23.09	-47.81	95.80	-25.03	27.63	36.05	-97.51	4.44
ccsbBroad304_01854	OE	MLLT10	Zinc fingers, PHD-type, myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 10			0.00, 0.00	0.95, 0.23	35.24	-96.25	78.21	NaN	-77.29	47.71	70.87	-36.09	-53.46	25.74
ccsbBroad304_02576	OE	MLLT11	myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 11			0.00, 0.00	0.86, 0.32	-49.46	-80.55	-33.42	-93.07	-65.49	-83.56	37.42	-33.98	7.99	-67.37
ccsbBroad304_10971	OE	MLLT6	Zinc fingers, PHD-type, myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 6			20.00, 20.00	1.08, 0.40	99.98	-44.93	98.84	-45.44	-49.58	-31.87	-99.98	-80.38	66.79	-28.87
ccsbBroad304_03937	OE	MLST8	WD repeat domain containing, MTOR associated protein, LST8 homolog (S. cerevisiae)			10.00, 0.00	1.02, 0.26	-94.75	28.50	-99.18	52.31	70.69	95.11	-88.51	-80.99	-99.95	-98.80
ccsbBroad304_06587	OE	MMP1	Matrix metallopeptidase, matrix metallopeptidase 1 (interstitial collagenase)			10.00, 10.00	1.07, 0.34	49.34	99.69	90.71	-51.91	-64.20	-96.41	-68.74	54.67	-96.97	-70.37
ccsbBroad304_06592	OE	MMP14	Matrix metallopeptidase, matrix metallopeptidase 14 (membrane-inserted)			0.00, 0.00	0.92, 0.26	80.32	-36.82	38.61	NaN	86.76	-92.28	-36.56	37.80	-52.18	16.33
ccsbBroad304_06590	OE	MMP7	Matrix metallopeptidase, matrix metallopeptidase 7 (matrilysin, uterine)			0.00, 0.00	0.75, 0.19	-98.33	-43.42	-70.00	NaN	-89.95	47.18	-15.47	-58.28	-87.71	-87.46
ccsbBroad304_01026	OE	MNAT1	RING-type (C3HC4) zinc fingers, menage a trois homolog 1, cyclin H assembly factor (Xenopus laevis)			11.11, 0.00	1.56, 0.52	-94.82	-45.34	-29.08	NaN	-75.83	93.57	-63.71	-39.45	97.23	-49.79
ccsbBroad304_02219	OE	MORF4L2	mortality factor 4 like 2			0.00, 0.00	1.42, 0.24	-73.86	-47.09	35.23	-92.10	-48.86	33.56	-36.86	-63.07	42.23	-45.03
ccsbBroad304_14008	OE	MPZL1	Immunoglobulin superfamily / V-set domain containing, myelin protein zero-like 1			11.11, 0.00	1.33, 0.38	-26.20	95.92	40.86	NaN	-55.38	36.14	49.69	-46.54	-99.86	-31.33
ccsbBroad304_09446	OE	MRGPRX4	GPCR / Class A : Orphans, MAS-related GPR, member X4			0.00, 0.00	1.02, 0.28	29.56	-57.29	-14.81	68.34	91.24	-78.97	35.81	-91.50	-26.00	8.01
ccsbBroad304_01034	OE	MSH2	mutS homolog 2, colon cancer, nonpolyposis type 1 (E. coli)			0.00, 0.00	1.55, 0.57	-30.90	92.18	-32.99	-34.02	47.20	59.97	-82.17	-65.05	53.57	8.47
ccsbBroad304_02702	OE	MSRB2	methionine sulfoxide reductase B2			0.00, 0.00	1.45, 0.39	-99.81	-55.45	-98.35	-98.80	53.05	53.02	-72.00	39.44	-71.92	-95.34
ccsbBroad304_06597	OE	MSX2	Homeoboxes / ANTP class : NKL subclass, msh homeobox 2			10.00, 10.00	1.49, 0.40	22.06	-98.13	84.75	-37.17	38.14	-93.84	-95.63	-34.41	99.52	-69.54
ccsbBroad304_02688	OE	MTF2	Zinc fingers, PHD-type, metal response element binding transcription factor 2			10.00, 10.00	1.05, 0.39	25.72	-34.34	-29.91	39.06	77.15	99.79	-97.85	48.74	38.66	10.14
ccsbBroad304_02955	OE	MYCBP	c-myc binding protein			0.00, 0.00	1.16, 0.34	54.28	NaN	-82.27	91.06	-81.14	63.13	-98.90	-36.97	-36.00	-77.41
ccsbBroad304_04191	OE	NAA50	N(alpha)-acetyltransferase subunits, N(alpha)-acetyltransferase 50, NatE catalytic subunit			0.00, 0.00	0.99, 0.38	34.98	48.35	-90.69	NaN	-43.61	35.86	86.17	59.60	92.52	31.00
ccsbBroad304_01061	OE	NAB2	NGFI-A binding protein 2 (EGR1 binding protein 2)			0.00, 0.00	1.03, 0.26	68.35	51.83	-29.41	NaN	-42.02	35.80	47.87	87.53	64.87	36.74
ccsbBroad304_12226	OE	NAGK	N-acetylglucosamine kinase			10.00, 0.00	1.01, 0.32	-43.17	89.44	-45.41	-58.02	-94.89	96.03	-22.32	90.21	-24.72	-10.65
ccsbBroad304_06617	OE	NASP	Tetratricopeptide (TTC) repeat domain containing, nuclear autoantigenic sperm protein (histone-binding)			10.00, 0.00	0.99, 0.23	52.91	97.46	80.51	20.05	31.97	-84.27	45.57	-55.71	-74.56	28.72
ccsbBroad304_02419	OE	NDRG1	N-myc downstream regulated 1			10.00, 10.00	1.53, 0.41	56.12	-87.51	74.84	50.00	99.57	-65.60	51.87	-54.45	45.57	57.36
ccsbBroad304_01064	OE	NDUFA1	Mitochondrial respiratory chain complex / Complex I, NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 1, 7.5kDa			0.00, 0.00	1.05, 0.32	-79.87	-66.16	-16.15	-96.09	-98.37	-35.74	-95.93	-85.59	33.50	-93.43
ccsbBroad304_13911	OE	NDUFA9	Short chain dehydrogenase/reductase superfamily / Extended SDR fold, NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 9, 39kDa			10.00, 0.00	1.00, 0.36	58.19	-76.88	-17.91	77.04	-35.98	82.64	96.70	-95.70	-89.64	-47.28
ccsbBroad304_13912	OE	NDUFB1	Mitochondrial respiratory chain complex / Complex I, NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 1, 7kDa			0.00, 0.00	1.17, 0.38	-96.97	49.04	-97.90	94.79	57.94	35.11	74.44	36.39	83.08	64.54
ccsbBroad304_01070	OE	NDUFB3	Mitochondrial respiratory chain complex / Complex I, NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 3, 12kDa			10.00, 0.00	1.19, 0.39	-69.62	-99.78	27.66	-48.13	82.21	-58.68	71.75	96.07	23.75	22.20
ccsbBroad304_01071	OE	NDUFB5	Mitochondrial respiratory chain complex / Complex I, NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 5, 16kDa			0.00, 0.00	1.23, 0.31	47.41	-55.60	39.01	-93.05	-99.85	-99.97	-52.75	-77.14	61.96	-86.91
ccsbBroad304_01072	OE	NDUFB6	Mitochondrial respiratory chain complex / Complex I, NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 6, 17kDa			20.00, 20.00	1.34, 0.33	-67.51	-98.88	-31.94	-69.83	-48.04	-88.65	99.93	45.92	99.03	-63.28
ccsbBroad304_06624	OE	NDUFC2	Mitochondrial respiratory chain complex / Complex I, NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2, 14.5kDa			0.00, 0.00	1.41, 0.34	59.47	-74.17	-37.81	NaN	63.41	-46.49	-70.47	-99.98	-60.42	-41.23
ccsbBroad304_06625	OE	NDUFS4	Mitochondrial respiratory chain complex / Complex I, NADH dehydrogenase (ubiquinone) Fe-S protein 4, 18kDa (NADH-coenzyme Q reductase)			0.00, 0.00	1.38, 0.47	62.44	56.48	19.39	-37.77	-59.09	-67.03	-74.57	58.72	-44.47	-28.24
ccsbBroad304_01077	OE	NDUFS6	Mitochondrial respiratory chain complex / Complex I, NADH dehydrogenase (ubiquinone) Fe-S protein 6, 13kDa (NADH-coenzyme Q reductase)			10.00, 0.00	1.45, 0.55	47.32	-51.33	-27.35	-88.85	-77.21	-99.96	-67.43	65.68	95.55	-64.95
ccsbBroad304_10064	OE	NDUFS7	Mitochondrial respiratory chain complex / Complex I, NADH dehydrogenase (ubiquinone) Fe-S protein 7, 20kDa (NADH-coenzyme Q reductase)		NADH ubiquinone oxidoreductase core subunits GOF	10.00, 10.00	1.22, 0.36	42.09	-96.26	-45.00	-27.32	-80.60	-99.85	99.32	-78.99	80.95	-92.73
ccsbBroad304_01075	OE	NDUFV1	Mitochondrial respiratory chain complex / Complex I, NADH dehydrogenase (ubiquinone) flavoprotein 1, 51kDa			20.00, 10.00	1.10, 0.40	79.78	95.62	-51.34	-65.05	98.71	53.19	44.39	92.36	66.08	89.73
ccsbBroad304_01078	OE	NDUFV2	Mitochondrial respiratory chain complex / Complex I, NADH dehydrogenase (ubiquinone) flavoprotein 2, 24kDa		NADH ubiquinone oxidoreductase core subunits GOF	0.00, 0.00	1.45, 0.44	81.27	NaN	54.90	-70.65	-98.78	72.19	-42.88	-36.61	19.55	23.55
ccsbBroad304_07680	OE	NEK6	NIMA (never in mitosis gene a)- related kinase (NEK) family, NIMA (never in mitosis gene a)-related kinase 6			11.11, 11.11	1.48, 0.30	-29.05	98.24	-62.66	NaN	-72.39	-47.96	39.43	-99.04	78.50	-68.29
ccsbBroad304_07582	OE	NET1	Rho guanine nucleotide exchange factors, neuroepithelial cell transforming 1			0.00, 0.00	0.98, 0.31	-49.25	36.67	94.82	-40.58	-97.93	26.35	38.89	58.95	-26.34	11.81
ccsbBroad304_01084	OE	NEU1	sialidase 1 (lysosomal sialidase)			11.11, 0.00	0.90, 0.19	-28.82	-64.51	-20.33	NaN	97.25	93.46	81.37	-93.00	-37.11	12.89
ccsbBroad304_01088	OE	NFATC3	Nuclear factor of activated T-cells, nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 3			0.00, 0.00	1.11, 0.30	19.49	-99.96	-32.87	NaN	-82.45	-25.59	-84.21	44.51	-34.47	-53.69
ccsbBroad304_01093	OE	NFKBIA	Ankyrin repeat domain containing, nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha			0.00, 0.00	0.93, 0.26	37.24	-94.03	-98.90	-83.57	-44.93	36.86	-54.91	-37.16	38.81	-49.44
ccsbBroad304_01094	OE	NFKBIB	Ankyrin repeat domain containing, nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta			0.00, 0.00	1.61, 0.50	16.08	-31.21	-13.52	-66.93	-23.38	-27.02	-13.84	-34.19	-80.22	-4.49
ccsbBroad304_06639	OE	NFYB	nuclear transcription factor Y, beta			10.00, 0.00	1.27, 0.39	-98.49	-82.65	-92.35	95.81	-50.65	-27.70	-99.80	72.16	47.69	-94.03
ccsbBroad304_07362	OE	NMI	N-myc (and STAT) interactor			20.00, 20.00	1.36, 0.26	-84.90	73.21	-18.87	-64.12	39.92	97.79	-31.70	99.82	61.67	60.39
ccsbBroad304_08663	OE	NMUR2	GPCR / Class A : Neuromedin U receptors, neuromedin U receptor 2			11.11, 11.11	1.32, 0.34	33.99	36.42	-60.66	NaN	-98.27	62.28	99.96	-37.28	-44.40	19.23
ccsbBroad304_03191	OE	NOSIP	nitric oxide synthase interacting protein			20.00, 0.00	0.72, 0.17	44.84	45.67	78.39	39.73	-62.46	97.30	-54.20	97.10	35.64	37.74
ccsbBroad304_06651	OE	NOV	nephroblastoma overexpressed gene			10.00, 10.00	1.25, 0.38	-98.67	-33.57	-94.61	99.94	83.98	-27.26	-9.19	55.39	56.45	28.06
ccsbBroad304_02533	OE	NOXA1	NADPH oxidase activator 1			0.00, 0.00	0.82, 0.13	32.98	89.49	62.23	NaN	34.60	88.28	74.16	-72.04	-80.54	76.46
ccsbBroad304_07662	OE	NPRL2	nitrogen permease regulator-like 2 (S. cerevisiae)			0.00, 0.00	0.82, 0.22	23.01	-97.36	49.43	40.36	-35.05	-85.85	6.50	-61.89	-67.82	-21.36
ccsbBroad304_06645	OE	NQO2	NAD(P)H dehydrogenase, quinone 2			0.00, 0.00	2.07, 0.52	44.02	NaN	80.68	-41.86	77.56	-32.81	52.31	-72.12	-82.93	26.51
ccsbBroad304_00041	OE	NR0B1	DAX-like receptors, nuclear receptor subfamily 0, group B, member 1			22.22, 22.22	1.22, 0.28	-58.21	-90.67	-76.77	NaN	39.80	-36.76	98.86	99.95	-68.55	-56.38
ccsbBroad304_02299	OE	NR1H3	Liver X receptor-like receptors, nuclear receptor subfamily 1, group H, member 3			10.00, 10.00	1.39, 0.47	-80.65	32.75	-60.87	-74.85	39.79	-73.50	-59.37	-55.65	99.48	-63.45
ccsbBroad304_01709	OE	NR2C1	Testicular receptors, nuclear receptor subfamily 2, group C, member 1			0.00, 0.00	0.89, 0.33	81.82	81.92	31.99	-39.80	-21.53	-46.27	46.33	71.10	-37.25	32.14
ccsbBroad304_00593	OE	NR5A2	Fushi tarazu F1-like receptors, nuclear receptor subfamily 5, group A, member 2			0.00, 0.00	1.50, 0.47	41.34	-95.49	-98.83	35.31	34.50	-27.28	68.39	-95.51	67.46	-54.43
ccsbBroad304_03121	OE	NRBF2	nuclear receptor binding factor 2			0.00, 0.00	1.00, 0.31	91.12	88.57	-29.78	-94.80	-85.35	51.50	-54.96	-51.95	68.42	46.58
ccsbBroad304_03118	OE	NRBP1	NRBP family, nuclear receptor binding protein 1			11.11, 11.11	1.08, 0.30	-56.12	93.68	-42.33	NaN	-35.14	-71.24	-52.97	99.83	-18.67	-15.51
ccsbBroad304_13598	OE	NRBP2	NRBP family, nuclear receptor binding protein 2			10.00, 0.00	1.03, 0.24	-30.99	-28.12	-25.15	15.15	95.11	-61.92	-95.93	44.28	-87.40	-16.82
ccsbBroad304_07600	OE	NSA2	NSA2 ribosome biogenesis homolog (S. cerevisiae)			0.00, 0.00	0.74, 0.26	53.63	-95.63	94.99	-52.02	45.53	-63.26	62.92	-33.31	-99.25	-53.38
ccsbBroad304_03687	OE	NSFL1C	UBX domain containing, NSFL1 (p97) cofactor (p47)			10.00, 10.00	1.50, 0.53	-41.48	-99.43	-72.25	-94.22	99.98	-37.10	-78.95	-98.97	-34.16	-89.97
ccsbBroad304_04775	OE	NTAN1	N-terminal asparagine amidase			40.00, 40.00	1.06, 0.30	84.21	46.67	48.81	99.20	27.88	82.81	23.41	99.83	99.82	98.70
ccsbBroad304_06660	OE	NTRK3	Type VII RTKs: Neurotrophin receptor/Trk family, neurotrophic tyrosine kinase, receptor, type 3			50.00, 40.00	1.16, 0.30	96.91	71.13	-44.18	98.03	-34.08	-23.75	99.95	99.30	53.73	99.68
ccsbBroad304_07763	OE	NUDT6	Nudix motif containing, nudix (nucleoside diphosphate linked moiety X)-type motif 6			40.00, 30.00	1.01, 0.34	99.60	84.77	97.08	-96.37	97.59	42.59	-35.73	75.27	-74.93	99.12
ccsbBroad304_03387	OE	NUDT9	Nudix motif containing, nudix (nucleoside diphosphate linked moiety X)-type motif 9			0.00, 0.00	1.02, 0.38	50.62	-28.82	-29.52	-29.73	37.61	-97.47	-54.07	-99.02	-54.65	-37.71
ccsbBroad304_14143	OE	NUSAP1	nucleolar and spindle associated protein 1			10.00, 10.00	1.32, 0.45	-25.76	-70.56	-25.88	-99.89	98.92	89.50	-41.22	25.91	60.12	17.59
ccsbBroad304_06665	OE	OAT	ornithine aminotransferase			0.00, 0.00	1.44, 0.49	-97.37	-84.91	-95.56	45.14	91.25	86.81	-78.70	-58.75	90.23	-84.47
ccsbBroad304_06670	OE	OGG1	8-oxoguanine DNA glycosylase			10.00, 10.00	1.02, 0.36	-94.48	99.76	-47.30	59.54	-47.94	81.98	-62.19	-45.49	-5.83	-20.13
ccsbBroad304_02806	OE	OPN3	GPCR / Class A : Opsin receptors, opsin 3			0.00, 0.00	1.14, 0.35	-25.13	84.84	18.76	74.98	-42.92	-54.75	-95.82	-59.86	-51.09	-16.15
ccsbBroad304_04616	OE	ORMDL3	ORM1-like 3 (S. cerevisiae)			0.00, 0.00	1.27, 0.39	-35.11	-41.77	-96.63	NaN	-31.76	-70.77	16.99	-99.79	-99.06	-94.04
ccsbBroad304_04691	OE	OSR2	Zinc fingers, C2H2-type, odd-skipped related 2 (Drosophila)			0.00, 0.00	1.26, 0.28	-48.58	66.11	-57.71	-30.40	-41.01	-99.82	62.89	32.22	-82.59	-22.33
ccsbBroad304_06678	OE	OTX1	Homeoboxes / PRD class, orthodenticle homeobox 1			0.00, 0.00	0.92, 0.26	-81.15	-67.55	-99.85	65.19	-99.48	-99.89	80.99	-87.23	-56.38	-99.10
ccsbBroad304_01128	OE	OTX2	Homeoboxes / PRD class, orthodenticle homeobox 2			10.00, 0.00	1.26, 0.48	-77.26	-76.18	-80.54	-49.57	-82.52	-99.50	-64.52	-96.85	97.33	-96.04
ccsbBroad304_03864	OE	OVOL2	Zinc fingers, C2H2-type, ovo-like 2 (Drosophila)			0.00, 0.00	4.39, 1.06	-90.08	NaN	-99.98	-98.08	-49.24	-98.14	-92.75	-88.76	25.23	-99.54
ccsbBroad304_01131	OE	OXCT1	3-oxoacid CoA transferase 1			22.22, 11.11	0.84, 0.20	99.60	NaN	14.01	-33.70	71.78	-56.41	86.64	95.49	40.08	84.70
ccsbBroad304_03006	OE	OXGR1	GPCR / Class A : Orphans, Oxoglutarate receptor, oxoglutarate (alpha-ketoglutarate) receptor 1			0.00, 0.00	1.25, 0.45	-97.61	41.22	59.69	-41.70	38.90	-69.37	-44.57	-98.35	-84.95	-79.87
ccsbBroad304_01137	OE	P2RY6	GPCR / Class A : Purinergic receptors, P2Y, pyrimidinergic receptor P2Y, G-protein coupled, 6		Purinergic receptors P2Y GOF	20.00, 10.00	1.02, 0.30	97.31	44.17	99.81	-46.46	-93.15	43.88	-93.29	-89.92	-74.17	-80.99
ccsbBroad304_02057	OE	P4HA2	prolyl 4-hydroxylase, alpha polypeptide II			0.00, 0.00	0.97, 0.27	80.74	52.90	35.04	-98.76	-69.13	62.05	-41.61	-56.33	-8.47	-16.46
ccsbBroad304_01138	OE	P4HB	Protein disulfide isomerases, prolyl 4-hydroxylase, beta polypeptide			0.00, 0.00	1.06, 0.38	-9.87	56.80	93.52	-89.70	-99.40	-26.35	61.50	48.02	34.41	15.01
ccsbBroad304_01139	OE	PA2G4	proliferation-associated 2G4, 38kDa			10.00, 0.00	1.26, 0.40	58.55	-32.57	61.12	66.78	-60.76	95.51	52.81	-69.55	-47.60	42.72
ccsbBroad304_03444	OE	PAF1	Paf1, RNA polymerase II associated factor, homolog (S. cerevisiae)			0.00, 0.00	0.82, 0.18	60.36	-34.15	30.30	NaN	47.84	-23.33	61.98	-53.23	-59.12	15.75
ccsbBroad304_06685	OE	PAH	Amino acid hydroxylases, phenylalanine hydroxylase			10.00, 0.00	1.06, 0.27	-98.91	29.70	96.87	-97.13	-78.28	30.10	55.76	-23.77	-83.56	-76.99
ccsbBroad304_02392	OE	PAK4	PAKB subfamily, p21 protein (Cdc42/Rac)-activated kinase 4			10.00, 10.00	0.92, 0.22	27.14	74.48	44.27	-32.23	-99.47	52.97	-52.80	99.38	40.50	9.61
ccsbBroad304_04170	OE	PANK2	pantothenate kinase 2			22.22, 11.11	0.65, 0.17	57.03	-43.36	99.15	NaN	48.38	97.35	-92.30	-78.21	35.13	41.84
ccsbBroad304_09756	OE	PAQR7	progestin and adipoQ receptor family member VII			11.11, 0.00	1.36, 0.35	95.66	32.14	27.10	NaN	-78.56	-95.56	47.93	-40.28	-99.44	-79.13
ccsbBroad304_08536	OE	PARL	presenilin associated, rhomboid-like			0.00, 0.00	1.24, 0.42	-96.60	-36.70	-58.01	-52.89	-56.61	61.30	-49.35	19.28	64.73	-26.94
ccsbBroad304_09578	OE	PASD1	PAS domain containing 1			0.00, 0.00	0.95, 0.22	-98.94	79.10	-99.33	-26.21	84.19	-71.72	-33.79	-99.96	62.26	-95.00
ccsbBroad304_01147	OE	PC	Carboxylases, pyruvate carboxylase			0.00, 0.00	0.92, 0.31	18.05	-49.22	7.58	-37.82	-65.88	37.10	-99.98	-64.47	-58.96	-34.28
ccsbBroad304_01148	OE	PCBD1	pterin-4 alpha-carbinolamine dehydratase/dimerization cofactor of hepatocyte nuclear factor 1 alpha			0.00, 0.00	0.76, 0.22	81.86	-52.87	-85.79	NaN	40.84	60.30	-23.09	-86.45	-82.26	-38.74
ccsbBroad304_02677	OE	PDAP1	PDGFA associated protein 1			10.00, 10.00	0.98, 0.32	-94.04	-44.85	-71.20	-87.82	-63.60	-89.99	-53.23	98.55	-92.22	-90.34
ccsbBroad304_06704	OE	PDE4D	Phosphodiesterases, phosphodiesterase 4D, cAMP-specific			0.00, 0.00	1.06, 0.28	-41.35	85.36	82.21	41.59	46.49	-55.91	-76.92	-40.90	-70.48	-23.98
ccsbBroad304_01164	OE	PDHB	pyruvate dehydrogenase (lipoamide) beta			10.00, 0.00	0.90, 0.34	-99.46	-27.20	-43.09	-67.87	67.97	41.57	-49.08	49.48	95.75	-14.35
ccsbBroad304_07197	OE	PDHX	pyruvate dehydrogenase complex, component X			0.00, 0.00	0.99, 0.22	76.86	47.58	40.91	-41.33	-97.15	42.28	55.51	-80.51	92.93	34.68
ccsbBroad304_01166	OE	PDK2	PDHK family, pyruvate dehydrogenase kinase, isozyme 2			10.00, 0.00	1.05, 0.28	90.19	25.75	-17.60	20.93	-47.77	75.72	-6.11	-29.36	96.32	7.58
ccsbBroad304_01168	OE	PDPK1	PDK1 family, 3-phosphoinositide dependent protein kinase-1			0.00, 0.00	1.38, 0.44	-40.25	-66.59	-93.87	-29.63	-79.22	-74.15	-57.81	-14.40	-29.68	-64.35
ccsbBroad304_13998	OE	PDXK	pyridoxal (pyridoxine, vitamin B6) kinase			10.00, 0.00	1.88, 0.52	-29.49	-27.96	-83.29	34.37	58.69	96.44	-87.67	89.61	94.90	75.30
ccsbBroad304_10441	OE	PEPD	Methionyl aminopeptidase, peptidase D			0.00, 0.00	0.90, 0.25	32.05	-31.31	-14.77	-23.71	-44.90	68.06	53.29	39.58	-98.01	2.49
ccsbBroad304_02017	OE	PEX11A	peroxisomal biogenesis factor 11 alpha			10.00, 10.00	0.78, 0.23	99.07	-30.44	81.03	-83.83	38.47	-79.93	41.82	-98.62	-99.84	-73.29
ccsbBroad304_01174	OE	PEX13	peroxisomal biogenesis factor 13			0.00, 0.00	1.27, 0.42	75.49	-32.58	43.97	NaN	-72.23	-95.03	-37.39	-28.69	30.61	-28.35
ccsbBroad304_01180	OE	PFKFB3	6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3			11.11, 11.11	1.44, 0.50	-95.10	-50.75	-68.15	NaN	-64.67	99.35	56.66	70.18	31.53	-50.05
ccsbBroad304_06718	OE	PFN2	profilin 2			0.00, 0.00	1.47, 0.42	-39.27	NaN	91.13	47.92	88.56	90.67	43.13	-37.78	-37.45	84.91
ccsbBroad304_01186	OE	PHB	prohibitin			0.00, 0.00	3.05, 0.97	-80.39	87.59	-90.31	NaN	-71.51	-99.97	92.42	-98.15	-25.88	-98.47
ccsbBroad304_02676	OE	PHB2	prohibitin 2			11.11, 11.11	1.75, 0.45	31.05	NaN	-33.09	97.96	55.06	-28.47	-95.08	53.35	28.73	30.74
ccsbBroad304_08228	OE	PHF11	Zinc fingers, PHD-type, PHD finger protein 11			11.11, 11.11	1.03, 0.27	68.34	-41.14	34.15	NaN	43.94	-84.80	-84.50	97.90	-44.89	-20.62
ccsbBroad304_09657	OE	PHF13	Zinc fingers, PHD-type, PHD finger protein 13			0.00, 0.00	1.32, 0.28	-93.69	34.18	28.56	74.66	41.39	-81.93	54.73	-92.34	-41.08	-21.60
ccsbBroad304_04153	OE	PHF17	PHD finger protein 17			10.00, 10.00	1.07, 0.36	97.86	52.38	-69.05	66.75	-95.17	32.30	-44.25	59.93	-45.92	39.40
ccsbBroad304_04054	OE	PHF23	Zinc fingers, PHD-type, PHD finger protein 23			11.11, 0.00	1.10, 0.22	35.91	NaN	-99.90	-60.04	61.81	-97.73	96.34	-75.91	83.13	-73.44
ccsbBroad304_04431	OE	PHF5A	Zinc fingers, PHD-type, PHD finger protein 5A			0.00, 0.00	0.67, 0.17	-97.96	-88.36	-76.52	NaN	-84.43	-99.97	-26.71	-22.24	-96.12	-99.43
ccsbBroad304_01190	OE	PHKG2	Phosphorylase kinase (PHK) family, phosphorylase kinase, gamma 2 (testis)			11.11, 11.11	0.86, 0.22	-49.15	NaN	99.17	-79.45	-25.41	-24.63	-99.08	-90.79	22.70	-80.13
ccsbBroad304_03798	OE	PHTF2	putative homeodomain transcription factor 2			10.00, 10.00	1.55, 0.44	99.28	-32.78	-59.62	-35.51	69.55	76.36	33.27	54.85	22.25	40.11
ccsbBroad304_06720	OE	PHYH	phytanoyl-CoA 2-hydroxylase			10.00, 10.00	0.56, 0.19	64.75	44.01	11.23	-46.37	39.94	33.71	99.32	81.12	-50.54	17.59
ccsbBroad304_13633	OE	PI4KAP2	phosphatidylinositol 4-kinase, catalytic, alpha pseudogene 2			0.00, 0.00	0.86, 0.31	-78.74	-41.82	70.22	55.57	-99.00	-64.96	54.34	75.89	-52.84	-48.44
ccsbBroad304_08452	OE	PIH1D1	PIH1 domain containing 1			10.00, 0.00	1.60, 0.51	25.15	-58.63	-27.92	64.03	-42.31	97.31	-84.27	-98.75	27.96	-31.06
ccsbBroad304_01202	OE	PIK3CB	Phosphatidylinositol kinases, phosphoinositide-3-kinase, catalytic, beta polypeptide			10.00, 10.00	1.41, 0.34	49.12	89.06	93.08	55.77	53.06	94.37	99.03	-99.33	-99.97	86.33
ccsbBroad304_01205	OE	PIN1	peptidylprolyl cis/trans isomerase, NIMA-interacting 1			10.00, 10.00	1.64, 0.38	-23.65	74.03	-90.34	83.43	-28.96	99.85	29.27	32.35	49.50	32.74
ccsbBroad304_08266	OE	PIPOX	pipecolic acid oxidase			0.00, 0.00	1.59, 0.45	-75.74	70.36	-79.44	-69.23	87.64	94.11	38.83	-51.60	-99.97	-63.62
ccsbBroad304_02840	OE	PISD	Decarboxylases, phosphatidylserine decarboxylase			0.00, 0.00	1.13, 0.34	36.92	70.09	-85.64	-94.34	-99.15	-99.97	25.62	-97.95	42.43	-98.61
ccsbBroad304_01208	OE	PITPNA	phosphatidylinositol transfer protein, alpha			0.00, 0.00	1.45, 0.43	-66.27	49.62	18.76	NaN	-33.07	38.19	-22.76	-55.10	-94.79	-13.92
ccsbBroad304_03936	OE	PJA1	RING-type (C3HC4) zinc fingers, praja ring finger 1			0.00, 0.00	2.00, 0.63	48.80	35.73	-75.54	NaN	-95.35	77.48	-66.66	63.60	-11.04	-44.18
ccsbBroad304_07500	OE	PJA2	RING-type (C3HC4) zinc fingers, praja ring finger 2			0.00, 0.00	1.05, 0.31	-49.44	-71.74	12.53	-83.40	-43.42	-57.75	76.63	-84.84	46.97	-32.58
ccsbBroad304_02626	OE	PKIG	protein kinase (cAMP-dependent, catalytic) inhibitor gamma			0.00, 0.00	0.86, 0.23	-69.73	-98.99	-95.90	-96.07	-95.53	-91.36	-50.46	-28.67	51.29	-98.98
ccsbBroad304_06735	OE	PLAU	Chymotrypsin, plasminogen activator, urokinase			20.00, 20.00	0.93, 0.26	-72.10	61.45	-98.39	98.51	99.07	75.19	65.20	94.09	-34.33	90.02
ccsbBroad304_01215	OE	PLAUR	CD molecules, plasminogen activator, urokinase receptor			0.00, 0.00	1.10, 0.31	-34.31	36.51	-32.13	-45.42	91.68	46.51	63.17	-61.31	-53.18	6.69
ccsbBroad304_06736	OE	PLCG2	Phosphoinositide-specific phospholipase C, phospholipase C, gamma 2 (phosphatidylinositol-specific)		Phospholipases GOF	11.11, 11.11	1.11, 0.33	-40.12	25.20	26.12	NaN	-61.99	-39.80	-92.43	98.94	27.42	-22.34
ccsbBroad304_07676	OE	PLK2	Polo-like kinase (PLK) family, polo-like kinase 2			11.11, 11.11	1.03, 0.36	39.01	-42.84	94.05	NaN	-90.93	21.34	99.95	91.12	77.84	93.46
ccsbBroad304_02058	OE	PLOD3	procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3			0.00, 0.00	1.19, 0.36	-61.07	79.23	36.33	93.25	-34.70	37.83	80.58	15.26	-61.50	55.25
ccsbBroad304_07783	OE	PMF1-BGLAP	PMF1-BGLAP readthrough			0.00, 0.00	1.03, 0.30	58.05	-42.16	35.19	-75.86	-87.68	54.66	-71.06	-96.11	51.58	-65.33
ccsbBroad304_06742	OE	PML	RING-type (C3HC4) zinc fingers, promyelocytic leukemia			20.00, 20.00	1.51, 0.32	83.60	99.91	54.36	99.96	74.22	23.44	42.94	44.67	39.34	65.72
ccsbBroad304_02668	OE	PNKP	polynucleotide kinase 3'-phosphatase			0.00, 0.00	0.59, 0.13	-70.47	-54.81	-54.17	38.06	42.16	40.17	63.49	-61.08	-39.04	-25.69
ccsbBroad304_01105	OE	PNP	purine nucleoside phosphorylase			0.00, 0.00	1.00, 0.17	-10.62	-99.91	-48.69	51.86	-28.99	47.32	-45.63	36.15	-94.95	-23.59
ccsbBroad304_02783	OE	POFUT1	Fucosyltransferases, protein O-fucosyltransferase 1			10.00, 0.00	1.18, 0.38	93.73	-57.29	-42.98	97.16	-43.09	-95.68	-51.34	-44.49	62.70	-31.29
ccsbBroad304_02187	OE	POLR1C	RNA polymerase subunits, polymerase (RNA) I polypeptide C, 30kDa			0.00, 0.00	1.02, 0.30	-60.48	-45.77	-83.65	-80.00	-83.64	-28.44	-29.34	76.90	-98.83	-82.96
ccsbBroad304_01238	OE	POLR2D	RNA polymerase subunits, polymerase (RNA) II (DNA directed) polypeptide D			20.00, 20.00	1.03, 0.30	99.82	54.46	99.86	51.05	50.73	72.96	-96.24	-30.72	-99.97	42.34
ccsbBroad304_07655	OE	POLR3C	RNA polymerase subunits, polymerase (RNA) III (DNA directed) polypeptide C (62kD)			0.00, 0.00	0.93, 0.27	-56.55	-91.22	10.25	-99.42	-57.66	55.70	-30.50	49.06	34.95	-66.02
ccsbBroad304_05901	OE	POLR3D	RNA polymerase subunits, polymerase (RNA) III (DNA directed) polypeptide D, 44kDa			0.00, 0.00	0.77, 0.22	85.94	-62.93	-19.73	61.52	51.17	71.78	-50.38	48.11	-71.18	44.41
ccsbBroad304_02526	OE	POP4	processing of precursor 4, ribonuclease P/MRP subunit (S. cerevisiae)			0.00, 0.00	1.01, 0.35	90.23	81.12	-10.88	31.00	46.90	64.19	55.27	-89.84	-94.57	31.87
ccsbBroad304_01967	OE	PPAP2A	Lipid phosphate phosphatases, phosphatidic acid phosphatase type 2A			10.00, 10.00	1.08, 0.31	-99.89	85.49	88.34	-86.47	94.85	-31.22	-88.07	66.11	99.97	94.92
ccsbBroad304_07272	OE	PPAP2B	Lipid phosphate phosphatases, phosphatidic acid phosphatase type 2B			50.00, 40.00	0.84, 0.34	38.20	38.57	-30.25	97.87	-28.60	99.78	95.00	99.94	93.90	98.98
ccsbBroad304_07245	OE	PPFIBP2	Sterile alpha motif (SAM) domain containing, PTPRF interacting protein, binding protein 2 (liprin beta 2)			40.00, 20.00	0.86, 0.27	97.77	96.81	87.04	-47.34	43.83	66.65	-97.14	99.92	74.84	95.51
ccsbBroad304_01252	OE	PPIA	Cis-trans-isomerases, peptidylprolyl isomerase A (cyclophilin A)			10.00, 0.00	1.09, 0.36	96.15	-52.86	70.29	-44.00	-82.57	-41.24	31.99	-82.19	-12.57	-24.51
ccsbBroad304_01255	OE	PPM1B	Serine/threonine phosphatases / Protein phosphatases, Mg2+/Mn2+ dependent, protein phosphatase, Mg2+/Mn2+ dependent, 1B			20.00, 20.00	0.85, 0.30	-60.95	-99.93	64.82	98.48	-56.20	33.74	-13.93	71.42	99.88	26.20
ccsbBroad304_01257	OE	PPOX	protoporphyrinogen oxidase			10.00, 10.00	1.27, 0.41	-47.75	52.29	61.14	51.03	72.99	39.60	-49.33	99.98	-50.77	45.93
ccsbBroad304_01259	OE	PPP1CC	Serine/threonine phosphatases / Protein phosphatase, catalytic subunits, protein phosphatase 1, catalytic subunit, gamma isozyme			10.00, 10.00	0.91, 0.27	-45.02	-32.25	-22.15	41.93	35.06	60.22	-90.63	63.47	99.46	15.59
ccsbBroad304_14081	OE	PPP1R13B	Ankyrin repeat domain containing, protein phosphatase 1, regulatory subunit 13B			0.00, 0.00	1.27, 0.33	-16.55	81.43	-21.09	-77.56	-32.33	40.99	29.70	-45.26	88.62	-3.77
ccsbBroad304_01262	OE	PPP2CB	Serine/threonine phosphatases / Protein phosphatase, catalytic subunits, protein phosphatase 2, catalytic subunit, beta isozyme			20.00, 20.00	0.80, 0.31	62.05	-24.43	98.50	-90.66	-37.10	-97.29	28.41	99.85	36.29	31.11
ccsbBroad304_08453	OE	PPP2R3C	Serine/threonine phosphatases / Protein phosphatase 2, regulatory subunits, protein phosphatase 2, regulatory subunit B'', gamma			10.00, 10.00	1.22, 0.35	38.44	-55.16	63.23	42.55	36.70	98.63	35.16	50.89	-99.96	15.84
ccsbBroad304_01266	OE	PPP3CA	Serine/threonine phosphatases / Protein phosphatase, catalytic subunits, protein phosphatase 3, catalytic subunit, alpha isozyme			0.00, 0.00	1.10, 0.26	82.80	48.22	-34.00	84.86	55.35	91.55	88.98	36.85	-62.56	63.47
ccsbBroad304_06761	OE	PPP3CC	Serine/threonine phosphatases / Protein phosphatase, catalytic subunits, protein phosphatase 3, catalytic subunit, gamma isozyme			0.00, 0.00	1.27, 0.28	-74.61	NaN	-12.69	86.12	-32.47	93.79	-13.47	-38.40	35.50	-3.41
ccsbBroad304_01267	OE	PPP4C	Serine/threonine phosphatases / Protein phosphatase, catalytic subunits, protein phosphatase 4, catalytic subunit			22.22, 22.22	1.07, 0.28	97.82	98.67	66.59	NaN	-54.58	-80.75	-70.75	-74.29	51.55	-68.93
ccsbBroad304_02788	OE	PRAME	preferentially expressed antigen in melanoma			0.00, 0.00	1.26, 0.43	-59.92	28.34	17.49	63.76	-91.17	-69.87	-99.66	87.19	-41.24	-55.92
ccsbBroad304_02621	OE	PRDM7	Zinc fingers, C2H2-type, PR domain containing 7			20.00, 20.00	1.81, 0.68	92.91	-33.56	98.84	51.77	50.60	-43.35	-87.70	29.73	97.94	85.10
ccsbBroad304_02864	OE	PRDX5	peroxiredoxin 5			0.00, 0.00	1.72, 0.53	-58.25	-80.77	85.67	-91.69	42.77	-35.40	-92.56	-99.03	75.84	-89.44
ccsbBroad304_02319	OE	PREB	WD repeat domain containing, prolactin regulatory element binding			22.22, 11.11	1.11, 0.28	-12.67	-66.97	-24.59	NaN	95.36	-33.07	99.91	-80.45	-99.54	-26.43
ccsbBroad304_06770	OE	PRKAA1	AMPK subfamily, protein kinase, AMP-activated, alpha 1 catalytic subunit			0.00, 0.00	1.13, 0.39	-22.40	32.29	36.22	-32.80	81.33	52.52	70.76	-44.92	-83.91	11.76
ccsbBroad304_01278	OE	PRKACB	Protein kinase A, protein kinase, cAMP-dependent, catalytic, beta			10.00, 10.00	1.06, 0.32	98.06	65.96	-32.31	-94.03	76.36	42.10	-55.03	50.56	26.82	38.91
ccsbBroad304_01279	OE	PRKAG1	AMPK subfamily, protein kinase, AMP-activated, gamma 1 non-catalytic subunit			0.00, 0.00	1.68, 0.48	-99.34	NaN	46.27	-59.41	40.92	57.10	-23.09	27.06	-91.53	-23.58
ccsbBroad304_11054	OE	PRKAR2A	Protein kinase A, protein kinase, cAMP-dependent, regulatory, type II, alpha			10.00, 10.00	1.01, 0.31	-46.91	70.54	86.80	85.62	86.53	99.56	-82.72	29.13	-77.28	83.91
ccsbBroad304_01283	OE	PRKCE	Eta subfamily, protein kinase C, epsilon			10.00, 0.00	1.30, 0.48	86.66	27.92	48.44	44.33	71.30	-99.91	96.68	-99.98	-99.99	69.36
ccsbBroad304_11055	OE	PRKCH	Eta subfamily, protein kinase C, eta			33.33, 22.22	2.05, 0.59	-91.69	99.43	-41.68	NaN	-43.63	99.16	-81.20	-59.40	97.14	69.30
ccsbBroad304_01284	OE	PRKCZ	Iota subfamily, protein kinase C, zeta			0.00, 0.00	1.43, 0.52	-51.82	-35.95	-9.46	NaN	-97.17	-82.95	-82.78	-89.50	-61.00	-83.94
ccsbBroad304_06777	OE	PRNP	CD molecules, prion protein			10.00, 0.00	1.49, 0.39	69.95	53.03	69.39	77.00	83.46	67.80	46.04	96.81	53.76	75.57
ccsbBroad304_06778	OE	PROC	Endogenous ligands, protein C (inactivator of coagulation factors Va and VIIIa)			10.00, 10.00	1.06, 0.35	39.15	36.66	-34.60	72.49	99.98	25.85	-26.09	-68.97	54.26	12.96
ccsbBroad304_02619	OE	PRSS23	Serine peptidases / Serine peptidases, protease, serine, 23		Serine proteases GOF	0.00, 0.00	1.42, 0.33	-63.00	-76.12	-78.70	-74.25	-67.78	-81.93	-75.04	80.83	-27.37	-71.96
ccsbBroad304_08152	OE	PSAT1	phosphoserine aminotransferase 1			10.00, 10.00	0.99, 0.36	-81.38	-94.59	6.22	-90.62	78.03	-90.93	60.14	99.94	45.21	-64.96
ccsbBroad304_01304	OE	PSEN1	Presenilin, presenilin 1			0.00, 0.00	0.84, 0.31	-74.35	-43.44	-56.08	NaN	-65.10	-31.91	-31.49	-56.67	-90.18	-34.99
ccsbBroad304_06789	OE	PSEN2	Presenilin, presenilin 2 (Alzheimer disease 4)			0.00, 0.00	1.08, 0.27	79.24	40.42	60.00	62.23	-24.41	-20.58	-35.59	-51.12	35.44	13.70
ccsbBroad304_01309	OE	PSMB1	Proteasome subunits, proteasome (prosome, macropain) subunit, beta type, 1			11.11, 11.11	0.81, 0.22	-75.74	27.69	41.49	NaN	-64.75	87.35	-16.92	99.41	-91.16	-44.14
ccsbBroad304_01310	OE	PSMB2	Proteasome subunits, proteasome (prosome, macropain) subunit, beta type, 2			0.00, 0.00	1.11, 0.34	51.49	88.38	66.77	45.88	-34.66	40.72	-30.76	45.10	-52.74	13.42
ccsbBroad304_06800	OE	PSMB7	Proteasome subunits, proteasome (prosome, macropain) subunit, beta type, 7			0.00, 0.00	1.11, 0.40	83.75	-99.36	90.35	-98.90	43.02	84.23	-52.47	-93.71	-31.06	-82.01
ccsbBroad304_01313	OE	PSMB9	Proteasome (prosome, macropain) subunits, proteasome (prosome, macropain) subunit, beta type, 9 (large multifunctional peptidase 2)			0.00, 0.00	1.59, 0.45	82.09	61.76	-99.96	NaN	24.42	-37.67	-78.40	-98.08	-77.94	-64.01
ccsbBroad304_01324	OE	PSMD10	Ankyrin repeat domain containing, proteasome (prosome, macropain) 26S subunit, non-ATPase, 10			0.00, 0.00	1.06, 0.36	-67.50	50.00	51.38	-65.98	-79.18	-20.14	35.82	-35.57	62.59	12.11
ccsbBroad304_01318	OE	PSMD2	Proteasome subunits, proteasome (prosome, macropain) 26S subunit, non-ATPase, 2			0.00, 0.00	0.86, 0.25	-12.02	-99.23	-84.56	NaN	-26.55	-33.53	69.02	-48.69	-33.34	-6.11
ccsbBroad304_06806	OE	PSMD3	Proteasome (prosome, macropain) subunits, proteasome (prosome, macropain) 26S subunit, non-ATPase, 3			0.00, 0.00	1.01, 0.36	-35.67	64.47	-29.81	47.85	48.05	88.52	-30.68	-58.79	-24.85	18.92
ccsbBroad304_01321	OE	PSMD5	Proteasome (prosome, macropain) subunits, proteasome (prosome, macropain) 26S subunit, non-ATPase, 5			0.00, 0.00	1.26, 0.35	-89.21	-90.77	-28.33	-70.24	-92.58	72.91	-37.40	40.39	25.16	-57.22
ccsbBroad304_01336	OE	PTGS2	Cyclooxygenase, prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)			0.00, 0.00	1.32, 0.36	-93.66	NaN	-12.43	41.59	-93.14	-31.46	-42.95	58.60	24.70	-7.60
ccsbBroad304_07374	OE	PTPLA	protein tyrosine phosphatase-like (proline instead of catalytic arginine), member A			10.00, 10.00	1.09, 0.32	49.12	-29.18	55.10	-99.67	35.89	-80.27	67.81	-92.99	99.93	33.32
ccsbBroad304_13936	OE	PTPRF	Receptor tyrosine phosphatases (RTP), protein tyrosine phosphatase, receptor type, F			11.11, 11.11	1.55, 0.53	-96.86	77.28	-40.67	NaN	-98.20	-95.08	99.48	-48.56	-76.29	-95.43
ccsbBroad304_02691	OE	PUF60	RNA binding motif (RRM) containing, poly-U binding splicing factor 60KDa			0.00, 0.00	1.33, 0.40	-82.18	40.63	-50.86	-61.88	-99.37	-54.28	76.79	-77.09	72.78	-58.17
ccsbBroad304_06824	OE	PVR	Immunoglobulin superfamily / C2-set domain containing, poliovirus receptor			0.00, 0.00	1.42, 0.42	-85.13	66.50	-99.95	NaN	-55.06	-65.73	33.53	-41.17	-89.47	-78.56
ccsbBroad304_01350	OE	PVRL2	Immunoglobulin superfamily / C2-set domain containing, poliovirus receptor-related 2 (herpesvirus entry mediator B)			30.00, 20.00	1.32, 0.27	75.30	96.78	-79.59	99.94	-88.52	99.97	-40.68	-62.93	56.99	88.24
ccsbBroad304_07759	OE	PWP1	WD repeat domain containing, PWP1 homolog (S. cerevisiae)			10.00, 10.00	0.59, 0.14	-95.39	99.93	-69.82	-99.82	46.96	-56.33	-90.89	-43.22	-66.48	-94.42
ccsbBroad304_06828	OE	PYCR1	pyrroline-5-carboxylate reductase 1			0.00, 0.00	1.02, 0.27	-24.51	-98.80	89.27	-63.04	-64.60	-99.97	89.29	87.19	50.13	-49.05
ccsbBroad304_01355	OE	PYGL	Glycogen phosphorylases, phosphorylase, glycogen, liver			11.11, 11.11	0.83, 0.17	-93.36	31.29	-12.50	NaN	-49.04	98.50	66.84	40.84	-33.65	-1.67
ccsbBroad304_07889	OE	QPRT	quinolinate phosphoribosyltransferase			11.11, 11.11	2.65, 0.91	-84.03	-99.74	-88.37	NaN	-51.67	99.79	-58.33	-82.08	83.74	-86.82
ccsbBroad304_03570	OE	QRSL1	glutaminyl-tRNA synthase (glutamine-hydrolyzing)-like 1			10.00, 10.00	0.91, 0.33	-34.88	-99.61	98.28	74.57	-51.97	-41.59	23.30	-31.27	-77.65	-40.89
ccsbBroad304_06830	OE	RAB5A	RAB, member RAS oncogene, RAB5A, member RAS oncogene family			20.00, 20.00	1.45, 0.49	94.90	-47.46	98.50	98.93	-36.83	42.78	31.19	-82.73	51.81	72.40
ccsbBroad304_01363	OE	RABGGTA	Prenyltransferase alpha subunit repeat containing, Rab geranylgeranyltransferase, alpha subunit			0.00, 0.00	0.92, 0.31	-30.57	-53.41	30.69	NaN	-32.43	-95.65	84.00	-99.30	92.66	-36.62
ccsbBroad304_06831	OE	RAC1	Endogenous ligands, ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)			20.00, 0.00	1.44, 0.38	29.96	-64.81	-41.51	95.69	95.28	-35.94	-97.57	16.31	32.47	-11.23
ccsbBroad304_01347	OE	RAD1	RAD1 homolog (S. pombe)			0.00, 0.00	0.78, 0.23	33.54	-32.87	-66.47	-36.39	-80.26	-76.95	-76.30	37.59	-27.22	-54.20
ccsbBroad304_02376	OE	RAMP1	Receptor (G protein-coupled) activity modifying proteins, receptor (G protein-coupled) activity modifying protein 1			0.00, 0.00	1.32, 0.30	73.35	-68.64	-96.27	28.01	-84.24	-35.32	-49.41	-88.07	60.43	-59.78
ccsbBroad304_01373	OE	RAN	RAN, member RAS oncogene family			10.00, 0.00	1.11, 0.35	-43.31	-99.96	-84.87	96.97	-34.20	52.89	-21.95	-54.92	-55.10	-16.63
ccsbBroad304_01374	OE	RAP1A	RAP1A, member of RAS oncogene family			22.22, 11.11	1.13, 0.40	68.98	NaN	98.55	-89.71	-74.27	96.64	17.61	-63.48	90.15	71.16
ccsbBroad304_06845	OE	RARRES3	retinoic acid receptor responder (tazarotene induced) 3			10.00, 10.00	1.00, 0.36	99.89	-47.90	91.01	71.83	-41.80	-95.89	-18.74	-52.33	-54.72	-15.75
ccsbBroad304_01378	OE	RASA1	Pleckstrin homology (PH) domain containing, RAS p21 protein activator (GTPase activating protein) 1			0.00, 0.00	1.42, 0.42	-64.63	-86.98	89.97	45.72	-37.75	-52.05	-90.84	-42.27	69.15	-44.71
ccsbBroad304_03357	OE	RASD1	RAS, dexamethasone-induced 1			10.00, 0.00	1.94, 0.42	87.76	-50.52	69.75	47.47	-30.29	30.69	95.75	-35.20	-76.07	48.58
ccsbBroad304_02239	OE	RASSF2	Ras association (RalGDS/AF-6) domain family member 2			10.00, 10.00	0.98, 0.30	99.56	-41.26	46.83	-68.56	-28.62	-46.02	-80.33	-39.78	-54.91	-10.07
ccsbBroad304_06847	OE	RBBP4	WD repeat domain containing, retinoblastoma binding protein 4			20.00, 10.00	1.01, 0.30	45.24	27.86	96.02	-33.08	87.28	75.17	-99.79	70.53	99.94	86.55
ccsbBroad304_01379	OE	RBBP6	retinoblastoma binding protein 6			0.00, 0.00	1.01, 0.28	62.31	-53.38	-15.23	NaN	-45.68	-90.98	-87.21	46.91	-54.30	-29.95
ccsbBroad304_12492	OE	RBM15	RNA binding motif (RRM) containing, RNA binding motif protein 15			20.00, 20.00	1.19, 0.38	-86.30	49.02	-13.77	97.64	99.54	52.96	-68.48	-35.03	-37.48	11.44
ccsbBroad304_07565	OE	RBM6	G patch domain containing, RNA binding motif protein 6			0.00, 0.00	0.70, 0.16	44.71	65.01	-86.02	57.34	52.06	74.05	71.16	-99.80	-99.63	22.59
ccsbBroad304_03028	OE	RBMX	RNA binding motif (RRM) containing, RNA binding motif protein, X-linked			40.00, 40.00	0.78, 0.24	99.66	63.01	58.90	-92.85	97.56	99.94	49.80	64.30	93.92	98.47
ccsbBroad304_02279	OE	RBX1	RING-type (C3HC4) zinc fingers, ring-box 1, E3 ubiquitin protein ligase			11.11, 11.11	0.84, 0.15	-56.54	37.55	85.70	NaN	-82.57	99.79	41.51	80.56	-68.42	51.67
ccsbBroad304_07961	OE	RCHY1	RING-type (C3HC4) zinc fingers, ring finger and CHY zinc finger domain containing 1			0.00, 0.00	1.50, 0.48	-76.95	-99.69	71.59	-67.34	-50.27	71.28	-95.73	-29.33	-26.13	-70.37
ccsbBroad304_08221	OE	RDH11	Short chain dehydrogenase/reductase superfamily / Classical SDR fold cluster 2, retinol dehydrogenase 11 (all-trans/9-cis/11-cis)			10.00, 10.00	0.90, 0.34	-37.15	50.08	-45.18	47.86	98.62	90.97	75.12	88.95	71.10	87.09
ccsbBroad304_08511	OE	RFK	riboflavin kinase			10.00, 10.00	0.94, 0.27	46.97	35.15	97.63	-29.29	-99.24	54.97	40.17	-76.79	13.35	9.23
ccsbBroad304_09881	OE	RFX6	regulatory factor X, 6			10.00, 10.00	1.22, 0.38	23.63	-38.80	97.94	48.34	79.54	24.90	-71.37	-51.32	-57.10	-13.59
ccsbBroad304_06862	OE	RGS3	regulator of G-protein signaling 3			11.11, 11.11	0.83, 0.30	81.75	-25.62	56.42	NaN	-29.69	86.01	-79.91	97.91	46.09	66.51
ccsbBroad304_01396	OE	RGS4	Regulators of G-protein signaling, regulator of G-protein signaling 4			10.00, 10.00	1.05, 0.40	98.85	-73.60	-20.26	-56.06	40.65	-40.56	60.61	-83.31	8.63	-19.55
ccsbBroad304_01398	OE	RHEB	Ras homolog enriched in brain			10.00, 0.00	1.64, 0.39	-98.45	-47.05	95.75	-27.92	74.51	94.53	31.15	92.57	83.43	88.82
ccsbBroad304_00100	OE	RHOA	ras homolog gene family, member A			0.00, 0.00	1.55, 0.49	-90.57	-28.19	74.43	91.99	-33.67	94.17	-98.02	-95.55	57.52	66.95
ccsbBroad304_02266	OE	RHOBTB1	BTB/POZ domain containing, Rho-related BTB domain containing 1			0.00, 0.00	1.42, 0.33	-98.80	91.60	65.00	NaN	-99.66	-31.98	-97.31	-91.31	-32.76	-95.64
ccsbBroad304_00101	OE	RHOC	ras homolog gene family, member C			0.00, 0.00	1.16, 0.27	27.99	57.69	85.84	-42.47	86.51	-35.11	-87.24	36.02	76.77	58.23
ccsbBroad304_02979	OE	RNF11	RING-type (C3HC4) zinc fingers, ring finger protein 11			10.00, 10.00	1.50, 0.43	88.94	98.52	-83.30	-69.03	-40.64	-99.35	65.83	94.74	26.24	73.84
ccsbBroad304_02209	OE	RNF14	RING-type (C3HC4) zinc fingers, ring finger protein 14			0.00, 0.00	1.11, 0.34	-71.51	65.00	-47.99	89.16	82.08	-39.84	48.31	36.02	-71.26	26.80
ccsbBroad304_04256	OE	RNF146	RING-type (C3HC4) zinc fingers, ring finger protein 146			0.00, 0.00	1.08, 0.39	42.83	-46.69	-40.14	-83.28	46.93	65.55	-98.01	52.67	-95.61	-46.76
ccsbBroad304_03713	OE	RNF20	RING-type (C3HC4) zinc fingers, ring finger protein 20			30.00, 10.00	0.91, 0.24	-97.84	95.09	-67.53	-51.97	99.98	87.19	92.15	-36.01	-34.08	96.32
ccsbBroad304_03939	OE	RNF25	RING-type (C3HC4) zinc fingers, ring finger protein 25			0.00, 0.00	0.93, 0.16	57.82	-31.53	-28.54	NaN	88.34	92.83	21.19	-93.14	-7.82	12.62
ccsbBroad304_07450	OE	RNF7	RING-type (C3HC4) zinc fingers, ring finger protein 7			0.00, 0.00	0.88, 0.30	-95.78	59.89	44.88	NaN	-78.83	-37.26	-37.43	-99.96	31.68	-60.09
ccsbBroad304_06870	OE	RNH1	ribonuclease/angiogenin inhibitor 1			0.00, 0.00	0.82, 0.26	54.98	-99.58	-41.46	41.56	49.38	-38.98	-46.03	-81.18	69.59	-19.90
ccsbBroad304_09006	OE	RPF1	ribosome production factor 1 homolog (S. cerevisiae)			0.00, 0.00	1.19, 0.35	80.56	-25.76	-22.06	-67.98	94.87	39.95	48.73	33.20	38.46	20.31
ccsbBroad304_01423	OE	RPL19	L ribosomal proteins, ribosomal protein L19			0.00, 0.00	1.01, 0.28	47.33	44.16	84.23	-27.99	26.56	40.31	-32.27	-96.42	-37.70	6.80
ccsbBroad304_04718	OE	RPL39L	L ribosomal proteins, ribosomal protein L39-like			10.00, 0.00	1.39, 0.36	-50.09	86.46	85.86	88.81	95.63	74.18	56.93	-64.50	-41.32	86.70
ccsbBroad304_06888	OE	RPN1	ribophorin I			10.00, 10.00	1.91, 0.51	-99.69	-69.83	65.61	32.06	-42.46	-41.53	-66.91	46.31	99.97	-42.67
ccsbBroad304_06889	OE	RPN2	ribophorin II			40.00, 20.00	1.01, 0.33	73.89	89.52	98.45	71.58	-34.89	95.00	99.98	-98.29	-74.05	97.39
ccsbBroad304_01453	OE	RPS14	S ribosomal proteins, ribosomal protein S14			0.00, 0.00	1.01, 0.36	69.07	78.21	-33.56	NaN	-40.65	-42.23	-40.28	-97.38	-80.90	-22.18
ccsbBroad304_01454	OE	RPS15A	S ribosomal proteins, ribosomal protein S15a			0.00, 0.00	1.01, 0.36	90.33	-70.08	32.44	-95.89	37.80	75.99	53.26	42.65	86.80	60.19
ccsbBroad304_01455	OE	RPS16	S ribosomal proteins, ribosomal protein S16			0.00, 0.00	1.02, 0.28	-91.60	94.77	-23.78	NaN	-32.38	-54.14	82.75	-99.87	-81.50	-73.34
ccsbBroad304_01463	OE	RPS27A	S ribosomal proteins, ribosomal protein S27a			0.00, 0.00	0.98, 0.36	62.45	70.18	33.20	NaN	-71.48	30.88	90.89	-36.35	-58.11	37.76
ccsbBroad304_06896	OE	RPS6KA1	RSK subfamily, ribosomal protein S6 kinase, 90kDa, polypeptide 1			11.11, 0.00	0.76, 0.17	84.19	58.25	-92.53	NaN	58.59	-39.79	96.75	73.55	-72.86	45.40
ccsbBroad304_02123	OE	RPS6KA5	MSK subfamily, ribosomal protein S6 kinase, 90kDa, polypeptide 5			11.11, 11.11	0.98, 0.39	-99.35	NaN	62.57	-47.21	-39.62	99.90	-99.57	-54.21	33.56	-37.73
ccsbBroad304_11109	OE	RPS6KB1	p70 subfamily, ribosomal protein S6 kinase, 70kDa, polypeptide 1			11.11, 11.11	1.48, 0.44	72.04	-27.96	-11.96	NaN	76.62	99.07	93.48	-95.81	-79.01	74.37
ccsbBroad304_03928	OE	RRAGC	Ras-related GTP binding C			0.00, 0.00	1.41, 0.45	86.28	29.33	66.86	-44.40	28.11	25.90	-97.95	-87.43	-23.18	7.50
ccsbBroad304_01466	OE	RRM2	Ribonucleoside-diphosphate reductases, ribonucleotide reductase M2			0.00, 0.00	1.28, 0.33	78.06	NaN	-30.23	56.63	-45.32	75.32	-28.60	31.61	51.17	18.98
ccsbBroad304_02756	OE	RRP8	ribosomal RNA processing 8, methyltransferase, homolog (yeast)			10.00, 10.00	0.97, 0.32	62.41	-54.94	97.99	34.93	-91.27	50.12	56.42	-80.02	-99.52	-59.14
ccsbBroad304_01966	OE	RUVBL1	ATPases / AAA-type, RuvB-like 1 (E. coli)			60.00, 20.00	1.18, 0.43	98.19	97.02	95.89	95.38	27.95	-25.46	99.57	-76.71	-91.77	97.31
ccsbBroad304_02538	OE	RUVBL2	ATPases / AAA-type, RuvB-like 2 (E. coli)			0.00, 0.00	1.31, 0.35	27.61	-26.45	-94.04	38.12	42.23	86.27	19.19	-37.03	36.73	9.26
ccsbBroad304_03880	OE	RXFP1	GPCR / Class A : Relaxin family peptide receptors, relaxin/insulin-like family peptide receptor 1			0.00, 0.00	0.97, 0.23	91.60	-35.13	-62.83	28.65	57.98	-78.56	-55.34	-74.24	29.09	-49.36
ccsbBroad304_01470	OE	RXRG	Retinoid X receptors, retinoid X receptor, gamma			0.00, 0.00	1.11, 0.40	-32.00	52.37	-93.19	NaN	-31.83	-32.05	-54.65	41.94	-50.47	-16.00
ccsbBroad304_07884	OE	RYBP	RING1 and YY1 binding protein			0.00, 0.00	1.57, 0.31	40.65	NaN	-96.19	92.18	-98.81	-60.77	-40.35	-52.05	94.82	-76.34
ccsbBroad304_01478	OE	S100A11	EF-hand domain containing, S100 calcium binding protein A11			20.00, 20.00	1.33, 0.33	99.87	-66.98	93.16	-37.24	37.19	99.94	-55.35	-54.82	87.71	94.35
ccsbBroad304_06907	OE	S100A13	S100 calcium binding proteins, S100 calcium binding protein A13			0.00, 0.00	1.25, 0.41	25.91	59.40	89.67	24.12	-99.23	-60.99	80.47	67.76	-38.98	32.94
ccsbBroad304_01475	OE	S100A6	EF-hand domain containing, S100 calcium binding protein A6			0.00, 0.00	0.90, 0.38	-45.68	36.10	-50.45	-85.29	-99.41	72.84	43.56	-62.11	-74.60	-39.17
ccsbBroad304_06908	OE	S100B	EF-hand domain containing, S100 calcium binding protein B			0.00, 0.00	1.24, 0.36	-11.48	65.87	-96.67	NaN	52.00	-48.00	-25.44	46.95	48.79	15.94
ccsbBroad304_01480	OE	S100P	EF-hand domain containing, S100 calcium binding protein P			10.00, 10.00	1.17, 0.32	99.89	42.12	69.38	93.38	21.81	-76.79	-53.54	-37.93	-47.96	21.24
ccsbBroad304_01481	OE	SARS	Aminoacyl tRNA synthetases / Class II, seryl-tRNA synthetase			11.11, 11.11	1.31, 0.33	29.23	NaN	-31.51	99.98	76.55	24.68	41.55	58.45	-66.28	33.09
ccsbBroad304_01484	OE	SATB1	Homeoboxes / CUT class, SATB homeobox 1			10.00, 10.00	0.72, 0.22	65.09	28.93	99.96	93.23	27.71	-62.44	-72.31	77.40	37.28	47.62
ccsbBroad304_02751	OE	SATB2	Homeoboxes / CUT class, SATB homeobox 2			0.00, 0.00	1.35, 0.40	-35.87	-99.89	50.60	67.95	71.92	-99.24	-57.27	-96.05	-96.33	-99.35
ccsbBroad304_07490	OE	SCRN1	secernin 1			10.00, 10.00	0.85, 0.35	-32.76	99.88	50.98	-31.00	-87.14	-24.67	-99.00	-42.48	-99.92	-49.59
ccsbBroad304_06926	OE	SDHA	Mitochondrial respiratory chain complex, succinate dehydrogenase complex, subunit A, flavoprotein (Fp)			11.11, 11.11	1.15, 0.28	-64.31	-95.82	37.67	NaN	-99.87	99.47	-97.81	-93.58	-59.43	-95.69
ccsbBroad304_01515	OE	SDHD	Mitochondrial respiratory chain complex / Complex II, succinate dehydrogenase complex, subunit D, integral membrane protein			0.00, 0.00	0.91, 0.32	87.79	35.15	-20.67	-99.34	-69.50	46.12	-54.01	63.01	76.74	22.80
ccsbBroad304_03878	OE	SENP2	SUMO1/sentrin/SMT3 specific peptidase 2			0.00, 0.00	0.82, 0.24	24.25	-73.22	-99.53	65.90	-83.88	-49.57	-64.21	-38.98	35.55	-63.63
ccsbBroad304_04976	OE	SERPINA12	Serine (or cysteine) peptidase inhibitors, serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 12			11.11, 11.11	1.23, 0.26	75.95	NaN	82.06	-96.44	-59.17	-94.14	-20.81	-90.61	99.45	-86.36
ccsbBroad304_06694	OE	SERPINA5	Serine (or cysteine) peptidase inhibitors, serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5			0.00, 0.00	0.90, 0.19	-45.37	78.31	-6.46	NaN	-61.31	-77.43	-80.82	26.55	89.06	-33.30
ccsbBroad304_00232	OE	SERPINA6	Serine (or cysteine) peptidase inhibitors, serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 6			11.11, 11.11	1.01, 0.33	63.65	-99.93	-36.84	NaN	-62.48	-69.42	99.98	-83.56	-85.26	-68.14
ccsbBroad304_06687	OE	SERPINB2	Serine (or cysteine) peptidase inhibitors, serpin peptidase inhibitor, clade B (ovalbumin), member 2			10.00, 10.00	1.17, 0.38	-14.34	62.70	17.98	-32.91	-56.08	99.60	-74.77	-63.20	50.28	-14.71
ccsbBroad304_06354	OE	SERPIND1	Serine (or cysteine) peptidase inhibitors, serpin peptidase inhibitor, clade D (heparin cofactor), member 1			11.11, 11.11	1.44, 0.41	61.97	NaN	-37.40	-98.23	-71.28	27.76	47.32	93.94	99.77	31.13
ccsbBroad304_01519	OE	SET	SET nuclear oncogene			0.00, 0.00	0.80, 0.26	47.51	-66.71	91.94	60.57	85.18	-71.90	-52.55	-82.02	54.63	58.48
ccsbBroad304_01789	OE	SF1	Zinc fingers, CCHC domain containing, splicing factor 1			10.00, 10.00	1.45, 0.31	-87.65	-45.91	-58.05	98.93	-99.63	-99.68	-33.80	-99.71	-99.78	-99.91
ccsbBroad304_01527	OE	SGK1	SGK family, serum/glucocorticoid regulated kinase 1			0.00, 0.00	1.01, 0.31	45.01	-33.27	-99.98	-99.98	-78.51	80.51	-36.78	-46.16	47.92	-44.28
ccsbBroad304_14020	OE	SH3BP5	SH3-domain binding protein 5 (BTK-associated)			0.00, 0.00	0.91, 0.30	81.70	-45.19	37.68	71.42	93.38	55.44	-25.54	-99.69	83.39	70.31
ccsbBroad304_01531	OE	SHC1	SH2 domain containing, SHC (Src homology 2 domain containing) transforming protein 1			0.00, 0.00	0.67, 0.18	-31.18	91.57	54.91	-62.55	66.34	68.41	54.18	92.86	76.17	39.35
ccsbBroad304_01532	OE	SIAH1	seven in absentia homolog 1 (Drosophila)			0.00, 0.00	1.05, 0.28	40.58	-43.97	-44.65	-57.76	-28.64	-25.84	-93.50	-27.36	69.55	-12.38
ccsbBroad304_09665	OE	SIK1	QIK subfamily, salt-inducible kinase 1			10.00, 0.00	1.01, 0.39	42.86	93.40	46.92	42.06	95.67	68.60	-99.26	-66.58	-99.97	33.34
ccsbBroad304_02705	OE	SIRT2	Histone deacetylases, sirtuin 2			10.00, 10.00	0.80, 0.18	75.98	-60.07	-55.07	-53.28	50.17	85.60	-51.24	-94.41	98.97	32.78
ccsbBroad304_03332	OE	SIRT6	Histone deacetylases (HDACs), sirtuin 6		Sirtuins GOF	20.00, 10.00	0.95, 0.18	99.98	96.47	-16.75	-36.56	-28.46	-22.89	56.13	89.04	67.88	79.62
ccsbBroad304_06952	OE	SKP1	S-phase kinase-associated protein 1			22.22, 22.22	0.98, 0.20	16.43	21.11	60.78	NaN	98.89	75.35	98.93	-42.53	85.07	84.01
ccsbBroad304_06957	OE	SLC1A5	Alanine/serine/cysteine transporter subfamily, solute carrier family 1 (neutral amino acid transporter), member 5			20.00, 20.00	1.05, 0.34	-85.67	45.08	-55.61	53.81	76.44	-55.86	99.10	79.37	99.97	75.60
ccsbBroad304_06675	OE	SLC22A18	Orphan or poorly characterized SLC22 family members, solute carrier family 22, member 18			0.00, 0.00	1.75, 0.42	-89.74	89.11	57.84	31.57	-43.15	-97.01	-36.44	94.45	-55.85	-20.87
ccsbBroad304_00383	OE	SLC25A10	Mitochondrial di- and tri-carboxylic acid transporter subfamily, solute carrier family 25 (mitochondrial carrier; dicarboxylate transporter), member 10			11.11, 11.11	0.78, 0.19	79.84	NaN	42.28	99.69	-72.66	28.95	32.64	-33.23	-96.32	11.68
ccsbBroad304_04117	OE	SLC25A22	Mitochondrial amino acid transporter subfamily, solute carrier family 25 (mitochondrial carrier: glutamate), member 22			0.00, 0.00	1.52, 0.35	-82.31	57.65	63.35	-38.76	-55.36	-65.59	-35.03	-99.98	50.97	-48.86
ccsbBroad304_01187	OE	SLC25A3	Mitochondrial phosphate transporters, solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 3			20.00, 20.00	1.60, 0.45	93.10	31.94	-92.67	60.20	-34.87	97.91	48.28	-36.36	98.52	81.24
ccsbBroad304_09058	OE	SLC25A32	Mitochondrial nucleotide transporter subfamily, solute carrier family 25, member 32			0.00, 0.00	0.73, 0.25	81.69	50.16	29.67	-34.25	-64.19	28.79	-29.30	-42.54	69.19	12.70
ccsbBroad304_02590	OE	SLC27A3	SLC27 family of fatty acid transporters, solute carrier family 27 (fatty acid transporter), member 3			0.00, 0.00	1.00, 0.40	55.10	93.69	-18.26	-97.44	53.44	78.83	81.08	70.40	-71.67	53.88
ccsbBroad304_07764	OE	SLC2A6	Solute carriers, solute carrier family 2 (facilitated glucose transporter), member 6			0.00, 0.00	1.31, 0.38	-99.83	-98.16	-99.60	-45.45	94.76	-99.29	-35.50	-69.30	31.80	-99.35
ccsbBroad304_03451	OE	SLC35F2	SLC35 family of nucleotide sugar transporters, solute carrier family 35, member F2			0.00, 0.00	0.57, 0.20	-94.89	30.35	37.23	-99.96	-60.72	-97.01	78.68	-99.73	61.69	-97.37
ccsbBroad304_03413	OE	SLC38A2	System A-like transporters, solute carrier family 38, member 2			40.00, 40.00	0.78, 0.17	42.69	35.45	-99.98	34.45	85.74	91.71	99.95	99.96	99.93	99.77
ccsbBroad304_01545	OE	SLC3A2	SLC3 family, solute carrier family 3 (activators of dibasic and neutral amino acid transport), member 2			11.11, 11.11	1.23, 0.38	-26.03	79.43	-16.87	NaN	-29.91	-78.47	91.62	52.76	99.95	48.11
ccsbBroad304_02826	OE	SLC7A11	Solute carriers, solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11			10.00, 0.00	1.25, 0.45	95.65	-94.31	52.93	-52.02	-79.03	-29.31	48.82	88.62	-50.25	42.12
ccsbBroad304_00963	OE	SMAD5	SMADs, SMAD family member 5			10.00, 10.00	0.93, 0.34	86.35	-30.42	-59.58	-46.55	-33.55	84.08	-66.53	85.02	99.97	72.73
ccsbBroad304_03556	OE	SMU1	WD repeat domain containing, smu-1 suppressor of mec-8 and unc-52 homolog (C. elegans)			11.11, 11.11	1.30, 0.32	34.17	NaN	-4.82	-73.08	-99.87	44.16	19.39	99.98	36.31	2.27
ccsbBroad304_01555	OE	SNAI2	Snail homologs, snail homolog 2 (Drosophila)			0.00, 0.00	0.73, 0.20	-84.80	86.54	25.57	NaN	-38.94	-49.92	-26.32	-33.83	-43.14	-11.96
ccsbBroad304_01566	OE	SNRPA	RNA binding motif (RRM) containing, small nuclear ribonucleoprotein polypeptide A			0.00, 0.00	1.38, 0.35	-42.53	37.80	-21.71	-99.88	-80.08	42.08	80.04	-98.58	-92.51	-96.52
ccsbBroad304_02242	OE	SNX17	Sorting nexins, sorting nexin 17			10.00, 10.00	1.10, 0.40	51.45	-51.60	-57.91	45.43	99.54	-53.10	-52.71	25.09	28.55	10.75
ccsbBroad304_08782	OE	SNX6	Sorting nexins, sorting nexin 6			10.00, 0.00	0.95, 0.33	-29.40	-28.20	97.20	-87.72	43.79	-32.41	71.95	-42.86	28.42	7.25
ccsbBroad304_01576	OE	SOAT1	sterol O-acyltransferase 1			0.00, 0.00	1.17, 0.49	-41.71	70.04	80.97	-99.89	73.12	46.56	-47.57	-49.12	-39.22	55.67
ccsbBroad304_02028	OE	SOCS2	SH2 domain containing, suppressor of cytokine signaling 2		Supressors of cytokine signaling GOF	20.00, 20.00	1.13, 0.36	45.23	99.37	26.93	-96.34	33.23	54.61	5.30	99.98	-84.53	13.32
ccsbBroad304_04767	OE	SOCS4	SH2 domain containing, suppressor of cytokine signaling 4		Supressors of cytokine signaling GOF	0.00, 0.00	1.23, 0.38	-67.97	73.26	33.76	-65.54	-62.63	32.17	61.19	-40.51	33.56	-15.56
ccsbBroad304_07459	OE	SOCS5	SH2 domain containing, suppressor of cytokine signaling 5			10.00, 10.00	0.90, 0.41	60.12	99.82	20.58	-54.32	-64.45	68.37	-39.79	-74.24	-52.81	-17.31
ccsbBroad304_02340	OE	SORBS3	sorbin and SH3 domain containing 3			0.00, 0.00	1.30, 0.33	51.30	-32.16	-20.94	-57.54	-98.71	-52.72	32.56	-96.22	-28.86	-32.72
ccsbBroad304_06985	OE	SORD	sorbitol dehydrogenase			22.22, 22.22	1.02, 0.26	-42.70	NaN	99.80	39.03	-99.86	-89.58	-28.89	38.39	99.02	-12.08
ccsbBroad304_01578	OE	SOS2	Rho guanine nucleotide exchange factors, son of sevenless homolog 2 (Drosophila)			20.00, 10.00	1.22, 0.35	36.24	50.92	95.88	74.63	99.67	43.87	58.48	44.71	-54.86	60.03
ccsbBroad304_03386	OE	SPA17	sperm autoantigenic protein 17			10.00, 0.00	0.69, 0.23	95.21	-44.68	-28.01	57.69	83.61	-61.96	-31.14	-58.74	42.24	31.41
ccsbBroad304_02195	OE	SPAG7	sperm associated antigen 7			10.00, 0.00	0.52, 0.11	67.48	96.74	-27.90	-57.69	-97.59	-75.48	44.45	65.30	37.62	24.49
ccsbBroad304_02855	OE	SPDEF	ETS Transcription Factors, SAM pointed domain containing ets transcription factor			0.00, 0.00	0.76, 0.22	29.94	90.33	-86.77	-95.83	-84.50	-28.76	48.27	-88.44	60.21	-80.31
ccsbBroad304_04754	OE	SPIC	ETS Transcription Factors, Spi-C transcription factor (Spi-1/PU.1 related)			0.00, 0.00	0.72, 0.23	89.23	-68.33	38.22	-86.06	-74.18	47.06	-47.50	-53.32	-25.68	-49.35
ccsbBroad304_01588	OE	SPP1	Endogenous ligands, secreted phosphoprotein 1			20.00, 10.00	1.03, 0.41	95.01	34.32	99.14	-92.20	-40.94	-29.76	58.28	-38.00	-74.80	15.76
ccsbBroad304_02373	OE	SPRY2	sprouty homolog 2 (Drosophila)			10.00, 0.00	1.69, 0.42	80.21	33.74	96.26	27.93	-60.76	26.89	-77.35	52.02	82.06	41.44
ccsbBroad304_01589	OE	SQLE	Lanosterol biosynthesis pathway, squalene epoxidase			0.00, 0.00	1.05, 0.31	-58.21	90.11	43.03	-93.50	-35.35	59.30	-97.06	-99.37	34.24	-90.16
ccsbBroad304_08775	OE	SQRDL	sulfide quinone reductase-like (yeast)			30.00, 20.00	1.25, 0.33	97.94	72.49	-65.95	43.59	92.30	95.70	84.62	42.91	72.60	97.87
ccsbBroad304_07320	OE	SQSTM1	sequestosome 1			10.00, 10.00	1.26, 0.38	31.80	-23.93	-51.18	-37.91	99.94	-29.62	-94.34	-89.52	79.30	-16.42
ccsbBroad304_06992	OE	SRC	Src family, v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)			0.00, 0.00	1.77, 0.51	24.68	-83.94	-54.40	-63.22	30.27	-99.90	-29.10	-32.79	-81.91	-84.98
ccsbBroad304_06993	OE	SRD5A1	steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1)			10.00, 10.00	1.33, 0.41	99.92	-32.15	19.73	81.36	-79.09	-31.92	-50.93	-52.12	-97.99	-31.37
ccsbBroad304_06995	OE	SREBF1	Basic helix-loop-helix proteins, sterol regulatory element binding transcription factor 1			0.00, 0.00	1.14, 0.24	42.09	-22.58	-81.35	NaN	-15.23	-97.72	-75.96	-34.89	42.82	-51.39
ccsbBroad304_02815	OE	SSBP2	single-stranded DNA binding protein 2			10.00, 0.00	0.92, 0.33	64.27	-33.93	50.52	-39.54	-99.98	-73.48	97.46	-55.47	-53.61	-24.30
ccsbBroad304_07006	OE	ST14	Serine peptidases / Transmembrane, suppression of tumorigenicity 14 (colon carcinoma)		Serine proteases GOF	10.00, 0.00	1.47, 0.48	-87.48	70.65	-99.27	47.80	-27.71	95.04	-86.04	-53.46	33.05	-62.04
ccsbBroad304_02485	OE	STAMBP	STAM binding protein			0.00, 0.00	1.03, 0.26	-33.92	-47.83	-89.49	NaN	-51.43	89.19	-56.10	38.32	38.35	-12.19
ccsbBroad304_01607	OE	STAT1	SH2 domain containing, signal transducer and activator of transcription 1, 91kDa			0.00, 0.00	1.25, 0.23	90.66	NaN	-59.30	-99.98	-32.09	-79.11	-13.04	54.59	-71.98	-48.79
ccsbBroad304_01609	OE	STAT3	SH2 domain containing, signal transducer and activator of transcription 3 (acute-phase response factor)			0.00, 0.00	0.88, 0.28	-78.34	NaN	-54.84	-48.79	42.81	37.75	-36.82	-33.91	31.38	-7.97
ccsbBroad304_01610	OE	STAT4	SH2 domain containing, signal transducer and activator of transcription 4			0.00, 0.00	1.15, 0.39	77.92	-64.37	71.65	-24.59	-61.58	-72.54	-93.95	-97.86	-46.06	-90.03
ccsbBroad304_01962	OE	STK16	NAK family, serine/threonine kinase 16			0.00, 0.00	0.77, 0.25	83.19	-47.76	-98.85	-90.84	-48.21	-48.90	33.12	-34.95	37.50	-24.53
ccsbBroad304_12518	OE	STK33	CAMK-unique family, serine/threonine kinase 33			20.00, 20.00	0.88, 0.19	72.80	99.43	-86.83	30.91	-33.93	69.45	97.98	-99.85	-82.85	74.64
ccsbBroad304_08534	OE	STRADB	STLK subfamily, STE20-related kinase adaptor beta			0.00, 0.00	1.45, 0.39	43.85	62.69	-19.54	NaN	-16.36	-33.33	45.63	-41.95	-31.75	-4.72
ccsbBroad304_07704	OE	SUB1	SUB1 homolog (S. cerevisiae)			0.00, 0.00	0.83, 0.19	-75.48	35.80	94.76	NaN	-72.36	57.44	-85.30	-96.54	-85.11	-72.51
ccsbBroad304_03736	OE	SUCNR1	GPCR / Class A : Orphans, succinate receptor 1			0.00, 0.00	1.32, 0.35	-98.70	-65.87	90.97	NaN	-97.32	84.34	52.63	-96.66	94.65	-94.68
ccsbBroad304_01623	OE	SUPT4H1	suppressor of Ty 4 homolog 1 (S. cerevisiae)			11.11, 11.11	0.89, 0.24	98.63	-72.82	-34.68	NaN	-26.67	29.62	-31.18	88.63	58.50	46.60
ccsbBroad304_01624	OE	SUPV3L1	suppressor of var1, 3-like 1 (S. cerevisiae)			20.00, 20.00	1.05, 0.35	90.01	-44.36	40.54	46.58	60.74	-87.64	-39.17	99.84	98.22	57.42
ccsbBroad304_04114	OE	SUV39H2	Histone methyltransferases (HMTs), suppressor of variegation 3-9 homolog 2 (Drosophila)			11.11, 11.11	1.58, 0.45	75.39	NaN	99.91	-74.47	60.90	-53.66	-80.12	-45.03	-26.98	-33.89
ccsbBroad304_02890	OE	SYF2	SYF2 homolog, RNA splicing factor (S. cerevisiae)			10.00, 0.00	1.01, 0.32	43.60	88.14	72.96	-59.25	-99.93	-62.32	-90.90	97.05	-85.59	-83.01
ccsbBroad304_02092	OE	SYNGR3	synaptogyrin 3			10.00, 10.00	0.83, 0.19	-94.57	30.73	-94.22	91.86	67.76	-99.97	-32.78	-99.90	98.87	-98.05
ccsbBroad304_07029	OE	TADA2A	transcriptional adaptor 2A			0.00, 0.00	0.89, 0.18	-48.02	-53.21	29.15	-46.70	-93.26	58.67	-86.07	71.10	25.40	-20.19
ccsbBroad304_02446	OE	TADA3	transcriptional adaptor 3			10.00, 0.00	1.01, 0.31	86.91	40.07	-31.32	58.99	97.29	67.22	-30.51	-71.05	-73.53	59.14
ccsbBroad304_07337	OE	TAF1B	TATA box binding protein (TBP)-associated factor, RNA polymerase I, B, 63kDa			0.00, 0.00	1.02, 0.36	-57.13	36.84	87.79	NaN	-37.57	-45.09	89.83	-38.32	-36.62	-7.87
ccsbBroad304_08053	OE	TAF5L	WD repeat domain containing, TAF5-like RNA polymerase II, p300/CBP-associated factor (PCAF)-associated factor, 65kDa			10.00, 0.00	0.82, 0.23	80.60	-30.75	44.05	-34.89	-94.60	96.43	-94.84	-97.72	-53.66	-66.41
ccsbBroad304_01642	OE	TAL2	Basic helix-loop-helix proteins, T-cell acute lymphocytic leukemia 2			10.00, 10.00	0.95, 0.24	66.60	-96.14	-35.84	-54.12	-29.37	-97.24	98.77	-91.24	-99.96	-91.36
ccsbBroad304_01644	OE	TAP1	ATP binding cassette transporters / subfamily B, transporter 1, ATP-binding cassette, sub-family B (MDR/TAP)			0.00, 0.00	1.63, 0.48	-38.62	NaN	-39.76	-82.07	-33.07	30.09	-78.87	-74.66	58.22	-66.81
ccsbBroad304_11668	OE	TBC1D9B	EF-hand domain containing, TBC1 domain family, member 9B (with GRAM domain)			20.00, 20.00	1.43, 0.34	52.45	99.96	99.72	53.89	-76.69	-35.20	73.26	-45.14	-99.63	61.29
ccsbBroad304_08116	OE	TBK1	IKK family, TANK-binding kinase 1			11.11, 11.11	1.72, 0.50	69.45	NaN	53.04	66.10	99.50	35.21	-39.60	-64.10	-92.38	53.76
ccsbBroad304_07037	OE	TCF12	Basic helix-loop-helix proteins, transcription factor 12			20.00, 20.00	0.83, 0.26	26.25	-55.82	98.27	82.35	-99.71	-94.93	-90.61	-75.37	99.90	-58.02
ccsbBroad304_07036	OE	TCF4	Basic helix-loop-helix proteins, transcription factor 4			20.00, 0.00	0.85, 0.19	-31.90	96.34	97.16	-38.38	-95.76	-99.36	78.63	-92.13	42.95	70.46
ccsbBroad304_01933	OE	TEAD2	TEA domain family member 2			20.00, 10.00	1.32, 0.45	-86.31	-45.45	-37.40	-39.52	-74.81	99.97	-56.51	-65.86	95.15	-54.00
ccsbBroad304_08426	OE	TEX10	testis expressed 10			0.00, 0.00	1.26, 0.36	-97.68	-37.58	43.61	-96.45	-86.76	31.37	-93.02	91.18	72.37	-86.91
ccsbBroad304_01662	OE	TFDP2	transcription factor Dp-2 (E2F dimerization partner 2)			10.00, 0.00	0.75, 0.24	37.17	52.41	97.16	-40.75	86.66	-53.09	38.12	-47.38	-27.04	5.66
ccsbBroad304_01663	OE	TFF2	trefoil factor 2			0.00, 0.00	2.75, 0.91	35.57	NaN	-51.88	-46.00	56.29	92.37	-89.93	-38.01	-27.96	-19.85
ccsbBroad304_07053	OE	TFPI	tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)			0.00, 0.00	0.83, 0.20	-24.46	65.97	-57.46	-74.59	-99.59	-82.62	31.01	63.20	22.21	-46.22
ccsbBroad304_01664	OE	TGFA	transforming growth factor, alpha			10.00, 10.00	0.82, 0.19	99.21	-74.38	29.52	-63.56	-36.66	-73.59	35.19	62.08	-82.39	-52.74
ccsbBroad304_07056	OE	TGFB1	Endogenous ligands, transforming growth factor, beta 1			10.00, 0.00	0.85, 0.30	-45.12	-67.36	-99.70	51.72	-47.83	-34.87	-41.09	97.35	-25.11	-11.89
ccsbBroad304_11186	OE	TGFBR2	Type II receptor serine/threonine kinases, transforming growth factor, beta receptor II (70/80kDa)			20.00, 20.00	1.01, 0.25	63.67	99.10	32.23	99.98	26.37	-35.01	-54.52	-94.77	-61.24	18.42
ccsbBroad304_04525	OE	TGIF2LY	Homeoboxes / TALE class, TGFB-induced factor homeobox 2-like, Y-linked			0.00, 0.00	0.81, 0.22	41.28	8.45	32.91	-24.97	32.05	-40.05	-25.61	-31.90	69.40	2.13
ccsbBroad304_02278	OE	THRAP3	thyroid hormone receptor associated protein 3			10.00, 0.00	1.02, 0.22	28.70	-31.51	82.59	-86.90	62.85	-55.85	-87.37	96.21	27.43	26.16
ccsbBroad304_05528	OE	TICAM2	toll-like receptor adaptor molecule 2			20.00, 10.00	1.08, 0.34	77.34	95.17	-77.69	-81.34	-99.96	-91.44	82.95	98.63	-36.68	84.89
ccsbBroad304_09345	OE	TIMM50	Serine/threonine phosphatases / CTD aspartate-based phosphatases, translocase of inner mitochondrial membrane 50 homolog (S. cerevisiae)			0.00, 0.00	1.94, 0.59	36.59	85.54	32.64	45.51	48.45	35.49	43.68	64.33	-47.36	31.34
ccsbBroad304_02964	OE	TIMM9	translocase of inner mitochondrial membrane 9 homolog (yeast)			50.00, 40.00	0.95, 0.26	-58.07	98.77	95.60	78.85	68.21	99.97	50.88	-98.08	98.12	99.77
ccsbBroad304_01674	OE	TIMP4	TIMP metallopeptidase inhibitor 4			10.00, 10.00	1.08, 0.27	-82.22	99.63	83.70	-24.97	-95.89	-65.43	-60.36	-75.22	-99.41	-64.46
ccsbBroad304_07071	OE	TKT	transketolase			0.00, 0.00	1.50, 0.44	79.14	NaN	-96.30	-36.15	-73.90	86.68	15.95	-51.06	-24.74	-5.28
ccsbBroad304_01676	OE	TLE1	WD repeat domain containing, transducin-like enhancer of split 1 (E(sp1) homolog, Drosophila)			0.00, 0.00	1.70, 0.52	-56.13	63.18	-99.98	-50.98	91.23	-99.85	-32.45	-77.28	37.47	-60.31
ccsbBroad304_01677	OE	TLE2	WD repeat domain containing, transducin-like enhancer of split 2 (E(sp1) homolog, Drosophila)			11.11, 11.11	1.23, 0.33	99.98	NaN	-22.20	-48.45	73.71	-55.63	47.48	-67.15	-22.34	-11.48
ccsbBroad304_11580	OE	TLK2	Tousled-like kinase (TLK) family, tousled-like kinase 2			11.11, 11.11	1.19, 0.41	45.67	-34.27	32.60	NaN	-57.64	-79.20	98.40	-35.89	-47.79	-9.68
ccsbBroad304_07074	OE	TLR2	Toll-like receptor family, toll-like receptor 2			0.00, 0.00	1.26, 0.35	-51.55	57.20	-96.30	-47.13	-24.69	44.04	-61.04	-62.20	-37.17	-33.17
ccsbBroad304_08275	OE	TLR8	Toll-like receptor family, toll-like receptor 8			0.00, 0.00	1.55, 0.53	-79.85	-99.22	-38.40	39.09	-46.61	-37.74	-99.00	-25.51	77.63	-47.78
ccsbBroad304_07080	OE	TM7SF2	transmembrane 7 superfamily member 2			0.00, 0.00	0.98, 0.28	89.02	-71.91	-13.50	NaN	-84.54	35.75	94.96	50.92	-41.21	-19.15
ccsbBroad304_02580	OE	TMED10	transmembrane emp24-like trafficking protein 10 (yeast)			11.11, 11.11	1.45, 0.31	99.93	NaN	-96.95	-26.63	-95.79	-99.97	29.05	-99.65	-91.54	-99.58
ccsbBroad304_03173	OE	TMED7	transmembrane emp24 protein transport domain containing 7			30.00, 30.00	1.10, 0.17	98.38	-24.45	-54.53	99.83	97.67	-58.00	-61.49	32.01	86.42	94.29
ccsbBroad304_03450	OE	TMED9	transmembrane emp24 protein transport domain containing 9			0.00, 0.00	1.85, 0.53	-21.53	31.20	63.74	41.12	87.18	94.15	67.57	-19.44	31.46	51.63
ccsbBroad304_09821	OE	TMEM154	transmembrane protein 154			20.00, 20.00	0.81, 0.26	98.39	-73.37	-41.39	-96.19	-99.98	97.78	59.40	54.95	65.73	43.17
ccsbBroad304_02402	OE	TMEM5	transmembrane protein 5			0.00, 0.00	0.89, 0.23	90.27	-79.98	-22.94	-29.19	-45.99	47.93	-91.97	46.12	-45.14	-9.20
ccsbBroad304_07306	OE	TNFRSF10A	Tumour necrosis factor (TNF) receptor family, tumor necrosis factor receptor superfamily, member 10a		NFKB Activation GOF	11.11, 11.11	1.56, 0.53	-88.97	51.15	64.46	NaN	-58.28	-99.94	76.11	-82.59	99.03	-89.78
ccsbBroad304_07304	OE	TNFRSF10B	Tumour necrosis factor (TNF) receptor family, tumor necrosis factor receptor superfamily, member 10b		NFKB Activation GOF	0.00, 0.00	2.63, 0.73	-29.86	-87.50	-50.21	74.19	-34.72	-99.81	-37.28	-97.31	44.78	-72.26
ccsbBroad304_01688	OE	TNFRSF1A	Tumour necrosis factor (TNF) receptor family, tumor necrosis factor receptor superfamily, member 1A		NFKB Activation GOF	11.11, 11.11	3.11, 0.97	-46.71	99.80	-63.89	NaN	-99.22	41.44	-43.38	-46.50	-99.85	-66.79
ccsbBroad304_14122	OE	TNFRSF21	Tumour necrosis factor (TNF) receptor family, tumor necrosis factor receptor superfamily, member 21			0.00, 0.00	0.95, 0.32	80.79	-61.96	31.20	-60.53	-33.36	43.53	70.64	-81.72	34.31	-9.22
ccsbBroad304_02011	OE	TNFRSF6B	Tumour necrosis factor (TNF) receptor family, tumor necrosis factor receptor superfamily, member 6b, decoy			11.11, 11.11	1.58, 0.36	99.17	NaN	43.73	-47.81	-35.39	-44.42	-55.26	44.11	34.82	-15.70
ccsbBroad304_07294	OE	TNFSF10	CD molecules, tumor necrosis factor (ligand) superfamily, member 10			20.00, 20.00	1.23, 0.34	-87.77	65.03	-38.43	99.80	-39.17	99.25	85.94	-50.03	-59.94	76.67
ccsbBroad304_02503	OE	TNFSF13B	CD molecules, tumor necrosis factor (ligand) superfamily, member 13b			0.00, 0.00	1.90, 0.60	-99.90	-98.71	-28.79	NaN	46.23	-36.07	-35.63	-45.27	-38.42	-29.01
ccsbBroad304_04457	OE	TOX2	TOX high mobility group box family member 2			0.00, 0.00	1.59, 0.53	52.20	42.70	-81.81	NaN	73.62	-24.94	-30.81	-32.91	-31.09	-8.52
ccsbBroad304_07088	OE	TP53	tumor protein p53			10.00, 10.00	0.98, 0.25	-66.03	49.25	99.78	-30.12	-77.63	-84.87	-98.80	39.77	86.72	-72.03
ccsbBroad304_04633	OE	TP53RK	Bud32 family, TP53 regulating kinase			10.00, 0.00	1.00, 0.24	-88.55	90.89	-18.40	-35.48	-94.95	54.46	96.08	-34.77	25.51	8.79
ccsbBroad304_01699	OE	TPD52L2	tumor protein D52-like 2			10.00, 0.00	0.90, 0.33	-51.36	97.20	53.53	-63.88	38.73	42.79	78.13	-98.59	-72.01	-43.83
ccsbBroad304_09281	OE	TPD52L3	tumor protein D52-like 3			30.00, 20.00	0.85, 0.32	44.75	92.27	79.77	-73.02	87.19	74.98	96.57	-40.97	97.75	98.38
ccsbBroad304_01710	OE	TRAF2	RING-type (C3HC4) zinc fingers, TNF receptor-associated factor 2			0.00, 0.00	4.18, 0.90	-53.13	37.82	-95.75	52.93	-99.31	-93.31	-95.74	-99.33	-97.03	-98.89
ccsbBroad304_03850	OE	TRIB3	Trbl family, tribbles homolog 3 (Drosophila)			0.00, 0.00	1.05, 0.30	28.87	-69.50	-9.06	76.18	83.21	-83.05	-28.42	69.80	-57.68	-11.14
ccsbBroad304_02354	OE	TRIM13	RING-type (C3HC4) zinc fingers, tripartite motif containing 13			0.00, 0.00	1.03, 0.36	-56.03	67.74	-16.52	NaN	-97.15	84.31	-47.02	-37.06	-97.61	-75.38
ccsbBroad304_07656	OE	TRIM16	Tripartite motif containing, tripartite motif containing 16			0.00, 0.00	1.08, 0.27	40.81	-98.55	-43.22	NaN	52.04	76.32	-97.91	-45.89	-94.05	-93.70
ccsbBroad304_02752	OE	TRIM2	RING-type (C3HC4) zinc fingers, tripartite motif containing 2			10.00, 10.00	1.18, 0.31	-39.70	-59.30	99.70	-36.39	-97.30	52.84	-51.90	-40.03	-13.48	-18.99
ccsbBroad304_01392	OE	TRIM27	tripartite motif containing 27			0.00, 0.00	1.24, 0.39	-31.71	NaN	-99.46	-98.16	-42.53	84.76	91.02	-58.33	-29.69	-15.65
ccsbBroad304_07922	OE	TRIM29	tripartite motif containing 29			0.00, 0.00	1.09, 0.30	-32.73	NaN	-23.33	-26.46	46.55	94.76	-50.03	53.31	63.22	40.26
ccsbBroad304_02137	OE	TRIP13	ATPases / AAA-type, thyroid hormone receptor interactor 13			10.00, 0.00	1.26, 0.30	-20.53	-78.39	95.50	52.48	-57.41	88.33	-34.91	-64.89	-44.38	-15.29
ccsbBroad304_02032	OE	TSC22D1	TSC22 domain family, member 1			0.00, 0.00	1.52, 0.50	30.25	-49.95	94.79	-73.86	-42.68	-51.26	-10.48	-70.40	93.59	-30.28
ccsbBroad304_06126	OE	TSC22D3	TSC22 domain family, member 3			0.00, 0.00	1.17, 0.36	27.30	-24.12	-92.86	-54.00	-60.63	37.77	29.32	-30.39	32.50	-11.20
ccsbBroad304_09043	OE	TSEN2	tRNA splicing endonuclease subunits, tRNA splicing endonuclease 2 homolog (S. cerevisiae)			0.00, 0.00	1.03, 0.24	30.72	-38.40	-50.23	-73.70	-75.54	51.28	66.73	55.74	47.84	-8.20
ccsbBroad304_07079	OE	TSPAN4	Tetraspanins, tetraspanin 4			0.00, 0.00	1.22, 0.40	-95.38	-59.28	-23.44	-40.57	-44.44	83.24	86.08	-53.64	-97.77	-54.78
ccsbBroad304_07077	OE	TSPAN8	Tetraspanins, tetraspanin 8			0.00, 0.00	1.84, 0.49	-14.71	39.01	88.92	66.92	-98.98	86.55	-95.83	77.18	-54.07	73.11
ccsbBroad304_07548	OE	TSSC4	tumor suppressing subtransferable candidate 4			10.00, 10.00	1.58, 0.43	-97.46	-86.54	-9.51	55.95	38.73	-85.07	97.55	-99.66	-39.68	-85.39
ccsbBroad304_01723	OE	TTK	TTK family, TTK protein kinase			10.00, 10.00	0.99, 0.25	-90.49	-72.79	-88.84	-80.97	-37.19	-91.68	28.83	-39.63	99.97	-84.73
ccsbBroad304_01831	OE	TUBA1A	Tubulins, tubulin, alpha 1a			10.00, 10.00	0.85, 0.38	91.46	99.08	73.61	93.26	-49.53	60.47	39.44	84.12	-29.31	88.00
ccsbBroad304_07109	OE	TUBB2A	Tubulins, tubulin, beta 2A			10.00, 0.00	0.84, 0.27	-18.38	52.06	28.50	47.26	48.85	-92.84	95.94	-67.51	-40.32	2.27
ccsbBroad304_02416	OE	TUBB4B	tubulin, beta 4B class IVb			30.00, 20.00	0.95, 0.32	61.62	96.99	98.03	-87.21	47.23	97.83	-35.64	-41.55	-86.60	82.25
ccsbBroad304_04404	OE	TUBB6	Tubulins, tubulin, beta 6			11.11, 11.11	2.00, 0.51	47.76	NaN	19.57	-28.59	40.35	98.56	43.59	-99.98	29.98	16.29
ccsbBroad304_07802	OE	TWF2	Twinfilin subfamily, twinfilin, actin-binding protein, homolog 2 (Drosophila)			10.00, 10.00	1.14, 0.31	-32.93	-25.58	67.86	-99.88	-23.17	33.18	46.74	99.49	-37.48	8.85
ccsbBroad304_07401	OE	TXNL1	thioredoxin-like 1			0.00, 0.00	1.22, 0.28	-34.86	NaN	60.16	38.10	10.70	32.60	-81.64	-37.48	-32.71	-2.15
ccsbBroad304_03497	OE	TXNL4B	thioredoxin-like 4B			0.00, 0.00	1.56, 0.35	-96.71	-41.13	-99.90	NaN	-97.92	-95.60	-98.57	-99.00	40.66	-99.07
ccsbBroad304_07506	OE	UBAP2L	ubiquitin associated protein 2-like			0.00, 0.00	1.07, 0.27	87.97	49.42	-88.96	NaN	-43.12	-85.96	-99.54	-54.07	56.51	-74.06
ccsbBroad304_02448	OE	UBE2E3	Ubiquitin-conjugating enzymes E2, ubiquitin-conjugating enzyme E2E 3			10.00, 10.00	1.47, 0.33	-51.15	-37.89	30.67	38.76	-43.90	98.69	33.97	-37.48	-28.15	-15.79
ccsbBroad304_00737	OE	UBE2K	Ubiquitin-conjugating enzymes E2, ubiquitin-conjugating enzyme E2K			10.00, 0.00	1.07, 0.35	20.67	97.17	-11.71	-39.24	-87.78	-19.61	-25.44	37.59	24.40	1.39
ccsbBroad304_02121	OE	UBE2L6	Ubiquitin-conjugating enzymes E2, ubiquitin-conjugating enzyme E2L 6			0.00, 0.00	0.76, 0.28	-73.41	-56.99	-22.68	-74.55	51.30	-85.31	60.78	84.60	-57.55	-45.06
ccsbBroad304_03874	OE	UBL5	ubiquitin-like 5			10.00, 10.00	0.89, 0.28	-57.44	-87.54	78.37	-60.04	94.75	-39.28	-93.42	99.98	-55.92	-58.26
ccsbBroad304_01748	OE	UFD1L	ubiquitin fusion degradation 1 like (yeast)			11.11, 11.11	0.84, 0.27	39.21	94.62	99.35	NaN	-85.83	-92.84	-52.00	-58.31	-67.71	-36.97
ccsbBroad304_08322	OE	UFM1	ubiquitin-fold modifier 1			10.00, 10.00	0.82, 0.24	-71.21	91.63	-25.38	-92.34	-83.47	98.04	38.15	20.61	-99.42	-66.33
ccsbBroad304_07124	OE	UROD	uroporphyrinogen decarboxylase			30.00, 20.00	1.50, 0.49	-63.04	98.07	31.41	-82.62	36.43	36.23	98.76	80.88	96.41	93.27
ccsbBroad304_01760	OE	USP1	Ubiquitin-specific peptidases, ubiquitin specific peptidase 1			11.11, 11.11	1.23, 0.26	51.73	NaN	99.70	-29.25	86.83	-93.07	-44.62	-66.33	38.67	29.18
ccsbBroad304_07520	OE	USP15	Ubiquitin-specific peptidases, ubiquitin specific peptidase 15			30.00, 30.00	1.08, 0.30	-19.53	58.02	-44.00	99.94	92.14	70.25	92.60	99.33	40.78	97.55
ccsbBroad304_02231	OE	USP6NL	USP6 N-terminal like			0.00, 0.00	1.58, 0.47	-78.77	-30.94	-63.45	NaN	51.23	-48.41	25.19	-37.37	80.64	-17.97
ccsbBroad304_02534	OE	UTP14A	UTP14, U3 small nucleolar ribonucleoprotein, homolog A (yeast)			10.00, 10.00	1.30, 0.33	65.69	-39.19	86.87	-45.49	52.70	99.97	59.75	47.99	28.67	40.85
ccsbBroad304_02145	OE	VAMP3	Vesicle-associated membrane proteins, vesicle-associated membrane protein 3 (cellubrevin)			10.00, 10.00	1.17, 0.36	-38.10	93.65	-64.82	67.18	98.89	-83.56	-65.60	47.11	90.03	80.39
ccsbBroad304_01767	OE	VDR	Vitamin D receptors, vitamin D (1,25- dihydroxyvitamin D3) receptor			0.00, 0.00	0.98, 0.22	91.80	-90.94	-86.82	40.79	-33.78	19.27	-99.79	19.34	49.35	-22.44
ccsbBroad304_01769	OE	VEGFB	vascular endothelial growth factor B			0.00, 0.00	1.33, 0.31	15.42	-82.30	-18.75	79.48	76.43	-60.57	-66.39	-57.87	33.66	-26.47
ccsbBroad304_07466	OE	VGLL4	vestigial like 4 (Drosophila)			0.00, 0.00	3.43, 1.07	-99.92	-27.74	-87.85	NaN	-21.99	-99.97	-98.06	-96.39	87.31	-99.72
ccsbBroad304_07128	OE	VHL	von Hippel-Lindau tumor suppressor			10.00, 10.00	1.01, 0.27	39.57	40.74	-30.65	-32.06	43.56	-84.43	36.91	97.73	-50.65	-10.65
ccsbBroad304_01771	OE	VIM	Intermediate filaments type III, vimentin			0.00, 0.00	0.86, 0.30	-55.51	-98.97	65.66	37.83	-62.25	90.24	39.12	-38.95	-93.22	-40.18
ccsbBroad304_09992	OE	VN1R2	GPCR / Unclassified : Vomeronasal receptors, type 1, vomeronasal 1 receptor 2			11.11, 0.00	1.39, 0.36	52.09	72.54	60.97	NaN	-14.63	-99.85	-50.81	45.74	95.63	20.75
ccsbBroad304_05422	OE	VN1R5	GPCR / Unclassified : Vomeronasal receptors, type 1, vomeronasal 1 receptor 5 (gene/pseudogene)			0.00, 0.00	2.05, 0.67	-98.34	-76.75	38.85	NaN	46.37	-25.52	-63.01	-99.98	89.43	-87.87
ccsbBroad304_07590	OE	WARS2	Aminoacyl tRNA synthetases / Class I, tryptophanyl tRNA synthetase 2, mitochondrial			20.00, 20.00	1.06, 0.33	57.61	99.65	98.11	-95.58	-99.45	-43.10	-74.73	-93.94	-76.47	-91.07
ccsbBroad304_09036	OE	WDR61	WD repeat domain containing, WD repeat domain 61			10.00, 0.00	1.65, 0.39	-83.57	-74.17	-63.98	97.48	-96.54	92.30	-36.01	-65.84	-49.91	-75.12
ccsbBroad304_01781	OE	WNT7B	Endogenous ligands, wingless-type MMTV integration site family, member 7B			0.00, 0.00	1.53, 0.44	49.56	30.23	-40.58	NaN	-72.67	64.06	59.40	-79.63	-83.12	-34.37
ccsbBroad304_02889	OE	WWTR1	Hippo Signaling, WW domain containing transcription regulator 1			40.00, 30.00	1.72, 0.57	64.07	-99.91	96.61	-49.86	-48.95	99.90	99.98	-95.26	94.26	99.49
ccsbBroad304_01786	OE	XRCC4	XRCC DNA Repair, X-ray repair complementing defective repair in Chinese hamster cells 4			10.00, 10.00	0.80, 0.26	98.27	-77.06	-94.46	53.97	74.78	51.56	-35.10	57.45	71.28	57.04
ccsbBroad304_06236	OE	XRCC6	XRCC DNA Repair, X-ray repair complementing defective repair in Chinese hamster cells 6			30.00, 30.00	0.97, 0.27	68.10	90.52	89.84	38.80	99.88	56.72	-26.07	99.95	50.70	98.56
ccsbBroad304_07561	OE	YAF2	YY1 associated factor 2			10.00, 10.00	1.08, 0.30	65.55	-86.76	-79.63	99.89	-51.05	-36.67	62.20	-98.37	-42.97	-54.43
ccsbBroad304_01958	OE	YARS	Aminoacyl tRNA synthetases / Class I, tyrosyl-tRNA synthetase			0.00, 0.00	1.52, 0.51	-98.29	-68.18	35.29	-85.25	91.38	86.30	-93.12	37.24	37.50	-69.07
ccsbBroad304_01862	OE	YEATS4	YEATS domain containing 4			11.11, 11.11	1.76, 0.27	39.40	NaN	97.66	63.11	-33.21	47.93	-64.39	38.33	-47.78	13.47
ccsbBroad304_01787	OE	YES1	Src family, v-yes-1 Yamaguchi sarcoma viral oncogene homolog 1			0.00, 0.00	0.91, 0.31	37.73	74.57	-99.09	-67.71	-99.58	47.19	47.80	-62.45	-37.76	-66.88
ccsbBroad304_03308	OE	YTHDF2	YTH domain family, member 2			0.00, 0.00	1.42, 0.31	42.14	91.97	79.19	NaN	34.48	94.56	92.91	33.91	-63.79	78.10
ccsbBroad304_03382	OE	ZAK	MLK subfamily, sterile alpha motif and leucine zipper containing kinase AZK			10.00, 10.00	0.88, 0.32	-91.28	52.31	-49.52	-83.01	-25.87	-57.74	99.50	-98.66	70.47	-71.55
ccsbBroad304_02257	OE	ZBTB24	BTB/POZ domain containing, zinc finger and BTB domain containing 24			30.00, 10.00	1.10, 0.38	77.59	66.65	99.91	57.54	96.41	72.65	-51.71	-61.90	95.35	94.79
ccsbBroad304_03839	OE	ZBTB26	BTB/POZ domain containing, zinc finger and BTB domain containing 26			20.00, 20.00	0.94, 0.24	49.85	38.55	99.10	29.97	-30.45	-52.17	-46.25	65.45	99.96	32.93
ccsbBroad304_08307	OE	ZC3HC1	Zinc fingers, C3HC-type, zinc finger, C3HC-type containing 1			0.00, 0.00	1.60, 0.42	-39.58	-23.96	-43.88	-99.93	30.32	-36.35	53.42	61.32	-51.70	-20.88
ccsbBroad304_02436	OE	ZER1	ZYG11 cell cycle regulator family, zer-1 homolog (C. elegans)			0.00, 0.00	0.83, 0.19	-65.86	-31.91	-88.14	NaN	-85.19	-32.47	90.99	-99.80	-36.61	-83.32
ccsbBroad304_07145	OE	ZFP161	zinc finger protein 161 homolog (mouse)			10.00, 0.00	0.75, 0.20	97.17	-85.87	61.96	-98.20	-57.76	-99.97	24.78	76.14	57.96	-74.83
ccsbBroad304_09206	OE	ZGPAT	G patch domain containing, zinc finger, CCCH-type with G patch domain			0.00, 0.00	0.89, 0.28	88.53	-56.67	41.36	-67.17	87.29	83.03	31.56	44.25	32.09	53.45
ccsbBroad304_04654	OE	ZIM3	Zinc fingers, C2H2-type, zinc finger, imprinted 3			10.00, 0.00	0.95, 0.25	81.71	26.89	21.56	-35.28	91.03	52.95	96.30	-74.85	30.76	40.83
ccsbBroad304_10035	OE	ZKSCAN2	Zinc fingers, C2H2-type, zinc finger with KRAB and SCAN domains 2			10.00, 0.00	1.43, 0.33	23.29	58.95	33.08	32.94	95.17	45.11	91.31	77.77	-88.69	45.14
ccsbBroad304_01808	OE	ZNF134	Zinc fingers, C2H2-type, zinc finger protein 134			0.00, 0.00	0.89, 0.17	29.95	64.84	6.14	NaN	-81.43	32.90	-98.48	-39.44	-22.97	-2.27
ccsbBroad304_01809	OE	ZNF136	Zinc fingers, C2H2-type, zinc finger protein 136			0.00, 0.00	1.19, 0.34	77.72	33.64	-90.62	-51.98	-95.99	-29.59	-50.36	-76.32	61.81	-38.39
ccsbBroad304_07169	OE	ZNF174	Zinc fingers, C2H2-type, zinc finger protein 174			20.00, 20.00	1.13, 0.30	99.96	43.08	85.51	99.07	-55.30	94.44	57.05	-99.27	-54.68	92.92
ccsbBroad304_08255	OE	ZNF219	Zinc fingers, C2H2-type, zinc finger protein 219			22.22, 22.22	1.24, 0.40	76.77	-38.73	-90.63	NaN	63.43	-37.56	-95.39	98.13	98.92	72.94
ccsbBroad304_01795	OE	ZNF22	Zinc fingers, C2H2-type, zinc finger protein 22 (KOX 15)			10.00, 10.00	1.00, 0.30	-31.97	-39.75	-82.26	-41.33	-72.16	97.50	-13.82	-37.87	-28.86	-7.43
ccsbBroad304_07153	OE	ZNF24	Zinc fingers, C2H2-type, zinc finger protein 24			10.00, 10.00	1.00, 0.34	-41.66	99.91	21.62	-78.75	51.26	55.02	72.33	56.73	-88.72	35.87
ccsbBroad304_07679	OE	ZNF274	Zinc fingers, C2H2-type, zinc finger protein 274			22.22, 22.22	1.66, 0.52	64.89	NaN	63.33	-54.37	-75.67	24.62	-34.06	99.43	99.89	41.46
ccsbBroad304_08742	OE	ZNF398	Zinc fingers, C2H2-type, zinc finger protein 398			11.11, 11.11	1.13, 0.33	-79.59	86.63	-51.21	NaN	28.24	-38.65	98.43	-98.74	-99.97	-57.62
ccsbBroad304_09050	OE	ZNF436	Zinc fingers, C2H2-type, zinc finger protein 436			0.00, 0.00	1.02, 0.38	-82.77	40.09	-12.82	-99.98	74.21	-66.00	76.66	-34.47	-99.96	-45.95
ccsbBroad304_04732	OE	ZNF488	Zinc fingers, C2H2-type, zinc finger protein 488			11.11, 0.00	1.08, 0.24	96.43	-23.73	68.30	NaN	-31.26	35.89	-27.89	-51.71	60.58	26.92
ccsbBroad304_08734	OE	ZNF490	Zinc fingers, C2H2-type, zinc finger protein 490			20.00, 10.00	0.97, 0.31	99.50	-96.56	66.18	94.57	-40.73	95.73	-33.91	-68.50	73.45	93.83
ccsbBroad304_10012	OE	ZNF546	Zinc fingers, C2H2-type, zinc finger protein 546			11.11, 11.11	1.09, 0.16	98.68	-23.89	-98.25	NaN	74.76	-57.48	52.00	-46.15	46.22	39.12
ccsbBroad304_09648	OE	ZNF548	Zinc fingers, C2H2-type, zinc finger protein 548			0.00, 0.00	0.89, 0.25	-52.03	67.91	-96.71	-78.22	-31.57	-25.35	-47.55	38.96	-42.02	-13.67
ccsbBroad304_05008	OE	ZNF558	Zinc fingers, C2H2-type, zinc finger protein 558			10.00, 10.00	0.84, 0.20	26.38	45.48	-11.17	-98.51	-31.41	53.61	99.84	62.72	-99.92	14.39
ccsbBroad304_03461	OE	ZNF562	Zinc fingers, C2H2-type, zinc finger protein 562			0.00, 0.00	1.25, 0.36	84.43	-37.61	-25.17	-26.62	62.41	-69.25	45.25	-76.71	-78.12	-44.11
ccsbBroad304_09497	OE	ZNF57	Zinc fingers, C2H2-type, zinc finger protein 57			0.00, 0.00	1.10, 0.31	-25.15	-39.76	-97.77	92.68	-83.87	-33.33	-95.35	31.60	36.81	-47.64
ccsbBroad304_08313	OE	ZNF581	Zinc fingers, C2H2-type, zinc finger protein 581			10.00, 10.00	0.99, 0.33	-51.55	99.41	63.26	-56.50	-93.38	31.22	-47.43	36.99	30.72	-9.62
ccsbBroad304_04990	OE	ZNF597	Zinc fingers, C2H2-type, zinc finger protein 597			0.00, 0.00	1.15, 0.36	-55.66	-48.19	-93.16	28.93	89.03	-96.96	24.02	-86.24	58.73	-70.25
ccsbBroad304_09746	OE	ZNF610	Zinc fingers, C2H2-type, zinc finger protein 610			0.00, 0.00	2.47, 0.75	-42.72	77.19	37.43	-83.89	57.75	-39.27	-83.87	33.76	-97.36	-71.52
ccsbBroad304_05180	OE	ZNF626	Zinc fingers, C2H2-type, zinc finger protein 626			40.00, 30.00	1.14, 0.38	77.19	52.68	70.62	40.11	86.70	99.41	98.42	99.95	83.38	97.05
ccsbBroad304_04690	OE	ZNF653	Zinc fingers, C2H2-type, zinc finger protein 653			0.00, 0.00	1.16, 0.23	-26.64	42.22	-77.42	NaN	-60.57	-98.39	53.72	-98.20	63.80	-59.13
ccsbBroad304_03615	OE	ZNF673	zinc finger family member 673			0.00, 0.00	0.99, 0.27	-81.00	67.97	53.62	35.76	-98.78	-26.31	-41.26	-31.89	-80.42	-38.76
ccsbBroad304_10484	OE	ZNF707	Zinc fingers, C2H2-type, zinc finger protein 707			0.00, 0.00	1.07, 0.35	-26.59	-89.82	-95.84	53.06	91.41	-69.04	79.60	50.44	50.04	-33.97
ccsbBroad304_07158	OE	ZNF74	Zinc fingers, C2H2-type, zinc finger protein 74			0.00, 0.00	1.86, 0.50	-99.89	-57.38	-39.40	NaN	-32.07	34.24	-80.90	-31.82	80.64	-44.10
ccsbBroad304_04001	OE	ZNF747	Zinc fingers, C2H2-type, zinc finger protein 747			0.00, 0.00	1.06, 0.35	-59.08	-49.51	26.46	63.50	-93.24	-47.71	-96.53	-55.79	89.36	-25.54
ccsbBroad304_03861	OE	ZNF77	Zinc fingers, C2H2-type, zinc finger protein 77			22.22, 22.22	0.97, 0.28	57.88	80.24	99.82	NaN	-92.85	99.73	-52.26	-39.40	-67.94	42.21
ccsbBroad304_04991	OE	ZNF785	Zinc fingers, C2H2-type, zinc finger protein 785			10.00, 10.00	0.97, 0.31	69.29	42.26	68.64	-99.12	-89.43	41.78	-49.20	-51.44	99.10	30.04
ccsbBroad304_10094	OE	ZNF790	Zinc fingers, C2H2-type, zinc finger protein 790			11.11, 11.11	0.88, 0.28	-98.12	-82.72	-34.30	NaN	99.87	-42.07	16.60	-38.16	-62.48	-21.47
ccsbBroad304_07147	OE	ZNF8	Zinc fingers, C2H2-type, zinc finger protein 8			30.00, 30.00	0.99, 0.39	-35.57	-59.72	97.64	-22.38	99.42	-35.72	99.98	-37.02	-46.72	-10.62
ccsbBroad304_10216	OE	ZPBP2	Immunoglobulin superfamily / Immunoglobulin-like domain containing, zona pellucida binding protein 2			10.00, 10.00	1.32, 0.40	-80.30	72.06	42.22	-95.55	-96.15	-46.90	-99.31	76.25	99.37	-86.86
ccsbBroad304_02108	OE	AURKB	Aurora kinase, aurora kinase B			0.00, 0.00	1.03, 0.30	79.69	11.26	-99.60	-71.52	-22.76	-32.08	19.43	-27.97	-98.45	-30.66
ccsbBroad304_02875	OE	BRP44	brain protein 44			0.00, 0.00	0.98, 0.26	17.81	-23.01	-92.89	-58.65	-89.71	-64.85	-32.96	-39.35	90.94	-34.92
ccsbBroad304_03910	OE	CCDC90A	coiled-coil domain containing 90A			10.00, 10.00	1.17, 0.33	-70.60	47.48	-93.52	98.77	33.11	-38.46	32.36	-75.58	-96.37	-88.39
ccsbBroad304_00520	OE	ETV1	ETS Transcription Factors, ets variant 1			0.00, 0.00	1.35, 0.35	-35.31	74.45	93.51	-27.24	-30.80	-99.59	-30.64	-92.26	-46.17	-22.38
ccsbBroad304_00763	OE	HNF4A	Hepatocyte nuclear factor-4 receptors, hepatocyte nuclear factor 4, alpha			0.00, 0.00	4.83, 1.56	-99.97	44.77	-99.91	-99.80	-53.42	-99.65	85.99	-99.86	76.33	-99.91
ccsbBroad304_01144	OE	PAK1	PAKA subfamily, p21 protein (Cdc42/Rac)-activated kinase 1			10.00, 10.00	0.63, 0.18	-53.23	57.07	65.28	-32.27	98.15	87.77	82.98	66.14	-70.03	69.04
ccsbBroad304_01371	OE	RALA	v-ral simian leukemia viral oncogene homolog A (ras related)			0.00, 0.00	0.70, 0.20	80.61	32.33	-49.19	42.28	37.25	36.38	-55.37	75.47	-89.06	13.61
ccsbBroad304_07981	OE	SENP6	Ulp1 endopeptidase, SUMO1/sentrin specific peptidase 6			10.00, 10.00	0.44, 0.08	82.07	99.25	-79.03	-97.97	-80.63	71.31	72.87	-76.32	-91.59	-83.47
ccsbBroad304_07709	OE	AFG3L2	ATPases / AAA-type, AFG3 ATPase family gene 3-like 2 (S. cerevisiae)			20.00, 10.00	1.06, 0.34	58.44	26.33	28.25	97.11	-35.10	-47.81	-41.24	99.61	-65.75	16.20
ccsbBroad304_05832	OE	AIRE	Zinc fingers, PHD-type, autoimmune regulator			0.00, 0.00	1.51, 0.51	58.87	-51.37	-78.75	77.59	64.75	62.44	27.63	65.44	-47.72	48.06
ccsbBroad304_02310	OE	ARPC4	Actin related protein 2/3 complex subunits, actin related protein 2/3 complex, subunit 4, 20kDa			0.00, 0.00	1.41, 0.32	-99.98	-27.66	75.22	-83.05	-48.23	-77.70	94.87	68.54	-56.35	-62.59
ccsbBroad304_00115	OE	ASPH	aspartate beta-hydroxylase			0.00, 0.00	1.05, 0.30	-51.32	-97.00	-32.37	-46.53	-35.31	-72.86	-47.25	-35.86	33.16	-47.86
ccsbBroad304_03512	OE	ATG16L1	WD repeat domain containing, ATG16 autophagy related 16-like 1 (S. cerevisiae)			0.00, 0.00	1.53, 0.43	-24.54	34.07	51.96	-73.20	80.27	-76.75	-43.48	-65.84	-29.11	-34.97
ccsbBroad304_05868	OE	ATP5C1	ATPases / F-type, ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1			0.00, 0.00	1.08, 0.25	-95.26	43.44	-27.78	54.92	85.77	-37.50	77.05	-34.87	-84.66	36.64
ccsbBroad304_02048	OE	BCL10	B-cell CLL/lymphoma 10		NFKB Activation GOF	0.00, 0.00	6.08, 2.06	-24.72	-99.62	-58.02	-87.35	-99.74	-98.05	-98.96	-96.02	-99.97	-99.58
ccsbBroad304_11251	OE	BRD3	Bromodomain kinase (BRDK) family, bromodomain containing 3			30.00, 20.00	1.18, 0.28	45.05	99.25	-88.97	-48.00	43.05	-98.00	92.69	93.96	99.97	96.67
ccsbBroad304_11738	OE	BRD4	Bromodomain kinase (BRDK) family, bromodomain containing 4			0.00, 0.00	1.09, 0.33	-21.64	26.75	40.70	53.74	38.90	27.80	76.69	-97.16	88.66	9.40
ccsbBroad304_00184	OE	C2	Complement system, complement component 2			10.00, 10.00	1.11, 0.30	-29.65	-37.19	65.96	-68.06	44.90	80.69	98.27	-52.14	-30.12	30.22
ccsbBroad304_03372	OE	CAB39	calcium binding protein 39			0.00, 0.00	1.40, 0.27	77.95	63.13	-71.88	-99.98	-99.02	63.89	35.56	-41.36	48.90	-74.45
ccsbBroad304_04360	OE	CAPNS2	EF-hand domain containing, calpain, small subunit 2			10.00, 0.00	1.26, 0.34	60.07	91.59	96.56	-25.84	39.67	71.67	-77.38	-86.68	71.35	80.20
ccsbBroad304_02801	OE	CASP14	Caspases, caspase 14, apoptosis-related cysteine peptidase			0.00, 0.00	1.66, 0.41	-54.29	86.80	34.36	73.16	75.13	40.34	-42.55	-28.38	-31.86	48.46
ccsbBroad304_06649	OE	CNOT4	RNA binding motif (RRM) containing, CCR4-NOT transcription complex, subunit 4			20.00, 10.00	1.38, 0.45	-28.88	54.16	36.78	61.40	-27.64	96.31	-39.08	97.53	30.07	27.92
ccsbBroad304_07861	OE	COBL	cordon-bleu homolog (mouse)			0.00, 0.00	1.03, 0.33	-51.05	-21.94	-11.39	-64.66	71.09	-69.61	40.84	50.08	40.28	2.04
ccsbBroad304_00356	OE	CPD	Carboxypeptidase A, carboxypeptidase D			0.00, 0.00	1.28, 0.32	49.05	-38.44	-42.89	88.42	70.35	-40.01	-40.94	-63.42	33.65	17.00
ccsbBroad304_06041	OE	CRYAA	Heat shock proteins / HSPB, crystallin, alpha A			0.00, 0.00	0.76, 0.25	26.93	50.08	32.69	-93.48	-88.46	75.50	46.90	-30.61	23.42	10.72
ccsbBroad304_00376	OE	CSK	Csk family, c-src tyrosine kinase			10.00, 10.00	1.42, 0.39	-98.98	23.06	-36.74	-96.54	-28.29	-87.06	-64.26	-55.83	98.84	-75.80
ccsbBroad304_00378	OE	CSNK1D	Casein kinase 1 (CK1) family, casein kinase 1, delta			0.00, 0.00	1.38, 0.24	-21.45	-73.01	-99.46	-94.07	92.91	-60.50	-83.26	-93.28	60.34	-87.76
ccsbBroad304_06085	OE	DCK	deoxycytidine kinase			0.00, 0.00	0.92, 0.38	-99.93	27.77	-95.67	-77.43	-56.11	58.60	91.19	-90.17	90.66	-79.57
ccsbBroad304_07252	OE	DGKZ	diacylglycerol kinase, zeta			10.00, 10.00	1.32, 0.30	88.60	99.96	-13.13	56.31	-32.24	-93.65	-87.84	88.71	57.96	56.80
ccsbBroad304_00446	OE	DKC1	dyskeratosis congenita 1, dyskerin			10.00, 10.00	1.10, 0.33	99.95	35.61	49.72	89.17	36.17	-55.73	-38.64	42.19	61.30	20.32
ccsbBroad304_06120	OE	DRD1	Dopamine receptors, dopamine receptor D1			0.00, 0.00	1.43, 0.36	-70.96	-89.66	-31.02	94.57	33.11	-19.69	-71.82	-23.97	31.28	-13.84
ccsbBroad304_01929	OE	DYRK2	Dyrk2 subfamily, dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2			0.00, 0.00	1.11, 0.30	-38.95	24.46	-81.60	-58.83	24.95	31.57	69.33	36.67	-97.28	-10.86
ccsbBroad304_06138	OE	EDNRB	Endothelin receptors, endothelin receptor type B			0.00, 0.00	0.68, 0.14	-22.85	-29.88	52.10	-31.94	-76.01	64.95	64.14	-86.72	-40.54	-1.71
ccsbBroad304_00486	OE	EFNB2	Ephrins, ephrin-B2			0.00, 0.00	1.11, 0.28	48.33	-35.74	-24.58	-34.95	-44.92	-27.74	48.21	-72.92	30.85	-6.11
ccsbBroad304_06144	OE	EFNB3	Ephrins, ephrin-B3			0.00, 0.00	1.05, 0.23	88.96	46.67	-91.66	-94.53	29.03	-33.55	-44.00	60.21	43.10	8.56
ccsbBroad304_08023	OE	EIF2C1	eukaryotic translation initiation factor 2C, 1			0.00, 0.00	1.38, 0.44	-38.28	-99.69	-41.13	-67.15	61.45	-50.27	-58.96	-32.21	-46.79	-45.73
ccsbBroad304_06149	OE	EIF4B	RNA binding motif (RRM) containing, eukaryotic translation initiation factor 4B			0.00, 0.00	1.19, 0.35	-90.21	-25.29	42.91	52.65	80.70	64.49	-42.55	-30.04	83.99	52.56
ccsbBroad304_03378	OE	ERAP1	Aminopeptidase N, endoplasmic reticulum aminopeptidase 1			10.00, 10.00	0.98, 0.26	19.10	-52.96	17.64	-82.60	-70.75	26.49	98.84	88.18	33.52	15.04
ccsbBroad304_07843	OE	FCHO1	FCH domain only 1			0.00, 0.00	1.01, 0.30	82.68	-49.27	-43.72	8.31	-62.57	-38.58	-99.94	-97.32	76.24	-19.86
ccsbBroad304_06320	OE	FFAR1	Fatty acid receptors, free fatty acid receptor 1			0.00, 0.00	0.98, 0.28	-25.81	87.91	-21.61	45.98	88.66	43.96	83.97	-56.00	-70.24	40.01
ccsbBroad304_00580	OE	FLT1	Type IV RTKs: VEGF (vascular endothelial growth factor) receptor family, fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor)		Targets of VEGFR inhibitors GOF	10.00, 10.00	1.10, 0.26	-57.06	-52.60	-33.25	-34.13	59.73	92.96	99.09	80.28	-91.51	85.71
ccsbBroad304_00587	OE	FOSL2	basic leucine zipper proteins, FOS-like antigen 2		FOS transcription factor family GOF	0.00, 0.00	1.38, 0.38	-97.33	-97.31	-37.61	-33.47	-33.02	65.50	-95.33	46.49	79.53	-72.22
ccsbBroad304_00577	OE	FOXO3	Forkhead boxes, forkhead box O3			0.00, 0.00	1.06, 0.31	70.70	-31.78	-98.50	49.90	-46.73	-99.91	-99.22	-78.72	-90.11	-98.83
ccsbBroad304_06234	OE	G6PC	glucose-6-phosphatase, catalytic subunit			0.00, 0.00	1.11, 0.32	37.72	-98.61	-85.37	-99.46	26.66	-93.66	-98.91	-35.18	55.94	-98.70
ccsbBroad304_06237	OE	GAA	Glycosidases, glucosidase, alpha; acid			20.00, 20.00	1.18, 0.36	25.07	-89.87	99.66	-44.74	99.37	-40.68	41.25	-27.79	40.74	7.45
ccsbBroad304_04619	OE	GNG8	guanine nucleotide binding protein (G protein), gamma 8			20.00, 20.00	0.84, 0.24	-96.90	-98.58	-43.98	37.66	99.39	-46.28	93.11	99.98	-73.31	-59.59
ccsbBroad304_04780	OE	GPR139	GPCR / Class A : Orphans, G protein-coupled receptor 139			0.00, 0.00	1.57, 0.45	35.56	56.49	-36.82	91.23	83.34	-27.06	-59.99	-92.55	-93.47	-22.06
ccsbBroad304_00709	OE	GUK1	guanylate kinase 1			0.00, 0.00	1.32, 0.38	-32.62	58.92	-12.76	-78.28	-49.57	85.92	-60.71	-27.77	-50.74	-19.58
ccsbBroad304_00738	OE	HINT1	histidine triad nucleotide binding protein 1			0.00, 0.00	0.93, 0.23	90.09	35.82	30.91	-40.55	-79.96	-83.45	29.42	76.02	41.72	13.06
ccsbBroad304_01894	OE	HIST1H2AC	Histones / Replication-dependent, histone cluster 1, H2ac			10.00, 10.00	0.83, 0.22	22.14	-39.52	-97.92	-74.68	48.30	31.75	98.83	48.36	-43.54	-9.91
ccsbBroad304_00752	OE	HMGB3	High-mobility group / Canonical, high mobility group box 3			0.00, 0.00	0.97, 0.17	25.13	-85.64	54.22	-38.24	-57.81	56.30	-99.91	-92.92	77.46	-92.62
ccsbBroad304_00756	OE	HMGCS2	Lanosterol biosynthesis pathway, 3-hydroxy-3-methylglutaryl-CoA synthase 2 (mitochondrial)			10.00, 10.00	1.14, 0.38	-94.89	-36.75	-24.01	98.24	-32.89	-33.17	35.82	90.75	39.51	-2.64
ccsbBroad304_00781	OE	HPD	Oxidoreductases, 4-hydroxyphenylpyruvate dioxygenase			0.00, 0.00	0.98, 0.33	65.68	-39.32	-34.06	-99.18	-65.91	27.55	27.62	43.50	60.12	-5.23
ccsbBroad304_04613	OE	HSPB9	Heat shock proteins / HSPB, heat shock protein, alpha-crystallin-related, B9			0.00, 0.00	1.55, 0.38	69.72	44.20	84.47	-56.19	77.84	28.12	-38.21	41.75	36.04	39.94
ccsbBroad304_02772	OE	ICMT	isoprenylcysteine carboxyl methyltransferase			10.00, 0.00	1.10, 0.33	55.05	31.99	57.51	95.97	76.46	48.00	-89.50	71.04	-36.17	64.11
ccsbBroad304_00833	OE	IFNG	Interferons, interferon, gamma			10.00, 10.00	4.43, 1.83	-98.86	-89.23	-98.69	-99.58	-99.80	-63.07	-83.31	-91.86	99.96	-99.81
ccsbBroad304_02459	OE	KAT5	Histone acetyltransferases (HATs), K(lysine) acetyltransferase 5			10.00, 10.00	0.93, 0.24	-90.92	-44.41	20.37	-44.16	-99.66	-43.02	99.98	81.06	63.41	15.86
ccsbBroad304_00903	OE	KCNQ1	Voltage-gated potassium channels, potassium voltage-gated channel, KQT-like subfamily, member 1			0.00, 0.00	1.25, 0.38	25.82	-40.35	40.79	87.58	-28.25	28.58	33.47	-81.56	54.10	6.50
ccsbBroad304_05523	OE	KRT26	Intermediate filaments type I, keratins (acidic), keratin 26			0.00, 0.00	0.93, 0.28	45.15	92.41	23.92	-40.19	-75.36	87.28	-49.76	71.07	55.45	55.08
ccsbBroad304_03323	OE	LARS	Aminoacyl tRNA synthetases / Class I, leucyl-tRNA synthetase			0.00, 0.00	1.45, 0.36	-69.01	-99.87	-35.24	-38.92	56.50	-70.17	-95.91	62.13	51.26	-72.94
ccsbBroad304_03934	OE	LEPRE1	leucine proline-enriched proteoglycan (leprecan) 1			10.00, 0.00	1.27, 0.40	58.17	29.28	82.79	-62.97	57.52	-89.87	95.23	34.88	46.39	42.38
ccsbBroad304_00937	OE	LGALS2	Lectins, galactoside-binding, lectin, galactoside-binding, soluble, 2			0.00, 0.00	1.14, 0.35	-10.86	34.75	32.12	-32.80	70.01	94.55	28.55	40.79	86.02	15.81
ccsbBroad304_09445	OE	MRGPRX3	GPCR / Class A : Orphans, MAS-related GPR, member X3			0.00, 0.00	1.00, 0.23	-30.87	-91.60	37.93	-33.33	85.48	36.95	69.82	-68.45	-39.16	-8.54
ccsbBroad304_03175	OE	MRPS16	Mitochondrial ribosomal proteins / small subunits, mitochondrial ribosomal protein S16			0.00, 0.00	1.13, 0.25	33.23	-78.58	21.12	-36.89	-63.12	-40.39	35.01	-56.88	-80.11	-34.80
ccsbBroad304_13991	OE	NCOA3	Histone acetyltransferases, nuclear receptor coactivator 3			10.00, 10.00	1.25, 0.24	65.48	52.95	99.98	90.97	93.04	34.70	53.69	-78.46	-59.40	72.22
ccsbBroad304_01066	OE	NDUFA4	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4, 9kDa			20.00, 10.00	1.14, 0.34	-99.12	99.91	95.11	87.37	36.77	45.08	33.78	-39.36	-26.51	70.77
ccsbBroad304_03112	OE	NENF	neudesin neurotrophic factor			0.00, 0.00	0.85, 0.30	-96.94	-49.77	24.01	-95.11	-68.05	50.33	47.91	-56.18	87.09	-44.13
ccsbBroad304_06173	OE	NR2F6	COUP-TF-like receptors, nuclear receptor subfamily 2, group F, member 6			0.00, 0.00	1.07, 0.34	22.70	-51.28	93.19	82.26	-13.51	31.38	-34.83	-84.87	90.55	35.10
ccsbBroad304_00736	OE	NRG1	Immunoglobulin superfamily / I-set domain containing, neuregulin 1			0.00, 0.00	1.28, 0.34	-87.81	-71.74	66.35	-14.06	36.87	90.05	78.80	-26.89	-32.30	16.49
ccsbBroad304_08873	OE	P2RY12	GPCR / Class A : Purinergic receptors, P2Y, purinergic receptor P2Y, G-protein coupled, 12		Purinergic receptors P2Y GOF	0.00, 0.00	1.09, 0.26	-44.41	-41.40	-39.87	-89.36	-47.74	34.53	92.35	-44.01	-99.84	-29.67
ccsbBroad304_03555	OE	PANK4	pantothenate kinase 4			0.00, 0.00	1.60, 0.44	-25.69	-96.99	23.63	-79.64	-99.86	71.30	-40.85	-51.57	-43.91	-63.49
ccsbBroad304_05135	OE	PARP15	poly (ADP-ribose) polymerase family, member 15			10.00, 10.00	1.02, 0.25	-75.10	19.32	99.98	-74.53	57.13	51.89	37.36	-44.64	-53.55	-12.89
ccsbBroad304_03707	OE	PCDHA10	Cadherins / Protocadherins : Clustered, protocadherin alpha 10			0.00, 0.00	1.06, 0.32	44.14	39.15	-52.92	63.11	-75.13	-80.05	67.59	-38.31	84.21	38.21
ccsbBroad304_02741	OE	PDS5A	PDS5, regulator of cohesion maintenance, homolog A (S. cerevisiae)			10.00, 0.00	0.97, 0.23	-97.66	-51.78	-25.24	-69.39	37.82	95.22	70.04	-99.37	-64.80	-47.27
ccsbBroad304_06711	OE	PFAS	phosphoribosylformylglycinamidine synthase			10.00, 10.00	1.16, 0.25	76.99	-36.19	35.11	-49.58	-37.74	-37.87	-41.27	-67.63	98.93	-15.04
ccsbBroad304_09708	OE	PNLDC1	poly(A)-specific ribonuclease (PARN)-like domain containing 1			0.00, 0.00	1.00, 0.26	32.03	-38.35	-86.54	-54.07	-29.17	-39.81	71.91	75.22	-46.71	-10.49
ccsbBroad304_06745	OE	PNN	pinin, desmosome associated protein			20.00, 10.00	1.09, 0.32	94.54	99.65	-55.40	95.20	74.71	48.65	49.21	-55.00	-54.30	94.21
ccsbBroad304_01276	OE	PRKAB1	AMPK subfamily, protein kinase, AMP-activated, beta 1 non-catalytic subunit			0.00, 0.00	1.14, 0.40	93.81	-30.89	68.06	67.21	-65.93	29.22	-52.66	35.72	-83.98	-13.81
ccsbBroad304_03391	OE	PRKAG3	AMPK subfamily, protein kinase, AMP-activated, gamma 3 non-catalytic subunit			10.00, 10.00	0.64, 0.17	85.70	99.04	64.29	-92.64	-76.25	-39.18	-50.48	-75.65	-88.54	-67.03
ccsbBroad304_06773	OE	PRKAR2B	Protein kinase A, protein kinase, cAMP-dependent, regulatory, type II, beta			0.00, 0.00	1.42, 0.50	-99.98	-48.43	-39.11	NaN	-42.06	-74.44	48.84	-37.70	67.00	-43.35
ccsbBroad304_01281	OE	PRKCA	Delta subfamily, protein kinase C, alpha			10.00, 10.00	1.16, 0.36	87.29	54.42	73.69	99.41	57.85	43.25	-47.58	-68.04	-44.67	66.85
ccsbBroad304_01312	OE	PSMB8	Proteasome (prosome, macropain) subunits, proteasome (prosome, macropain) subunit, beta type, 8 (large multifunctional peptidase 7)			0.00, 0.00	2.49, 0.86	-20.06	-99.67	-34.04	-99.84	45.71	-89.16	-94.71	-41.51	-56.85	-94.26
ccsbBroad304_07808	OE	RAB11FIP2	RAB11 family interacting protein 2 (class I)			0.00, 0.00	1.39, 0.38	54.28	41.88	-39.48	-33.40	45.10	40.13	-33.79	-32.36	38.93	12.73
ccsbBroad304_01377	OE	RARG	Retinoic acid receptors, retinoic acid receptor, gamma			0.00, 0.00	1.70, 0.31	-26.38	51.02	75.23	-86.88	-98.33	-37.01	87.04	-76.58	-99.95	-97.51
ccsbBroad304_04544	OE	RCCD1	RCC1 domain containing 1			0.00, 0.00	1.02, 0.43	72.59	-47.28	32.75	-25.04	-46.09	-68.00	-98.37	-33.87	-35.14	-18.99
ccsbBroad304_08585	OE	RIOK2	RIO2 subfamily, RIO kinase 2 (yeast)			0.00, 0.00	1.06, 0.36	69.15	55.75	-88.18	-26.11	26.07	87.94	-75.89	43.18	-88.24	-28.73
ccsbBroad304_07976	OE	RNF167	RING-type (C3HC4) zinc fingers, ring finger protein 167			0.00, 0.00	1.08, 0.34	-65.57	-67.67	68.91	43.86	45.26	-62.94	28.82	-95.48	-93.41	-68.23
ccsbBroad304_01418	OE	RPL7	L ribosomal proteins, ribosomal protein L7			0.00, 0.00	0.88, 0.26	16.64	36.80	-32.24	-82.42	-53.21	31.31	-99.85	-41.90	47.19	-20.75
ccsbBroad304_06897	OE	RPS6KB2	p70 subfamily, ribosomal protein S6 kinase, 70kDa, polypeptide 2			0.00, 0.00	1.07, 0.27	77.01	38.06	-65.98	86.21	69.23	44.69	84.78	-29.67	-58.14	67.61
ccsbBroad304_04227	OE	SETD7	Histone methyltransferases (HMTs), SET domain containing (lysine methyltransferase) 7			0.00, 0.00	1.42, 0.33	26.52	-77.13	18.44	-26.11	53.61	30.29	86.61	37.56	31.76	4.86
ccsbBroad304_06934	OE	SFPQ	RNA binding motif (RRM) containing, splicing factor proline/glutamine-rich			0.00, 0.00	1.14, 0.18	55.67	-58.54	-43.23	-58.78	-33.24	-72.91	35.02	-91.83	-97.87	-63.90
ccsbBroad304_01540	OE	SLC2A1	Solute carriers, solute carrier family 2 (facilitated glucose transporter), member 1			0.00, 0.00	0.95, 0.30	-23.03	32.39	-24.13	-76.49	-53.64	-31.29	-67.99	48.81	73.92	-11.61
ccsbBroad304_08386	OE	SMOX	spermine oxidase			0.00, 0.00	0.90, 0.30	66.92	-73.98	-47.71	-58.45	-72.31	37.99	48.86	52.17	44.35	-42.58
ccsbBroad304_04257	OE	SPRY4	sprouty homolog 4 (Drosophila)			10.00, 10.00	0.98, 0.24	98.55	-39.06	-84.49	-86.15	-99.67	21.99	83.66	-52.28	60.30	-54.69
ccsbBroad304_10230	OE	STK19	G11 family, serine/threonine kinase 19			0.00, 0.00	1.25, 0.38	35.41	-26.43	-84.53	-90.54	-55.29	67.44	-32.42	40.34	55.07	-20.97
ccsbBroad304_07204	OE	TAF15	RNA binding motif (RRM) containing, TAF15 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 68kDa			10.00, 10.00	1.55, 0.36	99.51	71.04	44.88	-52.10	42.44	33.81	84.87	-88.10	52.81	58.78
ccsbBroad304_01650	OE	TCEA1	General transcription factors, transcription elongation factor A (SII), 1			0.00, 0.00	1.14, 0.38	-90.30	25.29	-96.64	57.06	37.13	-54.99	63.58	76.50	45.30	41.51
ccsbBroad304_04086	OE	TCTN1	Tectonic proteins, tectonic family member 1			10.00, 10.00	1.40, 0.39	99.04	60.29	-20.86	-43.13	-89.84	-34.90	-34.63	74.52	46.89	7.31
ccsbBroad304_03594	OE	TNFRSF19	Tumour necrosis factor (TNF) receptor family, tumor necrosis factor receptor superfamily, member 19			0.00, 0.00	1.42, 0.40	-95.13	-71.03	21.96	-31.38	-33.58	-93.80	-30.08	-81.85	33.73	-88.61
ccsbBroad304_07091	OE	TPM1	Tropomyosins, tropomyosin 1 (alpha)			10.00, 10.00	0.80, 0.23	75.42	-93.19	-87.21	-98.27	-99.98	-75.56	70.35	99.98	88.32	-88.12
ccsbBroad304_07101	OE	TSC2	tuberous sclerosis 2			20.00, 20.00	0.92, 0.32	28.96	-99.89	-40.58	-71.74	98.44	-30.62	99.89	56.66	-72.69	-20.08
ccsbBroad304_04728	OE	TWIST2	Basic helix-loop-helix proteins, twist homolog 2 (Drosophila)			20.00, 10.00	3.26, 0.73	78.07	-93.87	99.61	81.39	-37.25	-98.24	-39.13	-99.49	93.26	96.81
ccsbBroad304_05183	OE	TXLNA	taxilin alpha			0.00, 0.00	1.59, 0.32	26.09	59.53	-87.08	48.62	-33.19	31.21	-55.53	-58.77	-96.54	-35.60
ccsbBroad304_11796	OE	ULK3	Unc-51-like kinase (ULK) family, unc-51-like kinase 3 (C. elegans)			20.00, 0.00	1.72, 0.42	10.56	95.38	95.93	74.77	42.06	61.02	30.77	66.09	-99.18	93.43
ccsbBroad304_09993	OE	VN1R4	GPCR / Unclassified : Vomeronasal receptors, type 1, vomeronasal 1 receptor 4			10.00, 10.00	1.10, 0.28	27.70	36.33	-11.07	73.70	26.80	74.93	91.57	-73.68	99.33	40.08
ccsbBroad304_01777	OE	WNT1	Endogenous ligands, wingless-type MMTV integration site family, member 1		Wnt family GOF	0.00, 0.00	1.08, 0.27	68.40	27.53	-23.86	-69.25	80.00	-75.33	-58.19	-83.55	93.38	-35.26
ccsbBroad304_07136	OE	WNT9A	Wingless-type MMTV integration sites, wingless-type MMTV integration site family, member 9A		Wnt family GOF	0.00, 0.00	1.03, 0.24	18.02	35.82	-18.37	-99.61	-77.86	-79.16	36.03	-48.09	40.50	-21.77
ccsbBroad304_05394	OE	ZNF621	Zinc fingers, C2H2-type, zinc finger protein 621			0.00, 0.00	1.13, 0.22	-91.97	-44.63	-30.65	46.66	-24.34	37.31	-96.16	51.41	-42.82	-6.78
ccsbBroad304_07211	OE	ZRSR2	RNA binding motif (RRM) containing, zinc finger (CCCH type), RNA-binding motif and serine/arginine rich 2			10.00, 0.00	0.83, 0.24	-22.12	-25.22	-39.19	50.81	96.57	-16.89	-27.27	-39.55	-31.98	-7.08
DMSO	CTRL	DMSO	Dimethyl sulfoxide			0.00, 0.00	0.00, 0.00	51.46	6.72	54.39	60.02	60.26	91.10	37.01	89.98	92.85	56.43
BRD-K39569857	CP	avrainvillamide-analog-3	nucleophosmin inhibitor	NPM1	Nucleophosmin inhibitor	11.11, 11.11	0.43, 0.32	99.21	NaN	-92.31	-51.81	82.52	-61.47	86.95	-80.63	74.62	94.58
BRD-A70731303	CP	avrainvillamide-analog-5	nucleophosmin inhibitor	NPM1	Nucleophosmin inhibitor	11.11, 11.11	0.40, 0.24	80.14	NaN	-83.41	100.00	46.24	-97.78	-49.06	-68.41	28.01	-61.92
BRD-A83237092	CP	fulvestrant	estrogen receptor antagonist, DNA directed DNA polymerase inhibitor, soluble epoxide hydrolase inhibitor	ESR1, EPHX2, ESR2, GPER1	Estrogen receptor antagonist	44.44, 44.44	0.74, 0.31	49.51	NaN	99.87	71.80	99.54	82.96	99.94	-99.85	-88.61	98.98
BRD-K68488863	CP	ENMD-2076	Aurora kinase inhibitor, FLT3 inhibitor, VEGFR inhibitor, angiogenesis inhibitor, colony stimulating factor receptor antagonist, ephrin receptor inhibitor, FGFR inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, src inhibitor	AURKA, FLT3, KDR, PDGFRA, SRC, CSF1R, EPHA1, FGFR1, FGFR2, FGFR3, FLT4, KIT, PTK2	Aurora kinase inhibitor	0.00, 0.00	1.09, 0.32	37.82	NaN	-98.64	-93.72	76.69	-92.80	-94.53	-98.69	-99.89	-98.63
BRD-A74907996	CP	equol	estrogen receptor agonist	ESR2, ESR1		55.56, 55.56	0.52, 0.39	100.00	NaN	69.39	99.88	-69.07	92.02	98.70	99.98	92.93	99.65
BRD-K98948170	CP	BRD-K98948170	kelch-like ECH-associated protein ligand	KEAP1		33.33, 22.22	0.55, 0.43	76.21	NaN	88.58	84.12	-92.68	95.02	47.23	99.96	86.39	98.24
BRD-K42573370	CP	avrainvillamide-analog-2	nucleophosmin inhibitor	NPM1	Nucleophosmin inhibitor	11.11, 11.11	0.59, 0.16	-86.64	NaN	-95.57	41.80	99.25	-99.85	-64.43	-94.93	-49.70	-97.33
BRD-K61691971	CP	avrainvillamide-analog-1	nucleophosmin inhibitor	NPM1	Nucleophosmin inhibitor	44.44, 44.44	0.49, 0.40	91.22	NaN	63.43	100.00	64.71	23.45	59.62	99.82	99.44	99.30
BRD-K25079130	CP	avrainvillamide-analog-4	nucleophosmin inhibitor	NPM1	Nucleophosmin inhibitor	33.33, 22.22	0.49, 0.15	60.78	NaN	97.27	99.20	79.29	-31.75	84.78	-53.77	-36.02	98.13
BRD-K50324045	CP	avrainvillamide-analog-6	nucleophosmin inhibitor	NPM1	Nucleophosmin inhibitor	11.11, 0.00	0.51, 0.22	-48.22	NaN	93.66	96.05	70.41	39.93	-98.00	33.88	87.94	91.54
BRD-K79877282	CP	PF-543	sphingosine kinase inhibitor	SPHK1		22.22, 22.22	0.60, 0.36	67.52	NaN	79.62	49.25	56.75	55.80	99.95	99.98	-43.91	86.34
BRD-K24576554	CP	AT-9283	Aurora kinase inhibitor, JAK inhibitor, Abl kinase inhibitor, Bcr-Abl kinase inhibitor, FLT3 inhibitor, mitotic inhibitor, protein kinase inhibitor	AURKA, AURKB, ABL1, BCR, FLT3, JAK2, JAK3, RPS6KA6, STK17A	Aurora kinase inhibitor	22.22, 22.22	0.88, 0.31	-60.85	NaN	-99.80	-72.94	-27.44	99.84	99.15	-93.68	-99.54	-95.86
BRD-K53665955	CP	MK-5108	Aurora kinase inhibitor	AURKA, AURKB, AURKC	Aurora kinase inhibitor	66.67, 55.56	1.05, 0.53	99.88	NaN	99.74	77.75	97.28	99.99	99.96	-89.20	27.09	99.61
BRD-K67174588	CP	toremifene	selective estrogen receptor modulator (SERM), estrogen receptor antagonist	ESR1, CYP3A5	Estrogen receptor antagonist	55.56, 55.56	0.51, 0.34	99.60	NaN	99.92	100.00	57.14	81.36	35.12	84.11	99.90	99.47
BRD-K75295174	CP	alisertib	Aurora kinase inhibitor, mitotic inhibitor, protein kinase inhibitor	AURKA	Aurora kinase inhibitor	22.22, 22.22	0.98, 0.51	99.84	NaN	-92.33	-95.88	93.04	100.00	-63.31	-98.87	-94.97	-96.52
BRD-K10466330	CP	AVA	nucleophosmin inhibitor		Nucleophosmin inhibitor	22.22, 11.11	0.59, 0.35	50.17	NaN	99.98	-97.21	33.68	-31.16	-56.18	96.71	56.93	53.13
CP_ADENOSINE_RECEPTOR_AGONIST	PCL	Adenosine receptor agonist				40.00, 20.00		68.18	91.20	99.54	24.01	39.53	95.80	-15.30	95.28	76.24	98.05
CP_ANDROGEN_RECEPTOR_MODULATOR	PCL	Androgen receptor modulator				0.00, 0.00		-18.98	-98.12	-14.70	36.23	82.64	-22.00	-19.15	3.56	17.43	-11.98
CP_ANGIOTENSIN_RECEPTOR_ANTAGONIST	PCL	Angiotensin receptor antagonist				0.00, 0.00		-98.35	50.43	-92.51	-49.72	-94.42	68.91	-13.41	15.74	-27.30	-22.80
CP_AROMATASE_INHIBITOR	PCL	Aromatase inhibitor				0.00, 0.00		-60.69	-97.79	-52.64	76.67	87.62	93.60	35.61	-18.47	-49.04	-32.08
CP_ATP_SYNTHASE_INHIBITOR	PCL	ATP synthase inhibitor				0.00, 0.00		-99.69	-99.27	-98.96	-97.08	-99.57	-20.94	-79.15	-91.71	NaN	-99.10
CP_ATPASE_INHIBITOR	PCL	ATPase inhibitor				0.00, 0.00		-48.73	-64.23	-98.74	-69.20	-78.24	-47.01	-96.02	60.27	-37.53	-93.40
CP_AURORA_KINASE_INHIBITOR	PCL	Aurora kinase inhibitor				40.00, 40.00		99.11	100.00	-93.44	-99.29	82.70	100.00	98.76	-99.89	-99.43	93.37
CP_BACTERIAL_30S_RIBOSOMAL_SUBUNIT_INHIBITOR	PCL	Bacterial 30S ribosomal subunit inhibitor				0.00, 0.00		-23.29	58.60	26.76	-69.92	31.21	87.88	52.96	-15.35	NaN	42.07
CP_BACTERIAL_CELL_WALL_SYNTHESIS_INHIBITOR	PCL	Bacterial cell wall synthesis inhibitor				0.00, 0.00		-14.70	-35.63	-12.84	-31.03	90.61	48.08	-15.17	73.84	45.85	25.24
CP_BACTERIAL_DNA_GYRASE_INHIBITOR	PCL	Bacterial DNA gyrase inhibitor				0.00, 0.00		-32.21	31.22	-51.26	-8.81	-23.92	31.64	36.01	9.10	83.57	-13.96
CP_BCL_INHIBITOR	PCL	BCL inhibitor				0.00, 0.00		-96.12	-73.48	-98.19	-97.44	-99.65	-47.04	-75.20	-98.38	-97.97	-98.66
CP_BENZODIAZEPINE_RECEPTOR_AGONIST	PCL	Benzodiazepine receptor agonist				0.00, 0.00		-5.23	33.99	-8.78	8.30	38.66	NaN	62.49	8.28	NaN	6.64
CP_BETA_ADRENERGIC_RECEPTOR_AGONIST	PCL	Beta-adrenergic receptor agonist				20.00, 20.00		89.02	85.02	99.08	45.67	5.84	99.14	-41.50	30.99	8.96	88.74
CP_BILE_ACID	PCL	Bile acid				30.00, 10.00		96.34	86.51	-83.58	54.31	-76.88	67.72	-16.43	75.49	98.53	96.08
CP_BROMODOMAIN_INHIBITOR	PCL	Bromodomain Inhibitor				0.00, 0.00		-49.79	89.33	-99.36	8.00	-76.81	-91.87	-31.07	-97.06	-83.18	-92.37
CP_CALCIUM_CHANNEL_BLOCKER	PCL	Calcium channel blocker				0.00, 0.00		-82.73	-91.39	-48.02	-81.95	-63.41	NaN	-24.79	-41.60	NaN	-79.22
CP_CALMODULIN_ANTAGONIST	PCL	Calmodulin antagonist				0.00, 0.00		53.12	78.36	-49.98	-68.89	-18.79	22.52	-91.36	-95.68	-99.07	-96.63
CP_CANNABINOID_RECEPTOR_AGONIST	PCL	Cannabinoid receptor agonist				0.00, 0.00		-66.53	26.14	-16.35	28.82	4.19	-7.39	-88.21	-81.94	-46.64	-1.44
CP_CCK_RECEPTOR_ANTAGONIST	PCL	CCK receptor antagonist				0.00, 0.00		-98.85	14.23	42.73	-18.27	4.11	-67.61	-97.16	-99.72	-88.05	-98.51
CP_CDK_INHIBITOR	PCL	CDK inhibitor				0.00, 0.00		-99.72	-46.66	-99.04	-99.73	-99.54	-99.99	-99.96	-99.78	-99.59	-99.76
CP_CYCLOOXYGENASE_INHIBITOR	PCL	Cyclooxygenase inhibitor				30.00, 0.00		97.32	13.99	-30.90	97.13	70.41	97.37	89.40	38.26	5.56	79.55
CP_DIHYDROFOLATE_REDUCTASE_INHIBITOR	PCL	Dihydrofolate reductase inhibitor				0.00, 0.00		-99.98	-76.51	-99.33	-99.84	-58.85	22.92	-99.82	-99.71	-99.89	-100.00
CP_DNA_DEPENDENT_PROTEIN_KINASE_INHIBITOR	PCL	DNA dependent protein kinase inhibitor				0.00, 0.00		-99.45	-41.89	-89.18	66.01	-98.48	-98.84	-94.75	-98.31	-40.75	-99.06
CP_DNA_POLYMERASE_INHIBITOR	PCL	DNA polymerase inhibitor				0.00, 0.00		29.10	84.49	-37.55	85.08	-42.99	-32.28	10.47	-10.59	NaN	16.28
CP_DNA_SYNTHESIS_INHIBITOR	PCL	DNA synthesis inhibitor				0.00, 0.00		-99.26	-98.45	-99.62	-91.71	-98.19	-99.03	-99.77	-99.51	NaN	-99.76
CP_DOPAMINE_RECEPTOR_ANTAGONIST	PCL	Dopamine receptor antagonist				0.00, 0.00		-25.29	-85.93	12.84	-44.46	-85.30	-75.95	-59.52	-88.88	-18.75	-88.48
CP_EGFR_INHIBITOR	PCL	EGFR inhibitor				0.00, 0.00		-98.86	-98.04	-99.09	-97.67	-88.48	-96.20	52.16	-99.84	-97.69	-98.38
CP_ESTROGEN_RECEPTOR_AGONIST	PCL	Estrogen receptor agonist				20.00, 20.00		77.99	-30.62	51.49	20.43	87.53	99.83	25.82	73.63	99.90	2.15
CP_ESTROGEN_RECEPTOR_ANTAGONIST	PCL	Estrogen receptor antagonist				0.00, 0.00		-74.86	-29.16	91.08	-86.02	-94.12	-99.17	35.26	-99.95	-72.02	-99.60
CP_FGFR_INHIBITOR	PCL	FGFR inhibitor				0.00, 0.00		-18.73	-60.72	-93.40	16.70	58.59	91.41	-55.71	27.97	66.35	-6.27
CP_FLT3_INHIBITOR	PCL	FLT3 inhibitor				0.00, 0.00		-99.90	-99.65	-99.94	-99.88	-59.42	-99.59	-97.64	-99.93	-94.11	-99.87
CP_FXR_ANTAGONIST	PCL	FXR antagonist				10.00, 0.00		95.48	83.81	-93.38	56.07	70.68	63.52	-24.41	24.00	-97.76	61.50
CP_GABA_RECEPTOR_ANTAGONIST	PCL	GABA receptor antagonist				10.00, 10.00		54.53	39.22	-69.76	-8.63	99.43	41.39	48.94	-55.33	87.35	-3.42
CP_GAMMA_SECRETASE_INHIBITOR	PCL	Gamma secretase inhibitor				0.00, 0.00		7.31	88.91	-100.00	-22.47	73.77	-75.86	-99.93	27.95	84.55	-97.06
CP_GLUCOCORTICOID_RECEPTOR_AGONIST	PCL	Glucocorticoid receptor agonist				0.00, 0.00		17.52	65.12	-11.48	-95.41	-71.62	-98.44	42.04	16.15	41.75	-34.36
CP_GLYCOGEN_SYNTHASE_KINASE_INHIBITOR	PCL	Glycogen synthase kinase inhibitor				0.00, 0.00		-99.70	-33.68	-98.79	-98.62	-36.26	-99.09	-83.07	-98.59	-65.34	-99.34
CP_HDAC_INHIBITOR	PCL	HDAC inhibitor				0.00, 0.00		-99.14	-75.92	-99.41	-97.53	-99.64	-99.54	-99.59	-99.37	-99.52	-99.60
CP_HIF_ACTIVATOR	PCL	HIF activator				0.00, 0.00		-97.13	-98.21	-97.33	-94.24	88.19	-86.65	-94.88	-97.37	-98.88	-98.92
CP_HIV_PROTEASE_INHIBITOR	PCL	HIV protease inhibitor				10.00, 0.00		-78.19	-41.18	-67.98	-73.37	64.88	95.19	-30.54	30.22	58.24	19.80
CP_HMGCR_INHIBITOR	PCL	HMGCR inhibitor				0.00, 0.00		-96.41	-78.44	-89.99	-99.72	49.57	-95.55	-66.83	-99.72	22.70	-98.29
CP_HRH1	PCL	HRH1 antagonist				0.00, 0.00		-13.80	-29.71	-27.44	-44.63	27.59	-29.93	-79.55	-48.24	NaN	-13.96
CP_HSP_INHIBITOR	PCL	HSP inhibitor				10.00, 0.00		-99.31	-98.60	-99.74	-26.36	88.95	-71.26	97.18	-33.54	-92.25	-90.50
CP_IGF_1_INHIBITOR	PCL	IGF-1 inhibitor				0.00, 0.00		40.83	-99.76	-98.74	-77.45	67.69	-99.71	-98.97	-99.71	-80.09	-99.59
CP_IKK_INHIBITOR	PCL	IKK inhibitor				0.00, 0.00		-98.87	-100.00	-98.39	-99.37	-89.90	-99.66	-97.03	-97.44	-98.23	-99.84
CP_IMIDAZOLINE_LIGAND	PCL	Imidazoline ligand				20.00, 20.00		100.00	98.30	90.37	55.94	9.40	-70.94	89.40	89.73	37.16	81.49
CP_IMPDH_INHIBITOR	PCL	IMPDH inhibitor				0.00, 0.00		-98.88	-63.02	-98.91	-90.92	58.12	-69.12	-99.84	-99.81	-99.52	-99.86
CP_JAK_INHIBITOR	PCL	JAK inhibitor				0.00, 0.00		-99.96	-99.30	-100.00	-100.00	-44.66	-99.91	-99.93	-99.39	-99.74	-99.94
CP_KCNJ11	PCL	KCNJ11 modulator				0.00, 0.00		26.60	17.63	48.23	39.98	-65.70	-21.75	-45.88	-45.34	-45.28	-11.43
CP_LEUCINE_RICH_REPEAT_KINASE_INHIBITOR	PCL	Leucine rich repeat kinase inhibitor				10.00, 10.00		-96.65	84.76	30.70	32.80	-76.52	-67.81	82.84	-22.49	97.53	-35.57
CP_MDM_INHIBITOR	PCL	MDM inhibitor				10.00, 10.00		6.52	45.40	18.81	65.27	81.54	99.97	80.53	-64.66	49.10	89.13
CP_MEK_INHIBITOR	PCL	MEK inhibitor				10.00, 0.00		-41.84	45.78	-45.70	-99.69	-70.35	-83.75	95.33	-99.52	90.66	-67.22
CP_MTOR_INHIBITOR	PCL	MTOR inhibitor				0.00, 0.00		-98.95	-99.52	-99.34	-99.77	-95.88	-94.56	-72.73	-98.71	-22.63	-99.40
CP_NA_K_CL_TRANSPORTER_INHIBITOR	PCL	Na-K-Cl transporter inhibitor				22.22, 11.11		99.52	-22.68	23.59	96.87	69.73	87.38	-10.76	48.20	NaN	58.77
CP_NFKB_PATHWAY_INHIBITOR	PCL	NFkB pathway inhibitor				0.00, 0.00		-96.40	-99.47	-85.40	-99.45	-99.06	-98.57	-89.30	-95.45	-99.61	-99.70
CP_NOREPINEPHRINE_REPUTAKE_INHIBITOR	PCL	Norepinephrine reuptake inhibitor				0.00, 0.00		23.55	-87.57	-16.22	41.46	-94.65	-68.06	-49.28	-33.56	-91.48	-25.46
CP_NUCLEOPHOSMIN_INHIBITOR	PCL	Nucleophosmin inhibitor				22.22, 11.11		77.74	NaN	95.31	99.83	71.55	-38.79	-55.51	-52.13	77.15	90.82
CP_NUCLEOSIDE_REVERSE_TRANSCRIPTASE_INHIBITOR	PCL	Nucleoside reverse transcriptase inhibitor				12.50, 12.50		19.23	93.42	99.70	68.92	40.76	NaN	-24.70	42.80	NaN	18.76
CP_P38_MAPK_INHIBITOR	PCL	P38 MAPK inhibitor				0.00, 0.00		64.00	76.21	-24.85	19.80	-86.37	-75.69	15.97	-24.47	-24.96	12.50
CP_PARP_INHIBITOR	PCL	PARP inhibitor				10.00, 10.00		-87.99	98.10	-94.98	64.60	23.33	-95.07	-55.09	64.17	-85.10	-39.56
CP_PDGFR_KIT_INHIBITOR	PCL	PDGFR/KIT inhibitor				0.00, 0.00		-98.83	-71.94	-99.58	-99.98	-45.46	-84.40	57.21	-99.17	-99.28	-99.15
CP_PI3K_INHIBITOR	PCL	PI3K inhibitor				0.00, 0.00		-97.40	-99.74	-98.18	-99.78	-79.87	-98.80	-92.64	-98.86	-24.29	-99.18
CP_PKA_INHIBITOR	PCL	PKA inhibitor				0.00, 0.00		-75.54	29.17	-91.30	-41.67	-66.65	-99.88	-56.54	43.80	-65.42	-85.88
CP_PKC_ACTIVATOR	PCL	PKC activator				0.00, 0.00		-81.83	28.84	84.79	-96.84	43.27	-99.56	-75.98	-98.76	-49.84	-95.34
CP_PKC_INHIBITOR	PCL	PKC inhibitor				0.00, 0.00		-99.09	-99.30	-53.53	-99.52	-49.14	-99.01	-72.21	-99.95	-99.27	-99.84
CP_POTASSIUM_CHANNEL_ACTIVATOR	PCL	Potassium channel activator				0.00, 0.00		-9.18	5.21	72.87	94.50	-18.78	11.45	73.30	-20.64	-11.71	4.84
CP_POTASSIUM_CHANNEL_BLOCKER	PCL	Potassium channel blocker				0.00, 0.00		7.70	-59.77	-30.79	6.60	-12.29	-25.09	-53.82	2.59	NaN	-2.10
CP_PPAR_RECEPTOR_AGONIST	PCL	PPAR receptor agonist				0.00, 0.00		-57.50	10.61	-60.59	-9.49	-17.41	-15.95	-83.30	-27.55	47.65	-34.81
CP_PROGESTERONE_RECEPTOR_AGONIST	PCL	Progesterone receptor agonist				0.00, 0.00		-11.59	-97.90	-18.05	-11.62	-20.00	-29.51	-67.53	73.42	54.56	-38.12
CP_PROGESTERONE_RECEPTOR_ANTAGONIST	PCL	Progesterone receptor antagonist				0.00, 0.00		-27.55	-96.60	-48.53	44.22	69.14	-60.05	-60.20	-33.75	-47.84	-15.95
CP_PROTEASOME_INHIBITOR	PCL	Proteasome inhibitor				0.00, 0.00		-99.53	-98.10	-80.86	-99.10	-99.46	-99.38	-92.08	-99.42	-99.60	-99.55
CP_PROTEIN_SYNTHESIS_INHIBITOR	PCL	Protein synthesis inhibitor				10.00, 0.00		-99.46	-98.52	-99.23	-97.73	97.14	-96.87	-99.31	-90.93	-90.10	-99.33
CP_RAF_INHIBITOR	PCL	RAF inhibitor				0.00, 0.00		-98.42	-81.53	-99.42	-93.87	-56.37	-69.81	38.18	-91.20	-14.17	-96.76
CP_RETINOID_RECEPTOR_AGONIST	PCL	Retinoid receptor agonist				10.00, 10.00		-90.72	83.22	-25.94	-49.82	-19.58	98.58	15.35	-93.15	38.24	-29.97
CP_REVERSE_TRANSCRIPTASE_INHIBITOR	PCL	Reverse transcriptase inhibitor				0.00, 0.00		42.24	49.08	-48.28	-22.37	44.95	-28.90	-39.72	56.51	NaN	12.71
CP_RHO_ASSOCIATED_KINASE_INHIBITOR	PCL	Rho associated kinase inhibitor				11.11, 0.00		-6.85	37.82	-11.38	-15.36	40.08	-28.44	41.27	95.28	NaN	8.41
CP_RIBONUCLEOTIDE_REDUCTASE_INHIBITOR	PCL	Ribonucleotide reductase inhibitor				0.00, 0.00		-99.65	-99.80	-99.21	-99.85	-95.51	-99.63	-99.87	-99.66	-99.96	-99.84
CP_SEROTONIN_RECEPTOR_AGONIST	PCL	Serotonin receptor agonist				10.00, 0.00		-27.86	-34.13	-35.60	90.78	-16.64	91.79	97.07	-86.67	29.44	-23.36
CP_SEROTONIN_RECEPTOR_ANTAGONIST	PCL	Serotonin receptor antagonist				0.00, 0.00		12.36	-93.22	-18.93	-60.92	-79.76	-77.03	-64.01	-98.47	-92.96	-36.93
CP_SIGMA_RECEPTOR_ANTAGONIST	PCL	Sigma receptor antagonist				0.00, 0.00		24.94	67.70	87.96	34.77	67.08	-35.28	91.71	-48.59	41.14	20.86
CP_SODIUM_CHANNEL_BLOCKER	PCL	Sodium channel blocker				0.00, 0.00		-20.03	44.48	53.84	-76.30	-35.28	84.16	27.08	37.68	26.21	18.73
CP_SRC_INHIBITOR	PCL	SRC inhibitor				0.00, 0.00		-98.02	29.14	-54.78	-96.14	80.24	-97.58	91.23	-97.25	47.53	-85.86
CP_STEROL_DEMETHYLASE_INHIBITOR	PCL	Sterol demethylase inhibitor				0.00, 0.00		-67.58	-64.75	-44.22	11.71	-83.72	-100.00	-45.15	-97.55	-75.01	-72.10
CP_T_TYPE_CALCIUM_CHANNEL_BLOCKER	PCL	T-type calcium channel blocker				0.00, 0.00		-99.29	-98.42	-98.01	-99.32	-96.26	-99.82	-79.36	-98.58	-89.49	-98.32
CP_TACHYKININ_ANTAGONIST	PCL	Tachykinin antagonist				0.00, 0.00		-85.51	-98.98	-13.50	-84.89	-71.18	-84.91	43.60	-93.14	18.36	-98.22
CP_TGF_BETA_RECEPTOR_INHIBITOR	PCL	TGF beta receptor inhibitor				0.00, 0.00		69.29	72.47	35.45	-5.83	45.77	61.80	71.66	92.69	88.06	49.19
CP_THROMBOXANE_RECEPTOR_ANTAGONIST	PCL	Thromboxane receptor antagonist				0.00, 0.00		-23.39	-24.39	23.86	32.42	-10.70	-63.67	-32.44	26.16	-37.98	-4.32
CP_THYMIDYLATE_SYNTHASE_INHIBITOR	PCL	Thymidylate synthase inhibitor				0.00, 0.00		-55.46	-34.18	-87.33	-98.73	33.74	-26.78	-99.96	-99.19	39.90	-99.70
CP_TOPOISOMERASE_INHIBITOR	PCL	Topoisomerase inhibitor				0.00, 0.00		-99.42	-96.20	-98.75	-99.85	-99.24	-95.36	-99.47	-98.98	-97.76	-99.33
CP_TRICYCLIC_ANTIDEPRESSANT	PCL	Tricyclic antidepressant				0.00, 0.00		-16.24	-95.16	-19.12	-5.33	-44.43	-73.32	-79.31	-74.71	-90.49	-44.29
CP_TUBULIN_INHIBITOR	PCL	Tubulin inhibitor				30.00, 20.00		-59.80	100.00	-27.39	19.34	33.98	99.91	-76.03	-62.49	-53.50	96.25
CP_VEGFR_INHIBITOR	PCL	VEGFR inhibitor				0.00, 0.00		-97.35	-99.80	-99.01	-98.43	-45.82	-83.51	-24.72	-94.63	-30.03	-43.78
CP_VITAMIN_D_RECEPTOR_AGONIST	PCL	Vitamin D receptor agonist				0.00, 0.00		30.73	-94.07	-31.57	-37.04	56.08	83.16	-48.06	-8.92	-64.99	-6.14
KD_A_KINASE_ANCHORING_PROTEINS	PCL	Kinase anchoring proteins LOF				0.00, 0.00		24.63	-60.15	-94.25	-84.31	-39.32	NaN	-95.43	20.57	70.08	-70.24
KD_AHSP_PATHWAY	PCL	AHSP Pathway LOF				0.00, 0.00		-99.96	-84.63	-44.05	-37.35	-46.63	-99.21	-73.50	-93.67	26.47	-70.88
KD_AKT_SIGNALING	PCL	Akt Signaling LOF				0.00, 0.00		-29.24	-35.65	-8.64	-22.07	19.27	61.97	-30.38	-91.10	-91.28	-12.61
KD_ALDEHYDE_DEHYDROGENASES	PCL	Aldehyde dehydrogenases LOF				0.00, 0.00		-81.83	-95.38	-21.41	-97.69	-83.45	NaN	21.68	-99.36	-13.74	-98.02
KD_AMINOACYL_TRNA_SYNTHETASES_CLASS_II	PCL	Aminoacyl tRNA synthetases class II LOF				0.00, 0.00		-21.42	77.05	-99.76	9.45	22.73	13.86	91.14	32.21	-81.52	6.83
KD_APOLIPOPROTEINS	PCL	Apolipoproteins LOF				11.11, 11.11		-28.57	-62.59	-66.43	-100.00	-34.73	97.64	-32.15	-99.94	NaN	-95.01
KD_BACULOVIRAL_IAP_REPEAT_DOMAIN_CONTAINING	PCL	Baculoviral IAP repeat domain containing LOF				0.00, 0.00		-96.29	-85.24	-3.37	-61.56	-57.03	NaN	-27.51	58.76	-91.87	-61.49
KD_BMP_SIGNALING	PCL	BMP Signaling LOF				0.00, 0.00		-69.63	-77.46	-97.84	-70.53	-26.72	-77.90	-99.96	-98.48	-30.37	-90.78
KD_C2_DOMAIN_CONTAINING_PROTEIN_KINASES	PCL	C2 domain containing protein kinases LOF				11.11, 0.00		-36.10	-80.75	-39.54	97.29	91.24	89.57	NaN	-23.20	43.08	24.69
KD_CANONICAL_HIGH_MOBILITY_GROUP_PROTEINS	PCL	Canonical high mobility group proteins LOF				0.00, 0.00		-66.65	21.27	35.26	35.93	-63.89	-35.63	-58.93	-61.81	NaN	-75.52
KD_CYCLIN_DEPENDENT_KINASES	PCL	Cyclin dependent kinases LOF				0.00, 0.00		-78.85	-25.12	81.28	22.32	31.17	-100.00	-90.82	-44.97	-38.48	-67.50
KD_CYCLINS	PCL	Cyclins LOF				10.00, 10.00		-74.60	-99.47	12.49	67.00	30.33	12.82	-88.34	-65.97	98.93	-71.94
KD_DNA_REPLICATION	PCL	DNA Replication LOF				0.00, 0.00		85.76	64.81	-87.71	-38.02	-39.40	-38.06	76.26	-99.89	-23.52	-37.33
KD_EIF_PROTEINS	PCL	EIF Proteins LOF				0.00, 0.00		91.49	-33.74	-60.89	-80.56	86.87	NaN	-83.13	-97.43	-58.31	-63.28
KD_EMSY_COMPLEX	PCL	EMSY complex LOF				0.00, 0.00		58.72	54.29	39.30	49.12	-19.20	NaN	65.11	43.48	69.37	21.79
KD_G2_M_CHECKPOINT	PCL	G2 M Checkpoint LOF				0.00, 0.00		-17.90	69.37	17.97	61.18	89.06	-47.55	11.10	28.17	19.79	70.78
KD_GATA_ZINC_FINGER_DOMAIN_CONTAINING	PCL	GATA Zinc finger domain containing LOF				0.00, 0.00		-99.27	-46.89	-98.82	-24.40	-37.82	20.38	-37.36	-85.37	64.77	-43.44
KD_GENERAL_TRANSCRIPTION_FACTORS_GROUP_1	PCL	General transcription factors group 1 LOF				11.11, 11.11		-39.06	-61.25	89.63	65.71	32.04	NaN	-56.40	99.95	40.36	-25.51
KD_GENERAL_TRANSCRIPTION_FACTORS_GROUP_2	PCL	General transcription factors group 2 LOF				0.00, 0.00		-48.95	35.37	-22.05	-41.78	-36.24	-99.71	-99.88	57.92	-99.96	-62.18
KD_HEAT_SHOCK_70KDA_PROTEINS	PCL	Heat shock 70kDa proteins LOF				0.00, 0.00		-93.79	NaN	-31.04	NaN	-34.51	NaN	-97.34	-63.84	63.10	-89.39
KD_HISTONE_DEACETYLASES	PCL	Histone deacetylases LOF				20.00, 20.00		-68.99	99.80	99.13	-70.32	-79.58	24.40	61.96	-31.47	-70.06	-27.34
KD_HOXL_SUBCLASS_HOMEOBOXES	PCL	HOXL subclass homeoboxes LOF				0.00, 0.00		-99.58	-99.52	-13.89	-25.42	94.37	-20.70	-93.35	-52.14	-95.58	-59.54
KD_IL4_PATHWAY	PCL	IL4 Pathway LOF				0.00, 0.00		-51.44	-35.78	-6.37	-31.08	53.11	-43.03	-100.00	-71.55	-29.33	-34.57
KD_INTEGRIN_SUBUNITS_ALPHA	PCL	Integrin subunits alpha LOF				0.00, 0.00		-49.56	35.58	-61.32	-44.79	-54.66	NaN	-24.79	27.58	80.19	-21.08
KD_INTEGRIN_SUBUNITS_BETA	PCL	Integrin subunits beta LOF				57.14, 57.14		-65.57	NaN	99.70	NaN	42.36	NaN	99.18	99.48	56.01	99.17
KD_INTERLEUKIN_RECEPTORS	PCL	Interleukin receptors LOF				0.00, 0.00		-88.51	-37.57	-76.24	-37.02	-97.00	-99.93	18.90	-20.88	53.46	-62.43
KD_KRUPPEL_LIKE_TRANSCRIPTION_FACTORS	PCL	Kruppel like transcription factors LOF				0.00, 0.00		-80.89	-82.37	53.22	30.60	77.88	-29.50	-100.00	18.15	-48.16	-70.96
KD_LYSINE_ACETYLTRANSFERASES	PCL	Lysine acetyltransferases LOF				0.00, 0.00		-98.60	-99.74	-93.23	-91.34	24.16	-98.53	-51.63	-99.18	-99.66	-99.75
KD_MCM_FAMILY	PCL	MCM family LOF				0.00, 0.00		-17.14	-54.77	-17.36	56.74	27.36	26.55	-12.68	15.15	NaN	6.16
KD_MEDIATOR_COMPLEX	PCL	Mediator complex LOF				10.00, 0.00		-68.60	65.90	-19.05	39.43	27.60	-87.69	96.04	-93.48	61.66	-24.24
KD_MINOR_HISTOCOMPATIBILITY_ANTIGENS	PCL	Minor histocompatibility antigens LOF				10.00, 10.00		52.99	-98.76	-98.99	-93.89	98.36	-100.00	-93.51	-64.20	-98.87	-99.86
KD_MITOCHONDRIAL_COMPLEX_IV	PCL	Mitochondrial complex IV LOF				0.00, 0.00		-99.70	NaN	57.71	NaN	69.23	NaN	-99.73	41.25	-33.95	-93.03
KD_MITOGEN_ACTIVATED_PROTEIN_KINASES	PCL	Mitogen activated protein kinases LOF				10.00, 10.00		-53.57	99.69	11.92	-26.21	29.12	30.89	71.52	55.46	-15.90	6.52
KD_NADH_UBIQUINONE_OXIDOREDUCTASE_SUPERNUMERARY_SUBUNITS	PCL	NADH ubiquinone oxidoreductase supernumerary subunits LOF				33.33, 33.33		36.80	99.96	40.92	86.99	-46.88	NaN	6.17	99.98	92.98	97.52
KD_NKL_SUBCLASS_HOMEOBOXES_AND_PSEUDOGENES	PCL	NKL subclass homeoboxes and pseudogenes LOF				0.00, 0.00		-44.68	-90.17	22.15	-35.71	-99.92	58.18	-17.12	-73.76	NaN	-26.10
KD_NON_HOMOLOGOUS_END_JOINING	PCL	Non Homologous End Joining LOF				20.00, 0.00		45.95	64.24	90.40	6.31	96.36	63.05	17.25	95.08	5.22	85.07
KD_NUCLEOPORIN	PCL	Nucleoporin LOF				10.00, 10.00		88.41	-52.62	-50.17	-94.77	-99.88	-89.66	-77.58	-10.49	97.55	-96.02
KD_PHOSPHOLIPASES	PCL	Phospholipases LOF				40.00, 40.00		85.10	100.00	90.55	99.11	99.08	71.33	-48.27	69.42	-80.28	98.44
KD_PI3K_SIGNALING	PCL	PI3K Signaling LOF				0.00, 0.00		-56.42	-69.07	47.69	67.16	16.28	43.71	-46.94	36.53	93.85	-38.44
KD_POLY_ADP_RIBOSE_POLYMERASES	PCL	Poly ADP ribose polymerases LOF				0.00, 0.00		-23.95	NaN	-47.83	-91.87	-100.00	NaN	-24.94	-92.90	-71.84	-97.63
KD_PRD_CLASS_HOMEOBOXES_AND_PSUDOGENES	PCL	PRD class homeoboxes and psudogenes LOF				30.00, 20.00		94.90	-37.81	91.98	43.62	95.73	98.24	-6.14	26.32	8.30	97.86
KD_PROTEASOME_PATHWAY	PCL	Proteasome Pathway LOF				0.00, 0.00		-98.20	-99.96	-89.98	24.95	-53.27	-39.39	-95.34	-99.56	34.93	-99.64
KD_PROTEIN_PHOSPHATASE_CATALYTIC_SUBUNITS	PCL	Protein phosphatase catalytic subunits LOF				0.00, 0.00		-15.58	-70.67	-19.03	-49.23	-44.96	50.34	23.78	-99.58	-99.97	-33.21
KD_RHO_GTPASE_ACTIVATING_PROTEINS	PCL	Rho GTPase activating proteins LOF				0.00, 0.00		-94.37	NaN	-29.61	-76.95	-31.04	NaN	-38.49	-98.76	25.31	-92.07
KD_RIBOSOMAL_40S_SUBUNIT	PCL	Ribosomal 40s Subunit LOF				0.00, 0.00		-84.19	14.29	-92.65	-38.82	-29.77	-38.79	-99.69	-94.09	-73.71	-99.12
KD_RNA_POLYMERASE_ENZYMES	PCL	RNA Polymerase Enzymes LOF				0.00, 0.00		61.66	69.86	-18.84	15.97	11.65	18.64	-43.45	-44.45	-39.64	-14.53
KD_S100_CALCIUM_BINDING_PROTEINS	PCL	S100 calcium binding proteins LOF				50.00, 40.00		99.62	57.81	94.79	99.96	89.31	-71.61	5.10	99.98	95.84	100.00
KD_SERPIN_PEPTIDASE_INHIBITORS	PCL	Serpin peptidase inhibitors LOF				0.00, 0.00		27.13	23.62	40.21	45.40	49.25	66.97	24.65	61.53	39.18	35.07
KD_SMAD_FAMILY	PCL	SMAD family LOF				0.00, 0.00		-16.76	52.85	-10.73	-23.60	-24.22	-29.69	-15.89	-24.30	74.71	10.19
KD_SRY_SEX_DETERMINING_REGION_Y_BOXES	PCL	SRY LOF				0.00, 0.00		-38.91	-28.23	-39.51	-17.65	17.45	-49.03	36.28	46.28	24.63	-2.09
KD_STRUCTURAL_MAINTENANCE_OF_CHROMOSOMES_PROTEINS	PCL	Structural maintenance of chromosomes proteins LOF				0.00, 0.00		-83.78	-30.67	-92.73	-81.15	-76.13	-75.12	-94.98	-93.41	76.47	-73.04
KD_TOLL_LIKE_RECEPTORS	PCL	Toll like receptors LOF				20.00, 10.00		17.01	-16.43	-24.19	53.43	96.18	78.00	21.92	-17.38	99.06	12.94
KD_TRACE_AMINE_RECEPTORS	PCL	Trace amine receptors LOF				11.11, 11.11		-23.39	-5.67	30.18	30.62	36.59	98.30	NaN	39.30	-6.92	14.00
KD_TUMOR_NECROSIS_FACTOR_SUPERFAMILY	PCL	Tumor necrosis factor superfamily LOF				0.00, 0.00		-96.21	-99.82	-68.74	-86.85	-82.18	-69.44	-70.34	-52.47	94.62	-94.59
KD_UBIQUITIN_SPECIFIC_PEPTIDASES	PCL	Ubiquitin-specific peptidases LOF				0.00, 0.00		-98.09	-27.72	-91.58	-96.11	-31.09	-42.91	-27.08	-95.69	-99.93	-96.96
KD_V_TYPE_ATPASES	PCL	V type ATPases LOF				0.00, 0.00		-46.80	-34.21	-56.80	-76.56	-27.64	-99.35	-93.66	-69.06	-99.21	-95.60
KD_VESICULAR_TRANSPORT	PCL	Vesicular Transport LOF				0.00, 0.00		-91.73	-98.37	-87.33	-99.64	-52.46	-99.54	-98.09	-60.56	-99.99	-99.48
KD_WNT_FAMILY	PCL	Wnt family LOF				10.00, 0.00		80.35	41.09	50.09	71.99	-53.99	83.22	91.81	96.90	92.93	90.73
KD_XLMR_GROUP_1	PCL	X linked mental retardation group 1 LOF				22.22, 22.22		100.00	97.93	-99.74	-99.47	-39.02	NaN	-14.48	-59.96	-99.47	-43.33
KD_XLMR_GROUP_2	PCL	X linked mental retardation group 2 LOF				10.00, 10.00		48.22	-42.49	86.78	-32.44	33.55	99.50	80.41	-32.91	92.91	51.74
KD_ZINC_FINGERS_RANBP2_TYPE	PCL	Zinc fingers RanBP2 type LOF				0.00, 0.00		-99.99	76.62	-50.88	-89.01	24.44	87.76	-18.74	-94.94	-17.95	-99.97
OE_AKT_SIGNALING	PCL	Akt Signaling GOF				30.00, 30.00		-96.65	44.20	31.45	100.00	99.95	57.33	99.66	-92.70	59.27	83.40
OE_CELL_CYCLE_INHIBITION	PCL	Cell Cycle Inhibition GOF				0.00, 0.00		-98.29	-98.24	-99.85	-99.96	-99.41	-99.93	-99.62	-99.96	-99.90	-99.98
OE_FOS_TRANSCRIPTION_FACTOR_FAMILY	PCL	FOS transcription factor family GOF				10.00, 10.00		-99.90	-81.41	-93.46	9.36	-58.40	50.32	-73.13	-96.50	98.83	-77.05
OE_GPCR_SUBSET	PCL	GPCR Subset GOF				40.00, 40.00		100.00	-94.42	-55.17	-37.72	99.84	-38.31	-29.20	57.75	99.69	99.78
OE_HOMEOBOX_GENE	PCL	Homeobox Gene GOF				0.00, 0.00		-98.34	-99.83	-97.53	46.88	-97.27	-95.99	73.19	-99.93	88.06	-99.68
OE_INTERLEUKINS	PCL	Interleukins GOF				20.00, 20.00		34.48	-64.37	55.56	-57.12	-29.34	-62.49	94.38	97.50	-24.45	99.31
OE_LIM_CLASS_HOMEOBOXES	PCL	LIM class homeoboxes GOF				0.00, 0.00		38.68	-55.26	-61.08	27.21	-46.07	-92.10	-59.54	-99.88	-48.18	-86.05
OE_LIPOCALINS	PCL	Lipocalins GOF				11.11, 0.00		96.78	93.56	9.20	NaN	-99.78	32.61	37.22	62.79	-34.86	-20.64
OE_NADH_UBIQUINONE_OXIDOREDUCTASE_CORE_SUBUNITS	PCL	NADH ubiquinone oxidoreductase core subunits GOF				0.00, 0.00		54.92	NaN	-56.57	-86.08	-99.36	-98.70	63.16	-57.01	30.84	-92.14
OE_NFKB_ACTIVATION	PCL	NFKB Activation GOF				0.00, 0.00		-45.03	-96.88	-62.02	-60.08	-99.57	-99.79	-97.38	-94.98	-76.19	-99.23
OE_PHOSPHOLIPASES	PCL	Phospholipases GOF				10.00, 0.00		96.93	-16.66	-42.70	-98.25	-37.35	-28.24	-71.30	60.31	-79.50	-14.40
OE_PURINERGIC_RECEPTORS_P2Y	PCL	Purinergic receptors P2Y GOF				10.00, 0.00		95.84	-47.20	91.08	66.56	-74.41	-99.35	-98.82	-89.82	-99.99	-87.59
OE_SERINE_PROTEASES	PCL	Serine proteases GOF				0.00, 0.00		-72.77	-83.48	-97.65	-92.93	-61.20	-92.95	-88.86	-68.23	9.74	-89.18
OE_SIRTUINS	PCL	Sirtuins GOF				20.00, 10.00		96.00	99.45	28.92	-9.91	92.29	-18.92	46.43	-17.14	82.46	73.75
OE_SUPRESSORS_OF_CYTOKINE_SIGNALING	PCL	Supressors of cytokine signaling GOF				10.00, 10.00		-47.57	98.00	10.28	-82.95	29.24	47.83	12.68	-43.65	-69.56	-2.65
OE_TARGETS_OF_VEGFR_INHIBITORS	PCL	Targets of VEGFR inhibitors GOF				22.22, 11.11		-39.94	-89.95	97.38	NaN	-82.02	58.22	99.16	-32.10	-98.41	-61.26
OE_WNT_FAMILY	PCL	Wnt family GOF				0.00, 0.00		19.57	39.94	-18.79	-77.55	-41.28	-72.13	-63.15	-66.09	47.72	-36.78
KD_C2_DOMAIN_CONTAINING	PCL	C2 domain containing LOF				0.00, 0.00		NaN	NaN	-95.91	-100.00	-78.98	-76.44	-99.91	-99.99	-99.88	-100.00
